<SEC-DOCUMENT>0001178913-23-001275.txt : 20230331
<SEC-HEADER>0001178913-23-001275.hdr.sgml : 20230331
<ACCEPTANCE-DATETIME>20230331163217
ACCESSION NUMBER:		0001178913-23-001275
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230331
DATE AS OF CHANGE:		20230331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36848
		FILM NUMBER:		23788394

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>zk2329433.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:chek="http://check-cap.com/20221231"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Check-Cap Ltd - 1610590 - 2023</title></head><body><div style="font-size: 10pt;"><div style="font-size: 10pt;"><div style="font-size: 10pt;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20220101to20221231"  id="Fdei_EntityCentralIndexKey20220110140253530" >0001610590</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20220101to20221231"  id="Fdei_AmendmentFlag20220110140258433" >false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20220101to20221231"  id="Fdei_DocumentFiscalPeriodFocus20220110140316782" >FY</ix:nonNumeric><ix:footnote id="FN20230326072614795_263" xml:lang="en-US">As of December 31, 2022, all the outstanding options in the amount of 191,892 with an average exercise price $35.35 are out of the money. </ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="chek-20221231.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-01-26</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-26</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-01-25</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-25</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200401to20200531"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220302to20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-02</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211223_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221123to20221123"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-11-23</xbrli:startDate>
        <xbrli:endDate>2022-11-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221123"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-11-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220811to20220811"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-08-11</xbrli:startDate>
        <xbrli:endDate>2022-08-11</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:DesignerRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:DesignerRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:PredecessorUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:PredecessorUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220131_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230223_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2014-07-13</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:NonExecutiveDirectorsCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekGeneralTransactionsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:GeneralTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200801to20200805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-08-01</xbrli:startDate>
        <xbrli:endDate>2020-08-05</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-08-01</xbrli:startDate>
        <xbrli:endDate>2020-08-05</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201201to20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:SeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-10</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:SeniorManagementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-10</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate1Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate3Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate4Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate5Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate5Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate6Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate7Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate8Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate9Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate9Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate10Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate10Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate17Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate17Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate17Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate13Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate13Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate13Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210901to20210920_srtTitleOfIndividualAxis_chekVpClinicalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:VpClinicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-09-01</xbrli:startDate>
        <xbrli:endDate>2021-09-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210920_srtTitleOfIndividualAxis_chekVpClinicalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:VpClinicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-09-20</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekTwentyTwoJuneMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:TwentyTwoJuneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-09</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-12-01</xbrli:startDate>
        <xbrli:endDate>2021-12-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220127_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230104_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-01-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221201to20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-12-01</xbrli:startDate>
        <xbrli:endDate>2022-12-29</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-29</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210801to20210805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-08-01</xbrli:startDate>
        <xbrli:endDate>2021-08-05</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapAwardDateAxis_chekGrantDate11Member"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficersChiefExecutiveOfficerAndBoardMembersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-02</xbrli:startDate>
        <xbrli:endDate>2022-03-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficersChiefExecutiveOfficerAndBoardMembersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-02</xbrli:startDate>
        <xbrli:endDate>2022-03-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-02</xbrli:startDate>
        <xbrli:endDate>2022-03-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-02</xbrli:startDate>
        <xbrli:endDate>2022-03-21</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220321"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-21</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200101to20201231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">chek:DevelopmentAreaAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-22</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">chek:RestOfCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2016-12-01</xbrli:startDate>
        <xbrli:endDate>2016-12-22</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapForeignCountryMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_deiLegalEntityAxis_chekCheckCapUsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">chek:CheckCapUsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_deiLegalEntityAxis_chekCheckCapUsIncMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">chek:CheckCapUsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20100501to20100511_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2010-05-01</xbrli:startDate>
        <xbrli:endDate>2010-05-11</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190101to20191231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180101to20181231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200501to20200511_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-11</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-24</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2015-02-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2015-02-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2015-02-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-24</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2015-02-24</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-02-01</xbrli:startDate>
        <xbrli:endDate>2015-02-24</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150301to20150306_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:UnderwriterWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-03-01</xbrli:startDate>
        <xbrli:endDate>2015-03-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150401to20150406_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-04-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2014-08-20</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2014-08-01</xbrli:startDate>
        <xbrli:endDate>2014-08-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:UnderwriterWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LegalWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LegalWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-11</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2016-08-11</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2017-01-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20170101to20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-05-08</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-05-08</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180508_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesCWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-05-08</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapCommonClassCMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-05-08</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-02-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-02-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-02-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-04-22</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-05-04</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-05-13</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-22</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-04</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-13</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210301to20210318_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-18</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesDWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-02-06</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2014-08-01</xbrli:startDate>
        <xbrli:endDate>2014-08-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2014-08-01</xbrli:startDate>
        <xbrli:endDate>2014-08-20</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2017-06-01</xbrli:startDate>
        <xbrli:endDate>2017-06-02</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2017-06-02</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2017-11-01</xbrli:startDate>
        <xbrli:endDate>2017-11-22</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2017-11-22</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2018-04-25</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200727_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-08</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_chekPreFundedUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-08</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsToPurchaseOrdinarySharesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesCWarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2019-12-19</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200727_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-27</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210331_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200723_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200701to20200723_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-23</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20150401to20150406_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-04-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapOtherCommitmentsAxis_chekWarrantAmendmentAgreementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:WarrantAmendmentAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210601to20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190201to20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220202to20220301_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-02-02</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-23</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20141001to20141014_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-10-14</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsOneMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-06</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200727_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20200727_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-07-27</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610590</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="Euro"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Percent"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="Squaremeters"><xbrli:measure>utr:sqm</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_Per_Euro"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="USD_Per_unit"><xbrli:measure>chek:USD_Per_unit</xbrli:measure></xbrli:unit>
<xbrli:unit id="US_cents_Per_unit"><xbrli:measure>chek:US_cents_Per_unit</xbrli:measure></xbrli:unit>
<xbrli:unit id="Unit"><xbrli:measure>chek:Unit</xbrli:measure></xbrli:unit>
<xbrli:unit id="Usd_per_share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="F20230326072614626_125" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="F20230326072614638_133" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="F20230326072614645_137" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143351049_20230326072614626_125" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143351121_20230326072614638_133" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143351150_20230326072614645_137" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143354706_20230326072614626_125" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143354740_20230326072614638_133" toRefs="FN20230326072614795_263"/><ix:relationship fromRefs="Fxbrl_20220110143354757_20230326072614645_137" toRefs="FN20230326072614795_263"/></ix:resources></ix:header></div><div>
  <div>
    <div>
      <div>
        <div>
          <div>
            <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>
              </div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">UNITED STATES</span></span></div>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">SECURITIES AND EXCHANGE COMMISSION</span></span></div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Washington, D.C. 20549</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:14pt"><span style="font-family:Times New Roman,Times,serif">FORM <ix:nonNumeric id="Fxbrl_20220110112754448" name="dei:DocumentType" contextRef="C_20220101to20221231">20-F</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:7.3pt">&#160;</td>
                <td style="width:23.7pt;vertical-align:top;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110220558257" name="dei:DocumentRegistrationStatement" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
          <div style="line-height:1.25">
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:7.3pt">&#160;</td>
                  <td style="width:23.7pt;vertical-align:top;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220405010018911" name="dei:DocumentAnnualReport" contextRef="C_20220101to20221231" format="ixt:fixed-true">&#9746;</ix:nonNumeric></span></span></td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
          </div>
          <div style="margin-left:31pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the fiscal year ended <ix:nonNumeric id="Fxbrl_20230304203327546" name="dei:DocumentPeriodEndDate" contextRef="C_20220101to20221231" format="ixt:date-monthname-day-year-en"><ix:nonNumeric id="Fxbrl_20230304203402324" name="dei:CurrentFiscalYearEndDate" contextRef="C_20220101to20221231" format="ixt:date-monthname-day-en">December 31</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230304203448951" name="dei:DocumentFiscalYearFocus" contextRef="C_20220101to20221231">2022</ix:nonNumeric></ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:7.35pt">&#160;</td>
                <td style="width:23.1pt;vertical-align:top;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110112827095" name="dei:DocumentTransitionReport" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">OR</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:7.35pt">&#160;</td>
                <td style="width:22.65pt;vertical-align:top;font-family:'Segoe UI Symbol', sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110112831064" name="dei:DocumentShellCompanyReport" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:30pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">for the transition period from _______ to _______</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commission file number <ix:nonNumeric id="Fxbrl_20220111112239172" name="dei:EntityFileNumber" contextRef="C_20220101to20221231">001-36848</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:16pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113004755" name="dei:EntityRegistrantName" contextRef="C_20220101to20221231">Check-Cap Ltd.</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:400;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none">
            <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:30%;color:#000000;text-align:center;text-align:center" />
          </div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Exact name of the Registrant as specified in its charter)</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113025339" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20220101to20221231" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:400">
            <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:30%;color:#000000;text-align:center;text-align:center" />
          </div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Jurisdiction of incorporation or organization) </span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113044188" name="dei:EntityAddressAddressLine1" contextRef="C_20220101to20221231">Check-Cap Building</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113053886" name="dei:EntityAddressAddressLine2" contextRef="C_20220101to20221231">29 Abba Hushi Avenue</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113058527" name="dei:EntityAddressAddressLine3" contextRef="C_20220101to20221231">P.O. Box 1271</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113102150" name="dei:EntityAddressCityOrTown" contextRef="C_20220101to20221231">Isfiya</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220110113106830" name="dei:EntityAddressPostalZipCode" contextRef="C_20220101to20221231">3009000</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220110113111117" name="dei:EntityAddressCountry" contextRef="C_20220101to20221231" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25;font-weight:bold">
            <hr style="background-color:#000000;border-bottom:medium none;border-left:medium none;border-right:medium none;border-top:medium none;margin:0px auto;height:2px;width:30%;color:#000000;text-align:center" />
          </div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Address of principal executive offices)</span></span></div>
          <div style="text-align:center;line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113523373" name="dei:ContactPersonnelName" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Alex Ovadia</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chief Executive Officer</span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113437511" name="dei:EntityAddressAddressLine1" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">29 Abba Hushi Avenue</ix:nonNumeric></span></span></div>
          <div style="text-align:center;text-indent:11.1pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110113453015" name="dei:EntityAddressAddressLine2" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">P.O. Box 1271</ix:nonNumeric>&#160;<ix:nonNumeric id="Fxbrl_20220110113459773" name="dei:EntityAddressCityOrTown" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Isfiya</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220110113508757" name="dei:EntityAddressPostalZipCode" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">3009000</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20220110113516510" name="dei:EntityAddressCountry" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Telephone: +<ix:nonNumeric id="Fxbrl_20220110113605014" name="dei:CityAreaCode" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">972</ix:nonNumeric>&#160;<ix:nonNumeric id="Fxbrl_20220110113610333" name="dei:LocalPhoneNumber" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">546706451</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Email: <ix:nonNumeric id="Fxbrl_20220110113627845" name="dei:ContactPersonnelEmailAddress" contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">Alex.Ovadia@check-cap.com</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></span></div>
          <div style="text-align:center;line-height:1.25">&#160;</div>
          <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

              <tr>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Title of each class</span></span></div>
                </td>
                <td style="width:33.33%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trading Symbol(s)</span></span></div>
                </td>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Name of each exchange on which registered</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline"><ix:nonNumeric id="Fxbrl_20220110113751747" name="dei:Security12bTitle" contextRef="C_20220101to20221231">Ordinary Shares</ix:nonNumeric>, par value NIS 48.00</span></span></span></div>
                </td>
                <td style="width:33.33%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline"><ix:nonNumeric id="Fxbrl_20220110113759016" name="dei:TradingSymbol" contextRef="C_20220101to20221231">CHEK</ix:nonNumeric></span></span></span></div>
                </td>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;margin-right:37.65pt;margin-left:45pt;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline"><ix:nonNumeric id="Fxbrl_20220110113803150" name="dei:SecurityExchangeName" contextRef="C_20220101to20221231" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</span></span></span></div>
                </td>
              </tr>
              <tr>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Warrants to purchase Ordinary Shares</span></span></span></div>
                </td>
                <td style="width:33.33%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">CHEKZ</span></span></span></div>
                </td>
                <td style="width:33.34%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman', Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Nasdaq Capital Market</span></span></span></div>
                </td>
              </tr>
              <tr>
                <td style="width:33.34%;vertical-align:top">&#160;</td>
                <td style="width:33.33%;vertical-align:top">&#160;</td>
                <td style="width:33.34%;vertical-align:top">&#160;</td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities registered or to be registered pursuant to Section 12(g) of the Act:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">None</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;margin-right:150.65pt;margin-left:150.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, the registrant had <ix:nonFraction id="Fxbrl_20220110113930779" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,844,463</ix:nonFraction> ordinary shares outstanding, NIS 48.00 par value per share.</span></span></div>
          <div style="margin-left:7.35pt;line-height:1.25;font-weight:bold">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;</span>&#160;<ix:nonNumeric id="Fxbrl_20220110114044302" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_20220101to20221231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes&#160;<span>&#9744;</span>&#160;<ix:nonNumeric id="Fxbrl_20220110114049951" name="dei:EntityVoluntaryFilers" contextRef="C_20220101to20221231">No</ix:nonNumeric>&#160;<span>&#9746;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110114055200" name="dei:EntityCurrentReportingStatus" contextRef="C_20220101to20221231">Yes</ix:nonNumeric>&#160;<span>&#9746;</span> No <span>&#9744;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-indent:-0.05pt;margin-left:7.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220110114059372" name="dei:EntityInteractiveDataCurrent" contextRef="C_20220101to20221231">Yes</ix:nonNumeric>&#160;<span>&#9746;</span> No <span>&#9744;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div>
              <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td rowspan="1" style="width:25%;vertical-align:top;font-family:'Segoe UI Symbol',sans-serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9744; <span>Large Accelerated filer</span>&#160;</span></span></td>
                    <td style="width:25%;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744; </span>Accelerated filer </span></span></td>
                    <td style="width:25%;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9746; </span><ix:nonNumeric id="Fxbrl_20220405010417258" name="dei:EntityFilerCategory" contextRef="C_20220101to20221231" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric>&#160;</span></span></td>
                    <td style="width:25%;vertical-align:top;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="Fxbrl_20220110114407643" name="dei:EntityEmergingGrowthCompany" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric>&#160;</span>Emerging growth company</span></span></td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. <span>&#9744;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span><ix:nonNumeric id="Fxbrl_20220406182733027" name="dei:IcfrAuditorAttestationFlag" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9744;</ix:nonNumeric></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <span>&#9744;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <span>&#9744;</span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:21.16%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9746; </span><ix:nonNumeric id="Fxbrl_20220110114457450" name="dei:DocumentAccountingStandard" contextRef="C_20220101to20221231">U.S. GAAP</ix:nonNumeric></span></span></div>
                </td>
                <td style="width:52.17%;vertical-align:top">
                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744; </span>International Financial Reporting</span></span></div>
                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Standards as issued by the International Accounting Standards Board</span></span></div>
                </td>
                <td style="width:26.67%;vertical-align:top">
                  <div style="text-indent:-13.1pt;margin-left:20.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#9744;</span> Other</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td rowspan="1" style="width:239.7pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#9744; <span>Item 17</span>&#160;<span>&#9744; </span>Item 18</span></span></td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes <span>&#9744;</span> No <span><ix:nonNumeric id="Fxbrl_20220110114514834" name="dei:EntityShellCompany" contextRef="C_20220101to20221231" format="ixt:fixed-false">&#9746;</ix:nonNumeric></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-left:7.4pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of the securities under a plan confirmed by a court.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Yes <span>&#9744;</span> No <span>&#9744;</span></span></span></div>
        </div>
      </div>
      <div style="text-align:center">
        <div style="text-align:center;line-height:1.25">
          <div style="text-align:center;line-height:1.25">
            <div>&#160;</div>
            <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
              <div style="page-break-after:always">
                <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>

  <div>
    <!-- Field: Include-Text; File: PF\body.htm; Date: 2023%2D03%2D31T14:36:29; Size: 0x00163D46; Options: XMLPreprocess -->
<div><br /> <br />

<div style="text-align: center; margin-left: 6.35pt; line-height: 1.25; font-weight: bold">TABLE OF CONTENTS</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="2" border="0" id="z8402ed56daa14837b3441c7e2d34b660" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTI">Part I</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">&#160;</td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25; font-weight: bold">Page</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM1">Item 1.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM1">Identity of Directors,
        Senior Management and Advisers</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Directors and Senior Management</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Advisers</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Auditors</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM2">Item 2.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM2">Offer Statistics and
        Expected Timetable</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM3">Item 3.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM3">Key Information</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">[Reserved.]</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Capitalization and Indebtedness</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Reasons for the Offer and Use of Proceeds</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Risk factors</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">3</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM4">Item 4.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM4">Information on our Company</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">25<br /> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">History and Development of the Company</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">25</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Business Overview</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">25</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Organizational Structure</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">44</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Property, Plants and Equipment</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">44</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM4A">Item 4A.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM4A">Unresolved Staff Comments</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">44</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM5">Item 5.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM5">Operating and Financial
        Review and Prospects</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">44</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Operating Results</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">45</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Liquidity and Capital Resources</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">48</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Research and development, patents and
        licenses, etc.</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">50</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Trend Information</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">50</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">E.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Critical Accounting Estimates</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">50</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM6">Item 6.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM6">Directors, Senior Management
        and Employees</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">51</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Directors and senior management</div>
        </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">51<br /> </div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Compensation of Directors and Executive
        Officers</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">53</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.3pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Board Practices</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">55</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Employees</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">61</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; margin-left: 27pt">E.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Share Ownership</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">63</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; margin-left: 27pt">F.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.55pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Disclosure of a Registrant&#8217;s Action
        to Recover Erroneously Awarded Compensation</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">63</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM7">Item 7.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM7">Major Shareholders and
        Related Party Transactions</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">63</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Major shareholders</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">63</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Related Party Transactions</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">64</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Interests of Experts and Counsel</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">64</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM8">Item 8.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM8">Financial Information</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">65</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Consolidated Statements and Other Financial
        Information</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.25pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Significant Changes</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM9">Item 9.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM9">The Offer and Listing</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Offer and Listing Details</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Plan of Distribution</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Markets for Ordinary Shares</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Selling Shareholders</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">E.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Dilution</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">F.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Expenses of the Issue</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM10">Item 10.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM10">Additional Information</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">A.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Share Capital</div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">65</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">B.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Memorandum and Articles of Association</div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">65</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">C.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Material Contracts</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">66</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">D.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Exchange controls</div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">66</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">E.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Taxation</div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">66</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">F.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Dividends and paying agents</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">74</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">G.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Statement by experts</div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">74</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">H.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Documents on display</div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">74</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; margin-left: 27pt">I.</div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif">Subsidiary Information</div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">74</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM11">Item 11.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM11">Quantitative and Qualitative
        Disclosure About Market Risk</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">74</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM12">Item 12.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM12">Description of Securities
        Other Than Equity Securities</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">74</td> </tr>
  </table>

<div><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div><br /> </div>

<table cellspacing="0" cellpadding="2" border="0" style="font: 10pt Times New Roman,Times,serif; width: 100%; text-align: left; color: rgb(0, 0, 0)">
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTII">Part II</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">&#160;</td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">&#160;</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM13">Item 13.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM13">Defaults, Dividend Arrearages
        and Delinquencies</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM14">Item 14.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM14">Material Modifications
        to the Rights of Security Holders and Use of Proceeds</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM15">Item 15.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM15">Controls and Procedures</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">75<br /> </div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16">Item 16.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16">[Reserved]</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16A">Item 16A.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16A">Audit Committee Financial
        Expert</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16B">Item 16B.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16B">Code of Ethics</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16C">Item 16C.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16C">Principal Accountant
        Fees and Services</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16D">Item 16D.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16D">Exemptions from the
        Listing Standards for Audit Committees</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16E">Item 16E.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16E">Purchases of Equity
        Securities by the Issuer and Affiliated Purchasers</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">75</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16F">Item 16F.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16F">Change in Registrant&#8217;s
        Certifying Accountant</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">76</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16G">Item 16G.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16G">Corporate governance</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">76</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16H">Item 16H.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16H">Mine Safety Disclosure</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">76</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16I">Item 16I.</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM16I">Disclosure Regarding
        Foreign Jurisdictions that Prevent Inspections</a></div> </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">76</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#PARTIII">Part III</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">&#160;</td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">&#160;</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM17">Item 17.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM17">Financial Statements</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top; text-align: right">77</td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM18">Item 18.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM18">Financial Statements</a></div>
        </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">77</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM19">Item 19.</a></div> </td>
    <td style="width: 74.96%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#ITEM19">Exhibits</a></div> </td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">77</div> </td> </tr>
  <tr>
    <td style="width: 13.08%; vertical-align: top">
        <div style="margin-right: 2.4pt; line-height: 1.25; font-family: Times New Roman, Times, serif"><a href="#SIGNATURES">Signatures</a></div>
        </td>
    <td style="width: 74.96%; vertical-align: top">&#160;</td>
    <td style="width: 11.95%; vertical-align: top">
        <div style="text-align: right; line-height: 1.25">79</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">CERTAIN INFORMATION</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Unless otherwise stated, all of our financial information
presented in this annual report has been prepared in accordance with generally accepted accounting principles in the United States of
America, or U.S. GAAP.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In this Annual Report on Form 20-F, or the Annual
Report, unless the context indicates otherwise, references to &#8220;NIS&#8221; are to the legal currency of Israel, &#8220;U.S. dollars,&#8221;
&#8220;$&#8221; or &#8220;dollars&#8221; are to United States dollars, and the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221;
&#8220;our,&#8221; and &#8220;Check-Cap&#8221; refer to Check-Cap Ltd. Unless otherwise indicated, U.S. dollar translation of NIS amounts
presented in this Annual Report are translated using the rate of $1.00 = NIS 3.519, the exchange rate published by the Bank of Israel
on December 30, 2022, and U.S. dollar translation of Euro amounts presented in this Annual Report are translated using the rate of $1.00
= Euro 0.938, based on the exchange rates published by the Bank of Israel on December 30, 2022.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We effected a 1-for-20 reverse share split of our
Ordinary Shares, effective as of November 23, 2022, in accordance with the approval of our shareholders at a meeting held on August 11,
2022. All share numbers in this Annual Report are reflected on a post-reverse stock split basis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">USE OF TRADE NAMES
AND TRADEMARKS</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Throughout this Annual Report, we refer to various
trademarks, service marks and trade names that we use in our business. The &#8220;CHECK-CAP&#8221; and &#8220;C-Scan&#8221; trademarks
and design logos are the property of Check-Cap Ltd. Other trademarks and service marks appearing in this Annual Report are the property
of their respective holders. We do not intend our use or display of other companies&#8217; tradenames, trademarks or service marks to
imply a relationship with, or endorsement or sponsorship of us by these other companies. Solely for convenience, trademarks and trade
names referred to in this Annual Report appear without the &#174; or TM symbols, but such references are not intended to indicate, in
any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these
trademarks and trade names.</div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>
<!--PROfilePageNumberReset%Num%2%%%-->

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">FORWARD-LOOKING STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This Annual Report contains forward-looking statements,
about our expectations, beliefs or intentions regarding, among other things, our ongoing and planned product development and clinical
trials; the timing of, and our ability to make, regulatory filings and obtain and maintain regulatory approvals for our product candidates;
our intellectual property position; the degree of clinical utility of our products, particularly in specific patient populations; our
ability to develop commercial functions; expectations regarding product launch and revenue; our results of operations, cash needs; financial
condition, liquidity, prospects, growth and strategies; the industry in which we operate; and the trends that may affect the industry
or us. In addition, from time to time, we or our representatives have made or may make forward-looking statements, orally or in writing.
Forward-looking statements can be identified by the use of forward-looking words such as &#8220;believe,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;should&#8221; or &#8220;anticipate&#8221; or their negatives or other
variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current
matters. These forward-looking statements may be included in, but are not limited to, various filings made by us with the U.S. Securities
and Exchange Commission, or the SEC, press releases or oral statements made by or with the approval of one of our authorized executive
officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made.
Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and
uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking
statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated
in forward-looking statements, including, but not limited to, the factors summarized below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This Annual Report identifies important factors
which could cause our actual results to differ materially from those indicated by the forward-looking statements, particularly those set
forth under the heading &#8220;Risk Factors.&#8221; The risk factors included in this Annual Report are not necessarily all of the important
factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Given these
uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Factors that could cause our actual
results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z711a55df06d240f1823b23d2b44fb6a8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our history of losses;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z02d3487a8c94464d9072af70aa092604" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our needs for additional capital to fund our operations and our inability to obtain additional capital
        on acceptable terms, or at all;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z91faa020d24347d99df5b13a733dcca8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the initiation, timing, progress and results of our clinical trials and other product development efforts;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2a62713c59ae40e09b3a2b2176b8c11d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our reliance on one product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcd49c9c7733a42a9adf1fb15bae164d3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the clinical development, commercialization and market acceptance of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf8c13a4237d74d519e7b3e737584e851" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to receive de novo classification or premarket approval and other regulatory approvals for
        C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6d06d69f675c4cfeaba5385c4b250d1a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to successfully complete clinical trials and obtain desired performance.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z63916ceb196b49d3ba4bcbf0d57efc03" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our reliance on single-source suppliers;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6e4657d4dc2e4a2c8e6ae02a06253ae7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to achieve an acceptable cost of goods;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0caaeac418db44bb80abb23c513c6811" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our reliance on third parties, such as for purposes of our clinical trials and clinical development and
        the manufacturing, marketing and distribution of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9318eb71f72147d89037eb7a3d43e696" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to establish and maintain strategic partnerships and other corporate collaborations;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9bc086212ba04bd683b906241c50c2a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to achieve reimbursement and coverage from government and private third-party payors;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2dbafddc9cca422182ac99346a82964e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the implementation of our business model and strategic plans for our business;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0969a5d280f448eead47512e18069fbe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the scope of protection we are able to establish and maintain for intellectual property rights covering
        C-Scan and our ability to operate our business without infringing the intellectual property rights of others;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd4b0cf021e1b4f648ba32adf7e499788" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">competitive companies, technologies and our industry;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf26411b8733f4c45849d7d1636b6f151" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; font-family: Times New Roman,Times,serif">current or future unfavorable economic and market conditions
        and adverse developments with respect to financial institutions and associated liquidity risk; and</div> </div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9955404c5e084da3be2dd30e4222c3e7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">those factors referred to in &#8220;Item 3. Key Information &#8211; D. Risk Factors,&#8221; &#8220;Item
        4. Information on the Company,&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221;, as well as in this Annual
        Report generally.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">All forward-looking statements attributable to
us or persons acting on our behalf speak only as of the date of this Annual Report and are expressly qualified in their entirety by the
cautionary statements included in this Annual Report. We undertake no obligations to update or revise forward-looking statements to reflect
events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. In evaluating forward-looking
statements, you should consider these risks and uncertainties.</div>

<div class="BRPFPageHeader">

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">2</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">EXPLANATORY NOTE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Market data and certain industry data and forecasts
used throughout this Annual Report were obtained from internal company surveys, market research, consultant surveys commissioned by the
Company, publicly available information, reports of governmental agencies and industry publications and surveys. Industry surveys, publications,
consultant surveys commissioned by the Company and forecasts generally state that the information contained therein has been obtained
from sources believed to be reliable. However, this information may prove to be inaccurate because of the method by which some of the
data for the estimates is obtained or because this information cannot always be verified with complete certainty due to the limits on
the availability and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties.
As a result, the market and industry data and forecasts included or incorporated by reference in this Annual Report, and estimates and
beliefs based on that data, may not be reliable. We have relied on certain data from third-party sources, including internal surveys,
industry forecasts and market research, which we believe to be reliable based on our management&#8217;s knowledge of the industry. However,
we have not ascertained the underlying economic assumptions relied upon therein. Forecasts are particularly likely to be inaccurate, especially
over long periods of time. In addition, we do not necessarily know what assumptions regarding general economic growth were used in preparing
the forecasts we cite. Statements as to our market position are based to the best of our knowledge on the most currently available data.
While we are not aware of any misstatements regarding the industry data presented in this Annual Report, our estimates involve risks and
uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk Factors&#8221;
in this Annual Report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold"><span id="PARTI"><!--Anchor--></span>PART
I</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 1<span id="ITEM1"><!--Anchor--></span>. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT
AND ADVISERS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Directors
and Senior Management</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Advisers</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Auditors</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 2<span id="ITEM2"><!--Anchor--></span>. OFFER STATISTICS AND EXPECTED TIMETABLE</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM3"><!--Anchor--></span>ITEM 3. KEY INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">[Reserved.]</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-family: Times New Roman,Times,serif; font-weight: bold">B.</span><span style="font-weight: bold">&#160;</span>&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Capitalization and Indebtedness</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Reasons
for the Offer and Use of Proceeds</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not required.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Risk
factors</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; font-style: italic; text-align: justify; text-indent: 25.2pt">In conducting our business,
we face many risks that may interfere with our business objectives. Some of these risks could materially and adversely affect our business,
financial condition and results of operations. In particular, we are subject to various risks resulting from changing economic, political,
industry, regulatory, business and financial conditions. The risks and uncertainties described below are not the only ones we face. Additional
risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our
business operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; font-style: italic; text-align: justify; text-indent: 25.2pt">You should carefully consider
the following factors and other information in this Annual Report before you decide to invest in our ordinary shares. If any of the risks
referred to below occur, our business, financial condition and results of operations could suffer. In any such case, the trading price
of our ordinary shares could decline, and you may lose all or part of your investment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Summary Risk Factors</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our business is subject to numerous risks and uncertainties,
including those highlighted in the section titled &#8220;Risk Factors&#8221; immediately following this summary. The principal factors
and uncertainties that make investing in our ordinary shares risky, include, among others:</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Financial Position</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5b33fd1d6731472fb8f77e66a35e77f6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We have a history of losses, may incur future losses and may not achieve profitability;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8b268b81d89d45f1a38885cf032637bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25; text-align: justify">We will require additional funding in order to complete the development, scale up
        manufacturing and commercialization of C-Scan, which may cause dilution to our existing shareholders, restrict our operations or require
        us to relinquish rights to C-Scan or intellectual property. If additional capital is not available, we may have to delay, reduce or cease
        the development or commercialization of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">3</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Business</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z75399758b7b444fdba98c0cd6e81203c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: justify; line-height: 1.25; font-family: Times New Roman,Times,serif">Although we received FDA approval of our
        Investigational Device Exemption, or IDE (including our IDE amended application) for our U.S. pivotal study, the timing of the initiation
        of the second part of the U.S. pivotal study and, if commenced, the outcome of the study is inherently uncertain, even if the study is
        completed;</div> </div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1a3549f641c744dc9fb05573b19d6ceb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Clinical failure can occur at any stage of clinical development and we may not succeed in completing the
        development of our product. Our clinical experience to date does not necessarily predict future results and may not have revealed certain
        potential limitations of the technology and potential complications from C-Scan and may require further clinical validation. Any product
        version we advance through clinical trials may not have favorable results in later clinical trials or receive regulatory approval;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z45ec8c7d36634aa389233b84ff3dc6bd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We may face a number of challenges with respect to our commercialization efforts and may not succeed to
        commercialize our product, obtain required regulatory approvals or manufacture commercial quantities of C-Scan at an acceptable cost to
        enable us to generate significant revenues;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z509b083ade4b42b094d39f44b0338a60" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We expect to derive most of our revenues from sales of one product. Our inability to successfully commercialize
        this product, or any subsequent decline in demand for this product, could severely harm our ability to generate revenues.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9e99d7b1ba2d410f9c8b76690641b2a4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If healthcare professionals do not recommend our product to their patients, C-Scan may not achieve market
        acceptance and we may not become profitable;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z26609856a9f84dc29a3ea5aced409694" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We expect to face competition from large, well-established manufacturers of traditional technologies for
        CRC screening and detection of gastrointestinal disorders, as well as from new competitive technologies, especially within the field of
        biomarkers;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfe9038a5cb59403dbad5dfc6f0273189" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We may rely on local distributors and/or strategic partners to market and distribute C-Scan in those countries
        where we intend to market and distribute C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7cc40dad61994709b5e956dc20e19b48" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We have limited manufacturing capabilities and if we are unable to scale up our manufacturing operations
        to meet the necessary quantities for our upcoming clinical studies or anticipated market demand, our growth could be limited and our business,
        financial condition and results of operations could be materially adversely affected;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z576eb81ad37041bab3e8bdabe2162fe5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our reliance on sole or single source suppliers could harm our ability to conduct clinical trials and meet
        demand for our product in a timely manner or within budget;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9daca11595e24e26abb38b243d8eabd2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">A health epidemic, pandemic or other outbreak, including the current COVID-19 pandemic, may materially
        and adversely affect our business, financial condition and results of operations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6c652497e53943839721a83e0eec2155" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">We may not be successful in establishing and maintaining strategic partnerships, which could adversely
        affect our ability to develop and commercialize C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Regulations</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z49f3ee9d48ff484588a3c8e35ad8c628" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If we are unable to obtain, or experience significant delays in obtaining, FDA clearances or approvals,
        or equivalent third country approvals for C-Scan or future products or product enhancements, our ability to commercially distribute and
        market our products could suffer;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zeddc124a6d4d4ac98f2f6ef466c50cf1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">There is no guarantee that the FDA will grant a de novo classification request or PMA approval of C-Scan
        and failure to obtain necessary clearances or approvals for our future products would adversely affect our ability to grow our business;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf4dad7609c874805a879ce477f3efabc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If we or our future manufacturers or distributors do not obtain and maintain the necessary regulatory clearances
        or approvals, or equivalent third country approvals in a specific country or region, we or our future distributors will not be able to
        market and sell C-Scan or future products in that country or region;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z97fa27afee72417388cae7f123a6b047" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">The results of our current or future clinical trials may not support our product candidate requirements
        or intended use claims or may result in the discovery of adverse side effects;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zdece6bfb045046cf8ab307d3d30f4e8e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If we fail to obtain or maintain necessary regulatory clearances or CE Certificates for C-Scan or if there
        are regulatory changes in our existing or future target markets, our ability to sell C-Scan and generate revenues could be harmed;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2fadcad6e41a4b218d4bf76449b5f8f8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our failure to comply with radiation safety or radio frequency regulations in a specific country or region
        could impair our ability to conduct our clinical trials, or commercially distribute and market C-Scan in that country or region;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z982344a35cd6468899cc66bed2e0dc04" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our business is subject to complex environmental and health legislation in various jurisdictions that may
        increase our costs and our risk of noncompliance; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z518e676508f7466da4a6c805d84b332d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If we are unable to achieve reimbursement and coverage from government and private third-party payors for
        procedures using C-Scan, or if reimbursement is insufficient to create an economic benefit for purchasing or using C-Scan when compared
        to alternative procedures, demand for our products may not grow at the rate we expect.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Intellectual Property</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze31a7e63e258494a84355bf896365a7c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">If we are unable to protect our intellectual property rights, our competitive position could be harmed.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf601ea9a892d422a825c91f5d76c8361" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Third-party claims of infringement or other claims against us could require us to redesign C-Scan, seek
        licenses, or engage in future costly intellectual property litigation, which could negatively affect our future business and financial
        performance.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Our Operations in Israel</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd8e7f75a412542fcbad0500db01b8f38" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our principal offices, research and development facilities&#160; our manufacturing sites and some of our
        suppliers are located in Israel and, therefore, our business, financial condition and results of operation may be adversely affected by
        political, economic and military instability in Israel.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z410274308abb4889a94d12fa89006543" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Pursuant to the terms of the Israeli government grants we received for research and development expenditures,
        we are obligated to pay certain royalties on our revenues to the Israeli government. In addition, the terms of Israeli government grant
        we received require us to satisfy specified conditions and to make additional payments in addition to repayment of the grants upon certain
        events.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Risks Related to Ownership of our Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf086201ccae342de8439ea63c3f81bb0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our ordinary shares could be delisted from the Nasdaq Capital Market.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z60c7c880263d4cb69b4214c715eb70b9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our stock price has and may be subject to fluctuation, and purchasers of our securities could incur substantial
        losses.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zc3242d345b594c409eae6635314cc137" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Our business, operating results and growth rates may be adversely affected by current or future unfavorable
        economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">4</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.7pt; line-height: 1.25; font-weight: bold">Risks Related to Our
Financial Position</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have a history of losses, may incur future losses and may not
achieve profitability.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are a clinical and development-stage medical
diagnostics company with a limited operating history. We have incurred net losses in each fiscal year since we commenced operations in
2009. We incurred net losses of $19.1 million in 2022 and $17.2 million in 2021. As of December 31, 2022, our accumulated deficit was
$127.3 million. We expect our losses to continue for the foreseeable future as we continue our investment in research and development
and clinical trials to complete the development of our technology and to attain regulatory approvals, manufacturing scale up, begin the
commercialization efforts for C-Scan, increase our marketing and selling expenses, and incur additional costs as a result of being a public
company in the United States. Successful completion of our development program and, ultimately, the attainment of profitable operations
is dependent upon future events, including obtaining adequate financing to fulfill our development activities and our ability to manufacture
commercial quantities of C-Scan at an acceptable cost and generate significant revenues. The extent of our future operating losses and
the timing of becoming profitable are highly uncertain, and we may never achieve or sustain profitability.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We will require additional funding in order to complete the development,
scale up manufacturing and commercialization of C-Scan, which may cause dilution to our existing shareholders, restrict our operations
or require us to relinquish rights to C-Scan or intellectual property. If additional capital is not available, we may have to delay, reduce
or cease the development or commercialization of C- Scan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our operations have consumed substantial amounts
of cash. We expect that we will need to continue to raise and spend substantial amounts in order to complete the clinical development,
regulatory approval and commercialization of C-Scan. We intend to use our cash resources, including the proceeds of our March 2022 and
July 2021 registered direct offerings to finance these efforts.&#160; We recently announced the temporary postponement of the initiation
of the second part of the U.S. pivotal study that was expected in mid-2023 and that as a result, we adopted a plan of action, including
(among other things) a cost reduction plan in order to extend our cash runway to longer than initially planned, which we are in the process
of implementing. Based on such plan, we believe that we have sufficient capital to fund our ongoing operations and plans into the fourth
quarter of 2024. We will therefore need to raise additional funds to obtain the required capital prior to completing the development,
clinical trials and commercialization of C-Scan (see Item 5B &#8220;Operating and Financial Review and Prospects &#8212; Liquidity and
Capital Resources &#8212; Sources of Liquidity&#8221;). We may seek additional funding through equity offerings, debt financings, collaborations,
licensing arrangements or any other means to conduct clinical trials and develop, manufacture and market C-Scan or for our general corporate
purposes. Securing additional financing may divert our management&#8217;s attention from its day-to-day activities, which may adversely
affect our ability to develop and commercialize C-Scan. Additional financing may not be available to us on a timely basis on terms acceptable
to us, or at all. In addition, if we raise additional funds by issuing equity securities, you may experience significant dilution of your
ownership interest and the newly issued securities may have rights senior to those of the holders of our ordinary shares. In addition,
the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our ordinary shares
to decline. Alternatively, if we raise funds by obtaining loans from third parties, the terms of those financing arrangements may include
negative covenants, may require us to grant a lender a security interest in our assets or may include other restrictions on our business
that could impair our operational flexibility, and could also result in high interest expense. If we raise additional funds through collaborations,
licensing arrangements or other structured financing transactions, we may relinquish rights to certain of our technologies or products,
grant security interests in our assets or grant licenses to third parties on terms that are unfavorable to us. If adequate additional
financing on acceptable terms is not available, we may not be able to develop C-Scan at the rate or to the stage we desire, and we may
have to delay or abandon the commercialization of C-Scan. Any of these factors could materially adversely affect our business, financial
condition and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.6pt; line-height: 1.25; font-weight: bold">Risks Related to Our
Business</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Although we received FDA approval of our IDE (including our IDE
amended application) for our U.S. pivotal study, the timing of the initiation of the second part of the U.S. pivotal study and, if commenced,
the outcome of the study is inherently uncertain, even if the study is completed.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We received U.S. Food and Drug Administration,
or FDA, approval of our IDE and our IDE amended application for our planned U.S. pivotal study. While we initiated the first part of the
U.S. pivotal study in May 2022, following our internal assessment of the clinical data collected to date from our Israeli and U.S. calibration
studies, we have determined that the current efficacy results do not meet our goal in order to proceed to the powered portion of the U.S.
pivotal study and, therefore, the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 is temporarily
postponed. We have adopted a plan of action that includes conducting additional clinical data analysis and approaching the FDA to make
amendments to the U.S. pivotal study protocol that are expected to be part of an IDE supplement submission to the FDA, and which are subject
to FDA approval.&#160; There can be no assurance that the FDA would approve such an IDE supplement or that we will be able to commence
or complete the powered potion of the U.S. pivotal study. Furthermore, in the event that the FDA or any other regulatory authority requires
us to complete additional studies or we are required to satisfy other FDA or other regulatory requests, the start of the second part of
the U.S. pivotal study may be further delayed. Even after we receive and incorporate guidance from the FDA, the FDA could disagree that
we have satisfied their requirements to commence our second part of the U.S. pivotal study or change their position on the acceptability
of our planned trial design or the clinical endpoints selected, which may require us to complete additional studies or clinical trials
or impose stricter approval conditions than we currently expect. As a result of the foregoing, the research and development, preclinical
studies and clinical testing is expensive and can take years to complete, and its outcome is inherently uncertain. Failure can occur at
any time during the development process. (see &#8220;<span style="font-style: italic">Risk Factors &#8211; Risks Related to Our Business
&#8211; Clinical failure can occur at any stage of clinical development and we may not succeed in completing the development of our product.
Our clinical experience to date does not necessarily predict future results and may not have revealed certain potential limitations of
the technology and potential complications from C-Scan and may require further clinical validation. Any product version we advance through
clinical trials may not have favorable results in later clinical trials or receive regulatory approval.</span>&#8221;).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Clinical failure can occur at any stage of
clinical development and we may not succeed in completing the development of our product. Our clinical experience to date does not necessarily
predict future results and may not have revealed certain potential limitations of the technology and potential complications from C-Scan
and may require further clinical validation. Any product version we advance through clinical trials may not have favorable results in
later clinical trials or receive regulatory approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Clinical failure can occur at any stage of clinical
development. To date, we have performed clinical studies with iterative versions of both scanning and non-scanning capsules, in conjunction
with iterative versions of the C-Scan Track , C-Scan View application and we are continuing to develop further iterative versions of our
C-Scan Cap and C-Scan Track. In addition, our clinical trials were conducted to date under differing protocols, while using specific inclusion
criteria and enriched and average risk patients&#8217; enrolment. Therefore, we have a limited ability to identify potential problems
and/or inefficiencies concerning current and future versions of C-Scan in advance of its use in general and expanded groups of average
risk patients and we cannot assure you that its actual clinical performances will be satisfactory to support proposed indications and
regulatory approvals and clinical acceptance and adoption, or that its use will not result in unanticipated complications. For example,
in previous studies we have experienced technical failures of the C-Scan Cap and are continuously engaged in implementing a plan to ensure
improved reliability in later versions. To this end, we have been collecting additional clinical data in a study in Israel (initially
enrolling both average risk and high-risk patients and starting May 2022, have shifted to enrollment of only average risk patients), for
the purpose of further calibration of the C-Scan system, in parallel to conducting the first stage of the U.S. pivotal study that was
initiated in May 2022.&#160; As part of the approved amended IDE, we designed the U.S. pivotal study to include two stages: the first
stage, aimed to support our C-Scan calibration among the average risk population, which is intended to include up to 200 patients in the
U.S.; and the second stage, which is intended to include up to 800 subjects (400 in the US and 400 in Israel) and aims to demonstrate
C-Scan performance in a statistically significant manner.&#160; The initiation of the powered portion of the U.S. pivotal study was dependent
upon successful completion of the calibration portion of the U.S. pivotal study.&#160; Following our internal assessment of the clinical
data collected to date from our calibration studies, we have determined that the current efficacy results do not meet our goal in order
to proceed to the powered portion of the U.S. pivotal study.&#160; Therefore, the initiation of the powered portion of the U.S. pivotal
study that was expected in mid-2023 is temporarily postponed.&#160; We have adopted a plan of action that includes conducting additional
clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal study protocol that are expected to be part of an
IDE supplement submission to the FDA, and which are subject to FDA approval. In addition, we plan to continue conducting our calibration
studies, albeit at a slower pace.&#160; However, there can be no assurance that we will be able to commence or complete the powered potion
of the U.S. pivotal study, that the FDA will approve our amendments to the U.S. pivotal study, or that the implementation of our plan
will be successful.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">5</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, the results from laboratory, non-clinical
and completed clinical studies, as well as results from our ongoing clinical trials may not be indicative of final clinical results obtained
from our current C-Scan version or future versions of C-Scan on expanded average risk screening populations. In addition, the results
of our clinical trials are subject to human analyses and interpretation of the data accumulated, which could be affected by various errors
due to, among others, lack of sufficient clinical experience with C-Scan, assumptions used in the statistical analysis of results, interpretation
errors in the analysis of the clinical trials results, including the reconstructed images by C-Scan, or due to uncertainty in the actual
efficacy of C-Scan in its current clinical stage. Therefore, the safety and efficacy of C-Scan and the clinical results to date will require
further independent professional validation and require further clinical study. If C-Scan does not function as expected over time, we
may not be able to develop C-Scan at the rate or to the stage we desire, we could be subject to liability claims, our reputation may be
harmed, C-Scan may not achieve regulatory clearances, and C-Scan may not be widely adopted by healthcare providers and patients.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may face a number of challenges with respect to our commercialization
efforts and may not succeed to commercialize our product, obtain required regulatory approvals or manufacture commercial quantities of
C-Scan at an acceptable cost to enable us to generate significant revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Since commencing our operations, we have focused
on the research and development and limited clinical trials of C-Scan. Although we have received a CE-certificate from our notified body
(DEKRA - 0344) according to the EU Regulation 2017/745 on Medical Devices for the marketing and sale of C-Scan in the European Union,
valid until December 1, 2026, we have not commenced marketing and sales in the European Union and may require additional regulatory approval
in Member States of the European Union, for instance from the German Federal Office for Radiation Protection (Bundesamt f&#252;r Strahlenschutz,
BfS) before we can commence marketing and sale of C-Scan such states. Furthermore, we may require additional regulatory certifications,
registrations and/or approvals from regulatory authorities in European jurisdictions outside the European Union, including with the UK
Medicines and Healthcare Products Regulatory Agency and the Swiss National Cooperative for the Disposal of Radioactive Waste (Nagra).
In Israel, we received approval from the Medical Devices and Accessories Division of the Israeli Ministry of Health, or AMAR, for the
marketing and sale of C-Scan in Israel, which is valid until December 31, 2024. We have not received approvals in other jurisdictions,
including the United States, and there can be no assurance that we will be able to receive regulatory approvals to commence marketing
and sales for C-Scan in the foreseeable future or ever. Our ability to generate revenues and achieve profitability depends on our ability
to successfully complete the development of our C-Scan product, demonstrate sufficient clinical evidence, obtain required regulatory approvals
and commercial licenses, manufacture commercial quantities of C-Scan at an acceptable cost to enable us to generate significant revenues.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The future success of our business cannot be determined
at this time, and we do not anticipate generating significant revenues from product sales for the foreseeable future. In addition, we
have no experience in commercializing C-Scan and may face a number of challenges with respect to our commercialization efforts, including,
among others, that:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9a3b6632329e444fbce3ddb8b4adc17d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not have adequate financial or other resources to complete the development of our product, demonstrate
        adequate clinical results, attain required regulatory approvals and licensures, obtain adequate manufacturing and capacity and begin the
        commercialization efforts for C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z496b8c10ac7d4c8dbe1a513854ba2145" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may fail to obtain or maintain required regulatory approvals and licensures for C-Scan in our target
        markets or may face adverse regulatory or legal actions relating to our system even if regulatory approval is obtained;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0b19369dbec44e6a84dc90cb9b04881e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not demonstrate adequate clinical safety and clinical effectiveness results from our current or
        future versions of C-Scan, to support regulatory body approval or market acceptance and adoption;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0b9dedaf9adc47b58577261013a28471" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may face ongoing limitations imposed by the Nuclear Regulatory Commission, or NRC, or other nuclear
        regulatory commissions in jurisdictions in which we intend to commercialize C-Scan in relation to the disposal of our C-Scan Cap in the
        sanitary system, such as requiring patients to retrieve our C-Scan Cap after use, which could impact engagement with clinical sites and
        enrollment pace in our clinical studies and make C-Scan less attractive;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd9c04b6b6f2544128b77061677ca75c4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to maintain an adequate supply chain due to reliance on single or sole suppliers for
        critical components and scale up the manufacture of C-Scan to commercial quantities at an adequate quality or at an acceptable cost;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5c5164ce95f2485d8ce0721ec4adfd29" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to establish adequate sales, marketing and distribution channels;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zff31b76d97824ed18852750aa933a84f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">healthcare professionals and patients may not accept C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z27c3d7520dc043b5bf084ced2dd6f144" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be aware of possible complications from the continued use of C-Scan because we have limited
        clinical experience with respect to the actual use of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zdeaf576278784453bf2b8727b3f6d2f0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">other technological breakthroughs in colorectal cancer, or CRC, screening, treatment and prevention may
        reduce the demand for C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z769d2aa70a2145f8b74696ad0121276f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">changes in the market for CRC screening, new alliances between existing market participants and the entrance
        of new market participants may interfere with our market penetration efforts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfdfc692d2d0a46de8c292a31b899e845" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">government and private third-party payors may not agree to provide coding, coverage and payment adequate
        to reimburse healthcare providers and patients for any or all of the purchase price in conjunction with clinical effectiveness of C-Scan,
        which may adversely affect healthcare providers&#8217; and patients&#8217; willingness to purchase C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf6a47e41de6d4715ba6ccf0674ec1aef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">uncertainty as to market demand may result in inefficient pricing of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zad69671a23cd4a9ea9250b3378746939" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to adequately protect our intellectual property or may face third-party claims of intellectual
        property infringement; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z489e859979264204bb889fcd444818dc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we are dependent upon the results of ongoing clinical studies relating to C-Scan which may impact its perceived
        value as against competing products.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we are unable to meet any one or more of these
challenges successfully, our ability to effectively commercialize C-Scan could be limited, which in turn could have a material adverse
effect on our business, financial condition and results of operations.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">6</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">We expect to derive most of our revenues from
sales of one product. Our inability to successfully commercialize this product, or any subsequent decline in demand for this product,
could severely harm our ability to generate revenues.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are currently dependent on the successful commercialization
of C-Scan to generate revenues. As a result, factors adversely affecting our ability to successfully commercialize, or the pricing of
or demand for, this product could have a material adverse effect on our financial condition and results of operations. If we are unable
to successfully commercialize or create market demand for C-Scan, we will have limited ability to generate revenues.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, we may be vulnerable to fluctuations
in demand for C-Scan. Such fluctuations in demand may be due to many factors, many of which are beyond our control, including, among others:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbffe654bbef14b739affe504e933a6a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">market acceptance of a new product, including healthcare professionals&#8217; and patients&#8217; preferences;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc97033fe551d4a46b6d31c4b6e4d2091" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">market acceptance of the clinical safety and performance of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbe4dc5897c954110b2b96bbcd950d221" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">development of competitive or similarly cost-effective products by our competitors;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbd47c19eaa804b4184bc70865fd4e8e8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">development delays of C-Scan, including delays in clinical trials or FDA clearance;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zabec46ed21174df7bd58ad30192f22a1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">technological innovations in CRC screening, treatment and prevention;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z3b9cd0593d8d4c43947e99bee529961e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">adverse medical side effects suffered by patients using C-Scan, whether actually resulting from the use
        of C-Scan or not;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf5dd03e4db28401386ea01d46cee756a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">changes in regulatory policies toward CRC screening or imaging technologies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd3a0e7ba8fce4bb79859be83b4d3d815" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">regulatory approval, changes in regulatory approval, clearance requirements and licensure for our product,
        including by the NRC or other radiation safety authorities;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5cf02b67e5ec451bb9ee3498d78a8cf6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">third-party claims of intellectual property infringement;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z99325b1086494128b119ed4b37cb6d71" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">budget constraints and the availability of reimbursement or insurance coverage from third-party payors
        for C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8ab64830910b4ebeb57482ea7213d286" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">increases in market acceptance of other technologies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z619f83627bb44a9aae34866cb80868c7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">adverse responses from certain of our competitors to the offering of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z233236578626491b81369331fc6008d4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">licensure and perceived risk of manufacturing and using a product containing a radioactive source (including
        associated agencies refusal to authorize capsule disposal), loss or theft;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0eaa5f9de747403cb37ea2dd38ef15cd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25; font-weight: bold">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">licensure of medical centers (including clinical study sites) to use or offer product containing a radioactive
        source; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd734c44b545e4962b9f48db10ac54efa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the shelf life of our C-Scan Cap.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If healthcare professionals do not recommend our product to their
patients, C-Scan may not achieve market acceptance and we may not become profitable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">CRC screening candidates are generally referred
by their healthcare professional to approved tests and screening technology options. If healthcare professionals, including physicians,
do not recommend or prescribe our product to their patients, C-Scan may not achieve market acceptance and we may not become profitable.
In addition, physicians have historically been slow to change their medical diagnostic and treatment practices because of perceived liability
risks arising from the use of new products. Delayed adoption of C-Scan by healthcare professionals could lead to a delayed adoption by
patients and government and private third-party payors. Healthcare professionals may not recommend or prescribe C-Scan until certain conditions
have been satisfied including, among others:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za12f9dd51f684413842af4ec84e18c39" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">there is sufficient long-term clinical and health-economic evidence to convince them to alter their existing
        screening methods and device recommendations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0e8e0b4ec8844d8b8518b33290075016" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">there are recommendations from prominent physicians, educators and/or associations that C-Scan is safe
        and effective;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z404b291c86b940299d1a5656a0869868" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we obtain favorable data from clinical and health-economic studies for C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za3bb015d18fd4a4b8be1af266316eaf2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">reimbursement or insurance coverage from government and private third-party payors is available;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z17dde30480574196b12d7a845ad87fc2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">healthcare professionals obtain required approvals and licensures for the handling, storage, dispensing
        and disposal of C-Scan; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z52aac1aaa3fc417caeb953b944b0b5c7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">healthcare professionals become familiar with the complexities of C-Scan.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We cannot predict when, if ever, healthcare professionals
and patients may adopt the use of C-Scan. Even if favorable data is obtained from clinical and health-economic studies for the regulatory
approval of C-Scan, there can be no assurance that prominent physicians would endorse it or that future clinical studies will continue
to produce favorable data regarding C- Scan. In addition, prolonged market exposure may also be a pre-requisite to reimbursement or insurance
coverage from government and private third-party payors. If C-Scan does not achieve an adequate level of acceptance by patients, healthcare
professionals and government and private third-party payors, we may not generate significant product revenues and we may not become profitable.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We expect to face competition from large, well-established manufacturers
of traditional technologies for CRC screening and detection of gastrointestinal disorders, as well as from new competitive technologies,
especially within the field of biomarkers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Competition for C-Scan comes from traditional well-entrenched
manufacturers of tests and equipment for CRC screening, such as colonoscopy, sigmoidoscopy, CT Colonography, or CTC, optical capsule endoscopy,
fecal occult blood tests, or FOBTs, and fecal immunochemical tests, or FITs. The principal manufacturers of equipment for optical colonoscopy
and sigmoidoscopy include Olympus, Pentax, Hoya and Fuji Film. The principal manufacturers of equipment for CTC include General Electric
Healthcare Systems, Siemens Medical Solutions, Philips Healthcare. and Toshiba Corporation. The principal manufacturer of equipment for
optical capsule endoscopy includes Medtronic plc. All of these companies have substantially greater financial resources than we do, and
they have established reputations as well as worldwide distribution channels for providing medical instruments to physicians.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, several companies have developed or
are developing non-invasive technologies based on stool, serum (from blood and other bodily fluids), or molecular diagnostics, or MDx,
tests that are used to indicate the presence of CRC and polyps in the colon. These companies include Exact Sciences, Polymedco, Epigenomics
AG, Gene News, EDP Biotech Corporation, Illumina, Inc., Quest Diagnostics, VolitionRx Nu.Q diagnostic, Freenome, Grail, Guardant, Genoscopy
and Universal DX. Exact Sciences commenced sales of its Cologuard &#174;, a non-invasive stool DNA screening test for colorectal cancer
in 2015, and is constantly seeking performance improvements through additional studies, alongside commercial expansion. During the past
years, there has been an extensive effort on the part of our competitors to utilize molecular biology and advanced computational techniques
to develop methods capable of identifying cell-free cancer biomarkers.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In December 2022, Guardant Health released results
from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode), an over 20,000 patient registrational study evaluating
the performance of its blood test for detecting colorectal cancer (CRC) in average-risk adults. The test demonstrated 83% sensitivity
in detecting individuals with CRC. Specificity was 90% in both individuals without advanced neoplasia and in those who had a negative
colonoscopy result. This test also demonstrated 13% sensitivity in detecting advanced adenomas. In this study, two configurations of a
multimodal blood-based screening test were evaluated independently - a cell-free DNA (cfDNA)-only test and a cfDNA test with protein biomarkers.
The announced results were derived from the cfDNA-only test, which outperformed the cfDNA test with protein biomarkers. Based on these
study results, Guardant Health plans to complete its premarket approval submission to the FDA in the first quarter of 2023.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">7</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In January 2023, Geneoscopy Inc., released results
from the CRC-PREVENT trial &#8211; a pivotal clinical trial evaluating the efficacy of its noninvasive, stool-based, at-home diagnostic
screening test to detect colorectal cancer (CRC) and advanced adenomas (AA) in average-risk individuals. The CRC-PREVENT trial included
8,289 individuals with diverse racial, ethnic, and socioeconomic backgrounds across more than 2,900 zip codes in all lower 48 states,
with colonoscopies performed in more than 3,800 endoscopy centers. Efficacy results from the study demonstrated 94% sensitivity for detecting
CRC, 45% sensitivity for detecting advanced adenoma (AA), and 88% specificity for no findings on a colonoscopy.&#160; The company submitted
a Premarket Approval (PMA) application to the FDA in January 2023.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These advancement efforts are assisted by large
capital investments, supported in turn by claims that certain products may promise the possibility of defeating certain cancers in their
early stages.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, procedures for bowel cleansing that
are less onerous are constantly being developed, which could make our entry into the market more difficult. For instance, bowel cleansing
initiated by the ingestion of pills or food-substitute diet regimes rather than through drinking large amounts of distasteful liquids
may be viewed as an improvement to the cleansing process, but other screening methods may be even more palatable to patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we are unable to convince patients and physicians
to adopt C-Scan over the current technologies marketed by our competitors or future new technologies that may be marketed by our existing
or potential competitors, our business and results of operations may suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may rely on local distributors and/or strategic partners to market
and distribute C-Scan in those countries where we intend to market and distribute C-Scan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We may rely on local distributors and/or strategic
partners for the marketing and distribution of C-Scan. Our success in generating sales in countries or regions where we will engage local
distributors and/or strategic partners will depend in large part on the efforts of these third parties over whom we have limited control.
If we are unable to identify and engage with suitable local distributors and/or strategic partners in the countries where we intend to
market and distribute C-Scan, our business, financial condition and results of operations could be negatively affected.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have limited manufacturing capabilities and if we are unable
to scale up our manufacturing operations to meet the necessary quantities for our upcoming clinical studies or anticipated market demand,
our growth could be limited and our business, financial condition and results of operations could be materially adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We currently have limited resources, facilities
and experience in manufacturing sufficient quantities of C-Scan to meet the quantities we need for the demand we may expect from commercialization
efforts, if we are able to obtain regulatory clearance in the United States for C-Scan. We do not have experience in manufacturing C-Scan
in the commercial quantities that we expect to require to meet demand for C-Scan, nor can we be certain of our manufacturing costs. We
have in the past, and we may in the future, face certain technical challenges as we increase manufacturing capacity, including, among
others, equipment design and automation, material procurement and lower than expected yields and increased scrap costs, as well as challenges
related to maintaining quality control and assurance standards, manufacturing commercial quantities of C-Scan capsules at an acceptable
cost and logistics associated with the handling of radioactive materials and the shelf life of our C-Scan Cap, which have resulted in
and could result in delays in our clinical trial and commercialization plans and lost revenue. We may be unable to establish or maintain
reliable, high-volume manufacturing capacity. Even if we can establish and maintain this capacity, the cost of doing so may increase the
cost of C-Scan and reduce our ability to successfully compete. In addition, while we have established our own X-ray source production
line in Israel to support our clinical needs and potentially future sales in Israel and in Europe, subject to the successful progress
of our clinical studies and sufficient available capital, we plan to expand in the future our in-house X-ray production line to support
future commercial quantities demand and may not be successful in such efforts. Despite our continuing cost-cutting efforts, we may not
be able to achieve adequate cost that will be profitable or adequate quality at an acceptable cost. C-Scan includes several components
that are based on new technologies and are difficult to manufacture and some are being supplied to us by single source suppliers (see
&#8220;<span style="font-style: italic">Risk Factors &#8211; Risks Related to Our Business &#8211; Our reliance on sole or single source
suppliers could harm our ability to conduct clinical trials and meet demand for our product in a timely manner or within budget</span>.&#8221;).
Furthermore, we may encounter similar or unforeseen challenges initiating and later expanding production of any new products. If we are
unable to scale up our manufacturing capabilities to meet market demand, or to achieve adequate product cost, our growth could be limited
and our business, financial condition and results of operations could be materially adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, we received and may receive in the
future grants from the Government of the State of Israel through the IIA (formerly the OCS) for the financing of a portion of our research
and development expenditures and to support the funding of our transition from research and development to manufacturing, pursuant to
the Encouragement of Research, Development and Technological Innovation in the Industry Law 5744-1984 (formerly known as the Encouragement
of Industrial Research and Development Law 5744-1984), or the Innovation Law. The terms of the IIA grants subject us to certain restrictions
relating to (among other things) the transfer of the manufacturing of IIA-funded products outside Israel. See &#8220;<span style="font-style: italic">Risk
Factors &#8211; Risks Related to Our Operations in Israel &#8211; Pursuant to the terms of the Israeli government grants we received for
research and development expenditures, we are obligated to pay certain royalties on our revenues to the Israeli government. In addition,
the terms of Israeli government grants we received require us to satisfy specified conditions and to make additional payments in addition
to repayment of the grants upon certain events</span>.&#8221; Such restrictions may impair our ability to outsource or transfer development
or manufacturing activities with respect to any product or technology outside of Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our reliance on sole or single source suppliers could harm our ability
to conduct clinical trials and meet demand for our product in a timely manner or within budget.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We currently depend on sole or single source suppliers
for some of the components and materials necessary for the production of C-Scan. For example, we currently have a sole or single supplier
for the motor used to rotate the collimated X-ray source in C-Scan, for the customized X-ray detectors and batteries used in C-Scan, as
well as for the X-Ray enriched isotope substance. There is a limited number of manufacturers worldwide who are capable of manufacturing
the motor, the customized X-ray detectors and the batteries that we currently use in C-Scan. In addition, the application-specific integrated
circuit, or ASIC, residing in C-Scan is currently manufactured for us by a single semiconductor fabrication plant, or FAB. Furthermore,
we do not currently have written contracts with all our sole or single suppliers. While our current suppliers have been able to supply
the required quantities of such components to date, if the supply of these components is disrupted or terminated or if our current suppliers
are unable to supply required quantities of components now or in the commercialization period, we may not be able to find alternative
sources for these key components in a timely manner. Although we are planning to maintain strategic inventory of key components, the inventory
may not be sufficient to satisfy the demand for C-Scan if such supply is interrupted or may be subject to risk of loss due do catastrophic
events, such as a global political crisis or war, or a fire at our storage facility. In addition, to partially mitigate the risks of reliance
on sole and single source suppliers, we are seeking alternate manufacturers for some of our components which requires us to dedicate significant
resources and investment. There can be no assurance that we will be successful in seeking alternate suppliers or establish our own production
line. As a result of the foregoing, we may be unable to meet our clinical trials timelines and meet the demand for C-Scan, which could
harm our ability to generate revenues, lead to customer dissatisfaction and damage our reputation. If we are required to change the supplier
of any of these key components, there may be a significant delay in locating a suitable alternative manufacturer. In addition, we may
be required to verify that the new manufacturer maintains facilities and procedures that comply with FDA and other applicable quality
standards and with all applicable regulations and guidelines. As part of our mitigation plan, in December 2021, we signed an amendment
to the agreement, or the Amended Service Agreement, with the sole supplier of the X-ray source used in C-Scan and concurrently entered
into a Sub-lease Agreement, or the Sub-lease Agreement with the supplier, according to which lease approximately 70 square meters of laboratory
space at the supplier premises. According to the Amended Service Agreement, we independently produce the X-ray source using our own production
employees. The Amended Service Agreement extended the terms of the service agreement we had with the sole supplier, until the Sub-lease
Agreement entered into effect on September 21, 2022, after receipt of certain certificates including a business license from the Petach
Tikva municipality. Subject to the successful progress of our clinical studies and sufficient available capital, we plan to continue to
expand our in-house production line for our X-ray source in Israel, however we cannot assure you that we will commence or successfully
complete this effort and we may be required to find an alternative supplier for the X-ray source, which we may not be able to do in a
timely manner. The delays associated with the introduction of a new manufacturer for certain key components or new suppliers for certain
materials, could delay our ability to manufacture C-Scan in a timely manner or within budget. Furthermore, in the event that the manufacturer
of a key component of C-Scan ceases operations or otherwise ceases to do business with us, we may not have access to the information necessary
to enable an alternative supplier to manufacture the component. The occurrence of any of these events could harm our ability to meet demand
for C-Scan in a timely manner or within budget.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">8</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The use of any of our C-Scan Cap, C-Scan Track or C-Scan View could
result in product liability or similar claims that could be expensive, damage our reputation and harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our business exposes us to an inherent risk of
potential product liability or similar claims related to the manufacturing, marketing and sale of medical devices. The medical device
industry has historically been litigious, and we face financial exposure to product liability or similar claims if the use of any of our
C-Scan Cap, C-Scan Track or C-Scan View were to cause or contribute to injury or death, including, without limitation, harm to the body
caused by the procedure or inaccurate diagnoses from the procedure that could affect treatment options. There is also the possibility
that defects in the design or manufacture of any of these products might necessitate a product recall. Although we plan to maintain product
liability insurance, the coverage limits of these policies may not be adequate to cover future claims. In the future, we may be unable
to maintain product liability insurance on acceptable terms or at reasonable costs and such insurance may not provide us with adequate
coverage against potential liabilities. A product liability claim, regardless of merit or ultimate outcome, or any product recall could
result in substantial costs to us, damage to our reputation, customer dissatisfaction and frustration, and a substantial diversion of
management attention. A successful claim brought against us in excess of, or outside of, our insurance coverage could have a material
adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">C-Scan is a complex medical device that requires training for qualified
personal and care for data analysis.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan is a complex medical device that requires
training for qualified personal, including physicians, and care for data analysis. Although our distributors will be required to ensure
that C-Scan is prescribed only by trained clinicians, the potential for misuse of C-Scan still exists due to its complexity. Such misuse
could result in adverse medical consequences for patients that could damage our reputation, subject us to costly product liability litigation
and otherwise have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We depend on third parties to manage our clinical studies and trials,
perform related data collection and analysis, and to enroll patients for our clinical trials, and, as a result, we may face costs and
delays that are beyond our control.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We rely on third parties, such as third-party clinical
research organizations, or CROs, clinical investigators, clinical research coordinators, physicians and clinical sites, to manage our
clinical trials and perform data collection and analysis, and to enroll patients for our clinical trials. Although we have and expect
to continue to have contractual arrangements with these third parties, we control only certain aspects of their activities. Nevertheless,
we are responsible for ensuring that each of our studies is conducted in accordance with the applicable protocol and legal, regulatory
and scientific standards, and our reliance on such third parties does not relieve us of our regulatory responsibilities. If such third
parties fail to comply with applicable regulatory requirements, the clinical data generated in our clinical trials may be deemed unreliable
and regulatory authorities may require us to perform additional clinical trials before approving our marketing applications, which would
delay the regulatory approval process. Furthermore, we may not be able to control the amount and timing of resources that these parties
devote to our studies and trials or the quality of these resources. In addition, our engagement with clinical centers for conducting our
clinical trial in the U.S depends upon site-specific licensing and regulatory requirements associated with the X-ray technology within
our C-Scan capsules related to nuclear regulatory compliance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If these third parties fail to properly manage
our studies and trials or enroll patients for our clinical trials, we will be unable to complete them at all or in a satisfactory or timely
manner, which could delay or prevent us from obtaining regulatory approvals for, or achieving market acceptance of, our product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, termination of relationships with
third parties may result in delays, inability to enter into arrangements with alternative third parties or do so on commercially reasonable
terms. Switching or adding additional clinical sites involves additional cost and requires management time and focus. In addition, there
is a natural transition period when a new clinical site commences work. As a result, delays occur, which can materially impact our ability
to meet our desired clinical development timelines.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We currently expect to sell our products mainly in the United States,
Europe, Israel and Japan and, if we are unable to manage our operations in these territories, our business, financial condition and results
of operations could be materially adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our headquarters and substantially all of our operations
and employees are presently located in Israel, but we currently expect to market our products mainly in the United States, Europe, Israel
and Japan. Accordingly, we are subject to risks associated with international operations, and our international sales and operations will
require significant management attention and financial resources. In addition, our international sales and operations will subject us
to risks inherent in international business activities, many of which are beyond our control and include, among others:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4b2d130ad2da4eb7a5ae3416e69de030" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">foreign certification, registration and other regulatory requirements;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zaa107088e2d94688a5bbea1d24d5092f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">customs clearance and shipping delays;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za1f0d00b7ade4dd6868ccfac0c6cdb5c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">import and export controls;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zff205cf610dc46a78c7087b4d9739176" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">trade restrictions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6e386a083e854b36b0a6f027009ac78e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">multiple and possibly overlapping tax structures;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc897f44d5a594d19822cad9fd0cfc132" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">difficulty forecasting the results of our international operations and managing our inventory due to our
        reliance on third-party distributors;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za4da4c4ba6d64cafba59d909defb1c94" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">differing laws and regulations, business and clinical practices, licensures, government and private third-party
        payor reimbursement policies and patient preferences;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc5fd3481034e4f8593304f154dc1c563" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">differing standards of intellectual property protection among countries;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z607e2612d24849b7a82f1f91ec0cb017" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">difficulties in staffing and managing our international operations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z44bdd1787334411389d132b3d49d8b9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">difficulties in penetrating markets in which our competitors&#8217; products are more established and achieving
        a competitive sale price for our product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2ac3d8454b70408994554e590e1ac05b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">currency exchange rate fluctuations and foreign currency exchange controls and tax rates; and</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z653e5e7a05e64fde91b7f111d191f7bb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">political and economic instability, war or acts of terrorism or natural disasters, emergence of a pandemic,
        or other widespread health emergencies (or concerns over the possibility of such an emergency, including for example, the COVID-19 pandemic).</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">If we are unable to manage our international operations effectively, our business,
financial condition and results of operations could be materially adversely affected.</div>

<div style="margin-left: 32.6pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">9</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may not be successful in establishing and maintaining strategic
partnerships, which could adversely affect our ability to develop and commercialize C-Scan.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A part of our strategy is to evaluate and, as deemed
appropriate, enter into partnerships in the future when strategically attractive, including potentially with major medical device companies.
We face significant competition in seeking appropriate partners for C-Scan, and the negotiation process is time-consuming and complex.
In order for us to successfully partner C- Scan, potential partners must view C-Scan as economically valuable in markets they determine
to be attractive in light of the terms that we are seeking and other available products for licensing by other companies. Even if we are
successful in our efforts to establish strategic partnerships, the terms that we agree upon may not be favorable to us, and we may not
be able to maintain such strategic partnerships if, for example, development or approval of a product is delayed or sales of an approved
product are disappointing. Any delay in entering into strategic partnership agreements related to C-Scan could delay the development and
commercialization of our product candidates and reduce their competitiveness even if they reach the market.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, our strategic partners may breach
any future agreement with us, and we may not be able to adequately protect our rights under these agreements. Furthermore, our strategic
partners will likely negotiate for certain rights to control decisions regarding the development and commercialization of C-Scan, if approved,
and may not conduct those activities in the same manner as we would do so.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we fail to establish and maintain strategic
partnerships related to C-Scan, we will bear all the risks and costs related to the development and commercialization of C-Scan, and we
will need to seek additional significant financing, hire additional employees and otherwise develop expertise which we do not have and
for which we have not budgeted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we lose our key personnel or are unable to attract and retain
additional personnel, our business and ability to compete will be harmed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our success relies upon the continued service and
performance of the principal members of our management and research and development team, including Alex Ovadia and Yoav Kimchy. In order
to implement our business strategy, we will need to retain our key personnel with expertise in the areas of research and development,
clinical testing, government regulation, manufacturing, finance, marketing and sales. Our product development plans depend in part on
our ability to retain engineers with expertise in a variety of technical fields. Larger companies may have a competitive advantage in
hiring such engineers, due to the relatively high compensation they are able to offer. The loss of a number of these persons or our inability
to attract and retain qualified personnel could harm our business and our ability to compete. We do not maintain key man insurance for
Alex Ovadia or Yoav Kimchy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Substantially all of our operations are currently conducted at our
facility near Haifa, Israel, and at our own X-ray source production line in Petach Tikva, Israel and any disruption at our facilities
could materially adversely affect our business, financial condition and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Substantially all of our operations are currently
conducted at our facility near Haifa, Israel (other than certain production activities conducted by subcontractors) and at our own X-ray
source production line in Petach Tikvah, Israel. We take precautions to safeguard our facilities, including obtaining insurance coverage
and implementing health and safety protocols. However, a natural or other disaster, such as a fire, flood, earthquake, an armed conflict
involving Israel (as detailed further under &#8220;<span style="font-style: italic">Risks Related to Our Operations in Israel</span>&#8221;)
or a terrorist attack, could damage or destroy our facilities and our manufacturing equipment or inventory, cause substantial delays in
our operations and otherwise cause us to incur additional unanticipated expenses. In addition, the insurance we maintain against fires,
floods and other natural disasters and the war and terrorism insurance we maintain may not be adequate to cover our losses in any particular
case. Damage to our facilities or our other property or to any of our suppliers&#8217; facilities and properties, whether located in Israel
or elsewhere, due to fire, a natural disaster or casualty event or an armed conflict or terrorist attack, could materially adversely affect
our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">A security breach or disruption or failure in a computer or communications
systems could adversely affect us.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Despite the implementation of security measures,
our internal computer systems, and those of our CROs and other third parties on which we rely, are vulnerable to damage from computer
viruses, unauthorized access, cyber-attacks, natural disasters, fire, terrorism, war, and telecommunication and electrical failures. If
such an event were to occur and interrupt our operations, it could result in a material disruption of our clinical program. For example,
the loss of clinical trial data from ongoing or planned clinical trials could result in delays in our regulatory approval efforts and
significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach results in a loss
of or damage to our data or applications, loss of trade secrets or inappropriate disclosure of confidential or proprietary information,
including protected health information or personal data of clinical trial participants or employees or former employees, access to our
clinical data, or disruption of the manufacturing process, we could incur liability and the further development of C-Scan could be delayed.
We may also be vulnerable to cyber-attacks by hackers or other malfeasance. This type of breach of our cybersecurity may compromise our
confidential information and/or our financial information and adversely affect our business or result in legal proceedings. Further, these
cybersecurity breaches may inflict reputational harm upon us that may result in decreased market value and erode public trust.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We or the third parties upon whom we depend may be adversely affected
by natural disasters and/or health epidemics or pandemics, such as the COVID-19 pandemic, and our business continuity and disaster recovery
plans may not adequately protect us from a serious disaster.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Natural disasters could severely disrupt our operations
and have a material adverse effect on our business, results of operations, financial condition and prospects. If a natural disaster, power
outage or other event occurred that prevented us from using all or a significant portion of our office, manufacturing and/or lab spaces,
that damaged critical infrastructure, such as the manufacturing facilities of our third-party contract manufacturers, subcontractors,
suppliers, CROs, clinical sites, clinical investigators, clinical coordinators, third parties ongoing activities and schedules or that
otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our plans and business for a substantial
period of time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In early 2020, the World Health Organization declared
the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. We experienced disruptions to our operations as a result of
the COVID-19 pandemic, including disruptions to the Company&#8217;s clinical studies.&#160; For example, during a period of few months
during the year ending December 31, 2022, there was a global shortage in Iodine due to COVID-19, which is critical patient intake used
in the C-Scan procedure. As a result, we faced delays in our clinical trials.&#160; The extent to which the COVID-19 pandemic shall impact
our operations in the future will depend on future developments, which are highly uncertain and cannot be predicted with confidence. In
particular, any future spread of COVID-19 globally or the reinstatement of restrictions or other actions that may be required to contain
COVID-19 or treat its impact could materially adversely impact our operations and workforce, including our research and clinical trials
and our ability to continue to raise capital, could affect the operations of key governmental agencies, such as the FDA, which may delay
our development plans, and could result in the inability of our suppliers to deliver components or raw materials on a timely basis or
at all, each of which in turn could have a material adverse impact on our business, financial condition and results of operation.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The disaster recovery and business continuity plans
we have in place may prove inadequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result
of the limited nature of our disaster recovery and business continuity plans, which could have a material adverse effect on our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">Risks Related to
Regulations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to obtain, or experience significant delays in
obtaining, FDA clearances or approvals, or equivalent third country approvals for C-Scan or future products or product enhancements, our
ability to commercially distribute and market our products could suffer.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our products are subject to rigorous regulation
by the FDA and numerous other federal, state and foreign governmental authorities and notified bodies. The process of obtaining regulatory
clearances or approvals, or equivalent third-country approvals to market a medical device can be costly and time consuming, and we may
not be able to obtain these clearances or approvals, or equivalent third-country approvals on a timely basis, if at all. In particular,
we expect to eventually generate a portion of our revenues from sales of C-Scan and future products in the United States, the European
Union, or third countries. Before a new medical device, or a new use of, or claim for, an existing product can be marketed in the United
States, it must first receive clearance under Section 510(k) of the Federal Food, Drug, and Cosmetic Act, or FDA approval of a premarket
approval application, or PMA, unless an exemption applies. The FDA will clear marketing of a low or moderate risk medical device through
the 510(k) process if sufficiently similar predicate devices have previously been cleared via this pathway. In the 510(k) clearance process,
the FDA must only determine that the proposed device is &#8220;substantially equivalent&#8221; to a device legally on the market, known
as a &#8220;predicate&#8221; device, with respect to intended use/indications for use, technological characteristics and principles of
operation in order to clear the proposed device for marketing. Clinical data is sometimes required to support substantial equivalence.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">High risk devices deemed to pose the greatest risk,
such as life-sustaining, life-supporting, or implantable devices, or devices not deemed substantially equivalent to a previously cleared
device, require approval of a PMA. The PMA process is more costly, lengthy and more uncertain than the 510(k) clearance process. The PMA
pathway requires an applicant to demonstrate the safety and effectiveness of the device based, in part, on the data obtained in clinical
trials. A PMA application must be supported by extensive data, including, but not limited to, technical, preclinical, clinical trial,
manufacturing and labeling data, to demonstrate to the FDA&#8217;s satisfaction the safety and efficacy of the device for its intended
use.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In instances where a device is novel and there
is no suitable predicate device, but that device is deemed to be of low or moderate risk, the FDA can reclassify the device to class I
or class II via de novo reclassification. This process involves the submission of a reclassification petition, and the FDA accepting that
&#8220;special controls&#8221; are adequate to ensure the product&#8217;s performance and safety. The FDA now allows &#8220;direct&#8221;
de novo reclassification petitions, a mechanism by which a sponsor can directly submit a detailed de novo reclassification petition as
the device&#8217;s initial submission without having to first receive a not substantially equivalent, or NSE, decision on a 510(k) submission.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">10</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These processes can be expensive and lengthy. FDA&#8217;s
510(k) clearance process may take 6 to 9 months, but it can last longer. Direct de novo reclassification typically may take at least 9
to 12 months from filing to clearance if no comments or disapproval from the FDA. The PMA pathway is much more costly and uncertain than
the 510(k) clearance process or de novo reclassification, and generally may take at least 12 to 18 months, or even longer, from the time
the application is filed with FDA to ultimate approval if no comments or disapproval from the FDA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are not aware of any legally marketed predicate
device upon which FDA could base a determination of substantial equivalence under a 510(k) clearance process. Our proposed strategy, therefore,
is to submit a direct de novo reclassification petition for C-Scan. To support this petition, our objective is to demonstrate that the
device poses a low or moderate risk to patients. We cannot assure you that FDA will not demand that we obtain PMA approval of C-Scan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">FDA can delay, limit or deny clearance or approval
of an application for many reasons, including, among others:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zaa25c16c37ce435ea3461994cc319dc7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to demonstrate to FDA&#8217;s satisfaction that our products are safe and effective
        for their intended use;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z3e80aed719fc4347ac429fcfd0ccc368" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">in the case of a 510(k) submission, we may not be able to demonstrate to FDA&#8217;s satisfaction that
        our products are substantially equivalent to a legally marketed predicate;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z43770403ecbd41ee8ab557772ca0edd8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the data from our non-clinical studies and clinical trials may be insufficient to support clearance or
        approval;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z86d96b8bee3b415dbe0927d89c4d7ed3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">in the case that PMA submission is required, that the manufacturing process or facilities we use may not
        meet applicable requirements; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z1ba6715c736646d88efd239a48228576" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">changes in FDA&#8217;s 510(k) clearance, de novo reclassification, or PMA approval processes and policies,
        or the adoption of new regulations may require additional data and delays in getting to market.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We may not obtain the necessary regulatory clearances,
approvals or equivalent third country approvals to market C-Scan or future products in the United States or elsewhere. Any delay in, or
failure to receive or maintain, clearance, approval for C-Scan or other products under development could prevent us from generating revenue
from these products or achieving profitability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">There is no guarantee that the FDA will grant a de novo classification
request or PMA approval of C-Scan and failure to obtain necessary clearances or approvals for our future products would adversely affect
our ability to grow our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan and some of our future products may require
FDA clearance of a 510(k), de novo classification, or may require FDA approval of a PMA. The FDA may not approve or provide clearance
of C- Scan or our future products for the indications that are necessary or desirable for successful commercialization. Indeed, the FDA
may deny our requests for 510(k) clearance, de novo reclassification or PMA approval for C-Scan or any other future product, new intended
uses or modifications to these products once they are cleared or approved for marketing.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our strategy is to submit a direct de novo classification
petition for C-Scan following completion of a U.S. pivotal study. A de novo reclassification generally applies when the 510(k) pathway
is not available due to the lack of a suitable predicate device and the FDA believes the device poses a low to moderate risk. De novo
petitions can either be submitted in lieu of a 510(k) notice, such as in our case, or after a 510(k) notice has been filed and found NSE
(Not Substantial Equivalent). If a 510(k) notice is found NSE, a de novo petition must be submitted within 30 days from the receipt of
the NSE determination.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To support our direct de novo petition, our objective
is to demonstrate that the device poses a low to moderate risk to patients. If the FDA determines that C-Scan is not a candidate for de
novo classification, it will require approval of the device for market through the PMA process. A PMA application must be supported by
extensive data, including, but not limited to, technical, preclinical, clinical trial, manufacturing and labeling data, to demonstrate
to the FDA&#8217;s satisfaction the safety and efficacy of the device for its intended use. By statute, the FDA has 180 days to review
the &#8220;accepted application,&#8221; although, generally, FDA can extend the review of the application and final review may take between
one and three years. During this review period, the FDA may request additional information or clarification of information already provided
or even request new data that may require us to conduct additional tests. Also during the review period, an advisory panel of experts
from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability
of the device. In addition, the FDA will conduct a preapproval inspection of the manufacturing facility to ensure compliance with quality
system regulations. The FDA&#8217;s review of a PMA could significantly delay our plans to get to market. There is also no guarantee that
the FDA would approve a PMA. Failure to receive clearance or approval for C-Scan or future products would have an adverse effect on our
ability to expand our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Even if the FDA ultimately accepts our de novo
reclassification petition, to support our petition, we still may be required to conduct additional clinical trials before a petition can
be filed.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"> <br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"> Such studies or trials can be costly and the results
uncertain. If we are unable to successfully complete required clinical studies or trials, we will not receive FDA clearance or approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we or our future manufacturers or distributors do not obtain
and maintain the necessary regulatory clearances or approvals, or equivalent third country approvals in a specific country or region,
we or our future distributors will not be able to market and sell C-Scan or future products in that country or region.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We intend to market C-Scan in a number of international
markets. To be able to market and sell C-Scan in a specific country or region, we and/or our distributors must comply with the regulations
of that country or region. While the regulations of some countries do not impose barriers to marketing and selling part or all of our
products or only require notification, others require that we and/or our distributors obtain the approval of specified regulatory authorities
such as the Nuclear Regulatory Commission (NRC) in the U.S., the Swiss National Cooperative for the Disposal of Radioactive Waste (Nagra)
and the German Federal Office for Radiation Protection (Bundesamt f&#252;r Strahlenschutz, BfS), in addition to the CE mark that is required
for medical devices throughout the EU. These regulations, and the time required for regulatory review, vary from country to country. Obtaining
regulatory approvals is expensive and time-consuming, and we cannot be certain that we or our distributors will receive regulatory approvals
required for C-Scan or any future products in each country or region in which we plan to market such products. With regard to obtaining
the CE-certification, we have engaged with Dekra Certification as our Notified Body. If we modify C-Scan or any future products, we or
our distributors may need to apply for new regulatory approvals or our Notified Body may need to review the planned changes before we
are permitted to sell the respective products. We may not meet the quality and safety standards required to maintain the authorizations
that we or our distributors have received. If we or if permitted, our distributors are unable to maintain our authorizations or CE Certificates
in a particular country or region, we will no longer be able to sell C-Scan and/or any potential future products in that country or region,
and our ability to generate revenues will be materially and adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If the indications for use or instructions for use for which the
iodinated oral contrast medium is approved are not sufficiently broad to support its use throughout the C-Scan procedure, the FDA or the
competent regulatory authorities in the European Union (EU) Member States and other foreign countries may consider that contrast agent
is being used off-label.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Ingestion of C-Scan requires the preparatory use
of iodinated oral contrast medium to provide a coating for colonic imaging. We cannot be sure that the indications for which iodinated
oral contrast medium are approved in the United States, or in other countries is sufficiently broad to cover such use. If the FDA or the
competent regulatory authorities in other countries consider that iodinated oral contrast medium is not approved for the purpose for which
it is used with the system, we may be considered to promote the off-label use of the iodinated oral contrast medium. Because the promotion
of off-label use of drugs or medicinal products is prohibited in the United States, and in other countries, we could face both related
issues with the FDA and/or the competent authorities of and/or other countries. In these circumstances, the FDA and/or the competent regulatory
authorities and/or other countries may require us to obtain appropriate regulatory approvals for the iodinated oral contrast medium prior
to marketing C-Scan with such substances. Under such circumstances, should we fail to obtain approval of the contrast agent for use with
C-Scan, in a timely fashion, or at all, this could delay or prevent regulatory clearance or approval of the C-Scan, and our business and
financial condition will be adversely affected.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">11</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to successfully complete clinical trials with respect
to C-Scan, we may be unable to receive regulatory approvals or clearances for C-Scan and/or our ability to achieve market acceptance of
C-Scan will be harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The development of the C-Scan system requires the
submission of data generated from clinical trials, which can be long, expensive and uncertain processes, subject to delays and failure
at any stage. The data obtained from the studies and trials may be inadequate to support regulatory clearances or approvals, or equivalent
third-country approval, or to allow market acceptance of the products being studied. C-Scan technology is currently undergoing clinical
development and clinical trials. To date, we have performed clinical studies with several versions of C-Scan including several versions
of our non-scanning capsules.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The development of sufficient and appropriate clinical
protocols to demonstrate safety, clinical performance and clinical effectiveness are required, and we may not adequately develop such
protocols to support clearance, approval, or equivalent third country approval. The clinical trials that were conducted using prior versions
of C-Scan, were conducted under differing protocols, used groups of patients different and/or smaller in size from those we intend to
study in future clinical trials with future versions of C-Scan, and the results from such clinical trials were subject to human interpretations
and based on statistical assumptions that could be affected by erroneous considerations. Further, the FDA, the competent regulatory authorities
of other countries, or our Notified Body in the EU may require us to submit data on a greater number of patients than we originally anticipated
and/or for a longer follow-up period or they may change the data collection requirements or data analysis applicable to our clinical trials.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The commencement or completion of any of our clinical
studies or trials may be delayed or halted, or be inadequate to support regulatory clearance, approval or product acceptance, or equivalent
third country approval, for numerous reasons, including, among others:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9cf5e5a2f5c64db798683774c1d05655" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patients do not enroll in the clinical trial at the rate we expect;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd106d8cb698a48a28a82510aefb11614" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patients do not comply with trial protocols;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4c27d3020d544db28202c274a64402e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patient follow-up is not at the rate we expect;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z53a4cd7a8720474bb63c113329204a2c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patients withdraw from the study;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z4b7df25d561f422b85b41b3e07732e34" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patients experience severe adverse side effects, including damage to the colon wall or related to excessive
        radiation exposure as a result of capsule malfunction or break down or retention and may require to undergo a surgical procedure;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z074529b9c8884b7aaae1a04b150dd8ce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">patient death during a clinical trial, even though their death may be unrelated to our product;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8328925fd4e84f17bad0ff0ab109cce9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">FDA, institutional review boards, or IRBs, or other regulatory authorities do not approve a clinical trial
        protocol or a clinical trial, or place a clinical trial on hold;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9c292abd6c4f4910b34a9613812836c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">IRBs, Ethics Committees and third-party clinical investigators may delay or reject our trial protocol and
        Informed Consent Form;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z60bbfe90a235406e9c91f22dca1392a6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">third-party clinical investigators decline to participate in a study or trial or do not perform a study
        or trial on our anticipated schedule or consistent with the investigator agreements, study or trial protocol, good clinical practices,
        quality of clinical data or other FDA or IRBs, Ethics Committees, or any other applicable requirements;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z68901c0540d74a94bdcf157a86015aeb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate
        manner or consistent with the study or trial protocol or investigational or statistical plans;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze405678e92c54427a7af4f939f863470" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">regulatory inspections of our studies, trials or manufacturing facilities may require us to, among other
        things, undertake corrective action or suspend or terminate our studies or clinical trials;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0b2ac0413dba4115ae517a3b15687c42" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">changes in governmental regulations or administrative actions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2a8874edca2641e587c753d5e628d9c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to develop C-Scan at the rate or to the stage we desire;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z7b2055dcd41449999918fd7630de1b37" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the interim or final results of the study or clinical trial are inconclusive or unfavorable as to safety
        or efficacy;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5d31a882887f4efa833244fdd3c120d1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a regulatory agency or our Notified Body concludes that our trial design is or was inadequate to demonstrate
        safety and efficacy;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2881dbc8b1b748ed96320f26e630db33" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the capsule disposal was not authorized by regulatory agencies or patients failed to collect the capsule
        following procedure completion;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb08a37d59ffe4174917ee48478f3c8ab" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the capsule was lost in the sewer system;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8e4085e23a9040b88d1d35ee180c19f0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">loss of clinical data; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7e4555b9010f4ba8979c1d44fddbdf6d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a health epidemic, pandemic or other outbreak, including the current COVID-19 pandemic.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The results of non-clinical and clinical studies
do not necessarily predict future clinical trial results, and predecessor clinical trial results may not be repeated in subsequent clinical
trials. Additionally, the FDA and/or other third country regulatory entities may disagree with our interpretation of the data from our
non-clinical studies and clinical trials, or may find the clinical trial design, conduct or results inadequate to demonstrate safety or
efficacy, and may require us to pursue additional non-clinical studies or clinical trials, which could further delay the clearance, approval
of our products. The data we collect from our non-clinical testing, and other clinical trials may not be sufficient to support regulatory
clearance and approval.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If the third parties on which we rely to conduct our clinical trials
and clinical development do not perform as contractually required or expected, we may not be able to obtain regulatory clearance or approval,
or equivalent third country approval for, or commercialize, C-Scan or future products.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We do not have the ability to independently conduct
our clinical trials for C-Scan and we must rely on third parties, such as contract research organizations, medical institutions, clinical
investigators and contract laboratories to conduct such trials. If these third parties do not successfully carry out their contractual
duties or regulatory obligations or meet expected deadlines, if these third parties need to be replaced, or if the quality or accuracy
of the data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for other
reasons, our non-clinical development activities or clinical trials may be extended, delayed, suspended or terminated, and we may not
be able to obtain regulatory clearance, approval for, or successfully commercialize, C-Scan or future products on a timely basis, if at
all, and our business, operating results and prospects may be adversely affected. Furthermore, our third-party clinical trial investigators
may be delayed in conducting our clinical trials for reasons outside of their control.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">12</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The results of our current or future clinical trials may not support
our product candidate requirements or intended use claims or may result in the discovery of adverse side effects.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Even if our current or future clinical trials are
completed as planned, we cannot be certain that their results will support our product requirements or intended use claims, which could
inhibit our marketing strategies, or that the FDA, foreign authorities or our Notified Body will agree with our conclusions regarding
them. Success in non-clinical studies and early clinical trials does not ensure that later clinical trials will be successful, and we
cannot be sure that clinical trials will replicate the results of prior trials. The clinical trial process may fail to demonstrate that
C- Scan, or any future products, are safe and effective for the desired or proposed indicated uses, which could cause us to abandon a
product and may delay development of others. Any delay or termination of our clinical trials will delay the filing of our product submissions
and, ultimately, our ability to commercialize C-Scan, or any future products, and generate revenues. It is also possible that patients
enrolled in clinical trials will experience adverse side effects that are not currently part of the product candidate&#8217;s profile.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we fail to obtain or maintain necessary regulatory clearances
or CE Certificates for C-Scan, or if there are regulatory changes in our existing or future target markets, our ability to sell C-Scan
and generate revenues could be harmed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan is a medical device that is subject to extensive
regulations that are in particular intended to assure its safety, effectiveness and compliance with applicable consumer laws. These laws
require medical devices to obtain approval or other market clearance before being placed on the market. If we fail to obtain or maintain
these regulatory approvals or clearances, our ability to sell C-Scan and generate revenues will be materially harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These laws and regulations relate <span style="font-style: italic">inter
alia </span>to the design, development, testing, manufacturing, storage, labeling, packaging, content and language of the instructions
for use of the device, sale, promotion, distribution, importing and exporting, shipping, post-sale surveillance and recall from C-Scan&#8217;s
markets, and all countries in which we intend to sell C-Scan apply some form of regulations of this kind. Most notably, we must comply
with the EU law on medical devices, in particular, the European Medical Device Regulation (MDR) and EU Member States&#8217; laws implementing
and complementing it, and other applicable EU and Member States&#8217; law, and we are subject to extensive regulation in the United States
by the FDA and other federal, state and local authorities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are and will be subject to audits by our Notified
Body under the MDR. During this audit, the third-party assessor or Notified Body will examine the maintenance and implementation of our
quality control system, device post-marketing vigilance system and any changes or modifications made to our products.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On May 26, 2021, the MDR became formally applicable
and replaced the former regulatory framework for medical devices in the EU under the medical devices directives. The MDR strengthens the
medical devices rules in the EU. In particular, the MDR results in several medical devices being classified in higher risk classes and
therefore face elevated regulatory requirements. In addition, the MDR generally elevates regulatory requirements to medical devices. As
a result, it has become more difficult to market medical devices and costs incurred for clinical evaluation, conformity assessment and
post marketing surveillance have increased and will increase further; such regulatory changes may adversely affect our business, financial
condition and results of operations or restrict our operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Even if C-Scan or future products are cleared or approved by regulatory
authorities or after obtaining CE Certificates from our Notified Body, modifications to C-Scan or future products may require new regulatory
clearances or approvals, new CE Certificates, or may require us to recall or cease marketing it until the necessary clearances, approvals
or CE Certificates are obtained.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Once cleared, approved or marketed, modifications
to C-Scan or future products may require new regulatory approvals, clearances, including CE Certificates from our Notified Body, 510(k)
clearances or premarket approvals, or require us to recall or cease marketing the modified devices until these clearances or approvals
are obtained. Any modification to a 510(k)-cleared device that could significantly affect its safety or efficacy, or that would constitute
a major change in its intended use, requires a new 510(k) clearance or, possibly, a new de novo classification petition or PMA. The FDA
requires device manufacturers to initially make and document a determination of whether or not a modification requires a new approval,
supplement or clearance. A manufacturer may determine that a modification could not significantly affect safety or efficacy and does not
represent a major change in its intended use, so that no new 510(k) clearance is necessary. However, the FDA can review a manufacturer&#8217;s
decision and may disagree. The FDA may also on its own initiative determine that a new clearance or approval is required. Subject to compliance
with FDA guidance we may make modifications to C-Scan in the future that we believe do not or will not require additional clearances or
approvals. Further, our products could be subject to recall if the FDA determines, for any reason, that our products are not safe or effective.
Any recall or FDA requirement that we seek additional approvals or clearances could result in significant delays, fines, increased costs
associated with modification of a product, loss of revenue and potential operating restrictions imposed by the FDA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If a manufacturer determines that a modification
to an FDA-cleared device could significantly affect its safety or efficacy, or would constitute a major change in its intended use, then
the manufacturer must file for a new 510(k) clearance or possibly a new de novo classification petition or premarket approval application.
Where we determine that modifications to our products require a new clearance or approval, we may not be able to obtain those additional
clearances or approvals for the modifications or additional indications in a timely manner, or at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Any modification to a PMA-approved device that
affects the device&#8217;s safety or effectiveness must either be approved in a PMA Supplement, or if the modification does not impact
the device&#8217;s safety or effectiveness, described in a 30-Day Notice or in the device&#8217;s Annual Report. The FDA may not approve
a modification described in a PMA Supplement, in which case the modified device cannot be marketed. The FDA can also disagree that a change
described in an Annual Report is appropriately described in either filing, and request that the company file a PMA Supplement and/or request
that the company cease marketing the modified device until the PMA Supplement is approved.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Similar rules also apply in foreign jurisdictions.
In the EU, we must inform the Notified Body that was involved in the conformity assessment of the medical devices we market or sell in
the EU of any planned substantial changes to our quality system with regard to C-Scan or other devices we may place on the market, if
such changes could affect compliance with the essential requirements laid down in the Annexes to the MDR (Essential Requirements), respectively,
or changes to the devices&#8217; intended purpose. The Notified Body will then assess the changes and verify the products&#8217; conformity
with the Essential Requirements. If the assessment is favorable, the Notified Body will issue a new CE Certificate or an addendum to the
existing CE Certificate attesting compliance with the Essential Requirements.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If the Notified Body or a relevant regulatory authority
disagrees with our assessments and repeals an authorization or an existing CE Certificate, we may be required to apply for a new CE Certificate
or other new regulatory clearances or approvals for modifications, and until such new CE-Certificate or other regulatory clearance or
change approval is obtained, we may be required to recall and/or to stop marketing the modified devices.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Obtaining clearances and approvals, or new or amended
CE Certificates for device modifications can be a time-consuming process, and delays in obtaining required future clearances, approvals,
or CE Certificates could adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn could harm
our future growth.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">13</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Even if C-Scan and future products are cleared
or approved by regulatory authorities or after obtaining CE Certificates from our Notified Body, if we or our suppliers fail to comply
with ongoing FDA or other foreign regulatory authority requirements, or if we experience unanticipated problems with our products, our
products could be subject to restrictions or withdrawal from the market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The manufacturing processes, reporting requirements,
post-approval clinical data and promotional activities associated with any product for which we obtain clearance, approval or CE Certificates,
or equivalent third country approval will be subject to continuous regulatory review, oversight and periodic inspections by the FDA other
domestic and foreign regulatory authorities and our Notified Body. In particular, we and certain of our suppliers are required to comply
with the FDA&#8217;s Quality System Regulations, or QSR, as well as current good manufacturing practices, or cGMP. In the EU, we will
also be subject to the quality management system requirements laid down in the Annexes to the MDR. Such compliance can be facilitated
by, a certificate of compliance with the current version of the ISO 13485 (which, at this point, is ISO 13485:2016). Through compliance
with the ISO 13485:2016 standard, we will benefit from a presumption of conformity with the relevant quality management system requirements
laid down in the Annexes to the MDR. These regulations and standards govern inter alia the methods and documentation of the design, testing,
production, control, quality assurance, labeling, packaging, storage and shipping of any product for which we obtain clearance or approval,
CE Certificates, or equivalent third country approval. Regulatory authorities, such as the FDA, and our Notified Body enforce the QSR
and other regulations through periodic inspections. For example, the failure by us or one of our suppliers to comply with applicable statutes
and regulations falling within the competence of the FDA, or the failure to timely and adequately respond to any adverse inspectional
observations or product safety issues, could result in, among other things, any of the following enforcement actions:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zde201046812541848ac3b63fb03a5ef1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">untitled letters, warning letters, fines, injunctions, corporate integrity agreements, consent decrees
        and civil penalties;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0350766fbb1c4c87ba3406a278e4dbea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">unanticipated expenditures to address or defend such actions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1aa71039164145958fd26c3296248fb7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">customer notifications for repair, replacement or refunds;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcce4810f7dcc46cda7bed22ca19f45f6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">recall, detention or seizure of our products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc51629b72c9d4bfaab15d2a55c7cb0dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">operating restrictions or partial suspension or total shutdown of production;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze837ae1d7fd24bc5944e98ed995cab74" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">refusing or delaying our requests for 510(k) clearance, de novo classification or premarket approval of
        new products or modified products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zed3c53f8d6a5493fbd112ab7b92cd6b0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">operating restrictions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z58ed78028b9347b986ee8807f23afd69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">withdrawing 510(k) clearances, de novo classification, or PMA approvals that have already been granted;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z01f0f1fe10a44c5d840e7f5d010c3a78" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">suspension or withdrawal of our CE Certificates;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z549d72d4c07f43ed914388f850a2de42" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">refusal to grant export approval for our products; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z18b3ac873f8048f6a4e3183705e53aa3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">civil or criminal prosecution.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If any of these actions were to occur, our reputation
would be harmed, our product sales and profitability would suffer and we may not be able to generate revenue. Furthermore, our key suppliers
may not currently be or may not continue to be in compliance with all applicable regulatory requirements which could result in our failure
to produce our products on a timely basis and in the required quantities, if at all.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Even if regulatory clearance or approval of a product
is granted, or after obtaining CE Certificates, such clearance or approval, or CE Certificates may be subject to limitations on the intended
uses for which the product may be marketed and reduce our potential to successfully commercialize the product and generate revenue from
the product. If FDA or the competent regulatory authorities of foreign countries determines that our promotional materials, labeling,
training or other marketing or educational activities constitute the promotion of an unapproved use or the promotion of an intended purpose
not covered by our CE mark, they could request that we cease or modify our training or promotional materials or subject us to regulatory
enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider
our training or other promotional materials to constitute promotion of an unapproved use, which could result in significant fines or penalties
under other statutory authorities, such as laws prohibiting false claims for reimbursement.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, we may be required to conduct costly
post-market testing and surveillance to monitor the safety or effectiveness of our products, and we must comply with medical device reporting
requirements, including the reporting of adverse events and malfunctions related to our products. Later discovery of previously unknown
problems with our products, including unanticipated adverse side effects or adverse side effects of unanticipated severity or frequency,
manufacturing problems, or failure to comply with regulatory requirements such as the Quality System Regulations, may result in changes
to labeling, restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory
recalls, a requirement to repair, replace or refund the cost of any medical device we manufacture or distribute, fines, suspension or
withdrawal of regulatory approvals or CE Certificates, product seizures, injunctions or the imposition of civil or criminal penalties,
all of which would adversely affect our business, financial condition and operating results and prospects.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">C-Scan may in the future be subject to product recalls that could
harm our reputation, business and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The FDA and similar foreign governmental authorities
have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture
or a public health/safety issue. In the case of the FDA, the authority to require a recall must be based on an FDA finding that there
is a reasonable probability that the device would cause injury or death. In addition, foreign governmental bodies have the authority to
require the recall of our products in the event of material deficiencies or defects in design or manufacture. Manufacturers may, under
their own initiative, recall a product if any material deficiency in a device is found. A government-mandated or voluntary recall by us
or one of our distributors could occur as a result of component failures, manufacturing errors, design or labeling defects or other deficiencies
and issues. Once marketed, recalls of any of our products, including C-Scan, would divert managerial and financial resources and have
an adverse effect on our business, financial condition and results of operations. FDA requires that certain classifications of recalls
be reported to the FDA within 10 working days after the recall is initiated. Companies are required to maintain certain records of recalls,
even if they are not reportable to FDA. We may initiate voluntary recalls involving our products in the future that we determine do not
require us to notify the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls.
A future recall announcement could harm our reputation with customers and negatively affect our sales. In addition, the FDA could take
enforcement action against us based on our failure to report the recalls when they were conducted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If C-Scan or future products cause or contribute to a death or a
serious injury, or malfunction in such a way that causes or contributes to a death or serious injury, we will be subject to medical device
reporting regulations, which can result in corrective actions or enforcement actions from regulatory authorities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under FDA medical device reporting regulations,
medical device manufacturers are required to report to the FDA information that a device has or may have caused or contributed to a death
or serious injury or has malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction
of our device (or any similar future product) were to recur. If we fail to investigate and report these events to FDA within the required
timeframes, or at all, the FDA could take enforcement action against us. Any such adverse event involving our products also could result
in future corrective actions, such as recalls or customer notifications, or agency action, such as inspection or enforcement action. Any
corrective action, whether voluntary or involuntary, including any legal action taken against us, will require us to devote sufficient
time and capital to the matter, distract management from operating our business, and may harm our reputation and financial results.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the EU MDR we will now have to comply with
the increased requirements of medical devices vigilance provisions. In particular, according to Art. 83 MDR, we are required to have a
post-market surveillance system in place in a manner that is proportionate to the risk class and appropriate for the type of device, as
an integral part of the quality management system. Depending on the devices&#8217; risk class, either a post market surveillance report
or a periodic safety update report, or PSUR, must be created and provided to the competent authority upon request. The PSUR also has to
be provided to the Notified Body. Furthermore, requirements on vigilance and incident reporting are increased and market surveillance
competencies of the authorities are strengthened.</div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">14</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our failure to comply with radiation safety or radio frequency regulations
in a specific country or region could impair our ability to conduct our clinical trials, or commercially distribute and market C-Scan
in that country or region.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan includes a small X-ray source and wireless
radio frequency transmitter and receiver, and is therefore subject to equipment authorization requirements in a number of countries and
regions. In the United States, the EU and Japan, authorities often require advance clearance of all radiation and radio frequency devices
before they can be sold or marketed in these jurisdictions, subject to limited exceptions. Competent authorities for such additional approval
requirements include the Swiss National Cooperative for the Disposal of Radioactive Waste (Nagra) and the German Federal Office for Radiation
Protection (Bundesamt f&#252;r Strahlenschutz, BfS). Modifications to the approved C-Scan version design and specifications may require
new or further regulatory clearances or approvals before we are permitted to market and sell a modified C-Scan version. If we are unable
to obtain any required clearances or approvals from the authorities responsible for the radiation as well as the radio frequency regulations
in these and other jurisdictions, the sale or use of C-Scan could be prevented in these countries. Any such action could negatively affect
our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our business is subject to complex environmental and health legislation
in various jurisdictions that may increase our costs and our risk of noncompliance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our research and development and manufacturing
processes, including through our service providers, involve the handling of potentially harmful radioactive and other hazardous materials.
Therefore, we and our service providers may be subject to various environmental, health and safety laws and regulations, including governing
the use, shipping, handling, storage and disposal of these materials, and we incur expenses related to compliance with these laws and
regulations. If we are found to have violated applicable environmental, health and safety laws, whether as a result of human error, equipment
failure or other causes, we could be held liable for damages, penalties and costs of remedial actions and could be subject to work stoppages
or delays, which could materially adversely affect our business, financial condition and results of operations. The risk of contamination
or injury from these materials cannot be eliminated. If an accident or release of any radioactive or other hazardous material occurs,
we could be held liable for resulting damages, including for investigation, remediation and monitoring of the contamination, including
the costs of which could be substantial. In addition, we may be required to pay damages or civil judgments in respect of third-party claims,
including those relating to personal injury (including exposure to radioactive materials) or contribution claims. In the future, we could
be subject to additional environmental requirements or existing environmental laws could become more stringent, which could lead to greater
compliance costs and increasing risks and penalties associated with violations. For example, changes to, or restrictions on, permitting
requirements or processes, hazardous or radioactive material storage or handling might require an unplanned capital investment or relocation.
If we or our service providers fail to comply with existing or new environmental laws or regulations, our business, financial condition
and results of operations could be materially adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to achieve reimbursement and coverage from government
and private third-party payors for procedures using C-Scan, or if reimbursement is insufficient to create an economic benefit for purchasing
or using C-Scan when compared to alternative procedures, demand for our products may not grow at the rate we expect.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The demand for C-Scan will depend significantly
on the eligibility of the procedures performed using C-Scan for reimbursement through government-sponsored healthcare payment systems
and private third-party payors. Reimbursement practices vary significantly from country to country and within some countries, by region,
and we must obtain reimbursement approvals on a country-by-country and/or region-by-region basis. In general, the process of obtaining
reimbursement and coverage approvals has been longer outside of the United States. We may not be able to obtain reimbursement approvals
in a timely manner or at all and existing reimbursement and coverage policies may be revised from time to time by government and private
third-party payors. If physicians, hospitals and other healthcare providers are unable to obtain sufficient coverage and reimbursement
from government and private third-party payors for procedures using C-Scan, if reimbursement is, or is perceived by our customers to be,
insufficient to create an economic incentive for purchasing or using C-Scan, or if such reimbursement does not adequately compensate physicians
and health care providers compared to the other procedures they offer, demand for our products may not grow at the rate we expect.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Federal and state privacy laws, and equivalent laws of third countries,
may increase our costs of operation and expose us to civil and criminal sanctions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Health Insurance Portability and Accountability
Act of 1996, as amended, and the regulations that have been issued under it, to which we refer collectively as HIPAA, and similar laws
outside the United States, contain substantial restrictions and requirements with respect to the use and disclosure of individuals&#8217;
protected health information. The HIPAA privacy rules prohibit &#8220;covered entities,&#8221; such as healthcare providers and health
plans, from using or disclosing an individual&#8217;s protected health information, unless the use or disclosure is authorized by the
individual or is specifically required or permitted under the privacy rules. Under the HIPAA security rules, covered entities must establish
administrative, physical and technical safeguards to protect the confidentiality, integrity and availability of electronic protected health
information maintained or transmitted by them or by others on their behalf. While we do not believe that we are a covered entity under
HIPAA, many of our customers may be covered entities subject to HIPAA. Such customers may require us to enter into business associate
agreements, which will obligate us to safeguard certain health information we obtain in the course of our relationship with them, restrict
the manner in which we use and disclose such information and impose liability on us for failure to meet our contractual obligations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, under The Health Information Technology
for Economic and Clinical Health Act of 2009, or HITECH, which was signed into law as part of the U.S. stimulus package in February 2009,
certain of HIPAA&#8217;s privacy and security requirements are now also directly applicable to &#8220;business associates&#8221; of covered
entities and subject them to direct governmental enforcement for failure to comply with these requirements. We may be deemed as a &#8220;business
associate&#8221; of some of our customers. As a result, we may be subject as a &#8220;business associate&#8221; to civil and criminal
penalties for failure to comply with applicable privacy and security rule requirements. Moreover, HITECH created a new requirement obligating
&#8220;business associates&#8221; to report any breach of unsecured, individually identifiable health information to their covered entity
customers and imposes penalties for failing to do so.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition to HIPAA, most U.S. states have enacted
patient confidentiality laws that protect against the disclosure of confidential medical information, and many U.S. states have adopted
or are considering adopting further legislation in this area, including privacy safeguards, security standards, and data security breach
notification requirements. These U.S. state laws, which may be even more stringent than the HIPAA requirements, are not preempted by the
federal requirements, and we are therefore required to comply with them to the extent they are applicable to our operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These and other possible changes to HIPAA or other
U.S. federal or state laws or regulations, or comparable laws and regulations in countries where we conduct business, could affect our
business and the costs of compliance could be significant. Failure by us to comply with any of the standards regarding patient privacy,
identity theft prevention and detection, and data security may subject us to penalties, including civil monetary penalties and in some
circumstances, criminal penalties. In addition, such failure may damage our reputation and adversely affect our ability to retain customers
and attract new customers.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The protection of personal data, particularly patient
data, is subject to strict laws and regulations in many countries. The collection and use of personal health data in the EU is governed
by the General Data Protection Regulation Reg. EU 2016/679, which became applicable on May 25, 2018, or the GDPR. The GDPR imposes a number
of requirements, including an obligation to seek the consent of individuals to whom the personal data relate, the information that must
be provided to the individuals, notification of data processing obligations to the competent national data protection authorities of individual
EU Member States and the security and confidentiality of the personal data. The GDPR also imposes strict rules on the transfer of personal
data out of the EU to the U.S. Failure to comply with the requirements of the GDPR and the related national data protection laws of the
EU Member States may result in fines and other administrative penalties and harm our business. We may incur extensive costs in ensuring
compliance with these laws and regulations, particularly if we are considered to be a data controller within the meaning of the GDPR.</div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">15</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The adoption of healthcare reform and deficit reduction measures
in the United States may adversely affect our business and financial results.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Patient Protection and Affordable Care Act
of 2010, or the PPACA, which was modified on March 30, 2010 by the enactment of the Health Care and Education Reconciliation Act of 2010,
affects the way healthcare is financed by both governmental and private insurers, and significantly impacts the device industry. The PPACA
is intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud
and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on pharmaceutical
and medical device manufacturers, and impose additional health policy reforms. The PPACA imposes, among other things, an annual excise
tax of 2.3% on any entity that manufactures or imports medical devices offered for sale in the United States beginning in 2013, resulting
in an anticipated cost to the medical device industry of up to $20 billion over the next decade. We likely will be subject to the excise
tax with respect to C-Scan if it is approved for sale in the United States. The PPACA also limits the rate of growth in Medicare payments
to providers and authorizes certain voluntary demonstration projects beginning no later than 2013 around development of bundling payments
for acute, inpatient hospital services, physician services, and post-acute services for episodes of hospital care. In addition, the PPACA
provides for the establishment of an Independent Payment Advisory Board, or IPAB, that, beginning in 2014, could recommend changes in
Medicare payments to physicians and other providers that would take effect unless Congress passes an alternative measure to achieve the
same amount of savings. The IPAB has not yet been created. The PPACA also increases fraud and abuse penalties and expands the scope and
reach of the Federal Civil False Claims Act and government enforcement tools, which may adversely impact healthcare companies.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There have been judicial and congressional challenges
to the PPACA. The U.S. Supreme Court heard a constitutional challenge to the PPACA and in June 2012 held that the PPACA is constitutional.
However, states are allowed to opt out of the expansion of eligibility criteria for Medicaid under the PPACA and many states have chosen
to do so, causing many uninsured patients to remain without coverage. In addition to the PPACA, the effect of which cannot presently be
quantified given its recent enactment, various healthcare reform proposals have also emerged at the state level. If a law is enacted,
many if not all of the provisions of the PPACA may no longer apply to prescription drugs. While we are unable to predict what changes
may ultimately be enacted, to the extent that future changes affect how any future products are paid for and reimbursed by government
and private payers our business could be adversely impacted. On December 14, 2018, a federal district court in Texas ruled that the PPACA
is unconstitutional as a result of the Tax Cuts and Jobs Act, the federal income tax reform legislation previously passed by Congress
and signed by President Trump on December 22, 2017, that eliminated the individual mandate portion of the PPACA. The case, Texas, et al,
v. United States of America, et al., (N.D. Texas), is an outlier, but in 2019, the Fifth Circuit Court of Appeals subsequently upheld
the lower court decision which was then appealed to the United States Supreme Court. On June 17, 2021, the U.S. Supreme Court held that
the plaintiffs did not have standing to challenge the individual mandate because they have not shown a past or future injury. In November
2020, Joseph Biden was elected President and, in January 2021, the Democratic Party obtained control of the Senate. As a result of these
electoral developments, it is unlikely that continued legislative efforts will be pursued to repeal PPACA. Instead, it is possible that
legislation will be pursued to enhance or reform PPACA. We are not able to state with any certainty what will be the impact of this court
decision on our business pending further court action and possible appeals.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We cannot predict whether future healthcare initiatives
will be implemented at the federal or state level or the effect any future legislation or regulation will have on us. However, we anticipate
that the PPACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria
and an additional downward pressure on the price that we receive for any approved product, and could adversely affect our business. Any
reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors.
Insurers may also refuse to provide any coverage of uses of approved products for medical indications other than those for which the FDA
has granted market approvals, all of which may adversely affect our business, financial condition and results of operations, possibly
materially.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, other legislative changes have been
proposed and adopted since the PPACA was enacted. In August 2011, President Obama signed into law the Budget Control Act of 2011, which,
among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending reductions.
The Joint Select Committee did not achieve a targeted deficit reduction of an amount greater than $1.2 trillion for the years 2013 through
2021, triggering the legislation&#8217;s automatic reduction to several government programs. This includes aggregate reductions to Medicare
payments to healthcare providers of up to 2.0% per fiscal year, starting in 2013. In January 2013, President Obama signed into law the
American Taxpayer Relief Act of 2012, which, among other things, reduced Medicare payments to several categories of healthcare providers
and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. If we
ever obtain regulatory approval and commercialization of C-Scan or any future product candidates, these laws may result in additional
reductions in Medicare and other healthcare funding, which could have a material adverse effect on our customers and accordingly, our
financial operations. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and
promotional activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether
the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of C-Scan
or any future product candidates may be.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Although we cannot predict the full effect on our
business of the implementation of existing legislation or the enactment of additional legislation pursuant to healthcare and other legislative
reform, we believe that legislation or regulations that would reduce reimbursement for, or restrict coverage of, C-Scan or any future
product candidates, could adversely affect how much or under what circumstances healthcare providers will prescribe or administer our
products. This could materially and adversely affect our business by reducing our ability to generate revenue, raise capital, obtain additional
collaborators and market C-Scan or any future product candidates. In addition, we believe the increasing emphasis on managed care in the
United States has and will continue to put pressure on the price and usage of pharmaceutical products, which may adversely impact any
future product sales.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition to healthcare reform, other deficit
reduction measures could affect reimbursement for our device and related procedures. For example, beginning April 1, 2013, Medicare payments
for all items and services have been reduced by 2% under the sequestration (i.e., automatic spending reductions) required by the Budget
Control Act of 2011, as amended by the American Taxpayer Relief Act of 2012. These cuts will remain in effect until 2024 unless Congress
enacts legislation to cancel or delay the cuts. These payment reductions, or similar efforts to reduce Medicare spending to control the
federal deficit, could adversely affect our business by reducing reimbursement to the providers who purchase and use our devices and perform
related procedures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The implementation of the reporting and disclosure
obligations of the Physician Payment Sunshine Act&#8217;s provisions relating to healthcare reform could adversely affect our business.
A health care reform provision, generally referred to as the Physician Payment Sunshine Act or Open Payments Program, has imposed new
reporting and disclosure requirements for drug and device manufacturers with regard to payments or other transfers of value made to certain
practitioners (including physicians, dentists and teaching hospitals), and for such manufacturers and for group purchasing organizations,
with regard to certain ownership interests held by physicians in the reporting entity. On February 1, 2013, the Centers for Medicare and
Medicaid Services, or CMS, released the final rule to implement the Physician Payment Sunshine Act. As required under the Physician Payment
Sunshine Act, CMS will publish information from these reports on a publicly available website, including amounts transferred and physician,
dentist and teaching hospital identities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The final rule implementing the Physician Payment
Sunshine Act is complex, ambiguous, and broad in scope. If we participate in federal healthcare programs, meaning our product is reimbursed
by a federal healthcare program such as Medicare, Medicaid, or Children&#8217;s Health Insurance Program, our product would be considered
a &#8220;covered device.&#8221; Within 180 days of becoming &#8220;covered,&#8221; we would be required to collect and report detailed
information regarding certain financial relationships we have with physicians and teaching hospitals. The Physician Payment Sunshine Act
preempts similar state reporting laws, although we may be required to report under certain of such state laws. Our compliance with the
new final rule imposes additional costs on us and requires additional resources including dedicated personnel with experience and expertise
in this area. Failure to comply may expose us to federal and/or state enforcement action and fines.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">16</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">If we fail to comply with the U.S. federal
Anti-Kickback Statute and similar state and third-country laws, we could be subject to criminal and civil penalties and exclusion from
federally funded healthcare programs including the Medicare and Medicaid programs and equivalent third-country programs, which would have
a material adverse effect on our business and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A provision of the Social Security Act, commonly
referred to as the federal Anti-Kickback Statute, prohibits the knowing and willful offer, payment, solicitation or receipt of any form
of remuneration, directly or indirectly, in cash or in kind, to induce or reward the referring, ordering, leasing, purchasing or arranging
for, or recommending the ordering, purchasing or leasing of, items or services payable, in whole or in part, by Medicare, Medicaid or
any other federal healthcare program. PPACA, among other things, clarified that a person or entity needs not to have actual knowledge
of the federal Anti-Kickback Statute or specific intent to violate it. Although there are a number of statutory exemptions and regulatory
safe harbors to the federal Anti- Kickback Statute protecting certain common business arrangements and activities from prosecution or
regulatory sanctions, the exemptions and safe harbors are drawn narrowly, and practices that do not fit squarely within an exemption or
safe harbor may be subject to scrutiny. The federal Anti-Kickback Statute is very broad in scope and many of its provisions have not been
uniformly or definitively interpreted by existing case law or regulations. In addition, most of the states have adopted laws similar to
the federal Anti-Kickback Statute, and some of these laws are even broader than the federal Anti-Kickback Statute in that their prohibitions
may apply to items or services reimbursed under Medicaid and other state programs or, in several states, apply regardless of the source
of payment. Violations of the federal Anti-Kickback Statute may result in substantial criminal, civil or administrative penalties, damages,
fines and exclusion from participation in federal healthcare programs.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">All of our financial relationships with healthcare
providers, purchasers, and others who provide products or services to federal healthcare program beneficiaries are potentially governed
by the federal Anti-Kickback Statute and similar state laws. We believe our operations are in compliance with the federal Anti-Kickback
Statute and similar state laws. However, we cannot be certain that we will not be subject to investigations or litigation alleging violations
of these laws, which could be time-consuming and costly to us and could divert management&#8217;s attention from operating our business,
which in turn could have a material adverse effect on our business. In addition, if our arrangements were found to violate the federal
Anti- Kickback Statute or similar state laws, the consequences of such violations would likely have a material adverse effect on our business,
results of operations and financial condition.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There are other federal and state laws that may
affect our ability to operate, including the federal civil False Claims Act, which prohibits, among other things, individuals or entities
from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds or knowingly making,
using or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly
concealing or knowingly and improperly avoiding, decreasing, or concealing an obligation to pay money to the federal government. PPACA
amended the Social Security Act to provide that the government may assert that a claim including items or services resulting from a violation
of the federal Anti- Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Moreover,
we may be subject to other federal false claim laws, including, among others, federal criminal healthcare fraud and false statement statutes
that extend to non-government healthcare benefit programs. Moreover, there are analogous state laws. Violations of these laws can result
in substantial criminal, civil or administrative penalties, damages, fines and exclusion from participation in federal healthcare programs.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Similar restrictions are imposed by the national
legislation of many third countries in which our medical devices will be marketed. Moreover, the provisions of the Foreign Corrupt Practices
Act of 1997 and other similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from providing
money or anything of value to officials of foreign governments, foreign political parties, or international organizations with the intent
to obtain or retain business or seek a business advantage. Recently, there has been a substantial increase in anti-bribery law enforcement
activity by U.S. regulators, with more aggressive and frequent investigations and enforcement by both the U.S. Securities and Exchange
Commission and the Department of Justice. A determination that our operations or activities violated United States or foreign laws or
regulations could result in imposition of substantial fines, interruption of business, loss of supplier, vendor or other third-party relationships,
termination of necessary licenses and permits, and other legal or equitable sanctions. In addition, lawsuits brought by private litigants
may also follow as a consequence.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our failure to comply with the necessary regulatory approval regarding
the use of radioactive materials could significantly impair our ability to develop, manufacture and/or sell C-Scan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The manufacture of C-Scan requires the use and
storage of radioactive materials. In order to use such materials in the development and manufacture of C-Scan in Israel, we are required
to obtain a permit from the Israeli Commissioner for Environmental Radiation, or the Commissioner, pursuant to the Israeli Pharmaceutical
Regulations (Radioactive Elements and By-Products), 5740&#8211;1980. Should we fail to comply with the conditions of our currently existing
permit, the Commissioner would have authority to cancel our permit. Should the Commissioner determine that our activities or facilities,
or the activities or facilities adjacent to our premises, constitute a danger to the health and well-being of a person, the public or
the environment, the cancellation or suspension of our permit could be immediate and without prior notice. Furthermore, we cannot guarantee
the annual renewal of our permit and/or annual renewal subject to identical conditions, as the approval of an annual application and the
conditions thereof are at the discretion of the Commissioner. Similar requirements and regulations may apply to the manufacture of C-Scan
in other countries. Cancellation of or failure to renew our permit could have materially adverse consequences on our ability to manufacture
and sell our products and therefore on our ability to continue our business and operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Environmental, social and corporate governance
(ESG) issues, including those related to climate change and sustainability, may have an adverse effect on our business, financial condition
and results of operations and damage our reputation.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.4pt; line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There is an increasing focus from certain investors,
customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative pressure
related to public companies&#8217; ESG practices continue to grow. If our ESG practices fail to meet regulatory requirements or investor,
employee or other stakeholders&#8217; evolving expectations and standards for responsible corporate citizenship in areas including environmental
stewardship, support for local communities, Board of Director and employee diversity, human capital management, employee health and safety
practices, product quality, supply chain management, corporate governance and transparency, our reputation and employee retention may
be negatively impacted, and our suppliers may be unwilling to continue to do business with us.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.4pt; line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Investors and other stakeholders are increasingly
focusing on environmental issues, including climate change, energy and water use, plastic waste and other sustainability concerns. Concern
over climate change may result in new or increased legal and regulatory requirements to reduce or mitigate impacts to the environment.
Increased regulatory requirements may result in increased demands or requirements regarding components of our products and their environmental
impact on sustainability. Complying with these demands or requirements could cause us to incur additional manufacturing, operating or
product development costs.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, new sustainability rules and regulations
have been adopted and may continue to be introduced in various states and other jurisdictions. For example, the SEC has published proposed
rules that would require companies to provide significantly expanded climate-related disclosures in their periodic reporting, which may
require us to incur significant additional costs to comply and impose increased oversight obligations on our management and board of directors.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we do not adapt to or comply with new regulations,
or fail to meet evolving investor, industry or stakeholder expectations and concerns regarding ESG issues, investors may reconsider their
capital investment in our Company, which could have a material adverse effect on our business or financial condition.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">17</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.6pt; line-height: 1.25; font-weight: bold">Risks Related to Our
Intellectual Property</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we are unable to protect our intellectual property rights, our
competitive position could be harmed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our success and ability to compete depends in large
part upon our ability to protect our intellectual property. Although we have patents issued in Israel, Europe, United States, Japan, China,
India, Hong Kong, Canada, South Korea, Brazil and Australia, we continue to file and prosecute in many of the same countries and additional
countries. We face several risks and uncertainties in connection with our intellectual property rights, including, among others:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc05f363cf3d14cae9e81581bcf25774f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">pending and future patent applications may not result in the issuance of patents or, if issued, may not
        be issued in a form that will be advantageous to us;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze329c7c6904e493a899c33e966dfb407" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our issued patents may be challenged, invalidated or legally circumvented by third parties;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z90b4cdcff26241f4a4413aa1d6c63709" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our patents may not be upheld as valid and enforceable or prevent the development of competitive products;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb18e2a359ecb4e24bced52949eff54e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the eligibility of certain inventions related to diagnostic medicine, more specifically diagnostic methods
        and processes, for patent protection in the United States has been limited recently which may affect our ability to enforce our issued
        patents in the United States or may make it difficult to obtain broad patent protection going forward in the United States;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z96534988dc4e47c08644fc56b5a1aba1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the eligibility to protect methods for treating humans, which is available in the US, is generally not
        available in other countries, for example in Europe;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z95b269c12e76427791a4d089ffa72452" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">for a variety of reasons, we may decide not to file for patent protection on various improvements or additional
        features; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9f0e2172cf3b4a1f8386b11d50becfb4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">intellectual property protection and/or enforcement may be unavailable or limited in some countries where
        laws or law enforcement practices may not protect our proprietary rights to the same extent as the laws of the United States, the European
        Union, Canada or Israel.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Consequently, our competitors could develop, manufacture
and sell products that directly compete with our products, which could decrease our sales and diminish our ability to compete. In addition,
competitors could attempt to develop their own competitive technologies that fall outside of our intellectual property rights. If our
intellectual property does not adequately protect us from our competitors&#8217; products and methods, our competitive position could
be materially adversely affected.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Because the medical device industry is litigious, we are susceptible
to intellectual property suits that could cause us to incur substantial costs or pay substantial damages or prohibit us from selling C-Scan.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">There is a substantial amount of litigation over patent and other
intellectual property rights in the medical device industry. Whether a product infringes a patent involves complex legal and factual issues,
the determination of which is often uncertain. Searches typically performed to identify potentially infringed patents of third parties
are often not conclusive and because patent applications can take many years to issue, there may be applications now pending, which may
later result in issued patents which our current or future products may infringe. In addition, our competitors or other parties may assert
that C-Scan and the methods it employs may be covered by patents held by them. If C-Scan or any of its components infringes a valid patent,
we could be prevented from manufacturing or selling it unless we can obtain a license or redesign the product to avoid infringement. For
example, in March 2021, we entered into an exclusive license agreement with the University of Missouri pursuant to which we were granted
an exclusive license in the medical field to certain patents held by the University of Missouri that the University of Missouri claimed
included background intellectual property in C-Scan. While we do not currently expect to utilize such patents, should we sell C-Scan units
incorporating such patents, we shall pay the University royalties ranging from $0.30 to $5.00 per C-Scan unit depending on the number
of units sold, up to $15,000,000 in the aggregate. Third parties may currently have, or may eventually be issued, patents on which our
current or future products or technologies may infringe.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A license may not always be available or may require
us to pay substantial royalties. We also may not be successful in any attempt to redesign our product to avoid infringement. Infringement
and other intellectual property claims, with or without merit, can be expensive and time-consuming to litigate and could divert our management&#8217;s
attention from operating our business.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">18</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The steps we have taken to protect our intellectual property may
not be adequate, which could have a material adverse effect on our ability to compete in the market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition to patents, we rely on confidentiality,
non-compete, non-disclosure and assignment of inventions provisions, as appropriate, with our employees, consultants, subcontractors,
suppliers and clinical investigators to protect and otherwise seek to control access to, and distribution of, our proprietary information.
These measures may not be adequate to protect our intellectual property from unauthorized disclosure, third-party infringement or misappropriation,
for the following reasons:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc51221639e5b4279ae36a0032e8b36bf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the agreements may be breached, may not provide the scope of protection we believe they provide or may
        be determined to be unenforceable, in part or in whole;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6fbd4b67d1504c8c8fb105cc2af4e3bb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may have inadequate remedies for any breach;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5ab6b9d5e67c464da06781eac897adfd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">proprietary information could be disclosed to our competitors; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc45aeae640ce49c9b1235dc3cc22d17d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">others may independently develop substantially equivalent or superior proprietary information and techniques
        or otherwise gain access to our trade secrets or disclose such technologies.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If, for any of the above reasons, our intellectual
property is disclosed or misappropriated, it could harm our ability to protect our rights and could have a material adverse effect on
our business, financial condition and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, although our employees and consultants
have agreed to assign to us all rights to any intellectual property created in the scope of their employment or engagement with us and
most of our current employees and consultants, have agreed to waive their economic rights with respect to our intellectual property, we
cannot assure you that such claims will not be brought against us by current or former employees or consultants, despite their contractual
representations and obligations toward us, or by any of the medical and/or governmental institutions that employ or engage such consultants,
claiming alleged rights to our intellectual property or demanding remuneration in consideration for assigned intellectual property rights,
which could result in litigation and adversely affect our business, financial condition and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Third-party claims of infringement or other claims against us could
require us to redesign C-Scan, seek licenses, or engage in future costly intellectual property litigation, which could negatively affect
our future business and financial performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Substantial litigation over intellectual property
rights exists in the medical device industry in general and in the medical imaging or screening sectors in particular. We expect that
we may be subject to third-party infringement claims as our profile grows, we generate any future revenues, the number of competitors
grows or the functionality of products and technology in different industry segments converges. For example, in March 2021, we entered
into an exclusive license agreement with the University of Missouri with respect to certain patents held by the University of Missouri
that the University of Missouri claimed included background intellectual property in C-Scan. In consideration for the grant of an exclusive
license to those patents in the medical field, we agreed to pay royalties ranging from $0.30 to $5.00 per C-Scan unit depending on the
number of units sold up to $15,000,000 in the aggregate. Third parties may currently have, or may eventually be issued, patents on which
our current or future products or technologies may infringe.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, litigation in which we are accused
of infringement may cause negative publicity, adversely impact prospective customers, cause product shipment delays, prohibit us from
manufacturing, marketing or selling our current or future products, require us to develop non-infringing technology, make substantial
payments to third parties or enter into royalty or license agreements, which may not be available on acceptable terms, or at all. If a
successful claim of infringement were made against us and we could not develop non-infringing technology or license the infringed or similar
technology in a timely and cost-effective manner, our ability to generate significant revenues may be substantially harmed and we could
be exposed to significant liability. A court could enter orders that temporarily, preliminarily or permanently enjoin us, our suppliers,
distributors or our customers from making, using, selling, offering to sell or importing our current or future products, or could enter
an order mandating that we undertake certain remedial activities. Claims that we have misappropriated the confidential information or
trade secrets of third parties can have a similar negative impact on our reputation, business, financial condition or results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We may also become involved in litigation in connection
with our brand name rights. We do not know whether others will assert that our brand name infringes their trademark rights. In addition,
names we choose for our products may be claimed to infringe names held by others. If we have to change the names we use, we may experience
a loss in goodwill associated with our brand name, customer confusion and a loss of sales.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Third parties may challenge the validity of our issued patents or
challenge patent applications in administrative proceedings before various patent offices which, if successful, could negatively affect
our future business and financial performance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Various patent offices, including in the United
States and Europe, provide administrative proceedings by which a third party can challenge the validity of an issued patent or challenge
an application that is being examined absent any threat of litigation. In some instances, including in the United States, the administrative
proceedings provide a more efficient and favorable forum to challenge our patents which may lead to more opportunities for competitors
to do so, particularly smaller competitors with limited resources. Moreover, the standards utilized in these administrative proceedings,
at least in the United States, provide certain legal advantages versus challenging the validity of a patent in a district court. If a
third party is successful in one of these administrative proceedings, the patent will no longer be enforceable in the corresponding jurisdiction.
With this loss in patent rights, we will not be able to prevent third parties from offering identical or similar competing products which
may result in lower profits and a less substantial market share.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may need to initiate lawsuits to protect or enforce our patents
and other intellectual property rights, which could be expensive and, if we lose, could cause us to lose some of our intellectual property
rights, which would harm our ability to compete in the market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We rely on patents to protect a portion of our
intellectual property and our competitive position. Patent law relating to the scope of claims in the technology fields in which we operate
is still evolving and, consequently, patent positions in the medical device industry are generally uncertain. In order to protect or enforce
our patent rights, we may initiate patent and related litigation against third parties, such as infringement suits or interference proceedings.
Any lawsuits that we initiate could be expensive, take significant time and divert our management&#8217;s attention from other business
concerns and the outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks
is highly unpredictable. Litigation also puts our patents and other registered intellectual property at risk of being invalidated or interpreted
narrowly and our patent applications at risk of not being issued. In addition, we may provoke third parties to assert claims against us.
We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, including attorney fees, if any, may not
be commercially valuable. The occurrence of any of these events could have a material adverse effect on our business, financial condition
and results of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We rely on trademark protection to distinguish our products from
the products of our competitors; however, if a third party is entitled to use our trademark, we could be forced to rebrand, which could
result in loss of brand recognition and our ability to distinguish our products may be impaired, which could adversely affect our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We rely on trademark protection to distinguish
our products from the products of our competitors. In jurisdictions where we have not registered our trademarks and logos and are using
them, and as permitted by applicable local law, we rely on common law trademark protection. Third parties may oppose our trademark applications,
or otherwise challenge our use of the trademarks, and may be able to use our trademarks in jurisdictions where they are not registered
or otherwise protected by law. If our trademarks are successfully challenged or if a third party is using confusingly similar or identical
trademarks in particular jurisdictions before we do, we may be prevented from using our brands and/or domain names and/or could be forced
to rebrand our products, which could result in loss of brand recognition, and could require us to devote additional resources to marketing
new brands. If others are able to use our trademarks, our ability to distinguish our products may be impaired, which could adversely affect
our business. Further, we cannot assure you that competitors will not infringe upon our trademarks, or that we will have adequate resources
to enforce our trademarks.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">19</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may not be able to enforce covenants not to compete at all or,
we may be unable to enforce them for the duration contemplated in our employment contracts and may, therefore, be unable to prevent competitors
from benefiting from the expertise of some of our former employees involved in research and development activities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We currently have non-compete agreements with substantially
all of our employees who are involved in research and development, all of whom are located in Israel. These agreements prohibit our employees,
if they cease working for us, from directly competing with us or working for our competitors for a limited period of time following termination
of employment. In many jurisdictions, courts are increasingly refusing to enforce restrictions on competition by former employees or have
interpreted them narrowly. For example, in Israel, where currently all of our employees&#160; reside, courts have required employers seeking
to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm
one of a limited number of material interests of the employer which have been recognized by the courts, such as the secrecy of a company&#8217;s
confidential commercial information or its intellectual property. If we cannot demonstrate that harm would be caused to us, an Israeli
court may refuse to enforce our non-compete restrictions or reduce the contemplated period of non- competition such that we may be unable
to prevent our competitors from benefiting from the expertise of our former employees.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">Risks Related to
Our Operations in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our principal offices, research and development facilities, our
manufacturing sites and some of our suppliers are located in Israel and, therefore, our business, financial condition and results of operation
may be adversely affected by political, economic and military instability in Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our principal offices and research and development
facilities are located near Haifa, in the northern part of Israel and our own X-ray production line is located in Petach Tikva, Israel.
In addition, all of our employees and officers, and one of our directors, are residents of Israel. Accordingly, political, economic and
military conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed
conflicts have taken place between Israel and its neighboring countries. In recent years, Israel has been engaged in sporadic armed conflicts
with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large
portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel, may
be developing nuclear weapons and has targeted cyber attacks against Israeli entities. Some of these hostilities were accompanied by missiles
being fired from the Gaza Strip against civilian targets in various parts of Israel, and negatively affected business conditions in Israel.
Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect
our operations and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Popular uprisings in various countries in the Middle
East and North Africa are affecting the political stability of those countries. Such instability may lead to deterioration in the political
and trade relationships that exist between the State of Israel and these countries. Furthermore, several countries, principally in the
Middle East, restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business
with Israel and Israeli companies if hostilities in the region continue or intensify. Such restrictions may seriously limit our ability
to sell our products to customers in those countries. Similarly, Israeli corporations are limited in conducting business with entities
from several countries. Parties with whom we may do business could decline to travel to Israel during periods of heightened unrest or
tension. In addition, the political and security situation in Israel may result in parties with whom we may have agreements involving
performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure
provisions in such agreements. In addition, any hostilities involving Israel could have a material adverse effect on our facilities including
our corporate office or on the facilities of our local suppliers, in which event all or a portion of our inventory may be damaged, and
our ability to deliver products to customers could be materially adversely affected.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, the war and terrorism insurance we
maintain may not be adequate to cover our losses associated with armed conflicts and terrorist attacks. Although the Israeli government
in the past covered the reinstatement value of certain damages that were caused by terrorist attacks or acts of war, we cannot assure
you that this government coverage will be maintained, or if maintained, will be sufficient to compensate us fully for damages incurred.
Any losses or damages incurred by us could have a material adverse effect on our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, our operations could also be disrupted
by the obligations of personnel to perform military service. As of December 31, 2022, we had 85 employees and independent contractors,
all of whom were based in Israel, except one in the U.S. Some of these Israeli employees and independent contractors may be called upon
to perform up to 54 days in each three year period (and in the case of military officers, up to 84 days in each three year period) of
military reserve duty until they reach the age of 40 (and in some cases, depending on their specific military profession up to 45 or even
49 years of age) and, in certain emergency circumstances, may be called to immediate and unlimited active duty. In response to increases
in terrorist activity, there have been periods of significant call-ups of military reservists and it is possible that there will be similar
large-scale military reserve duty call-ups in the future. Our operations could be disrupted by the absence of a significant number of
employees related to military service, which could materially adversely affect our business and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Any hostilities involving Israel, terrorist activities
or political instability in the region or the interruption or curtailment of trade between Israel and its present trading partners, or
significant downturns in the economic or financial condition of Israel, could adversely affect our operations and product development,
cause our revenues to decrease and adversely affect our share price.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, the Israeli government is currently
pursuing extensive changes to Israel&#8217;s judicial system. In response to the foregoing developments, individuals, organizations and
institutions, both within and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business environment
in Israel including due to reluctance of foreign investors to invest or conduct business in Israel, as well as to increased currency fluctuations,
downgrades in credit rating, increased interest rates, increased volatility in securities markets, and other changes in macroeconomic
conditions. Such proposed changes may also adversely affect the labor market in Israel or lead to political instability or civil unrest.
To the extent that any of these negative developments do occur, they may have an adverse effect on our business, our results of operations
and our ability to raise additional funds.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pursuant to the terms of the Israeli government grants we received
for research and development expenditures, we are obligated to pay certain royalties on our revenues to the Israeli government. In addition,
the terms of Israeli government grant we received require us to satisfy specified conditions and to make additional payments in addition
to repayment of the grants upon certain events.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have received grants from the Government of
the State of Israel through the IIA (formerly the OCS) for the financing of a portion of (i) our research and development expenditures
and (ii) a portion of the development of our manufacturing line, pursuant to the Innovation Law and related regulations and guidelines.
As of December 31, 2022, we had received funding from the IIA for research and development of C-Scan in the aggregate amount of approximately
$5.6 million. As of December 31, 2022, we had not paid any royalties to the IIA and had a contingent obligation to the IIA with respect
to such funding (including interest at the rate of 12-month LIBOR) in the amount of approximately $6.2 million. In addition, in January
2021, we received an IIA grant approval to support the funding of our transition from research and development to manufacturing. The final
IIA grant amounted to $620,000 (NIS 2.18 million) (along with a co-investment by us of the same amount), which we are not required to
repay to the IIA, subject to the terms and conditions set forth in the grant approval, of which we received approximately $222,000 (NIS
784,000) in February 2023, $82,000 (NIS 264,000) in January 2022 and $349,000 (NIS 1,134,000) in 2021. We may apply for additional IIA
grants in the future; however, there is no assurance that such applications will be approved in the amount requested or at all. Furthermore,
the funds available for IIA grants out of the annual budget of the State of Israel have been reduced in the past and may be further reduced
in the future. We cannot predict whether we will be entitled to any future grants, or the amounts of any such grants.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">20</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the terms of the Innovation Law as currently
in effect, products developed with IIA funding are required to be manufactured in Israel, unless the IIA approved grant program includes
a pre-determined portion of manufacturing that may be performed outside Israel (as certain of our IIA approved grants included). The approval
of the IIA is required for the transferring of manufacturing outside Israel in excess of such pre-determined portion (however, only a
notice to the IIA, as opposed to approval, is required for the transfer outside Israel of up to 10% of the cumulative manufacturing in
excess of such pre-approved portion). If manufacturing of IIA-funded products is transferred outside Israel (following IIA approval) in
excess of the pre-determined percentage included in the grant approval, then the royalty repayment rate will be increased by 1% with respect
to the additional approved percentage to be manufactured outside Israel and the royalty repayment for the entire approved program may
be increased to up to three times the amount of the grants received, depending on the percentage manufactured outside Israel (plus accrued
interest). We may explore from time to time whether certain other components of C-Scan can be assembled outside of Israel. For example,
we may in the future explore whether it would be possible to assemble the capsule without the X-ray source in Israel, and have the X-ray
source subsequently manufactured and assembled into C-Scan at a certified radioisotope production facility or at a distribution center
outside Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Over the years, we received approval of grant applications
that included a certain predetermined percentage of manufacturing to be performed outside of Israel of the X-ray source but additional
examination of these approvals and consequent manufacturing is required to determine liabilities to the IIA, if any. IIA prior approval
is also required for the transfer of IIA-funded know-how to a third party outside of Israel (including by way of license), which we may
not receive (and any such approval would typically be subject to payment of a redemption fee, calculated according to a formula under
the Innovation Law, which may be in the amount of up to six times the amount of the grants received (less paid royalties, if any, and
depreciation, but no less than the total grants received), plus accrued interest. Even following the full repayment of any IIA grants,
we must nevertheless continue to comply with the requirements of the Innovation Law and related regulations and guidelines. The foregoing
restrictions and requirements for payment may impair our ability to sell our technology assets outside of Israel or to outsource or transfer
development or manufacturing activities with respect to any product or technology outside of Israel. Furthermore, the consideration available
to our shareholders in a transaction involving the transfer outside of Israel of technology or know-how developed with IIA funding (such
as a merger or similar transaction) may be reduced by any amounts that we are required to pay to the IIA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we fail to comply with any of the conditions
and restrictions imposed by the Innovation Law and related regulations and guidelines, or by the specific terms under which we received
the grants, we may be required to refund any grants previously received together with interest and penalties, and, in certain circumstances,
may be subject to criminal charges.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Your rights and responsibilities as a shareholder are governed by
Israeli law, which differ in some material respects from the rights and responsibilities of shareholders of U.S. companies.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The rights and responsibilities of the holders
of our ordinary shares are governed by our amended articles of association and by Israeli law. These rights and responsibilities differ
in some material respects from the rights and responsibilities of shareholders in U.S. based corporations. In particular, a shareholder
of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations
towards the company and other shareholders, and to refrain from abusing its power in the company, including, among other things, in voting
at a general meeting of shareholders on matters such as amendments to a company&#8217;s articles of association, increases in a company&#8217;s
authorized share capital, mergers and acquisitions and certain related party transactions requiring shareholder approval under Israeli
law. In addition, a controlling shareholder of an Israeli company or a shareholder who is aware that it possesses the power to determine
the outcome of a shareholder vote or to appoint or prevent the appointment of a director or executive officer in the company or has other
powers towards the company, has a duty of fairness toward the company. There is limited case law available to assist us in understanding
the nature of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations
and liabilities on holders of our ordinary shares that are not typically imposed on shareholders of U.S. corporations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">It may be difficult to enforce a judgment of a U.S. court against
us, certain of our officers and directors or the Israeli experts named in this Annual Report in Israel or the United States, to assert
U.S. securities laws claims in Israel or to serve process on certain of our officers and directors and these experts.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are incorporated in Israel. A majority of our
executive officers and directors are not residents of the United States, and a substantial portion of our assets are located outside the
United States. Therefore, a judgment obtained against us, or any of these persons, including a judgment based on the civil liability provisions
of the U.S. federal securities laws, may not be collectible in the United States and may not be enforced by an Israeli court. It also
may be difficult for you to effect service of process on these persons in the United States or to assert U.S. securities law claims in
original actions instituted in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws
on the grounds that Israel is not the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees
to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable,
the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time consuming and costly process. Certain
matters of procedure will also be governed by Israeli law. There is little binding case law in Israel that addresses the matters described
above. As a result of the difficulty associated with enforcing a judgment against us in Israel, you may not be able to collect any damages
awarded by either a U.S. or foreign court.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Provisions of Israeli law and our amended articles of association
may delay, prevent or otherwise impede a merger with, or an acquisition of, us, even when the terms of such a transaction are favorable
to us and our shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Israeli corporate law regulates mergers, requires
tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors,
officers or significant shareholders and regulates other matters that may be relevant to such types of transactions. For example, a full
tender offer for all of a public company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive
responses from the holders of at least 95% of the issued share capital and the approval of a majority of the offerees that do not have
a personal interest in the tender offer, unless at least 98% of the company&#8217;s outstanding shares are tendered. Furthermore, the
shareholders, including those who indicated their acceptance of the tender offer (unless the acquirer stipulated in its tender offer that
a shareholder that accepts the offer may not seek appraisal rights), may, at any time within six months following the completion of the
tender offer, petition an Israeli court for an appraisal right, to alter the consideration for the acquisition. In addition, a statutory
merger may not be consummated unless at least 50 days have passed from the date on which a proposal for approval of the merger was filed
by each party with the Israeli Registrar of Companies and at least 30 days have passed from the date on which the merger was approved
by the shareholders of each party.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may become subject to claims for payment of compensation for
assigned service inventions by our current or former employees, which could result in litigation and adversely affect our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Patents Law, 5727-1967, or the
Patents Law, inventions conceived by an employee during the scope of his or her employment are regarded as &#8220;service inventions&#8221;
and are owned by the employer, absent a specific agreement between the employee and employer giving the employee service invention rights.
Section 134 of the Patents Law provides that if no agreement between an employer and an employee exists that prescribes whether, to what
extent, and on what conditions the employee is entitled to remuneration for his or her service inventions, then such matters may, upon
application by the employee, be decided by a government-appointed compensation and royalties committee established under the Patents Law,
or the Committee. Although our employees have agreed to assign to us all rights to any intellectual property created in the scope of their
employment and most of our current employees, including all those involved in the development of our intellectual property, have agreed
to waive their economic rights with respect to service inventions, we cannot assure you that claims will not be brought against us by
current or former employees demanding remuneration in consideration for assigned service inventions. If any such claims were filed, we
could potentially be required to pay remuneration to our current or former employees for such assigned service inventions, or be forced
to litigate such claims, which could negatively affect our business.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">21</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">Risks Related to
Ownership of our Ordinary Shares</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We incur and will continue to incur significant costs as a result
of operating as a public company in the United States, and our management is required to devote substantial time to compliance initiatives.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As a public company whose securities are traded
in the United States, we incur and will continue to incur significant legal, accounting and other expenses. The Sarbanes-Oxley Act of
2002, as well as rules and regulations implemented by the U.S. Securities and Exchange Commission and the Nasdaq Stock Market, impose
various requirements on public companies, including requiring the establishment and maintenance of effective disclosure and financial
controls.&#160; If we lose our status as a &#8220;non-accelerated filer&#8221;, we will be required to include an attestation report on
internal control over financial reporting issued by our independent registered public accounting firm. Our management and other personnel
devote a substantial amount of time to these compliance initiatives. Changes in the laws, rules and regulations affecting public companies
would result in increased costs to us as we respond to their requirements. These rules and regulations could make it more difficult or
more expensive for us to obtain certain types of insurance, including directors&#8217; and officers&#8217; liability insurance, and we
may be required to accept reduced policy limits and coverage or incur substantial costs to obtain or maintain the same or similar coverage.
The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board
of directors, our board committees or as executive officers. We cannot predict or estimate the amount or timing of additional costs we
may incur in order to comply with such requirements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we fail to maintain effective internal control over financial
reporting, the price of our ordinary shares may be adversely affected.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our internal control over financial reporting may
have weaknesses and conditions that could require correction or remediation, the disclosure of which may have an adverse impact on the
price of our ordinary shares. We are required to establish and maintain appropriate internal control over financial reporting. Failure
to establish those controls, or any failure of those controls once established, could adversely affect our public disclosures regarding
our business, prospects, financial condition or results of operations. In addition, management&#8217;s assessment of internal control
over financial reporting may identify weaknesses and conditions that need to be addressed in our internal control over financial reporting
or other matters that may raise concerns for investors. In addition, as a &#8220;non-accelerated filer,&#8221; we are exempt from the
provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation
report on the effectiveness of internal control over financial reporting. Decreased disclosures in our SEC filings due to our status as
a &#8220;non-accelerated filer&#8221; may make it harder for investors to analyze our results of operations and financial prospects and
may make our ordinary shares a less attractive investment.. Any actual or perceived weaknesses and conditions that need to be addressed
in our internal control over financial reporting or disclosure of management&#8217;s assessment of our internal control over financial
reporting may have an adverse impact on the price of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our ordinary shares could be delisted from the Nasdaq Capital Market.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Nasdaq has established certain standards for the
continued listing of a security on the Nasdaq Capital Market. The standards for continued listing include, <span style="font-style: italic">inter
alia</span>, that the minimum bid price for the listed securities be at least $1.00 per share. Under these rules, a security is considered
deficient if it fails to achieve at least a $1.00 closing bid price for a continuous period of 30 business days.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On December 23, 2021, we received a letter from
the Staff, indicating that we are not in compliance with the minimum bid price requirement for continued listing set forth in Listing
Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share, or the Minimum Bid Price Requirement.
We had 180 calendar days (i.e., until June 21, 2022) to regain compliance with the Minimum Bid Price Requirement pursuant to Nasdaq Listing
Rules.&#160; On June 22, 2022, we received a letter from the Staff notifying us that Nasdaq granted us a 180-day extension, until December
19, 2022 to regain compliance with the Minimum Bid Price Requirement.&#160; On November 23, 2022, we effected a 1-for-20 reverse share
split of our ordinary shares, in accordance with the approval of our shareholders at a meeting held on August 11, 2022.&#160; On December
9, 2022, following the increase of the share price in Nasdaq from November 25, 2022 to December 8, 2022, we were notified by Nasdaq that
we regained compliance with the minimum $1.00 bid price rule.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we are delisted from Nasdaq, our ordinary shares
may be eligible for trading on an over-the-counter market in the United States. In the event that we are not able to obtain a listing
on another U.S. stock exchange or quotation service for our ordinary shares, it may be extremely difficult or impossible for shareholders
to sell their ordinary shares in the United States. Moreover, if we are delisted from Nasdaq, but obtain a substitute listing for our
ordinary shares in the United States, it will likely be on a market with less liquidity, and therefore, experience potentially more price
volatility than experienced on Nasdaq. Shareholders may not be able to sell their ordinary shares on any such substitute U.S. market in
the quantities, at the times, or at the prices that could potentially be available on a more liquid trading market. As a result of these
factors, if our ordinary shares are delisted from Nasdaq, the price of our ordinary shares is likely to decline. A delisting of our ordinary
shares from Nasdaq could also adversely affect our ability to obtain financing for our operations and/or result in a loss of confidence
by investors, or employees.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We are a foreign private issuer and, as a result, we are not subject
to U.S. proxy rules and are subject to the Securities Exchange Act of 1934 reporting obligations that, to some extent, are more lenient
and less frequent than those applicable to a U.S. issuer.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We report under the Securities Exchange Act of
1934, as amended, or the Exchange Act as a foreign private issuer. Because we qualify as a foreign private issuer under the Exchange Act,
we are exempt from certain provisions of the Exchange Act that are applicable to U.S. public companies, including (i) the sections of
the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange
Act; (ii) the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and
liability for insiders who profit from trades made in a short period of time; and (iii) the rules under the Exchange Act requiring the
filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports
on Form 8-K, upon the occurrence of specified significant events. We intend to furnish quarterly reports to the SEC on Form 6-K for so
long as we are subject to the reporting requirements of Section 13(g) or 15(d) of the Exchange Act, although the information we furnish
may not be the same as the information that is required in quarterly reports on Form 10-Q for U.S. domestic issuers. In addition, while
U.S. domestic issuers that are not large accelerated filers or accelerated filers are required to file their annual reports on Form 10-K
within 90 days after the end of each fiscal year, foreign private issuers are not required to file their annual report on Form 20-F until
120 days after the end of each fiscal year. Foreign private issuers are also exempt from the Regulation FD (Fair Disclosure), aimed at
preventing issuers from making selective disclosures of material information. Although we intend to make interim reports available to
our shareholders in a timely manner, you may not have the same protections afforded to shareholders of companies that are not foreign
private issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">As a foreign private issuer, we are permitted, to follow, and follow
certain home country corporate governance practices instead of otherwise applicable Nasdaq requirements, which may result in less protection
than is accorded to investors under rules applicable to domestic U.S. issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As a foreign private issuer, we are permitted to
follow certain home country corporate governance practices instead of those otherwise required under the Listing Rules of the Nasdaq Stock
Market for domestic U.S. issuers. For instance, we follow home country practice in Israel with regard to, among other things, director
nomination procedures, the approval of compensation of officers and quorum requirements at general meetings of our shareholders. In addition,
we follow our home country law instead of the Listing Rules of the Nasdaq Stock Market that require us to obtain shareholder approval
for certain dilutive events, such as the establishment or amendment of certain equity based compensation plans, an issuance that will
result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or greater
interest in the company, and certain acquisitions of the stock or assets of another company. Following our home country governance practices
as opposed to the requirements that would otherwise apply to a United States company listed on Nasdaq may provide less protection to you
than what is accorded to investors under the Listing Rules of the Nasdaq Stock Market applicable to domestic U.S. issuers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If we lose our status as a foreign private issuer under the SEC&#8217;s
rules, our compliance costs will increase.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We would lose our foreign private issuer status
if more than 50 percent of our outstanding voting securities are directly or indirectly held of record by residents of the United States
and if a majority of our directors or executive officers are U.S. citizens or residents and we fail to meet additional requirements necessary
to avoid loss of foreign private issuer status. Although we have elected to comply with certain U.S. regulatory provisions, our loss of
foreign private issuer status would make such provisions mandatory. The regulatory and compliance costs for us under U.S. securities laws
as a U.S. domestic issuer may be significantly higher. If we are not a foreign private issuer, we will be required to file periodic reports
and registration statements on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available
to a foreign private issuer. We would also be required to follow U.S. proxy disclosure requirements, including the requirement to disclose
more detailed information about the compensation of our senior executive officers on an individual basis. We may also be required to modify
certain of our policies to comply with corporate governance practices associated with U.S. domestic issuers. Such conversion and modifications
will involve additional costs. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements
on U.S. stock exchanges that are available to foreign private issuers.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">22</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Exchange rate fluctuations between the U.S. dollar and the NIS and
the Euro and inflation may negatively affect our earnings and we may not be able to hedge our currency exchange risks successfully.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The dollar is our functional and reporting currency.
However, a significant portion of our operating expenses, including personnel and facilities related expenses, are incurred in NIS. As
a result, we are exposed to the risks that the NIS may appreciate relative to the U.S. dollar, or, if the NIS instead depreciates relative
to the U.S. dollar, that the inflation rate in Israel may exceed such rate of depreciation of the NIS, or that the timing of such depreciation
may lag behind inflation in Israel. In any such event, the dollar cost of our operations in Israel would increase and our dollar- denominated
results of operations would be adversely affected. In year 2022, the NIS depreciated by 13.15% relative to the U.S. dollar compared to
an appreciation of 3.266% in year 2021 and the Israeli rate of inflation increased by 5.3% and 2.8% during years 2022 and 2021, respectively,
and decreased by 0.7% in year 2020, and therefore has not had a material adverse effect on our financial condition during these years.
In addition, we may incur operating expenses denominated in Euros, and therefore, our operating results may also be subject to fluctuations
due to changes in the U.S. dollar/Euro exchange rate. We cannot predict any future trends in the rate of inflation in Israel or the rate
of devaluation (if any) of the NIS, the Euro and other foreign currencies against the U.S. dollar. Although we engage in currency hedging
arrangements from time to time, these measures may not adequately protect us from fluctuations in the exchange rates of the NIS, the Euro
and other foreign currencies in relation to the U.S. dollar (and/or from inflation of such foreign currencies), and involve costs and
risk of their own.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have never declared or paid a dividend and currently do not intend
to pay cash dividends in the foreseeable future. Any return on investment may be limited to the value of our securities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have never declared and do not anticipate paying
cash dividends on our ordinary shares in the foreseeable future. Our board of directors has discretion to declare and pay dividends on
our ordinary shares and will make any determination to do so based on a number of factors, such as our operating results, financial condition,
current and anticipated cash needs and other business and economic factors that our board of directors may deem relevant. In addition,
we are only permitted to pay dividends out of &#8220;profits&#8221; (as defined by the Israeli Companies Law, 1999, or the Israeli Companies
Law), provided that there is no reasonable concern that the dividend distribution will prevent us from meeting our existing and foreseeable
obligations, as they become due. If we do not pay dividends, our ordinary shares may be less valuable because a return on your investment
will only occur if the trading price of our securities appreciates. Further, you should not rely on an investment in us if you require
dividend income from your investments.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If securities or industry analysts do not publish research or reports
about us or our business or publish unfavorable research about us or our business, the price of our securities and their trading volume
could decline.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The trading market for our securities will depend
in part on the research and reports that securities or industry analysts publish about us or our business. We currently have limited research
coverage by securities and industry analysts. If one or more of the analysts who covers us downgrades our securities, the price of our
securities would likely decline. We do not have control over these analysts and we do not have commitments from them to continue to write
research reports about us or our business. The price of our ordinary shares could decline if one or more equity research analysts downgrade
our ordinary shares or if those analysts issue other unfavorable commentary or cease publishing reports about us or our business.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our stock price has and may be subject to fluctuation, and purchasers
of our securities could incur substantial losses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our stock price has been subject to considerable
fluctuation since our initial public offering in February 2015, with the closing price per share having varied from a low of $1.93 to
a high of $1,411.22, and may be subject to fluctuation in the future. The stock market in general has experienced extreme volatility that
has often been unrelated to the operating performance of particular companies. As a result of this volatility, investors may not be able
to sell their securities at or above the purchase price. The market price for our ordinary shares on the Nasdaq Capital Market may fluctuate
as a result of a number of factors, some of which are beyond our control, including, among others:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z0787e73aa6b8438c8591d52f541281ae" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we may not be able to develop C-Scan at the rate or to the stage we desire;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd7ee94d8c0bf4b0d81c13088a1719d01" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">inability to obtain the approvals necessary to commence further clinical trials;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4f167888d4b64dbb8f5d393270598834" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">unsatisfactory results of clinical trials;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze944957fa5714fe09eed5698f0df680e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">announcements of regulatory approval or the failure to obtain it, or specific label indications or patient
        populations for its use, or changes or delays in the regulatory review process;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbb8605e15a9c49cebc04e944b6b7f38b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">any intellectual property infringement actions in which we may become involved;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z8f13d977f51e40dda656c902ce05b220" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">announcements concerning our competitors or the medical device industry in general;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za3887bb283d146fb9a218ddf62cb2be1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">achievement of expected product sales and profitability or our failure to meet expectations;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z08a4152e93b844a9bbbfd09377655993" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our commencement of, or involvement in, litigation;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z94844ec316eb4a19a47f97d17169afb0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">any major changes in our board of directors or management;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z92e1c6dd86b842ec8bbad5a6d79cf47e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">legislation in the United States relating to the sale or pricing of medical device;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcdf79e33e35b411aa2ff305ba6b5c251" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">future substantial sales of our ordinary shares;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9e6cb9c1cf474c60aca6686386ad1a22" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">changes in earnings estimates or recommendations by securities analysts, if our ordinary shares are covered
        by analysts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcb98dcd8a0cb49d3891afd16ad4ce187" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the trading volume of our ordinary shares; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z346af96d0ddb4686baa2997870b09e2c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">natural disasters and political and economic instability, including wars, terrorism, political unrest,
        results of certain elections and votes, emergence of a pandemic, or other widespread health emergencies (or concerns over the possibility
        of such an emergency, including for example, the COVID-19 pandemic), boycotts, adoption or expansion of government trade restrictions,
        and other business restrictions.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, the stock market in general, and Nasdaq
Stock Market in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of small companies. Broad market and industry factors may negatively affect the market price of our ordinary
shares, regardless of our actual operating performance. Further, a systemic decline in the financial markets and related factors beyond
our control may cause our share price to decline rapidly and unexpectedly.</div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">23</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The trading market for our ordinary shares is not always active,
liquid and orderly, which may inhibit the ability of our shareholders to sell ordinary shares.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Since our initial public offering in February 2015,
the trading market for our ordinary shares has not always been active, liquid or orderly. The lack of an active market at times may impair
your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. The lack of an active market
may also reduce the fair market value of your shares. An inactive market may also impair our ability to raise capital by selling shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">In December 2020, we amended our articles of association to increase
our authorized share capital. There are certain risks associated with this increase.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In December 2020, our shareholders approved an
increase to our authorized share capital and to amend our Articles of Association accordingly. As a result, our authorized and registered
share capital is NIS 864,000,000 divided into 18,000,000 ordinary shares, nominal (par) value NIS 48 each. The increase of our authorized
share capital is designed to enable us to have sufficient authorized share capital that would allow us to meet our future business needs
as they arise. These needs could include, among other things, the sale of shares in public and private offerings to raise additional capital,
the purchase of property or assets, the use of shares for various equity compensation and other employee benefit plans and arrangements,
the declaration of share splits, and other bona fide corporate purposes. The possible future issuance of equity securities consisting
of ordinary shares or securities convertible into ordinary shares could affect our current shareholders in a number of ways, including
the following: (i) diluting the voting power of the current holders of ordinary shares; (ii) diluting the market price of the ordinary
shares, to the extent that the new ordinary shares are issued and sold at prices below current trading prices of the existing ordinary
shares, or if the issuance consists of equity securities convertible into ordinary shares, to the extent that the securities provide for
the conversion into ordinary shares at prices that could be below current trading prices of the ordinary shares; and (iii) diluting the
book value per share of the outstanding ordinary shares. Furthermore, the authorized shares could, in theory, also be used to resist or
frustrate a third-party transaction that is favored by a majority of the independent shareholders (for example, by permitting issuances
that would dilute the share ownership of a person seeking to effect a change in the composition of our board of directors or management
or contemplating a tender offer or other transaction for the combination of our company with another company).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We have broad discretion in how we use the net proceeds from our
financings, and we may not use these proceeds effectively.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Our management has broad discretion as to the application of
the net proceeds of our financings. Our shareholders may not agree with the manner in which our management chooses to allocate and spend
the net proceeds. Moreover, our management may use the net proceeds for corporate purposes that may not increase our market value.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Our business, operating results and growth rates may be adversely
affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions
and associated liquidity risk.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">Our business depends on the economic health of the global economies.
If the conditions in the global economies remain uncertain or continue to be volatile, or if they deteriorate, including as a result of
the impact of military conflict, such as the war between Russia and Ukraine, terrorism or other geopolitical events, our business, operating
results and financial condition may be materially adversely affected. Economic weakness, inflation and increases in interest rates, limited
availability of credit, liquidity shortages and constrained capital spending could negatively affect our financial condition, results
of operations or cash flows. In addition, the military conflict may affect the ability to purchase materials sourced in Russia.&#160;
For example, one of our suppliers sources the enriched X-ray isotope substance used in C-Scan from Russia and while we have sufficient
amounts of such material for our U.S. pivotal study, we could experience disruptions in our supply chain in the future if sanctions and
export control restrictions on Russian entities and individuals are still imposed, and we may not be able to find alternative sources
for such key material in a timely manner.</div> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, increases in inflation raise our costs
for commodities, labor, materials and services and other costs required to operate our business, and failure to secure these on reasonable
terms may adversely impact our financial condition. Additionally, increases in inflation, along with the uncertainties surrounding COVID-19,
geopolitical developments and global supply chain disruptions, have caused, and may in the future cause, global economic uncertainty and
uncertainty about the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional financing.
A failure to adequately respond to these risks could have a material adverse impact on our financial condition, results of operations
or cash flows.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif">More recently, the closures of SVB and Signature Bank and their
placement into receivership with the FDIC created bank-specific and broader financial institution liquidity risk and concerns. Although
the Department of the Treasury, the Federal Reserve and the FDIC jointly released a statement that depositors at SVB and Signature Bank
would have access to their funds, even those in excess of the standard FDIC insurance limits, under a systemic risk exception, future
adverse developments with respect to specific financial institutions or the broader financial services industry may lead to market-wide
liquidity shortages, impair the ability of companies to access near-term working capital needs, and create additional market and economic
uncertainty. There can be no assurance that future credit and financial market instability and a deterioration in confidence in economic
conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, liquidity shortages,
volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate,
or if adverse developments are experienced by financial institutions, it may cause short-term liquidity risk and also make any necessary
debt or equity financing more difficult, more costly, more onerous with respect to financial and operating covenants and more dilutive.
Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our strategy,
our financial condition, results of operations or cash flows and stock price and could require us to alter our plans. In addition, there
is a risk that one or more of our service providers, financial institutions, manufacturers and suppliers and other partners may be adversely
affected by the foregoing risks, which could directly affect our ability to attain our operating goals on schedule and on budget.</div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">Risks Related to
Taxation</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">There is a risk that we could be treated as a domestic (U.S.) corporation
for U.S. federal income tax purposes by reason of the transactions related to our acquisition of all of the business operations and substantially
all of the assets of Check-Cap LLC on May 31, 2009, or the Reorganization.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Section 7874(b) of the Internal Revenue Code of
1986, as amended, or the Code, generally provides that a foreign corporation (i.e., a corporation created or organized under the laws
of a jurisdiction outside of the United States) would be treated as a domestic (U.S.) corporation for U.S. federal income tax purposes
if, pursuant to a plan or a series of related transactions, (1) the foreign corporation acquires, directly or indirectly, substantially
all of the assets of a domestic corporation (or substantially all of the properties constituting a trade or business of a domestic partnership),
(2) after the acquisition, the former shareholders of the acquired corporation by reason of holding shares of the acquired corporation
(or, in the case of an acquisition with respect to a domestic partnership, the former partners of the domestic partnership by reason of
holding a capital or profits interest in the domestic partnership) own at least 80% of the stock (by vote or value) of the acquiring corporation,
and (3) after the acquisition, the expanded affiliated group that includes the acquiring corporation does not have substantial business
activities in the foreign country in which, or under the laws of which, the acquiring corporation is created or organized when compared
to the total business activities of such expanded affiliated group. On the basis of analysis of the relevant facts and circumstances and
the relevant law (including the temporary regulations under Section 7874 applicable at the time of the Reorganization), it was determined
that the third condition described in the preceding sentence was not met with respect to the Reorganization and, therefore, that the inversion
tax rules of Section 7874(b) would not apply to treat us as a domestic corporation for U.S. federal income tax purposes. However, since
this determination was made on the basis of all of the relevant facts and circumstances, and it is not clear which facts and circumstances
the Internal Revenue Service, or the IRS, may consider more important than others, this conclusion is not free from doubt.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If Section 7874(b) were to apply to the Reorganization
(and we were to be treated as a domestic corporation for U.S. federal income tax purposes), then, among other things, (i) we would be
subject to U.S. federal income tax on our worldwide taxable income (if and when we have taxable income); (ii) certain payments (e.g.,
interest and dividends) that we make (or have made) to our foreign investors may be (or may have been) subject to U.S. withholding taxes;
(iii) we may be subject to significant penalties for the failure to file certain tax returns and reports, including reports with respect
to our foreign bank accounts; and (iv) the U.S. unitholders of Check-Cap LLC would not have been subject to U.S. federal income tax on
royalties that are deemed to be paid to them under Section 367(d) of the Code as a result of the Reorganization. As discussed under Item
5B &#8220;Operating and Financial Review and Prospects &#8211; Liquidity and Capital Resources &#8211; Application of Critical Accounting
Policies and Estimates &#8211; Royalties provision &#8211; Reimbursement liability to Check-Cap LLC unitholders,&#8221; as part of the
Reorganization, we committed to reimburse the unitholders of Check-Cap LLC for any tax burdens that may be imposed on them due to the
Reorganization, including royalties that are deemed to be paid to the U.S. unitholders under Section 367(d) of the Code.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">24</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Prospective investors are urged to consult their
own advisors on these issues. The balance of this discussion, including the discussion under Item 10E &#8220;Additional Information &#8211;
Taxation &#8211; U.S. Federal Income Taxation,&#8221; assumes that we will be and have been treated as a foreign corporation for U.S.
federal income tax purposes.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">We may be eligible for tax benefits from government programs, which
require us to meet certain conditions, including regarding the location of our property, plant and equipment and manufacturing in Israel.
We can provide no assurance that we would continue to be eligible for such benefits and/or that any such benefits will not be terminated
in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our manufacturing facilities in Israel may qualify
as a &#8220;Benefited Enterprise&#8221; under the Israeli Law for Encouragement of Capital Investments, 5719-1959, which would entitle
us to receive certain tax benefits. In order to be eligible for such benefits, we would be required to meet certain conditions, including
the making of a minimum capital investment in our productive assets and the carrying on of a required portion of our manufacturing in
Israel. The amount of the benefit will be determined in accordance with various conditions, including the location of our property, plant
and equipment and the location of certain of our sub-contractors. If we cease to meet the required conditions for eligibility, the tax
benefits could be cancelled and we could be required to pay increased taxes or to refund the amounts of the benefits received with interest
and penalties. We can provide no assurance as to the amount of future capital investment in our productive assets, our future manufacturing
location and the future location of our property, plant and equipment and certain of our sub-contractors, and therefore, we cannot provide
assurance that we will be eligible for such tax benefits or assurance as to the amount of such tax benefits. Even if we continue to meet
the relevant requirements, the tax benefits that Benefited Enterprises receive may not be continued in the future at their current levels
or at all. If these tax benefits were reduced or eliminated, the amount of taxes that we would be required to pay would likely increase,
as all of our operations would consequently be subject to corporate tax at the standard rate, which could adversely affect our results
of operations. See Item 10E &#8220;Additional Information&#8212;Taxation&#8212;Israeli Tax Considerations and Government Programs&#8212;Law
for the Encouragement of Capital Investments, 5719-1959&#8221; for additional information concerning these tax benefits.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">There is a risk that we may be classified as a passive foreign investment
company, or PFIC, which could result in adverse U.S. federal income tax consequences to U.S. investors.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In general, we will be treated as a passive foreign
investment company, or a PFIC, for any taxable year in which either (1) at least 75% of our gross income (including our pro rata share
of the gross income of our 25% or more- owned corporate subsidiaries) is passive income or (2) at least 50% of the average value of our
assets (including our pro rata share of the assets of our 25% or more-owned corporate subsidiaries) is attributable to assets that produce,
or are held for the production of, passive income. Passive income generally includes dividends, interest, rents, royalties, and gains
from the disposition of passive assets. If we are determined to be a PFIC for any taxable year (or portion thereof) that is included in
the holding period of a U.S. Holder (as defined in Item 10E &#8220;Additional Information&#8212;Taxation&#8212;U.S. Federal Income Taxation&#8221;)
of our securities, the U.S. Holder may be subject to increased U.S. federal income tax liability upon a sale or other disposition of our
securities or the receipt of certain excess distributions from us and may be subject to additional reporting requirements. We believe
that we were a PFIC for the taxable year ended December 31, 2022 and may be a PFIC for the taxable year ending December 31, 2023. Our
actual PFIC status for our current taxable year or any subsequent taxable year is uncertain and will not be determinable until after the
end of such taxable year. Accordingly, there can be no assurance with respect to our status as a PFIC for our taxable year ending December
31, 2023 or any subsequent taxable year.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">U.S. investors are urged to consult their own tax
advisors regarding the possible application of the PFIC rules. For more information, see Item 10E &#8220;Additional Information&#8212;Taxation&#8212;U.S.
Federal Income Taxation&#8212;U.S. Holders&#8212;Passive Foreign Investment Company Rules.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 4<span id="ITEM4"><!--Anchor--></span>. INFORMATION ON OUR COMPANY</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">History
and Development of the</span>&#160;<span style="font-weight: bold">Company Our History</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our legal and commercial name is Check-Cap Ltd.
We were formed as a company in Israel on April 5, 2009. On May 31, 2009, we acquired all of the business operations and substantially
all of the assets of Check-Cap LLC, a Delaware limited liability company formed in December 2004. On May 15, 2015, we formed our wholly-owned
subsidiary Check-Cap US, Inc., a Delaware corporation.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On February 24, 2015, we successfully completed
an initial public offering in the United States and the listing of our securities on the Nasdaq Capital Market.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are subject to the provisions of the Israeli
Companies Law. Our principal executive offices are located at Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000,
Israel. Our telephone number is +972-4-8303400 and our website is located at <span style="text-decoration: underline">www.check-cap.com</span>&#160;(the
information contained therein or linked thereto shall not be considered incorporated by reference in this Annual Report). Our U.S. agent
is Puglisi &amp; Associates, located at 850 Library Avenue, Suite 204, Newark, Delaware 19711.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We use our website (<span style="text-decoration: underline">http://www.check-cap.com</span>)
as a channel of distribution of company information. The information we post through this channel may be deemed material. Accordingly,
investors should monitor our website, in addition to following our press releases, SEC filings and public conference calls and webcasts.
The contents of our website are not, however, a part of this Annual Report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Principal Capital Expenditures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For a discussion of our capital expenditures, see
Item 5 &#8220;Operating and Financial Review and Prospects&#8212;Liquidity and Capital Resources.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Business</span>&#160;<span style="font-weight: bold"></span></div>

<div style="margin-right: 479.1pt; margin-left: 7.4pt; line-height: 1.25"><span style="font-weight: bold"> <br /> </span></div>

<div style="line-height: 1.25"><span style="font-weight: bold">Overview Our Company</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are a clinical stage medical diagnostics company
aiming to redefine CRC screening through the introduction of C-Scan&#174;, the first and only patient-friendly preparation-free test designed
to detect polyps before they may transform into cancer to enable early intervention and cancer prevention.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The disruptive capsule-based screening technology
aims to increase screening adherence worldwide and enable millions of people to stay healthy. The system utilizes ultra-low-dose X- rays
to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. CRC is the third most commonly diagnosed
cancer, with more than 1.9 million new cases identified every year globally. Nearly 935,000 deaths occur annually worldwide as a result
of CRC. While approximately 0.5% of the average-risk screening population presents with cancerous polyps in the colon and rectum at any
given time, approximately 25% of the same population presents with benign polyps that could potentially turn into cancer over time. It
can take up to 10 years before a pre-cancerous polyp develops into invasive cancer. As such, there is a crucial detection window for the
prevention of colorectal cancer, through the detection of these benign polyps. While routine screening is recommended by The American
Cancer Society for healthy people aged 45 years and older, screening adherence remains low. Currently, colonoscopy is the gold standard
for the detection of colorectal polyps, but about 1 in 3 adults among the targeted screening population avoids having a colonoscopy in
the U.S., and adherence in other regions of the world such as Europe and Asia is even lower, due to the invasiveness of the procedure
and bowel preparation. Most patient-friendly CRC screening tests currently available, or poised to enter the market, such as fecal or
liquid biopsy tests, are primarily designed to detect cancer and demonstrate low sensitivity in detecting pre-cancerous polyps. As such,
they do not necessarily provide patients with the time window to pre-empt the disease. C-Scan is non-invasive and requires no bowel cleansing
or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal
tract by natural motility. C-Scan is comprised of three main components: (1) C-Scan Cap, an ingestible X-ray scanning capsule; (2) C-Scan
Track, three miniaturized patches worn on the patient&#8217;s back for integrated positioning, control and data recording; and (3) C-Scan
View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon. We believe that this solution
has the potential to become an alternative for both physicians and patients and to increase the number of people completing CRC screening.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">25</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our C-Scan Cap is swallowed and propelled by natural
motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection (currently, during clinical
trials in the U.S., the C-Scan capsule is not intended to be disposed of in the sanitary sewer system, and is therefore collected by the
patient, and returned to the medical facility administering the device for further decay and disposal). Unlike other existing CRC screening
methods, this process should not disrupt a patient&#8217;s normal activities or require fasting. Our C-Scan Cap employs ultra-low-dose
X-rays, which allow the C-Scan system to scan the interior lining of the colon even when surrounded by intestinal content. As such, we
believe that patients using C-Scan will not be required to undergo any prior bowel cleansing.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our C-Scan Cap is being designed to transmit position,
motility and the data it collects to the C-Scan Track that will be attached to the patient&#8217;s back. The external data recorder is
being designed to enable the download of the data to our C-Scan View application to allow physicians to analyze the data collected by
our C-Scan Cap. The C-Scan Track is being designed to provide the physician with localization data aligned with a reconstructed image.
We intend for physicians to be able to review the colon&#8217;s inner structural information.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Colonic polyps are tissue growths that occur on
the lining of the colon. Polyps in the colon are common, and certain types of polyps may become cancerous over time. In the event that
polyps are identified by C-Scan, the patient may be advised to undergo a subsequent traditional colonoscopy procedure to examine, remove
and biopsy the polyps. For those patients who require a subsequent colonoscopy, concerns regarding pain, discomfort and embarrassment
may still remain. We do not, however, believe that these concerns will make the use of C-Scan any less attractive to physicians and patients.
Although patients who are initially screened utilizing a traditional colonoscopy could avoid the need for a second colonoscopy if polyps
are discovered, we believe that C-Scan will still be attractive to physicians and patients who object to or cannot undergo a colonoscopy
as a large number of these patients if screened will not require a subsequent colonoscopy and those found with suspicious findings, will
likely agree to undergo colonoscopy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We initiated our first clinical studies in 2010,
consisting of two single-center feasibility studies with non-scanning (no X-ray source) capsules for the purposes of measuring gastrointestinal
tract activity, colon contractions and associated capsule motility, and shortening capsule transit time.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In 2013, we initiated a multi-center prospective
clinical feasibility study, designed to allow for the recruitment of 100 subjects, to establish clinical proof of concept, safety and
functionality of C-Scan in patients eligible for CRC screening. Analysis conducted on the first 66 capsules swallowed by participants
showed that 65 of 66 capsules swallowed were naturally eliminated, without major or minor side effects, after 62&#177;40.7 hours. The
average calculated radiation exposure was 0.06 &#177; 0.04 mSv (similar to a single chest radiograph). Both pedunculated and sessile polyps
were detected in several patients and validated later by colonoscopy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In September 2017, we completed a multi-center
study of C-Scan in support of CE Mark submission. The objective of the study was to assess safety and the clinical performance of C- Scan
in detecting patients with polyps. The three-center trial enrolled 66 patients, with a mean age of 59 years. Following capsule ingestion,
subjects swallowed small doses of contrast agent and fiber supplements with each meal throughout capsule passage. Average capsule transit
time was 52&#177;32 hours, and the average total X-ray dose was 0.05 mSv (CT colonography effective dose is ~ 6.0 mSv). No bowel preparation,
sedation, or change in diet was required. Both confirmatory colonoscopy, performed by an independent investigator, and C-Scan review,
performed by a central review group, were blinded to results. The study demonstrated a 44% sensitivity in the 45 subjects included in
the analysis for polyps, with specificity (ability to correctly identify lack of polyps) of 89%. Sensitivity strongly correlated (R-squared
= 0.98) to the percentage of the colon scanned. Sensitivity was 78% (p&lt;0.05) and 100% (p&lt;0.05) for subjects where greater than 50%
and 70% of the colon was scanned, respectively. Specificity was consistent for all subjects.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In the fourth quarter of 2017, we initiated an
interim clinical study for the purpose of introducing an advanced version of C-Scan, Version 3, which incorporated the then latest algorithms
and system optimization and tailored scanning of the colon to the patient&#8217;s natural colonic movements to maximize the amount of
the colon that is tracked and imaged. In March 2018, we announced results from the interim study. Evaluable results of 21 patients showed
average colon imaging coverage of 64%, a 40% improvement over 46% average colon imaging coverage in the multi-center study. Sensitivity
was 78% (p&lt;0.05) for subjects with greater than 50% colon imaging coverage and 100% (p&lt;0.05) for subjects with greater than 70%
colon imaging coverage. Specificity was consistent at around 89%.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Following our certification to ISO 13485:2016 by
our Notified Body, and completion of our multi-center clinical study and achievement of compliance with the requirements of the Medical
Devices Directive, in September 2017, we submitted a request for CE marking for the marketing and sale of C-Scan in the European Union.
We received the CE Mark certification from our notified body (DEKRA - 0344) on January 9, 2018 and a renewal certificate according to
MDR (EU Regulation 2017/745) was granted on January 12, 2022, which is valid until December 1, 2026. In September 2018, we received approval
from AMAR for the marketing and sale of C-Scan in Israel. Following the MDR approval we received from our notified body according to the
EU Regulation 2017/745, the AMAR approval was renewed and is valid until December 31, 2024.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">During the first quarter of 2018, we initiated
a multi-center, open label, home monitoring, prospective study designed to determine the performance characteristics of C-Scan system
Version 3, for detecting pre-cancerous polyps compared with the fecal immunochemical test (FIT), in each case using colonoscopy as the
reference method, for the purpose of collecting additional evidence of clinical effectiveness and clinical utility to support market adoption.
The study included 90 evaluable patients who either had known polyps or were considered to be of average risk. Each patient ingested a
C-Scan capsule and also underwent a FIT and a comparative colonoscopy performed by independent gastroenterologists, who were blinded to
the corresponding test&#8217;s results. The C-Scan clinical evaluation was obtained using the evaluable patient population implementing
a gender-based motility analysis and the results of both C-Scan and FIT were compared to colonoscopy. The primary efficacy endpoint of
the study was sensitivity (ability to correctly identify patients with polyps) and specificity (ability to correctly identify patients
with lack of polyps) of the C-Scan system compared to FIT in detecting subjects with polyps &#8805;10 mm. In July 2019, we announced final
results from our post-CE approval study. The results demonstrate that C-Scan achieved a sensitivity of 76% (p=0.0005) in patients with
polyps &#8805;10 mm, while FIT achieved a sensitivity of 29% (p=0.005) in patients with polyps &#8805;10 mm. C- Scan achieved a specificity
of 82% in all patients, while FIT achieved a specificity of 96% in all patients. In addition, C-Scan detected all 4 patients (100%) with
polyps &#8805;40 mm, while the FIT detected only 1 of the 4 patients (25%) with polyps &#8805;40mm. Overall, C-Scan achieved a sensitivity
of 66% (p=0.01) in all patients, including patients with polyps &lt;10mm, while FIT achieved a sensitivity of 23% (p&lt;0.0001) in all
patients, including patients with polyps &lt;10mm. In total, 142 patients enrolled in the study and after factoring in technical and physiological
dropouts and protocol violations, the number of evaluable patients was 90. No serious adverse events were reported, and the adverse events
were mild in severity.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We conducted pre-submission meetings with the FDA
during the period of December 2016 and February 2017 for the purpose of receiving feedback on the regulatory pathway for our system in
the United States. We also sought feedback on a proposed protocol for a feasibility or pilot study, the primary purposes of which is to
establish the safety of the C-Scan system and evaluate user compliance and satisfaction. In December 2018, we received from the FDA conditional
approval of our IDE application to initiate a U.S. pilot study of C-Scan and received final approval from the FDA in February 2019.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In April 2019, we initiated the U.S. pilot study
of C-Scan. The U.S. pilot study (NCT03735407 ) was a prospective, multi-center, open label, single arm study was designed to evaluate
the safety, usability and subject compliance of the C-Scan system. The study included 28 evaluable patients, more than two thirds of whom
were considered to be of average risk for colorectal cancer. Each patient ingested a C-Scan capsule and also underwent a fecal immunochemical
test (FIT) as well as a comparative colonoscopy, which was performed by an independent gastroenterologist who was blinded to the corresponding
test results. The study was performed at two sites, the NYU Grossman School of Medicine and Mayo Clinic, Rochester. The primary endpoint
of the study was to evaluate the incidence of device or procedure related serious adverse events. Secondary endpoints included patient
compliance, subject satisfaction and device and procedure related performance. Due to sample size, the study was not designed to be powered
for statistical significance. In December 2019, we announced the results of the pilot study. No device or procedure related serious adverse
events (SAEs) were reported and all device or procedure related adverse events were mild in severity. In total, 45 patients enrolled in
the study, of which 40 patients underwent the study procedure. 39 patients complied with the procedure and completed a questionnaire following
the procedure and reported higher satisfaction with the C-Scan System procedure compared to colonoscopy. A total of 28 patients were evaluable
after factoring in technical and physiological dropouts and protocol violations. Analysis of the evaluable patient results revealed agreement
between C-Scan and colonoscopy in detection of polyps was consistent with data from the post-CE approval study.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In preparation for our U.S. pivotal study, we have
continued to optimize C-Scan&#8217;s functionality and patient experience by additional clinical data collection in a study in Israel,
using advanced C-Scan versions, which incorporate mainly advanced algorithms, improved detection capability and reduced energy consumption.
During the current study in Israel, we initially enrolled both average risk and high-risk patients (e.g., &#8220;enriched population&#8221;)
and in May 2022, shifted to enrollment of only average risk patients, for the purpose of further calibration of the C-Scan system, in
parallel to conducting the first stage of the U.S. pivotal study that was initiated in May 2022, as described below.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">26</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In November 2020, we finalized our proposed U.S
pivotal study design and submitted our IDE application to the FDA and in March 2021, our IDE application was approved by the FDA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In January 2022, we submitted to the FDA an amended
IDE application to amend the U.S. pivotal study design to add a first part to the study that is designed to enable further calibration
of the C-Scan system and enhancement of C-Scan algorithms, specifically for the average risk U.S. population and in February 2022, our
IDE amended application was approved by the FDA. Following this amended IDE, the U.S. pivotal study consists of two parts. The first part
is designed to enable further calibration of the C-Scan system for the average risk U.S. population, and is intended to include up to
200 patients in the U.S. The second part is a statistically powered, randomized study which will compare the performance of C-Scan to
traditional colonoscopy, and is intended to include up to 800 patients.&#160; The goal of the pivotal study in the United States is to
(i) demonstrate device safety as evidenced by a lack of device related serious adverse events; and (ii) provide efficacy data concerning
C- Scan&#8217;s performance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In May 2022, we initiated the first part of the
U.S. pivotal study. In December 2022, we submitted an IDE supplement to the FDA to include enrollment of patients at age 45-75 instead
of 50-75, which was approved by the FDA in January 2023.&#160;&#160; To date, we have enrolled more than 300 average risk patients as
part of our Israeli study and only 17 average risk patients in the first part of our U.S. pivotal study, mainly as a result of slower
than expected U.S. site recruitment pace, due to licensing requirements with local states associated with the X-ray technology within
our C-Scan capsule. The initiation of the powered potion of the U.S. pivotal study was dependent upon successful completion of the calibration
portion of the U.S. pivotal study.&#160; Following our internal assessment of the clinical data collected to date from our calibration
studies, we have determined that the current efficacy results do not meet our goal in order to proceed to the powered portion of the U.S.
pivotal study.&#160; As a result, we have adopted a plan of action that includes conducting additional clinical data analysis and approaching
the FDA to make amendments to the U.S. pivotal study protocol that are expected to be part of an IDE supplement submission to the FDA,
and which are subject to FDA approval. In addition, we plan to continue conducting our calibration studies, albeit at a slower pace, to
collect additional clinical data and we also implementing a cost reduction plan, in order to extend our cash runway. The initiation of
the powered portion of the U.S. pivotal study that was expected in mid-2023 is therefore temporarily postponed.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Following and subject to the successful completion
of our U.S. pivotal study and available capital, our current strategy is to submit a direct de novo reclassification petition for FDA
approval for the marketing of C-Scan in the United States. Direct de novo reclassification typically takes at least 9 to 12 months from
filing to clearance if there are no comments or disapproval from the FDA. If the FDA determines that C-Scan is not a candidate for de
novo reclassification, it will require approval of the device for market through the PMA process. The PMA pathway is much more costly
and uncertain than the 510(k) clearance process or de novo reclassification, and generally takes at least 12 to 18 months, or even longer,
from the time the application is filed with FDA to ultimate approval if there are no comments or disapproval from the FDA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Since our formation, we have not generated any
revenue. We do not anticipate generating any significant revenue for the foreseeable future and we do not yet have any specific launch
dates for our product. We incurred net losses of $19.1 in 2022, $17.2 million in 2021, and $13.8 million in 2020. As of December 31, 2022,
we had an accumulated deficit of $127.3 million and a total shareholders&#8217; equity of $41.3 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Our Solution</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">CRC screening can reduce the incidence of and mortality
from the disease by enabling detection of precancerous polyps in the colon at an earlier, more treatable stage. CRC is one of the few
cancers that can be prevented through screening because pre-cancerous polyps, from which colon cancers often develop, can be identified
and removed. Today, there is a range of options for CRC screening in the average-risk population, with current technology falling into
two general categories: (i) structural exams that enable physicians to visualize the colon for abnormalities, such as optical colonoscopy
(which is currently regarded as the &#8220;gold standard&#8221; for CRC screening), sigmoidoscopy, CTC and optical capsules. All such
exams require aggressive bowel preparation and are invasive exams; and (ii) stool and serum based tests, such as FOBTs, FITs, stool DNA,
and blood tests, which test for blood in stool and irregularities in blood and DNA. Notwithstanding the many CRC screening alternatives
and despite the fact that the tests are encouraged by clinicians and insurers and the proven clinical value of screening for CRC, a large
portion of the population is still reluctant to perform CRC screening.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan is designed to enable early detection of
precancerous polyps while providing a patient friendly solution without requiring any colon cleansing. The purpose of C-Scan is to detect
colorectal polyps in subjects who, based on demographics and medical history factors, are considered average risk for CRC. If polyps are
detected, the patient is elevated to high risk for CRC, which studies have shown increases the adherence of patients to undergo a colonoscopy
procedure. If a positive result is obtained through the C-Scan, the patient should be referred to colonoscopy.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Although C-Scan utilizes X-Ray technology (exposing
the patient to approx. 0.05 mSv), we believe that the potential risks associated with such radiation exposure are low compared to the
potential risks associated with other procedures such as perforation, bleeding or sedation related effects (optical colonoscopy and sigmoidoscopy)
and dehydration and damage to kidneys. Unlike FOBTs, FITs and stool DNA tests, our capsule-based imaging modality generates structural
information on the colon, which could assist in the detection of pre-cancerous polyps. We therefore do not believe that the ultra-low-dose
radiation in our capsule will make C-Scan less attractive to physicians and patients than other less-effective products that do not employ
any radiation.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Radiation Safety Division of the Soreq Nuclear
Research Center found, as set forth in its report of November 2010 that was prepared at our request and based on the information provided
by us and the relevant methods and principles known at such time, or the Report, that the radiation dose to the patient in the proposed
screening procedure utilizing the scanning device developed by us at that time in routine operation and normal conditions is low relative
to the radiation dose involved in conventional imaging procedures using X-rays (such as fluoroscopy and CT) and is also low when compared
to the radiation dose involved in established screening procedures such as mammography, all as more fully described in the Report In addition,
Michael S. Gossman, M.S., DABR, FAAPM, FACR, the Chief Medical Physicist in Radiation Oncology and Radiation Safety Officer, Regulation
Directive Medical Physics, concluded, as set forth in his report dated November 14, 2018 that was prepared at our request and submitted
to the FDA in connection with the IDE application for the U.S. pilot study, following analysis of both normal capsule transit and extreme
conditions, that C-Scan is radiation dose safe for medical diagnostics and exposes patients to very low dose radiation during normal operation
and that even in extreme and unlikely scenarios, patient exposure to radiation is unlikely to cause severe harm to patients undergoing
the C-Scan procedure.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We believe that gastroenterologists will adopt
our technology and recommend the use of our capsule. This may increase the number of people undergoing CRC screening and may encourage
more people with polyps to undergo a polypectomy &#8211; a therapeutic procedure during which polyps are removed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our goal is to become a leading supplier of CRC
screening technology and to establish our technology as a leading CRC screening method. Key elements of our strategy include:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zfe18aee5fcae44b38dafb0b567ee8a5d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">seeking to obtain regulatory approvals for the sale of C-Scan in the United States;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z81b1c47ac42443ea8ee66571c7d68087" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">enter into partnerships in the future when strategically attractive, including potentially with major medical
        device companies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zcb828bdf02c54b24bf19ce168d2ef1b7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">obtaining government and private third-party reimbursement for our technology;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z15d50eea697f41fd9f0b3a82091094f3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">improving and enhancing our existing technology portfolio and developing new technologies; and</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z950b2ea3e13a4f6286ed787d763e5705" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">successfully marketing our product to establish a large customer base, primarily in the U.S.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">27</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Our Technology</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our technology is based on an ingestible capsule
(C-Scan Cap), which is swallowed by the patient and propelled by natural motility through the gastrointestinal tract. Our capsule transmits
information to a receiving device (C-Scan Track) worn on the patient&#8217;s body that stores the information for off-line analysis. Our
C-Scan Cap consists of an X-ray source and several X- ray detectors. The X-ray source is contained in a rotating radiation shield, enabling
the generation of 360-degree angular scans. The collection of successive angular scans is intended to enable the virtual reconstruction
of a portion of the colon&#8217;s inner surface. During movement of our capsule longitudinally through the colon, successive images of
portions of the colon enable the three- dimensional reconstruction of the colon. C-Scan is also intended to enable structural identification
of polyps, and masses, which protrude inward into the colon, through the detection of irregularities in the topography of the colon&#8217;s
inner surface.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan is intended to be prescribed to patients
by physicians. Prior to capsule ingestion, patients will swallow 15ml of iodinated oral contrast medium, three times a day, combined with
oral fiber, and continue to do so in order to enhance the contrast of the colon surface. The capsule is propelled by natural motility
through the gastrointestinal tract. During transit, information is transmitted to the C-Scan Track, which stores the information for off-line
analysis. After our C-Scan Cap is expelled from a patient&#8217;s body, the C-Scan Track data will be downloaded into our workstation
(C-Scan View) and uploaded to a cloud-based server, through which an expert analyst will perform pre-analysis to be followed by a physician&#8217;s
final interpretation that includes a findings report and a determination of whether the patient is considered average or elevated risk.
Currently, our internal analysts are expected to perform the complete interpretation of the data and prepare a report accordingly. We
anticipate that we will begin involving physicians in this process upon the initiation of the statistically powered portion of the U.S
pivotal study. Our proprietary software is being designed to process the data and produce a two and three-dimensional visualization of
the colon&#8217;s inner surface.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan consists of the following three main subsystems
that together enable the generation of high-resolution 3D imaging of the colon&#8217;s inner surface, further described below: (i) an
ultra- low-dose X-ray based colon scanning capsule (C-Scan Cap); (ii) C-Scan Track; and (iii) a client\server PC-based application (C-Scan-View).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan system enables a patient-friendly, preparation
free and painless evaluation of colorectal abnormalities. Using the C-Scan system, suspicious findings that may be colorectal polyps can
be identified, thus assisting the physician in deciding to elevate the patient to high-risk category and refer the patient to a colonoscopy
procedure. Studies have shown that the adherence of an elevated-risk patient to undergo a colonoscopy procedure is higher than that of
an average risk patient.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan system provides information for the
physician, enabling him to make a &#8220;YES / NO&#8221; decision for suspected presence of polyps in the colon, based on the premise
that the presence of polyps in the colon is associated with the potential development of CRC. The C-Scan system is intended to be used
as a preliminary tool to assist in the detecting of subjects who are at elevated risk for polyps and thus may increase the adherence of
those subjects to undergo colonoscopy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan system is designed to evaluate the presence
of polyps, without the need for fasting and prior bowel cleansing, through identifying suspects in the human colon supported by physiological
data, such as measured transit time of the capsule through the GI tract.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan system presented in Figure 1 includes
three main units, C-Scan Cap, C-Scan Track and C-Scan View. The C-Scan procedure steps are illustrated in Figure 2. The C-Scan Track is
attached to the patient&#8217;s back, after which, the patient ingests the C-Scan capsule. The capsule starts moving through the patient&#8217;s
gastrointestinal system until it reaches the colon where it starts scanning the colon walls and transmitting the acquired data to the
C-Scan Track. Following the natural excretion of the capsule, the patient returns the C-Scan Track to enable data loading and analysis
using C-Scan View. The analysis report includes an indication of either &#8220;NO- Average Risk&#8221; in cases where no suspicious findings
were identified or &#8220;YES- Elevated Risk&#8221; in cases where suspicious findings were identified. An operational block diagram is
presented below in Figure 4.</div>

<div style="text-align: center; line-height: 1.25">

<div> <br /> </div>

<div>Figure 1: Illustration of C-Scan system units</div>

<div><br /> </div> <img src="image1.jpg" alt="" style="width: 309px; height: 115px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">&#160;

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.7pt; line-height: 1.25">Figure 2: Illustration of C-Scan system
procedure</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div style="line-height: 1.25">

<div style="text-align: center; line-height: 1.25"><img src="image00014.jpg" alt="" style="width: 971px; border: black 0px solid; height: 126px" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">C-Scan Cap</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan Cap is an X-ray scanning capsule, which
enables detection of suspected polyps. C-Scan Cap is ingested by the patient and propelled by peristalsis, natural motility, it passes
through the gastrointestinal tract and is excreted naturally, with either no need for retrieval or required retrieval of the capsule,
depending on the local agency guidance ( currently, during clinical trials in the U.S., the C-Scan capsule is not intended to be disposed
of in the sanitary sewer system, and is therefore collected by the patient, and returned to the medical facility administering the device
for further decay and disposal.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">C-Scan Cap is designed to measure, collect and transmit structural information, and
is comprised of the following components:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z204158f947654c15bdc276a718e382d9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">X-ray Source &#8211; Including radioactive material sealed in a cylindrical housing.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z5c1002ab64ad4ed7a664127f139ca854" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Collimator &#8211; Radiation shield around the source, which absorbs most of the radiation. Several radial
        holes enable emission of radiation in defined directions.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z34090c13f5334419b2f9a1224d7f794b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">X-ray Sensor &#8211; Comprised of several solid state X-ray detectors for measuring the scattered radiation
        intensity.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6cc4776693d84d6c87ff5bc657f28e25" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Tilt Sensor &#8211; Indication of capsule motion (3D acceleration).</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbcd0085e68094032a730291354333f18" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Rotation Motor &#8211; For rotating the collimator and X-ray Source.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">28</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z64b1882f864f45fa816a0b51176c7290" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Compass sensor &#8211; Indication of true north (reference coordinate system).</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z1baa88a80d6e42bd953d427442fa0f82" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Pressure sensor &#8211; indicating the hydrostatic pressure inside the colon.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zea2cb52739cb4580b5a0e69079ffaeeb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Source Concealment Mechanism &#8211; Conceals the source inside the radiation shield.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z8c89a5c9860a42449782a3dbb8f64f8c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">R-T &#8211; Radio frequency transceiver device to communicate with the receiver.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z0be7f8221086435b85e0951032818b5d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Batteries &#8211; Electrical power supply for the capsule.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf3a39a68d2a24227bf4b4cc1259eaee4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Memory &#8211; Data storage. The capsule should be able to store up to an hour of measured data.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze633228816994b64b5a92ae13c85a744" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">C-Scan Track Coil &#8211; Transmits a continuous electromagnetic field utilized by an external localization
        system to track 3D position.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; line-height: 1.25">

<div style="margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration purpose only<br />
<br /> </div> <img src="image3.jpg" alt="" style="width: 240px; height: 135px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">&#160;

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25">Figure 3: C-Scan Cap</div> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic"><br /> </div>

<div style="text-align: center; line-height: 1.25"><img src="image4.jpg" alt="" style="width: 76px; height: 43px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">C-Scan Track</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan Track is a small, disposable system attached
to the patient&#8217;s back via biocompatible adhesive skin patches. C-Scan Track communicates with the C-Scan Cap and enables data download
for analysis purposes. Both the C-Scan Track and C-Scan Capsule are equipped with an electromagnetic capability allowing for capsule position
and orientation estimations through the C-Scan Track. A dedicated scan control algorithm (SCA) identifies the C-Scan Cap&#8217;s movements
in the colon and, accordingly, commands the C-Scan Cap when to perform a scan. C-Scan Track also measures the transit time from capsule
ingestion to excretion through radio frequency communication to a non-volatile memory device, and enable data retrieval, to an external
processor.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan Track is comprised of the following
components:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6ce68b3c06974691b693c88818b00c88" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Sticker Housings &#8211; Biocompatible and water-resistant stickers and housing integrating all functional
        components, attached to the patient&#8217;s back, enabling approximately five days of continuous operation.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd32a3d9c0e104a2497dad0643d7206a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Recorder &#8211; Consists of receiver electronics embedded software and nonvolatile memory.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zce14e99e5f69445e8d219974740f9cbb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Antennas &#8211; Radio frequency antennas are embedded into the sticker housings and used to communicate
        with the capsule.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb2909e6c84514185b0bd58c9411c1958" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Activation/Deactivation Circuit &#8211; Used to activate/deactivate the C-Scan Track through a specialized
        protocol.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf59fa85132e14d6e925a82c258f91b89" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">UI Indicators &#8211; Provides user with vocal and vibration indication as required.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zfd88e6979b944dd897b0a1ef0fb991f2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">PCB &#8211; Electronics&#8217; printed circuit boards.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze1b88cfd5b034254b72a2eff843feb6d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Microcontroller &#8211; Runs embedded software, logic that manages the C-Scan Track and SCA.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9456af8cfde842a0b4bbdeff93ad1c35" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">RF Transceivers &#8211; Several transceivers used to communicate with the capsule.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z56a78b1e66194a8d89b01ae694ad315d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">TILT/Compass Sensors &#8211; To determine the patient&#8217;s body movements.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zc91c752864af410f9a9814d8802f11c3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Batteries &#8211; Electrical power supply for the C-Scan Track.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zc463d709afe54967a38dadff3fdc76dc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Memory &#8211; Non-volatile data storage to store data acquired by the system.</div> </td> </tr>
  </table>

<div style="text-align: center; line-height: 1.25"> <br />

<div>

<div>

<div style="line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Image for illustration purpose only</div>
</div>

<div><br /> </div> <img src="image5.jpg" alt="" style="width: 79px; height: 45px" /></div> <br />

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">29</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> <br /> <br /> </div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">C-Scan View</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan View software is a client/server-based
application that enables procedure data download from the C-Scan Track, data analysis and report generation. The C-Scan View&#8217;s main
functions are:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze3e4c8fa06bf46c18039cb0bf0971c9d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Load and display procedure information and data;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zeeedfc9a30f9478cbba340f638699849" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Image review, enabling the user to view structural information of the colon wall;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z8be29d6457944bd38591d7f426840183" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Produce procedure report; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z436b638d2e75409fa05e9a7fabd78159" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Store procedure results on server.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The data from the C-Scan Track is loaded and processed
to create a reconstruction model of the colon wall, which is displayed in the C-Scan View as structural information of the colon wall,
as well as Whole-Gut-Transit-Time (WGTT) data. The data is analyzed by a team that includes expert analysts, who review the structural
information to identify suspicious findings that are protruding or bulging on the colon wall. The analysts consider capsule&#8217;s WGTT
as part of the analysis process. The gastroenterology physician reviews the analysis in the C-Scan View and generates the final report
as to whether the patient is assessed to be at average or at elevated risk, determined through a combined analysis consisting of both
structural analysis and transit time analyses.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25">

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25">Figure 4: Conceptual block-diagram of
the C-Scan system</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25"> <br /> </div> </div>

<div style="text-align: center; line-height: 1.25"><img src="image6.jpg" alt="" style="width: 268px; height: 100px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">C-Scan System Non-Clinical and Clinical History</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have developed and validated our capsule-based
imaging modality for providing structural information on colonic polypoid lesions and masses for CRC screening. Below is a summary of
the validation tests carried out by us in the laboratory, in phantoms, animals and humans, which were designed to evaluate this new imaging
modality&#8217;s performance and potential clinical value.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Non-Clinical Testing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Imaging Performance Testing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The C-Scan Cap transmits data as it transits the
colon. This data consists of imaged slices perpendicular to the capsule&#8217;s longitudinal axis; slices are then reconstructed by the
C-Scan View to produce 2D and 3D images of the inner surface of the colon. Following are performance measurements of the capsule imaging.</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6c3f6048578f4c50b66acb1cacf8ea9b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-style: italic">Modulation Transfer Function, or MTF</span>. The capsule was moved along
        a longitudinal-edge phantom setup in 3mm steps. The figure below shows a typical raw signal after filtering for peak detection. The same
        test was carried out using an angular-edge phantom setup, which demonstrated similar results to those shown below. These tests do not
        take into account noise characteristics.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">

<div><br /> </div>

<div style="text-align: center">

<div style="margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration purpose only</div>

<div style="margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic"> <br /> </div> </div>

<div style="text-align: center"><img src="image7.jpg" alt="" style="width: 93px; height: 52px" /></div> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For each position of the capsule in the phantom,
the mean signal intensity (peak) was measured, the result of which is shown in the right figure below. Resulting line spread function,
or LSF, which is the differential of the curve in the left figure below.</div>

<div style="text-indent: 25.2pt; margin-right: 8.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div style="text-align: center; text-indent: 25.2pt; margin-right: 8.3pt; margin-left: 7.35pt; line-height: 1.25; font-family: Times New Roman,Times,serif">
<span style="font-style: italic">Image for illustration purpose only</span></div>

<div style="text-align: center; text-indent: 25.2pt; margin-right: 8.3pt; margin-left: 7.35pt; line-height: 1.25; font-family: Times New Roman,Times,serif"><span style="font-style: italic">
<br /> </span></div>

<div style="text-align: center; line-height: 1.25"><img src="image8.jpg" alt="" style="width: 107px; height: 60px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The graphs above demonstrate that the existing
design of C-Scan can detect objects of approximately 2-3mm when noise is not taken into account.</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z94e807d7dfa544c99e9a370f958e1a90" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25"><span style="font-style: italic">Resolution Limit: Estimation of the Smallest Visible Object Size. </span>In
        order to estimate the size of the smallest visible object, both spatial resolution and noise characteristics must be taken into account.
        The graph below presents the estimated MTF of C-Scan. Noise analysis indicates MTF 1/3 for minimum visibility, which demonstrates that
        the smallest visible object that can be detected with the existing design of C-Scan (in the conditions used, which included a colon diameter
        of 30mm) is of approximately 5-6 mm (see graph below).</div> </td> </tr>
  </table> </div>

<div style="text-align: center; line-height: 1.25">

<div><br /> </div>

<div>

<div style="margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-family: Times New Roman,Times,serif; font-style: italic">Image
for illustration purpose only</div> </div>

<div><br /> </div> <img src="image9.jpg" alt="" style="width: 93px; height: 52px" />

<div><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">30</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div><br /> </div> <br /> </div>

<div style="line-height: 1.25; font-style: italic">Image Reconstruction</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 32.54pt; line-height: 1.25">Two main characteristics of C-Scan contribute to the image reconstruction performance:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z06aecdc6a2e441e79d2f65cea457552c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">The number of photons hitting the detector per time frame.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z84f7034316a6405e8ef87a8bade5c06f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">The angular spread of the photon beam coming out of the capsule collimator.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Based on the laboratory tests performed with a
previous version of C-Scan, polyps of 6 mm and larger should be visible and 10 mm polyps and larger are expected to be detected at higher
sensitivity. To further enhance the visibility of 6 mm &#8211; 9 mm polyps, a new design of the collimator was successfully incorporated
and tested in our advanced C-Scan Cap that is expected to enable 1.5 times the number of photons to be detected by the detectors, allowing
our recently enhanced algorithm to improve the imaging performance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Animal Testing and Tissue Equivalent Phantom Image Reconstruction</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The physics of our imaging modality was tested
in the laboratory on phantoms with tissue equivalent material and in animals to ensure that laboratory conditions mimic real life clinical
scenarios.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Following the initial proof of concept, we performed
a series of studies in order to evaluate the feasibility and preliminary safety of our technology. All studies were performed in pigs
ranging from 60 to 90 kg. Pigs, which are commonly used in gastrointestinal studies, were selected as the animal model for preliminary
evaluation of C-Scan based on the resemblance of the porcine colon size and morphology to the human colon. However, there are marked differences
between the colon of pigs and that of humans. The pig colon is much longer and has a larger diameter, in addition to other anatomical
differences. In the pig model, the pressure waves of peristalsis are believed to be more frequent and shorter than in humans. As a result,
we believe that colon content movement is substantially slower and more frequent in pigs than in humans. In these studies, we did not
intend to collect statistically significant data; hence, the tests were repeated a limited number of times until adequate data was collected.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The first test was performed to demonstrate imaging
proof-of-concept using a wired C-Scan. This technology included all the basic features intended to be included in the clinical C- Scan,
but on a larger scale due to the use of off-the-shelf components. The subsequent studies used versions of the C-Scan that integrated most
of the imaging components, software and electronics of C-Scan that we used with humans. Since off-the-shelf components were used, the
animal capsules were larger and heavier than the version of C-Scan that are used clinically.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Raw data from an animal colon showing a decrease
in X-ray florescence, or XRF, photon signals and an increase in Compton backscattering, or CMT, signals corresponding to the position
of a polyp that was detected when our C-Scan Cap passed over the polyp is shown in the image below. These two signals are combined in
order to form a three dimensional image below.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br />

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration
purpose only</div> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="text-align: center; line-height: 1.25"><img src="image10.jpg" alt="" style="width: 146px; height: 82px" /></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The animal studies conducted to date demonstrate
that our technology provides sufficient resolution, in these studies, for the detection of 10 mm polyps which is the size of clinically
significant polyps. The animal studies also demonstrated that 5 mm polyps can be detected, though with lower resolution than 10 mm polyps
in the first animal capsule. Animal health was maintained throughout the studies. No adverse effects related to passage of our capsule
were noted.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The capsules evaluated in the animal studies were
significantly larger than the capsules that we are using with humans. The differences in anatomy, physiology, and capsules may have several
effects on the data compared to use in the human population. Motility of the capsules through the digestive C-Scan was slow due to the
specific shape of the porcine gastrointestinal tract. In addition, because of the size of the capsule, it was retained in the stomach
for many hours and even days. Accordingly, the animal model required that normal ingestion be replaced by direct insertion of the capsule
into the small bowel. In order to simplify the development and animal testing, we used Tungsten radiation source with long half-life (120
days).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Following the success of the animal testing, a
series of in-vitro tests were conducted to simulate different clinical scenarios in the laboratory using a miniaturized human capsule.
Polyps were created and reconstruction of the laboratory phantoms with a human capsule was generated to assess the ability to detect polyps
as the capsule advances in the colon. The in-vitro tests demonstrated the imaging capabilities of our imaging technology. Below is the
reconstruction of a laboratory phantom image.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25">

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration
purpose only</div> </div>

<div style="text-align: center; line-height: 1.25"><img src="image11.jpg" alt="" style="width: 146px; height: 82px" /></div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">31</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Polyp Detection Analysis</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Laboratory tests were carried out to estimate the
capsule&#8217;s ability to detect polyps in phantoms and demonstrate sensitivity and specificity of such detection. Below is an example
of the reconstruction of a scan composed of three slices: XRF, CMT and a fused (combined) image.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25">

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic"> <br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration
purpose only</div> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div style="text-align: center; line-height: 1.25"><img src="image12.jpg" alt="" style="width: 146px; height: 82px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Receiver Operating Characteristics</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Standard receiver operating characteristics, or
ROC, curves were generated from phantom data with 8 mm polyp in a 30 mm barrel phantom with 3% iodine concentration mimicking the colon
contents. CMT, XRF and fused (combined) data were analyzed based on 2D slices that were generated and standard deviation indicator. There
were a few cases where the noise in the phantoms was high enough to generate polyp false positive condition separately for each data type,
especially in CMT. However, fusion of CMT and XRF data contributed to noise reduction and enabled to demonstrate 100% true positive and
0% false positive.</div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25">

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-style: italic">Image for illustration
purpose only</div> </div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="text-align: center; line-height: 1.25"><img src="image13.jpg" alt="" style="width: 92px; height: 52px" /></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Clinical Trials</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We initiated our first clinical study at University
Hospital, Hamburg, Germany in 2010. The purpose of this study was to monitor and record the colon contractions and the associated motility
of the capsule in the colon. This study was conducted with a passive capsule that contained no X-ray source or detectors. It included
several electronic components of C-Scan and had similar dimensions to the current capsule. 63 healthy volunteers were enrolled and no
adverse events were reported.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We completed a limited, single-center, feasibility
study at Rambam Medical Center, Haifa, Israel to assess the motility of a non-scanning capsule in healthy subjects. The objective of the
study was optimizing the daily routine of the subjects in order to shorten the transit time of our capsule. 15 subjects participated and
swallowed a capsule with the same weight and dimensions as our current C-Scan capsule. No adverse events were reported and all capsules
were retrieved. A structured daily routine determined the timing of the following: capsule ingestion, the subjects&#8217; daily meals,
the contrast agent ingestion and one evening dose of 10 mg of Bisacodyl, and all subjects continued their regular active lifestyles (such
as work and exercise). The average transit time of the capsule in the 15 subjects was approximately 38 &#177; 19 hours, which is comparable
to the average transit time of our capsule in subjects participating in the multi-center feasibility study, in which the participants
do not ingest a daily dose of Bisacodyl, and participants are released to their homes and continue their regular lifestyles during the
study.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A 10 subject clinical proof-of-concept study, conducted
at Tel Aviv Sourasky Medical Center in Israel and using a prior version of C-Scan, did not identify any material safety or feasibility
issues. The study demonstrated the applicability of C-Scan to the human colon, generating images of the colon without any prior bowel
preparation. All subjects ingested the capsule easily with smooth passage within the designated transit time, on average, within 48-72
hours. There were no reported device-related adverse events. Mild effects on bowel movements were noted, which were determined to be related
to the contrast agent and passed within one to two days after the capsule excretion. Estimated total radiation exposure was calculated
using standard established factors for calculating effective radiation exposure, such as the duration of the capsule inside the body,
and was based on the activity of the radiation source inside the C-Scan Cap and radiation energy, both of which were measured for each
case study. The average calculated exposure for the entire procedure in the 10-case study, from ingestion of the capsule to excretion,
was 0.03 mSv (STD 0.007 mSv). This level of radiation exposure is similar to a single chest X-ray (approximately 0.06mSv) and two orders
of magnitude less than a CTC.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 10-subject study constituted the initial phase
of a multi-center, prospective clinical feasibility study to establish the safety, functionality and preliminary efficacy of C-Scan in
patients eligible for CRC screening, by comparing results from the clinical feasibility study with those from non-invasive, low-sensitivity
FITs, as well as from optical colonoscopies. The feasibility study has been designed to allow for the recruitment of 100 subjects. The
study was conducted at multiple centers in Israel. The clinical feasibility study was used to evaluate the image resolution generated
by the capsule in a human colon without cathartic preparation, assess polyp imaging in various shapes and in different segments of the
colon, and evaluated the safety of the device in terms of total and segmental transit time and analyze the effects of the presence of
polyps and variable colon dimensions on these parameters. During the feasibility study we collected data regarding the overall imaging
of the colon&#8217;s internal surfaces during the passage of the capsule to support the development of a correlation map of polyps identified
through our imaging system with polyps imaged by optical colonoscopy and CTC. Additionally, the feasibility study allowed for the measurement
of total radiation exposure and the distribution of contrast material within the colon.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Analysis conducted on the first 66 capsules swallowed
by participants enrolled in the multi-center, prospective clinical feasibility study showed that 65 of 66 capsules swallowed were naturally
eliminated, without major or minor side effects, after 62&#177;40.7 hours. The average calculated radiation exposure was 0.06 &#177; 0.04
mSv (similar to a single chest radiograph). Image reconstructions allowed 2D/3D views of the colonic wall and lumen with the typical contour
of different segments (hepatic flexure, triangular shape of the transverse colon). Both pedunculated and sessile polyps were detected
in several patients and validated later by colonoscopy.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In September 2017, we completed a multi-center
study of C-Scan in support of CE Mark submission. The objective of the study was to assess safety and the clinical performance of C- Scan
in detecting patients with polyps. The three-center trial enrolled 66 patients, with a mean age of 59 years. Following capsule ingestion,
subjects swallowed small doses of contrast agent and fiber supplements with each meal throughout capsule passage. Average capsule transit
time was 52&#177;32 hours, and the average total X-ray dose was 0.05 mSv (CT colonography effective dose is ~ 6.0 mSv). No bowel preparation,
sedation, or change in diet was required. Both confirmatory colonoscopy, performed by an independent investigator, and C-Scan review,
performed by a central review group, were blinded to results. The study demonstrated a 44% sensitivity in the 45 subjects included in
the analysis for polyps, with specificity (ability to correctly identify lack of polyps) of 89%. Sensitivity strongly correlated (R-squared
= 0.98) to the percentage of the colon scanned. Sensitivity was 78% (p&lt;0.05) and 100% (p&lt;0.05) for subjects where greater than 50%
and 70% of the colon was scanned, respectively. Specificity was consistent for all subjects.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In the fourth quarter of 2017, we initiated an
interim clinical study for the purpose of introducing an advanced C-Scan version, Version 3, which incorporated the then latest algorithms
and system optimization and tailored scanning of the colon to the patient&#8217;s natural colonic movements to maximize the amount of
the colon that is tracked and imaged. In March 2018, we announced results from the interim study. Evaluable results of 21 patients showed
average colon imaging coverage of 64%, a 40% improvement over 46% average colon imaging coverage in the multi-center study. Sensitivity
was 78% (p&lt;0.05) for subjects with greater than 50% colon imaging coverage and 100% (p&lt;0.05) for subjects with greater than 70%
colon imaging coverage. Specificity was consistent at around 89%.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">32</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">During the first quarter of 2018, we initiated
a multi-center, open label, home monitoring, prospective study designed to determine the performance characteristics of C-Scan Version
3, for detecting pre-cancerous polyps compared with the fecal immunochemical test (FIT), in each case using colonoscopy as the reference
method, for the purpose of collecting additional evidence of clinical effectiveness and clinical utility to support market adoption. The
study included 90 evaluable patients who either had known polyps or were considered to be of average risk. Each patient ingested a C-Scan
capsule and also underwent a FIT and a comparative colonoscopy performed by independent gastroenterologists, who were blinded to the corresponding
test&#8217;s results. The C-Scan clinical evaluation was obtained using the evaluable patient population implementing a gender-based motility
analysis and the results of both C-Scan and FIT were compared to colonoscopy. The primary efficacy endpoint of the study was sensitivity
(ability to correctly identify patients with polyps) and specificity (ability to correctly identify patients with lack of polyps) of the
C-Scan system compared to FIT in detecting subjects with polyps &#8805;10 mm. In July 2019, we announced final results from our post-CE
approval study. The results demonstrate that C-Scan achieved a sensitivity of 76% (p=0.0005) in patients with polyps &#8805;10 mm, while
FIT achieved a sensitivity of 29% (p=0.005) in patients with polyps &#8805;10 mm. C-Scan achieved a specificity of 82% in all patients,
while FIT achieved a specificity of 96% in all patients. In addition, C-Scan detected all 4 patients (100%) with polyps &#8805;40 mm,
while the FIT detected only 1 of the 4 patients (25%) with polyps &#8805;40mm. Overall, C-Scan achieved a sensitivity of 66% (p=0.01)
in all patients, including patients with polyps &lt;10mm, while FIT achieved a sensitivity of 23% (p&lt;0.0001) in all patients, including
patients with polyps &lt;10mm. In total, 142 patients enrolled in the study and after factoring in technical and physiological dropouts
and protocol violations, the number of evaluable patients was 90. No serious adverse events were reported, and the adverse events were
mild in severity.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In December 2018, we received from the FDA conditional
approval of our IDE application to initiate a U.S. pilot study of the C-Scan Version 3 and received final approval from the FDA in February
2019. In April 2019, we initiated the U.S. pilot study of C-Scan. The U.S. pilot study (NCT03735407) was a prospective, multi-center,
open label, single arm study was designed to evaluate the safety, usability and subject compliance of the C-Scan. The study included 28
evaluable patients, more than two thirds of whom were considered to be of average risk for colorectal cancer. Each patient ingested a
C-Scan capsule and also underwent a fecal immunochemical test (FIT) as well as a comparative colonoscopy, which was performed by an independent
gastroenterologist who was blinded to the corresponding test results. The study was performed at two sites, the NYU Grossman School of
Medicine and Mayo Clinic, Rochester. The primary endpoint of the study was to evaluate the incidence of device or procedure related serious
adverse events. Secondary endpoints included patient compliance, subject satisfaction and device and procedure related performance. Due
to sample size, the study was not designed to be powered for statistical significance. In December 2019, we announced the results of the
study. No device or procedure related serious adverse events (SAEs) were reported and all device or procedure related adverse events were
mild in severity. In total, 45 patients enrolled in the study, of which 40 patients underwent the study procedure. 39 patients complied
with the procedure and completed a questionnaire following the procedure and reported higher satisfaction with C-Scan procedure compared
to colonoscopy. A total of 28 patients were evaluable after factoring in technical and physiological dropouts and protocol violations.
Analysis of the evaluable patient results revealed agreement between C-Scan and colonoscopy in detection of polyps was consistent with
data from the post-CE approval study.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In preparation of the U.S. pivotal study, we continued
to optimize the functionality of our advanced version of C-Scan, which incorporates mainly advanced algorithms, improved detection capability
and reduced energy consumption, through additional clinical data collection in a study in Israel (initially on average risk and high-risk
patients and in May 2022, shifted to enrollment of only average risk patients), for the purpose of further calibration of the C-Scan system,
which we have continued in parallel to conducting the first stage of the U.S. pivotal study that was initiated in May 2022.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In November 2020, we finalized our proposed U.S.
pivotal study design and submitted our IDE application to the FDA and in March 2021, our IDE application was approved by the FDA. In January
2022, we submitted a supplement to the FDA to amend the U.S. pivotal study design to add a first part to the study that is designed to
enable further device calibration of the C-Scan system and enhancement of C-Scan algorithms, specifically for the average risk U.S. population.
In February 2022, we received the FDA&#8217;s approval for our IDE supplement. Following this amended IDE, the U.S. pivotal study consists
of two parts. The first part is designed to enable further calibration of the C-Scan system for the average risk U.S. population, and
is intended to include up to 200 patients in the U.S. The second part is a statistically powered, randomized study which will compare
the performance of C-Scan to traditional colonoscopy, and is intended to include up to 800 patients.&#160; The goal of the pivotal study
in the United States is to (i) demonstrate device safety as evidenced by a lack of device related serious adverse events; and (ii) provide
efficacy data concerning C- Scan&#8217;s performance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In May 2022, we initiated the first part of the
U.S. pivotal study, which focuses on device calibration and enhancement of C-Scan algorithm among average risk population, initially at
Mayo Clinic Rochester, Minnesota and New York University (NYU) School of Medicine. In addition, we recently added a new site as well as
expanded the NYU site.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In January 2023, we obtained approval from the
FDA for our protocol amendment to lower the patient age enrollment criteria to 45-75 years (from 50-75 years previously) in the U.S. pivotal
study.&#160; Our NYU site has already obtained approval of this amendment from its Institutional Review Board (IRB) and begun to implement
it to recruit younger patients as part of the first part of our U.S. pivotal study.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To date, we have enrolled more than 300 average
risk patients as part of our Israeli study and only 17 average risk patients in the first part of our U.S. pivotal study, mainly as a
result of slower than expected U.S. site recruitment pace, due to licensing requirements with local states associated with the X-ray technology
within our C-Scan capsule.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The initiation of the powered potion of the U.S.
pivotal study was dependent upon successful completion of the calibration portion of the U.S. pivotal study.&#160; Following our internal
assessment of the clinical data collected to date from our calibration studies, we have determined that the current efficacy results do
not meet our goal in order to proceed to the powered portion of the U.S. pivotal study.&#160; As a result, we adopted a plan of action
that includes conducting additional clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal study protocol
that are expected to be part of an IDE supplement submission to the FDA, and which are subject to FDA approval. In addition, we plan to
continue conducting our calibration studies, albeit at a slower pace, to collect additional clinical data and we are also implementing
a cost reduction plan, in order to extend our cash runway. The initiation of the powered portion of the U.S. pivotal study that was expected
in mid-2023 is therefore temporarily postponed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Research and Development</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our research and development strategy is centered
on developing C-Scan. Our research and development team consists of 76 individuals employed (including independent contractors) on a full-time
basis and 3 individuals on a part-time basis as of March 15, 2023, including our research and development employees, clinical team, quality
and assurance team and manufacturing team. All our research and development employees are located at our facility in Isfiya, Israel, except
for 5 full time employees who are located at our facility in Petach Tikva, Israel and one independent contractor who is located in the
U.S.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have received grants from the Government of
the State of Israel through the IIA (formerly the OCS) for the financing of a portion of our research and development expenditures and
a portion of our expenditures relating to our transition to manufacturing pursuant to the Innovation Law and related regulations and guidelines.
As of December 31, 2022, we had received funding from the IIA for research and development of our C-Scan in the aggregate amount of approximately
$5.6 million. As of December 31, 2022, we had not paid any royalties to the IIA and had a contingent liability to the IIA with respect
to such funding (including interest at the rate of 12-month LIBOR) in the amount of approximately $6.2 million. In addition, in January
2021, we received an IIA grant approval to support the funding of our transition from research and development to manufacturing. The final
IIA grant amounted to approximately $620,000 (NIS 2.18 million) (along with a co-investment by us of the same amount), which we are not
required to repay to the IIA, subject to the terms and conditions set forth in the grant approval, of which we received approximately
$222,000 (NIS 784,000) in February 2023, $82,000 (NIS 264,000) in January 2022 and $349,000 (NIS 1,134,000) in 2021. We may apply for
additional IIA grants in the future; however, there is no assurance that such applications will be approved in the amount requested or
at all. We cannot predict whether we will be entitled to any future grants, or the amounts of any such grants. See &#8220;<span style="font-style: italic">Risk
Factors &#8211; Risks Related to Our Operations in Israel &#8211; Pursuant to the terms of the Israeli government grants we received for
research and development expenditures, we are obligated to pay certain royalties on our revenues to the Israeli government. In addition,
the terms of Israeli government grants we received require us to satisfy specified conditions and to make additional payments in addition
to repayment of the grants upon certain events</span>.&#8221;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="text-indent: 25.15pt; line-height: 1.25">We incurred approximately $14.3 million, $12.3 million and $10.0 million in research
and development expenses, net (after deducting participation by government grants) for the years ended December 31, 2022, 2021, and 2020,
respectively. For additional information, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of
Operations&#8212; Financial Operations Overview&#8212;Research and Development Expenses, Net.&#8221;</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">33</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Intellectual Property</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">An important part of our competitive strategy is
to seek, when appropriate, protection for our products and proprietary technology through a combination of U.S. and foreign patents, trademarks,
trade secrets, non-disclosure and confidentiality, assignment of invention and other contractual arrangements with our employees, consultants
and suppliers. These measures, however, may not be adequate to protect our technology from unauthorized disclosure, third-party infringement
or misappropriation as these parties may breach these agreements, and we may not have adequate remedies for any such breach. We intend
to prosecute and defend our proprietary technology. The primary test for patent protection eligibility includes patentability, novelty,
non- obviousness, and utility.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We submit applications under the Patent Cooperation
Treaty, or PCT, which is an international patent law treaty that provides a unified procedure for filing a single initial patent application
to seek patent protection for an invention simultaneously in each of the member states. Although a PCT application is not itself examined
and cannot issue as a patent, it allows the applicant to seek protection in any of the member states through national-phase applications.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, we had 56 granted patents
(not including separate validations in Europe) in main world markets, covering various aspects of our technology. In addition, we have
19 additional pending patent applications in the pipeline. We have submitted patent applications covering our technology in the United
States, member states of the European Patent Organization, Australia, Brazil, Canada, China, Hong Kong, India, Israel, Japan and South
Korea. We have received patent grants for our core patent by the United States Patent and Trademark Office as well as from the European
Patent Office, Australia, Brazil, China, Hong Kong, Israel, India, Canada, South Korea and Japan. We also filed patent applications describing
the use of our technology in several other medical applications.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our registered U.S. Patent Number 7,787,926 discloses
an ingestible capsule with a radiation source and radiation detectors that, when used in conjunction with a radio opaque contrast agent,
is adapted to detect clinically relevant findings in the colon. Utilizing X-ray fluorescence and Compton back scatterings, the capsule
is able to measure the distance between the capsule and the colon wall and to distinguish between gas, intestinal contents, and clinically
significant findings in the gastrointestinal tract. If the appropriate maintenance, renewal, annuity or other governmental fees are paid,
the non-extended patent term for this patent will expire on August 28, 2026.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A PCT patent application (PCT/IL2008/000163), granted
in Europe, Israel, United States, Australia, India, China, Canada and Hong Kong, discloses additional features such as a rotating collimator
and improved scanning mechanisms, the capability to determine tissue density to differentiate between different types of polyps, as well
as the capability to determine capsule movement in the colon. If the appropriate maintenance, renewal, annuity or other governmental fees
are paid, the non-extended patent term for all national phases will expire on February 6, 2028, other than the U.S. patent that will expire
on April 4, 2030.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Another PCT application (PCT/IL2011/000462), granted
in Europe, Israel, United States, Canada, Australia, South Korea and Brazil, discloses a number of alternate fail safe concealment mechanisms
that can be utilized in the capsule to ensure that the X-ray source is blocked when the capsule is not scanning and is open when it is
scanning, allowing the capsule to image the colon. The fail-safe feature ensures that in the event of power failure, the radiation source
is blocked and X-rays do not escape. If the appropriate maintenance, renewal, annuity or other governmental fees are paid, the non-extended
patent term for all national phases will expire on June 9, 2031, other than the U.S. patent that will expire on July 5, 2032.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In another PCT patent application (PCT/IL2008/000765),
which was granted in the United States, Europe, Israel and Japan, we disclose an imaging catheter that utilizes X-ray fluorescence, Compton
back scattering and electron back scattering. The imaging catheter is designed for use in cardiac applications as well as intra-operative
imaging applications such as imaging inside blood vessels where optical imaging cannot be performed because of obscuring circumstances.
If the appropriate maintenance, renewal, annuity or other governmental fees are paid, the non- extended patent term for all national phases
will expire on June 4, 2028, other than the U.S. patent that will expire on July 28, 2028.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, during the year 2022 we were granted
two new patents:</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">"Position Estimation of Imaging Capsule in Gastrointestinal
Tract" granted in Israel, covering C-Scan's proprietary tracking technology, which enables real time tracking of the capsule and its activation
when it moves throughout the colon. This functionality allows for optimal scanning along the gastrointestinal (GI) tract while maintaining
low energy consumption during the procedure. The patent also covers the capsule positioning data recording utilized by the C-Scan analysis
suite, which enables gastroenterologists to make a clinical decision and generate a report with their diagnosis and recommendations.&#160;
Corresponding patents were granted in Japan, China, Europe and the United States.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">"System and method for polyp detection through
capsule dynamics" granted in Japan.&#160; This patent was submitted following analysis of hundreds of patients that showed that certain
capsule dynamic properties correlate with increased likelihood for the presence of polyps. Corresponding patents were filed in Europe&#160;and
the United States.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">While our policy is to obtain patents by application,
to maintain trade secrets and to seek to operate without infringing on the intellectual property rights of third parties, technologies
related to our business have been rapidly developing in recent years. Additionally, patent applications that we may file may not result
in the issuance of patents, and our issued patents and any issued patents that we may receive in the future may be challenged, invalidated
or circumvented. For example, we cannot predict the extent of claims that may be allowed or enforced in our patents nor be certain of
the priority of inventions covered by pending third-party patent applications. If third parties prepare and file patent applications that
also claim technology or therapeutics to which we have rights, we may have to partake in proceedings to determine priority of invention,
which could result in substantial costs to us, even if the eventual outcome is favorable to us. Moreover, because of the extensive time
required for clinical development and regulatory review of a product we may develop, it is possible that, before C-Scan can be commercialized,
related patents will have expired or will expire a short period following commercialization, thereby reducing the advantage of such patent.
Loss or invalidation of certain of our patents, or a finding of unenforceability or limited scope of certain of our intellectual property,
could have a material adverse effect on us. See &#8220;Item 3D &#8220;Key Information&#8212;Risk Factors&#8212;Risks Related to Our Intellectual
Property.&#8221;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition to patent protection, we rely on trade
secrets, including unpatented know-how, technology innovation, drawings, technical specifications and other proprietary. We also rely
on protection available under trademark laws, and hold the following registered trademarks in the United States and Hong Kong: &#8220;CHECK
CAP&#8221;, CHECK CAP (logo), &#8220;C-Scan&#8221; and C-Scan (logo) and the following registered trademarks in the European Union: CHECK
CAP (logo), &#8220;C-Scan&#8221; and C-Scan (logo), and the following trademark applications are pending in China: &#8220;CHECK CAP&#8221;,
CHECK CAP (logo), &#8220;C-Scan&#8221; and C-Scan (logo).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In March 2021, we entered into an exclusive license
agreement with the University of Missouri with respect to certain patents held by the University of Missouri that the University of Missouri
claimed included background intellectual property in C-Scan. In consideration for the grant of an exclusive license to those patents in
the medical field, we agreed to pay royalties ranging from $0.30 to $5.00 per C-Scan unit depending on the number of units sold up to
$15,000,000 in the aggregate.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">34</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Competition</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Competition for C-Scan comes from traditional well-entrenched
manufacturers of tests and equipment for CRC screening, such as colonoscopy, sigmoidoscopy, CTC, optical capsule endoscopy, FOBTs and
FITs. The principal manufacturers of equipment for optical colonoscopy and sigmoidoscopy include Olympus, Pentax, Hoya and Fuji Film.
The principal manufacturers of equipment for CTC include General Electric Healthcare Systems, Siemens Medical Solutions, Philips Healthcare
and Toshiba Corporation. The principal manufacturer of equipment for optical capsule endoscopy includes Medtronic plc. All of these companies
have substantially greater financial resources than we do, and they have established reputations as well as worldwide distribution channels
for providing medical instruments to physicians.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, several companies have developed or
are developing non-invasive technologies based on stool, serum (from blood and other bodily fluids), or molecular diagnostics (MDx), tests
that are used to indicate the presence of CRC and polyps in the colon. These companies include Exact Sciences, Polymedco, Epigenomics
AG, Gene News, EDP Biotech Corporation, Illumina, Inc., Quest Diagnostics, VolitionRx Nu.Q diagnostic, Freenome , Grail, , Guardant, Genoscopy
and Universal DX. Exact Sciences commenced sales of its Cologuard &#174;, a non-invasive stool DNA screening test for colorectal cancer
in 2015, and is constantly seeking performance improvements through additional studies, alongside commercial expansion. During the past
years, there has been an extensive effort on the part of our competitors to utilize molecular biology and advanced computational techniques
to develop methods capable of identifying cell-free cancer biomarkers.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In December 2022, Guardant Health released results
from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode), an over 20,000 patient registrational study evaluating
the performance of its blood test for detecting colorectal cancer (CRC) in average-risk adults. The test demonstrated 83% sensitivity
in detecting individuals with CRC. Specificity was 90% in both individuals without advanced neoplasia and in those who had a negative
colonoscopy result. This test also demonstrated 13% sensitivity in detecting advanced adenomas. In this study, two configurations of a
multimodal blood-based screening test were evaluated independently - a cell-free DNA (cfDNA)-only test and a cfDNA test with protein biomarkers.
The announced results were derived from the cfDNA-only test, which outperformed the cfDNA test with protein biomarkers. Based on these
study results, Guardant Health plans to complete its premarket approval submission to the FDA in the first quarter of 2023.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In January 2023, Geneoscopy Inc., released results
from the CRC-PREVENT trial &#8211; a pivotal clinical trial evaluating the efficacy of its noninvasive, stool-based, at-home diagnostic
screening test to detect colorectal cancer (CRC) and advanced adenomas (AA) in average-risk individuals. The CRC-PREVENT trial included
8,289 individuals with diverse racial, ethnic, and socioeconomic backgrounds across more than 2,900 zip codes in all lower 48 states,
with colonoscopies performed in more than 3,800 endoscopy centers. Efficacy results from the study demonstrated 94% sensitivity for detecting
CRC, 45% sensitivity for detecting advanced adenoma (AA), and 88% specificity for no findings on a colonoscopy.&#160; The company submitted
a Premarket Approval (PMA) application to the FDA in January 2023.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These advancement efforts are assisted by large
capital investments, supported in turn by claims that certain products may promise the possibility of defeating certain cancers in their
early stages.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Procedures for bowel cleansing that are less onerous
are constantly being developed, which could make our entry into the market more difficult. For instance, bowel cleansing initiated by
the ingestion of pills or food-substitute diet regimes rather than through drinking large amounts of distasteful liquids may be viewed
as an improvement to the cleansing process, but other screening methods may be even more palatable to patients.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Sales and Marketing</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our goal is to establish our position as a leading
player in the CRC screening market. Although we do not currently generate revenues, we expect to generate revenues through sales of C-Scan
following demonstration of acceptable clinical safety and effectiveness and obtaining required regulatory approvals and licensures.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Because we are still in the clinical and development
stage, we are subject to certain challenges, including, among others, that:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z78ce4a718fa64149a9c0f9e6e16f9612" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our technology has been tested on a limited basis and therefore we cannot assure the product&#8217;s clinical
        value;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z67121e7a42384e649932b0adfdcf7c52" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we need to raise an amount of capital sufficient to complete the development of our technology, obtain
        the requisite regulatory approvals and commercialize our current and future products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6ff398e1e5294a7e8652267dd071d2da" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">following the receipt of CE Mark of conformity to protection standards for sale of the C-Scan system in
        the European Union, we may need to obtain additional regulatory approvals in certain local jurisdictions in the European Union before
        we can commence marketing and sale of C-Scan and will need to obtain the requisite regulatory approvals in the United States, Japan and
        other markets where we plan to focus our commercialization efforts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zee60f7c93860480a98df4f5d7ab88c8f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we need to obtain reimbursement coverage from third-party payors for procedures using C-Scan;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze22aab13468c4f04a851cc32e37abf41" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we need to scale-up our manufacturing capabilities of C-Scan in commercial quantities at an adequate quality
        and at an acceptable cost; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6e7d857167f14c998b30c83d9e8aaea6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">we need to establish and expand our user base while competing against other sellers of capsule endoscopy
        systems as well as other current and future CRC screening technologies and methods.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our ability to operate our business and achieve
our goals and strategies is subject to numerous risks as described more fully in &#8220;Risk Factors.&#8221;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our primary corporate objective is obtaining the
U.S. clearance/approval for C-Scan. However, based on the MDR approval that we received from our notified body according to the EU Regulation,
available capital and market assessment, we plan to evaluate opportunities in Europe and Israel, including possible engagement with strategic
partners and/or local distributors who are active in the gastroenterology field.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In Europe, we currently expect to offer C-Scan
as an imaging and screening tool for the general population. In the United States, we may choose to first obtain regulatory clearance/approval
for C- Scan in a screening sub-population, and after we have conducted more extensive clinical studies supported by compelling evidence
in the United States, we would anticipate applying to the FDA for the use of C-Scan as a primary screening tool.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Subject to the successful completion of our clinical
trials and the receipt of our initial FDA clearance/approval, we expect to launch the product in the U.S. market, where we will consider
to either set up our own sales force or align with a strategic partner. Initially, we anticipate selling C-Scan to the private sector.
In parallel to our efforts to obtain FDA approval, we plan to build and execute our strategy for reimbursement, primarily for Medicare
and private insurers</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Subject to local regulatory approval, we also may
at a later stage market C-Scan in key markets in Asia.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">35</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Manufacturing and Suppliers</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our manufacturing operations are conducted at our
facility located in Isfiya, Israel and in our own X-ray production line in Petach Tikva. In Isfiya, we lease approximately 1,550 square
meters at this facility under a lease agreement expiring on December 31, 2023, and we have an option to extend the agreement for an additional
period of three years. We have the right to terminate the Isfiya lease agreement at any time, upon at least 60 days prior written notice.
In December 2021, we signed a Sub-lease Agreement with one of our suppliers, according to which we lease approximately 70 square meters
of laboratory production space at the supplier&#8217;s premises. The Sub-lease Agreement entered into effect on September 21, 2022, after
receipt of certain certificates, including a business license from the Petach Tikva municipality. The Sub-lease Agreement expires on January
31, 2025, and we have an option to extend the lease period for an additional two years. We have the right to terminate the agreement at
any time, upon at least 90 days prior written notice. The lessor has the right to terminate the Sub-lease Agreement, upon at least 12
months prior written notice. We currently have sufficient space to manufacture C-Scan for the contemplated clinical studies, but have
limited resources and facilities in commercially manufacturing large quantities of C-Scan and C-Scan View to meet the demand we expect
for our future commercialization efforts. We have faced and expect to face certain technical challenges as we increase manufacturing capacity,
including, among others, logistics associated with the handling of radioactive materials, equipment design and automation, material procurement,
lower than expected yields and increased scrap costs, as well as challenges related to maintaining quality control and assurance standards,
while maintaining commercially efficient pricing for C-Scan. Our production objective is to establish a scalable capacity in order to
meet such expanded demand for C-Scan and market expansion. If we are unable to scale up our manufacturing capabilities to meet our clinical
trials needs and future market demand, our growth could be limited and our business, financial condition and results of operations could
be materially adversely affected.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In July 2016, we entered into an agreement with
GE Healthcare to develop and demonstrate proof of principle of the process for high-volume manufacturing for the production of the X-
ray source and its assembly into our C-Scan capsule. The agreement was amended in November 2017 in order to further our manufacturing
collaboration with GE Healthcare. The agreement involves GE&#8217;s final assembly, packaging and shipping of C-Scan capsules. We supplied
GE Healthcare with supporting calibration and final assembly methodology and equipment and in August 2019, we announced the completion
of manufacturing line transfer implementation and qualification for C-Scan operated by GE Healthcare, primarily to enable the availability
of C-Scan for U.S. clinical trials. At present, we intend to ship systems for our U.S. clinical studies directly from our local site in
Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In January 2021, we received an IIA grant approval
to support the funding of our transition from research and development to manufacturing. The final IIA grant amounted to $620,000 (NIS
2.18 million) including for the purpose of the establishment of our own X-Ray source manufacturing line in Israel. We do not currently
have any sales. We are planning to develop a scale-up plan to meet our expected commercial supply needs. During 2022, we expanded our
manufacturing capacity to support the expected larger clinical volume and subsequent higher volumes expected in the early commercialization
stage. We are continuously exploring whether certain components of C-Scan can be assembled outside of Israel. In addition, we are exploring
possible alternative sources for the key capsule components. All of the facilities in which manufacturing and assembly of our products
will be conducted (including those of sub-contractors) will need to comply with applicable regulations and standards for medical devices.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We currently depend on sole or single source suppliers
for some of the components necessary for the production of C-Scan. For example, we currently have a sole supplier for the motor used to
rotate the collimated X-ray source in C-Scan, for the customized X-ray detectors and batteries used in C-Scan. There is a limited number
of manufacturers worldwide who are capable of manufacturing the motor, the customized X-ray detectors and the batteries that we currently
use in C-Scan. In addition, the ASIC residing in C-Scan is currently manufactured for us by a single FAB. However, there are many alternative
FABs worldwide and the design of our current ASIC could be adapted in the event it became necessary to use an alternative FAB. Furthermore,
we do not currently have written contracts with all our sole or single suppliers. While our current suppliers have been able to supply
the required quantities of such components to date, if the supply of these components is disrupted or terminated or if our current suppliers
are unable to supply required quantities of components now or in the commercialization period, we may not be able to find alternative
sources for these key components in a timely manner. Although we are planning to maintain strategic inventory of key components, the inventory
may not be sufficient to satisfy the demand for C-Scan if such supply is interrupted, or subject to risk of loss due to catastrophic events
such as a global political crisis or war, or a fire at our storage facility. In addition, to partially mitigate the risks of reliance
on sole and single source suppliers, we are seeking alternate manufacturers for some of our components which requires us to dedicate significant
resources and investment. There can be no assurance that we will be successful in seeking alternate suppliers or establish our own production
line. As a result of the foregoing, we may be unable to meet our clinical trials timelines and to meet the demand for C-Scan, which could
harm our ability to generate revenues, lead to customer dissatisfaction and damage our reputation. If we are required to change the supplier
of any of these key components, there may be a significant delay in locating a suitable alternative manufacturer. In addition, we may
be required to verify that the new manufacturer maintains facilities and procedures that comply with FDA and other applicable quality
standards and with all applicable regulations and guidelines. As part of our mitigation plan, in December 2021, we signed the Amended
Service Agreement with the sole supplier of the X-ray source used in C-Scan, and we concurrently entered into the Sub-lease Agreement
with the supplier, according to which we agreed to lease approximately 70 square meters of laboratory production space at the supplier
premises. According to the Amended Service Agreement, we independently produce the X-ray source using our own production employees. The
Amended Service Agreement extended the terms of the service agreement we had with the sole supplier until the Sub-lease Agreement entered
into effect on September 21, 2022, after receipt of certain certificates, including a business license from the Petach Tikva municipality.
Upon successful progress of our clinical studies and available sufficient capital, we plan to continue to expand our own production line
for our X-ray source in Israel, however, we cannot assure you that we will commence this effort or succeed in expanding our in house production
line and we may be required to find an alternative source for the X-ray source, which we may not be able to do in a timely manner. The
delays associated with the introduction of a new manufacturer for certain key components or new suppliers for certain materials, could
delay our ability to manufacture C-Scan in a timely manner or within budget. Furthermore, in the event that the manufacturer of a key
component of C-Scan ceases operations or otherwise ceases to do business with us, we may not have access to the information necessary
to enable an alternative supplier to manufacture the component. The occurrence of any of these events could harm our ability to meet demand
for C-Scan in a timely manner or within budget.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Environmental Health and Safety Matters</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are subject to environmental health and safety
laws and regulations in Israel, governing, among other things, the use of radioactive materials, including the Israeli Radioactive Elements
and their Products, Regulation, 1980, the Hazardous Substances Law, 5753-1993 and regulations thereunder, including the Licensing of Business
Regulations (Disposal of Hazardous Substances), 5750-1990, the Israeli Work Safety Regulations (Occupational Safety and Health of Ionizing
Radiation Practitioners) 1992-5753 and Women Employment Regulations (Work with Ionizing Radiation), 1979-5739. Our current research and
development activities, including our production activities, require (and our currently contemplated commercial activities will require)
permits from various governmental authorities including, Israel&#8217;s Ministry of Environmental Protection, Israel&#8217;s Ministry
of Health, local municipal authorities and the NRC and Agreement State regulators. Failure to obtain or maintain any such permits or to
comply with their conditions could have a material adverse effect on our business, financial condition and results of operations. The
Ministry of Environmental Protection and the Ministry of Health conduct from time to time periodic inspections in order to review and
ensure our compliance with the various regulations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">These laws, regulations and permits could potentially
require expenditure by us for compliance or remediation. If we fail to comply with such laws, regulations or permits, we may be subject
to fines and other civil, administrative or criminal sanctions, including the revocation of permits and licenses necessary to continue
our business activities and could be subject to work stoppages or delays. In addition, we may be required to pay damages or civil judgments
in respect of third-party claims, including those relating to personal injury (including exposure to radioactive materials) or contribution
claims. Some environmental, health and safety laws apply strict, joint and several liability. We may be identified as a responsible party
under such laws. Such developments could have a material adverse effect on our business, financial condition and results of operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, laws and regulations relating to environmental,
health and safety matters are often subject to change. In the event of any changes or new laws or regulations, we could be subject to
new compliance measures or to liabilities for activities which were previously permitted.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">U.S. Government Regulation</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">C-Scan is a medical device subject to extensive
regulation by FDA and other U.S. federal and state regulatory bodies. To ensure that medical products distributed in the United States
are safe and effective for their intended use, FDA has promulgated regulations that govern, among other things, the following activities
that we or our partners perform and will continue to perform:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z341a3a98187e4d5c949c263e420f56e5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product design and development;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9699df2befab47c4bab2e1151570b909" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product testing;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5318c81a3e724b1a96663cb930e347bf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">validation and verifications;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z206cf15a07b941d4b972c90ad4afe949" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product manufacturing (good manufacturing practices);</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z998f5f13938a493d9c9ae9bf811d0237" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product labeling;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze2c5864d4810473c908af94549c9ba59" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product storage, shipping and handling;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1f6fb76a0d86451eb1871123617e4364" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">premarket clearance or approval;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z8eb702fc6269479295531ef100536bc7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">advertising and promotion;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">36</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zaeb3e8f3190c49e2b005934e127bceff" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product marketing, sales and distribution;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z0d5b704abc514d90bbc0114672f81215" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">product recalls; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z78dc6e39f8b04acb8ef6b04b3cdd9937" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">post-market surveillance reporting death or serious injuries and medical device reporting.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">FDA&#8217;s Premarket Clearance and Approval Requirements</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Unless an exemption applies, before we can commercially
distribute medical devices in the United States, we must obtain, depending on the type of device, either prior premarket notification,
or 510(k) clearance, de novo authorization or approval of a Premarket Approval Application, or PMA from the FDA. The FDA classifies medical
devices into one of three classes:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z318a3c62bdd1444584df83120543c353" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Class I devices, which are subject to only general controls (<span style="font-style: italic">e.g.</span>,
        labeling, medical devices reporting, and prohibitions against adulteration and misbranding) and, in some cases, to the 510(k) premarket
        clearance requirements;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z1c3187aa778d434bab8bf131aa84c26c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Class II devices, generally requiring 510(k) premarket clearance before they may be commercially marketed
        in the United States; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb4ce513d5bd149918a04e60a8102040a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Class III devices, consisting of devices deemed by the FDA to pose the greatest risk, such as life-sustaining,
        life-supporting or implantable devices, or devices deemed not substantially equivalent to a predicate device, generally requiring the
        submission of a PMA approval supported by clinical trial data.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">510(k) Clearance Pathway</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To obtain 510(k) clearance, we must submit a premarket
notification, or 510(k) notice, demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device
or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of premarket
approval applications. By regulation, a premarket notification must be submitted to the FDA at least 90 days before we intend to market
a device, and we must receive 510(k) clearance from the FDA before we actually market the device. The Medical Device User Fee Amendments,
or the MDUFA, performance goal for a traditional 510(k) clearance is 90 days. As a practical matter, however, the 510(k) clearance pathway
may take approximately between 6 to 9 months, but it can take significantly longer. FDA may require additional information, including
clinical data, to make a determination regarding substantial equivalence.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There are three types of 510(k)s: traditional,
special, and abbreviated. Special 510(k)s are typically for devices that have certain technological, design or labelling changes that
require a new 510(k) but where the method(s) to evaluate the changes are well established and the results of change evaluation can be
sufficiently reviewed in a summary or risk analysis format. Abbreviated 510(k)s are for devices that conform to special controls for the
device type or to a recognized standard. The special and abbreviated 510(k)s are intended to streamline review, and the FDA intends to
process special 510(k)s within 30 days of receipt.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">After a device receives 510(k) clearance, any modification
that could significantly affect its safety or effectiveness, or that would constitute a new or major change in its intended use, will
require a new 510(k) clearance or, depending on the modification, require premarket approval. The FDA requires each manufacturer to determine
whether the proposed change requires submission of a 510(k), or a premarket approval, but the FDA can review any such decision and can
disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA can require
the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or premarket approval is obtained. If the
FDA requires us to seek 510(k) clearance or premarket approval for any modifications to a previously cleared product, we may be required
to cease marketing or recall the modified device until we obtain this clearance or approval. Also, in these circumstances, we may be subject
to significant regulatory fines or penalties.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">De Novo Reclassification</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Medical device types that the FDA has not previously
classified as Class I, II or III are automatically classified into Class III regardless of the level of risk they pose. To market low
to moderate risk medical devices that are automatically placed into Class III due to the absence of a predicate device, a manufacturer
may request a de novo down-classification. This procedure allows a manufacturer whose novel device is automatically classified into Class
III to request classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk,
rather than requiring the submission and approval of a PMA application. A medical device may be eligible for de novo classification if
the manufacturer first submitted a 510(k) premarket notification and received a determination from the FDA that the device was not substantially
equivalent or a manufacturer may request de novo classification directly without first submitting a 510(k) premarket notification to the
FDA and receiving a not substantially equivalent determination. The FDA is required to classify the device within 120 calendar days following
receipt of the de novo application, although in practice, the FDA&#8217;s review may take significantly longer. During the pendency of
the FDA&#8217;s review, the FDA may issue an additional information letter, which places the de novo request on hold and stops the review
clock pending receipt of the additional information requested. In the event the de novo requestor does not provide the requested information
within 180 calendar days, the FDA will consider the de novo request to be withdrawn. If the manufacturer seeks reclassification into Class
II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety
and effectiveness of the medical device. In addition, the FDA may reject the de novo request for classification if it identifies a legally
marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk or that general
controls would be inadequate to control the risks and special controls cannot be developed. In the event the FDA determines the data and
information submitted demonstrate that general controls or general and special controls are adequate to provide reasonable assurance of
safety and effectiveness, the FDA will grant the de novo request for classification. When the FDA grants a de novo request for classification,
the device is granted marketing authorization and further can serve as a predicate for future devices of that type, through a 510(k) premarket
notification.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our current strategy is to submit a direct de novo
reclassification petition for C-Scan. To support a direct de novo reclassification petition, our objective is to demonstrate that the
device poses a low to moderate risk to patients. If the FDA determines that C-Scan is not a candidate for de novo reclassification, it
will require approval of the device for market through the PMA process.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Alternatively, if we seek 510(k) clearance and
our device is found not substantially equivalent, or NSE, a de novo petition must be filed within 30 days from the receipt of the NSE
determination. The request should include a description of the device, labeling for the device, reasons for the recommended classification
and information to support the recommendation. The de novo process following an NSE determination has a 60-day review period, although
it is typical for the review to take far longer. If the FDA classifies the device into class II, the company will then receive an approval
order to market the device. This device type can then be used as a predicate device for future 510(k) submissions. However, if the FDA
subsequently determines that the device will remain in the class III category, then the device may not be marketed until the company has
obtained an approved PMA.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Premarket Approval Pathway</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A premarket approval application must be submitted
if the device cannot be cleared through the 510(k) process or is found ineligible for de novo reclassification. PMAs are generally required
for Class III devices that support or sustain human life, are of substantial importance in preventing impairment of human health, or which
present a potential, unreasonable risk of illness or injury. The premarket approval application process is generally more costly and time
consuming than the 510(k) process. A premarket approval application must be supported by extensive data including, but not limited to,
technical, preclinical, clinical trials, manufacturing and labeling to demonstrate to the FDA&#8217;s satisfaction the safety and effectiveness
of the device for its intended use.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">After a PMA application is submitted, the FDA has
45 days to determine whether the application is sufficiently complete to permit a substantive review and thus whether the FDA will file
the application for review. After a premarket approval application is sufficiently complete, the FDA will accept the application and begin
an in-depth review of the submitted information. By statute, the FDA has 180 days to review the &#8220;accepted application,&#8221; although,
generally, review of the application may take at least 12 to 18 months, but it may take significantly longer. During this review period,
the FDA may request additional information or clarification of information already provided. Also during the review period, an advisory
panel of experts from outside FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to
the approvability of the device. In addition, the FDA will conduct a preapproval inspection of the manufacturing facility to ensure compliance
with quality system regulations.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">37</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Upon completion of the PMA application review,
the FDA may: (i) approve the PMA which authorizes commercial marketing with specific prescribing information for one or more indications,
which can be more limited than those originally sought; (ii) issue an approvable letter which indicates the FDA&#8217;s belief that the
PMA application is approvable and states what additional information the FDA requires, or the post-approval commitments that must be agreed
to prior to approval; (iii) issue a not approvable letter which outlines steps required for approval, but which are typically more onerous
than those in an approvable letter, and may require additional clinical trials that are often expensive and time consuming and can delay
approval for months or even years; or</div>

<div style="text-align: justify; margin-left: 7.35pt; line-height: 1.25">(iv) deny the application. If the FDA issues an approvable or
not approvable letter, the applicant has 180 days to respond, after which the FDA&#8217;s review clock is reset.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">New premarket approval applications or premarket
approval application supplements are required for modifications that affect the safety or effectiveness of the device, including, for
example, certain types of modifications to the device&#8217;s indication for use, manufacturing process, labeling and design. Premarket
approval supplements often require the submission of the same type of information as a premarket approval application, except that the
supplement is limited to information needed to support any changes from the device covered by the original premarket approval application
and may not require as extensive clinical data or the convening of an advisory panel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Breakthrough Device Program</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The FDA has implemented a Breakthrough Device Program
that is intended to help patients receive more timely access to breakthrough medical technologies that have the potential to provide more
effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions. A device also must meet one
of the following criteria: (i) it represents breakthrough technology; (ii) there is no approved or cleared alternative; (iii) it offers
significant advantages over existing cleared or approved devices; or (iv) availability of the device is in the best interest of patients.
Under the program, we are eligible to receive priority review and interactive communications from the FDA regarding device development
and clinical trial protocols, all the way through to commercialization decisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In February 2021, the FDA granted us a Breakthrough
Device designation for C-Scan for the indication as stated in the FDA&#8217;s Breakthrough Device designation approval, as follows: &#8220;C-
Scan is intended to identify adult subjects 50 years or older, within the average risk population, who are at elevated risk for polyps
larger than or equal to 1 cm. It is intended for adults who are poor candidates for colonoscopy. Polyps have been shown to be associated
with the development of colorectal cancer. C-Scan is not intended to replace colonoscopy. A positive C-Scan result should be followed
by colonoscopy.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Clinical Trials</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Clinical trials are almost always required to support
a premarket approval application or de novo reclassification petition and are sometimes required for a 510(k) premarket notification.
If the device presents a &#8220;significant risk,&#8221; as defined by the FDA, to human health, the FDA requires the device sponsor to
file an IDE application with the FDA and obtain IDE approval prior to commencing the human clinical trials. During the trial, the sponsor
must comply with the FDA&#8217;s IDE requirements for investigator selection, trial monitoring, reporting, and recordkeeping. The investigators
must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of investigational
devices, and comply with all reporting and recordkeeping requirements. Clinical trials for significant risk devices may not begin until
the IDE application is approved by the FDA and the appropriate institutional review boards, or IRBs, at the clinical trial sites. An IRB
is an appropriately constituted group that has been formally designated to review and monitor medical research involving subjects and
which has the authority to approve, require modifications in, or disapprove research to protect the rights, safety and welfare of human
research subjects. A nonsignificant risk device does not require FDA approval of an IDE; however, the clinical trial must still be conducted
in compliance with various requirements of FDA&#8217;s IDE regulations and be approved by an IRB at the clinical trials sites. We, the
FDA, or the IRB at each site at which a clinical trial is being performed may withdraw approval of a clinical trial at any time for various
reasons, including a belief that the risks to study subjects outweigh the benefits or a failure to comply with FDA or IRB requirements.
Even if a trial is completed, the results of clinical testing may not demonstrate the safety and effectiveness of the device, may be equivocal
or may otherwise not be sufficient to obtain approval or clearance of the product.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Similarly, in Europe the clinical study must be
approved by the local ethics committee and in some cases, including studies of high-risk devices, by the Ministry of Health in the applicable
country.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Sponsors of clinical trials of devices are required
to register with clinicaltrials.gov, a public database of clinical trial information. Information related to the device, patient population,
phase of investigation, study sites and investigators, and other aspects of the clinical trial is made public as part of the registration.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Pervasive and Continuing FDA Regulation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 36pt; line-height: 1.25">After a device is cleared or approved for marketing, numerous and pervasive regulatory
requirements continue to apply. These include:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6f33b2bf39564a6fb2d76b343d5d015d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>establishment registration and device listing with the FDA;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbfaf5a11c94649cc882474b5c90799a0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control,
        documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z23ce2354b1dc46098a3b900da4855b52" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>labeling regulations and FDA prohibitions against the promotion of investigational products, or the promotion of &#8216;&#8216;off-label&#8217;&#8217;
        uses of cleared or approved products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbabf384661e540abb1dc92692c69b4f0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>requirements related to promotional activities;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb51a781f1aff4fc187ab17302a434c62" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness
        or that would constitute a major change in intended use of one of our cleared devices, or approval of certain modifications to PMA-approved
        devices;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc99fdf2cc170464d98154ae8feb6567c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused
        or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to
        cause or contribute to a death or serious injury, if the malfunction were to recur;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z208da00341684893814927f66d574005" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product
        recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present
        a risk to health;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7af0426cd95241e4a749009ef6332f12" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in
        violation of governing laws and regulations; and</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf14117ad14944ade93944902786b223a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect the public health
        or to provide additional safety and effectiveness data for the device.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">38</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25; font-style: italic">Quality Systems Regulation Requirements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our manufacturing processes are required to comply
with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design, manufacture, testing,
production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing of finished devices
intended for human use. The QSR requires that each manufacturer establish a quality systems program by which the manufacturer monitors
the manufacturing process and maintains records that show compliance with FDA regulations and the manufacturer&#8217;s written specifications
and procedures relating to the devices. The QSR also requires, among other things, maintenance of records and certain documentation, a
device master file, device history file, and complaint files. QSR compliance is necessary to receive and maintain FDA clearance or approval
to market new and existing products. As a manufacturer, we are subject to periodic scheduled or unscheduled audits or inspections by the
FDA. Our failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions on, our manufacturing
operations and the recall or seizure of our products, which would have a material adverse effect on our business. The discovery of previously
unknown problems with any of our products, including unanticipated adverse events or adverse events of increasing severity or frequency,
whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice of medicine,
could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The FDA has broad regulatory compliance and enforcement
powers. As manufacturers, we and our third-party manufacturers are subject to announced and unannounced inspections by the FDA to determine
our compliance with quality system regulation and other regulations. We have not yet been inspected by the FDA. If the FDA determines
that we failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, which may
result in any of the following sanctions:</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za11f66cba11348c3ae3ac4f7d91dc065" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>FDA untitled letters, FDA Form 483s, FDA warning letters, it has come to our attention letters, fines, injunctions, consent decrees
        and civil penalties;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd45987685c3d44afae4597ae79ab416c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>unanticipated expenditures to address or defend such actions;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc988aa46af8f467ba408fdeb87f2f790" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>customer notifications or repair, replacement, refunds, recall, detention or seizure of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb559067956ef4ffaa87385340f32167f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>recall, detention or seizure of our products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2197df08bd594dad94e496789cb8ad62" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>operating restrictions, partial suspension or total shutdown of production;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2880a22d2b0b48a9ad0d5ab0ec365cfd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>refusing or delaying our requests for regulatory approvals or clearances of new products or modified products;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z19faacdbc14643158d8e0e2aaaf55d94" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>withdrawing of 510(k) clearances or PMA approvals that have already been granted;</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zb2eea47105f649409fa3912153d30fb0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>refusal to grant export approval for our products; or</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="za724a95502a54026ae24c91b97ddb538" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 36pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top">
        <div>civil or criminal prosecution.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The FDA can also publish Safety Communications
or Letters to Health Care Providers when the agency becomes aware of new issues involving a specific product or, or more broadly, a product
family. These communications are posted on the FDA&#8217;s website and describe the FDA&#8217;s analysis of a current issue and provide
specific regulatory approaches and clinical recommendations for patient management.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Regulatory Pathway for C-Scan</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">We have established a clinical and regulatory
strategy with our advisors and have conducted a pre submission meeting during the period of December 2016 and February 2017, with the
FDA (an informal interaction to facilitate a clearer understanding of FDA&#8217;s expectations). During this process, we received the
FDA&#8217;s feedback on our submission and our questions. We also sought feedback on a proposed protocol for a feasibility or pilot study,
the primary purposes of which was to establish the safety of the C-Scan system and evaluate user compliance and satisfaction. In December
2018, we received from the FDA conditional approval of our IDE application to initiate a U.S. pilot study of the C-Scan system and received
final approval from the FDA in February 2019. In April 2019, we initiated the U.S. pilot study of C-Scan that was completed by December
2019.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">In November 2020, we finalized our proposed
U.S. pivotal study design and submitted our IDE application to the FDA and in March 2021, our IDE application was approved by the FDA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In January 2022, we submitted to the FDA
an amended IDE application to amend the U.S. pivotal study design to add a first part to the study that is designed to enable further
calibration of the C-Scan system, specifically for the average risk U.S. population and in February 2022, our IDE amended application
was approved by the FDA. Following this amended IDE, the U.S. pivotal study consists of two parts. The first part is designed to enable
further calibration of the C-Scan system for the average risk U.S. population, and is intended to include up to 200 patients in the United
States. The second part is a statistically powered, randomized study which will compare the performance of C-Scan to traditional colonoscopy,
and is intended to include up to 800 patients.&#160; The goal of the pivotal study in the United States is to (i) demonstrate device safety
as evidenced by a lack of device related serious adverse events; and (ii) provide efficacy data concerning C- Scan&#8217;s performance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">In May 2022, we announced we had initiated
the first part of the U.S. pivotal study, among the average risk U.S. population. In December 2022, we submitted an IDE supplement to
the FDA to include enrollment of patients at age 45-75 instead of 50-75, which was approved by the FDA in January 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">As part of the U.S. pivotal study, we have
continued to optimize the functionality and patient experience of our advanced version of C-Scan, which incorporates mainly advanced algorithms,
improved detection capability and reduced energy consumption, through additional clinical data collection in a study in Israel (initially
on average risk and high-risk patients and starting May 2022, shifted to enrollment of only average risk patients) for the purpose of
further calibration of the C-Scan system, in parallel to conducting the first part of the U.S. pivotal study that was initiated in May
2022.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">The initiation of the powered potion of
the U.S. pivotal study was dependent upon successful completion of the calibration portion of the U.S. pivotal study.&#160; Following
our internal assessment of the clinical data collected to date from our calibration studies, we have determined that the current efficacy
results do not meet our goal in order to proceed to the powered portion of the U.S. pivotal study.&#160; As a result, we have adopted
a plan of action that includes conducting additional clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal
study protocol that are expected to be part of an IDE supplement submission to the FDA, and which are subject to FDA approval. In addition,
we plan to continue conducting our calibration studies, albeit at a slower pace, to collect additional clinical data and we also implementing
a cost reduction plan, in order to extend our cash runway. The initiation of the powered portion of the U.S. pivotal study that was expected
in mid-2023 is therefore temporarily postponed.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">Following and subject to the successful
completion of our U.S. pivotal study and available capital, our current strategy is to submit a direct de novo reclassification petition
for our system. Although the FDA could require us to submit a PMA, we believe that the device could be considered for evaluation under
the FDA&#8217;s de novo reclassification provisions, which allow a novel device to be reclassified into class I or class II. To support
this, our objective is to demonstrate that the device poses a low to moderate risk to patients.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">We believe that important potential benefits
of C-Scan for CRC screening are the elimination of the need for bowel preparation, the elimination of the need for conscious sedation,
the minimally invasive, painless nature of the examination, and the ability to pursue normal daily activities immediately following the
procedure. Furthermore, the C-Scan system is being designed to generate information from segments of the colon (<span style="font-style: italic">e.g.</span>,
cecum and ascending colon) that are difficult to access by conventional optical colonoscopy (<span style="font-style: italic">i.e.</span>,
incomplete colonoscopies) without the risks and discomforts of operative examination or other invasive methods. We believe these benefits
will be attractive to a large number of patients from the target populations that so far refrained from any screening tests. Thus, we
anticipate that our capsule will increase the public compliance to screening recommendation.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">39</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">If FDA determines that C-Scan is not a candidate
for de novo reclassification, it will require approval of the device for market through the PMA process. Because of the technological
characteristics of this device, the non-clinical tests (including lab and animals) and clinical data required may not be significantly
different between de novo and PMA regulatory processes. We believe that under both scenarios, we are required to conduct a multi-center
clinical study to establish the safety and efficacy and to demonstrate sensitivity and specificity of C-Scan in several hundreds of patients.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.25pt; line-height: 1.25">In February 2021, the FDA granted us a
Breakthrough Device designation for C-Scan for the indication as stated in the FDA&#8217;s Breakthrough Device designation approval, as
follows: &#8220;C- Scan is intended to identify adult subjects 50 years or older, within the average risk population, who are at elevated
risk for polyps larger than or equal to 1 cm. It is intended for adults who are poor candidates for colonoscopy. Polyps have been shown
to be associated with the development of colorectal cancer. C-Scan is not intended to replace colonoscopy. A positive C-Scan result should
be followed by colonoscopy.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; line-height: 1.25">The FDA&#8217;s Breakthrough Device Program
aims to provide patients and providers with expedited access to innovative medical devices that offer more effective diagnosis by expediting
their development, assessment and review while preserving the statutory standards for premarket approval. In addition, the Centers for
Medicare &amp; Medicaid Services (CMS) has created expedited and special reimbursement pathways and programs based on FDA&#8217;s Breakthrough
Device designation, for which we may be eligible.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">FCC Clearance and Regulation</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Because C-Scan includes a wireless radio
frequency transmitter and receiver, it is subject to equipment authorization requirements in the United States. The U.S. Federal Communications
Commission, or FCC, requires authorization of radio frequency devices before they can be sold or marketed in the United States, subject
to limited exceptions. The authorization requirements are intended to confirm that the proposed products comply with FCC radio frequency
emission, power level standards, and other technical requirements and will not cause interference. Our system is using the same frequency
band as other approved capsules. The current design of C-Scan complies with the FCC&#8217;s technical requirements and received FCC authorization.
We expect that our future advanced design will also be comply with the FCC&#8217;s technical requirements, so it is expected that it will
be authorized by the FCC as well.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Third-Party Coverage and Reimbursement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; line-height: 1.25">Coverage of and reimbursement for C-Scan
and related procedures, after approval, will be subject to the requirements of various third-party payors, including government-sponsored
healthcare payment systems and private third-party payors. Coverage policies and reimbursement methodologies vary significantly from program-to-program
and may be subject to federal and state regulations. For example, the Social Security Act requires all items and services to be &#8220;reasonable
and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member&#8221; in order
to be covered by Medicare. While Medicare might not provide separate reimbursement for a device, it, may include payment for the device
in the payment to the facility or physician for the related procedure. Third-party payors&#8217; coverage and reimbursement policies,
including their interpretations of whether an item or service is &#8220;reasonable and necessary&#8221; or experimental and/or investigational,
and their payment methodologies, are subject to change pursuant to legislation, regulation, or, in the case of private payors, negotiations
with industry and providers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Fraud and Abuse Laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In the United States, the healthcare industry
is subject to extensive federal, state, and local regulation. Both federal and state governmental agencies subject the healthcare industry
to intense regulatory scrutiny, including heightened civil and criminal enforcement efforts. These laws constrain the sales, marketing
and other promotional activities of manufacturers of medical devices, by limiting the kinds of financial arrangements (including sales
programs) we may have with hospitals, physicians and other potential purchasers of the medical devices. The laws and regulations that
may affect our ability to operate include, but are not limited to:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z216e3cfa29e04436907b7204751a1fad" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The federal Anti-Kickback Statute, which prohibits, among other things, knowingly
        or willingly offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or in kind, to induce or reward the
        purchasing, leasing, ordering or arranging for or recommending the purchase, lease or order of any health care items or service for which
        payment may be made, in whole or in part, by federal healthcare programs such as Medicare and Medicaid. This statute has been interpreted
        to apply to arrangements between medical device manufacturers on one hand and prescribers, purchasers and formulary managers on the other.
        Further, PPACA, among other things, clarified that a person or entity needs not to have actual knowledge of the federal Anti-Kickback
        Statute or specific intent to violate it. Although there are a number of statutory exemptions and regulatory safe harbors to the federal
        Anti-Kickback Statute protecting certain common business arrangements and activities from prosecution or regulatory sanctions, the exemptions
        and safe harbors are drawn narrowly, and practices that do not fit squarely within an exemption or safe harbor may be subject to scrutiny;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zdd47a3792c0f4ddb9014f33a3f04b2a3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The federal civil False Claims Act, which prohibits, among other things, individuals
        or entities from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds or knowingly
        making, using or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly
        concealing or knowingly and improperly avoiding, decreasing, or concealing an obligation to pay money to the federal government. In addition,
        PPACA amended the Social Security Act to provide that the government may assert that a claim including items or services resulting from
        a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims
        Act. Many medical device manufacturers and other healthcare companies have been investigated and have reached substantial financial settlements
        with the federal government under the civil False Claims Act for a variety of alleged improper marketing activities, including providing
        free product to customers with the expectation that the customers would bill federal programs for the product; providing consulting fees,
        grants, free travel, and other benefits to physicians to induce them to use the company&#8217;s products. In addition, in recent years
        the government has pursued civil False Claims Act cases against a number of manufacturers for causing false claims to be submitted as
        a result of the marketing of their products for unapproved, and thus non-reimbursable, uses. Device manufacturers also are subject to
        other federal false claim laws, including, among others, federal criminal healthcare fraud and false statement statutes that extend to
        non-government health benefit programs;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc47ab9a283d64433a52f54439cee474c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">Analogous state laws and regulations, such as state anti-kickback and false claims
        laws, may apply to items or services reimbursed under Medicaid and other state programs or, in several states, apply regardless of the
        payor. Several states now require medical device manufacturers to report expenses relating to the marketing and promotion or require them
        to implement compliance programs or marketing codes. For example, California, Connecticut and Nevada mandate the implementation of corporate
        compliance programs, while Massachusetts and Vermont impose more detailed restrictions on device manufacturers&#8217; marketing practices
        and tracking and reporting of gifts, compensation and other remuneration to healthcare providers;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z14d83aeb83434aea8b6e547e12906762" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The federal Foreign Corrupt Practices Act of 1997 and other similar anti-bribery laws
        in other jurisdictions generally prohibit companies and their intermediaries from providing money or anything of value to officials of
        foreign governments, foreign political parties, or international organizations with the intent to obtain or retain business or seek a
        business advantage. Recently, there has been a substantial increase in anti-bribery law enforcement activity by U.S. regulators, with
        more frequent and aggressive investigations and enforcement proceedings by both the Department of Justice and the U.S. Securities and
        Exchange Commission. Violations of these laws can result in the imposition of substantial fines, interruptions of business, loss of supplier,
        vendor or other third-party relationships, termination of necessary licenses and permits, and other legal or equitable sanctions. Other
        internal or government investigations or legal or regulatory proceedings, including lawsuits brought by private litigants, may also follow
        as a consequence; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1b295c6adec14f0eb3765dbbda68af5d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25">The federal Physician Payment Sunshine Act, being implemented as the Open Payments
        Program, requires manufacturers of &#8220;covered products&#8221; (drugs, devices, biologics, or medical supplies for which payment is
        available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program) to track and publicly report payments and other
        transfers of value that they provide to U.S. physicians and teaching hospitals, as well as any ownership interests that U.S. physicians
        hold in applicable manufacturer. Applicable manufacturers must submit a report to the Centers for Medicare &amp; Medicaid Services, or
        CMS, by the 90th day of each calendar year disclosing payments and transfers of value made in the preceding calendar year.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; line-height: 1.25">Violations of any of the laws described above or any other governmental
regulations that apply to us, may cause us to be subject to significant civil, criminal and administrative penalties, damages, fines,
exclusion from government-funded healthcare programs, like Medicare and Medicaid, and the curtailment or restructuring of our operations.</div>

<div style="line-height: 1.25"><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">40</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Privacy Laws</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">HIPAA/HITECH and related U.S. federal and
state laws protect the confidentiality of certain patient health information, including patient records, and restrict the use and disclosure
of that protected information. In particular, the U.S. Department of Health and Human Services promulgated patient privacy rules under
HIPAA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">These privacy rules protect medical records
and other personal health information by limiting their use and disclosure, giving individuals the right to access, amend and seek accounting
of their protected health information and limiting most use and disclosures of health information to the minimum degree reasonably necessary
to accomplish the intended purpose. Because we intend to sell products, once approved, to persons and entities subject to HIPAA and are
exposed to personally-identifiable health information in the course of our operations, we also may be subject to certain elements of HIPAA,
particularly as a business associate to covered entities, as well as similar state laws. HIPAA imposes civil and criminal penalties for
violations of its provisions, which could be substantial. State privacy laws have their own penalty provisions which may be applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">NRC Regulatory Matters</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 27.35pt; margin-right: 7.3pt; line-height: 1.25">As a manufacturer of a medical device containing
a sealed, radioactive source, we are subject to regulation by various governmental authorities that oversee the possession, use, and disposal
of radioactive material. These regulations govern, among other things, the design, development, testing, manufacturing, packaging, labeling,
distribution, import/export, sale, and marketing and disposal of our product.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.25pt; line-height: 1.25">The C-Scan capsule contains within the
device a radioactive sealed source, which contains a small amount of radioactive material. This material aids in the imaging and scanning
capabilities of the device as it passes through the patient. The C-Scan capsule is ingested by the patient, and passes through the patient&#8217;s
gastrointestinal tract before exiting the human body.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Depending on where we manufacture and distribute
the device, various countries nuclear regulatory laws and regulations may apply. In Israel, where we manufacture the device, Israel nuclear
regulatory laws apply to the radioactive material in the device. We adhere to the Israeli regulations and guidance for the design, development,
testing, manufacturing and packaging, as well as the applicable nuclear regulations in the manufacturing phase.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 25.2pt; margin-right: 8.25pt; line-height: 1.25">In the United States, the C-Scan capsule is undergoing clinical
trials. The U.S. Nuclear Regulatory Commission, or the NRC, and state nuclear regulatory agencies oversee the use of radioactive materials
in the United States. The NRC regulates the use of radioactive materials in medical devices under several parts of its regulations, including
10 C.F.R. Part 20, &#8220;Standards for Protection Against Radiation,&#8221; 10 C.F.R. Part 30, &#8220;Rules of General Applicability
to Domestic Licensing of Byproduct Material,&#8221; and 10 C.F.R. Part 35, &#8220;Medical Use of Byproduct Material.&#8221; NRC Agreement
States implement similar regulations under a nuclear regulatory framework developed by the state pursuant to authority delegated by the
NRC.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In accordance with applicable NRC regulations,
and relevant NRC Agreement State requirements, we comply with the radioactive materials safety and handling requirements applicable for
our development of our C-Scan technology applicable to clinical trials. Regarding disposal of the device, the NRC places conditions and
limitations on the disposal of radioactive material in the sanitary sewer. In 2022, after extensive engagement with the NRC, we submitted
a petition for rulemaking to the NRC, requesting that the agency amend the NRC regulations at 10 CFR 20.2003(b), which pertains to disposal
of radioactive material into the sanitary sewer system, to include the disposal of the C-Scan capsule.&#160; Under the NRC&#8217;s current
interpretation of the 10 CFR 20.2003(b) regulations, disposal of a device like the C-Scan capsule into the sanitary sewer system is not
currently permitted. The NRC&#8217;s review of the rulemaking request remains ongoing. Therefore, during the U.S. pivotal study, the C-Scan
capsule is not intended to be disposed of in the sanitary sewer system, and is instead intended to be collected by the patient and returned
to the medical facility administering the device for further storage, decay and disposal. For the collection and disposal phase of the
U.S. pivotal study, we have established, through a third party, a decay and disposal process of the C-Scan capsule that is in accordance
with the NRC and Agreement State requirements.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In the U.S, engagement with various sites
to participate in the U.S. pivotal study has been progressing slower than expected, in part due to compliance with, and the need for,
the site-specific licensing and compliance with radioactive materials regulatory requirements associated with the X-ray technology contained
within our C-Scan capsule.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 27.15pt; margin-right: 7.25pt; line-height: 1.25">The future commercial sale of C-Scan will
also be subject to extensive nuclear regulations in various jurisdictions around the world where the C-Scan capsule will be used, and
we intend to comply with such regulations as they become applicable. We expect the commercial manufacture and distribution of C-Scan will
also require us, or a company affiliated with our company, to obtain a number of licenses and certifications related to nuclear regulatory
compliance. We also expect that in commercialization, clinical centers/hospitals will need to obtain a number of licenses and certifications
related to nuclear regulatory compliance.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Regulation in Europe, Israel, Japan and Other Countries</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">The European Union has adopted numerous
directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices.
Each European Union member state has implemented legislation applying these directives and standards at the national level. Other countries,
such as Switzerland, have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices.
Devices that comply with the requirements of the laws of the relevant member state applying the applicable European Union directive are
entitled to bear CE conformity marking and, accordingly, can be commercially distributed throughout the member states of the European
Union and other countries that comply with or mirror these directives. The method of assessing conformity varies depending on the type
and class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a
&#8220;Notified Body,&#8221; an independent and neutral institution appointed to conduct conformity assessment. This third-party assessment
consists of an audit of the manufacturer&#8217;s quality system and clinical information, as well as technical review of the manufacturer&#8217;s
product. An assessment by a Notified Body in one country within the European Union is required in order for a manufacturer to commercially
distribute the product throughout the European Union. In addition, compliance with ISO 13845:2016 on quality systems issued by the International
Organization for Standards, among other standards, establishes the presumption of conformity with the essential requirements for a CE
marking. In addition, many countries apply requirements in their reimbursement, pricing or health care systems that affect companies&#8217;
ability to market products.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">On January 9, 2018, we obtained the CE
mark of conformity for C-Scan. On December 21, 2021, the European MDR issued a renewal of our CE mark according to the EU Regulation 2017/745
on Medical Devices for the marketing and sale of C-Scan in the European Union, valid until December 1, 2026.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">C-Scan and our operations are also subject
to regulation by AMAR, which is responsible for the registration of medical devices in Israel, issuance of import licenses and monitoring
of marketing of medical equipment. In September 2018, we received approval from AMAR for the marketing and sale of C-Scan in Israel. Following
the approval we received from our notified body according to the EU Regulation 2017/745, the AMAR approval was renewed and is valid until
December 31, 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.35pt; line-height: 1.25">In Japan, manufacturing and marketing medical
devices are regulated by the Pharmaceutical Affairs Law, or PAL. In accordance with the PAL, manufacturers must obtain a license for manufacturing
medical devices from the Ministry of Health, Labour and Welfare, or MHLW. A license is required for each manufacturing plant specified
by an MHLW Ministerial Ordinance.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.35pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">41</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.35pt; line-height: 1.25">A licensed manufacturer is responsible
only for manufacturing medical devices. In regard to the marketing of medical devices, the PAL specifies that a Marketing Authorization
Holder, or MAH, licensed by MHLW is responsible for putting medical devices into marketplace. Licenses for marketing medical devices are
divided into the following 3 types, which correspond to the classifications below:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4a0aede65e6244a5b6db27ce8ee2cd6b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">No. 1 type license for marketing &#8211; Specially controlled medical devices (Class III, IV)</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z38628a8b750c48d58f8a4a78df00ae74" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">No. 2 type license for marketing &#8211; Controlled medical devices (Class II)</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za053dfd3bd1d42deaf67a45876e02aef" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">No. 3 type license for marketing &#8211; General medical devices (Class I)</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.35pt; line-height: 1.25">Generally, the process for obtaining marketing
clearance for medical devices in Japan ranges from twelve months (for products with only very minor modifications from previously cleared
product versions) to a few years in the case of a completely new device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.2pt; line-height: 1.25">In order for us to market our products
in countries other than the United States, Israel, the EU and Japan (which were described above), we must obtain regulatory approvals
and comply with extensive safety and quality regulations in these countries. These regulations, including the requirements for approvals
or clearance and the time required for regulatory review varies from country to country. It is customary that once a product has been
cleared for sales in the US and is CE marked in the EU, many other countries will follow. Failure to obtain regulatory approval or clearance
in any foreign country in which we plan to market our product may harm our ability to generate revenue and harm our business.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">United Kingdom</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">The withdrawal of the United Kingdom (UK)
from the EU took effect on January 1, 2021, and there are 27 member states remaining in the EU. As of January 1, 2021, the UK is a &#8220;third
country&#8221; with regard to the EU (subject to the terms of the EU UK Trade Agreement) and EU law ceased to apply directly in the UK.
However, the UK has retained the EU regulatory regime with certain modifications as standalone UK legislation. Therefore, the UK regulatory
regime is currently similar to EU regulations, but under new legislation, the Medicines and Medical Devices Act, the UK may adopt changed
regulations that may diverge from the EU legislative regime for medicines and medical devices and their research, development and commercialization.
For a two-year period starting January 1, 2021, the UK has adopted transitional provisions, which inter alia apply to the importation
of medical devices into the UK and the acceptance of CE-certificates until the end of June 2023, subject to certain registrations with
the UK Medicines and Healthcare Products Regulatory Agency. From July 1, 2023, certification under the new UK medical device legislation
will be required to place products on the market in the UK. Medical devices, will need to be registered with the MHRA before they are
placed on the Great Britain market. Medical device manufacturer based outside the UK that wish to place a device on the Great Britain
market, will need to appoint a single UK Responsible Person, who will act on its behalf to carry out specified tasks, such as registration.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Third-Party Reimbursement</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Reimbursement in the United States</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In the United States, healthcare providers
that purchase and/or prescribe medical devices generally rely on third-party payors, such as Medicare, Medicaid, or private health insurance
plans, to reimburse all or a portion of the cost of the devices, as well as any related healthcare services utilizing the device.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">Coverage is not guaranteed simply because
a product has received FDA clearance or approval or has a CPT or HCPCS code that describes the product or service. For example, Medicare&#8217;s
general definition of a medically necessary service is one that is reasonable and necessary for the diagnosis or treatment of an illness
or injury, or that improves the functioning of a malformed body member.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Colorectal cancer (CRC) is the fourth most
common cancer and the second leading cause of cancer deaths in the United States, and is expected to cause about 52,550 deaths during
2023. It is an important issue for the Medicare and the commercial population. Approximately 4.1 percent of men and women will be diagnosed
with colorectal cancer at some point during their lifetime, based on 2016&#8211;2018 data. In 2018, there were an estimated 1,365,135
people living with colorectal cancer in the United States. In 2022, the National Institutes of Health (NIH) National Cancer Institute
(NCI) estimated that there will be over 151,000 new cases of colon and rectal cancer in the United States with a median age at diagnosis
of 66 years. Colorectal cancer is most frequently diagnosed among people aged 6 &#8211; 74 years (NIH). The American Cancer Society&#8217;s
estimates for the number of colorectal cancer cases in the United States for 2023 forecast over 153,000 new cases of colon and rectal
cancer. From 2013 to 2019, while incidence rates dropped by about 1% each year, there is a rising incidence among younger adults since
at least the mid-1990s. From 2012 through 2016, it increased every year by 2% in people younger than 50 and 1% in people 50 to 64. While
the death rate from colorectal cancer has been dropping among both men and women for several decades, deaths from colorectal cancer among
people younger than 55 have increased 1% per year from 2008 to 2017.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 25.2pt; line-height: 1.25">Among all races, African Americans have the highest death rate. Based on data from
SEER 17 2012-2018, the five-year relative survival rate was 65.1%. The earlier colorectal cancer is caught, the better chance a person
has of surviving five years after being diagnosed. For colorectal cancer, 37.2% are diagnosed at the local stage. The 5-year relative
survival for localized colorectal cancer is 90.9%.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">COVID-19 has caused an unprecedented disruption
in cancer prevention efforts, including CRC screening. In general, colorectal cancer screening decreased by 28% to as much as 100% in
different countries and at different times after the onset of the COVID-19 pandemic. During this period, completion of colonoscopies requiring
examination showed a decrease of 65.7%, surveillance colonoscopy showed a decrease of 44.6 to 79%, prescription colonoscopy decreased
60 to 81%, and referrals to colonoscopy showed a 43% decline. In a simulation model by Issaka, et al, COVID-19&#8211;related reductions
in care utilization resulted in an estimated 1,176,942 to 2,014,164 fewer colorectal cancer screenings, 8,346 to 12,894 fewer colorectal
cancer diagnoses, and 6113 to 9301 fewer early-stage colorectal cancer diagnoses between 2020 and 2023. In an extended period of limited
CRC screenings due to the pandemic, up to 43% of eligible adults could remain unscreened.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25">Since the 1990s, Medicare
has covered a number of CRC screening tests from non-invasive fecal based tests to colonoscopy, providing a range of choices for patients
to choose the most individually suitable modalities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">The cost-effectiveness of a device (or the
service in which a device is used) may be a key factor in obtaining third-party payer reimbursement for such device or service, but is
not commonly a factor for Medicare. Medicare covers certain colorectal cancer (CRC) screening tests and procedures for Medicare beneficiaries
that meet certain eligibility criteria, as authorized by Sections 1861(s)(2)(R) and 1861(pp) of the Social Security Act and regulations
at 42 CFR 410.37. However, Medicare coverage of CRC screening tests as defined under Section 1861(pp)(1)(D) states &#8220;Such other tests
or procedures, and modifications to tests and procedures under this subsection, with such frequency and <span style="font-style: italic">payment
limits</span>, as the Secretary determines appropriate, in consultation with appropriate organizations.&#8221; (emphasis added).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">A key factor affecting the cost-effectiveness
of colorectal cancer screening is patient adherence. Adherence is strongly affected by patients&#8217; willingness to use the device (or
service incorporating a device) as a screening tool for CRC.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-right: 8.3pt; line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Several models have been designed
to demonstrate the cost effectiveness of optical colonoscopy, CT colonography (CTC), fecal testing and capsule endoscopy. Today, several
technologies - FOBT / FIT, Flexible Sigmoidoscopy, Optical Colonoscopy, Barium Enema, and multi-target stool DNA &#8211; are covered for
Medicare beneficiaries meeting certain eligibility criteria for screening for colorectal cancer, while other technologies including CTC,
capsule endoscopy, and liquid biopsy are not currently covered by Medicare for CRC screening.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In 2009, the Centers for Medicare and Medicaid
Services (CMS) issued a decision memorandum concluding that the evidence was inadequate to support Medicare coverage of CT colonography
(CTC) for CRC screening. Their main argument for the decision was based on available evidence that screening with CTC would not necessarily
result in cost savings at least at current screening compliance rates. CTC was not seen as a tool which could potentially increase patients&#8217;
adherence. This procedure involves bowel preparation, as well as insufflations of the colon and the exposure of patients to very significant
amount of radiation. Extracolonic incidental findings on CT colonography are common, with the percentage of participants with extracolonic
findings ranging from 58% to 66%. Further, as CTC potentially detects lesions outside of the colon, CMS has no ability to pay for the
evaluation of incidental findings in a patient without signs or symptoms unless specifically directed by Congress to do so.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">There are benefits of screening for advanced
adenomas. The adenoma detection rate (based on colonoscopies) was inversely associated with the risks of interval colorectal cancer, advanced-stage
interval cancer, and fatal interval cancer.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">42</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">An important European study (C. Hassan et
al, &#8220;Cost-Effectiveness of Capsule Endoscopy in Screening for Colorectal Cancer,&#8221; Endoscopy; 2008 40: 414-421) assessed the
potential cost effectiveness of screening with optical capsule endoscopy and compared its cost-effectiveness with optical colonoscopy.
Cost-effectiveness of screening was measured in terms of cost per life-year saved through prevention or down staging of CRC. The conclusion
was that the cost effectiveness of capsule endoscopy in CRC screening will depend mainly on its ability to improve compliance in the general
population.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">Third-party payors in the United States
began issuing coverage policies for capsule endoscopy in early 2002, subsequent to FDA approval and availability of the technology. Initially,
reimbursement policies provided coverage for capsule endoscopy of the small bowel only for the diagnosis of obscure gastrointestinal bleeding.
Subsequently, reimbursement coverage has been expanded to include other diagnoses and as of December 31, 2022, approximately 300 million
people in the United States have coverage of this technology for a number of capsule endoscopy of the small bowel indications including
obscure gastrointestinal bleeding, suspected Crohn&#8217;s disease, suspected small bowel tumors, celiac disease and other small bowel
pathologies.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Currently, there is no Medicare, Medicaid,
or commercial insurance reimbursement for capsule endoscopy of the colon in the United States for CRC screening, despite the availability
of CPT code 91113 Gastrointestinal tract imaging, intraluminal (e.g., capsule endoscopy), colon, with interpretation and report, which
became effective January 1, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">In February 2020, CMS received a formal
request for a national coverage determination from Epigenomics to consider coverage of Epi proColon, one example of a blood-based biomarker
screening test for colorectal cancer. Over the last several years, blood-based biomarker tests have emerged as another potential non-invasive
option for the early detection of colorectal cancer. A blood-based biomarker (biological marker in the patient&#8217;s blood) is a measurable
DNA, RNA or protein component that indicates disease, in this case cancer. Blood-based cancer biomarkers include but are not limited to
specific gene mutations, methylation of genes, and antigens. The blood-based biomarker that is measured in a person&#8217;s blood can
be an indicator of a process, such as disease risk or progression, like progression to colorectal cancer, thought to be correlated with
a long term outcome, such as mortality. It is typically easier to measure a biomarker than the true outcome of interest, such as mortality
from colorectal cancer. However, the biomarker might not be a good surrogate for and not well correlated with the clinical outcome of
interest, such as cancer survival or mortality, or it might not identify a patient early enough to alter the clinical course of disease.
One example test, Epi proColon, functions as a blood-based colorectal cancer screening test by identifying the circulating mSEPT9 (Septin9)
gene in cell-free DNA isolated from plasma. CRC tumors have an increased likelihood of exhibiting aberrant methylation at the promoter
region of the SEPT9 gene DNA.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In the past CRC screening NCDs, CMS has
discussed appropriate test performance criteria such as point sensitivity and specificity compared to colonoscopy. The determination of
appropriateness is similar to the consideration of what is appropriate for the device to be, &#8220;at least as beneficial as an existing
and available medically appropriate alternative.&#8221; Through the evaluation of evidence from published studies, the clinical data for
the device must reach the threshold for being appropriate. The direct evidence suggests that there is clinical utility in using FOBT and
FIT for early detection of colorectal cancer (CRC) because these tests reduce mortality of the disease. Conversely, there is no direct
evidence on outcomes such as mortality for blood-based biomarker tests used in screening for colorectal cancer. By comparing the test
performance characteristics, defined as sensitivity, specificity, and positive predictive value, of new screening tests to gFOBT or FIT,
CMS can assess whether blood-based tests might translate into similar reductions in disease mortality for Medicare beneficiaries. Thus,
if the sensitivity and specificity of the new screening tests are as good as or better than the sensitivity and specificity of gFOBT or
FIT, then there is indirect evidence suggesting that the new blood-based biomarker tests may reduce colorectal cancer mortality.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">In January 2021, CMS updated National Coverage
Determination 210.3, stating that, effective for dates of service on or after January 19, 2021, a blood-based biomarker test is covered
as an appropriate colorectal cancer screening test once every 3 years for Medicare beneficiaries (i) when performed in a Clinical Laboratory
Improvement Act (CLIA)-certified laboratory, (ii) when ordered by a treating physician and (iii) when all of the following requirements
are met: The patient is: age 50-85 years; and, asymptomatic (no signs or symptoms of colorectal disease including but not limited to lower
gastrointestinal pain, blood in stool, positive guaiac fecal occult blood test or fecal immunochemical test); and, at average risk of
developing colorectal cancer (no personal history of adenomatous polyps, colorectal cancer, or inflammatory bowel disease, including Crohn&#8217;s
Disease and ulcerative colitis; no family history of colorectal cancers or adenomatous polyps, familial adenomatous polyposis, or hereditary
nonpolyposis colorectal cancer). The blood-based biomarker screening test must have all of the following: FDA market authorization with
an indication for colorectal cancer screening; and, proven test performance characteristics for a blood-based screening test with both
sensitivity greater than or equal to 74% and specificity greater than or equal to 90% in the detection of colorectal cancer compared to
the recognized standard (accepted as colonoscopy at this time), as minimal threshold levels, based on the pivotal studies included in
the FDA labeling.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">CMS concluded that the published evidence
does not show that the available blood-based biomarker CRC screening test improves health outcomes for Medicare beneficiaries. The indirect
evidence (comparing a blood-based screening test to another test that has been shown to improve mortality such as screening fecal immunochemical
test) does not show that blood- based screening test is equivalent in the detection of large adenomas or early stage cancer. The test
performance of the Epi proColon&#174; test does not meet sensitivity and specificity levels established by prior evidence at which the
benefits of using the screening test outweigh harms to Medicare patients.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In July 2022, a group of colorectal cancer
survivors, patient advocates, and life-science professionals met to discuss opportunities for stakeholders to improve access to treatment
and screening in the US.&#160; Joined by White House Cancer Moonshot Coordinators, the group centered discussion on three initiatives:<br />
<br /> </div>

<table cellspacing="0" cellpadding="0" id="z76e4600f6099434ba16f0a4de175f68c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.6pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>CRC education and awareness as part of First Lady Jill Biden&#8217;s cancer screening messaging efforts,</div> </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="zb1730999f4fa492f910a00196855df97" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.6pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Comprehensive CRC screening solutions supporting current screening tools, enabling the workgroup to reach underserved communities,</div>
        </td> </tr>
  </table>

<table cellspacing="0" cellpadding="0" id="z00841de6dc64403c94a93f83d4a453cc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 50.6pt"><br /> </td>
    <td style="width: 18pt; vertical-align: top">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify">
        <div>Building on previous successes of the CDC&#8217;s Colorectal Cancer Control Program (CRCCP).</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In December 2022, Guardant Health released
results from ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode), an over 20,000 patient registrational
study evaluating the performance of its blood test for detecting colorectal cancer (CRC) in average-risk adults. The test demonstrated
83% sensitivity in detecting individuals with CRC. Specificity was 90% in both individuals without advanced neoplasia and in those who
had a negative colonoscopy result. This test also demonstrated 13% sensitivity in detecting advanced adenomas. In this study, two configurations
of a multimodal blood-based screening test were evaluated independently - a cell-free DNA (cfDNA)-only test and a cfDNA test with protein
biomarkers. The announced results were derived from the cfDNA-only test, which outperformed the cfDNA test with protein biomarkers. Based
on these study results, Guardant Health plans to complete its premarket approval submission to the FDA in the first quarter of 2023.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In January 2023, Geneoscopy Inc., released
results from the CRC-PREVENT trial &#8211; a pivotal clinical trial evaluating the efficacy of its noninvasive, stool-based, at-home diagnostic
screening test to detect colorectal cancer (CRC) and advanced adenomas (AA) in average-risk individuals. The CRC-PREVENT trial included
8,289 individuals with diverse racial, ethnic, and socioeconomic backgrounds across more than 2,900 zip codes in all lower 48 states,
with colonoscopies performed in more than 3,800 endoscopy centers. Efficacy results from the study demonstrated 94% sensitivity for detecting
CRC, 45% sensitivity for detecting advanced adenoma (AA), and 88% specificity for no findings on a colonoscopy.&#160; The company submitted
a Premarket Approval (PMA) application to the FDA in January 2023.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">There can be no assurance that coverage
of the C-Scan by Medicare and/or commercial payors will be obtained in the near future or at all. Third-party payors may deny coverage
of the C-Scan if they determine that a procedure was not reasonable or necessary as determined by the payor, was experimental, does not
improve health outcomes, is not equivalent in the detection of large adenomas or early stage cancers, and/or was used for an unapproved
indication (among other factors).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Coverage Outside the United States</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">In countries outside the United States,
coverage for CRC screening may be obtained from various sources, including governmental authorities, private health insurance plans, and
labor unions. In some countries, private insurance systems may also offer payments for some therapies. Although not as prevalent as in
the United States, health maintenance organizations are emerging in certain European countries. Coverage systems in international markets
vary significantly by country and, within some countries, by region. Coverage approvals must be obtained on a country-by- country or region-by-region
basis.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">43</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Organizational
Structure</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 23.55pt; line-height: 1.25">On May 15, 2015, we formed our wholly-owned subsidiary Check-Cap US, Inc., a Delaware
corporation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Property,
Plants and Equipment</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">Our principal executive offices and operations
are conducted at a facility located in Isfiya, Israel since June 1, 2009. We also have an X-ray production line in Petach Tikva, Israel.
In Isfiya, we lease approximately 1,550 square meters at this facility under a lease agreement expiring on December 31, 2023, and we have
an option to extend the agreement for an additional period of three years. We have the right to terminate the Isfiya lease agreement at
any time, upon at least 60 days prior written notice. We currently plan to extend the Isfiya lease agreement by the additional three years.&#160;
In December 2021, we signed the Sub-lease Agreement with one of our suppliers, according to which we lease approximately 70 square meters
of laboratory production space at the supplier&#8217;s premises. The Sub-lease Agreement entered into in effect on September 21, 2022,
after receipt of certain certificates, including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on
January 31, 2025, and we have an option to extend the lease period for an additional two years. We have the right to terminate the Sub-lease
Agreement at any time, upon at least 90 days prior written notice. The lessor has the right to terminate the Sub-lease Agreement, upon
at least 12 months prior written notice.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">We believe that our current facilities
are adequate to meet our current needs for the clinical phase of our development. See Item 4B &#8220;Information on Our Company &#8211;
Business Overview &#8211; Manufacturing and Suppliers.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 4A<span id="ITEM4A"><!--Anchor--></span>. Unresolved Staff Comments</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 23.55pt; line-height: 1.25">None.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 5<span id="ITEM5"><!--Anchor--></span>. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25; font-style: italic">You should read the
following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated financial
statements and related notes included in this Annual Report beginning on page F-1. The following discussion and analysis contain forward-looking
statements that involve risks and uncertainties. Our actual results and the timing of selected events could differ materially from those
anticipated in these forward-looking statements as a result of various factors, including those set forth under Item 3D &#8220;Key Information
- Risk factors&#8221; and elsewhere in this Annual Report.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Overview</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">We are a clinical stage medical diagnostics
company aiming to redefine CRC screening through the introduction of C-Scan&#174;, the first and only patient-friendly preparation-free
test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. The disruptive
capsule-based screening technology aims to increase screening adherence worldwide and enable millions of people to stay healthy. The system
utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. CRC
is the third most commonly diagnosed cancer, with more than 1.9 million new cases identified every year globally. Nearly 935,000 deaths
occur annually worldwide as a result of CRC. While approximately 0.5% of the average-risk screening population presents with cancerous
polyps in the colon and rectum at any given time, approximately 25% of the same population presents with benign polyps that could potentially
turn into cancer over time. It can take up to 10 years before a pre-cancerous polyp develops into invasive cancer. As such, there is a
crucial detection window for the prevention of colorectal cancer, through the detection of these benign polyps. While routine screening
is recommended by The American Cancer Society for healthy people aged 45 years and older, screening adherence remains low. Currently,
colonoscopy is the gold standard for the detection of colorectal polyps, but about 1 in 3 adults among the targeted screening population
avoids having a colonoscopy in the U.S., and adherence in other regions of the world such as Europe and Asia is even lower, due to the
invasiveness of the procedure and bowel preparation. Most patient-friendly CRC screening tests currently available, or poised to enter
the market, such as fecal or liquid biopsy tests, are primarily designed to detect cancer and demonstrate low sensitivity in detecting
pre-cancerous polyps. As such, they do not necessarily provide patients with the time window to pre-empt the disease. C-Scan is non- invasive
and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is
propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: (1) C-Scan Cap, an ingestible
X-ray scanning capsule; (2) C-Scan Track, three miniaturized patches worn on the patient&#8217;s back for integrated positioning, control
and data recording; and (3) C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
We believe that this solution has the potential to become an alternative for both physicians and patients and to increase the number of
people completing CRC screening.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Check-Cap LLC was formed in 2004 as a Delaware
limited liability company to develop a novel and superior solution for colon cancer screening. In 2009, all of the business operations
and substantially all of the assets of Check-Cap LLC were transferred to Check Cap Ltd., a newly-incorporated Israeli company. Our headquarters
are located near Haifa, in the northern part of Israel. Our management team includes an experienced group of executives in the business,
research, clinical and regulatory fields. As of March 15, 2022, our research and development team consists of 78 experienced professionals
(including employees and independent contractors) in a variety of fields such as clinics, physics, algorithms, electronics, software,
mechanical engineering, verification and validation, and manufacturing.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">C-Scan is being designed to create a reconstructed
three-dimensional representation of the interior surface of the colon and to enable detection of clinically significant polyps with a
high degree of sensitivity. Colonic polyps are tissue growths that occur on the lining of the colon. Polyps in the colon are extremely
common and certain types of polyps can become cancerous over time.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">For the past several years, we have focused
on the research and development of our imaging technology. For details regarding our clinical trials, see Item 4B &#8220;Business Overview&#8212;C-
Scan System Non-Clinical and Clinical History.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">We have generated significant losses to
date, and we expect to continue to generate losses for at least the next several years as we continue our investment in research and development
and clinical trials in order to complete the development of C-Scan and to attain regulatory approvals, manufacturing scale up, begin the
commercialization efforts for our products, increase our marketing and selling expenses, and incur additional costs as a result of being
a public company in the United States. The extent of our future operating losses and the timing of becoming profitable are highly uncertain,
and we may never achieve or sustain profitability. As of December 31, 2022, we had accumulated losses of approximately $127.3 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 23.6pt; line-height: 1.25">Our financing activities are described below under &#8220;Liquidity and Capital Resources.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">Since our inception, we have devoted substantially
all of our efforts to research and development, clinical trials, recruiting management and technical staff, acquiring assets and raising
capital. We are still in the development and clinical stage and have not yet generated revenues. We have incurred losses of $19.1 million
and $17.2 million for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, our accumulated deficit was approximately
$127.3 million. The extent of our future operating losses and the timing of becoming profitable are uncertain.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">We have funded our operations to date primarily
through equity financings, sales of our ordinary shares and warrants, the exercise of warrants and other funding transactions and through
grants from the IIA.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">44</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">Additional funding will be required to
complete our research and development and clinical trials, to attain regulatory approvals, to establish manufacturing infrastructure and
to begin the commercialization efforts of C-Scan. We have not yet commercialized our product. Even if we commercialize our product, we
may not become profitable in the foreseeable future. Our ability to achieve profitability depends on a number of factors, including our
ability to obtain regulatory approval for our product, successfully reduce the manufacturing cost of our C-Scan product, successfully
complete any post-approval regulatory obligations and successfully commercialize our product alone or in partnership.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">To meet our capital needs, we are considering
multiple alternatives, including, but not limited to, additional equity financings and other funding transactions. While we have been
successful in raising financing in the past, there can be no assurance that we will be able to do so in the future on a timely basis on
terms acceptable to us, or at all. Uncertain market conditions and approval by regulatory bodies and adverse results from clinical trials
may (among other reasons) adversely impact our ability to raise capital in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">We recently announced the temporary postponement
of the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 and that as a result, we adopted a plan of
action, including (among other things) a cost reduction plan in order to extend our cash runway to longer than initially planned, which
we are in the process of implementing.&#160; Based on such plan, we believe that current cash on hand will be sufficient to fund our ongoing
operations and plans into the fourth quarter of 2024. Management expects that we will continue to generate losses from the development,
manufacturing and infrastructure costs, clinical development and regulatory activities of C-Scan, which will result in negative cash flow
from operating activity. The actual amount of cash that we will need to operate is subject to many factors, including, but not limited
to, the timing, conduct of clinical trials for C-Scan and regulatory path along with cost to commercialize our product.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 23.55pt; line-height: 1.25">For a more detailed description of our business and plans, see Item 4B &#8220;Information
on Our Company &#8211; Business Overview.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-right: 440.4pt; line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160; <span style="font-weight: bold">Operating</span>&#160;<span style="font-weight: bold">Results</span></div>

<div style="margin-right: 440.4pt; margin-left: 7.35pt; line-height: 1.25"><span style="font-weight: bold"> <br /> </span></div>

<div style="margin-right: 64.75pt; line-height: 1.25; font-weight: bold">Financial Operations Overview</div>

<div style="margin-right: 64.75pt; margin-left: 7.35pt; line-height: 1.25; font-weight: bold"> <br /> </div>

<div style="margin-right: 466.7pt; line-height: 1.25; font-style: italic; font-weight: bold">Revenue</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: 25.2pt; margin-right: 8.3pt; line-height: 1.25">We have not generated any revenue since our inception. To date,
we have funded our operations primarily through equity financings, as well as from grants that we received from the IIA. If our product
development efforts result in clinical success, regulatory approval and the successful commercialization, we expect to generate revenue
from sales of C-Scan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Operating Cost and Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; line-height: 1.25">Our operating costs and expenses are classified
into two categories: research and development expenses and general and administrative expenses. For each category, the largest component
is personnel costs, which consists of salaries, employee benefits and share-based compensation. Operating costs and expenses also include
allocated overhead costs for depreciation of equipment. Operating costs and expenses are generally recognized as incurred. We recently
announced the temporary postponement of the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 and
that as a result, we adopted a plan of action including (among other things) a cost reduction plan in order to extend our cash runway
to longer than initially planned, which we are in the process of implementing. However, we expect personnel costs and operating costs
to continue to increase in the future as we continue the development of C-Scan, including the pivotal study and scale up of our manufacturability.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Research and Development Expenses, Net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">Research and development activities are
central to our business model. We intend to increase our research and development operations in order to complete the development of C-Scan,
to conduct our clinical trials, including the pivotal study in the United States, and to attain regulatory approvals.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Since 2018, we have spent approximately $54.7 million
on research and development expenses as of December 31, 2022, of which $0.95 million was funded by government grants. Our total research
and development expenses, net of participations in the years ended December 31, 2022, 2021, and 2020 were approximately $14.3, $12.3 million,
and $10.0 million, respectively. All research and development expenses are expensed as incurred. We expect research and development expenses
to slightly increase in 2023 and may further increase according to the progress of our clinical program.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Research and development expenses consist primarily
of costs incurred for our development activities, including:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z629958d2cdde4c4295619741a2bf954b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">employee-related expenses for research and development staff (including research and development, clinical,
        operations, production and Q&amp;A staff), including salaries, benefits and related expenses, share-based compensation and travel expenses;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5e9f5106f0ec47bd8fdcaede16cb213e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">payments associated with clinical activities including payments made to third-party CROs, investigative
        sites, patients, materials and consultants;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5896f3584b704c2898b5cd437a87695d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">payments associated with the development activities of our advanced C-Scan system and non-clinical activities,
        including payments made to third-party subcontractors, providers and consultants;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z66fa07ff32104f5cb786b33aadbdd246" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">manufacturing development costs and manufacturing scale up costs;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5a604bd7240e44efba8bc1a3ada1ef13" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">costs associated with regulatory operations;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zac4d60f213804ca5be344c1e3e4fe1f9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">facilities, depreciation and other expenses, which include direct and allocated expenses for rent and maintenance
        of facilities; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z85c366f76cb7451abeaab79f87c07951" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">costs associated with obtaining and maintaining patents.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our research and development expenses, net, are
net of grants for the research and development for C-Scan and for the transition from research and development to manufacturing that we
have received from the Government of Israel through the IIA. Under the terms of the Innovation Law as currently in effect, in exchange
for the research and development grants we received, we are required to pay the IIA royalties from our revenues up to an aggregate of
100% (which may be increased under certain circumstances) of the U.S. dollar-linked value of the grant, plus interest at the rate of 12-month
LIBOR. Pursuant to regulations under the Innovation Law, the rate of royalty repayment is 3% or 4% of revenues (which may be increased
under certain circumstances) from sales of products and services based on know-how funded by the IIA research and development grants we
have received. As of December 31, 2022, we had received funding from the IIA for the research and development of C-Scan in the aggregate
amount of approximately $5.6 million. As of December 31, 2022, we had not paid any royalties to the IIA and had a contingent obligation
to the IIA in respect of such research and development grants (including interest at the rate of 12-month LIBOR) in the amount of approximately
$6.2 million. In addition, in January 2021, we received an IIA grant approval to support the funding of our transition from research and
development to manufacturing. The final IIA grant amounted to&#160; $620,000 (NIS 2.18 million) (along with a co- investment by us of
the same amount), which we are not required to repay to the IIA, subject to the terms and conditions set forth in the grant approval,
of which we received approximately $222,000 (NIS 784,000) in February 2023, $82,000 (NIS 264,000) in January 2022 and $349,000 (NIS 1,134,000)
in 2021 . For additional information regarding the IIA grants, see Item 10E &#8220;Additional Information - Taxation - Israeli Tax Considerations
and Government Programs - The Encouragement of Research, Development and Technological Innovation in the Industry Law 5744-1984 (formerly
the Encouragement of Industrial Research and Development Law, 5744-1984).&#8221; There can be no assurance that we will continue to receive
grants from the IIA in amounts sufficient for our operations, if at all. See also &#8220;Item 3D &#8220;Key Information - Risk Factors&#8212;
Risks Related to Our Operations in Israel&#8212;<span style="font-style: italic">Pursuant to the terms of the Israeli government grants
we received for research and development expenditures, we are obligated to pay certain royalties on our revenues to the Israeli government.
In addition, the terms of the Israeli government grants we received require us to satisfy specified conditions and to make additional
payments in addition to repayment of the grants upon certain events</span>.&#8221;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">45</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">General and Administrative Expenses</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our general and administrative expenses consist
primarily of salaries and other related costs, including share-based compensation expense, for persons serving as o<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-style: normal; font-variant: normal; text-transform: none">ur
directors and executives, finance, legal, human resources and administrative personnel, professional service fees, directors&#8217; and
officers&#8217; liability insurance and other general corporate expenses, such as communication, office and travel expenses. Based on
our current plans, we expect that our general and administrative expenses will slightly decrease in 2023; however, we expect general and
administrative expenses to increase in the future, in part due to costs associated with being a public company in the United States, including
compliance under the Sarbanes-Oxley Act of 2002 and rules promulgated by the U.S. Securities and Exchange Commission. These public company-related
expense increases will likely include costs of additional legal fees, accounting and audit fees, directors&#8217; and officers&#8217;
liability insurance premiums and costs related to investor relations.</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Finance Income, net</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our finance income, net in 2022, 2021, and 2020
consists primarily of interest earned on our cash equivalents and short-term bank deposits and changes in provision for royalties.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Foreign currency transactions are translated into
U.S. dollars using the exchange rates prevailing at the dates of the transactions or valuation where items are re-measured. Foreign exchange
gains and losses resulting from the settlement of such transactions and from the translation of year-end exchange rates of monetary assets
and liabilities denominated in foreign currencies are recognized to &#8220;finance income, net&#8221; in the consolidated statement of
operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Taxes on Income</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The standard corporate tax rate in Israel is 23%
for the 2018 tax year and thereafter.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We do not generate taxable income in Israel, as
we have historically incurred operating losses resulting in carryforward tax losses totaling approximately $105 million as of December
31, 2022. We anticipate that we will be able to carry forward these tax losses indefinitely to future tax years. However, a tax loss that
can be utilized in a certain tax year cannot be carried forward to future tax years. Accordingly, we do not expect to pay taxes in Israel
until we have taxable income after the full utilization of our carry forward tax losses.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Law for the Encouragement of Capital
Investments, 5719-1959 and other Israeli legislation, we may be entitled to certain additional tax benefits, including reduced tax rates,
accelerated depreciation and amortization rates for tax purposes on certain assets, deduction of public offering expenses in three equal
annual installments and amortization of other intangible property rights for tax purposes. See Item 10E &#8220;Additional Information
&#8212; Taxation&#8212; Israeli Tax Considerations and Government Programs&#8221; for additional information concerning these tax benefits.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Results of Operations</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For convenience purposes, the numbers set forth
in the management&#8217;s discussion and analysis below are, where applicable, rounded up and presented in millions, whereas the numbers
in the tables below are presented in thousands. As result, the percentages set forth in the year-over-year comparisons below are based
on numbers that have (where applicable) been rounded up to millions, which may slightly differ than the percentages that would result
from the corresponding numbers set forth in the table that are presented in thousands.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Year Ended December 31, 2022 Compared to Year Ended December 31, 2021</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2e4b318df67145d680fed5e7cd7cc577" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31,</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands, except per share data)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Research and development expenses, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">14,271</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,349</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">General and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,763</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,972</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25; font-weight: bold">Operating loss</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">20,034</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">17,321</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; padding-bottom: 2px">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Finance income, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">926</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">119</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25; font-weight: bold">Net loss</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">19,108</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">17,202</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Research and Development
Expenses, net</span>.&#160; Research and development expenses, net for the year ended December 31, 2022 were approximately $14.3 million,
as compared with approximately $12.3 million for the year ended December 31, 2021 an increase of $1.9 million or 15.6%. The increase in
research and development expenses, net between 2022 and 2021 was primarily due to (i) an increase of approximately $0.8 million in salary
and related expense, mainly as a result of an expansion in head count that was offset in part by a reduction in bonuses expense in 2022
and by exchange rate fluctuations, (ii) an increase of approximately $0.6 million in subcontractors and consultants including regulatory
consultants, (iii) an increase of approximately $0.2 million in share-based compensation, (iv) an increase of approximately $0.8 million
in other research and development expenses, including clinical study expenses, and (iv) a $0.2 million decrease in the participation of
the IIA in research and development expenses. The increase in research and development expenses, net between 2022 and 2021, was offset
in part by a $0.8 million decrease in material expenses.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf3e4dbac0ad44545acdb9ade50783ec3" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Change</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Salaries and related expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,257</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,428</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">829</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Share-based compensation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">493</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">329</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">164</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Materials</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,258</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,020</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(762</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Subcontractors and consultants (*)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,375</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">820</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">555</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Depreciation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">289</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">169</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">120</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Cost for registration of patents</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">140</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">153</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(13</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Other research and development expenses(*)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,681</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">861</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">820</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">14,493</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">12,780</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,713</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Less participation of the IIA (formerly the OCS)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">(222</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">)</div> </div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">(431</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">)</div> </div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">209</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 4px">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Total research and development expenses, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">14,271</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">12,349</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">1,922</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="margin-left: 36pt; line-height: 1.25"> <br /> </div>

<div style="margin-left: 36pt; line-height: 1.25">(*) Reclassified</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="text-indent: 25.15pt; line-height: 1.25"><span style="font-style: italic">General and Administrative Expenses</span>.&#160;
Our general and administrative expenses for the year ended December 31, 2022 were approximately $5.8 million, as compared to approximately
$5.0 million for the year ended December 31, 2021, an increase of $0.8 million, or 15.9%.&#160; The increase in general and administrative
expenses is primarily due to (i) a $0.4 million increase in professional services expenses, (ii) a $0.2 million increase in share-based
compensation expenses, and (iii) a $0.4 million increase in other general expenses, mainly associated with directors&#8217; and officers&#8217;
liability insurance, offset in part by a $0.3 million decrease in salaries and related expenses, mainly due to a reduction in bonuses
expense in 2022.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">46</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z0c5a27e8cc84431a964c85e5ac7d5913" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Change</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Salaries and related expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,784</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,042</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(258</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Share-based compensation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">386</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">162</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">224</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Professional services</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,092</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">710</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">382</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Office rent and maintenance</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">246</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">172</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">74</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Depreciation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">116</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">36</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">80</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Other general and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">2,139</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">1,850</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">289</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Total general and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">5,763</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">4,972</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">791</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Operating Loss</span>.&#160;
Our operating loss for the year ended December 31, 2022 was approximately $20.0 million, as compared with approximately $17.3 million
for the year ended December 31, 2021, an increase of approximately $2.7 million, or 15.7%. The increase was as a result of the $1.9 million
increase in research and development expenses, net for the year ended December 31, 2022 and the $0.8 million increase in general and administrative
expenses for the year ended December 31, 2022, as compared to the year ended December 31, 2021.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Finance Income,
net</span>.&#160; Our finance income, net for the year ended December 31, 2022 was approximately $926,000, as compared to approximately
$119,000 for the year ended December 31, 2021, an increase of approximately $807,000. The change in our finance income, net is primarily
due to an increase of $946,000 of interest income on short-term deposits recorded for the year ended December 31, 2022, as compared to
the year ended December 31, 2021, offset in part by a $173,000 decrease in fair value of derivatives recorded for the year ended December
31, 2022, as compared to the year ended December 31, 2021.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Net loss</span>.
Our net loss for the year ended December 31, 2022 was approximately $19.1 million, as compared to approximately $17.2 million for the
year ended December 31, 2021, an increase of $1.9 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Year Ended December 31, 2021 Compared to Year Ended December 31, 2020</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z8a1581fceed34724b4eae4a7be1fb223" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2020</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="line-height: 1.25"> </span></div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands, except per share data)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Research and development expenses, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">12,349</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">10,008</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="line-height: 1.25">General and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,972</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,924</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Operating loss</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">17,321</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">13,932</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="line-height: 1.25">Finance income, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">119</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">86</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Net loss</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-weight: bold">17,202</span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25"><span style="font-weight: bold">13,846</span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Research and Development
Expenses, net</span>.&#160; Research and development expenses, net for the year ended December 31, 2021 were approximately $12.3 million,
as compared with approximately $10.0 million for the year ended December 31, 2020, an increase of $2.3 million or 23.4%. The increase
in research and development, net expenses between 2021 and 2020 was primarily due to (i) an increase of approximately $1.3 million in
salary and related expense, mainly as a result of an expansion in head count and currency exchange rate fluctuation, (ii) a $1.2 million
increase in material expenses, (iii) an increase of approximately $0.16 million in share-based compensation, and (iv) an increase of approximately
$0.4 million in other research and development expenses, including clinical expenses. The increase in research and development expenses,
net between 2021 and 2020, was offset in part by a $0.3 million decrease in subcontractors and consultants and a $0.43 million grant received
from the IIA, which amount was recorded as a deduction from research and development expenses in 2021.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z2863c823fafa4f1ea724279e6f90a4db" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td rowspan="1" style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"></td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 20pt">2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 20pt">2020</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top; font-family: Times New Roman,Times,serif; text-align: center">
        <div style="font-weight: bold">Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td rowspan="1" style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td rowspan="1" colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Salaries and related expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,428</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">6,173</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,255</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Share-based compensation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">329</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">165</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">164</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Materials</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,020</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,792</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,228</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Subcontractors and consultants(*)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">820</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,103</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(283</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Depreciation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">169</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">123</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">46</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Cost for registration of patents</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">153</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">164</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(11</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Other research and development expenses(*)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">861</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">488</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">373</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">12,780</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">10,008</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25; font-weight: bold">2,772</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px">
        <div style="line-height: 1.25">Less participation of the IIA (formerly the OCS)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">(431</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">
        <div style="line-height: 1.25; font-weight: bold">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">-</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(431</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="line-height: 1.25">Total research and development expenses, net</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25"><span style="font-weight: bold">12,349</span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25"><span style="font-weight: bold">10,008</span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25"><span style="font-weight: bold">2,341</span></div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.4pt; line-height: 1.25">(*) Reclassified</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">General and Administrative
Expenses</span>. Our general and administrative expenses for the year ended December 31, 2021 were approximately $5.0 million, as compared
to approximately $3.9 million for the year ended December 31, 2020, an increase of $1.0 million, or 27%.&#160; The increase in general
and administrative expenses is primarily due to a $0.3 million increase in salaries and related expenses, a $0.1 million increase in professional
services expenses and a $0.6 million increase in other general expenses, mainly associated with directors&#8217; and officers&#8217; liability
insurance, offset in part by a $0.1 million decrease in share-based compensation expenses.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zaa6bb0f1946b4832bbfa1d5db41b3cc5" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td rowspan="1" colspan="1" style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px"></td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 20pt">2020</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top; font-family: Times New Roman,Times,serif; text-align: center; font-weight: bold">
        <div>Change</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td rowspan="1" colspan="1" style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td rowspan="1" colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">(US$ in thousands)</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Salaries and related expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">2,042</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,698</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">344</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Share-based compensation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">162</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">243</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(81</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Professional services</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">710</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">574</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">136</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="line-height: 1.25">Office rent and maintenance</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">172</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">174</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(2</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Depreciation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">36</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">25</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">11</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px">
        <div style="line-height: 1.25">Other general and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,850</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,210</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">640</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Total general and administrative expenses</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">4,972</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,924</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,048</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">

<div style="text-indent: 25.15pt; line-height: 1.25"><span style="font-style: italic">Operating Loss</span>.&#160; Our operating loss
for the year ended December 31, 2021 was approximately $17.3 million, as compared with approximately $13.9 million for the year ended
December 31, 2020, an increase of approximately $3.4 million, or 24.3%.&#160; The increase was as a result of the $2.3 million increase
in research and development expenses, net for the year ended December 31, 2021 and the $1.0 million increase in general and administrative
expenses for the year ended December 31, 2021, as compared to the year ended December 31, 2020.</div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">47</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Finance Income,
net</span>.&#160; Our finance income, net for the year ended December 31, 2021 was approximately $119,000, as compared to approximately
$86,000 for the year ended December 31, 2020, an increase of approximately $33,000. The change in our finance income, net is primarily
due to an increase of $31,000 of interest income on short-term deposits recorded for the year ended December 31, 2021, as compared to
the year ended December 31, 2020.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Net loss</span>.
Our net loss for the year ended December 31, 2021 was approximately $17.2 million, as compared to approximately $13.8 million for the
year ended December 31, 2020, an increase of $3.4 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Liquidity
and Capital Resources</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold">Sources of Liquidity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To date, we have funded our operations primarily
through equity financings consummated prior to our initial public offering, our initial public offering, private placements, registered
direct and underwritten public offerings, our warrant exercise transaction and grants that we received from the IIA (formerly the OCS)
and the BIRD Foundation. As of December 31, 2022, we had approximately $42.1 million cash and cash equivalents, including restricted cash,
and had invested most of our available cash in short term bank deposits.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Effective November 23, 2022, our Board of Directors
effected a reverse share split of 1-for-20 (i.e., 20 ordinary shares were combined into one ordinary share). Share and per share amounts,
prior to November 23, 2022, have been adjusted to reflect the reverse share split.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">During the first quarter of 2021, certain warrant
holders exercised warrants to purchase 1,210,235 ordinary shares, at exercise prices ranging from $15-$16 per share, for total gross proceeds
of approximately $19.2 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On July 2, 2021, we consummated a registered direct
offering of 1,296,297 ordinary shares and warrants to purchase up to 1,296,297 ordinary shares, or the July 2021 Offering. Each ordinary
share was sold together with one warrant to purchase one ordinary share at a combined purchase price of $27 per share and accompanying
warrant, for aggregate gross proceeds of approximately $35,000,000, excluding any proceeds that may be received upon exercise of the warrants.
Each warrant will be immediately exercisable and will expire on January 2, 2024. The exercise price of each warrant is $30 per ordinary
share, subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if at the time of exercise thereof,
there is no effective registration statement registering the issuance or resale of ordinary shares underlying the warrants. The ordinary
shares and the warrants are separable and were issued separately, but purchased together in this offering. We agreed to pay the placement
agent an aggregate fee equal to 7.0% of the gross proceeds of the offering, a management fee of 1.0% of the gross proceeds of the offering,
a non-accountable expenses allowance of $25,000, fees and expenses up to $100,000, and a clearing fee of $15,950. In addition, issued
to the placement agent or its designees warrants to purchase up to a total of 5.0% of the aggregate number of ordinary shares sold in
the transaction, or warrants to purchase up to 64,815 ordinary shares, substantially on the same terms as the warrants issued to the investors
in the private placement, except that the placement agent warrants will have an exercise price of $33.75 per share (which represents 125%
of the investors&#8217; purchase price per share and accompanying warrant). Upon any exercise of the warrants for cash, we agreed to pay
the placement agent a total cash fee equal to 7.0% of the aggregate gross proceeds from the exercise of the warrants, a management fee
equal to 1.0% of the aggregate gross proceeds from the exercise of the warrants, and warrants to purchase up to 5.0% of the number of
ordinary shares issued upon the cash exercise of the warrants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On March 3, 2022, we consummated a registered direct
offering of 1,000,000 ordinary shares and warrants to purchase up to 750,000 ordinary shares, or the March 2022 Offering. Each ordinary
share was sold together with one warrant to purchase 0.75 ordinary share at a combined purchase price of $10 per share and accompanying
warrant, for aggregate gross proceeds of $10,000,000, excluding any proceeds that may be received upon exercise of the warrants. Each
warrant will be immediately exercisable and will expire on March 3, 2027. The exercise price of each warrant is $13 per ordinary share,
subject to adjustment as set forth therein. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there
is no effective registration statement registering the issuance or resale of ordinary shares underlying the warrants. The ordinary shares
and the warrants are separable and were issued separately, but purchased together in this offering. We agreed to pay the placement agent
an aggregate fee equal to 7.0% of the gross proceeds of the offering, a management fee of 1.0% of the gross proceeds of the offering,
a non-accountable expenses a of $70,000, and a clearing fee of $15,950. In addition, we agreed to issue to the placement agent or its
designees warrants to purchase up to a total of 5.0% of the aggregate number of ordinary shares sold in the transaction, or warrants to
purchase up to 50,000 ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement,
except that the placement agent warrants will have an exercise price of $12.5 per share (which represents 125% of the investors&#8217;
purchase price per share and accompanying warrant) and expiration date of March 1, 2027. Upon any exercise of the warrants for cash, we
agreed to pay the placement agent a total cash fee equal to 7.0% of the aggregate gross proceeds from the exercise of the warrants, a
management fee equal to 1.0% of the aggregate gross proceeds from the exercise of the warrants, and warrants to purchase up to 5.0% of
the number of ordinary shares issued upon the cash exercise of the warrants. Simultaneously with this offering, we entered into a warrant
amendment agreement, or the Warrant Amendment Agreement, with the investors in the March 2022 Offering. Pursuant to the Warrant Amendment
Agreement, certain warrants to purchase up to an aggregate of 926,297 ordinary shares of the Company that were issued to the investors
in the July 2021 Offering were amended to have a reduced exercise price of $13 per share and the term of exercise was extended to January
2, 2025.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Since our inception through December 31, 2022,
we had received funding from the IIA for research and development of C-Scan in the aggregate amount of approximately $5.6 million, of
which $31,000 was received in the year ended December 31, 2020. We did not receive IIA funding for research and development for the years
ended December 31, 2022 and 2021. As of December 31, 2022, we had not paid any royalties to the IIA and had a contingent obligation to
the IIA with respect to such funding (including interest at the rate of 12-month LIBOR) in the amount of approximately $6.2 million. In
addition, in January 2021, we received an IIA grant approval to support the funding of our transition from research and development to
manufacturing. The final IIA grant amounted to $620,000 (NIS 2.18 million) (along with a co-investment by us of the same amount), which
we are not required to repay to the IIA, subject to the terms and conditions set forth in the grant approval, of which we received approximately
$222,000 (NIS 784,000) in February 2023, $82,000 (NIS 264,000) in January 2022 and $349,000 (NIS 1,134,000) in 2021.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are a clinical and development-stage medical
diagnostics company and have not yet generated revenues. We have incurred net losses in each fiscal year since we commenced operations
in 2009. We incurred net losses of $19.1 million, $17.2 million, and $13.8 million in 2022, 2021, and 2020, respectively. As of December
31, 2022, our accumulated deficit was $127.3 million. The extent of our future operating losses and the timing of becoming profitable
are uncertain.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We recently adopted a cost reduction plan in order
to extend our cash runway to longer than initially planned, which we are in the process of implementing.&#160; Based on such plan, we
believe that current cash on hand will be sufficient to fund our ongoing operations and plans into the fourth quarter of 2024. We expect
that we will continue to generate losses from our research and development and clinical trials, regulatory activities, manufacturing infrastructure
and commercialization efforts of C-Scan, which will result in a negative cash flow from operating activity. The actual amount of cash
that we will need to operate is subject to many factors, including, but not limited to, the initiation, timing, progress and results of
our clinical trials and other product development efforts along with cost to commercialize our product.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We anticipate that we will need to raise substantial
additional financing in the future to fund our operations. In order to meet these additional cash requirements, we may incur debt, license
certain intellectual property, and seek to sell additional equity or convertible securities that may result in dilution to our shareholders.
If we raise additional funds through the issuance of equity or convertible securities, these securities could have rights or preferences
senior to those of our ordinary shares and could contain covenants that restrict our operations. There can be no assurance that we will
be able to obtain additional equity or debt financing on terms acceptable to us, if at all. Our future capital requirements will depend
on many factors, including:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z711d9750305a436384d7892782c651e2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">our ability to obtain funding from third parties, including any future collaborative partners;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z4629dbe0c4974b85b64f3d70a1bbc6af" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the scope, rate of progress and cost of our clinical trials and other research and development programs;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">48</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"> <br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6c51af222682496e8b498f3a22e90f81" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the time and costs required to gain regulatory approvals;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z304218e16dfa47e08fe5f2f9fb02300d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the terms and timing of any collaborative, licensing and other arrangements that we may establish;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z58b5738efdb64f9382f452f6df843e91" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the costs of filing, prosecuting, defending and enforcing patents, patent applications, patent claims,
        trademarks and other intellectual property rights;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbf6c785167d346738ba959551b73973d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">any product liability or other lawsuits related to our product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf966696cdd8749bea28add3cfdfc2fe1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the expenses needed to attract and retain skilled personnel;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9d8cbb8fae224e5aa3f4996fa95448be" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the costs and timing of future commercialization activities, including product manufacturing, marketing,
        sales, and distribution;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z593638194c654633af853af2e61e54f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the revenue, if any, received from commercial sales of our product;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbf669f0c21ed4e95a48beae70903cc3e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the general and administrative expenses related to being a public company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9a1c28495ff54a59b7d51049ddfa33a5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the effect of competition and market developments</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zb2453d26e289453b8244a734f3002858" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">future clinical trial results;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6467bc35dea240a6867abfb891d81e8c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the COVID &#8211; 19 pandemic; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zeef38970394a45278cd94d979ac9cf7e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the political and security situation in Israel.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Historical Cash Flows</div>

<div style="margin-left: 7.35pt; line-height: 1.25; font-style: italic; font-weight: bold"> <br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following table summarizes our statement of
cash flows for the years ended December 31, 2022, 2021, and 2020.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z2f475f9691894d3da3a065b6e8fd4147" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Year Ended December 31,</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2020</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25">US$ (in thousands)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Net cash used in operating activities</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(18,707</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(16,264</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(13,113</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Net cash used in investing activities</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(12,508</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(16,006</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">(10,451</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">)</div> </td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 64%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Net cash provided by financing activities</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">8,850</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">51,024</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">23,582</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Operating Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Net cash used in operating activities for the year
ended December 31, 2022 was $18.7 million, as compared to $16.3 million for the year ended December 31, 2021. The increase in net cash
used in operating activities in 2022 was attributable primarily to the increase in operating loss and due to a decrease of accruals on
account of employee compensation and a decrease of trade accounts payable, accruals and other current liabilities, offset in part by a
decrease in prepaid and other current assets and non-current assets, as compared to 2021. Net cash used in operating activities for the
year ended December 31, 2021 was $16.3 million, as compared to $13.1 million for the year ended December 31, 2020. The increase in net
cash used in operating activities in 2021 was attributable primarily to the increase in operating loss and increase in prepaid and other
current assets and non-current assets offset in part by an increase in trade accounts payable, accruals and other current liabilities,
as compared to 2020</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Investing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Net cash used in investing activities for the year
ended December 31, 2022 was $12.5 million, comprised primarily of investment in short-term bank deposits in the amount of $12.0 million
and purchase of property and equipment in the amount of $0.5 million. Net cash used in investing activities for the year ended December
31, 2021 was $16.0 million, comprised primarily of investment in short-term bank deposits in the amount of $15 million and purchase of
property and equipment in the amount of $1.0 million. Net cash used in investing activities for the year ended December 31, 2020 was $10.5
million, comprised primarily of investment in short-term bank and other deposits in the amount of $10.1 million and purchase of property
and equipment in the amount of $0.4 million.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Financing Activities</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Net cash provided by financing activities for the
year ended December 31, 2022 was $8.9 million, comprised of net proceeds from the issuance of ordinary shares in the March 2022 registered
direct offering. Net cash provided by financing activities for the year ended December 31, 2021 was $51.0 million, comprised primarily
of net proceeds of $31.8 million from the issuance of ordinary shares in the July 2021 registered direct offering and $19.2 from exercise
of warrants during the first quarter of 2021. Net cash provided by financing activities for the year ended December 31, 2020 was $23.6
million, comprised primarily of net proceeds of $4.73 million from the issuance of ordinary shares in the February 2020 private placement,
net proceeds of $10.2 million from the April 2020 and May 2020 registered direct offerings and net proceeds of $8.7 million from the July
2020 warrant exercise transaction.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We expect that our sources of cash for the year
ended December 31, 2023 will include cash held in our bank accounts and may include proceeds from issuance of ordinary shares as a result
of financing transactions or from the exercise of warrants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Capital and Operating Expenditures</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25">We expect to incur
losses from operations for the foreseeable future.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 32.54pt; line-height: 1.25">Our expected future expenditures related to product, clinical and regulatory clearances
include the following:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zaf59727aa8434c72bb854d6529644db7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">completion of the clinical development of C-Scan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z41f34958cbb449e2a34b089548b18242" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">conducting clinical trials in the United States and other territories for purposes of regulatory approval
        and post-marketing validation;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze4b3f4ccd7474c2ba82d9f037b6b2e6c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">development of advanced version and future generations of C-Scan and future products;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zab156239f6ad4c6e8ba820513fb95d96" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">FDA and additional regulatory filing activities in countries we intend to commercialize our system;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">49</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"> <br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6273b02453e64b85afb425e7a3f3b76f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Manufacturing scale up costs; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z234c790f38224d24b40f2f58bfaa4a43" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">Capital expenditures.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We recently adopted a cost reduction plan in order
to extend our cash runway to longer than initially planned, which we are in the process of implementing.&#160; Accordingly, based on the
cost reduction plan, we believe that our cash and cash equivalents and short-term deposits will be sufficient to fund our operations and
plans, including the U.S. pivotal study, into the fourth quarter of 2024.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Management&#8217;s plans include additional fund
raising in the future in order to secure sufficient cash resources to finance our research and development and clinical trials, regulatory
activities, manufacturing infrastructure and future commercialization efforts for C-Scan.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To meet our capital needs, we are considering multiple
alternatives, including, but not limited to, additional equity financings and other funding transactions. While we have been successful
in raising financing in the past, there can be no assurance that we will be able to do so in the future on a timely basis on terms acceptable
to us, or at all. Uncertain market conditions and approval by regulatory bodies and adverse results from clinical trials may (among other
reasons) adversely impact our ability to raise capital in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In the event we are unable to successfully raise
additional capital, we will not have sufficient cash flows and liquidity to finance our business operations as currently contemplated.
Accordingly, in such circumstances we would be compelled to immediately reduce general and administrative expenses and delay research
and development projects and clinical trials, until we are able to obtain sufficient financing. If such sufficient financing is not received
timely, we would then need to pursue a plan to license or sell our assets, seek to be acquired by another entity, cease operations and/or
seek bankruptcy protection.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">See &#8220;Item 3D &#8220;Key Information &#8211;
Risk Factors&#8212;Risks Related to Our Financial Position.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have operating lease obligations consisting
of payments pursuant to a lease agreement for office facilities in effect as of December 31, 2022, as well as lease agreements for vehicles,
which generally run for a period of three years. See Note 5 to our audited consolidated financial statements presented elsewhere in this
Annual Report.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Royalties provision</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Provision for royalties to an ASIC designer</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In December 2007, we entered into an agreement
for the development of an application specific integrated circuit, or ASIC, component to be used as an amplifier for the capture of signals
at low frequencies from X-ray detectors contained in our product. The ASIC developer is entitled to receive royalties from us in the amount
of &#8364;0.5 (approximately $0.53) for every ASIC component that we will sell, up to &#8364;200,000 (approximately $213,299). The net
present value of the royalty liability to the ASIC designer is dependent upon our management estimates and assumption as to future product
shipments and interest rates used to calculate the present value of the cash payments required to repay the royalties to the ASIC designer.
In calculating the present value of future royalty payments to the ASIC designer, we used a discount factor of 17.6%, commensurate with
our risk at the date of initial recognition of the liability. Any updates in the expected product shipments and the liability will be
recorded to profit and loss each period. As of December 31, 2022, it was probable that we will be required to pay the above mentioned
royalties, and accordingly, a liability for this reimbursement has been accounted for in our financial statements in the amount of $94,000.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As more information is gathered to assist our management
in making forecasts, the liability will be updated.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Research
and development, patents and licenses, etc.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For a description of our research and development
programs and the amounts that we have incurred over the last three years pursuant to those programs, see Item 4B &#8220;Information on
Our Company&#8212;Business Overview&#8212;Research and Development.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Trend
Information</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our results of operations and financial condition
may be affected by various trends and factors discussed in Item 3D &#8220;Key Information&#8212;Risk factors,&#8221; Item 4 &#8220;Information
on Our Company&#8221; and elsewhere in this Item 5 &#8220;Operating and Financial Review and Prospects.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">E.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Critical
Accounting Estimates</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our consolidated financial statements are prepared
in accordance with U.S. GAAP. The preparation of our financial statements requires us to make estimates, judgments and assumptions that
can affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting periods. We base our estimates, judgments and assumptions on historical
experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances
change and additional information becomes known. See Note 2 to our audited consolidated financial statements presented elsewhere in this
Annual Report for a description of the significant accounting policies that we used to prepare our consolidated financial statements.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We believe the following critical policies reflect
the more significant judgments and estimates used in preparation of the Consolidated Financial Statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Share-based compensation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We recognize expense for our share-based compensation
based on the fair value of the awards granted. We estimate the fair value of equity-based payment awards on the date of grant. The value
of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our consolidated
statement of operations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-top: 0px; margin-bottom: 0px; line-height: 1.25; text-align: justify">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
We recognize compensation expenses for the value of our awards granted based on the graded-vesting method over the requisite service period
for each separately vesting portion of the award.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We recognize compensation cost for awards with
performance conditions if and when we conclude that it is probable that the performance conditions will be achieved. We reassess at each
reporting period the probability of vesting for awards with performance conditions and adjust compensation cost based on our probability
assessment.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We use the Black-Scholes-Merton option-pricing
model for our share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair
market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the year ended December
31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods
ending on the grant date, equal to the expected term of the options.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The expected option term represents the period
of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in
accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The risk-free interest rate is based on the yield
from U.S. treasury bonds with an equivalent term. We have historically not paid dividends and have no foreseeable plans to pay dividends.</div>

<div style="margin-left: 36.3pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">50</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Equity</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In the years ended December 31, 2022 and December
31, 2021 we completed certain financing transactions in which we issued ordinary shares and warrants. The warrants are immediately exercisable
at a fixed exercise price per ordinary share, subject to certain adjustments and will expire on the expiring date as determined in the
applicable warrant. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration
statement registering the ordinary shares underlying the warrants. We analyzed the terms of the warrants and concluded that the terms
of the warrants did not include features that would preclude equity classification. Therefore, we classified the warrants as equity.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Recent Accounting Pronouncements</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">See Note 2 to our audited consolidated financial
statements presented elsewhere in this Annual Report for a description of the recent accounting policies.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM6"><!--Anchor--></span>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</div>

<div style="margin-left: 7.35pt; line-height: 1.25; font-weight: bold"> <br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Directors
and senior management</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following table sets forth information for
our executive officers and directors as of March 30, 2023. Unless otherwise stated, the address for our directors and executive officers
is c/o Check-Cap Ltd., 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf3221816a74d4d09be928fe5f8498f3c" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Name</span></div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; font-weight: bold">
        <div style="text-align: center"><span style="text-decoration: underline">Age</span></div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.1pt; line-height: 1.25; font-weight: bold"><span style="text-decoration: underline">Position(s)</span></div>
        </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">Alex Ovadia</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">61</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.15pt; line-height: 1.25">Chief Executive Officer</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Mira Rosenzweig</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">51</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.05pt; line-height: 1.25">Chief Financial Officer</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">Yoav Kimchy</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">62</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.15pt; line-height: 1.25">Chief Technology Officer</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Boaz Shpigelman</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">51</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.1pt; line-height: 1.25">Vice President, Research and Development</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">Joshua (Shuki) Belkar</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">54</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.05pt; line-height: 1.25">Vice President, Operations</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Hanit Brenner-Lavie</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">51</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.05pt; line-height: 1.25">Vice President, Clinical Affairs</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">Israel Hershko</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">57</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.1pt; line-height: 1.25">Vice President, Quality Assurance and Regulatory Affairs</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Steven Hanley (1)(2)</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">55</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.1pt; line-height: 1.25">Chairman of the Board of Directors</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">Clara Ezed (3)(4)</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">53</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.2pt; line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Mary Jo Gorman (1)(2)(3)(4)</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">63</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.15pt; line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.5pt; line-height: 1.25">XiangQian (XQ) Lin</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">41</div> </td>
    <td style="width: 65.82%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 24.15pt; line-height: 1.25">Director</div> </td> </tr>
  <tr>
    <td style="width: 21.34%; vertical-align: top">
        <div style="margin-left: 0.5pt; line-height: 1.25">Yuval Yanai (1)(2)(3)(4)</div> </td>
    <td style="width: 12.84%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">70</div> </td>
    <td style="width: 65.82%; vertical-align: top">
        <div style="margin-left: 24.15pt; line-height: 1.25">Director</div> </td> </tr>
  </table>

<div style="line-height: 1.25"> <hr style="border-style: none; height: 2px; width: 10%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto" />
</div>

<table cellspacing="0" cellpadding="0" id="z0c073273d4354e9a87c06d40403cd04b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Member of our Nominating Committee.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9d3588d11413478686c653bf3e40b27b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Member of our Financing Committee.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfc89eba8145a4335aff2f2d52f7b53e3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Member of our Compensation Committee.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7c21deb9924a4500927734efdc91fada" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top">
        <div>Member of our Audit Committee.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Executive Officers and Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Alex
Ovadia </span>has served as our Chief Executive Officer since February 26, 2018. Mr. Ovadia has served as a member of the Board of Directors
of our U.S. subsidiary, Check-Cap US, Inc., since March 2018. Prior to that, Mr. Ovadia served as our Chief Operating Officer and Israeli
Site Manager since July 1, 2015, in addition to serving as our Vice President of Research and Development since January 2013. Mr. Ovadia
has more than 25 years of experience leading global operations, in addition to worldwide management of complex projects. From 2001 to
2012, Mr. Ovadia served in various positions as global director and senior manager for CT research and development at Philips Healthcare
&#8211; CT Systems. Mr. Ovadia was also appointed as a member of Global CT R&amp;D staff and as a member of management of Philips Medical
System Technologies Ltd. Prior to that, from 1990 to 2001, Mr. Ovadia served as project/systems engineering manager for large scale military
projects, mainly aircraft upgrades for U.S. and European governments performed by Elbit Systems Ltd. Mr. Ovadia holds a BSc degree in
electrical engineering from the Technion-Israel Institute of Technology.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Mira
Rosenzweig </span>has served as our Chief Financial Officer since April 2019. Ms. Rosenzweig has 20 years of financial management experience.
Prior to joining Check-Cap, Ms. Rosenzweig served as Chief Financial Officer of Entera Bio Ltd. (Nasdaq: ENTX) since May 2014. Prior to
Entera Bio, from May 2013 to April 2014, Ms. Rosenzweig served as Chief Financial Officer of privately-held Paskal Technologies and, before
that, from September 2008 to November 2011, as Vice President and Chief Financial Officer of Camtek Ltd. (Nasdaq: CAMT). Prior to that,
Ms. Rosenzweig served in various finance roles including at Elron Electronic Industries Ltd. (TASE: ELRN). Ms. Rosenzweig began her career
as a senior accountant at Luboshitz Kasierer, which is now part of Ernst &amp; Young. Ms. Rosenzweig holds a Bachelor of Arts in Accounting
and Economics from the University of Haifa, Israel, and is a Certified Public Accountant (Israel).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Yoav
Kimchy </span>has served as our Chief Technology Officer since our inception in April 2009 and served as a member of our board of directors
from 2009 and until December 1, 2015. Dr. Kimchy founded Check-Cap LLC in December 2004, serving as its president and chief executive
officer until March 2008, and as its president and chief technical officer since March 2008. Dr. Kimchy has also served as a member of
the board of directors of Check-Cap Ltd. (Delaware), the manager of Check-Cap LLC, since December 2004. Between 2005 and 2012, Dr. Kimchy
also served as our vice president of research and development. Between 2000 and 2003, Dr. Kimchy served as the vice president of research
and development of V-Target Ltd. (Israel), a medical device company developing gamma imaging applications. Prior to that, from 1998 to
2000, Dr. Kimchy served as the Director of Cardiovascular Research at Impulse Dynamics Ltd. (Israel), a medical device company developing
a unique therapeutic pulsing technology for chronic heart failure. From 1994 to 1998, Dr. Kimchy served as a systems engineer and algorithm
specialist for an Israeli government contract project with the Israeli Navy. Dr. Kimchy also served as a lieutenant in the Israeli Navy.
Dr. Kimchy holds a B.Sc. degree in physics and mathematics from the Hebrew University of Jerusalem, an M.Sc. degree in biomedical engineering
from Tel Aviv University and a PhD from the Technion-Israel Institute of Technology.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Boaz
Shpigelman </span>has served as our Vice President, Research and Development since March 2018. From 2012 to 2018, Mr. Shpigelman served
as our director of development. From 2007 to 2012, Mr. Shpigelman served as R&amp;D Manager at Orsan Medical Technologies Ltd., which
develops technologies for brain monitoring, with particular attention to intracranial pressure and its influence on cerebral perfusion.
From 2003 to 2007, Mr. Shpigelman served as Vice R&amp;D Manager at GI-View, a medical company that developed a single use auto maneuvering
colonoscopy. From 1993 to 2003, Mr. Shpigelman held various positions at Scitex/Creo, a company that developed devices for the graphic
art field, initially as a hardware/software developer and subsequently as a director in the input division. Mr. Shpigelman holds a BSc
degree in Electrical Engineering from the Technion-Israel Institute of Technology.</div>

<div style="text-align: justify; text-indent: 25.25pt; margin-right: 7.35pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">51</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Joshua
(Shuki) Belkar </span>has served as Vice President of Operation since June 2019. Mr. Belkar has more than 20 years of experience managing
operations at global medical device companies, including managing large volume manufacturing of capsule-based products. Prior to joining
Check-Cap, Mr. Belkar served as vice president of operations and global services at Mazor Robotics Ltd., which was recently acquired by
Medtronic Plc. Prior to Mazor Robotics, Mr. Belkar served in various executive roles at Medtronic, including director of operations, <span style="font-weight: bold; font-style: italic">vice
</span>president of manufacturing and operations and director of production. Before joining Medtronic Plc., Mr. Belkar served as manager
of production at Elscint Medical Systems Ltd. Mr. Belkar holds a BD degree in Social Sciences from the Open University, Israel, and an
MA degree in logistic management and an executive MBA degree, both from Bar-Ilan University, Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Hanit
Brenner-Lavie, Ph.D. </span>has served as Vice President of Clinical Affairs since September 2021. Dr. Brenner-Lavie brings more than
15 years of experience in global clinical and regulatory affairs, including experience within the medical devices industry. Most recently,
from 2017 to August 2021, Dr. Brenner-Lavie served as the Vice President of Clinical Affairs at Alma Lasers, a global company developing
medical technology for the surgical and medical markets, where she led the successful introduction of innovative medical devices utilizing
laser, ultrasound and radio frequency (RF) technologies to address various medical indications. Previously, from 2012 to 2017, Dr. Brenner-Lavie
held the position of Clinical Director at Lumenis Ltd., a leader in lasers and light-based technological solutions for medical and aesthetic
treatments, and Clinical Research Manager at Syneron Ltd. (today Candela Medical), a global leader in aesthetic medical devices. Dr. Brenner-Lavie
holds a Ph.D. in Medical Sciences from the Technion &#8211; Israel Institute of Technology and an M.Sc. degree in Medical Sciences from
the Hebrew University of Jerusalem.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Israel
Hershko </span>has served as Vice President of Quality Assurance and Regulatory Affairs since August 2019. Mr. Hershko has more than 30
years of experience in quality assurance and regulatory affairs in the medical device industry. Mr. Hershko has led the transfer of several
new products into global markets from the regulatory and quality aspects. Prior to joining Check- Cap, Mr. Hershko held executive positions
as director of quality assurance and regulatory affairs in several medical device companies, including Medical Compression Systems Ltd.,
Q Core Medical Ltd., Syneron and GE Healthcare. Mr. Hershko holds a BA degree in Business from Derby University.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Steven
Hanley </span>has served as a member of our Board of Directors since February 2015 and as the Chairman of our Board of Directors since
September 2017, and has served as a member of our Nominating Committee since October 2015 and as a member of our Financing Committee since
June 2016. Mr. Hanley served as a member of our Audit Committee from March 2015 until December 2017 and as a member of our Compensation
Committee from March 2015 until March 2019. Mr. Hanley is currently the Co-Founder, board member and Chief Executive Officer of MediBeacon
Inc., an optical diagnostic company based in St. Louis, Missouri formed upon acquiring assets and intellectual property from Covidien
in 2012. Mr. Hanley is an experienced global business leader who has managed highly complex pharmaceutical and medical device operations
with annual global revenue exceeding US$1 billion. As the President of Covidien plc&#8217;s Imaging Solutions business unit, Mr. Hanley
led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. Internationally,
Mr. Hanley&#8217;s track record includes numerous new drug and device product introductions and sales force expansion in Eastern Europe,
China and Latin America. Mr. Hanley is experienced working in different cultures and successfully navigating dynamic regulatory environments.
Over his nearly 18 years with the Covidien family of companies, Mr. Hanley developed a large network of business leaders and clinicians
to help determine market needs, commercial potential and product positioning. As a sales leader, Mr. Hanley called on radiologists, nuclear
medicine physicians, cardiologists, as well as surgeons in specialties including general, orthopedic, and OB/GYN. Mr. Hanley is Principal
and Founder of Neem LLC, which was founded in 2009 to focus on startup and entrepreneurial medical device and other life science companies
with whom the firm works to bridge the gap between breakthrough technology and commercialization. Mr. Hanley is the Chairman of the Board
of Managers for Daya CNS LLC, based in St Louis Missouri. In addition, Mr. Hanley is currently on the Advisory Board for Kogent Surgical
LLC, based in St Louis Missouri. Mr. Hanley provided consultancy services to us on behalf of Neem LLC from November 2009 until December
31, 2014 and served as a Scientific Advisor to our company from June 2011 until his election to our Board of Directors in February 2015.
Mr. Hanley holds B.A. and M.A. degrees in business administration from Marquette University.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Clara
Ezed </span>has served as a member of our Board of Directors since June 2017, and has served as a member of our Audit Committee since
December 2017 and as a member of our Compensation Committee since March 2019. Since 2022, Ms. Ezed has served as a director at AXA Investment
Managers UK Ltd., a global investment management firm. Ms. Ezed serves as an Executive Board Director Business Development of DLRC Ltd.,
an EU based life-sciences consulting firm, since May 2021. Ms. Ezed has served as Head of EU Operations, EU General Counsel and VP European
Regulatory Affairs of La Jolla Pharmaceutical, a San Diego based biopharmaceutical company, from December 2017 to December 2020. Prior
to that, Ms. Ezed served as VP, Legal &amp; Regulatory Affairs of Emas Pharma Ltd., a global contract research organization, from October
2013 to November 2017. From September 2009 to October 2013, Ms. Ezed served as VP, Regulatory Affairs &amp; Drug Safety of European Medical
Advisory Services Ltd., a global contract research organization. Since 2011, Ms. Ezed has served as a director of a privately listed company,
Sebaroyale Ltd, focused on the development and commercialization of a range of cosmeceuticals. Ms. Ezed, a lawyer and pharmacist with
22 years&#8217; experience working in the pharmaceutical industry, has managed a large and varied portfolio working in regulatory and
medical affairs, quality assurance, clinical operations and pharmacovigilance. Ms. Ezed holds a BSc. in Pharmacy from the University of
Strathclyde, an MBA degree from Middlesex University, a Postgraduate Diploma in Pharmacovigilance from the University of Hertfordshire,
a Postgraduate Diploma in Law from Nottingham University and a Postgraduate Diploma in Legal Professional Services from City Law School,
London. Ms. Ezed is a member of the Bar of England and Wales and a member of the General Pharmaceutical Council.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Dr.
Mary Jo Gorman </span>has served as a member of our Board of Directors and as a member of our Audit Committee and Compensation Committee
since May 2015, and has served as a member of our Financing Committee since June 2016. Dr. Gorman currently serves on the board of directors
of Flosonics Medical, a privately-held medical company based in Canada, and serves on its compensation committee. Dr. Gorman also serves
on the not-for-profit boards of Barnes Jewish Hospital, Goldfarb School of Nursing and Stowe State University Foundation. From 2019 to
2021, Dr. Gorman served as the chief executive officer of Healthy Bytes, a venture backed healthcare services company, located in St.
Louis, Missouri. Dr. Gorman also serves as Managing Director at Prosper Capital, an early stage investment fund focused on women-led businesses.
In 2006, Dr. Gorman founded Advanced ICU Care, the largest telemedicine ICU services provider in the United States, in which she also
served as Chairman and Chief Executive Officer from 2006 and 2014. From December 2016 to 2018, Dr. Gorman served as interim CEO and as
a member of the audit committee of TripleCare, a U.S. provider of telemedicine-based healthcare services to skilled nursing facilities,
subsequently sold to Curavi Health. Dr. Gorman served on the board of directors of Curavi Health from 2019 to July 2020. From 1999 to
2006, Dr. Gorman served at IPC-The Hospitalist Company (Nasdaq:IPCM), a leading national physician group practice, as Chief Medical Officer
(2003-2006), Vice President of Medical Affairs (2001-2003) and Regional Medical Director (1999-2001). From 1996 to 1998, Dr. Gorman served
as President of Inpatient Care Group, a hospitalist group in St. Louis, Missouri, which she had founded to provide hospitalist services
to primary care physicians and hospitals and which was subsequently sold to IPC. From 1991 to 2008, Dr. Gorman served as President of
Critical Care Services, Inc., a privately held corporation which she had founded and which was later sold to Advanced ICU Care. Dr. Gorman
was awarded with the following awards: 2015 Distinguished Alumni Award, Southern Illinois University School of Medicine; 2013 Distinguished
Alumni Award, Olin School of Business, Washington University; 2011 EY Entrepreneurial Winning WomenTM Class of 2011; 2009 Top 25 Influential
Women in Healthcare by Modern HealthCare Magazine. Dr. Gorman holds a B.A. degree in Chemistry and Biology (Cum Laude) from St. Louis
University, an M.B.A degree from Olin School of Business, Washington University and an M.D. from Southern Illinois University School of
Medicine.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">XiangQian
(XQ) Lin </span>has served as a member of our Board of Directors since February 2015. Mr. Lin has served as the President and Chief Executive
Officer of the Esco Group since 2011, and is a life sciences entrepreneur and investor with a demonstrated track record across the United
States, Asia and Europe. In 2018, Mr. Lin served as the founder and managing partner of EVX Ventures, a venture capital firm which builds
and invests in biotech companies across Asia. Mr. Lin has co-founded multiple companies including Carmine Therapeutics and PairX Bio.
Mr. Lin holds a BSc degree in Economics and Finance from the Wharton School of Business, University of Pennsylvania.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Yuval
Yanai </span>has served as a member of our Board of Directors since March 2015 and has served as the Chairman of our Audit Committee and
Compensation Committee since March 2015, as the Chairman of our Nominating Committee since October 2015 and as the Chairman of our Financing
Committee since June 2016. Mr. Yanai served as Senior Vice President and Chief Financial Officer of Given Imaging Ltd. from September
2005 through March 2014. From October 2000 through August 2005, Mr. Yanai served as Senior Vice President and Chief Financial Officer
of Koor Industries Ltd. Prior to that, from April 1998 to September 2000, Mr. Yanai served as Vice President and Chief Financial Officer
of NICE Systems Ltd., an Israeli global provider of Insight from Interactions, and, from 1991 to April 1998, he served as the Vice President,
Finance and Chief Financial Officer of Elscint Ltd., a former Israeli company engaged in the developing and manufacturing of medical imaging
devices. Mr. Yanai joined Elscint in 1985 and served as Corporate Controller and Corporate Treasurer through 1991. Mr. Yanai also serves
as an external director (within the meaning of the Israeli Companies Law) of S&amp;P Global Maalot. Mr. Yanai also serves as an external
director (within the meaning of the Israeli Companies Law) of Clal Biotechnology Industries and serves as the Chairman of its audit, financial
reporting and compensation committees. Mr. Yanai also serves as a member of the board of directors of PulseNmore Ltd. and as a member
of its financial reporting and audit committees and as Chairman of its investment committee. Mr. Yanai also serves as a member of the
board of directors of Nobio Ltd. and BRH Medical Ltd., CellSound Aesthetics Ltd., Notal Vision, Inc. and as an acting CFO (part time)
of Art Medical Ltd. Previously, Mr. Yanai served as the Chairman of The Israeli Fund for UNICEF (pro bono) and as an external director
(within the meaning of the Israeli Companies Law) of Hadassah Medical Organization and as the Chairman of its finance and compensation
committees and as a member of its tenders and donation committee. Mr. Yanai also previously served as an external director (within the
meaning of the Israeli Companies Law) of Mazor Robotics Ltd. and Medical Compression Systems Ltd. and as a director of Medigus Ltd. and
Alcobra Ltd. Mr. Yanai also served as a director of Macrocure Ltd., Citycon Oj, Starplast Industries Ltd., Adama Ltd. (formerly Makteshim-Agan
Industries Ltd.), ECI Telecom Ltd., Equity One, Inc., BVR Systems Ltd., Tadiran Communication Ltd., The Elisra Group, Telrad Networks
Ltd. and Medical Compression Systems (D.B.N) Ltd. Mr. Yanai holds a B.Sc. degree in Accounting and Economics from Tel-Aviv University.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">52</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Arrangements Concerning Election of Directors; Family Relationships</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are not a party to, and are not aware of, any
voting agreements among our shareholders. In addition, there are no family relationships among our executive officers and directors.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Scientific Advisors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Certain of our officers and employees, including
our chief executive officer, our chief technology officer and our clinical director, consult from time to time, on an individual, as needed
basis with the individuals listed below with respect to matters of scientific relevance. We refer to these individuals as our Scientific
Advisors. The amount of consulting services provided by our Scientific Advisors ranges from several hours a month to several hours a year.
The names and biographies of the individuals who act as our Scientific Advisors are set forth below:</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-weight: bold; font-style: italic">Prof.
Nadir Arber </span>is a full Professor of Medicine and Gastroenterology. Prof. Arber is a holder of the Yechiel and Helen Lieber chair
for Cancer Research at Tel Aviv University, Sackler School of Medicine. Prof. Arber serves as the Director of the Integrated Cancer Prevention
Center (ICPC) at Tel Aviv Sourasky Medical Center in Tel Aviv. He chaired the grants committee of the Sackler School of Medicine at Tel
Aviv University. Prof. Arber is the Head of Cancer Research Center, Head of Djerassi Oncology Center. Prof. Arber, a noted expert in the
field of early detection and prevention, has been serving as the principal investigator (PI) of several international, multicenter clinical
trials in the field of early detection, prevention and therapy of gastrointestinal malignancies using NSAIDs and in particular, CRC. Prof.
Arber has published more than 330 publications. Prof. Arber received a MD from the Hadassah School of Medicine of the Hebrew University
of Jerusalem in 1987, an MSc degree from Sackler School of Medicine, Tel Aviv University in 1991 and a MHA degree from Rekanaty School
of Management, Tel Aviv University in 1991. Prof. Arber has served as a Scientific Advisor to the Company since January 2012. We have
entered into a consultation service agreement with Prof. Arber who is a leading investigator in our multicenter clinical study which is
held at Tel Aviv Sourasky Medical Center and other sites.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Compensation
of Directors and Executive Officers</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The aggregate compensation paid and share-based
compensation and other payments expensed by us to our directors and executive officers with respect to the year ended December 31, 2022
was $3.1 million. This amount includes approximately $0.34 million set aside or accrued to provide pension, severance, retirement or similar
benefits or expenses, but does not include business travel, professional and business association dues and expenses reimbursed to office
holders, and other benefits commonly reimbursed or paid by companies in our industry. As of December 31, 2022, (i) options to purchase
1,456 ordinary shares granted to our directors and executive officers were outstanding under our 2006 Unit Option Plan, with a weighted
average exercise price of approximately $1,185.2 per share, (ii) options to purchase 68,213 ordinary shares granted to our directors and
executive officers were outstanding under our 2015 Equity Incentive Plan and the United States Sub-Plan to our 2015 Equity Incentive Plan,
with a weighted average exercise price of approximately $20.07 per share; and (iii) 6,180 restricted share units awarded to our directors
and executive officers were outstanding under our 2015 Equity Incentive Plan and the United States Sub-Plan to our 2015 Equity Incentive
Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">At our 2022 annual general meeting held on December
29, 2022, our shareholders approved, following the approval of our Compensation Committee and Board of Directors, the payment to each
of our directors of the following fees: (i) an annual fee of $25,000 for service on the Board of Directors and $2,500 for service on the
Audit Committee; and (ii) a per meeting fee of $850 for each meeting of the Board of Directors or any committee thereof attended in person
or via telephone or any resolution approved by written consent. In addition, our shareholders approved an annual fee of (i) $10,000 for
service as Chairman of the Board of Directors (other than an Active Chairman, who may be entitled to an increased fee in accordance with
our Compensation Policy) and (ii) $5,000 for service as Chairman of the Audit Committee. Our directors also benefit from directors&#8217;
and officers&#8217; indemnification and exculpation agreements as well as from our directors&#8217; and officers&#8217; liability insurance
policy. The directors are also entitled to reimbursement of expenses (including travel, stay and lodging), subject to the Israeli Companies
Law and the regulations promulgated thereunder, and in accordance with our company practices and our Compensation Policy for Executive
Officers and Directors, or the Compensation Policy. The foregoing fees are the same annual and per meeting fees that have been paid to
our directors since our 2017 annual general meeting.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The directors are also entitled to reimbursement
of expenses (including travel, stay and lodging), subject to the Israeli Companies Law and the regulations promulgated thereunder, and
in accordance with our company practices and our Compensation Policy for Executive Officers and Directors, or the Compensation Policy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We do not have any written agreements with any
current director providing for benefits upon the termination of such director&#8217;s relationship with us.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To our knowledge, there are no agreements and arrangements
between any director and any third party relating to compensation or other payment in connection with their candidacy or service on our
Board of Directors.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The table below sets forth the compensation paid
to our five most highly compensated office holders (within the meaning of the Israeli Companies Law), in each case during or with respect
to the year ended December 31, 2022. We refer to the five individuals for whom disclosure is provided herein as our &#8220;Covered Executives.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For purposes of the table and the summary below,
&#8220;compensation&#8221; includes salary cost, consultancy fees, bonuses, equity-based compensation, retirement or termination payments,
benefits and perquisites such as car, phone and social benefits, to the extent applicable, and any undertaking to provide such compensation.
All amounts reported in the table are in terms of cost to us, as recognized in our financial statements for the year ended December 31,
2022, including compensation paid to such Covered Executive following the end of the year in respect of services provided during the year.
Each of the Covered Executives was covered by our directors&#8217; and officers&#8217; liability insurance policy and was entitled to
indemnification and exculpation in accordance with indemnification and exculpation agreements, our articles of association and applicable
law.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The exchange rate that we used to calculate the
&#8220;Salary Cost&#8221; as presented in the following table, was NIS 3.38 to US $1.00, and is provided herein for convenience (such
exchange rate is based on the average of the last-day exchange rate of each of the 12 months during 2022, as published by the Bank of
Israel).</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z2444f69c05d84716a969c00c3c151ab6" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Salary Cost (1)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Bonus (2)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Share-Based Compensation (3)</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25; font-weight: bold">Name and Principal Position</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
    <td colspan="14" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">US$</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255); padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Alex Ovadia &#8211; Chief Executive Officer</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">405,742</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,603</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">309,320</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">718,665</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Yoav Kimchy &#8211; Chief Technology Officer</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">369,727</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(7,074</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">26,425</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">389,078</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Mira Rosenzweig- Chief Financial Officer</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">285,710</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,275</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">40,669</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">328,654</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Boaz Shpigelman -Vice President, Research and Development</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">285,883</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">(1,260</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">33,055</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">317,678</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 52%">
        <div style="line-height: 1.25">Joshua (Shuki) Belkar- Vice President, Operation</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">268,171</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,395</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">38,430</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">307,996</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  </table>

<div style="line-height: 1.25">________________________</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="ze57340a738e54c4191ef31944b7133c6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>&#8220;Salary Cost&#8221; includes the Covered Executive&#8217;s gross salary plus payment of social benefits made by us on behalf
        of such Covered Executive. Such benefits may include, to the extent applicable to the Covered Executive, payments, contributions and/or
        allocations for savings funds, education funds, pension, severance, risk insurances, payments for social security and tax gross-up payments,
        vacation, a leased car and associated expenses, medical insurances and benefits, convalescence or recreation pay and other benefits and
        perquisites consistent with our policies.</div> </td> </tr>
  </table>

<div><br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">53</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> <br />

<table cellspacing="0" cellpadding="0" id="ze8dc26c4b45a46288573efa771cc7d15" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Represents an adjustment to the amount of the estimated 2021 annual bonus that was recorded in the year ended December 31, 2021 to
        the actual 2021 annual bonus that was approved for payment in 2022.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zbb6dec00dbb74f61810b869bbaf1e3ce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Represents the share-based compensation expenses recorded in our consolidated financial statements for the year ended December 31,
        2022 based on the fair value of the grant date of the equity awards, in accordance with accounting guidance for equity-based compensation.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">The following table sets forth information with respect to the options and RSUs granted
to the Covered Executives for the year ended December 31, 2022.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6ea0ab9436704f5a9b6bf039f789e584" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="border-bottom: #000000 2px solid; width: 14.99%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; font-weight: bold">Name</div> </div> </td>
    <td style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 10.99%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Date of Grant</div> </div> </td>
    <td style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 12.22%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Security Type</div> </div> </td>
    <td style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 10.99%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Purchase Price</div> </div> </td>
    <td style="width: 1.01%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 10.99%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number of Shares Underlying Award</div> </div> </td>
    <td style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 11.12%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Expiration Date</div> </div> </td>
    <td style="width: 1%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 10.99%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Total Benefit (in US$)</div> </div> </td>
    <td style="width: 1.01%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: #000000 2px solid; width: 10.66%; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Benefit recognized in 2022 (in US$)</div> </div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 12.22%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 11.12%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.66%; vertical-align: top">&#160;</td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Mira Rosenzweig(1)</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.05pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 22.1pt; margin-left: 21.8pt; line-height: 1.25">Options</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4pt; line-height: 1.25">$10.184</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; margin-right: 16.05pt; line-height: 1.25">1,225</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 11.12%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.8pt; margin-left: 4.35pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.75pt; line-height: 1.25">$8,596</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">$3,948</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.3pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 12.22%; vertical-align: top">
        <div style="text-align: center; margin-right: 22.05pt; margin-left: 21.9pt; line-height: 1.25">RSU</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">525</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 11.12%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.75pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.85pt; line-height: 1.25">$4,341</div> </td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">$1,994</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Yoav Kimchy(1)</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.2pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 22.1pt; margin-left: 21.9pt; line-height: 1.25">Options</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.15pt; line-height: 1.25">$10.184</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">700</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 11.12%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.75pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.8pt; line-height: 1.25">$4,912</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">$2,256</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.3pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 12.22%; vertical-align: top">
        <div style="text-align: center; margin-right: 22.05pt; margin-left: 21.9pt; line-height: 1.25">RSU</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">300</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 11.12%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.75pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.85pt; line-height: 1.25">$2,480</div> </td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">$1,140</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Boaz Shpigelman(1)</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 22.1pt; margin-left: 21.75pt; line-height: 1.25">Options</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4pt; line-height: 1.25">$10.184</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; margin-right: 16.05pt; line-height: 1.25">1,050</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 11.12%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.8pt; margin-left: 4.35pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.8pt; line-height: 1.25">$7,368</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">$3,384</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.3pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 12.22%; vertical-align: top">
        <div style="text-align: center; margin-right: 22.05pt; margin-left: 21.9pt; line-height: 1.25">RSU</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">450</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 11.12%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.75pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.85pt; line-height: 1.25">$3,721</div> </td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">$1,709</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">Joshua (Shuki) Belkar(1)</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.25pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 12.22%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 22.05pt; margin-left: 21.9pt; line-height: 1.25">Options</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.2pt; line-height: 1.25">$10.184</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">1,225</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 11.12%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.7pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.99%; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.9pt; line-height: 1.25">$8,596</div> </td>
    <td style="width: 1.01%; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif; background-color: rgb(204, 238, 255)">
        <div style="text-align: center">$3,948</div> </td> </tr>
  <tr>
    <td style="width: 14.99%; vertical-align: top">&#160;</td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 4.3pt; line-height: 1.25">March 21, 2022</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 12.22%; vertical-align: top">
        <div style="text-align: center; margin-right: 22.05pt; margin-left: 21.9pt; line-height: 1.25">RSU</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">&#160;</td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: right; margin-right: 16pt; line-height: 1.25">525</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 11.12%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.75pt; margin-left: 4.4pt; line-height: 1.25">March 21, 2032</div> </td>
    <td style="width: 1%; vertical-align: top">&#160;</td>
    <td style="width: 10.99%; vertical-align: top">
        <div style="text-align: center; margin-right: 4.3pt; margin-left: 3.8pt; line-height: 1.25">$4,341</div> </td>
    <td style="width: 1.01%; vertical-align: top">&#160;</td>
    <td style="width: 10.66%; vertical-align: top; font-family: Times New Roman,Times,serif">
        <div style="text-align: center">$1,994</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="text-indent: -26.65pt; margin-left: 30.05pt; line-height: 1.25">________________________</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd5553cebf4e44b23a051e25cc6540455" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 3.4pt"><br /> </td>
    <td style="width: 26.65pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>All options and RSUs granted to the Covered Executives in fiscal year 2022 vest over a four-year period commencing on their date
        of grant, such that 25% of the award shall vest on the first anniversary of the date of grant and 2.0833% will vest at the end of each
        month thereafter.&#160; Alex Ovadia, our chief executive officer, was not granted any equity-based compensation in 2022.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Employment Agreements with Covered Executives</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have entered into written employment agreements
with each of our executive officers. These agreements contain standard provisions for a company in our industry regarding non- competition,
confidentiality of information and assignment of inventions. The enforceability of covenants not to compete in Israel and the United States
is subject to limitations. For example, Israeli courts have recently required employers seeking to enforce non-compete undertakings of
a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material
interests of the employer which have been recognized by the courts, such as the secrecy of a company&#8217;s confidential commercial information
or its intellectual property.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We entered into an Employment Agreement dated as
of December 27, 2012, as amended, with Alex Ovadia, or Mr. Ovadia&#8217;s Employment Agreement, pursuant to which Mr. Ovadia served as
our Vice President of Research and Development, Israeli Site Manager and Chief Operations Officer until February 26, 2018. Effective as
of February 26, 2018, Mr. Ovadia was appointed as our Chief Executive Officer and Mr. Ovadia&#8217;s Employment Agreement was amended
accordingly, effective as of such date. The terms of Mr. Ovadia&#8217;s engagement in his capacity as our Chief Executive Officer were
approved by our shareholders at the extraordinary general meeting of shareholders held on April 2, 2018. Mr. Ovadia&#8217;s Employment
Agreement, as currently in effect, may be terminated by either us or Mr. Ovadia upon 90 days&#8217; prior notice to the other party. Pursuant
to Mr. Ovadia&#8217;s Employment Agreement, we also have the right to immediately terminate Mr. Ovadia&#8217;s employment for &#8220;Cause&#8221;
(as defined in Mr. Ovadia&#8217;s Employment Agreement). Pursuant to Mr. Ovadia&#8217;s Employment Agreement, Mr. Ovadia was entitled
to an annual salary of NIS 924,000 ($273,372 per annum, paid in NIS based on an exchange rate of $1= NIS 3.38). Mr. Ovadia&#8217;s salary
was subsequently increased in May 2019 to a monthly salary of NIS 80,808 (approximately $23,908 based on an exchange rate of $1= NIS 3.38)
and effective as of December 1, 2019, to a monthly base salary NIS 84,500 (approximately $25,000 based on an exchange rate of $1= NIS
3.38), in each case by our Compensation Committee in reliance on an exemption from shareholder approval available under Israel law. Mr.
Ovadia is also entitled to a leased car and associated expenses up to an aggregate monthly cost of NIS 12,000 (approximately $3,550 based
on an exchange rate of $1= NIS 3.38). In addition, prior to fiscal year 2022, Mr. Ovadia&#8217;s employment terms provided that he may
be entitled to an annual bonus of up to 30% of his annual salary subject to receipt of requisite approvals and commencing as of fiscal
year 2022, Mr. Ovadia may be entitled to an annual bonus of up 50%, as approved by the shareholders at the annual general meeting held
on December 9, 2021. Payment of the annual bonus shall be subject to the achievement of certain milestones determined by the Compensation
Committee and Board of Directors. Mr. Ovadia&#8217;s Employment Agreement also contains confidentiality, intellectual property, and non-competition
and non-solicitation provisions.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; line-height: 1.25">We entered into an Employment Agreement
effective as of April 28, 2019 with Mira Rosenzweig, or Ms. Rosenzweig&#8217;s Employment Agreement, pursuant to which Ms. Rosenzweig
serves as our Chief Financial Officer. Ms. Rosenzweig&#8217;s Employment Agreement may be terminated by either us or Ms. Rosenzweig upon
90 days&#8217; prior notice to the other party. Pursuant to Ms. Rosenzweig&#8217;s Employment Agreement, we also have the right to immediately
terminate Ms. Rosenzweig&#8217;s employment for &#8220;cause&#8221; (as described in Ms. Rosenzweig&#8217;s Employment Agreement). Pursuant
to Ms. Rosenzweig&#8217;s Employment Agreement, Ms. Rosenzweig is entitled to a salary of NIS 720,000 ($213,018 based on an exchange rate
of $1= NIS 3.38) per annum. In addition, prior to fiscal year 2022, Ms. Rosenzweig may be entitled to an annual bonus of up to 25% of
her annual salary and commencing as of fiscal year 2022, Ms. Rosenzweig may be entitled to an annual bonus of up to 30% of her annual
salary, subject to receipt of customary approvals.&#160; Payment of the annual bonus shall be subject to the achievement of certain milestones
determined by the Compensation Committee and Board of Directors. Ms. Rosenzweig&#8217;s Employment Agreement also contains confidentiality,
intellectual property, and non-competition and non-solicitation provisions.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; line-height: 1.25">We entered into an Employment Agreement
dated as of September 17, 2014, as amended from time to time, with Yoav Kimchy, or Mr. Kimchy&#8217;s Employment Agreement, pursuant to
which Mr. Kimchy serves our Chief Technology Officer. Mr. Kimchy&#8217;s Employment Agreement may be terminated by either us or Mr. Kimchy
upon 120 business days&#8217; prior notice to the other party. Pursuant to Mr. Kimchy&#8217;s Employment Agreement, we also have the right
to immediately terminate Mr. Kimchy&#8217;s employment for &#8220;Cause&#8221; (as defined in Mr. Kimchy&#8217;s Employment Agreement)
or if Mr. Kimchy is unable to perform his duties for a period of two consecutive months by reason of illness or accident. Pursuant to
Mr. Kimchy&#8217;s Employment Agreement, Mr. Kimchy is entitled to a salary of NIS 1,003,800 ($296,982 based on an exchange rate of $1=
NIS 3.38) per annum. In addition, Mr. Kimchy may be entitled to an annual bonus of up to 30% of his annual salary, subject to receipt
of requisite approvals. Payment of the annual bonus shall be subject to the achievement of certain milestones determined by the Compensation
Committee and Board of Directors. Mr. Kimchy&#8217;s Agreement also contains confidentiality, intellectual property, and non-competition
and non-solicitation provisions.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">54</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">We entered into an Employment Agreement
dated as of March 30, 2018, with Boaz Shpigelman, as amended from time to time, or Mr. Shpigelman&#8217;s Employment Agreement, pursuant
to which Mr. Shpigelman serves as our Vice President, Research and Development. Mr. Shpigelman&#8217;s Employment Agreement may be terminated
by either us or Mr. Shpigelman upon 90 days&#8217; prior notice to the other party. Pursuant to Mr. Shpigelman&#8217;s Employment Agreement,
we also have the right to immediately terminate Mr. Shpigelman&#8217;s employment for &#8220;Cause&#8221; (as defined in Mr. Shpigelman&#8217;s
Employment Agreement). Pursuant to Mr. Shpigelman&#8217;s Employment Agreement, Mr. Shpigelman is entitled to a salary of NIS 711,000
($210,355 based on an exchange rate of $1= NIS 3.38) per annum. In addition, Mr. Shpigelman may be entitled to an annual bonus of up to
25% of his annual salary, subject to receipt of customary approvals. Payment of the annual bonus shall be subject to the achievement of
certain milestones determined by the Compensation Committee and Board of Directors. Mr. Shpigelman&#8217;s Employment Agreement also contains
confidentiality, intellectual property, and non-competition and non-solicitation provisions.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">We entered into an Employment Agreement
effective as of June 16, 2019 with Joshua (Shuki) Belkar, or Mr. Belkar&#8217;s Employment Agreement, pursuant to which Mr. Belkar serves
as our Vice President, Operation. Mr. Belkar&#8217;s Employment Agreement may be terminated by either us or Mr. Belkar upon 90 days&#8217;
prior notice to the other party. Pursuant to Mr. Belkar&#8217;s Employment Agreement, we also have the right to immediately terminate
Mr. Belkar&#8217;s employment for &#8220;cause&#8221; (as described in Mr. Belkar&#8217;s Employment Agreement). Pursuant to Mr. Belkar&#8217;s
Employment Agreement, Mr. Belkar is entitled to a salary of NIS 672,000 ($198,817 based on an exchange rate of $1= NIS 3.38) per annum.
In addition, Mr. Belkar may be entitled to an annual bonus of up to 25% of his annual salary, subject to receipt of customary approvals.
Payment of the annual bonus shall be subject to the achievement of certain milestones determined by the Compensation Committee and Board
of Directors. Mr. Belkar&#8217;s Employment Agreement also contains confidentiality, intellectual property, and non-competition and non-solicitation
provisions.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">Our agreements with our executive officers
do not provide for benefits upon the termination of their respective employment with us, other than payment of salary and benefits during
the required notice period for termination of these agreements, which varies under these individual agreements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Board
Practices</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Board of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, the management
of our business, including strategy and policies, is vested in our board of directors. Our board of directors may exercise all powers
and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible
for our day-to-day management and have individual responsibilities established by our board of directors. Our chief executive officer
is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered into
with him. All other executive officers are appointed by our chief executive officer, and are subject to the terms of any applicable employment
agreements that we may enter into with them.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under our amended articles of association, our
board of directors must consist of at least four and not more than eleven directors, including the external directors (if external directors
serve on the board of directors).</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our Board of Directors currently consists of five
members, four of whom satisfy the independence requirements of the Nasdaq Listing Rules, such that we comply with the Nasdaq Listing Rule
that requires that a majority of our board of directors be comprised of independent directors, within the meaning of Nasdaq Listing Rules.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our directors are elected by the general meeting
of our shareholders by the vote of a majority of the ordinary shares present, in person or by proxy, and voting at that meeting. Each
director will hold office until the first annual general meeting of shareholders following his or her appointment, unless the tenure of
such director expires earlier pursuant to the Israeli Companies Law or unless he or she is removed from office as described below. In
addition, our amended articles of association allow our board of directors to appoint directors (other than the external directors) to
fill vacancies on our board of directors, for a term of office equal to the remaining period of the term of office of the director(s)
whose office(s) have been vacated.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our Board of Directors elected to rely on the exemption
available to foreign private issuers under the Nasdaq Listing Rules and follow Israeli law and practice with regard to the process of
nominating directors, in accordance with which the board of directors (or a committee thereof) is authorized to recommend to the shareholders
director nominees for election (other than directors elected by the board of directors to fill a vacancy). Our Board of Directors established
a Nominating Committee, whose role is to select and recommend to the Board of Directors for selection, director nominees, while considering
the appropriate size and composition of the Board of Directors, the requirements of applicable law regarding service as a member of our
Board of Directors and the criteria for the selection of new members of the Board of Directors, and determined that our Nominating Committee
need not be composed solely of independent directors (within the meaning of Nasdaq Listing Rules).&#160; However, our Nominating Committee
currently consists solely of independent directors.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law and our amended
articles of association, nominations for directors may also be added to the agenda of a future general meeting of shareholders, at the
request of any one or more shareholders holding at least 1% of our outstanding voting power. Any director nominated by a shareholder is
required to certify to us, as required by all director nominees, that he or she meets all the requirements of the Israeli Companies Law
for election as a director of a public company, and possesses the necessary qualifications and is able to dedicate sufficient time, to
fulfill his or her duties as a director of our company, taking into consideration our company&#8217;s size and special needs.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, our board of directors
must determine the minimum number of directors who are required to have accounting and financial expertise (as defined in regulations
promulgated under the Israeli Companies Law). In determining the number of directors required to have such expertise, our board of directors
must consider, among other things, the type and size of the company and the scope and complexity of its operations. Our board of directors
has determined that the minimum number of directors of our company who are required to have accounting and financial expertise is one.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">External Directors</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, companies incorporated
under the laws of the State of Israel that are &#8220;public companies,&#8221; must appoint at least two external directors who meet the
qualification requirements in the Companies Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">However, pursuant to regulations promulgated under
the Israeli Companies Law, Israeli companies whose shares are listed on certain stock exchanges outside of Israel (including the Nasdaq
Capital Market) with no controlling shareholder (within the meaning of the Israeli Companies Law), such as ourselves, that satisfy the
requirements of the laws in the foreign jurisdiction where the company&#8217;s shares are listed, as they apply to companies incorporated
in such jurisdiction, with respect to the appointment of independent directors and the composition of the audit committee and compensation
committee, may elect to exempt themselves from the requirements of Israeli law with respect to (i) the requirement to appoint outside
directors and that one outside director serve on each committee of the board of directors authorized to exercise any of the powers of
the board of directors; (ii) certain limitations on the employment or service of an outside director or his or her spouse, children or
other relatives, following the cessation of the service as an outside director, by or for the company, its controlling shareholder or
an entity controlled by the controlling shareholder; (iii) the composition, meetings and quorum of the audit committee; and (iv) the composition
and meetings of the compensation committee. If a company has elected to avail itself from the requirement to appoint external directors
and at the time a director is appointed all members of the board of directors are of the same gender, a director of the other gender must
be appointed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Following analysis of our qualification to rely
on the exemption, our Board of Directors determined to adopt the exemption, subject to and effective as of the approval by our shareholders
of a certain amendment to our articles of association, which was obtained at our 2017 annual general meeting held on June 22, 2017. If
in the future we were to have a controlling shareholder, we would again be required to comply with the requirements relating to external
directors and the composition of the audit committee and compensation committee under Israeli law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Audit Committee</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our audit committee currently consists of Yuval
Yanai, May Jo Gorman and Clara Ezed. Yuval Yanai serves as the Chairman of the audit committee.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Composition of the Audit Committee</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In accordance with regulations promulgated under
the Companies Law described above, we elected to &#8220;opt out&#8221; from the Israeli Companies Law requirement to appoint external
directors and related rules concerning the composition of the audit committee and compensation committee. Under such exemption, among
other things, the composition of our audit committee must comply with the requirements of SEC and Nasdaq rules.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Nasdaq corporate governance rules, we
are required to maintain an audit committee consisting of at least three independent directors, within the meaning of the Exchange Act
and Nasdaq Listing Rules, each of whom must be able to read and understand fundamental financial statements, including the company&#8217;s
balance sheet, income statement and cash flow statement (and one of whom has past employment experience in finance or accounting, requisite
professional certification in accounting or other comparable experience or background that leads to financial sophistication) and none
of whom has participated in the preparation of our or any of our subsidiary&#8217;s financial statements at any time during the prior
three years.</div>

<div style="text-align: justify; text-indent: 25.25pt; margin-right: 7.1pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">55</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">All members of our audit committee meet the requirements
for financial literacy under the applicable rules and regulations of the U.S. Securities and Exchange Commission and the Nasdaq Listing
Rules. Our board of directors has determined that Mr. Yanai is an audit committee financial expert as defined by the U.S. Securities and
Exchange Commission rules and has the requisite financial sophistication required by the Nasdaq Listing Rules.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Each of the members of the audit committee qualifies
as an &#8220;independent director&#8221; within the meaning of Nasdaq Listing Rules and is &#8220;independent&#8221; as such term is defined
in Rule 10A- 3(b)(1) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which is different from the general Nasdaq
test for independence of board and committee members.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Audit Committee Role</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our board of directors adopted an audit committee
charter, which became effective upon the listing of our securities on the Nasdaq Capital Market, as subsequently amended, which sets forth
the responsibilities of the audit committee consistent with the rules of the U.S. Securities and Exchange Commission and the Nasdaq Listing
Rules, as well as the requirements for audit committees under the Israeli Companies Law, including the following:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z6fcf1d6c53e742d1a936e62d0a129346" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">oversight of our independent registered public accounting firm and recommending the engagement, compensation
        or termination of engagement of our independent registered public accounting firm to the board of directors or shareholders for their
        approval, as applicable, in accordance with the requirements of the Israeli Companies Law;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z17fc0b7a4d8845099eb4b650404b176e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">recommending the engagement or termination of the person filling the office of our internal auditor; and</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z79786083735d4bde809a1e6f444a7505" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">recommending the terms of audit and non-audit services provided by the independent registered public accounting
        firm for pre-approval by our board of directors or shareholders for their approval, as applicable, in accordance with the requirements
        of the Israeli Companies Law.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our audit committee provides assistance to our
board of directors in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting,
internal control and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their
reports regarding our accounting practices and systems of internal control over financial reporting. Our audit committee also oversees
the audit efforts of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants
are independent of management.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, our audit committee
is responsible for:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z7ea3e5ff2b93492187c10a86701bead5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">determining whether there are deficiencies in the business management practices of our company, including
        in consultation with our internal auditor or the independent auditor, and making recommendations to the board of directors to improve
        such practices;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z62efd8e9fc304129aab207ff53496ddd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">determining whether to approve certain related party transactions (including transactions in which an office
        holder has a personal interest) and whether such transaction is extraordinary or material under Israeli Companies Law (see &#8220;&#8212;
        Approval of Related Party Transactions under Israeli Law&#8221;);</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z41c296785d7b45acb52e6981e69c6981" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">determining whether a competitive process must be implemented for the approval of certain transactions
        with controlling shareholders or its relative or in which a controlling shareholder has a personal interest (whether or not the transaction
        is an extraordinary transaction), under the supervision of the audit committee or other party determined by the audit committee and in
        accordance with standards to be determined by the audit committee, or whether a different process determined by the audit committee should
        be implemented for the approval of such transactions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5ee93a6c9b25483a8f65793b5bb4890b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">determining the process for the approval of certain transactions with controlling shareholders or in which
        a controlling shareholder has a personal interest that the audit committee has determined are not extraordinary transactions but are not
        immaterial transactions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zde43a8b2dec44f73a4e643d46e89cc70" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">where the board of directors approves the working plan of the internal auditor, to examine such working
        plan before its submission to the board of directors and proposing amendments thereto;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z1355442471aa4499a21a76799e71fdd0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">examining our internal controls and internal auditor&#8217;s performance, including whether the internal
        auditor has sufficient resources and tools to dispose of its responsibilities;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1db27a21e75b4126bd1f7f5614c20d75" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">examining the scope of our auditor&#8217;s work and compensation and submitting a recommendation with respect
        thereto to our board of directors or shareholders, depending on which of them is considering the compensation of our auditor; and</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf28cd02a2c6c4c65ba352644cb4a8a11" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">establishing procedures for the handling of employees&#8217; complaints as to the management of our business
        and the protection to be provided to such employees.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Compensation Committee and Compensation Policy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our compensation committee currently consists Yuval
Yanai, Mary Jo Gorman and Clara Ezed. Yuval Yanai serves as the Chairman of the compensation committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Composition of the Compensation Committee</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In accordance with regulations promulgated under
the Companies Law described above, we elected to &#8220;opt out&#8221; from the Israeli Companies Law requirement to appoint external
directors and related rules concerning the composition of the audit committee and compensation committee.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Nasdaq Listing Rules, we are required
to maintain a compensation committee consisting of at least two directors, each of whom is an independent director within the meaning
of the Nasdaq Listing Rules. Our compensation committee currently complies with the provisions of Nasdaq Listing Rules relating to composition
requirements.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">56</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Compensation Committee Role</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our board of directors adopted a compensation committee
charter, which became effective upon the listing of our shares on the Nasdaq Capital Market, as subsequently amended, which sets forth
the responsibilities of the compensation committee consistent with the Nasdaq Listing Rules and the requirements for compensation committees
under the Israeli Companies Law, including the following:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zc15b0ab38a9b4cb7931646e1fbfcbe1c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">recommending to the board of directors for its approval (i) a compensation policy; (ii) whether a compensation
        policy should continue in effect, if the then-current policy has a term of greater than three years (approval of either a new compensation
        policy or the continuation of an existing compensation policy must in any case occur every three years); and (iii) periodic updates to
        the compensation policy. See &#8220;&#8212; Compensation Committee and Compensation Policy.&#8221; In addition, the compensation committee
        is required to periodically examine the implementation of the compensation policy;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd9a93dc74d314d1eb89d27148d0108d5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the approval of the terms of employment and service of office holders (including determining whether the
        compensation terms of a candidate for chief executive officer of the company need not be brought to approval of the shareholders); and</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd67cee00667648e393fe91ef4a367a17" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">reviewing and approving grants of options and other incentive awards to persons other than office holders
        to the extent such authority is delegated by our board of directors, subject to the limitations on such delegation as provided in the
        Israeli Companies Law.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Compensation Policy</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, the duties of
the compensation committee include the recommendation to the company&#8217;s board of directors of a policy regarding the terms of engagement
of office holders, as such term is defined in the Israeli Companies Law, to which we refer to as a compensation policy, and any extensions
and updates thereto. The compensation policy must be approved at least once every three years, first, by our board of directors, upon
recommendation of our compensation committee, and second, by the shareholders by the Special Approval for Compensation (as defined below
under &#8220;&#8212; Approval of Related Party Transactions under Israeli Law &#8212; Disclosure of Personal Interests of an Office Holder
and Approval of Certain Transactions&#8221;).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our current Compensation Policy for Executive Officers
and Directors, which was approved by our shareholders at the 2020 annual general meeting held on December 10, 2020, serves as the basis
for decisions concerning the financial terms of employment or engagement of our office holders, including exculpation, insurance, indemnification
and any benefit, monetary payment or obligation of payment in respect of employment or engagement, including and any severance payment
or benefit.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Compensation Policy must be determined and
later reevaluated according to certain factors, including: (i) the advancement of a company&#8217;s objectives, business plan and its
long- term strategy; (ii) the creation of appropriate incentives for executives, while considering (among other things) the company&#8217;s
risk management policy; (iii) the size and the nature of the company&#8217;s operations; and (iv) with respect to variable compensation,
the contribution of the office holder towards the achievement of the company&#8217;s long-term goals and the maximization of its profits,
all with a long-term objective and in accordance with the position of the office holder.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In accordance with the Israeli Companies law, our
Compensation Policy refers to the following factors:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z73391ef1ca1e45a3b2d71752d25c1256" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the knowledge, skills, expertise, professional experience and accomplishments of the relevant office holder;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6f508de518094d9e84778cc98f4c1116" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the office holder&#8217;s roles and responsibilities and prior compensation agreements with him or her;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zda12ede9ceed49fa85240f3afd25c5fd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">with respect to variable compensation &#8211; the possibility of reducing variable compensation at the
        discretion of the board of directors, and the possibility of setting a limit on the exercise value of non-cash variable equity-based compensation;
        and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd85c2d70a5ca4745b27a1b3d6cf4f27b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">with respect to severance compensation, the period of employment or service of the office holder, the terms
        of his or her compensation during such period, the company&#8217;s performance during such period, the person&#8217;s contribution towards
        the company&#8217;s achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving
        the company.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, in according with the Israeli Companies
Law, our Compensation Policy includes the following principles:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9e272f22ae2b490585bcd885e0c06487" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the link between variable compensation (e.g., bonuses) and long-term performance and measurable criteria
        (i.e., variable compensation must be determined based on long-term performance and measurable criteria). Only &#8220;non-material&#8221;
        portion of variable compensation may be determined based on criteria that is not measurable, taking into account office holders&#8217;
        contribution to the company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze3149e41a2b94fea81ee1fc61f290abe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the ratio of variable to fixed compensation, and the ceiling for the value of variable compensation, which
        is determined at the time of payment, except that the ceiling for equity-based compensation is determined at the time of grant;</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0c6406da289e49028e5096daa55ab2e1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the conditions under which an office holder would be required to repay compensation paid to him or her
        if it was later shown that the data upon which such compensation was based was inaccurate and was required to be restated in the company&#8217;s
        financial statements;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z81ae0769d64049b0b0779282ca434e1f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the minimum holding or vesting period for variable, equity-based compensation, while taking into account
        long-term objectives; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0e34c44a4b1b481ca083cec1a5e8ae69" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">maximum limits for severance compensation.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Nominating Committee</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our Board of Directors has established a Nominating
Committee, whose role is to select and recommend to the Board of Directors for selection, director nominees, while considering the appropriate
size and composition of the Board of Directors, the requirements of applicable law regarding service as a member of our Board of Directors
and the criteria for the selection of new members of the Board of Directors. While our Board of Directors elected to rely on the exemption
available to foreign private issuers under the Nasdaq Listing Rules with respect to the process of nominating directors, and determined
that our Nominating Committee need not be composed solely of independent directors (within the meaning of Nasdaq Listing Rules), our Nominating
Committee currently consists solely of independent directors.&#160; The Nominating Committee is currently comprised of the following directors:
Yuval Yanai, Steven Hanley and Mary-Jo Gorman. Yuval Yanai serves as the Chairman of the Nominating Committee.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Financing Committee</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our Board of Directors has established a financing
committee, which currently consists of Steven Hanley, Yuval Yanai and Mary Jo Gorman. Our financing committee is responsible for the review,
approval and oversight of any potential financings, including the negotiations of any potential financings, and to provide a recommendation
to our Board of Directors concerning the approval of any potential financings.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.35pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">57</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Internal Auditor</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, the board of directors
of an Israeli public company must appoint an internal auditor recommended by the audit committee. An internal auditor may not be:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z223c7fd0c849436d8dc5496970f0e830" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a person (or a relative of a person) who holds more than 5% of the company&#8217;s outstanding shares or
        voting rights;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zafd67235c76f402f8ce266d53687cd80" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a person (or a relative of a person) who has the power to appoint a director or the general manager of
        the company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zaf2afade680645a0a6a92269f45d761e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an office holder, within the meaning of the Israeli Companies Law (including a director and the general
        manager) of the company (or a relative thereof); or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zdc620ed3c8034abc81d3011dede2ee1f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a member of the company&#8217;s independent accounting firm, or anyone on his or her behalf.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The role of the internal auditor is to examine,
among other things, our compliance with applicable law and orderly business procedures. The audit committee is required to oversee the
activities and to assess the performance of the internal auditor as well as to approve the internal auditor&#8217;s work plan. We have
appointed Ms. Dana Gottesman Erlich of BDO as our internal auditor.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Approval of Related Party Transactions under Israeli Law</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Fiduciary Duties of Directors and Executive Officers</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Israeli Companies Law codifies the fiduciary
duties that office holders owe to a company. Each person listed in the table under &#8220;Management&#8212;Executive Officers and Directors&#8221;
is an office holder under the Israeli Companies Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">An office holder&#8217;s fiduciary duties consist
of a duty of care and a duty of loyalty. The duty of care requires an office holder to act with the level of care with which a reasonable
office holder in the same position would have acted under the same circumstances. The duty of care includes a duty to use reasonable means
to obtain:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf0bc9ff5ab3c46769bc7f53de03b77c6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">information on the advisability of a given action brought for his or her approval or performed by virtue
        of his or her position; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z463120c31f1f4645aac484bf5d8301ca" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">all other important information pertaining to any such action.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">The duty of loyalty requires an office holder to act in good faith and in the best
interests of the company, and includes, among other things, the duty to:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z3b416c0880e14ef694ee15f4c6e90c04" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">refrain from any conflict of interest between the performance of his or her duties to the company and his
        or her other duties or personal affairs;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z535d4cc9d77948da8ffc64a494047cd1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">refrain from any activity that is competitive with the company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z91314f3bb7404eebbdeca2c5c9f8c5d8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">refrain from exploiting any business opportunity of the company to receive a personal gain for himself
        or herself or others; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z41c5f0cd70b44d5ca474c82718923e2d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">disclose to the company any information or documents relating to the company&#8217;s affairs which the
        office holder received as a result of his or her position as an office holder.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We may approve an act specified above which would
otherwise constitute a breach of the office holder&#8217;s duty of loyalty, provided that the office holder acted in good faith, the act
or its approval does not harm the company and the office holder discloses his or her personal interest a sufficient amount of time before
the date for discussion of approval of such act.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Disclosure of Personal Interests of an Office Holder</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Israeli Companies Law requires that an office
holder promptly disclose to the company any &#8220;personal interest&#8221; that he or she may be aware of and all related material information
or documents concerning any existing or proposed transaction with the company. An interested office holder&#8217;s disclosure must be
made promptly and in any event no later than the first meeting of the board of directors at which the transaction is considered. A personal
interest includes an interest of any person in an act or transaction of a company, including a personal interest of such person&#8217;s
relative or of a corporate entity in which such person or a relative of such person holds 5% or more of the outstanding shares or voting
rights, is a director or general manager or in which he or she has the right to appoint at least one director or the general manager,
but excluding a personal interest arising from one&#8217;s ownership of shares in the company. A personal interest includes the personal
interest of a person for whom the office holder holds a voting proxy or the personal interest of the office holder with respect to his
or her vote on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter. An
office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her relative
in a transaction that is not considered an extraordinary transaction. Under the Israeli Companies Law, an extraordinary transaction is
defined as any of the following: a transaction other than in the ordinary course of business; a transaction that is not on market terms;
or a transaction that may have a material impact on a company&#8217;s profitability, assets or liabilities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Generally, a person who has a personal interest
in a matter which is considered at a meeting of the board of directors or the audit committee shall not be present at such a meeting or
vote on that matter unless, with respect to an office holder, the chairman of the audit committee or board of directors (as applicable)
determines that the office holder should be present during the discussions in order to present the transaction that is subject to approval
(provided that the office holder may not vote on the matter). If a majority of the members of the audit committee or the board of directors
(as applicable) has a personal interest in the approval of a transaction, then all directors may participate in discussions of the audit
committee or the board of directors (as applicable) on such transaction and the voting on approval thereof. If a majority of the members
of the board of directors has a personal interest in the approval of a transaction, shareholder approval is also required for such transaction.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Approval of Transactions with Officer Holders</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If it is determined that an office holder has a
personal interest in a transaction that is not an extraordinary transaction, approval by the board of directors is required for the transaction,
unless the company&#8217;s articles of association provide for a different method of approval. Further, so long as an office holder has
disclosed his or her personal interest in a transaction, the board of directors may approve an act by the office holder that would otherwise
be deemed a breach of his or her duty of loyalty, provided that the transaction is in the company&#8217;s best interest and the office
holder acted in good faith. An extraordinary transaction in which an office holder has a personal interest requires approval first by
the company&#8217;s audit committee and subsequently by the board of directors.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">58</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Compensation of Officers Other than the Chief Executive Officer</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The compensation of an office holder (other than
the chief executive officer) who is not a director generally requires approval first by the company&#8217;s compensation committee, then
by the company&#8217;s board of directors, according to the company&#8217;s compensation policy. In special circumstances the compensation
committee and board of directors may approve a compensation arrangement that is inconsistent with the company&#8217;s compensation policy,
provided that they have considered the same considerations and matters required for the approval of a compensation policy in accordance
with the Israeli Companies Law and such arrangement must be approved by a majority vote of the shares present and voting at a shareholders
meeting on the matter, provided that either: (i) such majority includes at least a majority of the shares held by all shareholders who
are not controlling shareholders and shareholders who do not have a personal interest in such compensation arrangement present and voting
on the matter, excluding abstentions; or (ii) the total number of shares of non-controlling shareholders and shareholders who do not have
a personal interest in the matter and who vote against the matter does not exceed 2% of the company&#8217;s aggregate voting rights. We
refer to this as the Special Approval for Compensation. However, if the shareholders of the company do not approve a compensation arrangement
with an executive officer that is inconsistent with the company&#8217;s compensation policy, the compensation committee and board of directors
may, in special circumstances, override the shareholders&#8217; decision if each of the compensation committee and the board of directors
discuss the arrangement again, analyze the shareholders&#8217; objection and provide detailed reasons for their decision.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">An amendment to an existing arrangement with an
office holder (other than the chief executive officer) who is not a director requires only the approval of the compensation committee,
if the compensation committee determines that the amendment is not material in comparison to the existing arrangement. However, according
to regulations promulgated under the Israeli Companies Law, an amendment to an existing arrangement with an office holder (who is not
a director) who is subordinate to the chief executive officer shall not require the approval of the compensation committee, if (i) the
amendment is approved by the chief executive officer and the company&#8217;s compensation policy determines that a non-material amendment
to the terms of service of an office holder (other than the chief executive officer) may be approved by the chief executive officer and
(ii) the engagement terms are consistent with the company&#8217;s compensation policy.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Compensation of Chief Executive Officer</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The compensation of a public company&#8217;s chief
executive officer generally requires the approval of first, the company&#8217;s compensation committee; second, the company&#8217;s board
of directors and third (except for a number of exceptions), the company&#8217;s shareholders by the Special Approval for Compensation.
However, if the shareholders of the company do not approve a compensation arrangement with a chief executive officer, the compensation
committee and board of directors may, in special circumstances, override the shareholders&#8217; decision if each of the compensation
committee and the board of directors discuss the arrangement again, analyze the shareholders&#8217; objection and provide detailed reasons
for their decision. However, an amendment to an existing arrangement with a chief executive officer who is not a director requires only
the approval of the compensation committee, if the compensation committee determines that the amendment is not material in comparison
to the existing arrangement.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">According to regulations promulgated under the
Israeli Companies Law, the renewal or extension of an existing arrangement with a chief executive officer shall not require shareholder
approval if (i) the renewal or extension is not beneficial to the chief executive officer as compared to the prior arrangement or there
is no substantial change in the terms and other relevant circumstances; and (ii) the engagement terms are consistent with the company&#8217;s
compensation policy and the prior arrangement was approved by the shareholders by the Special Approval for Compensation.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Compensation of Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Arrangements regarding the compensation of a director
require the approval of the compensation committee, board of directors and (except for a number of exceptions) shareholders by ordinary
majority, in that order. The approval of the compensation committee and board of directors must be in accordance with the compensation
policy. In special circumstances, the compensation committee and board of directors may approve a compensation arrangement that is inconsistent
with the company&#8217;s compensation policy, provided that they have considered the same considerations and matters required for the
approval of a compensation policy in accordance with the Israeli Companies Law and that shareholder approval was obtained by the Special
Approval for Compensation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">With respect to compensation of an officer (including
chief executive officer) or director who is also a controlling shareholder, see &#8220;&#8212; Disclosure of Personal Interests of Controlling
Shareholders and Approval of Certain Transactions.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Disclosure of Personal Interests of Controlling Shareholders and Approval of Certain
Transactions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Pursuant to Israeli law, the disclosure requirements
regarding personal interests that apply to directors and executive officers also apply to a controlling shareholder of a public company.
In the context of a transaction involving a shareholder of the company, a controlling shareholder also includes a shareholder who holds
25% or more of the voting rights in the company if no other shareholder holds more than 50% of the voting rights in the company. For this
purpose, the holdings of all shareholders who have a personal interest in the same transaction will be aggregated. Extraordinary transactions
with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private placement in which a
controlling shareholder has a personal interest, and the terms of engagement with a controlling shareholder or a relative thereof, directly
or indirectly (including through a corporation controlled by a controlling shareholder), for the provision of services to the company
and his or her terms of employment or service as an office holder or employment as other than an office holder, require the approval of
each of (i) the audit committee or the compensation committee with respect to the terms of service or employment by the company as an
office holder, an employee or service provider; (ii) the board of directors; and (iii)&#160;the shareholders, in that order. The shareholder
approval requires one of the following, which we refer to as a Special Majority:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za9de5f68b4fe4cd39f8cff46145b4ab3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a majority of the shares held by all shareholders who do not have a personal interest in the transaction
        and who are present and voting on the matter approves the transaction, excluding abstentions; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zacdb69b3473f48ed85abb785fb46ffbb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the shares voted against the transaction by shareholders who have no personal interest in the transaction
        and who are present and voting at the meeting do not exceed 2% of the voting rights in the company.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Each shareholder voting on the approval of an extraordinary
transaction with a controlling shareholder must inform the company prior to voting whether or not he or she has a personal interest in
the approval of the transaction, otherwise, the shareholder is not eligible to vote on the proposal and his or her vote will not be counted
for purposes of the proposal.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To the extent that any such transaction with a
controlling shareholder is for a period of more than three years, approval is required once every three years, unless, with respect to
any such extraordinary transactions, the audit committee determines that the duration of the transaction is reasonable given the related
circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The compensation committee and board approval for
arrangements regarding the terms of service or employment of a controlling shareholder must be in accordance with the company&#8217;s
compensation policy. In special circumstances the compensation committee and board of directors may approve a compensation arrangement
that is inconsistent with the company&#8217;s compensation policy, provided that they have considered the same considerations and matters
required for the approval of a compensation policy in accordance with the Israeli Companies Law and that shareholder approval was obtained
by the Special Majority.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Pursuant to regulations promulgated under the Israeli
Companies Law, certain transactions with a controlling shareholder or his or her relative, or with directors, relating to terms of service
or employment that would otherwise require approval of a company&#8217;s shareholders may be exempt from shareholder approval upon certain
determinations of the audit committee and board of directors. In addition, disclosure of a personal interest in a private placement of
a public company (including disclosure of any material fact or document) is required by (i) a shareholder holding 5% or more of the company&#8217;s
issued and outstanding capital or its voting rights whose holdings will increase as result of the private placement and a shareholder
who will hold 5% or more of the company&#8217;s issued and outstanding capital or its voting rights as a result of the private placement,
if 20% or more of the company&#8217;s outstanding share capital prior to the private placement is issued in the private placement and
the payment for which is not only in cash or listed securities or the transaction is not on market terms; and (ii) a person or entity
that will become a controlling shareholder as a result of the private placement.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">59</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Shareholder Duties</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Pursuant to the Israeli Companies Law, a shareholder
has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or
her power in the company, including, among other things, in voting at a meeting of shareholder with respect to the following matters:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7549333c2dfa4cbaaabe388e1a3d1b2c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an amendment to the company&#8217;s articles of association;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zaeb0655f4dc94d40b028c4ff907657ea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an increase of the company&#8217;s authorized share capital;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z3a4d41f0b70a43a7ac673c23c0881253" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a merger; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z1ae74a0f94d24bd6917f9bd8b0cee0d0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the approval of related party transactions and acts of office holders that require shareholder approval.</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, a shareholder has a general duty to
refrain from discriminating against other shareholders.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Certain shareholders have a duty of fairness toward
the company. These shareholders include any controlling shareholder, any shareholder who knows that he or she has the power to determine
the outcome of a shareholder vote and any shareholder who has the power to appoint or to prevent the appointment of an office holder of
the company or other power towards the company. The Israeli Companies Law does not define the substance of the duty of fairness, except
to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with
fairness.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Exculpation, Insurance and Indemnification of Directors and Officers</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, a company may
not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in
advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care,
but only if a provision authorizing such exculpation is included in its articles of association. Our amended articles of association include
such a provision, to the fullest extent permitted by law. The company may not exculpate in advance a director from liability arising out
of a prohibited dividend or other distribution to shareholders.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law and the Israeli
Securities Law, 5728-1968, or the Israeli Securities Law, a company may indemnify an office holder in respect of the following liabilities
and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking made in advance of any such
event or following an event, provided its articles of association include a provision authorizing such indemnification:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2d0f045973e44dbd84779ca93c688910" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a financial liability imposed on him or her in favor of another person pursuant to a judgment, including
        a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an office holder with respect to
        such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors,
        can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount or according to criteria
        determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen
        events and amount or criteria;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z26c0e44335ba4dcca6a7f2c71d51a0e4" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder (1) as a
        result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding,
        provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial
        liability was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or,
        if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and
        (2) in connection with a monetary sanction;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf26cbf550d144481bad557de5b2e29aa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or imposed
        by a court in proceedings instituted against him or her by the company, on its behalf, or by a third party, or in connection with criminal
        proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal
        intent; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="za8de90efbc17483ebb64dd7580600aeb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation
        to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured party imposed
        on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law and the Israeli
Securities Law, a company may insure an office holder against the following liabilities incurred for acts performed by him or her as an
office holder if and to the extent provided in the company&#8217;s articles of association:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z9096e097823e4cb0b49be941e37c48df" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and
        had a reasonable basis to believe that the act would not harm the company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zcfb3f21974f04528a583e3e48ecf814a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a breach of the duty of care to the company or to a third party, to the extent such a breach arises out
        of the negligent conduct of the office holder;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze8ad4185fda449b1a202b98df946063d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a financial liability imposed on the office holder in favor of a third party; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z33c845112c14470ebbfbad34fc19da05" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation
        to an administrative proceeding instituted against such office holder or certain compensation payments to an injured party imposed on
        an office holder by an administrative proceeding, pursuant to certain provisions of the Securities Law.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, a company may
not indemnify, exculpate or enter into an insurance contract for office holder liability, for any of the following:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4e60a8f6a9c94f85a5fd8aa86c456f19" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty
        to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice
        the company;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z4a35e228543349c39b2ae3160701e1a8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the
        negligent conduct of the office holder;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0372ff3e33be410ea6ff47512de1710e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an act or omission committed with intent to derive illegal personal benefit; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z11e50798133043708c05baf9d025ca00" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a fine, monetary sanction or forfeit levied against the office holder.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, exculpation, indemnification
and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with
respect to the chief executive officer and a director or (under certain circumstances), also by the shareholders. See &#8220;&#8212; Approval
of Related Party Transactions under Israeli Law.&#8221; However, the insurance of office holders shall not require shareholder approval
and may be approved only by the compensation committee, if the engagement terms are determined in the company&#8217;s compensation policy
and that policy was approved by the shareholders by the Special Approval for Compensation, provided that the policy is on market terms
and is not likely to materially impact the company&#8217;s profitability, assets or obligations.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our amended articles of association permit us to
exculpate, indemnify and insure our office holders to the fullest extent permitted under the Israeli Companies Law and the Israeli Securities
Law. We have obtained directors&#8217; and officers&#8217; liability insurance for the benefit of our office holders and intend to continue
to maintain such coverage and pay all premiums thereunder to the fullest extent permitted by the Israeli Companies Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have entered into indemnification and exculpation
agreements with each of our current officers and directors exculpating them from a breach of their duty of care to us to the fullest extent
permitted by the Israeli Companies Law and undertaking to indemnify them to the fullest extent permitted by the Israeli Companies Law
and the Israeli Securities Law, to the extent that these liabilities are not covered by insurance. This indemnification is limited to
events determined as foreseeable by our board of directors based on our activities, as set forth in the indemnification agreements. Under
such indemnification agreements, the maximum aggregate amount of indemnification that we may pay to any and all of our currently serving
or future officers and directors together may not exceed the higher of $5 million and 25% of our shareholders equity according to our
most recent financial statements at the time of payment. In the opinion of the SEC, however, indemnification of directors and office holders
for liabilities arising under the Securities Act of 1933, as amended, is against public policy and therefore unenforceable.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">60</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Employees</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, we had 85 employees and
independent contractors, all of whom were based in Israel other than one based in the United States, and of whom 10 persons were in administrative,
legal, accounting, information technology and human resources and 75 persons were in research and development. Under Israeli law, we and
our employees are subject to protective labor provisions, including the length of the workday, minimum wages for employees, annual leave,
sick pay, determination of severance pay and advance notice of termination of employment, as well as procedures for hiring and dismissing
employees and equal opportunity and anti-discrimination laws. While none of our employees are party to any collective bargaining agreements,
orders issued by the Israeli Ministry of Economy and Industry may make certain industry-wide collective bargaining agreements applicable
to us. These agreements affect matters such as the length of the workday and week, recuperation pay, travel expenses and pension rights.
We have never experienced labor-related work stoppages and believe that our relationships with our employees are a significant part of
our operations and that we maintain a good and positive relationship with our employees.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Israeli law generally requires the payment of severance
compensation by employers upon the retirement, death or dismissal of an employee. We fund our ongoing severance obligations by making
monthly payments to insurance policies. All of our current employees have agreed that upon termination of their employment, they will
be entitled to receive only the amounts accrued in the insurance policies with respect to severance pay. Furthermore, Israeli employees
and employers are required to pay predetermined sums to the National Insurance Institute, which is similar to the U.S. Social Security
Administration. These amounts also include payments for national health insurance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, we have various consulting arrangements
with experts including in regulatory, research and clinical matters, including with physicians.</div>

<div style="margin-left: 32.54pt; line-height: 1.25"> <br /> </div> <span style="font-weight: bold"> E.</span>&#160;&#160;&#160;&#160;&#160;
<span style="font-weight: bold">Share Ownership</span>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Share Ownership of Executive Officers and Directors</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For information concerning the beneficial ownership
of our ordinary shares by our executive officers and directors, see the table in Item 7A. &#8220;Major Shareholders and Related Party
Transactions&#8212;Major shareholders.&#8221; As of December 31, 2022, (i) options to purchase 1,665 ordinary shares granted to our directors
and executive officers were outstanding under our 2006 Unit Option Plan, with a weighted average exercise price of approximately $1,185.6
(ii) options to purchase 130,449 ordinary shares granted to our directors and executive officers were outstanding under our 2015 Equity
Incentive Plan and the United States Sub-Plan to our 2015 Equity Incentive Plan, with a weighted average exercise price of approximately
$24.24 per share; and (iii) 8,153 restricted share units awarded to our directors and executive officers were outstanding under our 2015
Equity Incentive Plan and the United States Sub-Plan to our 2015 Equity Incentive Plan.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Option and Incentive Plans</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In connection with the transfer of all of the business
operations and substantially all of the assets of Check-Cap LLC to us in 2009, we assumed the Check-Cap LLC 2006 Unit Option Plan, or
the 2006 Plan. On June 23, 2015, our board of directors approved and adopted the Check-Cap Ltd. 2015 Equity Incentive Plan, or the 2015
Israeli Plan, and the Check-Ltd. 2015 United States Sub-Plan to Check-Cap Ltd. 2015 Equity Incentive Plan, or the 2015 U.S. Sub-Plan.
The 2015 Israeli Plan and 2015 U.S. Sub-Plan are referred together as the 2015 Plan. As of such date, we ceased to grant options under
the 2006 Plan and all equity-based awards made after such date shall be made under the 2015 Plan. Our shareholders approved the 2015 Plan
at an extraordinary general meeting of shareholders held on August 13, 2015.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The primary provisions of the 2006 Plan and 2015
Plan are described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">2006 Plan</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">General</span>.
The 2006 Plan provided for the grant of options to purchase our ordinary shares to our employees, consultants and service providers. For
the purpose of the 2006 Plan: (i) an &#8220;employee&#8221; means any person, including officers, directors or affiliates who are employed
by us or by our affiliates; (ii) a &#8220;consultant&#8221; means any person who is engaged by us to render consulting or advisory services
to us or to any of our entities provided that such services are provided in good faith and are (a) not in connection with the offer or
sale of our securities in a capital raising transaction and (b) not directly or indirectly promoting or maintaining a market for our securities;
(iii) a &#8220;service provider&#8221; means an employee, director, supplier or officer holder as defined in the Israeli Companies Law;
and (iv) an &#8220;affiliate&#8221; means any entity which is directly or indirectly our parent or subsidiary.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Administration
of the 2006 Plan</span>. Our board of directors has had the authority to administer the 2006 Plan and to grant options under the 2006
Plan, including, the authority to determine the persons to whom options would be granted, the number of shares subject to each option,
the time or times at which the options would be granted, restrictions on the transferability of the options, and the schedule and conditions
on which such options may be exercised.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Awards under the
2006 Plan. </span>The 2006 Plan provided for the grant of options pursuant to Sections 102 and 3(i) of the Israeli Income Tax Ordinance
[New Version], 5721-1961, which we refer to as the Tax Ordinance. The 2006 Plan provides that Section 102 options may be granted only
to employees who are Israeli residents and who do not own interests possessing more than 10% of the total combined voting power of all
classes of our equity or the equity of our affiliates immediately before such option is granted. Options granted to optionees who are
Israeli residents that are not intended to qualify as Section 102 Options are granted under Section 3(i) of the Tax Ordinance, which does
not provide for similar tax benefits, and are referred to as Section 3(i) options. The 2006 Plan was submitted for the approval of the
Israeli Tax Authority, which we refer to as the ITA, as required by applicable law. Options granted to employees under the 2006 Plan were
granted under Section 102(b)(2) of the Tax Ordinance, which permits the issuance to a trustee under the &#8220;capital gains track.&#8221;
In order to comply with the terms of the capital gains track, all options granted under a specific plan and subject to the provisions
of Section 102 of the Tax Ordinance, as well as the shares issued upon exercise of such options and other shares received subsequently
following any realization of rights with respect to such options, such as share dividends and share splits, must be registered in the
name of a trustee selected by the board of directors and held in trust for the benefit of the relevant employee, director or officer for
a period of two years from the date of the grant. However, under this track, we are not allowed to deduct an expense with respect to the
issuance of the options or shares.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Exercise Price;
Vesting. </span>The exercise price of an option granted under the 2006 Plan has been determined by the board of directors or a committee
appointed by it. The first option grant to an employee generally vested over a period of three years and nine months commencing on the
date of grant, such that 8.33% vest on the first anniversary of the date of grant and an additional 8.33% vest on each subsequent three-month
period thereafter, for 33 months. Additional options granted to an employee generally vest over a period of three years commencing on
the three months anniversary of the date of grant, such that 8.33% is fully vested on the date of grant and an additional 8.33% vest on
each subsequent three-month period thereafter, for 33 months.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Options Term;
Termination of Employment or Service</span>. Options granted under the 2006 Plan generally expire within ten years of the grant date or
upon the earlier termination of employment of, or services provided by, the optionee, as applicable, subject to the extended period of
exercisability upon termination of employment or services, as applicable. Upon termination of the employment of or services rendered by
an optionee, as applicable (other than for cause, disability or death), generally vested options may be exercised within three months
after the date of such termination or within such shorter time period (not to be less than 30 days) or such longer time period (not to
exceed five years) as our board of directors or a committee appointed by it shall determine, but in any event no later than the expiration
date of the options. If the employment or services of the optionee are terminated because of death or disability (or if the optionee dies
within three months after termination of employment or services other than for cause), the optionee&#8217;s options may be exercised by
the optionee or the optionee&#8217;s legal representative or authorized assignee to the extent exercisable on the date of such termination
or within 12 months thereafter or as otherwise determined by the board of directors or a committee appointed by it. If the employment
or services of the optionee are terminated for cause, all outstanding options will, to the extent not previously exercised, be of no force
and effect as of the date of termination, unless otherwise determined by the board of directors or a committee appointed by it.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">M&amp;A Transaction</span>.
The 2006 Plan provides that in the event of a merger or consolidation of our company in which our company is not the surviving entity,
an acquisition of all or substantially all of the outstanding capital of our company or the sale of all or substantially all of our assets,
the optionee shall be provided the opportunity to (i) exercise his or her options in connection with the transaction and to receive in
the transaction such consideration as the holder of ordinary shares shall receive in the transaction; or (ii) retain his or her options
or receive a substitute option from the surviving company, if any.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, we had granted options
to purchase an aggregate 8,825 ordinary shares under the 2006 Plan, of which options to purchase an aggregate 1,292 ordinary shares had
been exercised into our ordinary shares, options to purchase an aggregate 5,781 ordinary shares had been forfeited without having been
exercised and options to purchase an aggregate 1,752 ordinary shares were outstanding with a weighted average exercise price of approximately
$1,273.9 per share. As of December 31, 2022, no shares are available for future awards under the 2006 Plan.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">61</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">2015 Equity Incentive Plan</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Awards under the
2015 Plan. </span>Awards under the 2015 Plan may be options granted pursuant to Section 102 of the Tax Ordinance, or Section 102 Options,
or Section 3(i) of the Tax Ordinance, or Section 3(i) Options, &#8220;incentive stock options&#8221;, or ISOs, within the meaning of Section
422 of the U.S. Internal Revenue Code of 1986, as amended, and options not intended to qualify as ISOs, or Non-statutory Stock Options,
stock appreciation rights, or SARs, restricted stock awards, or RSAs, and restricted stock units, or RSUs, or any combination of the foregoing.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Unless the Administrator (as defined below) determines
otherwise and subject to applicable law, Section 102 Options may be granted only to Israeli employees, executives and directors (excluding
controlling shareholders) and Section 3(i) Options may be granted to consultants, controlling shareholders and non-Israeli employees,
executives and directors, in each case of our company or any subsidiary. The Section 102 Options may be granted either pursuant to Section
102(c) of the Tax Ordinance, which are not required to be held in trust by a trustee, or pursuant to Section 102(b), which are required
to be held in trust for a specified period to qualify for certain tax benefits. Options granted pursuant to Section 102(b) shall be designated
to qualify for capital gain tax treatment in accordance with Section 102(b)(2) of the Tax Ordinance or ordinary income tax in accordance
with Section 102(b)(1) of the Tax Ordinance and thereafter, only such type of Section 102(b) options shall be granted until the Administrator
has determined otherwise in accordance with applicable law (which may not be prior to one year after the first grant of such type of Section
102(b) options).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Unless the Administrator determines otherwise and
subject to applicable law, ISOs may be granted only to non-Israeli employees and Non-statutory Stock Options may be granted to non- Israeli
employees and consultants, in each case of our company or any subsidiary. To the extent that the aggregate fair market value of the ordinary
shares with respect to which ISOs are exercisable for the first time by a participant during any calendar year under all company plans
exceeds $100,000, then unless the Administrator determines otherwise at any time and subject to applicable law, such options shall be
treated as Non-statutory Stock Options.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Administration
of the 2015 Plan</span>. The Plan 2015 will be administered by the Board of Directors or, subject to applicable law, a committee appointed
by the Board of Directors, or Committee and the Administrator. Subject to the provisions of the 2015 Plan and, in the case of a Committee,
the specific duties delegated by the Board of Directors, and subject to the approval of any relevant authorities and compliance with all
applicable laws, the Administrator shall have the full power and authority at its sole discretion, from time to time and at any time,
among other things:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z7e531f470cb84832b476b95defc5c8a8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To determine whether and to what extent awards are to be granted to participants under the 2015 Plan and
        to select the eligible recipients of awards under the 2015 Plan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0fe5c5152d624a16bfeb02df838c3c08" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To approve forms of agreement for use under the 2015 Plan;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z031b5c096ccb4b729139204e4e6f2040" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To determine the terms and conditions of any award under the 2015 Plan, including the exercise price, the
        time or times and the extent to which the awards may be exercised (which may be based on performance criteria), any vesting acceleration
        or waiver of forfeiture restrictions, and any restriction or limitation regarding any award or the ordinary shares relating thereto, based
        in each case on such factors as the Administrator, at its sole discretion, shall determine;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z5afd2e001233483785606bdfbfff2c46" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To determine the fair market value of the shares covered by each award;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z2b08496abe9044dfa1ab75f6a6a71f20" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To make an election as to the type of Section 102 Option;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zbe67355739a94bbc9c79b145e7951a3a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To prescribe, amend and rescind rules and regulations relating to the 2015 Plan, including rules and regulations
        relating to sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="ze33f240cb75445e2b2ecc5aa77aede34" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To authorize conversion or substitution under the 2015 Plan of any or all awards and to cancel or suspend
        awards, as necessary, provided the material interests of the participants are not harmed;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z0c89b5f93260467c84250699d84f7020" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To construe and interpret the terms of the 2015 Plan and awards granted pursuant to the 2015 Plan; and</div>
        </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z90ebda5dcbe54709adbf31dc0fd7ccd8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">To alter, revise or otherwise adjust the terms of the 2015 Plan and the award agreement, as may be required
        pursuant to any applicable laws of local or foreign jurisdictions.</div> </td> </tr>
  </table> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Term of Awards.
</span>The term of each option shall be stated in the award agreement but in no event may it be more than ten years from the date of grant.
Unless the Administrator determines otherwise and subject to applicable law, no ISO may be granted under the 2015 Plan to a grantee who
possess more than 10% of the total combined voting power of our company or any of our affiliate (a &#8220;10% Shareholder&#8221;) unless
the option terminates on a date that is not later than the day preceding the fifth anniversary of the date of grant. Unless otherwise
specified in the applicable award agreement, the term of a SAR will be ten years.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Exercise Price.
</span>The exercise price of any award under the 2015 Plan shall be determined by the Administrator, subject to applicable law. Unless
the Administrator determines otherwise and subject to applicable law, in the case of ISOs and Non-Statutory Stock Options, the exercise
price per share shall be no less than the fair market value per ordinary share on the date of grant and in the case of an ISO granted
to a 10% Shareholder, no less than 110% of the fair market value per ordinary share on the date of grant.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Non-Transferability
of Awards. </span>Unless the Administrator determines otherwise and subject to applicable law: (i) options and SARs may not be sold, pledged,
assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may
be exercised, during the lifetime of the participant, only by the participant. For as long as options or shares purchased upon the exercise
of options are held by a trustee on behalf of the participant, all rights of the participant with respect to such options and shares shall
be personal, and may not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution; (ii)
RSUs may not be sold, pledged, transferred, assigned or encumbered; and (iii) RSAs may not be sold, transferred, pledged, assigned or
otherwise disposed of during the restricted period, provided that the Administrator may provide for the lapse of such restrictions in
installments and may accelerate or waive such restrictions in whole or in part.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin-top: 0px; margin-bottom: 0px; line-height: 1.25; text-align: justify; font-weight: bold; font-style: italic">Termination
of Employment or Service.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Options and SARs</span>.
If a participant ceases to be an employee or consultant, in the absence of specified period in the award agreement and unless the Administrator
determines otherwise, such participant may exercise his/her options (to the extent vested on the date of such termination) or SARs within
three months following such termination (but in no event later than the expiration date of the option or SAR). If a participant retires,
he/she may continue to enjoy such rights with respect to awards under the 2015 Plan, on such terms and conditions as the Administrator
may determine. If the participant&#8217;s employment or service is terminated as a result if his/her death or permanent disability, the
participant (or, if the participant died, the participant&#8217;s estate or any person who acquired the right to exercise the option by
bequest or inheritance), may exercise his/her options (to the extent vested on the date of such termination) and/or SARs within such additional
period of time following such termination as specified in the award agreement (which may not be less than six months), or in the absence
of a specified period in the award agreement, until 12 months following such termination or any longer period determined by the Administrator,
but in no event later than the expiration date of the option or SAR.</div>

<div style="text-align: justify; text-indent: 25.15pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">62</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">RSAs</span>. If
a participant&#8217;s service of employment is terminated prior to the restricted period, subject to the terms of the award agreement
or as otherwise determined by the Administrator, the participant&#8217;s restricted stock and any associated dividends that remain subject
to forfeiture will then be forfeited automatically.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">RSUs</span>. If
a participant&#8217;s service of employment is terminated prior to the RSU vesting, subject to the terms of the award agreement or as
otherwise determined by the Administrator, the participant&#8217;s RSUs that remain subject to forfeiture will then be forfeited automatically.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">M&amp;A Transaction</span>.
In the event of a Transaction (as defined in the 2015 Plan, which generally includes (among other things) a sale of all or substantially
all of our assets or shares, a merger, consolidation or amalgamation with or into another company or a scheme of arrangement for effecting
any of the foregoing or such other transaction determined as such by the Administrator, all subject to the conditions and limitations
in the 2015 Plan), unless otherwise determined by the Administrator, in its sole discretion, any award granted under the 2015 shall be
assumed or substituted by us or the successor company, under terms determined by the Administrator or the terms of the 2015 Plan applied
by the successor company to such assumed or substituted awards, all in accordance with the terms of the 2015 Plan. Regardless of whether
or not the awards are assumed or substituted, the Administrator may, at its sole discretion, among other things, provide for the exercise
of any exercisable and vested awards, the cancellation of unexercised and unvested awards, the acceleration of unvested awards, or the
cancellation of awards for payment in cash, shares or other property of our company or the acquiring company or other party to the Transaction,
under such terms as the Administrator may determine, all in accordance with the terms of the 2015 Plan.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Term and Termination
of the 2015 Plan</span>. The 2015 Plan became effective upon its adoption by our Board of Directors and shall continue in effect for a
term of ten years. Our Board of Directors may at any time amend, alter, suspend or terminate the 2015 Plan. No amendment, alteration,
suspension or termination of the 2015 Plan shall impair the rights of any participant, unless mutually agreed otherwise in writing between
the participant and the Administrator.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, we had granted options
to purchase an aggregate 221,541 ordinary shares under the 2015 Plan, of which options to purchase an aggregate 350 ordinary shares had
been exercised into ordinary shares, an aggregate 31,051 ordinary shares had been forfeited without having been exercised and options
to purchase an aggregate 190,140 ordinary shares were outstanding as of such date, with a weighted average exercise price of approximately
$24.8 per share. In addition, as of December 31, 2022, we had issued 35,152 RSUs under the 2015 Plan, of which 5,988 RSUs had been forfeited,
9,461 RSUs had vested, and 19,703 RSUs were outstanding as of such date. As of December 31, 2022, no ordinary shares are available for
future awards under the 2015 Plan. In January 2023, our Board of Directors resolved to increase the number of ordinary shares reserved
for issuance under the 2015 Plan by 30,000 shares.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">F.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Disclosure
of a registrant&#8217;s action to recover erroneously awarded compensation.</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM7"><!--Anchor--></span>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Major
shareholders</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following table sets forth information with
respect to the beneficial ownership of our ordinary shares as of March 15, 2023 by (i) each person or entity known to us to beneficially
own more than 5% of our outstanding ordinary shares; (ii) each of our current executive officers and directors individually; and (iii)
all of our current executive officers and directors as a group.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The percentage of beneficial ownership of our ordinary
shares is based on 5,846,989 ordinary shares, NIS 48.00 par value per share outstanding as of March 15, 2023. Beneficial ownership is
determined in accordance with the rules of the SEC and generally includes voting power or investment power with respect to securities.
All ordinary shares subject to options and warrants currently exercisable or exercisable into ordinary shares within 60 days of March
15, 2023, and underlying RSUs that shall vest within 60 days of March 15, 2023, are deemed to be outstanding and beneficially owned by
the shareholder holding such options, warrants or RSUs for the purpose of computing the number of shares beneficially owned by such shareholder.
Such shares are also deemed outstanding for purposes of computing the percentage ownership of the person holding the option, warrant or
RSU. They are not, however, deemed to be outstanding and beneficially owned for the purpose of computing the percentage ownership of any
other shareholder.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This table is based upon information supplied by
officers and directors and is believed to be accurate. Except as indicated in footnotes to this table, we believe that the shareholders
named in this table have sole voting and investment power with respect to all shares shown to be beneficially owned by them, based on
information provided to us by such shareholders. Unless otherwise noted below, each shareholder&#8217;s address is: c/o 29 Abba Hushi
Avenue, P.O. Box 1271, Isfiya, 3009000, Mount Carmel, Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z506cc18383ee430c9cbfdb6c3f8d1aee" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Ordinary Shares Beneficially Owned</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Number</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: top">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">Percent</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25; font-weight: bold">Directors and Executive Officers</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; vertical-align: top; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Alex Ovadia (1)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">19,271</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Yoav Kimchy (2)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">7,440</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Boaz Shpigelman (3)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">4,823</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Joshua (Shuki) Belkar (4)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,370</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Hanit Brenner-Lavie (5)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">790</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Israel Hershko (6)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">3,279</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Mira Rosenzweig (7)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">3,660</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Steven Hanley (8)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,253</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">Clara Ezed (9)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">1,207</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Mary Jo Gorman (10)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,247</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25">XiangQian (XQ) Lin (11)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">2,150</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="margin-left: 0.05pt; line-height: 1.25">Yuval Yanai (12)</div> </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">1,254</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">*</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: top; width: 76%">
        <div style="margin-left: 0.05pt; line-height: 1.25; font-weight: bold">All director and executive officers as a group (12 persons)(13)</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">49,743</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">0.84</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">%</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160; <hr style="border-style: none; height: 2px; width: 10%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto" /></div>

<div style="line-height: 1.25">

<div style="margin-left: 0.05pt; line-height: 1.25">* Less than 1% of the Company&#8217;s ordinary shares.</div> </div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zad22017706cd4198a4e8939fdaef38aa" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 752 outstanding ordinary shares, and (ii) 18,519 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zc0a79638a64d48a8bb3d028154b49d03" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 2,289 ordinary shares directly held by Yoav Kimchy, (ii) 3,730 ordinary shares subject to options and RSUs held by Yoav
        Kimchy currently exercisable or options and/or RSUs held by Yoav Kimchy that will become exercisable or vested within 60 days of the date
        of this table, (iii) 1,334 ordinary shares directly held by Sigalit Kimchy, the wife of Yoav Kimchy, and (iv) 87 ordinary shares subject
        to options and RSUs held by Sigalit Kimchy currently exercisable or options and/or RSUs that will become exercisable or vested within
        60 days of the date of this table. Yoav Kimchy and Sigalit Kimchy have joint beneficial ownership over the shares beneficially held by
        them.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zde4796a8e6c747f98e24d4f102a9ecc7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes&#160;(i)&#160;914 outstanding&#160;ordinary&#160;shares,&#160;and&#160;(ii)&#160;3,909 ordinary shares subject to options
        currently exercisable or options and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td>
        </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z49e7b20ac75f437f9f5454e5cf7d3436" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i)&#160;385 ordinary shares, and&#160;(ii)&#160;2,985 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd71a6019a8f442668d0db0d698229ba6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(5)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes 790 ordinary shares subject to options currently exercisable or options and/or RSUs that will become exercisable or vested
        within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">63</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"> <br /> </div>

<table cellspacing="0" cellpadding="0" id="ze72f58c9293b4cc9ad139b7cf75c9b77" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(6)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 565 outstanding ordinary shares, and (ii) 2,714 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z84cf730976514d17b68f188b16d1f837" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(7)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 415 outstanding ordinary shares, and (ii) 3,245 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd6548807df15466fbd4573c734c45de9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(8)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 258 outstanding ordinary shares, and (ii) 995 ordinary shares subject to options currently exercisable or options and/or
        RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdfad6cbecf574a74b3b17ff738fe271a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(9)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 212 outstanding ordinary shares, and (ii) 995 ordinary shares subject to options currently exercisable or options and/or
        RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z199915c3d91f4ab3a5f936c655246210" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(10)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 252 outstanding ordinary shares, and (ii) 995 ordinary shares subject to options currently exercisable or options and/or
        RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9bd50a3332034a0db53307c0777ae376" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(11)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 953 outstanding ordinary shares, and (ii) 1,197 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6ac3e8ce4cd34615b297b21e0dbf4f52" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(12)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 259 outstanding ordinary shares, and (ii) 995 ordinary shares subject to options currently exercisable or options and/or
        RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z79cfef65b1cb4239958d281dd63c8e37" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(13)</td>
    <td style="width: auto; vertical-align: top">
        <div>Includes (i) 8,588 outstanding ordinary shares, and (ii) 41,155 ordinary shares subject to options currently exercisable or options
        and/or RSUs that will become exercisable or vested within 60 days of the date of this table.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of March 15, 2023, based on information provided
to us by our transfer agent in the United States and other information reasonably available to us, we had 51 holders of record of our
ordinary shares in the United States. Such holders of record held, as of that date, 99.87 % of our outstanding ordinary shares. The number
of record holders is not representative of the number of beneficial holders of our ordinary shares, as 99.81 % of our outstanding ordinary
shares are recorded in the name of Cede &amp; Co. as nominee for the Depository Trust Company, in whose name all shares held in &#8220;street
name&#8221; are held in the United States.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">None of our shareholders have voting rights different
from the voting rights of other shareholders. To the best of our knowledge, we are not owned or controlled, directly or indirectly, by
another corporation or by any government. We are not aware of any arrangement that may, at a subsequent date, result in a change of control
of our company.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">To our knowledge, other than as disclosed in the
table above, our other filings with the SEC and this Annual Report, there has been no significant change in the percentage ownership held
by any major shareholder since January 1, 2020.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Related
Party Transactions</span></div>

<div style="margin-left: 7.35pt; line-height: 1.25"><span style="font-weight: bold"> <br /> </span></div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Other than the executive and director compensation,
executive officer employment agreements, indemnification and exculpation arrangements and directors&#8217; and officers&#8217; liability
insurance policy discussed in &#8220;Management,&#8221; and the transactions described below, since January 1, 2020, we have not been
or are not a party to any related party transactions. The descriptions provided below are summaries of the terms of such agreements, do
not purport to be complete and are qualified in their entirety by the complete agreements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Pontifax Warrants</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On October 14, 2014, we issued warrants to purchase
an aggregate of 924 of our ordinary shares at an exercise price of NIS 48 per share, or the Pontifax Warrants, to the Pontifax Funds in
consideration of their commitment to provide to us, for no consideration, the following services, if and to the extent requested by us:
(i) business development services, in such scope and substance as shall be agreed between us and the Pontifax; and (ii) a representative
designated by Pontifax to serve as the chairman of our board of directors. The Pontifax Funds subsequently agreed that the exercise price
of fifty-percent of their warrants will increase to equal the price at which our ordinary shares are sold to the public in the initial
public offering of our securities, or if units are sold in the initial public offering of our securities, the exercise price per share
will increase to be equal to the effective price per share of the ordinary shares underlying the units sold to the public in the offering.
The Pontifax Funds also agreed that such portion of their warrants would vest and become exercisable only upon the consummation of the
initial public offering of our securities prior to their expiration date. The remaining warrants with an NIS 48 exercise price would vest
on a quarterly basis in eight equal installments during a period of 24 months from issuance. In addition, the Pontifax Funds agreed to
reduce the term of their respective warrants such that these warrants will now expire after eight years (instead of ten years) following
their issuance, i.e., on October 14, 2022. Upon the closing of our initial public offering any unvested portion of the warrants became
fully vested and exercisable. In September 2018, Pontifax exercised 462 of the Pontifax Warrants, with an exercise price of 48 per share,
into 376 ordinary shares on a cashless basis. On October 14, 2022, the remaining Pontifax Warrants to purchase 462 ordinary shares, with
an exercise price of $1,214.4 per share, expired.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; line-height: 1.25; font-weight: bold">Transactions with Check-Cap LLC and the Members and Manager of
Check-Cap LLC</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">On May 31, 2009, we entered into an asset transfer
agreement with Check-Cap LLC pursuant to which Check-Cap LLC transferred all of its business operations and substantially all of its assets
to us. Our shareholders&#8217; holdings on the date of the asset transfer transaction reflected their interests as members of Check-Cap
LLC. In the framework of the asset transfer agreement and under the Shareholders Agreement, we undertook to use commercially reasonable
efforts to procure that distributions or advance funds are made to our shareholders holding (at the date of the transaction) ordinary
shares, Series A preferred shares and/or Series B preferred shares (i.e., the shareholders who are also members of Check-Cap LLC), as
would be necessary to eliminate the tax impact on such shareholders of the Reorganization and the transfer of all of the business operations
and substantially all of the assets from Check-Cap LLC to us. Notwithstanding the foregoing, we will not advance payments to such shareholders
to address the fact that they will no longer receive a &#8220;pass through&#8221; of losses generated by us as they previously received
while owning units of Check-Cap LLC. These advances, if and to the extent made, will be deducted from any distributions such shareholders
are entitled to receive from us. Since we do not expect to be profitable in year 2023, the liability based on the discounted outflows
is $0. As a result, as of December 31, 2022, the balance of the reimbursement liability totaled $0 ($0 as of December 31, 2021 and $14,000
as of December 31, 2020).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In connection with the asset transfer agreement
entered into in May 2009, we assumed the former obligation of Check-Cap LLC to distribute any proceeds it collects on the $1 million key
man life insurance policy with respect to Yoav Kimchy, the Company&#8217;s chief technology officer and a former director, to the former
holders of the Series A preferred units in an amount equal to their respective capital contributed to Check-Cap LLC, less any amounts
previously distributed to them, plus any accrued and unpaid dividends due to them as of the date of distribution. On November 16, 2016,
we cancelled the key man life insurance policy with respect to Yoav Kimchy.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Interests
of Experts and Counsel</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 23.6pt; line-height: 1.25">Not applicable.</div>

<div style="margin-left: 32.6pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">64</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM8"><!--Anchor--></span>ITEM 8. FINANCIAL INFORMATION</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160; <span style="font-weight: bold">Consolidated
Statements and Other Financial Information.</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Consolidated Financial Statements</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; text-indent: 27pt">See Item 18 &#8220;Financial Statements.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Legal Proceedings</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">From time to time, we may be involved in litigation
that arises through the normal course of business. As of the date of this filing, we are not a party to any material litigation nor are
we aware of any such threatened or pending litigation.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There are no material proceedings in which any
of our directors, officers or affiliates or any registered or beneficial shareholder of more than 5% of our ordinary shares, or any associate
of any of the foregoing is an adverse party or has a material interest adverse to our interest.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Dividend Policy</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have never declared or paid dividends on our
ordinary shares and currently do not intend to pay cash dividends on our ordinary shares in the foreseeable future. We currently intend
to retain all of our future earnings, if any, to finance the growth and development of our business. See Item 3D &#8220;Key Information
&#8211; Risk factors - Risks Related to the Company.&#8221;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our ability to distribute dividends also may be
limited by future contractual obligations and by Israeli law. The Israeli Companies Law restricts our ability to declare dividends. Unless
otherwise approved by a court, we can distribute dividends only from &#8220;profits&#8221; (as defined by the Israeli Companies Law),
and only if there is no reasonable concern that the dividend distribution will prevent us from meeting our existing and foreseeable obligations
as they become due. Subject to the foregoing, payment of future dividends, if any, will be at the discretion of our board of directors
and will depend on various factors, such as our financial condition, operating results, current and anticipated cash needs and other business
and economic factors that our board of directors may deem relevant. See Exhibit 2.1 &#8220;Description of Securities&#8212;Dividend and
Liquidation Rights.&#8221; The payment of dividends may be subject to Israeli withholding taxes. See Item 10E. &#8220;Additional Information&#8212;Taxation&#8212;Israeli
Tax Considerations and Government Programs&#8212;Taxation of Our Shareholders&#8212;Taxation of Non-Israeli Shareholders on Receipt of
Dividends.&#8221; Furthermore, if we pay a dividend out of income attributed to our Benefited Enterprise that was generated during the
tax exemption period, we may be subject to tax on the grossed- up amount of such distributed income at the corporate tax rate which would
have been applied to our Benefited Enterprise&#8217;s income had we not enjoyed the exemption. See Item 10E. &#8220;Additional Information&#8212;Taxation
&#8211; Israeli Tax Considerations and Government Programs &#8212; Law for the Encouragement of Capital Investments, 5719-1959 &#8212;
Tax Benefits Subsequent to the 2005 Amendment.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160; <span style="font-weight: bold">Significant
Changes</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Except as disclosed elsewhere in this Annual Report,
there have been no other significant changes since December 31, 2022, until the date of the filing of this Annual Report.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold"><span id="ITEM9"><!--Anchor--></span>ITEM 9. THE OFFER AND LISTING</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Offer
and Listing Details</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our units were listed on the Nasdaq Capital Market
on February 19, 2015 under the symbol &#8220;CHEKU.&#8221; Prior to that date, there was no public trading market for our securities.
Our initial public offering was priced at $1,440 per unit on February 20, 2015. Each unit consisted of one ordinary share and one-half
of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive
Warrants. On March 18, 2015, the units separated and ceased to exist. Since such date, our ordinary shares and Series A Warrants were
listed on the Nasdaq Capital Market under the symbols &#8220;CHEK&#8221; and &#8220;CHEKW&#8221;, respectively. The Series A Warrants
expired on February 24, 2020 and ceased to be listed on the Nasdaq Capital Market since February 20, 2020. The Long Term Incentive Warrants
expired on February 24, 2022. Since May 8, 2018, our Series C Warrants have also been listed on the Nasdaq Capital Market under the symbol
&#8220;CHEKZ&#8221;. On April 4, 2018, we effected a 1-for-12 reverse share split of our ordinary shares. On November 23, 2022, we effected
a 1-for-20 reverse share split of our ordinary shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Plan
of Distribution</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Markets
for Ordinary Shares</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">See &#8220;&#8212;Offer and Listing Details&#8221;
above.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Selling
Shareholders</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">E.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Dilution</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">F.</span>&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Expenses
of the Issue</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 10<span id="ITEM10"><!--Anchor--></span>. ADDITIONAL INFORMATION</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">A.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Share
Capital</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">B.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Memorandum
and Articles of Association</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A copy of our amended and restated articles of
association is incorporated by reference attached as Exhibit 1.1 to this Annual Report. Other than as disclosed below, the information
called for by this Item is set forth in Exhibit 2.1 to this Annual Report and is incorporated by reference into this Annual Report.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">65</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Registration Number and Purposes of the Company</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our registration number with the Israeli Registrar
of Companies is 51-425981-1. Our purpose as set forth in our amended articles of association is to engage in any lawful activity.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Shareholder Meetings</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under Israeli law, we are required to hold an annual
general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the previous
annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our amended articles of
association as special general meetings. Our board of directors may call special general meetings whenever it sees fit, at such time and
place, within or outside of Israel, as it may determine. In addition, the Israeli Companies Law provides that our board of directors is
required to convene a special general meeting upon the written request of (i) any two of our directors or one-quarter of the serving members
of our board of directors; or (ii) one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding shares
and 1% of our outstanding voting power or (b) 5% or more of our outstanding voting power.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Furthermore, the Israeli Companies Law requires
that resolutions regarding the following matters be approved by our shareholders at a general meeting:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="za6645274cd0443d192bd7a01f5cc9e76" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">approval of certain related party transactions;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z746298b4491749b4a866080afe505aa1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">increases or reductions of our authorized share capital;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z68989accd4c640d3975bc04764726eb1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">mergers; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9ea29adc219145a29bb68b1dec4ede10" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the exercise of our board of director&#8217;s powers by a general meeting, if our board of directors is
        unable to exercise its powers and the exercise of any of its powers is essential for our proper management.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Subject to the provisions of the Israeli Companies
Law and regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of
record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four
and 40 days prior to the date of the meeting.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Israeli Companies Law requires that a notice
of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if the
agenda of the meeting includes, among other things, the appointment or removal of directors, the approval of transactions with office
holders or interested or related parties, an approval of a merger or the approval of the compensation policy, notice must be provided
at least 35 days prior to the meeting.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, our shareholders
are not permitted to take action via written consent in lieu of a meeting.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Borrowing powers</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Pursuant to the Israeli Companies Law and our amended
articles of association, our board of directors may exercise all powers and take all actions that are not required under law or under
our amended articles of association to be exercised or taken by our shareholders, including the power to borrow money for company purposes.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">For details regarding the approvals required under
the Israeli Companies Law for the approval of director compensation, see &#8220;Item 6C &#8220;Directors, Senior Management and Employees
&#8212; Board Practices -Approval of Related Party Transactions under Israeli Law &#8212; Disclosure of Personal Interests of an Office
Holder and Approval of Certain Transactions&#8212;Compensation of Directors.&#8221;</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">C.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Material
Contracts</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have not entered into any material contracts
other than in the ordinary course of business and other than those described in Item 4. &#8220;Information on Our Company,&#8221; Item
7B &#8220;Major Shareholders and Related Party Transactions - Related Party Transactions&#8221; or elsewhere in this Annual Report.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">D.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Exchange
controls</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">There are currently no Israeli currency control
restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments to
non- residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">E.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Taxation</span></div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following description is not intended to constitute
a complete analysis of all tax consequences relating to our ordinary shares, Series C Warrants and Series D Warrants (sometimes referred
to collectively or individually as our &#8220;securities&#8221;). You should consult your own tax advisor concerning the tax consequences
of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, non-U.S. or other taxing
jurisdiction.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">Israeli Tax Considerations and Government Programs</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following is a brief summary of the material
Israeli tax laws applicable to us and certain Israeli Government programs that benefit us. This section also contains a discussion of
material Israeli tax consequences concerning the ownership and disposition of our securities purchased by investors who are non-Israeli
resident shareholders. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor
in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law.
Examples of such investors include residents of Israel or traders in securities who are subject to special tax regimes not covered in
this discussion. Because parts of this discussion are based on new tax legislation that has not yet been subject to judicial or administrative
interpretation, we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion.
The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative
interpretations of Israeli law, which change could affect the tax consequences described below.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">General Corporate Tax Structure in Israel</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Israeli resident companies are generally subject
to corporate tax, currently at the rate of 23% (effective as of January 1, 2018) of a company&#8217;s taxable income. However, the effective
tax rate payable by a company that derives income from an Approved Enterprise, a Benefited Enterprise a Preferred Enterprise or a Preferred
Technological Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli resident company are subject
to tax at the prevailing corporate tax rate.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">66</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Law for the Encouragement of Industry (Taxes), 5729-1969</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Law for the Encouragement of Industry (Taxes),
5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221;
The Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as a company resident in Israel, of which 90% or more of its
income in any tax year, other than income from defense loans, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located
in Israel or in the &#8220;Area&#8221; (as such term is defined under Section 3A of the Israeli Income Tax Ordinance (New Version), 5721-1961,
referred to as the Ordinance). An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given
tax year is industrial production.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following corporate tax benefits, among others,
are available to Industrial Companies:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zf354c978b70140aaac836db3ed7165cb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">amortization over an eight-year period, beginning from the year in which such rights were first used, of
        the cost of purchased know-how and patents and rights to use a patent and know-how which are used for the development or advancement of
        the Industrial Enterprise;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z7621e96c0d4d4e08bb4134f7e3f38947" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">under limited conditions, a Parent Company (as such term defined in the Industry Encouragement Law) may
        elect to file consolidated tax returns with related Israeli Industrial Companies; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z09aa4678d2c242eba78bfa5ece230c60" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">expenses related to a public offering are deductible in equal amounts over three years beginning from the
        year of the offering.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Eligibility for the benefits under the Industry
Encouragement Law is not subject to receipt of prior approval from any governmental authority. We believe that we may qualify as an &#8220;Industrial
Company&#8221; within the meaning of the Industry Encouragement Law; however, there can be no assurance that we will qualify as an Industrial
Company or that the benefits described above will be available in the future.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Law for the Encouragement of Capital Investments, 5719-1959</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Law for the Encouragement of Capital Investments,
5719-1959, generally referred to as the Investment Law, was originally enacted in order to provide certain incentives for capital investments
in production facilities (or other eligible assets).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The Investment Law has been amended several times
in recent years, primarily: Amendment 60, effective as of April 1, 2005, referred to as the 2005 Amendment; Amendment 68, effective as
of January 1, 2011, referred to as the 2011 Amendment; Amendment 71, effective as of January 1, 2014, referred to as the 2014 Amendment;
Amendment 73, effective as of January 1, 2017, referred to as the 2017 Amendment; and Amendment 74, effective as of August 15, 2021, referred
to as the 2021 Amendment. Pursuant to the foregoing amendments, generally tax benefits that were granted in accordance with the provisions
of the Investment Law prior to each such amendment remain in force; however, any benefits granted subsequent to the respective amendment
are subject to the provisions of the Investment Law as amended.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Tax Benefits Prior to the 2005 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Prior to the 2005 Amendment, a capital investment
in eligible production facilities (or other eligible assets) could, upon application to the Investment Center of the Israeli Ministry
of Economy (formerly named the Ministry of Industry, Trade and Labor), be designated as an &#8220;Approved Enterprise&#8221; and accordingly,
entitled to certain tax benefits under the Investment Law. Each certificate of approval for an Approved Enterprise relates to a specific
investment program in the Approved Enterprise, delineated both by the financial scope of the investment and by the physical characteristics
of the facility or the asset. We do not have any Approved Enterprises.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Tax Benefits Subsequent to the 2005 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Pursuant to the 2005 Amendment, a company whose
facilities meet certain criteria set forth in the 2005 Amendment may claim certain tax benefits offered by the Investment Law (as further
described below) directly in its tax returns, without the need to obtain prior approval. In order to receive the tax benefits, a company
must make an investment which meets all of the conditions, including exceeding a minimum entitling investment amount, set forth in the
Investment Law. Such investment allows a company to receive &#8220;Benefited Enterprise&#8221; status, and may be made over a period of
no more than three years ending at the end of the year in which the company chose to have the tax benefits apply to its Benefited Enterprise,
referred to as the &#8220;Year of Election.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The extent of the tax benefits available under
the 2005 Amendment to qualifying income of a Benefited Enterprise depends on, among other things, the geographic location in Israel of
the Benefited Enterprise. The location will also determine the period for which tax benefits are available. Under the &#8220;Exemption
Track&#8221; the tax benefits include an exemption from corporate tax on undistributed income generated by the Benefited Enterprise for
a period of two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax
rate of 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year.
The benefits period is for a duration of seven or ten years, depending on the location of the Benefited Enterprise, from the later of
the first year in which the company generated taxable income from its Benefited Enterprise and the Year of Election, but in any event
not more than 12 or 14 years from the Year of Election, depending on the location of the Benefited Enterprise. A company qualifying for
tax benefits under the Exemption Track which pays a dividend (as well as a deemed dividend, such as investments in foreign resident subsidiaries,
granting loans to related parties, repurchases of shares, acquisitions of securities/shares, capital reductions and additional events
which reflect the transfer of funds out of the Benefitted Enterprise activity) out of income derived during the tax exemption period by
its Benefited Enterprise will be subject to corporate tax in respect of the amount of the dividend (grossed-up to reflect the pre-tax
income that it would have had to earn in order to distribute the dividend) at the corporate tax rate which would have otherwise been applicable.
Dividends paid out of income attributed to a Benefited Enterprise are generally subject to withholding tax at source at the rate of 20%
or such lower rate as may be provided in an applicable tax treaty. With respect to such dividends, the recently enacted 2021 Amendment
introduced a new dividend distribution ordering rule as well as a Temporary Order to incentivize the distribution thereof (see discussion
below under &#8220;<span style="font-style: italic">Tax Benefits under the 2021 Amendment&#8221;</span>)<span style="font-style: italic">.
</span>Applying reduced tax rates in accordance with a certain tax treaty is subject to the receipt in advance of a valid certificate
from the Israel Tax Authority allowing for a reduced tax rate.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The benefits available to a Benefited Enterprise
are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions,
it may be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, plus interest, or other monetary
penalties.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We currently have one Benefited Enterprise program
under the Investment Law, which, we believe, entitles us to certain tax benefits with respect to income to be derived from our Benefited
Enterprise. We chose 2010 as the Year of Election. We believe that we are located in the Zone A specified development zone and therefore,
believe we are entitled to a 10-year benefit period, during which taxable income from our Benefited Enterprise program (once generated)
will be tax exempt, commencing with the year we will first earn taxable income relating to such enterprise, subject to a 14-year limitation
from the Year of Election, and therefore, the tax benefit period will in any event end in 2023.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Tax Benefits under the 2011 Amendment and the 2014
Amendment</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 2011 Amendment canceled the availability of
the benefits granted to companies under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by
a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; or &#8220;Special Preferred Enterprise&#8221; (as such
terms are defined in the Investment Law) as of January 1, 2011. The definition of a Preferred Company includes, among other limitations
detailed under the Investment Law, a company incorporated in Israel that is not wholly-owned by a governmental entity, and that, among
other things, owns a Preferred Enterprise or Special Preferred Enterprise and is controlled and managed from Israel. Under the 2014 Amendment,
effective as of January 1, 2014, a Preferred Company is entitled to a reduced corporate tax rate of 16% with respect to its income derived
by its Preferred Enterprise in 2014 and thereafter, unless the Preferred Enterprise is located in a specified development zone (referred
to as &#8220;Zone A&#8221;), in which case the rate will be 9% for the tax years 2014-2016 and, pursuant to the 2017 Amendment (as discussed
below), 7.5% from 2017 and thereafter. We believe our facilities are located in the Zone A specified development zone.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Dividends paid out of income attributed to a Preferred
Enterprise are generally subject to withholding tax at source at the rate of 20% or such lower rate as may be provided in an applicable
tax treaty. However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends
are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided
in an applicable tax treaty will apply).</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">67</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 2011 Amendment also provided transitional provisions
to address companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide, among other
things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income
to be derived as of January 1, 2011, a Benefited Enterprise can elect to continue to benefit from the benefits provided to it before the
2011 Amendment came into effect, provided that certain conditions are met.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are currently examining whether we are eligible
for the tax benefits under the 2011 Amendment and the possible effect, if any, of the provisions of the 2011 Amendment on our financial
statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Tax Benefits under the 2017 Amendment</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 2017 Amendment was enacted as part of the Economic
Efficiency Law that was published on December 29, 2016, and became effective as of January 1, 2017. The 2017 Amendment provides new tax
benefits for two types of &#8220;Technological Enterprises&#8221;, as described below, and is in addition to the other existing tax beneficial
programs under the Investment Law.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 2017 Amendment provides two new tax incentive
tracks &#8211; the &#8220;Preferred Technological Enterprise&#8221; track and &#8220;Special Preferred Technological Enterprise&#8221;
track (as such terms are defined in the Investment Law). The benefits available to a Preferred Technological Enterprise or Special Preferred
Technological Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A Preferred Technological Enterprise is entitled
(among other things) to a reduced corporate tax rate of 12% with respect to its income which qualifies as &#8220;Preferred Technology
Income&#8221;, as defined in the Investment Law, unless the Preferred Technological Enterprise is located in a specified development zone
(referred to as &#8220;Zone A&#8221;), in which case the rate will be 7.5%. A Special Preferred Technological Enterprises is entitled
to a reduced corporate tax rate of 6% with respect to its Preferred Technology Income, regardless of the company&#8217;s enterprise geographic
location within Israel.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are currently examining whether we are eligible
for the tax benefits under the 2017 Amendment and the possible effect, if any, of the provisions of the 2017 Amendment on our financial
statements.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Tax Benefits under the 2021 Amendment</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The 2021 Amendment introduced a new dividend distribution
ordering rule to cause the distribution of earnings that were tax-exempt under the historical Approved or Beneficial Enterprise regimes
(Trapped Earnings), to be on a pro-rata basis from any dividend distribution, which is applicable to distributions starting from August
15, 2021 onwards. Accordingly, the corporate income tax claw-back will apply to any dividend distribution, as long as the company has
Trapped Earnings.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; text-indent: 27pt">The termination or substantial reduction of any of the benefits
available under the Investment Law could materially increase our future tax liabilities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">The Encouragement of Research, Development and Technological Innovation
in the Industry Law 5744-1984 (formerly known as the Encouragement of Industrial Research and Development Law, 5744-1984)</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Encouragement of Research, Development
and Technological Innovation in the Industry Law 5744-1984 (formerly known as the Encouragement of Industrial Research and Development
Law, 5744-1984), referred to as the Innovation Law, research and development programs that meet specified criteria and are approved by
the IIA are eligible for grants. As of December 31, 2022, we had received funding from the IIA for the financing of a portion of our research
and development expenditures for C-Scan in the aggregate amount of approximately $5.6 million. As of December 31, 2022, we had not paid
any royalties to the IIA and had a contingent liability to the IIA with respect to such funding (including interest at the rate of 12-month
LIBOR) in the amount of approximately $6.2 million. In addition, in January 2021, we received an IIA grant approval to support the funding
of our transition from research and development to manufacturing. The final IIA grant amounted to $620,000 (NIS 2.18 million) (along with
a co-investment by us of the same amount), subject to the terms and conditions set forth in the grant approval, which we are not required
to repay to the IIA, of which we received approximately $222,000 (NIS 784,000) in February 2023, $82,000 (NIS 264,000) in January 2022
and $349,000 (NIS 1,134,000) in 2021.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Innovation Law as currently in effect,
the research and development grants are typically up to 50% of the project&#8217;s approved expenditures. The grantee is required to pay
royalties to the State of Israel from the sale of products (and associated services) developed using IIA research and development funding.
Regulations under the Innovation Law, as currently in effect, generally provide for the payment of royalties of 3% or 4% (and at an increased
rate under certain circumstances) on sales of products and services based on technology and know-how developed using such IIA research
and development grants, until 100% (which may be increased under certain circumstances) of the grant, linked to the U.S. dollar and bearing
interest at the LIBOR rate, is repaid.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The terms of IIA grants that we have received (the
research and development grants and the transition to manufacturing grants) require that products developed with IIA funded be manufactured
in Israel, unless the IIA approved grant program includes a pre-determined portion of manufacturing that may be performed outside Israel
(as certain of our IIA approved grants included). The approval of the IIA is required for the transferring of manufacturing outside Israel
in excess of such pre-determined portion (however, only a notice to the IIA, as opposed to approval, is required for the transfer outside
Israel of up to 10% of the cumulative manufacturing in excess of such pre-approved portion). If manufacturing of IIA-funded products is
transferred outside Israel (following IIA approval) in excess of the pre-determined percentage included in the grant approval, then the
royalty repayment rate is increased by 1% with respect to the additional approved percentage to be manufactured outside Israel and the
royalty repayment for the entire approved program may be increased to up to three times the amount of the grants received, depending on
the percentage manufactured outside Israel (plus accrued interest). We may explore from time to time whether certain other components
of C-Scan can be assembled outside of Israel. For example, we may in the future explore whether it would be possible to assemble the capsule
without the X-ray source in Israel, and have the X-ray source subsequently manufactured and assembled into C-Scan at a certified radioisotope
production facility or at a distribution center outside Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Over the years, we received approval of grant applications
(research and development grants and the transition to manufacturing grant) that included a certain predetermined percentage of manufacturing
of the X-ray source to be performed outside of Israel but additional examination of these approvals and consequent manufacturing is required
to determine liabilities to the IIA, if any.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">IIA prior approval is also required for the transfer
of IIA-funded know-how to a third party outside of Israel (including by way of license), which we may not receive (and any such approval
would be subject to payment of a redemption fee, calculated according to a formula under the Innovation Law, which may be in the amount
of up to six times the amount of the grants received, (less paid royalties, if any, and depreciation, but no less than the total grants
received), plus accrued interest). Even following the full repayment of any IIA grants, we must nevertheless continue to comply with the
requirements of the Innovation Law. If we fail to comply with any of the conditions and restrictions imposed by the Innovation Law and
regulations and guidelines thereunder, or by the specific terms under which we received the grants, we may be required to refund any grants
previously received together with interest and penalties, and, in certain circumstances, may be subject to criminal charges.</div>

<div style="text-align: justify; text-indent: 27.3pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">68</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Taxation of our Shareholders</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Capital Gains
Taxes Applicable to Non-Israeli Resident Shareholders</span>. A non-Israeli resident who derives capital gains from the sale of securities
of an Israeli resident company will be exempt from Israeli tax so long as (i) the capital gains are not attributed to a permanent establishment
that the non-resident maintains in Israel, (ii) the securities were not received from a relative or in a tax free reorganization transaction
and (iii) the securities are not traded on the Tel Aviv Stock Exchange on the date of sale (provided, however, that other exemptions may
apply if a an Israeli resident company is listed for trading on the Tel Aviv Stock Exchange). However, non-Israeli corporations will not
be entitled to the foregoing exemption if Israeli residents: (i) have a controlling interest of 25% or more in such non-Israeli corporation;
or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether
directly or indirectly.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Additionally, a sale of securities by a non-Israeli
resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the Convention
Between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended,
generally referred to as the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares by a shareholder who (i)
is a U.S. resident (for purposes of the treaty); (ii) holds the shares as a capital asset; and (iii) is entitled to claim the benefits
afforded to such person by the treaty, is generally exempt from Israeli capital gains tax. Such exemption will not apply if, among other
things: (i) the capital gain arising from such sale, exchange or other disposition is treated as industrial or commercial profits attributed
to a permanent establishment in Israel, subject to certain conditions; (ii) the shareholder holds, directly or indirectly, shares representing
10% or more of the voting capital of the corporation during any part of the 12-month period preceding the disposition, subject to certain
conditions; (iii) the capital gain arising from such sale, exchange or disposition is treated as royalties; or (iv) such U.S. resident
is an individual and was present in Israel for 183 days or more during the relevant taxable year. In such case, the sale, exchange or
disposition of our securities would be subject to Israeli tax, to the extent applicable; however, under the United States-Israel Tax Treaty,
the taxpayer would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale,
exchange or disposition, subject to the limitations under U.S. law applicable to foreign tax credits. The United States-Israel Tax Treaty
does not relate to U.S. state or local taxes. The United States-Israel Tax Treaty is currently under review and subject to change.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In some instances where our shareholders may be
liable for Israeli tax on the sale of their securities, the payment of the consideration may be subject to the withholding of Israeli
tax at source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains and to obtain an exemption
from withholding tax certificate from the Israel Tax Authority in order to avoid withholding at source at the time of sale.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Taxation of Non-Israeli
Shareholders on Receipt of Dividends</span>. Non-Israeli residents are generally subject to Israeli withholding tax on the receipt of
dividends paid on our ordinary shares at the rate of 25%, unless relief is provided in a treaty between Israel and the shareholder&#8217;s
country of residence (subject to the receipt of a valid certificate from the Israeli Tax Authority allowing for a reduced tax rate). With
respect to a person who is a &#8220;substantial shareholder&#8221; at the time of receiving the dividend or at any time during the preceding
12 months, the applicable withholding tax rate is 30%, unless such &#8220;substantial shareholder&#8221; holds such shares through a nominee
company, in which case the rate is 25%. A &#8220;substantial shareholder&#8221; is generally a person who alone or together with such
person&#8217;s relative (as such term is defined in the Ordinance) or another person who collaborates with such person on a permanent
basis, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation. &#8220;Means of control&#8221;
generally include the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or
order someone who holds any of the aforesaid rights how to act, regardless of the source of such right.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">However, a distribution of dividends to non-Israeli
residents is subject to withholding tax at source at a rate of 15% if the dividend is distributed from income attributed to an Approved
Enterprise or a Benefited Enterprise and 20% if the dividend is distributed from income attributed to a Preferred Enterprise or a Preferred
Technological Enterprise, unless a reduced tax rate is provided under an applicable tax treaty. The corporate income tax claw-back may
apply upon any dividend distribution, as long as the company has Trapped Earnings (see discussion above under &#8220;<span style="font-style: italic">Tax
Benefits under the 2021 Amendment&#8221;</span>). We cannot assure you that in the event we declare a dividend we will designate the income
out of which the dividend is paid in a manner that will reduce shareholders&#8217; tax liability.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the United States-Israel Tax Treaty, the
maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a U.S. resident (for purposes
of the United States-Israel Tax Treaty) is 25%. With respect to dividends paid to a U.S. corporation that held 10% or more of the capital
of the paying corporation throughout the tax year in which the dividend is distributed and the preceding tax year and provided that not
more than 25% of the gross income of the paying corporation for such prior taxable year (if any) consists of certain interest or dividends,
the maximum rate of tax withheld at source is 12.5%; provided, however, that if the paying corporation is an Approved Enterprise, the
applicable withholding tax rate under such circumstances is reduced to 15% (rather than 12.5%). We believe that the reference in the United
States-Israel Tax Treaty to an Approved Enterprise under the Investment Law is deemed to include also a Benefitted Enterprise Preferred
Enterprise and Preferred Technological Enterprise under the Investment Law. The United States-Israel Tax Treaty is currently under review
and subject to change.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">U.S. residents who are subject to Israeli withholding
tax on a dividend may be entitled to a credit or deduction for U.S. federal income tax purposes in the amount of the taxes withheld, subject
to detailed rules contained in U.S. tax legislation.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Exercise or Lapse
of Series C Warrant or Series D Warrant. </span>A holder of a Series C Warrant or Series D Warrant generally will not recognize gain or
loss upon the exercise of a Series C Warrant or Series D Warrant for cash. An ordinary share acquired pursuant to the exercise of a Series
C Warrant or Series D Warrant for cash generally will have a tax basis equal to the holder&#8217;s tax basis in the Series C Warrant or
Series D Warrant (as the case may be), increased by the amount paid to exercise the Series C Warrant or Series D Warrant. The holding
period of such ordinary share generally would begin on the day after the date of exercise of the Series C Warrant or Series D Warrant.
If a Series C Warrant or Series D Warrant is allowed to lapse unexercised, the holder generally will recognize a capital loss equal to
such holder&#8217;s tax basis in the Series C Warrant or Series D Warrant (as the case may be).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">It is possible that a cashless exercise would be
treated as a taxable exchange in which gain or loss is recognized. In such event, a holder could be deemed to have surrendered a number
of Series C Warrants or Series D Warrants with a fair market value equal to the exercise price for the number of Series C Warrants or
Series D deemed exercised. For this purpose, the number of Series C Warrants or Series D Warrants deemed exercised would be equal to the
number of Series C Warrants or Series D Warrants, as applicable, that would entitle the holder to receive upon exercise the number of
ordinary shares issued pursuant to the cashless exercise of the Series C Warrants or Series D Warrants (as the case maybe). In this situation,
the holder would recognize capital gain or loss in an amount equal to the difference between the fair market value of the Series C Warrants
or Series D Warrants deemed surrendered to pay the exercise price and the holder&#8217;s tax basis in the Series C Warrants or Series
D Warrants deemed surrendered.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt"><span style="font-style: italic">Adjustments with
Respect to Warrants. </span>The terms of the Series C Warrant and Series D Warrant provide for an adjustment to the number of ordinary
shares for which the warrant may be exercised or adjustment to the exercise price of the warrant in certain events. An adjustment of the
exercise price or an adjustment that has the effect of preventing dilution generally is not taxable. However, the holders of the Series
C Warrants and Series D Warrants may be treated as receiving a constructive distribution from us if, for example, the adjustment increases
the warrant holders&#8217; proportionate interest in our assets or earnings and profits (e.g., through a decrease in the exercise price
of the Series C Warrants or Series D Warrants) as a result of a distribution of cash to the holders of our ordinary shares, which is taxable
to the holders of such ordinary shares as described under &#8220;&#8212;Taxation of our Shareholders&#8221; above. Such constructive distribution
would be subject to tax as described under that section in the same manner as if the holders of the Series C Warrants or Series D Warrants
received a cash distribution from us equal to the fair market value of such increased interest. Holders of Series C Warrants and Series
D Warrants are urged to consult their own tax advisors on these issues.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Surtax</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Subject to the provisions of an applicable tax
treaty, individuals who are subject to tax in Israel are also subject to an additional tax at a rate of 3% on annual income (including,
but not limited to, dividends, interest and capital gain) exceeding NIS 698,280 for 2023, which amount is linked to the annual change
in the Israeli consumer price index.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Estate and Gift Tax</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Israeli law presently does not impose estate or
gift taxes.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">EACH HOLDER OF OUR SECURITIES IS URGED TO CONSULT
ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH HOLDER OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR
SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT OF ANY ISRAELI TAX LAWS AND ANY APPLICABLE TAX TREATIES.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">69</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">If a United States person is treated as owning at least 10% of our
shares, such holder may be subject to adverse U.S. federal income tax consequences.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If a United States person is treated as owning
(directly, indirectly or constructively) at least 10% of the value or voting power of our shares, such person may be treated as a &#8220;United
States shareholder&#8221; with respect to each &#8220;controlled foreign corporation&#8221; in our group (if any). A United States shareholder
of a controlled foreign corporation may be required to annually report and include in its U.S. taxable income its pro rata share of &#8220;Subpart
F income,&#8221; &#8220;global intangible low-taxed income&#8221; and investments in U.S. property by controlled foreign corporations,
whether or not we make any distributions, and may be subject to tax reporting obligations. An individual that is a United States shareholder
with respect to a controlled foreign corporation generally would not be allowed certain tax deductions or foreign tax credits that would
be allowed to a United States shareholder that is a U.S. corporation. A failure to comply with these reporting obligations may subject
you to significant monetary penalties and may prevent the statute of limitations with respect to your U.S. federal income tax return for
the year for which reporting was due from starting. We cannot provide any assurances that we will assist any shareholder in determining
whether such shareholder is treated as a United States shareholder with respect to any &#8220;controlled foreign corporation&#8221; in
our group (if any) or furnish to any United States shareholders information that may be necessary to comply with the aforementioned reporting
and tax paying obligations. A United States investor should consult its tax advisors regarding the potential application of these rules
to its investment in the shares.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">U.S. Federal Income Taxation</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following are certain material U.S. federal
income tax consequences of the acquisition, ownership and disposition of our securities.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The discussion below of the U.S. federal income
tax consequences to &#8220;U.S. Holders&#8221; will apply to a beneficial owner of our securities that is for U.S. federal income tax
purposes:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zf087af4ff0e845f1ba419c7dada32ea5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an individual citizen or resident of the United States;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc4a4fcf29819423ea319b23aeebc4ca8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a corporation (or other entity treated as a corporation) that is created or organized (or treated as created
        or organized) in or under the laws of the United States, any state thereof or the District of Columbia;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z173cd7260be64eaa81fa9dbe4da7e18d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">an estate whose income is includible in gross income for U.S. federal income tax purposes regardless of
        its source; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zee80f83eb2184dbf9299e518e8de5013" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">a trust if (i) a U.S. court can exercise primary supervision over the trust&#8217;s administration and
        one or more U.S. persons are authorized to control all substantial decisions of the trust; or (ii) it has a valid election in effect under
        applicable U.S. Treasury regulations to be treated as a U.S. person.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A beneficial owner of our securities that is described
above is referred to herein as a &#8220;U.S. Holder.&#8221; If a beneficial owner of our securities is not described as a U.S. Holder
and is not an entity treated as a partnership or other pass-through entity for U.S. federal income tax purposes, such owner will be considered
a &#8220;Non-U.S. Holder.&#8221; Certain material U.S. federal income tax consequences of the acquisition, ownership and disposition of
our securities applicable specifically to Non-U.S. Holders are described below under the heading &#8220;Non-U.S. Holders.&#8221;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This discussion is based on the Code, its legislative
history, Treasury regulations promulgated thereunder, the United States-Israel Tax Treaty, or the Treaty, published rulings and court
decisions, all as currently in effect. These authorities are subject to change or differing interpretations, possibly on a retroactive
basis.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This discussion does not address all aspects of
U.S. federal income taxation that may be relevant to any particular holder based on such holder&#8217;s individual circumstances. In particular,
this discussion considers only holders that own and hold our securities as capital assets within the meaning of Section 1221 of the Code
(generally, property held for investment), and does not address the potential application of the alternative minimum tax or the U.S. federal
income tax consequences to holders that are subject to special rules, including, but not limited to:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zaf8ed8223c8b4e0c832a4dc9f1116350" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">financial institutions or financial services entities;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z090325d6dec74107964b6b712f36d898" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">broker-dealers;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd5337b2a065e4ebb8804555646d79174" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">persons that are subject to the mark-to-market accounting rules under Section 475 of the Code;</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z61d16cd90549489a9bb4e4f680274ec3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">tax-exempt entities;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z01888f6f918c4481ba7e7e7758c9ba4a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">retirement plans;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z32c4818df6694220baeeb511b62b9848" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">governments or agencies or instrumentalities thereof;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zdf35f4e6c7e549779d807dffde623db8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">insurance companies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd2d976ae74754a8d86980c4eea8398f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">regulated investment companies;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd4d9abc240654fe19776946b003f1b49" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">real estate investment trusts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zcdb7505ad18d4052aeb6b878f6b28035" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">grantor trusts;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zbbf1e1e4fad043b4baafb179e92ec4c0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">certain expatriates or former long-term residents of the United States;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z2757a517bc18487ba385bf432e174dfe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">persons that actually or constructively own 5% or more of our shares (by vote or value);</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z0690ad6d1ccd44f69a1fc5b322d5d7e5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">persons that acquired our securities pursuant to an exercise of employee options, in connection with employee
        incentive plans or otherwise as compensation;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zd46911b3f50d43af975cc8a09dda8004" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">persons that hold our securities as part of a straddle, constructive sale, hedging, conversion or other
        integrated transaction;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z363a25eccc864f6b9a8c88ede384cdbd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">persons whose functional currency is not the U.S. dollar;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zb2cb0458f0274efcad7a3c7f5d2d5f7c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">passive foreign investment companies; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z17d3965e6eba4ccebddc91d713beb282" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">controlled foreign corporations.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">70</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">This discussion does not address any aspect of
U.S. federal non-income tax laws, such as gift or estate tax laws, or state, local or non-U.S. tax laws or, except as discussed herein,
any tax reporting obligations applicable to a holder of our securities. Additionally, this discussion does not consider the tax treatment
of partnerships or other pass-through entities or persons who hold our securities through such entities. If a partnership (or other entity
classified as a partnership for U.S. federal income tax purposes) is the beneficial owner of our securities, the U.S. federal income tax
treatment of a partner (or person or entity treated as a partner) in the partnership generally will depend on the status of the partner
and the activities of the partnership. This discussion also assumes that any distribution made (or deemed made) to a holder in respect
of our securities and any consideration received (or deemed received) by a holder in connection with the sale or other disposition of
our securities will be in U.S. dollars. In addition, as described in &#8220;Risk Factors &#8211; Risks Related to Taxation&#8221;, there
is a risk that we could be treated as a domestic (U.S.) corporation for U.S. federal income tax purposes by reason of the Reorganization;
this discussion also assumes that we will be and have been treated as a foreign corporation for U.S. federal income tax purposes. Moreover,
this discussion assumes that a holder owns a sufficient number of Series C Warrants and/or Series D Warrants, such that the holder will
not have a fractional warrant upon the exercise of a Series C Warrant and/or, Series D Warrant, as the case may be.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have not sought, and will not seek, a ruling
from the IRS or an opinion of counsel as to any U.S. federal income tax consequence described herein. The IRS may disagree with the description
herein, and its determination may be upheld by a court. Moreover, there can be no assurance that future legislation, regulations, administrative
rulings or court decisions will not adversely affect the accuracy of the statements in this discussion.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">EACH HOLDER OF OUR SECURITIES IS URGED TO CONSULT
ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES TO SUCH HOLDER OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR
SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL, AND NON-U.S. TAX LAWS, AS WELL AS U.S. FEDERAL TAX LAWS AND ANY
APPLICABLE TAX TREATIES.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">U.S. Holders</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Taxation of Cash Distributions</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As noted above, we currently do not intend to pay
cash dividends on our ordinary shares in the foreseeable future. Subject to the passive foreign investment company, or PFIC, rules discussed
below, a U.S. Holder generally will be required to include in gross income as ordinary income the amount of any cash dividend paid in
respect of our ordinary shares. A cash distribution on our ordinary shares generally will be treated as a dividend for U.S. federal income
tax purposes to the extent the distribution is paid out of our current or accumulated earnings and profits (as determined for U.S. federal
income tax purposes). Such dividend generally will not be eligible for the dividends-received deduction generally allowed to U.S. corporations
in respect of dividends received from other U.S. corporations. The portion of such cash distribution, if any, in excess of such earnings
and profits will be applied against and reduce (but not below zero) the U.S. Holder&#8217;s adjusted tax basis in the ordinary shares.
Any remaining excess generally will be treated as gain from the sale or other taxable disposition of such ordinary shares. We do not intend
to calculate our earnings and profits under U.S. federal income tax principles. Therefore, a U.S. Holder should expect that a distribution
will be reported as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain
under the rules described above.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">With respect to non-corporate U.S. Holders, any
such cash dividends may be subject to U.S. federal income tax at the lower applicable regular long term capital gains tax rate (see &#8220;&#8212;
Taxation on the Disposition of Ordinary Shares or Series C Warrants or Series D Warrants&#8221; below) provided that (a) our ordinary
shares are readily tradable on an established securities market in the United States or we are eligible for the benefits of the Treaty,
(b) we are not a PFIC, as discussed below, for either the taxable year in which the dividend was paid or the preceding taxable year, and
(c) certain holding period requirements are met. Therefore, if our ordinary shares are not readily tradable on an established securities
market, and we are not eligible for the benefits of the Treaty, then cash dividends paid by us to non-corporate U.S. Holders will not
be subject to U.S. federal income tax at the lower regular long term capital gains tax rate. Under published IRS authority, shares are
considered for purposes of clause (a) above to be readily tradable on an established securities market in the United States only if they
are listed on certain exchanges, which presently include the Nasdaq Capital Market. Although our ordinary shares are currently listed
and traded on the Nasdaq Capital Market, U.S. Holders nevertheless should consult their own tax advisors regarding the availability of
the lower rate for any cash dividends paid with respect to our ordinary shares.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Dividends paid to a U.S. Holder with respect to
our ordinary shares generally will be foreign source income, which may be relevant in calculating such U.S. Holder&#8217;s foreign tax
credit limitations. Subject to certain conditions and limitations, non-refundable Israeli tax withheld on dividends may be deducted from
such U.S. Holder&#8217;s taxable income or credited against such U.S. Holder&#8217;s U.S. federal income tax liability. The election to
deduct, rather than credit, foreign taxes, is made on a year-by-year basis and applies to all foreign taxes paid by a U.S. Holder or withheld
from a U.S. Holder that year. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes
of income. For this purpose, dividends that we distribute generally should constitute &#8220;passive category income,&#8221; or, in the
case of certain U.S. Holders, &#8220;general category income.&#8221; A foreign tax credit for foreign taxes imposed on distributions may
be denied if a U.S. Holder does not satisfy certain minimum holding period requirements. As a result of recent changes to the U.S. foreign
tax credit rules, a withholding tax generally will need to satisfy certain additional requirements in order to be considered a creditable
tax for a U.S. Holder.&#160; We have not determined whether these requirements have been met and, accordingly, no assurance can be given
that any withholding tax on dividends paid by us will be creditable. The rules relating to the determination of the foreign tax credit
are complex, and U.S. Holders should consult their tax advisors to determine whether and to what extent they will be entitled to this
credit.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Adjustments with Respect to Warrants</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The terms of each Series C Warrant and Series D
Warrant provide for an adjustment to the number of ordinary shares for which the warrant may be exercised or to the exercise price of
the warrant in certain events. An adjustment that has the effect of preventing dilution generally is not taxable. However, the U.S. Holders
of the Series C Warrants and Series D Warrants would be treated as receiving a constructive distribution from us if, for example, the
adjustment increases the warrant holders&#8217; proportionate interest in our assets or earnings and profits (e.g., through a decrease
in the exercise price of the Series C Warrants or Series D Warrants) as a result of a distribution of cash to the holders of our ordinary
shares, which is taxable to the U.S. Holders of such ordinary shares as described under &#8220;&#8212; Taxation of Cash Distributions,&#8221;
above. Such constructive distribution would be subject to tax as described under that section in the same manner as if the U.S. Holders
of the Series C Warrants and Series D Warrants received a cash distribution from us equal to the fair market value of such increased interest.
U.S. Holders of Series C Warrants and Series D Warrants are urged to consult their own tax advisors on these issues.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Taxation on the Disposition of Ordinary Shares or Series C Warrants or Series D Warrants</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Upon a sale or other taxable disposition of our
ordinary shares or the Series C Warrants or Series D Warrants, and subject to the PFIC rules discussed below, a U.S. Holder generally
will recognize capital gain or loss in an amount equal to the difference between the amount realized and the U.S. Holder&#8217;s adjusted
tax basis in the securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The regular U.S. federal income tax rate on capital
gains recognized by U.S. Holders generally is the same as the regular U.S. federal income tax rate on ordinary income, except that long
term capital gains recognized by non-corporate U.S. Holders generally are subject to U.S. federal income tax at a maximum regular rate
of 20%. Capital gain or loss will constitute long term capital gain or loss if the U.S. Holder&#8217;s holding period for the securities
exceeds one year. The deductibility of capital losses is subject to various limitations. Any such gain or loss that a U.S. Holder recognizes
generally will be treated as U.S. source income or loss for foreign tax credit limitation purposes.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As discussed in &#8220;Israel Tax Consideration
and Government Programs &#8722; Taxation of our Shareholders&#8221; above.&#160; an Israeli capital gains tax may apply to any gains from
the disposition of our ordinary shares or the Series C Warrants or Series D Warrants by a U.S. Holder. If such Israeli tax applies to
any such gain, a U.S. Holder generally will not be entitled to claim a foreign tax credit for such tax unless the U.S. holder is eligible
for benefits under the Treaty, if such holder is considered a resident of the United States for purposes of the Treaty, and otherwise
meets the requirements for claiming benefits under the Treaty. In lieu of claiming a credit, a U.S. Holder may be able to elect to deduct
the Israeli taxes in computing taxable income, subject to applicable limitations.&#160; An election to deduct foreign taxes instead of
claiming foreign tax credits applies to all foreign taxes paid or accrued in the relevant taxable year. U.S. Holders should consult their
own tax advisors regarding the deduction or credit for any such Israeli tax and their eligibility for the benefits of the Treaty.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.2pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">71</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Additional Taxes</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">U.S. Holders that are individuals, estates or trusts
and whose income exceeds certain thresholds generally may be subject to a 3.8% Medicare contribution tax on unearned income, including,
without limitation, dividends on, and gains from the sale or other taxable disposition of, our ordinary shares or the Series C Warrants
or Series D Warrants, subject to certain limitations and exceptions. U.S. Holders should consult their own tax advisors regarding the
effect, if any, of such tax on their ownership and disposition of our ordinary shares or the Series C Warrants or Series D Warrants.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic">Exercise or Lapse of a Series C Warrant or Series D Warrant</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Subject to the PFIC rules discussed below, a U.S.
Holder generally will not recognize gain or loss upon the exercise of a Series C Warrant or Series D Warrant for cash. An ordinary share
acquired pursuant to the exercise of a Series C Warrant or Series D Warrant for cash generally will have a tax basis equal to the U.S.
Holder&#8217;s tax basis in the Series C Warrant or Series D Warrant, as applicable, increased by the amount paid to exercise the Series
C Warrant or Series D Warrant. The holding period of such ordinary share generally would begin on the day after the date of exercise of
the Series C Warrant or Series D Warrant. If a Series C Warrant or Series D Warrant is allowed to lapse unexercised, a U.S. Holder generally
will recognize a capital loss equal to such holder&#8217;s tax basis in the Series C Warrant or Series D Warrant.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The tax consequences of a cashless exercise of
Series C Warrants and Series D Warrants are not clear under current tax law. A cashless exercise may be tax-free, either because it is
not a realization event (i.e., not a transaction in which gain or loss is realized) or because the transaction is treated as a recapitalization
for U.S. federal income tax purposes. In either tax-free situation, a U.S. Holder&#8217;s tax basis in the ordinary shares received would
equal the U.S. Holder&#8217;s basis in the Series C Warrants or Series D Warrants surrendered. If the cashless exercise were treated as
not being a realization event, the U.S. Holder&#8217;s holding period in the ordinary shares could be treated as commencing on the date
following the date of exercise of the Series C Warrants or Series D Warrants. If the cashless exercise were treated as a recapitalization,
the holding period of the ordinary shares received would include the holding period of the Series C Warrants or Series D Warrants, as
applicable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">It is also possible that a cashless exercise could
be treated as a taxable exchange in which gain or loss is recognized. In such event, a U.S. Holder could be deemed to have surrendered
a number of Series C Warrants or Series D Warrants, as applicable, with a fair market value equal to the exercise price for the number
of Series C Warrants or Series D Warrants deemed exercised. For this purpose, the number of Series C Warrants or Series D Warrants deemed
exercised would be equal to the amount needed to receive on exercise the number of ordinary shares issued pursuant to the cashless exercise
of the Series C Warrants or Series D Warrants. In this situation, the U.S. Holder would recognize capital gain or loss in an amount equal
to the difference between the fair market value of the Series C Warrants or Series D Warrants deemed surrendered to pay the exercise price
and the U.S. Holder&#8217;s tax basis in such Series C Warrants or Series D Warrants deemed surrendered. Such gain or loss would be long-term
or short-term depending on the U.S. Holder&#8217;s holding period in the Series C Warrants or Series D Warrants, as applicable. In this
case, a U.S. Holder&#8217;s tax basis in the ordinary shares received would equal the sum of the fair market value of the Series C Warrants
or Series D Warrants deemed surrendered to pay the exercise price and the</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">U.S. Holder&#8217;s tax basis in the Series C Warrants
or Series D Warrants deemed exercised, and a U.S. Holder&#8217;s holding period for the ordinary shares should commence on the date following
the date of exercise of the Series C Warrants or Series D Warrants. There also may be alternative characterizations of any such taxable
exchange that would result in similar tax consequences, except that a U.S. Holder&#8217;s gain or loss would be short-term.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Due to the absence of authority on the U.S. federal
income tax treatment of a cashless exercise of Series C Warrants and Series D Warrants, it is unclear which, if any, of the alternative
tax consequences and holding periods described above would be adopted by the IRS or a court of law. Accordingly, U.S. Holders should consult
their tax advisors regarding the tax consequences of a cashless exercise of Series C Warrants and Series D Warrants.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic">Passive Foreign Investment Company Rules</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A foreign (i.e., non-U.S.) corporation will be
a PFIC if either (a) at least 75% of its gross income in a taxable year of the foreign corporation, including its pro rata share of the
gross income of any corporation in which it is considered to own at least 25% of the corporation by value, is passive income, or (b) at
least 50% of the average value of its assets in a taxable year of the foreign corporation, including its pro rata share of the assets
of any corporation in which it is considered to own at least 25% of the corporation by value, are held for the production of, or produce,
passive income. Passive income generally includes dividends, interest, rents and royalties (other than certain rents or royalties derived
from the active conduct of a trade or business), and gains from the disposition of passive assets.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We believe that we were a PFIC for the taxable
year ended December 31, 2022 and may be a PFIC for the taxable year ending December 31, 2023. Our PFIC status for our current taxable
year or any subsequent taxable year is uncertain and will not be determinable until after the end of such taxable year. Accordingly, there
can be no assurance with respect to our status as a PFIC for our taxable year ending December 31, 2023 or any subsequent taxable year.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we are determined to be a PFIC for any taxable
year (or portion thereof) that is included in the holding period of a U.S. Holder of our ordinary shares or Series C Warrants or Series
D Warrants, and, in the case of our ordinary shares, the U.S. Holder did not make a timely qualified electing fund or a QEF, election
for our first taxable year as a PFIC in which the U.S. Holder held (or was deemed to hold) the ordinary shares, a purging election, a
QEF election along with a purging election, or a mark-to-market election, each as described below, such holder generally will be subject
to special rules for regular U.S. federal income tax purposes with respect to:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zdc3c2ffa8dfe4c03b7c67ba4abc7494f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">any gain recognized by the U.S. Holder on the sale or other disposition of its ordinary shares or Series
        C Warrants or Series D Warrants; and</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z772adb1f1b1d4eb4a52557561fa8e675" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">any &#8220;excess distribution&#8221; made to the U.S. Holder (generally, any distributions to such U.S.
        Holder during a taxable year of the U.S. Holder that are greater than 125% of the average annual distributions received by such U.S. Holder
        in respect of the ordinary shares during the three preceding taxable years of such U.S. Holder or, if shorter, such U.S. Holder&#8217;s
        holding period for the ordinary shares).</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under these rules,</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="zc58e4d4209d549a1b51f6d6a70210609" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the U.S. Holder&#8217;s gain or excess distribution will be allocated ratably over the U.S. Holder&#8217;s
        holding period for the ordinary shares or Series C Warrants or Series D Warrants;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zcb9096648abc4d9c81612bb95d8c1b5f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the amount allocated to the U.S. Holder&#8217;s taxable year in which the U.S. Holder recognized the gain
        or received the excess distribution or to the period in the U.S. Holder&#8217;s holding period before the first day of our first taxable
        year in which we qualified as a PFIC will be taxed as ordinary income;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z313719b3d0744e73a87d741249b5d5c3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the amount allocated to other taxable years (or portions thereof) of the U.S. Holder and included in its
        holding period will be taxed at the highest ordinary tax rate in effect for that year and applicable to the U.S. Holder; and</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze8cdc7e77f2c4f25a3d46ad977f5729d" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">the interest charge generally applicable to underpayments of tax will be imposed in respect of the tax
        attributable to each such other taxable year of the U.S. Holder.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Although a determination as to our PFIC status
is made annually, an initial determination that we are a PFIC generally will apply for subsequent years to a U.S. Holder that held (or
was deemed to hold) our ordinary shares or Series C Warrants or Series D Warrants while we were a PFIC, whether or not we meet the test
for PFIC status in those subsequent years. If we are determined to be a PFIC in any taxable year, and then cease to meet the test for
PFIC status in a subsequent taxable year, a U.S. Holder may be able to make a purging election to eliminate this continuing PFIC status
with respect to its ordinary shares in certain circumstances. A purging election generally creates a deemed sale of such ordinary shares
at their fair market value on the last day of our tax year during which we qualified as a PFIC (or, in the case of a purging election
made in connection with a QEF election, the first day of our taxable year in which qualify as a QEF with respect to such U.S. Holder).
Any gain recognized by the purging election generally will be treated as an excess distribution subject to the special tax and interest
charge rules described above. As a result of the purging election, the U.S. Holder generally will increase the adjusted basis in its ordinary
shares by the amount of gain recognized and will also have a new holding period in its ordinary shares for purposes of the PFIC rules.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.15pt; margin-left: 7.35pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">72</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In general, if we are determined to be a PFIC,
a U.S. Holder may avoid the PFIC tax consequences described above with respect to the ordinary shares by making a timely QEF election
(or a QEF election along with a purging election). Pursuant to the QEF election, a U.S. Holder generally will be required to include in
income its pro rata share of our net capital gains (as long term capital gain) and other earnings and profits (as ordinary income), on
a current basis, in each case whether or not distributed, in the taxable year of the U.S. Holder in which or with which our taxable year
ends if we are treated as a PFIC for that taxable year. However, a U.S. Holder may make a QEF election only if we agree to provide certain
tax information to such holder annually. At this time, we do not intend to provide U.S. Holders with such information as may be required
to make a QEF election effective.&#160; In any event, a QEF election may not be made with respect to warrant.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Alternatively, if a U.S. Holder, at the close of
its taxable year, owns ordinary shares in a PFIC that are treated as marketable stock, the U.S. Holder may make a mark-to-market election
with respect to such ordinary shares for such taxable year. If the U.S. Holder makes a valid mark-to-market election for the first taxable
year of the U.S. Holder in which the U.S. Holder holds (or is deemed to hold) the ordinary shares and for which we are determined to be
a PFIC, such holder generally will not be subject to the PFIC rules described above with respect to its ordinary shares as long as such
shares continue to be treated as marketable stock. Instead, in general, the U.S. Holder will include as ordinary income for each year
that we are treated as a PFIC the excess, if any, of the fair market value of its ordinary shares at the end of its taxable year over
the adjusted tax basis in its ordinary shares. The U.S. Holder also will be allowed to take an ordinary loss in respect of the excess,
if any, of the adjusted tax basis of its ordinary shares over the fair market value of its ordinary shares at the end of its taxable year
(but only to the extent of the net amount of previously included income as a result of the mark-to-market election). The U.S. Holder&#8217;s
adjusted tax basis in its ordinary shares will be adjusted to reflect any such income or loss amounts, and any further gain recognized
on a sale or other taxable disposition of the ordinary shares in a taxable year in which we are treated as a PFIC generally will be treated
as ordinary income. Special tax rules may also apply if a U.S. Holder makes a mark-to-market election for a taxable year after the first
taxable year in which the U.S. Holder holds (or is deemed to hold) our ordinary shares and for which we are determined to be a PFIC. Currently,
a mark-to-market election may not be made with respect to warrants.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The mark-to-market election is available only for
stock that is regularly traded on a national securities exchange that is registered with the U.S. Securities and Exchange Commission,
including the Nasdaq Capital Market, or on a foreign exchange or market that is regulated or supervised by a governmental authority of
the country in which the exchange or market is located and which (A) meets certain requirements, that are enforced by law, relating to
trading volume, listing, financial disclosure, surveillance and other requirements that are designed to (i) prevent fraudulent and manipulative
acts and practices, (ii) remove impediments to and perfect the mechanism of a free and open, fair and orderly market and (iii) protect
investors and (B) has rules that effectively promote the active trading of listed stock. Although our ordinary shares are currently listed
and traded on the Nasdaq Capital Market, U.S. Holders nevertheless should consult their own tax advisors regarding the availability and
tax consequences of a mark-to-market election with respect to our ordinary shares under their particular circumstances.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">If we are a PFIC and, at any time, have a foreign
subsidiary that is classified as a PFIC, a U.S. Holder of our ordinary shares generally should be deemed to own a portion of the shares
of such lower-tier PFIC, and generally could incur liability for the deferred tax and interest charge described above if we receive a
distribution from, or dispose of all or part of our interest in, or the</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">U.S. Holder were otherwise deemed to have disposed
of an interest in, the lower-tier PFIC. A mark-to-market election generally would not be available with respect to such a lower-tier PFIC.
U.S. Holders are urged to consult their own tax advisors regarding the tax issues raised by lower-tier PFICs.</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A U.S. Holder that owns (or is deemed to own) ordinary
shares in a PFIC during any taxable year of the U.S. Holder generally is required to file an IRS Form 8621 (whether or not a mark-to-market
election is or has been made) with such U.S. Holder&#8217;s U.S. federal income tax return and provide such other information as may be
required by the U.S. Treasury Department. Failure to file IRS Form 8621 for each applicable taxable year may result in substantial penalties
and the statute of limitations on the assessment and collection of U.S. federal income taxes of such U.S. Holder for the related taxable
year may not close until three years after the date on which the required information is filed.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The rules dealing with PFICs and purging and mark-to-market
elections are very complex and are affected by various factors in addition to those described above. Accordingly, U.S. Holders of our
securities should consult their own tax advisors concerning the application of the PFIC rules to our securities under their particular
circumstances.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Non-U.S. Holders</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Cash dividends paid or deemed paid to a Non-U.S.
Holder with respect to our ordinary shares generally will not be subject to U.S. federal income tax unless such dividends are effectively
connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable
income tax treaty, are attributable to a permanent establishment or fixed base that such holder maintains or maintained in the United
States).</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, a Non-U.S. Holder generally will not
be subject to U.S. federal income tax on any gain attributable to a sale or other taxable disposition of our securities unless such gain
is effectively connected with its conduct of a trade or business in the United States (and, if required by an applicable income tax treaty,
is attributable to a permanent establishment or fixed base that such holder maintains or maintained in the United States) or the Non-U.S.
Holder is an individual who is present in the United States for 183 days or more in the taxable year of such sale or other disposition
and certain other conditions are met (in which case, such gain from U.S. sources generally is subject to U.S. federal income tax at a
30% rate or a lower applicable tax treaty rate).</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Dividends and gains that are effectively connected
with the Non-U.S. Holder&#8217;s conduct of a trade or business in the United States (and, if required by an applicable income tax treaty,
are attributable to a permanent establishment or fixed base that such holder maintains or maintained in the United States) generally will
be subject to regular U.S. federal income tax at the same regular U.S. federal income tax rates as applicable to a comparable U.S. Holder
and, in the case of a Non-U.S. Holder that is a corporation for U.S. federal income tax purposes, may also be subject to an additional
branch profits tax at a 30% rate or a lower applicable tax treaty rate.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Backup Withholding and Information Reporting</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In general, information reporting for U.S. federal
income tax purposes should apply to distributions made on our securities within the United States to a U.S. Holder (other than an exempt
recipient) and to the proceeds from sales and other dispositions of our securities by a U.S. Holder (other than an exempt recipient) to
or through a U.S. office of a broker. Payments made (and sales and other dispositions effected at an office) outside the United States
will be subject to information reporting in limited circumstances. In addition, certain information concerning a U.S. Holder&#8217;s adjusted
tax basis in its securities and adjustments to that tax basis and whether any gain or loss with respect to such securities is long term
or short term also may be required to be reported to the IRS, and certain holders may be required to file an IRS Form 8938 (Statement
of Specified Foreign Financial Assets) to report their interest in our securities.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Moreover, backup withholding of U.S. federal income
tax, currently at a rate of 24%, generally will apply to dividends paid on our securities to a U.S. Holder (other than an exempt recipient)
and the proceeds from sales and other dispositions of our securities by a U.S. Holder (other than an exempt recipient), in each case who:</div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="ze367f40944e341458d968193caf3f929" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">fails to provide an accurate taxpayer identification number;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z6aef03acca244a5695f39e0af103fa51" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">is notified by the IRS that backup withholding is required; or</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z7c315484c3b44bcdae260a71a3455dc7" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="line-height: 1.25">in certain circumstances, fails to comply with applicable certification requirements.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A Non-U.S. Holder generally may eliminate the requirement
for information reporting and backup withholding by providing certification of its foreign status, under penalties of perjury, on a duly
executed applicable IRS Form W-8 or by otherwise establishing an exemption.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Backup withholding is not an additional tax. Rather,
the amount of any backup withholding will be allowed as a credit against a U.S. Holder&#8217;s or a Non-U.S. Holder&#8217;s U.S. federal
income tax liability and may entitle such holder to a refund, provided that certain required information is timely furnished to the IRS.</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.25pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">73</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Holders are urged to consult their own tax advisors
regarding information reporting, the application of backup withholding, and the availability of and procedures for obtaining an exemption
from backup withholding in their particular circumstances.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25; font-weight: bold">THE DISCUSSION ABOVE
IS A GENERAL SUMMARY. IT DOES NOT COVER ALL TAX MATTERS THAT MAY BE OF IMPORTANCE TO A PROSPECTIVE INVESTOR. EACH PROSPECTIVE INVESTOR
IS URGED TO CONSULT ITS OWN TAX ADVISOR ABOUT THE TAX CONSEQUENCES RELATING TO THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY
SHARES, SERIES C WARRANTS OR SERIES D WARRANTS, IN EACH CASE IN LIGHT OF THE INVESTOR&#8217;S OWN CIRCUMSTANCES, INCLUDING THE CONSEQUENCES
OF ANY PROPOSED CHANGE IN APPLICABLE LAWS.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">F.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Dividends
and paying agents</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">G.</span>&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Statement
by experts</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="margin-left: 32.6pt; line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25"><span style="font-weight: bold">H.</span>&#160;&#160;&#160;&#160; <span style="font-weight: bold">Documents
on display</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We are subject to the informational requirements
of the Exchange Act. Accordingly, we are required to file reports and other information with the SEC, including annual reports on Form
20-F and reports on Form 6-K. As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing
the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and
short swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange
Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are
registered under the Exchange Act. The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements
and other information regarding registrants like us that file electronically with the SEC. You can also inspect this Annual Report on
such website.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">A copy of each document (or a translation thereof
to the extent not in English) concerning our company that is referred to in this Annual Report is available for public view (subject to
confidential treatment of certain agreements pursuant to applicable law) at our principal executive offices at Check-Cap Building, 29
Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><span style="font-weight: bold">I.</span>&#160;&#160;&#160;&#160;&#160;&#160; <span style="font-weight: bold">Subsidiary
Information</span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 11<span id="ITEM11"><!--Anchor--></span>. QUANTITATIVE AND QUALITATIVE DISCLOSURE
ABOUT MARKET RISK</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Foreign Currency Exchange Rate Risk</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Some of our assets and liabilities are affected
by fluctuations in the exchange rate between the U.S. dollar and the NIS and between the U.S. dollar and the Euro. For example, salaries
and related expenses for Israeli employees are paid in NIS and some of our suppliers are located in Europe and require payment in Euros.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">During 2022, we entered into zero-cost collars
or minimal cost collars contracts to hedge against the risk of changes in exchange rates on future cash flow from payments denominated
in NIS. As of December 31, 2022, we had outstanding foreign exchange collars in the notional amount of approximately $5.3 million with
a fair value liability net of $56.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, our total assets and liabilities
(including leases) linked to the NIS amounted to approximately $1.3 million and $3.3 million, respectively. A 10% depreciation of the
dollar in relation to the NIS would cause an exchange rate loss of approximately $180,000.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">As of December 31, 2022, we had no assets linked
to the Euro and our total liabilities linked to the Euro amounted to approximately $117,000. A 10% depreciation of the dollar in relation
to the Euro would cause an exchange rate gain of approximately $11,000.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">During the year ended December 31, 2022, the exchange
rate between the U.S. dollar and the NIS increased by 13.15 % and the exchange rate between the U.S. dollar and the Euro increased by
6.12 %. During the year ended December 31, 2021, the exchange rate between the U.S. dollar and the NIS decreased by 3.27% and the exchange
rate between the U.S. dollar and the Euro increased by 8.39%. During the year ended December 31, 2020, the exchange rate between the U.S.
dollar and the NIS decreased by 6.97% and the exchange rate between the U.S. dollar and the Euro decreased by 8.53%.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-style: italic; font-weight: bold">Interest Rate Risk</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our obligation to pay royalties to the IIA is linked
to LIBOR and we are therefore exposed to changes in LIBOR.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The primary objective of our investment activities
is to preserve principal while maximizing the interest income we receive from our investments, without increasing risk. Currently, we
do not have any outstanding borrowings.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">In addition, we invest and intend to invest our
cash balances, including certain of the net proceeds from our financings pending their ultimate use, primarily in bank deposits, and fixed-income
securities issued by corporations and securities issued by the U.S. and Israeli governments. We are exposed to market risks resulting
from changes in interest rates relating primarily to our financial investments in cash and deposits. We do not use derivative financial
instruments to limit exposure to interest rate risk. Our interest income increased in 2022 mainly due to the increase of the interest
rates as a result of changes in the financial markets especially in the U.S and the increase in our cash amounts.&#160; Our interest rates
may decline in the future as a result of changes in the financial markets. The effect of a hypothetical 10% change in interest rates would
have impacted our interest income by approximately $100,000&#160;for the year ended December&#160;31, 2022. The impact would have been
immaterial for the years ended December 31, 2021 and 2020.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 12<span id="ITEM12"><!--Anchor--></span>. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">74</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">PART II<span id="PARTII"><!--Anchor--></span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 13<span id="ITEM13"><!--Anchor--></span>. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 14<span id="ITEM14"><!--Anchor--></span>. MATERIAL MODIFICATIONS TO THE RIGHTS
OF SECURITY HOLDERS AND USE OF PROCEEDS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Not applicable.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 15<span id="ITEM15"><!--Anchor--></span>. CONTROLS AND PROCEDURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25"><span style="font-weight: bold">(a)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-style: italic">Disclosure
Controls and Procedures</span><span style="font-style: italic">. </span>Our management, including our Chief Executive Officer and Chief
Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e)
and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Annual Report, or the Evaluation Date. Based on such evaluation,
the Chief Executive Officer and the Chief Financial Officer have concluded that, as of the Evaluation Date, the Company&#8217;s disclosure
controls and procedures are effective.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25"><span style="font-weight: bold">(b)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-style: italic">Management&#8217;s
Annual Report on Internal Control Over Financial Reporting</span><span style="font-weight: bold">. </span>Our management is responsible
for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f)
of the Exchange Act. Our management, including our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of
the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control&#8212;Integrated
Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as of the Evaluation Date. Based
on that evaluation, our management has concluded that our internal control over financial reporting was effective as of the Evaluation
Date. As all internal control systems, no matter how well designed, have inherent limitations, our internal control over financial reporting
may not prevent or detect misstatements.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25"><span style="font-weight: bold">(c)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-style: italic">Attestation
Report of Registered Public Accounting Firm</span>.&#160; Not applicable (we are exempt from this requirement due to our status under
the Exchange Act as a non-accelerated filer as of the current time).</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; line-height: 1.25"><span style="font-weight: bold">(d)</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-style: italic">Changes
in Internal Control Over Financial Reporting. </span>Based on the evaluation conducted by our Chief Executive Officer and our Chief Financial
Officer pursuant to Rules 13a-15(d) and 15d-15(d) under the Exchange Act, our management has concluded that there was no change in our
internal control over financial reporting that occurred during the year ended December 31, 2022 that materially affected, or is reasonably
likely to materially affect, our internal control over financial reporting.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16<span id="ITEM16"><!--Anchor--></span>. [RESERVED]</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16A<span id="ITEM16A"><!--Anchor--></span>. Audit Committee Financial Expert.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: justify; text-indent: 25.2pt; margin-right: 7.3pt; margin-left: 7.35pt; line-height: 1.25">Our Board of Directors
has determined that Mr. Yuval Yanai, a member of our audit committee is an audit committee financial expert as defined by rules of the
U.S. Securities and Exchange Commission and is an independent director under Nasdaq Listing Rules.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16B<span id="ITEM16B"><!--Anchor--></span>. Code of Ethics.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">We have adopted a Code of Business Conduct and
Ethics that applies to all of our directors and employees, including our chief executive officer, chief financial officer, controller
or principal accounting officer, or other persons performing similar functions, which complies with the &#8220;code of ethics&#8221; contemplated
by Item 16B of Form 20-F promulgated by the U.S. Securities and Exchange Commission. A copy of our Code of Business Conduct and Ethics
is available on our website at <span style="font-style: italic"><span style="text-decoration: underline">http://ir.check-cap.com/corporate</span>-g<span style="text-decoration: underline">overnance</span></span>.
Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report and is not incorporated
by reference herein. If we make any amendment to the Code of Business Conduct and Ethics or grant any waivers, including any implicit
waiver, from a provision of the code of ethics, we will disclose the nature of such amendment or waiver on our website to the extent required
by the rules and regulations of the U.S. Securities and Exchange Commission. Under Item 16B of the U.S. Securities and Exchange Commission&#8217;s
Form 20-F, if a waiver or amendment of the Code of Business Conduct and Ethics applies to our principal executive officer, principal financial
officer, principal accounting officer or controller and relates to standards promoting any of the values described in Item 16B(b) of Form
20-F, we will disclose such waiver or amendment on our website in accordance with the requirements of Instruction 4 to such Item 16B.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16C<span id="ITEM16C"><!--Anchor--></span>. Principal Accountant Fees and Services.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">The following table represents aggregate fees billed
to us for professional services rendered for fiscal years ended December 31, 2022 and 2021 by Deloitte Brightman Almagor Zohar &amp; Co.,
a Firm in the Deloitte Global Network, an independent registered accounting firm.</div>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3e2d36701fcb440ea75115d2da8bcb5c" class="cfttable" style="font: 10pt Times New Roman, Times, serif; text-align: left; color: #000000; width: 100%">
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold"> 2022</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; vertical-align: bottom">
        <div style="line-height: 1.25">
        <div style="text-align: center; line-height: 1.25; font-weight: bold">2021</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; padding-bottom: 2px">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Audit Fees (1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">110,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">140,000</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Tax Fees (2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">15,264</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">$</div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">5,060</div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25">Other Fees (3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">4,070</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 2px solid; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255)">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">2,961</div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255)">&#160;</td>
        </tr>
  <tr>
    <td style="vertical-align: bottom; vertical-align: bottom; width: 76%; padding-bottom: 4px">
        <div style="text-indent: -10.8pt; margin-left: 10.8pt; line-height: 1.25"><span style="font-weight: bold">Total</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        </td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25">$</div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="font-weight: bold">129,339</span></div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftguttercell" style="vertical-align: bottom; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
    <td colspan="1" class="cftcurrcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; width: 1%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="font-weight: bold">$</span></div> </div> </td>
    <td colspan="1" class="cftnumcell" style="vertical-align: bottom; border-bottom: rgb(0, 0, 0) 4px double; vertical-align: bottom; text-align: right; width: 9%">
        <div style="line-height: 1.25">
        <div style="line-height: 1.25"><span style="font-weight: bold">148,021</span></div> </div> </td>
    <td colspan="1" class="cftfncell" style="vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1%; padding-bottom: 4px">&#160;</td>
        </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zc2939dbe8965428182cb86895c0e3f9c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>The audit fees for the years ended December 31, 2022 and 2021 were for professional services rendered for the audits of our financial
        statements, consents and in connection with certain of our filings with the U.S. Securities and Exchange Commission.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdaf2564a39084b43ac22eb30865aecdd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>Tax fees for the year ended December 31, 2022, are for services rendered by our auditors in connection with a tax audit and tax study.
        Tax fees for the year ended December 31, 2021 are for services rendered by our auditors in connection with a tax audit.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc1150bc4890d446d8266865d55a741ac" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 26.65pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Other fees for the year ended December 31, 2022 and 2021, are for services rendered by our auditors in connection with a benchmark
        study.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">Audit Committee Pre-approval Policies and Procedures</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Our audit committee has adopted a pre-approval
policy for the engagement of our independent registered public accounting firm to perform certain audit and non-audit services. Pursuant
to this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the audit committee
pre-approves annually a catalog of specific audit and non-audit services in the categories of audit services, audit-related services and
tax services that may be performed by our independent registered public accounting firm. If a type of service, that is to be provided
by our auditors, has not received such general pre-approval, it will require specific pre-approval by our audit committee. The policy
prohibits retention of the independent registered public accounting firm to perform the prohibited non-audit functions defined in applicable
SEC rules.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16D<span id="ITEM16D"><!--Anchor--></span>. Exemptions from the Listing Standards
for Audit Committees.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.54pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16E<span id="ITEM16E"><!--Anchor--></span>. Purchases of Equity Securities by the
Issuer and Affiliated Purchasers.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.54pt; line-height: 1.25">Not applicable.</div>

<div style="margin-left: 32.54pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">75</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16F<span id="ITEM16F"><!--Anchor--></span>. Change in Registrant&#8217;s Certifying
Accountant.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.54pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16G<span id="ITEM16G"><!--Anchor--></span>. Corporate governance.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Under the Israeli Companies Law, companies incorporated
under the laws of the State of Israel whose shares are publicly traded, including companies with shares listed on the Nasdaq Capital Market,
are considered public companies under Israeli law and are required to comply with various corporate governance requirements relating to
such matters as external directors, the audit committee, the compensation committee and an internal auditor. These requirements are in
addition to the corporate governance requirements imposed by the Listing Rules of the Nasdaq Stock Market and other applicable provisions
of U.S. securities laws to which we became subject (as a foreign private issuer) upon the closing of our initial public offering and the
listing of our securities on the Nasdaq Capital Market. Under the Listing Rules of the Nasdaq Stock Market, a foreign private issuer,
such as us, may generally follow its home country rules of corporate governance in lieu of the comparable requirements of the Listing
Rules of the Nasdaq Stock Market, except for certain matters including (among others) the composition and responsibilities of the audit
committee and the independence of its members within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission.
We currently rely on this &#8220;home country practice exemption&#8221; solely with respect to the following items:</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="zd9e19d7f01374c248795db661a2789b1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Nomination of our directors</span>. Israeli law and
        our amended articles of association do not require director nominations to be made by a nominating committee of our board of directors
        consisting solely of independent directors, as required under the Listing Rules of the Nasdaq Stock Market. Our Board of Directors elected
        to rely on the exemption available to foreign private issuers under the Nasdaq Listing Rules and follow Israeli law and practice with
        regard to the process of nominating directors, in accordance with which directors are recommended by the board of directors for election
        by the shareholders (other than directors elected by the board of directors to fill a vacancy). Our Board of Directors established a Nominating
        Committee, whose role is to select and recommend to the Board of Directors for selection, director nominees, while considering the appropriate
        size and composition of the Board of Directors, the requirements of applicable law regarding service as a member of our Board of Directors
        and the criteria for the selection of new members of the Board of Directors, and determined that our Nominating Committee need not be
        composed solely of independent directors (within the meaning of Nasdaq Listing Rules).&#160; However, our Nominating Committee currently
        consists solely of independent directors (within the meaning of Nasdaq Listing Rules).</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" id="z47b90c82fec34257aae64415d6c5c41e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Compensation of officers</span>. We follow Israeli
        law and practice with respect to the approval of officer compensation. While our compensation committee currently complies with the provisions
        of the Nasdaq Listing Rules relating to composition requirements and Israeli law generally requires that the compensation of the chief
        executive officer and all other executive officers be approved, or recommended to the board for approval, by the compensation committee
        (and in certain instances, shareholder approval is required), Israeli law includes relief from compensation committee approval in certain
        instances. For details regarding the approvals required under the Israeli Companies Law and regulation promulgated thereunder for the
        approval of compensation of the chief executive officer, all other executive officers and directors, see Item 6C &#8220;Directors, Senior
        Management and Employees&#8212; Board Practices &#8212; Approval of Related Party Transactions under Israeli Law &#8212; Disclosure of
        Personal Interests of an Office Holder and Approval of Certain Transactions&#8221;.</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z232aed124b43491baecdb8fdfd086fd3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Shareholder approval. </span>We will seek shareholder
        approval for all corporate actions requiring such approval under the requirements of the Israeli Companies Law, rather than seeking approval
        for corporate actions in accordance with Nasdaq Listing Rule 5635. In particular, under the Nasdaq Listing Rule, shareholder approval
        is generally required for: (i) an acquisition of shares/assets of another company that involves the issuance of 20% or more of the acquirer&#8217;s
        shares or voting rights or if a director, officer or 5% shareholder has greater than a 5% interest (or such persons collectively have
        a 10% or greater interest) in the target company or the assets to be acquired or the consideration to be received and the present or potential
        issuance of ordinary shares, or securities convertible into or exercisable for ordinary shares, could result in an increase in outstanding
        common shares or voting power of 5% or more; (ii) the issuance of shares leading to a change of control; (iii) adoption/amendment of a
        stock option or purchase plan or other equity compensation arrangements, pursuant to which stock may be acquired by officers, directors,
        employees or consultants (with certain limited exception); and (iv) issuances of 20% or more of the shares or voting rights (including
        securities convertible into, or exercisable for, equity) of a listed company via a private placement (and/or via sales by directors/officers/5%
        shareholders) if such equity is issued (or sold) at below the greater of the book or market value of shares. We will seek shareholder
        approval for all actions requiring such under the Israeli Companies Law. Under the Israeli Companies Law, the adoption of, and material
        changes to, equity-based compensation plans generally require the approval of the board of directors. For details regarding the approvals
        required under the Israeli Companies Law for the approval of compensation of the chief executive officer, all other executive officers
        and directors, see &#8220;Item 6C &#8220;Directors, Senior Management and Employees &#8212; Board Practices -Approval of Related Party
        Transactions under Israeli Law &#8212; Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions.&#8221;
        For details regarding the approvals required under the Israeli Companies Law for the approval of transactions with and compensation of
        controlling shareholders, see &#8220;Item 6C &#8220;Directors, Senior Management and Employees &#8212; Board Practices - Approval of Related
        Party Transactions under Israeli Law &#8212; Disclosure of Personal Interests of Controlling Shareholders and Approval of Certain Transactions.&#8221;
        For details regarding the approvals required under the Israeli Companies Law for certain acquisitions of our shares and mergers, see Exhibit
        2.1. &#8220;Description of Securities &#8212; Acquisitions under Israeli Law.&#8221;</div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div>

<table cellspacing="0" cellpadding="0" id="z9c2ffc66f44445648af2ef41b2fbe352" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 54pt; vertical-align: top; text-align: right">
        <div style="text-align: left; margin-left: 36pt; line-height: 1.25">&#8226;</div> </td>
    <td style="width: auto; vertical-align: top">
        <div style="text-align: justify; line-height: 1.25"><span style="font-style: italic">Quorum requirement. </span>Under our amended and
        restated articles of association and as permitted under the Israeli Companies Law, a quorum for any meeting of shareholders shall be the
        presence of at least two shareholders present in person, by proxy or by a written ballot, who hold at least 25% of the voting power of
        our shares (or if a higher percentage is required by law, such higher percentage) instead of 33 1/3% of the issued share capital required
        under the Nasdaq Listing Rules. If the meeting was adjourned for lack of a quorum, at the adjourned meeting, at least two shareholders
        present in person or by proxy shall constitute a quorum, unless the meeting of shareholders was convened at the demand of shareholders,
        in which case, the quorum shall be the presence of one or more shareholders holding at least 5% of our issued share capital and at least
        one percent of the voting power of our shares, or one or more shareholders with at least 5% of the voting power of our shares.</div> </td>
        </tr>
  </table> </div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin: 0px; line-height: 1.25; text-align: justify; text-indent: 25.15pt">Except as stated above, we currently intend to
comply with the rules generally applicable to U.S. domestic companies listed on Nasdaq. We may in the future decide to use the foreign
private issuer exemption with respect to some or all of the other Nasdaq corporate governance rules. Following our home country governance
practices, as opposed to the requirements that would otherwise apply to a company listed on Nasdaq, may provide less protection than is
accorded to investors under Nasdaq listing requirements applicable to domestic issuers. For more information, see &#8220;Item 3D &#8220;Key
Information - Risk Factors Risks Related to the Company&#8221;- As a foreign private issuer, we are permitted, and intend, to follow certain
home country corporate governance practices instead of otherwise applicable Nasdaq requirements, which may result in less protection than
is accorded to investors under rules applicable to domestic U.S. issuers.&#8221;</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16H<span id="ITEM16H"><!--Anchor--></span>. Mine Safety Disclosure.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 32.54pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 16I<span id="ITEM16I"><!--Anchor--></span>. Disclosure Regarding Foreign Jurisdictions
that Prevent Inspections.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-left: 32.6pt; line-height: 1.25">Not applicable.</div>

<div style="margin-left: 32.6pt; line-height: 1.25"> <br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">76</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25">&#160;</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">PART III<span id="PARTIII"><!--Anchor--></span></div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 17<span id="ITEM17"><!--Anchor--></span>. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">Not applicable.</div>

<div style="line-height: 1.25">&#160;</div>

<div style="line-height: 1.25; font-weight: bold">ITEM 18<span id="ITEM18"><!--Anchor--></span>. FINANCIAL STATEMENTS</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 32.6pt; line-height: 1.25">Our Financial Statements beginning on pages F-1 through F- 37 are hereby incorporated
herein by reference. These Financial Statements are filed as part of this Annual Report.</div>

<div style="line-height: 1.25"><br /> </div>

<div style="line-height: 1.25; font-weight: bold">ITEM 19<span id="ITEM19"><!--Anchor--></span>. EXHIBITS</div>

<div style="line-height: 1.25"><br /> </div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold">Exhibit Index</div>

<div style="line-height: 1.25"><br /> </div>

<div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zad733245935645188711ee6874aec285" style="font: 10pt Times New Roman, Times, serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="vertical-align: top; width: 54pt">
        <div style="line-height: 1.25"><span style="font-weight: bold">Exhibit No.</span></div> </td>
    <td style="vertical-align: top; width: auto">
        <div style="line-height: 1.25"><span style="font-weight: bold">Description</span></div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25">

<div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm"><br /> </a>
</div> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm"> </a> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm"> </a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm"> </a>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="exhibit_1-1.htm">1.1</a></td>
    <td style="width: auto; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_1-1.htm">
        </a>
        <div><a href="exhibit_1-1.htm">Amended and Restated Articles of Association of the Registrant</a></div> </td> </tr>
  </table>

<div style="margin-left: 7.35pt; line-height: 1.25">&#160;&#160;&#160;&#160;&#160;&#160; <br /> </div> </div> <span style="text-decoration: underline">
</span><span style="text-decoration: underline"> </span><span style="text-decoration: underline"> </span><span style="text-decoration: underline">
</span>

<table cellspacing="0" cellpadding="0" id="z5fcd00de3df6446ca90b6edc1555bfe8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><span style="text-decoration: underline"><br /> </span> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322001429/exhibit_2-1.htm">2.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322001429/exhibit_2-1.htm">Description of Securities Registered
        under Section 12 (19)<br /> </a></div> </td> </tr>
  </table> <span style="text-decoration: underline"> </span>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z21ccde3f000f4a5d9f6868a5d6db33bb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-14.htm">2.2</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-14.htm">Form of Registrant&#8217;s Ordinary
        Share Warrant Certificate (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z28a0cfea95d648be9a23fca89da8e648" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">2.3</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315000567/exhibit_4-6.htm">Form of Warrant Agreement dated as of
        February 24, 2015 between Check-Cap Ltd. and American Stock Transfer &amp; Trust Company LLC, as Warrant Agent (20)</a></div> </td> </tr>
  </table>

<div style="margin-left: 429.5pt; line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z85e98392872e440d8aa134153dcd8b88" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.4pt"><br /> </td>
    <td style="width: 50.35pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315002104/exhibit_4-1.htm">2.4</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315002104/exhibit_4-1.htm">Amendment No.1 dated as of June 24,
        2015, to Warrant Agreement dated as of February 24, 2015 between Check-Cap Ltd. and American Stock Transfer &amp; Trust Company LLC, as
        Warrant Agent (4)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zdbf8b7584b9643f18907dc36df462948" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">2.5</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891317003232/exhibit_4-2.htm">Form of Ordinary Shares Warrant Certificate
        issued pursuant to a certain Credit Line Agreement dated as of August 20, 2014 (21)</a></div> </td> </tr>
  </table>

<div><br /> </div>

<table cellspacing="0" cellpadding="0" id="z2fdfa10ae5ea4976a5a560c520f8c47e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-15.htm">2.6</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-15.htm">Forms of Ordinary Shares Warrant Certificate
        issued to the Pontifax entities (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z7093b82dc77d49a2865f49e11dafdf8a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-14.htm">2.7</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-14.htm">Form of Series C Warrant (5)</a></div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z26c4932168044caf9fab88b70b6ac54f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-15.htm">2.8</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001272/exhibit_4-15.htm">Form of Warrant Agent Agreement between
        Check-Cap Ltd. and American Stock Transfer &amp; Trust Company LLC, as Warrant Agent (5)</a></div> </td> </tr>
  </table>

<div style="margin-left: 363.05pt; line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z9361e3287fb844b0813deadd6e02c5bf" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-1.htm">2.9</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-1.htm">Form of February 2019 Series D Warrant
        (7)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm"><br /> </a>
</div> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm"> </a> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm"> </a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm"> </a>

<table cellspacing="0" cellpadding="0" id="z2151c9cc428b49b78fb695ea567b81c6" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-3.htm">2.10</a></td>
    <td style="width: auto; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/zk1922567.htm"> </a>
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_4-3.htm">Form of the February 2019 Placement
        Agent Warrant (7)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z53344a678ba54b8daf91019c58d54aa3" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-1.htm">4.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-1.htm">2006 Unit Option Plan and Amendments
        thereto (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z07ecfa595d814da394f799ec63785f33" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-4.htm">4.2</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-4.htm">Form of Series C-1 preferred shares
        purchase warrant (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z7dd671ded9ca418d8c27cabaa0b4fce5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-5.htm">4.3</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-5.htm">Forms of Series C-2 preferred shares
        purchase warrant (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z04709365dca941b0a113b05300ef3bea" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-10.htm">4.4</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-10.htm">Asset Transfer Agreement, dated as
        of May 31, 2009 by and between Check-Cap Ltd. and Check-Cap LLC (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z70518cab16044398b1f376ebe73c08af" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-11.htm">4.5</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-11.htm">The Agreement for ASIC Design and
        Development dated November 26, 2009 by and between Check-Cap Ltd. and Politechnico di Milano (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf722b1338f75416fb01c5afbd5a01854" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-12.htm">4.6</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891314003928/exhibit_10-12.htm">Form of Indemnification Agreement
        (1)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc489118274d749548b73d9b1c815dcbe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315002199/exhibit_99-3.htm">4.7</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891315002199/exhibit_99-3.htm">2015 Equity Incentive Plan and 2015
        United States Sub-Plan to 2015 Equity Incentive Plan (2)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zdd24bd8f4f0a4b259da99fee3e5dcdbd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002868/exhibit_99-1.htm">4.8</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002868/exhibit_99-1.htm">Compensation Policy for Executive Officers
        and Directors (15)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z9d0c331566ab477d990f902a70060766" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001462/exhibit_1-1.htm">4.9</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891318001462/exhibit_1-1.htm">Underwriting Agreement, dated as of
        May 4, 2018, by and between Check-Cap Ltd. and H.C. Wainwright &amp; Co., LLC (6)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zbb67db33afbb4bfcac1aa704f77b613a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">4.10</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891319000303/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of February 4, 2019 by and between Check-Cap Ltd. and the Purchasers named therein (7)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z0630830b9c224567b696a77611e5df1e" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320000745/exhibit_4-15.htm">4.11</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320000745/exhibit_4-15.htm">Form of Securities Purchase Agreement
        dated as of December 19, 2019 by and between Check-Cap Ltd. and the Purchasers named therein (8)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4953817b84b94b1e99b486ec6ccf4590" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhibit_10-1.htm">4.12</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of April 20, 2020 by and between Check-Cap Ltd. and the Purchasers signatory thereto (9)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf64e043e74ac4d45b14c9bd259d8776f" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-1.htm">4.13</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of April 30, 2020 by and between Check-Cap Ltd. and the Purchasers signatory thereto (10)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z565aad5b50984508b570e58eb4846416" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-1.htm">4.14</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of May 8, 2020 by and between Check-Cap Ltd. and the Purchasers signatory thereto (11)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z538e4b2c08db408ea38c54e2ca9e19d2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-1.htm">4.15</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of June 30, 2021 by and between Check-Cap Ltd. and the Purchasers signatory thereto (16)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">
</a> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm"> </a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm"> </a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">
</a>

<table cellspacing="0" cellpadding="0" id="z87c5fb1a119140f09d4072c5fb57b2fe" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">4.16</a></td>
    <td style="width: auto; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">
        </a>
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">Form of Warrant Exercise A</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">g</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">reement
        dated as of July 23, 2020 by and between Check-Cap Ltd. and the Purchasers s</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">ig</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">nato</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-1.htm">ry
        thereto (12)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z77ad7b9123524a5dbc770443d1612457" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-1.htm">4.17</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-1.htm">Form of Securities Purchase Agreement
        dated as of March 1, 2022 by and between Check-Cap Ltd. and the Purchasers signatory thereto (17)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zfad0d2103cbc45f5b1466b242f56ebc1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322001429/exhibit_4-22.htm">4.18</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322001429/exhibit_4-22.htm">Form of Warrant Amendment Agreement
        dated as of March 1, 2022 by and between Check-Cap Ltd. and the Purchasers signatory thereto (19)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z3695eb76d58d48f592c010ab5803c2e0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">4.19</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001161/exhiibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on April 22, 2020 (9)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z9c1b886f4baa4b6983d259ba74ffa3dd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-2.htm">4.20</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001286/exhibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on May 4, 2020 (10)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z8c420dd22f5448e88adc3798e71fa463" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-2.htm">4.21</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001436/exhibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on May 13, 2020 (11)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z413447b6b2e54ee59f1b85580fab0898" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-2.htm">4.22</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on July 27, 2020 (12)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm"><br /> </a>
</div> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm"> </a> <a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm"> </a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">
</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm"> </a>

<table cellspacing="0" cellpadding="0" id="z285887e8eb8f4684a800179ecc39d9a2" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">4.23</a></td>
    <td style="width: auto; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">
        </a>
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on Ju</a><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-2.htm">ly 2, 2021 (16)</a></div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><span style="text-decoration: underline"><br /> </span> </div> <span style="text-decoration: underline">
</span>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">77</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf60b440c0e71489a92669278d9c00ec5" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-2.htm">4.24</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-2.htm">Form of Warrant issued by Check-Cap
        Ltd. on March 3, 2022 (17)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf7b037790bea47bfa09d1b2010bf1313" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-5.htm">4.25</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-5.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on April 22, 2020 (13)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zf3de3003c2444e6cbe35a3bad9278edd" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-6.htm">4.26</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-6.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on May 4, 2020 (13)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z524eb2b0fea344baba551bcdf4d413c9" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-7.htm">4.27</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320001553/exhibit_10-7.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on May 13, 2020 (13)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zca448455a3d9473a80233545b2ed48dc" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-3.htm">4.28</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891320002081/exhibit_10-3.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on July 27, 2020 (12)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zc01279589d1a491aaaaaf57e92432763" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-3.htm">4.29</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321002209/exhibit_10-3.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on July 2, 2021 (16)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zb4aa7143a54c415199985521e9a8d23a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-3.htm">4.30</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891322000913/exhibit_10-3.htm">Form of Placement Agent Warrant issued
        by Check-Cap Ltd. on March 3, 2022 (17)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zeffeb2748b1c446fb63bbc4923bf4059" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_4-28.htm">4.31</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321001100/exhibit_4-28.htm">Exclusive License Agreement between
        the Company and the Curators of the University Of Missouri, dated February 26, 2021 (18)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891316004712/exhibit_8-1.htm">8.1
        <br /> </a> </td>
    <td style="width: auto; vertical-align: top">
        <div><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891316004712/exhibit_8-1.htm">List of Subsidiaries (22)</a></div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div> </div>

<table cellspacing="0" cellpadding="0" id="z9c042a366ecd429f9d63ce5a899cd22a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="exhibit_12-1.htm">12.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_12-1.htm">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z6ab2b21a66c04d8683805dd78f5707f1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="exhibit_12-2.htm">12.2</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_12-2.htm">Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="exhibit_13-1.htm">13.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_13-1.htm">Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350,
        as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></div> </td> </tr>
  </table> <br /> </div>

<table cellspacing="0" cellpadding="0" id="z445368907d8440aeb5293639a7bfcc48" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 50.4pt; vertical-align: top"><a href="exhibit_15-1.htm">15.1</a></td>
    <td style="width: auto; vertical-align: top">
        <div><a href="exhibit_15-1.htm">Consent of Brightman Almagor Zohar &amp; Co., independent registered public accounting firm&#160;101.INSInline
        XBRL Instant Document</a></div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 7.4pt; line-height: 1.25">101.SCH&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Inline XBRL Taxonomy Extension
Schema Document</div>

<div style="line-height: 1.25"><br /> </div>

<div style="margin-right: 319.7pt; margin-left: 7.4pt; line-height: 1.25">101.CAL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Inline
XBRL Taxonomy Extension Calculation Linkbase Document </div>

<div style="margin-right: 319.7pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="margin-right: 319.7pt; margin-left: 7.4pt; line-height: 1.25">101.DEF&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Inline
XBRL Taxonomy Extension Definition Linkbase</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-right: 348.35pt; margin-left: 7.4pt; line-height: 1.25">101.LAB&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Inline
XBRL Taxonomy Extension Label Linkbase </div>

<div style="margin-right: 348.35pt; margin-left: 7.4pt; line-height: 1.25"> <br /> </div>

<div style="margin-right: 348.35pt; margin-left: 7.4pt; line-height: 1.25">101.PRE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inline
XBRL Taxonomy Extension Presentation Linkbase</div>

<div><br /> </div>

<div><span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><br /> </div> <br />

<table cellspacing="0" cellpadding="0" id="z6077e46eff8b4e039c0a19ff461e4048" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 25.2pt; vertical-align: top">(1)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Registration Statement on Form F-1 of the Registrant (File No. 333-201250).</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z6c9dc3c42a884978b09d7a99ce02a079" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 25.2pt; vertical-align: top">(2)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: Times New Roman,serif">Incorporated by reference to Annex B of Exhibit
        99.3 to the Form 6-K filed by the Registrant with the Form 6-K filed by the Registrant with the Securities Exchange Commission on July
        6, 2015.</div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z56a67929b8564c8a8f12df475dbcddd1" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 25.2pt; vertical-align: top">(3)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on August 12, 2016.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z25ce12f58a7145e68dbb7c8bea7c277c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(4)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on June 24, 2015.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z7df6b60f55134dc392e68b04b0b6f883" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(5)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Registration Statement on Form F-1/A by the Registrant with the Securities and Exchange Commission
        on April 25, 2018.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc3d2a2ff71624a5687b9ce56f0d574fb" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(6)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on May 4, 2018.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z95e4688b6feb44ca9e153071cd2f7491" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(7)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on February 6, 2019.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z5244e09cfdb24b499ff30069c099b9f8" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(8)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Annual Report on Form 20-F filed by the Registrant with the SEC on March 6, 2020.</div> </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="zb106816ea33e4379a2c2278e46034a7a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.35pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(9)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on April 22, 2020.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="za5c936e6f3e04b63975bdada2ee3fd00" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(10)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on May 4, 2020.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z2675805aca4849e2b96092109031c450" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(11)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on May 12, 2020.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zd9a244446a4c4459b39615e70c94d440" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(12)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on July 24, 2020.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z1b2b68bce2174cf598ee1ff1821b1c85" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(13)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Registration Statement on Form F-1 by the Registrant with the SEC on May 20, 2020.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zf5603d2cdd2840fcabce27865f6dd767" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(14)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Annual Report on Form 20-F filed by the Registrant with the Securities and Exchange Commission on
        March 15, 2016.</div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z4a5da8389e0341edb3918eea0481bc7a" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(15)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25; color: rgb(0, 0, 0); font-family: Times New Roman,serif">Incorporated by reference to the Annex A of Exhibit
        99.1 to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on October 11, 2020.</div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="z210fa1322d9b402584f0dad0afb1425b" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(16)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on July 2, 2021.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25">&#160;</div>

<table cellspacing="0" cellpadding="0" id="zc0336f238d524d9d958649d157d9627c" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(17)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Form 6-K filed by the Registrant with the Securities and Exchange Commission on March 3, 2022.</div>
        </td> </tr>
  </table>

<div style="line-height: 1.25"><br /> </div>

<table cellspacing="0" cellpadding="0" id="z02e92e96dde14306ae7c63d8bb5c5bce" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(18)</td>
    <td style="width: auto; vertical-align: top">
        <div>Incorporated by reference to the Annual Report on Form 20-F filed by the Registrant with the SEC on March 18, 2021.</div> </td> </tr>
  </table>

<div><br /> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(19)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25">Incorporated by reference to the Annual Report on Form 20-F filed by the Registrant with the SEC on April
        6, 2022.</div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">

<div><br /> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(20)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif">Incorporated by reference to the Registration Statement
        on Form F-1/A by the Registrant with the Securities and Exchange Commission on February 17, 2015.</div> </div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">

<div><br /> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(21)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif">Incorporated by reference to the Form 6-K filed by
        the Registrant with the Securities and Exchange Commission on November 22, 2017.</div> </div> </div> </td> </tr>
  </table>

<div style="line-height: 1.25">

<div style="line-height: 1.25">

<div><br /> </div>

<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font: 10pt Times New Roman, Times, serif; width: 100%; text-align: left; color: #000000">
  <tr>
    <td style="width: 7.3pt"><br /> </td>
    <td style="width: 25.25pt; vertical-align: top">(22)</td>
    <td style="width: auto; vertical-align: top">
        <div>
        <div style="line-height: 1.25">
        <div style="line-height: 1.25; color: #000000; font-family: Times New Roman, serif">Incorporated by reference to the Annual Report on
        Form 20-F filed by the Registrant with the SEC on March 15, 2016.</div> </div> </div> </td> </tr>
  </table> </div> </div> </div> </div> </div>

<div style="line-height: 1.25">&#160;</div> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageNumberArea" style="text-align: center"><span class="BRPFPageNumber" style="font-weight: normal; font-style: normal">78</span></div>

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div>

<div style="text-align: center; margin-right: 150.65pt; margin-left: 150.65pt; line-height: 1.25; font-weight: bold"><span id="SIGNATURES"><!--Anchor--></span>SIGNATURES</div>

<div style="line-height: 1.25">&#160;</div>

<div style="margin-left: 7.4pt; line-height: 1.25">The Registrant hereby certifies that it meets all of the requirements for filing on
Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</div>

<div style="line-height: 1.25">&#160;

<table cellspacing="0" cellpadding="0" border="0" id="z18ec28ae78a14a45ba540a1b93977660" style="font: 10pt Times New Roman, Times, serif; color: #000000; width: 100%">
  <tr>
    <td style="width: 50%; text-align: left; vertical-align: top">
        <div>&#160;<span style="font-family: Times New Roman,Times,serif">Date: March 31, 2023</span>&#160; <br /> </div> </td>
    <td style="width: 50%">
        <div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif; font-weight: bold">CHECK-CAP LTD.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; line-height: 1.25"><span style="font-family: Times New Roman,Times,serif">By: <span style="text-decoration: underline">/s/
        Alex Ovadia</span></span></div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">Name: Alex Ovadia</div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">Title: Chief Executive Officer (Principal Executive
        Officer)</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">By: <span style="text-decoration: underline">/s/
        Mira Rosenzwe</span>ig </div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">Name: Mira Rosenzweig</div>
        <div style="text-align: left; line-height: 1.25; font-family: Times New Roman,Times,serif">Title: Chief Financial Officer (Principal Financial
        Officer and Principal Accounting Officer)</div> </div> </td> </tr>
  </table> </div>

<div style="line-height: 1.25"> <br /> </div>

<div style="line-height: 1.25; text-align: center">79<br /> </div>

<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt">

<div class="BRPFPageBreak" style="page-break-after: always"> <hr style="border-width: 0px; margin: 4px 0px; clear: both; width: 100%; height: 2px; color: #000000; background-color: #000000" /></div>
</div> <br /> </div>
<!-- Field: /Include-Text -->
<div>&#160;</div>
    <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
      <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
    </div>
  </div>
  <div>&#160;<div>
      <div style="text-align:center;margin-right:1.05pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;margin-right:1.05pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
      <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Table of Contents</span></span></div>
      <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="width:100%">

          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Page</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#FIRM_integixAnchor">Report of Independent Registered Public Accounting Firm</a> (PCAOB ID No. <ix:nonNumeric id="Fxbrl_20220319133813796" name="dei:AuditorFirmId" contextRef="C_20220101to20221231">1197</ix:nonNumeric>)</span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-2</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#SHEETS_integixAnchor">Consolidated Balance Sheets</a></span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-4</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#OPERATIONS_integixAnchor">Consolidated Statements of Operations</a></span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-5</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#EQUITY_integixAnchor">Consolidated Statements of Changes in Shareholders' Equity</a></span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-6</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#FLOWS_integixAnchor">Consolidated Statements of Cash Flows</a></span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-7- F-8</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:91%">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#NOTES_integixAnchor">Notes to Consolidated Financial Statements</a></span></span></div>
            </td>
            <td style="vertical-align:bottom;width:1%">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td style="vertical-align:bottom;width:8%">
              <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-9 - F-37</span></span></div>
            </td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="page-break-after:always">
        <hr style="background:rgb(0, 0, 0);width:100%;border-top:2px solid black" />
      </div>
      <div style="line-height:1.25;font-weight:bold;margin-bottom:10pt">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><img alt="image0.jpg" src="image0.jpg" style="width:144px;height:27px" /></div>
      <div style="line-height:1.25;font-weight:bold">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><span id="FIRM_integixAnchor"></span> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To the shareholders and the Board of Directors of Check-Cap Ltd.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Opinion on the Financial Statements</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have audited the accompanying consolidated balance sheets of Check-Cap Ltd. and subsidiaries (the "Company") as of December 31, 2022 and 2021, the related consolidated statements of operations, shareholders' equity, and cash flows, for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the " consolidated financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basis for Opinion</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical Audit Matter</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 2</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
      <div>
        <div>
          <div style="text-align:justify;line-height:1.25;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in Ordinary Share Capital&#8211; Refer to Note 10 to the Consolidated Financial Statements</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Critical Audit Matter Description</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the year ending December 31, 2022, the Company raised equity in the aggregate amount of $10,000 thousands ($8,850 thousands net of issuance expenses), through an equity transaction, by issuing shares and warrants.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We deemed our audit over the allocation, classification and accuracy of equity transaction as challenging from a perspective of audit effort in comparison to our audit as a whole, because of the amount of equity transaction and due to the magnitude of total amounts raised. As such, we believe this represents a critical audit matter.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">How the Critical Audit Matter Was Addressed in the Audit</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Our audit procedures related to equity transaction included the following, among others:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:13.5pt">&#160;</td>
                <td style="width:11.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We read the agreements and analyzed the terms of the Company&#8217;s equity transaction.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:13.5pt">&#160;</td>
                <td style="width:11.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We evaluated the interpretation and application of the relevant accounting guidance in relation to the appropriateness of the classification in equity of warrants issued in this transaction.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:13.5pt">&#160;</td>
                <td style="width:11.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We agreed the consideration received from the transaction to the respective bank statement.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:13.5pt">&#160;</td>
                <td style="width:11.5pt;vertical-align:top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We compared the shares issued and outstanding to the confirmation obtained directly from the transfer agent.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">/s/ <ix:nonNumeric id="Fxbrl_20230304161929360" name="dei:AuditorName" contextRef="C_20220101to20221231">Brightman Almagor Zohar &#38; Co.</ix:nonNumeric></span></span></div>
          </div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certified Public Accountants</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A Firm in the Deloitte Global Network</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20230304161939673" name="dei:AuditorLocation" contextRef="C_20220101to20221231">Tel Aviv, Israel</ix:nonNumeric></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 31<sup style="vertical-align:text-top;line-height:1;font-size:smaller">st</sup>, 2023</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">We have served as the Company's auditor since 2005.</span></span></div>
        </div>
      </div>
    </div>
  </div>
  <div style="text-align:justify;line-height:1.25">&#160;</div>
  <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
    <div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:normal;font-style:normal">F - 3</span></span></span></div>
    <div style="page-break-after:always">
      <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
    </div>
  </div>

  <div>
    <div>
      <div>
        <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold">&#160;</div>
        <div>
          <div>
            <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD</span></span></div>
            <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED BALANCE <span id="SHEETS_integixAnchor"></span>SHEETS</span></span></div>
            <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Assets</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current assets</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;text-align:center" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255);text-align:center" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_46" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,090</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_410" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,457</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2(N)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_57" name="us-gaap:RestrictedCashCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_511" name="us-gaap:RestrictedCashCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposit</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_67" name="us-gaap:ShortTermInvestments" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,609</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_611" name="us-gaap:ShortTermInvestments" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,104</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current assets</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_77" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">579</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_711" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">839</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current assets</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_87" name="us-gaap:AssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,630</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_811" name="us-gaap:AssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,750</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current assets</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_117" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,751</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_1111" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,793</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_127" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,060</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_1211" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,116</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total non-current assets</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_137" name="us-gaap:AssetsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,811</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_1311" name="us-gaap:AssetsNoncurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,909</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total assets</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_147" name="us-gaap:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,441</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_1411" name="us-gaap:Assets" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,659</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities and shareholders' equity</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable and accruals</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_197" name="us-gaap:AccountsPayableCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">952</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_1911" name="us-gaap:AccountsPayableCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,050</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_207" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">802</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2011" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">680</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Employees and payroll accruals</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_217" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,261</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2111" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,961</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_227" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">337</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2211" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303014440873" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303014449199" name="us-gaap:OtherLiabilitiesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_237" name="us-gaap:LiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,408</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2311" name="us-gaap:LiabilitiesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,041</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Non-current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties provision</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8(A)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_267" name="chek:RoyaltiesProvision" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2611" name="chek:RoyaltiesProvision" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_277" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">627</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2711" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">795</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total non-current liabilities</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_287" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">721</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_2811" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">927</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders' equity</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share capital, Ordinary shares <ix:nonFraction id="Fxbrl_20220110100156262" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20211231" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100152327" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20221231" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal">48</ix:nonFraction></ix:nonFraction> NIS par value (<ix:nonFraction id="Fxbrl_20220318215058864" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100242260" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">18,000,000</ix:nonFraction></ix:nonFraction> authorized shares as</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of December 31, 2022 and 2021; <ix:nonFraction id="Fxbrl_20220110100335726" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220204170028268" name="us-gaap:CommonStockSharesIssued" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,844,463</ix:nonFraction></ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220110100412456" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220204170036612" name="us-gaap:CommonStockSharesIssued" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,840,089</ix:nonFraction></ix:nonFraction> shares issued and</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">outstanding as of December 31, 2022 and 2021, respectively) (1)</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_337" name="us-gaap:CommonStockValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,664</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_3311" name="us-gaap:CommonStockValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,787</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional paid-in capital</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_347" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,941</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_3411" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90,089</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110094722862_357" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">127,293</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110094722862_3511" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">108,185</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total shareholders' equity</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_367" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,312</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_3611" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,691</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25">&#160;</div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities and shareholders' equity</span></span></div>
                  </td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:center;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_387" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,441</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110094722862_3811" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,659</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
            <div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>
            <div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) All share amounts have been retroactively adjusted to reflect a 1-for-20 share reverse split, see Note 1(A)(6).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes to the consolidated financial statements are an integral part of them.</span></span></div>
          </div>
        </div>
      </div>
    </div>
    <div style="line-height:1.25">&#160;</div>
    <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
      <div style="text-align:center"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 4</span></span></span></span></div>
      <div style="page-break-after:always">
        <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
      </div>
    </div>
  </div>

  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span id="OPERATIONS_integixAnchor"></span> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD</span></span></div>
      <div>
        <div>
          <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF OPERATIONS</span></span></div>
          <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended December 31,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Note</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development expenses, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_37" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,271</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_311" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,349</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_315" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,008</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative expenses</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_47" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,763</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_411" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,972</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_415" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_57" name="us-gaap:OperatingIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">20,034</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_511" name="us-gaap:OperatingIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,321</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_515" name="us-gaap:OperatingIncomeLoss" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,932</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Finance income, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_77" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">926</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_711" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_715" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_117" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_1111" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_1115" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Comprehensive loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_147" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_1411" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110100807950_1415" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss per share:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss per ordinary share - basic and diluted</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20221103162004278" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_167" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.37</ix:nonFraction></ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230327125341719" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_1611" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.14</ix:nonFraction></ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230327125429631" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20200101to20201231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_1615" name="us-gaap:EarningsPerShareBasic" contextRef="C_20200101to20201231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.01</ix:nonFraction></ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:center;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Weighted average number of ordinary shares outstanding - basic and diluted</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230327125604401" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_187" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">5,671,786</ix:nonFraction></ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230327125547242" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_1811" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">4,159,870</ix:nonFraction></ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><ix:nonFraction id="Fxbrl_20230327125532585" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20200101to20201231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110100807950_1815" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" contextRef="C_20200101to20201231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">1,537,060</ix:nonFraction></ix:nonFraction></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes to the consolidated financial statements are an integral part of them.</span></span></div>
        </div>
      </div>
      <div style="line-height:1.25;font-weight:bold">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 5</span></span></span></div>
      </div>
    </div>
  </div>
  <div style="page-break-after:always">
    <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000;margin-bottom:10pt" />
  </div>

  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold;margin-top:0pt">&#160;</div>
      <div>
        <div><span id="EQUITY_integixAnchor"></span>
          <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD</span></span></div>
          <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></span></div>
          <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

              <tr>
                <td style="vertical-align:bottom" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">paid-in</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders&#8217;</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amount</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">capital</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2019</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_223" name="us-gaap:SharesOutstanding" contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">433,129</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_227" name="us-gaap:StockholdersEquity" contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,407</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2211" name="us-gaap:StockholdersEquity" contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,964</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_2219" name="us-gaap:StockholdersEquity" contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">77,137</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2223" name="us-gaap:StockholdersEquity" contextRef="C_20191231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,234</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during 2020:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares in private</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">placement, net of issuance expenses in</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">an amount of approximately $<ix:nonFraction id="Fxbrl_20220110135859552" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_20200101to20201231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_263" name="chek:StockIssuedDuringPeriodSharesPrivatePlacementShares" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">136,009</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_267" name="chek:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,894</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2611" name="chek:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,837</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2619" name="chek:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2623" name="chek:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,731</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares and warrants</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">in the April &#8211; May 2020 Financings, net</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">of issuance expenses in an amount of $<ix:nonFraction id="Fxbrl_20220110140010029" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_20200401to20200531" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,361</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_293" name="chek:StockAndWarrantIssuedDuringPeriodSharesInFinancing" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">958,335</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_297" name="chek:StockAndWarrantIssuedDuringPeriodValueInFinancing" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,039</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_2911" name="chek:StockAndWarrantIssuedDuringPeriodValueInFinancing" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,900</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2919" name="chek:StockAndWarrantIssuedDuringPeriodValueInFinancing" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_2923" name="chek:StockAndWarrantIssuedDuringPeriodValueInFinancing" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,139</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares and</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">warrants in the Warrant Exercise Transaction,</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">net of issuance expenses in an amount of $<ix:nonFraction id="Fxbrl_20220318175401467" name="chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">920</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_323" name="chek:StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">802,712</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_327" name="chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,290</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_3211" name="chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,578</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3219" name="chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3223" name="chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,712</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU vesting</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_333" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,258</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_337" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_3311" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3319" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3323" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_343" name="chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_347" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3411" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3423" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_357" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3511" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_3519" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_3523" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2020</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_363" name="us-gaap:SharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,331,443</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_367" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,646</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3611" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75,715</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110102728392_3619" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">90,983</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110102728392_3623" name="us-gaap:StockholdersEquity" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,378</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during 2021:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of warrants, net of issuance expenses in an amount of $<ix:nonFraction id="Fxbrl_20220318175413882" name="chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000202575_xbrl_20220110102728392_293" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,210,235</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000202575_xbrl_20220110102728392_297" name="chek:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,099</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000202575_xbrl_20220110102728392_2911" name="chek:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,120</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000202575_xbrl_20220110102728392_2919" name="chek:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000202575_xbrl_20220110102728392_2923" name="chek:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,219</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $<ix:nonFraction id="Fxbrl_20220203235823127" name="chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" contextRef="C_20210601to20210630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,199</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000224573_xbrl_20220110102728392_323" name="chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,296,297</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000224573_xbrl_20220110102728392_327" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,011</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000224573_xbrl_20220110102728392_3211" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,790</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000224573_xbrl_20220110102728392_3219" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000224573_xbrl_20220110102728392_3223" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,801</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Option exercise</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_323" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_327" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204012510481" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_3219" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_3223" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU vesting</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000300886_xbrl_20220110102728392_333" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000300886_xbrl_20220110102728392_337" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204181420700" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000300886_xbrl_20220110102728392_3319" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000300886_xbrl_20220110102728392_3323" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324113453670" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000412732_xbrl_20220110102728392_343" name="chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">491</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000412732_xbrl_20220110102728392_3411" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000412732_xbrl_20220110102728392_3423" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318175435891_xbrl_20220110102728392_357" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318175435891_xbrl_20220110102728392_3511" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220318175435891_xbrl_20220110102728392_3519" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220318175435891_xbrl_20220110102728392_3523" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000438363_xbrl_20220110102728392_363" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,840,089</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000438363_xbrl_20220110102728392_367" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,787</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000438363_xbrl_20220110102728392_3611" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90,089</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204000438363_xbrl_20220110102728392_3619" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">108,185</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204000438363_xbrl_20220110102728392_3623" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,691</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes during 2022:</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares and warrants in the March 2022 Registered Direct Offering, net of issuance expenses in an amount of $<ix:nonFraction id="Fxbrl_20230303025654861" name="chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" contextRef="C_20220302to20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,150</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230326115250330" name="chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230305163210175" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,815</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303030209057" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,965</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030219827" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030228341" name="chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,850</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RSU vesting</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030241198" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,374</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030250501" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303030301467" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">62</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030323916" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030334466" name="chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">879</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030350937" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303030405691" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">879</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230303025948552" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">)</span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">(<ix:nonFraction id="Fxbrl_20230303025955824" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303025818543" name="us-gaap:SharesOutstanding" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,844,463</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303025825034" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,664</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303025831895" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84,941</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303025841086" name="us-gaap:StockholdersEquity" contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">127,293</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303025853585" name="us-gaap:StockholdersEquity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,312</ix:nonFraction></span></span></div>
                </td>
                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="margin-right:7.3pt;margin-left:21.55pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1) All share amounts have been retroactively adjusted to reflect a 1-for-20 share reverse split, see Note 1(A)(6).</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes to the consolidated financial statements are an integral part of them.</span></span></div>
        </div>
      </div>
      <div style="line-height:1.25;font-weight:bold">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="font-weight:normal;font-style:normal">F - 6</span></span></span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD</span></span></div>
    </div>
  </div>
  <div>
    <div>
      <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span id="FLOWS_integixAnchor"></span> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
      <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table border="0" cellpadding="0" cellspacing="0" style="width:100%">

          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM OPERATING ACTIVITIES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net loss</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110113921085" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204002357179" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110113959290" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments required to reconcile net loss to net cash used in operating activities:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation and amortization</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_53" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_57" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_511" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">148</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_63" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">879</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_67" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_611" name="us-gaap:ShareBasedCompensation" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Financial expense (income), net</p>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303034308944" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">624</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_77" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_711" name="us-gaap:OtherNoncashIncomeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in assets and liabilities items:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease (increase) in prepaid and other current assets and non-current assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204003058063" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">273</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303034341577" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">549</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_911" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">106</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in trade accounts payable, accruals and other current liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_103" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">207</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204003324702" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">362</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303033525847" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">317</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;padding-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Increase (decrease) in employees and payroll accruals</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303033513587" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">700</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_117" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_1111" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">409</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Decrease in royalties provision</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_123" name="us-gaap:IncreaseDecreaseInRoyaltiesPayable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">38</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_127" name="us-gaap:IncreaseDecreaseInRoyaltiesPayable" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_1211" name="us-gaap:IncreaseDecreaseInRoyaltiesPayable" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">28</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:0pt;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_133" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">18,707</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_137" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,264</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_1311" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,113</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM INVESTING ACTIVITIES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property and equipment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_163" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">486</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_167" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,006</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303040610122" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">379</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;padding-bottom:0pt;background-color:rgb(204, 238, 255);width:1%" valign="bottom">)</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Investment in short-term bank and other deposits</p>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_173" name="us-gaap:PaymentsForProceedsFromInvestments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,022</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204003703620" name="us-gaap:PaymentsForProceedsFromInvestments" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303034540276" name="us-gaap:PaymentsForProceedsFromInvestments" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,072</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:0pt;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">)</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in investing activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110112640402_183" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,508</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204003713499" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">16,006</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303034550576" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10,451</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM FINANCING ACTIVITIES</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of warrants into ordinary shares, net of issuance expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204011210270" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180356453" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,219</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180400016" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares in the registered direct offerings, net of issuance expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204011219076" name="chek:ProceedsFromIssuanceResisteredDirectOffering" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,850</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180412989" name="chek:ProceedsFromIssuanceResisteredDirectOffering" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,801</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180415539" name="chek:ProceedsFromIssuanceResisteredDirectOffering" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,139</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options exercise</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204011225719" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180429204" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318180431996" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_213" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_217" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_2111" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,712</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares in the private placement, net of issuance expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_223" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_227" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_2211" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,731</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by financing activities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_253" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,850</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_257" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,024</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_2511" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,582</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net increase (decrease) in cash, cash equivalents and restricted cash</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303035003661" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22,365</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_277" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,754</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220204005101962" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash, cash equivalents and restricted cash at the beginning of the year</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113557934" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,807</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110114107155" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,053</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113614233" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20191231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,035</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25">&#160;</div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash, cash equivalents and restricted cash at the end of the year</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110112640402_313" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,442</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113447569" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,807</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:1%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113504336" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,053</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:64%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Supplemental information for Cash Flow:</span></strong></p>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:64%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(255, 255, 255)" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental disclosure of non-cash flow information</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property and equipment</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_33" name="us-gaap:FairValueOfAssetsAcquired" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_37" name="us-gaap:FairValueOfAssetsAcquired" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_311" name="us-gaap:FairValueOfAssetsAcquired" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities arising from obtaining right-of-use assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_53" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">307</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_57" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,048</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_511" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental disclosure of cash flow information</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(204, 238, 255)">
            <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash paid for taxes</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_73" name="us-gaap:IncomeTaxesPaid" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_77" name="us-gaap:IncomeTaxesPaid" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113707527_711" name="us-gaap:IncomeTaxesPaid" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
          </tr>
          <tr style="background-color:rgb(255, 255, 255)">
            <td style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest received</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303035926934" name="us-gaap:InterestPaidNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">548</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303035935814" name="us-gaap:InterestPaidNet" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(255, 255, 255);width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303035952550" name="us-gaap:InterestPaidNet" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap;background-color:rgb(255, 255, 255);width:1%" valign="bottom">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes to the consolidated financial statements are an integral part of them.</span></span></div>
      <div>
        <div>&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 7</span></span></span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="text-align:center;margin-right:0.1pt;margin-left:0.1pt;line-height:1.25;font-weight:bold;margin-top:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHECK CAP LTD</span></span></div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEET</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:64%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and Cash equivalents</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202840048_xbrl_20220110113707527_33" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,090</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202840048_xbrl_20220110113707527_37" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,457</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202840048_xbrl_20220110113707527_311" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,703</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%;padding-bottom:2px" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash included current assets</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202844840_xbrl_20220110113707527_33" name="chek:RestrictedCashIncludedCurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202844840_xbrl_20220110113707527_37" name="chek:RestrictedCashIncludedCurrentAssets" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202844840_xbrl_20220110113707527_311" name="chek:RestrictedCashIncludedCurrentAssets" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total cash, cash equivalents, and restricted cash</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202846878_xbrl_20220110113707527_33" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,442</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202846878_xbrl_20220110113707527_37" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,807</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220318202846878_xbrl_20220110113707527_311" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,053</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes to the consolidated financial statements are an integral part of them.</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:normal;font-style:normal">F - 8</span></span></span></div>
        </div>
      </div>
    </div>
  </div>
  <div>
    <div>
      <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
    </div>
  </div>

  <div style="text-align:center;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">CHECK CAP LTD</span></strong></div>
  <div style="text-align:center;line-height:1.25">
    <div style="font-family:Times New Roman, Times, serif;display:inline">
      <div style="font-size:10pt;display:inline">
        <div style="display:inline">
          <div style="display:inline">
            <div style="display:inline">
              <div style="display:inline">
                <div style="display:inline">
                  <div style="display:inline">
                    <div style="display:inline">
                      <div style="display:inline">
                        <div style="display:inline">
                          <div style="display:inline">
                            <div style="display:inline">
                              <div style="display:inline">
                                <div style="font-weight:bold;display:inline"><span id="NOTES_integixAnchor">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <div style="text-align:center;line-height:1.25"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">(U.S. dollars in thousands, except share and per share data)</span></strong></div>
  <div style="line-height:1.25">&#160;</div>
  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20230324124605931" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1&#160; -&#160; GENERAL INFORMATION</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check Cap Ltd. (the &#8220;Company") was incorporated under the laws of the State of Israel. The registered address of its offices is 29 Abba Hushi Avenue, Isfiya 3009000, Israel.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a wholly-owned subsidiary, Check-Cap US, Inc., that was incorporated under the laws of the State of Delaware on May 15, 2015.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening and prevention through the introduction of C-Scan&#174;, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into cancer. The Company&#8217;s disruptive capsule-based screening technology aims to significantly increase screening adherence worldwide and help millions of people to stay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since its inception, the Company has devoted substantially all of its efforts to research and development, clinical trials, recruiting management and technical staff, acquiring assets and raising capital. The Company is still in its development and clinical stage and has not yet generated revenues. The Company has incurred losses of $<ix:nonFraction id="Fxbrl_20211122094228145" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230303145707513" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction> for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the Company's accumulated deficit was approximately $<ix:nonFraction id="Fxbrl_20211122094301552" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">127,293</ix:nonFraction>. The extent of the Company's future operating losses and the timing of becoming profitable are uncertain.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has funded its operations to date primarily through equity financings, sale of its ordinary shares and warrants, the exercise of warrants and other financing transactions and through grants from the Israel Innovation Authority of the Ministry of Economy and Industry (the "IIA").</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional funding will be required to complete the Company's research and development and clinical trials, to attain regulatory approvals, to establish manufacturing infrastructure and to begin the commercialization efforts of C-Scan. The Company has not yet commercialized its product. Even if the Company commercializes its product, it may not become profitable in the foreseeable future. The Company&#8217;s ability to achieve profitability depends on a number of factors, including its ability to obtain regulatory approval for its product, successfully complete any post-approval regulatory obligations and successfully commercialize its product alone or in partnership.</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To meet its capital needs, the Company is considering multiple alternatives, including, but not limited to, additional equity financings and other financing transactions. While the Company has been successful in raising funds in the past, there can be no assurance that it will be able to do so in the future on a timely basis on terms acceptable to the Company, or at all. Uncertain market conditions and approval by regulatory bodies and adverse results from clinical trials may (among other reasons) adversely impact the Company's ability to raise capital in the future.</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2023 , the Company announced that following its internal assessment of the clinical data collected to date from its clinical calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study and that therefore, the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 is temporarily postponed. The Company adopted a plan of action that includes (among other things) a cost reduction plan in order to extend its cash runway, which it is in the process of implementing. Based on such plan, the Company believes that current cash on hand will be sufficient to fund its ongoing operations and plans into the fourth quarter of 2024. Management expects that the Company will continue to generate losses from the development, manufacturing and infrastructure costs, clinical development and regulatory activities of C-Scan, which will result in negative cash flow from operating activity. The actual amount of cash that the Company will need to operate is subject to many factors, including, but not limited to, the initiation, timing, progress and results of clinical trials and other product development efforts regulatory path along with cost to commercialize its product.</span></span></div>
            <div style="text-align:justify;margin-left:76pt;line-height:1.25;font-family:Times New Roman, Times, serif">&#160;</div>
            <div><ix:exclude>
              <div>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                  <div>
                    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">9</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                  </div>
                </div>
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1&#160; -&#160; GENERAL INFORMATION (Cont.)</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;width:29pt">
                          <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">A.</span></span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:left;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">General</span>&#160;<span style="font-weight:bold">(cont.)</span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:exclude></div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As described in Notes 10B(2)(b) and 10B(2)(d), on February 24, 2015, the Company consummated an Initial Public Offering in the United States (U.S.) (the "IPO") concurrently with a private placement.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 11, 2016, the Company consummated a registered direct offering of ordinary shares and pre-funded warrants. See Note 10B(2)(h).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On June 2, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(i).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 22, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(j).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 8, 2018, the Company consummated an underwritten public offering of ordinary shares, pre-funded warrants and Series C warrants. See Note 10B(2)(k).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 6, 2019, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(l).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2020, the Company consummated a private placement of ordinary shares. See Note 10B(2)(m).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During April and May 2020, the Company consummated three registered direct offerings of ordinary shares and simultaneous private placements of warrants. See Note 10B(2)(n).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 27, 2020, the Company consummated a warrant exercise transaction to purchase ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(o).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During the first quarter of 2021, certain investors exercised their warrants previously issued by the Company</span>. See<span> Note 10B(2)(p).</span></span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 1, 2021, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(q).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 3, 2022, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(r).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's ordinary shares and Series C Warrants are listed on the NASDAQ Capital Market under the symbols "CHEK" and CHEKZ&#8221; respectively.</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s Series A Warrants, formerly listed on the NASDAQ Capital Market under the symbol &#8220;CHEKW&#8221;, expired on February 24, 2020; and their listing was suspended on February 28, 2020.</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements of the Company as of and for the year ended December 31, 2022 include the financial statements of the Company and its wholly-owned U.S. subsidiary.</span></span></div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif">&#160;</div>
              <div><ix:exclude>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                  <div>
                    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">10</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                  </div>
                </div>
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1&#160; -&#160; GENERAL INFORMATION (Cont.)</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General (cont.)</span></span></div>
                      </td>
                    </tr>

                </table>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 23, 2021, the Company announced that it received a letter from the Staff, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of $<ix:nonFraction id="Fxbrl_20230304162454834" name="chek:MinimumBidPriceValuePerShare" contextRef="C_20211223_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.00</ix:nonFraction> per share. The Company was provided by Nasdaq with a compliance period of 180 calendar days (i.e., until June 21, 2022) to regain compliance pursuant to Nasdaq Listing Rules. On June 22, 2022, the Company received a letter from the Staff notifying it that Nasdaq granted the Company a 180-day extension, or until December 19, 2022, or the Extension Period, to regain compliance with the Minimum Bid Price Requirement. In order to regain compliance, on August 11, 2022, the Company&#8217;s shareholders approved a reverse share split (&#8220;Reverse Share Split&#8221;) of its ordinary shares within a range of <ix:nonNumeric id="Fxbrl_20230304170954828" name="us-gaap:StockholdersEquityReverseStockSplit" contextRef="C_20220811to20220811">1 for 10 to 1 for 20</ix:nonNumeric>, the exact ratio to be determined by further action of the Company&#8217;s Board of Directors, to be effective on a date to be determined by the Company&#8217;s Board of Directors and announced by the Company, and to amend the Company&#8217;s Articles of Association accordingly. The Board of Directors subsequently approved a reverse share split of the Company&#8217;s ordinary shares at the ratio of <ix:nonNumeric id="Fxbrl_20230304170702241" name="us-gaap:StockholdersEquityReverseStockSplit" contextRef="C_20221123to20221123">1-for-20</ix:nonNumeric>, such that each twenty (20) ordinary shares, par value NIS <ix:nonFraction id="Fxbrl_20230304170729148" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20221123" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.40</ix:nonFraction> per share, consolidated into one (1) ordinary share, par value NIS <ix:nonFraction id="Fxbrl_20230304170736222" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">48.00</ix:nonFraction>, effective as of November 23, 2022. The first date when the Company&#8217;s ordinary shares began trading on the Nasdaq Capital Market after implementation of the Reverse Share Split was November 25, 2022. Following the implementation of the Reverse Share Split, the Company&#8217;s authorized share capital comprised of <ix:nonFraction id="Fxbrl_20230304170806553" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">18,000,000</ix:nonFraction> ordinary shares. No fractional ordinary shares were issued as a result of the Reverse Share Split. All fractional ordinary shares were rounded up to the nearest whole ordinary share. In addition, a proportionate adjustment made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase ordinary shares. Furthermore, following completion of the Reverse Share Split, the number of ordinary shares issuable pursuant to the Company&#8217;s 2006 Unit Option Plan and 2015 Equity Incentive Plan and 2015 US Sub-Plan to the 2015 Equity Incentive Plan, as well as the number of shares and exercise prices subject to outstanding options under the plans and the number of shares subject to outstanding restricted stock units (&#8220;RSUs&#8221;) under the plans were appropriately adjusted. The Company subsequently received a letter informing it that, for the 10 consecutive business days from November 25, 2022 to December 8, 2022, the closing bid price of the Company&#8217;s ordinary shares had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. The Company experienced temporary disruptions to its operations as a result of the COVID-19 pandemic including disruptions to the Company&#8217;s clinical studies For example, during a period of few months during the year ending December 31, 2022, there was a global shortage in iodine due to COVID-19, which is critical patient intake used in the C-Scan procedure. As a result, the Company faced delays in its clinical trials. &#160;The extent to which the COVID-19 pandemic shall impact the Company&#8217;s operations in the future will depend on future developments, which are highly uncertain and cannot be predicted with confidence. In particular, any future spread of COVID-19 globally or the reinstatement of restrictions or other actions that may be required to contain COVID-19 or treat its impact could materially adversely impact the Company&#8217;s operations and workforce, including its research and clinical trials and its ability to continue raise capital, could affect the operations of key governmental agencies, such as the U.S. Food and Drug Administration (&#8220;FDA&#8221;), which may delay the Company&#8217;s development plans, and could result in the inability of the Company&#8217;s suppliers to deliver components or raw materials on a timely basis or at all, each of which in turn could have a material adverse impact on the Company&#8217;s business, financial condition and results of operation.</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </div>
  <div>
    <div>
      <div>&#160;</div>
    </div>
  </div>
  <div style="line-height:1.25">
    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">11</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220318132820613" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div>
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></div>
            <div style="line-height:1.25;font-weight:bold">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company`s consolidated financial statements are presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").</span></span></div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324125801951" name="us-gaap:UseOfEstimates" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates in preparation of financial statements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</span></span></div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324125810887" name="us-gaap:ConsolidationPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's consolidated financial statements include the financial statements of Check-Cap Ltd. and its wholly-owned subsidiary, Check-Cap US, Inc. The Company's consolidated financial statements are presented after elimination of inter-company transactions and balances.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324125825983" name="chek:FunctionalCurrencyPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial statements in U.S. dollars</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has not yet generated revenues and the majority of its expenses are in U.S. dollars (dollar or USD) or NIS.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements are presented in dollars, which is the functional currency of the Company. In management's judgment, setting the dollar as the Company's functional currency, is based mainly on the following criteria: the Company's budget and other Company internal reports, including reports to the Company's Board of Directors and investors, are presented in dollars. Management uses these reports in order to make decisions for the Company. All of the Company's equity financings have been in dollars; and it is expected that a significant portion of the Company's future revenues will be in dollars.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances denominated in dollars are presented at their original amounts. Non&#8209;dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324125844556" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents include cash in hand, short&#8211;term deposits in banks and short-term, highly liquid investments with an original maturity of up to three months, with a high level of liquidity that may be easily converted to known amounts of cash, and that are exposed to insignificant risk of change in value.</span></span></div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324125857756" name="us-gaap:MarketableSecuritiesPolicy" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">E.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposit</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits are deposits with maturities of more than three months but less than one year. The short&#8211;term bank deposits are presented at their cost, including accrued interest, which approximates fair value.</span></span></div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324125915126" name="us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash flow hedges</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
                <div><ix:exclude>
                  <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                    <div>
                      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">12</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                    </div>
                  </div>
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2&#160; -&#160; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F.</span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash flow hedges (cont.)</span></span></div>
                        </td>
                      </tr>

                  </table>
                </ix:exclude></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $<ix:nonFraction id="Fxbrl_20230303142439415" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,264</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230303142448068" name="us-gaap:DerivativeAssetNotionalAmount" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,466</ix:nonFraction>, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company&#8217;s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $<ix:nonFraction id="Fxbrl_20230303142457720" name="chek:FairValueOfHedgingOption" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction> and an asset, net, of $<ix:nonFraction id="Fxbrl_20230303142508937" name="chek:FairValueOfHedgingOption" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65</ix:nonFraction>, respectively and is included in other current liabilities and other current assets, respectively.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324125934006" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">G.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>
                <ix:nonNumeric id="Fxbrl_20230324223227787" name="chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div style="margin-left:49pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Length&#160;of&#160;useful&#160;life</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dep</span><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">reciation&#160;</span></span></span><span style="font-size:10pt"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">rate</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211122102619344" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" format="ixt-sec:duryear">10</ix:nonNumeric>-<ix:nonNumeric id="Fxbrl_20211122102653603" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" format="ixt-sec:duryear">14</ix:nonNumeric></span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122102715061" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">7</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211122102732737" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211122102833075" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric>-<ix:nonNumeric id="Fxbrl_20211122102839885" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" format="ixt-sec:duryear">7</ix:nonNumeric></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122102845493" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20211122102850414" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20211122102933869" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric></span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122102939725" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324125949406" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">H.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's long-lived assets are reviewed for impairment in accordance with ASC 360-10 "Accounting for the Impairment or Disposal of Long-Lived Assets" whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324130002877" name="us-gaap:ResearchAndDevelopmentExpensePolicy" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and consist primarily of costs for personnel, subcontractors and consultants (mainly in connection with clinical trials) and materials for research and development and clinical activities. Grants received by the Company from the IIA are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. Such grants are included as a deduction of research and development costs.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            </ix:nonNumeric>
            <div><ix:exclude>
              <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">13</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2&#160; -&#160; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324130020717" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">J.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent liabilities</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC No. 450, "Contingencies". A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2022, and 2021, the Company is not a party to any ligation that could have a material adverse effect on the Company's business, financial position, results of operations or cash flows.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324130045079" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">K.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes expense for its share-based compensation based on the fair value of the awards granted. The Company&#8217;s share-based compensation plans provide for the award of stock options and restricted stock units. In accordance with ASC 718-10 "Compensation-Stock Compensation", the Company estimates the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the graded-vesting method over the requisite service period for each separately vesting portion of the award. Accounting Standards Update (&#8220;ASU&#8221;) 2016-09, Compensation-Stock Compensation (Topic 718) allows companies to account for forfeitures when they occur.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation cost for awards with performance conditions if and when the company concludes that it is probable that the performance conditions will be achieved. ASC 718&#8217;s use of the term probable is consistent with that term&#8217;s use in ASC 450, Contingencies, which refers to an event that is likely to occur (ASC Master Glossary). The Company reassess at each reporting period the probability of vesting for awards with performance conditions and adjusts compensation cost based on its probability assessment.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the years ended December 31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            </ix:nonNumeric>
            <div><ix:exclude>
              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                <div>
                  <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">14</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                </div>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2&#160; -&#160; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324130059523" name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740-10 "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 740, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered 'more-likely-than-not' that the position taken will be sustained by a taxing authority. As of December 31, 2022 and 2021, the Company had no unrecognized income tax positions, and, accordingly, there is no impact on the Company's effective income tax rate associated with these items.</span></span></div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324130115207" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">M.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of financial instruments</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures its investments in money market funds (classified as cash equivalents) and its foreign currency net purchased options at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2</span>. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3</span>. Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</span></span></div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            </ix:nonNumeric>
            <div><ix:exclude>
              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                <div>
                  <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">15</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                </div>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2&#160; -&#160; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Cont.)</span></span></div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <ix:nonNumeric id="Fxbrl_20230324130138280" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" contextRef="C_20220101to20221231" escape="true">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">N.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted Cash</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has granted a pledge in favor of Bank Leumi Le-Israel B.M in the amount of $<ix:nonFraction id="Fxbrl_20220204103001310" name="us-gaap:RestrictedCashCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20230327201802154" name="us-gaap:RestrictedCashCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction> as of &#160;December 31, 2022 and 2021, respectively to secure certain payment obligations of the Company in connection with hedge transactions. This amount was classified as restricted cash balance.</span></span></span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324130152596" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">O.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for leases in accordance with ASC 842 "Lesses.&#8221; Arrangements that are determined to be leases at inception are recognized as long-term operating lease assets and lease liabilities in the consolidated balance sheet at lease commencement. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As the Company&#8217;s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at the commencement date in determining the present value of future lease payments. Lease terms may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has also elected the practical expedient to include both lease and non-lease components as a single component and account for it as a lease. Additionally, the Company has made a policy election not to capitalize leases with an original term of 12 months or less.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 360-10, management reviews operating lease assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable based on estimated future undiscounted cash flows. If so indicated, an impairment loss would be recognized for the difference between the carrying amount of the asset and its fair value.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324130207004" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">P.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent accounting pronouncements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2021, the FASB issued ASU No. 2021- 10, Government Assistance (Topic 832). This ASU requires business entities to disclose information about government assistance they receive if the transactions were accounted for by analogy to either a grant or a contribution &#160;accounting &#160;model. &#160;The disclosure requirements include the nature of the transaction and the related accounting policy used, the line items on the balance sheets and statements of operations that are affected and the amounts applicable to each financial statement line item and the significant terms and conditions of the transactions. The ASU is effective for annual periods beginning after December 15, 2021. The disclosure requirements can be applied either retrospectively or prospectively to all transactions in the scope of the amendments that are reflected in the financial statements at the date of initial application and new transactions that are entered into after the date of initial application. The Company already adopted ASU No. 2021- 10, in its financial statements.</span></span></div>
              </div>
            </ix:nonNumeric>
            <ix:nonNumeric id="Fxbrl_20230324130219815" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;width:29pt">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Q.</span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassification</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders&#8217; deficit, net loss or net cash used in operating activities.</span></span></div>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <div>
    <div style="line-height:1.25">
      <div style="margin:0pt">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">16</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="Fxbrl_20220318134426817" name="chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock" contextRef="C_20220101to20221231" escape="true">
    <div>
      <div>
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 3&#160; -&#160; PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></strong></div>
      </div>
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
            <ix:nonNumeric id="Fxbrl_20230324113850184" name="chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_33" name="chek:GovernmentInstitutionalAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">88</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_37" name="chek:GovernmentInstitutionalAssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">206</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_43" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">260</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_47" name="us-gaap:PrepaidExpenseCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">470</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deposits</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_53" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_57" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_63" name="us-gaap:OtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">223</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_67" name="us-gaap:OtherAssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_73" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">579</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122111256860_77" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">839</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div>&#160;</div>

  <ix:nonNumeric id="Fxbrl_20230303041948260" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 4&#160; -&#160; PROPERTY AND EQUIPMENT, NET</span></span></strong></p>
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
            <ix:nonNumeric id="Fxbrl_20230324114327481" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042931920" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">799</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042940323" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">723</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042916493" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,915</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042951755" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,721</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042911561" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">574</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042956743" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">540</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042612131" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,288</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042620142" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,984</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042429767" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,537</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042437863" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,191</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042324075" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,751</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303042347481" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,793</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses amounted to $<ix:nonFraction id="Fxbrl_20230303042112113" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">346</ix:nonFraction>, $<ix:nonFraction id="Fxbrl_20230303042120726" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230303042136779" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">148</ix:nonFraction> for the years ended December 31, 2022, 2021 and 2020, respectively.</span></span></div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>

  <ix:nonNumeric id="Fxbrl_20220318135101502" name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="C_20220101to20221231" escape="true">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 5&#160; -&#160; LEASES</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 1, 2019, the Company adopted ASU 2016-02, using the modified retrospective approach for all lease arrangements at the beginning period of adoption.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 26, 2021, the Company entered into a new lease agreement, as amended (the &#8220;Amended Lease Agreement&#8221;), according to which, effective as of April 1, 2021, the Company leases a total of approximately <ix:nonFraction id="Fxbrl_20230304132358476" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">1,550</ix:nonFraction> square meters at its facility located in Isfiya, Israel. The Amended Lease Agreement expires on <ix:nonNumeric id="Fxbrl_20230304132411140" name="us-gaap:LeaseExpirationDate1" contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">December 31, 2023</ix:nonNumeric>, and the Company has an option to extend the lease period for an additional <ix:nonNumeric id="Fxbrl_20230304132425123" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The Company has the right to terminate the Amended Lease Agreement at any time, upon at least 60 days prior written notice. Monthly rental expenses under the lease agreement are $<ix:nonFraction id="Fxbrl_20230304132433773" name="us-gaap:LeaseAndRentalExpense" contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">16.1</ix:nonFraction>. Prior to entering into the Amended Lease Agreement, the Company leased approximately <ix:nonFraction id="Fxbrl_20230304132441183" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">900</ix:nonFraction> square meters at the same facility under a lease agreement, originally scheduled to expire on <ix:nonNumeric id="Fxbrl_20230304132449132" name="us-gaap:LeaseExpirationDate1" contextRef="C_20210101to20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">May 31, 2022</ix:nonNumeric>. According to ASC 842, the Amended Lease Agreement was accounted for as a lease modification and, therefore, the lease liability was remeasured as of the modification date with an adjustment recorded to the underlying right of use asset.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#8220;Sub-lease Agreement&#8221;), with a Company supplier (the &#8220;Lessor&#8221;) according to which, the Company leases approximately <ix:nonFraction id="Fxbrl_20230304155709886" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">70</ix:nonFraction> square meters laboratory space for the production of certain components, at the supplier&#8217;s premises in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on <ix:nonNumeric id="Fxbrl_20230304155916068" name="us-gaap:LeaseExpirationDate1" contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">January 31, 2025</ix:nonNumeric>, and the Company has an option to extend the lease period for an additional <ix:nonNumeric id="Fxbrl_20230304155752972" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric>. The Company has the right to terminate the Sub-lease Agreement at any time, upon at least 90 days prior written notice.</span></span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">17</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
            </div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 5&#160; -&#160; LEASES (Cont.)</span></span></div>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-right:0pt;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended service agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $<ix:nonFraction id="Fxbrl_20230304155722508" name="us-gaap:LeaseAndRentalExpense" contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">26.9</ix:nonFraction>. Following the effectiveness of the Sub-lease Agreement, the lease is recorded under ASC 842. As the Sub-lease Agreement is part of a service agreement with the supplier, management is required to evaluate the fair market amount attributed to the lease per month and based on its estimations, the amount allocated to the lease is approximately $<ix:nonFraction id="Fxbrl_20230304160448438" name="us-gaap:LeaseCost" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">2.8</ix:nonFraction> and the portion allocated to monthly services is $<ix:nonFraction id="Fxbrl_20230304160233683" name="us-gaap:OperatingLeaseExpense" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">24.1</ix:nonFraction>.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately <ix:nonFraction id="Fxbrl_20230304160535364" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">140</ix:nonFraction> square meters offices, The lease agreement expires on <ix:nonNumeric id="Fxbrl_20230304160621890" name="us-gaap:LeaseExpirationDate1" contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">February 28, 2024</ix:nonNumeric>, and the Company has an option to extend the lease period for two additional periods of <ix:nonNumeric id="Fxbrl_20230304160548676" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric> each. Total monthly rental expense under the lease agreement is approximately $<ix:nonFraction id="Fxbrl_20230304160601125" name="us-gaap:LeaseAndRentalExpense" contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">1.7</ix:nonFraction>. The lease agreement is recorded under ASC 842.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the Company leases vehicles under various operating lease agreements.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 31, 2022, the Company&#8217;s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $<ix:nonFraction id="Fxbrl_20230304160826542" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,060</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230304160834192" name="us-gaap:OperatingLeaseLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">964</ix:nonFraction>, respectively.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental cash flow information related to operating leases was as follows:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20220318135110150" name="chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash payments for operating leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114553545" name="us-gaap:OperatingLeasePayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">389</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>&#160;<div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the Company&#8217;s operating leases had a weighted average remaining lease term of <ix:nonNumeric id="Fxbrl_20230304140659061" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_20221231" format="ixt-sec:duryear">3.4</ix:nonNumeric> years and a weighted average borrowing rate of <ix:nonFraction id="Fxbrl_20230304140718589" name="us-gaap:DebtWeightedAverageInterestRate" contextRef="C_20221231" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.4</ix:nonFraction>%. Upon adoption of ASC 842, discount rates for existing operating leases were established as of January 1, 2019. Future lease payments under operating leases as of December 31, 2022 were as follows:</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20220318135119231" name="chek:ScheduleOfFutureLeasePaymentsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114633102_33" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114633102_43" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">282</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025 and after</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114633102_53" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">410</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total future lease payments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114633102_63" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,044</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interest</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211122114633102_73" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:4px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease liability balance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122114633102_83" name="us-gaap:OperatingLeaseLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">964</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
    <div style="text-align:center">
      <div style="line-height:1.25;text-align:left">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">18</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220318135318310" name="chek:EmployeeRelatedLiabilitiesTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 6&#160; -&#160; EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</span></span></div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  </td>
                </tr>

            </table>
            <ix:nonNumeric id="Fxbrl_20230324115006385" name="chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits for vacation and recreation pay</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_33" name="us-gaap:AccruedVacationCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">529</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_37" name="us-gaap:AccruedVacationCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">573</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability for payroll, bonuses and wages</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_43" name="us-gaap:AccruedSalariesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">732</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_47" name="us-gaap:AccruedSalariesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,388</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_53" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,261</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122115411339_57" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,961</ix:nonFraction></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            </ix:nonNumeric>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-employment benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Israel's Severance Pay Law, 1963, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. All of the Company's employees elected to be included under Section 14 of the Severance Pay Law, 1963 ("Section 14"). According to Section 14, employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments under the Israeli Severance Pay Law, 1963 in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Paid vacation days</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the Yearly Vacation Law-1951 (the "Vacation Law"), the Company's employees are entitled to a certain number of paid vacation days for each year of employment. In accordance with the Vacation Law and its appendix, and as determined in the agreement between the Company and the employees, the number of vacation days per year to which each employee is entitled is based on the seniority of the employee.</span></span></div>
            <div style="line-height:1.25;margin-left:78pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The employee may use vacation days based on his or her needs and with the Company's consent, and accrue the remainder of unused vacation days, subject to the provision of the Vacation Law. The vacation days utilized first are those credited for the current year and subsequently from any balance transferred from the prior year (on a "LIFO" basis). An employee who ceased working before utilizing the balance of vacation days accrued is entitled to payment for the balance of unutilized vacation days.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For information regarding related parties, see Note 16.</span></span></div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <div style="line-height:1.25">
    <p style="margin:0pt">&#160;</p>
    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">19</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220318140733171" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7&#160; -&#160; INCOME TAXES</span></span></div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap Ltd. is taxed according to Israeli tax laws:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rates in Israel</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:77pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli corporate tax rate in years 2020, 2021, 2022 and onwards is <ix:nonFraction id="Fxbrl_20211122122241320" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20200101to20201231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211122122240606" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211122122236098" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>%.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Law for the Encouragement of Capital Investments, 1959 (the "Investments Law")</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:77pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Under the Investments Law, including Amendment No. 60 to the Investments Law as published in April 2005, by virtue of the "Benefited Enterprise" status, the Company is entitled to various tax benefits as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reduced tax rates</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has one Benefited Enterprise program under the Investments Law, which entitles it to certain tax benefits with respect to income to be derived from the Company's Benefited Enterprise. During the benefits period, taxable income from its Benefited Enterprise program (once generated) will be tax exempt for a period of ten years commencing with the year the Company will first earn taxable income relating to such enterprise. The Company chose 2010 as the year of election (the "Year of Election"). Due to the location of the Company's offices, the Company believes it is entitled to a 10 year benefit period, subject to a 14 year limitation from the Year of Election, and therefore, the tax benefit period will, in any event, end in 2023.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Conditions for entitlement to the benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment of the Law for the Encouragement of Capital Investments, 1959</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Investments Law was amended as part of the Economic Policy Law for the years 2011-2012, which was passed by the Israeli Knesset on December 29, 2010 (the "Capital Investments Law Amendment").</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Capital Investments Law Amendment set alternative benefit tracks to those in effect prior to such amendment under the provisions of the Investments Law.</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The benefits granted to the Preferred Enterprise will be unlimited in time, unlike the benefits granted to special Benefited Enterprises, which will be limited for a 10 year period. The benefits shall be granted to companies that will qualify under criteria set forth in the Investments Law; for the most part, those criteria are similar to the criteria that were set forth in the Investments Law prior to its amendment.</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the transitional provisions of the Investments Law, the Company is entitled to take advantage of the tax benefits available under the Investments Law prior to its amendment until the end of the benefits period, as defined in the Investments Law. The Company was entitled to set the "year of election" no later than tax year 2012, provided that the minimum qualifying investment was made not later than the end of 2010. On each year during the benefits period, the Company will be able to elect that the Investments Amendment applies to the Company, thereby making the tax rates described above available to the Company. An election to have the Capital Investments Amendment apply is irrecoverable. The Company elected not to have the Capital Investments Amendment apply to the Company.</span></span></div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:106pt">&#160;</div>
            <div><ix:exclude>
              <div>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                  <div>
                    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">20</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                  </div>
                </div>
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7&#160; -&#160; INCOME TAXES (Cont.)</span></span></div>
              </div>
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Law for the Encouragement of Capital Investments, 1959 (the "Investments Law") (Cont.)</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:77pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c)</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment of the Law for the Encouragement of Capital Investments, 1959 (Cont.)</span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:exclude></div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 22, 2016, the Knesset approved the 2017-2018 State budget, which includes amendment number 73 to the Investments Law. The amendment includes:</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adoption of a new incentive tax regime that applies to high-tech companies that are deemed a &#8220;Preferred Technological Enterprise&#8221; or &#8220;Special Preferred Technological Enterprise,&#8221; based on the provisions and rules adopted by the Organization for Economic Cooperation and Development, creating new reduced corporate tax rate tracks of <ix:nonFraction id="Fxbrl_20211122122652529" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction>% for Preferred Technological Enterprises located in Development Area A and <ix:nonFraction id="Fxbrl_20211122122812392" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">12</ix:nonFraction>% for the rest of the country; and a reduced corporate tax rate of <ix:nonFraction id="Fxbrl_20230328162152638" name="chek:ReductionInIncomeTaxRate" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">6</ix:nonFraction>% for a &#8220;Special Preferred Technological Enterprise&#8221; regardless of the company&#8217;s geographic location within Israel.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reduction of corporate tax rate for all Preferred Enterprises from <ix:nonFraction id="Fxbrl_20220318140037075" name="chek:ReductionInIncomeTaxRate" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">9</ix:nonFraction>% to <ix:nonFraction id="Fxbrl_20211122122857615" name="chek:ReductionInIncomeTaxRate" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction>%.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lowering the threshold for the conditions that were previously set in order to enter the track of a "Special Preferred Enterprise" for very large enterprises entitled to a reduced tax rate of <ix:nonFraction id="Fxbrl_20211122123027464" name="chek:ReductionInIncomeTaxRate" contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction>% in Development Area A or <ix:nonFraction id="Fxbrl_20211122123042461" name="chek:ReductionInIncomeTaxRate" contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">8</ix:nonFraction>% in the rest of the country.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Updating the definitions of preferred income, Preferred Enterprise, etc.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the Israeli Income Tax Ordinance [New Version], 1961, as of December 31, 2022, all of the Company&#8217;s tax assessments through tax year 2017 are considered final.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc. is taxed according to U.S. tax laws at a rate of <ix:nonFraction id="Fxbrl_20220204121746373" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapForeignCountryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction>%.</span></span></div>
              <div style="line-height:1.25;margin-left:49pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc. operating loss or &#8220;NOL&#8221; carry-forwards was $<ix:nonFraction id="Fxbrl_20220318140650322" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20221231_deiLegalEntityAxis_chekCheckCapUsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction> as of December 31, 2022 and $<ix:nonFraction id="Fxbrl_20230324120001584" name="us-gaap:OperatingLossCarryforwards" contextRef="C_20211231_deiLegalEntityAxis_chekCheckCapUsIncMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction> as of December 31, 2021.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company's history of losses, the Company established a full valuation allowance on its net-operating loss carryforwards.</span></span></div>
              <ix:nonNumeric id="Fxbrl_20230324120023591" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry-forward tax losses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122123118515" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,232</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122123131030" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,677</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less valuation allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211122123222958_xbrl_20211122123118515" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,232</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211122123222958_xbrl_20211122123131030" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,677</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122123314296" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122123319762" name="us-gaap:DeferredTaxAssetsNet" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              <div><ix:exclude>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">21</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7&#160; -&#160; INCOME TAXES (Cont.)</span></span></div>
              </ix:exclude></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of the theoretical tax expense to actual tax expense</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The main reconciling item between the statutory tax rate of the Company and the effective rate is the provision of full valuation allowance in respect of tax benefits from carry forward tax losses due to the uncertainty of the realization of such tax benefits (see above).</span></span></div>
            </div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>

  <ix:nonNumeric id="Fxbrl_20220318142620632" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 8&#160; -&#160; COMMITMENTS AND CONTINGENT LIABILITIES</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties provision</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties to an ASIC designer</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a liability to pay royalties for the development of an ASIC component which is used as an amplifier for the capture of signals at low frequencies from X-ray detectors contained in the capsule. The institution that developed the ASIC is entitled to receive royalties from the Company in the amount of <ix:nonFraction id="Fxbrl_20230303125601175" name="chek:RoyaltiesPayablePerUnitSold" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="USD_Per_Euro" scale="0" decimals="0" format="ixt:num-dot-decimal">50</ix:nonFraction> &#8364; cents (<ix:nonFraction id="Fxbrl_20230324231014545" name="chek:RoyaltiesPayablePerUnitSold" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="US_cents_Per_unit" scale="0" decimals="1" format="ixt:num-dot-decimal">53.3</ix:nonFraction> U.S. cents) for every ASIC component that the Company will sell, capped at &#8364;<ix:nonFraction id="Fxbrl_20230303125625894" name="chek:MaximumRoyaltyObligation" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="Euro" scale="3" decimals="-3" format="ixt:num-dot-decimal">200</ix:nonFraction> (approximately $<ix:nonFraction id="Fxbrl_20230303125635366" name="chek:MaximumRoyaltyObligation" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">213</ix:nonFraction>). This royalty is considered as a liability.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The royalty liability is calculated based on estimated future sales generated by products which include the ASIC component. As of December 31, 2022, the Company believes that it will be required to pay the above mentioned royalties, and accordingly, recorded, as of December 31, 2022, a provision in a total amount of $<ix:nonFraction id="Fxbrl_20230303125702678" name="chek:RoyaltiesProvision" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction>.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reimbursement liability to Predecessor Entity's unit holders</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2009, the Company entered into an asset transfer agreement with Check Cap LLC (the "Predecessor Entity"), a company with the same shareholders as the Company at the time of transfer. According to the agreement, the Predecessor Entity transferred all of its business operations and substantially all of its assets to the Company, including development and consulting agreements, cash, property and equipment and intangible ownership rights, free of any debt.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a part of the reorganization, the Company committed to reimburse the unit holders of the Predecessor Entity for any tax burdens that may be imposed on them due to the reorganization. The reimbursement liability is calculated assuming deemed royalties are paid to the U.S. unit holders of Check-Cap LLC under Section 367(d) of the Code, and is based in part on the Company&#8217;s forecasted sales with a cap calculated as the fair value of the share as determined at the date of the financial statements. The reimbursement liability is calculated by multiplying the estimated tax rate by the lowest of: (1) expected cash outflows for a period of 15 years ending December 31, 2023, discounted using a discount factor commensurate with the risk of the Company, and (2) value of the shares held by U.S. unit holders of the Predecessor Entity as of December 31, 2022 multiplied by $2.2, the last reported price per share of the Company&#8217;s ordinary shares on the Nasdaq Capital Market on December 31, 2022. Any updates in the contingent liability will be charged to earnings. Since the Company does not expect to be profitable in year 2023, the liability based on the discounted outflows is $0. As a result, as of December 31, 2022 and 2021, the balance of the reimbursement liability totaled $<ix:nonFraction id="Fxbrl_20230304213706931" name="chek:RoyaltiesProvision" contextRef="C_20211231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230303130051073" name="chek:RoyaltiesProvision" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction>.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <ix:nonNumeric id="Fxbrl_20220318142631222" name="us-gaap:OtherCommitmentsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;text-indent:22pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2&#160;0&#160;2&#160;2</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties to an ASIC designer</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122192727517_33" name="chek:RoyaltiesProvision" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122192727517_37" name="chek:RoyaltiesProvision" contextRef="C_20211231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122192727517_53" name="chek:RoyaltiesProvision" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211122192727517_57" name="chek:RoyaltiesProvision" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          </ix:nonNumeric>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div><ix:exclude>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
              <div>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">22</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
            </div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 8&#160; -&#160; COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)</span></span></div>
          </ix:exclude></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commitments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's research and development efforts are financed, in part, through funding from the IIA and the BIRD Foundation. Since the Company's inception through December 31, 2022, the Company received funding from the IIA and the BIRD Foundation in the total amount of approximately $<ix:nonFraction id="Fxbrl_20230303130424349" name="chek:GrantedRevenue" contextRef="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,600</ix:nonFraction> and $<ix:nonFraction id="Fxbrl_20230303130437477" name="chek:GrantedRevenue" contextRef="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction>, respectively. In year 2021, the Company received grant approval from the IIA to support the funding of the Company&#8217;s transition from research and development to manufacturing. The final grant amounted to $<ix:nonFraction id="Fxbrl_20230303131255141" name="chek:GrantedRevenue" contextRef="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">620</ix:nonFraction>, of which approximately $<ix:nonFraction id="Fxbrl_20230303130457366" name="chek:GrantedRevenue" contextRef="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">349</ix:nonFraction> was received in year 2021, $<ix:nonFraction id="Fxbrl_20230303130523298" name="chek:GrantedRevenue" contextRef="C_20220101to20220131_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction> was received in January 2022 and $<ix:nonFraction id="Fxbrl_20230303131341021" name="chek:GrantedRevenue" contextRef="C_20230201to20230223_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222</ix:nonFraction> was received in February 2023. The grants received under this plan are not subject to future royalties.</span></span></div>
          <div style="line-height:1.25;margin-left:77pt">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">According to the terms of applicable law as currently in effect regarding the grants received before year 2021, the IIA is entitled to royalties equal to <ix:nonFraction id="Fxbrl_20230303131451718" name="chek:RoyaltiesPayablePercentageOfProductSales" contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction>-<ix:nonFraction id="Fxbrl_20230303131502151" name="chek:RoyaltiesPayablePercentageOfProductSales" contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction>% (or at an increased rate under certain circumstances) of the revenues from sales of products and services based on technology developed using IIA grants, up to the full principal amount (which may be increased under certain circumstances) of the U.S. Dollar-linked value of the grants, plus interest at the rate of 12-month LIBOR. The obligation to pay these royalties is contingent on actual sales of the applicable products and services and in the absence of such sales, no payment is required. As of December 31, 2022, the Company had not paid any royalties to the IIA and had a contingent liability to the IIA in the amount of approximately $<ix:nonFraction id="Fxbrl_20230303131519358" name="chek:ContingentLiability" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,199</ix:nonFraction>.</span></span></div>
          <div style="line-height:1.25;margin-left:77pt">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 13, 2014, the Company entered into a Cooperation and Project Funding Agreement with the BIRD Foundation and Synergy and during 2014-2017, the Company, together with Synergy, had received funding from the BIRD Foundation in the aggregate amount of approximately $<ix:nonFraction id="Fxbrl_20230303131658340" name="chek:MaximumRoyaltyObligation" contextRef="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">127</ix:nonFraction>. Based on the aggregate expenses that the Company incurred for such project, it refunded to the BIRD Foundation an amount of approximately $<ix:nonFraction id="Fxbrl_20230303131712431" name="chek:RefundExpenses" contextRef="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction>. The Company will not be receiving additional funding from the BIRD Foundation for the project, which is no longer active. As of December 31, 2022, the Company had not paid any royalties to the BIRD Foundation and had a contingent obligation to the BIRD foundation in the amount of approximately $<ix:nonFraction id="Fxbrl_20230303131736830" name="chek:ContingentLiability" contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209</ix:nonFraction>.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental agreements</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:78pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 26, 2021, the Company entered into the Amended Lease Agreement according to which, effective as of April 1, 2021, it leases approximately <ix:nonFraction id="Fxbrl_20230303132047038" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">1,550</ix:nonFraction> square meters at the facility located in Isfiya, Israel. The Amended Lease Agreement expires on <ix:nonNumeric id="Fxbrl_20230303132119508" name="us-gaap:LeaseExpirationDate1" contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">December 31, 2023</ix:nonNumeric>, and the Company has an option to extend the lease period for an additional <ix:nonNumeric id="Fxbrl_20230305013713959" name="chek:LesseeOperatingLeaseAdditionalTerm" contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric>. The Company has the right to terminate the agreement at any time, upon at least 60 days prior written notice.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="text-align:justify;text-indent:18pt;margin-left:72pt;line-height:1.25">&#160;</div>
          <div style="margin:0px 0px 0px 107pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Monthly rental expenses under the Amended Lease Agreement are $<ix:nonFraction id="Fxbrl_20220204020137808" name="chek:OperatingLeaseRentExpenseMonthly" contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">14.2</ix:nonFraction>. See also Note 5.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:78pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#8220;Sub-lease Agreement&#8221;), with a Company supplier (the &#8220;Lessor&#8221;) according to which, the Company leases approximately <ix:nonFraction id="Fxbrl_20230303133133621" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">70</ix:nonFraction> square meters laboratory space for the production of certain components in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on <ix:nonNumeric id="Fxbrl_20230303133155444" name="us-gaap:LeaseExpirationDate1" contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">January 31, 2025</ix:nonNumeric>, and the Company has an option to extend the lease period for an additional <ix:nonNumeric id="Fxbrl_20230303133212039" name="chek:LesseeOperatingLeaseAdditionalTerm" contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric>. The Company has the right to terminate the agreement at any time, upon at least 90 days prior written notice. The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $<ix:nonFraction id="Fxbrl_20230303133234812" name="chek:OperatingLeaseRentExpenseMonthly" contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">26.9</ix:nonFraction>.</span></span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div><ix:exclude>
            <div>
              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                <div>
                  <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">23</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                </div>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 8&#160; -&#160; COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)</span></span></div>
            </div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commitments (Cont.)</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </ix:exclude></div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately <ix:nonFraction id="Fxbrl_20230304195943361" name="us-gaap:AreaOfRealEstateProperty" contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="Squaremeters" scale="0" decimals="0" format="ixt:num-dot-decimal">140</ix:nonFraction> square meters offices, The lease agreement expires on <ix:nonNumeric id="Fxbrl_20230303135553595" name="us-gaap:LeaseExpirationDate1" contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt:date-monthname-day-year-en">February 28, 2024</ix:nonNumeric>, and the Company has an option to extend the lease period for two additional periods of <ix:nonNumeric id="Fxbrl_20230303135605430" name="chek:LesseeOperatingLeaseAdditionalTerm" contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric> each. Total monthly rental expense under the lease agreement is approximately $<ix:nonFraction id="Fxbrl_20230303135615013" name="chek:OperatingLeaseRentExpenseMonthly" contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">1.7</ix:nonFraction>. .</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle lease and maintenance agreements</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin:0px 0px 0px 106pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company entered into several <ix:nonNumeric id="Fxbrl_20230303140128537" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember" format="ixt-sec:durmonth">36</ix:nonNumeric> months lease and maintenance agreements for vehicles, which are regularly amended as new vehicles are leased. The current monthly lease fees are approximately $<ix:nonFraction id="Fxbrl_20230303140147513" name="chek:MonthlyVehicleLeaseExpense" contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">13.7</ix:nonFraction>. See also Note 5.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company issued purchase orders to certain suppliers in order to secure strategic inventory of key components that as of December 31, 2022 have not yet been supplied.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the date of the financial statements, the Company is not a party to any pending litigation.</span></span></div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>

  <div>
    <ix:nonNumeric id="Fxbrl_20220318143124445" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 9&#160; -&#160; FAIR VALUE MEASUREMENTS</span></span></div>
        <div>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC No. 820, the Company measures its money market funds and foreign currency derivative contracts at fair value. Money market funds are classified within Level 1. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.</span></span></div>
              <div style="line-height:1.25;margin-left:49pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:</span></span></div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:54pt">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20230324124144953" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="C_20220101to20221231" escape="true">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093302962" name="us-gaap:MoneyMarketFundsAtCarryingValue" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093320293" name="us-gaap:MoneyMarketFundsAtCarryingValue" contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230303044122846" name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230304191528089" name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211124093337142" name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets (liabilities)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093423085" name="us-gaap:FairValueNetAssetLiability" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230304191856646" name="us-gaap:FairValueNetAssetLiability" contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">56</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20211124093458697" name="us-gaap:FairValueNetAssetLiability" contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal" sign="-">53.5</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516658_xbrl_20211124093302962" name="us-gaap:MoneyMarketFundsAtCarryingValue" contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,160</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516658_xbrl_20211124093320293" name="us-gaap:MoneyMarketFundsAtCarryingValue" contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,160</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current assets:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516665_xbrl_20211124093405438" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516665_xbrl_20211124093337142" name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516671_xbrl_20211124093423085" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,160</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516671_xbrl_20211124093444574" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211124093516671_xbrl_20211124093458697" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,225</ix:nonFraction></span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
  </div>
  <div style="line-height:1.25;clear:both">
    <p style="margin:0pt">&#160;</p>
    <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">24</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
  </div>

  <div>
    <ix:nonNumeric id="Fxbrl_20220318150316478" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY</span></span></span></span></span></span></span></span></div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span style="font-weight:bold">A</span>.</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Effective November 23, 2022, the Company's Board of Directors effected a Reverse Share Split of <ix:nonNumeric id="Fxbrl_20230304164957895" name="us-gaap:StockholdersEquityReverseStockSplit" contextRef="C_20221123to20221123">1-for-20</ix:nonNumeric> (i.e., 20 ordinary shares were combined into one ordinary share). Share and per share amounts in the financial statements, prior to November 23, 2022, have been adjusted to reflect the Reverse Share Split.&#160;</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>B.</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1.</span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The ordinary shares provide their holder with rights to receive dividends in cash and shares, and rights to participate at the time of distributing liquidation dividends. Additionally, the ordinary shareholders have the right to vote at shareholder meetings in a manner that each share provides one voting right to its holder.</span></span></span></span></span></span></p>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital</span></span></span></span></span></span></span></p>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;margin-left:47.25pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>a)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On May 11, 2010, the Company issued, free of charge, to all of its shareholders (except for certain ordinary shareholders), warrants to purchase an aggregate of <ix:nonFraction id="Fxbrl_20211124094323826" name="chek:WarrantsIssued" contextRef="C_20100501to20100511_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,609</ix:nonFraction> ordinary shares (hereafter- "Anti-dilution Warrants"). The Anti-dilution Warrants were issued in order to prevent the dilution of the holdings of such Company shareholders due to certain options granted to the then Company's CEO ("CEO options"). The Anti-dilution Warrants were subject to automatic exercise, without consideration (unless the holder thereof objected to such exercise), upon the exercise by the Company's CEO of the CEO Options. The fair value of the Anti-dilution Warrants on the grant date was immaterial. Anti-dilution warrants to purchase <ix:nonFraction id="Fxbrl_20211124094416032" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20190101to20191231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">37</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20211124094508471" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20180101to20181231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">387</ix:nonFraction> ordinary shares were exercised during the years ended December 31, 2019 and 2018, respectively. The remaining Anti-dilution Warrants to purchase <ix:nonFraction id="Fxbrl_20211124094532066" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="C_20200501to20200511_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">326</ix:nonFraction> ordinary shares expired on May 11, 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>b)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On February 24, 2015, the Company consummated an IPO in the U.S. of <ix:nonFraction id="Fxbrl_20211124094641298" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,334</ix:nonFraction> units at a public offering price of $<ix:nonFraction id="Fxbrl_20211124094804955" name="us-gaap:SharePrice" contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,440</ix:nonFraction> per unit, before underwriting discounts and offering expenses. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $<ix:nonFraction id="Fxbrl_20211124095429429" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,800</ix:nonFraction>. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $<ix:nonFraction id="Fxbrl_20211124095138755" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,656</ix:nonFraction>. The Series A Warrants expired on <ix:nonNumeric id="Fxbrl_20211124095535508" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" format="ixt:date-monthname-day-year-en">February 24, 2020</ix:nonNumeric>.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company granted the underwriters a 45-day over-allotment option to purchase up to <ix:nonFraction id="Fxbrl_20211124095650607" name="chek:UnitsPurchased" contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,250</ix:nonFraction> additional units (together with an accompanying <ix:nonFraction id="Fxbrl_20211124095812364" name="chek:WarrantsIssued" contextRef="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,875</ix:nonFraction> Long Term Incentive Warrants). The option to purchase additional <ix:nonFraction id="Fxbrl_20211124101201799" name="chek:WarrantsIssued" contextRef="C_20150301to20150306_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">417</ix:nonFraction> units was partially exercised on March 6, 2015. The units were separated into one ordinary share and one-half of a Series A Warrant to purchase one ordinary share on March 18, 2015, and the units ceased to exist as of such date. On April 6, 2015, the option to purchase an additional <ix:nonFraction id="Fxbrl_20220204193323740" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20150401to20150406_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">625</ix:nonFraction> ordinary shares and <ix:nonFraction id="Fxbrl_20211124101333474" name="chek:StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" contextRef="C_20150401to20150406_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">313</ix:nonFraction> Series A Warrants was partially exercised. The Company received net proceeds from the IPO and partial exercise of the over-allotment option of approximately $<ix:nonFraction id="Fxbrl_20211124101510980" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,800</ix:nonFraction> (net of issuance cost of approximately $<ix:nonFraction id="Fxbrl_20211124101654428" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction>, including certain warrants with a value of $<ix:nonFraction id="Fxbrl_20211124101745433" name="chek:FairValueOfWarrantsIssued" contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction> issued in connection with the IPO).</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>c)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Immediately prior to the consummation of the IPO, certain members of the Company's management exercised options to purchase <ix:nonFraction id="Fxbrl_20211124101834470" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,282</ix:nonFraction> ordinary shares granted to them under the 2006 Unit Option Plan.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                </tr>

            </table>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">25</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY (Cont.)</span></span></span></span></span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>B.</span></span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares (Cont.)</span></span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt">&#160;</td>
                      <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                    </tr>
                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital&#160;</span><span style="font-weight:bold">(Cont.)</span></span></span></span></span></span></span></p>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>d)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On August 20, 2014, the Company entered into a certain credit line agreement, pursuant to which it obtained a credit line in an aggregate principal amount of $<ix:nonFraction id="Fxbrl_20211124102153309" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,000</ix:nonFraction> from certain lenders and existing shareholders (the "Lenders"). The credit line amount was deposited in an escrow account at the closing, which was consummated on October 14, 2014. The Company issued to each Lender at closing a warrant (collectively, the "Credit Line Warrants"), to purchase a number of the Company's ordinary shares constituting <ix:nonFraction id="Fxbrl_20211124103616710" name="chek:PercentageOfSharesFullyDiluted" contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction>% of its share capital on a fully diluted basis (assuming conversion of all of the Company's convertible securities into ordinary shares at a 1:1 conversion rate) as of the closing for each $<ix:nonFraction id="Fxbrl_20211124103659011" name="chek:AmountOfPortionOfOrdinarySharesOfSuchLender" contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,000</ix:nonFraction> (or portion thereof) extended by such Lender. The Company issued Credit Line Warrants ("CLA Warrants") to purchase in the aggregate <ix:nonFraction id="Fxbrl_20211124102444128" name="chek:WarrantsIssued" contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">11,078</ix:nonFraction> of its ordinary shares. The CLA Warrants are exercisable for a period of <ix:nonNumeric id="Fxbrl_20220110192914574" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric> at an exercise price of NIS <ix:nonFraction id="Fxbrl_20220319002514196" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal">48</ix:nonFraction> per share, and may be exercised on a net issuance basis.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Under the terms of the credit line agreement, the Company directed that the entire credit line amount (that was in escrow) be invested in the Private Placement, consummated simultaneously with the consummation of the IPO on February 24, 2015. The Company issued to the Lenders <ix:nonFraction id="Fxbrl_20220204024348217" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,334</ix:nonFraction> units at a price of $<ix:nonFraction id="Fxbrl_20220318145627566" name="us-gaap:SharePrice" contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,440</ix:nonFraction> per unit, before issuance cost. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $<ix:nonFraction id="Fxbrl_20211124105747562" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,800</ix:nonFraction>. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $<ix:nonFraction id="Fxbrl_20220204024414745" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,656</ix:nonFraction>. The Company received net proceeds from the Private Placement of approximately $<ix:nonFraction id="Fxbrl_20220204024422784" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,900</ix:nonFraction> (net of issuance cost of approximately $<ix:nonFraction id="Fxbrl_20220204024430984" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,200</ix:nonFraction>, including certain warrants with a value of $<ix:nonFraction id="Fxbrl_20220204024440096" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125</ix:nonFraction> issued in connection with the Private Placement). The Series A Warrants expired on February 24, 2020. As of December 31, 2021, Long Term Incentive Warrants to purchase <ix:nonFraction id="Fxbrl_20220204024448385" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">18,903</ix:nonFraction> ordinary shares were outstanding. The Long Term Incentive Warrants expired on February 24, 2022.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>e)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>No CLA Warrants were exercised during the years ended December 31, 2022, 2021 and 2020. As of December 31, 2022, CLA Warrants to purchase <ix:nonFraction id="Fxbrl_20230324202950754" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">370</ix:nonFraction> ordinary shares were outstanding.</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:78pt">&#160;</td>
                      <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>f)</span></span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>On October 14, 2014, the Company issued warrants to purchase an aggregate <ix:nonFraction id="Fxbrl_20230324232851708" name="chek:WarrantsIssued" contextRef="C_20141001to20141014_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">924</ix:nonFraction> ordinary shares (the &#8220;Pontifax Warrants&#8221;) to the Pontifax Funds in consideration of their commitment to provide to the Company, for no consideration, certain business development and chairman services. As of December 31, 2021, Pontifax Warrants to purchase <ix:nonFraction id="Fxbrl_20230324233006688" name="chek:WarrantsIssued" contextRef="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">462</ix:nonFraction> ordinary shares, with an exercise price of $<ix:nonFraction id="Fxbrl_20230324233147669" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">1,214.4</ix:nonFraction> per share, were outstanding. These warrants expired on October 14, 2022.</span></span></span></span></span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>g)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Upon the closing of the IPO, the Company issued warrants to purchase <ix:nonFraction id="Fxbrl_20211124105644803" name="chek:WarrantsIssued" contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">417</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20220318145759564" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">1,800</ix:nonFraction> to the IPO lead underwriter and warrants to purchase <ix:nonFraction id="Fxbrl_20211124110133547" name="chek:WarrantsIssued" contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">63</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20211124110246407" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">1,214.4</ix:nonFraction> to the Company's U.S. legal counsel. These warrants expired on February 24, 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>h)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On August 11, 2016, the Company consummated a registered direct offering of <ix:nonFraction id="Fxbrl_20211124110341728" name="chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,682</ix:nonFraction> ordinary shares at a price of $<ix:nonFraction id="Fxbrl_20211124110618048" name="us-gaap:SharePrice" contextRef="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">456</ix:nonFraction> per share and pre-funded warrants to purchase <ix:nonFraction id="Fxbrl_20211124110919512" name="chek:PreFundedWarrantsPurchaseSharesIssuable" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,477</ix:nonFraction> ordinary shares at a purchase price of $<ix:nonFraction id="Fxbrl_20211124111056314" name="chek:PricePerUnit" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">444</ix:nonFraction> per pre-funded warrant. The pre-funded warrants have an exercise price of $<ix:nonFraction id="Fxbrl_20211124111140944" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">12</ix:nonFraction> per share, subject to certain adjustments and will expire on <ix:nonNumeric id="Fxbrl_20211124111308614" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" format="ixt:date-monthname-day-year-en">August 11, 2023</ix:nonNumeric>, unless otherwise extended in accordance with the terms of the pre-funded warrants. The Company received gross proceeds from the August registered direct offering of approximately $<ix:nonFraction id="Fxbrl_20211124111222278" name="chek:ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,900</ix:nonFraction> (including proceeds from the exercise of <ix:nonFraction id="Fxbrl_20211124111248575" name="chek:PreFundedWarrantsPurchase" contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,396</ix:nonFraction> pre-funded warrants at the closing of the offering). On January 23, 2017, the remaining pre-funded warrants to purchase <ix:nonFraction id="Fxbrl_20211124111349653" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,209</ix:nonFraction> ordinary shares were exercised, for additional proceeds of approximately $<ix:nonFraction id="Fxbrl_20211124111433554" name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="C_20170101to20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">14.5</ix:nonFraction>.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">26</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
              <div style="line-height:1.25">
                <div style="line-height:1.25">
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY (Cont.)</span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                      <tr>
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>B.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Ordinary shares (Cont.)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="margin-left:47.25pt;text-align:justify;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;line-height:1.25">
                    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                        <tr>
                          <td style="width:49pt">&#160;</td>
                          <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                          <td style="vertical-align:top;text-align:justify;width:auto">
                            <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital&#160;</span><span style="font-weight:bold">(Cont.)</span></span></span></span></span></span></span></p>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              </div>
            </ix:exclude></div>
            <div style="line-height:1.25">
              <div style="line-height:1.25">&#160;</div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>i)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On June 2, 2017, the Company consummated a registered direct offering of <ix:nonFraction id="Fxbrl_20220204025055336" name="chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" contextRef="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,623</ix:nonFraction> ordinary shares at a price of $<ix:nonFraction id="Fxbrl_20220204025106575" name="us-gaap:SharePrice" contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">480</ix:nonFraction> per share and a simultaneous private placement of one-year warrants to purchase <ix:nonFraction id="Fxbrl_20220319004246376" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,623</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20220204025117630" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">510</ix:nonFraction> per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $<ix:nonFraction id="Fxbrl_20220204025124736" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,690</ix:nonFraction>. On June 2, 2018, all of the warrants issued to investors in this offering expired. As of December 31, 2021, warrants to purchase <ix:nonFraction id="Fxbrl_20220204025134703" name="chek:WarrantsOutstandingAmount" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">282</ix:nonFraction> ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;</span></span><span>These placement agent warrants expired on June 2, 2022.</span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <p style="margin:0pt">&#160;</p>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>j)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>On November 22, 2017, the Company consummated a registered direct offering of </span><ix:nonFraction id="Fxbrl_20220204025449015" name="chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" contextRef="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">9,470</ix:nonFraction><span> ordinary shares at a price of $</span><ix:nonFraction id="Fxbrl_20220204025500424" name="us-gaap:SharePrice" contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">264</ix:nonFraction><span> per share and a simultaneous private placement of five-year warrants to purchase </span><ix:nonFraction id="Fxbrl_20220319004210858" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">7,103</ix:nonFraction><span> ordinary shares at an exercise price of $</span><ix:nonFraction id="Fxbrl_20220319004353025" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">300</ix:nonFraction><span> per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $</span><ix:nonFraction id="Fxbrl_20220204025517711" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,500</ix:nonFraction><span>. On April 25, 2018, </span><ix:nonFraction id="Fxbrl_20220204025529639" name="chek:WarrantsExercisedCashlessBasis" contextRef="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,841</ix:nonFraction><span> of these warrants were cashless exercised into </span><ix:nonFraction id="Fxbrl_20220204025537363" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">679</ix:nonFraction><span> ordinary shares.</span><span style="font-weight:bold"> </span><span> On July 27</span><span>,&#160;</span><span>2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), all of the </span><ix:nonFraction id="Fxbrl_20220204025616278" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20200701to20200727_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,262</ix:nonFraction><span> warrants that were outstanding as of that date&#160;were exercised into ordinary shares. As of December 31, 2021, warrants to purchase </span><ix:nonFraction id="Fxbrl_20220204025623599" name="chek:WarrantsOutstandingAmount" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">474</ix:nonFraction><span> ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;</span></span></span>These placement agent warrants expired on November 22, 2022.</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>k)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On May 8, 2018, the Company consummated an underwritten public offering (the &#8220;2018 Public Offering&#8221;) of <ix:nonFraction id="Fxbrl_20211124114029535" name="chek:UnitsPurchased" contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">136,924</ix:nonFraction> units (the &#8220;2018 Units&#8221;), at a public offering price of $<ix:nonFraction id="Fxbrl_20211124114154689" name="us-gaap:SharePrice" contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">110</ix:nonFraction> per unit, and <ix:nonFraction id="Fxbrl_20211124114235593" name="chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">22,546</ix:nonFraction> pre-funded units (the &#8220;2018 Pre-funded Units&#8221;), at a public offering price of $<ix:nonFraction id="Fxbrl_20211124114522142" name="chek:PrefundedWarrantsToPurchasePrice" contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">109.8</ix:nonFraction> per 2018 Pre-funded Unit. Each 2018 Unit consisted of one ordinary share of the Company and one Series C warrant to purchase one ordinary share of the Company. Each 2018 Pre-funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series C Warrant to purchase one ordinary share. The exercise price of each pre-funded warrant included in the 2018 Pre-funded Unit was $<ix:nonFraction id="Fxbrl_20211124114604887" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">0.2</ix:nonFraction> per share. The Series C warrants have an exercise price of $<ix:nonFraction id="Fxbrl_20211124114631756" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20180508_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">110</ix:nonFraction> per share, are exercisable immediately and will expire five years from the date of issuance.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company granted the underwriters a 30-day over-allotment option to purchase up to an additional <ix:nonFraction id="Fxbrl_20211124114737970" name="us-gaap:CommonStockSharesIssued" contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">23,921</ix:nonFraction> ordinary shares and/or Series C Warrants to purchase up to an additional <ix:nonFraction id="Fxbrl_20211124114824795" name="us-gaap:CommonStockSharesIssued" contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapCommonClassCMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">23,921</ix:nonFraction> ordinary shares at the public offering price. The underwriters&#8217; option was exercised in full on May 8, 2018.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company received gross proceeds from the 2018 Public Offering and exercise in full of the over-allotment option of approximately $<ix:nonFraction id="Fxbrl_20220204030024134" name="chek:ProceedsFromIssuanceOfPublicOffering" contextRef="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,200</ix:nonFraction> (before deducting underwriting discounts and commissions and other offering fees and expenses). During May 2018, the <ix:nonFraction id="Fxbrl_20220204030031742" name="chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">22,546</ix:nonFraction> pre-funded warrants were exercised in full in consideration of additional gross proceeds of approximately $<ix:nonFraction id="Fxbrl_20220204030041295" name="chek:ProceedsFromExerciseOfPrefundedWarrants" contextRef="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_chekPreFundedUnitsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,500</ix:nonFraction>. As of December 31, 2022, Series C Warrants to purchase <ix:nonFraction id="Fxbrl_20220204030048453" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsToPurchaseOrdinarySharesMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">183,390</ix:nonFraction> ordinary shares were outstanding.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>l)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On February 6, 2019, the Company issued <ix:nonFraction id="Fxbrl_20211124115346120" name="chek:CommonStockUnitsIssued" contextRef="C_20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="Unit" decimals="INF" format="ixt:num-dot-decimal">94,075</ix:nonFraction> units, (the &#8220;2019 Units&#8221;) at a purchase price of $<ix:nonFraction id="Fxbrl_20220321200754325" name="chek:PurchasePricePerUnit" contextRef="C_20190201to20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember" unitRef="USD_Per_unit" scale="0" decimals="1" format="ixt:num-dot-decimal">51.6</ix:nonFraction> per unit, and <ix:nonFraction id="Fxbrl_20211124115419176" name="chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,024,876</ix:nonFraction> pre-funded units (the &#8220;2019 Pre-funded Units&#8221;), at a purchase price of $<ix:nonFraction id="Fxbrl_20211124115624763" name="chek:PrefundedWarrantsToPurchasePrice" contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">51.4</ix:nonFraction> per 2019 Pre-Funded Unit, in a registered direct offering (the &#8220;2019 Registered Direct Offering&#8221;). Each unit consisted of one ordinary share of the Company and one Series D Warrant to purchase <ix:nonFraction id="Fxbrl_20220318145520350" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">0.5</ix:nonFraction> ordinary share of the Company. Each 2019 Pre-Funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series D Warrant to purchase <ix:nonFraction id="Fxbrl_20230325013509983" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">0.5</ix:nonFraction> ordinary share. The exercise price of each pre-funded warrant included in the 2019 Pre-Funded Unit was $<ix:nonFraction id="Fxbrl_20211124115959557" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">0.2</ix:nonFraction> per share. The Series D Warrants have an exercise price of $<ix:nonFraction id="Fxbrl_20220111022603144" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">51.6</ix:nonFraction> per ordinary share and are immediately exercisable and will expire on the fifth anniversary of the original issuance date. The Company also issued placement agent warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20211124120101870" name="chek:WarrantsIssued" contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,173</ix:nonFraction> ordinary shares, on the same terms as the warrants issued to the investors, except they have an exercise price of $<ix:nonFraction id="Fxbrl_20211124120230764" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">64.5</ix:nonFraction> per share. The Company received gross proceeds from the February 2019 Registered Direct Offering of approximately $<ix:nonFraction id="Fxbrl_20211124120405294" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,500</ix:nonFraction> </span></span></span></span><span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial">(including proceeds from the exercise of&#160;</span><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><ix:nonFraction id="Fxbrl_20230324234508720" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">51,244</ix:nonFraction>&#160;</span><span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial">pre-funded warrants), or approximately $<ix:nonFraction id="Fxbrl_20230324234518122" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsOneMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,500</ix:nonFraction>, net of issuance expenses in the amount of</span><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400">&#160;$<ix:nonFraction id="Fxbrl_20230324234526379" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">987</ix:nonFraction>.&#160; On July 27</span><sup style="color:#000000;font-family:Times New Roman, Times, serif;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;vertical-align:text-top;line-height:1;font-size:smaller">,&#160;</sup><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400">2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), warrants to purchase <ix:nonFraction id="Fxbrl_20230324234556493" name="chek:WarrantThatWereExercised" contextRef="C_20200727_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">48,450</ix:nonFraction> ordinary shares were exercised for ordinary shares and warrants. As of December 31, 2022, warrants to purchase <ix:nonFraction id="Fxbrl_20230324234609207" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">24,210</ix:nonFraction> ordinary shares held by certain investors and warrants to purchase <ix:nonFraction id="Fxbrl_20230325005545784" name="chek:WarrantsIssued" contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,173</ix:nonFraction> ordinary shares held by the placement agent were outstanding.</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <p style="margin:0pt">&#160;</p>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">27</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY (Cont.)</span></span></span></span></span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>B.</span></span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares (Cont.)</span></span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="text-align:justify;margin-left:47.25pt;line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital&#160;</span><span style="font-weight:bold">(Cont.)</span></span></span></span></span></span></span></p>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>m)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On December 19, 2019, the Company entered into definitive agreements with certain investors to sell an aggregate of <ix:nonFraction id="Fxbrl_20220204030818101" name="us-gaap:CommonStockSharesIssued" contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">136,009</ix:nonFraction> ordinary shares at a purchase price of $<ix:nonFraction id="Fxbrl_20220204030825749" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">35</ix:nonFraction> per share in a private placement, resulting in gross proceeds of approximately $<ix:nonFraction id="Fxbrl_20220204030832565" name="chek:ProceedsFromIssuanceOfShares" contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,760</ix:nonFraction>. The closing of the transaction occurred in February 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>n)</span></span></span></span></span></span></span></p>
                  </td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>April &#8211; May 2020 registered direct offerings</span></span></span></span></span></span></span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>On April 22, 2020, May 4, 2020 and May 13, 2020, the Company issued <ix:nonFraction id="Fxbrl_20211124121633331" name="us-gaap:CommonStockSharesIssued" contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">333,334</ix:nonFraction>, <ix:nonFraction id="Fxbrl_20211124121704182" name="us-gaap:CommonStockSharesIssued" contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">375,001</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20211124121729365" name="us-gaap:CommonStockSharesIssued" contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">250,000</ix:nonFraction> ordinary shares, respectively, in registered direct offerings (the &#8220;April-May 2020 Registered Direct Offering&#8221;) at a purchase price of $<ix:nonFraction id="Fxbrl_20211124121813472" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211124121813015" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20211124121748933" name="us-gaap:SharesIssuedPricePerShare" contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">12</ix:nonFraction></ix:nonFraction></ix:nonFraction> per share and issued to the investors unregistered warrants to purchase an aggregate of <ix:nonFraction id="Fxbrl_20211124122016310" name="chek:WarrantsIssued" contextRef="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">333,334</ix:nonFraction>, <ix:nonFraction id="Fxbrl_20211124122110422" name="chek:WarrantsIssued" contextRef="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">375,001</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20211124122227687" name="chek:WarrantsIssued" contextRef="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">250,000</ix:nonFraction> ordinary shares, respectively, in a private placement. The warrants are immediately exercisable </span></span></span></span></span></span>at an exercise price of $<ix:nonFraction id="Fxbrl_20230325000105180" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200727_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">16</ix:nonFraction> per ordinary share, subject to certain adjustments,&#160;<span><span><span><span><span><span>and will expire five and one-half years from the issuance date. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued unregistered placement agent warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20211124122338170" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">23,334</ix:nonFraction>, <ix:nonFraction id="Fxbrl_20211124122358593" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">26,250</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20211124122415696" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">17,500</ix:nonFraction> ordinary shares, respectively, on the same terms as the warrants issued to the investors in the private placement, except they have a term of <ix:nonNumeric id="Fxbrl_20211124122513983" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" format="ixt-sec:durwordsen"><ix:nonNumeric id="Fxbrl_20211124122513720" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" format="ixt-sec:durwordsen"><ix:nonNumeric id="Fxbrl_20220110171535516" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextRef="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> and an exercise price of $<ix:nonFraction id="Fxbrl_20211124122805852" name="chek:ExercisePriceOfWarrants" contextRef="C_20210301to20210318_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">15</ix:nonFraction> per share. The Company received gross proceeds from the April-May 2020 Registered Direct Offerings of approximately $<ix:nonFraction id="Fxbrl_20211124122911740" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,500</ix:nonFraction>, or approximately $<ix:nonFraction id="Fxbrl_20211124123003429" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,139</ix:nonFraction>, net of issuance expenses in the amount of $<ix:nonFraction id="Fxbrl_20211124123036734" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,361</ix:nonFraction>.</span></span></span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On July 27, 2020, as part of the Warrants Exercise Transaction, warrants to purchase an aggregate <ix:nonFraction id="Fxbrl_20220204031334117" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20200701to20200727_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">750,001</ix:nonFraction> ordinary shares were exercised. During the first quarter of 2021, warrants to purchase <ix:nonFraction id="Fxbrl_20220204031345805" name="chek:WarrantThatWereExercised" contextRef="C_20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">208,334</ix:nonFraction> ordinary shares held by certain investors and warrants to purchase <ix:nonFraction id="Fxbrl_20220204031358005" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20210101to20210331_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">67,084</ix:nonFraction> ordinary shares held by the placement agent warrants were exercised into ordinary shares (see Note 10B(2)(n)).</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>o)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On July 23, 2020, the Company entered into a warrant exercise agreement, (the &#8220;Warrants Exercise Transaction&#8221;), with several existing institutional investors who are the holders (the &#8220;Holders&#8221;) of warrants issued in May 2020, April 2020, February 2019 and November 2017 (the &#8220;Old Warrants&#8221;), to purchase ordinary shares, pursuant to which the Holders agreed to exercise in cash their Old Warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20220204031543892" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">802,712</ix:nonFraction> ordinary shares having exercise prices ranging from $<ix:nonFraction id="Fxbrl_20220318145932131" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">300.00</ix:nonFraction> to $<ix:nonFraction id="Fxbrl_20220318145940852" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">16</ix:nonFraction> per share issued by the Company, at a reduced exercise price of $<ix:nonFraction id="Fxbrl_20230305032326163" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">12</ix:nonFraction>&#160;per share, resulting in gross proceeds to the Company of approximately $<ix:nonFraction id="Fxbrl_20220204031613492" name="chek:ProceedsFromExerciseOfWarrants" contextRef="C_20200701to20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,632</ix:nonFraction> or approximately $<ix:nonFraction id="Fxbrl_20220204031626235" name="chek:ProceedsFromExerciseOfWarrants" contextRef="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,712</ix:nonFraction>, net of issuance expenses in the amount of approximately $<ix:nonFraction id="Fxbrl_20220204031635811" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">920</ix:nonFraction>. Closing occurred on July 27, 2020. Under the Warrants Exercise Transaction agreement, the Company also issued to the Holders new unregistered warrants to purchase up to <ix:nonFraction id="Fxbrl_20220204031650283" name="chek:WarrantsIssued" contextRef="C_20200701to20200723_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">963,254</ix:nonFraction> ordinary shares, (the &#8220;Private Placement Warrants&#8221;). The Private Placement Warrants are immediately exercisable, expire five and one-half years from issuance date and have an exercise price of $<ix:nonFraction id="Fxbrl_20211124135317049" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200723_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">16</ix:nonFraction> per share, subject to certain adjustment. The Private Placement Warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. In addition, the Company issued unregistered placement agent warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20220204031714579" name="chek:WarrantsIssued" contextRef="C_20200701to20200723_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">56,190</ix:nonFraction> ordinary shares on the same terms as the warrants issued to the Holders, except that they have an exercise price of $<ix:nonFraction id="Fxbrl_20220204031721899" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">15</ix:nonFraction> per share. During the first quarter of 2021, an aggregate of <ix:nonFraction id="Fxbrl_20220204031814388" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">878,628</ix:nonFraction> warrants held by certain investors and <ix:nonFraction id="Fxbrl_20220204031746214" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">56,190</ix:nonFraction> warrants held by the placement agent, were exercised into ordinary shares. As of December 31, 2022&#160;and 2021, warrants to purchase <ix:nonFraction id="Fxbrl_20230305031312094" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220204031754796" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">84,626</ix:nonFraction></ix:nonFraction> ordinary shares held by certain investors, were outstanding.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div><ix:exclude>
              <div style="line-height:1.25">
                <p style="margin:0pt">&#160;</p>
                <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">28</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              </div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY (Cont.)</span></span></span></span></span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20.25pt">&#160;</td>
                    <td style="width:23pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>B.</span></span></span></span></span></span></span></span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares (Cont.)</span></span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:59px">&#160;</td>
                      <td style="vertical-align:top;width:34px;font-family:Times New Roman, Times, serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                      <td style="width:auto;vertical-align:top;text-align:justify">
                        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital&#160;</span><span style="font-weight:bold">(Cont.)</span></span></span></span></span></span></span></p>
                      </td>
                    </tr>

                </table>
              </div>
            </ix:exclude></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:79pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>p)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>During the first quarter of 2021, as a result of an exercise of warrants by the investors from the Warrants Exercise Transaction and the April-May 2020 Offerings, the Company issued an aggregate of <ix:nonFraction id="Fxbrl_20211124135204986" name="chek:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,210,235</ix:nonFraction> ordinary shares, at exercise prices ranging from $<ix:nonFraction id="Fxbrl_20211124135258333" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">15</ix:nonFraction>-$<ix:nonFraction id="Fxbrl_20220318150021220" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">16</ix:nonFraction> per share, for total gross proceeds of approximately $<ix:nonFraction id="Fxbrl_20211124135340669" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,240</ix:nonFraction> to the Company.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>q)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>On June 30, 2021, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of <ix:nonFraction id="Fxbrl_20220204035038567" name="chek:WarrantsIssued" contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,296,297</ix:nonFraction> of the Company's ordinary shares and accompanying short-term warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20220204035137374" name="chek:WarrantsIssuedNotExercised" contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,296,297</ix:nonFraction> of the Company's ordinary shares in a registered direct offering (the &#8220;June 2021 Registered Direct Offering&#8221;). The June 2021 Registered Direct Offering was consummated on July 2, 2021. The warrants are immediately exercisable at an exercise price of $<ix:nonFraction id="Fxbrl_20230325001816522" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">30</ix:nonFraction> per ordinary share, subject to certain adjustments, and will expire three and one-half years from the issuance date.&#160;The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20220204035407847" name="chek:WarrantsIssuedNotExercised" contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">64,815</ix:nonFraction> ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $<ix:nonFraction id="Fxbrl_20220204035503645" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">33.75</ix:nonFraction> per share. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to <ix:nonFraction id="Fxbrl_20220319012440955" name="chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" contextRef="C_20210601to20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% of the number of ordinary shares issued upon the cash exercise of the warrants (up to <ix:nonFraction id="Fxbrl_20220319012541037" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">64,815</ix:nonFraction> warrants). As of December 31, 2022 and 2021, warrants to purchase <ix:nonFraction id="Fxbrl_20230305032837835" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220319012108113" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,296,297</ix:nonFraction></ix:nonFraction> ordinary shares held by certain investors and <ix:nonFraction id="Fxbrl_20230305032852538" name="chek:WarrantsIssued" contextRef="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220319011829600" name="chek:WarrantsIssued" contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">64,815</ix:nonFraction></ix:nonFraction> warrants held by the placement agent, were outstanding. The Company received gross proceeds from the June 2021 Registered Direct Offering of approximately $<ix:nonFraction id="Fxbrl_20220318150552113" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20210601to20210630_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,000</ix:nonFraction>, or approximately $<ix:nonFraction id="Fxbrl_20220318151127189" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20210601to20210630_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,801</ix:nonFraction>, net of issuance expenses in the amount of $<ix:nonFraction id="Fxbrl_20220318150637536" name="chek:IssuanceExpenses" contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,199</ix:nonFraction>. (See Note 17(2) regarding change of exercise price and term of exercise of date of <ix:nonFraction id="Fxbrl_20220318150759991" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapOtherCommitmentsAxis_chekWarrantAmendmentAgreementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">926,297</ix:nonFraction> warrants).</span></span></span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>r)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On March 1, 2022, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of <ix:nonFraction id="Fxbrl_20230304183011229" name="chek:WarrantsIssued" contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> of the Company's ordinary shares and accompanying warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20230304183031955" name="chek:WarrantsIssuedNotExercised" contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">750,000</ix:nonFraction> of the Company's ordinary shares in a registered direct offering (the &#8220;March 2022 Registered Direct Offering&#8221;). The March 2022 Registered Direct Offering was consummated on March 3, 2022. The warrants are immediately exercisable at an exercise price of $<ix:nonFraction id="Fxbrl_20230304183054018" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">13</ix:nonFraction> per share, subject to certain adjustments,&#160;</span></span></span></span></span></span><span>and will expire five years from the issuance date.&#160;</span><span><span><span><span><span><span>The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20230304183129070" name="chek:WarrantsIssuedNotExercised" contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction> ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $<ix:nonFraction id="Fxbrl_20230304183147156" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember" unitRef="Usd_per_share" scale="0" decimals="1" format="ixt:num-dot-decimal">12.5</ix:nonFraction> per share and expiration date is March 1, 2027. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to <ix:nonFraction id="Fxbrl_20230304183202872" name="chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" contextRef="C_20220202to20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction>% of the number of ordinary shares issued upon the cash exercise of the warrants (up to <ix:nonFraction id="Fxbrl_20230304183218647" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="C_20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">37,500</ix:nonFraction> warrants). Simultaneously with this offering, the Company has entered into a warrant amendment agreement, or the Warrant Amendment Agreement, with the investors in this March 2022 Registered Direct Offering. Pursuant to the Warrant Amendment Agreement, certain warrants to purchase up to an aggregate of <ix:nonFraction id="Fxbrl_20230304183235983" name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">926,297</ix:nonFraction> ordinary shares of the Company that were issued to the investors in July 2021 were amended to have a reduced exercise price of $<ix:nonFraction id="Fxbrl_20230325013051672" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember" unitRef="Usd_per_share" scale="0" decimals="0" format="ixt:num-dot-decimal">13</ix:nonFraction> per share and the term of exercise was extended to January 2, 2025. The Company received gross proceeds from the March 2022 Registered Direct Offering of $<ix:nonFraction id="Fxbrl_20230304183340856" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20220202to20220301_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,000</ix:nonFraction>, or approximately $<ix:nonFraction id="Fxbrl_20230304183403195" name="chek:ProceedsFromIssuanceOfRegistredDirectOffering" contextRef="C_20220202to20220301_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,850</ix:nonFraction>, net of issuance expenses in the amount of approximately $<ix:nonFraction id="Fxbrl_20230304183429250" name="chek:IssuanceExpenses" contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,150</ix:nonFraction>.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div>
      <div>&#160;</div>
    </div>
  </div>
  <div>
    <div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">29</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>

  <div>
    <ix:nonNumeric id="F20230326072614723_213" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextRef="C_20220101to20221231" escape="true">
      <div>
        <div>
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 11 - SHARE-BASED COMPENSATION</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20.25pt">&#160;</td>
                  <td style="width:27pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In connection with the transfer of all of the business operations and substantially all of the assets of Check-Cap LLC to the Company in 2009, the Company assumed the Check-Cap LLC 2006 Unit Option Plan (the "2006 Plan"). According to the 2006 Plan, the Company is authorized to grant options to purchase ordinary shares of the Company to employees, directors and consultants of the Company. The options granted according to the 2006 Plan are generally exercisable for <ix:nonNumeric id="F20230326072614678_185" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" contextRef="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">10 years</ix:nonNumeric> from the grant date unless otherwise determined by the Company's Board of Directors, vest over a period to be determined by the Company's Board of Directors, and have an exercise price to be determined by the Company's Board of Directors.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 13, 2015, the shareholders approved and adopted the Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 Israeli Plan") and the Check-Cap Ltd. 2015 United States Sub-Plan to Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 U.S. Sub-Plan" and together with the 2015 Israeli Plan, the "2015 Plan"). As of such date, the Company ceased to grant options under the 2006 Plan. All of the remaining shares authorized but unissued under the 2006 Plan were rolled over to the 2015 Plan.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 5, 2020, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional <ix:nonFraction id="F20230326072614504_0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_20200801to20200805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">17,500</ix:nonFraction> shares to <ix:nonFraction id="F20230326072614506_1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">77,780</ix:nonFraction> shares.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 5, 2021, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional <ix:nonFraction id="F20230326072614771_245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_20210801to20210805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">125,000</ix:nonFraction>.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 27, 2022, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional <ix:nonFraction id="F20230326072614726_215" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_20220101to20220127_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">25,000</ix:nonFraction>.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, no shares were available for future awards under the 2015 Plan.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 4, 2023, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional <ix:nonFraction id="F20230326072614727_216" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_20230101to20230104_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">30,000</ix:nonFraction>.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of share-based grants made by the Company</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif">
              <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables presents the grant dates, number of underlying shares and related exercise prices of awards granted to employees and non-employees during the years 2022, 2021 and 2020 as well as the estimated fair value of the underlying ordinary shares on the grant date:</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-weight:normal">
                  <div style="line-height:1.25">
                    <div><ix:exclude>
                      <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
                        <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">30</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>NOTE 11 - SHARE-BASED COMPENSATION (Cont.)</span></strong></span></span></p>
                        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                      </div>
                      <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif">
                        <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                            <tr>
                              <td style="width:20pt">&#160;</td>
                              <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:normal;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>B.</span></span></span></td>
                              <td style="vertical-align:top;text-align:justify;width:auto">
                                <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>Details of share-based grants made by the Company (Cont.)</strong></span></span></span></p>
                                <p style="margin:0pt">&#160;</p>
                              </td>
                            </tr>

                        </table>
                      </div>
                    </ix:exclude></div>
                  </div>
                </div>
              </div>
              <ix:nonNumeric id="F20230326072614716_209" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" contextRef="C_20220101to20221231" escape="true">
                <div>
                  <div>
                    <div>
                      <div style="text-indent:49pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options:</span></span></div>
                      <div>
                        <div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="margin-left:49pt">
                            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">
                                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Fair value</span></p>
                                    </div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of options</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">on grant</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$in </span></span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vesting</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">399</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614523_10" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member" format="ixt:date-monthname-day-year-en">March 5, 2030</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate1Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">36.4</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">23.44</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 27, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">133</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614535_18" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member" format="ixt:date-monthname-day-year-en">May 27, 2030</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate2Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">11.8</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.47</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">18,014</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614537_23" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member" format="ixt:date-monthname-day-year-en">August 5, 2030</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate3Member" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.73</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">175</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 17, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,036</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614539_28" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member" format="ixt:date-monthname-day-year-en">November 17, 2030</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate4Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">6.4</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.22</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 10, 2020 (3)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">11,250</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614542_33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member" format="ixt:date-monthname-day-year-en">December 10, 2030</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate5Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">6.4</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">5.5</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 17, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,274</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614544_38" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member" format="ixt:date-monthname-day-year-en">March 17, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate6Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">45.4</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">42.8</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 11, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">903</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614547_43" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member" format="ixt:date-monthname-day-year-en">May 11, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate7Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">11.8</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">26.07</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (5)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">36,701</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614550_48" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member" format="ixt:date-monthname-day-year-en">August 4, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate8Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">24.6</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">18.47</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">678</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 13, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">750</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614552_53" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member" format="ixt:date-monthname-day-year-en">September 13, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate9Member" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:num-dot-decimal">21</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.92</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 20, 2021 (6)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,250</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614554_58" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member" format="ixt:date-monthname-day-year-en">September 20, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate10Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">20.6</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">16.15</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 2, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,556</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614773_246" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member" format="ixt:date-monthname-day-year-en">November 2, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate17Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">22.2</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">18.91</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7(</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">38,334</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614789_258" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member" format="ixt:date-monthname-day-year-en">December 9, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate11Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">26.8</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.98</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">497</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,167</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614775_247" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member" format="ixt:date-monthname-day-year-en">December 9, 2031</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate13Member" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">26.8</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">13.14</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022(9)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">16,800</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614777_248" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member" format="ixt:date-monthname-day-year-en">January 27, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne1Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.98</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">134</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,472</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614778_249" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member" format="ixt:date-monthname-day-year-en">March 21, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne2Member" unitRef="NIS_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">10.184</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.02</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,157</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614780_250" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member" format="ixt:date-monthname-day-year-en">May 31, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne3Member" unitRef="NIS_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">7.254</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">6.27</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,661</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614781_251" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember" format="ixt:date-monthname-day-year-en">August 29, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.23</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">6.91</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614730_217" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,024</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614783_252" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember" format="ixt:date-monthname-day-year-en">November 29, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614733_219" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.81</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614736_221" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.38</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614739_223" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 29, 2022(11)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614731_218" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">29,125</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614784_253" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember" format="ixt:date-monthname-day-year-en">December 29, 2032</ix:nonNumeric></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614734_220" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.14</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614737_222" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.64</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614741_224" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                      <div style="margin-left:45pt">&#160;</div>
                    </div>
                  </div>
                  <div style="text-indent:36pt;margin-left:11.25pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>RSUs:</span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of RSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value on</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and PSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (7)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614742_225" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614744_226" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt:date-monthname-day-year-en">August 4, 2031</ix:nonNumeric></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614745_227" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">21.8</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614747_228" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">327</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022 (9)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614559_83" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">7,200</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614559_84" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt:date-monthname-day-year-en">January 27, 2032</ix:nonNumeric></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614561_85" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.58</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614563_86" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614565_87" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,850</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="F20230326072614567_88" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt:date-monthname-day-year-en">March 21, 2032</ix:nonNumeric></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614568_89" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">8.27</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="F20230326072614569_90" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div><ix:exclude>
                      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">31</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman, Times, serif;font-size:10pt">NOTE 11 - SHARE-BASED COMPENSATION (Cont.)</span></strong></p>
                      <div style="line-height:1.25;font-weight:bold">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                          <tr>
                            <td style="width:20pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">B.</span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div style="font-weight:bold"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">Details of share-based grants made by the Company (Cont.)</span></div>
                              <div style="font-weight:bold">&#160;</div>
                            </td>
                          </tr>

                      </table>
                    </ix:exclude></div>
                    <div style="line-height:1.25">
                      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                          <tr>
                            <td style="vertical-align:top;width:49pt">&#160;</td>
                            <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span>1.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span>Share based expenses are based on their fair value on grant date. The amount is charged to the statement of operations over the vesting periods.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div>
                    <div>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of three years commencing on the date of grant, such that one third of the options vested on the first anniversary of the date of grant and thereafter, the remaining options vest in quarterly installments.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="text-align:justify;line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 10, 2020, the Company's Board of Directors approved the award of <ix:nonFraction id="F20230326072614508_2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20201201to20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">11,250</ix:nonFraction> options to the Company&#8217;s officers, with an exercise price of $<ix:nonFraction id="F20230326072614509_3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">6.4</ix:nonFraction>, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of <ix:nonNumeric id="F20230326072614686_190" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric> commencing on the date of grant, such that <ix:nonFraction id="F20230326072614687_191" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction>% of the options vest and become exercisable on the first anniversary of the date of grant and thereafter, vest monthly in equal portions at the end of each month over the subsequent thirty-six (36) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 4, 2021, the Company's Board of Directors approved the award of <ix:nonFraction id="F20230326072614679_186" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">36,694</ix:nonFraction> options and <ix:nonFraction id="F20230326072614681_187" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction> RSUs, of which, <ix:nonFraction id="F20230326072614682_188" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,075</ix:nonFraction> options and <ix:nonFraction id="F20230326072614685_189" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">5,175</ix:nonFraction> RSUs were issued to certain of the Company&#8217;s officers. The remaining options and RSUs were issued to certain employees.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2021, the Company's Board of Directors approved the award of <ix:nonFraction id="F20230326072614689_192" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210901to20210920_srtTitleOfIndividualAxis_chekVpClinicalMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,250</ix:nonFraction> options to the Company&#8217;s VP clinical, with an exercise price of $<ix:nonFraction id="F20230326072614690_193" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20210920_srtTitleOfIndividualAxis_chekVpClinicalMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">20.6</ix:nonFraction>, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 9, 2021, the Company's shareholders approved the award of <ix:nonFraction id="F20230326072614692_194" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekTwentyTwoJuneMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">57,500</ix:nonFraction> options to the Company&#8217;s CEO. The options shall vest as follows: (i) two-thirds of the options (<ix:nonFraction id="F20230326072614710_205" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">38,334</ix:nonFraction> options) shall vest over a period of <ix:nonNumeric id="F20230326072614694_195" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric> commencing on their date of grant, such that <ix:nonFraction id="F20230326072614696_196" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction>% of the options shall vest on the first anniversary of the date of grant and an additional <ix:nonFraction id="F20230326072614698_197" name="chek:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember" unitRef="Percent" scale="-2" decimals="6" format="ixt:num-dot-decimal">2.0833</ix:nonFraction>% will vest at the end of each month thereafter; and (ii) one third of the options (<ix:nonFraction id="F20230326072614712_206" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,166</ix:nonFraction> options) shall fully vest upon the approval by the FDA of the use of our C-Scan, in humans, subject, in each case, to the CEO&#8217;s continuing service with the Company on each applicable vesting date. The exercise price of the options of $<ix:nonFraction id="F20230326072614699_198" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">26.8</ix:nonFraction>, equal to the average closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders, plus a <ix:nonFraction id="F20230326072614713_207" name="chek:PremiumPercentageToCalculateExercisePrice" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction>% premium. The compensation expense was based on the fair value on the grant date and was estimated at approximately $<ix:nonFraction id="F20230326072614700_199" name="chek:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">749</ix:nonFraction>. The fair value amount is charged to the statement of operations over the vesting periods of which $<ix:nonFraction id="F20230326072614789_259" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">335</ix:nonFraction> and $<ix:nonFraction id="F20230326072614702_200" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction> were recorded to general and administrative expenses in the year ended December 31, 2022 and 2021, respectively.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted to service provider. The options vest over a period of twelve (12) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 27, 2022, the Company's Board of Directors approved the award to certain employees of <ix:nonFraction id="F20230326072614791_260" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">16,800</ix:nonFraction> options, with an exercise price of $<ix:nonFraction id="F20230326072614749_230" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">12.96</ix:nonFraction>, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date, and <ix:nonFraction id="F20230326072614752_231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">7,200</ix:nonFraction> RSUs.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2022, the Company's Board of Directors approved the award of <ix:nonFraction id="Fxbrl_20230328162410605" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,472</ix:nonFraction> options and <ix:nonFraction id="Fxbrl_20230328162420796" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,850</ix:nonFraction> RSUs to certain executive officers and employees, of which <ix:nonFraction id="Fxbrl_20230328162431460" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">6,650</ix:nonFraction> options and the <ix:nonFraction id="Fxbrl_20230328162441044" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,850</ix:nonFraction> RSUs were granted to certain officers. The options have an exercise price of $<ix:nonFraction id="Fxbrl_20230328162447947" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20220321" unitRef="NIS_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">10.184</ix:nonFraction>, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 29, 2022, the Company's shareholders approved the award of <ix:nonFraction id="F20230326072614756_234" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20221201to20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">29,125</ix:nonFraction> options to members of the Company's Board of Directors. The options shall become fully vested on the first anniversary of the date of grant, subject to each of the Board of Directors continuing service with the Company on the vesting date. The exercise price of the options is $<ix:nonFraction id="F20230326072614758_235" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.14</ix:nonFraction>, equal to two times the closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market on the date of the approval of the option grant by the Company&#8217;s shareholders.</span></span></div>
                              <div>&#160;</div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </div>
              </ix:nonNumeric>
              <div><ix:exclude>
                <div style="line-height:1.25">
                  <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">32</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                  <p style="margin:0pt"><strong><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>NOTE 11 - SHARE-BASED COMPENSATION (Cont.)</span></span></span></span></span></span></span></strong></p>
                  <p style="margin:0pt">&#160;</p>
                </div>
              </ix:exclude></div>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;width:29pt"><span><span><span style="font-size:10pt"><span><span><span><span>C.</span></span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span><span><span style="font-size:10pt"><span><span><span><span>Options Fair Value</span></span></span></span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>
                <div>
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;margin-left:49pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>The parameters which were used in applying the model are as follows:</span></span></span></span></span></span></span></div>
                    <ix:nonNumeric id="F20230326072614724_214" name="chek:ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected volatility</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614571_91" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">109</ix:nonFraction>%-<ix:nonFraction id="F20230326072614577_94" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">118</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614572_92" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">115</ix:nonFraction>%-<ix:nonFraction id="F20230326072614578_95" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">153</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614574_93" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">95</ix:nonFraction>%-<ix:nonFraction id="F20230326072614579_96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">98</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Risk-free rate</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614581_97" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.7</ix:nonFraction>%-<ix:nonFraction id="F20230326072614582_98" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614584_99" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.81</ix:nonFraction>%-<ix:nonFraction id="F20230326072614585_100" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.34</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonFraction id="F20230326072614588_101" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.31</ix:nonFraction>%-<ix:nonFraction id="F20230326072614590_102" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.83</ix:nonFraction></span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Dividend yield</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><ix:nonFraction id="F20230326072614591_103" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><ix:nonFraction id="F20230326072614592_104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><ix:nonFraction id="F20230326072614594_105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="Percent" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected term (in years)</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonNumeric id="F20230326072614595_106" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">5.5</ix:nonNumeric>-<ix:nonNumeric id="F20230326072614597_107" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">6.08</ix:nonNumeric></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><ix:nonNumeric id="F20230326072614703_201" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20210101to20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">5.27</ix:nonNumeric>-<ix:nonNumeric id="F20230326072614705_202" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20210101to20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">6.41</ix:nonNumeric></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:center;width:10%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><ix:nonNumeric id="F20230326072614768_243" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20200101to20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">5.88</ix:nonNumeric> - <ix:nonNumeric id="F20230326072614769_244" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20200101to20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" format="ixt-sec:duryear">6.1</ix:nonNumeric></span></span></span></span></span></span></span></td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>Share price</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$<ix:nonFraction id="F20230326072614600_108" name="us-gaap:SharePrice" contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.07</ix:nonFraction> - $<ix:nonFraction id="F20230326072614601_109" name="us-gaap:SharePrice" contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.58</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$<ix:nonFraction id="F20230326072614603_110" name="us-gaap:SharePrice" contextRef="C_20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">0.8</ix:nonFraction> - $<ix:nonFraction id="F20230326072614714_208" name="us-gaap:SharePrice" contextRef="C_20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">2.27</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$<ix:nonFraction id="F20230326072614604_111" name="us-gaap:SharePrice" contextRef="C_20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.28</ix:nonFraction> - $<ix:nonFraction id="F20230326072614605_112" name="us-gaap:SharePrice" contextRef="C_20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">1.57</ix:nonFraction></span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
                      </div>
                    </ix:nonNumeric>
                    <div style="line-height:1.25">&#160;</div>
                  </div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>D.</span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Effect of share-based compensation transactions on the Company's statements of operations</span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:49pt">
                <ix:nonNumeric id="F20230326072614719_210" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_20220101to20221231" escape="true">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Research and development, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614607_113" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">493</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614608_114" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">329</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614611_115" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>General and administrative, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614612_116" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614614_117" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614615_118" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Total</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614616_119" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">975</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614618_120" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">491</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614619_121" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">408</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </ix:nonNumeric>
              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>E.</span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>A summary of the Company's option activity related to options granted to employees, service providers and directors, and related information under the 2006 Plan and the 2015 Plan is as follows:</span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <ix:nonNumeric id="F20230326072614720_211" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2022</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614622_122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">145,895</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614623_123" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">48.2</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="F20230326072614625_124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20220101to20221231" format="ixt-sec:duryear">9.13</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614626_125" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614627_126" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">58,239</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614629_127" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">7.75</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614630_128" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">12,242</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614633_129" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">59.07</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercised</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614707_203" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20221231" unitRef="shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614709_204" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20220101to20221231" unitRef="NIS_Per_Share" scale="0" decimals="0" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614634_130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">191,892</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614636_131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">35.35</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="F20230326072614637_132" name="chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" contextRef="C_20220101to20221231" format="ixt-sec:duryear">8.59</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614638_133" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614640_134" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_20221231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">55,259</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614641_135" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">79.79</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="F20230326072614644_136" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_20220101to20221231" format="ixt-sec:duryear">7.39</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614645_137" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div><ix:exclude>
                    <div style="line-height:1.25">
                      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">33</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
                      <p style="margin:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;font-weight:bold">NOTE 11 - SHARE-BASED COMPENSATION (Cont.)</span></p>
                    </div>
                    <div style="line-height:1.25;font-weight:bold">
                      <p style="margin:0pt">&#160;</p>
                    </div>
                  </ix:exclude></div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2021</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351049_20230326072614622_122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20201231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">54,516</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351049_20230326072614623_123" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20201231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">95.3</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143351049_20230326072614625_124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20210101to20211231" format="ixt-sec:duryear">8.74</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351049_20230326072614626_125" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351080_20230326072614627_126" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">99,935</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351080_20230326072614629_127" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">26.0</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="Fxbrl_20220110143351102_20230326072614630_128" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">8,206</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351102_20230326072614633_129" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">92.9</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">Options exercised</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230304182917882_xbrl_20220110143351102_20230326072614630_128" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">350</ix:nonFraction></span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif">)</span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230304182917882_xbrl_20220110143351102_20230326072614633_129" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_20210101to20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">12.0</ix:nonFraction></span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351121_20230326072614634_130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">145,895</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351121_20230326072614636_131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">48.2</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143351121_20230326072614637_132" name="chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" contextRef="C_20210101to20211231" format="ixt-sec:duryear">9.13</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351121_20230326072614638_133" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351150_20230326072614640_134" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_20211231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">27,037</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351150_20230326072614641_135" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_20211231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">154.3</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143351150_20230326072614644_136" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_20210101to20211231" format="ixt-sec:duryear">7.03</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143351150_20230326072614645_137" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2020</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Weighted</span></strong></span></span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>average of</span></span></span></p>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>exercise</span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>price</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(in $)</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354706_20230326072614622_122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20191231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">27,456</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354706_20230326072614623_123" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20191231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">204.8</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143354706_20230326072614625_124" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_20200101to20201231" format="ixt-sec:duryear">8.30</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354706_20230326072614626_125" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354723_20230326072614627_126" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20200101to20201231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">30,832</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354723_20230326072614629_127" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_20200101to20201231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">10.4</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="Fxbrl_20220110143354731_20230326072614630_128" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="C_20200101to20201231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,772</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354731_20230326072614633_129" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_20200101to20201231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">196.6</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354740_20230326072614634_130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20201231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">54,516</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354740_20230326072614636_131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20201231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">95.3</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143354740_20230326072614637_132" name="chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" contextRef="C_20200101to20201231" format="ixt-sec:duryear">8.74</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354740_20230326072614638_133" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354757_20230326072614640_134" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_20201231" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,486</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354757_20230326072614641_135" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_20201231" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">282.8</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonNumeric id="Fxbrl_20220110143354757_20230326072614644_136" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_20200101to20201231" format="ixt-sec:duryear">7.00</ix:nonNumeric></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="Fxbrl_20220110143354757_20230326072614645_137" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>1.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>The weighted average grant date fair values of options granted during the years ended December 31, 2022, 2021 and 2020 were $<ix:nonFraction id="F20230326072614761_238" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">4.5</ix:nonFraction>, $<ix:nonFraction id="F20230326072614761_239" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">15.7</ix:nonFraction> and $<ix:nonFraction id="F20230326072614764_240" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">8.2</ix:nonFraction>, respectively.</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>As of December 31, 2022, all the outstanding options in the amount of <ix:nonFraction id="F20230326072614765_241" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">191,892</ix:nonFraction>, with an average exercise price of $<ix:nonFraction id="F20230326072614766_242" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">35.35</ix:nonFraction>, are out of the money.&#160;</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>A summary of the Company&#8217;s RSUs activity is as follows:</span></span></span></span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:78pt">
                <ix:nonNumeric id="F20230326072614722_212" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" escape="true">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number of RSUs</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at beginning of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614655_170" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">16,628</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614656_171" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,637</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614657_172" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20191231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,985</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Granted</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614658_173" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">10,050</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614660_174" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><ix:nonFraction id="F20230326072614662_175" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Vested</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614664_176" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">4,374</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614665_177" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,764</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614667_178" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,258</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Forfeited</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614668_179" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,601</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614669_180" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">245</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(<ix:nonFraction id="F20230326072614671_181" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">90</ix:nonFraction></span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at end of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong><ix:nonFraction id="F20230326072614674_182" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">19,703</ix:nonFraction></strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong><ix:nonFraction id="F20230326072614675_183" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">16,628</ix:nonFraction></strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong><ix:nonFraction id="F20230326072614676_184" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">3,637</ix:nonFraction></strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </ix:nonNumeric>
              </div>
              <div style="line-height:1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt">3.</td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div>The weighted average grant date fair values of RSUs awarded during the years ended December 31, 2022 and 2021 were $<ix:nonFraction id="F20230326072614511_4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">9.2</ix:nonFraction> and $<ix:nonFraction id="F20230326072614513_5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="NIS_Per_Share" scale="0" decimals="1" format="ixt:num-dot-decimal">21.8</ix:nonFraction>, respectively.</div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt">4.</td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div>As of December 31, 2022, 2021 and 2020, there was $<ix:nonFraction id="F20230326072614517_6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,111</ix:nonFraction>, $<ix:nonFraction id="F20230326072614519_7" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,644</ix:nonFraction> and $<ix:nonFraction id="F20230326072614520_8" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">328</ix:nonFraction> unrecognized compensation cost related to non-vested share-based compensation arrangements (options and RSUs) granted under the 2006 Plan and 2015 Plan. This cost is expected to be recognized over a period of up to 4 years.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div>&#160;</div>
      </div>
    </ix:nonNumeric>
    <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
      <div>
        <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">34</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </div>
    </div>
  </div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220318170316474" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div>
              <div>
                <div>
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 12 - RESEARCH AND DEVELOPMENT EXPENSES, NET</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <ix:nonNumeric id="Fxbrl_20230324125052875" name="chek:ScheduleOfResearchAndDevelopmentExpensesNet" contextRef="C_20220101to20221231" escape="true">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;margin-left:20pt">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121226219" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,257</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_37" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,428</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_311" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,173</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_43" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">493</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_47" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">329</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_411" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">165</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Materials</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_53" name="us-gaap:SuppliesExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,258</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_57" name="us-gaap:SuppliesExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,020</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_511" name="us-gaap:SuppliesExpense" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,792</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subcontractors and consultants</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_63" name="chek:SubcontractorsAndConsultantFees" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,375</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_67" name="chek:SubcontractorsAndConsultantFees" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">820</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_611" name="chek:SubcontractorsAndConsultantFees" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,103</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_73" name="us-gaap:DepreciationNonproduction" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_77" name="us-gaap:DepreciationNonproduction" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">169</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_711" name="us-gaap:DepreciationNonproduction" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost for registration of patents</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_83" name="chek:PaymentsExpensesForPatents" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_87" name="chek:PaymentsExpensesForPatents" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">153</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_811" name="chek:PaymentsExpensesForPatents" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">164</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_93" name="us-gaap:OtherExpenses" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,681</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_97" name="us-gaap:OtherExpenses" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">861</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_911" name="us-gaap:OtherExpenses" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">488</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230324125535959" name="chek:ResearchAndDevelopmentExpenseGross" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,493</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_107" name="chek:ResearchAndDevelopmentExpenseGross" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,780</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_1011" name="chek:ResearchAndDevelopmentExpenseGross" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,008</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less participation of the IIA</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220204020317683" name="chek:GrantedRevenue" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303045057570" name="chek:GrantedRevenue" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">431</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_1111" name="chek:GrantedRevenue" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total research and development expenses, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_123" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,271</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_127" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,349</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110120609957_1211" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,008</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </ix:nonNumeric>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </div>
  <div>&#160;</div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220318170550975" name="chek:GeneralAndAdministrativeExpensesTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13 - GENERAL AND ADMINISTRATIVE EXPENSES</span></span></div>
            <div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <ix:nonNumeric id="Fxbrl_20230324124200824" name="chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_33" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,784</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_37" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,042</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_311" name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,698</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_43" name="chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">386</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_47" name="chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_411" name="chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional services</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_53" name="us-gaap:ProfessionalFees" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,092</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_57" name="us-gaap:ProfessionalFees" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">710</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_511" name="us-gaap:ProfessionalFees" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">574</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office rent and maintenance</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_63" name="chek:OfficeRentAndMaintenance" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_67" name="chek:OfficeRentAndMaintenance" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">172</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_611" name="chek:OfficeRentAndMaintenance" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">174</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_73" name="us-gaap:DepreciationNonproduction" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_77" name="us-gaap:DepreciationNonproduction" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_711" name="us-gaap:DepreciationNonproduction" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_83" name="us-gaap:OtherCostAndExpenseOperating" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,139</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_87" name="us-gaap:OtherCostAndExpenseOperating" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,850</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_811" name="us-gaap:OtherCostAndExpenseOperating" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,210</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total general and administrative expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_93" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,763</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_97" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,972</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121809950_911" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,924</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </ix:nonNumeric>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
        <div style="margin-left:57px">
          <p style="margin:0pt">&#160;</p>
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220318170710488" name="us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 14 - FINANCE INCOME (EXPENSES), NET</span></span></div>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>
                <ix:nonNumeric id="Fxbrl_20230324115006791" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                  <div>
                    <div>
                      <div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:90%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on short-term deposits and other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_33" name="us-gaap:InvestmentIncomeInterest" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,047</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_37" name="us-gaap:InvestmentIncomeInterest" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">101</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_311" name="us-gaap:InvestmentIncomeInterest" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank fees and interest expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_43" name="us-gaap:InterestExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_47" name="us-gaap:InterestExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_411" name="us-gaap:InterestExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in provision for royalties</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_53" name="chek:ChangesInLiabilityToPayRoyalties" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_57" name="chek:ChangesInLiabilityToPayRoyalties" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_511" name="chek:ChangesInLiabilityToPayRoyalties" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange rate differences</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_63" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">25</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_67" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">43</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110121730045_611" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value of derivatives</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230303045658403" name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">121</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_77" name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_711" name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financing income, net</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_83" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">926</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_87" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110121730045_811" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
        <div>
          <div style="margin-left:42pt">
            <p style="margin:0pt">&#160;</p>
          </div>
        </div>
      </div>
      <div style="line-height:1.25;clear:both">
        <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">35</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
      </div>
    </div>
  </div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220318170846973" name="us-gaap:EarningsPerShareTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div>
              <div>
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 15 - LOSS PER SHARE</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Basic loss per share is computed based on the weighted average number of shares outstanding during each year. Diluted net loss per share is computed based on the weighted average number of shares outstanding during each year, plus the dilutive potential of the ordinary shares considered outstanding during the year, in accordance with ASC 260-10 "Earnings per share".</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">All outstanding options and warrants have been excluded from the calculation of the diluted loss per share for each period presented, since all such securities have an anti-dilutive effect.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The following table sets forth the computation of the Company`s basic and diluted net loss per ordinary share:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <ix:nonNumeric id="Fxbrl_20220318170853896" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_20220101to20221231" escape="true">
                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220110121317968_33" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,108</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220110121317968_37" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17,202</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220110121317968_311" name="us-gaap:NetIncomeLoss" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">13,846</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Shares used in computing net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20221103164109496" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_43" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20221231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">5,671,786</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230327130014330" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_47" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20211231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">4,159,870</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230327130044155" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20200101to20201231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_411" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20200101to20201231" unitRef="shares" scale="0" decimals="0" format="ixt:num-dot-decimal">1,537,060</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20221103163923054" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20221231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_53" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20221231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">3.37</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230327130101595" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20211231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_57" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20211231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">4.14</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230327130116883" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20200101to20201231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220110121317968_511" name="us-gaap:EarningsPerShareBasic" contextRef="C_20200101to20201231" unitRef="Usd_per_share" scale="0" decimals="2" format="ixt:num-dot-decimal">9.01</ix:nonFraction></ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </ix:nonNumeric>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Instruments that may potentially dilute the basic loss per share in the future but were not included in the calculation of diluted loss per share, since their effect is anti-dilutive.</span></span></div>
                <ix:nonNumeric id="Fxbrl_20230324120311516" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextRef="C_20220101to20221231" escape="true">
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(number)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Warrants and share options</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20230304173554680" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">2,912,147</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220110121447078_37" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,170,262</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><ix:nonFraction id="Fxbrl_20220110121447078_311" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20200101to20201231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember" unitRef="shares" decimals="INF" format="ixt:num-dot-decimal">1,104,431</ix:nonFraction></span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </ix:nonNumeric>
              </div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
        <div style="text-align:center">
          <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><div style="margin-top:10pt;margin-bottom:14px;text-align:left"><div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">36</span></span></span></span></span></span></span></span></div><div><hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" /></div></div><div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">CHECK CAP LTD</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></span></div><div style="text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:rgb(0, 0, 0);font-style:normal;line-height:1.25;font-weight:bold"><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></span></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
        </div>
      </div>
    </div>
  </div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220318172242420" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_20220101to20221231" escape="true">
        <div>
          <div>
            <div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 16 - RELATED PARTIES</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation to the non-executive directors:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20220318172300169" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember" escape="true">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fees, including reimbursement of expenses</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_33" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">270</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_37" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_311" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">251</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:baseline;width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220110113112075_43" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></p>
                            </div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_47" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_411" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_53" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">260</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_57" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113112075_511" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">327</ix:nonFraction></span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              </ix:nonNumeric>&#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
              <ix:nonNumeric id="Fxbrl_20230324123455756" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekGeneralTransactionsMember" escape="true">
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees, including share-based compensation and reimbursement of expenses</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_33" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_37" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_311" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:65%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_43" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_47" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20210101to20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220110113620668_411" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="C_20200101to20201231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57</ix:nonFraction></span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>

                  </table>
                </div>
              </ix:nonNumeric>
              <div style="margin-left:48pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">&#160;</span></div>
              <div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 4, 2016, the Company entered into an employment agreement with Sigalit Kimchy, according to which Ms. Kimchy serves as marcom and user interface lead, in a 50% part-time role (no less than 112 hours per month), for a monthly salary of NIS <ix:nonFraction id="Fxbrl_20220110114924624" name="chek:MonthlyRetainer" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="NIS" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction> ($<ix:nonFraction id="Fxbrl_20220110114910685" name="chek:MonthlyRetainer" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="USD" scale="3" decimals="-1" format="ixt:num-dot-decimal">2.84</ix:nonFraction>), plus up to 35 monthly overtime hours at a gross monthly rate of NIS <ix:nonFraction id="Fxbrl_20230304175229439" name="chek:GrossOvertimeMonthlyRate" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="NIS" scale="3" decimals="-2" format="ixt:num-dot-decimal">2.5</ix:nonFraction> ($<ix:nonFraction id="Fxbrl_20220110114933927" name="chek:GrossOvertimeMonthlyRate" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">0.7</ix:nonFraction>), or an aggregate monthly salary of up to NIS <ix:nonFraction id="Fxbrl_20220110114940757" name="chek:MaximumAggregateMonthlySalary" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="NIS" scale="3" decimals="-2" format="ixt:num-dot-decimal">12.5</ix:nonFraction> ($<ix:nonFraction id="Fxbrl_20220110114945527" name="chek:MaximumAggregateMonthlySalary" contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" unitRef="USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">3.6</ix:nonFraction>). Ms. Kimchy is entitled to an education fund, managers' insurance or pension fund and reimbursement of monthly travel expenses. Sigalit Kimchy is the wife of Yoav Kimchy, the Company&#8217;s Chief Technology Officer.</span></span></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align:justify;margin-left:45pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
    </div>
  </div>

  <div>
    <div>
      <div>
        <ix:nonNumeric id="Fxbrl_20220318172458396" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_20220101to20221231" escape="true">
          <div>
            <div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17 - SUBSEQUENT EVENTS</span></span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2023, the Company announced that following its internal assessment of the clinical data collected to date from its calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study. &#160;As a result, the Company has adopted a plan of action that includes conducting additional clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal study protocol that are expected to be part of an IDE supplement submission to the FDA, and which are subject to FDA approval. In addition, the Company plans to continue conducting its calibration studies, albeit at a slower pace, to collect additional clinical data and it is also implementing a cost reduction plan, in order to extend its cash runway. The initiation of the powered portion of the U.S. pivotal study that was expected in mid-2023 is therefore temporarily postponed.</span></span></div>
            </div>
          </div>
        </ix:nonNumeric>
      </div>
    </div>
  </div>
  <div style="text-align:center">
    <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="font-weight:normal;font-style:normal">F - </span></span></span><span><span><span><span style="font-weight:normal;font-style:normal">37</span></span></span></span></span></span></span></span>
  </div>
  <div>
    <hr style="border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4pt;margin-bottom:0px;page-break-after:always" />
  </div>
</div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>exhibit_1-1.htm
<DESCRIPTION>EXHIHBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div> <br>
    </div>
    <div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 1.1</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">THE COMPANIES LAW, 5759-1999&#160;</div>
      <div style="text-align: center; line-height: 1.25;">A LIMITED LIABILITY COMPANY</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ARTICLES OF ASSOCIATION</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Preliminary</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0f2ac49497454abc9282caddb1065cea" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Definitions; Interpretation</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z554d08d5352e4620b5e39d50438050fd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context
                requires otherwise:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0cb7a09af4e145609af16101f404fde1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Articles&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean these Articles of Association, as amended from time to time.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Administrative Proceeding&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean a proceeding instituted pursuant to (a) Chapter H3 of the Securities Law, &#8220;Imposition of Monetary Sanctions by the
                Securities Authority&#8221;; (b) Chapter H4 of the Securities Law, &#8220;Imposition of Administrative Enforcement Sanctions by the Enforcement Committee&#8221;; (c) Chapter I1 of the Securities Law, &#8220;Arrangement for the Avoidance of Proceedings or
                Termination of Proceedings, which is Subject to Conditions&#8221; or (d) pursuant to Chapter I4(d) of the Companies Law.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Board of Directors&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the Board of Directors of the Company.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Chairman&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the Chairman of the Board of Directors, or the Chairman of the General Meeting, as the context implies.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Committee&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall have the meaning assigned thereto in Article 38.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Company&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean Check-Cap Ltd.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Companies Law&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the Israeli Companies Law, 5759-1999. The Companies Law shall include reference to the Companies Ordinance (New
                Version), 5743-1983, of the State of Israel, to the extent in effect according to the provisions thereof.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Director(s)&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the member(s) of the Board of Directors holding office at any given time, including alternate directors.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;External Director(s)&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall have the meaning provided for such term in the Companies Law.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;General Meeting&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean an Annual General Meeting or a Special General Meeting of the Shareholders (each, as defined in Article 24 of these
                Articles), as the case may be.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;NIS&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean New Israeli Shekels.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze5673cff1fbe4946912ed22631d4258e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Office&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the registered office of the Company at any given time.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Office Holder&#8221; or &#8220;Officer&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall have the meaning provided for such term in the Companies Law.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;RTP Law&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the Israeli Restrictive Trade Practices Law, 5758-1988.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Securities Law&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the Israeli Securities Law 5728-1968.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;Shareholder(s)&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean the shareholder(s) of the Company, at any given time.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">&#160;</td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 4.01%; vertical-align: top;">&#160;</td>
            <td style="width: 16%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#8220;in writing&#8221; or &#8220;writing&#8221;</div>
            </td>
            <td style="width: 3.04%; vertical-align: top;">&#160;</td>
            <td style="width: 76.96%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">shall mean written, printed, photocopied, photographed or typed, including if appearing in an email, facsimile or if produced
                by any visible substitute for a writing, or partly one and partly another. The term &#8220;signed&#8221; or &#8220;signature&#8221; shall be construed in a corresponding manner.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zda9dc576acef41f0a99c94be534fe040" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Unless otherwise defined in these Articles or required by the context, terms used herein shall have the meaning provided therefor under the Companies Law.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd0d3915171b94a249a628f737d3bb0f2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Unless the context shall otherwise require: words in the singular shall also include the plural, and <font style="font-style: italic;">vice versa</font>; any pronoun shall include the corresponding masculine, feminine and neuter forms; the words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without
                limitation&#8221;; the words &#8220;herein&#8221;, &#8220;hereof&#8221; and &#8220;hereunder&#8221; and words of similar import refer to these Articles in their entirety and not to any part hereof; all references herein to Articles, Sections or clauses shall be deemed references to
                Articles, Sections or clauses of these Articles; any references to any agreement or other instrument or law, statute or regulation are to it as amended, supplemented or restated, from time to time (and, in the case of any law, to any
                successor provisions or re-enactment or modification thereof being in force at the time); any reference to &#8220;law&#8221; shall include any supranational, national, federal, state, local, or foreign statute or law and all rules and regulations
                promulgated thereunder (including, any rules, regulations or forms prescribed by any governmental authority or securities exchange commission or authority, if and to the extent applicable); any reference to a &#8220;day&#8221; or a number of &#8220;days&#8221;
                (without any explicit reference otherwise, such as to business days) shall be interpreted as a reference to a calendar day or number of calendar days; any reference to a month<font style="font-weight: bold;">&#160;</font>or<font style="font-weight: bold;">&#160;</font>year shall be interpreted in accordance with the Gregorian calendar; any reference to a
                &#8220;company&#8221;, &#8220;corporate body&#8221; or &#8220;entity&#8221; shall include a partnership, corporation, limited liability company, association, trust, unincorporated organization, or a government or agency or political subdivision thereof, and any reference to a
                &#8220;person&#8221; shall include any of the foregoing types of entities or a natural person.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zfab670d3b5fc4f74adb4c080e74a53c0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The captions in these Articles are for convenience only and shall not be deemed a part hereof or affect the construction or interpretation of any provision hereof.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Limited Liability</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9e8e29514ab84091a78bdc8d9d2298c1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">2.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div>The Company is a limited liability company and each Shareholder&#8217;s obligations to the Company shall therefore be limited to the payment of the nominal value of the
                shares held by such Shareholder, subject to the provisions of the Companies Law.&#160;If at any time the Company shall issue shares with no nominal value, the liability of the Shareholders shall be limited to the payment of the amount which the
                Shareholders should have paid the Company in respect of each share in accordance with the conditions of such issuance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Public Company; Company&#8217;s Objectives</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zcf979e1e17684ad1bf31720cafc71c82" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div>The Company is a Public Company as such term is defined in, and as long as the Company qualifies as such under, the Companies Law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd32f84eb5fce43778ecdcb6f4f8a4462" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">4.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div>The Company&#8217;s objectives are to carry on any business, and do any act, which is not prohibited by law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za13e46ef62cd427888de71199108d416" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">5.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div>The Company may donate a reasonable amount of money (in cash or in kind, including the Company&#8217;s securities) for any purpose that the Board of Directors finds
                appropriate, even if such donation is not for business considerations or for the purpose of achieving profits for the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Share Capital</div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zcba1e2177c8c4a168fa4db900b0cd062" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">6.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Authorized Share Capital</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb34ab1a4501841a2af79f432fb42e463" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The share capital of the Company shall consist of NIS 864,000,000 divided into 18,000,000 Ordinary Shares, of a nominal value of NIS 48.0 each (referred to in this
                Article 6 as the &#8220;<font style="font-weight: bold;">Shares</font>&#8221; and elsewhere throughout these Articles as &#8220;<font style="font-weight: bold;">shares</font>&#8221;).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zeefeb56d68d74709b9d0429017be3a8d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Shares shall entitle their owners to:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zed38c05cc90649c78859e14a739c5870" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an equal right to participate in and vote at the General Meetings of the Company. Each of the Shares in the Company shall entitle its owner present at the meeting and
                participating in the vote in person, by proxy, or by means of a letter of voting, to one vote;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zfb9c6727b889495982afa23fb4be5fcf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an equal right to participate in the distribution of dividends, whether in cash or in benefit Shares, in the distribution of assets, or in any other distribution,
                according to the proportionate nominal value of the Shares held thereby;&#160; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z8bc28c8920ce451ca4208e472698f9e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>an equal right to participate in the distribution of the surplus assets of the Company in the event of its liquidation in accordance with the proportionate nominal
                value of the Shares held thereby.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb5b59f26af7c409c92c3a1e8afc22847" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Shares shall rank pari passu in all respects.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc2d832d1a1504507a4501739ba855680" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">7.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Increase of Authorized Share Capital</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0c53f472a00f4bbe92b7c13564192175" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company may, from time to time, by a Shareholders&#8217; resolution, whether or not all of the shares then authorized have been issued, and whether or not all of the
                shares theretofore issued have been called up for payment, increase its authorized share capital by increasing the number of shares it is authorized to issue. Any such increase shall be in such amount and shall be divided into shares of
                such nominal amounts, and such shares shall confer such rights and preferences, and shall be subject to such restrictions, as such resolution shall provide.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4f9568fcd97b4f07abe43ea7d135488c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Except to the extent otherwise provided in such resolution, any new shares included in the authorized share capital increase as aforesaid shall be subject to all of
                the provisions of these Articles that are applicable to shares of such class that are included in the existing share capital.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdf774347666b498b82ba926f61144a21" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">8.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Special or Class Rights; Modification of Rights</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z35b5f06191f04cd5a9ea46638c6c117e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company may, from time to time, by a Shareholders&#8217; resolution, provide for shares with such preferred or deferred rights or other special rights and/or such
                restrictions, whether in regard to dividends, voting, repayment of share capital or otherwise, as may be stipulated in such resolution, subject to applicable law.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z87b510937aae4675b9d56e9c94dbc955" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If at any time the share capital of the Company is divided into different classes of shares, the rights attached to any class, unless otherwise provided by these
                Articles, may be modified or cancelled by the Company by a resolution of the General Meeting of the holders of all shares as one class, without any required separate resolution of any class of shares.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc5c129fbc1f74424aec6f2dffef6e734" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The provisions of these Articles relating to General Meetings shall apply, <font style="font-style: italic;">mutatis mutandis</font>, to any separate General Meeting of the holders of the shares of a particular class, it being clarified that the requisite quorum at any such separate General Meeting shall be two or more Shareholders
                present in person or by proxy and holding not less than twenty-five percent (25%) of the issued shares of such class.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z83805900e3974ea99f50d6258b11fa01" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Unless otherwise provided by these Articles, an increase in the authorized share capital, the creation of a new class of shares, an increase in the authorized share
                capital of a class of shares, or the issuance of additional shares thereof out of the authorized and unissued share capital, shall not be deemed, for purposes of this Article 8, to modify or derogate or cancel the rights attached to
                previously issued shares of such class or of any other class.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9bad87173e0e45e294014cea4d70a6ef" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">9.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Consolidation, Division, Cancellation and Reduction of Share Capital</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0252d8e27bd04ec78cf9bf11e410e1a5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company may, from time to time, by or pursuant to an authorization of a Shareholders&#8217; resolution, and subject to applicable law:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za20fec15dc514a389dac8175a12c3a37" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>consolidate all or any part of its issued or unissued authorized share capital into shares of a per share nominal value which is larger, equal to or smaller than the
                per share nominal value of its existing shares;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6dcdb8fb62434e69ba617cd669b3d1ac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>divide or sub-divide its shares (issued or unissued) or any of them, into shares of smaller or the same nominal value (subject, however, to the provisions of the
                Companies Law), and the resolution whereby any share is divided may determine that, as among the holders of the shares resulting from such subdivision, one or more of the shares may, in contrast to others, have any such preferred or
                deferred rights or rights of redemption or other special rights, or be subject to any such restrictions, as the Company may attach to unissued or new shares;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf5e11b2363be4aa191577de6104448ce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>cancel authorized share capital not yet issued, provided that the Company has made no commitment, including a conditional commitment, to issue such shares, and
                diminish the amount of its share capital by the amount of the shares so cancelled; or</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb80c9f8eeba74641bfb71e28de338aa9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>reduce its share capital in any manner.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z070837e4f57f4983adbd90eee67c00e2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>With respect to any consolidation of issued shares and with respect to any other action which may result in fractional shares, the Board of Directors may settle any
                difficulty which may arise with regard thereto, as it deems fit, and, in connection with any such consolidation or other action which could result in fractional shares, may, without limiting its aforesaid power:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf003c228bf9149a18d46c1f9aeed8564" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>determine, as to the holder of shares so consolidated, which issued shares shall be consolidated into a share of a larger, equal or smaller nominal value per share;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5121132b2a70496e9b4cbdab25154fb6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>issue, in contemplation of or subsequent to such consolidation or other action, shares sufficient to preclude or remove fractional share holdings;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z040de850f80547a3b2d6cd1891330db1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>redeem such shares or fractional shares sufficient to preclude or remove fractional share holdings;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z25670371a9e744129dff9f1cd976e52f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>round up, round down or round to the nearest whole number, any fractional shares resulting from the consolidation or from any other action which may result in
                fractional shares; or</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9ac51dd1bd4547469c927e7e75b39e0a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>to the extent permitted by applicable law, cause the transfer of fractional shares by certain Shareholders of the Company to other Shareholders thereof so as to most
                expediently preclude or remove any fractional shareholdings, and cause the transferees of such fractional shares to pay the transferors thereof the fair value thereof, and the Board of Directors is hereby authorized to act in connection
                with such transfer, as agent for the transferors and transferees of any such fractional shares, with full power of substitution, for the purposes of implementing the provisions of this sub-Article 9(b)(v).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5bce085b42d149d0861955410b718141" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">10.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Issuance of Share Certificates, Replacement of Lost Certificates</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdf3937e82d814eba8d51360574e435ce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To the extent that the Board of Directors determines that all shares shall be certificated or, if the Board of Directors does not so determine, to the extent that any
                Shareholder requests a share certificate or the Company&#8217;s transfer agent so requires, share certificates shall be issued under the corporate seal of the Company or its written, typed or stamped name and shall bear the signature of one
                Director, or of any person or persons authorized therefor by the Board of Directors. Signatures may be affixed in any mechanical or electronic form, as the Board of Directors may prescribe.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb20644d54f5c4282a464af63cfb64d9d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of Article 10(a), each Shareholder shall be entitled to one numbered certificate for all of the shares of any class registered in his name.
                Each certificate shall specify the serial numbers of the shares represented thereby and may also specify the amount paid up thereon. The Company (as determined by an officer of the Company to be designated by the Chief Executive Officer)
                shall not refuse a request by a Shareholder to obtain several certificates in place of one certificate, unless such request is, in the opinion of such officer, unreasonable. Where a Shareholder has sold or transferred some of such
                Shareholder&#8217;s shares, such Shareholder shall be entitled to receive a certificate in respect of such Shareholder&#8217;s remaining shares, provided that the previous certificate is delivered to the Company before the issuance of a new
                certificate.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1897e65c915a458289ab27cf1771d61b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A share certificate registered in the names of two or more persons shall be delivered to the person first named in the Register of Shareholders in respect of such
                co-ownership.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z502b93506780470aad00110328f46979" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A share certificate which has been defaced, lost or destroyed, may be replaced, and the Company shall issue a new certificate to replace such defaced, lost or
                destroyed certificate upon payment of such fee, and upon the furnishing of such evidence of the certificate's loss or destruction, as applicable, as well as such evidence of ownership and such indemnity, as the Board of Directors in its
                discretion deems fit.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7211e2cbc3e2487faef146474fb4d346" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">11.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Registered Holder</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Except as otherwise provided in these Articles or the Companies Law, the Company shall be entitled to treat
        the registered holder of each share as the absolute owner thereof, and accordingly, shall not, except as ordered by a court of competent jurisdiction, or as required by the Companies Law, be obligated to recognize any equitable or other claim to,
        or interest in, such share on the part of any other person.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z79413339bb794682a775fe618858ec18" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">12.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Issuance and Repurchase of Shares</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z85ca141727ad400b8f73f8b244431c3a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The unissued shares from time to time shall be under the control of the Board of Directors, which shall have the power to issue, or otherwise dispose of shares and of
                securities convertible or exercisable into or other rights to acquire from the Company, to such persons, on such terms and conditions (including, inter alia, terms relating to calls set forth in Article 14(f) hereof), and either at par or
                at a premium, or subject to the provisions of the Companies Law, at a discount and/or with payment of commission, and at such times, as the Board of Directors deems fit, and the power to give to any person the option to acquire from the
                Company any shares or securities convertible or exercisable into or other rights to acquire from the Company, either at par or at a premium, or, subject as aforesaid, at a discount and/or with payment of commission, during such time and for
                such consideration as the Board of Directors (or the Committee, as the case may be) deems fit.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf7c140e2a4a94eef90feecf06aeb7b50" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company may at any time and from time to time, subject to the Companies Law, repurchase or finance the purchase of any shares or other securities issued by the
                Company, in such manner and under such terms as the Board of Directors shall determine, whether from any one or more Shareholders. Such purchase shall not be deemed as payment of dividends and no Shareholder will have the right to require
                the Company to purchase his shares or offer to purchase shares from any other Shareholders.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb33f4f5a15374fd8adbacd5f56f20670" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">13.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Payment in Installment</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">If pursuant to the terms of issuance of any share, all or any portion of the price thereof shall be payable
        in installments, every such installment shall be paid to the Company on the due date thereof by the then registered holder(s) of the share or the person(s) then entitled thereto.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7eeb64e3d75249e59487bd2aea74c67f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">14.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Calls on Shares</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z646ad091298d4c809f60258bd1cc429a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may, from time to time, as it, in its discretion, deems fit, make calls for payment upon Shareholders in respect of any sum (including premium)
                which has not been paid up in respect of shares held by such Shareholders and which is not, pursuant to the terms of issuance of such shares or otherwise, payable at a fixed time, and each Shareholder shall pay the amount of every call so
                made upon him (and of each installment thereof if the same is payable in installments), to the person(s) and at the time(s) and place(s) designated by the Board of Directors, as any such times may be thereafter extended and/or such
                person(s) or place(s) changed. Unless otherwise stipulated in the resolution of the Board of Directors (and in the notice hereafter referred to), each payment in response to a call shall be deemed to constitute a <font style="font-style: italic;">pro rata</font> payment on account of all the shares in respect of which such call was made.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za83579b8786547c4941195e7d138b13f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Notice of any call for payment by a Shareholder shall be given in writing to such Shareholder not less than fourteen (14) days prior to the time of payment fixed in
                such notice, and shall specify the time and place of payment, and the person to whom such payment is to be made. Prior to the time for any such payment fixed in a notice of a call given to a Shareholder, the Board of Directors may in its
                absolute discretion, by notice in writing to such Shareholder, revoke such call in whole or in part, extend the time fixed for payment thereof, or designate a different place of payment or person to whom payment is to be made. In the event
                of a call payable in installments, only one notice thereof need be given.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc2aeac381daf42f4a193049c4eb80ca4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If pursuant to the terms of issuance of a share or otherwise, an amount is made payable at a fixed time (whether on account of such nominal value of such share or by
                way of premium), such amount shall be payable at such time as if it were payable by virtue of a call made by the Board of Directors and for which notice was given in accordance with paragraphs (a) and (b) of this Article 14, and the
                provision of these Articles with regard to calls (and the non-payment thereof) shall be applicable to such amount or such installment (and the non-payment thereof).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z21df41344fd14563835e49495f52ac26" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Joint holders of a share shall be jointly and severally liable to pay all calls for payment in respect of such share and all interest payable thereon.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z94095ad439aa4c218fbfdf3eeca23c74" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any amount called for payment which is not paid when due shall bear interest from the date fixed for payment until actual payment thereof, at such rate (not exceeding
                the then prevailing debitory rate charged by leading commercial banks in Israel), and payable at such time(s) as the Board of Directors may prescribe.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7a225ddfedf140f1ae221975c82e808c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Upon the issuance of shares (whether of the same class or different classes), the Board of Directors may provide for differences among the holders of such shares as
                to the amounts and times for payment of calls for payment in respect of such shares.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb816736ec03644b7a422049c52f34c2a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">15.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Prepayment</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">With the approval of the Board of Directors, any Shareholder may pay to the Company any amount not yet
        payable in respect of his shares, and the Board of Directors may approve the payment by the Company of interest on any such amount until the same would be payable if it had not been paid in advance, at such rate and time(s) as may be approved by
        the Board of Directors. The Board of Directors may at any time cause the Company to repay all or any part of the money so advanced, without premium or penalty. Nothing in this Article 15 shall derogate from the right of the Board of Directors to
        make any call for payment before or after receipt by the Company of any such advance.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze205a018800c472db0394f0be18e572a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">16.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Forfeiture and Surrender</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z31fab72d7f5043ff9ceb9d85a6276308" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If any Shareholder fails to pay an amount payable by virtue of a call, installment or interest thereon as provided for in accordance herewith, on or before the day
                fixed for payment of the same, the Board of Directors may at any time after the day fixed for such payment, so long as such amount (or any portion thereof) or interest thereon (or any portion thereof) remains unpaid, forfeit all or any of
                the shares in respect of which such payment was called for. All expenses incurred by the Company in attempting to collect any such amount or interest thereon, including, without limitation, attorneys&#8217; fees and costs of legal proceedings,
                shall be added to, and shall, for all purposes (including the accrual of interest thereon) constitute a part of, the amount payable to the Company in respect of such call.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z602ac84e97394dd0a2ebd3ea82432896" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Upon the adoption of a resolution as to the forfeiture of a Shareholder&#8217;s share, the Board of Directors shall cause notice thereof to be given to such Shareholder,
                which notice shall state that, in the event of the failure to pay the entire amount so payable by a date specified in the notice (which date shall be not less than fourteen (14) days after the date such notice is given and which may be
                extended by the Board of Directors), such shares shall be ipso facto forfeited, provided, however, that, prior to such date, the Board of Directors may cancel such resolution of forfeiture, but no such cancellation shall stop the Board of
                Directors from adopting a further resolution of forfeiture in respect of the non-payment of the same amount.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4c925e96167a4d6b9ccc68fa60e81f91" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from Articles 53 and 57 hereof, whenever shares are forfeited as herein provided, all dividends, if any, theretofore declared in respect thereof
                and not actually paid shall be deemed to have been forfeited at the same time.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z540c610cc9104f27be71fabb56976868" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company, by resolution of the Board of Directors, may accept the voluntary surrender of any share.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z53e3888ed1964909b0b86cc120468aad" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any share forfeited or surrendered as provided herein, shall become the property of the Company as a dormant share, and the same, subject to the provisions of these
                Articles, may be sold, re-issued or otherwise disposed of as the Board of Directors deems fit.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z314c7c9a05ef4a1b9f454b897435076b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any Shareholder whose shares have been forfeited or surrendered shall cease to be a Shareholder in respect of such forfeited or surrendered shares, but shall,
                notwithstanding, be liable to pay, and shall forthwith pay, to the Company, all calls, interest and expenses owing upon or in respect of such shares at the time of forfeiture or surrender, together with interest thereon from the time of
                forfeiture or surrender until actual payment, at the rate prescribed in Article 14(e) above, and the Board of Directors, in its discretion, may, but shall not be obligated to, enforce or collect the payment of such amounts, or any part
                thereof, as it shall deem fit. In the event of such forfeiture or surrender, the Company, by resolution of the Board of Directors, may accelerate the date(s) of payment of any or all amounts then owing to the Company by the person in
                question (but not yet due) in respect of all shares owned by such Shareholder, solely or jointly with another.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z94648fa428294b3181c44e88a50c559d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may at any time, before any share so forfeited or surrendered shall have been sold, re-issued or otherwise disposed of, nullify the forfeiture
                or surrender on such conditions as it deems fit, but no such nullification shall stop the Board of Directors from re-exercising its powers of forfeiture pursuant to this Article 16.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z880ff1b799b049eeaaee709a83f26bf7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">17.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Lien</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb2b8dd92a68f4081865db0c9c5e130a6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Except to the extent the same may be waived or subordinated in writing, to the extent permitted by applicable law, the Company shall have a first and paramount lien
                upon all the shares registered in the name of each Shareholder (without regard to any equitable or other claim or interest in such shares on the part of any other person), and upon the proceeds of the sale thereof, for liabilities to the
                Company arising from any amount payable by such Shareholder in respect of any unpaid or partly paid share, whether or not such liability has matured. Such lien shall extend to all dividends from time to time declared or paid in respect of
                such share. Unless otherwise provided, the registration by the Company of a transfer of shares shall be deemed to be a waiver on the part of the Company of the lien (if any) existing on such shares immediately prior to such transfer.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z915c9645b35b4fc3ad0badcd6190fc22" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may cause the Company to sell a share subject to such a lien when the liability giving rise to such lien has matured, in such manner as the
                Board of Directors deems fit, but no such sale shall be made unless such liability has not been satisfied within fourteen (14) days after written notice of the intention to sell shall have been served on such Shareholder, his executors or
                administrators.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc1d36eac0f854e80bde3458b2d253701" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The net proceeds of any such sale, after payment of the costs and expenses thereof or ancillary thereto, shall be applied in or toward satisfaction of the liabilities
                of such Shareholder in respect of such share (whether or not the same have matured), and the remaining proceeds (if any) shall be paid to the Shareholder, his executors, administrators or assigns.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
      <table cellspacing="0" cellpadding="0" id="z475ee9ce419144358079ea0b618fc744" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">18.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Sale After Forfeiture of Surrender or in Enforcement of Lien</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Upon any sale of a share after forfeiture or surrender or for enforcing a lien, the Board of Directors may
        appoint any person to execute an instrument of transfer of the share so sold and cause the purchaser&#8217;s name to be entered in the Register of Shareholders in respect of such share. The purchaser shall be registered as the Shareholder and shall not
        be bound to see to the regularity of the sale proceedings, or to the application of the proceeds of such sale, and after his name has been entered in the Register of Shareholders in respect of such share, the validity of the sale shall not be
        impeached by any person, and the remedy of any person aggrieved by the sale shall be in damages only and against the Company exclusively.&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z95edbee78bbe4dedb1de5dc1b6602e14" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">19.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Redeemable Shares</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Company may, subject to applicable law, issue redeemable shares or other securities and redeem the same
        upon terms and conditions to be set forth in a written agreement between the Company and the holder of such shares or in their terms of issuance.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Transfer of Shares</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdad2a5f99ebd4cfebee5638d065d29a0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">20.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Registration of Transfer</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">No transfer of shares shall be registered unless a proper writing or instrument of transfer (in any
        customary form or any other form satisfactory to the Board of Directors) has been submitted to the Company (or its transfer agent, in the case of shares registered with a transfer agent), together with any share certificate(s) and such other
        evidence of title as the Board of Directors may reasonably require. Until the transferee has been registered in the Register of Shareholders in respect of the shares so transferred, the Company may continue to regard the transferor as the owner
        thereof. The Board of Directors, may, from time to time, prescribe a fee for the registration of a transfer.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze3133060bef24cd1b6060b143a381b06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">21.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Suspension of Registration</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors may, to the extent it deems necessary in its discretion, close the Register of
        Shareholders of registration of transfers of shares for a period determined by the Board of Directors, and no registrations of transfers of shares shall be made by the Company during any such period during which the Register of Shareholders is so
        closed. The Company shall notify the shareholders with respect to such suspension of registration in such manner as shall be determined by the Board of Directors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Transmission of Shares</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf26b70fd21ac47f98f80c5e237329ee9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">22.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Decedents&#8217; Shares</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9ba301fd7e7644159e559126822e96b1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In case of a share registered in the names of two or more holders, the Company may recognize the survivor(s) as the sole owner(s) thereof unless and until the
                provisions of Article 22(b) have been effectively invoked.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze7bcf732b62448aebe4bc7c7ebbbe55d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Upon the death of a Shareholder, the Company shall recognize the custodian or administrator of the estate or executor of the will, and in the absence of such, the
                lawful heirs of the Shareholder, as the only holders of the right for the shares of the deceased Shareholder, after receipt of evidence to the entitlement thereto, as determined by the Board of Directors.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze658f00c70d84a0aa1ce21f5cb8f7a74" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 19.35pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">23.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Receivers and Liquidators</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1007bbf7f8c04d508561b4acc3a8d30c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company may recognize any receiver, liquidator or similar official appointed to wind-up, dissolve or otherwise liquidate a corporate Shareholder, and a trustee,
                manager, receiver, liquidator or similar official appointed in bankruptcy or in connection with the reorganization of, or similar proceeding with respect to a Shareholder or its properties, as being entitled to the shares registered in the
                name of such Shareholder.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z994b987673aa42768e0d3fa6e45b8a43" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Such receiver, liquidator or similar official appointed to wind-up, dissolve or otherwise liquidate a corporate Shareholder and such trustee, manager, receiver,
                liquidator or similar official appointed in bankruptcy or in connection with the reorganization of, or similar proceedings with respect to, a Shareholder or its properties, upon producing such evidence as the Board of Directors (or an
                officer of the Company to be designated by the Chief Executive Officer) may deem sufficient as to his authority to act in such capacity or under this Article, shall with the consent of the Board of Directors or such officer, as the case may
                be (which the Board of Directors or such officer, as the case may be, may grant or refuse in its absolute discretion), be registered as a Shareholder in respect of such shares, or may, subject to the regulations as to transfer herein
                contained, transfer such shares.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">General Meetings</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z43f128cc2f0c4dfa818935edc017d892" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">24.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>General Meetings</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z8a67f113ece744698f6c1cd1fa5bb797" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>An annual General Meeting (&#8220;<font style="font-weight: bold;">Annual General Meeting</font>&#8221;) shall be
                held once in every calendar year, but not later than fifteen (15) months after the last Annual General Meeting, at such time and at such place, either within or out of the State of Israel, as may be determined by the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z556597b269264084bc924f2629507a7f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>All General Meetings other than Annual General Meetings shall be called &#8220;<font style="font-weight: bold;">Special General Meetings</font>&#8221;. The Board of Directors may, whenever it thinks fit, convene a Special General Meeting at such time and place, within or out of the State of Israel, as may be determined by the Board of Directors,
                and shall be obliged to do so upon requisition in writing in accordance with the Companies Law.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2167d313cd0248f886c060cc9e2f29b1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">25.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Record Date for General Meeting</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Notwithstanding any provision of these Articles to the contrary, and to allow the Company to determine the
        Shareholders entitled to notice of or to vote at any General Meeting or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or grant of any rights, or entitled to exercise any rights in respect of or to
        take or be the subject of any other action, the Board of Directors may fix a record date, which shall not be more than the maximum period and not less than the minimum period permitted by law. A determination of Shareholders of record entitled to
        notice of or to vote at a General Meeting shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2749d4f9531b454ebc0c2346af4c0c21" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">26.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Shareholder Proposal Request</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6f348d0615764b6a86d126dfccb90c7a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any Shareholder or Shareholders of the Company holding at least one percent (1%) of the voting rights of the Company (the &#8220;<font style="font-weight: bold;">Proposing Shareholder(s)</font>&#8221;) may request, subject to the Companies Law, that the Board of Directors include a matter on the agenda of a General Meeting to be held in the future,
                provided that the Board of Directors determines that the matter is appropriate to be considered at a General Meeting (a &#8220;<font style="font-weight: bold;">Proposal Request</font>&#8221;).
                In order for the Board of Directors to consider a Proposal Request and whether to include the matter stated therein in the agenda of a General Meeting, notice of the Proposal Request must be timely delivered in accordance with applicable
                law, and the Proposal Request must comply with the requirements of these Articles (including this Article 26) and any applicable law. The Proposal Request must be in writing, signed by all of the Proposing Shareholder(s) making such
                request, delivered, either in person or by certified mail, postage prepaid, and received by the Secretary (or, in the absence thereof, by the Chief Executive Officer of the Company). To be considered timely, a Proposal Request must be
                received within the time periods prescribed by applicable law. The announcement of an adjournment or postponement of a General Meeting shall not commence a new time period (or extend any time period) for the delivery of a Proposal Request
                as described above. In addition to any information required to be included in accordance with applicable law, a Proposal Request must include the following: (i) the name, address, telephone number, fax number and email address of the
                Proposing Shareholder (or each Proposing Shareholder, as the case may be) and, if an entity, the name(s) of the person(s) that controls or manages such entity; (ii) the number of Shares held by the Proposing Shareholder(s), directly or
                indirectly (and, if any of such Shares are held indirectly, an explanation of how they are held and by whom), which shall be in such number no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence
                satisfactory to the Company of the record holding of such Shares by the Proposing Shareholder(s) as of the date of the Proposal Request, and a representation that the Proposing Shareholder(s) intends to appear in person or by proxy at the
                meeting; (iii) the matter requested to be included on the agenda of a General Meeting, all information related to such matter, the reason that such matter is proposed to be brought before the General Meeting, the complete text of the
                resolution that the Proposing Shareholder proposes to be voted upon at the General Meeting and, if the Proposing Shareholder wishes to have a position statement in support of the Proposal Request, a copy of such position statement that
                complies with the requirement of any applicable law (if any), (iv) a description of all arrangements or understandings between the Proposing Shareholders and any other Person(s) (naming such Person or Persons) in connection with the matter
                that is requested to be included on the agenda and a declaration signed by all Proposing Shareholder(s) of whether any of them has a personal interest in the matter and, if so, a description in reasonable detail of such personal interest;
                (v) a description of all Derivative Transactions (as defined below) by each Proposing Shareholder(s) during the previous twelve (12) month period, including the date of the transactions and the class, series and number of securities
                involved in, and the material economic terms of, such Derivative Transactions; and (vi) a declaration that all of the information that is required under the Companies Law and any other applicable law and stock exchange rules and regulations
                to be provided to the Company in connection with such matter, if any, has been provided to the Company. The Board of Directors, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s) provide
                additional information necessary so as to include a matter in the agenda of a General Meeting, as the Board of Directors may reasonably require.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">A &#8220;<font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">Derivative
          Transaction</font>&#8221; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or any of its affiliates or associates, whether of record or beneficial: (1) the value
        of which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (2) which otherwise provides any direct or indirect opportunity to gain or share in any gain derived from a change in the
        value of securities of the Company, (3) the effect or intent of which is to mitigate loss, manage risk or benefit of security value or price changes, or (4) which provides the right to vote or increase or decrease the voting power of, such
        Proposing Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement, interest or understanding may include, without limitation, any option, warrant, debt
        position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement to borrow or lend shares (whether or not subject to
        payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the securities of the Company held by any general or limited partnership, or any limited liability company, of
        which such Proposing Shareholder is, directly or indirectly, a general partner or managing member.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">If the proposal of the Proposing Shareholder(s) is to nominate a candidate for election to the Board of
        Directors, the Proposal Request shall set forth, in addition to the requirements set forth in Sub-Article 26(a) above, the following: (i) a declaration signed by the nominee and the other information required under Section 224B of the Companies
        Law; (ii) to the extent not otherwise provided in the Request Proposal, all the declarations, documents and other information required pursuant to the Companies Law and any other law to which the Company shall be subject at that time, in order to
        propose the candidate for election and in order for him to be appointed as a director and any other documents and questionnaires that the Company may reasonably request.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zfd0fd65b9cf64c99b9a02030baa449c9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The information required pursuant to this Article shall be updated as of (i) the record date of the General Meeting, (ii) five business days before the General
                Meeting, and (iii) as of the General Meeting, and any adjournment or postponement thereof.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9831dde0ae9f47de92a59ba617110f1b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A Shareholder holding (i) five percent (5%) or more of the outstanding voting rights in the Company or (ii) five percent (5%) or more of the outstanding share capital
                and one percent (1%) or more of the voting rights in the Company, may request that the Board of Directors convene a Special General Meeting, provided that the request complies with all the applicable requirements of a &#8220;Proposal Request&#8221; set
                forth in this Article 26 above, these Articles and applicable law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdf354025c53443b390332318413e0290" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">27.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Notice of General Meetings; Omission to Give Notice</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z241be6ddf95045428bda8df7f74e1e65" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company is not required to give notice of a General Meeting, subject to any mandatory provision of the Companies Law and regulations thereunder. Notices of
                General Meetings shall be given as required by the provisions of the Companies Law and any other applicable laws.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z35e03e991b8c41b4bc2e49bb10919c1e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The accidental omission to give notice of a General Meeting to any Shareholder, or the non-receipt of notice sent to such Shareholder, shall not invalidate the
                proceedings at such meeting or any resolution adopted thereat.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z3fedcd6f58e745239f6e1c062826a9f0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>No Shareholder present, in person or by proxy, at any time during a General Meeting shall be entitled to seek the cancellation or invalidation of any proceedings or
                resolutions adopted at such General Meeting on account of any defect in the notice of such meeting relating to the time or the place thereof, or any item acted upon at such meeting.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze97fec8b27294607b93df47af0e10e8e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In addition to any places at which the Company may make available for review by Shareholders the full text of the proposed resolutions to be adopted at a General
                Meeting, as required by the Companies Law, the Company may add additional places for Shareholders to review such proposed resolutions, including an internet site.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Proceedings at General Meetings</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zbdd88617757b428ea767eb145e50ca7f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">28.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Quorum</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6a85fa88fc484ca9b6e73cae8962b508" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>No business shall be transacted at a General Meeting, or at any adjournment thereof, unless the quorum required under these Articles for such General Meeting or such
                adjourned meeting, as the case may be, is present when the meeting proceeds to business.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z8bdb49f0f3914518ad824ca47a73b0fd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>In the absence of contrary provisions in these Articles, two or more Shareholders (not in default in payment of any sum referred to in Article 14 hereof), present in
                person, by a proxy or by a written ballot (to the extent relevant), and holding shares conferring in the aggregate at least twenty-five percent (25%) of the voting power of the Company (or if a higher percentage is required under applicable
                law, such higher percentage), shall constitute a quorum of General Meetings. A proxy may be deemed to be one (1) or more Shareholders pursuant to the number of Shareholders represented by the proxy holder.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd07194ee1f2349eaa35ea5ef5e70fa9c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If within half an hour from the time appointed for the meeting a quorum is not present, then without any further notice the meeting shall be adjourned either (i) to
                the same day in the next week, at the same time and place, (ii) to such day and at such time and place as indicated in the notice of such meeting, or (iii) to such day and at such time and place as the Chairman of the General Meeting shall
                determine (which may be earlier or later than the date pursuant to clause (i) above). No business shall be transacted at any adjourned meeting except business which might lawfully have been transacted at the meeting as originally called. At
                such adjourned meeting, if the original meeting was convened upon requisition under Section 63 of the Companies Law, any number of Shareholders, present in person or by proxy, and holding the number of shares required for making such
                requisition, shall constitute a quorum, but in any other case any two (2) Shareholders (not in default as aforesaid) present in person or by proxy, shall constitute a quorum.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9bb9d80cf8494f989efd134b3abc549c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">29.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Chairman of General Meeting</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Chairman of the Board of Directors shall preside as Chairman of every General Meeting of the Company.
        If at any meeting the Chairman is not present within fifteen (15) minutes after the time fixed for holding the meeting or is unwilling to act as Chairman, any of the following may preside as Chairman of the meeting (and in the following order): a
        Director, the Chief Executive Officer, Chief Financial Officer, Secretary or any person designated by any of the foregoing. If at any such meeting none of the foregoing persons is present or all are unwilling to act as Chairman, the Shareholders
        present (in person or by proxy) shall choose a Shareholder or its proxy present at the meeting to be Chairman. The office of Chairman shall not, by itself, entitle the holder thereof to vote at any General Meeting nor shall it entitle such holder
        to a second or a casting vote (without derogating, however, from the rights of such Chairman to vote as a Shareholder or proxy of a Shareholder if, in fact, he is also a Shareholder or such proxy).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zbafc8f4204184a66817d234155506c80" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">30.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold; font-variant: small-caps;"><u>Adoption of Resolutions at General
                    Meetings</u></font>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7a30ae96abac455c88e23ef0d6599438" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Except as required by the Companies Law or these Articles, including, without limitation, Article 40 below, a resolution of the Shareholders shall be adopted if
                approved by the holders of a simple majority of the voting power represented at the General Meeting in person or by proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power present and voting.
                Without limiting the generality of the foregoing, a resolution with respect to a matter or action for which the Companies Law prescribes a higher majority or pursuant to which a provision requiring a higher majority would have been deemed
                to have been incorporated into these Articles, but for which the Companies Law allows these Articles to provide otherwise, shall be adopted by a simple majority of the voting power represented at the General Meeting in person or by proxy
                and voting thereon, as one class, and disregarding abstentions when determining the voting power present and voting.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd22158516d084f898c8d7115e8ec5f26" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Every question submitted to a General Meeting shall be decided by a show of hands, but the Chairman of the General Meeting may determine that a resolution shall be
                decided by a written ballot. A written ballot may be implemented before the proposed resolution is voted upon or immediately after the declaration by the Chairman of the results of the vote by a show of hands. If a vote by written ballot is
                taken after such declaration, the results of the vote by a show of hands shall be of no effect, and the proposed resolution shall be decided by such written ballot.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6566c75f477141a8998a9eb5252073f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of the Companies Law, a defect in convening or conducting a General Meeting, including a defect deriving from the non-fulfillment of any
                provision or condition set forth in the Companies Law or these Articles, including with regard to the manner of convening or conducting the General Meeting, shall not disqualify any resolution passed at the General Meeting and shall not
                affect the discussions or decisions which took place thereat.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb4d7085ee2a940798c928c1893f8ef8d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A declaration by the Chairman of the General Meeting that a resolution has been carried unanimously, or carried by a particular majority, or rejected, and an entry to
                that effect in the minute book of the Company, shall be prima facie evidence of the fact without proof of the number or proportion of the votes recorded in favor of or against such resolution.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0712b1bacb6f4e4bb8408f5e952620cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">31.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Power to Adjourn</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zba6fdeadd6304d58afdcb7f3f05f2e3c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The consideration of any matter on the agenda of a General Meeting or the resolution on any matter on the agenda, may be postponed or adjourned, from time to time and
                from place to place: (i) at a General Meeting, by the Chairman of a General Meeting at which a quorum is present (and he shall if so directed by the General Meeting, with the consent of the holders of a majority of the voting power
                represented in person or by proxy and voting on the question of adjournment); or (ii) by the Board of Directors, whether prior to or at a General Meeting. No business shall be transacted at any such adjourned meeting except business which
                might lawfully have been transacted at the meeting as originally called or a matter on the agenda for the original called meeting with respect to which no resolution was adopted at the meeting originally called.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z923f971ff2bb46c78d536ea8af2660e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Where a General Meeting has been adjourned to a date that is more than twenty-one (21) days, notice thereof shall be given in the manner required for the meeting as
                originally called.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z77024be4554b49809616f3e39e1af214" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Where a General Meeting has been adjourned without changing its agenda, to a date that is not more than twenty-one (21) days, notices shall be given for the new date,
                as early as possible, and by no later than seventy-two (72) hours before the General Meeting.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z882220e7e6e1428ba3bf7f3316933475" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">32.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Voting Power</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to the provisions of Article 33(a) and to any provision hereof conferring special rights as to
        voting, or restricting the right to vote, every Shareholder shall have one vote for each share held by him of record or beneficially held by him (including, without limitation, shares held in his name with an &#8220;exchange member&#8221; that are held of
        record by a &#8220;nominee company,&#8221; as such terms are defined under Section 1 of the Companies Law), on every resolution, without regard to whether the vote thereon is conducted by a show of hands, by written ballot or by any other means.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5293aa2f432c4d29beb6ec7ccce0d0e9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">33.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Voting Rights</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z308021eb706943d08ad5448cd11726f9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>No Shareholder shall be entitled to vote at any General Meeting (or be counted as a part of the quorum thereat), unless all calls then payable by him in respect of
                his shares in the Company have been paid.</div>
            </td>
          </tr>

      </table>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zc41426eb1f984521a01c78963bcd58dc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A company or other corporate body being a Shareholder of the Company may duly authorize any person to be its representative at any meeting of the Company or to
                execute or deliver a proxy on its behalf. Any person so authorized shall be entitled to exercise on behalf of such Shareholder all the power, which the Shareholder could have exercised if it were an individual. Upon the request of the
                Chairman of the General Meeting, written evidence of such authorization (in form acceptable to the Chairman) shall be delivered to him.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdabe092d3090435bb29a98cbf2e42caa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any Shareholder entitled to vote may vote either in person or by proxy (who need not be a Shareholder of the Company), or, if the Shareholder is a company or other
                corporate body, by representative authorized pursuant to Article 33(b) above.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2ee37cc2051340d68b1ae073413c1538" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If two or more persons are registered as joint holders of any share, the vote of the senior who tenders a vote, in person or by proxy, shall be accepted to the
                exclusion of the vote(s) of the other joint holder(s). For the purpose of this Article 33(d), seniority shall be determined by the order of registration of the joint holders in the Register of Shareholder.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z94875ebdd1e74512b56fb01a8915f765" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If a Shareholder is a minor, under protection, bankrupt or legally incompetent, or in the case of a corporation, is in receivership or liquidation, it may vote
                through his or its trustees, receiver, liquidator, natural guardian or another legal guardian, as the case may be, and the persons listed above may vote in person or by proxy.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Proxies</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zbc6b6a3958144a77b36b5746ff972e0d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">34.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Instrument of Appointment</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z03039379347846f69e224cd06fab5179" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>An instrument appointing a proxy shall be in writing and shall be substantially in the following form:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 18pt;">
        <table cellspacing="0" cellpadding="0" border="0" id="z0f65c2bc70fc4a159d13ee6d5d75c546" style="width: 90%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 15%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">&#8220;I</div>
              </td>
              <td style="width: 37%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">of</div>
              </td>
              <td style="width: 43%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">&#160;</td>
              <td style="width: 37%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-style: italic;">(Name of Shareholder)</div>
              </td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 43%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-style: italic;">(Address of Shareholder)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">
                <div style="text-align: justify; line-height: 1.25;">Being a shareholder of CHECK-CAP LTD. hereby appoints</div>
              </td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">&#160;</td>
              <td style="width: 37%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 5%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">of</div>
              </td>
              <td style="width: 43%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 15%; vertical-align: top;">&#160;</td>
              <td style="width: 37%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-style: italic;">(Name of Proxy)</div>
              </td>
              <td style="width: 5%; vertical-align: top;">&#160;</td>
              <td style="width: 43%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-style: italic;">(Address of Proxy)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">
                <div style="text-align: justify; line-height: 1.25;">as my proxy to vote for me and on my behalf at the General Meeting of the Company to be held on the ___ day of _______,
                  _______ and at any adjournment(s) thereof.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">
                <div style="text-align: justify; line-height: 1.25;">Signed this ____ day of ___________, ______.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">&#160;</td>
            </tr>
            <tr>
              <td style="width: 100%; vertical-align: top;" colspan="4">
                <div style="text-align: right; line-height: 1.25;">(Signature of Appointor)&#8221;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">or in any usual or common form or in such other form as may be approved by the Board of Directors. Such
        proxy shall be duly signed by the appointor of such person&#8217;s duly authorized proxy, or, if such appointor is company or other corporate body, in the manner in which it signs documents which binds it together with a certificate of an attorney with
        regard to the authority of the signatories.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9ae0d6f7f98147c0a1f160cbde91f7cb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the Companies Law, the original instrument appointing a proxy or a copy thereof certified by an attorney (and the power of attorney or other authority, if
                any, under which such instrument has been signed) shall be delivered to the Company (at its Office, at its principal place of business, or at the offices of its registrar or transfer agent, or at such place as notice of the meeting may
                specify) not less than forty eight (48) hours (or such shorter period as may be determined by the Board of Directors or the Chairman of the General Meeting) before the time fixed for the meeting at which the person named in the instrument
                proposes to vote. A document appointing a proxy shall be valid for every adjourned meeting of the General Meeting to which the document relates.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zdd47d71a838548d2ad9289d666881726" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">35.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Effect of Death of Appointor of Transfer of Share and or Revocation of Appointment</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb323ca8320bd47c6b04a70c665f77877" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A vote cast in accordance with an instrument appointing a proxy shall be valid notwithstanding the prior death or bankruptcy of the appointing Shareholder (or of his
                attorney-in-fact, if any, who signed such instrument), or the transfer of the share in respect of which the vote is cast, unless written notice of such matters shall have been received by the Company or by the Chairman of such meeting prior
                to such vote being cast.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0109105a0ca64a8eb0d9184ab6d8f9ec" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the Companies Law, an instrument appointing a proxy shall be deemed revoked (i) upon receipt by the Company or the Chairman, subsequent to receipt by the
                Company of such instrument, of written notice signed by the person signing such instrument or by the Shareholder appointing such proxy canceling the appointment thereunder (or the authority pursuant to which such instrument was signed) or
                of an instrument appointing a different proxy (and such other documents, if any, required under Article 34(b) for such new appointment), provided such notice of cancellation or instrument appointing a different proxy were so received at the
                place and within the time for delivery of the instrument revoked thereby as referred to in Article 34(b) hereof, or (ii) if the appointing Shareholder is present in person at the meeting for which such instrument of proxy was delivered,
                upon receipt by the Chairman of such meeting of written notice from such Shareholder of the revocation of such appointment, or if and when such Shareholder votes at such meeting. A vote cast in accordance with an instrument appointing a
                proxy shall be valid notwithstanding the revocation or purported cancellation of the appointment, or the presence in person or vote of the appointing Shareholder at a meeting for which it was rendered, unless such instrument of appointment
                was deemed revoked in accordance with the foregoing provisions of this Article 35(b) at or prior to the time such vote was cast.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Board of Directors</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z952eab58069f494794848fa6a9afa078" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">36.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Powers of Board of Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z13f536004e3548fd9d157e0d0cdca3a4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may exercise all such powers and do all such acts and things as the Board of Directors is authorized by law or as the Company is authorized to
                exercise and do and are not hereby or by law required to be exercised or done by the General Meeting. The authority conferred on the Board of Directors by this Article 36 shall be subject to the provisions of the Companies Law, these
                Articles and any regulation or resolution consistent with these Articles adopted from time to time at a General Meeting, provided, however, that no such regulation or resolution shall invalidate any prior act done by or pursuant to a
                decision of the Board of Directors which would have been valid if such regulation or resolution had not been adopted.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z505567d7651c48bc82dd0697b88ff5a0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without limiting the generality of the foregoing, the Board of Directors may, from time to time, set aside any amount(s) out of the profits of the Company as a
                reserve or reserves for any purpose(s) which the Board of Directors, in its absolute discretion, shall deem fit, including without limitation, capitalization and distribution of bonus shares, and may invest any sum so set aside in any
                manner and from time to time deal with and vary such investments and dispose of all or any part thereof, and employ any such reserve or any part thereof in the business of the Company without being bound to keep the same separate from other
                assets of the Company, and may subdivide or re-designate any reserve or cancel the same or apply the funds therein for another purpose, all as the Board of Directors may from time to time think fit.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zad7c2325daa44833aedaf5a805a207e8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">37.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Exercise of Powers of Board of Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z927a4bb3145e4f588e66e9e6db4dfcfe" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A meeting of the Board of Directors at which a quorum is present shall be competent to exercise all the authorities, powers and discretion vested in or exercisable by
                the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb6a72666a5d749a884da217f7a4c9e79" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A resolution proposed at any meeting of the Board of Directors shall be deemed adopted if approved by a majority of the Directors present, entitled to vote and voting
                thereon when such resolution is put to a vote. In the event of a tie-vote, the Chairman of the Board of Directors shall not have casting vote on such matter.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7c36b11278164af5b2f9e6f8d1382b1f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may adopt resolutions, without convening a meeting of the Board of Directors, in any other manner permitted by the Companies Law. Subject to
                the Companies Law:</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd1e73f0e76d4484781552b4540d2887f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the consent of a Director to adopt a resolution without convening a meeting may be obtained in writing or orally; and</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1a2c692a69784e259af0527507ee1b06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>the position of a Director to approve or oppose any resolution may be obtained in writing or orally.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb9b9b4928bc248e4abf931e5548b40bb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">38.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Delegation of Powers</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze8430009a8c5496d9480cfcf5cdcfbff" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may, subject to the provisions of the Companies Law, delegate any or all of its powers to committees (in these Articles referred to as a &#8220;<font style="font-weight: bold;">Committee of the Board of Directors</font>&#8221;, or &#8220;<font style="font-weight: bold;">Committee</font>&#8221;),
                each consisting of one or more persons, subject to the provisions of the Companies Law, and it may from time to time revoke such delegation or alter the composition of any such Committee. Any Committee so formed shall, in the exercise of
                the powers so delegated, conform to any regulations imposed on it by the Board of Directors, subject to applicable law. No rule imposed by the Board of Directors on any Committee and no resolution of the Board of Directors shall invalidate
                any prior act taken pursuant to a resolution by the Committee that would have been valid if such rule or resolution of the Board of Directors had not been adopted. The meeting and proceedings of any such Committee of the Board of Directors
                shall, <font style="font-style: italic;">mutatis mutandis</font>, be governed by the provisions herein contained for regulating the meetings of the Board of Directors, to the
                extent not superseded by any rules or resolutions adopted by the Board of Directors. Unless otherwise expressly provided by the Board of Directors in delegating powers to a Committee of the Board of Directors, such Committee of the Board of
                Directors shall not be empowered to further delegate such powers.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z150d16614d1444f09f2a2762728598dd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors shall determine, in the conditions of empowerment of a Committee, whether specific authorities of the Board of Directors shall be delegated to
                the Committees of the Board of Directors, in such manner that the decision of the Committee of the Board of Directors shall be considered tantamount to a decision of the Board of Directors, or whether the decision of the Committee of the
                Board of Directors shall merely constitute a recommendation, subject to the authorization of the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zbcc576d8cb2541d3b2f3624ad8770741" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A person who is not a Director shall not serve in a Committee of the Board of Directors to which the Board of Directors has delegated authorities. Persons who are not
                members of the Board of Directors may serve in a Committee of the Board of Directors whose function is merely to advise or submit recommendations to the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z07bd2bbaf0f7464b93262164474c3d4a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Without derogating from the provisions of Article 50, the Board of Directors may from time to time appoint a Secretary to the Company, as well as Officers, agents,
                employees and independent contractors, as the Board of Directors deems fit, and may terminate the service of any such person. The Board of Directors may, subject to the provisions of and any other requisite approvals required by the
                Companies Law, determine the powers and duties, as well as the salaries and compensation, of all such persons.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; text-indent: -27pt; margin-left: 47.25pt; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd8c229876b3b4d7da378f51b716eff75" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may from time to time, by power of attorney or otherwise, appoint any person, company, firm or body of persons to be the attorney or attorneys
                of the Company at law or in fact for such purposes(s) and with such powers, authorities and discretions, and for such period and subject to such conditions, as it deems fit, and any such power of attorney or other appointment may contain
                such provisions for the protection and convenience of persons dealing with any such attorney as the Board of Directors deems fit, and may also authorize any such attorney to delegate all or any of the powers, authorities and discretions
                vested in him.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd86a64ff839e4affa98e397eb00e2470" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">39.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Number of Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors shall consist of such number of Directors (not less than four (4) nor more than 11
        (eleven), including the External Directors (if External Directors serve on the Board of Directors)), as may be fixed from time to time by the Board of Directors.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb998cf56d8ed45178d38e3558ebcc9a3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">40.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Election and Removal of Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7d9762f1ca084fce8d7b4a232dc32e22" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Directors shall be elected at the Annual General Meeting by the vote of a Shareholders&#8217; resolution, and each director shall serve, subject to Article 43 hereof, and
                with respect to a Director appointed pursuant to Article 42 hereof, subject to such Article, until the next Annual General Meeting following the Annual General Meeting at which such Director was appointed, or his earlier removal pursuant to
                this Article 40. The General Meeting, by a Shareholders&#8217; resolution, shall be entitled to remove any Director(s) from office, to elect director(s) in place of the Director(s) so removed or to fill any vacancy, however created, on the Board
                of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6b045df5c2094da3ad78492cbf44f206" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Company shall appoint as directors only persons who are competent to serve as directors according to any law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf5acf9ed088846e9bc3adb318fda22f3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The provisions of this Article 40 shall not apply to External Directors who shall be elected or removed pursuant to the provisions of the Companies Law and their
                service as directors shall be governed by all the relevant provisions of the Companies Law which apply to external directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z31f030afa8f643fcaab01dbe0bfc78e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">41.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Commencement of Directorship</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Without derogating from Article 40, the term of office of a Director shall commence as of the date of his
        appointment or election, or on a later date if so specified in his appointment or election.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z35ade93f40b343d8bed5a9f3a03ae15c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">42.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Continuing Directors in the Event of Vacancies</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors may at any time and from time to time appoint any person as a Director to fill a
        vacancy (whether such vacancy is due to a Director no longer serving or due to the number of Directors serving being less than the maximum number stated in Article 39 hereof). In the event of one or more such vacancies in the Board of Directors,
        the continuing Directors may continue to act in every matter, provided, however, that if they number less than the minimum number provided for pursuant to Article 39 hereof, they may only act in an emergency or to fill the office of director which
        has become vacant up to a number equal to the minimum number provided for pursuant to Article 39 hereof, or in order to call a General Meeting of the Company for the purpose of electing Directors to fill any or all vacancies. The office of a
        Director that was appointed by the Board of Directors to fill any vacancy shall only be for the remaining period of time during which the Director whose service has ended was filled would have held office.&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z95655cb750cb4765a2448f90171d4251" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">43.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold; font-variant: small-caps;"><u>Vacation of Office</u></font>&#160; &#160; &#160; &#160; &#160; &#160;
                &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The office of a Director shall be vacated and he shall be dismissed or removed:</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0d6faf1fb0954c709505d5b1151b4703" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-style: italic;">ipso facto</font>, upon his death;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4044c149ce764f9b9a5928a17e259c42" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if he is prevented by applicable law from serving as a Director;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z26af0b272628488e8e7730cefdc8508a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>such director becomes legally incompetent;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zcea12cdfd9904050b4af06adc6ebf908" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if his directorship expires pursuant to these Articles and/or applicable law;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5356a6b9c3194afba378b8654c283d83" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>by his written resignation, such resignation becoming effective on the date fixed therein, or upon the delivery thereof to the Company, whichever is later; or</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0e4239d6120c44b0ae85f99954b33d3a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>with respect to an External Director, and notwithstanding anything to the contrary herein, only pursuant to applicable law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdb59fd4c01a64dfeb5e4ccbeb490fccc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">44.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Conflict of Interests; Approval of Related Party Transactions</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to the provisions of the Companies Law and these Articles, no Director shall be disqualified by
        virtue of his office from holding any office or place of profit in the Company or in any company in which the Company shall be a shareholder or otherwise interested, or from contracting with the Company as vendor, purchaser or otherwise, nor shall
        any such contract, or any contract or arrangement entered into by or on behalf of the Company in which any Director shall be in any way interested, be avoided, nor, other than as required under the Companies Law, shall any Director be liable to
        account to the Company for any profit arising from any such office or place of profit or realized by any such contract or arrangement by reason only of such Director&#8217;s holding that office or of the fiduciary relations thereby established, but the
        nature of his interest, as well as any material fact or document, must be disclosed by him at the meeting of the Board of Directors at which the contract or arrangement is first considered, if his interest then exists, or, in any other case, at no
        later than the first meeting of the Board of Directors after the acquisition of his interest.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z18ebc2870e0d4835acc07c67fc5f12d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">45.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Alternate Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z298d973cf8a04935b4a272a08572080d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of the Companies Law, a Director may, by written notice to the Company, appoint, remove or replace any person as an alternate for himself
                (in these Articles, an &#8220;<font style="font-weight: bold;">Alternate Director</font>&#8221;). Unless the appointing Director, by the instrument appointing an Alternate Director or by
                written notice to the Company, limits such appointment to a specified period of time or restricts it to a specified meeting or action of the Board of Directors, or otherwise restricts its scope, the appointment shall be for all purposes,
                and for a period of time concurrent with the term of the appointing Director.&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4f9c0da0028e4f139d370b73522c08dc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any notice to the Company pursuant to Article 45(a) shall be given in person to, or by sending the same by mail to the attention of the Chairman of the Board of
                Directors at the principal office of the Company or to such other person or place as the Board of Directors shall have determined for such purpose, and shall become effective on the date fixed therein, upon the receipt thereof by the
                Company (at the place as aforesaid) or upon the approval of the appointment by the Board of Directors, whichever is later.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zfac8dfcdc9c94e1cbf79d30c226934f7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>An Alternate Director shall have all the rights and obligations of the Director who appointed him, provided however, that (i) he may not in turn appoint an alternate
                for himself (unless the instrument appointing him otherwise expressly provides and such appointment is approved by the Board of Directors); and (ii) an Alternate Director shall have no standing at any meeting of the Board of Directors or
                any Committee thereof while the Director who appointed him is present.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z91f8e333dac54837888986504081142f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any individual, who qualifies to be a member of the Board of Directors, may act as an Alternate Director. One person may not act as Alternate Director for several
                directors or if he is serving as a Director.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z929721976abf4145b3d2d09d5a9b0353" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The office of an Alternate Director shall be vacated under the circumstances<font style="font-style: italic;">, mutatis mutandis</font>, set forth in Article 43, and such office shall ipso facto be vacated if the office of the Director who appointed such Alternate Director is vacated, for any reason.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Proceedings of the Board of Directors</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb8f7fbf9ac5b4798974bf9e81237b3f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">46.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Meetings</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z0153e65528dc4e988d23c25a897521f8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the Companies Law, the Board of Directors may meet and adjourn its meetings and otherwise regulate such meetings and proceedings as the Directors think
                fit.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z53ef69b850b745e69e91e3f92880d608" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Notice of any such meeting shall be given in writing.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zab400983544f4ea8ad55c5e84db2c3fc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any Director may at any time, and the Chairman, upon the request of such Director, shall, convene a meeting of the Board of Directors, and notice thereof shall be
                given within a reasonable time prior to the meeting, unless the matters to be discussed at such meeting are of such urgency and importance that notice ought reasonably to be waived under the circumstances and provided that a majority of the
                Directors then in offices consent to such a waiver.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z30cdb99976f842ee899dcfb5c4481540" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Notwithstanding anything to the contrary herein and subject to the Companies Law, failure to deliver notice to a director of any such meeting in the manner required
                hereby may be waived by such Director, and a meeting shall be deemed to have been duly convened notwithstanding such defective notice if such failure or defect is waived prior to action being taken at such meeting, by all Directors entitled
                to participate at such meeting to whom notice was not duly given as aforesaid. Without derogating from the foregoing, no Director present at any time during a meeting of the Board of Directors shall be entitled to seek the cancellation or
                invalidation of any proceedings or resolutions adopted at such meeting on account of any defect in the notice of such meeting relating to the date, time or the place thereof.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc5e510e8ad914e48ae2f3a0456c29368" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">47.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Quorum</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Until otherwise unanimously decided by the Board of Directors, a quorum at a meeting of the Board of
        Directors shall be constituted by the presence in person or by any means of communication, provided that each Director participating in such a meeting can hear and be heard by all other Directors participating in such a meeting, of a majority of
        the Directors then in office who are lawfully entitled to participate and vote in the meeting. No business shall be transacted at a meeting of the Board of Directors unless the requisite quorum is present (in person or by any means of
        communication) when the meeting proceeds to business.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6478270a1aa043b6b634809de41eb72d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">48.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Chairman of the Board of Directors</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors shall, from time to time, elect one of its members to be the Chairman of the Board
        of Directors, remove such Chairman from office and appoint in his place. The Chairman of the Board of Directors shall preside at every meeting of the Board of Directors, but if there is no such Chairman, or if at any meeting he is not present
        within fifteen (15) minutes of the time fixed for the meeting or if he is unwilling to take the chair, the Directors present shall choose one of the Directors present at the meeting to be the Chairman of such meeting. The office of Chairman of the
        Board of Directors shall not, by itself, entitle the holder to a second or casting vote.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z56bca3ddd29e4157ad114f2f7c98558c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">49.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Validity of Acts Despite Defects</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to the provisions of the Companies Law, all acts done or transacted at any meeting of the Board of
        Directors, or of a Committee of the Board of Directors, or by any person(s) acting as Director(s), shall, notwithstanding that it may afterwards be discovered that there was some defect in the appointment of the participants in such meeting or any
        of them or any person(s) acting as aforesaid, or that they or any of them were disqualified, be as valid as if there were no such defect or disqualification.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Chief Executive Officer</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd456d6dc55eb47038ec11968d89ce288" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">50.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Chief Executive Officer</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z90d2c2af9c0d4849a8036571498f739f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors shall from time to time appoint one or more persons, whether or not Directors, as Chief Executive Officer of the Company and may confer upon
                such person(s), and from time to time modify or revoke, such titles and such duties and authorities of the Board of Directors as the Board of Directors may deem fit, subject to such limitations and restrictions as the Board of Directors may
                from time to time prescribe. Subject to the provisions of the Companies Law, such appointment(s) may be either for a fixed term or without any limitation of time, and the Board of Directors may from time to time (subject to any additional
                approvals required under, and the provisions of, the Companies Law and of any contract between any such person and the Company) fix their salaries and compensation, remove or dismiss them from office and appoint another or others in his or
                their place or places.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z16c886b6f0cc4b86ba27ca8539f52185" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Unless otherwise determined by the Board of Directors, the Chief Executive Officer shall have authority with respect of the management and operations of the Company
                in the ordinary course of business.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Minutes</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf06c4c1562eb4913bec323f170bbe425" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">51.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Minutes</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Any minutes of the General Meeting or the Board of Directors or any Committee, if purporting to be signed
        by the Chairman of the General Meeting, the Board of Directors or such Committee, as the case may be, or by the Chairman of the next succeeding General Meeting, meeting of the Board of Directors or meeting of such Committee, as the case may be,
        shall constitute prima facie evidence of the matters recorded therein.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Dividends</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zfc144ef9407b41cfa492662bf1821b24" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">52.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Declaration of Dividends</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors may from time declare, and cause the Company to pay, such dividend as may appear to
        the Board of Directors to be justified by the profits of the Company and as permitted by the Companies Law. Subject to the Companies Law, the Board of Directors shall determine the time for payment of such dividends and the record date for
        determining the Shareholders entitled thereto.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2c570747c37f410daf500293c530a36d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">53.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Amount Payable by Way of Dividends</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd63ad22b7d8f41cbaf7d30f56617998a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of these Articles and subject to the rights or conditions attached at that time to any share in the capital of the Company granting
                preferential, special or deferred rights or not granting any rights with respect to dividends, any dividend paid by the Company shall be allocated among the Shareholders (not in default in payment of any sum referred to in Article 14
                hereof) entitled thereto in proportion to their respective holdings of the shares in respect of which such dividends are being paid.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z27cc887669fe48159af9aae1038173c3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Whenever the rights attached to any shares or the terms of issue of the shares do not provide otherwise, shares which are fully paid up or which are credited as fully
                or partly paid within any period which in respect thereof dividends are paid shall entitle the holders thereof to a dividend in proportion to the amount paid up or credited as paid up in respect of the nominal value of such shares and to
                the date of payment thereof (pro rata temporis).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z664741001a4e43b691adc4c85c1bb4cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">54.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Interest</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">No dividend shall carry interest as against the Company.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb729253bf9b840a4b87aeeae6e0bde74" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">55.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Payment in Specie</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors may determine that the Company (i) may cause any moneys, investments, or other
        assets forming part of the undivided profits of the Company, standing to the credit of a reserve fund, or to the credit of a reserve fund for the redemption of capital, or in the hands of the Company and available for dividends, or representing
        premiums received on the issuance of shares and standing to the credit of the share premium account, to be capitalized and distributed among such of the Shareholders as would be entitled to receive the same if distributed by way of dividend and in
        the same proportion, on the footing that they become entitled thereto as capital, or may cause any part of such capitalized fund to be applied on behalf of such Shareholders in paying up in full, either at par or at such premium as the resolution
        may provide, any unissued shares or debentures or debenture stock of the Company which shall be distributed accordingly, in payment, in full or in part, of the uncalled liability on any issued shares or debentures or debenture stock; and (ii) may
        cause such distribution or payment to be accepted by such Shareholders in full satisfaction of their interest in the said capitalized sum.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zdb6b0b83bc66454990205bf732134a1e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">56.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Implementation of Powers</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">For the purpose of giving full effect to any resolution under Article 55, and without derogating from the
        provisions of Article 57 hereof, the Board of Directors may settle any difficulty which may arise in regard to the distribution as it thinks expedient, and, in particular, may fix the value for distribution of any specific assets and may determine
        that cash payments shall be made to any Shareholders upon the basis of the value so fixed, or that fractions of less value than a certain determined value may be disregarded in order to adjust the rights of all parties, and may vest any such cash,
        shares, debentures, debenture stock or specific assets in trustees upon such trusts for the persons entitled to the dividend or capitalized fund as may seem expedient to the Board of Directors. Where required under applicable law, a proper
        instrument shall be executed in accordance with Section 291 of the Companies Law, and the Board of Directors may appoint any person to sign such contract on behalf of the persons entitled to the dividend or capitalized fund.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd1d6ad21cfe74d479f4fd86ef6fd1207" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">57.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Deductions from Dividends</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors may deduct from any dividend or other moneys payable to any Shareholder in respect
        of a share any and all sums of money then payable by him to the Company on account of calls or otherwise in respect of shares of the Company and/or on account of any other matter of transaction whatsoever.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zef612efc86b1429ab5713ba87fe6f5fa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">58.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Retention of Dividends</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze7a05ef9a8324089abf2567479450ed6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share on which the Company has a lien, and may apply
                the same in or toward satisfaction of the debts, liabilities, or engagements in respect of which the lien exists.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za86b5d94dba44b5ab4e25893dc6f25f2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share in respect of which any person is, under
                Articles 22 or 23, entitled to become a Shareholder, or which any person is, under said Articles, entitled to transfer, until such person shall become a Shareholder in respect of such share or shall transfer the same.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7418e503f8ac45e98e218a15bb6c2600" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">59.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Unclaimed Dividends</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">All unclaimed dividends or other moneys payable in respect of a share may be invested or otherwise made use
        of by the Board of Directors for the benefit of the Company until claimed. The payment by the Directors of any unclaimed dividend or such other moneys into a separate account shall not constitute the Company a trustee in respect thereof, and any
        dividend unclaimed after a period of seven (7) years from the date of declaration of such dividend, and any such other moneys unclaimed after a like period from the date the same were payable, shall be forfeited and shall revert to the Company,
        provided, however, that the Board of Directors may, at its discretion, cause the Company to pay any such dividend or such other moneys, or any part thereof, to a person who would have been entitled thereto had the same not reverted to the Company.
        The principal (and only the principal) of any unclaimed dividend of such other moneys shall be if claimed, paid to a person entitled thereto.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4fdc50fbcac240d880431d69eccdc2aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">60.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Mechanics of Payment</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Any dividend or other moneys payable in cash in respect of a share may be paid by check or warrant sent
        through the post to, or left at, the registered address of the person entitled thereto or by transfer to a bank account specified by such person (or, if two or more persons are registered as joint holders of such share or are entitled jointly
        thereto in consequence of the death or bankruptcy of the holder or otherwise, to the joint holder whose name is registered first in the Register of Shareholders or his bank account or the person who the Company may then recognize as the owner
        thereof or entitled thereto under Article 22 or 23 hereof, as applicable, or such person&#8217;s bank account), or to such person and at such other address as the person entitled thereto may by writing direct, or in any other manner the Board of
        Directors deems appropriate. Every such check or warrant or other method of payment shall be made payable to the order of the person to whom it is sent, or to such person as the person entitled thereto as aforesaid may direct, and payment of the
        check or warrant by the banker upon whom it is drawn shall be a good discharge to the Company.</div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zeb73b0211b794389adde7b06f294ee9c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">61.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Receipt from a Joint Holder</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">If two or more persons are registered as joint holders of any share, or are entitled jointly thereto in
        consequence of the death or bankruptcy of the holder or otherwise, any one of them may give effectual receipts for any dividend or other moneys payable or property distributable in respect of such share.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Accounts</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z3770048d17584a6db90302a41d5d63a2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">62.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Books of Account</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The Board of Directors must ensure that bookkeeping and publication of financial statements are made in
        accordance with the provisions of the Companies Law and any other law applicable to the Company. The Company shall not be required to send copies of its annual financial statements to Shareholders, unless required by applicable law.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z42109777af79485cb1ade5c35b577eb7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">63.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Auditors</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">The appointment, authorities, rights and duties of the auditor(s) of the Company, shall be regulated by
        applicable law, provided, however, that in exercising its authority to fix the remuneration of the auditor(s), the Shareholders in General Meeting may act (and in the absence of any action in connection therewith shall be deemed to have so acted)
        to authorize the Board of Directors to fix such remuneration subject to such criteria or standards, and if no such criteria or standards are so provided, such remuneration shall be fixed in an amount commensurate with the volume and nature of the
        services rendered by such auditor(s).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z8d49548791a74c2ab90ab0104844c8bf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">63A.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Internal Auditor</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4e49cd02d3624d45b4d70cc5686bcef6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The internal auditor of the Company shall be appointed in accordance with the rules and regulations of the Companies Law, and shall report to the Chairman or as
                otherwise determined by the Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z13ce2f05f8964916bc44212d5a591254" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The internal auditor shall submit to the Audit Committee (unless decided otherwise by the Board of Directors) a proposal for an annual or other periodic work plan.
                Such proposed work plan shall be approved by the Audit Committee (unless decided otherwise by the Board of Directors) with such amendments and/or adjustments as the Audit Committee (or such other person or organ) deems fit.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Supplementary Registers</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb7d481ca60db4a088cf5c723889ac463" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">64.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Supplementary Registers</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to and in accordance with the provisions of Sections 138 and 139 of the Companies Law, the Company
        may cause supplementary registers to be kept in any place outside Israel as the Board of Directors may think fit, and, subject to all applicable requirements of law, the Board of Directors may from time to time adopt such rules and procedures as it
        may think fit in connection with the keeping of such supplementary registers.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Exemption, Indemnity and Insurance</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6e68131198984b6aacd542201ebb80ca" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">65.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Insurance</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to the provisions of the Companies Law with regard to such matters, the Company may enter into a
        contract for the insurance of the liability, in whole or in part, of any of its Office Holders imposed on such Office Holder due to an act performed by the Office Holder in the Office Holder&#8217;s capacity as an Office Holder of the Company arising
        from any matter permitted by law, including the following:</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z93e832d94ac746ab88b9bbd6a89b63e1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>a breach of duty of care to the Company or to any other person;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zde7041aa3c7a4806b5d6a3768093e610" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>a breach of his fiduciary duty to the Company, provided that the Office Holder acted in good faith and had reasonable grounds to assume that act that resulted in such
                breach would not prejudice the interests of the Company;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc38337a9a5134e5ea1bd6aa6b8e7182e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>a financial liability imposed on such Office Holder in favor of any other person;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd759b2b58774405599b2f302a47c2c5a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>expenses, including reasonable litigation expenses and legal fees, incurred by an Office Holder as a result of an Administrative Proceeding instituted against the
                Office Holder;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb750fa141fb74fb8a6799ddbd7aef167" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>payments to an injured party imposed on the Office Holder pursuant to Section 52ND(a)(1)(a) of the Securities Law; and</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zec56b9f1f1da4a398266f24aa353d660" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>any other event, occurrence, matters or circumstances under any law with respect to which the Company may, or will be able to, insure an Office Holder, and to the
                extent such law requires the inclusion of a provision permitting such insurance in these Articles, then such provision is deemed to be included and incorporated herein by reference (including, without limitation, in accordance with Section
                50P of the RTP Law, if and to the extent applicable).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2affd193253f434eae3e0c5b8a71f586" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">66.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Indemnity</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb7da1265962e4c32b809d0db93644ef9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of the Companies Law, the Company may retroactively indemnify an Office Holder of the Company with respect to the following liabilities and
                expenses, provided that such liabilities or expenses were imposed on such Office Holder or incurred by such Office Holder due to an act performed by the Office Holder in such Office Holder&#8217;s capacity as an Office Holder of the Company:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zaf60586d9c1742518ac21d333b3770f2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>a financial liability imposed on an Office Holder in favor of another person by any court judgment, including a judgment given as a result of a settlement or an
                arbitrator&#8217;s award which has been confirmed by a court in respect of an act performed by the Office Holder;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z01a41f87a63340d7ad799e4d3fdbda35" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>reasonable litigation expenses, including attorneys&#8217; fees, expended by the Office Holder as a result of an investigation or proceeding instituted against him or her
                by an authority authorized to conduct such investigation or proceeding, or in connection with a financial sanction, provided that (1) no indictment (as defined in the Companies Law) was filed against such office holder as a result of such
                investigation or proceeding; and (2) no financial liability in lieu of a criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding or if such financial liability was
                imposed, it was imposed with respect to an offence that does not require proof of criminal intent or in connection with a monetary sanction ("<font style="font-style: italic;">Itzum
                  Caspi</font>");</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z72dfc487727b4ce287c2b3d3807a9b04" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>reasonable litigation costs, including attorney&#8217;s fees, expended by an Office Holder or which were imposed on an Office Holder by a court in proceedings filed against
                the Office Holder by the Company or in its name or by any other person or in a criminal charge in respect of which the Office Holder was acquitted or in a criminal charge in respect of which the Office Holder was convicted for an offence
                which did not require proof of criminal intent;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za026e037b21c4ed2af7b46474f99407e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>expenses, including reasonable litigation expenses and legal fees, incurred by an Office Holder as a result of an Administrative Proceeding instituted against the
                Office Holder;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z7681e9c1c1da41a4a7a2bd2242e56cbf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>payments to an injured party imposed on the Office Holder pursuant to Section 52ND(a)(1)(a) of the Securities Law; and</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4d05dc54f25247599e128f711a0e8fb7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(vi)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>any other event, occurrence, matter or circumstances under any law with respect to which the Company may, or will be able to, indemnify an Office Holder, and to the
                extent such law requires the inclusion of a provision permitting such indemnity in these Articles, then such provision is deemed to be included and incorporated herein by reference (including, without limitation, in accordance with Section
                50P(b)(2) of the RTP Law, if and to the extent applicable).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zafca8862a3a245d5ad1dba5f7aef9127" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Subject to the provisions of the Companies Law, the Company may undertake to indemnify an Office Holder, in advance, with respect to those liabilities and expenses
                described in the following Articles:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z3593eed5a2d04f1da078f539a0ff3127" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Sub-Article 66(a)(ii) to 66(a)(vi); and</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb30c084c923a486f8b4f8525ee745c52" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Sub-Article 66(a)(i), provided that&#160;the undertaking to indemnify is limited to such events which the Directors shall deem to be likely to occur in light of the
                operations of the Company at the time that the undertaking to indemnify is made and for such amounts or criterion which the Directors may, at the time of the giving of such undertaking to indemnify, deem to be reasonable under the
                circumstances.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2267e35d89e048aba6a23d9e1dac93c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">67.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Exemption</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">Subject to the provisions of the Companies Law, the Company may exempt and release, in advance, any Office
        Holder from any liability for damages arising out of a breach of a duty of care towards the Company.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1ab977c8fb3b49328c338555444cb60e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">68.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>General</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z2265f6d619734ab8bc20f5897626e589" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any amendment to the Companies Law and/or the Securities Law or any other applicable law adversely affecting the right of any Office Holder to be indemnified, insured
                or exempt pursuant to Articles 65 to 67 and any amendments to Articles 65 to 67 shall be prospective in effect, and shall not affect the Company&#8217;s obligation or ability to indemnify, insure or exempt an Office Holder for any act or omission
                occurring prior to such amendment, unless otherwise provided by applicable law.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5031434a3a7d45fea3f20ff55f2b90a2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The provisions of Articles 65 to 67 (i) shall apply to the maximum extent permitted by law (including, the Companies Law, the Securities Law and the RTP Law); and
                (ii) are not intended, and shall not be interpreted so as to restrict the Company, in any manner, in respect of the procurement of insurance and/or in respect of indemnification (whether in advance or retroactively) and/or exemption, in
                favor of any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who is not an Office Holder; and/or any Office Holder to the extent that such insurance and/or
                indemnification is not specifically prohibited under law.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Winding Up</div>
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z01fada89ab294942a0660af21771c604" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">69.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Winding Up</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 18pt;">If the Company is wound up, then, subject to applicable law and to the rights of the holders of shares with
        special rights upon winding up, the assets of the Company available for distribution among the Shareholders shall be distributed to them in proportion to the nominal value of their respective holdings of the shares in respect of which such
        distribution is being made.</div>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-variant: small-caps; font-weight: bold;">Notices</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zce9bf4abe0ac4d188deeabc8f195ecac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">70.</td>
            <td style="vertical-align: top; text-align: justify;">
              <div style="font-variant: small-caps; font-weight: bold;"><u>Notices</u></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z17a5b7c468c24baa95f0ad175eae12ac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any written notice or other document may be served by the Company upon any Shareholder either personally, by facsimile, email or other electronic transmission, or by
                sending it by prepaid mail (airmail if sent internationally) addressed to such Shareholder at his address as described in the Register of Shareholders or such other address as he may have designated in writing for the receipt of notices and
                other documents.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z8173f966cda74959b6f9d366a638e434" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any written notice or other document may be served by any Shareholder upon the Company by tendering the same in person to the Secretary or the Chief Executive Officer
                of the Company at the principal office of the Company, by facsimile transmission, or by sending it by prepaid registered mail (airmail if posted outside Israel) to the Company at its Office.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze16a5ac10d5942f4bd55e2fe6552e857" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any such notice or other document shall be deemed to have been served:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z58369ce3b37f4aa286320d85f21ed003" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>in the case of mailing, three (3) business days after it has been posted or when actually received by the addressee if sooner;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z3196a8ddedad45d38fbb8065e52946a2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>in the case of overnight air courier, on the next business day following the day sent, with receipt confirmed by the courier, or when actually received by the
                addressee if sooner than three business days after it has been sent;</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze6e48efb4df94f34bef8f71fa59171d9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>in the case of personal delivery, when actually tendered in person, to such addressee; or</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zd8fe7c4b7dac4842b6cc7fe2cdb5e8a4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>in the case of facsimile, email or other electronic transmission, the on the first business day (during normal business hours in place of addressee) on which the
                sender receives automatic electronic confirmation by the addressee&#8217;s facsimile machine that such notice was received by the addressee or delivery confirmation from the addressee&#8217;s email or other communication server.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z152bb4ed3a604f8798eb10ffcf1b6153" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>If a notice is, in fact, received by the addressee, it shall be deemed to have been duly served, when received, notwithstanding that it was defectively addressed or
                failed, in some other respect, to comply with the provisions of this Article 70(d).</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z66a1201afcf14bf8a9167598eb0c4867" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>All notices to be given to the Shareholders shall, with respect to any share to which persons are jointly entitled, be given to whichever of such persons is named
                first in the Register of Shareholders, and any notice so given shall be sufficient notice to the holders of such share.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z4bd1650efc2e4182b7548ea6559b57fc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Any Shareholder whose address is not described in the Register of Shareholders, and who shall not have designated in writing an address for the receipt of notices,
                shall not be entitled to receive any notice from the Company.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="zb39a2ca3e01b4b9ea4c985c1cfdfdcf9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Notwithstanding anything to the contrary contained herein, notice by the Company of a General Meeting, containing the information required by applicable law and these
                Articles to be set forth therein, which is published, within the time otherwise required for giving notice of such meeting, in either/both of the following manners (as applicable) shall be deemed to be notice of such meeting duly given, for
                the purposes of these Articles, to any Shareholder whose address as registered in the Register of Shareholders (or as designated in writing for the receipt of notices and other documents) is located either inside or outside the State of
                Israel:</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="ze7533699b69a46a48222106dd48393eb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if the Company&#8217;s shares are then listed for trading on the Tel Aviv Stock Exchange, publication of notice of a General Meeting in at least two daily newspapers in the
                State of Israel (or in such other publications (if any) as may otherwise be required from time to time under the Companies Law regulations); and</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z387eaf670a5144f89414d74376dfe374" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 47.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>if the Company&#8217;s shares are then listed for trading on a national securities exchange in the United States or quoted in an over-the-counter market in the United
                States, publication of notice of a General Meeting in a press release via an international wire service, and the furnishing of such press release in a Report of Foreign Private Issuer on Form 6-K (or an equivalent form subsequently adopted
                by the SEC) to the SEC.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z01e7b5af2f9c42259f9a1f058f572b7d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20.25pt;"><br>
            </td>
            <td style="width: 27pt; vertical-align: top;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The mailing or publication date and the record date and/or date of the meeting (as applicable) shall be counted among the days comprising any notice period under the
                Companies Law and the regulations thereunder.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">28</font></div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
      <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>3
<FILENAME>exhibit_12-1.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: right; margin-left: 1pt; line-height: 1.25; font-weight: bold;"><u>Exhibit 12.1</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; margin-left: 1pt; line-height: 1.25; font-weight: bold;">Certification Pursuant to Rule 13a-14(a) of the Exchange Act</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 8pt; line-height: 1.25;">I, Alex Ovadia, certify that:</div>
      <div style="margin-left: 8pt; line-height: 1.25;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z712f83837cd044769334aacf0305cdec">

          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">1.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="line-height: 1.25;">I have reviewed this annual report on Form 20-F of Check-Cap Ltd.;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">2.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
                circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">3.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
                operations and cash flows of the company as of, and for, the periods presented in this report;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">4.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
                and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(a)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
                company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(b)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
                regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(c)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
                procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(d)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or
                is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">5.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit
                committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(a)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s
                ability to record, process, summarize and report financial information; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(b)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50.03%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Date: March 31, 2023</div>
            </td>
            <td style="width: 50.03%; vertical-align: middle;">
              <div style="text-indent: -9pt; margin-right: 133.85pt; margin-left: 9pt; line-height: 1.25;">By: <u>/s/&#160; Alex Ovadia</u></div>
              <div style="text-indent: -9pt; margin-right: 133.85pt; margin-left: 9pt; line-height: 1.25;">Name: Alex Ovadia</div>
              <div style="text-indent: -9pt; margin-right: 27.85pt; margin-left: 9pt; line-height: 1.25;">Title: Chief Executive Officer (Principal Executive Officer)</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 7.9pt; line-height: 1.25;"><br>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>4
<FILENAME>exhibit_12-2.htm
<DESCRIPTION>EXHIBIT 12.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: right; margin-left: 1pt; line-height: 1.25; font-weight: bold;"><u>Exhibit 12.2</u></div>
      <div style="text-align: center; margin-left: 1pt; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-left: 1pt; line-height: 1.25; font-weight: bold;">Certification Pursuant to Rule 13a-14(a) of the Exchange Act</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 8pt; line-height: 1.25;">I, Mira Rosenzweig, certify that:</div>
      <div style="margin-left: 8pt; line-height: 1.25;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z471b3886f95d4ea09542c5db5eaf475c">

          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">1.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="line-height: 1.25;">I have reviewed this annual report on Form 20-F of Check-Cap Ltd.;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">2.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
                circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">3.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
                operations and cash flows of the company as of, and for, the periods presented in this report;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">4.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The company&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
                and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(a)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
                company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(b)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
                regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(c)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
                procedures, as of the end of the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(d)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or
                is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">5.</div>
            </td>
            <td style="width: 94%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The company&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit
                committee of the company&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(a)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s
                ability to record, process, summarize and report financial information; and</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: middle;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">(b)</div>
            </td>
            <td style="width: 91%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
      <div style="margin-left: 7.95pt; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7a662a9436e5464c9691211e16f001ef">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Date: March 31, 2023</div>
            </td>
            <td style="width: 50%; vertical-align: middle;">
              <div style="text-indent: -9pt; margin-right: 133.85pt; margin-left: 9pt; line-height: 1.25;">By: <u>/s/ Mira&#160; Rosenzweig</u></div>
              <div style="text-indent: -9pt; margin-right: 133.85pt; margin-left: 9pt; line-height: 1.25;">Name: Mira Rosenzweig</div>
              <div style="text-indent: -9pt; margin-right: 27.85pt; margin-left: 9pt; line-height: 1.25;">Title: Chief Financial Officer</div>
              <div style="text-indent: -9pt; margin-right: 27.85pt; margin-left: 9pt; line-height: 1.25;">(Principal Financial Officer and Principal Accounting Officer)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>exhibit_13-1.htm
<DESCRIPTION>EXHIBIT 13.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 13.1</u></div>
      <div style="text-align: center; margin-right: 137.5pt; margin-left: 139.5pt; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-right: 137.5pt; margin-left: 139.5pt; line-height: 1.25; font-weight: bold;">Certification Pursuant to 18 U.S.C. Section 1350</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-right: 6.45pt; margin-left: 8pt; line-height: 1.25;">Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned
        officers of Check- Cap Ltd. (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 8pt; line-height: 1.25;">The Annual Report on Form 20-F for the year ended December 31, 2022 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange
        Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
      <div style="text-align: center; margin-right: 137.5pt; margin-left: 139.35pt; line-height: 1.25; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-right: 137.5pt; margin-left: 139.35pt; line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze02639e058ba4a258cd8d0d1fd6aba81">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">March 31, 2023</div>
            </td>
            <td style="width: 4%; vertical-align: top;">
              <div style="margin-right: 16.4pt; line-height: 1.25;">By:</div>
            </td>
            <td style="width: 46%; vertical-align: top;">
              <div style="margin-left: 3.8pt; line-height: 1.25;"><u>/s/ Alex Ovadia</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 4%; vertical-align: top;">
              <div style="line-height: 1.25;">Name:</div>
              <div style="line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 46%; vertical-align: top;">
              <div style="margin-left: 3.8pt; line-height: 1.25;">Alex Ovadia</div>
              <div style="margin-left: 3.8pt; line-height: 1.25;">Chief Executive Officer (Principal Executive Officer)</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 4%; vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 46%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-left: 2.5pt; line-height: 1.25;">March 31, 2023</div>
            </td>
            <td style="width: 4%; vertical-align: top;">
              <div style="margin-right: 16.4pt; line-height: 1.25;">By:</div>
            </td>
            <td style="width: 46%; vertical-align: top;">
              <div style="margin-left: 3.8pt; line-height: 1.25;"><u>/s/ Mira Rosenzweig</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 4%; vertical-align: top;">
              <div style="line-height: 1.25;">Name:</div>
              <div style="line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 46%; vertical-align: top;">
              <div style="margin-left: 3.8pt; line-height: 1.25;">Mira Rosenzweig</div>
              <div style="margin-left: 3.8pt; line-height: 1.25;">Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageFooter">
        <div style="line-height: 1.25;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>6
<FILENAME>exhibit_15-1.htm
<DESCRIPTION>EXHIBIT 15.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using Broadridge PROfile 23.3.1.5138
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div><br>
    </div>
    <div>
      <div style="text-align: right; line-height: 1.25;"><font style="font-family: 'Times New Roman', serif; font-size: 1pt;">e</font><font style="font-weight: bold;"><u>Exhibit 15.1</u></font></div>
      <div style="line-height: 1.25;"><img width="171" height="74" src="image00002.jpg"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-211065,
        333-225789, 333-248200 and 333-262401), of our report dated March 31, 2023, relating to the financial statements of Check-Cap Ltd. (the &#8220;Company&#8221;) appearing in this Annual Report on Form 20-F of the Company for the year ended December 31, 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">/s/ Brightman Almagor Zohar &amp; Co.</div>
      <div style="line-height: 1.25; font-weight: bold;">Brightman Almagor Zohar &amp; Co.</div>
      <div style="line-height: 1.25; font-weight: bold;">Certified Public Accountants</div>
      <div style="line-height: 1.25; font-weight: bold;">A Firm in the Deloitte Global Network</div>
      <div style="line-height: 1.25;">Tel Aviv, Israel</div>
      <div style="line-height: 1.25;">March 31, 2023</div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>chek-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:chek="http://check-cap.com/20221231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" targetNamespace="http://check-cap.com/20221231" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://check-cap.com/role/chek-dei" id="chek-dei">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/check-cbs" id="check-cbs">
        <link:definition>0002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-csoo" id="chek-csoo">
        <link:definition>0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-equity" id="chek-equity">
        <link:definition>0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-equityp" id="chek-equityp">
        <link:definition>0006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-csocf" id="chek-csocf">
        <link:definition>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-info" id="chek-info">
        <link:definition>0008 - Disclosure - GENERAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sigp" id="chek-sigp">
        <link:definition>0009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-peaoca" id="chek-peaoca">
        <link:definition>0010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-ppe" id="chek-ppe">
        <link:definition>0011 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/Leases" id="Leases">
        <link:definition>0012 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-ebapa" id="chek-ebapa">
        <link:definition>0013 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-itax" id="chek-itax">
        <link:definition>0014 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-cacl" id="chek-cacl">
        <link:definition>0015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-fvm" id="chek-fvm">
        <link:definition>0016 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sed" id="chek-sed">
        <link:definition>0017 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sbp" id="chek-sbp">
        <link:definition>0018 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-raden" id="chek-raden">
        <link:definition>0019 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-gaae" id="chek-gaae">
        <link:definition>0020 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-fien" id="chek-fien">
        <link:definition>0021 - Disclosure - FINANCE INCOME (EXPENSES), NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-eps" id="chek-eps">
        <link:definition>0022 - Disclosure - LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-relp" id="chek-relp">
        <link:definition>0023 - Disclosure - RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0024 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sigpp" id="chek-sigpp">
        <link:definition>0025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sigpt" id="chek-sigpt">
        <link:definition>0026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-peaocat" id="chek-peaocat">
        <link:definition>0027 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-ppet" id="chek-ppet">
        <link:definition>0028 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LeasesTable" id="LeasesTable">
        <link:definition>0029 - Disclosure - LEASES (Table)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-ebapat" id="chek-ebapat">
        <link:definition>0030 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-itaxt" id="chek-itaxt">
        <link:definition>0031 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-caclt" id="chek-caclt">
        <link:definition>0032 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
        <link:definition>0033 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sbpt" id="chek-sbpt">
        <link:definition>0034 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-radent" id="chek-radent">
        <link:definition>0035 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-gaaet" id="chek-gaaet">
        <link:definition>0036 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-fient" id="chek-fient">
        <link:definition>0037 - Disclosure - FINANCE INCOME (EXPENSES), NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-epst" id="chek-epst">
        <link:definition>0038 - Disclosure - LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-relpt" id="chek-relpt">
        <link:definition>0039 - Disclosure - RELATED PARTIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-infod" id="chek-infod">
        <link:definition>0040 - Disclosure - GENERAL INFORMATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" id="SummaryOfSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sosapd" id="chek-sosapd">
        <link:definition>0042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-peaocad" id="chek-peaocad">
        <link:definition>0043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails" id="PROPERTYANDEQUIPMENTNETNarrativeDetails">
        <link:definition>0044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-pped" id="chek-pped">
        <link:definition>0045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LeasesDetails" id="LeasesDetails">
        <link:definition>0046 - Disclosure - LEASES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" id="LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails">
        <link:definition>0047 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" id="LeasesScheduleOfFutureLeasePaymentsDetails">
        <link:definition>0048 - Disclosure - LEASES (Schedule of Future Lease Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-ebapad" id="chek-ebapad">
        <link:definition>0049 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/INCOMETAXESNarrativeDetails" id="INCOMETAXESNarrativeDetails">
        <link:definition>0050 - Disclosure - INCOME TAXES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-itaxd" id="chek-itaxd">
        <link:definition>0051 - Disclosure - INCOME TAXES (Schedule of Deferred Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails" id="COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails">
        <link:definition>0052 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails" id="COMMITMENTSANDCONTINGENTLIABILITIESDetails">
        <link:definition>0053 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails" id="FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails">
        <link:definition>0054 - Disclosure - FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails" id="ShareholdersEquityOrdinarySharesDetails">
        <link:definition>0055 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/Share-basedCompensationAwardsDetails" id="Share-basedCompensationAwardsDetails">
        <link:definition>0056 - Disclosure - SHARE-BASED COMPENSATION (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails" id="Share-basedCompensationDetailsOfShare-basedGrantsDetails">
        <link:definition>0057 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails" id="Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails">
        <link:definition>0058 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-sbpced" id="chek-sbpced">
        <link:definition>0059 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/Share-basedCompensationOptionActivityDetails" id="Share-basedCompensationOptionActivityDetails">
        <link:definition>0060 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-radend" id="chek-radend">
        <link:definition>0061 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-gaaed" id="chek-gaaed">
        <link:definition>0062 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/chek-fiend" id="chek-fiend">
        <link:definition>0063 - Disclosure - FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails" id="LossPerShareScheduleOfLossPerShareDetails">
        <link:definition>0064 - Disclosure - LOSS PER SHARE (Schedule of Loss Per Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails" id="LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails">
        <link:definition>0065 - Disclosure - LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails" id="RelatedPartiesTransactionsWithRelatedPartiesDetails">
        <link:definition>0066 - Disclosure - RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="chek-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="chek-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="chek-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="chek-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccountingPoliciesLineItems" id="chek_AccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AccountingPoliciesTable" id="chek_AccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" id="chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" id="chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares" id="chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree" id="chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree" id="chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AmountOfPortionOfOrdinarySharesOfSuchLender" id="chek_AmountOfPortionOfOrdinarySharesOfSuchLender" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="AntiDilutiveWarrantsMember" id="chek_AntiDilutiveWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AprilMayOfferingsMember" id="chek_AprilMayOfferingsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AprilMayRegisteredDirectOfferingMember" id="chek_AprilMayRegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AprilSixthMember" id="chek_AprilSixthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AsicComponentDesignerRoyaltiesMember" id="chek_AsicComponentDesignerRoyaltiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AugustThirteenthOneMember" id="chek_AugustThirteenthOneMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AugustThirteenthTwoMember" id="chek_AugustThirteenthTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BankLeumiCreditFacilityMember" id="chek_BankLeumiCreditFacilityMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BinationalIndustrialResearchAndDevelopmentFoundationMember" id="chek_BinationalIndustrialResearchAndDevelopmentFoundationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="C1WarrantsMember" id="chek_C1WarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="C2WarrantsMember" id="chek_C2WarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertainEmployeesMember" id="chek_CertainEmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertainOfficerMember" id="chek_CertainOfficerMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" id="chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangesInLiabilityToPayRoyalties" id="chek_ChangesInLiabilityToPayRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CheckCapUsIncMember" id="chek_CheckCapUsIncMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficerAndBoardMembersMember" id="chek_ChiefExecutiveOfficerAndBoardMembersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassOfWarrantOrRightExpiration" id="chek_ClassOfWarrantOrRightExpiration" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassOfWarrantOrRightExpirationPeriod" id="chek_ClassOfWarrantOrRightExpirationPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights" id="chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ClinicalTrialsAndRegulationExpense" id="chek_ClinicalTrialsAndRegulationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CommitmentsAndContingenciesLineItems" id="chek_CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommitmentsAndContingenciesTable" id="chek_CommitmentsAndContingenciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="CommonClassDMember" id="chek_CommonClassDMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CommonStockUnitsIssued" id="chek_CommonStockUnitsIssued" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CompensationExpenseEstimationForGrantDate" id="chek_CompensationExpenseEstimationForGrantDate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ConsultingFeesMember" id="chek_ConsultingFeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContingentLiability" id="chek_ContingentLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CounterpointVenturesFundTwoMember" id="chek_CounterpointVenturesFundTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CreditLineAgreementWarrantsMember" id="chek_CreditLineAgreementWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DerivativeChangeInFairValueOfOptionOutstanding" id="chek_DerivativeChangeInFairValueOfOptionOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DesignerRoyaltiesMember" id="chek_DesignerRoyaltiesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DevelopmentAreaAMember" id="chek_DevelopmentAreaAMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocorInternationalBVMember" id="chek_DocorInternationalBVMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformationAbstract" id="chek_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeeRelatedLiabilitiesTextBlock" id="chek_EmployeeRelatedLiabilitiesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EscoVenturesPteLtdMember" id="chek_EscoVenturesPteLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExercisePriceOfWarrants" id="chek_ExercisePriceOfWarrants" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FairValueOfHedgingOption" id="chek_FairValueOfHedgingOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FairValueOfWarrantsIssued" id="chek_FairValueOfWarrantsIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FebruaryEighteenthMember" id="chek_FebruaryEighteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FebruaryTwentyFourthOneMember" id="chek_FebruaryTwentyFourthOneMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FebruaryTwentyFourthTwoMember" id="chek_FebruaryTwentyFourthTwoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FeesAndReimbursementMember" id="chek_FeesAndReimbursementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FindersWarrantsMember" id="chek_FindersWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FirstMarchMember" id="chek_FirstMarchMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FiveYearWarrantsMember" id="chek_FiveYearWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignCurrencyDerivativeInstrumentsMember" id="chek_ForeignCurrencyDerivativeInstrumentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ForeignIncomeTaxRateMaximum" id="chek_ForeignIncomeTaxRateMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FourAugustMember" id="chek_FourAugustMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FourMayMember" id="chek_FourMayMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FunctionalCurrencyPolicyTextBlock" id="chek_FunctionalCurrencyPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FutureFederalIncomeTaxRate" id="chek_FutureFederalIncomeTaxRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FutureFederalIncomeTaxRateNextYear" id="chek_FutureFederalIncomeTaxRateNextYear" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAndAdministrativeExpensesLineItems" id="chek_GeneralAndAdministrativeExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralAndAdministrativeExpensesTable" id="chek_GeneralAndAdministrativeExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="GeneralAndAdministrativeExpensesTextBlock" id="chek_GeneralAndAdministrativeExpensesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GeneralTransactionsMember" id="chek_GeneralTransactionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GovernmentInstitutionalAssetsCurrent" id="chek_GovernmentInstitutionalAssetsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="GrantDate10Member" id="chek_GrantDate10Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate11Member" id="chek_GrantDate11Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate12Member" id="chek_GrantDate12Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate13Member" id="chek_GrantDate13Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate14Member" id="chek_GrantDate14Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate15Member" id="chek_GrantDate15Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate16Member" id="chek_GrantDate16Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate17Member" id="chek_GrantDate17Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate18Member" id="chek_GrantDate18Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate1Member" id="chek_GrantDate1Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate2Member" id="chek_GrantDate2Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate3Member" id="chek_GrantDate3Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate4Member" id="chek_GrantDate4Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate5Member" id="chek_GrantDate5Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate6Member" id="chek_GrantDate6Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate7Member" id="chek_GrantDate7Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate8Member" id="chek_GrantDate8Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDate9Member" id="chek_GrantDate9Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOne1Member" id="chek_GrantDateOne1Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOne2Member" id="chek_GrantDateOne2Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOne3Member" id="chek_GrantDateOne3Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOne4Member" id="chek_GrantDateOne4Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOneEightMember" id="chek_GrantDateOneEightMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOneFiveMember" id="chek_GrantDateOneFiveMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOneNineMember" id="chek_GrantDateOneNineMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOneSevenMember" id="chek_GrantDateOneSevenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateOneSixMember" id="chek_GrantDateOneSixMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantDateTwoZeroMember" id="chek_GrantDateTwoZeroMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="GrantedRevenue" id="chek_GrantedRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="GrossOvertimeMonthlyRate" id="chek_GrossOvertimeMonthlyRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IIAMember" id="chek_IIAMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InstitutionalAndAccreditedInvestorsMember" id="chek_InstitutionalAndAccreditedInvestorsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="InvestorWarrantsMember" id="chek_InvestorWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" id="chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceExpenses" id="chek_IssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="JanuaryFifteenthMember" id="chek_JanuaryFifteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="June2017RegisteredDirectOfferingMember" id="chek_June2017RegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JuneFirstMember" id="chek_JuneFirstMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JuneSixthMember" id="chek_JuneSixthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JuneThirdMember" id="chek_JuneThirdMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="KeyManInsurancePolicy" id="chek_KeyManInsurancePolicy" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="KeyManLifeInsurancePremiumMember" id="chek_KeyManLifeInsurancePremiumMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LegalWarrantsMember" id="chek_LegalWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LesseeOperatingLeaseAdditionalTerm" id="chek_LesseeOperatingLeaseAdditionalTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermIncentiveWarrantsMember" id="chek_LongTermIncentiveWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ManufacturingProgramMember" id="chek_ManufacturingProgramMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="March2022RegisteredDirectOfferingMember" id="chek_March2022RegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MarchFifteenthMember" id="chek_MarchFifteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MaximumAggregateMonthlySalary" id="chek_MaximumAggregateMonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MaximumRoyaltyObligation" id="chek_MaximumRoyaltyObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="MayFifteenthMember" id="chek_MayFifteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MayNineteenthMember" id="chek_MayNineteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MinimumBidPriceValuePerShare" id="chek_MinimumBidPriceValuePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MonthlyRentalFee" id="chek_MonthlyRentalFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MonthlyRetainer" id="chek_MonthlyRetainer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MonthlySalary" id="chek_MonthlySalary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MonthlyVehicleLeaseExpense" id="chek_MonthlyVehicleLeaseExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NetProceedsFromIssuanceOfSharesAndWarrants" id="chek_NetProceedsFromIssuanceOfSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NineMayMember" id="chek_NineMayMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonExecutiveDirectorsCompensationMember" id="chek_NonExecutiveDirectorsCompensationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonExecutiveDirectorsMember" id="chek_NonExecutiveDirectorsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="November2017RegisteredDirectOfferingMember" id="chek_November2017RegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" id="chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" id="chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesRestrictedStockVested" id="chek_NumberOfSharesRestrictedStockVested" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfWarrantsToBeGrantedUponExerciseOfWarrants" id="chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OctoberFourteenthMember" id="chek_OctoberFourteenthMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OctoberTwentiethMember" id="chek_OctoberTwentiethMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfficeOfTheChiefScientistMember" id="chek_OfficeOfTheChiefScientistMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OfficeRentAndMaintenance" id="chek_OfficeRentAndMaintenance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OfficersAndEmployeesMember" id="chek_OfficersAndEmployeesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneYearWarrantsMember" id="chek_OneYearWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OperatingLeaseRentExpenseMonthly" id="chek_OperatingLeaseRentExpenseMonthly" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="OrdinarySharesMember" id="chek_OrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentAssetsFairValueDisclosureAbstract" id="chek_OtherCurrentAssetsFairValueDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherCurrentLiabilitiesFairValueDisclosureAbstract" id="chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsExpensesForPatents" id="chek_PaymentsExpensesForPatents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise" id="chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant" id="chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" id="chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfSharesFullyDiluted" id="chek_PercentageOfSharesFullyDiluted" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PeriodOfVestingEqualPortion" id="chek_PeriodOfVestingEqualPortion" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlacementAgent2Member" id="chek_PlacementAgent2Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlacementAgentMember" id="chek_PlacementAgentMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlacementAgentsMember" id="chek_PlacementAgentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PlacementAgentWarrantsMember" id="chek_PlacementAgentWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PontifaxFundsMember" id="chek_PontifaxFundsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PontifaxMember" id="chek_PontifaxMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PredecessorUnitHoldersMember" id="chek_PredecessorUnitHoldersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredSharesConversionMember" id="chek_PreferredSharesConversionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredSharesMember" id="chek_PreferredSharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreferredShareWarrantsConversionMember" id="chek_PreferredShareWarrantsConversionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedUnitsMember" id="chek_PreFundedUnitsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedWarrantsMember" id="chek_PreFundedWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedWarrantsOneMember" id="chek_PreFundedWarrantsOneMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedWarrantsPurchase" id="chek_PreFundedWarrantsPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PreFundedWarrantsPurchaseSharesIssuable" id="chek_PreFundedWarrantsPurchaseSharesIssuable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrefundedWarrantsToPurchasePrice" id="chek_PrefundedWarrantsToPurchasePrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PremiumPercentageToCalculateExercisePrice" id="chek_PremiumPercentageToCalculateExercisePrice" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PrepaidExpensesAndOtherCurrentAssetsTextBlock" id="chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PricePerUnit" id="chek_PricePerUnit" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromExerciseOfPrefundedWarrants" id="chek_ProceedsFromExerciseOfPrefundedWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromExerciseOfWarrants" id="chek_ProceedsFromExerciseOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfPublicOffering" id="chek_ProceedsFromIssuanceOfPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfRegistredDirectOffering" id="chek_ProceedsFromIssuanceOfRegistredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceOfShares" id="chek_ProceedsFromIssuanceOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" id="chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceResisteredDirectOffering" id="chek_ProceedsFromIssuanceResisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuanceResisteredDirectOfferingTwo" id="chek_ProceedsFromIssuanceResisteredDirectOfferingTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PurchasePricePerUnit" id="chek_PurchasePricePerUnit" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReconciliationOfCashToBalanceSheetAbstract" id="chek_ReconciliationOfCashToBalanceSheetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReductionInIncomeTaxRate" id="chek_ReductionInIncomeTaxRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RefundExpenses" id="chek_RefundExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RegisteredDirectOfferingMember" id="chek_RegisteredDirectOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResearchAndDevelopmentExpenseGross" id="chek_ResearchAndDevelopmentExpenseGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentExpensesLineItems" id="chek_ResearchAndDevelopmentExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ResearchAndDevelopmentExpensesTable" id="chek_ResearchAndDevelopmentExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="RestOfCountryMember" id="chek_RestOfCountryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RestrictedCashIncludedCurrentAssets" id="chek_RestrictedCashIncludedCurrentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RevenueFromCashCommission" id="chek_RevenueFromCashCommission" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RoyaltiesPayablePercentageOfProductSales" id="chek_RoyaltiesPayablePercentageOfProductSales" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltiesPayablePerUnit" id="chek_RoyaltiesPayablePerUnit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RoyaltiesPayablePerUnitSold" id="chek_RoyaltiesPayablePerUnitSold" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltiesProvision" id="chek_RoyaltiesProvision" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RoyaltyAmountPerUnitMaximum" id="chek_RoyaltyAmountPerUnitMaximum" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltyAmountPerUnitMinimum" id="chek_RoyaltyAmountPerUnitMinimum" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RoyaltyIncomeExpenseNonoperating" id="chek_RoyaltyIncomeExpenseNonoperating" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RoyaltyRepaymentPercentageOfProductsSold" id="chek_RoyaltyRepaymentPercentageOfProductsSold" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" id="chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfFutureLeasePaymentsTableTextBlock" id="chek_ScheduleOfFutureLeasePaymentsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" id="chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" id="chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" id="chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfResearchAndDevelopmentExpensesNet" id="chek_ScheduleOfResearchAndDevelopmentExpensesNet" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" id="chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeniorManagementMember" id="chek_SeniorManagementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesAWarrantsMember" id="chek_SeriesAWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesC1PreferredStockMember" id="chek_SeriesC1PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesC2PreferredStockMember" id="chek_SeriesC2PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesC3PreferredStockMember" id="chek_SeriesC3PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesCPreferredShareWarrantsConversionMember" id="chek_SeriesCPreferredShareWarrantsConversionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesCWarrantsMember" id="chek_SeriesCWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesCWarrantsToPurchaseOrdinarySharesMember" id="chek_SeriesCWarrantsToPurchaseOrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesD1PreferredStockMember" id="chek_SeriesD1PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesD2PreferredStockMember" id="chek_SeriesD2PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesD3PreferredStockMember" id="chek_SeriesD3PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesD4PreferredStockMember" id="chek_SeriesD4PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SeriesDWarrantsMember" id="chek_SeriesDWarrantsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ServicesWarrantsMember" id="chek_ServicesWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" id="chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" id="chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" id="chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" id="chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationAwardTrancheFourMember" id="chek_ShareBasedCompensationAwardTrancheFourMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" id="chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ShareBasedCompensationInome" id="chek_ShareBasedCompensationInome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareBasedCompensationMember" id="chek_ShareBasedCompensationMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareCapital" id="chek_ShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShareCapitalLessIssuanceCosts" id="chek_ShareCapitalLessIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShortTermInvestmentInterestRate" id="chek_ShortTermInvestmentInterestRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodSharesInFinancing" id="chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" id="chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" id="chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantIssuedDuringPeriodValueInFinancing" id="chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" id="chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" id="chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" id="chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" id="chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" id="chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering" id="chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" id="chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesPrivatePlacementShares" id="chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesWarrantsCashExercised" id="chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesWarrantsExercised" id="chek_StockIssuedDuringPeriodSharesWarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" id="chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" id="chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares" id="chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" id="chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4" id="chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValuePrivatePlacement" id="chek_StockIssuedDuringPeriodValuePrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockIssuedDuringPeriodValueWarrantsExercised" id="chek_StockIssuedDuringPeriodValueWarrantsExercised" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="StockOptionsAndRestrictedStockUnitsRsuMember" id="chek_StockOptionsAndRestrictedStockUnitsRsuMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SubcontractorsAndConsultantFees" id="chek_SubcontractorsAndConsultantFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubleaseAgreementMember" id="chek_SubleaseAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThirtyOneOctoberMember" id="chek_ThirtyOneOctoberMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ThreeAugustMember" id="chek_ThreeAugustMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TweentyNineFebruaryMember" id="chek_TweentyNineFebruaryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwelveDecemberMember" id="chek_TwelveDecemberMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwentySevenFebruaryMember" id="chek_TwentySevenFebruaryMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwentyTwoJuneMember" id="chek_TwentyTwoJuneMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoNovemberMember" id="chek_TwoNovemberMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="TwoThousandFifteenPlanMember" id="chek_TwoThousandFifteenPlanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnderwriterWarrantsMember" id="chek_UnderwriterWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnitsPurchased" id="chek_UnitsPurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UniversityOfMissouriLicenseAgreementMember" id="chek_UniversityOfMissouriLicenseAgreementMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" id="chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="VariousDatesIn2015Member" id="chek_VariousDatesIn2015Member" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VariousDatesMember" id="chek_VariousDatesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VpClinicalMember" id="chek_VpClinicalMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantAmendmentAgreementMember" id="chek_WarrantAmendmentAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantAndShareOptionsMember" id="chek_WarrantAndShareOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantAwardsMember" id="chek_WarrantAwardsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantLiabilityReclassificationToEquity" id="chek_WarrantLiabilityReclassificationToEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WarrantsCashlessExercise" id="chek_WarrantsCashlessExercise" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="WarrantsExercisedCashlessBasis" id="chek_WarrantsExercisedCashlessBasis" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExerciseTransactionMember" id="chek_WarrantsExerciseTransactionMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsIssued" id="chek_WarrantsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsIssuedNotExercised" id="chek_WarrantsIssuedNotExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsOutstanding" id="chek_WarrantsOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="WarrantsOutstandingAmount" id="chek_WarrantsOutstandingAmount" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsPolicyTextBlock" id="chek_WarrantsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsSeriesCPreferredSharesMember" id="chek_WarrantsSeriesCPreferredSharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsSeriesDPreferredSharesMember" id="chek_WarrantsSeriesDPreferredSharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantThatWereExercised" id="chek_WarrantThatWereExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>chek-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#check-cbs" roleURI="http://check-cap.com/role/check-cbs"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-csoo" roleURI="http://check-cap.com/role/chek-csoo"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-csocf" roleURI="http://check-cap.com/role/chek-csocf"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-peaocad" roleURI="http://check-cap.com/role/chek-peaocad"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" roleURI="http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ebapad" roleURI="http://check-cap.com/role/chek-ebapad"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-itaxd" roleURI="http://check-cap.com/role/chek-itaxd"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails" roleURI="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-radend" roleURI="http://check-cap.com/role/chek-radend"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-gaaed" roleURI="http://check-cap.com/role/chek-gaaed"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-fiend" roleURI="http://check-cap.com/role/chek-fiend"/>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/check-cbs">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_ShortTermInvestments_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9" xlink:to="loc_us-gaap_LiabilitiesCurrent_10" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10" xlink:to="loc_us-gaap_AccountsPayableCurrent_10" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_13" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_10" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_14" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_16" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_16" xlink:to="loc_chek_RoyaltiesProvision_16" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9" xlink:to="loc_us-gaap_StockholdersEquity_19" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_19" xlink:to="loc_us-gaap_CommonStockValue_19" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_19" xlink:to="loc_us-gaap_AdditionalPaidInCapital_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_19" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_21" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-csoo">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1" xlink:to="loc_us-gaap_OperatingIncomeLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6" order="30" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-csocf">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRoyaltiesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOfferingTwo" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_4" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_10" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_10" xlink:to="loc_us-gaap_PaymentsForProceedsFromInvestments_11" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_13" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_14" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_15" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_17" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_13" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_18" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-peaocad">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GovernmentInstitutionalAssetsCurrent" xlink:label="loc_chek_GovernmentInstitutionalAssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_chek_GovernmentInstitutionalAssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_DepositsAssetsCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xlink:to="loc_us-gaap_OtherAssetsCurrent_4" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ebapad">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xlink:to="loc_us-gaap_AccruedVacationCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xlink:to="loc_us-gaap_AccruedSalariesCurrent_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-itaxd">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_0" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_0" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-radend">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClinicalTrialsAndRegulationExpense" xlink:label="loc_chek_ClinicalTrialsAndRegulationExpense_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubcontractorsAndConsultantFees" xlink:label="loc_chek_SubcontractorsAndConsultantFees_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense" xlink:label="loc_us-gaap_SuppliesExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_10"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_chek_ResearchAndDevelopmentExpenseGross_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_chek_ClinicalTrialsAndRegulationExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_chek_PaymentsExpensesForPatents_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_chek_SubcontractorsAndConsultantFees_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_us-gaap_SuppliesExpense_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_us-gaap_OtherExpenses_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_1" xlink:to="loc_us-gaap_DepreciationNonproduction_8" order="70" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_0" xlink:to="loc_chek_GrantedRevenue_10" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-gaaed">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" xlink:label="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_ProfessionalFees_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_chek_OfficeRentAndMaintenance_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_DepreciationNonproduction_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_0" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_6" order="50" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-fiend">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChangesInLiabilityToPayRoyalties" xlink:label="loc_chek_ChangesInLiabilityToPayRoyalties_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_us-gaap_InterestExpense_2" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_chek_ChangesInLiabilityToPayRoyalties_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_5" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6" order="50" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>chek-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-dei" roleURI="http://check-cap.com/role/chek-dei"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-equity" roleURI="http://check-cap.com/role/chek-equity"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-equityp" roleURI="http://check-cap.com/role/chek-equityp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#FairValueMeasurementsTables" roleURI="http://check-cap.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sbpt" roleURI="http://check-cap.com/role/chek-sbpt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-relpt" roleURI="http://check-cap.com/role/chek-relpt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-infod" roleURI="http://check-cap.com/role/chek-infod"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sosapd" roleURI="http://check-cap.com/role/chek-sosapd"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-pped" roleURI="http://check-cap.com/role/chek-pped"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesDetails" roleURI="http://check-cap.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails" roleURI="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#ShareholdersEquityOrdinarySharesDetails" roleURI="http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationAwardsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationAwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationDetailsOfShare-basedGrantsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sbpced" roleURI="http://check-cap.com/role/chek-sbpced"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationOptionActivityDetails" roleURI="http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-radend" roleURI="http://check-cap.com/role/chek-radend"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails" roleURI="http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#RelatedPartiesTransactionsWithRelatedPartiesDetails" roleURI="http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#INCOMETAXESNarrativeDetails" roleURI="http://check-cap.com/role/INCOMETAXESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#COMMITMENTSANDCONTINGENTLIABILITIESDetails" roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails" roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-dei">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_49"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityRegistrantName_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentType_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AmendmentFlag_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityVoluntaryFilers_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFilerCategory_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntitySmallBusiness_16" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_17" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityShellCompany_18" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_19" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_20" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_21" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_22" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_23" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityFileNumber_24" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAnnualReport_25" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_26" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentShellCompanyReport_27" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentRegistrationStatement_28" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelName_29" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_30" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_31" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine3_32" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_33" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressStateOrProvince_34" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressCountry_35" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_36" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_CityAreaCode_37" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_38" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelFaxNumber_39" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_ContactPersonnelEmailAddress_40" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_Security12bTitle_41" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_TradingSymbol_42" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_SecurityExchangeName_43" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AnnualInformationForm_44" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentAccountingStandard_45" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorName_46" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorLocation_47" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_AuditorFirmId_48" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_49" order="440" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_29"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_33"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_17" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_18" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_19" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_20" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_21" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_22" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_23" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_24" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_25" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_26" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_27" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_28" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_29" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_30" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_31" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_32" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_33" order="250" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-equityp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" xlink:label="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_chek_PreFundedUnitsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_us-gaap_IPOMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5" xlink:to="loc_us-gaap_PrivatePlacementMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_PrefundedWarrantsToPurchasePrice_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_15" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_16" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7" order="20" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sbpt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" xlink:label="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_10"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_10" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-relpt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsCompensationMember" xlink:label="loc_chek_NonExecutiveDirectorsCompensationMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralTransactionsMember" xlink:label="loc_chek_GeneralTransactionsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2" xlink:to="loc_chek_NonExecutiveDirectorsCompensationMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2" xlink:to="loc_chek_GeneralTransactionsMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-infod">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_March2022RegisteredDirectOfferingMember" xlink:label="loc_chek_March2022RegisteredDirectOfferingMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_22"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_WarrantMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5" xlink:to="loc_us-gaap_SubsequentEventMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9" xlink:to="loc_us-gaap_PrivatePlacementMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9" xlink:to="loc_chek_March2022RegisteredDirectOfferingMember_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_MinimumBidPriceValuePerShare_19" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_20" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_21" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_22" order="80" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sosapd">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember" xlink:label="loc_us-gaap_TechnologyEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShortTermInvestmentInterestRate" xlink:label="loc_chek_ShortTermInvestmentInterestRate_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_chek_AccountingPoliciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_OfficeEquipmentMember_4" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_TechnologyEquipmentMember_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_ComputerEquipmentMember_6" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_srt_RangeAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_10" xlink:to="loc_srt_RangeMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10" xlink:to="loc_srt_MinimumMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10" xlink:to="loc_srt_MaximumMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_10" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_chek_ShortTermInvestmentInterestRate_17" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_18" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_19" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-pped">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember" xlink:label="loc_us-gaap_TechnologyEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_OfficeEquipmentMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_TechnologyEquipmentMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_11" order="40" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseLiability_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_13" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_14" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LeaseExpirationDate1_15" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_16" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LeaseCost_17" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_LeaseAndRentalExpense_18" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_0" xlink:to="loc_us-gaap_OperatingLeaseExpense_19" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentAssetsFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaap_FairValueNetAssetLiability_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_11" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_13" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_15" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_FairValueNetAssetLiability_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_18" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AntiDilutiveWarrantsMember" xlink:label="loc_chek_AntiDilutiveWarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnderwriterWarrantsMember" xlink:label="loc_chek_UnderwriterWarrantsMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LongTermIncentiveWarrantsMember" xlink:label="loc_chek_LongTermIncentiveWarrantsMember_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesAWarrantsMember" xlink:label="loc_chek_SeriesAWarrantsMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CreditLineAgreementWarrantsMember" xlink:label="loc_chek_CreditLineAgreementWarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsMember" xlink:label="loc_chek_PreFundedWarrantsMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LegalWarrantsMember" xlink:label="loc_chek_LegalWarrantsMember_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OneYearWarrantsMember" xlink:label="loc_chek_OneYearWarrantsMember_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FiveYearWarrantsMember" xlink:label="loc_chek_FiveYearWarrantsMember_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsMember" xlink:label="loc_chek_SeriesCWarrantsMember_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsOneMember" xlink:label="loc_chek_PreFundedWarrantsOneMember_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesDWarrantsMember" xlink:label="loc_chek_SeriesDWarrantsMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExerciseTransactionMember" xlink:label="loc_chek_WarrantsExerciseTransactionMember_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsToPurchaseOrdinarySharesMember" xlink:label="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PontifaxMember" xlink:label="loc_chek_PontifaxMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentWarrantsMember" xlink:label="loc_chek_PlacementAgentWarrantsMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_30"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RegisteredDirectOfferingMember" xlink:label="loc_chek_RegisteredDirectOfferingMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaap_CommonClassCMember_32"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_33"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayRegisteredDirectOfferingMember" xlink:label="loc_chek_AprilMayRegisteredDirectOfferingMember_34"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayOfferingsMember" xlink:label="loc_chek_AprilMayOfferingsMember_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember_52"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_53"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentsMember" xlink:label="loc_chek_PlacementAgentsMember_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_58"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAmendmentAgreementMember" xlink:label="loc_chek_WarrantAmendmentAgreementMember_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_66"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapital" xlink:label="loc_chek_ShareCapital_67"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapitalLessIssuanceCosts" xlink:label="loc_chek_ShareCapitalLessIssuanceCosts_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_69"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonStockUnitsIssued" xlink:label="loc_chek_CommonStockUnitsIssued_70"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PurchasePricePerUnit" xlink:label="loc_chek_PurchasePricePerUnit_71"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_72"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_73"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_74"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_75"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_77"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_78"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfPrefundedWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_79"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_80"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_81"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssued" xlink:label="loc_chek_WarrantsIssued_82"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_83"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_84"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_85"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_87"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PricePerUnit" xlink:label="loc_chek_PricePerUnit_88"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnitsPurchased" xlink:label="loc_chek_UnitsPurchased_89"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfWarrants_90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_91"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpiration" xlink:label="loc_chek_ClassOfWarrantOrRightExpiration_92"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_94"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ExercisePriceOfWarrants" xlink:label="loc_chek_ExercisePriceOfWarrants_95"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_96"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" xlink:label="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_97"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_98"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfPublicOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfPublicOffering_99"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_100"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IssuanceExpenses" xlink:label="loc_chek_IssuanceExpenses_101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_104"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExercisedCashlessBasis" xlink:label="loc_chek_WarrantsExercisedCashlessBasis_105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_106"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssuedNotExercised" xlink:label="loc_chek_WarrantsIssuedNotExercised_107"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantThatWereExercised" xlink:label="loc_chek_WarrantThatWereExercised_108"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfWarrantsIssued" xlink:label="loc_chek_FairValueOfWarrantsIssued_109"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_110"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_115"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RevenueFromCashCommission" xlink:label="loc_chek_RevenueFromCashCommission_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_118"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfShares" xlink:label="loc_chek_ProceedsFromIssuanceOfShares_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_120"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstanding" xlink:label="loc_chek_WarrantsOutstanding_121"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstandingAmount" xlink:label="loc_chek_WarrantsOutstandingAmount_122"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfSharesFullyDiluted" xlink:label="loc_chek_PercentageOfSharesFullyDiluted_123"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AmountOfPortionOfOrdinarySharesOfSuchLender" xlink:label="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_124"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchaseSharesIssuable" xlink:label="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_125"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchase" xlink:label="loc_chek_PreFundedWarrantsPurchase_126"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" xlink:label="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_127"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_128"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_AntiDilutiveWarrantsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_UnderwriterWarrantsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_LongTermIncentiveWarrantsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_OrdinarySharesMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesAWarrantsMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_CreditLineAgreementWarrantsMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PreFundedWarrantsMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_LegalWarrantsMember_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_OneYearWarrantsMember_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_FiveYearWarrantsMember_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesCWarrantsMember_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PreFundedWarrantsOneMember_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesDWarrantsMember_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_us-gaap_WarrantMember_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_WarrantsExerciseTransactionMember_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PlacementAgentMember_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PontifaxMember_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PlacementAgentWarrantsMember_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_23" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23" xlink:to="loc_chek_OrdinarySharesMember_23" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23" xlink:to="loc_chek_PreFundedUnitsMember_24" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_28" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_28" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_us-gaap_IPOMember_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_us-gaap_OverAllotmentOptionMember_29" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_us-gaap_PrivatePlacementMember_30" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_chek_RegisteredDirectOfferingMember_31" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_us-gaap_CommonClassCMember_32" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_chek_PreFundedUnitsMember_33" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_chek_AprilMayRegisteredDirectOfferingMember_34" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_28" xlink:to="loc_chek_AprilMayOfferingsMember_35" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_28" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_srt_CurrencyAxis_39" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_39" xlink:to="loc_currency_AllCurrenciesDomain_39" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_39" xlink:to="loc_currency_ILS_39" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_39" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_srt_RangeAxis_43" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_43" xlink:to="loc_srt_RangeMember_43" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_43" xlink:to="loc_srt_MaximumMember_43" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_43" xlink:to="loc_srt_MinimumMember_44" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_43" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_48" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_48" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_48" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_48" xlink:to="loc_us-gaap_SubsequentEventMember_48" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_48" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_52" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_52" xlink:to="loc_us-gaap_RelatedPartyDomain_52" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_52" xlink:to="loc_us-gaap_InvestorMember_52" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_52" xlink:to="loc_chek_PlacementAgentMember_53" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_52" xlink:to="loc_chek_PlacementAgentsMember_54" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_52" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_58" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_58" xlink:to="loc_us-gaap_OtherCommitmentsDomain_58" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_58" xlink:to="loc_chek_WarrantAmendmentAgreementMember_58" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_58" xlink:to="loc_us-gaap_OtherCommitmentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_63" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_64" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_65" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_66" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ShareCapital_67" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ShareCapitalLessIssuanceCosts_68" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_69" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_CommonStockUnitsIssued_70" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PurchasePricePerUnit_71" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_72" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_73" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_74" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_75" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_76" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_77" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_78" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_79" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_MinimumBidPriceValuePerShare_80" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_81" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantsIssued_82" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_83" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SharePrice_84" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PrefundedWarrantsToPurchasePrice_85" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_86" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_87" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PricePerUnit_88" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_UnitsPurchased_89" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromExerciseOfWarrants_90" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_91" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ClassOfWarrantOrRightExpiration_92" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_93" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_94" order="320" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ExercisePriceOfWarrants_95" order="330" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_96" order="340" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_97" order="350" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_98" order="360" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromIssuanceOfPublicOffering_99" order="370" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_100" order="380" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_IssuanceExpenses_101" order="390" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_102" order="400" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_103" order="410" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_104" order="420" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantsExercisedCashlessBasis_105" order="430" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_106" order="440" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantsIssuedNotExercised_107" order="450" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantThatWereExercised_108" order="460" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_FairValueOfWarrantsIssued_109" order="470" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_110" order="480" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_111" order="490" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_112" order="500" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_113" order="510" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_114" order="520" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_115" order="530" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_RevenueFromCashCommission_116" order="540" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_117" order="550" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_CommonStockValue_118" order="560" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_ProceedsFromIssuanceOfShares_119" order="570" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_120" order="580" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantsOutstanding_121" order="590" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_WarrantsOutstandingAmount_122" order="600" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PercentageOfSharesFullyDiluted_123" order="610" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_124" order="620" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_125" order="630" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PreFundedWarrantsPurchase_126" order="640" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_127" order="650" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_128" order="660" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationAwardsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwoThousandFifteenPlanMember" xlink:label="loc_chek_TwoThousandFifteenPlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwentyTwoJuneMember" xlink:label="loc_chek_TwentyTwoJuneMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ThreeAugustMember" xlink:label="loc_chek_ThreeAugustMember_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwelveDecemberMember" xlink:label="loc_chek_TwelveDecemberMember_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainEmployeesMember" xlink:label="loc_chek_CertainEmployeesMember_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficerMember" xlink:label="loc_chek_CertainOfficerMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_24"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeniorManagementMember" xlink:label="loc_chek_SeniorManagementMember_25"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VpClinicalMember" xlink:label="loc_chek_VpClinicalMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_32"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_chek_ShareBasedCompensationAwardTrancheFourMember_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_52"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationInome" xlink:label="loc_chek_ShareBasedCompensationInome_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_55"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CompensationExpenseEstimationForGrantDate" xlink:label="loc_chek_CompensationExpenseEstimationForGrantDate_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_58"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PremiumPercentageToCalculateExercisePrice" xlink:label="loc_chek_PremiumPercentageToCalculateExercisePrice_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_61"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_65"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_69"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_70"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_chek_TwoThousandFifteenPlanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardDateAxis_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_7" xlink:to="loc_us-gaap_AwardDateDomain_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_TwentyTwoJuneMember_7" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_ThreeAugustMember_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDate11Member_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_TwelveDecemberMember_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDate2Member_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDate1Member_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDate3Member_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDateOne3Member_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_7" xlink:to="loc_chek_GrantDateOne4Member_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_7" xlink:to="loc_us-gaap_AwardDateDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_19" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_srt_ChiefExecutiveOfficerMember_19" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_CertainEmployeesMember_20" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_CertainOfficerMember_21" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_22" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_23" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_24" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_SeniorManagementMember_25" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_19" xlink:to="loc_chek_VpClinicalMember_26" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_19" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_VestingAxis_30" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_30" xlink:to="loc_us-gaap_VestingDomain_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_30" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_30" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_30" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_32" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_30" xlink:to="loc_chek_ShareBasedCompensationAwardTrancheFourMember_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_30" xlink:to="loc_us-gaap_VestingDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_37" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_37" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_37" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_37" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_37" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_37" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_41" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_41" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_41" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_41" xlink:to="loc_us-gaap_SubsequentEventMember_41" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_41" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_46" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_47" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_48" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_49" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_51" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_52" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_chek_ShareBasedCompensationInome_53" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_54" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_55" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_chek_CompensationExpenseEstimationForGrantDate_56" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_57" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_58" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_chek_PremiumPercentageToCalculateExercisePrice_59" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_60" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_61" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_62" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_63" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_65" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_66" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_67" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_68" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_69" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_70" order="250" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate4Member" xlink:label="loc_chek_GrantDate4Member_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate5Member" xlink:label="loc_chek_GrantDate5Member_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate6Member" xlink:label="loc_chek_GrantDate6Member_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate8Member" xlink:label="loc_chek_GrantDate8Member_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate7Member" xlink:label="loc_chek_GrantDate7Member_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate9Member" xlink:label="loc_chek_GrantDate9Member_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate10Member" xlink:label="loc_chek_GrantDate10Member_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate13Member" xlink:label="loc_chek_GrantDate13Member_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne1Member" xlink:label="loc_chek_GrantDateOne1Member_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne2Member" xlink:label="loc_chek_GrantDateOne2Member_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate17Member" xlink:label="loc_chek_GrantDate17Member_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneFiveMember" xlink:label="loc_chek_GrantDateOneFiveMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSixMember" xlink:label="loc_chek_GrantDateOneSixMember_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSevenMember" xlink:label="loc_chek_GrantDateOneSevenMember_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneEightMember" xlink:label="loc_chek_GrantDateOneEightMember_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneNineMember" xlink:label="loc_chek_GrantDateOneNineMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardDateAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_1" xlink:to="loc_us-gaap_AwardDateDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate1Member_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate2Member_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate3Member_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate4Member_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate5Member_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate6Member_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate8Member_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate7Member_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate9Member_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate10Member_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate11Member_11" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate13Member_12" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne1Member_13" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne2Member_14" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne3Member_15" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate17Member_16" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne4Member_17" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneFiveMember_18" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneSixMember_19" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneSevenMember_20" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneEightMember_21" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneNineMember_22" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_1" xlink:to="loc_us-gaap_AwardDateDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_26" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_31" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_32" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_33" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_34" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_35" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_36" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1" xlink:to="loc_us-gaap_SharePrice_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_chek_AccountingPoliciesLineItems_0" xlink:to="loc_chek_AccountingPoliciesTable_9" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_AccountingPoliciesTable_9" xlink:to="loc_us-gaap_AwardTypeAxis_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_AccountingPoliciesTable_9" xlink:to="loc_srt_RangeAxis_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MinimumMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MaximumMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sbpced">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_3" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationOptionActivityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_31"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_16" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_13" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_18" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_24" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_25" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_26" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_28" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_29" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_31" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-radend">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesLineItems" xlink:label="loc_chek_ResearchAndDevelopmentExpensesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesTable" xlink:label="loc_chek_ResearchAndDevelopmentExpensesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense" xlink:label="loc_us-gaap_SuppliesExpense_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClinicalTrialsAndRegulationExpense" xlink:label="loc_chek_ClinicalTrialsAndRegulationExpense_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubcontractorsAndConsultantFees" xlink:label="loc_chek_SubcontractorsAndConsultantFees_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_ResearchAndDevelopmentExpensesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_ResearchAndDevelopmentExpensesTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_SuppliesExpense_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_ClinicalTrialsAndRegulationExpense_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_SubcontractorsAndConsultantFees_10" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_DepreciationNonproduction_11" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_PaymentsExpensesForPatents_12" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_OtherExpenses_13" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_ResearchAndDevelopmentExpenseGross_14" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_chek_GrantedRevenue_15" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_16" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAndShareOptionsMember" xlink:label="loc_chek_WarrantAndShareOptionsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2" xlink:to="loc_chek_WarrantAndShareOptionsMember_2" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsMember" xlink:label="loc_chek_NonExecutiveDirectorsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ConsultingFeesMember" xlink:label="loc_chek_ConsultingFeesMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FeesAndReimbursementMember" xlink:label="loc_chek_FeesAndReimbursementMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationMember" xlink:label="loc_chek_ShareBasedCompensationMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRetainer" xlink:label="loc_chek_MonthlyRetainer_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManInsurancePolicy" xlink:label="loc_chek_KeyManInsurancePolicy_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlySalary" xlink:label="loc_chek_MonthlySalary_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrossOvertimeMonthlyRate" xlink:label="loc_chek_GrossOvertimeMonthlyRate_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumAggregateMonthlySalary" xlink:label="loc_chek_MaximumAggregateMonthlySalary_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_chek_NonExecutiveDirectorsMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6" xlink:to="loc_chek_ConsultingFeesMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6" xlink:to="loc_chek_FeesAndReimbursementMember_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_6" xlink:to="loc_chek_ShareBasedCompensationMember_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_6" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_chek_MonthlyRetainer_14" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_chek_KeyManInsurancePolicy_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_chek_MonthlySalary_16" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_chek_GrossOvertimeMonthlyRate_17" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0" xlink:to="loc_chek_MaximumAggregateMonthlySalary_18" order="60" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/INCOMETAXESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CheckCapUsIncMember" xlink:label="loc_chek_CheckCapUsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DevelopmentAreaAMember" xlink:label="loc_chek_DevelopmentAreaAMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestOfCountryMember" xlink:label="loc_chek_RestOfCountryMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReductionInIncomeTaxRate" xlink:label="loc_chek_ReductionInIncomeTaxRate_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_20"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_chek_CheckCapUsIncMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5" xlink:to="loc_chek_DevelopmentAreaAMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5" xlink:to="loc_chek_RestOfCountryMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5" xlink:to="loc_us-gaap_DomesticCountryMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_5" xlink:to="loc_us-gaap_ForeignCountryMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_srt_RangeAxis_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_12" xlink:to="loc_srt_RangeMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_12" xlink:to="loc_srt_MinimumMember_12" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_12" xlink:to="loc_srt_MaximumMember_13" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_12" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_18" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0" xlink:to="loc_chek_ReductionInIncomeTaxRate_19" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_20" order="30" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_7"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_CommitmentsAndContingenciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_DesignerRoyaltiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_PredecessorUnitHoldersMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_RoyaltiesProvision_7" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" xlink:label="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeOfTheChiefScientistMember" xlink:label="loc_chek_OfficeOfTheChiefScientistMember_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ManufacturingProgramMember" xlink:label="loc_chek_ManufacturingProgramMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AsicComponentDesignerRoyaltiesMember" xlink:label="loc_chek_AsicComponentDesignerRoyaltiesMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubleaseAgreementMember" xlink:label="loc_chek_SubleaseAgreementMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnitSold" xlink:label="loc_chek_RoyaltiesPayablePerUnitSold_35"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumRoyaltyObligation" xlink:label="loc_chek_MaximumRoyaltyObligation_36"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_37"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_38"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePercentageOfProductSales" xlink:label="loc_chek_RoyaltiesPayablePercentageOfProductSales_39"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ContingentLiability" xlink:label="loc_chek_ContingentLiability_40"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RefundExpenses" xlink:label="loc_chek_RefundExpenses_41"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OperatingLeaseRentExpenseMonthly" xlink:label="loc_chek_OperatingLeaseRentExpenseMonthly_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_45"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LesseeOperatingLeaseAdditionalTerm" xlink:label="loc_chek_LesseeOperatingLeaseAdditionalTerm_46"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyVehicleLeaseExpense" xlink:label="loc_chek_MonthlyVehicleLeaseExpense_47"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_CommitmentsAndContingenciesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_DesignerRoyaltiesMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_PredecessorUnitHoldersMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_OfficeOfTheChiefScientistMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_ManufacturingProgramMember_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_AsicComponentDesignerRoyaltiesMember_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_CurrencyAxis_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_11" xlink:to="loc_currency_AllCurrenciesDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_11" xlink:to="loc_currency_EUR_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_11" xlink:to="loc_currency_AllCurrenciesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_RangeAxis_15" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_15" xlink:to="loc_srt_RangeMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_15" xlink:to="loc_srt_MinimumMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_15" xlink:to="loc_srt_MaximumMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_15" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_20" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_20" xlink:to="loc_us-gaap_VehiclesMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_20" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_20" xlink:to="loc_chek_SubleaseAgreementMember_22" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_20" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_StatementGeographicalAxis_26" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_26" xlink:to="loc_srt_SegmentGeographicalDomain_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_26" xlink:to="loc_country_IL_26" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_26" xlink:to="loc_srt_SegmentGeographicalDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_30" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_30" xlink:to="loc_us-gaap_SubsequentEventMember_30" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_30" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_RoyaltiesPayablePerUnitSold_35" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_MaximumRoyaltyObligation_36" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_RoyaltiesProvision_37" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_GrantedRevenue_38" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_RoyaltiesPayablePercentageOfProductSales_39" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_ContingentLiability_40" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_RefundExpenses_41" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_OperatingLeaseRentExpenseMonthly_42" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_43" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_44" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_us-gaap_LeaseExpirationDate1_45" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_LesseeOperatingLeaseAdditionalTerm_46" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_0" xlink:to="loc_chek_MonthlyVehicleLeaseExpense_47" order="130" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>chek-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AmountOfPortionOfOrdinarySharesOfSuchLender" xlink:label="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AmountOfPortionOfOrdinarySharesOfSuchLender" xlink:label="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AmountOfPortionOfOrdinarySharesOfSuchLender" xlink:label="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AntiDilutiveWarrantsMember" xlink:label="loc_chek_AntiDilutiveWarrantsMember_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AntiDilutiveWarrantsMember" xlink:label="loc_chek_AntiDilutiveWarrantsMember_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayOfferingsMember" xlink:label="loc_chek_AprilMayOfferingsMember_24"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayOfferingsMember" xlink:label="loc_chek_AprilMayOfferingsMember_25"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayRegisteredDirectOfferingMember" xlink:label="loc_chek_AprilMayRegisteredDirectOfferingMember_26"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayRegisteredDirectOfferingMember" xlink:label="loc_chek_AprilMayRegisteredDirectOfferingMember_27"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilSixthMember" xlink:label="loc_chek_AprilSixthMember_28"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AsicComponentDesignerRoyaltiesMember" xlink:label="loc_chek_AsicComponentDesignerRoyaltiesMember_29"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AsicComponentDesignerRoyaltiesMember" xlink:label="loc_chek_AsicComponentDesignerRoyaltiesMember_30"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AsicComponentDesignerRoyaltiesMember" xlink:label="loc_chek_AsicComponentDesignerRoyaltiesMember_31"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AugustThirteenthOneMember" xlink:label="loc_chek_AugustThirteenthOneMember_32"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AugustThirteenthTwoMember" xlink:label="loc_chek_AugustThirteenthTwoMember_33"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_BankLeumiCreditFacilityMember" xlink:label="loc_chek_BankLeumiCreditFacilityMember_34"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_35"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_36"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_C1WarrantsMember" xlink:label="loc_chek_C1WarrantsMember_37"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_C2WarrantsMember" xlink:label="loc_chek_C2WarrantsMember_38"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainEmployeesMember" xlink:label="loc_chek_CertainEmployeesMember_39"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainEmployeesMember" xlink:label="loc_chek_CertainEmployeesMember_40"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainEmployeesMember" xlink:label="loc_chek_CertainEmployeesMember_41"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficerMember" xlink:label="loc_chek_CertainOfficerMember_42"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficerMember" xlink:label="loc_chek_CertainOfficerMember_43"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficerMember" xlink:label="loc_chek_CertainOfficerMember_44"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_45"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_46"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_47"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChangesInLiabilityToPayRoyalties" xlink:label="loc_chek_ChangesInLiabilityToPayRoyalties_48"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChangesInLiabilityToPayRoyalties" xlink:label="loc_chek_ChangesInLiabilityToPayRoyalties_49"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChangesInLiabilityToPayRoyalties" xlink:label="loc_chek_ChangesInLiabilityToPayRoyalties_50"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CheckCapUsIncMember" xlink:label="loc_chek_CheckCapUsIncMember_51"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CheckCapUsIncMember" xlink:label="loc_chek_CheckCapUsIncMember_52"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CheckCapUsIncMember" xlink:label="loc_chek_CheckCapUsIncMember_53"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_54"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_55"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_56"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpiration" xlink:label="loc_chek_ClassOfWarrantOrRightExpiration_57"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpiration" xlink:label="loc_chek_ClassOfWarrantOrRightExpiration_58"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpiration" xlink:label="loc_chek_ClassOfWarrantOrRightExpiration_59"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpirationPeriod" xlink:label="loc_chek_ClassOfWarrantOrRightExpirationPeriod_60"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpirationPeriod" xlink:label="loc_chek_ClassOfWarrantOrRightExpirationPeriod_61"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpirationPeriod" xlink:label="loc_chek_ClassOfWarrantOrRightExpirationPeriod_62"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights" xlink:label="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_63"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights" xlink:label="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_64"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights" xlink:label="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_65"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClinicalTrialsAndRegulationExpense" xlink:label="loc_chek_ClinicalTrialsAndRegulationExpense_66"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClinicalTrialsAndRegulationExpense" xlink:label="loc_chek_ClinicalTrialsAndRegulationExpense_67"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_68"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_69"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_70"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_71"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonClassDMember" xlink:label="loc_chek_CommonClassDMember_72"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonStockUnitsIssued" xlink:label="loc_chek_CommonStockUnitsIssued_73"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonStockUnitsIssued" xlink:label="loc_chek_CommonStockUnitsIssued_74"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonStockUnitsIssued" xlink:label="loc_chek_CommonStockUnitsIssued_75"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CompensationExpenseEstimationForGrantDate" xlink:label="loc_chek_CompensationExpenseEstimationForGrantDate_76"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CompensationExpenseEstimationForGrantDate" xlink:label="loc_chek_CompensationExpenseEstimationForGrantDate_77"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ConsultingFeesMember" xlink:label="loc_chek_ConsultingFeesMember_78"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ConsultingFeesMember" xlink:label="loc_chek_ConsultingFeesMember_79"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ContingentLiability" xlink:label="loc_chek_ContingentLiability_80"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ContingentLiability" xlink:label="loc_chek_ContingentLiability_81"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ContingentLiability" xlink:label="loc_chek_ContingentLiability_82"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CounterpointVenturesFundTwoMember" xlink:label="loc_chek_CounterpointVenturesFundTwoMember_83"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CreditLineAgreementWarrantsMember" xlink:label="loc_chek_CreditLineAgreementWarrantsMember_84"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CreditLineAgreementWarrantsMember" xlink:label="loc_chek_CreditLineAgreementWarrantsMember_85"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DerivativeChangeInFairValueOfOptionOutstanding" xlink:label="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_86"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DerivativeChangeInFairValueOfOptionOutstanding" xlink:label="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_87"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_88"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_89"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_90"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DevelopmentAreaAMember" xlink:label="loc_chek_DevelopmentAreaAMember_91"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DevelopmentAreaAMember" xlink:label="loc_chek_DevelopmentAreaAMember_92"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DevelopmentAreaAMember" xlink:label="loc_chek_DevelopmentAreaAMember_93"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DocorInternationalBVMember" xlink:label="loc_chek_DocorInternationalBVMember_94"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DocumentAndEntityInformationAbstract" xlink:label="loc_chek_DocumentAndEntityInformationAbstract_95"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_EmployeeRelatedLiabilitiesTextBlock" xlink:label="loc_chek_EmployeeRelatedLiabilitiesTextBlock_96"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_EmployeeRelatedLiabilitiesTextBlock" xlink:label="loc_chek_EmployeeRelatedLiabilitiesTextBlock_97"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_EscoVenturesPteLtdMember" xlink:label="loc_chek_EscoVenturesPteLtdMember_98"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ExercisePriceOfWarrants" xlink:label="loc_chek_ExercisePriceOfWarrants_99"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ExercisePriceOfWarrants" xlink:label="loc_chek_ExercisePriceOfWarrants_100"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ExercisePriceOfWarrants" xlink:label="loc_chek_ExercisePriceOfWarrants_101"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfHedgingOption" xlink:label="loc_chek_FairValueOfHedgingOption_102"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfHedgingOption" xlink:label="loc_chek_FairValueOfHedgingOption_103"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfWarrantsIssued" xlink:label="loc_chek_FairValueOfWarrantsIssued_104"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfWarrantsIssued" xlink:label="loc_chek_FairValueOfWarrantsIssued_105"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfWarrantsIssued" xlink:label="loc_chek_FairValueOfWarrantsIssued_106"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FebruaryEighteenthMember" xlink:label="loc_chek_FebruaryEighteenthMember_107"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FebruaryTwentyFourthOneMember" xlink:label="loc_chek_FebruaryTwentyFourthOneMember_108"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FebruaryTwentyFourthTwoMember" xlink:label="loc_chek_FebruaryTwentyFourthTwoMember_109"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FeesAndReimbursementMember" xlink:label="loc_chek_FeesAndReimbursementMember_110"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FeesAndReimbursementMember" xlink:label="loc_chek_FeesAndReimbursementMember_111"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FindersWarrantsMember" xlink:label="loc_chek_FindersWarrantsMember_112"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FirstMarchMember" xlink:label="loc_chek_FirstMarchMember_113"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FiveYearWarrantsMember" xlink:label="loc_chek_FiveYearWarrantsMember_114"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FiveYearWarrantsMember" xlink:label="loc_chek_FiveYearWarrantsMember_115"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ForeignCurrencyDerivativeInstrumentsMember" xlink:label="loc_chek_ForeignCurrencyDerivativeInstrumentsMember_116"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ForeignIncomeTaxRateMaximum" xlink:label="loc_chek_ForeignIncomeTaxRateMaximum_117"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ForeignIncomeTaxRateMaximum" xlink:label="loc_chek_ForeignIncomeTaxRateMaximum_118"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FourAugustMember" xlink:label="loc_chek_FourAugustMember_119"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FourMayMember" xlink:label="loc_chek_FourMayMember_120"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FunctionalCurrencyPolicyTextBlock" xlink:label="loc_chek_FunctionalCurrencyPolicyTextBlock_121"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FunctionalCurrencyPolicyTextBlock" xlink:label="loc_chek_FunctionalCurrencyPolicyTextBlock_122"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FunctionalCurrencyPolicyTextBlock" xlink:label="loc_chek_FunctionalCurrencyPolicyTextBlock_123"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRate" xlink:label="loc_chek_FutureFederalIncomeTaxRate_124"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRate" xlink:label="loc_chek_FutureFederalIncomeTaxRate_125"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRateNextYear" xlink:label="loc_chek_FutureFederalIncomeTaxRateNextYear_126"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRateNextYear" xlink:label="loc_chek_FutureFederalIncomeTaxRateNextYear_127"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesLineItems" xlink:label="loc_chek_GeneralAndAdministrativeExpensesLineItems_128"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesTable" xlink:label="loc_chek_GeneralAndAdministrativeExpensesTable_129"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_chek_GeneralAndAdministrativeExpensesTextBlock_130"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_chek_GeneralAndAdministrativeExpensesTextBlock_131"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_chek_GeneralAndAdministrativeExpensesTextBlock_132"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralTransactionsMember" xlink:label="loc_chek_GeneralTransactionsMember_133"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralTransactionsMember" xlink:label="loc_chek_GeneralTransactionsMember_134"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GovernmentInstitutionalAssetsCurrent" xlink:label="loc_chek_GovernmentInstitutionalAssetsCurrent_135"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GovernmentInstitutionalAssetsCurrent" xlink:label="loc_chek_GovernmentInstitutionalAssetsCurrent_136"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate10Member" xlink:label="loc_chek_GrantDate10Member_137"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate10Member" xlink:label="loc_chek_GrantDate10Member_138"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate10Member" xlink:label="loc_chek_GrantDate10Member_139"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_140"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_141"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_142"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate12Member" xlink:label="loc_chek_GrantDate12Member_143"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate13Member" xlink:label="loc_chek_GrantDate13Member_144"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate13Member" xlink:label="loc_chek_GrantDate13Member_145"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate13Member" xlink:label="loc_chek_GrantDate13Member_146"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate14Member" xlink:label="loc_chek_GrantDate14Member_147"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate15Member" xlink:label="loc_chek_GrantDate15Member_148"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate16Member" xlink:label="loc_chek_GrantDate16Member_149"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate17Member" xlink:label="loc_chek_GrantDate17Member_150"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate17Member" xlink:label="loc_chek_GrantDate17Member_151"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate17Member" xlink:label="loc_chek_GrantDate17Member_152"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate18Member" xlink:label="loc_chek_GrantDate18Member_153"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_154"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_155"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_156"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_157"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_158"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_159"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_160"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_161"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_162"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate4Member" xlink:label="loc_chek_GrantDate4Member_163"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate4Member" xlink:label="loc_chek_GrantDate4Member_164"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate4Member" xlink:label="loc_chek_GrantDate4Member_165"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate5Member" xlink:label="loc_chek_GrantDate5Member_166"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate5Member" xlink:label="loc_chek_GrantDate5Member_167"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate5Member" xlink:label="loc_chek_GrantDate5Member_168"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate6Member" xlink:label="loc_chek_GrantDate6Member_169"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate6Member" xlink:label="loc_chek_GrantDate6Member_170"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate6Member" xlink:label="loc_chek_GrantDate6Member_171"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate7Member" xlink:label="loc_chek_GrantDate7Member_172"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate7Member" xlink:label="loc_chek_GrantDate7Member_173"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate7Member" xlink:label="loc_chek_GrantDate7Member_174"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate8Member" xlink:label="loc_chek_GrantDate8Member_175"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate8Member" xlink:label="loc_chek_GrantDate8Member_176"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate8Member" xlink:label="loc_chek_GrantDate8Member_177"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate9Member" xlink:label="loc_chek_GrantDate9Member_178"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate9Member" xlink:label="loc_chek_GrantDate9Member_179"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate9Member" xlink:label="loc_chek_GrantDate9Member_180"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne1Member" xlink:label="loc_chek_GrantDateOne1Member_181"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne1Member" xlink:label="loc_chek_GrantDateOne1Member_182"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne1Member" xlink:label="loc_chek_GrantDateOne1Member_183"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne2Member" xlink:label="loc_chek_GrantDateOne2Member_184"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne2Member" xlink:label="loc_chek_GrantDateOne2Member_185"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne2Member" xlink:label="loc_chek_GrantDateOne2Member_186"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_187"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_188"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_189"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_190"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_191"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_192"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneEightMember" xlink:label="loc_chek_GrantDateOneEightMember_193"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneEightMember" xlink:label="loc_chek_GrantDateOneEightMember_194"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneEightMember" xlink:label="loc_chek_GrantDateOneEightMember_195"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneFiveMember" xlink:label="loc_chek_GrantDateOneFiveMember_196"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneFiveMember" xlink:label="loc_chek_GrantDateOneFiveMember_197"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneFiveMember" xlink:label="loc_chek_GrantDateOneFiveMember_198"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneNineMember" xlink:label="loc_chek_GrantDateOneNineMember_199"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneNineMember" xlink:label="loc_chek_GrantDateOneNineMember_200"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneNineMember" xlink:label="loc_chek_GrantDateOneNineMember_201"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSevenMember" xlink:label="loc_chek_GrantDateOneSevenMember_202"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSevenMember" xlink:label="loc_chek_GrantDateOneSevenMember_203"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSevenMember" xlink:label="loc_chek_GrantDateOneSevenMember_204"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSixMember" xlink:label="loc_chek_GrantDateOneSixMember_205"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSixMember" xlink:label="loc_chek_GrantDateOneSixMember_206"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSixMember" xlink:label="loc_chek_GrantDateOneSixMember_207"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateTwoZeroMember" xlink:label="loc_chek_GrantDateTwoZeroMember_208"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateTwoZeroMember" xlink:label="loc_chek_GrantDateTwoZeroMember_209"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_210"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_211"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_212"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_213"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrossOvertimeMonthlyRate" xlink:label="loc_chek_GrossOvertimeMonthlyRate_214"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrossOvertimeMonthlyRate" xlink:label="loc_chek_GrossOvertimeMonthlyRate_215"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IIAMember" xlink:label="loc_chek_IIAMember_216"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IIAMember" xlink:label="loc_chek_IIAMember_217"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_InstitutionalAndAccreditedInvestorsMember" xlink:label="loc_chek_InstitutionalAndAccreditedInvestorsMember_218"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_InstitutionalAndAccreditedInvestorsMember" xlink:label="loc_chek_InstitutionalAndAccreditedInvestorsMember_219"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_InstitutionalAndAccreditedInvestorsMember" xlink:label="loc_chek_InstitutionalAndAccreditedInvestorsMember_220"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_InvestorWarrantsMember" xlink:label="loc_chek_InvestorWarrantsMember_221"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" xlink:label="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_222"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" xlink:label="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_223"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" xlink:label="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_224"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IssuanceExpenses" xlink:label="loc_chek_IssuanceExpenses_225"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IssuanceExpenses" xlink:label="loc_chek_IssuanceExpenses_226"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IssuanceExpenses" xlink:label="loc_chek_IssuanceExpenses_227"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_JanuaryFifteenthMember" xlink:label="loc_chek_JanuaryFifteenthMember_228"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_June2017RegisteredDirectOfferingMember" xlink:label="loc_chek_June2017RegisteredDirectOfferingMember_229"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_JuneFirstMember" xlink:label="loc_chek_JuneFirstMember_230"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_JuneSixthMember" xlink:label="loc_chek_JuneSixthMember_231"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_JuneThirdMember" xlink:label="loc_chek_JuneThirdMember_232"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManInsurancePolicy" xlink:label="loc_chek_KeyManInsurancePolicy_233"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManInsurancePolicy" xlink:label="loc_chek_KeyManInsurancePolicy_234"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManLifeInsurancePremiumMember" xlink:label="loc_chek_KeyManLifeInsurancePremiumMember_235"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManLifeInsurancePremiumMember" xlink:label="loc_chek_KeyManLifeInsurancePremiumMember_236"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LegalWarrantsMember" xlink:label="loc_chek_LegalWarrantsMember_237"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LegalWarrantsMember" xlink:label="loc_chek_LegalWarrantsMember_238"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LesseeOperatingLeaseAdditionalTerm" xlink:label="loc_chek_LesseeOperatingLeaseAdditionalTerm_239"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LesseeOperatingLeaseAdditionalTerm" xlink:label="loc_chek_LesseeOperatingLeaseAdditionalTerm_240"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LesseeOperatingLeaseAdditionalTerm" xlink:label="loc_chek_LesseeOperatingLeaseAdditionalTerm_241"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LongTermIncentiveWarrantsMember" xlink:label="loc_chek_LongTermIncentiveWarrantsMember_242"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LongTermIncentiveWarrantsMember" xlink:label="loc_chek_LongTermIncentiveWarrantsMember_243"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ManufacturingProgramMember" xlink:label="loc_chek_ManufacturingProgramMember_244"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ManufacturingProgramMember" xlink:label="loc_chek_ManufacturingProgramMember_245"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_March2022RegisteredDirectOfferingMember" xlink:label="loc_chek_March2022RegisteredDirectOfferingMember_246"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_March2022RegisteredDirectOfferingMember" xlink:label="loc_chek_March2022RegisteredDirectOfferingMember_247"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MarchFifteenthMember" xlink:label="loc_chek_MarchFifteenthMember_248"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumAggregateMonthlySalary" xlink:label="loc_chek_MaximumAggregateMonthlySalary_249"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumAggregateMonthlySalary" xlink:label="loc_chek_MaximumAggregateMonthlySalary_250"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumRoyaltyObligation" xlink:label="loc_chek_MaximumRoyaltyObligation_251"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumRoyaltyObligation" xlink:label="loc_chek_MaximumRoyaltyObligation_252"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumRoyaltyObligation" xlink:label="loc_chek_MaximumRoyaltyObligation_253"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MayFifteenthMember" xlink:label="loc_chek_MayFifteenthMember_254"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MayNineteenthMember" xlink:label="loc_chek_MayNineteenthMember_255"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_256"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_257"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRentalFee" xlink:label="loc_chek_MonthlyRentalFee_258"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRentalFee" xlink:label="loc_chek_MonthlyRentalFee_259"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRetainer" xlink:label="loc_chek_MonthlyRetainer_260"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRetainer" xlink:label="loc_chek_MonthlyRetainer_261"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlySalary" xlink:label="loc_chek_MonthlySalary_262"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlySalary" xlink:label="loc_chek_MonthlySalary_263"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyVehicleLeaseExpense" xlink:label="loc_chek_MonthlyVehicleLeaseExpense_264"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyVehicleLeaseExpense" xlink:label="loc_chek_MonthlyVehicleLeaseExpense_265"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyVehicleLeaseExpense" xlink:label="loc_chek_MonthlyVehicleLeaseExpense_266"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_267"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_268"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_269"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_270"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NineMayMember" xlink:label="loc_chek_NineMayMember_271"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsCompensationMember" xlink:label="loc_chek_NonExecutiveDirectorsCompensationMember_272"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsCompensationMember" xlink:label="loc_chek_NonExecutiveDirectorsCompensationMember_273"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsMember" xlink:label="loc_chek_NonExecutiveDirectorsMember_274"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsMember" xlink:label="loc_chek_NonExecutiveDirectorsMember_275"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_November2017RegisteredDirectOfferingMember" xlink:label="loc_chek_November2017RegisteredDirectOfferingMember_276"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_277"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_278"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_279"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_280"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_281"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfSharesRestrictedStockVested" xlink:label="loc_chek_NumberOfSharesRestrictedStockVested_282"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfSharesRestrictedStockVested" xlink:label="loc_chek_NumberOfSharesRestrictedStockVested_283"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants" xlink:label="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_284"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants" xlink:label="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_285"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants" xlink:label="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_286"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OctoberFourteenthMember" xlink:label="loc_chek_OctoberFourteenthMember_287"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OctoberTwentiethMember" xlink:label="loc_chek_OctoberTwentiethMember_288"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeOfTheChiefScientistMember" xlink:label="loc_chek_OfficeOfTheChiefScientistMember_289"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeOfTheChiefScientistMember" xlink:label="loc_chek_OfficeOfTheChiefScientistMember_290"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_291"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_292"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_293"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_294"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficersAndEmployeesMember" xlink:label="loc_chek_OfficersAndEmployeesMember_295"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficersAndEmployeesMember" xlink:label="loc_chek_OfficersAndEmployeesMember_296"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficersAndEmployeesMember" xlink:label="loc_chek_OfficersAndEmployeesMember_297"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OneYearWarrantsMember" xlink:label="loc_chek_OneYearWarrantsMember_298"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OneYearWarrantsMember" xlink:label="loc_chek_OneYearWarrantsMember_299"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OperatingLeaseRentExpenseMonthly" xlink:label="loc_chek_OperatingLeaseRentExpenseMonthly_300"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OperatingLeaseRentExpenseMonthly" xlink:label="loc_chek_OperatingLeaseRentExpenseMonthly_301"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OperatingLeaseRentExpenseMonthly" xlink:label="loc_chek_OperatingLeaseRentExpenseMonthly_302"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_303"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_304"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_305"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentAssetsFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_306"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentAssetsFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_307"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_308"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_309"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_310"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_311"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_312"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_313"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise" xlink:label="loc_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_314"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise" xlink:label="loc_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_315"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant" xlink:label="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_316"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant" xlink:label="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_317"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant" xlink:label="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_318"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" xlink:label="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_319"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" xlink:label="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_320"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" xlink:label="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_321"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfSharesFullyDiluted" xlink:label="loc_chek_PercentageOfSharesFullyDiluted_322"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfSharesFullyDiluted" xlink:label="loc_chek_PercentageOfSharesFullyDiluted_323"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfSharesFullyDiluted" xlink:label="loc_chek_PercentageOfSharesFullyDiluted_324"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PeriodOfVestingEqualPortion" xlink:label="loc_chek_PeriodOfVestingEqualPortion_325"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PeriodOfVestingEqualPortion" xlink:label="loc_chek_PeriodOfVestingEqualPortion_326"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PeriodOfVestingEqualPortion" xlink:label="loc_chek_PeriodOfVestingEqualPortion_327"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgent2Member" xlink:label="loc_chek_PlacementAgent2Member_328"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgent2Member" xlink:label="loc_chek_PlacementAgent2Member_329"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_330"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_331"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_332"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentsMember" xlink:label="loc_chek_PlacementAgentsMember_333"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentsMember" xlink:label="loc_chek_PlacementAgentsMember_334"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentsMember" xlink:label="loc_chek_PlacementAgentsMember_335"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentWarrantsMember" xlink:label="loc_chek_PlacementAgentWarrantsMember_336"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentWarrantsMember" xlink:label="loc_chek_PlacementAgentWarrantsMember_337"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentWarrantsMember" xlink:label="loc_chek_PlacementAgentWarrantsMember_338"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PontifaxFundsMember" xlink:label="loc_chek_PontifaxFundsMember_339"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PontifaxMember" xlink:label="loc_chek_PontifaxMember_340"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_341"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_342"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_343"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreferredSharesConversionMember" xlink:label="loc_chek_PreferredSharesConversionMember_344"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreferredSharesMember" xlink:label="loc_chek_PreferredSharesMember_345"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreferredShareWarrantsConversionMember" xlink:label="loc_chek_PreferredShareWarrantsConversionMember_346"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_347"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_348"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsMember" xlink:label="loc_chek_PreFundedWarrantsMember_349"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsMember" xlink:label="loc_chek_PreFundedWarrantsMember_350"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsOneMember" xlink:label="loc_chek_PreFundedWarrantsOneMember_351"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsOneMember" xlink:label="loc_chek_PreFundedWarrantsOneMember_352"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchase" xlink:label="loc_chek_PreFundedWarrantsPurchase_353"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchase" xlink:label="loc_chek_PreFundedWarrantsPurchase_354"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchase" xlink:label="loc_chek_PreFundedWarrantsPurchase_355"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchaseSharesIssuable" xlink:label="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_356"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchaseSharesIssuable" xlink:label="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_357"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchaseSharesIssuable" xlink:label="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_358"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_359"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_360"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PremiumPercentageToCalculateExercisePrice" xlink:label="loc_chek_PremiumPercentageToCalculateExercisePrice_361"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PremiumPercentageToCalculateExercisePrice" xlink:label="loc_chek_PremiumPercentageToCalculateExercisePrice_362"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PremiumPercentageToCalculateExercisePrice" xlink:label="loc_chek_PremiumPercentageToCalculateExercisePrice_363"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_364"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_365"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_366"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PricePerUnit" xlink:label="loc_chek_PricePerUnit_367"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PricePerUnit" xlink:label="loc_chek_PricePerUnit_368"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfPrefundedWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_369"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfPrefundedWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_370"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfPrefundedWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_371"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfWarrants_372"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfWarrants_373"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfWarrants_374"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfPublicOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfPublicOffering_375"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfPublicOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfPublicOffering_376"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfPublicOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfPublicOffering_377"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_378"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_379"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_380"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_381"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfShares" xlink:label="loc_chek_ProceedsFromIssuanceOfShares_382"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfShares" xlink:label="loc_chek_ProceedsFromIssuanceOfShares_383"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfShares" xlink:label="loc_chek_ProceedsFromIssuanceOfShares_384"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" xlink:label="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_385"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" xlink:label="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_386"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" xlink:label="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_387"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_388"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_389"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOfferingTwo" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_390"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOfferingTwo" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_391"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOfferingTwo" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_392"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PurchasePricePerUnit" xlink:label="loc_chek_PurchasePricePerUnit_393"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PurchasePricePerUnit" xlink:label="loc_chek_PurchasePricePerUnit_394"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PurchasePricePerUnit" xlink:label="loc_chek_PurchasePricePerUnit_395"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReconciliationOfCashToBalanceSheetAbstract" xlink:label="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_396"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReconciliationOfCashToBalanceSheetAbstract" xlink:label="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_397"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReductionInIncomeTaxRate" xlink:label="loc_chek_ReductionInIncomeTaxRate_398"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReductionInIncomeTaxRate" xlink:label="loc_chek_ReductionInIncomeTaxRate_399"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReductionInIncomeTaxRate" xlink:label="loc_chek_ReductionInIncomeTaxRate_400"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RefundExpenses" xlink:label="loc_chek_RefundExpenses_401"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RefundExpenses" xlink:label="loc_chek_RefundExpenses_402"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RefundExpenses" xlink:label="loc_chek_RefundExpenses_403"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RegisteredDirectOfferingMember" xlink:label="loc_chek_RegisteredDirectOfferingMember_404"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RegisteredDirectOfferingMember" xlink:label="loc_chek_RegisteredDirectOfferingMember_405"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_406"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_407"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_408"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesLineItems" xlink:label="loc_chek_ResearchAndDevelopmentExpensesLineItems_409"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesLineItems" xlink:label="loc_chek_ResearchAndDevelopmentExpensesLineItems_410"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesTable" xlink:label="loc_chek_ResearchAndDevelopmentExpensesTable_411"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesTable" xlink:label="loc_chek_ResearchAndDevelopmentExpensesTable_412"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestOfCountryMember" xlink:label="loc_chek_RestOfCountryMember_413"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestOfCountryMember" xlink:label="loc_chek_RestOfCountryMember_414"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestOfCountryMember" xlink:label="loc_chek_RestOfCountryMember_415"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestrictedCashIncludedCurrentAssets" xlink:label="loc_chek_RestrictedCashIncludedCurrentAssets_416"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestrictedCashIncludedCurrentAssets" xlink:label="loc_chek_RestrictedCashIncludedCurrentAssets_417"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestrictedCashIncludedCurrentAssets" xlink:label="loc_chek_RestrictedCashIncludedCurrentAssets_418"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RevenueFromCashCommission" xlink:label="loc_chek_RevenueFromCashCommission_419"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RevenueFromCashCommission" xlink:label="loc_chek_RevenueFromCashCommission_420"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePercentageOfProductSales" xlink:label="loc_chek_RoyaltiesPayablePercentageOfProductSales_421"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePercentageOfProductSales" xlink:label="loc_chek_RoyaltiesPayablePercentageOfProductSales_422"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePercentageOfProductSales" xlink:label="loc_chek_RoyaltiesPayablePercentageOfProductSales_423"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnit" xlink:label="loc_chek_RoyaltiesPayablePerUnit_424"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnit" xlink:label="loc_chek_RoyaltiesPayablePerUnit_425"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnitSold" xlink:label="loc_chek_RoyaltiesPayablePerUnitSold_426"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnitSold" xlink:label="loc_chek_RoyaltiesPayablePerUnitSold_427"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnitSold" xlink:label="loc_chek_RoyaltiesPayablePerUnitSold_428"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_429"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_430"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_431"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMaximum" xlink:label="loc_chek_RoyaltyAmountPerUnitMaximum_432"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMaximum" xlink:label="loc_chek_RoyaltyAmountPerUnitMaximum_433"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMaximum" xlink:label="loc_chek_RoyaltyAmountPerUnitMaximum_434"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMinimum" xlink:label="loc_chek_RoyaltyAmountPerUnitMinimum_435"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMinimum" xlink:label="loc_chek_RoyaltyAmountPerUnitMinimum_436"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyAmountPerUnitMinimum" xlink:label="loc_chek_RoyaltyAmountPerUnitMinimum_437"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyIncomeExpenseNonoperating" xlink:label="loc_chek_RoyaltyIncomeExpenseNonoperating_438"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyIncomeExpenseNonoperating" xlink:label="loc_chek_RoyaltyIncomeExpenseNonoperating_439"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyRepaymentPercentageOfProductsSold" xlink:label="loc_chek_RoyaltyRepaymentPercentageOfProductsSold_440"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltyRepaymentPercentageOfProductsSold" xlink:label="loc_chek_RoyaltyRepaymentPercentageOfProductsSold_441"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" xlink:label="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_442"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" xlink:label="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_443"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfFutureLeasePaymentsTableTextBlock" xlink:label="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_444"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfFutureLeasePaymentsTableTextBlock" xlink:label="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_445"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" xlink:label="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_446"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" xlink:label="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_447"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" xlink:label="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_448"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" xlink:label="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_449"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_450"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_451"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" xlink:label="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_452"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" xlink:label="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_453"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfResearchAndDevelopmentExpensesNet" xlink:label="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_454"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfResearchAndDevelopmentExpensesNet" xlink:label="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_455"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_456"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_457"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeniorManagementMember" xlink:label="loc_chek_SeniorManagementMember_458"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeniorManagementMember" xlink:label="loc_chek_SeniorManagementMember_459"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesAWarrantsMember" xlink:label="loc_chek_SeriesAWarrantsMember_460"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesAWarrantsMember" xlink:label="loc_chek_SeriesAWarrantsMember_461"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesC1PreferredStockMember" xlink:label="loc_chek_SeriesC1PreferredStockMember_462"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesC2PreferredStockMember" xlink:label="loc_chek_SeriesC2PreferredStockMember_463"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesC3PreferredStockMember" xlink:label="loc_chek_SeriesC3PreferredStockMember_464"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCPreferredShareWarrantsConversionMember" xlink:label="loc_chek_SeriesCPreferredShareWarrantsConversionMember_465"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsMember" xlink:label="loc_chek_SeriesCWarrantsMember_466"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsMember" xlink:label="loc_chek_SeriesCWarrantsMember_467"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsToPurchaseOrdinarySharesMember" xlink:label="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_468"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsToPurchaseOrdinarySharesMember" xlink:label="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_469"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesD1PreferredStockMember" xlink:label="loc_chek_SeriesD1PreferredStockMember_470"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesD2PreferredStockMember" xlink:label="loc_chek_SeriesD2PreferredStockMember_471"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesD3PreferredStockMember" xlink:label="loc_chek_SeriesD3PreferredStockMember_472"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesD4PreferredStockMember" xlink:label="loc_chek_SeriesD4PreferredStockMember_473"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesDWarrantsMember" xlink:label="loc_chek_SeriesDWarrantsMember_474"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesDWarrantsMember" xlink:label="loc_chek_SeriesDWarrantsMember_475"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ServicesWarrantsMember" xlink:label="loc_chek_ServicesWarrantsMember_476"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_477"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_478"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_479"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_480"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_481"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_482"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_483"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_484"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_485"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_chek_ShareBasedCompensationAwardTrancheFourMember_486"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_chek_ShareBasedCompensationAwardTrancheFourMember_487"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" xlink:label="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_488"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" xlink:label="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_489"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" xlink:label="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_490"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationInome" xlink:label="loc_chek_ShareBasedCompensationInome_491"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationInome" xlink:label="loc_chek_ShareBasedCompensationInome_492"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationMember" xlink:label="loc_chek_ShareBasedCompensationMember_493"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationMember" xlink:label="loc_chek_ShareBasedCompensationMember_494"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapital" xlink:label="loc_chek_ShareCapital_495"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapital" xlink:label="loc_chek_ShareCapital_496"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapital" xlink:label="loc_chek_ShareCapital_497"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapitalLessIssuanceCosts" xlink:label="loc_chek_ShareCapitalLessIssuanceCosts_498"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapitalLessIssuanceCosts" xlink:label="loc_chek_ShareCapitalLessIssuanceCosts_499"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapitalLessIssuanceCosts" xlink:label="loc_chek_ShareCapitalLessIssuanceCosts_500"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShortTermInvestmentInterestRate" xlink:label="loc_chek_ShortTermInvestmentInterestRate_501"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShortTermInvestmentInterestRate" xlink:label="loc_chek_ShortTermInvestmentInterestRate_502"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_503"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_504"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_505"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_506"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_507"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_508"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_509"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_510"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_511"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_512"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_513"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_514"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_515"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_516"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_517"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_518"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_519"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_520"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_521"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_522"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_523"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_524"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_525"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_526"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_527"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_528"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_529"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_530"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_531"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_532"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_533"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_534"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_535"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_536"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_537"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_538"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_539"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_540"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_541"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_542"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_543"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_544"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_545"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_546"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_547"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_548"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_549"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_550"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_551"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_552"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_553"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_554"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_555"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_556"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_557"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_558"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_559"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_560"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_561"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_562"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_563"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_564"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_565"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockOptionsAndRestrictedStockUnitsRsuMember" xlink:label="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_566"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockOptionsAndRestrictedStockUnitsRsuMember" xlink:label="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_567"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockOptionsAndRestrictedStockUnitsRsuMember" xlink:label="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_568"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubcontractorsAndConsultantFees" xlink:label="loc_chek_SubcontractorsAndConsultantFees_569"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubcontractorsAndConsultantFees" xlink:label="loc_chek_SubcontractorsAndConsultantFees_570"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubleaseAgreementMember" xlink:label="loc_chek_SubleaseAgreementMember_571"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubleaseAgreementMember" xlink:label="loc_chek_SubleaseAgreementMember_572"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ThirtyOneOctoberMember" xlink:label="loc_chek_ThirtyOneOctoberMember_573"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ThreeAugustMember" xlink:label="loc_chek_ThreeAugustMember_574"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ThreeAugustMember" xlink:label="loc_chek_ThreeAugustMember_575"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TweentyNineFebruaryMember" xlink:label="loc_chek_TweentyNineFebruaryMember_576"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwelveDecemberMember" xlink:label="loc_chek_TwelveDecemberMember_577"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwelveDecemberMember" xlink:label="loc_chek_TwelveDecemberMember_578"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwentySevenFebruaryMember" xlink:label="loc_chek_TwentySevenFebruaryMember_579"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwentyTwoJuneMember" xlink:label="loc_chek_TwentyTwoJuneMember_580"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwentyTwoJuneMember" xlink:label="loc_chek_TwentyTwoJuneMember_581"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwoNovemberMember" xlink:label="loc_chek_TwoNovemberMember_582"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwoThousandFifteenPlanMember" xlink:label="loc_chek_TwoThousandFifteenPlanMember_583"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwoThousandFifteenPlanMember" xlink:label="loc_chek_TwoThousandFifteenPlanMember_584"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnderwriterWarrantsMember" xlink:label="loc_chek_UnderwriterWarrantsMember_585"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnderwriterWarrantsMember" xlink:label="loc_chek_UnderwriterWarrantsMember_586"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnitsPurchased" xlink:label="loc_chek_UnitsPurchased_587"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnitsPurchased" xlink:label="loc_chek_UnitsPurchased_588"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UniversityOfMissouriLicenseAgreementMember" xlink:label="loc_chek_UniversityOfMissouriLicenseAgreementMember_589"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" xlink:label="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_590"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" xlink:label="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_591"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VariousDatesIn2015Member" xlink:label="loc_chek_VariousDatesIn2015Member_592"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VariousDatesMember" xlink:label="loc_chek_VariousDatesMember_593"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VpClinicalMember" xlink:label="loc_chek_VpClinicalMember_594"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VpClinicalMember" xlink:label="loc_chek_VpClinicalMember_595"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VpClinicalMember" xlink:label="loc_chek_VpClinicalMember_596"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAmendmentAgreementMember" xlink:label="loc_chek_WarrantAmendmentAgreementMember_597"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAmendmentAgreementMember" xlink:label="loc_chek_WarrantAmendmentAgreementMember_598"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAmendmentAgreementMember" xlink:label="loc_chek_WarrantAmendmentAgreementMember_599"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAndShareOptionsMember" xlink:label="loc_chek_WarrantAndShareOptionsMember_600"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAndShareOptionsMember" xlink:label="loc_chek_WarrantAndShareOptionsMember_601"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAwardsMember" xlink:label="loc_chek_WarrantAwardsMember_602"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantLiabilityReclassificationToEquity" xlink:label="loc_chek_WarrantLiabilityReclassificationToEquity_603"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantLiabilityReclassificationToEquity" xlink:label="loc_chek_WarrantLiabilityReclassificationToEquity_604"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantLiabilityReclassificationToEquity" xlink:label="loc_chek_WarrantLiabilityReclassificationToEquity_605"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsCashlessExercise" xlink:label="loc_chek_WarrantsCashlessExercise_606"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsCashlessExercise" xlink:label="loc_chek_WarrantsCashlessExercise_607"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExercisedCashlessBasis" xlink:label="loc_chek_WarrantsExercisedCashlessBasis_608"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExercisedCashlessBasis" xlink:label="loc_chek_WarrantsExercisedCashlessBasis_609"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExerciseTransactionMember" xlink:label="loc_chek_WarrantsExerciseTransactionMember_610"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExerciseTransactionMember" xlink:label="loc_chek_WarrantsExerciseTransactionMember_611"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssued" xlink:label="loc_chek_WarrantsIssued_612"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssued" xlink:label="loc_chek_WarrantsIssued_613"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssued" xlink:label="loc_chek_WarrantsIssued_614"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssuedNotExercised" xlink:label="loc_chek_WarrantsIssuedNotExercised_615"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssuedNotExercised" xlink:label="loc_chek_WarrantsIssuedNotExercised_616"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssuedNotExercised" xlink:label="loc_chek_WarrantsIssuedNotExercised_617"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstanding" xlink:label="loc_chek_WarrantsOutstanding_618"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstanding" xlink:label="loc_chek_WarrantsOutstanding_619"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstandingAmount" xlink:label="loc_chek_WarrantsOutstandingAmount_620"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstandingAmount" xlink:label="loc_chek_WarrantsOutstandingAmount_621"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsPolicyTextBlock" xlink:label="loc_chek_WarrantsPolicyTextBlock_622"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsPolicyTextBlock" xlink:label="loc_chek_WarrantsPolicyTextBlock_623"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsSeriesCPreferredSharesMember" xlink:label="loc_chek_WarrantsSeriesCPreferredSharesMember_624"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsSeriesDPreferredSharesMember" xlink:label="loc_chek_WarrantsSeriesDPreferredSharesMember_625"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantThatWereExercised" xlink:label="loc_chek_WarrantThatWereExercised_626"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantThatWereExercised" xlink:label="loc_chek_WarrantThatWereExercised_627"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_628"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_629"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_630"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_631"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_632"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_633"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_634"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_635"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_636"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_637"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_638"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_639"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_640"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_641"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_642"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_643"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_644"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_645"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_646"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_647"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_648"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_649"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_650"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_651"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_652"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_653"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_654"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_655"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_656"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_657"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_658"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_659"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_660"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_661"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_662"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_663"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_664"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_665"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_666"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_667"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_668"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_669"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_670"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_671"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_672"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_673"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_674"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_675"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_676"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_677"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_678"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_679"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_680"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_681"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_682"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_683"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_684"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_685"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_686"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_687"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_688"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_689"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_690"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_691"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_692"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_693"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_694"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_695"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_696"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_697"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_698"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL" xlink:label="loc_stpr_IL_699"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_700"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_701"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_702"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_703"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_704"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_705"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_706"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_707"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_708"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_709"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_710"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_711"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_713"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_714"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_715"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_716"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_717"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_718"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_719"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_720"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_721"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_722"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_723"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_724"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_725"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_726"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_727"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_728"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_729"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_730"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_731"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_732"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_733"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_734"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_735"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_736"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_737"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_738"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_739"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_740"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_741"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_742"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_743"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_744"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaap_BasisOfAccounting_745"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_746"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_747"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_748"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_749"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_750"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_751"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_752"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_753"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_754"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_755"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_756"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_757"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_758"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_759"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_760"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_761"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_762"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_763"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_764"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_765"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_766"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_767"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_768"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_769"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_770"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_771"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_772"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaap_CommonClassCMember_773"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_774"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_775"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_776"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_777"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_778"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_779"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_780"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_781"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_782"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_783"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_784"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_785"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_786"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_787"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_788"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_789"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_790"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_791"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_792"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_793"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_794"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_795"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_796"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_797"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_798"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_799"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_800"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_801"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_802"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_803"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_804"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_805"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_806"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_807"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_808"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_809"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_810"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_811"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_812"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_813"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_814"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_815"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_816"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_817"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_818"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_819"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_820"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_821"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_822"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_823"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_824"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_825"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_826"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_827"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_828"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_829"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_830"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_831"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_832"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_833"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_834"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_835"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_836"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_837"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_838"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_839"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_840"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_841"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_842"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_843"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_844"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_845"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_846"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_847"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_848"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_849"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_850"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_851"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_852"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_853"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_854"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_855"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_856"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_857"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_858"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_859"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_860"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_861"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_862"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_863"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_864"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_865"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaap_FairValueNetAssetLiability_866"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaap_FairValueNetAssetLiability_867"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_868"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_869"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_870"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_871"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_872"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_873"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_874"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_875"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_876"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_877"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_878"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_879"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_880"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_881"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_882"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_883"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_884"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_885"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_886"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_887"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_888"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_889"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_890"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_891"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_892"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_893"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_894"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_895"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_896"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_897"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_898"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_899"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_900"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_901"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRoyaltiesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_902"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRoyaltiesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_903"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_904"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_905"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_906"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_907"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_908"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember_909"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_910"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_911"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_912"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_913"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_914"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_915"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_916"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_917"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_918"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_919"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_920"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_921"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_922"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_923"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOperatingAbstract" xlink:label="loc_us-gaap_LeasesOperatingAbstract_924"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_925"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_926"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_927"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_928"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_929"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_930"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_931"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_932"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_933"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_934"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_935"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_936"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_937"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_938"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_939"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_940"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_941"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_942"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_943"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_944"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_945"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_946"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_947"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_948"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_949"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_950"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_951"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_952"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_953"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_954"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_955"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_956"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_957"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_958"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_959"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_960"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_961"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_962"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_963"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_964"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_965"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_966"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_967"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_968"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_969"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_970"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_971"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_972"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_973"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_974"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_975"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_976"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_977"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_978"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_979"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_980"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_981"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_982"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_983"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_984"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_985"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_986"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_987"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_988"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_989"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_990"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_991"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_992"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_993"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_994"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_995"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_996"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_997"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_998"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_999"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1000"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1001"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_1002"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_1003"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1004"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1005"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_1006"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_1007"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_1008"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1009"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1010"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_1011"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_1012"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAbstract" xlink:label="loc_us-gaap_OtherCommitmentsAbstract_1013"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_1014"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDescription" xlink:label="loc_us-gaap_OtherCommitmentsDescription_1015"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1016"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_1017"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1018"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1019"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_1020"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_1021"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_1022"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_1023"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_1024"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1025"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1026"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1027"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1028"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1029"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1030"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1031"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_1032"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_1033"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_1034"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_1035"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1036"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_1037"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1038"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1039"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_1040"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1041"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1042"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1043"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1044"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1045"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1046"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_1047"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1048"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1049"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1050"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1051"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1052"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1053"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1054"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1055"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1056"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1057"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1058"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1059"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1060"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1061"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1062"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1063"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1064"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1065"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_1066"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1067"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1068"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1069"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1070"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1071"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_1072"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1073"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1074"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1075"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1076"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1077"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1078"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1079"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_1080"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1081"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1082"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1083"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_1084"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1085"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1086"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1087"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1088"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1089"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1090"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1091"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1092"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_1093"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1094"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1095"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1096"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1097"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1098"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1099"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_1102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_1103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_1104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_1105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_1110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_1113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_1117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_1126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_1131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_1132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_1134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_1213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_1221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_1224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_1225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_1226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_1244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_1245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_1246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_1252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense" xlink:label="loc_us-gaap_SuppliesExpense_1270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember" xlink:label="loc_us-gaap_TechnologyEquipmentMember_1271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_1272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_1280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_1283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_1284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_1285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1298"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AccountingPoliciesLineItems_0" xml:lang="en-US">Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AccountingPoliciesLineItems_1" xml:lang="en-US">Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AccountingPoliciesTable_0" xml:lang="en-US">Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AccountingPoliciesTable_1" xml:lang="en-US">Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_0" xml:lang="en-US">Share of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_1" xml:lang="en-US">Share-based compensation, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_0" xml:lang="en-US">Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with warrant exercise transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_1" xml:lang="en-US">Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_2" xml:lang="en-US">Issuance expenses warrant exercise transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_0" xml:lang="en-US">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_1" xml:lang="en-US">Adjustments To Additional Paid In Capital Warrant Issued Warrant Exercise Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_0" xml:lang="en-US">Issuance of ordinary shares and warrants in the July Financings, net of issuance expenses in an amount, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_1" xml:lang="en-US">Adjustments To Additional Paid In Capital Warrant Issued Warrant Exercise Shares Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_0" xml:lang="en-US">Issuance of ordinary shares and warrants in the July Financings, net of issuance expenses in an amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_1" xml:lang="en-US">Adjustments To Additional Paid In Capital Warrant Issued Warrant Exercise Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_0" xml:lang="en-US">It represents amount of portion of ordinary shares of such lender.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_1" xml:lang="en-US">Amount Of Portion Of Ordinary Shares Of Such Lender</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_2" xml:lang="en-US">Amount of portion of ordinary shares of such lender</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AntiDilutiveWarrantsMember_0" xml:lang="en-US">Anti-dilutive Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AntiDilutiveWarrantsMember_1" xml:lang="en-US">Anti-Dilutive Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AprilMayOfferingsMember_0" xml:lang="en-US">April-May 2020 Offerings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AprilMayOfferingsMember_1" xml:lang="en-US">April-May 2020 Offerings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AprilMayRegisteredDirectOfferingMember_0" xml:lang="en-US">April-May 2020 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AprilMayRegisteredDirectOfferingMember_1" xml:lang="en-US">April-May 2020 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AprilSixthMember_0" xml:lang="en-US">April 6 [2015]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AsicComponentDesignerRoyaltiesMember_0" xml:lang="en-US">Information about ASIC component designer royalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_AsicComponentDesignerRoyaltiesMember_1" xml:lang="en-US">Asic Component Designer Royalties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_AsicComponentDesignerRoyaltiesMember_2" xml:lang="en-US">ASIC component designer royalties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AugustThirteenthOneMember_0" xml:lang="en-US">August 13, Issuance One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_AugustThirteenthTwoMember_0" xml:lang="en-US">August 13, Issuance Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_BankLeumiCreditFacilityMember_0" xml:lang="en-US">Credit line agreement with Bank Leumi [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_0" xml:lang="en-US">Israel-United States Binational Industrial Research and Development Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_1" xml:lang="en-US">BIRD Foundation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_C1WarrantsMember_0" xml:lang="en-US">Warrants to purchase Series C1 convertible preferred shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_C2WarrantsMember_0" xml:lang="en-US">Warrants convertible into Series C2 convertible preferred shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CertainEmployeesMember_0" xml:lang="en-US">Certain Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CertainEmployeesMember_1" xml:lang="en-US">Certain Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_CertainEmployeesMember_2" xml:lang="en-US">Certain Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CertainOfficerMember_0" xml:lang="en-US">Certain Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CertainOfficerMember_1" xml:lang="en-US">Certain Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_CertainOfficerMember_2" xml:lang="en-US">Certain officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_0" xml:lang="en-US">Certain Officers, CEO, and Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_1" xml:lang="en-US">Certain Officers, CEO, and Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_2" xml:lang="en-US">Certain executive officers and employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ChangesInLiabilityToPayRoyalties_0" xml:lang="en-US">Represents value of changes in liability to pay royalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ChangesInLiabilityToPayRoyalties_1" xml:lang="en-US">Changes In Liability To Pay Royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ChangesInLiabilityToPayRoyalties_2" xml:lang="en-US">Changes in provision for royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CheckCapUsIncMember_0" xml:lang="en-US">This member stands for Check-Cap US, Inc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CheckCapUsIncMember_1" xml:lang="en-US">Check Cap Us Inc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_CheckCapUsIncMember_2" xml:lang="en-US">Check-Cap US, Inc. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_0" xml:lang="en-US">CEO and Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_1" xml:lang="en-US">CEO and Board Members [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_2" xml:lang="en-US">CEO and Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ClassOfWarrantOrRightExpiration_0" xml:lang="en-US">Number of warrants or rights expired during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ClassOfWarrantOrRightExpiration_1" xml:lang="en-US">Expiration of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ClassOfWarrantOrRightExpiration_2" xml:lang="en-US">Expiration period of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ClassOfWarrantOrRightExpirationPeriod_0" xml:lang="en-US">Represents the period of warrants expiration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ClassOfWarrantOrRightExpirationPeriod_1" xml:lang="en-US">Class Of Warrant Or Right, Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ClassOfWarrantOrRightExpirationPeriod_2" xml:lang="en-US">Warrants expiring period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_0" xml:lang="en-US">Represents the reduced exercise price per share or per unit of warrants or rights outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_1" xml:lang="en-US">Class Of Warrant Or Right Reduced Exercise Price Of Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_2" xml:lang="en-US">Reduced exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ClinicalTrialsAndRegulationExpense_0" xml:lang="en-US">Clinical trials and regulation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ClinicalTrialsAndRegulationExpense_1" xml:lang="en-US">Clinical trials and regulation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CommitmentsAndContingenciesLineItems_0" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CommitmentsAndContingenciesLineItems_1" xml:lang="en-US">Commitments and Contingencies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CommitmentsAndContingenciesTable_0" xml:lang="en-US">Commitments and Contingencies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CommitmentsAndContingenciesTable_1" xml:lang="en-US">Commitments and Contingencies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CommonClassDMember_0" xml:lang="en-US">Common Class D [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CommonStockUnitsIssued_0" xml:lang="en-US">Represents number of units issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CommonStockUnitsIssued_1" xml:lang="en-US">Common Stock Units Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_CommonStockUnitsIssued_2" xml:lang="en-US">Common stock, Units issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CompensationExpenseEstimationForGrantDate_0" xml:lang="en-US">Compensation expense estimation for grant date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CompensationExpenseEstimationForGrantDate_1" xml:lang="en-US">Compensation expense estimation for the grant date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ConsultingFeesMember_0" xml:lang="en-US">Consulting fees, including share based compensation and reimbursement of expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ConsultingFeesMember_1" xml:lang="en-US">Consulting fees, including share-based compensation and reimbursement of expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ContingentLiability_0" xml:lang="en-US">Represents amount of contingent liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ContingentLiability_1" xml:lang="en-US">Contingent Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ContingentLiability_2" xml:lang="en-US">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CounterpointVenturesFundTwoMember_0" xml:lang="en-US">Counterpoint Ventures Fund II LP [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_CreditLineAgreementWarrantsMember_0" xml:lang="en-US">CLA Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_CreditLineAgreementWarrantsMember_1" xml:lang="en-US">Credit Line Agreement Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_DerivativeChangeInFairValueOfOptionOutstanding_0" xml:lang="en-US">Change in fair value of option outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_DerivativeChangeInFairValueOfOptionOutstanding_1" xml:lang="en-US">Change in fair value of option outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_DesignerRoyaltiesMember_0" xml:lang="en-US">Royalties to an ASIC designer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_DesignerRoyaltiesMember_1" xml:lang="en-US">ASIC designer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_DesignerRoyaltiesMember_2" xml:lang="en-US">Royalties to an ASIC designer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_DevelopmentAreaAMember_0" xml:lang="en-US">Development Area A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_DevelopmentAreaAMember_1" xml:lang="en-US">Development Area A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_DevelopmentAreaAMember_2" xml:lang="en-US">Development Area A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_DocorInternationalBVMember_0" xml:lang="en-US">Docor International B.V. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_EmployeeRelatedLiabilitiesTextBlock_0" xml:lang="en-US">Disclosure for employee related liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_EmployeeRelatedLiabilitiesTextBlock_1" xml:lang="en-US">EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_EscoVenturesPteLtdMember_0" xml:lang="en-US">Esco Ventures Pte Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ExercisePriceOfWarrants_0" xml:lang="en-US">Represents exercise price of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ExercisePriceOfWarrants_1" xml:lang="en-US">Exercise Price Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ExercisePriceOfWarrants_2" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FairValueOfHedgingOption_0" xml:lang="en-US">Represents amount of fair value of hedging option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FairValueOfHedgingOption_1" xml:lang="en-US">Fair value of hedging option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FairValueOfWarrantsIssued_0" xml:lang="en-US">Represents fair value of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FairValueOfWarrantsIssued_1" xml:lang="en-US">Fair Value Of Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_FairValueOfWarrantsIssued_2" xml:lang="en-US">Fair value of warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FebruaryEighteenthMember_0" xml:lang="en-US">February 18 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FebruaryTwentyFourthOneMember_0" xml:lang="en-US">February 24, Issuance One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FebruaryTwentyFourthTwoMember_0" xml:lang="en-US">February 24, Issuance Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FeesAndReimbursementMember_0" xml:lang="en-US">Fees, including reimbursement of expenses [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FeesAndReimbursementMember_1" xml:lang="en-US">Fees and Reimbursement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FindersWarrantsMember_0" xml:lang="en-US">Finders Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FirstMarchMember_0" xml:lang="en-US">First March [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FiveYearWarrantsMember_0" xml:lang="en-US">Five-year warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FiveYearWarrantsMember_1" xml:lang="en-US">Five-year warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ForeignCurrencyDerivativeInstrumentsMember_0" xml:lang="en-US">Foreign currency derivative instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ForeignIncomeTaxRateMaximum_0" xml:lang="en-US">Highest income tax rate applicable to foreign jurisdiction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ForeignIncomeTaxRateMaximum_1" xml:lang="en-US">Foreign maximum tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FourAugustMember_0" xml:lang="en-US">Four August [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FourMayMember_0" xml:lang="en-US">Four May [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FunctionalCurrencyPolicyTextBlock_0" xml:lang="en-US">Disclosure of accounting policy for functional currency.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FunctionalCurrencyPolicyTextBlock_1" xml:lang="en-US">Functional Currency [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_FunctionalCurrencyPolicyTextBlock_2" xml:lang="en-US">Financial statements in U.S. dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FutureFederalIncomeTaxRate_0" xml:lang="en-US">Tax rate to be applied in the next taxable year and thereafter.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FutureFederalIncomeTaxRate_1" xml:lang="en-US">Tax rate in 2018 and thereafter</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_FutureFederalIncomeTaxRateNextYear_0" xml:lang="en-US">Tax rate to be applied in the next taxable year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_FutureFederalIncomeTaxRateNextYear_1" xml:lang="en-US">Tax rate in 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GeneralAndAdministrativeExpensesLineItems_0" xml:lang="en-US">General and Administrative Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GeneralAndAdministrativeExpensesTable_0" xml:lang="en-US">General and Administrative Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GeneralAndAdministrativeExpensesTextBlock_0" xml:lang="en-US">Disclosure for general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GeneralAndAdministrativeExpensesTextBlock_1" xml:lang="en-US">General and Administrative Expenses [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GeneralAndAdministrativeExpensesTextBlock_2" xml:lang="en-US">GENERAL AND ADMINISTRATIVE EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GeneralTransactionsMember_0" xml:lang="en-US">General Transactions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GeneralTransactionsMember_1" xml:lang="en-US">Transactions with Related Parties [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GovernmentInstitutionalAssetsCurrent_0" xml:lang="en-US">Current assets related to government institutions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GovernmentInstitutionalAssetsCurrent_1" xml:lang="en-US">Government institutions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate10Member_0" xml:lang="en-US">Grant Date 10 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate10Member_1" xml:lang="en-US">May 06, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate10Member_2" xml:lang="en-US">September 20, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate11Member_0" xml:lang="en-US">Grant Date 11 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate11Member_1" xml:lang="en-US">November 04, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate11Member_2" xml:lang="en-US">December 9, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate12Member_0" xml:lang="en-US">October 31, 2016 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate13Member_0" xml:lang="en-US">Grant Date 13 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate13Member_1" xml:lang="en-US">December 12, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate13Member_2" xml:lang="en-US">December 9, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate14Member_0" xml:lang="en-US">May 9, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate15Member_0" xml:lang="en-US">June 22, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate16Member_0" xml:lang="en-US">August 3, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate17Member_0" xml:lang="en-US">Grant Date 17 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate17Member_1" xml:lang="en-US">August 05, 2019 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate17Member_2" xml:lang="en-US">November 2, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate18Member_0" xml:lang="en-US">February 18, 2015 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate1Member_0" xml:lang="en-US">Grant Date 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate1Member_1" xml:lang="en-US">February 27, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate1Member_2" xml:lang="en-US">March 5, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate2Member_0" xml:lang="en-US">Grant Date 2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate2Member_1" xml:lang="en-US">May 09, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate2Member_2" xml:lang="en-US">May 27, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate3Member_0" xml:lang="en-US">Grant Date 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate3Member_1" xml:lang="en-US">June 22, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate3Member_2" xml:lang="en-US">August 5, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate4Member_0" xml:lang="en-US">Grant Date 4 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate4Member_1" xml:lang="en-US">August 03, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate4Member_2" xml:lang="en-US">November 17, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate5Member_0" xml:lang="en-US">Grant Date 5 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate5Member_1" xml:lang="en-US">November 02, 2017 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate5Member_2" xml:lang="en-US">December 10, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate6Member_0" xml:lang="en-US">Grant Date 6 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate6Member_1" xml:lang="en-US">February 13, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate6Member_2" xml:lang="en-US">March 17, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate7Member_0" xml:lang="en-US">Grant Date 7 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate7Member_1" xml:lang="en-US">July 30, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate7Member_2" xml:lang="en-US">May 11, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate8Member_0" xml:lang="en-US">Grant Date 8 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate8Member_1" xml:lang="en-US">September 20, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate8Member_2" xml:lang="en-US">August 4, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDate9Member_0" xml:lang="en-US">Grant Date 9 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDate9Member_1" xml:lang="en-US">November 01, 2018 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDate9Member_2" xml:lang="en-US">September 13, 2021 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOne1Member_0" xml:lang="en-US">Grant Date 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOne1Member_1" xml:lang="en-US">March 5, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDateOne1Member_2" xml:lang="en-US">January 27, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOne2Member_0" xml:lang="en-US">Grant Date 12 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOne2Member_1" xml:lang="en-US">May 27, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDateOne2Member_2" xml:lang="en-US">March 21, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOne3Member_0" xml:lang="en-US">Grant Date 13 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOne3Member_1" xml:lang="en-US">August 5, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDateOne3Member_2" xml:lang="en-US">May 31, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOne4Member_0" xml:lang="en-US">Grant Date 14 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOne4Member_1" xml:lang="en-US">November 17, 2020 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDateOne4Member_2" xml:lang="en-US">August 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOneEightMember_0" xml:lang="en-US">Grant Date One Eight [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOneEightMember_1" xml:lang="en-US">Grant Date One eight [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GrantDateOneEightMember_2" xml:lang="en-US">November 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOneFiveMember_0" xml:lang="en-US">Grant Date One five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOneFiveMember_1" xml:lang="en-US">Grant Date One Five [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_GrantDateOneFiveMember_2" xml:lang="en-US">November 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOneNineMember_0" xml:lang="en-US">Grant Date One Nine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOneNineMember_1" xml:lang="en-US">Grant Date One Nine [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GrantDateOneNineMember_2" xml:lang="en-US">December 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOneSevenMember_0" xml:lang="en-US">Grant Date One Seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOneSevenMember_1" xml:lang="en-US">Grant Date One seven [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GrantDateOneSevenMember_2" xml:lang="en-US">August 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateOneSixMember_0" xml:lang="en-US">Grant Date One Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateOneSixMember_1" xml:lang="en-US">Grant Date One six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GrantDateOneSixMember_2" xml:lang="en-US">November 29, 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantDateTwoZeroMember_0" xml:lang="en-US">Grant Date Two Zero [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantDateTwoZeroMember_1" xml:lang="en-US">Grant Date Two zero [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrantedRevenue_0" xml:lang="en-US">Revenue fron grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_chek_GrantedRevenue_1" xml:lang="en-US">Less participation of the IIA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrantedRevenue_2" xml:lang="en-US">Granted Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_GrantedRevenue_3" xml:lang="en-US">Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_GrossOvertimeMonthlyRate_0" xml:lang="en-US">Gross Overtime monthly rate.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_GrossOvertimeMonthlyRate_1" xml:lang="en-US">Gross Overtime monthly rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_IIAMember_0" xml:lang="en-US">IIA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_IIAMember_1" xml:lang="en-US">IIA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_InstitutionalAndAccreditedInvestorsMember_0" xml:lang="en-US">Institutional And Accredited Investors [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_InstitutionalAndAccreditedInvestorsMember_1" xml:lang="en-US">Institutional And Accredited Investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_InstitutionalAndAccreditedInvestorsMember_2" xml:lang="en-US">Institutional and accredited investors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_InvestorWarrantsMember_0" xml:lang="en-US">Investor Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_0" xml:lang="en-US">This member stands for Israel Innovation Authority of the Ministry of Economy and Industry.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_1" xml:lang="en-US">Israel Innovation Authority Ministry Of Economy And Industry [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2" xml:lang="en-US">IIA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_IssuanceExpenses_0" xml:lang="en-US">Represents amount of issuance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_IssuanceExpenses_1" xml:lang="en-US">Issuance Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_IssuanceExpenses_2" xml:lang="en-US">Issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_JanuaryFifteenthMember_0" xml:lang="en-US">January 15 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_June2017RegisteredDirectOfferingMember_0" xml:lang="en-US">June 2017 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_JuneFirstMember_0" xml:lang="en-US">June 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_JuneSixthMember_0" xml:lang="en-US">June 6 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_JuneThirdMember_0" xml:lang="en-US">June 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_KeyManInsurancePolicy_0" xml:lang="en-US">Amount of key man insurance policy held.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_KeyManInsurancePolicy_1" xml:lang="en-US">Key man insurance policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_KeyManLifeInsurancePremiumMember_0" xml:lang="en-US">Key man life insurance premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_KeyManLifeInsurancePremiumMember_1" xml:lang="en-US">Key man life insurance premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_LegalWarrantsMember_0" xml:lang="en-US">Legal Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_LegalWarrantsMember_1" xml:lang="en-US">Legal Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_LesseeOperatingLeaseAdditionalTerm_0" xml:lang="en-US">Term of lessee's operating lease additional, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_LesseeOperatingLeaseAdditionalTerm_1" xml:lang="en-US">Lessee, Operating Lease, Additional Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_LesseeOperatingLeaseAdditionalTerm_2" xml:lang="en-US">Additional lease period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_LongTermIncentiveWarrantsMember_0" xml:lang="en-US">Long Term Incentive Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_LongTermIncentiveWarrantsMember_1" xml:lang="en-US">Long Term Incentive Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ManufacturingProgramMember_0" xml:lang="en-US">Manufacturing Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ManufacturingProgramMember_1" xml:lang="en-US">Manufacturing Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_March2022RegisteredDirectOfferingMember_0" xml:lang="en-US">March 2022 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_March2022RegisteredDirectOfferingMember_1" xml:lang="en-US">March 2022 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MarchFifteenthMember_0" xml:lang="en-US">March 15 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MaximumAggregateMonthlySalary_0" xml:lang="en-US">Maximum aggregate monthly salary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MaximumAggregateMonthlySalary_1" xml:lang="en-US">Maximum aggregate monthly salary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MaximumRoyaltyObligation_0" xml:lang="en-US">Maximum amount payable for royalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MaximumRoyaltyObligation_1" xml:lang="en-US">Maximum Royalty Obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_MaximumRoyaltyObligation_2" xml:lang="en-US">Maximum royalties payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MayFifteenthMember_0" xml:lang="en-US">May 15 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MayNineteenthMember_0" xml:lang="en-US">May 19 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MinimumBidPriceValuePerShare_0" xml:lang="en-US">Minimum bid price value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MinimumBidPriceValuePerShare_1" xml:lang="en-US">Minimum bid price value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MonthlyRentalFee_0" xml:lang="en-US">Monthly rental fee.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MonthlyRentalFee_1" xml:lang="en-US">Monthly rental fee</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MonthlyRetainer_0" xml:lang="en-US">Amount of monthly retainer for services performed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MonthlyRetainer_1" xml:lang="en-US">Monthly retainer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MonthlySalary_0" xml:lang="en-US">Monthly Salary.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MonthlySalary_1" xml:lang="en-US">Monthly Salary</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_MonthlyVehicleLeaseExpense_0" xml:lang="en-US">Monthly vehicle lease expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_MonthlyVehicleLeaseExpense_1" xml:lang="en-US">Monthly Vehicle Lease Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_MonthlyVehicleLeaseExpense_2" xml:lang="en-US">Monthly vehicle lease expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_0" xml:lang="en-US">Represents cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_1" xml:lang="en-US">Net Proceeds From Issuance Of Shares And Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_2" xml:lang="en-US">Net proceeds of shares and warrant from registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_3" xml:lang="en-US">Net proceeds warrant from the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NineMayMember_0" xml:lang="en-US">May 9 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NonExecutiveDirectorsCompensationMember_0" xml:lang="en-US">Non-Executive Directors Compensation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NonExecutiveDirectorsCompensationMember_1" xml:lang="en-US">Compensation to the Non-Executive Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NonExecutiveDirectorsMember_0" xml:lang="en-US">Non-executive Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NonExecutiveDirectorsMember_1" xml:lang="en-US">Non-Executive Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_November2017RegisteredDirectOfferingMember_0" xml:lang="en-US">November 2017 Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_0" xml:lang="en-US">Number of ordinary shares available for purchase through pre-funded warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_1" xml:lang="en-US">Number of ordinary shares available for purchase through pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_0" xml:lang="en-US">Number of ordinary shares available for purchase through pre-funded warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_1" xml:lang="en-US">Pontifax Funds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_2" xml:lang="en-US">Number of ordinary shares available for purchase through pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NumberOfSharesRestrictedStockVested_0" xml:lang="en-US">Restricted stock unit vested.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NumberOfSharesRestrictedStockVested_1" xml:lang="en-US">RSUs vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_0" xml:lang="en-US">Represents number of warrants to be granted upon exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_1" xml:lang="en-US">Number Of Warrants To Be Granted Upon Exercise Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_2" xml:lang="en-US">Number of warrants to be granted upon exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OctoberFourteenthMember_0" xml:lang="en-US">October 14 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OctoberTwentiethMember_0" xml:lang="en-US">October 20 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OfficeOfTheChiefScientistMember_0" xml:lang="en-US">Office of the Chief Scientist of Israel's Ministry of Industry, Trade and Labor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OfficeOfTheChiefScientistMember_1" xml:lang="en-US">OCS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OfficeRentAndMaintenance_0" xml:lang="en-US">Represent the amount of office rent and maintenance expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OfficeRentAndMaintenance_1" xml:lang="en-US">Office Rent And Maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_chek_OfficeRentAndMaintenance_2" xml:lang="en-US">Operating Leases, Rent Expense, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_OfficeRentAndMaintenance_3" xml:lang="en-US">Office rent and maintenance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OfficersAndEmployeesMember_0" xml:lang="en-US">Officers And Employees [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OfficersAndEmployeesMember_1" xml:lang="en-US">Officers And Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_OfficersAndEmployeesMember_2" xml:lang="en-US">Officers and employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OneYearWarrantsMember_0" xml:lang="en-US">One-year warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OneYearWarrantsMember_1" xml:lang="en-US">One-year warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OperatingLeaseRentExpenseMonthly_0" xml:lang="en-US">Monthly rent expense for operating leased assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OperatingLeaseRentExpenseMonthly_1" xml:lang="en-US">Operating Lease Rent Expense Monthly</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_OperatingLeaseRentExpenseMonthly_2" xml:lang="en-US">Monthly rental property expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OrdinarySharesMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OrdinarySharesMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_OrdinarySharesMember_2" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OtherCurrentAssetsFairValueDisclosureAbstract_0" xml:lang="en-US">Other current assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OtherCurrentAssetsFairValueDisclosureAbstract_1" xml:lang="en-US">Other current assets:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_0" xml:lang="en-US">Other current liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_1" xml:lang="en-US">Other current liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PaymentsExpensesForPatents_0" xml:lang="en-US">Represents amount of payments /expenses for patents.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PaymentsExpensesForPatents_1" xml:lang="en-US">Payments /Expenses For Patents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_chek_PaymentsExpensesForPatents_2" xml:lang="en-US">Amortization of Intangible Assets, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PaymentsExpensesForPatents_3" xml:lang="en-US">Cost for registration of patents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_0" xml:lang="en-US">Represents percentage of number of ordinary shares issued upon the cash exercise.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_1" xml:lang="en-US">Percentage Of Number Of Ordinary Shares Issued Upon Cash Exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_0" xml:lang="en-US">Represents the percentage of options and RSUs expected to vest and exercisable on first anniversary of date of grant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_1" xml:lang="en-US">Percentage Of Options And Rsus Expected To Vest And Exercisable On First Anniversary Of Date Of Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_2" xml:lang="en-US">Percentage of options and RSUs expected to vest and exercisable on first anniversary of date of grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_0" xml:lang="en-US">Represents the percentage of ordinary shares issued upon cash exercise of warrants to placement agent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_1" xml:lang="en-US">Percentage Of Ordinary Shares Issued Upon Cash Exercise Of Warrants To Placement Agent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_2" xml:lang="en-US">Percentage of ordinary shares issued upon cash exercise of warrants to placement agent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PercentageOfSharesFullyDiluted_0" xml:lang="en-US">It represents percentage of shares fully diluted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PercentageOfSharesFullyDiluted_1" xml:lang="en-US">Percentage Of Shares Fully Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PercentageOfSharesFullyDiluted_2" xml:lang="en-US">Percentage of shares fully diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PeriodOfVestingEqualPortion_0" xml:lang="en-US">Represents the period of vesting equal portion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PeriodOfVestingEqualPortion_1" xml:lang="en-US">Period Of Vesting Equal Portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PeriodOfVestingEqualPortion_2" xml:lang="en-US">Period of vesting equal portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PlacementAgent2Member_0" xml:lang="en-US">PlacementAgent2Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PlacementAgent2Member_1" xml:lang="en-US">Placement agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PlacementAgentMember_0" xml:lang="en-US">Placement agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PlacementAgentMember_1" xml:lang="en-US">Placement agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PlacementAgentMember_2" xml:lang="en-US">Placement Agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PlacementAgentsMember_0" xml:lang="en-US">Placement agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PlacementAgentsMember_1" xml:lang="en-US">PlacementAgentsMember</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PlacementAgentsMember_2" xml:lang="en-US">Placement agent [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PlacementAgentWarrantsMember_0" xml:lang="en-US">Represent the placement agent warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PlacementAgentWarrantsMember_1" xml:lang="en-US">Placement Agent Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_PlacementAgentWarrantsMember_2" xml:lang="en-US">Placement agent warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PontifaxFundsMember_0" xml:lang="en-US">Pontifax Funds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PontifaxMember_0" xml:lang="en-US">Pontifax Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PredecessorUnitHoldersMember_0" xml:lang="en-US">Predecessor Entity's Unit Holders [Member[</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PredecessorUnitHoldersMember_1" xml:lang="en-US">Reimbursement liability to Predecessor Entity's Unit Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PredecessorUnitHoldersMember_2" xml:lang="en-US">Reimbursement liability to Predecessor Entity's unit holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreferredSharesConversionMember_0" xml:lang="en-US">Preferred shares converted to ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreferredSharesMember_0" xml:lang="en-US">Preferred Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreferredShareWarrantsConversionMember_0" xml:lang="en-US">Conversion of preferred share warrants to ordinary share warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreFundedUnitsMember_0" xml:lang="en-US">Pre funded Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PreFundedUnitsMember_1" xml:lang="en-US">Pre funded Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreFundedWarrantsMember_0" xml:lang="en-US">Pre Funded Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PreFundedWarrantsMember_1" xml:lang="en-US">Pre-funded Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreFundedWarrantsOneMember_0" xml:lang="en-US">Pre-funded Warrants one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PreFundedWarrantsOneMember_1" xml:lang="en-US">Pre-funded Warrants one [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreFundedWarrantsPurchase_0" xml:lang="en-US">It represents pre funded warrants purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PreFundedWarrantsPurchase_1" xml:lang="en-US">Pre Funded Warrants Purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PreFundedWarrantsPurchase_2" xml:lang="en-US">Shares issued under pre-funded warrants purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_0" xml:lang="en-US">Represents the number of share issuable under pre-funded warrants purchase.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_1" xml:lang="en-US">Pre Funded Warrants Purchase Shares Issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_2" xml:lang="en-US">Shares issuable under pre-funded warrants purchase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PrefundedWarrantsToPurchasePrice_0" xml:lang="en-US">Pre-funded warrants purchase price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PrefundedWarrantsToPurchasePrice_1" xml:lang="en-US">Pre-funded warrants purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PremiumPercentageToCalculateExercisePrice_0" xml:lang="en-US">Represents premium percentage to calculate the exercise price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PremiumPercentageToCalculateExercisePrice_1" xml:lang="en-US">Premium Percentage To Calculate Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PremiumPercentageToCalculateExercisePrice_2" xml:lang="en-US">Premium percentage to calculate the exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_0" xml:lang="en-US">Disclosure for prepaid expenses and other current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_1" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_2" xml:lang="en-US">PREPAID EXPENSES AND OTHER CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PricePerUnit_0" xml:lang="en-US">Price per unit sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PricePerUnit_1" xml:lang="en-US">Price per unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_0" xml:lang="en-US">Represents proceeds from exercise of prefunded warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_1" xml:lang="en-US">Proceeds From Exercise Of Prefunded Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_2" xml:lang="en-US">Proceeds from exercise of prefunded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromExerciseOfWarrants_0" xml:lang="en-US">Represents cash inflow from exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromExerciseOfWarrants_1" xml:lang="en-US">Proceeds From Exercise Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromExerciseOfWarrants_2" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceOfPublicOffering_0" xml:lang="en-US">The cash inflow associated with the amount received from entity's first offering of stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceOfPublicOffering_1" xml:lang="en-US">Proceeds From Issuance Of Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromIssuanceOfPublicOffering_2" xml:lang="en-US">Proceeds from issuance of public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_0" xml:lang="en-US">Represents amount of proceeds from issuance of registered direct offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_1" xml:lang="en-US">Proceeds From Issuance Of Registred Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_2" xml:lang="en-US">Proceeds from issuance of registred direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_3" xml:lang="en-US">Proceeds from issuance of registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceOfShares_0" xml:lang="en-US">Represents amounts of proceeds from issuance of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceOfShares_1" xml:lang="en-US">Proceeds From Issuance Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromIssuanceOfShares_2" xml:lang="en-US">Proceeds from issuance of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_0" xml:lang="en-US">Represents amount of proceeds from the issuance of shares, prefunded shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_1" xml:lang="en-US">Proceeds From Issuance Of Shares, Prefunded Shares And Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_2" xml:lang="en-US">Proceeds from issuance of shares, prefunded shares and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceResisteredDirectOffering_0" xml:lang="en-US">Proceed from Issuance of ordinary shares in the RD Offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceResisteredDirectOffering_1" xml:lang="en-US">Issuance of ordinary shares in the registered direct offerings, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_0" xml:lang="en-US">Proceed from Issuance of ordinary shares in the RD Offering, net of issuance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_1" xml:lang="en-US">Proceeds From Issuance Resistered Direct Offering Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_2" xml:lang="en-US">Issuance of ordinary shares in the registered direct offerings, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_PurchasePricePerUnit_0" xml:lang="en-US">Represents purchase price per unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_PurchasePricePerUnit_1" xml:lang="en-US">Purchase Price Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_PurchasePricePerUnit_2" xml:lang="en-US">Purchase price per unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ReconciliationOfCashToBalanceSheetAbstract_0" xml:lang="en-US">Reconciliation Of Cash To Balance Sheet [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_ReconciliationOfCashToBalanceSheetAbstract_1" xml:lang="en-US">RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ReductionInIncomeTaxRate_0" xml:lang="en-US">Reduction In Income Tax Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ReductionInIncomeTaxRate_1" xml:lang="en-US">Reduction in income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ReductionInIncomeTaxRate_2" xml:lang="en-US">Reduction in income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RefundExpenses_0" xml:lang="en-US">Refund expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RefundExpenses_1" xml:lang="en-US">Refund Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_RefundExpenses_2" xml:lang="en-US">Refund expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RegisteredDirectOfferingMember_0" xml:lang="en-US">Registered Direct Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RegisteredDirectOfferingMember_1" xml:lang="en-US">RD Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ResearchAndDevelopmentExpenseGross_0" xml:lang="en-US">The gross recognized cost of research and development during the period, before accounting for costs covered by grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ResearchAndDevelopmentExpenseGross_1" xml:lang="en-US">Research and Development Expense, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_chek_ResearchAndDevelopmentExpenseGross_2" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ResearchAndDevelopmentExpensesLineItems_0" xml:lang="en-US">Research and Development Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ResearchAndDevelopmentExpensesLineItems_1" xml:lang="en-US">Research and Development Expenses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ResearchAndDevelopmentExpensesTable_0" xml:lang="en-US">Research and Development Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ResearchAndDevelopmentExpensesTable_1" xml:lang="en-US">Research and Development Expenses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RestOfCountryMember_0" xml:lang="en-US">Rest of the Country [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RestOfCountryMember_1" xml:lang="en-US">Rest Of Country [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_RestOfCountryMember_2" xml:lang="en-US">Rest of the Country [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RestrictedCashIncludedCurrentAssets_0" xml:lang="en-US">Represents the amount of restricted cash included in current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RestrictedCashIncludedCurrentAssets_1" xml:lang="en-US">Restricted Cash Included Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_RestrictedCashIncludedCurrentAssets_2" xml:lang="en-US">Restricted cash included current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RevenueFromCashCommission_0" xml:lang="en-US">Cash commission.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RevenueFromCashCommission_1" xml:lang="en-US">Cash commission</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltiesPayablePercentageOfProductSales_0" xml:lang="en-US">Royalties payable as a percentage of product sales.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltiesPayablePercentageOfProductSales_1" xml:lang="en-US">Royalties Payable Percentage Of Product Sales</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_RoyaltiesPayablePercentageOfProductSales_2" xml:lang="en-US">Royalty repayment, percentage of products sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltiesPayablePerUnit_0" xml:lang="en-US">Amount payable for royalties per unit sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltiesPayablePerUnit_1" xml:lang="en-US">Royalties payable per unit sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltiesPayablePerUnitSold_0" xml:lang="en-US">Amount payable for royalties per unit sold.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltiesPayablePerUnitSold_1" xml:lang="en-US">Royalties Payable Per Unit Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_RoyaltiesPayablePerUnitSold_2" xml:lang="en-US">Royalties payable per unit sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltiesProvision_0" xml:lang="en-US">Amount of the liability recorded to pay royalties.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltiesProvision_1" xml:lang="en-US">Royalties provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_RoyaltiesProvision_2" xml:lang="en-US">Royalties provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltyAmountPerUnitMaximum_0" xml:lang="en-US">Royalties per unit, maximum.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltyAmountPerUnitMaximum_1" xml:lang="en-US">Royalties per unit, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_RoyaltyAmountPerUnitMaximum_2" xml:lang="en-US">Royalties per unit, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltyAmountPerUnitMinimum_0" xml:lang="en-US">Royalties per unit, minimum.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltyAmountPerUnitMinimum_1" xml:lang="en-US">Royalties per unit, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_RoyaltyAmountPerUnitMinimum_2" xml:lang="en-US">Royalties per unit, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltyIncomeExpenseNonoperating_0" xml:lang="en-US">Ancillary revenue earned, net of expense during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltyIncomeExpenseNonoperating_1" xml:lang="en-US">Changes in provision for royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_RoyaltyRepaymentPercentageOfProductsSold_0" xml:lang="en-US">Royalties payable as a percentage of product sales.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_RoyaltyRepaymentPercentageOfProductsSold_1" xml:lang="en-US">Royalty Repayment Percentage Of Products Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_0" xml:lang="en-US">Tabular disclosure for employee related liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_1" xml:lang="en-US">Schedule of Employee Benefits and Payroll Accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_0" xml:lang="en-US">Schedule of Future Lease Payments [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_1" xml:lang="en-US">Schedule of Future Lease Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_0" xml:lang="en-US">Tabular disclosure for general and administrative expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_1" xml:lang="en-US">Schedule of General and Administrative Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_0" xml:lang="en-US">Tabular disclosure of parameters used to calculate the fair value of options.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_1" xml:lang="en-US">Schedule of Parameters Used in Valuing Fair Value of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_0" xml:lang="en-US">Tabular disclosure of prepaid expenses and other current assets.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_1" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_0" xml:lang="en-US">Tabular disclosure of the information used to calculate depreciation for property, plant and equipment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_1" xml:lang="en-US">Schedule of Depreciation Inputs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfResearchAndDevelopmentExpensesNet_0" xml:lang="en-US">Tabular disclosure for the net expenses associated with research and development.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfResearchAndDevelopmentExpensesNet_1" xml:lang="en-US">Schedule of Research and Development Expenses, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_0" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Operating Leases [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_1" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeniorManagementMember_0" xml:lang="en-US">Senior Management [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SeniorManagementMember_1" xml:lang="en-US">Senior Management [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesAWarrantsMember_0" xml:lang="en-US">Series A Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SeriesAWarrantsMember_1" xml:lang="en-US">Series A Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesC1PreferredStockMember_0" xml:lang="en-US">Series C1 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesC2PreferredStockMember_0" xml:lang="en-US">Series C2 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesC3PreferredStockMember_0" xml:lang="en-US">Series C3 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesCPreferredShareWarrantsConversionMember_0" xml:lang="en-US">Series C preferred share warrants converted to ordinary share warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesCWarrantsMember_0" xml:lang="en-US">Series C Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SeriesCWarrantsMember_1" xml:lang="en-US">Series C Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_0" xml:lang="en-US">Series C Warrants to purchase ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_1" xml:lang="en-US">Series C Warrants to purchase ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesD1PreferredStockMember_0" xml:lang="en-US">Series D1 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesD2PreferredStockMember_0" xml:lang="en-US">Series D2 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesD3PreferredStockMember_0" xml:lang="en-US">Series D3 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesD4PreferredStockMember_0" xml:lang="en-US">Series D4 Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SeriesDWarrantsMember_0" xml:lang="en-US">Series D Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SeriesDWarrantsMember_1" xml:lang="en-US">Series D Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ServicesWarrantsMember_0" xml:lang="en-US">Services Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_0" xml:lang="en-US">Additional percentage of vesting of award under share-based payment arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_1" xml:lang="en-US">Additional vesting percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_0" xml:lang="en-US">Fair value of options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Period, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_2" xml:lang="en-US">Fair value of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_1" xml:lang="en-US">Aggregate intrinsic value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_0" xml:lang="en-US">Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_1" xml:lang="en-US">Outstanding at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationAwardTrancheFourMember_0" xml:lang="en-US">Fourth portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationAwardTrancheFourMember_1" xml:lang="en-US">Share-based Compensation Award, Tranche Four [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_0" xml:lang="en-US">Share-based compensation, net, allocated to general and administrative expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_1" xml:lang="en-US">Share-based compensation, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2" xml:lang="en-US">Compensation expense recorded to general and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationInome_0" xml:lang="en-US">Share-based Payment Arrangement, Noncash Income, Total.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationInome_1" xml:lang="en-US">Share based compensation income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareBasedCompensationMember_0" xml:lang="en-US">Share-Based Compensation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareBasedCompensationMember_1" xml:lang="en-US">Share-Based Compensation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareCapital_0" xml:lang="en-US">Value of shares issued and total premiums for shares issued presented as the amount of share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_chek_ShareCapital_1" xml:lang="en-US">Subtotal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareCapital_2" xml:lang="en-US">Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShareCapitalLessIssuanceCosts_0" xml:lang="en-US">Amount of share capital raised, less the associated issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShareCapitalLessIssuanceCosts_1" xml:lang="en-US">Share Capital Less Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_ShareCapitalLessIssuanceCosts_2" xml:lang="en-US">Share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ShortTermInvestmentInterestRate_0" xml:lang="en-US">Interest rate applied to short-term investment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ShortTermInvestmentInterestRate_1" xml:lang="en-US">Short-term bank deposit, interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_0" xml:lang="en-US">Number of ordinary shares and warrants issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_1" xml:lang="en-US">Stock And Warrant Issued During Period, Shares, In Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_0" xml:lang="en-US">Issuance of ordinary shares registered direct offering, net of issuance expenses, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_1" xml:lang="en-US">Stock And Warrant Issued During Period, Shares, In Registered Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_2" xml:lang="en-US">Issuance of ordinary shares and warrants, in the 2019 registered direct offering, net of issuance expenses in an amount of $987</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_0" xml:lang="en-US">Number of new ordinary shares and warrants issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_1" xml:lang="en-US">Stock And Warrant Issued During Period, Shares, In Registered Direct Offering Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_0" xml:lang="en-US">Equity impact of the value of ordinary shares and warrants issued in financing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_1" xml:lang="en-US">Stock And Warrant Issued During Period, Value, In Financing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_0" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance expenses in an amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_1" xml:lang="en-US">Stock And Warrant Issued During Period, Value, In Registered Direct Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_3" xml:lang="en-US">Issuance of ordinary shares and warrants, in the 2019 registered direct offering, net of issuance expenses in an amount of $987</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_0" xml:lang="en-US">Equity impact of the value of ordinary shares and warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_1" xml:lang="en-US">Stock And Warrant Issued During Period, Value, In Registered Direct Offering Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_3" xml:lang="en-US">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_0" xml:lang="en-US">Number of ordinary shares and warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_1" xml:lang="en-US">Stock And Warrants Issued During Period, Shares, In Warrant Exercise Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_0" xml:lang="en-US">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of Issuance expenses in an amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_1" xml:lang="en-US">Stock And Warrants Issued During Period, Value, In Warrant Exercise Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_0" xml:lang="en-US">Number of new stock issued during the period as part of a private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_1" xml:lang="en-US">Issuance of ordinary shares in the Private Placement, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_2" xml:lang="en-US">Issuance of ordinary shares in the Private Placement, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_0" xml:lang="en-US">Issuance of ordinary shares and pre-funded warrants in the registered direct offering, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_1" xml:lang="en-US">Warrants [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_2" xml:lang="en-US">Issuance of ordinary shares and pre-funded warrants in August 2016 registered direct offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_0" xml:lang="en-US">Issuance of ordinary shares and pre-funded warrants in the registered direct offering, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_1" xml:lang="en-US">Issuance of ordinary Shares in RD Offering, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_2" xml:lang="en-US">Issuance of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_0" xml:lang="en-US">Number of private placement issued during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_1" xml:lang="en-US">Stock Issued During Period, Shares, Private Placement Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_2" xml:lang="en-US">Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_0" xml:lang="en-US">Number of shares issued upon the cash exercise of warrants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_1" xml:lang="en-US">Stock Issued During Period Shares Warrants Cash Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_2" xml:lang="en-US">Number of warrants exercised in cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_0" xml:lang="en-US">Number of shares issued upon the exercise of warrants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_1" xml:lang="en-US">Exercise of warrants, net of issuance expenses in an amount of $22, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_2" xml:lang="en-US">Exercise of warrants into ordinary shares, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_3" xml:lang="en-US">Number of warrants exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_4" xml:lang="en-US">Exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_0" xml:lang="en-US">Number of shares issued upon the partial exercise of warrants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_1" xml:lang="en-US">Partial exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_0" xml:lang="en-US">Equity impact of the value of new stock issued during the period as part of a private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_1" xml:lang="en-US">Issuance of ordinary shares in the Private Placement, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_0" xml:lang="en-US">Issuance of ordinary shares in private placement, net of issuance expenses in an amount, shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_1" xml:lang="en-US">Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_0" xml:lang="en-US">Issuance of ordinary shares and pre-funded warrants in the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_1" xml:lang="en-US">Issuance of ordinary shares and pre-funded warrants in August 2016 registered direct offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_2" xml:lang="en-US">Issuance of ordinary Shares in RD Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_0" xml:lang="en-US">Issuance of ordinary shares registered direct offering, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_1" xml:lang="en-US">Issuance of ordinary shares and warrants, in the 2019 registered direct offering, net of issuance expenses in an amount of $987</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_0" xml:lang="en-US">Issuance of ordinary shares in private placement, net of issuance expenses in an amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_1" xml:lang="en-US">Stock Issued During Period, Value, Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_2" xml:lang="en-US">Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_0" xml:lang="en-US">Value of stock issued as a result of the exercise of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_1" xml:lang="en-US">Exercise of warrants into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_2" xml:lang="en-US">Exercise of warrants, net of issuance expenses in an amount of $22</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_0" xml:lang="en-US">Stock options and Restricted Stock Units RSU [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_1" xml:lang="en-US">Stock Options And Restricted Stock Units Rsu [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_2" xml:lang="en-US">Stock Options and Restricted Stock Units RSU [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SubcontractorsAndConsultantFees_0" xml:lang="en-US">Fees for the services provided by subcontractors and consultants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SubcontractorsAndConsultantFees_1" xml:lang="en-US">Subcontractors and consultants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_SubleaseAgreementMember_0" xml:lang="en-US">Represent the sub-lease agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_SubleaseAgreementMember_1" xml:lang="en-US">Sub-lease Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ThirtyOneOctoberMember_0" xml:lang="en-US">Thirty One October [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ThreeAugustMember_0" xml:lang="en-US">August 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ThreeAugustMember_1" xml:lang="en-US">August 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TweentyNineFebruaryMember_0" xml:lang="en-US">Tweenty Nine February [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TwelveDecemberMember_0" xml:lang="en-US">December 12 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_TwelveDecemberMember_1" xml:lang="en-US">December 12 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TwentySevenFebruaryMember_0" xml:lang="en-US">February 27 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TwentyTwoJuneMember_0" xml:lang="en-US">June 22 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_TwentyTwoJuneMember_1" xml:lang="en-US">June 22 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TwoNovemberMember_0" xml:lang="en-US">November 2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_TwoThousandFifteenPlanMember_0" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_TwoThousandFifteenPlanMember_1" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_UnderwriterWarrantsMember_0" xml:lang="en-US">Underwriter Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_UnderwriterWarrantsMember_1" xml:lang="en-US">Underwriter Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_UnitsPurchased_0" xml:lang="en-US">Number of units purchased, consisting of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share and one and one-half non-transferrable Long Term Incentive Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_UnitsPurchased_1" xml:lang="en-US">Number of units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_UniversityOfMissouriLicenseAgreementMember_0" xml:lang="en-US">University of Missouri License Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_0" xml:lang="en-US">Value of certain warrants associated with issuance expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_1" xml:lang="en-US">Value of certain warrants associated with issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_VariousDatesIn2015Member_0" xml:lang="en-US">Various dates in 2015 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_VariousDatesMember_0" xml:lang="en-US">Various Dates [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_VpClinicalMember_0" xml:lang="en-US">Represents company&#8217;s VP clinical.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_VpClinicalMember_1" xml:lang="en-US">Vp Clinical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_chek_VpClinicalMember_2" xml:lang="en-US">Vp Clinical [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantAmendmentAgreementMember_0" xml:lang="en-US">Warrant Amendment Agreement [Member].</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantAmendmentAgreementMember_1" xml:lang="en-US">Warrant Amendment Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_WarrantAmendmentAgreementMember_2" xml:lang="en-US">Warrant Amendment Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantAndShareOptionsMember_0" xml:lang="en-US">Warrant and Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantAndShareOptionsMember_1" xml:lang="en-US">Warrant and Share Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantAwardsMember_0" xml:lang="en-US">Warrant Awards [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantLiabilityReclassificationToEquity_0" xml:lang="en-US">Reclassification of warrant liability to equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantLiabilityReclassificationToEquity_1" xml:lang="en-US">Warrant Liability Reclassification to Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_WarrantLiabilityReclassificationToEquity_2" xml:lang="en-US">Reclassification of liability warrants to equity warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsCashlessExercise_0" xml:lang="en-US">Cashless exercise of warrants into ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsCashlessExercise_1" xml:lang="en-US">Cashless exercise of warrants to purchase ordinary shares into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsExercisedCashlessBasis_0" xml:lang="en-US">Number of warrants exercised on a cashless basis.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsExercisedCashlessBasis_1" xml:lang="en-US">Warrants exercised on a cashless basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsExerciseTransactionMember_0" xml:lang="en-US">Warrants Exercise Transaction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsExerciseTransactionMember_1" xml:lang="en-US">Warrants Exercise Transaction [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsIssued_0" xml:lang="en-US">Number of warrants issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsIssued_1" xml:lang="en-US">Warrants Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_WarrantsIssued_2" xml:lang="en-US">Warrants issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsIssuedNotExercised_0" xml:lang="en-US">Represents warrants issued not exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsIssuedNotExercised_1" xml:lang="en-US">Warrants Issued Not Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_WarrantsIssuedNotExercised_2" xml:lang="en-US">Warrants issued not exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsOutstanding_0" xml:lang="en-US">Represent the amount of warrants outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsOutstanding_1" xml:lang="en-US">Warrants Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsOutstandingAmount_0" xml:lang="en-US">WarrantsOutstandingAmount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_chek_WarrantsOutstandingAmount_1" xml:lang="en-US">Warrants outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsPolicyTextBlock_0" xml:lang="en-US">Policy for the accounting practices applied to the classification of warrant instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantsPolicyTextBlock_1" xml:lang="en-US">Warrants to purchase preferred shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsSeriesCPreferredSharesMember_0" xml:lang="en-US">Warrants to purchase Series C convertible preferred shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantsSeriesDPreferredSharesMember_0" xml:lang="en-US">Warrants to purchase Series D convertible preferred shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_chek_WarrantThatWereExercised_0" xml:lang="en-US">Warrant that were exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_chek_WarrantThatWereExercised_1" xml:lang="en-US">Warrant that were exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_IL_0" xml:lang="en-US">ISRAEL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_IL_1" xml:lang="en-US">Isfiya, ISRAEL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_AllCurrenciesDomain_0" xml:lang="en-US">All Currencies [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_EUR_0" xml:lang="en-US">Euro Member Countries, Euro</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_currency_ILS_0" xml:lang="en-US">ILS [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain_0" xml:lang="en-US">Address Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AnnualInformationForm_0" xml:lang="en-US">Annual Information Form</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId_0" xml:lang="en-US">Auditor Firm ID</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation_0" xml:lang="en-US">Auditor Location</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName_0" xml:lang="en-US">Auditor Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember_0" xml:lang="en-US">Business Contact [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelEmailAddress_0" xml:lang="en-US">Contact Personnel Email Address</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelFaxNumber_0" xml:lang="en-US">Contact Personnel Fax Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName_0" xml:lang="en-US">Contact Personnel Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAccountingStandard_0" xml:lang="en-US">Document Accounting Standard</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport_0" xml:lang="en-US">Document Annual Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentRegistrationStatement_0" xml:lang="en-US">Document Registration Statement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentShellCompanyReport_0" xml:lang="en-US">Document Shell Company Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine3_0" xml:lang="en-US">Entity Address, Address Line Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis_0" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesLineItems_0" xml:lang="en-US">Entity Addresses [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesTable_0" xml:lang="en-US">Entity Addresses [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince_0" xml:lang="en-US">Entity Address, State or Province</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation State Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers_0" xml:lang="en-US">EntityVoluntaryFilers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_IcfrAuditorAttestationFlag_0" xml:lang="en-US">Auditor Attestation Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Security Exchange Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_BoardOfDirectorsChairmanMember_0" xml:lang="en-US">Board of Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember_0" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CurrencyAxis_0" xml:lang="en-US">Currency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_MaximumMember_1" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_MinimumMember_1" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_RangeAxis_1" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SegmentGeographicalDomain_0" xml:lang="en-US">Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis_0" xml:lang="en-US">Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xml:lang="en-US">Title of Individual [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_stpr_IL_0" xml:lang="en-US">ILLINOIS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_0" xml:lang="en-US">Accounts payable and accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_0" xml:lang="en-US">Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent_0" xml:lang="en-US">Trade</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_1" xml:lang="en-US">Accrued Liabilities, Current, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_0" xml:lang="en-US">Accrued Royalties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1" xml:lang="en-US">Contingent liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedSalariesCurrent_0" xml:lang="en-US">Liability for payroll, bonuses and wages</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedVacationCurrent_0" xml:lang="en-US">Benefits for vacation and recreation pay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0" xml:lang="en-US">Accumulated depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0" xml:lang="en-US">Other Comprehensive Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_0" xml:lang="en-US">Supplemental information for Cash Flow:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid-in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_0" xml:lang="en-US">Capital investment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0" xml:lang="en-US">Issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments required to reconcile net loss to net cash used in operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_0" xml:lang="en-US">Compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_0" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1" xml:lang="en-US">Share based expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_0" xml:lang="en-US">Cost for registration of patents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0" xml:lang="en-US">Anti-dilutive instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AreaOfRealEstateProperty_0" xml:lang="en-US">Area of Real Estate Property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AreaOfRealEstateProperty_1" xml:lang="en-US">Area of lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_0" xml:lang="en-US">Assets, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_1" xml:lang="en-US">Total financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_2" xml:lang="en-US">Total financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_0" xml:lang="en-US">Cash and cash equivalents:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardDateAxis_0" xml:lang="en-US">Award Date [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardDateDomain_0" xml:lang="en-US">Award Date [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AwardTypeAxis_0" xml:lang="en-US">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccounting_0" xml:lang="en-US">Financial statements in U.S dollars</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred_0" xml:lang="en-US">Recognition of operating leases and operating lease liabilities from adoption of ASU 2016-02</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0" xml:lang="en-US">Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" xml:lang="en-US">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockLineItems_0" xml:lang="en-US">Class of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis_0" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis_1" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain_0" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xml:lang="en-US">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_0" xml:lang="en-US">Warrants issued to purchase ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xml:lang="en-US">Number of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2" xml:lang="en-US">Number of shares called by warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding_0" xml:lang="en-US">Warrant outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0" xml:lang="en-US">Contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassCMember_0" xml:lang="en-US">Series C [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US">Ordinary share, par value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_1" xml:lang="en-US">Authorized share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_2" xml:lang="en-US">Common stock, shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Ordinary shares, shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued_1" xml:lang="en-US">Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Ordinary shares, shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Aggregate consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Share capital, Ordinary shares 48 NIS par value (18,000,000 authorized shares as of December 31, 2022 and 2021; 5,844,463 and 4,840,089 shares issued and outstanding as of December 31, 2022 and 2021, respectively)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_0" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_1" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_2" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_3" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0" xml:lang="en-US">Other comprehensive loss:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_0" xml:lang="en-US">Comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComputerEquipmentMember_0" xml:lang="en-US">Computer and auxiliary equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComputerEquipmentMember_1" xml:lang="en-US">Computers and auxiliary equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk_0" xml:lang="en-US">Concentration of credit risks</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_0" xml:lang="en-US">Principles of Consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock_1" xml:lang="en-US">Principles of consolidation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1_0" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1_1" xml:lang="en-US">Conversion of preferred shares into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0" xml:lang="en-US">Cost, Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1" xml:lang="en-US">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract_0" xml:lang="en-US">Debt Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_0" xml:lang="en-US">Principal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_0" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1" xml:lang="en-US">Issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate_0" xml:lang="en-US">Weighted average borrowing rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US">Deferred income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract_0" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0" xml:lang="en-US">Carry-forward tax losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0" xml:lang="en-US">Less valuation allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_1" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_2" xml:lang="en-US">Depreciation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationNonproduction_0" xml:lang="en-US">Depreciation, Nonproduction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DepreciationNonproduction_1" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount_0" xml:lang="en-US">Notional amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0" xml:lang="en-US">Cash flow hedges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xml:lang="en-US">SHARE-BASED COMPENSATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0" xml:lang="en-US">Summary of Awards Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1" xml:lang="en-US">Schedule of Awards Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DomesticCountryMember_0" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DomesticCountryMember_1" xml:lang="en-US">Israeli tax rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareAbstract_1" xml:lang="en-US">Loss per share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Loss per share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">Net loss per ordinary share - basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_2" xml:lang="en-US">Net loss per ordinary share - Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">Net loss per ordinary share - Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract_0" xml:lang="en-US">Basic and diluted net loss per ordinary share:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_0" xml:lang="en-US">LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US">Income tax rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1" xml:lang="en-US">Employee benefits and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xml:lang="en-US">Employee-related Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0" xml:lang="en-US">Compensation cost not yet recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0" xml:lang="en-US">Period for recognizing compensation cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0" xml:lang="en-US">Share based expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeStockOptionMember_0" xml:lang="en-US">Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract_0" xml:lang="en-US">Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain_0" xml:lang="en-US">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants_0" xml:lang="en-US">Revaluation of fair value of warrants to purchase preferred share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants_1" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0" xml:lang="en-US">Summary of Fair Value Assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0" xml:lang="en-US">Fair Value By Fair Value Hierarchy Level [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0" xml:lang="en-US">Fair Value By Measurement Frequency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_0" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_0" xml:lang="en-US">FAIR VALUE MEASUREMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_0" xml:lang="en-US">Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_0" xml:lang="en-US">Level 2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0" xml:lang="en-US">Changes in Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" xml:lang="en-US">Schedule of Changes In Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0" xml:lang="en-US">Fair value of financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_0" xml:lang="en-US">Recurring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueNetAssetLiability_0" xml:lang="en-US">Fair Value, Net Asset (Liability)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueNetAssetLiability_1" xml:lang="en-US">Total financial assets (liabilities)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCountryMember_0" xml:lang="en-US">Foreign Tax Authority [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ForeignCountryMember_1" xml:lang="en-US">U.S. tax rate [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0" xml:lang="en-US">Exchange rate differences</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_1" xml:lang="en-US">Total general and administrative expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xml:lang="en-US">General and Administrative Expense [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_0" xml:lang="en-US">Sigalit Kimchy [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0" xml:lang="en-US">Impairment of Long-Lived Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1" xml:lang="en-US">Impairment of long-lived assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0" xml:lang="en-US">Loss before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0" xml:lang="en-US">Loss before income tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_0" xml:lang="en-US">Income Statement Location [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_0" xml:lang="en-US">Income Statement Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_0" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_0" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_0" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_1" xml:lang="en-US">INCOME TAXES [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_1" xml:lang="en-US">INCOME TAXES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaid_0" xml:lang="en-US">Cash paid for taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_0" xml:lang="en-US">Income taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0" xml:lang="en-US">Increase (decrease) in trade accounts payable, accruals and other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Increase (decrease) in employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1" xml:lang="en-US">Increase (decrease) in employees and payroll accruals</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0" xml:lang="en-US">Changes in assets and liabilities items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Decrease (increase) in prepaid and other current assets and non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInRoyaltiesPayable_0" xml:lang="en-US">Increase (decrease) in royalties provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInRoyaltiesPayable_1" xml:lang="en-US">Decrease in royalties provision</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestExpense_0" xml:lang="en-US">Bank fees and interest expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestExpense_1" xml:lang="en-US">Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestPaidNet_0" xml:lang="en-US">Cash paid for interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InterestPaidNet_1" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeInterest_0" xml:lang="en-US">Interest income on short-term deposits and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestorMember_0" xml:lang="en-US">Investor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IPOMember_0" xml:lang="en-US">IPO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_0" xml:lang="en-US">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xml:lang="en-US">Issuance of ordinary shares in the registered direct offerings, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2" xml:lang="en-US">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseAndRentalExpense_0" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseAndRentalExpense_1" xml:lang="en-US">Rental expenses under the lease agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCost_0" xml:lang="en-US">Lease, Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseCost_1" xml:lang="en-US">Amount allocated to lease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseExpirationDate1_0" xml:lang="en-US">Lease Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LeaseExpirationDate1_1" xml:lang="en-US">Lease expiration date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_0" xml:lang="en-US">Leaseholds and Leasehold Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_1" xml:lang="en-US">Office facilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesAbstract_0" xml:lang="en-US">Leases [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_0" xml:lang="en-US">LEASES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesOperatingAbstract_0" xml:lang="en-US">Leases:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems_0" xml:lang="en-US">Lessee, Lease, Description [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable_0" xml:lang="en-US">Lessee, Lease, Description [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xml:lang="en-US">Total future lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1" xml:lang="en-US">2025 and after</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1" xml:lang="en-US">2024</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0" xml:lang="en-US">Less imputed interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1" xml:lang="en-US">Option to extend the lease period for an additional time</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2" xml:lang="en-US">Additional Lease expiration date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock_1" xml:lang="en-US">LEASES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1" xml:lang="en-US">Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">Liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_0" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_1" xml:lang="en-US">Short-term bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MoneyMarketFundsAtCarryingValue_0" xml:lang="en-US">Money market funds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_3" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0" xml:lang="en-US">Net loss attributable to ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0" xml:lang="en-US">Recent accounting pronouncements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0" xml:lang="en-US">Supplemental disclosure of non-cash flow information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_0" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_1" xml:lang="en-US">Total financing income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_2" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense_3" xml:lang="en-US">Finance income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OfficeEquipmentMember_0" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_0" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_2" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_3" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseExpense_0" xml:lang="en-US">Operating Lease, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseExpense_1" xml:lang="en-US">Monthly services expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability_0" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability_1" xml:lang="en-US">Total lease liability balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasePayments_0" xml:lang="en-US">Cash payments for operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_1" xml:lang="en-US">Operating lease assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1" xml:lang="en-US">Total future lease payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_0" xml:lang="en-US">2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xml:lang="en-US">2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_0" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1" xml:lang="en-US">2023</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xml:lang="en-US">2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0" xml:lang="en-US">2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xml:lang="en-US">2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_0" xml:lang="en-US">Schedule of Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet_0" xml:lang="en-US">Rent expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0" xml:lang="en-US">Weighted average remaining lease term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwards_0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLossCarryforwards_1" xml:lang="en-US">Operating loss or NOL carry-forwards</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems_0" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable_0" xml:lang="en-US">Operating Loss Carryforwards [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0" xml:lang="en-US">GENERAL INFORMATION</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsCurrent_0" xml:lang="en-US">Other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure_0" xml:lang="en-US">Foreign currency derivative instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsAbstract_0" xml:lang="en-US">Royalties:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsAxis_0" xml:lang="en-US">Other Commitments [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsDescription_0" xml:lang="en-US">Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsDomain_0" xml:lang="en-US">Other Commitments [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock_0" xml:lang="en-US">Schedule of Reimbursement Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_0" xml:lang="en-US">Change in fair value of cash flow hedge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1" xml:lang="en-US">Change in fair values of cash flow hedge</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating_0" xml:lang="en-US">Others</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherExpenses_0" xml:lang="en-US">Other Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherExpenses_1" xml:lang="en-US">Others</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OtherExpenses_2" xml:lang="en-US">Other Expenses, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract_0" xml:lang="en-US">Other Income and Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent_0" xml:lang="en-US">Other current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_0" xml:lang="en-US">Foreign currency derivative instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_1" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_0" xml:lang="en-US">Financial expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_1" xml:lang="en-US">Other Noncash Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_2" xml:lang="en-US">Financial expense (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_0" xml:lang="en-US">FINANCE INCOME (EXPENSES), NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OverAllotmentOptionMember_0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsForProceedsFromInvestments_0" xml:lang="en-US">Proceeds from (Investment in) short-term bank and other deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForProceedsFromInvestments_1" xml:lang="en-US">Payments for (Proceeds from) Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_PaymentsForProceedsFromInvestments_2" xml:lang="en-US">Investment in short-term bank and other deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US">Stock issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments_0" xml:lang="en-US">Preferred shares dividend</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_0" xml:lang="en-US">Prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1" xml:lang="en-US">Reclassification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember_0" xml:lang="en-US">Private Placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0" xml:lang="en-US">Issuance of ordinary shares in the 2018 Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1" xml:lang="en-US">Issuance of ordinary shares, gross proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0" xml:lang="en-US">Issuance of ordinary shares in the private placement, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1" xml:lang="en-US">Issuance of ordinary shares in the Private Placement, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_1" xml:lang="en-US">Gross proceeds warrant from the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants_2" xml:lang="en-US">Proceeds warrant from the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_0" xml:lang="en-US">Proceeds from Issuance of shares and Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2" xml:lang="en-US">Gross proceeds warrant from the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_3" xml:lang="en-US">Proceeds from Issuance or Sale of Equity, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4" xml:lang="en-US">Proceeds warrant from the registered direct offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US">Options exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_0" xml:lang="en-US">Exercise of warrants into ordinary shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_1" xml:lang="en-US">Proceeds warrant from the exercise warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_2" xml:lang="en-US">Proceeds warrant from the exercise pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_3" xml:lang="en-US">Exercise of warrants into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfessionalFees_0" xml:lang="en-US">Professional services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisposals_0" xml:lang="en-US">Disposals amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_1" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_1" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_2" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0" xml:lang="en-US">Property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_0" xml:lang="en-US">Depreciation rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0" xml:lang="en-US">Schedule of Property and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0" xml:lang="en-US">Length of useful life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0" xml:lang="en-US">Segment Reconciliation [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain_0" xml:lang="en-US">Related Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0" xml:lang="en-US">Transactions with related parties</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis_0" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain_0" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems_0" xml:lang="en-US">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">RELATED PARTIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract_0" xml:lang="en-US">Research and Development [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Total research and development expenses, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0" xml:lang="en-US">Research and development, net [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0" xml:lang="en-US">Research and development costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1" xml:lang="en-US">RESEARCH AND DEVELOPMENT EXPENSES, NET</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_0" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashCurrent_1" xml:lang="en-US">Restricted Cash, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_2" xml:lang="en-US">Restricted cash balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedCashCurrent_3" xml:lang="en-US">Restricted cash included current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_1" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0" xml:lang="en-US">Assets acquired under operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1" xml:lang="en-US">Lease liabilities arising from obtaining right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalariesWagesAndOfficersCompensation_0" xml:lang="en-US">Salaries and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain_0" xml:lang="en-US">Sale of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0" xml:lang="en-US">Schedule of Anti-Dilutive Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_0" xml:lang="en-US">Summary of Ordinary Share Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0" xml:lang="en-US">Schedule of Deferred Income Taxes</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0" xml:lang="en-US">Schedule of Loss Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0" xml:lang="en-US">Schedule of Share-Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0" xml:lang="en-US">Schedule of Finance Income (Expense), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_0" xml:lang="en-US">Schedule of Related Party Transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_0" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0" xml:lang="en-US">Schedule of Stock Option Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0" xml:lang="en-US">Schedule of Fair Value Assumptions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_0" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_0" xml:lang="en-US">Summary of Stockholders' Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SeriesDPreferredStockMember_0" xml:lang="en-US">Series D Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xml:lang="en-US">Vesting terms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2" xml:lang="en-US">Award vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0" xml:lang="en-US">Vesting percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2" xml:lang="en-US">Number of RSU's granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Fair value of warrants on grant date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xml:lang="en-US">Unvested at end of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1" xml:lang="en-US">Unvested at beginning of year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0" xml:lang="en-US">Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2" xml:lang="en-US">Vested</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_0" xml:lang="en-US">Expiry date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1" xml:lang="en-US">Expiration date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0" xml:lang="en-US">Expiration period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_0" xml:lang="en-US">Black-Scholes-Merton option-pricing model assumptions:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1" xml:lang="en-US">Exercise price of award granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Expected term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0" xml:lang="en-US">Expected volatility, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0" xml:lang="en-US">Expected volatility, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0" xml:lang="en-US">Risk-free rate, maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_0" xml:lang="en-US">Risk-free rate, minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_0" xml:lang="en-US">Warrants granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0" xml:lang="en-US">Increase in shares available for additional grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0" xml:lang="en-US">Increase in shares available for grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0" xml:lang="en-US">Shares available for grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0" xml:lang="en-US">Weighted average remaining contractual life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0" xml:lang="en-US">Exercisable at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0" xml:lang="en-US">Exercisable at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0" xml:lang="en-US">Exercisable at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0" xml:lang="en-US">Exercisable at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0" xml:lang="en-US">Intrinsic value of options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0" xml:lang="en-US">Warrants expired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xml:lang="en-US">Options expiring during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Granted during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3" xml:lang="en-US">Number of award granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0" xml:lang="en-US">Fair value of options on grant date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US">Fair value on grant date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xml:lang="en-US">Outstanding at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xml:lang="en-US">Outstanding at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US">Outstanding at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US">Options outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0" xml:lang="en-US">Number of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Outstanding at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US">Outstanding at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0" xml:lang="en-US">Weighted average of exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0" xml:lang="en-US">Outstanding at the beginning of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1" xml:lang="en-US">Outstanding at the end of the year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0" xml:lang="en-US">Vested and expected to vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Vested and expected to vest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1" xml:lang="en-US">Options exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xml:lang="en-US">Award Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0" xml:lang="en-US">Tranche One [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_0" xml:lang="en-US">Share-based Compensation Award, Tranche Three [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0" xml:lang="en-US">Share-based Compensation Award, Tranche Two [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0" xml:lang="en-US">Exercise price range upper limit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0" xml:lang="en-US">Exercise price range lower limit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice_0" xml:lang="en-US">Share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare_0" xml:lang="en-US">Purchase price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharesIssuedPricePerShare_1" xml:lang="en-US">Price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Ending balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Beginning balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTextBlock_0" xml:lang="en-US">SHORT TERM LOANS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermInvestments_0" xml:lang="en-US">Short-term bank deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_0" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0" xml:lang="en-US">Value or warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract_0" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract_0" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_0" xml:lang="en-US">Amount raised, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityReverseStockSplit_0" xml:lang="en-US">Stockholders' Equity, Reverse Stock Split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityReverseStockSplit_1" xml:lang="en-US">Reverse share split ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0" xml:lang="en-US">Conversion of preferred shares into ordinary shares, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1" xml:lang="en-US">Conversion of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Issuance of ordinary shares in the 2018 public offering, net of issuance expenses in the amount of $2,413, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US">Issuance of ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2" xml:lang="en-US">Issuance of ordinary shares in the IPO, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_0" xml:lang="en-US">RSU vesting, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xml:lang="en-US">Option exercise, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_0" xml:lang="en-US">Conversion of preferred shares into ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_0" xml:lang="en-US">RSU vesting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xml:lang="en-US">Option exercise</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems_0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsequentEventMember_1" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable_0" xml:lang="en-US">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_0" xml:lang="en-US">Supplemental disclosure of cash flow information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SuppliesExpense_0" xml:lang="en-US">Materials</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TechnologyEquipmentMember_0" xml:lang="en-US">Laboratory equipment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized_0" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued_0" xml:lang="en-US">Temporary Equity, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued_1" xml:lang="en-US">Preferred Stock, Shares Issued, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding_0" xml:lang="en-US">Preferred Stock, Shares Outstanding, Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding_1" xml:lang="en-US">Preferred Stock, Shares Outstanding, Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding_2" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_0" xml:lang="en-US">Loss incurred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1" xml:lang="en-US">Unrealized Gain (Loss) on Cash Flow Hedging Instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives_0" xml:lang="en-US">Changes in fair value of derivatives</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of Estimates in Preparation of Financial Statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UseOfEstimates_1" xml:lang="en-US">Use of estimates in preparation of financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VehiclesMember_0" xml:lang="en-US">Vehicles [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VestingAxis_0" xml:lang="en-US">Vesting [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VestingDomain_0" xml:lang="en-US">Vesting [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember_0" xml:lang="en-US">Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding_0" xml:lang="en-US">Warrants value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">Weighted average number of ordinary shares outstanding - Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2" xml:lang="en-US">Shares used in computing net loss per ordinary share, diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2022)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0" xml:lang="en-US">Weighted average number of ordinary shares outstanding - basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1" xml:lang="en-US">Shares used in computing net loss per ordinary share, basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_2" xml:lang="en-US">Weighted average number of ordinary shares outstanding - Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2" xml:lang="en-US">Shares used in computing net loss per ordinary share, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AccountingPoliciesLineItems_1" xlink:to="lab_chek_AccountingPoliciesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AccountingPoliciesLineItems_2" xlink:to="lab_chek_AccountingPoliciesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AccountingPoliciesTable_3" xlink:to="lab_chek_AccountingPoliciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AccountingPoliciesTable_4" xlink:to="lab_chek_AccountingPoliciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_5" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_6" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_7" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_8" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_9" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_10" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_11" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_12" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_13" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_14" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_15" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseSharesThree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_16" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_17" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_18" xlink:to="lab_chek_AdjustmentsToAdditionalPaidInCapitalWarrantIssuedWarrantExerciseThree_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_19" xlink:to="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_20" xlink:to="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_21" xlink:to="lab_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AntiDilutiveWarrantsMember_22" xlink:to="lab_chek_AntiDilutiveWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AntiDilutiveWarrantsMember_23" xlink:to="lab_chek_AntiDilutiveWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AprilMayOfferingsMember_24" xlink:to="lab_chek_AprilMayOfferingsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AprilMayOfferingsMember_25" xlink:to="lab_chek_AprilMayOfferingsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AprilMayRegisteredDirectOfferingMember_26" xlink:to="lab_chek_AprilMayRegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AprilMayRegisteredDirectOfferingMember_27" xlink:to="lab_chek_AprilMayRegisteredDirectOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AprilSixthMember_28" xlink:to="lab_chek_AprilSixthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AsicComponentDesignerRoyaltiesMember_29" xlink:to="lab_chek_AsicComponentDesignerRoyaltiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AsicComponentDesignerRoyaltiesMember_30" xlink:to="lab_chek_AsicComponentDesignerRoyaltiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AsicComponentDesignerRoyaltiesMember_31" xlink:to="lab_chek_AsicComponentDesignerRoyaltiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AugustThirteenthOneMember_32" xlink:to="lab_chek_AugustThirteenthOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_AugustThirteenthTwoMember_33" xlink:to="lab_chek_AugustThirteenthTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_BankLeumiCreditFacilityMember_34" xlink:to="lab_chek_BankLeumiCreditFacilityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_35" xlink:to="lab_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_36" xlink:to="lab_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_C1WarrantsMember_37" xlink:to="lab_chek_C1WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_C2WarrantsMember_38" xlink:to="lab_chek_C2WarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainEmployeesMember_39" xlink:to="lab_chek_CertainEmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainEmployeesMember_40" xlink:to="lab_chek_CertainEmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainEmployeesMember_41" xlink:to="lab_chek_CertainEmployeesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficerMember_42" xlink:to="lab_chek_CertainOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficerMember_43" xlink:to="lab_chek_CertainOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficerMember_44" xlink:to="lab_chek_CertainOfficerMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_45" xlink:to="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_46" xlink:to="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_47" xlink:to="lab_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChangesInLiabilityToPayRoyalties_48" xlink:to="lab_chek_ChangesInLiabilityToPayRoyalties_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChangesInLiabilityToPayRoyalties_49" xlink:to="lab_chek_ChangesInLiabilityToPayRoyalties_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChangesInLiabilityToPayRoyalties_50" xlink:to="lab_chek_ChangesInLiabilityToPayRoyalties_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CheckCapUsIncMember_51" xlink:to="lab_chek_CheckCapUsIncMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CheckCapUsIncMember_52" xlink:to="lab_chek_CheckCapUsIncMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CheckCapUsIncMember_53" xlink:to="lab_chek_CheckCapUsIncMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_54" xlink:to="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_55" xlink:to="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_56" xlink:to="lab_chek_ChiefExecutiveOfficerAndBoardMembersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpiration_57" xlink:to="lab_chek_ClassOfWarrantOrRightExpiration_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpiration_58" xlink:to="lab_chek_ClassOfWarrantOrRightExpiration_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpiration_59" xlink:to="lab_chek_ClassOfWarrantOrRightExpiration_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpirationPeriod_60" xlink:to="lab_chek_ClassOfWarrantOrRightExpirationPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpirationPeriod_61" xlink:to="lab_chek_ClassOfWarrantOrRightExpirationPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightExpirationPeriod_62" xlink:to="lab_chek_ClassOfWarrantOrRightExpirationPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_63" xlink:to="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_64" xlink:to="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_65" xlink:to="lab_chek_ClassOfWarrantOrRightReducedExercisePriceOfWarrantsOrRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClinicalTrialsAndRegulationExpense_66" xlink:to="lab_chek_ClinicalTrialsAndRegulationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ClinicalTrialsAndRegulationExpense_67" xlink:to="lab_chek_ClinicalTrialsAndRegulationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_68" xlink:to="lab_chek_CommitmentsAndContingenciesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_69" xlink:to="lab_chek_CommitmentsAndContingenciesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommitmentsAndContingenciesTable_70" xlink:to="lab_chek_CommitmentsAndContingenciesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommitmentsAndContingenciesTable_71" xlink:to="lab_chek_CommitmentsAndContingenciesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommonClassDMember_72" xlink:to="lab_chek_CommonClassDMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommonStockUnitsIssued_73" xlink:to="lab_chek_CommonStockUnitsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommonStockUnitsIssued_74" xlink:to="lab_chek_CommonStockUnitsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CommonStockUnitsIssued_75" xlink:to="lab_chek_CommonStockUnitsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CompensationExpenseEstimationForGrantDate_76" xlink:to="lab_chek_CompensationExpenseEstimationForGrantDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CompensationExpenseEstimationForGrantDate_77" xlink:to="lab_chek_CompensationExpenseEstimationForGrantDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ConsultingFeesMember_78" xlink:to="lab_chek_ConsultingFeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ConsultingFeesMember_79" xlink:to="lab_chek_ConsultingFeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ContingentLiability_80" xlink:to="lab_chek_ContingentLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ContingentLiability_81" xlink:to="lab_chek_ContingentLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ContingentLiability_82" xlink:to="lab_chek_ContingentLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CounterpointVenturesFundTwoMember_83" xlink:to="lab_chek_CounterpointVenturesFundTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CreditLineAgreementWarrantsMember_84" xlink:to="lab_chek_CreditLineAgreementWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_CreditLineAgreementWarrantsMember_85" xlink:to="lab_chek_CreditLineAgreementWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_86" xlink:to="lab_chek_DerivativeChangeInFairValueOfOptionOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_87" xlink:to="lab_chek_DerivativeChangeInFairValueOfOptionOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DesignerRoyaltiesMember_88" xlink:to="lab_chek_DesignerRoyaltiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DesignerRoyaltiesMember_89" xlink:to="lab_chek_DesignerRoyaltiesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DesignerRoyaltiesMember_90" xlink:to="lab_chek_DesignerRoyaltiesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DevelopmentAreaAMember_91" xlink:to="lab_chek_DevelopmentAreaAMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DevelopmentAreaAMember_92" xlink:to="lab_chek_DevelopmentAreaAMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DevelopmentAreaAMember_93" xlink:to="lab_chek_DevelopmentAreaAMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DocorInternationalBVMember_94" xlink:to="lab_chek_DocorInternationalBVMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_DocumentAndEntityInformationAbstract_95" xlink:to="lab_chek_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_EmployeeRelatedLiabilitiesTextBlock_96" xlink:to="lab_chek_EmployeeRelatedLiabilitiesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_EmployeeRelatedLiabilitiesTextBlock_97" xlink:to="lab_chek_EmployeeRelatedLiabilitiesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_EscoVenturesPteLtdMember_98" xlink:to="lab_chek_EscoVenturesPteLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ExercisePriceOfWarrants_99" xlink:to="lab_chek_ExercisePriceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ExercisePriceOfWarrants_100" xlink:to="lab_chek_ExercisePriceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ExercisePriceOfWarrants_101" xlink:to="lab_chek_ExercisePriceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FairValueOfHedgingOption_102" xlink:to="lab_chek_FairValueOfHedgingOption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FairValueOfHedgingOption_103" xlink:to="lab_chek_FairValueOfHedgingOption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FairValueOfWarrantsIssued_104" xlink:to="lab_chek_FairValueOfWarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FairValueOfWarrantsIssued_105" xlink:to="lab_chek_FairValueOfWarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FairValueOfWarrantsIssued_106" xlink:to="lab_chek_FairValueOfWarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FebruaryEighteenthMember_107" xlink:to="lab_chek_FebruaryEighteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FebruaryTwentyFourthOneMember_108" xlink:to="lab_chek_FebruaryTwentyFourthOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FebruaryTwentyFourthTwoMember_109" xlink:to="lab_chek_FebruaryTwentyFourthTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FeesAndReimbursementMember_110" xlink:to="lab_chek_FeesAndReimbursementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FeesAndReimbursementMember_111" xlink:to="lab_chek_FeesAndReimbursementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FindersWarrantsMember_112" xlink:to="lab_chek_FindersWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FirstMarchMember_113" xlink:to="lab_chek_FirstMarchMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FiveYearWarrantsMember_114" xlink:to="lab_chek_FiveYearWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FiveYearWarrantsMember_115" xlink:to="lab_chek_FiveYearWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ForeignCurrencyDerivativeInstrumentsMember_116" xlink:to="lab_chek_ForeignCurrencyDerivativeInstrumentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ForeignIncomeTaxRateMaximum_117" xlink:to="lab_chek_ForeignIncomeTaxRateMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ForeignIncomeTaxRateMaximum_118" xlink:to="lab_chek_ForeignIncomeTaxRateMaximum_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FourAugustMember_119" xlink:to="lab_chek_FourAugustMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FourMayMember_120" xlink:to="lab_chek_FourMayMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FunctionalCurrencyPolicyTextBlock_121" xlink:to="lab_chek_FunctionalCurrencyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FunctionalCurrencyPolicyTextBlock_122" xlink:to="lab_chek_FunctionalCurrencyPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FunctionalCurrencyPolicyTextBlock_123" xlink:to="lab_chek_FunctionalCurrencyPolicyTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FutureFederalIncomeTaxRate_124" xlink:to="lab_chek_FutureFederalIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FutureFederalIncomeTaxRate_125" xlink:to="lab_chek_FutureFederalIncomeTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FutureFederalIncomeTaxRateNextYear_126" xlink:to="lab_chek_FutureFederalIncomeTaxRateNextYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_FutureFederalIncomeTaxRateNextYear_127" xlink:to="lab_chek_FutureFederalIncomeTaxRateNextYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralAndAdministrativeExpensesLineItems_128" xlink:to="lab_chek_GeneralAndAdministrativeExpensesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralAndAdministrativeExpensesTable_129" xlink:to="lab_chek_GeneralAndAdministrativeExpensesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralAndAdministrativeExpensesTextBlock_130" xlink:to="lab_chek_GeneralAndAdministrativeExpensesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralAndAdministrativeExpensesTextBlock_131" xlink:to="lab_chek_GeneralAndAdministrativeExpensesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralAndAdministrativeExpensesTextBlock_132" xlink:to="lab_chek_GeneralAndAdministrativeExpensesTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralTransactionsMember_133" xlink:to="lab_chek_GeneralTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GeneralTransactionsMember_134" xlink:to="lab_chek_GeneralTransactionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GovernmentInstitutionalAssetsCurrent_135" xlink:to="lab_chek_GovernmentInstitutionalAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GovernmentInstitutionalAssetsCurrent_136" xlink:to="lab_chek_GovernmentInstitutionalAssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate10Member_137" xlink:to="lab_chek_GrantDate10Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate10Member_138" xlink:to="lab_chek_GrantDate10Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate10Member_139" xlink:to="lab_chek_GrantDate10Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate11Member_140" xlink:to="lab_chek_GrantDate11Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate11Member_141" xlink:to="lab_chek_GrantDate11Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate11Member_142" xlink:to="lab_chek_GrantDate11Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate12Member_143" xlink:to="lab_chek_GrantDate12Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate13Member_144" xlink:to="lab_chek_GrantDate13Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate13Member_145" xlink:to="lab_chek_GrantDate13Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate13Member_146" xlink:to="lab_chek_GrantDate13Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate14Member_147" xlink:to="lab_chek_GrantDate14Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate15Member_148" xlink:to="lab_chek_GrantDate15Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate16Member_149" xlink:to="lab_chek_GrantDate16Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate17Member_150" xlink:to="lab_chek_GrantDate17Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate17Member_151" xlink:to="lab_chek_GrantDate17Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate17Member_152" xlink:to="lab_chek_GrantDate17Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate18Member_153" xlink:to="lab_chek_GrantDate18Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate1Member_154" xlink:to="lab_chek_GrantDate1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate1Member_155" xlink:to="lab_chek_GrantDate1Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate1Member_156" xlink:to="lab_chek_GrantDate1Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate2Member_157" xlink:to="lab_chek_GrantDate2Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate2Member_158" xlink:to="lab_chek_GrantDate2Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate2Member_159" xlink:to="lab_chek_GrantDate2Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate3Member_160" xlink:to="lab_chek_GrantDate3Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate3Member_161" xlink:to="lab_chek_GrantDate3Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate3Member_162" xlink:to="lab_chek_GrantDate3Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate4Member_163" xlink:to="lab_chek_GrantDate4Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate4Member_164" xlink:to="lab_chek_GrantDate4Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate4Member_165" xlink:to="lab_chek_GrantDate4Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate5Member_166" xlink:to="lab_chek_GrantDate5Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate5Member_167" xlink:to="lab_chek_GrantDate5Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate5Member_168" xlink:to="lab_chek_GrantDate5Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate6Member_169" xlink:to="lab_chek_GrantDate6Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate6Member_170" xlink:to="lab_chek_GrantDate6Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate6Member_171" xlink:to="lab_chek_GrantDate6Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate7Member_172" xlink:to="lab_chek_GrantDate7Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate7Member_173" xlink:to="lab_chek_GrantDate7Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate7Member_174" xlink:to="lab_chek_GrantDate7Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate8Member_175" xlink:to="lab_chek_GrantDate8Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate8Member_176" xlink:to="lab_chek_GrantDate8Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate8Member_177" xlink:to="lab_chek_GrantDate8Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate9Member_178" xlink:to="lab_chek_GrantDate9Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate9Member_179" xlink:to="lab_chek_GrantDate9Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDate9Member_180" xlink:to="lab_chek_GrantDate9Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne1Member_181" xlink:to="lab_chek_GrantDateOne1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne1Member_182" xlink:to="lab_chek_GrantDateOne1Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne1Member_183" xlink:to="lab_chek_GrantDateOne1Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne2Member_184" xlink:to="lab_chek_GrantDateOne2Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne2Member_185" xlink:to="lab_chek_GrantDateOne2Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne2Member_186" xlink:to="lab_chek_GrantDateOne2Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne3Member_187" xlink:to="lab_chek_GrantDateOne3Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne3Member_188" xlink:to="lab_chek_GrantDateOne3Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne3Member_189" xlink:to="lab_chek_GrantDateOne3Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne4Member_190" xlink:to="lab_chek_GrantDateOne4Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne4Member_191" xlink:to="lab_chek_GrantDateOne4Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOne4Member_192" xlink:to="lab_chek_GrantDateOne4Member_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneEightMember_193" xlink:to="lab_chek_GrantDateOneEightMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneEightMember_194" xlink:to="lab_chek_GrantDateOneEightMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneEightMember_195" xlink:to="lab_chek_GrantDateOneEightMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneFiveMember_196" xlink:to="lab_chek_GrantDateOneFiveMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneFiveMember_197" xlink:to="lab_chek_GrantDateOneFiveMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneFiveMember_198" xlink:to="lab_chek_GrantDateOneFiveMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneNineMember_199" xlink:to="lab_chek_GrantDateOneNineMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneNineMember_200" xlink:to="lab_chek_GrantDateOneNineMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneNineMember_201" xlink:to="lab_chek_GrantDateOneNineMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSevenMember_202" xlink:to="lab_chek_GrantDateOneSevenMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSevenMember_203" xlink:to="lab_chek_GrantDateOneSevenMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSevenMember_204" xlink:to="lab_chek_GrantDateOneSevenMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSixMember_205" xlink:to="lab_chek_GrantDateOneSixMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSixMember_206" xlink:to="lab_chek_GrantDateOneSixMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateOneSixMember_207" xlink:to="lab_chek_GrantDateOneSixMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateTwoZeroMember_208" xlink:to="lab_chek_GrantDateTwoZeroMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantDateTwoZeroMember_209" xlink:to="lab_chek_GrantDateTwoZeroMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantedRevenue_210" xlink:to="lab_chek_GrantedRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantedRevenue_211" xlink:to="lab_chek_GrantedRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantedRevenue_212" xlink:to="lab_chek_GrantedRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrantedRevenue_213" xlink:to="lab_chek_GrantedRevenue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrossOvertimeMonthlyRate_214" xlink:to="lab_chek_GrossOvertimeMonthlyRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_GrossOvertimeMonthlyRate_215" xlink:to="lab_chek_GrossOvertimeMonthlyRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IIAMember_216" xlink:to="lab_chek_IIAMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IIAMember_217" xlink:to="lab_chek_IIAMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_InstitutionalAndAccreditedInvestorsMember_218" xlink:to="lab_chek_InstitutionalAndAccreditedInvestorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_InstitutionalAndAccreditedInvestorsMember_219" xlink:to="lab_chek_InstitutionalAndAccreditedInvestorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_InstitutionalAndAccreditedInvestorsMember_220" xlink:to="lab_chek_InstitutionalAndAccreditedInvestorsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_InvestorWarrantsMember_221" xlink:to="lab_chek_InvestorWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_222" xlink:to="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_223" xlink:to="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_224" xlink:to="lab_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IssuanceExpenses_225" xlink:to="lab_chek_IssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IssuanceExpenses_226" xlink:to="lab_chek_IssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_IssuanceExpenses_227" xlink:to="lab_chek_IssuanceExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_JanuaryFifteenthMember_228" xlink:to="lab_chek_JanuaryFifteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_June2017RegisteredDirectOfferingMember_229" xlink:to="lab_chek_June2017RegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_JuneFirstMember_230" xlink:to="lab_chek_JuneFirstMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_JuneSixthMember_231" xlink:to="lab_chek_JuneSixthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_JuneThirdMember_232" xlink:to="lab_chek_JuneThirdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_KeyManInsurancePolicy_233" xlink:to="lab_chek_KeyManInsurancePolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_KeyManInsurancePolicy_234" xlink:to="lab_chek_KeyManInsurancePolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_KeyManLifeInsurancePremiumMember_235" xlink:to="lab_chek_KeyManLifeInsurancePremiumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_KeyManLifeInsurancePremiumMember_236" xlink:to="lab_chek_KeyManLifeInsurancePremiumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LegalWarrantsMember_237" xlink:to="lab_chek_LegalWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LegalWarrantsMember_238" xlink:to="lab_chek_LegalWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LesseeOperatingLeaseAdditionalTerm_239" xlink:to="lab_chek_LesseeOperatingLeaseAdditionalTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LesseeOperatingLeaseAdditionalTerm_240" xlink:to="lab_chek_LesseeOperatingLeaseAdditionalTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LesseeOperatingLeaseAdditionalTerm_241" xlink:to="lab_chek_LesseeOperatingLeaseAdditionalTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LongTermIncentiveWarrantsMember_242" xlink:to="lab_chek_LongTermIncentiveWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_LongTermIncentiveWarrantsMember_243" xlink:to="lab_chek_LongTermIncentiveWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ManufacturingProgramMember_244" xlink:to="lab_chek_ManufacturingProgramMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ManufacturingProgramMember_245" xlink:to="lab_chek_ManufacturingProgramMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_March2022RegisteredDirectOfferingMember_246" xlink:to="lab_chek_March2022RegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_March2022RegisteredDirectOfferingMember_247" xlink:to="lab_chek_March2022RegisteredDirectOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MarchFifteenthMember_248" xlink:to="lab_chek_MarchFifteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MaximumAggregateMonthlySalary_249" xlink:to="lab_chek_MaximumAggregateMonthlySalary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MaximumAggregateMonthlySalary_250" xlink:to="lab_chek_MaximumAggregateMonthlySalary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MaximumRoyaltyObligation_251" xlink:to="lab_chek_MaximumRoyaltyObligation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MaximumRoyaltyObligation_252" xlink:to="lab_chek_MaximumRoyaltyObligation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MaximumRoyaltyObligation_253" xlink:to="lab_chek_MaximumRoyaltyObligation_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MayFifteenthMember_254" xlink:to="lab_chek_MayFifteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MayNineteenthMember_255" xlink:to="lab_chek_MayNineteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MinimumBidPriceValuePerShare_256" xlink:to="lab_chek_MinimumBidPriceValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MinimumBidPriceValuePerShare_257" xlink:to="lab_chek_MinimumBidPriceValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyRentalFee_258" xlink:to="lab_chek_MonthlyRentalFee_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyRentalFee_259" xlink:to="lab_chek_MonthlyRentalFee_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyRetainer_260" xlink:to="lab_chek_MonthlyRetainer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyRetainer_261" xlink:to="lab_chek_MonthlyRetainer_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlySalary_262" xlink:to="lab_chek_MonthlySalary_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlySalary_263" xlink:to="lab_chek_MonthlySalary_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyVehicleLeaseExpense_264" xlink:to="lab_chek_MonthlyVehicleLeaseExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyVehicleLeaseExpense_265" xlink:to="lab_chek_MonthlyVehicleLeaseExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_MonthlyVehicleLeaseExpense_266" xlink:to="lab_chek_MonthlyVehicleLeaseExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_267" xlink:to="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_268" xlink:to="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_269" xlink:to="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_270" xlink:to="lab_chek_NetProceedsFromIssuanceOfSharesAndWarrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NineMayMember_271" xlink:to="lab_chek_NineMayMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NonExecutiveDirectorsCompensationMember_272" xlink:to="lab_chek_NonExecutiveDirectorsCompensationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NonExecutiveDirectorsCompensationMember_273" xlink:to="lab_chek_NonExecutiveDirectorsCompensationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NonExecutiveDirectorsMember_274" xlink:to="lab_chek_NonExecutiveDirectorsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NonExecutiveDirectorsMember_275" xlink:to="lab_chek_NonExecutiveDirectorsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_November2017RegisteredDirectOfferingMember_276" xlink:to="lab_chek_November2017RegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_277" xlink:to="lab_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_278" xlink:to="lab_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_279" xlink:to="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_280" xlink:to="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_281" xlink:to="lab_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfSharesRestrictedStockVested_282" xlink:to="lab_chek_NumberOfSharesRestrictedStockVested_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfSharesRestrictedStockVested_283" xlink:to="lab_chek_NumberOfSharesRestrictedStockVested_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_284" xlink:to="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_285" xlink:to="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_286" xlink:to="lab_chek_NumberOfWarrantsToBeGrantedUponExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OctoberFourteenthMember_287" xlink:to="lab_chek_OctoberFourteenthMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OctoberTwentiethMember_288" xlink:to="lab_chek_OctoberTwentiethMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeOfTheChiefScientistMember_289" xlink:to="lab_chek_OfficeOfTheChiefScientistMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeOfTheChiefScientistMember_290" xlink:to="lab_chek_OfficeOfTheChiefScientistMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeRentAndMaintenance_291" xlink:to="lab_chek_OfficeRentAndMaintenance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeRentAndMaintenance_292" xlink:to="lab_chek_OfficeRentAndMaintenance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeRentAndMaintenance_293" xlink:to="lab_chek_OfficeRentAndMaintenance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficeRentAndMaintenance_294" xlink:to="lab_chek_OfficeRentAndMaintenance_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficersAndEmployeesMember_295" xlink:to="lab_chek_OfficersAndEmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficersAndEmployeesMember_296" xlink:to="lab_chek_OfficersAndEmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OfficersAndEmployeesMember_297" xlink:to="lab_chek_OfficersAndEmployeesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OneYearWarrantsMember_298" xlink:to="lab_chek_OneYearWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OneYearWarrantsMember_299" xlink:to="lab_chek_OneYearWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OperatingLeaseRentExpenseMonthly_300" xlink:to="lab_chek_OperatingLeaseRentExpenseMonthly_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OperatingLeaseRentExpenseMonthly_301" xlink:to="lab_chek_OperatingLeaseRentExpenseMonthly_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OperatingLeaseRentExpenseMonthly_302" xlink:to="lab_chek_OperatingLeaseRentExpenseMonthly_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OrdinarySharesMember_303" xlink:to="lab_chek_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OrdinarySharesMember_304" xlink:to="lab_chek_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OrdinarySharesMember_305" xlink:to="lab_chek_OrdinarySharesMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_306" xlink:to="lab_chek_OtherCurrentAssetsFairValueDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_307" xlink:to="lab_chek_OtherCurrentAssetsFairValueDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_308" xlink:to="lab_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_309" xlink:to="lab_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PaymentsExpensesForPatents_310" xlink:to="lab_chek_PaymentsExpensesForPatents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PaymentsExpensesForPatents_311" xlink:to="lab_chek_PaymentsExpensesForPatents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PaymentsExpensesForPatents_312" xlink:to="lab_chek_PaymentsExpensesForPatents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PaymentsExpensesForPatents_313" xlink:to="lab_chek_PaymentsExpensesForPatents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_314" xlink:to="lab_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_315" xlink:to="lab_chek_PercentageOfNumberOfOrdinarySharesIssuedUponCashExercise_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_316" xlink:to="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_317" xlink:to="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_318" xlink:to="lab_chek_PercentageOfOptionsAndRsusExpectedToVestAndExercisableOnFirstAnniversaryOfDateOfGrant_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_319" xlink:to="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_320" xlink:to="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_321" xlink:to="lab_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfSharesFullyDiluted_322" xlink:to="lab_chek_PercentageOfSharesFullyDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfSharesFullyDiluted_323" xlink:to="lab_chek_PercentageOfSharesFullyDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PercentageOfSharesFullyDiluted_324" xlink:to="lab_chek_PercentageOfSharesFullyDiluted_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PeriodOfVestingEqualPortion_325" xlink:to="lab_chek_PeriodOfVestingEqualPortion_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PeriodOfVestingEqualPortion_326" xlink:to="lab_chek_PeriodOfVestingEqualPortion_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PeriodOfVestingEqualPortion_327" xlink:to="lab_chek_PeriodOfVestingEqualPortion_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgent2Member_328" xlink:to="lab_chek_PlacementAgent2Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgent2Member_329" xlink:to="lab_chek_PlacementAgent2Member_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentMember_330" xlink:to="lab_chek_PlacementAgentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentMember_331" xlink:to="lab_chek_PlacementAgentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentMember_332" xlink:to="lab_chek_PlacementAgentMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentsMember_333" xlink:to="lab_chek_PlacementAgentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentsMember_334" xlink:to="lab_chek_PlacementAgentsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentsMember_335" xlink:to="lab_chek_PlacementAgentsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentWarrantsMember_336" xlink:to="lab_chek_PlacementAgentWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentWarrantsMember_337" xlink:to="lab_chek_PlacementAgentWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PlacementAgentWarrantsMember_338" xlink:to="lab_chek_PlacementAgentWarrantsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PontifaxFundsMember_339" xlink:to="lab_chek_PontifaxFundsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PontifaxMember_340" xlink:to="lab_chek_PontifaxMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PredecessorUnitHoldersMember_341" xlink:to="lab_chek_PredecessorUnitHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PredecessorUnitHoldersMember_342" xlink:to="lab_chek_PredecessorUnitHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PredecessorUnitHoldersMember_343" xlink:to="lab_chek_PredecessorUnitHoldersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreferredSharesConversionMember_344" xlink:to="lab_chek_PreferredSharesConversionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreferredSharesMember_345" xlink:to="lab_chek_PreferredSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreferredShareWarrantsConversionMember_346" xlink:to="lab_chek_PreferredShareWarrantsConversionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedUnitsMember_347" xlink:to="lab_chek_PreFundedUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedUnitsMember_348" xlink:to="lab_chek_PreFundedUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsMember_349" xlink:to="lab_chek_PreFundedWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsMember_350" xlink:to="lab_chek_PreFundedWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsOneMember_351" xlink:to="lab_chek_PreFundedWarrantsOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsOneMember_352" xlink:to="lab_chek_PreFundedWarrantsOneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchase_353" xlink:to="lab_chek_PreFundedWarrantsPurchase_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchase_354" xlink:to="lab_chek_PreFundedWarrantsPurchase_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchase_355" xlink:to="lab_chek_PreFundedWarrantsPurchase_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_356" xlink:to="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_357" xlink:to="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_358" xlink:to="lab_chek_PreFundedWarrantsPurchaseSharesIssuable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PrefundedWarrantsToPurchasePrice_359" xlink:to="lab_chek_PrefundedWarrantsToPurchasePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PrefundedWarrantsToPurchasePrice_360" xlink:to="lab_chek_PrefundedWarrantsToPurchasePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PremiumPercentageToCalculateExercisePrice_361" xlink:to="lab_chek_PremiumPercentageToCalculateExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PremiumPercentageToCalculateExercisePrice_362" xlink:to="lab_chek_PremiumPercentageToCalculateExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PremiumPercentageToCalculateExercisePrice_363" xlink:to="lab_chek_PremiumPercentageToCalculateExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_364" xlink:to="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_365" xlink:to="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_366" xlink:to="lab_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PricePerUnit_367" xlink:to="lab_chek_PricePerUnit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PricePerUnit_368" xlink:to="lab_chek_PricePerUnit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_369" xlink:to="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_370" xlink:to="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_371" xlink:to="lab_chek_ProceedsFromExerciseOfPrefundedWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfWarrants_372" xlink:to="lab_chek_ProceedsFromExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfWarrants_373" xlink:to="lab_chek_ProceedsFromExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromExerciseOfWarrants_374" xlink:to="lab_chek_ProceedsFromExerciseOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfPublicOffering_375" xlink:to="lab_chek_ProceedsFromIssuanceOfPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfPublicOffering_376" xlink:to="lab_chek_ProceedsFromIssuanceOfPublicOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfPublicOffering_377" xlink:to="lab_chek_ProceedsFromIssuanceOfPublicOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_378" xlink:to="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_379" xlink:to="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_380" xlink:to="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_381" xlink:to="lab_chek_ProceedsFromIssuanceOfRegistredDirectOffering_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfShares_382" xlink:to="lab_chek_ProceedsFromIssuanceOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfShares_383" xlink:to="lab_chek_ProceedsFromIssuanceOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfShares_384" xlink:to="lab_chek_ProceedsFromIssuanceOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_385" xlink:to="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_386" xlink:to="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_387" xlink:to="lab_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_388" xlink:to="lab_chek_ProceedsFromIssuanceResisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_389" xlink:to="lab_chek_ProceedsFromIssuanceResisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_390" xlink:to="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_391" xlink:to="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_392" xlink:to="lab_chek_ProceedsFromIssuanceResisteredDirectOfferingTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PurchasePricePerUnit_393" xlink:to="lab_chek_PurchasePricePerUnit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PurchasePricePerUnit_394" xlink:to="lab_chek_PurchasePricePerUnit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_PurchasePricePerUnit_395" xlink:to="lab_chek_PurchasePricePerUnit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_396" xlink:to="lab_chek_ReconciliationOfCashToBalanceSheetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_397" xlink:to="lab_chek_ReconciliationOfCashToBalanceSheetAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ReductionInIncomeTaxRate_398" xlink:to="lab_chek_ReductionInIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ReductionInIncomeTaxRate_399" xlink:to="lab_chek_ReductionInIncomeTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ReductionInIncomeTaxRate_400" xlink:to="lab_chek_ReductionInIncomeTaxRate_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RefundExpenses_401" xlink:to="lab_chek_RefundExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RefundExpenses_402" xlink:to="lab_chek_RefundExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RefundExpenses_403" xlink:to="lab_chek_RefundExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RegisteredDirectOfferingMember_404" xlink:to="lab_chek_RegisteredDirectOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RegisteredDirectOfferingMember_405" xlink:to="lab_chek_RegisteredDirectOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_406" xlink:to="lab_chek_ResearchAndDevelopmentExpenseGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_407" xlink:to="lab_chek_ResearchAndDevelopmentExpenseGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpenseGross_408" xlink:to="lab_chek_ResearchAndDevelopmentExpenseGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_409" xlink:to="lab_chek_ResearchAndDevelopmentExpensesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_410" xlink:to="lab_chek_ResearchAndDevelopmentExpensesLineItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpensesTable_411" xlink:to="lab_chek_ResearchAndDevelopmentExpensesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ResearchAndDevelopmentExpensesTable_412" xlink:to="lab_chek_ResearchAndDevelopmentExpensesTable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestOfCountryMember_413" xlink:to="lab_chek_RestOfCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestOfCountryMember_414" xlink:to="lab_chek_RestOfCountryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestOfCountryMember_415" xlink:to="lab_chek_RestOfCountryMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestrictedCashIncludedCurrentAssets_416" xlink:to="lab_chek_RestrictedCashIncludedCurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestrictedCashIncludedCurrentAssets_417" xlink:to="lab_chek_RestrictedCashIncludedCurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RestrictedCashIncludedCurrentAssets_418" xlink:to="lab_chek_RestrictedCashIncludedCurrentAssets_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RevenueFromCashCommission_419" xlink:to="lab_chek_RevenueFromCashCommission_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RevenueFromCashCommission_420" xlink:to="lab_chek_RevenueFromCashCommission_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePercentageOfProductSales_421" xlink:to="lab_chek_RoyaltiesPayablePercentageOfProductSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePercentageOfProductSales_422" xlink:to="lab_chek_RoyaltiesPayablePercentageOfProductSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePercentageOfProductSales_423" xlink:to="lab_chek_RoyaltiesPayablePercentageOfProductSales_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePerUnit_424" xlink:to="lab_chek_RoyaltiesPayablePerUnit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePerUnit_425" xlink:to="lab_chek_RoyaltiesPayablePerUnit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePerUnitSold_426" xlink:to="lab_chek_RoyaltiesPayablePerUnitSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePerUnitSold_427" xlink:to="lab_chek_RoyaltiesPayablePerUnitSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesPayablePerUnitSold_428" xlink:to="lab_chek_RoyaltiesPayablePerUnitSold_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesProvision_429" xlink:to="lab_chek_RoyaltiesProvision_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesProvision_430" xlink:to="lab_chek_RoyaltiesProvision_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltiesProvision_431" xlink:to="lab_chek_RoyaltiesProvision_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMaximum_432" xlink:to="lab_chek_RoyaltyAmountPerUnitMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMaximum_433" xlink:to="lab_chek_RoyaltyAmountPerUnitMaximum_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMaximum_434" xlink:to="lab_chek_RoyaltyAmountPerUnitMaximum_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMinimum_435" xlink:to="lab_chek_RoyaltyAmountPerUnitMinimum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMinimum_436" xlink:to="lab_chek_RoyaltyAmountPerUnitMinimum_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyAmountPerUnitMinimum_437" xlink:to="lab_chek_RoyaltyAmountPerUnitMinimum_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyIncomeExpenseNonoperating_438" xlink:to="lab_chek_RoyaltyIncomeExpenseNonoperating_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyIncomeExpenseNonoperating_439" xlink:to="lab_chek_RoyaltyIncomeExpenseNonoperating_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyRepaymentPercentageOfProductsSold_440" xlink:to="lab_chek_RoyaltyRepaymentPercentageOfProductsSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_RoyaltyRepaymentPercentageOfProductsSold_441" xlink:to="lab_chek_RoyaltyRepaymentPercentageOfProductsSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_442" xlink:to="lab_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_443" xlink:to="lab_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_444" xlink:to="lab_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_445" xlink:to="lab_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_446" xlink:to="lab_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_447" xlink:to="lab_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_448" xlink:to="lab_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_449" xlink:to="lab_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_450" xlink:to="lab_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_451" xlink:to="lab_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_452" xlink:to="lab_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_453" xlink:to="lab_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_454" xlink:to="lab_chek_ScheduleOfResearchAndDevelopmentExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_455" xlink:to="lab_chek_ScheduleOfResearchAndDevelopmentExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_456" xlink:to="lab_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_457" xlink:to="lab_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeniorManagementMember_458" xlink:to="lab_chek_SeniorManagementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeniorManagementMember_459" xlink:to="lab_chek_SeniorManagementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesAWarrantsMember_460" xlink:to="lab_chek_SeriesAWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesAWarrantsMember_461" xlink:to="lab_chek_SeriesAWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesC1PreferredStockMember_462" xlink:to="lab_chek_SeriesC1PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesC2PreferredStockMember_463" xlink:to="lab_chek_SeriesC2PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesC3PreferredStockMember_464" xlink:to="lab_chek_SeriesC3PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesCPreferredShareWarrantsConversionMember_465" xlink:to="lab_chek_SeriesCPreferredShareWarrantsConversionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesCWarrantsMember_466" xlink:to="lab_chek_SeriesCWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesCWarrantsMember_467" xlink:to="lab_chek_SeriesCWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_468" xlink:to="lab_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_469" xlink:to="lab_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesD1PreferredStockMember_470" xlink:to="lab_chek_SeriesD1PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesD2PreferredStockMember_471" xlink:to="lab_chek_SeriesD2PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesD3PreferredStockMember_472" xlink:to="lab_chek_SeriesD3PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesD4PreferredStockMember_473" xlink:to="lab_chek_SeriesD4PreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesDWarrantsMember_474" xlink:to="lab_chek_SeriesDWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SeriesDWarrantsMember_475" xlink:to="lab_chek_SeriesDWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ServicesWarrantsMember_476" xlink:to="lab_chek_ServicesWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_477" xlink:to="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_478" xlink:to="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_479" xlink:to="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_480" xlink:to="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_481" xlink:to="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_482" xlink:to="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_483" xlink:to="lab_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_484" xlink:to="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_485" xlink:to="lab_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationAwardTrancheFourMember_486" xlink:to="lab_chek_ShareBasedCompensationAwardTrancheFourMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationAwardTrancheFourMember_487" xlink:to="lab_chek_ShareBasedCompensationAwardTrancheFourMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_488" xlink:to="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_489" xlink:to="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_490" xlink:to="lab_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationInome_491" xlink:to="lab_chek_ShareBasedCompensationInome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationInome_492" xlink:to="lab_chek_ShareBasedCompensationInome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationMember_493" xlink:to="lab_chek_ShareBasedCompensationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareBasedCompensationMember_494" xlink:to="lab_chek_ShareBasedCompensationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapital_495" xlink:to="lab_chek_ShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapital_496" xlink:to="lab_chek_ShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapital_497" xlink:to="lab_chek_ShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapitalLessIssuanceCosts_498" xlink:to="lab_chek_ShareCapitalLessIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapitalLessIssuanceCosts_499" xlink:to="lab_chek_ShareCapitalLessIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShareCapitalLessIssuanceCosts_500" xlink:to="lab_chek_ShareCapitalLessIssuanceCosts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShortTermInvestmentInterestRate_501" xlink:to="lab_chek_ShortTermInvestmentInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ShortTermInvestmentInterestRate_502" xlink:to="lab_chek_ShortTermInvestmentInterestRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_503" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_504" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_505" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_506" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_507" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_508" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_509" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_510" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_511" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_512" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_513" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_514" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_515" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_516" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_517" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_518" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_519" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_520" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_521" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_522" xlink:to="lab_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_523" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_524" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_525" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_526" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_527" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_528" xlink:to="lab_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_529" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_530" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_531" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_532" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_533" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_534" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_535" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_536" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_537" xlink:to="lab_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_538" xlink:to="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_539" xlink:to="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_540" xlink:to="lab_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_541" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_542" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_543" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_544" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_545" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_546" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_547" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_548" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsExercised_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_549" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_550" xlink:to="lab_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_551" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_552" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_553" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_554" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesPrivatePlacementShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_555" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_556" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_557" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_558" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_559" xlink:to="lab_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering4_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_560" xlink:to="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_561" xlink:to="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_562" xlink:to="lab_chek_StockIssuedDuringPeriodValuePrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_563" xlink:to="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_564" xlink:to="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_565" xlink:to="lab_chek_StockIssuedDuringPeriodValueWarrantsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_566" xlink:to="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_567" xlink:to="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_StockOptionsAndRestrictedStockUnitsRsuMember_568" xlink:to="lab_chek_StockOptionsAndRestrictedStockUnitsRsuMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SubcontractorsAndConsultantFees_569" xlink:to="lab_chek_SubcontractorsAndConsultantFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SubcontractorsAndConsultantFees_570" xlink:to="lab_chek_SubcontractorsAndConsultantFees_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SubleaseAgreementMember_571" xlink:to="lab_chek_SubleaseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_SubleaseAgreementMember_572" xlink:to="lab_chek_SubleaseAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ThirtyOneOctoberMember_573" xlink:to="lab_chek_ThirtyOneOctoberMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ThreeAugustMember_574" xlink:to="lab_chek_ThreeAugustMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ThreeAugustMember_575" xlink:to="lab_chek_ThreeAugustMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TweentyNineFebruaryMember_576" xlink:to="lab_chek_TweentyNineFebruaryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwelveDecemberMember_577" xlink:to="lab_chek_TwelveDecemberMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwelveDecemberMember_578" xlink:to="lab_chek_TwelveDecemberMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwentySevenFebruaryMember_579" xlink:to="lab_chek_TwentySevenFebruaryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwentyTwoJuneMember_580" xlink:to="lab_chek_TwentyTwoJuneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwentyTwoJuneMember_581" xlink:to="lab_chek_TwentyTwoJuneMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwoNovemberMember_582" xlink:to="lab_chek_TwoNovemberMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwoThousandFifteenPlanMember_583" xlink:to="lab_chek_TwoThousandFifteenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_TwoThousandFifteenPlanMember_584" xlink:to="lab_chek_TwoThousandFifteenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_UnderwriterWarrantsMember_585" xlink:to="lab_chek_UnderwriterWarrantsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_UnderwriterWarrantsMember_586" xlink:to="lab_chek_UnderwriterWarrantsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_UnitsPurchased_587" xlink:to="lab_chek_UnitsPurchased_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_UnitsPurchased_588" xlink:to="lab_chek_UnitsPurchased_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_UniversityOfMissouriLicenseAgreementMember_589" xlink:to="lab_chek_UniversityOfMissouriLicenseAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_590" xlink:to="lab_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_591" xlink:to="lab_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_VariousDatesIn2015Member_592" xlink:to="lab_chek_VariousDatesIn2015Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_VariousDatesMember_593" xlink:to="lab_chek_VariousDatesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_VpClinicalMember_594" xlink:to="lab_chek_VpClinicalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_VpClinicalMember_595" xlink:to="lab_chek_VpClinicalMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_VpClinicalMember_596" xlink:to="lab_chek_VpClinicalMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAmendmentAgreementMember_597" xlink:to="lab_chek_WarrantAmendmentAgreementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAmendmentAgreementMember_598" xlink:to="lab_chek_WarrantAmendmentAgreementMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAmendmentAgreementMember_599" xlink:to="lab_chek_WarrantAmendmentAgreementMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAndShareOptionsMember_600" xlink:to="lab_chek_WarrantAndShareOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAndShareOptionsMember_601" xlink:to="lab_chek_WarrantAndShareOptionsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantAwardsMember_602" xlink:to="lab_chek_WarrantAwardsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantLiabilityReclassificationToEquity_603" xlink:to="lab_chek_WarrantLiabilityReclassificationToEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantLiabilityReclassificationToEquity_604" xlink:to="lab_chek_WarrantLiabilityReclassificationToEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantLiabilityReclassificationToEquity_605" xlink:to="lab_chek_WarrantLiabilityReclassificationToEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsCashlessExercise_606" xlink:to="lab_chek_WarrantsCashlessExercise_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsCashlessExercise_607" xlink:to="lab_chek_WarrantsCashlessExercise_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsExercisedCashlessBasis_608" xlink:to="lab_chek_WarrantsExercisedCashlessBasis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsExercisedCashlessBasis_609" xlink:to="lab_chek_WarrantsExercisedCashlessBasis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsExerciseTransactionMember_610" xlink:to="lab_chek_WarrantsExerciseTransactionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsExerciseTransactionMember_611" xlink:to="lab_chek_WarrantsExerciseTransactionMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssued_612" xlink:to="lab_chek_WarrantsIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssued_613" xlink:to="lab_chek_WarrantsIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssued_614" xlink:to="lab_chek_WarrantsIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssuedNotExercised_615" xlink:to="lab_chek_WarrantsIssuedNotExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssuedNotExercised_616" xlink:to="lab_chek_WarrantsIssuedNotExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsIssuedNotExercised_617" xlink:to="lab_chek_WarrantsIssuedNotExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsOutstanding_618" xlink:to="lab_chek_WarrantsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsOutstanding_619" xlink:to="lab_chek_WarrantsOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsOutstandingAmount_620" xlink:to="lab_chek_WarrantsOutstandingAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsOutstandingAmount_621" xlink:to="lab_chek_WarrantsOutstandingAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsPolicyTextBlock_622" xlink:to="lab_chek_WarrantsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsPolicyTextBlock_623" xlink:to="lab_chek_WarrantsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsSeriesCPreferredSharesMember_624" xlink:to="lab_chek_WarrantsSeriesCPreferredSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantsSeriesDPreferredSharesMember_625" xlink:to="lab_chek_WarrantsSeriesDPreferredSharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantThatWereExercised_626" xlink:to="lab_chek_WarrantThatWereExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_chek_WarrantThatWereExercised_627" xlink:to="lab_chek_WarrantThatWereExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_628" xlink:to="lab_country_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL_629" xlink:to="lab_country_IL_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain_630" xlink:to="lab_currency_AllCurrenciesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR_631" xlink:to="lab_currency_EUR_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_ILS_632" xlink:to="lab_currency_ILS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain_633" xlink:to="lab_dei_AddressTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_634" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AnnualInformationForm_635" xlink:to="lab_dei_AnnualInformationForm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId_636" xlink:to="lab_dei_AuditorFirmId_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation_637" xlink:to="lab_dei_AuditorLocation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName_638" xlink:to="lab_dei_AuditorName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember_639" xlink:to="lab_dei_BusinessContactMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_640" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress_641" xlink:to="lab_dei_ContactPersonnelEmailAddress_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelFaxNumber_642" xlink:to="lab_dei_ContactPersonnelFaxNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName_643" xlink:to="lab_dei_ContactPersonnelName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_644" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_645" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard_646" xlink:to="lab_dei_DocumentAccountingStandard_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport_647" xlink:to="lab_dei_DocumentAnnualReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_648" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_649" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_650" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement_651" xlink:to="lab_dei_DocumentRegistrationStatement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport_652" xlink:to="lab_dei_DocumentShellCompanyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_653" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_654" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_655" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_656" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3_657" xlink:to="lab_dei_EntityAddressAddressLine3_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_658" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_659" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_660" xlink:to="lab_dei_EntityAddressesAddressTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems_661" xlink:to="lab_dei_EntityAddressesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable_662" xlink:to="lab_dei_EntityAddressesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_663" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_664" xlink:to="lab_dei_EntityAddressStateOrProvince_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_665" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_666" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_667" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_668" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_669" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_670" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_671" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_672" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_673" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_674" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_675" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_676" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_677" xlink:to="lab_dei_EntityVoluntaryFilers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_678" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag_679" xlink:to="lab_dei_IcfrAuditorAttestationFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_680" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_681" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_682" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_683" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_684" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_BoardOfDirectorsChairmanMember_685" xlink:to="lab_srt_BoardOfDirectorsChairmanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember_686" xlink:to="lab_srt_ChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis_687" xlink:to="lab_srt_CurrencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_688" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_689" xlink:to="lab_srt_MaximumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_690" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_691" xlink:to="lab_srt_MinimumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_692" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_693" xlink:to="lab_srt_RangeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_694" xlink:to="lab_srt_RangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_695" xlink:to="lab_srt_SegmentGeographicalDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_696" xlink:to="lab_srt_StatementGeographicalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_697" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_698" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL_699" xlink:to="lab_stpr_IL_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_700" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_701" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_702" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_703" xlink:to="lab_us-gaap_AccountsPayableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_704" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_705" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_706" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_707" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent_708" xlink:to="lab_us-gaap_AccruedSalariesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent_709" xlink:to="lab_us-gaap_AccruedVacationCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_710" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_711" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_712" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_713" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_714" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_715" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_716" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_717" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_718" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_719" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_720" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_721" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_722" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_723" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_724" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_725" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_726" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty_727" xlink:to="lab_us-gaap_AreaOfRealEstateProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty_728" xlink:to="lab_us-gaap_AreaOfRealEstateProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_729" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_730" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_731" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_732" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_733" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_734" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_735" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_736" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_737" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_738" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_739" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_740" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_741" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis_742" xlink:to="lab_us-gaap_AwardDateAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain_743" xlink:to="lab_us-gaap_AwardDateDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_744" xlink:to="lab_us-gaap_AwardTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting_745" xlink:to="lab_us-gaap_BasisOfAccounting_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsIncurred_746" xlink:to="lab_us-gaap_CapitalLeaseObligationsIncurred_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_747" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_748" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_749" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_750" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_751" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_752" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_753" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_754" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_755" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_756" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_757" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_758" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_759" xlink:to="lab_us-gaap_ClassOfStockLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_760" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_761" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_762" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_763" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_764" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_765" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_766" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_767" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_768" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding_769" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_770" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_771" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_772" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassCMember_773" xlink:to="lab_us-gaap_CommonClassCMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_774" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_775" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_776" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_777" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_778" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_779" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_780" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_781" xlink:to="lab_us-gaap_CommonStockSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_782" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_783" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_784" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_785" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_786" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_787" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_788" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_789" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_790" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_791" xlink:to="lab_us-gaap_ComputerEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_792" xlink:to="lab_us-gaap_ComputerEquipmentMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk_793" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_794" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock_795" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1_796" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1_797" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_798" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_799" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_800" xlink:to="lab_us-gaap_DebtDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_801" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_802" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_803" xlink:to="lab_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate_804" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_805" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_806" xlink:to="lab_us-gaap_DeferredTaxAssetsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_807" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_808" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_809" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_810" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_811" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_812" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_813" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_814" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction_815" xlink:to="lab_us-gaap_DepreciationNonproduction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction_816" xlink:to="lab_us-gaap_DepreciationNonproduction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount_817" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_818" xlink:to="lab_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_819" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_820" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_821" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_822" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_823" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_824" xlink:to="lab_us-gaap_DomesticCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_825" xlink:to="lab_us-gaap_DomesticCountryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_826" xlink:to="lab_us-gaap_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_827" xlink:to="lab_us-gaap_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_828" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_829" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_830" xlink:to="lab_us-gaap_EarningsPerShareBasic_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_831" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_832" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_833" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_834" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_835" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_836" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_837" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_838" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_839" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_840" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_841" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_842" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_843" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_844" xlink:to="lab_us-gaap_EmployeeStockOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_845" xlink:to="lab_us-gaap_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_846" xlink:to="lab_us-gaap_EquityComponentDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants_847" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants_848" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_849" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_850" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_851" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_852" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_853" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_854" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_855" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_856" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_857" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_858" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_859" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_860" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_861" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_862" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_863" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_864" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_865" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability_866" xlink:to="lab_us-gaap_FairValueNetAssetLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability_867" xlink:to="lab_us-gaap_FairValueNetAssetLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired_868" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_869" xlink:to="lab_us-gaap_ForeignCountryMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_870" xlink:to="lab_us-gaap_ForeignCountryMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_871" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_872" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_873" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_874" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_875" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_876" xlink:to="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_877" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_878" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_879" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_880" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_881" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_882" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_883" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_884" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_885" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_886" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_887" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_888" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_889" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_890" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_891" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_892" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid_893" xlink:to="lab_us-gaap_IncomeTaxesPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_894" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_895" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_896" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_897" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_898" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_899" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_900" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_901" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_902" xlink:to="lab_us-gaap_IncreaseDecreaseInRoyaltiesPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_903" xlink:to="lab_us-gaap_IncreaseDecreaseInRoyaltiesPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_904" xlink:to="lab_us-gaap_InterestExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_905" xlink:to="lab_us-gaap_InterestExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_906" xlink:to="lab_us-gaap_InterestPaidNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet_907" xlink:to="lab_us-gaap_InterestPaidNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest_908" xlink:to="lab_us-gaap_InvestmentIncomeInterest_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestorMember_909" xlink:to="lab_us-gaap_InvestorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember_910" xlink:to="lab_us-gaap_IPOMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_911" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_912" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_913" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_914" xlink:to="lab_us-gaap_LeaseAndRentalExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_915" xlink:to="lab_us-gaap_LeaseAndRentalExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_916" xlink:to="lab_us-gaap_LeaseCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_917" xlink:to="lab_us-gaap_LeaseCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseExpirationDate1_918" xlink:to="lab_us-gaap_LeaseExpirationDate1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseExpirationDate1_919" xlink:to="lab_us-gaap_LeaseExpirationDate1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_920" xlink:to="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_921" xlink:to="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_922" xlink:to="lab_us-gaap_LeasesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOfLesseeDisclosureTextBlock_923" xlink:to="lab_us-gaap_LeasesOfLesseeDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract_924" xlink:to="lab_us-gaap_LeasesOperatingAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_925" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_926" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_927" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_928" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_929" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_930" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_931" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_932" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_933" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_934" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_935" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_936" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_937" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_938" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_939" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_940" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_941" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock_942" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_943" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_944" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_945" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_946" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_947" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_948" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_949" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_950" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_951" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_952" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_953" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy_954" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy_955" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsAtCarryingValue_956" xlink:to="lab_us-gaap_MoneyMarketFundsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_957" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_958" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_959" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_960" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_961" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_962" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_963" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_964" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_965" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_966" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_967" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_968" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_969" xlink:to="lab_us-gaap_NetIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_970" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_971" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_972" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_973" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_974" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_975" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_976" xlink:to="lab_us-gaap_NonoperatingIncomeExpense_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember_977" xlink:to="lab_us-gaap_OfficeEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_978" xlink:to="lab_us-gaap_OperatingIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_979" xlink:to="lab_us-gaap_OperatingIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_980" xlink:to="lab_us-gaap_OperatingIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_981" xlink:to="lab_us-gaap_OperatingIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense_982" xlink:to="lab_us-gaap_OperatingLeaseExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense_983" xlink:to="lab_us-gaap_OperatingLeaseExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_984" xlink:to="lab_us-gaap_OperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_985" xlink:to="lab_us-gaap_OperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_986" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_987" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_988" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_989" xlink:to="lab_us-gaap_OperatingLeasePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_990" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_991" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_992" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_993" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_994" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_995" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_996" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_997" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_998" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_999" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1000" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1001" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_1002" xlink:to="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet_1003" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1004" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_1005" xlink:to="lab_us-gaap_OperatingLossCarryforwards_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_1006" xlink:to="lab_us-gaap_OperatingLossCarryforwards_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_1007" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1008" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1009" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1010" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_1011" xlink:to="lab_us-gaap_OtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure_1012" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAbstract_1013" xlink:to="lab_us-gaap_OtherCommitmentsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1014" xlink:to="lab_us-gaap_OtherCommitmentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDescription_1015" xlink:to="lab_us-gaap_OtherCommitmentsDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1016" xlink:to="lab_us-gaap_OtherCommitmentsDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTableTextBlock_1017" xlink:to="lab_us-gaap_OtherCommitmentsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1018" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1019" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating_1020" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses_1021" xlink:to="lab_us-gaap_OtherExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses_1022" xlink:to="lab_us-gaap_OtherExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenses_1023" xlink:to="lab_us-gaap_OtherExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_1024" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_1025" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1026" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_1027" xlink:to="lab_us-gaap_OtherLiabilitiesFairValueDisclosure_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_1028" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_1029" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_1030" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1031" xlink:to="lab_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember_1032" xlink:to="lab_us-gaap_OverAllotmentOptionMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromInvestments_1033" xlink:to="lab_us-gaap_PaymentsForProceedsFromInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromInvestments_1034" xlink:to="lab_us-gaap_PaymentsForProceedsFromInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromInvestments_1035" xlink:to="lab_us-gaap_PaymentsForProceedsFromInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_1036" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts_1037" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1038" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1039" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_1040" xlink:to="lab_us-gaap_PreferredStockDividendsAndOtherAdjustments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1041" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1042" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1043" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_1044" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1045" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1046" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember_1047" xlink:to="lab_us-gaap_PrivatePlacementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1048" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1049" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1050" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1051" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1052" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1053" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants_1054" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1055" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1056" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1057" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1058" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1059" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_1060" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_1061" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_1062" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_1063" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_1064" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_1065" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees_1066" xlink:to="lab_us-gaap_ProfessionalFees_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1067" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1068" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1069" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1070" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1071" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisposals_1072" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisposals_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_1073" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_1074" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1075" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1076" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1077" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1078" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1079" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_1080" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1081" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1082" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1083" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_1084" xlink:to="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_1085" xlink:to="lab_us-gaap_RelatedPartyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1086" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1087" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1088" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1089" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1090" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1091" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1092" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_1093" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_1094" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_1095" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1096" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1097" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1098" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1099" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1100" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1101" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_1102" xlink:to="lab_us-gaap_RestrictedCashCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_1103" xlink:to="lab_us-gaap_RestrictedCashCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_1104" xlink:to="lab_us-gaap_RestrictedCashCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent_1105" xlink:to="lab_us-gaap_RestrictedCashCurrent_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_1106" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_1107" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1108" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1109" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_1110" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1111" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1112" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalariesWagesAndOfficersCompensation_1113" xlink:to="lab_us-gaap_SalariesWagesAndOfficersCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1114" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1115" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_1116" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_1117" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1118" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1119" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1120" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_1121" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1122" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1123" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1124" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1125" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_1126" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1127" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1128" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1129" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1130" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_1131" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember_1132" xlink:to="lab_us-gaap_SeriesDPreferredStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1133" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_1134" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1135" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1136" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1137" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1138" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1139" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1140" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1141" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1142" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1143" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1144" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1145" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1146" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1147" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1148" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1149" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1150" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1151" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1152" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1153" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1154" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1155" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_1156" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1157" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1158" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_1159" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1160" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1161" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1162" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1163" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1164" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1165" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1166" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1167" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1168" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1169" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1170" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1171" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1172" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1173" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1174" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1175" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1176" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1177" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1178" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1179" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1180" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1181" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1182" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1183" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1184" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1185" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1186" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1187" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1188" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1189" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1190" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1191" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1192" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1193" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1194" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1195" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1196" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1197" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1198" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1199" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1200" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1201" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1202" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1203" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1204" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1205" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1206" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1207" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1208" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1209" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1210" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1211" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1212" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_1213" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1214" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1215" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1216" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1217" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_1218" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_1219" xlink:to="lab_us-gaap_SharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare_1220" xlink:to="lab_us-gaap_SharesIssuedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare_1221" xlink:to="lab_us-gaap_SharesIssuedPricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1222" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1223" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_1224" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock_1225" xlink:to="lab_us-gaap_ShortTermDebtTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments_1226" xlink:to="lab_us-gaap_ShortTermInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1227" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1228" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1229" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_1230" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1231" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1232" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1233" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_1234" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1235" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1236" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1237" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1238" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_1239" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1240" xlink:to="lab_us-gaap_StockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1241" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1242" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1243" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_1244" xlink:to="lab_us-gaap_StockholdersEquityPeriodIncreaseDecrease_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityReverseStockSplit_1245" xlink:to="lab_us-gaap_StockholdersEquityReverseStockSplit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityReverseStockSplit_1246" xlink:to="lab_us-gaap_StockholdersEquityReverseStockSplit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1247" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1248" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1249" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1250" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1251" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_1252" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1253" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1254" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1255" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1256" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1257" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1258" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1259" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_1260" xlink:to="lab_us-gaap_SubsequentEventLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1261" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_1262" xlink:to="lab_us-gaap_SubsequentEventMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1263" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_1264" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_1265" xlink:to="lab_us-gaap_SubsequentEventTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1266" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1267" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1268" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1269" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SuppliesExpense_1270" xlink:to="lab_us-gaap_SuppliesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyEquipmentMember_1271" xlink:to="lab_us-gaap_TechnologyEquipmentMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized_1272" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued_1273" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued_1274" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding_1275" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding_1276" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding_1277" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1278" xlink:to="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1279" xlink:to="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives_1280" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_1281" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_1282" xlink:to="lab_us-gaap_UseOfEstimates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember_1283" xlink:to="lab_us-gaap_VehiclesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis_1284" xlink:to="lab_us-gaap_VestingAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain_1285" xlink:to="lab_us-gaap_VestingDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember_1286" xlink:to="lab_us-gaap_WarrantMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding_1287" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1288" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1289" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1290" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1291" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1292" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1293" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1294" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1295" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1296" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1297" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1298" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>chek-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-dei" roleURI="http://check-cap.com/role/chek-dei"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#check-cbs" roleURI="http://check-cap.com/role/check-cbs"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-csoo" roleURI="http://check-cap.com/role/chek-csoo"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-equity" roleURI="http://check-cap.com/role/chek-equity"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-equityp" roleURI="http://check-cap.com/role/chek-equityp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-csocf" roleURI="http://check-cap.com/role/chek-csocf"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-info" roleURI="http://check-cap.com/role/chek-info"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sigp" roleURI="http://check-cap.com/role/chek-sigp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-peaoca" roleURI="http://check-cap.com/role/chek-peaoca"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ppe" roleURI="http://check-cap.com/role/chek-ppe"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Leases" roleURI="http://check-cap.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ebapa" roleURI="http://check-cap.com/role/chek-ebapa"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-itax" roleURI="http://check-cap.com/role/chek-itax"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-cacl" roleURI="http://check-cap.com/role/chek-cacl"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-fvm" roleURI="http://check-cap.com/role/chek-fvm"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sed" roleURI="http://check-cap.com/role/chek-sed"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sbp" roleURI="http://check-cap.com/role/chek-sbp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-raden" roleURI="http://check-cap.com/role/chek-raden"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-gaae" roleURI="http://check-cap.com/role/chek-gaae"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-fien" roleURI="http://check-cap.com/role/chek-fien"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-eps" roleURI="http://check-cap.com/role/chek-eps"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-relp" roleURI="http://check-cap.com/role/chek-relp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#SubsequentEvents" roleURI="http://check-cap.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sigpp" roleURI="http://check-cap.com/role/chek-sigpp"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sigpt" roleURI="http://check-cap.com/role/chek-sigpt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-peaocat" roleURI="http://check-cap.com/role/chek-peaocat"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ppet" roleURI="http://check-cap.com/role/chek-ppet"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesTable" roleURI="http://check-cap.com/role/LeasesTable"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ebapat" roleURI="http://check-cap.com/role/chek-ebapat"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-itaxt" roleURI="http://check-cap.com/role/chek-itaxt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-caclt" roleURI="http://check-cap.com/role/chek-caclt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#FairValueMeasurementsTables" roleURI="http://check-cap.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sbpt" roleURI="http://check-cap.com/role/chek-sbpt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-radent" roleURI="http://check-cap.com/role/chek-radent"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-gaaet" roleURI="http://check-cap.com/role/chek-gaaet"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-fient" roleURI="http://check-cap.com/role/chek-fient"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-epst" roleURI="http://check-cap.com/role/chek-epst"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-relpt" roleURI="http://check-cap.com/role/chek-relpt"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-infod" roleURI="http://check-cap.com/role/chek-infod"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" roleURI="http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sosapd" roleURI="http://check-cap.com/role/chek-sosapd"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-peaocad" roleURI="http://check-cap.com/role/chek-peaocad"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-pped" roleURI="http://check-cap.com/role/chek-pped"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesDetails" roleURI="http://check-cap.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" roleURI="http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" roleURI="http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-ebapad" roleURI="http://check-cap.com/role/chek-ebapad"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-itaxd" roleURI="http://check-cap.com/role/chek-itaxd"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails" roleURI="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#ShareholdersEquityOrdinarySharesDetails" roleURI="http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationAwardsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationAwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationDetailsOfShare-basedGrantsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails" roleURI="http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-sbpced" roleURI="http://check-cap.com/role/chek-sbpced"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#Share-basedCompensationOptionActivityDetails" roleURI="http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-radend" roleURI="http://check-cap.com/role/chek-radend"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-gaaed" roleURI="http://check-cap.com/role/chek-gaaed"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#chek-fiend" roleURI="http://check-cap.com/role/chek-fiend"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LossPerShareScheduleOfLossPerShareDetails" roleURI="http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails" roleURI="http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#RelatedPartiesTransactionsWithRelatedPartiesDetails" roleURI="http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#PROPERTYANDEQUIPMENTNETNarrativeDetails" roleURI="http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#INCOMETAXESNarrativeDetails" roleURI="http://check-cap.com/role/INCOMETAXESNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#COMMITMENTSANDCONTINGENTLIABILITIESDetails" roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails"/>
  <roleRef xlink:type="simple" xlink:href="chek-20221231.xsd#COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails" roleURI="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-dei">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_dei_EntityAddressesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_dei_EntityAddressesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_dei_IcfrAuditorAttestationFlag_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_dei_DocumentShellCompanyReport_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_dei_DocumentRegistrationStatement_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_dei_EntityAddressAddressLine3_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelFaxNumber" xlink:label="loc_dei_ContactPersonnelFaxNumber_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_dei_ContactPersonnelEmailAddress_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_dei_AnnualInformationForm_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_dei_DocumentAccountingStandard_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_47"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1" xlink:to="loc_dei_AddressTypeDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1" xlink:to="loc_dei_BusinessContactMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_1" xlink:to="loc_dei_EntityAddressesLineItems_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityRegistrantName_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentType_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AmendmentFlag_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_9" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCurrentReportingStatus_10" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityVoluntaryFilers_11" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFilerCategory_12" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_IcfrAuditorAttestationFlag_13" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntitySmallBusiness_14" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityEmergingGrowthCompany_15" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityShellCompany_16" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityInteractiveDataCurrent_17" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_18" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_19" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_20" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_21" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityFileNumber_22" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAnnualReport_23" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentTransitionReport_24" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentShellCompanyReport_25" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentRegistrationStatement_26" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelName_27" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine1_28" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine2_29" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressAddressLine3_30" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCityOrTown_31" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressStateOrProvince_32" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressCountry_33" order="290" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_EntityAddressPostalZipCode_34" order="300" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_CityAreaCode_35" order="310" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_LocalPhoneNumber_36" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelFaxNumber_37" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_ContactPersonnelEmailAddress_38" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_Security12bTitle_39" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_TradingSymbol_40" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_SecurityExchangeName_41" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AnnualInformationForm_42" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentAccountingStandard_43" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorName_44" order="400" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorLocation_45" order="410" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_AuditorFirmId_46" order="420" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_47" order="430" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/check-cbs">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaap_ShortTermInvestments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_30"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_RestrictedCashCurrent_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_ShortTermInvestments_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_7" xlink:to="loc_us-gaap_AssetsNoncurrent_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_11" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_AccountsPayableCurrent_13" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_14" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_18" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_13" xlink:to="loc_us-gaap_LiabilitiesCurrent_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_chek_RoyaltiesProvision_21" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13" xlink:to="loc_us-gaap_StockholdersEquityAbstract_25" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25" xlink:to="loc_us-gaap_CommonStockValue_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25" xlink:to="loc_us-gaap_AdditionalPaidInCapital_26" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_25" xlink:to="loc_us-gaap_StockholdersEquity_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_13" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_30" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-csoo">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareAbstract_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10" xlink:to="loc_us-gaap_EarningsPerShareBasic_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10" xlink:to="loc_us-gaap_EarningsPerShareDiluted_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_12" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_10" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_13" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesPrivatePlacementShares" xlink:label="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction" xlink:label="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo" xlink:label="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_27"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodValuePrivatePlacement_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement_17" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_18" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodValueWarrantsExercised_19" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_20" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo_21" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo_22" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_23" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_24" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_25" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_26" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_27" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares_28" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_29" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_30" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_NetIncomeLoss_31" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_StockholdersEquity_32" order="250" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_SharesOutstanding_33" order="260" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-equityp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses" xlink:label="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction" xlink:label="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_chek_PreFundedUnitsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_us-gaap_IPOMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_4" xlink:to="loc_us-gaap_PrivatePlacementMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_chek_PrefundedWarrantsToPurchasePrice_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_13" order="50" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-csocf">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInRoyaltiesPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaap_PaymentsForProceedsFromInvestments_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceResisteredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantLiabilityReclassificationToEquity" xlink:label="loc_chek_WarrantLiabilityReclassificationToEquity_27"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsCashlessExercise" xlink:label="loc_chek_WarrantsCashlessExercise_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:label="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaap_InterestPaidNet_36"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReconciliationOfCashToBalanceSheetAbstract" xlink:label="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_39"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestrictedCashIncludedCurrentAssets" xlink:label="loc_chek_RestrictedCashIncludedCurrentAssets_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_NetIncomeLoss_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_IncreaseDecreaseInRoyaltiesPayable_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsForProceedsFromInvestments_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_chek_ProceedsFromIssuanceResisteredDirectOffering_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_21" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_27" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_chek_WarrantLiabilityReclassificationToEquity_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_chek_WarrantsCashlessExercise_28" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_29" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_30" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_31" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_us-gaap_CapitalLeaseObligationsIncurred_32" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_27" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_33" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_27" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_35" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_35" xlink:to="loc_us-gaap_IncomeTaxesPaid_35" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_35" xlink:to="loc_us-gaap_InterestPaidNet_36" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_39" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_39" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_39" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_39" xlink:to="loc_chek_RestrictedCashIncludedCurrentAssets_40" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ReconciliationOfCashToBalanceSheetAbstract_39" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_41" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-info">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sigp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-peaoca">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ppe">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/Leases">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ebapa">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_EmployeeRelatedLiabilitiesTextBlock" xlink:label="loc_chek_EmployeeRelatedLiabilitiesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xlink:to="loc_chek_EmployeeRelatedLiabilitiesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-itax">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-cacl">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-fvm">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sed">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sbp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-raden">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-gaae">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralAndAdministrativeExpensesTextBlock" xlink:label="loc_chek_GeneralAndAdministrativeExpensesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_chek_GeneralAndAdministrativeExpensesTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-fien">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock" xlink:label="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-eps">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-relp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sigpp">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FunctionalCurrencyPolicyTextBlock" xlink:label="loc_chek_FunctionalCurrencyPolicyTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives" xlink:label="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsPolicyTextBlock" xlink:label="loc_chek_WarrantsPolicyTextBlock_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_20"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_FunctionalCurrencyPolicyTextBlock_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_WarrantsPolicyTextBlock_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sigpt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock" xlink:label="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-peaocat">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ppet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesTable">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfFutureLeasePaymentsTableTextBlock" xlink:label="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_chek_ScheduleOfFutureLeasePaymentsTableTextBlock_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ebapat">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock" xlink:label="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xlink:to="loc_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-itaxt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-caclt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OtherCommitmentsTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesDPreferredStockMember" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sbpt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock" xlink:label="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-radent">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfResearchAndDevelopmentExpensesNet" xlink:label="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_chek_ScheduleOfResearchAndDevelopmentExpensesNet_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-gaaet">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock" xlink:label="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-fient">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-epst">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-relpt">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsCompensationMember" xlink:label="loc_chek_NonExecutiveDirectorsCompensationMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GeneralTransactionsMember" xlink:label="loc_chek_GeneralTransactionsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1" xlink:to="loc_chek_NonExecutiveDirectorsCompensationMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1" xlink:to="loc_chek_GeneralTransactionsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_5" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-infod">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_March2022RegisteredDirectOfferingMember" xlink:label="loc_chek_March2022RegisteredDirectOfferingMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NetProceedsFromIssuanceOfSharesAndWarrants" xlink:label="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_WarrantMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4" xlink:to="loc_us-gaap_SubsequentEventMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7" xlink:to="loc_us-gaap_PrivatePlacementMember_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7" xlink:to="loc_chek_March2022RegisteredDirectOfferingMember_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_NetIncomeLoss_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_12" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_chek_NetProceedsFromIssuanceOfSharesAndWarrants_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_chek_MinimumBidPriceValuePerShare_15" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_16" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_17" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_11" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_18" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfHedgingOption" xlink:label="loc_chek_FairValueOfHedgingOption_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DerivativeChangeInFairValueOfOptionOutstanding" xlink:label="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_FairValueOfHedgingOption_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_DerivativeChangeInFairValueOfOptionOutstanding_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RestrictedCashCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sosapd">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember" xlink:label="loc_us-gaap_TechnologyEquipmentMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShortTermInvestmentInterestRate" xlink:label="loc_chek_ShortTermInvestmentInterestRate_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_AccountingPoliciesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_OfficeEquipmentMember_3" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_TechnologyEquipmentMember_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3" xlink:to="loc_us-gaap_ComputerEquipmentMember_5" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_srt_RangeAxis_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8" xlink:to="loc_srt_RangeMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8" xlink:to="loc_srt_MinimumMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8" xlink:to="loc_srt_MaximumMember_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_chek_AccountingPoliciesLineItems_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesLineItems_12" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesLineItems_12" xlink:to="loc_chek_ShortTermInvestmentInterestRate_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesLineItems_12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesLineItems_12" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_15" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-peaocad">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GovernmentInstitutionalAssetsCurrent" xlink:label="loc_chek_GovernmentInstitutionalAssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_chek_GovernmentInstitutionalAssetsCurrent_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_DepositsAssetsCurrent_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_OtherAssetsCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-pped">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaap_OfficeEquipmentMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyEquipmentMember" xlink:label="loc_us-gaap_TechnologyEquipmentMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisposals" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisposals_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_OfficeEquipmentMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_TechnologyEquipmentMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:to="loc_us-gaap_ComputerEquipmentMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisposals_9" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaap_OperatingLeaseExpense_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_srt_StatementGeographicalAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1" xlink:to="loc_srt_SegmentGeographicalDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1" xlink:to="loc_country_IL_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_OperatingLeaseLiability_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_10" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_LeaseExpirationDate1_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_LeaseCost_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_LeaseAndRentalExpense_15" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7" xlink:to="loc_us-gaap_OperatingLeaseExpense_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeasePayments_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_6"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0" xlink:to="loc_us-gaap_OperatingLeaseLiability_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-ebapad">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xlink:to="loc_us-gaap_AccruedVacationCurrent_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xlink:to="loc_us-gaap_AccruedSalariesCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-itaxd">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRateNextYear" xlink:label="loc_chek_FutureFederalIncomeTaxRateNextYear_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FutureFederalIncomeTaxRate" xlink:label="loc_chek_FutureFederalIncomeTaxRate_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ForeignIncomeTaxRateMaximum" xlink:label="loc_chek_ForeignIncomeTaxRateMaximum_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_chek_FutureFederalIncomeTaxRateNextYear_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_chek_FutureFederalIncomeTaxRate_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0" xlink:to="loc_chek_ForeignIncomeTaxRateMaximum_7" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentAssetsFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract" xlink:label="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetAssetLiability" xlink:label="loc_us-gaap_FairValueNetAssetLiability_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8" xlink:to="loc_us-gaap_MoneyMarketFundsAtCarryingValue_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" xlink:to="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_OtherCurrentAssetsFairValueDisclosureAbstract_10" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" xlink:to="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract_12" xlink:to="loc_us-gaap_OtherLiabilitiesFairValueDisclosure_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" xlink:to="loc_us-gaap_FairValueNetAssetLiability_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AntiDilutiveWarrantsMember" xlink:label="loc_chek_AntiDilutiveWarrantsMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnderwriterWarrantsMember" xlink:label="loc_chek_UnderwriterWarrantsMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LongTermIncentiveWarrantsMember" xlink:label="loc_chek_LongTermIncentiveWarrantsMember_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesAWarrantsMember" xlink:label="loc_chek_SeriesAWarrantsMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CreditLineAgreementWarrantsMember" xlink:label="loc_chek_CreditLineAgreementWarrantsMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsMember" xlink:label="loc_chek_PreFundedWarrantsMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LegalWarrantsMember" xlink:label="loc_chek_LegalWarrantsMember_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OneYearWarrantsMember" xlink:label="loc_chek_OneYearWarrantsMember_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FiveYearWarrantsMember" xlink:label="loc_chek_FiveYearWarrantsMember_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsMember" xlink:label="loc_chek_SeriesCWarrantsMember_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsOneMember" xlink:label="loc_chek_PreFundedWarrantsOneMember_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesDWarrantsMember" xlink:label="loc_chek_SeriesDWarrantsMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExerciseTransactionMember" xlink:label="loc_chek_WarrantsExerciseTransactionMember_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeriesCWarrantsToPurchaseOrdinarySharesMember" xlink:label="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PontifaxMember" xlink:label="loc_chek_PontifaxMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentWarrantsMember" xlink:label="loc_chek_PlacementAgentWarrantsMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OrdinarySharesMember" xlink:label="loc_chek_OrdinarySharesMember_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_28"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RegisteredDirectOfferingMember" xlink:label="loc_chek_RegisteredDirectOfferingMember_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaap_CommonClassCMember_30"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedUnitsMember" xlink:label="loc_chek_PreFundedUnitsMember_31"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayRegisteredDirectOfferingMember" xlink:label="loc_chek_AprilMayRegisteredDirectOfferingMember_32"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AprilMayOfferingsMember" xlink:label="loc_chek_AprilMayOfferingsMember_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_ILS" xlink:label="loc_currency_ILS_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaap_InvestorMember_46"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentMember" xlink:label="loc_chek_PlacementAgentMember_47"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PlacementAgentsMember" xlink:label="loc_chek_PlacementAgentsMember_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_51"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAmendmentAgreementMember" xlink:label="loc_chek_WarrantAmendmentAgreementMember_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaap_StockholdersEquityReverseStockSplit_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:label="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_57"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapital" xlink:label="loc_chek_ShareCapital_58"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareCapitalLessIssuanceCosts" xlink:label="loc_chek_ShareCapitalLessIssuanceCosts_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_60"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommonStockUnitsIssued" xlink:label="loc_chek_CommonStockUnitsIssued_61"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PurchasePricePerUnit" xlink:label="loc_chek_PurchasePricePerUnit_62"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants" xlink:label="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_63"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_64"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_65"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_66"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_67"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_68"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_69"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfPrefundedWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_70"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MinimumBidPriceValuePerShare" xlink:label="loc_chek_MinimumBidPriceValuePerShare_71"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_72"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssued" xlink:label="loc_chek_WarrantsIssued_73"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_74"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_75"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PrefundedWarrantsToPurchasePrice" xlink:label="loc_chek_PrefundedWarrantsToPurchasePrice_76"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_77"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_78"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PricePerUnit" xlink:label="loc_chek_PricePerUnit_79"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_UnitsPurchased" xlink:label="loc_chek_UnitsPurchased_80"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromExerciseOfWarrants" xlink:label="loc_chek_ProceedsFromExerciseOfWarrants_81"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_82"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClassOfWarrantOrRightExpiration" xlink:label="loc_chek_ClassOfWarrantOrRightExpiration_83"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_85"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ExercisePriceOfWarrants" xlink:label="loc_chek_ExercisePriceOfWarrants_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_87"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants" xlink:label="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_88"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfRegistredDirectOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_89"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfPublicOffering" xlink:label="loc_chek_ProceedsFromIssuanceOfPublicOffering_90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_91"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IssuanceExpenses" xlink:label="loc_chek_IssuanceExpenses_92"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_94"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_95"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsExercisedCashlessBasis" xlink:label="loc_chek_WarrantsExercisedCashlessBasis_96"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_97"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsIssuedNotExercised" xlink:label="loc_chek_WarrantsIssuedNotExercised_98"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantThatWereExercised" xlink:label="loc_chek_WarrantThatWereExercised_99"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FairValueOfWarrantsIssued" xlink:label="loc_chek_FairValueOfWarrantsIssued_100"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1" xlink:label="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_101"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering" xlink:label="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_106"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RevenueFromCashCommission" xlink:label="loc_chek_RevenueFromCashCommission_107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_109"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ProceedsFromIssuanceOfShares" xlink:label="loc_chek_ProceedsFromIssuanceOfShares_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_111"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstanding" xlink:label="loc_chek_WarrantsOutstanding_112"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantsOutstandingAmount" xlink:label="loc_chek_WarrantsOutstandingAmount_113"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfSharesFullyDiluted" xlink:label="loc_chek_PercentageOfSharesFullyDiluted_114"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AmountOfPortionOfOrdinarySharesOfSuchLender" xlink:label="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_115"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchaseSharesIssuable" xlink:label="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_116"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PreFundedWarrantsPurchase" xlink:label="loc_chek_PreFundedWarrantsPurchase_117"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent" xlink:label="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_118"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_StockIssuedDuringPeriodSharesWarrantsCashExercised" xlink:label="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_119"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_AntiDilutiveWarrantsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_UnderwriterWarrantsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_LongTermIncentiveWarrantsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_OrdinarySharesMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesAWarrantsMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_CreditLineAgreementWarrantsMember_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PreFundedWarrantsMember_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_LegalWarrantsMember_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_OneYearWarrantsMember_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_FiveYearWarrantsMember_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesCWarrantsMember_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PreFundedWarrantsOneMember_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesDWarrantsMember_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_us-gaap_WarrantMember_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_WarrantsExerciseTransactionMember_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_SeriesCWarrantsToPurchaseOrdinarySharesMember_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PlacementAgentMember_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PontifaxMember_18" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1" xlink:to="loc_chek_PlacementAgentWarrantsMember_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_22" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22" xlink:to="loc_chek_OrdinarySharesMember_22" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22" xlink:to="loc_chek_PreFundedUnitsMember_23" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_26" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_26" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_us-gaap_IPOMember_26" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_us-gaap_OverAllotmentOptionMember_27" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_us-gaap_PrivatePlacementMember_28" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_chek_RegisteredDirectOfferingMember_29" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_us-gaap_CommonClassCMember_30" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_chek_PreFundedUnitsMember_31" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_chek_AprilMayRegisteredDirectOfferingMember_32" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_26" xlink:to="loc_chek_AprilMayOfferingsMember_33" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_srt_CurrencyAxis_36" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_36" xlink:to="loc_currency_AllCurrenciesDomain_36" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_36" xlink:to="loc_currency_ILS_36" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_srt_RangeAxis_39" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_39" xlink:to="loc_srt_RangeMember_39" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39" xlink:to="loc_srt_MaximumMember_39" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39" xlink:to="loc_srt_MinimumMember_40" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_43" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_43" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_43" xlink:to="loc_us-gaap_SubsequentEventMember_43" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_46" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_46" xlink:to="loc_us-gaap_RelatedPartyDomain_46" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_46" xlink:to="loc_us-gaap_InvestorMember_46" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_46" xlink:to="loc_chek_PlacementAgentMember_47" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_46" xlink:to="loc_chek_PlacementAgentsMember_48" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_51" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_51" xlink:to="loc_us-gaap_OtherCommitmentsDomain_51" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_51" xlink:to="loc_chek_WarrantAmendmentAgreementMember_51" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1" xlink:to="loc_us-gaap_ClassOfStockLineItems_54" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockholdersEquityReverseStockSplit_54" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_55" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_56" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockholdersEquityPeriodIncreaseDecrease_57" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ShareCapital_58" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ShareCapitalLessIssuanceCosts_59" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_CommonStockSharesIssued_60" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_CommonStockUnitsIssued_61" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PurchasePricePerUnit_62" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants_63" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_64" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsExercised_65" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised_66" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement_67" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_68" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_69" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromExerciseOfPrefundedWarrants_70" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_MinimumBidPriceValuePerShare_71" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_72" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantsIssued_73" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_74" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_SharePrice_75" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PrefundedWarrantsToPurchasePrice_76" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_77" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_78" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PricePerUnit_79" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_UnitsPurchased_80" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromExerciseOfWarrants_81" order="270" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_82" order="280" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ClassOfWarrantOrRightExpiration_83" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_84" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_85" order="310" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ExercisePriceOfWarrants_86" order="320" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_87" order="330" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants_88" order="340" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromIssuanceOfRegistredDirectOffering_89" order="350" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromIssuanceOfPublicOffering_90" order="360" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_91" order="370" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_IssuanceExpenses_92" order="380" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_93" order="390" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_94" order="400" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_95" order="410" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantsExercisedCashlessBasis_96" order="420" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_97" order="430" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantsIssuedNotExercised_98" order="440" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantThatWereExercised_99" order="450" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_FairValueOfWarrantsIssued_100" order="460" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1_101" order="470" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering_102" order="480" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_103" order="490" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_104" order="500" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_105" order="510" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_106" order="520" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_RevenueFromCashCommission_107" order="530" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_108" order="540" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_CommonStockValue_109" order="550" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_ProceedsFromIssuanceOfShares_110" order="560" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_111" order="570" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantsOutstanding_112" order="580" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_WarrantsOutstandingAmount_113" order="590" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PercentageOfSharesFullyDiluted_114" order="600" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_AmountOfPortionOfOrdinarySharesOfSuchLender_115" order="610" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PreFundedWarrantsPurchaseSharesIssuable_116" order="620" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PreFundedWarrantsPurchase_117" order="630" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent_118" order="640" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_54" xlink:to="loc_chek_StockIssuedDuringPeriodSharesWarrantsCashExercised_119" order="650" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationAwardsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwoThousandFifteenPlanMember" xlink:label="loc_chek_TwoThousandFifteenPlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwentyTwoJuneMember" xlink:label="loc_chek_TwentyTwoJuneMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ThreeAugustMember" xlink:label="loc_chek_ThreeAugustMember_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_TwelveDecemberMember" xlink:label="loc_chek_TwelveDecemberMember_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainEmployeesMember" xlink:label="loc_chek_CertainEmployeesMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficerMember" xlink:label="loc_chek_CertainOfficerMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srt_BoardOfDirectorsChairmanMember_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember" xlink:label="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SeniorManagementMember" xlink:label="loc_chek_SeniorManagementMember_23"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_VpClinicalMember" xlink:label="loc_chek_VpClinicalMember_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_29"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationAwardTrancheFourMember" xlink:label="loc_chek_ShareBasedCompensationAwardTrancheFourMember_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_45"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationInome" xlink:label="loc_chek_ShareBasedCompensationInome_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_48"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CompensationExpenseEstimationForGrantDate" xlink:label="loc_chek_CompensationExpenseEstimationForGrantDate_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_50"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_51"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PremiumPercentageToCalculateExercisePrice" xlink:label="loc_chek_PremiumPercentageToCalculateExercisePrice_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_54"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_55"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_56"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_57"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_58"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_59"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_61"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_62"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_63"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_chek_TwoThousandFifteenPlanMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardDateAxis_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_6" xlink:to="loc_us-gaap_AwardDateDomain_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_TwentyTwoJuneMember_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_ThreeAugustMember_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDate11Member_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_TwelveDecemberMember_9" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDate2Member_10" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDate1Member_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDate3Member_12" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDateOne3Member_13" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_6" xlink:to="loc_chek_GrantDateOne4Member_14" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_17" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_srt_ChiefExecutiveOfficerMember_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_CertainEmployeesMember_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_CertainOfficerMember_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_srt_BoardOfDirectorsChairmanMember_20" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_ChiefExecutiveOfficerAndBoardMembersMember_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_SeniorManagementMember_23" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_17" xlink:to="loc_chek_VpClinicalMember_24" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_VestingAxis_27" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_27" xlink:to="loc_us-gaap_VestingDomain_27" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_27" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_27" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_27" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_28" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_27" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_29" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_27" xlink:to="loc_chek_ShareBasedCompensationAwardTrancheFourMember_30" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_33" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_33" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_33" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_33" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_33" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_36" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_36" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_36" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_36" xlink:to="loc_us-gaap_SubsequentEventMember_36" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_39" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_41" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_42" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_43" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_44" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_45" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_chek_ShareBasedCompensationInome_46" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_47" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_48" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_chek_CompensationExpenseEstimationForGrantDate_49" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_50" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue_51" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_chek_PremiumPercentageToCalculateExercisePrice_52" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_53" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_54" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1_55" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_56" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_57" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_58" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_59" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_61" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_62" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_63" order="240" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaap_AwardDateAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaap_AwardDateDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate1Member" xlink:label="loc_chek_GrantDate1Member_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate2Member" xlink:label="loc_chek_GrantDate2Member_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate3Member" xlink:label="loc_chek_GrantDate3Member_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate4Member" xlink:label="loc_chek_GrantDate4Member_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate5Member" xlink:label="loc_chek_GrantDate5Member_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate6Member" xlink:label="loc_chek_GrantDate6Member_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate8Member" xlink:label="loc_chek_GrantDate8Member_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate7Member" xlink:label="loc_chek_GrantDate7Member_8"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate9Member" xlink:label="loc_chek_GrantDate9Member_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate10Member" xlink:label="loc_chek_GrantDate10Member_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate11Member" xlink:label="loc_chek_GrantDate11Member_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate13Member" xlink:label="loc_chek_GrantDate13Member_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne1Member" xlink:label="loc_chek_GrantDateOne1Member_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne2Member" xlink:label="loc_chek_GrantDateOne2Member_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne3Member" xlink:label="loc_chek_GrantDateOne3Member_15"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDate17Member" xlink:label="loc_chek_GrantDate17Member_16"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOne4Member" xlink:label="loc_chek_GrantDateOne4Member_17"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneFiveMember" xlink:label="loc_chek_GrantDateOneFiveMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSixMember" xlink:label="loc_chek_GrantDateOneSixMember_19"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneSevenMember" xlink:label="loc_chek_GrantDateOneSevenMember_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneEightMember" xlink:label="loc_chek_GrantDateOneEightMember_21"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantDateOneNineMember" xlink:label="loc_chek_GrantDateOneNineMember_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardDateAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_1" xlink:to="loc_us-gaap_AwardDateDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate1Member_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate2Member_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate3Member_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate4Member_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate5Member_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate6Member_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate8Member_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate7Member_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate9Member_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate10Member_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate11Member_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate13Member_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne1Member_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne2Member_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne3Member_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDate17Member_16" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOne4Member_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneFiveMember_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneSixMember_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneSevenMember_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneEightMember_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1" xlink:to="loc_chek_GrantDateOneNineMember_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_25" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_25" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_25" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_25" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_33" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesTable" xlink:label="loc_chek_AccountingPoliciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AccountingPoliciesLineItems" xlink:label="loc_chek_AccountingPoliciesLineItems_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_chek_AccountingPoliciesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_srt_RangeAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4" xlink:to="loc_srt_RangeMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4" xlink:to="loc_srt_MinimumMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4" xlink:to="loc_srt_MaximumMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesTable_1" xlink:to="loc_chek_AccountingPoliciesLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_AccountingPoliciesLineItems_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_13" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_8" xlink:to="loc_us-gaap_SharePrice_14" order="60" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-sbpced">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/Share-basedCompensationOptionActivityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree" xlink:label="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_22"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_AwardTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_14" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_15" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_18" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_20" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_22" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_24" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-radend">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesTable" xlink:label="loc_chek_ResearchAndDevelopmentExpensesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpensesLineItems" xlink:label="loc_chek_ResearchAndDevelopmentExpensesLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense" xlink:label="loc_us-gaap_SuppliesExpense_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ClinicalTrialsAndRegulationExpense" xlink:label="loc_chek_ClinicalTrialsAndRegulationExpense_7"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubcontractorsAndConsultantFees" xlink:label="loc_chek_SubcontractorsAndConsultantFees_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_9"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PaymentsExpensesForPatents" xlink:label="loc_chek_PaymentsExpensesForPatents_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaap_OtherExpenses_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ResearchAndDevelopmentExpenseGross" xlink:label="loc_chek_ResearchAndDevelopmentExpenseGross_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0" xlink:to="loc_chek_ResearchAndDevelopmentExpensesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesTable_1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesTable_1" xlink:to="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_SuppliesExpense_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_chek_ClinicalTrialsAndRegulationExpense_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_chek_SubcontractorsAndConsultantFees_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_DepreciationNonproduction_9" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_chek_PaymentsExpensesForPatents_10" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_OtherExpenses_11" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_chek_ResearchAndDevelopmentExpenseGross_12" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_chek_GrantedRevenue_13" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_ResearchAndDevelopmentExpensesLineItems_4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_14" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-gaaed">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaap_SalariesWagesAndOfficersCompensation_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense" xlink:label="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeRentAndMaintenance" xlink:label="loc_chek_OfficeRentAndMaintenance_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationNonproduction" xlink:label="loc_us-gaap_DepreciationNonproduction_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_SalariesWagesAndOfficersCompensation_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_ProfessionalFees_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_chek_OfficeRentAndMaintenance_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_DepreciationNonproduction_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/chek-fiend">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ChangesInLiabilityToPayRoyalties" xlink:label="loc_chek_ChangesInLiabilityToPayRoyalties_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_InvestmentIncomeInterest_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_InterestExpense_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_chek_ChangesInLiabilityToPayRoyalties_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_WarrantAndShareOptionsMember" xlink:label="loc_chek_WarrantAndShareOptionsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:to="loc_chek_WarrantAndShareOptionsMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_NonExecutiveDirectorsMember" xlink:label="loc_chek_NonExecutiveDirectorsMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ConsultingFeesMember" xlink:label="loc_chek_ConsultingFeesMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_FeesAndReimbursementMember" xlink:label="loc_chek_FeesAndReimbursementMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ShareBasedCompensationMember" xlink:label="loc_chek_ShareBasedCompensationMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_10"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyRetainer" xlink:label="loc_chek_MonthlyRetainer_11"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_KeyManInsurancePolicy" xlink:label="loc_chek_KeyManInsurancePolicy_12"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlySalary" xlink:label="loc_chek_MonthlySalary_13"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrossOvertimeMonthlyRate" xlink:label="loc_chek_GrossOvertimeMonthlyRate_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumAggregateMonthlySalary" xlink:label="loc_chek_MaximumAggregateMonthlySalary_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_chek_NonExecutiveDirectorsMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_5" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5" xlink:to="loc_chek_ConsultingFeesMember_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5" xlink:to="loc_chek_FeesAndReimbursementMember_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_5" xlink:to="loc_chek_ShareBasedCompensationMember_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_10" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_chek_MonthlyRetainer_11" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_chek_KeyManInsurancePolicy_12" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_chek_MonthlySalary_13" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_chek_GrossOvertimeMonthlyRate_14" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_10" xlink:to="loc_chek_MaximumAggregateMonthlySalary_15" order="50" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/INCOMETAXESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CheckCapUsIncMember" xlink:label="loc_chek_CheckCapUsIncMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DevelopmentAreaAMember" xlink:label="loc_chek_DevelopmentAreaAMember_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RestOfCountryMember" xlink:label="loc_chek_RestOfCountryMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ReductionInIncomeTaxRate" xlink:label="loc_chek_ReductionInIncomeTaxRate_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_chek_CheckCapUsIncMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4" xlink:to="loc_chek_DevelopmentAreaAMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4" xlink:to="loc_chek_RestOfCountryMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4" xlink:to="loc_us-gaap_DomesticCountryMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_4" xlink:to="loc_us-gaap_ForeignCountryMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_srt_RangeAxis_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_10" xlink:to="loc_srt_RangeMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10" xlink:to="loc_srt_MinimumMember_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10" xlink:to="loc_srt_MaximumMember_11" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_14" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_14" xlink:to="loc_chek_ReductionInIncomeTaxRate_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_14" xlink:to="loc_us-gaap_OperatingLossCarryforwards_16" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_chek_CommitmentsAndContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_DesignerRoyaltiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_PredecessorUnitHoldersMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_chek_CommitmentsAndContingenciesLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_5" xlink:to="loc_chek_RoyaltiesProvision_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesTable" xlink:label="loc_chek_CommitmentsAndContingenciesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_DesignerRoyaltiesMember" xlink:label="loc_chek_DesignerRoyaltiesMember_1"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember" xlink:label="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_PredecessorUnitHoldersMember" xlink:label="loc_chek_PredecessorUnitHoldersMember_3"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OfficeOfTheChiefScientistMember" xlink:label="loc_chek_OfficeOfTheChiefScientistMember_4"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_BinationalIndustrialResearchAndDevelopmentFoundationMember" xlink:label="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_5"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ManufacturingProgramMember" xlink:label="loc_chek_ManufacturingProgramMember_6"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_AsicComponentDesignerRoyaltiesMember" xlink:label="loc_chek_AsicComponentDesignerRoyaltiesMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CurrencyAxis" xlink:label="loc_srt_CurrencyAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currency_AllCurrenciesDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2022/currency-2022.xsd#currency_EUR" xlink:label="loc_currency_EUR_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_18"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_SubleaseAgreementMember" xlink:label="loc_chek_SubleaseAgreementMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="loc_country_IL_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_25"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_CommitmentsAndContingenciesLineItems" xlink:label="loc_chek_CommitmentsAndContingenciesLineItems_28"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePerUnitSold" xlink:label="loc_chek_RoyaltiesPayablePerUnitSold_28"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MaximumRoyaltyObligation" xlink:label="loc_chek_MaximumRoyaltyObligation_29"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesProvision" xlink:label="loc_chek_RoyaltiesProvision_30"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_GrantedRevenue" xlink:label="loc_chek_GrantedRevenue_31"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RoyaltiesPayablePercentageOfProductSales" xlink:label="loc_chek_RoyaltiesPayablePercentageOfProductSales_32"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_ContingentLiability" xlink:label="loc_chek_ContingentLiability_33"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_RefundExpenses" xlink:label="loc_chek_RefundExpenses_34"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_OperatingLeaseRentExpenseMonthly" xlink:label="loc_chek_OperatingLeaseRentExpenseMonthly_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_38"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_LesseeOperatingLeaseAdditionalTerm" xlink:label="loc_chek_LesseeOperatingLeaseAdditionalTerm_39"/>
    <loc xlink:type="locator" xlink:href="chek-20221231.xsd#chek_MonthlyVehicleLeaseExpense" xlink:label="loc_chek_MonthlyVehicleLeaseExpense_40"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xlink:to="loc_chek_CommitmentsAndContingenciesTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_OtherCommitmentsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_1" xlink:to="loc_us-gaap_OtherCommitmentsDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_DesignerRoyaltiesMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_PredecessorUnitHoldersMember_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_OfficeOfTheChiefScientistMember_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_BinationalIndustrialResearchAndDevelopmentFoundationMember_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_ManufacturingProgramMember_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_1" xlink:to="loc_chek_AsicComponentDesignerRoyaltiesMember_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_CurrencyAxis_10" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_10" xlink:to="loc_currency_AllCurrenciesDomain_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_10" xlink:to="loc_currency_EUR_10" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_RangeAxis_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_13" xlink:to="loc_srt_RangeMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MinimumMember_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_13" xlink:to="loc_srt_MaximumMember_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_17" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_17" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17" xlink:to="loc_us-gaap_VehiclesMember_17" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_18" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_17" xlink:to="loc_chek_SubleaseAgreementMember_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_srt_StatementGeographicalAxis_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_22" xlink:to="loc_srt_SegmentGeographicalDomain_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_22" xlink:to="loc_country_IL_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_25" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_25" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_25" xlink:to="loc_us-gaap_SubsequentEventMember_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesTable_1" xlink:to="loc_chek_CommitmentsAndContingenciesLineItems_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_RoyaltiesPayablePerUnitSold_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_MaximumRoyaltyObligation_29" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_RoyaltiesProvision_30" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_GrantedRevenue_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_RoyaltiesPayablePercentageOfProductSales_32" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_ContingentLiability_33" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_RefundExpenses_34" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_OperatingLeaseRentExpenseMonthly_35" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_37" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_us-gaap_LeaseExpirationDate1_38" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_LesseeOperatingLeaseAdditionalTerm_39" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_chek_CommitmentsAndContingenciesLineItems_28" xlink:to="loc_chek_MonthlyVehicleLeaseExpense_40" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ^ 4H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#R'[?>?\_<
M_P#W\-'V^\_Y^Y_^_AJO2JI=PHZDX%("P-1O5.5O+@'U$K?XUIV/C+Q+IK;K
M37;^/V,[,/R.173CX*^,S&'%I;$$9&+A<UR6N>&=8\.3+'JMA+;%ONLP^5OH
M: /3?"OQWU&VE6W\20+=0$X^T0KMD7ZCHWZ?C7NVEZI9:SI\-_I]PEQ;2KE7
M0Y_#V/M7Q-7H?PF\;R^&/$<5A<S8TN^<1RACQ&QX#^WO[?2F!]14444 %%5[
MN_L["/S+NZA@7UD<+_.LH^-/#0;:=;LMWIYHH W:*J66J6&HKNLKR"X'_3.0
M-5N@#"\:_P#(CZY_UXR_^@FOC>OLCQK_ ,B/KG_7C+_Z":^-Z .R^%'_ "4_
M0_\ KJ__ *+:OK.ODSX4?\E/T/\ ZZO_ .BVKZSH ***S[W7-*TUMM[J-M W
M]UY #^5 &A16''XR\-ROL36[(L>WFBMF&:*XB$D,B21GHR,"#^- #ZXKXL_\
MDRUC_<3_ -#6NUK,\0:9I^L:)<V&JMMLI0!(2^SH01SVYH ^+:]+^!?_ "44
M?]><O_LM>D_\*L^'/_/PO_@:M;7A;P/X0\/ZQ]MT24->>6R8%R'^4XSP* .W
MKPKQ%\>=2L]2NK'3M'MD-O*\7F3R,^[:2,X&,=/6O;9[ZSM7"7%U!"Q&0))
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M'A!/!GBQ["W9GM)HQ/;EN2%)(P3Z@@_I7,V-Y/I]_;WMLYCG@D62-@>A!R*
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M!UGB![!LAL?B!^=>U4P"BBB@#X:J2#_CXB_WQ_.HZD@XN(R?[X_G2 ^W;?\
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M>01<#_"@#YROM4U#5)%DU"^N;MT&U6N)6D*CT!)JI7TS_P **\'_ /40_P#
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D2GYCW_"O18K"VBB2-85VHH49'85YN7X2M43G&7*B*<6]3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0U!WX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,BC(H 6B
MDR*,B@!:*3(HR* %HI,BC(H 6BDR*7- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_A(C_ST/YT >T?\)1#_ 'A^='_"40_WA^=>+?\ "1';Q(?SI%\1GIYA]N:
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M<T >OVVI13 889^M7^U>7Z5J3)=*S.=I/K7I-I.EQ;JZ'((I 3T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %(2%&3TJ-I C_ #=,5Q_B+Q4D"-%;N-YX
M !H W-2UV"U5E#@M7"ZC?W%_+B,G&>U96FSW&I7Q^TA@">,UT4MO#8X92*EL
M=C%-G)C]Z2?K3'L;?')&:=J.N6\8(9A[<USD^NQ/)\I^G-2V,W# %4A3FJ-K
M>7&G7NXL=BFFV&JI*P&?IDUI7T$=Q8.Z#DCBA;@>E>&]:BU6Q4JP+ 5L,"%X
M/2O%_ VKOIEXUO(V,M@ FO9Q(&B5AW&:T0F.Z1^M. ^7%-ZQ\4X'(IB#MC/-
M';K36Z\4[(VYH /:EJ-6Y)I2PHL -UI#QWZT@().:.M- **1NG6E!'>FCDT"
M <4?CWI7P*08I@'2DYSUH)Q1NXSB@ -&>V:3.12<?CWI!<7/;-!Z4G3GOWI2
M0%H"XA[\T8Z\T  Y]Z#CGBFD H^_C/6DV_> -*<*"::K<$XYI@,&<XSB@9SC
M.!3@05)(YH!!4YH0 ,@8SU_2D' QGK2DX.#^-)P>33 7K^/Z4U3SC-*6XZ?6
MD [T6$P;[W6D&3QFE.,TF0.U%@$.0,^E/MR2W)I>"M.A !_&D]@+-%%%9E!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>=>/\ 5-A\A&YKT0_=
M/TKQOQ^VW5 _;- ''WE[]FMI/-;)/3-<3=WLL\X6,GK5WQ)J(EN$B4U6B@\E
MX7VGFJ0%9Q.L@#$Y[5(9)EQR<UHRQB2YW$?*!2>4KH3CI0P,S;.Q+9/6DQ/_
M 'CUK6VJ5  [<T>6,]/_ -5(#,5YLY+'CBF[YBW4XK4,*#M08H^P]Z ,O$[#
M.X\4X>?@G)K2945<*.M&T!0"* ,P^>"I!/%.WSL"-QK3:-=N0.U,$0!_"@"@
M#,!U-,WS$YR:U/+7&<?_ *J01J.@_P#U4 9P>9NYXH#3;LAC5_R@"<="*:$
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M@Y.*#YZ#&X\]ZUB@P.*8Z*=H(H RQYX.[<>E+OG_ +QK3"+]TBD\H9Z?_JH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *:Q(&13J* &.Q R* X";C3CC'/2N4\4:^+*%H8OO'N* *OBCQ3]B<
MP0D$D8-<59Z9-=7/VN=F/.<$TD4;WTYN)VR,]ZT+ZZ6SA(W[0!4L!]Y=1VQ!
M557;U(%<KKOBB;8%B).?>J-SJLM[=M%&2PSCZUTGASP4UVX:Y^8=>:!G+V>F
M7NNC<P8 ^F:Z_3/AB9H@TA;)^M>FZ9X=L]/@5%B7..M:BJL"!10D!Y%J?@=]
M+M]\>[WZU4L)7*_9VY/0@U[%?VRW=LRL,\5Y%?1?8M<>,>M.P(PKV-K/7(Y1
M\HW<XKV_0+D7>E1/G)Q7C'B!2SB0=J]-^'MP9= C#')%- SK2.<"@$T9R]+Q
MSS5"%II.:7(QC-,Z4(!P--HI/QH 4GBF\XS[TOXTG:@!3R0129(?VI>XI#30
MA1SR:">:!T^M(>XH 0G<#BA3D48PN*3;SC/:@!?XL]J6D(^3K35!*GGFBP#C
MG'%!SCBFDX;&>M./(QF@!,D@D?A0OZ48Z\TWIQGK3 =SGVH_R*.YYIIZ]?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$ERW0C(J'5=0T^^LVB6\5<]ZXZR\.6T&LK<?VF"&.<9_^M0%CT]2&&12U'"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'E>],&1LW((%/&",TG0<]<4+D&@D3O4B8WKQ3#UJ1<^:M2RD6Z***@H****
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M]?K7T2(5BA<#N*\'T%S'\0=8(4'YWZ_6HD[%&<NE>)59E\_H<?YYJP-!\1E
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M?K7H6H6^W" Y(%9WPDT<1V$LKIRQSTK=UJ$P7[@]#TIH";PU+MFVENE=J,$
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M5S_:HSZU]+?#(@Z?'D<XYH ].'2B@=** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHI .2: %HHHH ***3IS0 M%)WI: "D.>U H'>@!K-@XH9L#CO2;,
MMDFFO]ZF(>6Z 5'<SBVM7E;@*,T*"3UKE_%FK!(C:(W+#!J;@<KK6HOJ-XVU
MCL8XQFLW4IAIVF$#C S4MLF0^>J\UQ7B/49K^^73H"2S-@XH&7- TV;Q7K"-
M@F.-N?I7O>B:5%I=HL:(%('85RGPY\-?V1IJR.O[QADUW1D$<;.QZ4[ 4M5O
M?LMJ^3\V*\QN[AKJZ<GD$UM^)=7,]P8HV]N*Y\)C:,_,356$6K"U>XO0@'%>
MB:7IXM(L%1G'I63X?TH)MG:NG+8(%  6XQ2]OYTFVD)P,4#%.7&/2D7.WFA/
ME')H]>:8A"<"B5A%;.Y_NFDQD@50U^?[/IC\\D5#8SRYU-[X@N&SG#5D^,YB
MPA@7J2!BMK3U(NY9?4USFI WWB.*W!SM<5-P/8/!.G?8=$B.T NH)XJEXD0M
MJ ..*ZC3$\G2X5]%%8?B*(X,GK5 <PK$7"]L'FO0;-S+8QM[5YZ1B4'/>N[T
M@[M-09JT!?&2M-*G=3B<**:3[TQ,1\G@4*"M*OI2G'3- A&R31DTGXTG3H:8
M"X-)BE/UIH!'&>M "'V]:=3=ISUIQX'!H 7W].:1<MUIHSG&:/NM@&@8Y\@C
M%1R':,^M//S8YZ4$HP53UHV :I=AE1D=J5V\M#(_&*6XF2TBW$X %>>Z_P"*
MGFG:WA./I4-@:>K>+/)E:*(C/:N.O;V\O[G<6;:?>G?93=@RLV&IZJL"_.V,
M5+86)(K"$0>8YRW;-5FF2!,+C K%U3Q(D$WD*W'K6*);_5)?W ;:?2@9TMWX
M@6(#!%5%\0Y8<]:++P??78!D#<UJ'P'<;1A2*FPT1IK:/M48R:Z6RMX;J+/!
MXKDKCP??PC*JPV]ZSX[_ %'2KE8I"P -,HZNYL66X9E)&WIBN@\*ZT\EXMF[
M''09-9<5[#?6";&'F$<U48G2;N*Z7CYN:5Q,]3<$' I2W(Z55L+D7U@DRG.5
MS4^TB+=GD5M$ACG;:<8[4Y6_>K3#AX@V><T] /-44V*Q=HHHK(H**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7B7Q,.R24?G7MK?=/TKP_
MXG O+(1S0!XI-'F5F(ZFI94(A&>#39L[R#V-.E;=&.>E QF"/+^M=9X*8CQ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!29I:* $!R<4M%(<XXH ":3/44*,<&E[FF =3CTH;M2TE "+0,<TG(YI3R..
M] ADD@1">]-A._DBG%,]12!OFV 4,8RYG2WMWD)QCN:\IU*Y:_U*1^2%8XKI
M_&VMB" 6<;?.?0UR=LPA0228^[DYJ&(S]9U)-*L6EZ,W%5_A]X;.L:S_ &K*
MA* YY%8&MSR>(=:2Q@Y3=CBO</!NB_V/I44!0!M@[4T,Z9$2"(*@P!6#XBU1
M;>Q=58;L>M:MW<B"UDWG! KS+5;V2^O=H8E0?7M6B!E$,TS^<V<ELUKZ-9&]
MU!05)7.<XJ@J&1Q$HYQBN_\ #6G_ &2V#L@W$=<4F(V8(UMX@@&,4[ +9_*A
MR2P '%.)XQ0 W> V,?2DZ_TI2"U!;Y<?G0)C2V3C%*G(HSGM2.2O(I@A4&9,
MGMTKEO'%WY-GL!Y-=6>0#Z=:\_\ &T_FWBQ*<^M0RC%M ([#S3QP>36#X/A_
MM+QQ+N&Y0W!K6U.<PZ#(IX..U/\ A/9,;V:\9<Y/4U-K@>N,1%$(QV%9'B'Y
MM.SBM1299&'YU0UQ&:V"XXQS5(#AP02IQS7;: ^ZQ4>E<4Q/FD8Z&NS\.MFT
MQ[U: U"QY!'>@TXG+' HY]*8F(O R:3ZTYLFDR>PH$(,=Z!BC!I<&F @.<Y'
M2D#CTIV:;[T )NR>E*",D8I6SP0*%SR<4 #LH7\*:HW+G%-56>3V!I\DH1]M
M*X#<_P (%$GEP)YDG&.].D?RH]^/<UQOB?Q,/L[6T#?,W'6DV4D4O%?B< FV
M@.[/'RG-<_9:=YBFYF^\>>:ATZQE>X\V8%@>?FYJQJFIQ6L/RMC:.E0V,<]_
M!9HP<@8ZY-<?KOB%IRT5IEF_V>:H7EY?ZW>!+<'!.!BNU\#_  \G6Y%Y>1EA
MG.&!-+41S_AOP9=Z]*LMS&PW'^):]<T3P3;Z5"NY 2.O KI(+.VLPBQ1HI X
MPN*L&;=D"J2"]BO'!!"F53D>U2--'G&S]*3!#BI"@ SBJL*XR1(IHF#*.:Y/
M6?"$-\))E0;@/05U/5_;M5@%47!Z&DT-,\'MFET76&BF!5"<<\5T=^HO]/8*
M,D+D5=^(F@M(HO($ V\Y K+\/W(N+9@_4+MK(9M^!=9:0-9L>5XQ7>;AN\O'
M45Y#HC/I7BK#<([9_6O7(&\P-..A'%:18AK$(-GOFI8R-ZU"V9?G]\4]>)U^
ME6V"+]%%%9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C?=/TK
MQ+XF,(W;CGM7MK?=/TKQ7XEK^];=T% 'B5T1YW ZU!OSM':K5X")F&*JN=CJ
M#0 ],"5<"NN\#CS-?Q_L_I7((Q:Y5?>NR\ K_P 52<] O]: /3W5!OAR.354
M P2;3T-6K/3I;K5W"Y*E\UT$_A:5BIV]\T6 Y>0!$.._-=%X&_X_G/JM2R^$
M9&'0\_6M3P_H3Z;<;B",B@#IY/\ 5MGTKP#2"%\?ZQGCYG_G7OLQ(A<CTKY]
MLI&;QSJF!CYV_G4RCS'-B96@=BOS=*R+\$2^W6KEM(X=E/>J.J2%%.>I-52H
M>1\_4K$EK, R\UMQW*@ 9KBQ=,FW'K6K;WC,%)-9XG!76QMAL99G;6TJMM J
M^2H %<[I]V#W_P#UUJ>>,=?_ -=?+8W"-7T/I<-B[Q1I%U5/YU2=]SY[=ZK-
M<L,_I35N<9S7!1P+;V-JF*2+_FJ%Q^="2KNYK-:[5@"#3&O!N&#S79_9NFQG
M''*^IL2N*C5E)K-:]R<9J6.Z!CX--X&W0W6,BRV[CIVJ(NI85!)<;8P35#^T
M,W 4?A67U*2>Q;Q47HC>:0+$GOUIT4H,H'YU7Y:W3]*SY]1%K>["?I5QP[4A
M2K*QS7B\8\9V)'3->M:60+)/]T5X[K]Z+GQ78XP>37L&DDG3X\>@KZ/!P<8G
M(Y\QHT445W$GSIJDNSXK7...#_.NR,I( ]:X?6R3\5IQ]?YUWCPD(K8_AK*I
M"YYV*FXL02JB'BJSWNS)I[N"-OM5>>#S$^@KG6'N>>\39EW3[MKB2MU< @US
M^B0D,W'2MB>X\J(UY6,PCL>O@\7=ZFK;D,/QJ4D!O:LW2KD2H>>:O;QTKYVK
MA)7/>A44D(TF21BE1^*C:08(&*A>YV 5E'!RN$JT4BTY'!J2-P_&>G%4#=H4
MZ\T13KCAJZOJ,K&#Q42_O&[%)N _I5%9LMUJ2:7Y,T0P,D+ZU$O':T6?RJM#
M( QP1FLZ[U)HK5CFJ>DW3W+,V:VAA9)A]83-J&8&[R>@KDOBXZ'1;''7>/YB
MMUI7BMI)6&,'DUPGQ%U'[5IUFN[.''?WKVL#AG&29C5J71[)H !T6R/_ $S'
M\JV*R/#^?[#L_P#<'\JUZ]\P04444#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *^4/'@ \=:RW_36OJ^ODSQ^3_PGVK^GF4 <D#\Q/YT/)^\Q
MBF*QW<>M.8D2@@?2@ICHL?:X^._-?27PR 73T]0.:^<8%/VJ-B.,\5]'_#7+
M6$3+V%!)Z9VHH[44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNC'_ (E-@,8S&/Y5M5/4Z4%%%% PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "ODSQ_C_A.M:.?^6E?6=?)GC\_\5UK(Q_RTH XN+YF//>G,W[\
M+FHXFPQXH<X?/>@;-*/#3(H/4_E7T3\,01IZ+GM7SI$"&B8#O7T;\+SG3DR.
MW6@1Z9VHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MDQSF@!:*** "BBB@!#2CI2=\TM !0>E%% "<_I2CI2>]+GC- !129 YHZ<T
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M D7TC$<(4=A2D']*8[ O@'O2[A^N*!BYI*3@8%(3T(_"@!K*3SW[TK XIW
M%+@?G0+J"YQS0IR^*CSS@=NE2;0B%O04 SB?']_M@6%&[XKF) +?2W*D#"YJ
MSK\WV[6S"22JGBL3Q1=_8;%8U/WABH8^A5\ 6CZ[XDDFD&X1-UKWS;MC4>@Q
M7F?PFT=;.RENF',G(.*]):3Y:I 1,#NR:AU,_P"A/]*M8!4$5FZQ-LLR!Z5=
M@.)DZMGUKLO#?_(.Y]:XUS@G'.379>' !I8Y[FE8#5C'SL<TC9)R*:1@=:4$
M&J2$'N/6@^WK2$#/6EX'XT" \CBEP3SFFG@&@,,4 P&>?>A%"\GUIP48-1W
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MOHGX79_LQ<^G%?/-F%8(":^A_A>!_9ZYZXYH(/2J*** "BBB@ HHHH ****
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M114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONGZ5XE\2/\
MC\;CO7MK?=/TKQ+XBY^V'/KS0!Y%K(VH>.M<N2=^<8KJ]:!\LDUR1.6H+18@
M/^DQ$^M>@>"8\^( <?PYKSN(DW,?/\5>B>!6?_A(57/&V@&>QZ'JOV*\D4\#
M-=4?$T(7D#-<#+"1=,P('-0NS[LD\4$'HL/B*)@>E6].U:.]D9 1D=J\I;4!
M;G[WZ]ZZGP1(9[R20G.138([Z7_5-]*^<HB?^$]U4G@!G_G7T=)_JVQZ5\WL
MQ'CC5D'7>_\ .MJ#M,X<>KTS9EEW*<=.E<YJKE'P.];!<K#@_P!ZL#5)"\Z#
M-?3T-4?,T(OVFIFSEDPQ'%0_:RXZ=*M:B?\ 10,BJ-O"63WKI5SW%!<IL6%^
M?)*?I2HX$^<>]94)>"0@]S6E&#C<>IK1'#.G[QIS:@K+@'-4&N98B6P<56-O
M(LF1G!Z5I&$26G49 K0SE"/4I_:W*DXJDL^^0Y/2I2&VLB_A5%K:8$D5-1::
M&U!1N3RW0#8_6H;F[DXVDU"()9,>U,\IWW 'I7.FTST+1L7+6\G9PI8\5T>A
MW'EZK&6&>?SKE;#>]QM%=1:6[I<QO6==*:LSSJ[Y7H>DWFHQ-&!QTKF=2D\V
M8%:CN#*Z1[<\]*A1767]X?IFO-J4U$\_G;F9C[AJL1QWKW#P>2=,&1VKQ"5_
M^)O$H/&>*]Q\(@C24],<5Y-=:GT. 1T-%%%<QZA\V:^Q'Q2N 1UR/UKI[J,0
MVZN1C-<OXD#'XI3$'ID_K73ZA(9K11GD"N_".S/G\S^+4QKL_N&;'6N2O9"0
MU=?>?\>?7D+7&7.YMP%?2T7='%AY),BMLIE_44L%ZZSY;@9I(-Q^4]J;=VTF
MW(Z5T*!ZT>6439FNO,@7 S3X641Y(K+MI'\D*QZ"M&)=T8)/%/E2//K4DF2.
MY_AXJG-=3J#UQ5P@<8-5;Q\1[<TVHF,4A8/,FB).3FJ%TQ24*WTK3L"WD\&L
MN\MYYKLXJ$D=U%1%0J75-O6KT=@RL&QC-9GE313QL>@KH+>X:64)GD"J4456
M:2(=,V)J*^8.AKT_2-0M(XWP%.5KS063_;"WYUU6BV#R&3V%>=BHIGDU9ZFQ
M)>V\MG,D2@$GM7">+8O*BM7QG,@_#FM<EK:>1<\9YK.\7,&L+/GDN,_F*\G$
M*T6=F"5YH]VT;_D&Z?D=8Q_*MT=*P-'<G3].S_SS'\JWZ\N1])!6"BBBI+"B
MBB@! <BC -+10 AX6HO/&[;4IY!%1" 9R: '[_Y5$\PWJ".M2[!LQ52ZFA@:
M/S",L<#F@"V6&?PI%D!H7:Z?*<TB18/- $@]:6BB@ HHHH **** "ODOX@?\
MCWK)QTDKZTKY,^(?R^-]8/?S#B@#S_)\QL#O02?-'%-#XW>YH+%I%QVH&=+8
M#Y5.,XKZ$^&#'^S%..:^?].!>*,CC-?0GPR0KIZ^F.*!'I':BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH .U':D/2@'G&* %I.^:,_-B
M@GG%, _VJ-PH]L=J:PYX'2@!3@_E3:7(].U!YZ"F #^E(#2Y'IVIM #AC]*5
M<<TVE) &: 8CJ<Y%&X*GS=J=NZ^E12'<.!D4 .&"I)-*$SR:8HVC)[4X3I_>
M%( )]::<[JKW&HP0\EA3(-4MIAD.*H"Z3Q]::/>A9XI&&U@:D.,9%*X"<%3F
MH\8.:"Q&>*4/S@CI0 +)R<_C2,FX[LTO&[(YI&)&,#@4"8I.W'K0>3]:&YQQ
M2\*-QZ#K0]AHQO%&J+I.D/(6PV.*\9BUKS[]WD;_ %C9%=GX^O\ [=,MI&V5
M)P:\XU:W_L^W\W&"G2HL,G\0:I':Q,JM\S"NP^%'AGR$?5Y%R9!D$BO-=(L;
MCQ-JD0V$QY )KZ1T"Q&F:/#:A<;0!3L!J%@45S7.>)]16.V\I6Y:MVY;:/EZ
M 5Y[X@N3-J 4= <&J2),=#M=O4FNN\+:<(W\UNYS7*",O?(JKD=Z],TJ 1V"
M';@A:8&BWM2%AC(Z]*2-]PYHQ\V:: :.O-../UI,9)[4HZ<CI3$-/ &/PIZX
MV<4G49(I,^U(!K  "GD_N\T-@BD)!3!XH ;&P(K@/&5X)M0C13\H-=[*5@@9
MCP,'FO*;Z8WFIR$_=4\&H9<2GJ<RVUD^#U'%3_"RQ\^]>\QD \&N;\5WK1M%
M"O\ &<5ZO\.M*_L_0PS)@N,THB9U>\,WR]NE";=],B(65@14G"O]:L0R1\L!
M6'XADQ;X[UO/&/OUS/B"0$8IH##CR705V^E@"Q45QL'S2Q@#K7:V(VVJC%,"
M;CU[TK>E-7&?QI<Y//:@0+C.*5QS@4P'YB<>]/4\;B* 8APO0]:& 3'--&6Y
M SBC?OE QP*!!QO />G.RPL#_"1S4-T3O C&:S];U&.TTB0EQYFWCZUG+8=S
MCO&^NF^G_LN!OE[X-9&G1"PM@K=>Y-4]/ADN;F6\GSG><$TS6-42UMI%8X=O
MNBH*1F^*-86Z;[#;MEV&WBNQ^&OA+[+&+J=,MZD5P_@[0;C5M?2ZF0E ^>:^
M@K:..QMECC4#CI35QL5U#OGHJTB.#R>U*S;2,#.[M3B%Q@"M4B$-8;3CNW6G
M28V\TA?)'RYQWI'._;@9Q3'8<5"KNIF=W Z=ZE8CR]IZU"#L.W%"!"E\,!0[
M>6PST[TYT &_TK+UF_6&W&TY84@(=:U-8(6"GFN1:?[;(26/O4DUTUU)\PR/
MYTR"'#_(*+ ,C@#,5]:U+32C*PR*NV&F9VMMS[5T5M;+& -O(JAHH66EJC_,
M/K6'XWM8TL.!W&?SKM&94/ Y%<?XXE#VVT>H_G4,#ET &GX)Z+6!X3FV^))A
MG@,:Z%B/L)&,?+7+Z ?+UB=@.=QYJ$)GNEL_FVJX.<5/"1YH!K/T.3S--4GK
MTJ]$?](  JF"-*BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 C?=/TKQ/XBX^WG/K7MA^Z?I7B?Q)/^F$CN?RH \FUS'V8D5QH(R>>E=?X@
M;_1>!BN/ ^7ZT#1);'-RGUKT3P*Q_P"$D3_=KSNU^6ZC)'\5>D>"'7_A)$X_
MAH*9Z;>'9.SYXIK7%NUORW.*74[=Y =G<UAMIUPP(#F@@J:G*H8"-B5KOOAN
M^X-ZXKA3ILJ)AP2<YKN_AXACG=",<47!GHTO^J;Z5\X1KO\ 'NK$_P!Y_P"=
M?1\O^J;Z5\]Z;#YWC[5\#.'?^=5!VD<V*5Z;)+Z/]V".G2N?OH#O#GTKM+RU
M(C(*_P 58]_:@!1M[5]%@ZZM8^8NH2U.*N6>5MHYQ4MD&5MI%;W]F ON"]>:
MFCTT [@G2N_VJN='URRL8K0!VSCFKT5ON513I(BEQC;QFM.%,*IV5?M4<U3%
M%?RT9/+(Y'6JS(8VVDG!K;^Q,/WP3(-5)82S<+G%'MTNIA[9R,AK?#%O6GM!
MB'.WFM )\^TKG%79(D%OR@Z4O;(Z*=6QR178&R,5GPJY,IQUK>NX@"QVTW2[
M99%DW+UJTU,ZUB-#*TF%A<%R.,\UT]M*'G0&F6UK&KD!0*=Y+PS!@O0USUO=
M..O6NSL_L\2VD3'TYKFM3N!]LV#CZ5L-=LUI",=JPKU-UZ&Q7!-\R,8-<US+
M=BNKQ[O6O>O![[M)3Z5X/=<:E$<=37NG@LYT=..U>9BHV1]+@MCIZ***X3TC
MYOUK:WQ2NN>Q_G6Y<.$1B:R[Z$2?%FZ&.H/\ZZG4]+Q Q [5M2K*+/&S&GS'
M)2OO@DYK"^S;U8^]=-)9LELYVYXK,M$^1]R]Z^APN(36YXR3@S(^R%'!QUJ:
MZC"09(K4DB&Y3MXJ/4$'V7[M>FJR.JG7Y487E%XODK2MHF^RX.<U+IB*00R]
M:U$@'0+4RK(RJ5^9F+)"RH#S6?,A;@YKL9;,&/.SM6'<0!9"-M2JT680J.Y6
ML5,:XJPVU&9R!P*N6D (!V]*J7F<R#;CC%7SQ>QTPK6,NXN$D9=F,U/IS-]N
M4]JIQQ'SEX[UMV<:BY3Y<4Y2LAU:NA:AF7[8H/<UW&A!!Y@']WBN)>'R[I&Q
MBNC\/7I.H2H1\N/Z5YE>:9Y\G=F9J8\J60GUKF/$-P)%LE)/WQC\ZZ[6E\Q)
M& [UPVN [[/C \P?SKAJV<6>K@+\R/I#1P%L--_W./RKHJYW2#_H.FC'\']*
MZ*O)D?1H****@H**** "BBB@ HHHH :Y(7-<UK5O-<,KH3\AS72O]WIUJO+$
MN%4C[W% $&C;_L8+YS6C3(XQ%'M4<"G#I0 M%%% !1110 4444 %?)GQ&'_%
M::P/^FG-?6=?)GQ&X\:ZQW_>?G0!YT<9;GO2KC=S29&6'?- XX[T =;IA_=1
M@]^M?0OPR_Y!B_K7SKIC'RD]:^B_AD?^)2!CM0!Z+1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 (>E'.*#TIJ].:8#N<>]'./PI.,Y]J
M./TH .?7M2<^O:CCU[4#W]*8A",4@)%&:&QQ0,.:**.E, Q2GDX-)FD/3(I
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M9_XK361_TTKZQKY-^(G_ ".VL9_YZ'% 'FS(2S'WJ3Z<YI.3NP>])'D<G\*
M.@TI@/*R.]?3'PR&=%4XZ"OF'3L^9'SWXKZ?^&1/]B*/44 >@4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% #3C//I3-H/)IS]:::?0 S
MF@<4S)W=.*=FF $YHSD4JGVI.<]*!!D4G?VI?PI/PH 6FAOWOX4N3NZ<4N ,
MG';- QC#?-CL!7'^*-7%NTR;NG'6NGU&]6QL)+AN,#K7D>HZA_:=TY!W;FI
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYK?\%K_Q-92?0U@0',N&KH/"#J-8D"GG;0,] !S2T44 %%%% !1110 AI"P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!-1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** (I<9S[5%U.:EEZ_A42G!Z52$Q2,FEZ"D+<\"E[9Q5"&\
M9S[4N >?:D_"E!YP!VH!"1*#DTJMF0Y[4T,4XQUID[B*%GZ<9I,HRO$>H)!:
M-&&Y88->62.TVHB+)()KHO$6H^;OPW(/ JEHEEY\7VIT^8&D!JQPI:0J!U*U
M&XQF3UZU+,^]AQTI6Y0#&?:I 8OSKGO4BXP,_C38_E.".E#94G SZ4P$./FI
MA&3D]NM.3D'(I<9;V%(!JXV'FD/+GG@4I^]P.*7H",9H 8 ,9S]: !@'/3K1
M'DOC'RTYN&X'% "$9.3^-( ,9S]:D+#GBHE)W'CB@!2I"@TNWIGMUIS$D\#(
MIN3QD4 !YY/6E&!'FD+9[=J!RO'TQ0 TGD$4\X*9S2=%R1[4F[CIVH =QY?6
MDP,=:,_+MVT9(XQVH :V!5/4YA!I\@!Y85>C3>V*P];8R7D5NG(Z&EU H:/<
M-;VD\KD\YJEX,UHR^-UAWG!?U]ZV/$MJ-,\/!U7!(KS'P+?E/'\+L<*7'\ZM
M ?6DR_/GMBF C@4Y'$MN).H(XJ"-\R8Q5(EDC8W<4,.#SVH<\]*5/O<]*;V&
M5[N=++3&<GG::\:L0=0U^YED)*JV1FO0/'-^T%IY$?WCT%</;+]CLO.VX9NM
M8L9C>+[L.BQ1L<].*[KX5:*;/2_,E7YFY&17G"0RZSXB6")2XW#I7T#I5M'9
M6,,2*!A1FFD!8D"JN0:.*24$G&.*%/R\BM$A <9XHQM3^5-C^>0BG,>V*8GH
M!P$)KD-8E#SX!SS75W3>7;Y;CBN*NG\R])QE?6BP$]H!P/RKJ[$;+85S-A&6
MDZ=ZZU%"0C(QQ3 3(X]Z3I@"D!P<D=:5"=_(H&2;<@5&\BQPR%NP.*59"9",
M5C^*[U;333@X=AC%0V%CA-7E.JZH5+$K&V>O:JNH72VUJR9Q@46Q,<AG8?>Z
MUS_BR]#*D<)R[GH*AZL9-X&T=];\3&>0%HXVW#->Z2@(B1Q\*H[5QW@#1SIV
MC1713$DH&:[0D=<=:N"$Q>!&&J-R"0<T\GY=N/>F'H.*L0[@_E0IP"#Z4W)X
M'J:']A0 Y  <FDD 8BG,RB'(]*C1OW)8^E RCJ]X(;;8#VKE)U#1%@?FJ]K%
MP9)]J\BJ$&Z2Y\O;D4;"9=TFT:>9=PX[UURA4B5.A%4=/M_(13MP:N DMTH
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M+'GMSWJK&0>#VJUJ1_TAN.IJFJG=0!/#S<Q^F:]'\&#.MQX/1:\YA_X^(_\
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M^/\ A--9R?\ EI7UE7R7\10?^$UUDD?\M* /.GZ-35QM_G3F.=P'6D0_)TH
MLZ>O^FQ#_:YKZW^&BXT1/91FOD?3VQ>1$C^*OKCX9O\ \2-/=1S0!W5%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45')*$J
M,SY&* )\CUIDD@5>M5FDV<YZ]:.9,@]#0!+YV<<]:81O&?RI!'TS5A5&W% $
M!C)_I3QD$?I3VQG^=(1SD_C18"1<GFF.Q!ZT+(,X].M-EP><T@$#D\TN\^M
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M1<XR.E(%.14W09H"Q&$R<$9Q4BIL.*:C8?)Z&I&.[&WK2$+D8Z4%^N!2;6I
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MX_*C<3T[]* &'LHI>%(XI<$<=^U)C(44 *1@8Q3$//(ZU*YXP*81E??%  <
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MT/ZUTVC2L\.&/2HK^V14]S5&QNA;72IGJ<4T5<Z?.#R:H:K>"SM&DSVJ:X?
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M]]%:IW(!Q30'8?#C2_/O_M,R_+GN.U>H7,>VXS'_  ]/I67H6CII.DP[1AF
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M5Q&@ "T//>NX\%@?VC)CTKFK(ZJ3._I#TI:*YCI&("#S3LCUH(R,5#L._.:
M)Z*8H/4T^@!#TJ@[R"<*/6M"F&-2<XYH <@PH%+110 4F><4M)CG- "T444
M%%%% $%YYGV5_*.'QQ7*V;:B;K8Q.W/'%=CUI@BC!R$7/TH (@1$N[KBGT44
M %5KD-M.#5FHK@9C]Z .;U.XDC"@'O3X7>1HW/I2W,8GFVCDYJU' $C ]*3'
MT)]_*JQ'-.FC3H".E9>H.Z3Q[":BFGF##DTXDLTT1QD9X[4BI()^/2F2WJ01
M6X)Y;&:M-*JLK>HS3:!%BS)VL#V-6JJVA!W$=S5JD,**** "BD Q2T %%%%
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MJ.H4"K2OA"3ZU% H\A-O3%2B+*D'O29420'(%?)OQ!)'CC6C_P!-*^KU79@
M]!7R?X_P?'&MY_YZ\TBCS@OAG]S0&(3ZT%<R-GIFE  4@T 3Z<#]MB/<M7UO
M\-L_V%'SV%?(^G?\?L>>FZOKCX;8_L).>PH [RBBB@ HHHH **** "BBB@ H
MHHH **** (I\!#Q6*9,.RXZUK7.XGCI63(I\[ZT 2(F$R1FFM,G0@9IEW<BW
MM2<@$"N/'B O?[=W?'6D@.Q9-W;WI\$04@D=*BT^;SHMY-/N93$I.>!28K&I
M%* #44]R$^8GH:Q8=4SD;NE4]0U'Y&P>U#&:U]?)+'QUQ7)O<N-04YZ-3;:]
M>9\$U'-@39/KFA"9W:W D@3OQ5>[036<@(R *K:>Y:R!![<59C??;R(.XKHB
MT9R5SBS,#;O;=#R,5C6.DFT:6Z/\/0>M7+Y9(-48]LUJP1/<VQ [BMU(PY3*
M\/Z@9M:,++P#UKI]3M%,Z$+G-8EKI?\ 9UU]HQ@U?GU;=@YZ=*4IFD8&G;PQ
MVZ=!DTR.,>?O"YYK%74WEF"@\5O6>2 3Z<5FYFG)8O23 A0!]:KR2G=@#I0,
M@DYJ$DYS6,WJ-(E9CMZ<TB.<<C)IIE (!IW8%>O:H;*2&G);I2[<+BE4C!)(
MQ48N(^>1Q[T@-S3H1Y(.WFM,<#%9NFSAH0,BM('(S5(8M%%% !1110 4444
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MJ8';BYB1]S$#'2LW6M9-Q&;5'R".E<3>:AJ+KM5CD#WJM;ZA-'<*\Y.0.:3
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MJP-=AQT.:0C7HK)&MPYQBGG6(L@8ZT#-.D9@HR3BHHKA94!%5M369H1Y1[T
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M-P'>@!GW3C'TI<;SGM37FC1PK, :<SA1QTH !P=I_"@( <TV.59/K4M %>X
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MO0!,'#V^*JQ(ZLQSQ3B/+7 -._A!_.@!@G(?FG2JLK(3T- C3=DT,%)Z]*3
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M5&: .[HHHH **** "BBB@ HHHH ***3(]: %IK, I/I48ERS<U5DNE0L,^U
M%@R!\#':J&I?*JX'>H1>A9!EABGWTZO""I&,4P,O6HOM&F$*N2!7G,>G/'>9
MV]6Z5Z9')NA*>M94^EGSPZX'-(#.T^ P2=,#-=9"QDMQQT%9AMCM&.Q_6M($
MPVO!QQ0!FW$N92I_"H7)\L #G-))_P ?&\G@_P Z5G*MN)XH :A()RM0W4I8
M!-O4U85]S;LBJ=Q(#(=OK2 L6J ,,#.*TD7=VJG9Q,,,.AJQ]J2#.XCCWIH!
MWED/TS1+/';QEB1GTK)N_$$4*-AP#]:Y/5/$XE)"OSVYH8'37VNQP$D.*Y+4
MO$QF9@IKFI]1GO)B,G;VHL]/GN9 ,'!/I0@-'[3+<@G!/]:GLM(DF8%E/^-;
M&D:%(<9'TXKL[/1-JJ0,'MQ0!S&G:$5 .S)_G766&B[4!\NMFTTPJ <?2MB.
M/8,>E &3!8;,?+C%:L<"HJC'2I:* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *T[?.!01DKQ
MWI)Q^\%/7.X>E4A'CGBRWQXHF<C'!_G7#W&^+4B-IVDYS7H7CDF+6]Q[UR>K
MVK-;K.G7% $.X +CO44F0<[:H073!P)#@ ]_6M.2>.2,!6&>G6I8Q@9<9%0L
MKEN!@4]8B.AH65CE3ZXH 4-M&#Z4#[V>Q%+Y>3^%1\@[?>@!VXXZ=Z<6/3;Q
M31GG/K4C,=H7-  3@9I%.T9(R/YTFXGIWZ4XG"A10 TMAL8ZT[D<@<TUOO=>
M>U*&;/'?I0 _>"I0BJMS8+)C%3D').?I0LIW8S]* ,Q[%K=MRG-6;?6)[=PF
M#A>]6W3*Y]:K/;*W'&: -NR\2D,-XX_G6[#KD+[6+"O/S P.!^%,WRQ8P30!
MZI%<6\Y'(-2&-F<@#*BO-;?6I+8 9.170V'B_,1WMV[F@"WK4^]5MB.2<5'O
M31](>4\-BJ]M(NJWHE# [3D<UC^/-3$%M]F##.WGF@#SKQ)J#:G?D_>R:Z+P
MEHK*%<IDM7):3;O>:D#C*YKVCPO8-%&"PZ=/I0!T&G0>198V\CBK*[I!CI4F
M"(^*105.?:@!NW'R'I2AN3@=.*5@6/7M302* $4YSD4X'D<=J0#-'+?@* %Q
MAL'O2'(XHY;\!2D$]3VH ,^W:D#>J]L4H)/Y4G+?@* %!"GD<TF2/E(Z_I1R
M<GTI0"Y)S0 1G:Q]Z>P5UPPYJ,C!Q3 Y<Y].M-L"G=:8LV<#K6%=>'G)RHKK
M=YQ3U<;,'\:5V!Q$,UYI;A51L UT>G^-Y8Y0LN1]:LW5HMP#G%8-[X>9D,BC
MD>E%V!Z79>*K26,,\BY(JOKOBVTATB3RY%W,,5Y++!>6X(7=@>U<QJ5Y?/+Y
M;[MN>>#1<#K['R[KSKIR-Y.17.:W>RSSQP(IWNV"*JQ:T]DF&S[UO>#-,/B+
MQ&LY&Y5.330'K_P_T)=)T-)2N&D )KJEPXD.._%1PIY-HL(_A %&6B4C/--
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MI0!/9$BZAP/XJ^N?AASH$9/4**^2;+_C[B(Z9XKZU^&/_( CSZ<4 =[1110
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M:$!Y\(Y-/E,1R*Z;PEK$EOJL:S.=C'')JW?:3'/;^;@;ZYVX_<*3"/WD?/%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*2H'/M6-=>'N6D&1]* *Z.#&N",FGCE/EK-G62TR#G(I(=190%8<"@#0RV[
MX%/5FP WX4R.[AEYSCUJ3*.,*>1UH :XCSA>,TR4'&%_"A[5OO9-#-M0 ]NM
M #U#>7_*D5"ZXS]*;Y^,^U*2=FX=Z &I$8Y#@]:E/ VCO3((V.9&JM=W8@=L
MGI0!'JS;H5A0\^U/LX@ECN488]:R+.YDN]8VMRF:W+V2.PAE=C@8XH Y+Q)=
M[H_+5NG:H?">G&YN%?&>:QKR9[Z_P"?G;%>E^#]*%JL6X=<4 =_H4/V2VV^U
M:CJ)0I/:FK D4: =Q2 X)'ITH )&?(&>*.WOB@A2N[/--')Y_"@!5RS?A0V5
M;\*"-N"/QI<!N?7^= "E<IDFF("QY-'.<4K#R\&@ ?AOY4NSY,]Z,9.[_.:1
MVQQZT *N6;\*<[8&T4@"A=V>:8I#L<T &."?2CELF@XS@=*=PO(_"@!&)!()
MZTW!/(Z#K28R0:><<X- #2<G-+R<GTIH&!BG'&>.E !RV301@XH.,\=*.,'/
M6@ V^9F@1#S@<].M*N$S@].E)$I:?.>M %#67##G!P*YG2;\VVO1C. S<UT&
MJQ[79<GVKB-4;^SY[>X!QE^OXT ?1R,3!;L#G*U,?NDUG:!.M[H5K,#GY*O@
M@1X)ZU:$Q\2@#)/UKCO&NI_N1#&W?L:ZB\E%O8RL3@[3BO)]6OS*TID8GKC-
M'42,Y8?MMW%WP1FNK\M88%C3MZ5B>'[;,<DS=QQ6U!P3N/%*Y0^%,Y+=A2@Y
M;VITF,?)T/6D 4+NJ6 C=?Y4 D_E0K!^#2, #@4 /'3F@KE<^])_#BG #:!F
M@ YV^V:;SN]JD;'&:3Y?UH 0<<BE .00>M)QNQVH'7GI0 HSQS2$8&?6E&..
M:..,F@!HR&)_*G#/R\T@QGGI2C''- #6!VY'>@K]UC2C&>>E-;)P.U $A/0C
MI3"25P.U.&,8]>M,QR3ZT 2J2$QGK3/*VPEQWI54L"O:DW@CRB>* )HWWP\U
MSEW:"/5OEZ2Y%;881L(R>.]9^JJ8KV!_]H4T!4\+RRZ5XJ%MG"N<_K7K?EX=
MI/45Y1*IA\0VUP1C@5ZI8S&Y@5CT(IB%$0WB2I$R9L^U&!@@'H:(N6YH8RS1
M114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A^Z?I7C'Q-7Y9
M"3SWKV<_=/TKQCXFX\N3GZ4 ?.^J?\?1^M5'8X JWJ0 N&^M5?E8X]* );;)
MNHP3_$*ZQRT/EG-<E;KMNH_]X5UIPZKN[+0!I+XAG@@"!C@?6F#Q)<Y&&/7/
M>L_"-^ I D9Z4 :TOBBXVXW'./>NX^$&MRWVOR)(2?EKS'8C1LQZBO0_@HD9
MU^8C[VTT ?0)D"R$#O31<C)![<5&,1R-YAY)X^E-\E)&9]U #FG;867IG%(M
MR^WGZ5)F-81G&.E(ZIM4BFD [SCLSGFG++A<L>U1%$?OVJ.4)(GE!OFQ28!!
M?I-=M$C#@>M2B5E=A6-IVFO;7[RNQP3QS6P[1J_)ZBIO8!DDIS@&G)*67&>:
M8VPY8GK359 W6CF LK(0H!/6D5_FSZ]*8X0C);%*JJ5SGI30!+<C&,]::ER<
M;0:K3QJ&))HM%4L2QZ4P+KSD*.>M(9_+AR2,TT+%(Q3=R*KWT 9 JL>*+@6V
MGW1*X/)J..X=I<$]:CB0>6J$].M-<+%,6S]:5P+*R/RM(LTGFX)X-1Q3JTF#
MU[T]RJ29-', Z25U8#L:4N>,>E-:17./SIB$%OI3N!,9@JX]:$;>P%0W41PN
M/K3E=8HP<\TF!(TV<JIZ'FA6PI8GBH$53NP?O<GZTV1#Y1C!.332 LF0LGR'
MBB*1CP>U5[8&/Y&]*FR ^!0P)A(.YICR9;Y#TZU2U&;R82ZGD"N9M?$LB73(
M_3-) =E<._D;T."!5*#58BPADD7S#ZFH;+45O248X#5YE\1KN]\-:Q;W<!;R
MRP)YI@>KRZG:0GRY)$!]VI]IJ$-VQ2!U.WT-> W7B#4M8D$\3.!MSP:[;X7W
M-U+=3_:68]>IH ]1!S)R>E5UED>9E)^44Z5@F"#R31(/D4)]XTF.PK2N$R#T
MI(IO,SD].M*,1C8W>J\T31G,?>FA,GAG$N0>U/9QN(!X%5UB,(^M.:/]UO!Y
MILE#K:8R?,W:K*ON.!5'<$C^6IXG4!6)ZU(SP_XH^++G2_$YLT?Y2>>37*GQ
M[<P%4W'WZU+\9-A\=YSQ_P#6KD0L4A)ZXZ4[C9U+_$"[B=E#'GZT1^/[I869
MV./QKFH8$FRS#ITJ*18IX6B3J*+ CI%\?79^<,<'ZU(OQ!OE#?O&S^-<L4AC
MM5C'WEIH4%-T8S4E,ZVV^(-ZSG=(<#W--/Q OFFVJ[8S[UR)BD6)I"A'/I3M
MTD<(81\N,=*9)U<WQ OBQ7S"<>YIB_$"^D 4NW7WKFH;5DA,DRXR>XI45!E5
M P1UH0'5/\0;U3@2'ICJ:B'CZ]1"Q<\GWKF4A0R@'I1?QI'A%[T.=B&=3'\0
MK_&?,;\S27'C^_(!$A_,UR_V1_(7"]O2G16;NF2O0^E<T\1J,Z4^/;]-C>8W
MYFE_X3V^,A<N?UKE+K$#*K#CMQ4D<7G8"CJ/2M(U[(F2.JC^(E\"1YA_,TQ_
M'U^K[A(?7J:Y<Z=+&<[3CZ4L=M)(^W;Q]*7M4V$6=/-X^O;EE9G;@>IKG=1N
M6O3-=N<L_--6!%D*D8QQ39U06\J@\"M6[FAR;/@M]:B[U-@%GSZU$1@X-4!9
ML/\ C^B^M?7'PR_Y ,?IBOD?3_\ C^C^M?7'PQ_Y 4?KM% V=[1110(****
M"BBB@!K<D"F.-OXU+2$9&* *3J2AXZUF7"87;C))K=*'%59+=6;CK0!SD]OD
M$;:P[NTY)*]*[*:V;G%9MS:%@<B@#C)K/>N,5G3VGE+]WZUV7]G,),XK.O\
M3I""5'&?2@#AKC2=X:0CW%9;02H" ""#7H']GR-%R.E4_P"QC(Q.W].] '&H
MDX7D$FKL%I*Y'!R:ZU/#[$9*\_2M&ST$\-M_3O0!SUIHS/MRO;K70:=H 1MS
M+FNDM-(*Q D?I6I!I[  =A0!EVVAQ[=V #6M;Z?Y4>,<XJ[# 5//:K5 %:&U
M5!R,U8P*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!&.:MV]@$XV_I6F$4=!2X H BC@"KC%2@ "EHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** (6/SX-,=<$,*E<?,#B@X8@8I
MH!G#K2* #S3R-IXIN/FY%4(S=1T&UU#)D1<GVK@]9^'WVBY/E*0 .P->HJ^7
MVXP,4H49)(J!GSMJ_ABZT9B^&X^M9@U2XCBVNO\ ^JO<?%<%O,H4J#7 :AH4
M,\64C I@<S:ZX" K'':M%)8IR#NK,O?#%P,M$I&/2LMX;W3W&[<0!0!UFUMX
MV<KBE:[C"^6P'Y5S]GK^T[77K6O;W5O*03CFD DT44Q('?K59M.\H%^A[U<E
M7]X6CY'M3A/O'ED9QUH RF=XSD9XJ=;YT17)/'6KLD<;?PC_ !J&2!"N N12
M F_MB&:V9)".1S3='T:"_O3(>AK'U&PD6%GB!X]*FT#4I;&W 8G<#0!V7_"%
M0RW&\CCZ4ZZ\,6UFI9\"L]O%SQ6X;/(K%UOQ5/=Q+Y;'GK0V!?OKNTT^,LI&
M17):AK?VAI"AX/I5:ZDFG3+L2*H6X 5]PX'ZT 9M\&N%+,Q_.LQ/FE6U'4FM
M*X;(;'2HM&M6DU!90F_::$!Z1X(TG9(BLOW #TKT>4JV%';C%8OAR-8+59]G
MWAC-;#$>;D#KS3 8  W'6G;]I-+@,Q-!7'/X4 1MC.1WI2V  *0J:7(].U
MQ^7(Z4H(''XTBMSR,"DP2QXQS0 @!&6]32L><CO3^/Z4T##$4 * !\W:H_4^
MM2=\8[4 <=/:@!./7M2@ <T@X;![T-GH.@H 4C(P/PH!YP.W2C([\9_2D&5!
MX_&@!QP%!IA&6P*7.[.!3T 49/6@!A(QCTI>%Y'X4A/WN*5C\OUH 3 ).#00
M.>:(F]1UIF3D9'6@!Z@*<+SZ4F_+LPZ8I@8Y%+=.MMI[,1R0: .6N[OS]3RA
MSM-><>/[C.ILH->A:8G^BW%S,,'DC->4>)+G[9K,C'[H/6@#T'X):H;74OL^
M<;SP*]T\3:HMA8% V))%XKYN^%4A'BZ #A<U[!XVO&EU%2IS'$HS5 <I(3+?
M<\O(V#]*ZVSVV,"H@'(Q7/Z/"MQ>FY/*]JZ0J"1D>]2Q(1B(W\T=:?\ Z]?-
M/:E8C;M(IH.V,H!UJ1CF?>@(^E,!ST^GX4^,A(]I&<T@&W/%- &T1\GO1P3]
M12,=V,]J7/H.U,!P./E]12#CY:09'.*4>O>@!PZ\TO'KWIH/SXQ3OP[T '&>
MM(,9YZ4'GMWI0>G'2@ P 0":08SSTH)RF>XIPZ XZ4 (,<<T#''-+T(&,T@[
M<4  QQS1QQDTG4 8II.!F@ S\^.W>G#&>: N03WI"?EX&2*0"[0&R>IH5ADK
M0V2@P,M2*ORY[T )<2+!:2%SC(K/\-H)3</(.!S1X@N ;:..([GS@@5;E1='
M\(3W+':YC)HL!Y'XLOXSXUB"'A7 _6OI#PXRS>'K1L_P"OCR[OGO/$0G/_/2
MOKCP/(9/"MJ2/X!_*J2 Z'C&*2(9:E_"GICTI@/HHHJ0"BBB@ HHHH ****
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M\]B^)^G0$A%09]JE/Q3L O\ #D^U,1M1^'MLDLI)V]:X37?B2OA^^>R5AM'
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MXYJE>:);W@(90<U+P!G)R*199!TR1UJ6,Y#5O",: F!.<<8'>N*N+35;*X*
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M1F!RHYIV,VCI[2 PVXM_3FK.,#![?RI2H5C(/3%-SE<T *.N?\XI-VX$"E&
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M))9_,,_3FN6/F!L;V_.@^8#]YOSH ZH/9@  CGWH9[0\ CU/-<MB09RS<>]
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M.:E"XB//>@!@!'7\*7=_GWHD&8<@\TD:G;S0 H./\]Z<1E?>DV_RIP!(Q^M
M#.6( ]>:>>,^M*$VG.:3&9.O% "@DJ!2=#1C#YS2@9&?>@!1G P.]'/IWHQ[
M]Z/Q[T &">/>D.=HI>_7O2'H.: $8G;@#I2[\;13<8)/K0P&T'/- #QGCB@9
MXXH ^[S0.W- !D@ XI"<@#TI<9QS2$< T *"> .U(N=YXH5#G.>OZ4FQOM
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M T;5;JWN]TA.TGBO3+#Q!;2VZJ2-PZ\UPLEC&+==H 8#GBJ0^T6TORDX[<T
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M,+DGG&CSN]1%E]*-RXQB@"0S_-FE\_O40*],4C%0>E,"7S^]+YYZU$"N ,4
MC?C% KDGGD'--^T'.:5PO0#K3/D';B@+D@N#C/2G"0O$>V:KY7)R..]2HRA3
M[4.X#-NT9)J[I1!GZXJ@S@DBKNDK_I"M4E(Z*BBBD:!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6%K=KN0R 5NU4U"+S;9A[
M4 <+&6\PC'&:E8<YQQ4TEJ8G(S4$A_A)Q5 )36!)QV%."_+G=[4@7C!/7O2
M:3FG#D4[R^,4%=J@9H 2CJ,]C0%R<9ZT[;T&<4P$QQ0<=!2@=.:11DXS0  9
M.!24XC;SWII&>_6@0J_-R*KZC/LLGQZ<5:B&U36#KL_EKY>< U++IRLSD5TT
M7]VY(R<\5 VA3).YB!XZ5T_A^V#R-*>E;2VL:R-G'-9,]*G535CB8I;VPBY!
MP*N6?B-?E$S8%=!=Z?'<(RKCFN2O- 83'8>,UF[FZ<);G5P:E'>!/((..M7,
M@-DUQ06?2D! /-7;;7<C$AY]ZI-F,\/?5'4NK@[\?+2\MC:*I:?JT,XV,PQ5
MKS%8[4/>K4CBG3E%A*VU2&I#D6_'?^5/,2LOSO@TV:,Q1J0<YJTS%[%#Q+&7
M\.L<=JQ? <N%=!T%=%J2-=:6T)&.*Y7P6?(U"Z@8XPQ ID7(/''B$+=_8U;@
MC!&:TO"-U:65LJ9 >09KG_$OA^:]UWS5!(S5JQTNXAOHD )  I-%*2-OQD2+
M52_"./EI/!D8ALI"!53QG-YL-K;9Y!%:WAJW\JQP3U%*P;FRIW?-WJ,$F6I.
M%&.E,V[<T[$N#>Q(!@$M1G)S2#YEQGI2?=D%5<(JP-QP:0@A?YTK#)ZTN/E'
M.:EB<KAR1COWJ,H23Z'K4BX]>E"D!<GH/UH0T4-8O!;6@B!^=^,5C7LRZ+X=
MD:0[7<&I+YCJ&HJJ\JAKF?B;J(CA2U1LX%,H\NN)FGU":;J">M6M.A^T7T>.
MH/-4X /)9B>M;_A& 2WH)['\Z!7-Z_L@DD?&!@9K5M/DA"J.,56UE@LR@'I5
MNV7%F&Z\4 .4C!8T9(9OTI$7OGKVIVP;,YH 4-E,4GW5]S1CW[4;>,Y[4 *<
MD#/6FN%*["!F@]5.>E)(,G<.M %.;28Y!N'KG\:B2XO=,8&#)&?6M)6/&322
M(LA*YH T--\5.[J+AL$'UKK[36;:X088=:\QDL2A9UI+>\N+:0<G% 'KX990
M-G.:8Z&/KT_K7&Z?XE$84,W-=/:ZE!>KEI0,]J +0<L,KSZT\-E<4Q=HYC.1
MWJ78FS._!- "JV$/Z4S!/W>M)C*X!SCO3C\BAB<4 *P(CYZCI2(<D$4P$R \
M]:=MV#=G&: !F^3'\7:G1?)"Q;[QZ4R-=S;C3I>H /6@!L.<'U[5-&1M8'J.
ME1E=B@]*ANG^S0F1CC(H R+M7U2_6T'*AJZ'6KA='T/$> 0E4/#=KYEU)=-T
MZUR?Q/\ $(MP8$?[PQ]* /(=<NWOM8GE8YRU5;>/S[B- ,J34'F;V=R>6-=7
MX,T)[VZ1V'RYH ],\&Z;_9^E*P7!(XK>@0+$Z_Q-4L4*VUHD(XP*;_$&% !L
M$:#\C3PHZXJ-CAAD]>U6&7]TI'K3 O:8 URBGK_2N_A&(4'M7"Z/%FZ5J[N,
M8C4>U(!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (WW3]
M*\G\7'.JGZ\UZPWW3]*\F\5<:F>_- ,RU+;>GUIQY&?SI!P,4=/QJS-B8HX/
M3M0?YTNS'0TAI #@8]Z<.F:;CCK2C@8H"PYCG! HQ2 =LTO?&: L.')X%(F<
MFE P.O6E'%.P6%QS1BD/!Z^U&/?M2L(4'C ]:*,<8S28YQGM0 O.ZG=\BF@=
M!FG8]^] "XQR/PIP!ZCMTIH' Y_^M3\<$9Q0(3.6XH.00>W:D"^^,TN/EQG_
M .M3+Z"Y/&.G:E&<?RI O&,]?TIX4$XIH01CY*=][I0H^8C-"K@GG%.P!\RC
M(%*.!D]>U '3FDQR 302*"20!3MI'X4P#YL=*D.?7K^E388 \_RIY&.M1_IG
M]*>><<T /9>!GO2;0*3.<<]*?_%U[4"L!7H1]*;R#GM3AR"*7;F/&:!6% W#
MG\*D0L%*U&J_*.>E2KUI%6&JHW;L5*23SCBDP,X_&G[>V:86!>>O2GK]X@4U
M5ZC-/5<,.: '8YQW_I3Q@?+0R\@@T8^8'TH < 1UZ5*O/;FHR,\@U*J<9SR*
M0 ?E/-/ZC/YTPC<1WI4!VD9H"PJCKG\:>.#S^- QG&>E& <<T"'#..:!G/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<BK"J77&* -K0(P\@)' KL5^Z*YOP] R*"172T %%%% !1110 4444 %%%%
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MBEC&YQS6Q;SI.=RMP:\E;S;0[036Q:>(9+&- Q)]: /2C"3.&S@5$^6N=N[
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MA<KUI,#=G%28QTIB$5>V:>J_,*;C'(J0=,_YS0(7'.,]ZD"YIH&!4HQCIWI
MQ@!]:D4'@9I1CT[T\8&>*8!M]Z!Q1UZ4\ $9_"D,1?G/7I2]!@'I21@*Q%+M
M'8=>E/J ;2,^U+M+=^E/W G@<&D!& !WH'<:>F,]/UI1UQGI^M.V@8]J3 !
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MKV.J6H+;=XJ*\T&WU%&X% 'E]GK"M*5:M*&0W!.RK.I^$Q:N[Q]JPE6YM&)
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M,0/05OZ##N;<!WK#6,$@@]>*ZW1+8Q0Y]: -D<"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7E7BWYM2^AYKU5ONGZ5Y=XF
M*_V@^?6FA,Q@V4XZ=Z O<]*% 9<#BI!M VYIW)(_O-3]O>G; O&:,=LT7&-^
ME S3RH!QFC:,XS3 :3GF@#)IVT9QFG; N/FI7 ;_ !4$9IQ ]:7 ]:+@-&1S
MVIXY'^>M-(XQGO4N $QFFF)D?S>G>E^OK1C;WSFE"X[T[B'@<9(H(!Q[4 C@
M$T[:/6D G).,<=J,$<@4X#C&>M(.6QF@0=J*4X+X!HZF@H2I!TX_"D &,4_
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "%0<^],\L$8-244 5)(
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M[_C5D:;,>=O2C^SICT6BX6*P((R?QI0<_P!:M#3IQCY>E2)IDQYV_2BX)%5
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M;7496B/S&G->2@'#&J]O"$MLXIX7(SCM3()!?3E0-YH-_..-QJ+;@=*-O?\
M"@"0:C,#G>:=_:LI&-Y]:A:(<#UIJVP)P!WIIE%K^U)B!\YH_M.;=C>:A\@#
MC'3^=)Y/H/>A"+!U.7^\:3^TY<XW'TJ'R1_GUI/('^?6A@6/[3E_O'TH_M67
M=C<>E0>0-N?\YI@@&::8%K^U9MV-YH75IM_WCQ4"VXR?6CR ,D#Z4- 6O[7D
M;YMYXI1JT@!&\G%4!:X)XXIWV; !]:0%J35)LY#DTG]I3MSO-5A"1VZ4@0\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-^:MN"MN,&@9%>V5M=PD21H6/J*X?6O!T<F7B7&/05V#R-D8.>U&X$?,<YH
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M:+!)^:@"CXDUJ;4YRSL2H]36#&WD6[2 ?*>]:-U&#;-ZUFVZ->R16T8SEN:
M.S^'6@_;[Y;J5,J#D9%>V%PL"0KPJBL'PCHB:9HR,  Q K>9/F'H: &D'RLX
MZ=*(MI.:61MGR]C^E1CY23GB@!PP&;';I3?F).!]*D504)S35!$G)QF@!1N^
M7%;6D1&25#C/-99CVRKSP?TKH]"C^;<.U &\JA5 %+110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M],DW0.Q4>IK5/0#V+5O#$<D9-J5!/TKDI=&U/3I#(S$HOH*KZ3X[OGD'G?=
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MU"@9!N[]* 'J-Y'ZUUND0B*V''-<W:PEYE11FNPMTV0J,=J ):*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!#T->2>)F#:R_^_7K3G",?:O(=9/F:S(>VXTT)E8Q@CI3".<"K;@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&<4 1X(&?SI0.G-.8C=C'7K0!CC\Z !8MW4XJ6 90KGD4J+N//2GQ*5E/ZT
M;.CVY:7?71@8&*H:7#LMU8=^M:% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM<'\/I"]H!GI7>5+*"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%-<X0GVIU0W1VVSD>E '$ZD0]ZS8S@\U6.WYN*F=RUP[=L\5&5)/'6@!L4H#
M88'(H<LK%EZ$YIS @AL<=Z-RR'':F _,=S'MD7/&*YW4/#,,GF-&F"?;O6^7
M$7W>:>)69?F YH \POO!UPN9$_E6')975NQRK?*?2O9VQ("C*.F.E4[G1[1H
M3O102..*FP'D+7[-^[D4\<=*QKF1(KU'0XYKT?4/"IP\D2#D\<5P.K>';RVD
M:5T.T'/>I: ZS2O$$4:1JYSQZUV=G?VMS:G)'/O7A$.HO;SA6SQ73V>LSB(%
M&./K6"CKJ!L^-;*-9(I(\<D=*JV$A6$ 'G&*H:UK'VN*)2V6&,\U-I<@;!![
M5O%6 N3L64AN:J%$9<8QBK\WRL,]ZSKMV29>,+WJP,*]F*7&S!YJ.;]RJFM+
M68XXU$PQC%9>G)+K%RD,8SDT S=\*Z#)J]^KE#LSW%>T)9QV-DJ0C!Q69X:T
M0:+I:NR 2$<\5MJYE.UN] MR-6'V0''S4D#CRBH%2-M'[L=3UJ-E\I]I[]:5
MQC<X;(%2L1N '>DX R:<,%\GO3 0??"CO4Z1?/40!\TL?QJW#G//0T!<N)CR
M\ 58@3?(HQQVJ.(8'(YJ[8(S2;L4 .OK?$)8#M7.P@+*R_C78W*[H2/:N/<%
M;AN.]  X(;ZTT=>:FP21FF2 A3B@!" /Q--+ /TXZTH)V GUH(S\U #"5+$X
M[4GR^G:G@@AO:F $?B,T 'R^G:D.#C'IS]*4 C/N,TBYYQ_DT )_G\*3=_GV
MIP&>G;G\:;M."&'7I0 @('0=_P!*< !T_P BE  3WS^M!!'7O_.@!F "..*0
M,/NX^M2#.UL#FHL=_6@!,YRO;O22?*P!Z4X_=)'WNU&-Y4>E #7Z#TH4A22W
MXT]AN90.U(RY;Y>U "<-D4K$!1QTZTA..G4TW<3T[]* ' _/[#K2K@-DCK3$
MR.&J;:6*JOX4 7(@I !%=)86X6,-CK6#8Q-)(@49]:ZJ)=D8% #Z*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JAJLP2V9<XR*OU@^(FVPY'6@#F>I;!ZFE&02<TV''^-2/
MA1[T -R.A-.\M ,YYIIC_>"AE.['I0 WR]Y)W4YEPHP>G-*%PN??FE &"3^%
M "1@'+&DG4RK@&FAL/BE4^6Q)Z'I30"HJB+8]-;1;/4(&24*,^M/^24'C_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3VH 8I(SD4C-D@8Z5*J?,*;@%V[4 ( P5N*0 @8(Y[4NXGC/MFFG+'.<?TH
M!G ]>U* 0.1SVIH'0Y_^M3CEFSG']* (UW;_ .5+P5P>HZ4= "#3<<DT )\P
M! _"I5'?N>E0]03G%2@?=Y_^M0!.L);;@9J]:0&20*HZ5%"F(B<]:T=)C)N-
MWIUH W(EV1A?04^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&!T&:<'&>?3-/VL$PPY_K4.W! ;_ ": 'EAG@=LTG#-]13B#M) H10!SUZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4]B/U[5%) C@FKGD+NQ3)(@O04 9$UH,\50FM3G/I71A%R21VJ.2&(CIUH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S$J+@=:T95ZX-4FB8MG- $"PEL8&:TK:VP V.E$%N2H/3-7E7:N* %HHHH
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M%>&'#9QUJW34XXIU, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1Q28PRUH1*0N2.: )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MH(R,444 )M&,5'Y>1@_C4M% $ 0*3Q2%>Q%6*,"@"N4Y(QUI4@Z;JGP** $
MP,"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0#%+10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @&!@4M%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)M'I2T4
M )M'I1M7TI:* $VCTHVCTI:* $VKZ4GEKG.*=10 F!Z4A13U%.HH C,$9ZJ*
M/)C_ +HJ2B@!GDQ_W11Y,?\ =%/HH 9Y,?\ =%'E(?X:?10 PQ(?X:78OI3J
M* $P/2EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BD!I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **3-%*X"T444P"BBDS0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M$@4UCD<&JFI70M;9I"0,5S*^+8AE2XSGUJXP<MC.4TMSLP:,^E<DOBB(J6WC
MGCK3U\56ZIRXS]:ITI(GVJ.JS1FN4/BZW'\0Y]Z3_A,;52,L/SH5.3%[5'5Y
MQ0&'K7)/XOMF<*&&3[T?\)1#YH7>/?FJ]A(/;(Z[<,XS2US5KK\,\^Q6'7UK
MHHVW(#ZUG*#CN:1FI#Z*2EK,L****8!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)[U;IB50]7HK.TO4DOX@ZD=*T:R:LS5.Z"BBBD,**** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSCTJW9;F:;9Y5:Z[<Z?=*C@@*<5ZQX;\01:C;JF1NQ7&^*O"9C1YD'OTK.\
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M^&=<E%_'$Q.,XKU5=-BND5W4'<,UQU(JFSKMSGANC^&+O^VEGVD#=[U[S81
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MV"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT5<JGI8(T^('^Z*N5D]S>.P4444AA1110 4444 %%%% !1110 4444 %%%%
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M0;4 '854@TZ"%BRKS5WH*<G<(QL%%%%24%%%% !1110 4444 %%%% !1110
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M&*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!4&  *3$:"@]Z6HH9TF4,ISFI:0PHHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KRCXE6+V3_P!H1+RIR<5ZO7/^+-*_
MMC1YK=1\Q4CI0!YEX"237K];B=254]Z]&\:VGF>&)(47.!P/PJKX%\-_V'8%
M7'SUU%_;BZM7B(R".: 9XIX0UUM&\RVVX)XJIXLL;O6()9%#8;-=)<^"YSK8
MDB7$>[GCM7=0>'8A8>6RC<1BA,$>,^ -2DT!WBD0[@,5W$'VG7[B1F!",,5#
M/X*D75VD5?DSZ5W^BZ5'8VJC;\V* /%;P?\ ",ZK(@&"[XI)]*E,JZP4) ^;
M-=+\0_#<UYKML\*\$@G KJSH1_X1!K;'SF/T]J:;"R.$\.WC>)-;C#+E(OEQ
M]*]ABT^W2-0(QP*\_P#AOX9ETJ>YEF7EG..*]*)Q0 * H ':EHHI %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!AZ]H
M<.IIO91N'M6+I_A1$G5F7Y0?2NVI  .@H KVUE%:_P"K ''85#<:5;W,XE=1
MN'M5^B@"&."*(;%4=/2HKP)#9RN  0IZ5;QSFH;I=]LZD9R* /(O"RF\\971
MFY&XXS]:];2VBB9650#C'2N9T?05M=5>Y5,;CFNNQ0 @')/K2T44 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% #/+7=G S3Z** &/$KD$CI3E4*.*6B@!CQK(,, :<% 7 I:* $
MP,5&8(R02H./:I:* &HJJOR@ >U-:)6<,1R*DZ44 (RJRX(!%1QP)$,*H'X5
M+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&4@CK2T4
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2BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0U!WT# 2(  A$! Q$!_\0
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MN<=J, G/>BX#J*0'/:EI@%%%% !12$X/2FECGIP* 'T4PD]!3ATYH 6BBB@
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M<!U%(#GM2T[@%%(3CM1D"@!:*:=N<^E(-IR* 'T4TD]!1]Q>!0 ZBD&<<TM
M!113=P!Q0 ZBD+ "@$&@!:**#TH **9NXX!I<D#GK2N ZBD!S11<!:*2EIW
M**** "BF-DG ''>A5[G\* 'T4AX&::!DY-(!]%,^Z?:EWC-,!U%1ESG^E*G?
M(YH ?128S2T %%%% !1110 4444 %%%% !136<#J:JS7\,0Y<5$II;E*+>Q<
MIK2*HY8#\:YZZ\46\((7)-8-WXA>ZR$9AFH=9&T,/)G;'4(%8@N/SI1?P$??
M'YUYD9[K?N:0\].:9)=W"@XD/OS4>V-'AF>G?VE;_P!\?G1_:=M_?'YUY.UY
M=@Y\P^W-1-=W8!/F-^="K">&=CV"&_@G.$<9^M6:\J\,WT[WN'<DY]:]2C.8
MU^E;1G<YYPY6/IA.&ZY]J?3&!)Z59 9R>M./3K3>>/EIU(8GIS2G..M%%*X"
M8.>M+12T"$HHHH 3!YYI<'CFEI#G(XI@!Z<'%*.E%% !3<')YI021R*6F W!
MP.:4]*6B@!,'CFD.0#\U.I",T )SD<T8..M**6E<!,'/6EHHI@)@\\T8/'-+
M10 W!YYI>U%%3<!.@Y-')/6E//6BF F#@<TN#SS10>E%P$P>.:=2#IS2T )1
M112 *!D#DT447 3!R>:,'CFEHH 3!YYI:** "BBB@ H[444 )@\<T8//-+11
M<!,'/6C!QUI:* #M28..M+13N M)112 ***6@!H!]:6BB@ .>QHHHH 0Y]:!
MGUI:09R>* #!R.:,'!YI:6F@#M2 '')I:*8!33D]#2XHJ6 4444  X')HP<Y
MSQ1C(YI:H!@R1PW>E)[#K2C Z48&<T@$Z#DTM!%%  <Y'-!SC@T44@$P<]:3
M!QUIU% "8.>M&#CK2T47 3GUHP>.:6BA  !YR:.<YSQ2T4P$SGI1^-& .@HI
M,!N#CK2X.>M+10 4444 %%%% !1110 4444 %&#G.>**3G/3BA '4<&EP<]:
M ,=!2TP$&0.328//-*,XY%+0 W!XYH.0#S3J1NG3- "=Q\U&#ZTH'?%% "<Y
MZT8.!S2T4@$P<]:,'CFG44P&$'!^:EY..:7J*.X % "8.#S2\YZTM% #<''6
ME .>M+10 4444 %)2T4 %(0>QI:* $HZ4M)2: !28.>M+10 $''6DYSU_"E.
M0.!0/6F F#CK1@Y/-.HH ;@X'-'.3S3J3&.U  .E)@X/-+12N F#D<TIR>AQ
M111< [4F#@<TZBF T@\\T<G'-+UHHN G.#@T8.1S0>!P*4>]%P$PV.M&#GK3
MJ3G=TH 3!P.:4]*"3V%+3 ;SD<T8.#S2XHI7 3!SUHP<=:6D.>PHN O.>M S
MCDT"BBX!@\\TF#QS2TM%P&X//-+@Y'-+13 ****0!2<Y/-!SV%% "'J.<4H!
MR<FC&>U+0 G.>O%)@XQFG44 )SGK3<$'EJ?28]: $P<GFC!XYIU% #<'GFC!
MR.:=247 3GUHP<]:6BD F#CK1@YZTM% "8/'-&#SS3J*8"8/'-)R0<-3J0#%
M,!/XNO:E&0.32?Q=/QIU(!,'=G/%!!R,&EHH 3.> :.G>C %+0 E)SGKQ2T4
M@"@TM%- (!@<FDVY;)IU)DY/% #2@S_.D/7 _.I*3 '2@!:09 Y.:6B@!,'=
MG/%!R>AI:* &X//-)L]_K3Z*8#-GOSVH"D'@T^BD W!QUI>U+10 W!P.:7!R
M>:6DH 3!SUH(..M+12 .?6F\@<MWIU& >HIH!,'/6C!P.:=2-G' I@&1FC(]
M:%&![T@7G)YI .I-P]:&.!FJQ)9OE_.A@.WMNQ3PA(]*<JC'(I] #57')ZTZ
MBBF 4444 %%%% !112%@.IH 6FLZK]XXK-O=:M[,D.PR*Y75O%ZO\L59RJ)&
ML:,F=G/J%M A9Y5&*Y^^\7P1,1&0V/0UPEQJ%U=D@LVTU76Q?.68G/>N>6(.
MF&&.@O/&-S(Q$1(K)DUF^N&^9S@]JC,,<8!(&:ADE1>AQ[UR3J-G=2PZ2+;-
MD;G.35<W.#QQ58W!/R]:CR<Y8<5G=G0HQ6A<^W2.<%\X_6A[IL<M5%WP<JM5
MI9BPVCK3N["?*7FO@O?/]:K3ZFH'WA66Q"O\S_\ UJS[B[AC<Y.:N*D9S<;'
M9^%;[S-2 W8YKVBW;,"'.>*^>?!]ZDVL*L?KUKZ$M5/V:/M\HKKIW/*KM-EF
MF _/U_"GU$1M-=ARCVZCFEI!R!GK2T@"@$'I2TG%(!:2BB@ HI.=WM3J+ %)
MD9Q113 "0!DTF,G.:7'K10 M%)2T@"BDHQ0 M%%%, HHHH **** "DI:2@ H
MHHI )G/0TM'2B@ HSBBB@!#S@@TH(.<44<4P"BBBD 44M)0 4"BB@ HHHH *
M*** "BBB@ HH-% !1110 444M "4444 %+244 %%%% !1124 +10*#TXHL 4
MM(/>EIH HHHH 2BBBD 4444 +1244[@)]T<FC'.<\4O!H[4 &0111Q12 ***
M* "F]1P:=1QZ4 %%%% !1110 FX4NX9Q1@48%,!:2BBD 4444 %%%%%@%HI*
M* %I*** "BBB@ HHHH ,@#FES2447  010!@DYHQ2TP$) Q2TG'>EH *3(-+
M2<4 &1G%%'&:6BP"4 Y%'!HX%%@%HI** %HHHH ***2@!:*2B@ (R0<T$9&,
MT447 ,C..]+2=Z/K1<!:0'-%'TI !Z&D!  YI:,"@ /-%%% !2TE%  3BBCZ
MT4 %%+24 %%&:* %HI** "BBB@ I,'.<TM%  *,C.**.,TP#('6EI.#2TP$H
MHHJ; %!('6B@CUH **** "EI*6A %%)13 6BDI: $R!UI:3K2T %%)2T %%%
M)0 M%)12N 4 8'6BB@ HHHH **** #%'>BB@ ()(YI-IYYI:*=P <"@#'>BB
MBX"?Q]?PIU)12N M%)10 M%)11<!:*2C-.X 2!UHSWHZ]:3G=CM0 H.:6DQ2
MT )D XH!S11Q0 M%)10 M%)10 M%)2T %%)10 M%)12 **** "BBB@!:0D#K
M11Q3 -PSB@D"C I&Z9Q0 TDY.#3LX7/6F[NIQUIC2\87''6@!DDP;Y0<>M2Q
MQ@ '-0PP@R%^QJW3 **** "BBB@ HHI&8*,GI0 M1O,J#)/%9]YJ\,((#C-8
M=UJDDX(1A^=9RJ)&].BY&W=ZM%", \USUYXD*;@IX]:RI9<D^9*<_6J<FQLD
MD8^M<\JKZ'=3PJ1%>WDE]+OW''?VJLMHCODMD=J;--''G#"LJ?4F23Y&^M<\
MIMG9&BD:\WEQ' -5Y[PI@+SQ65-JA9<MC-9LVI!027_6LK-FEHHW!.TS')P*
MBF& 3NZ5SD^M,B[8N6/I4=O_ &MJ$@$<;E2<=*<8-LRG52-*34XT;&[OUI?[
M90K@#-=-H?P]GNU5KF-AD9-=A:?#C3XQ\ZY^HKH5%M''/$I,\D;5G_AC+ U%
M]MFE;B(C^E>W1^ M*5B?+'TQ5^'PEI4)'^C1G'J*I8=F3Q1X5#H&IZH?W2,*
MUK+X8:C<,#,2!WKW*#3+.V_U4"+]!5D(J]% K>-%(REB+GGOAGX=QZ3.)G;Y
MAVKT)5VJ%'84ZBM5!(YY2;"F.F>:?15$D:C/T'2D/4X_&I:* (P2!C\J3^7>
MI:* &[>](O7CI3Z* $Q@DTP/\W0U)10 FWK[TT*<\]NE/HH 0C(Q36;:,"GT
M4 -3[M.HHH 8V=W/2G$X%+10 @Y&:3&T$TZB@!%R>301FEHH 2EHHI6 *2EH
MHL E%+118!,44M%%@$HI:*+ )31U/6GT46 2D;[M.HHL @Z4C' IU%%@&*.Y
MZTZEHHL!'MYI2I[4^BBP#-O%*,XYIU%%@$HYI:*+ -8X_&F#.?YU+118!,44
MM%%@$HI:*+ (>N:.M+118!*.E+118!H&*7%+118!**6BBP"4@.213J*+ )C)
MS3023[4^BBP#&^]QUI <>N*DHI@(>E,7]*DHI6 0C(I,8IU%%@$Q32.:?118
M!@7CO3L<8I:*+ - P*4C-+118"/&&&?PI]+118!I7G-+BEHHL W;U-(%I]%%
M@&,".1^-&> !UI]%,!FP^O7K1M/7TI]% $:C/KBCG=QUJ2B@!C=!2%"><_6I
M** &!3GGMTIQ&1BEHH 3%(%Q3J*5@&XYS2TM%%@&GI35./H>E2446 :W3FD4
M]C3Z*+ -!R*"3G ZTZBBP"$XQ2T44P&MC(H^]D4ZB@!C=0!UH(PO.:?10 FT
M=:0I\N,TZB@!B)MY)I&SN_E4E% #0G')ZTNWI[4M% $>"20.E+M;KWI]% $1
M!'TI5^]SUJ2B@!*0+@YIU%*P"4AX%.HHL T#G-!&:=118!,<8I ,"G446 :%
MP:4C)S2T46 2C%+118!,48YI:*+ )12T46 2D IU%%@&[><TG.?:GT46 3%-
M)V+Q3Z*+ -7)7)HV\TZBBP"4UASQ3Z*+ - P*-O)-.HHL!&IQ]*4DL<#\:?1
M3 9M;\NE&P^O7K3Z* &A3G)[4I&:6B@!C=>.M-Y_#M4M% $7//ZTH4D9_*I*
M* (@"21^=.VGKFGT4 -V\8S2[><TM% " 8&*81ECC\:DHH 0# Q2;>O/6G44
M ,"G/-+MXQ3J* &'/:G#I2T4K -V\YHV\TZBBP#2.*3.#BGT46 2DQ\V:=11
M8!,4TY[4^BBP#0,"EQ2T46 :,]Z4]*6BBP$9SGCK3E&!3J*+ ,(.[(IW:EHH
ML T]* .*=118!",BF@'J:?118!*;SOXI]%%@&L<4*#U/6G446 ;@DY/X4S^5
M2T4P&$]A2*<>N*DHH :1U-,YQ[=JEHH BYS_ #IX-.HI6 ;C%+BEHHL TC-+
MCC%+118!,87 I%&.3UIU%,!A#'G\J: 2<?G4M% $1R#CO1V[XJ6B@!!G'- .
M12T4 1/_ !8_&JA/S8 /-:%-V+G.* ",80"G444 %%%% !1110 5%.H>(J3C
M-07]_'91%W(X%<+K'C";8X@D ]*&F-(7Q!:2QRLZ.3Z8-<NVIW290(WY5J:/
MJ\]_>*EP^]6/-=V?#UC+ '$2[B.M<\Z;9VPJJ)Y!=:A=*"Y!S6'=:_=Q@\'%
M>D>(M(AM20% 7TKBYK6VD5MRC-8^S;.I8E(Y8^)9&8APP]:8WB.%.2&-7;K2
M()9&V* *S)M CP<#FJ]@-XH<NJG4FV0\5U^D> +K5XEEW\'WKSORI=+ES&<'
MM7J'@3QQ,I2W=A@'!HC1LS">(;6AU&E?"R"(J9SD#K7:Z;X7L-/ V1@D>HK4
ML;C[3;)+D'<,U9KHC!'%.K)C$C2,850/H*?115V,@HHHI@%%%% !1110 444
M4 %%%% !36<+U-)+($7.>:I[C.W#<^M %OS0>E+YGM4<46!S4V!G- #3)@9(
M-".''3%.(!ZT!0.E "T44U_NF@"(W WXJ56W#-45'[PG/.>M78ONT /HHHH
M**** "BBB@ HI,C.*6@ HHHH **** "BBB@ HHHH **** (GG"\=Z(I"_454
MF($IRV.:GMV)R.HH LT444 %%%% !1110 4444 %%%-=MJYH &8+3//7)%4V
MN/,D(5JL10YPQ_*@"='W#."*0O@]#3Z* $W<XP:6BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:M@OEC% $]%%% !1110 4U_NFG4U_NF@#.SB;IQZ5H1'*UG, 92 :T(?]70
MXY!R.?:HY)U0X/6IJJ7<8QNSS0!8C?>N>]/JC;R< &KU !44TWE+G&33I'V+
MD=:H.3*W4X[T 26\SS[CCH:MKNSDTRWC$:<#K4U(".0D?2E217X!YHD!*\51
M4F*3!/>@#1HI%.5S3925C)%,!))0@]_2H0[R' XJHC^9/@DUI(@5>* '#I36
M#%N#Q3Z* $&<<TM%% &9> >9P,\_E5RU_P!7TQ5*Z($W7O5^#!C!'I0 YY-E
M5BTC/@9HDW-)@U91  #WH 5,[?FZTZBB@ HI"0!DTP3(3UH DHI 0>E+0 54
MO)O+7;ZU;K-U ;G&#S0 ZS13R4&:T*H6(R.#5^@ HHHH **** "FODCBG4UG
M"]: &1[U)#<CUH+,#SQFG>:N<9I&PXX[4 *K=C3ZJF-BW!-3Q@@<F@!]07,A
M1>#BIZI7[': .M $D,C.,FGLKGH35:T)VX/2K]) ,)8)31+C@U+6?<L$8X-#
M OJP84M5K5]RU9I@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOVYI]% %=8"A^4X'>I@&QUIU% "<Y]J6BB@ HHHH C>%6[<TQ8F1AM/%3T4
M':FE<GGI3J* "BBB@"M+:^8V:FB0HN*?10 5!-;B1/EX:IZ* (((6B/)XJ>B
MB@ HHHH **** "BBB@!CQANE1K$RG@C%3T4 ,&[./3K2NNX>].HH 9L[=N]/
MZ"BB@ /(JI):;N5P#5K(I: (XT9$P32&,M]XU+10 SRP!\HIJ!MU2T4 %4;]
MMJ\FKCN$&367?W<1.TC/O1<"2TW;<@CKUK1YQ[UG6#@K@#CTK2I)@,VOW/%!
MB0G..E/HI@(% Z4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4A53U4'\*6CI0!5ET^VF^_$
MIS[5E7?A/3KDDF%<_2M^BI<4RE)H\^U#X=02QL854$UQ]W\.+V.1C$O':O<:
M0@=^]0Z2-8UY(^<KGPEJUM*08F/T%9\VGZE;MAHFX]J^E9;:"0_,@-4)_#^G
MW!): <UE*B;1Q+ZGSJ!=*#NC8?A43M<;LB-MV.N*^@W\&Z7)UA%0'P-IAZ1"
MH]BQ_6M#RGP$UTVKX=6Q[U[[$#Y29ZX%8FG>%+'3IO-BC ?UK> P,5O"%D<L
MY\S%IN?FZ_A3J3 S6K,PZT<^M%%(!H# \FEP<=:6B@!,'/6C#8ZTM%%P$P<D
MYIHSG[U/HP/RIW 3!YYI<'CFF\D^PI] $>3G /XTH0]SQ2[?FR*4#'>F W8?
M7F@J1T.!3Z2D T YSNIQZ48QTIO//%%P'9QP32=,DFCT)%+UZBE<!.<Y!XI.
MWWJ=VIA!]/PHN [G/6CG YH P*6BX"8//-+@\<T4ASGI3N 8//-&#GK2T47
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M!R:,$G.>*,9I>U.X#<''6C!SUI:*+@)@X'-&#SS2T47 ,'CFD/(X-+1TZ47
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M4X'D"EQ2XH 2DQ@DTZBBP#"00.M.(R*7%(>G% "9 P*;Q@]:<%Q]:0J3_2F
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MTI<4 -XW'K3@,#%!4$T4 -! SUHR-P-+MYR?PH*Y/M3 -PQFEW G%!''% 7
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MHL(*0KDT<YI,-QS]: '44G-%  3@4F1FG4TKD\]* #<,9Q1D$XH(..*4+@4
M)D+BD( !YZTK FD"G//;I0 H P#1@8H*D\=J,-C&: %HI I'3I2;3USS18!]
M%,*DFC#$ 9^M #LT9INP^O3I1L/Y]: %WC%+FFA,')I2N3STI@*1NI:0@XXI
M,-FD ZF[AD^U&&XY^M(5)/\ *@!P.:"<"DP>/UI<4 )D$XI.%%&W!XZ4H7G)
MZT +2TW!R?2C#8'-%@'44@SDTM !28YS2TASGVH *,<YI,-CK2X.: %HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4F!G/>EHH 2BBBI ***#SWH&&* :3'O2T +124
MM-""F*"#T_&GTT8WGDTP%I 3D\4M&*D!,G(XI>U%)D 4(!:**0_,.M(!U%(*
M6J6P!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M0C/>EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,<YS2T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A.!DTM "
M$D=!FEHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***3(SB@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I#FEHH **** "BBB@ HI ,4M !1110 4444 %%
M%% !1110 444A&2.: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "D(S2T4 )11G-%2 48H(HH **0_6C( ^E Q:6F(
MV:?30@IJDDY[4ZF+]XYZTP''.1BB@G!%%)@%'UHHQD4@#G/M1110 M%(*6FM
M@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4ASD8Z4M% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 44F #FEH **** "BBB@ HHHH **** "BBB@!.=WM2
MT44 %%%% !1110 44@ '2EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BD(!ZTM !1110 444@.: %HHI  .E "T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2#..:6B@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBDS\V* %HHHH **** "BBB@ HI,#.:6
M@ HI, '-+0 4G.[VI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BD)P* <C- "T444 %(:6D-)@(,XYI:1>G%+
M2 6DI:2FP"DYP:7'-&,BDAC4]NE/I 1G%+5(04T?>ZTZFC[YX_&@!3BB@@'K
M128!2<^M+1BD""BC'>@<TABT4E+5(04444P"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***0@$<T +1110 4444 %%%)D[
ML8H 6BBB@ HHHH **** "BBB@ HHHH *,T4A - "T444 %%%% !1110 444W
M<>>.E #J*0<BEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0')/%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 )SN]J6BB@ HHHH **0@$<TM !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12'@4#D4
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6D
M-)[ (N<4I]!1C%)C!S2 ,-QS]:7G- Y%%-@+2'D<49H'TI#$4 <4ZDQSFEJD
M(*8#\QR?PI],7K[4 !.2.:=2'J !3J3 3-!( R:*09/44D =3FE P.M%% PI
M:**:$%%%%, I,C.*6DP,T +1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%!.!F@'(S0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2 $$\TM%
M !1110 4444 %%%% !1110 44R5RD98=JQCXDMDN/*=@.<4 ;9('6EJ,2H8?
M,)^7&:RI?$5K'<>5O&: -?!+>@%.J&&;SHED7H:FH **PK[Q+:6<QC9QD=:K
M1^+;=P22/:@#IJ3<*S]/U>WOQ^[8$UH8&* %I"0*6DP*  C(Q0.!0"<G-+0
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 )D9Q2T44 %(#D9%+10
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M@3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DR=V,4M%
M!1110 4444 %9&I:L+3Y<<UK$X&:X?73ONR-_?\ *F@.HTR_-W%N(K1K'T&'
M;:!LUL4@"BBB@ HHHH **** "BD) '-+0 4F!G-+10 4444 %%%% !1110 4
M4'I2 8&* %HHHH **** $!SVI:** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M)\08&FN?:M:J&KVK7=D\2]2*$!XHUJUQJS>7QS7H>C:;?QPQXD.WOQ7(W_AK
M5;+4/-BW;<]N]=-I6I:K%"L;PL<=>:M,"QXN0Q62B1L\5@:/,L*>:ARR]JW=
M2LKW6$VLAQ2:+X:,+XEX&:=P.8U#7;FXNQ$0<$XS5P:-)<PB2/.[%=!K'AB-
M!YT*!F';%9EE+?VLP1HB%HO<#(SK6F,Q ?RQWQ3;?49]7G$$S$<\UZ9%%%?V
M/ER( Y7I7%:GX1NX+EIK3(],4K@;VD>%[>)5E+!C1XFTV%=/?Y.,=:PM*DUN
MVNE24/L4\C-=G<QMJ&GM&R\D=*5P/*=(TNQ^WDMC.[I7;ZY$;?10ML<+L[5S
M[^%[ZWOVEC4[<YSZ5TDEG<W6G"!@0=N,4[@<5X<L)M0U%A(Y.#TK7\37,VD*
M(HR1VS6UX>\/3Z?>L[$X-:7B'P^NJ0-C!?'%%^X')^&[ :TA%Q)G(Z4S7?#Z
M:0XDAD_"H;?1]5TB4B)GX]*M1:9JVJW'^D;]H/.30!2&MW#V7DC.,8SZ55T_
M2CJ%\-\G4UVLWA5(; A,%B/2HM$\.RPW/F,QP*+@8^K^'CIL2RQ2<@9JSX>U
M*:1&20D@"NAUK2I[Q-B$D 8K+TS09X W7-*X&%J%TXO6*G'-03:[</&+<DA:
MW9?#TTET6(SGM4]WX0$UCF-L28]*+@0:#H$%\@GE<,QYKHY-$"0D0MM('%</
M:V>M:5.4!<H#ZUU6G3:C(NZ3=^=*X'&:IHFII=2232,8L^E;7A[7=-M"ENY7
MS>F<U=UM[VYB:$(<'O7/:;X'N)+Y;J3(YS3 ]2AD22(.AR#4E5[*W^S6RQYS
M@58J0"BBB@ HHHH **** "BBB@ HHHH **** "@T4AH8 #D4'F@<BEI (!@8
MHI:2D 4 Y[44@[\T *#S2T@&*6F@"F 8-/IB_>YZT,!W'>BD(R:6D '.1CI2
M$'' IU-W"FP$ (-.HZ\T4@%HHHIH HHHI@%%%)D9Q0 M%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !112$@=: %HHHH **** "BBB@ HHHH I:E<?9[<\XR*Y
M&UC>]U#+#<N:W/$DZI$@)YJEX;3=*S8ZT^@'36T8B@50H&!VJ:BBD 4444 %
M%%% !1110 =:*** "BBB@ HHHH **** "BDR,XI: "BBB@ HHHH **** "BB
MB@! .2<TM%% !1110 4444 %%%% !1110 4444 %(!@8S2TF/FS0 M%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $;PQO]Y ?K
M2"V@'2)1^%2T4 ,$2+T4"E"*.BBG44 (55A@@&HC:P$Y,2_E4U% #5C1/NJ!
M2E0W49I:* (OL\.<^6N3[5($5>@ I:* &F-#U44"-!T44ZB@!, >U &!0V,<
MG% 92< @T ,:")CED4TJQ1I]U /I3B,TM "$ C!% 55Z#%+10 4@11T I:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"<#-+44[A(F)H Y;7Y?/N
M%0=C6KH=J8(06QR.,5@7.;C43M!.#77V2;+9!WQ38%FD&>]&><8I:0!1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LW59_+AP#6D>!7)>(K
MLF81J:: ATI#/?NV>]=B@VJ!Z5@^'+;9"9&7EJZ"AL HHHI %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4'I110 @R!S2T
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4T$D^U
M.J"XN8[>(LQ Q0!7U#4$M$(+ &N3,<NK7A8'*YZ4W5))=3NL19(Z<5U&B:<M
MG:*6'SD9S3 DTRQ6R@P1\U:"G(S0R[ABA1@8H 6BBBD 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444F#NSF@!:*** "BBB@ HHI#0
MYHI%Z=,4M2 <^M'3J:,^U'7M1T&'XT#ZT4#Z4 '>EHQSFBJ$%,'+<_E3Z:/O
M4 (W4<TZD;.1Q2U(!112#/<4 +12<YZ<4'/84 +2T@I:: ****8!29&<4M)Q
MF@!:*** "BBD)P,T +12 Y&:6@!,C.*6C'.:* "BBB@ HHHH **** "BBB@
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MO:@9[T +1129&<4 +1110 A.!DTO6CK10 A( YI:.M% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !111D4 %-.2V.@I001Q0Q"@D]J &S2+#$TC' 4<UP^HW\FH7
M?E1,=I-:>LZN6E-M'SGBIM&T9%'G2+\QY%- 3:+I:P0AW&6//-;@X&!2*H5<
M 4M)@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 )G.0#0!@8I<44 %%%% !0>E%!Z4 -7IUS2TB]*6I8!U[T&D.<C%
M+0 4#BBEH **3G=[4M- %-&-YIU-&=WM3 &QD4H&,FD.<BE&<G-(!:2EI*3
M*0G%+10 "EHHIK8 HHHI@%)CG-+10 4444 %(1D8I:1CA<T  &!BEKF-4\3#
M3YL.< &M/2M8AU&'>KK^= &I17/ZIXCALI_*# L?0U:TK4)+Y,G/Y4 :U%,
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M* "BBB@ HHHH ***3G=[4 +1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $)P1Q03@9I:*  <BBBB@ HH
MHH **3!W9SQ2T %%%% !1110 444C'':@!:* <CBB@ HHI#DCB@!:IWMVEG"
M6)P:EN[E;6!I&/2N/N[R359_+0Y7VI@0RS-JU]A=Q&:ZW3;(6T0R.:JZ1HT=
MI$KL/FK9'3B@!:0GD#%+12 **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML2_E6C10 U451A1@56N-.MKDYDC4GWJW10!F)H=FC9$2_E5I;&W48$2BK-%
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M.:J7%Y,G 8T@.Q>_MD&3(*:NHV[G"N*\\NKZXZ[C]*JQZE.A)WF@#U 7D).
MW/:AKN- 2QQBO-DU^2(@NW-/_P"$E\YMI?\ 6@#T1;Z)CU^E*;Z$'&ZO/EUX
M= _UYIRZ[N;[U '>G4(1P&YIIU*'/!KA9=;51G=CWJ--75CG?^% '?\ ]HP#
M[S8-*=0@QPW7I7%IJ43J,OS]:9+J')"MP* .W-_$,<_6C[?$03GZ5Q,=[(P'
MS&IEDD/1SSU]J8'7'4X >6^M+_:5O_?%<JHW=6.:7/.W<<5* ZC^U+;^_P 4
MHU&$C[U<G)G/RGBE&]4SN-,#J_[2@Y^;Z4W^TX,XW<]ZY0;^26/-/1&V_>-
M'5'480/O?2D.IP#&6XKEG#%<;SQUI%!(QN)- '5-J$(B9BV.*X[5-3@FGVB3
M)SUJ34"T-N<.>E<DH::YR2<YIV ](T:>W2U4EAG'2M0ZC %SNKD;&,I; %CT
MIQ+<KN/%-H#K%U" C.[ZT'4(<<-R>E<D"RC&XTHW]=YXJ6!U3:E"/XJ/[2AQ
MRW-<G().NXYIP+<98]*3 ZHZG;@\MQ1_:<'3=S7*'/\ >I.5Q\QII =8=3MP
M>6^E']IP  EOK7+GD<MS2D@KC<:; ZC^TK?^^*/[2M_[]<D P_B-#,PX!YI
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M Q112 **"<#- .1F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H[44AZ4 (O3IBEI%Z=:6I
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MB@ HHHH **3'S9I: "BBB@ HHHH *0TM(:3 !110:0!10*3[W% "T4 8% H
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MU]JKV:EE -7MN$P*!W*^T9X[?K2%0!U-2[& Y%&T@CCZ4!8CVCK2>6,YR:E
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MCGK34?8,]<U8F4N P[U#M&,=QUJRAI168-S]*FC8H>O!Z4B9V]/I01@<]^M
M$\<BDG<<<UK6UTI0#/3@5S[%AR/PJ6WN6#C]: .I4AAD4M06T@>,5/0 A('6
MC<.?:EHH  <C-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%(<]J  YR,4M%% !1110 4444 (!@=:#TH&<<TM(!@&0,$TX$'-+24 -!.
M<&E Q2T4@%HHHJ@"F+]XYZT^FC[W6@!&QD4ZBD&<]:D!>])G-.I* $W<XI:.
M** "EHHIH HHHI@%%%% !1110 4444 %%%% &1KN/LS>N*R?#H43-C/6M;71
M_HS'/:L7PV2+IN<T =CVHH[44 %)GG%+10 A&1BE' HHH 0C-+110 4444 %
M%%% !1110 4444 %%%% !29^;%+TI.=V>U "U4NY3&#MZXJV>E8FJ3,C8!XH
M RKBYDED*GIFH"% QW[T;R7)/>D;@\<4 /1$7KD^E+*R&(CICK3HP6C^8C-9
MUV^P,-W_ -:@"A>/MS@FJ CRA=>?6K#L7)4G.:<L6P9'% $:'='SUIJQ+NR<
MT_:<YR,>E3QH,=10!8MIE0[?:B9ER2.AZ56&5? Z5([8'7GO0 JPC:6R:E0'
M;QG-+:(SGCGTK6BLR5SQ[U2,VS*PQXYQ0D<G8FM86I+8..*<EM@<XQ6AFS&,
M;;NK4PQOGO6XUJ<9XJLJ$-C Q02V9LBD(#S[5DL6:8CGKS73W2!8>W3FL6WB
M,MP1QUXJ6(UM-L R!ORK3, QMP:M:?:E80#CI5AHMAXQF@9F>1^=)Y"YP0<5
MI&$GG%'E9X[T6!,SC ,\ TX6PP.M7_)(XIPC('\Z!F=]G /0T>4/>M H2>V*
M:8":5P*0B'H:4VX+@]ZOK&V,<9IPMSUH!'/WP"C !K/"Y<$CZUMZJA' (K,B
M!SCBD:H3@'//M37(<'(/O5[R04/3-56.WY5H:-$9TT(&"#5&5,$]:U)D-4)B
M4.*1214*9/-)L&,<U*3O_J*<0, @CTI"97Q\Q !IR@ 8.:G48;'&*"O.5Q[T
M"(.O&#3!'SS5KD9Y'M3(\[SR*!EJT4*1P:U.B=Z@LH^1TS6D\8V=J *]J TN
M.:ZJP39"#[5SUA'^^XKJ(CLA_"@# UI]V0<]>*P%?:QZ^];&LR;YB >]90&T
M9/?I28AI;S".*K3PE3E<^^*NL %R"/>JPEG\P ?=/M0D D9DX!S4S:4EX '%
M62-L)D? P.:Y34O&L>GR[%?D5O!!ZG4Q>%[-$RRJ6^E<]XBTNVMX6\M/TK,7
MXE+MP2U9NI^-%OE*YZUUP1+.1U*18[AE /O5:-E*YY]JENV%Q.9,C!Z4P+GC
M<*Z$0(WS>M+M(P*7!!'S"G;MK8SG-4!'R/6E_.GGGZ^M-[XQ5 (/?-'?G-.S
MR>1GO1QQS]*+,+C&(!XS14K#"YR,GK3,%<,#18!,#'(.:56SP>E!<D<THX8<
MBBPQ5;+8[TC*$.3R*7*X]J3)R>10 H(//YT,!CO[4 $J,$<4F3EN12L GRD8
MY]Z-H4?RH48(PPS2CC.3QWI@)QGO2<5)@$9R,]J1U&.",46$,&#ZXI1C'>G
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M5*%R,YY':FG.<4 ,V<XQ^-*5&.E/I",#K0 S _SWI2OMU_2G!21G_(IZ#U-
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MH **** "D)QVI:* "BDZY - &!0 M%%% !2,"1P:6@]* &KTZ8I30!@4=Z3
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )@9S2T44 %%%%
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M@ I&&1BEHH RKG3_ #&R ,4R'30L@) S6LV*3C-2]R+"HH50!3J**HL****
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M?-FH-(NA+>J">]) CTNU;=;J?:IZ@M /LZ8':IZT-$%%%% !1110 4A.!1N
M/6J-_>+#&<<F@3=A;B[$9QFH(K\,V-U<U>:MES\WXU5AU;$H%8O<Q;9Z#&VY
M:?63I5_YZ*#Z=:TY'VJ36JV-4]!])D>M4VN#MJ(W+8Y[4RC1R/6C(]:S!<.Q
MST%.\]L9Q0 FJ2 Q[ ?QJOII .WMVI;@>:.E2V<(5Z -,'CDTZF;.?:GT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(<]J6B@!#G'%
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M(J2W.+A<-W_.B'_=JPJ!7#;?_K4 =;9@^0I)[=*L53T]BT STQQ5R@ HHHH
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M]*$E !5FZU&S]A^5$:^8<D8P:0%H0DKPQQZU:MQC'/-2!2+<#;BDMU/0]N]
M%JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M.E(#D9%+1TH **** "D-+2&DP '-+2"@T@%I />FDG'2E4GO3 7/-)U!YI:.
M@X% Q!@&G4GO2TQ!3%^\<]:?3%.3GM28#J*#12 3(SBEQ110 8YHHHI# 4M)
M2U2V$%%%%, IIQO')IU'>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***:Q(7B@!6&5-8=]$"Q8#FMQ<XY
MJK<0;LD=,4 <X,;^^*G0[3@#K1*NV0C%&2%!XX- "2QGU-498NO%:0E\QNV1
MUHF@WJ#W[4 8@CR#CJ#2H&/';UJ6YBD23:N,'K4\$)*8XH B1%;@U8,*!1DF
MK4%OD9P,9J\FG;SNH RTLU893O4ZZ<V!U-;,=BB8]JM!0!C% %:QC,<6#5JB
MB@ HHHH **** "F*BQDMGK3B0HR:YS5=<,19(^2* -/4-02&,JA^<]*S[.RD
MO)1-,25ST-5]*MIM0/FS<+UKIHXUB0*HX% !'&L2;5  I]%% !1110 4444
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MD_6G3L4C)!P<41YW=LU#J#^5"<]* .3UJ4NQRQZUE0^]6[Z0R2'ZU3P25VT
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MY'-+0 4444  I:04M-; %%%%, I,#.:6DYW>U "T444 %%%% !1110 4444
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M5W4[@)$L8&2?TJA'+Y*;@>:NZ7:/J5TN[D9H2U'8Z+P5IV^=93&1SDGUKO\
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!,@'%+110 44A&1BEH **** "D(##!&:6B@#-N]-24[E7'TK&D
MMWB+*P/M75U#);))U H Y($QMWQ5H7/RC.*UKC3%92RCFL&6TECD.%.,T 7H
MKD@[LU,UQY@XZ]ZR)9/*X.?>K=M<1-'C/S=J +1DDC 9.2.@J:#5?*/^D$**
MJ%EB0O(<#O7*:S?>>^R!B6[8H Z/5O$2.K16[Y8^E4M(M7GG\V=CCKR:QM*L
MI<[[@$#U-:TER(N(C^5,#J_MD-M#M&T$>E5QJ_'.,=JYM9F<;F)Q3#(W)R:
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MI<>Y]J7M)=P,[_A'--_YX)^5-;PUIK'/D)^5:."1WHP>G-'/+N!FGPSIN/\
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MA2T@I::V ****8!2<[O:EI,\XQ0 M%%% !1110 4444 %%%% !1110 4444
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M!SKZ9(!C-5GL)P.,UU6 :0HIZBG<#D?L]RHZGC]:0B7[I'/K76&WC/5:8;*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !28.[.:6B@ HHHH **** "BBB@ HHHH **** "B
MD.<<4<XH 6BD&>]+0 4444 %%%% !1110 4444 %%%% "$X&32]:.M% !111
M0 4444 %%%% !1110 4444 %%%% " @G%&1G%+@48H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH 0D#K2T8HH **** "BBB@ HHHH ***
M* "BBB@!"0!S2T=:* "CI110 @.1D4?>R :6C% $<D:2+L<9R*P-0\-1R*TL
M.!)VP*Z/'.:*8'!0WE_I$VR0,4SZUU>GZQ!>1K\V&/:K4]E!<##QJ??%<YJ6
M@7"N7L21[ T@.I YSFE(R,5Q]G>ZAIS[+S.T=S7166JV]VO#C=W% %U5V]\T
MZ@$'I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 F :6D.<<4#..: %HHHH *0TM(>E)
M@ .>E%(O2EI +32.O-.I*8">G-*/K2=^E+2&+124M-""F+][GK3Z:,[NV* $
M/WN?PIP;)Q2'.>U**  GD"BBD&>](!:.M%%  *6BBFM@"BBBF 4F><4M% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %)GYL4M% "$9I:** "F.RQ*6)IS,%&37-ZMK#;C#%R3Q0 S
M5M7:5S;P=Z?HVB!&%Q*26)SS46DZ2\S_ &B;N<UU"($0*.@H %POR@8IU%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %)GYL4M% !1110 A&:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!",C%+110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 5+^PBOH#&XQ[BN0N]*GTF7?;%BOO7<\Y]JCEBCG5
MD=0<^U '/:5K^XK%."&[UTB2+(H92"#7.ZCH 6-I+;B0=*RK/6;^PF\F9,J#
MR<4 =S29^;%9MEK-O=;5W ,?4UI @\@YH 6BDW#=BEH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;M&*=10
M 4444 %%%% !2'I2TAI,!%Z<4ZD&0.:3)S[4 .HHI*& M-^Z,TM(,]Z5P%7/
M>EI*6F@"F#!8XI]- PV ?PI@#8R.#2@ &C(%%( I/O=12T9]Z0!1FBD/'>D
MHI:04M4M@"BBBF 444F#G.>* %HHHH **** "BBB@ S12  =*6@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,XII?#8I2 10 M
M(S!%))P!32PC3+'I7.ZMK76&'DGCB@!^K:P%/E0G+'CBH-)TEII?/G'!YYJ'
M2=,>YE\V8$8.>:ZQ%$<84< 4V J(L:!5& *4'/:EHI %%%% !U%(!@8%+10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1129&<4 +1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 AZ=,U3N=.@N1DH-Q]JNDX'-% '&7OAR>VF-Q WRCG -26'B
M,6\@M[DD,.YKKB,@@]ZY^_\ "]M=S&8<-0!M0SQ7,89&!S4]<2T]WHLFP9*B
MM[2];CO% <A6QT- &Q12 AAD'-+0 44@))/%+0 444 YZ4 %%%% !1110 44
M44 %%(P)'!Q2T %%%)D4 +1110 44G.:6@ HH/2FX;UH =128//- Z4 +111
M0 44T9!P:=0 4444 %%%% !1110 4444 (3@4 Y%+10 4444 %%%% !1110
M4A.!FEHH !THHHH 3/S8Q2T44 %%%% !1110 4AI:0TF  Y%)M&:%Z=<TZD
MG08%%%% !110#[T@#/.,4M)2U2V *8H(/3\:?3"<-3 4]1QFEI/O8(-+4L H
MP**3(]: %IO4<BG4AY'!H 44M(*6FM@"BBBF 4444 %%%% !1110 4444 %%
M)@[LYI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@!C+SGK[4K,$7+' I"PB0LQXKF-7U=VG\J'N,4 /UK5)'8V]L-Q/'%.TC22X
M62X7YNO-+H6FMCSI_F)]:Z( ( %'%  D:QC"@"G$9ZT44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4F!G-+10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@.THK$M/$MA/!YAE K,O_&MK#-Y46&.:+ ==16#I6L/?GA./6MT=*0"T444
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MFGZ9HR,HEDR3UYKH40(H4#@4 "(L:A5  %.I",TM !12$9I: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3/S8I:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3BEINP;LTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY/ _&@!6ZCFE)Q2'J.*7&:D I,X[THI.O44 +UH /<T4F: '44E+30!1113
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIIR#D<^U+DYZ4 +1
M1G'6LK4];M[!<,_S>E &K17 S^-Y59A'!N'KFI]-\67%Q, \! /3F@#MZ0\C
M@U'!*)H5?ID5)\HXXH 6BBL;6-9731DCOS0@-@@'K52XT^*X8,1SWKFU\7AT
M+*F5[&F6_BTS3; G?UJDF!V$42Q(%48 I]9/]J'8IV]:T+:7S8]U)W E!!Z4
MA.&Y/X4HP.F*1E#=Q2 <#D<44@P!1D>M !D"EIN!G)-&]<XSUH =115>6]AA
M.)7"T 6**AANH;@9C<,*FH **0LHZFEH *"<44G!XXH  0>E&1G%  '2C SF
M@!:3(SBC(]:.,YH 6BBDR/6@!:*3(]:#G'% "T@!'4YI$R!\U4M3U%;"V,AP
M: +]%<AI?BL7U]Y&,<]:ZX'(S0 M%1RS)"I9SC%<OJ/C*WM6:./YC0!UE%>>
MIXTN6G!$!VD^M=;I>IF]C#%,9H U:*3(QS0&!Z$4 +1THIK#/>@!U)N'K0".
M@-&U3VH 6D!!Z4M-#*#C(H =11G-% "9&<4M)P,D=:0,V>10 ZFA@3BE+*#@
MFC ZB@!?K17+^(?$']ER $?A5C0?$(U50-N/>G8#H*0?>/-&10,=1BD M%)D
M49'K0 M%%(2!UH  <]J6D#!NAH)/84 +129 [T9'K0 9!H!SVI"50%CP*K_V
MA;;MOF#- %JBF+(L@RIS3@-H.30 M%<]K7BB#2@0V":=H'B2WU>,[6&118#>
M+ $ GK2U%*Z(A=OX>:XO5O']M97/DC&X'%.P'<T5E:%JRZK9B9>]:N<4F 44
MF1ZT-G'% !D9Q2TU1@9/6E#*3@&@!:*YC7_$1TPX"YJ70-?_ +3R"N/QIV Z
M*BC(]:3)STXI +129&>M&0: %I,@]Z#TI% 6@!U%&1ZU6NKH6R$XSQ0!9HK%
MM=8-U*0J\"M>-BRY88IV ?129![TM( HI,CUH/(ZT +129 XS2T %%%% !11
M10 4444 %%%% !1110 @!R>:6BB@ HHHH **** "BBB@ HHHH **** "BBB@
M! #D\TM%% !1110 4444 %%%% !1110 4444 %%%% !112'D4 &0:6D P*6@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HI 3D\4M !1110 444AI, %'>@4M(!*6D_"
MBF 444#Z4D,6BBBJ$%,& W!_"GTW^*DP%- (-%(,Y/%(!/XAS3J3G<.*6CH
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M*\[NX'75E*1D /V'O2T ]L@E$T*N.XS4E9VBE_[/C#]<"M&I **** "BBB@
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MW'M?I5JF%3G*\47 IVFEV]B&,8ZU#?:+;:ES*O/TK34-_%S2X.>.E%P,C3]
M@TY\Q$XK6.""A[BE&>]!4'K2 S/[#MOM'FXYSFKC6D;Q[&&15BB@#/@T>UMY
M-Z( ?I4EW80WT?ER#Y:N$9%(!BG<"G::9;VBX11CZ5#?:/;7Z%77'N!6G2'.
M.*+@<W;^%8X)=ZNWYUOQVZI"(SR!ZU-11<#(O_#]I?*=RX)]!6;9^#;:TGWJ
M[8SZUU-%%P,Y]'MY  PS4MMI\-L<H,5;&<G-!&1@T@*=UIL-T?G%-CTJVC7
M0?E5_H*:0V>#3N!AS^&K:60L!@&G0^&;.([B"6K;7..>M'.[VHN!0;2;>2,*
M5X'3BE@TZ&%AL'2K](>G%%P*US80W2X<5!'I%O&-H'%: SCFEHN!032;:-B5
M')]JJ7WA^&[&"[?G6SSN]J6E<# T_P -6]F=S*"?<5?FTJVG R@&/:KX.12T
M[@5;:QBM1A.]5[C1K>YDWR+S]*TJ0YR,=*5P(8[6..#RE'RUG-X=LVG\XK\V
M?2MBB@"*.-+= J]*EI,#.:.=WM0 M%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !112<[O:@!:*** "BBB@!",G-+110 4
M444 %%%% !1110 4444 %%%% !1110 444ASCB@!:*!TYHH 3'S9I:** $!R
M<4M%% !1110 4AI:2DP # HHHI +24M)3 6DHYHI +1115 %-_C/'XTZF_Q=
M?PH 1NHXIU(W4<XI:D QS1110 4444@"EHHJD 4444P"DP,YI:3!SG/% "T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)@[LYXI:
M* "BBB@ HHHH 0C(P:7I110 4F?FQBEHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DP,YI:* "BBB@!-H
MQ2T44 %%%% !1110 4A..U+10 4444 (1D8-+110 4444 %%%% !1110 4F#
MG.>*6B@ HHHH **** "BBB@ HHHH 0'(I:** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I#P*6B@!!R*6BB@ HHHH 0\"@'(S2T4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !129!I: "BBB@ HHHH **** "BBB@ HHHH **** $!))XI:** "BBB@
MHHHH **** "BBB@ HHI,@4 +1110 4444 %(:6D-)@(IXI:1>G7-+2 6BD%+
M3 *2EI*0"T444T 4Q00>1^-/IO&X\T +@&BBEI )[8HQ0>HHIV *09[BC'.<
MTO:D M%)2TT 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!A!!R*
M<!@<TM% !1110 4444 %%%% !1110 44@&#UI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $P!2T44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F
M :6B@ HHHH **** "D-+24F  8Z4444@%HHHI@%':BB@ HHHIH IF<-[4^HV
MY;B@!]+31P*6I 6BDH!S3 6DI:2D M%%%4@"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *0G I:1NE# **:,8'6E]JD=AU%(.!2TQ"444$9
M%*X"T4Q?O<]:?5 %1L<-4E,P"W(_&@!1TYI:,4@))/%2 M%&>0,44 %%%(#G
MJ* %%+24M- %%%%, IO.[K3J3 SF@!:*** "BBB@ HHHH ***0'/:@!:***
M"BBB@ HHHH **** "BBD!Y(Q0 M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444@.>U "T444 %%%% !1110 4444 %%%% !1110 444A (YH 6
MBBB@ SSBBDP,YH)((XH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,T4A /6EH
M **** "BBB@ HHHH **** "BBB@ HHHH **0  <4M !1110 4444 %%%% !1
M0>E-W'CCK0 ZBD/ H'(H 6BBB@ HHHH **** "BBB@ HHHH ***0G':@!:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0G Z4O:@ HI <
MCI2T %%(201Q2T %%%% !1110 4444 %%(3@9I1TH **;N..E.H **** "C-
M%( !0 M%%% !1110 4444 %%%% !FBD  Z4M !1110 4444 %%(3R!BEH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *:PR*=24F F#BEHI"V#2&.HI <
MC)I <D\4Q"T444@  #@4M)@9S2U0!3%Y8Y_*GGI3%Z_UH =0/K114@(?O#F@
M CO1CF@$GJ*.@"T@(/0TM&,=*  4M)2TT 4444P"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ I,C.*6C% !1110 4444 %%%% !1110 4444 %("",BEHZ4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !2 $$\TM% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 A)R,"EHHH **** "D-+2&DP$7IUS010O3IB
MEI# =*.U***8A* ,=Z*!20"T4450!3.-Q -/I@&#[4 -;<"!3QTYI>**E@%%
M%%2 4G"CDTM%4@ G'- .1D4,,T#@4P%HHHI@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%)D>M+0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4AI:;S28 "",T>U"YQ2U(Q.G%+0,]Z#GM3 0]12
M@YHH[4( SSBEI ,4M4(*9QN-/IG\5)@  (%.I#G/%+2 3O2T44@"@@'K2<Y]
MJ6F M)2TE   !1110 $9&*3.#BEHH 3A12YXS110 F[@&E."***+@)P"!2$
M TZBBX"8'6D !%+SGVH^E%QA@;J4  <4447$)GK30<MD_A3^<T47&-)!!R*4
M'H*6B@0M%)11< (SUH.",4447 !@"DW=?:EHHN #IF@@$444 &><4  "EHI@
M)@9)H(!/-+10 @.2:6DI: "BBDYW>U "TF><4M(:  G&*"<#- SCGK2 'G-
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M@ ]: #<<=*7 SGO2T4AA29.[&*6B@!#2T4M.PA,44C9ZBD ..M%@'T4@I::
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M446 ;S0,XYIU%*P#1FCG-.HIV :,TM+118!HSWIU(1GO2T6 2DYIU%%@&C-
MSWIU%%@&\Y]J6EHI6 2BEHHL E%+118!**6BG8!**6BE8!.U(33J*=@&C- S
MZ4ZBBP#><T'/84ZBBP"<T@SCFG446 ;SFCG-.HHL E%+12L E'.:6BG8!*".
MX'-+118!OS<<4ISCBEHHL WG-+2T46 3'-&*6BBP"<T@SCFG446 0Y XHYI:
M*+ -&>XHYS[4ZBBP"44M%%@$HYI:*+ -.=WM2\TM%%@$H&2.:6BBP!11118!
M**6BBP"44M%%@$H-+118!HSCFEI:*+ )S12T468"4ASVIU%%@&C.?:EI:*+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#2S161I&JB]7D8:M>@ HHHH **** "BBDW+ZT +12 @]#2T %%(2 .:0.K'
M.: '44=JS+F6X\\",''\J -.BHXF8H-PYJ2@ HI-Z^M+UH ***:74=30 ZBD
MW ]Z6@ HHJ"YN4MHR[$<4 3TF0:XS4O%LAD,-K&<],BJ<&M:T),O$^P]L4 >
M@45FZ7>37$*^:A#>IK2Z4 %%("#2T %%%)D"@!:*0,"< TM !11TIN]?6@!U
M%%% !1110 45@ZYJLMBRA <$U>TR]^UQ D8.* -"BBF>='DC<,B@!]%'6B@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;FZU#][!,R@GM5S3-8>VG2WGD);.#FL?P_!<2Q[0<?4UL6_AZ8WXG?D YZT
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MQ][N* &MJ6KIB5U<(>>M='HFKR73*KYSZ5>U"&#^R<B->5]*YS1YMMV%4=Z
M.KU&]%M!D?>-<M<+JEZ3+!(X7K@&MO7"%M0W?%<G8Z[<12^2H!4G'- %[3-0
MOH;LPW#,>>I-=O Q:)2>]<UI]F]W<-+*JKZ8-=-&@C0*#G% #ZYCQ5,ZIM4X
M!'6NGKD_%RRA=R)NP.F* *WAO3H&82R8<DYP178?9XB -@Q7'^%M2CQLEPA!
MQSQ78B>(CB1#_P "% #EC5/NC%9FIPWDHQ Q'TK1>553=FN?U#Q&;=RB $T
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MGUKMJ3:OH* ,_3K>XA7]Z0:T:** "BBB@ HHHH **** "BBB@ HHHH ****
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M4N>G'6BBBX";N,XI<\XQ111< )QVHSSC%&:#1<!:;NZ\'BC!XYI3TXHN A?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
H* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!W@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBDS0 M%,+@4>8* 'TF:C,HJ,RC- %C-&:A
M$PQUIIE&: +-%5Q./6G>>* )J*B\X4\-F@!U%)NHS0 M%)FEH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **0M2;J '44S>*4-0 ZD+4TN*B9Z )MU(7
M%0&3 J!IN>M %TR#%0O.!WJL9^.M5)9"3UH NM.,]:8;D>M4#(?6HF<YZT 7
MVN.>M-\_WJCO-'- VB]Y_O09_>J631R33"Q:\TYZTX3D=ZKCI32K9HN%RXLQ
MSUJW'<#')K+7(IX+4A&KYPIPN%]:S1(0.M1F4YZT#1K><#3A,*RA/[T]9N>M
M ,UPV12[JHQW QUJ43 T"+5%1+(*?NH =12;J6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH%E!%/#9K+BF]ZN(^: +5%,5J?0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%(30 M(6IAD J)I10!/NIID J
ML;@"HFGSWH N^:/6D,X%4//]ZB>;GK0!JB4&D,P%98NPHZTUKK/>@#2:84PW
M %9_G^],9R>] [%UK@>M,^T"J632;6)H!%MI0:@=Q30"*0H30-:$;#)INVK"
MQFCR":$+J0"/-3I$/2I%BQ4R1TV@:(!!D]*G6WXZ5,J@591012$4#;\]*E1
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)FD-.X :-PI*-O- ,7%.!Q2@<4TCFD&X_M4;'FG9IA'-,6PF:7S.U--1D'-
M[W)"<U$U.!HVY-%P0P+4JG%*!Q3&% D.WT><*A)J/!S0BMRT6!J&10PI5IX7
M-/05C,FMB><52DB(-;[1@BJ<UMWQ20-F0H(:M"";&*A>+!IH4@T$FS%,"*M*
M^:Q8I<'&:TH7R!0!<HIBM3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BFEL4TR8H DI"<5 9P*A>Y% %HR8IAG J@]T/6J
MSW?O0!K?:!4;W('>LK[7[TTS;N] &@UQGO49N0.]4MYJ-F)H NO<Y[U6DN/>
MH@":# 6H 0R%J3)J5;<BG>0: $0\5,%R*6. U:2#B@"B8234T2;15DQ8I-E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **:6Q1NH =149DQ2J^: 'TTMB
MFL^*B+YH G#9IK/BH?-VU$\N: +/FBFF<"J1EQ4339[T 7C/FJTMSCO4'F5!
M+EJ )FN<]ZA:7/>H=I%*%- ",2:KR$U9(I/(+T 55!-3+D5.ML1VJ06Q- $
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:6Q37?%1&3-
M $V^FM)BJKS[:A:YSWH O><*7S:RVN<=Z3[7[T :OFU%)<A>]9_VOWJ-Y=]
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MN*$383'>C=VI<TW;WIL&(5XS4+MVJ=FPN*IN<M2$0R+GFJC<-5\\BH&AYS0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4449H **C=\5'YU $Q.*;OJ!YO>HO/H
MN[JAFGV=ZJO=[1UJG-<^9WH N&\SWIIO,=ZRS)BF[RU %^2[W=ZIRW..]1$D
M5&REZ '>>6[TY9<5&L6*D$6: '%RU.5L4+%BIT@W4 ,5LT^I/(VT;*5T BKF
MG>73E&*E49HN!$(<TX)MJPHQ05S3 C"YIWW:<%Q367- #@V:D5L5"HQ4H7-
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MIACR:0B+/.:>S_)BE\ND>/Y: ,RX/)JF'^?%:$T><U2:':V: +]J>AK:MY>
M*YN*XVD"M>UEW8H W$.13JBA^[4M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY- $P;BD+TP-3MN>:!:BXSS06Q1G%,/-%RMP+<TH>F4N* U'$YHWXIM&*EC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !112$XH 6BHFD [TWSAZT 3TTG%0-.!WJ![D>M
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M!/-.#\4RGA.*9(UC41?G%2L*B*<T  &>:=OQ2@8%-*T,I,=FDWTF<<4;<T-
MM!V>*;NYIV.*;MYH%H.!I-]+BFE:!IC\\5&7YQ2;NU&W/- A<9YI-^#BESCB
MC;GF@'<>#Q3&?G%)NQQ1MSS0(-O>C=VHW8XHV]Z #;WHW=J W.*D$6>: (]N
M>:-^.*F*XXJ)D[T 12<BJ$W-7W'%5)4[T 9Q3YLU/$^TTUAS3E3O0!J6TW(Y
MK:@?*US5NV' KHK7[@H MBBD%+0 4444 %%%% !1110 4444 %%%% !1110
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MW4AH8#F@G%+MQ2[,T"ZC,9HSMI^,4A7- TP!S2%L4H&*-N:8NH YIU- Q3J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4449H **:6%-WB@"2DR*ADE"CK59[H#O0!>+"HI)
M0*S9+['>JKW^>]2!J&X]ZB>YVCK61)>X[U4DO\]Z8&P]][U6DU#;WK$EOL=Z
MJ/?%N],#;EU,GO55M1QWK$EN\=ZI/>GUJ6T!T,FI9[U1GU#WK$>]/K4#71;O
M32 TI+\GO5.:^([U2>8U6=RU,"T]\6[U7>Y/K4&#3UCWTKV !.6IV\U(MMBI
M!;^U%P*Q8FF8JTT.*18LTP*_-'-6_(%.6WS1<"JJYI67%7EML4\6N[M0!E["
MU2+%MK0-IM[4H@SVI/8"E@TY25JVUOBFB#-)6!C$E-6HYR*B\C%*%Q3=@1H1
M7)/>KT%UM[UBJ=M689,TM4+J='#?'UK3MKS..:Y19=O>M"TN>1S3Z%'6QS[N
M]64>N?AN<=ZU+6;?WI:AL::MFGU&F,5+UIW ;FF,V*D(Q497-2 BMFE8XIOW
M:!\U-(0#YJ/NT\+B@C-'4!%;-/IH7%+1U 6BDZ4X#- #:7-*1BFT68"]:8S8
MI]-*YIH!GWJ/NT\+B@KFCJ *<T$XH Q2XS3TN- #FEI ,4\#- AM%*1BE S0
M VBE(Q2@9H ;12L,4*,T )3&;%2$8IA7- #,YHW8IVS%&S- [Z"J<T_.*8!B
MI ,T"%'S4UABI0,4C+F@" BE7BGE:4+3'J'6DZ5(!2%<U(AH&:0\5(%Q2%<T
MP(^M,8XJ<+33'FF-6(,9J1>*>(\4NRD%P'-(3BG@8I"N:!7&CF@G%/"XI&7-
M $9.:3-*1BE IV 3K2YQ1TI0,TT G6DZ4[&*,9H8[#*86Q4A%0MUI(0[=2;^
M:9FBFQDRG(IK-BFAL"FGFE80O6DZ4"I N:&AW("N:,XJ1ABF8I F.!R*4FFC
MBG8HL.Y&5S3".:F-)MS18$QJK2D[:=TI",T)#N0LU1F7!J1Q46S-4MR&QX;-
M.WTQ5Q4HCS5V$[C,YIX;%+LQ2$521/-80G)I ^.*0GFG*N:+ WV'#GFC=BG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1129% "T9J-Y .]0-< =Z +613'<"J;W0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:6%1RR;15*6ZQWH
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MO*S0T %3GBD'-%KB*WDTX18JUM%)MH6@R)8\U((P*<!BG9IW ;MI"E/I5YI
M-6,&E:("GYVT [J0)D&REV5,RXI%&:?0+$!BW57EAQ6@PQ4++NI#,TQ9J%TV
M=*TGCVU6>/=18+%#>:D2<I2R18J,)FFGH%C1MKLDCFMBVNR,<USB?)5V"?GK
M1U!'76USNQS6E')7*VESC'-;=M/NQS1U'<UT.:1^*A23BI<[J8QH.:=1MQ3E
M&:DEC:7.*<10!3"PF<TG2E(Q0!FBP"4E.(Q0!FF(;13R*4+F@=B.EJ392[*$
M(BHJ791LI@0U(E.V4H7%  5S49XJ:FE<T ,'S4\+B@+BG4 %1LV*DII7- #
M-U/5<4!<4Z@ HHHH **** "BBB@ HHHH ***,T %%)D4FX4"N.J-FH+TPG-
MPSFC.*2BF I-0N^*<S8J,\T[,3$SFFE\4C'% &ZA)@.!W4ZD Q4J@$4P(2F:
M51BI&P*;D4 /"Y%-88IAE"]Z89<T#'%<FE P*C\RI%.:8A"N:83MJ:F%0: !
M3D4C-BDSBC@T6 C)S3>].;BD'--(5[CU&:?BF XJ0$8I"=QK)FH6&*D9\4S@
MT-"2(=F35F(8%-"U*O%"8B3'%5II=II[R[169=7'7FJBA7))+CWJL]_M/6LN
MXO<'K5)[O/>FEJ2W<WC?\=:JR:D0>M8CWA'>JLEWD]:TBA<QT:ZAN/6M&VN]
MPZUPRWQ#CFMJQO,@<UI8S;.L#[ES6;>3E<TD5UE<9J.X&]2:<8A<PKV[()YK
M(DU,J^,U8U1BK&N8N9B'ZT[ CIHK[>.M3>;N%<O;79R!FNCL?WH%4D%R.6$M
MSBJ4L1':NLBL0Z9Q5:YTX $XI<H''2*0U2V]P4<#-6[VVV,>*RV^5Z30U<[+
M3;S*CFNDMIMRUP%A<X(&:['3I=R#FLVC2YL[<\TW.#3HSD4I45DT;)Z #D4U
MFII;'%)G-9,I :-V*3-&*DK<,TNZFT5(;BYIID[4M)M[TT/<"<U&6.:4GM1M
MH):' \4QFYI-V#BG;<C- A U+OIG>G@<4,I,?GBFEJ3-&*0;"XSS1NI,]J<%
MSS5 A<TPM3\4;128(;CO29I^*-M"!!MXS3=W.*?1MIH=P'K3MU-I":1+!C4>
M[F@MSBEV\9H$.!XIC-S2;N<4[;D9H B;I4#=:G84PJ* "%?F%;MHV *QH?OB
MMNU4;10!I1GY:?3(QQ3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBD) H 7-0RR!1UID\P4=:R[B]QGF@":XN0 >:Q;V]V@\U!?7^ <&N:O-1
M8YYH M7FI$YYK%GOSZU4GNBQ/-5M^\T 2R7C/WJ S$<U)Y5(8<T 1BY8T_S3
M0( #3O*H %D)-2[JC"8J11F@!=QHWTXIQ3,4#L!:FTUSBDC.34M")4&>M),N
M!4N !4;'=19C*$F:8I(-7FB!IGDBBX6"!LGFM",@5GXV=*EBE)-(+(V(7S5V
M-L5DPO6E;G=0!?B;-7(ZJQK@5:CJ6*Q(RY%5Y!MJUVIC(&I;"MJ558FI0<4-
M&%I!57*'%LU$QQ4AI53=UH"Q ,L:=@BK(A H,8IIAL5U)H8XJ5D IFW-/J Q
M6S3Z-F*<HS28 @S1)\HXJ8*!2^6'ZT"*0<M4BDBK!MPM-V"@8U?FI2-M."XI
M^W=0A$(^:AEQ4I3;3#S0Q<Q6<9JNZXJZRTSRMU,J^AG,A:H)%VUK- !56:$4
MA<QF[S3EE(I98]M-C7-5H-&C:W!R.:V[2YZ<US:_)TJ];3X/6E<K8ZV"XSWJ
M_$^:YRUGSCFMVS?=B@3+U&<4IZ4WK3L(<#F@G%-SBG*-U( '-!XIX7%*5S0A
M#!S1C%/"XHQFCJ-#1S3@*4"EHL#8E%+13L(****$ 4444P"BBB@ HHHH ***
M* "DI:2@3 4444Q ***:30#=AU%,W4;A187,/S3&;%,,@'>H7E'K5)"YB?S*
MC:7'>JKW '>H'N1ZU7*3SEQKC'>HS<^]9,]X >M1K> ]Z.4NYN+-GO3_ #*R
MHKD'O5E)<]ZE1L+F+ZMFAFJ!'J4<T[#3&G)J-B15C:*C912*N1=:7.*#Q3<B
MK2$.WTTW&WO5>24+WJE-<@=ZKE&:1N1ZU5EO=IZUD2W^WH:SYK\D]:' 5SHO
MMF>])]JYZUS0OSZT];X^M2XA>QU,<X/>IA-[US$6H'/6M2VN=XY--1%?4V5D
MR*"]5$D]ZLI\PI\H.0N<U$TA%/;BHS@CFBQ/,K#/,S2B3%02.%[U7>X '6AH
M7,7_ #ACK3&N<=ZQ)KXJ< TP7N>IJ>4?,;9N,GK3EFS6(+L9ZU9AN >]/E%S
M&VCY%.+\52AER.M3EAMIJ)+9%/-@'FN>O[PJ3S5Z_G*Y -<Q>SEG-6HD-C)[
MHLW6HO.8U$,L:M10@BK4!7(&8D5GSRL#6]]F!%4KFS7!-6HV)<C&\X[JTK2]
M*D#-9-TOEMQ4$=P58<U?*0V>@V5SO4<UHEMT9KCM-O3\HS7867[V')]*'HA\
MVASNJQ9W&N*U#*R&O1=3A'-<5J5L-Y-).XKF3;N=XKKM(<D+7)(FV4"NNT8#
M"T)E([BPC#1"BZMQM/%.TYL1BKLJ!D-1>S'8X74X,%N*Y.[RLM=_JD'+5QU_
M;C>35WN4M"O9RD,*[#3+D[17%1_)(!73Z9)P*SEH4=E;R;EJ<L:I63945I*@
M*YK*31K%E<\T4Z08-,K*2-$+BF%L&G9II%9W+N&>*0MS29I0N:30;"CI2%J=
MBFE:!)C,TFZE-,-.XV.H#=J05(JT"#;D9IN2#4H':G^4",TA$(&129J4C%,(
M% TP I]0[B#4@.10%Q33=QS3J-HH&A1THHI:0!29HI*8F!J)F-2TW:#0(A[Y
MIV[BGE.*B88H .].W&FBI=HQ0!$U1%CFIFQ4; 8H ?"?F%;5JQP*P8#^] KI
M+.(% : +T?W:?2*,"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"<
M4 !.*J74XC7K3KB<*O6N>U*^PIYH +K4>HS6'>:B0#S6?>:@=QYK(GO"^>:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHI"<4 !.*IW4X1>M/N9@B]:Y[4+[@\T -O=1(SS7,ZC?D@\TE]>GGFL&XN&<
MF@"*6X9V-0G)IR(6:K\%KNZB@"E#$6/(K1CM>.E7HK #M5Z&U'I0!G16F>U7
M%M,#I6G':@#I5I;8'M0!CK;YZBFR6@ X%;IME45&T - '/BWYZ5(+7VK6:U
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MCLQ33&%Z4JTA&O9RYQ6]:OTKF+9]I%;EE+TYH W%;BG561ZG4YJN@A]%%%"
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M0:E<XV;3^>E1K:;3TKKY[$>E9\EJJGI56T&V06<> *U8EXK.4A#BM&W=2.M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%8MU*>:UKIA@\UC3X.:!-F1<LS9JCY)+=*UVB!-/BM03TH S[>V)/(K;L[4
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M#[E2TU1@4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME<1"35:9JL2D#I5*1O6DQD1?UJG<-4LKXZ53D?- K%:1JI2GTJQ,:K=>M R
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M1+A:EI%&!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXK<%AQ0!/9QG K;@&%JK;08 XK0C7 H >*6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *J79^2K=5;K[E &*Y^<TY ,TR7[QHBSNH$D7(UJ;G'%1Q]*L*!3%
M8@):HWZ5;=1BJ<O%(=RM)S5?'-2N:10,T"W$0'/-3<8I" !Q30>:$,D%(V<<
M4N13E /6@:(T+9YJTIIC  <4U6YIBL38S0%H!R*D2D,81BH7.*LRX JDS<TR
M6@W$THJ//-/0CO2;!,<:8S8I[N,53DE [T%(D,OO2>:/6J$UP!T-0QW/S=:
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M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHO;#/2ID!D6]L1CBMBUMCQQ3HK<<<5JVT0 '%+<!]K;\#BM6&/ J.% *MH5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8.ZM.$?+0!:C?BK2&J2H<U;CX% %I"<U:0&JD?6KT9&* )$JRF:KKUJTA&*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG)[TPR>] BUY_O2^:?6J!8YJ17H M^93P":K("3FK:$;: &-4# YJTPS3,4
M5MIIPC-6 F:F6,8Z4 5UCXI_E58$53+'0!1\GVI1 <]*T!#[5(L0]* **P^U
M.$!STJ^(>>E3I!QTH SA!QTIAM6)Z5L"W]JE6W'I0!CK;$#I3E@8-TK9^S>U
M M>>E %*.'CI4RVS9Z5?BM#QQ5V.V&.E &=' ?2K<4+9JXMH<]*MQV^.U %:
M.'CI4BP'/2KR0>U6%@XZ4 5$CXJ5(#FK*P'/2K<<0 Z4 010<=*MQQ'-2I&*
MLI'[4 )''Q4@C.:F1*F"B@"$)Q3A&<U+@4]<4 -1*F'2@ 4M !1110 4444
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MU#<]*CJ1#QS0 +QUI&YZ4,:$/K2L S!%*%S2N0:<A%,!A&*2GMS49.* %HI
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M0 T)Q1M-3#%&* (=II0IJ7%&!0 +2T44 %%%% !1110 4444 %%%% !1110
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MO0!M27PQUK-GN\MUK*EO_>J<FH#UH V&O@J]:S;C4#GAJS);W/0U1EN23UH
MU)+\^M4I;S)ZUGM,3WJN\I]: +SW?O51Y68]:K\DU(O2@ ,AIAR:<4)-/5*
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MJ +C% &68/:G);G-:!BYZ4\*!0! D>!3Q&:G"U(%&* (ECXI=M2XHQ0!%M-
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ML9J50,4 0B.GB+FI@M2*M $2Q\4H6IL48H 9MXINWFI:,4 -44ZBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $:J-T,K5UNE5I!D
M4 8<L95B:C1N<5?NH^#69]UZ -.W/(K31LK6-;R@D"M6+H* )''%5FJRQR*A
M(H%<KLIJ)EJT>:B=<<T 5B,5&W-2N<U'TIA=C4&#5A34.X4Y6Q2M<&2-TJC<
MIN%7"V143#-%B3!FMCD\5EW5H2#Q7521;NU4IK7/:G=".,DLRI/%598.*ZNY
MM.#Q6/<P;,\4FBT8#QE:@>K]P16?(V#3$]QG>G 9J,-FI4I%;"JM.(XIU-)Q
M3)>Y'C%2Q'FHF:EC;!I6&M39L^M;$2Y%8EBV2*W[<<"F)[E6[C(6L>08-=#>
M#*5A3C::74+EO3FPXKJK.3(%<=9/\]=-8R=*+:@D=%&W%+)R*KQ-D5*3Q56&
MB KBGQKDTC$&G1<&I&3@;:>&S33R*%&#3L!*HH=>*>AI9!Q1<J]BL.#0QS0U
M-!Q2=PW$(Q4$JYJPS5$QI$E)X\5 RYJ[)@U7;BI8D1*N*LQU""#3P^VD43DX
M%,/-,,FZE5L4Q#2N*2GLP-1DXH0Q:*;NS1NQ1;45Q]%-#9H+8I^0#J:PS0&S
M02!1Y#$ H(I0P-!;%'4+C0,4IYII<4!Z+:BN[C@"*=3=XI/,I-#N.+8J-OFI
MK-FA&Q18 QBF/S4K'-1GBF@(&XJ(\U+)S48XH8#<8J-QFI6;-,IJP7(,8HQF
MGN*:IQ3%?H68/EK1AYK.B^:M&WXI,"VHP*1P33P>*0G%,!@^6AOFIK-FA6H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGYXH "<5&6S06S28QS0 8QS3@U-)XIHH G)XJ,M1NXJ,\4 (_2HNAI[-FHZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHI"<4 !.*C+9H9JC)Q0 _'>@M3!)GB@GO0 HIQ;BH@W-./2@!:*9OI#)
MB@"0\5&S5&TU1^90!)2'BF[Z:[\4 .WT;ZJF3FD,N* +>^C?5+S^:0W&* +Q
MDQ4339JDUUFH_.]Z +IEQ43S9XJL9<BHS)B@"9FIGF5"9LU$TF*!W+)DQ43R
MY%5VFS432XH$.E:JX?FFR39J#S,&DA(TX7YK1B?-844_/6K\5QCO5"O;8UL\
M4QFS587&12^92&F/)Q4;-FAFS43'% Q6.*:&R:C:2F;]M KEL4]355)=U2%]
MHS18&6<XI-V:J?:,G%.$E.X%H'%2JV:IB7-2*^*";,MTUAFHA+FG[Z &E<5$
MPS4K-D5$QQ0P&JN#3]NZD7DU,!BI2 KM#4?DU=ZTA7%-#15$.*4Q9JR!F@C
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M+#FK"PYJ58\4 5EBQ4@AS5D19J41XH K+'BI!#FIME/ Q0!&(\4X19I].5J
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MFRC94M% #5&!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7F;J-VV@9,?EI =U1>;NIRG% $A&VF,V:5FS3* $Q12TUCB@!U-(S2*V:?0
MP+BI5&:;2@XH DQMI,[J:S9I <&@ *XH5<TI;-(#B@$3(E6%CS5='JS&](1*
MD>VI-FZFJV:D#8I@T5Y8L53DBS6A(V:JO5$I%00XI_D;JG49J0+BDT65/L^V
MCR-U7",T!0*+ 55M<5(L.*L\5%(X6A(!0N*<1FJWG^]1O=;>]#6H%EF"5$TH
M-49;S/>J<E]M[TF/H:;SA>]5VN0>]9$NH9[U3DU#;WH$;CW6WO5">[SWK)?4
M2>]4;C4".](2-@WF.]59[K=WK%-^3WIAO,]Z=AEV6XQWJE+<9[U$\VZJ[O0
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MU6XH\=J *PM\=JM0VV14ZQ9J9%VT 1"WQ3UMLU849J0#% %<6^*=Y%6,TF:
M(ECQ4BQ9J15S4@&* (Q'BGB+-2@9IX&* &+'BG;*?10!'LHV5)10 T#%.HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4>72!_FQ4A;B@!A3 J$BI&?FHV- #"N*B89IY:F,: (C$!S3&7/%2%S49.*
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M $7D5-% *>JYJ4<4 ,\K%&RIAS36&* (]E'D@U*HS2GB@!BP 4\1XIRG-/H
M0#%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(1FEHH 9LYIV.*
M6D- $96D+4,QIM !112-P* %HZU%N.:D[4 -9!47>G[LFG%>* (2<"HBQJ8B
MF,E $5%!ZTC' H &.!4>_)Q368TP9H F*C&:B/6G;CBF,: &,M1D4XL:8QH
M:5%02#(J0L:8W2@"HRX.:C+'I4Y!-1LE $=(1FE[TA.* &,HJ,C-.+&FT 1L
ME1$59ZTQEH K%<5$RYJR13&6@"FT(ZU \=7B,U#*O% %!EQ49&:G8'-,9: *
M[+BHB,U8(-,9: *Y7;3,EN*GVY-.\K'- %8Q8YIA%6B.U1,F* *[+BF ;C4Q
M!IH7% #/*P,TPBK&,BF,N* *[+BHB,U9(S4;)0!!LI=@IW.:1CB@!C*!41&:
M<6-)S0!$RXJ(C-62,U&R4T!6*XI58U*$R:4Q8%4@&F0J*%N#2%<U&R8H:$78
M[HCO5Z"]/K6&I.:M1,122%8Z.&\/K6A#>9[US$<Q%64NRO>@+'5+=X'6GK>9
M[US"WQ]:D%\1WI%6.G^U>].6YSWKF5OR>]2B^([T@.G%P!WH-QGO7.K?D]ZD
M^VGUH"R-PS#UJ-I_>LD7F>]1R7>!UI7U)ZFD]QCO4#77O66;LGO43W)]:!V-
M*2Y]ZJO=>]43<$]ZB>4TPL7OM)]:7S\]ZS5D-.,I% .QH&7%)YFZJ F)I_F8
MH0;(N;]M-,V:J^;FD+T,%L3-)BF>=41;-0R-BE<+EAI\=ZC,Y-5MY-(213N,
MF:8BF>87J+DT]5Q0%Q22M <M3PFZGB+% $=/5<U*L6:<8]M #0,4X)NH52:E
M"D4 1%-M($W59";J>(<=J *PBQ4BQ9JRL.>U2"+':@"N(L5(L6:L+%GM4@BQ
MVH @$6*<(=U65BSVJ418[4 4Q;X[5*L&>U6UBSVJ018[4 5!;X[5(MOGM5M8
MB>U3I![4 5$M?:K"V@/:KB0^U2B/':G=@4UM@O:I5@SVJVL6>U3I![4@*(M\
M=JL0V^>U7EMP>U2K#M[4 5A;X[4];<'M5M8\U((\4 51;@=J7R:M[:390!6$
M>*D6/-2[*DC2@!L<%3"+%31IQ2N,4 0[*>L6:>JYJ0#% #!%BI5BS3E7-2 8
MH 8(\4\1YJ11FI ,4 ,$>*793Z* &A<4%<TZB@!H7%!7-.HH :%Q3J** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+2-TH C9:8:=
MDYI2.* &4G6E YIS# H CVC-.Q46X[JE'2@!A7%-W=JE/-,*XH "HQFHS2EC
M3&- #645$PIQ8TWF@!FRCRQ3Z1CQ0 PH *A(YJ3<2:<5&* *S+4;"K!ZTQEH
M K[*7RP:=WI"<4 1/$ *JL.:M,Q-1,M %9DJ$BK#]*KGK0 QEJ.I^M,9>* (
MZ.M)@YH;(% #645$13P232E>* (&7%0LN>*LD4QEH IM"*B,=7"*C9<4 5&B
M J(Q@U9>H>] $8B IVP8IU(QP* (FB%1&/-3@DFE*\4 4VA%1^75LBF,M %5
MEQ41&:M$9J)EQ0!#LI"@-/IK$@4 1M$!41C!J0L:2@"!H14>RK9&:C9: *[+
M@4P+N-3$$T@7%" 9Y0'-&W-2TUN*K<9$T0IHA!J4$FE(Q1<1";<"D"XJ4M43
MG%%F ,VVD64DU"Q)I!D5(%HR8I%G)J L33&)6JN!?$V.]/6?/>LQ92:>92M2
M!K"?'>G?:?>L9;@U)YQH U?M1'>G"XW=366DA-/,I4<4 7VD]ZC,F:IK.30\
MF!0!:WTY?FJBLI)J82$4 62 !49-1F4FF[S0!,#BI%.:KJ<U*#B@"1N*13FF
M%B:0'% $K<4S;NI1\U/"XH"Q$8L4@CS5D+NIPBQ0!7\FI$BJRL>:E$6* *HB
MQ4J1YJRL6:4Q[:+@1"("G"$-4BJ34@4B@"(6X%2+;@U*H)J=%H K_9P.U3Q6
MV[M4ZQYJS%%BH;&5#:A1TH6WSVK1,>:018JD(J"W [5(MN#VJVL>>U2"+':F
M!4%N!VJ1;<'M5M8\]JD$6.U %06X':IXK8-VJPL6:LQ18[4 5OL@':I4MAZ5
M=$>:>(\5-]0*OV<"GK #5C9[4H7':GJP(Q !4R1"G*,U(!BF@$\O%2+'FG*N
M:E"XH 8(L4NRIE&:?LH K>73UB!J793@,4 1^0*D2$5(HS4@&* &B/%(8LU.
MHS3MM %818J18\U+MIP&* &"/%+LI]% " 8I:** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+@5&!DU88'--"8H C,0Q4)CJYCBHV6@"J8@*C(-6@,FG&(8H H,N*C(JXZ5
MR4 5V7BHB,U.0:390!4>/BH-G-:#IQ5=TQ0!69<"HPN34Y4T@0B@!AC %,(J
M?!IC+0!79:C()JR%)-*8AB@"BRXJ(@FKYCS4;1"@"EY=)Y6:M>7S367% %1H
M147EU="Y/-*T0Q0!GLN*:JY-73%GM3&BVT 5FB%1;*N*N3S1)'@4 4F7%,"Y
MJ8J2: F*8$9CQ49%6<9J&08Z4 0L*8%W'FG<DU(%Q0P(6A%1^75U1FE:,8I
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MJ18\U*$IP7% (A*8IR+FI@FZGB,"J AV4Y8\U-LI0,4 0E=M*HS4A7-*%Q0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME- %5H@*B,>:M%3Z4FR@"FT6.E1%/:M$QYJ-X?:@"AY=2+%GK5E8>>E/,6*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBFMTH 7-'6H@3FI1TH 3;3J** "D-+36Z4 -8"F8YI>2:<1Q0 F!BF
M@<THSFG8XH 3 Q3#2\TULT -8"HP.:<,DU($H 0**7;2]** &,M1$58Q3&6@
M"NRU$15@BF,G% $&RCRZD"G-/*\4 5_*%+Y=2 <T\KQ0!5:(8J$I5PJ:C9*
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M6B@! N*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I",TM% ";:6BB@ HHHH **** "BBB@ HHHH **** "BBB@!-HHQ2T4 %(1
MFEHH 3%&*6B@!,48I:* $Q2T44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0P!W@# 2(  A$! Q$!_\0
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M.*0-F@0X FGKQUI$(%*W/2AC!N>E*IQUI%..M#<]* !N>E"\=:%..M#<]*&
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M:"<50PHH!S03BBP!4;9-.)S1D=Z2%<%X%-8$FG=:,@#FBX IP*:V32'DTX$
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M%)G- GH(P)J,C%2[@*8QS0-$#*<T=!3RP%1D9.:0,:5SS33TJ3.!3&IDZD3
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M1G'%"MVHVYYH>HPVY.:D44P-CBG@T /"T$\4>9QBF$TMQ"YYIV<C%1YIP.*
M';<<T=:4MQ3,X-(+#P,4I.::7S2*<&@8N,4=:"V:9NVTUJ)H?THZTS?NHW;:
M %(Q24N_=3&;%,!U(10IS06Q0 H%%,WTGF4!L2&HRI)I-^:=OXI( #8XI,9.
M:83DT\-Q3&+NP,4FTGFFD\T[=Q28"9[4F.](3SFEWT$["YI"*3/-+NH#8;10
M3BF;L\46*%;FFA<&G=*3=FF(4\BF ;:=NQ3&?- )COO4PKBA6Q2E]U%AW&TT
MMB@MBHR=U,!3\U)]VE!VT'YJ!"=::13L[::3F@29&RDF@# I^:0T(&QA3-,(
MJ0OBHV;- TR)DJ,BI2U1M0AD10FBE+XHIZ@>F74_[L\US-ZY9CS5B34-ZXS6
M?(^\YK2Y%F5U0^9FK\2Y%5HQEJO1K@5+8TA?+P,T@%2YR,4FW%0V)B;<4 9I
M2:0'!J-2D2!<4A&:4-FE)Q2N%M1JKBE(S2!LTN<4T%]0 Q05S0#FE)VT+<-1
MN=M&-U(?FI0=M4%Q.E&,TN-U&=O%(=@SCBC;GFDZTN['%"%<3..*7;WI,9YI
M=V!B@$&[M1M[TS/-+YG:C88N>U&*83WI/-[4")":903QFF!\FF ^FGBG9P*B
M9LT +G=2A<5&IP:D#9H 4C--QMI2V*87S23!,=]ZFE<4@;%*6W4=1C:*:S8I
M V:; ?14;28IOF9I"N34UFQ4?F8II.:8(DVYYHSMXJ/S=O%-+YH8[CB<FG;N
M*A+TF^DPW'D9-+BF!Z=NXI["V'=*7?4)DI-U+<&3&FYI@?-+G'-%P;'TG6F&
M2DWT[@R3%.I@?-!;%.X;#P<4%MU1[LT9Q2ZB>X[I2YIF[-&[%'4.I)3&7)H#
MYH+XH*N*JXIU-4YI2: N%/"YI@IX; IB]!I%."]Z0GFE#<4!J.W8XH*YYJ,G
MFGA^,4AAGM2[>]&WO1N[4PL&[M0$YS1M[T!^U("0444F:!#@,TXI@4T'%.+Y
M%(8T#-/QMIH.*=G=3 ,[J<JXIN-M.5LT .I132<4 YH D S2%<4JMBD9LT@$
M I>E(#0:8QVW(II&*<'Q2,<TA#:*87P:<#Q38#2E)G'%*6[4W'>A"8I7/-1L
M*DW8XJ-C0,CV<YI_;%-W\XIW;-,3N,*XYI,YXH9^U,!YH'8>4J,U(7R*C- "
M 4IHS2T"0@%(RYIU-9L4AV&_=H^]1]ZC[M,!RKBAES0K9H9L4 (.*"N: <T%
ML4"&=*7;FEQNYHW;: L1D8-."<4TG)IX?B@8F<<48H(SS1G%(D,]J"*;3MU
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M0QZKGFG=.*8'Q3QS0Q";,FG@8%)FEHT87$Q3@*2E%-!87928I=U)F@$+MXI
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M&.* %Z4F,TBG-.Z4R=@"XIU(#3&8B@K<DII7-"G--9B#0 \# I"N:%/%-9J
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M6.:D'2F FT4[M46XYJ3/% #2H%-#<XI&8TV@"0J,4P=:-U-8XH D(&*C(S3
MY)IS'BF) %%.J-6.:<QXXI#'4A&:C#&E+4Q7%QBE'-,#9H)H%U)1BD(!J'<:
M-YH*)@ *"H-,#4C,:!7 G%* "*CSDTH;% Q2<&C@TTTFXT$L?FC Q3:3<:5@
M8M)F@GBHLG-!0_-+2=J9N.:!6'TO%(>E,!.: L/QFC:!03@5&6-%[A8DP#2'
MCI49<BF[R:8TB4'-/  J$<5(A- B91FI ,5"#Z5*I)H&3* :D Q4()%2J:0#
MJD6HZE3% F/HHHI6&2*!BD)P<4W=29I("4*#S3^E0AJESQ38"T5%N.:?GBDP
M'8%+4.XYIY/%.]@L.HJ,,<TXGBDP'45&&.:<QP*& XFFXS3%;)J08HN*P!<4
MM%,8XHO=C'TA&::I]:&/I3Z@+C%&,TBG/6D8XZ4=16 \=* ,]:3KUHSB@+@>
M*4 $4=:3)%  3BG8!%-HR: N-(YIV.*=@8IAH!B&DXH:HMQS3&2]:85 IV>*
MCR<T7  >:4J,44TL:!7$ YIY Q4>:7=1<+"$9IAXZ4K'BFKR>::& YZT'CI0
MPQTH7GK3N #GK4@ %1MQTI4;UI,!Y - &*8[4J$D47T <5S1C%+FBB^@"44A
MI:3$@Q124N>*+ %-S3"QS2YXHL#';12U'N.:?GBF IZ5'NR:0DYI>U*X;#L
M"F9S1DT'@9HN#8I %,)INXYH-%P0ZBF@TI- 7&L<4U?FZTIYIO2BX7''Y>E"
M_-UIA;--W8I@2GY>E1DYHSFFF@+CJ*0&HV;F@!^:0J#4>ZDWFG80XG%-S2$Y
MJ-F-)#)MU)4.XT;S3V EHR*@+\5'YAS2M<99S2\5!OXI@D.:20K%G-!P!4)?
M I@D)-%@2)PW-/XJN6P*19#FG898S32<5$S\4U6)/-"6A-B<'/6E.%Z5"7QT
MI%?/6BQ1*#GK03CI43-CI0K9ZT6T%8E!S0>*A9B.E*K9ZT6T"Q*.:"<4T&B@
M+$@&:=TJ(-BEW4[ QY -,)P:3<:2E8!^,BFFC-)UIH$%%'-%%T!UX44ZF#-.
MJ;A<*44SFGBA!>XX@8I%'- S3NU(6P,!BFKUH.:04[%#V QQ2*/6E7WI6Z<4
M@$8>E(H]:!D]:#D4>0KZBL/2HZD7WI''I1>PQE(0*7%1MG/%" =1@8I%/'-(
MQ/:A;BL-:F<4XU"Q-,8,:9F@]*BR<T 2TU@*,_+4+,<TQ7%)YIC$8H8\5 S'
M- -V'%J;Q3":86-.]@W),TA8"H6?BHC(:5Q6)]^::QJ'?1OS0F4*332V*8[5
M$7-.XK%@-FF.WI4.^C?FBXEH2!O6AFJ!FQTH#^M/S!DF::343-2!Z O<G!%!
M>JY>EW4 2YS1FH=U*&H$2YI0]0$FE!I D3\&E%0AJE!XH91+QBD!YJ/)I0::
M$B4@8IH.33=QHS211(0 *16YIFXTE" LYIR\U74FI@U)L"1L <4BG/6FYI.:
M?01,,4ZHT)[T.?2DADH-/7!ZU A/>I.:IB)@ *6F(33ZD!*E4#%1TH)H 5AS
M3@!BDI.<T F+D[JLJ!MJ%13\X% P/6EQQ3>M'-"'<!UJ4 8J*G*32 ?3ABD/
M2F G-.X7)J*0=*6A,D*,BF-FFKG-5T F%!I**E#N**7.*;138=!<YH-)29I,
M+A1112 7:*,8HS24[CN.XI#3#G-*.E*P/8,"EIASFG9XH$T(0*CR<T$G-+0%
MQV!BHCUI23330 M!IHZT-TH!,,"BF G/-.)XXIBL(V!TI%.>M(,YYI3Q0%Q6
M '2FB@'UI30)B'BE7GK3*,XH&A[@4B@4F<TW)% ,>>*!@TS-&30+H.--R*,\
M5&Q.:!HEI.*:IXIA)S0!-2<4@/%1L3FD!)FD(&*BW&C<:8(=NYQ2\8J.C)H$
MQX/-.(&*BI=U(8N[FDXIC&FJ3F@JY(:3BD8\<4U2<\T")U IY&.E1 ^E/4^M
M,"6/GK4X JN#CI4J-0!.@%./'2HMU/!S0@O8E0CO3MV.E0$GM3U)[T,=[EA6
MIU0#-2J>*1(ZBHR3FG \4#'9IP:H"3NJ1: )L#&:;GG%-W&D[TK 2X&,TW/.
M*;NI*$!*0,4T'FF[C29IL"4@ 4T')IN324D!(1@<4*::#FE/M2L*Y+28!J,&
ME+4):A<&XZ4+SUI <]:#[4V%Q6..E"\CFF&@$BFACFX-*N"*83FC)I,!S<&G
M* 1S49I033 4]:< ,4E-)-(2%+<T[ (J*EW&AC!NM,8"G$U%R33 .<T[ Q2X
MXIG.: #G-.(&*#C%,.:6X#:***+@!IN .E#'BFJ3FF _KUIC<=*5O:FCWH6H
MMA5YZT-QTI#[4#WIA<5>>M2 "HC[4Y3ZTAC\T5&Q.>*53QS0 _BBHF)SQ3U/
M% 6''%1$G-#$YIP Q0  #%,[T$G-.[4Q-BX&*86YQ02:8:0R3C%-S3,FES2$
MB3C%,)IN30QXIH$!Q2 TP$YI<T"ZCR10#4632%C18"1B*C)]:3=ZTQSZ4QH<
M313 3WH8^E NH_-&14.33&8T(=B9F]*9G-1ACWII;FC8+DA-'%-!XJ-F-!-]
M1Y;FCC%1;N*86.::*)3UII(Q3=W%1,QS2L*X_=S3L#%1 TNZFRAV><4XXQ41
M:DW&ABN.+4F::QXJ,,<T+8=R?=29Q49;BF;C0A)EI6!ZTXX XJF&-2*Y/6BP
MQ^[/6C.*8Q]*13ZT= +"D'K0Q Z5 S$=*%8GK0@)UP>M(QQTJ/=CI1G/6@5R
M=#Q3\BJ^31N-&XRQD45 ":D!XIL!]%1$G-/!XH0AV10*B).:D7I0T!, **CW
M&BH Z_BE%,P:>*$"'8&*0#F@4XTA;"G&*:O7F@ YIY''%&Q0C 8IJCGF@9SS
M3CTXIM@(WM0OO0/>AO:D _ I /6D7WH;VIV%81O:A?>D'O030]0N#XIAQWI2
MU0NU P8X-*N,<U'2$FDQ#VJ%B*5FXJM(3FDD%[CF89I,KBH2_%1%SFJ2!*Q.
M6IC&DWC%1L>:8P)IC$8H9N*A9^:! 3S3&:FL]1%C185QQ:F,>*:S5&30-.XI
M:DWTQVJ+<:=[C+&^HW-1%Z3?ZTFA7';J-U1LWI2*:?0&2[J0M4;&FEJ:V#<D
MW4PFF$GM0*=R5N2J:7-0\U(IXI-@QV:,U&<YIP/%%A$E)3.<TN>*5BF/!IZF
MH,G-2 \50RP",4F>:B!-.W<5-Q,DR*3/-19.:?GB@&/R*<*A4G-2;N*;0^A(
M2,4*W-1Y-.YH0D3YIZU I/>I0?2I91(W'2D4YZTS- S5(1/QVJ1<=ZA7-2<T
MF,E^E*#48-.I$7U']Z>,8J,4N:"MQ2>:D7&*BI1F@"6ES29XJ/G- )$PJ3C%
M1+TI<T T*.M2<8J*EYI#%!YJ48J#O3UR* ):,TTGBF+G/- $O:CBFL>.*:I.
M>:KH!+G%&:C8YZ4)FCH!*#033&S2 ^M+H/H.S1G-1MGM2IGO2$/S136S0#Q3
ML%AV:*B;.:>IXI /XHJ%B<T\-QS0-L4XI*8<DT\=*3$P.,5&<YH.<TO:F)AQ
MBF&E.:0T(!.*6F]Z&Z4P3$;':F+UHYSS2F@+BM@"F \TAS2&@&/.* :C!-*:
M!=![8IF:-WK3&.>E T29I#BF*<=:1CGI2&/S1D4P&D8GM3)Z@S<TY<8YJ,T9
M-(H<QYI1TJ/-+DT"8I/-.XQ4=+DT!8#3<T,W%1\YH EHIN>*;SFFD!)36/%!
M;BHB:0Q0<FGG&*BI=U #E/-.8@"H=U&30*Y/$>>:E8\<572I>:8NI(C>M2[J
MK\U(F>](HL(WK4FZH!GM4BTP)UQWJ057&>U3*?6D!.N,4UCS3=U)0(E&"*:<
MYI!FG4 V.7%.J+G-/SQ0 [-%1<YJ0=* %HIO>@GB@!<TM1#.:>3Q2L,=FBHU
MSFG-TI@.W4X'UJ%<YJ2AB8\FF$TF?6FL<]*2!#P?2G@U F>]/S38,>V*;F@&
MHVS0@1)3QBHDSBE.:3!CSUIZXQ40-+FAC0I/-.XQ4=&:!6%-)F@FHN<TQCZ4
M8I.U,YS0(E[4UL49XJ,YH& /-/.,5%2\T (>M%!I!UI,5Q:;QVH;I35SGFG8
M8[ZTUO:E8^E(H/>A "^]#>U##TH7WH %]Z1O:E;VH7WH %]Z1NO%#>U.7IS0
M +TYIC'GBE;/:F4 2C&*83S3<FB@"08Q3<\TW-%,5B3C%1FC-(QH!:"9%)FF
M<YIV>*5A,=Q32::,YH8\4F# D4@-,R:7- +8><4TTT&FLU-#0.?2D7GK3**=
M@'M[4BFF[J0GTHL#'MBH^*":C8T"3!O:F9H+5$S<TT42;J7(Q48:FLU/J2MQ
M6/-&13"U1$G--H;)BU-R*9NXII)I(29)F@L,5"6I,FDT&P_=S3R1BH=U)OIL
M=QQ:DS36/%-4\TEL!+FDS36/%-4\T+8"84I([5$S<<4BL<\T= L3 \\T%AVJ
M%F]*16/>E<+$X/K03CI3,TFZFF+J3*:<:A!IZFD#) :6H2U/5N*I[#1.N,4A
M//%5V<YIZM0D,G&,4TGFF;J6DMP)5QBGU "<U(&XIL!V1141R313T [HXIG>
MC!I*R3$D/R,4@ZT!33L<4)BV'<8HIJ@YIQZ4,8-C'%-7KS0 <\TK#CBG<8-C
MM2+UYH''6E//2BX Q]*1?>D''6@F@5Q7]JC)Q06Q4;'/2F CM4>ZG5"](9)N
M%(7 J'=BHF)-*P$CO4;,,5&6Q43,<T6%8)#S41D I6;BJKYW4P)=YS3_ #!B
MJV<"HS)@TP18=ZK/*/6F/+QUJHS'-.(%CS>:5I!BJ9>DWFFQ,L;^:1I!BH&?
MBHMQJ1HG+TQG%0,],#'O3M8"8M32]1L:CR10V*]R?S/6C>#TJJ[&A&--;#L6
M]X'6HWD%0.Y[5'DTP2+B2"G%@>E4LFI%?UI T6@PHW<U7W9I=^*!;EH.,4A;
MFJNXYJ0-Q2O8DL;QBF%N:A.<TX-0P)PPQ0#S4&3FGAN*:*18#C%)NJ'FES0&
MY/O%*&JL,YJ3=Q2"Y/N&*%/-0KG-29I]!HG!&*>E5U.*DW5(R9B.U"-S40S3
MA5(1/FGI4*9J2I8$XIZXJ%#3LYH!CV-/1JBI0#2!%C-&:8O I33!L4=:F!&*
MA%.&: %/6GKBFTF#F@$R:DW"F[N*;@YI#)5ZU*<8J%:=@TP ?>J0D8J+O2\T
M@%4\T\XQQ45/4$=:8"CKS2GVH;D<4U>.M%P%7KS4@Q4;<]*%R.M#8$A(%,//
M2D8YZ4J"@$ ]Z>,4QP:$R* 8XD4T\]*1P32KP.:$-"C'>D/M36!SQ3@<"@+B
M\8J,YS2G)-.!&*0@7%+3"#FG \4F#0I(Q46>:5@33:8#^,4P]:,TC=* $R**
M8 <T\CBF*PC8I@ZT8.>:7M0)@<8J.G$&FF@8M(329Q36.>E (1CGI0OO2#CK
M0>>E(!6]J0>]*..M(>>E,3$8TH(IIIO- ,>U,)HW5&<DTAK8DS1NI@.!2'.:
M8D2YI"U,!I#F@=Q,\T_C%1T9HL,7/-.R,4S--YIDL<33<BANE1C(-)(9+3&/
M%!.1BF '/- Q5SFI 0:C-"\&BPDRPIQ4F0:K[J<I-%A-EI,=ZER.U5@:D4T#
MN64([TXL*K@TX9H%>Y91Q2EN>*K<U(K>M TBRK4_-5@:E#4 R<,*3/-0'.:>
MK8H!(G!&*83S3,DTM($3#&*6H0>:DSQ3$Q6(Q4>>:0GFDI%$O&*:.M(,TX]*
M8KCN,44U0<TYAQ2L HQ2U&N0:5CD4K#$8^E(OO1C'6@\]*8A_':C.*:O'6AN
M>E+J%AQ-''>F#B@Y/2@74EI,BFJ<=:1LD\4+<H=2@TT=.:0@YH6XB2D+"D!P
M*802:8Q]'%*!Q49!S0*P^AB,4=JC8&@ !YI_&*BIP!H&&.:4XQ2TT@TA;C:*
M#2"A@+4;8[4YN148!'6GL,5?>I..U1GGI2KQUH0MQ_UJ-O:E8YZ4@XZTPV%7
MWI&]J#[4#WH"XJ].::QYXH;VIM(:)%(QS3'I,FB@!*6F\YI>U,5Q<T4VC=Q0
M"8I84E,P<T_^&@&(<8J//-!)S3&H DW#%-)J'G-*6XI(6PXD4@:H\TF:+#9*
MS<5'FDYIK4UN"8[<*0N!UJ$MBHV8GI5- 3L^>E"L!UJ!21UI&;TI>0R=W%1F
M05 7-1L2:?*!,SYZ4S=48/K3&)I;$MDI:D,@J+=Q4;$YIV"Q-NYI=XQ4&[ J
M-F.:5Q7)RW-(9!BH-_%,).:8T3[N:=O&*K;N*3<<T;@F3EN:;O%1EN*C.<T+
M4+EC?1O%0$TW<0:6P7+.^C>*K[Z0,138[EG?1O%5R^:;N(I;!?4L[Z-]5]^:
M4$TD@N6E<4,V:K;C3E:@7F65<#K3O,%522>E )'6@'JBV'I=]5P32[L528UL
M3[J4-5?=FGJ:7,#+2N*=N%5<FG@T6$F3[A2@\U ,U*#Q0QE@,.]%5\FBE85V
M=\2,4T=:-I%)4)7':Q,",48IB@BGDY%.P6#(I13 IS4G:BU@84WI1TI&.:-P
M$8YZ4+QUI ,4$T;!<5B.U1DXH+8J-FS3N,1FS2!L=::3BHG:@1*SBH'<4W?4
M+DFA(!&?FD\X 5 [8J!F-##<GDE&:A,X%0/)BJSL2:I($6VF%,,ZU2+G'6HF
M8T^49<>857>:H"_%1$G-"5A$Y>F,XJ,R<5&6HN*['%J:9,5&TE0LU)!<L><,
MTAF!%4R2:3)%# LF04TS"JS-4>330V7/.%-:4&JF32;B.]%D),L;Z-]5]V:-
MV* N6=])O%5]^:-]-H+EC>*0O4&[-(6Q32$V6UD%*7S5+?[U,KTF):%D/3@]
M5MU&ZC<"Z)!BDSSFJ@)J42<5(%@.,4;N:KYYIV[BJ2*V+(E&*-_>JO.:7=QB
M@&6?-%.5^:J '.:D!XI,=BZ'&*4-516(J0/FA("SNIZFJZFI-U)@60<TX'%0
M*V*<3NZ4D%R<.*>'%5E!%/ )IA8L!LU(K5 @Q3Z38%@&I5(%5E;%2 YI#)\T
M;L4P&D()IDK<E!IV\5$.!32#F@-R;.34H88J!:> :!["\YIZD4VD .<T F3"
MG;Q46[C%- .<T T3#K3^HJ(&G T *HP:<S#'%&<BF$&@$Q5//-.)R.*C IPX
MH&Q5X/-*QSTI#STH QUH$"\=:E!!J(\]*5?EZT#0\D"DSFFGYNE*HQ2$Q<@=
M:3KTI&!-*O IC09 '--()/%*PR:<HXH :#@<TA!)I64YI00!2 ,@"F=Z4@DY
MHSVIB8[(Q41ZTXJ:;B@844NVFL*0"9%.[5%@@TXMD8I@(S"F \TI4]:8:!,>
M2,4PG%)2-S0)#6.:%XZTF,4=:D8K$=J1#CK33Q3:87)&/I2!P.M,IK FF&Y*
M2#3"0*:#CK2-\U(!K'FGJ1BHR,44#%8\TH88IF:3FFB6.)YI=XIG:F$'-"'N
M2DTW<*;NXQ3>^:=@'YHW"FYII!ZT6$A^X4C.,5$32<T6 D!YIS$8J.BD4*#S
M2EA3#S28-,GJ2JU2!LU !FGK\M+<HL*<5(#FH <U*O%(1.IQ4@.:@ S4B\4!
M=$PQ0?:D'-.'%,0Y>*?GFF#FGB@:9(&&*83S24E R96&*?VJ$*>M/W<8I .W
M<TN>*BP<YJ3M0 FX9IZU#M.:E'2@!Y88I >:9S2TR43;AB@-4-%(=B1B,4U3
MSS3:*!DC$8I%-,I0* 'L?2D4^M-(H -*P#VYZ4+Q2#BC&>E KBGGI2J<=:51
M@4UADT(8[K1D"A>!36!)IB$()-.4@4HZ4T@YI)C).U-)% Z4W:<TQ#J"12XX
MIA!S0@L)MYS3B1BC(QBF%3188 \T\D8J*BBP 3BF[@:5AD5&%(- #Z:W/2E;
MD4T#'6DM@0*,=:'8=J4\]*85(IH!R'UH<^E, H(H <IH8T@4F@C%,+"J:1J2
MB@+#=V*=FHV4YH!P,4@'[A2BHB"3FG!L#%,!685%GFE8$\TWI0!*&&*1FXJ/
M.*8S9&*!- 7&:3=49!SFDH$M28D$5$PQ0#BAG!&*0QFX4F\"FE3FHGSB@+$_
MF TUG%5 Y!IQ?--":U'.V:0-CK3,XJ-VS57N43/(.U1[_6H"Q%-+T6$V3,V:
M:' ZU"7Q4;/GI03J62X[5&T@JOYN*87S22*MH3EZ42#%52^*89/>FQ/8LL]1
MF45 9:C+$T)$E@R<T[S1BJFZDR:&-HLF3FCS!BJNZC<:8(L^91YHJJ7IH8YH
ML"+9<4TR U7+\4P$YHL(M!Z4N*KEN*0$TAW+"MS2LU0;J-](+DP;%/$@JH7S
M2!\46#<N>8!2"055WYI0Q%.P6+RR#O09 :IAB:=NQ2M<$75D&*1GS54,33PV
M!3M8ILLK(!3PX-4MQS3U?%*P%T2BG!QFJ6234JL:";%X.,4;N:K*34@-,>Q9
M#C%%0 &BE8+L](+ TW;SFE"$4[MBHV*N-)XQ2#@TNW'-)FC838_<,4W=BFD4
MTT,!Y?--SBF=*:S9H0$AD%,,@%1$XJ)FS3 E:0&HS+BHB<5$[9I)#)VE!J%I
M,5 TFVHFDS56%N6#)FF&4"JQEQ4329I!L22R9-0&4 5$\F*KO)56!,=+)DU$
M9143O4+$U6P$S25&THJ%GJ%FS4MA<G,HIAF%5F>F%O>FF),G:2HVG'2H&>H6
M)S3T!LG,M-,U5F>HC)BC0$[EWS12-,#5 S^]-\ZE;4-BZ9,4TRBJ9FS3#-CO
M38)EWS133**I>?FD\WWI68BZ)@*#*&J@TN>]-$^WO3L!>,N*3S@:HF;=WIOF
MX[TP1J+.!0TH-9HFSWIPGQWI@T7?-Q4J2UF&7)ZU(LV*EC-/SJ/,K/$M2";B
MFA,O>>!0),FJ.XDU*CTAHT%>GAJIJU2"3BAA=EGS!2@\U6![U*&[46'L3[QB
MDWU%@T4,1-Y@I4DP:KX-.I6!(NB88IRRU1!(J16S2:&R\),U(DF*I*<5*IS2
M3"UB^K@U(K8JI'Q4X.:8FVR??2AZA HI#2+ .:E5L565L5,OS4ADX.:E5@*K
M [:D!S0!/2;A3 U+M)-,E;DHI^>*B'%.H'N&>:DW#%1TX*>M !CG-/##I3<]
MJ I'- (?[T;J:6R,4!><T D2 XIQ8$4P]*3%('N/!Q2E@:9C-&TBBXGN/4XI
MS'/2HP*<.*"A5XI3\U)]ZE'RT @'R]:>#FF'YJ =M"!CB0*3K2'YJ<JX%.X+
M03.*>#4;+DTX<"@&!84S&:4J2:>!Q2 ;G Q3=ISFE9><T;N,4 &X 8J/O3RI
M/-,QS0 _/%,-+MXIK4Q(:6!IH&#FE"\T\CB@8PL,5$3BG$<TQAF@0F[-&<4T
M+B@BE<3W!CFF]*4<4UN:0,&.:9G%+TIK#-"!#LYH)Q31\M(?FIC&L<FG*V!3
M",4E QS&F%L4M,93FF@'=:6F XIW6F38*0L*"U,(S0A[#2>:<#Q3<4X+3!AC
MG-(6XQ2D\5'CF@D0T!A2GD4S;@TRD2=*;NS29SQ2 8I6 =TH#9I"<TT#;0")
MUXH8U&&S3J206)HC5@<U52IU;%#"Q.IQ4@.:KYS4J'%*Y-BPO%(QR::#FEH*
ML/5L5*#FH0N:E48% PS2BFD4 TA7)@PQ32.<T@'>G9[4POV'!A2YJ/'>ESVH
M$]1X84[/%1A><TX]*10;AFG$XJ,+S3CR*  ,#3JC5"#4E ,**3%.QF@702G
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M6F%AI;%*#FFLN: ,4 *S8J,\T\KFF_=H$Q0V*8QS3MNZFL,4 ,S3J;BFENU
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M@.@T';4BMFF;<TY5Q0"!FQ0IS0RYH48H&.HHH[T""BGA,BFD8- Q*#2TAIV
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M"L#@TI;-(!EJE""@"('%/!S2, *K22E.E %A@!4+OBHEE=^QJS';22?PFIU
MK&X*U&;EC6S%HTDG\!_*K(\//C_5G\J?F!SRW3"D-RQKH&\/N/X#^5-&@2?W
M#^5,#"%TPI_GEJWAX=?&=A_*JEQI$D6?D/Y4F!G"7FK$0#<U3FAEC;[I_*G1
M2NO!!I6; UHQ5V*/O69!+DC-:]O@@4K 68AVJVD?&:BC2K<8SQ2&+$><5H1)
MTJ".$=:LH<4M1IE@#BG+UIBG-31KDT7'=$JC-2!<4*N!4BC-*Y0*,U)MQ2A<
M4\#-)B>PP4N*<5Q2J,T"2$ S4B\4;<4HYI('N+G-/#8IM/5<U0T/4YJ0-BF
M8J15S4L9(IS4@;%1@8J55S2 <.:=TIO2G"AW&%/#]J8*E"<9H$+CO0&I,]J<
M!0O,8X4E**7'%,5A <5(&S48&34@7 H 4C%(&S2]: N*!L<O%2 YIJC-.Z4K
M$L#Q0/FH'S5(JXH!(15Q3NM%% QI.*4'-+MS1MQ3Z#MH%%*!0:0K"45(JY%-
M88- A0V!32<T <4=Z!V$HIX7BFGK3%<2@\44AYI!<C9^U,-2LE1'K3&)FANE
M%)UH%<B)IIJ5EJ(T )UI#Q0W%-!W4@0UFS2 XIS+BF@4 !.:C)VU*1BHRN:
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M?A&&$#"C\JW+72DM\8 XI(#B+7P#" /D%7AX$@Q]P5W21A1TJ2J X ^ X#_
M*;_P@,']P?E7H'%'% '!?\() !]P5GWG@"!E)V"O3L5&\0<8Q0!\^ZSX&2-F
MVQ_I7&:AX;> G$9X]J^G[K1([@G*BL'4?!T$D;'8.GI28'RY-#)!-C:1^%:5
MG*<#->B>(?""Q.Y6/I[5Y_=V,UM/@(< ^E(#6MR"!5^-1UK!MYF0 -6K;S[L
M#-2,T%/%2*>:1 "M/1?FI:C9-$,FKR+@5#$@ JP,8J0L.7FIE%1J.:F2AAL+
M1G%/(XI ,T="MP'-+]VGA<4NW-) -4YIQXH Q3U7-4PL,&:<"13]@I0E"$A5
M.:D#$4P#%2J :3L4.4YJ0-BF@8IX'%2)CQS2]*CS@T\<T,-QPIX8]*:!4@48
MH&*!GFES29IV*$)NXM**11S4FT 4QB8Q0&).*3O4@44"0H%+2K3B.*!W& XI
MZ\TU1DU, !0 @7%.!HHI"ZA13E%##% 7$S2]:50#0W%%RD)13E&:1A@T!<-V
M*.M*JY%(W!H ;25* "*8PQ0)L-U-8T<44"(MQW4_M1M&:6F#(V8U&U3,HJ(]
M:!D08DT\\#-&T4'I0)D9:F&GD"FT!N-QFFD;:?2=:!#,YH/%*PQ30<T@8TG-
M)3B*;0,*8S8I](5S30#0-W6@G;TI^,4A&:=]0(B<TE.88-."@BFP(Z3-/88-
M,Q18&&.*C+'.*EII44 ,QQ32QZ4I-!'%)B&&FYIQI"*!L:3BF%J<U1T6%$1C
M3 233R,TFW%/H,7M0#24M).PAP.*>IS35&:DQBD]1C@=M2JV:@%31T6&B4-B
MI5.:8H!J0#%(0\,14JG-,50:D Q0 \,14B\TU5!J0#%,8E+10*2 <'/2I1S3
M504_I0 444HI(!0<T_&!FE"BG8H8$><\4[;WI=N*>HS3 8#3@:>4&*:HYI(0
MHYI3Q2D8'%(.>M%A@/FH/RT\ "@C-+J P?-UH/RT\#%!&:JX#5.:=TI0,4$4
M6$ IC,13Z0KFDAC ,T9*FGXQ2$9I7U  <BFLW-(3@TX*#32 ;CO1N(I^*0J,
M4A(B--SS3SUI,4P849HI#@"FF# GBHF8TH;)I2HQ0 P&E+9%-HH&-8XJ(L34
MQ&:C90*$P(\XHW9HI#Q0)B,<5$3FIL9IC "F P'%*33:0FD UFQ49.:D(S49
M%%PN,)I<9%! IC-BJW*N0R,0:9O-2, :A88-580[?43MQ2GI4+&H$R-I#G%(
M3QFG%14;&JL)H:6J)SQ3C49.:2$D0[CNIP-*5&:2FP8_=FD8X%-)Q3,YHV&A
M"V:C8XJ1ABHCS1<+C-](6I2*;3W#<0MFHV;%.;BHF.:5A6(W;-5G8BIWJ(@'
MK307T("<U7DDV\5+*=O2JCG)JA$;_/S5=SMJSD8JG.U"&F5Y9*HR')J:1N:A
M?&W--"&X&,U6EGV\ U%/<$' J!0\KX )HL &1G? S6E86$L[@;#S[5>T71)+
MFX3*'!]J]B\.^"(FB1F0?E3!GG]AX5,R F,_E6NO@H%?]7^E>S6?A.&.,?**
MOCP]$!C:*8CPM? ZY_U?Z5(W@=0O^K_2O<AX?B'\(I3H$1'W10P/G74O"9@0
ME8_TKC[W2YHB<1M^5?5UUX4AG7!45SU_\/K9P3L'Y4D@/ETQSQG[C?E3@SG[
MP->XZMX BB5BL8_*O/M;\./:!ML9X]J8'*QXITF,5#+#/$Q^4_E46^3N#0!(
MSE3Q3X\OUIL0#]:LJJKTI>8#E^6GB4BH'>A#FC<"ZDQJU$^:H)BI5DQ4C->-
M\591ZRXI,BK:24@-))*G62LY'JPCT6 OI*:M(W%9Z&K2/0-Z%GS,44P$44"N
MSK6F.*@>8TQI!BH&;FIM8L<93FF,]-9A4)?FBXQYE.:C:2FLPQ41?FF XRDU
M&\F*:[#%0E\T6);'&4TQI2*C9A49:BY.H\RDU&\I%1LPJ/<#UIH!YE)J)I<4
MUV Z57=Z )C+5:22HVEJ(R ]Z5@0\O4+RXIKR57=Z8]QSR9JL\AS2._-1$TP
M8_?1NJ DYJ1318D4U&TAZ5)32HI[@0CDU87I487FGG@4MAM"L:B+D&C>"<4D
MB%E^6K$,>7CBF*9)&P 33X+&XE?&PUV'A_PW)/*N^,_E0!C:5I,UTX#(?RKT
M/0_" )4M'^E=AH/A") I,8_*N[M-#A@484?E0!S>C>&8H=OR#\J["VL$@ P!
M5B*V6/H*>W%) .  %.J-":DI@%%%% $;$YI5-.*YH Q0 M%%% !3)$#J13Z2
MDV!@ZAH<5R&RHYKAM=\'0B-W"#/TKU8KD50U"S66%ACJ*5@/F'5].>UN655.
M :I0RLC &O6_$GAQ6WN$_2O+M2L9+>=@%/%(9H6MQD 9K33&,URMO*R. :WK
M:?*C)I :*R$&K"/FJ:D$58A^]2&7$J<=*B& *<C9-2-$P.:>*;P!0IH#<D!H
M-%/4 ]:0Q@S3@2*DVB@+5(2!>:?28Q4J $4FRB.E!(IS#TI5 [T= '*<U(":
M8!4R@8J0 +FGCBDI:&A)CP.*,G--!-2JHI(!0,BG 4"G\8JK ] Q@4@))Q1G
MFI% H!";>,T@)S4E)@4T,4=*<,FD7K4N!28F-(Q0A-.Q2@"A@A:09IZC-*0*
M!=1H.*"<TE%(8H)IW7K2J!0W% "9QTIPYZTBX-(3@\4ABL<=*83S4@P1S3&%
M, #4TG-&:* (B3FI >*0@44";&;CFGYXH(%1%J!BL],;I2T4 1 G-.;@4$ 5
M&6IB8W<<T&CBEH!(:*1N!2G%'6@1"230#BGL!4=(H7-)110(*7-)10,7-1L?
M2ACZ4#D<U0B/-.#&AAS2C&*8-C2<TS-//6F\4KW .U1ECFGTA HN"&XXIA:E
M)II(IV 2DS1FFDTMB6[@:C-*#S3CC%(:T(Z3-.IC'% [ W%(I.:0')YJ0 4]
M@%!Q4BG-,%./%)(+DE2QU74YJPE-H9*"14BDFD4"G@"I$.!(J52334 -2"@!
MP8U*IS35 IXZTQBX.:>%I5 IU2V)@.*=2#%.'6F@08I^,"EP,4WO2W!@"<U*
M*: *<*&,*44X@8I!UH0KB@D]:<1@4' '%-!R>:!B@DGFE88Z4N *7K3N*XU6
M-*YQ36XZ4+R>:!BH2:<:  *6D  TA-!]J![T$@*#2T<4#MH&:C8G-(S<TX8(
MIV&  --R0:"<&G#!%+8!0>*8Q-!/-.X(I 1&BE/6DS38 >E0DG-24$"A"N0B
MG;J::,TQB,:8I.:DZTP@#I0M0%8X%1%LT$FDH 8V::#GK4A IC8'2F)@3CI3
M"<TH.>M!Q0)$+DBD!SUIY -,;CI2&Q&--)I":B9J 2%9J832Y!I"15+0=B)F
M-,-3$"H6ZT^8"%B:8:F(&*B:E<"$L:8U2-BH33N3<C)YIC'BI&QBHCUHN%QF
MXYI2>*0XIH/-#0;B@Y-#<4IQ3":-PW&Y)IK\4[BF,: V&9S3&.*=WI#BA=A[
M$1.:A<XJ9\"J[D4[ZBO<C+57ED(Z5)(<5"<'K3L20EBW6H7%3M@5!(PQ3 I2
MRE:J.Y:GW#?-3 1LYH JRD 9K,GN#G JQ=S8) -4HH7GG QG)IB&Q0R3RC"D
MYKL=!\.O/(A,9_*K_ASPV9V0M'^E>S^'O"L,<*,4&?I3'8RO#?A")$1R@S]*
M](T_34MX@ .E2VE@D"  =*OJ,"F BKM&*=110(**** "F/&'%/HH S+G2HYP
M00*Y/6_",,RM\@_*N_J&:%9!@T > :QX*1-Q6/\ 2O/]8T![8MB,C'M7U9<Z
M+#.#E17">)_"D95MJ?I0!\SRK) QR"*6*<GK79^(_#DD+-MC/Y5Q,UI-;L<J
M10!8)R*0'%0Q,>]3<&@!PE.:LQ-FJ=2H^*3"]C21L59CDK.23BI5EYJ5J)&L
MCU91ZRXI?>K<<E"T*-%'JPLE4$D&.M3JXHL!;\TT5&I!%%6(Z;S#3&DXIK.N
M.*@,G-9&C8]I#4;.:&<8J$N,T"8XR&F/)37<8J R4P;'&0TQI*8[CM4)>DR2
M4R&HGD]*8SBHRX[T(=QV\GK4;2$4QI!4+RCUIB)#+ZFJTTA[5&\OH:B,F>M
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M0TAHL#GI4BYJ.+CK5@#/2I8  :E7-"C%/ H$* :E6A!3N] Q0#FIE'%,4BI
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M-!/%(6%--"U#<6F,,BG4$XIE$:@@TX\T!@:7I3$-'!YH/(XI&;(IH?;UIVN
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M!P* *=M9I$!\HJZ% Z"FEL4JG- #J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M"*6B@"/9GK7)^+K02VK #M785DZO:^?$1BE:X'SUJ.GF"=FQWJ&UFVOBNZ\2
MZ1Y:LVVO/908)#]:"D;HFWBI8AFLFQF\PXS6POR#-0Q[$ZC%2J,U6$F:G1\5
M :EA/EJ3&ZH0V:D5L4AZ$BKBK"=*A4YJ17Q575@):<$S3%.:D5L5+8R51BI
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M-*IS0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 0C(KF->L!.K?+FNHJM<0B13D4 > ^*=-:%VVKBN?LLQ
MGYJ]9\6:4)-Q"UYE?VYM7/&*EL"Y%(".*LJPQ61:RYJ^A)%07T+)?FIHV%4L
M\U8CR:+ BZK5)N%5U)IW-("<-S4RD8JJ#4JYI(+DV:,BF9I,'--#N3 U)D8J
M$=* 3FAB;)\TN14>>*3G-*X(D%+3 :>*8A!3LTAH% R13ZTYO:HJ<II=2AR^
M]#>U!]J0>],5Q5]ZDJ(^U.4XZTF@'YHS4;<]*53CK1T&/R*,U&<DTJG YHZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM:D!4$QP*GJ*5<T 4]QS44LA'>K/E'-036[-TH =;39[U;,JU1A@9:E>)J+
M6//7%4KB^1#UIWE/BL:_MY2_&:5@-F"6.;T-6A;1-_"*QM-1T'-:ZS!1S22
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDB[
MD(I]% '&Z]H0N59MN:\?\1:4;>X/R]Z^B[B(/$PQVKS7Q/H?FL[[?TJ=0/)8
ME\L5:2XQQ46K*;2<IC'-06Y\SFC<=C7C?=S5I9<#%48C@5.*3*2+8?-.#U65
MNU3J.]2&Q*I[U*K]J@!IXX-)C3)\XYH$O.*CW9&*4+WI; T3AZ>'S5<4\<4A
MKR+"G%68FR:J)\QJY$N*DN*+L7%65YJO",U<5,4KFJ&$8H S4NS-*$Q315G8
MJ2G;4:MEJM21;J@\O:U40;VE]JZNS^Z*YC2%! KJ;5<+5P,9ENBBDK2YB!&1
M4#19;-6**8#$7 HV\T^B@=Q *6BB@04444 %%%% !1110 4444 %%(32 YH'
M8=1110(****0#6^[6#J<&\'BMMWQ52>+S$-,+GGE]&4N/QKH]$NPD8!-9.M0
M[)2<50M-0,,@7/>DQH]#?$L)/M7&ZLF)374:;-Y]KGVK&U6VRY.*307.7*<T
M]>*?*NU\4JIFLW<M;"%>*C[U8(XJ/9S4DNXW9Q3"*L8XJ-UQS5(1/8+B4&NQ
ML'^517'6)S*!78V*_*#36@":S_Q[GZ5PS\S'ZUW.KC-N?I7%,F)C]:-QIB@;
M1FE#9I2,BA$J?4H>IQ4J'=3-E2Q+BDP18C^2G,V: ,TA7%*XTA\=/I\$>ZI'
MBQ0#&QUH0+FJ:)5V!MM4KDMF@BX3%9=Y%E\UJQG*U2N?O55@13C&WBI<<4S%
M/!XQ4,-2)FYQ2;<\U*8L\TW&.*@H3/:FE>].V\T_'%4ALASGBK%I'^\!I@CY
MS5JV&'%6B/0VH1A!4M1Q?<%25JB HHHI@%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/2HRI[U<6+UI'CI#,R0,&XJY:GCFFR1\TL?%,5BV>>E$;E9!SWIT?(I/+/F
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M^#[-'\LE:]Z\-Q!+50!VH W8D"+@5)110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0/[[\:WXS^[-8&H#,WXTQ:$UJN4S5@G%06C83%6"N>:ACL1DTUNE*>*0CBA
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHF%.?-"C-#19 4!ZTHC%2L.:51Q2L U4%2# J-N*86-("9B,54E:AG-0NW%
M/0KRL*K,W-.E)W5$:I&38'F@#FD'6I.,47,V&!BH^]*<TVFD(E %.J(9IY/%
M*Q-M0; IH/-(<TG2G8HD8#%,'6DS118!QXH4YIIS0,T(5B6EX[TQ30Q]*+"6
MY)]*3CO2)GO2/GM3';4D&**8F:<:0,7O4@QBHZ7F@-Q6IM!I<&@!*3;2TH%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!I,XGMU;-?,7ABXE%S& 3C-?1GA5F:P0GTJD@.CHHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0:!)E?;3&%6'%1;:$RBN>.M5Y>1Q5F8<<56QZU:U$5F'K4#BK4@JL_%(FVI
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 1S?ZL_2N#\0-AVKO)O\ 5GZ5P/B!?G:ID-'%W)S-^-:5DV$%95R<
M3?C6A9G*BH*1K(U3J]5(S5E%R,U*&2@U*KCI40%/5*38R534JMVJ)14BIWI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXC2W'-2#I3=G-.%,!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP#J*@R1)4S5&!EZN(C4M.5%:*_=K.M> *TH^5JXD,9CYJF7I2;:=6@@HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#TI::WW:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.?6ID7$K1PG-7%A..E/CVU;C45DS:.A62W/I5A(<=JLC;3Q@5+-DR)4QUIY
MI68=JCW4K%)#UXI6:HB])OH;*L2*^.M*6STJNS9Z4^,XZTO,3)0*<%H'-2H*
M";@HI^*,5(HH$W8%%.HH+4T1N(6JO(QI[FH6;BF)D+]:: <T,>:>I&*>QDV.
M'2DHI=PI;D;B$<5&0:DS2,1BE>PUJ0OTJJ^:LN:KL0:>X6('JLYJQ(<55=A3
M&59NAJJ<YJ[)59A0(KN,U%MJR5J-Q0,K.M1%:M8]:C9:I(3*,B$]*AV$5?*@
M=:@D HN+8H2J:J2#%:;@50G'/%,1G2KS567 !J])C%9MP>35Q!&/?9.<5A2
M"7)KHKA<@US]VI5B:L5SH_#EVJ7<8SWKZ*\*7B-8H,]J^5-)N3'>ISWKW[P=
MJ!-M&-U)B/5U8,,BG54LGWQ U;I@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ8H:.(M7NVBW(N;17!ZBF(U**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,:Z0?Q"O+&\63CN:KR>+9_4T#/74N8S_ !"D>ZC'\0KQX^,KA>[4H\83MW-
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MJ%B5Z4W>:=[B9;#^].$OO6<TI!IZ2FG8+HU%((I<UGK.14RRYI6!%OBDSVJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4C' -+52ZEV*>: .8\37GE*V
M#7G=W*;ECDUU'BNY+!L&N.MR6?FLV-$L,>PU<3FH]N*>M(HD JQ&H-1**F7(
MI;A>Y,.*F1<U"E64I-#2)4&*LHHQ4"5,N:0):DJCYJN1J,571>*F!(J7J,F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0U!WX# 2(  A$! Q$!_\0
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MKI_LL>2=HY]J/LD>[.T?E0!S'V^\_N?I1]OO/[GZ5TYM(R0=HX]J7[-'_=%
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M\_N?I74?9H_[HH^S1_W10!R_V^\_N?I1]OO/[GZ5U'V:/^Z*/LT?]T4 <O\
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MWG]S]*ZC[-'_ '11]FC_ +HH Y9KV\88V?I2F^O",;/TKJ/LT?\ =%'V:/\
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MG093@<]*WM+N&E@YZ@59:RB\LKM'Y54TU=LLRCL: *^CL/M3#&.*W:Q-+/\
MIC<<XK;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BD8D#B@=* %HHHH **0$[C2T %%1O,D?WCBG!U(R#0 ZBD# ]
M*0NHZF@!U%-617) /(ZTK$C&* %HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!CYPQ]JR[ EYY\'H:U7&4(/<5CV7$\X[ T )I8
M/VUR>N*VZQ-+)^W.OH.M;= !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %(V=IQUI:I7FH):@<@DGI0!,TX@B!D
M.#[UF3ZR@N-B-QCUK.4W&JW\R$E4'3%;5KI4,,>)%W-ZF@#GM135+V=6M]Y0
M>E:FFQ7ZJ!/NZ8YK;CC6-<*,4[/S8H KJDBJ<9]JQM5BU)L_9]_3C%=%10!Q
MFDMJUG/))>[PA]:V[768F8K(XS[FM62))5PZY%9=_HT=PH\KY&!ZB@#4BE66
M,.I!!I]<DDEUIET8BS-&#WKI+:[2=!AANQTH LT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "-C:<UCV?_'Q/Z9XK8;[IK'L_P#CXG/O
M0 FE@?:V^E;58FE#-\^/NXK;H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBHKB80PL['&* (KV[2VCR3ACTK$BL'U
M.Z$TQ8*IR.>M 5M4N26RR+TKHH4$<*H!C Q0 V*WCA^ZH!/<"I:** "BBB@
MHHHH **** (+FUCN(F5D&3WQ6 UK+IET)(V8J>#DUTU1S1+-&584 16=VMS'
MP<L.M6:YLA],U%<96.0UT,;AT##O0 ^BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2-GM01
MR#4-W*(;:1R<8% &/>2-<ZK';$YC/WA6U! EO&$08%9&CP>?*UXYSNZ>U;E
M!1110 4444 %%%% !1110 4444 %%%% !4-S$LL#*PR,5-01D8- &!I-P;>^
MDM6^ZWW/:M^N<U6+[#?PWB] >:WH)?.A5QW% $ASD4M%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5;^Z%M 6[]J
M*.IW#23);IWZU?L[9;>+&/F/6J6GQ?:9#=2#V%:U !1110 4444 %%%% !11
M10 4444 9NK60N+9W48E494^]5?#UW-)"T%RV9DZGUK;(!&#TK"O8S87\<\?
M"N?F% &]13(W#QJWJ*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 U_N'Z5CV6?/GSZUL/\ </TK'LAB>?G/- #-).;UQZ"MVL/2@!?.
M1T(K<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ,UE:YA[18]Q!9L<&M0@9SZ5@:MYEUJEO!&<%"'/TH T]*@^S:?'&>HJ[2
M#H*6@ HHHH ***0D 9- "T5G?VS;?;OLNX;OK5_>",CUH =1110 4444 %%%
M% !1110!G:U;K<:<ZGM@YINBS"2UVYR5.*OSQB2%T;H17/:*WE:K+;#T+4 =
M(1R#Z4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %8>I8O+U+<'A>N*U[F7RH&?T%9FE)'//+<$?.>IH U((A#"J*,8
M%24BY'6EH **** "BBB@ HHHH **** "BBB@ JEJ< GLV&.1R*NTC#*D>HH
MR-(O#< PL?F2MBN9F3^RM625?NRG;72@Y - "T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 U_N'Z5CV6!//CUK9894BL:RP+B<#UH 32N;
MYS[=*VZP]*.;USZBMR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ / K%C82>)R0.!#_6M*]D,5J[CM6'X=E:\NKBY;JI*4 =
M)1110 4444 %<]XSUA]$\/37<:Y8# KH&) XK'U[3EU?2YK29<JRT >4>%7O
M?$LB:HMVZMGE!7I6J^(4T*RMU?#R' (->+6-]=_#WQ5+:L"MFY^7=TXKIO#]
MPOQ!\13--*3'%&< ' H [RY\9K;Z='=F-=K4Z/QG ^D&^^3:&Q7&>,S96.F-
MI$<O[Q <#/-<+ 9O^%<7.97R+@X.X^] 'L5E\0;:ZNHX?D&\X!KLT.]5<'@C
M-?*L5I)8V'A^^$\FZ:0[CO/J*^H]-.[3+4DYS$O\J +5%%% !1110 'D8K 7
M9:>(B<??3%;]<AKTDB>(K7;D*2!0!U]%(.@^E+0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &=K$PCM=O=SBG:3!Y-FN1\
MQZUFZ]YK7]HB9*[P370* %  Q0 M%%% !1110 4444 %%%% !1110 4444 %
M%%% &/K]OYEND@'*-FKFF2F:QC8G)I]^ ;&;(S\M9/AJY:9)HCTCQB@#?HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z:Q[/_CYG^M;#
M?=-8]G_Q\3_6@!FDKMOI#G^&MRL+223?OSVK=H **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!%<_P"H:LOP\P:&YQVE-:5X2+9R/2L;PK('M[L#J)S0!T%%%% !2,<"
MEIDKK'$SMT49H 7< /F(%*&!Z$&O,=3\37^J^(VL=+=56$_/WKH/#7]JVQE?
M5)U9>=O&* .NS@XI:SDU6W>=$W#+=.:)]9MK>38S+GZT :-%<YKOB6&R\/W5
M_&0WD@=#6;X(\91:_H\MT^%V.1UH [0G!Q1N&">PK-76;5X6E#*0G7FFR:I
MUI(R,!D<<T 2PZS:7%^]G&Y,R=16A7B/A+5KJ?XO7ENS@Q9Z?G7MN?FQ0 M%
M%% !6?JHS"H]6J^3@9K,U2=5:*/N6H MV2;+=1G(JS4< Q$HJ2@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN)/+A9O2I:K7W
M_'H] $.G11_/,H&YCR:OUGZ02;9\_P!ZM"@!LC;8V;T%>4/\1;H_$-M"0#;G
M KU:0 QL#TQ7S=\J?M!$ '&_B@#U+3?&;P>+9=,OOEC,9=3[UTDGBS38Y_*9
MSN^E>8_$ZW33=>T^^MF"2R;4;/I4'B&VDAT6VU**3+G[V* .NN_B/':^*H].
M8_NG3<#Q777'B&QM;5+B1B%?IQ7BL>CK?>+M+EE)+/;JQQ]:]&\1:3'*MK8I
M(%R#@9H ZK3=:M-54FV<G'7->-_'/7+S2=1TLVTKH&+9"MBE^&^M7,'CJ^TB
M1MR1@XK/^/B[]7TA7^Z2U 'K/@?Q!!JF@6B[R9A$"V:T)_$^GV]X;5W(DKQ_
M39[KPUJ&F>7(%MY[920?4U8\?-)::6^LV\H\SKUH ]>OM?LM/A22=\*XR,4V
M+Q!83V+7B.?*3K7S]:>(M2UU;3[2282H3CUK9N-0N8;^U\/VLHQ/G=^% 'N&
MG:I;:DAD@?(''-7Z\:T/4-1\->*8=+G)>.90<X]:]D4Y4&@!:Y:Z@$/B:*<'
MEB<UU-<UJSA-8MCCN<T =(IRH/M2TV/F-3[4Z@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** &O]P_2L>RQY\^/6MA_N'Z5CV6//GQZT ,THYU"0
MCTK=K"TD8U"0'^[6[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2T (WW:Y/Q!<LFLVD2C@N,UUO:N=N[5;W7X^F(QNH Z%>%'TI:!THH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9V(Q\W:NEH *YG6G4ZM;*!R"<UTU<A(7E\8)&WW03B@#K(O]4OTI](!@ 4M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -?[A^E8]E_KY_K6P_
MW#]*Q[+/GSY]: &:22=0<^U;M86DC%_)Z;:W: "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>A^E+10!Q>@12I
MXMNV<_*5.*[2L2X6*QU%)%P'D.*V0WK0 IZ4@!XI0<C-+UH 9S^M.&<G-(,A
ML4I/(%  !B@YR,4M% "'/:D.>:4#%!&10 @SG\*3G?G/%.QQBFE20.: '-GC
M%)@\YZ4ASD"G$9% "T444 %<\;<-XE28=LYK;NI#%:R..H'%8/A^:2\N[F25
M2"N,9H Z2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &O\
M</TK'LL^?/GUK8?[A^E8]D,7$_.>: &:61]N<=L5NUA:6!]N<]L5NT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9^K6QFL7
M4=1S6A374.A4]Z ,G0I@UG]G8_.G6M<8'%<RK-I^ML/^6;GFNE0AP''<4 *1
MD@^E+110 4444 %%%% !1110 4444 %%%% "'&X49&<4A(##-,9PH:3L!0!C
M>(9Q)$EHI^>0UHZ;$8K50PP<5@QQOJ.OK*3^[B/2NJ4 * * %HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"UR FXA
MGS\J$5K6\JSVRR#H:KZM'YE@_J!Q5;0)=]AY+?>3K0!K@#;B@# Q3%;&0>U/
M!R,T +1110 4444 %%%% !1110 4444 %-SC.>E.IC\C;ZT 4]4G2*PD=CVX
MJKX>C!M3<#_EI4&OR!TCM%ZLW-:>EV_V6Q2'^[0!=HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!&.%)K&L^;B<CUK9;E2*Q;$8N;@?[5 #
M=+/_ !,'X[=*W:P]+_X_G/?%;E !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!F:M9B2+SD7]XM+I%T9K<J>J'!K190RD
M'O6$=VEWN%YBD.2: -Q>Y-*IS4/FB559/NGK4PP%H  >2*6F,3@%:<IR* %H
MHI!GO0 M%%% !1110 @/)%&?FQ0,Y.::S<9% !(I*<=:RM;N_L]JL2'YW.*U
M'D$<1=NPKG=K:EJ()^ZO- %[0K8Q0,[CYF[UL5'$FQ=N.!4E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9$$B%2
M.#7/6KFRUF:+&%<\5T=86N6[QE;N(99: -G[Q&!UIXQT%4]-N3<V:N?O#@U;
M4=SU- #J**3.#B@!:*3G=[4'.10 M%%(<XXH 6BD'2EH **;EOUIU !4<A$:
M.['@"G$X;VK)UJZ81"&+EFX- &9:*^IZJ9FSL0\5U0&!6=I%D+6#)^\W-:5
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #7^X?I6/9'-Q
M/]:V6^Z<UC60Q<W'IF@!FEY_M!\^E;M8>EG_ $YU]!6Y0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%)D49%  /<TM,VY[]Z=D4 +129%+F@ I!G)I!P#WIA<(C.QP!0 V1Q$I>1@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 C*&&",UEWVC)='*84^M:ASVI: .+O+:]L)A'$K.O7(J_:WUS:VV^6)AFNC
M9%;DJ":JWD,36C"7"K[4 <Y/XQ2 E64Y':GVWBL741=$8L.U4CX;AU&]9PYV
M 8Z58L=$@TR]:-V)4].* +-U>7<T(ECB?D=*K6NFW>H_-*3'[&NIA@C5 % *
MU.%5>@ H HV.FQVL>" 6]:O  # I:* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH 1ONFL>S_X^)Q[UL-]TYK'L_P#CXG],
MT ,TO_C^<?Q8K<K"TH?\3!_3%;M !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5SVLW$UW<QV5L<$_>-:6HW
MHME"@9=NPJOI]JSSFY<8/O0!<L;,6MNJG[^/FJ.^LQ,"Z_?'2K]1XVN2>AH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,E
M?9&6]*?2, PP: .2DU2"75#]I;:$Z5IIXDTQ1M$G3Z5+<:-%*Y<(,FJY\/Q8
M.$% &G97\5]$SPMD XJ"_P!7M=/:-+E]I?I6=X:0Q27,797/%9?B2$W7B*QA
M/0DT ;4WB#3)HS&9.H]JS=+UA/[4:VA.Y&/!K07P_%M0[!D=:L0:+%!/YJ(
MW:@#50?+]:=34!5<&G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 C?=.*QK/_ (^;CUSS6RWW36-9_P#'S./>@!FED_V@
M_':MVL/2_P#C^?\ O8YK<H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ*SM.U2&^7Y6Y-:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZTZ:YO8HQN3CZT =0&!&0:0R(.IKSR\\5WMO.L21Y&<'FK0U34YXPRQ=1ZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5MK3*#5B.5)5W(V0>] #Z*** "BBB@ HHHH **** "BBB@ I#]TTM(WW3]*
M.?T$C[;=_P"^:I:P#_PE6G\]S5SP_P#\?MX/^FAJEK _XJK3^>YH ZY?NBEI
M%^Z*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!#]TUF6;;;B<>]:9Z5FV/_ !\W'UH JZ6!]O<CIBMVL+2S_P 3
M!_3%;M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 50U.Z\F,(I^8U>) &2<5B!3>:D>ZK0 ZRLC,_FRKD=LULJH50HZ
M"A5"*%'04M !1110 4444 %%%% !1110 4A 8$'O2T4 <_K=L]L8[NW!!0\D
M5HZ5>?:[4,3DC@U;F198S&PR&K"A#:;J.P\1OT]* .AHI 0PR#D4M !1110
M4444 %%%% !1110 4444 %9.M3CREMP?FD;&*UJY+7I&'B"R09P9%H Z:SC\
MJTC3&,"IZ*:[B-"Q. * (+NZ2WA9F.,5DV$/V^X:6494=,TMP_VZZ5%&4SS6
MM;VXAC"J,4 3(@10H'2G444 %%%% !1110 4444 %,EB65=K#(I]% '/7<3:
M?<++&"$SSBMJVN$N(@RG/%.N(5GB*L,UBVLC6=YY39"YXH WZ*0$$9%+0 44
M44 %%%% !115*_O$MHL;AN;@#O0!DZKJ;M=+:P,=S'! K4L]/CA"OM&['-5]
M/TY1(;B5?F;D9K7H **** "BBB@ HHHH **** "LZ^LHKM&^4%L5HT@ % '/
M:==O:3?9YB0H. #71 Y&:SM1T\3QEHQ\XYS3[&Y#J$8X8<8- %ZL'6;<17$5
MTHP=XR:WJR=>_P"/5/\ >H TX7\R%']1FGU!9_\ 'G#_ +HJ>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5CV0Q<3_ %H CTC_ (_W^E;U86E$?VA(1_=K=H **** "BBB@ HHHH ****
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M:Z2LW6D!M-YZ1_-0!?C<.@(I]5-.E6:SC92#D5;H *R-9N$\K[.3R_RXK7K
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P"/B?ZT 1Z0,7\F?[M;M86E$G4'/M6[0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!4U$D6,A!P<5B^$6:6&Z=^6$Q )K>O
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M)'6O8M2UR2PTS3WCF;)E5>OM7SU$D^EW2N599%/'%>BQZB;W3+!9B21<*>:
M.ROH#=>.M!F=CF7+'FLCXM^++K3]?NM.C/[MHPN,5K7[R6?BWP[=3Y$"@\GI
M7!_&603^,YY4Y4JN,4 9OA/Q-/HZRI;MMDG('%>CP:OJFAZC9/YDA6:10=QS
MUKQ[PWIMQ=ZI#(B,51@3Q7T#%<Z?JTMG;2[6E1EP#ZT >K6,QN+.*5NK#)J+
M6%W:1= =3&<5-:1^5:1H/X1BG2J'MW5^A&#0!B>%2_V#8^?E'>N@K&TJ1$N9
M(4QC/2MF@!'.$8^@KCM(U62_\2S6[G/EC.*["3_5M]#7'>'M/,/B&XNMN&8$
M$T =G1110 4444 97B0;O#]X!_SS/\J^<--U.:X\)S:9#"K.[.H.T9Y-?1_B
M1BF@7;#J(S_*O*/A#HMI>6IN)8P9!(QY'O0!B>'M2OM'N=.TF5G7SEP03Z51
M\?>+=2\/ZW+;12NJX'&:Z#QK$=,^(>E7<Z[;=&;G'%<;\28CXD\5R262ETP#
M\HS0!>\0?$*]\G1S%.V3"F[![\5TFM^/+VVO(9(Y#MC56/Y5XP+"[O&:)48O
M VT<=,5V7A>RN_$-GJ@N%9V2U;;D=P* .MAUW4-<TJYU..1]RR<;33-:\6:D
ML.EV[.RF2=5-1?#R\ATS09K"\PK>9@AJ3QYY U/2#;@;?M2'B@#W?1XR-,MF
M).XQ@FK]4]*.=*MCZQBKE !1110 5QGBR!C>VTO.T2@UV=<[XN&;&/'7=Q0!
MMVK VD3>JBIZJ::,Z9;ANNP9JW0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !112'I0!B:[*S!(%/4]JT=.@%O9(@&.*QK;=>ZW(7YC3C\
M:Z0# Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,2!Q2T4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH AN1FW;Z5F>'1B"Y_ZZFM*[.VV<^U9
M?ALYM[D_]-C0!MTT##9[4ZB@ HHHH ***3(H 6BDSSBF2NJ1L[' 7DT .7.Y
MJ=5"RU:UOI6CAD#,O4 U?[T %%%(#F@  .36;K.EC5=.>V<!L],UIT4 >>6'
MP[BAN(WEB4A#D=*[^")8(5C48"C%/8D#BEH *H:JVVW7_>J_6;JN#&B_[5 %
MFR8M;+GK5FJ]FNV "K% !1110 4444 %%%% !1110 5QOB(?\5%8?]=5KLJX
MWQ%C_A([#U\Q: .RJIJ=HM_IMQ:L 1*A7%6Z0#% '%:5X&@L-/N;;REQ**;I
M/@*UL%N T*YD! Z5W%)CG- 'G\7P_3^T8I9(U,:'..*W9O"\#ZG#<K&O[L 5
MTE% '.:3X:BT[5[B]5 #(V<U8\3Z&FOZ4;1U##.0#6T2=P%(QP0!0!S^C^%[
M;3=)-IY2@,N"*QK3P)''JS7$D:F(]J[ND VT <!J7PWL;NY,BP)C.>@J%/AS
M&C18B7:C!NU>BD9&*/:@#F-5\+1W\-JH0%H.E96M_#Z#5;E9FB4GC).*[P#!
M-+0!Q.C> K/3%E_<J"W3BHM.\$O::V+PJ-@;(YKNB,C%+0 U3V]*5AE2/6EI
M#TH Y'1YB?$<\>>CFNOKA]"_Y&N[Y_C-=Q0 R9ML3'VJIIL2K#OXW$]:GO/^
M/5_I5?2?^/,#WH OT444 %%%% %>]MQ=6<D)&0XQ61X=T&/0K?RT0+DGI6_1
M0!S?B?PS'KL:_("Z]":S-,\#Q6Q+RQJ6(QGBNWHH XK3? EI:74\CPK^\8GH
M.]:.C^%+72S+LB4"0$' KHSQ2T >?:AX!\V\,MNBA2V35ZZ\%QW26F^-2T,@
M8_A79]12 8% #88Q%"D8& HQ3Z;D[L=J=0 4444 %8'BD9L4_P!ZM^L7Q)S9
MIGUH T--_P"0;;_[@JU5;3^+"#_<%6: "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *J:E+Y-B[YQBK1.*R-?D_T/R,\O0 NAP%86E(Y=LU
MKU6L$V6,*XZ+5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!",C%<AJ44*:ZD4BC]\?ES785S_B.RC817Q.'@SC!H RT,NA7_P"\SY3\
MC'2NKM+R*[B#HP.>V:SVM(M7TJ/> 2!G/>L0K<:),60MY0ZYH [2BJ.G:@E]
M""&!;'-70,#% "T444 5KZ98;5RQ R,<UG:'!AII^H?&#2^)(7GTX(F<ENU3
MZ% UOI,4;?>'7- &E1110 4444 %%%% !1110 4444 %%%% "$ @@]ZP;1/L
MFO3ACA93\M;]<SK4C0^(=-V\*Q;=0!TU%(AR@/M2T %%%% !1110 4444 %%
M%% #7^XWTK+L7Q--GUK4?[A^E9%BN9Y\>M #-* %^Y'0BMRL+2C_ ,3!_3%;
MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^@K0H **** "BBB@ HHHH **** &O]P_2LBP;;//M]>:UW^X?I6/9?Z^?ZT
M-TO_ (_G/?%;E86E9_M&3/7%;M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !6'"-GB9NP,-;9.!FN?UJ1K;4[6=>-Y"$T =
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MH **** "BBB@!DO^J?Z5R/A=''B35RQ.W*[:ZRYSY#8]*R]$M=C2SX_UAZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH .M9.N1*;=)",[&R*UJKWD(GMF0^E #--G\^R1R>:M8^;-
M8NC2B*::V8_=Q@5MGD4 )C)!S2XYS2#@ 4M !BDX%+28^;- "T@ '04M% !1
MC-%% "8%&*6B@ HHHH 0]0:"<#-!&1BD(!P/2@#.UFY\C37?N>*BT"(+:F3&
M"QS536Y/M=Y#8J>"?F K;LX%MX%C'84 6**** "BBB@ HHHH **** "BBB@
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M*U-5:P_X\8?]T59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKUW3DF?RLI_%TH ]93QK;,I8E !)LJY)XIMDU%+0,A9AD5X1J-H\'AY;E)Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6;IU^+A/+?[Z]:TZ "BBB@ HHHH **** "BBB@ I,;5XH;..*:0V[KQ0 JC
MR:PM6U LS6J'EN*O:G?"UA./O5FZ;IC33+=S<L3F@#6TR#R+15QSCFJNOC-L
MG^]6N!@8K(\0'%JGNU %^R_X\XO]T58JO8_\>47^Z*L4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS1R%1SVKJCTXK(T%HHHH **** "BBB@ HHHH *0Y! %(#N!Q3))/*A+,>@H
MS=?NC#:"-#\SM@U)HL/EV2DCFLI-VK:@,_=0UTT:"- J]!0 ZBBB@ HHHH *
M*** "BBB@ HHHH :_P!P_2LS3<^?<?6M-_N'Z5E:>VV>?//- $.E#;J$G^[6
M[6'I9'VYU]!6Y0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML[S';-D].* )-9OV,300'YB<9':GZ/I[HBRRL6/7FHM)TT^89Y@69^2&[5T
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MO\7I0!L*00.:6J5E+OLXWSGC%7: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L[7)3!I4L@ZBM'/.*Y[Q/=JD"6I/^N[4 /\,#_1'<]7
M;-;U9ND6Z0:?&!WYK2H **** "H)>>]3U7E ]:J),BC)G#.3QTQ63JZ8T*Z)
M/!'2MB883%8^M<:)<C/&.*UZ$HPO!^ZPTN:X0\-.017?VEPMU;@JP)[UR'@J
MU2Z\.W4;<YF-:-DC:-=;"S%'/.3FL7N:'3]!2U")!+$&4\5(N  *0#J*0C-(
M6PP% #J*3/-+GF@ I#R,49.[':@8R: &GY36#XGU#[-;(B-\SG&*OZCJ$=JA
M(8;_ $KCM7'VN>VO)'.T'IGB@#K-#LQ;P"3.6<9)K7JGIF/L:8]!5R@ HHHH
M **** "BBB@ HHHH **** &O]P_2LC3F_P!(N,C/-:\G^K;'I6/IKXGN..IH
M 9I8'VYSVQ6[6%I1_P")@_IBMV@ HHHH **** "BBB@ HHHH **** "BBB@
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M.IK'-O=DYW=>G%!M[L]6Z<=* -DSH!G-'G)C.:QC;W>,%AQUXH^SW>,;Q^5
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M $7V:#_GDG_?--^R6^[/DI_WS4]% $0MH5.5B0?1:DP!VI:* "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7,:VQ&MV?_ %T%=/7-:R!_;5IZ[Q0!TM%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M(#D<4 +1110 4444 %%%% !1110 4444 %%%% !6/XA/^BI[M6Q6-XA&ZUC_
M -Z@#2LO^/*'_<%3U!9<64(_V14] !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7+:T?^)]: ?WQ74URVM<Z_:?[XYH ZFBBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHJ.:9(4+,<8H >3@XIC3(IP6%85YX@=9DCMH?-!^
M\P_AJJ^G:A>R"03M&"<XH Z.6[2)&;KBLV;Q%#"2#&3CWJ6#3)!&%EE+<<YI
MPT6W/WU#4 .M-7BNP-J%<^IJZT\:C)852&EQH#Y6$],5EZAHE[,V^.[91GI0
M!TBL&&0<TM<U%?WE@@C>)G"\;JU+/58K@A68*Y[4 :-,3KQTIV>0/6D"X.:
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ML?Q#_P >J?[U;%9'B 9M$^M &A9?\>4/^X*GJ"R_X\H?]P5/0 4444 %%%%
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MPD\5V-5+^QBOH2D@H 33;U+ZT65/QJY7)6T[Z%J7V9QF%^5]JZF*59D#*>M
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M8]*Z#3M/2QMU0 9 ZURNBV_]I>()+I_NKRM=O0 4444 %%%% !1110 4444
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M#>6JN9!PO3FI-/U\3W3PR @J<4 =%GG%%4/[4M3<^5N._%7E8,,@T +1110
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M<*O:5=?:]/BD[E1F@"X#D9I:.E% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "$X&:YV,?VAKC-_RRC&,>]:NJW7V2Q>3TJCX?MF$;W#'
M_6-D4 ;8& !Z4M%% !1110 4449S0 44=** "BD9@JY8X J&.ZBF!,3A\'!Q
M0!/12*<C-+0 4444 %5KZ 7%HZ=\<59HZT <]H5SY4TUHX^=,9-=#7,75S%I
M_B&-=H!G/)^E=,C!D##H: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D)Q2T8S0 @.21Z4M)BESF@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *YC62O]NV@_BWBNGKEM:_Y#]GV^<<T =31110 4444 %%%% !1110
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M&I#MUK4HH Y*YT>YCO&N5?I[4V'5;J-V#_=6NN90XPPR*J2Z;;21LHC )[T
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M/Q)U'4X<P'RV6+<=P/- 'O8(/0@TM>7?"#Q;>^)TU(7AR8& ! KU&@ HHHH
MYOQ%IP>>"^S@PYK<LGWV<3?[-4?$8<Z/+LZT_093+IB9ZKP: -.BBB@ HHHH
M **** "BBB@ HHHH ***3.#DGB@!:*A>[MX_OSQK]6%4KK7;"U3<US$?^!BB
MP&E1G'6N+U'XE:18<,ZL?9JYC5?C'IJQGR!ST')_PIV ];W#U'YU%-<Q0)N=
MA@>]?/=W\8[AHSY)P1]:YR\^+&L743*) !]#3L*Y]*Q^)=.EO!:)(3*>U:R8
MQQWYKYR^$UUJ?B+Q2US.28T/)QQ7T8BE<>PI#'T444@"BBB@ HHHH **** "
MBBB@ HHHH **** "N6UO_D/6>>F\5U-<OK0SKUIGIO% '44444 %%%% !111
M0 4444 %%%!X&: $)PI/H*YU-U_K8R/DC&:UK^<P6,LOH*SO#BF5)+AA@DD4
M ;W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K.UFW,]@^T?,HR*T::Z
MAT93W&* ,K09S):^6W5!BM>N9L9FM=9:  A6)KIJ "BBB@ HHHH **** "BB
MB@ K'\08^RI_O<5L5C>(L_98\?WJ -&Q_P"/*'_=%3MGC%06/_'E#_NBISGC
M% '/Z_<):3I,W0"I$\5::47YVZ>E6M6TM=2A*GK7/_\ "&X4@$_G0!K_ /"5
MZ9C[[<>U'_"5Z9DC>W'M6-_PA9R.3COS1_PA9]3GOS0!L_\ "5Z9D#>W/M1_
MPE>F<?.W/M6-_P (6?4Y[<TO_"%]>3[<T ;'_"5Z9@_.W'M2_P#"4Z;_ 'V_
M*L7_ (0LY')QWYI?^$-;Y>3[\T ;/_"4Z;_?;\J3_A*],X^=N?:L?_A#3@\G
MKZT?\(7UY/MS0!L?\)7IG]]N/:C_ (2O3.?G;CVK&_X0LY')QWYH_P"$+/')
M]^: -G_A*],R!O;GVH_X2O3./G;GVK&_X0L^ISVYI?\ A"^O)]N: -C_ (2O
M3/[[<>U'_"5Z9S\[<>U8W_"%G(Y.._-'_"%GCD^_- &S_P )7IF0-[<^U'_"
M5Z9Q\[<^U8W_  A9]3GMS2_\(7UY/MS0!L_\)3IO]]ORH_X2G3?[[?E6/_PA
MIR.3TYYI/^$-;Y>3[\T ;'_"5Z;G&]ORH_X2O3./G;GVK'/@PG)R<]N:/^$+
MZ\GVYH V1XJTT_QM^5!\5::!G>WY5C#P80>IZ>M'_"&D@#)]^: -C_A*],_O
MM^5'_"5Z9Q\[<^U8W_"%GL3U]:7_ (0OKR?;F@#8_P"$KTS^^W7'2C_A*],Y
M^=N/:L?_ (0OU)_.D_X0L\<GWYH V?\ A*],_OM^5'_"5Z9Q\[<^U8W_  A9
M[$]?6E_X0OKR?;F@#8_X2O3/[[=<=*/^$KTWGYVX]JQ_^$+]2?SI5\&<<DY/
M7F@#H[+6;2^;;"Q)QGFKYSD8KC;&P;2=76$'JN:[%<]3Z4 .HHHH **;G&=Q
MJ-[J&,9>5%]B: )J3(]16%>^(H82412Q[$5E&\U2ZD\R$XC]"* .BN]:L[.0
M)*QR?2LC5]7E7:UG&&W>M1-H%Q?E);ALG.>*W(=)A5%#C.T<4 <C)X>FU0+=
M2?+)G.!77:7 ]K:*C]ABK<4:H-JC"BI2 1B@ )..*6CM10 4444 %%%% !11
M10 4444 %<[XW_Y%:ZSTXKHJYWQO_P BM=9Z<4 0>!#_ ,4_STW4W7[1[:5=
M3M?F=>HI? P)\.X]6XITD\L&IO:WG,$WW#CI0!7FQJ=G'J5M_KXQM=:U]'U/
MS;=4FXE]*Q;?=H=\\3#=:S_,,=LU9U"W985O;!@0O+ <T ;]W:K>6SQL!R.#
M7)Q/-X>NG$G,!/RFM[1-8COH?+;Y9%X(-6M4TR+4H-CCD=,4 /L+^*_MO-B.
M>QS5M<XYKC4CNO#LV#EK=CT KI[&_AO(0R,,]QGF@"Y1110!G:EID6HP%3P1
MWQ7*R6]]HEVGD+NC/7FNZ Q44]K'<+B09Q0!0TO7+;4!Y:,?-4?,#ZU?N9#'
M;LZ\D"N7F\/W&GS2W-DV,G)!J33M=W.;2\4AFXW'@4,#SZ\O[[5/$4EW'Q';
M/M;GTKU'1+]-5TM#U./FKS+69!H&I7"Q*98KHG&P9P3]*[WP+:R0:,LD@(\S
MH#4)D+<WFA2"$JH&,Y-36S!H@1TJ*_;RK">4_P *DUE>%]0-_;2'.0O2K+-\
M]*;OQC)'YU6U2_CTVPDN9#\J#)KQK5?B#J%SJ2M9$+;LW!(/- 'MY8 9R/SI
M%(;G(XKQC4_']\!'90G_ $H@,>#TJ33OB)/_ &5>P3,/M< &3S0![(77'4?G
M320H#,0*\+TGXCZBVHP?:>(7EV=#71^+/'CM?V]EIOWP"7ZF@#U3<,9R*:S@
M#@C/UKQ>7XFRPZ%+EA]H0^]/\*^)]=UNU:]S^Y'^R: /95D5APP_.J@U:U-_
M]B#_ +[TKR*]\4ZUIFJQ1RR*$E;:!@U1L;W6I/B*L[2KY R6_+ZT >[!@!\Q
M IVX>HKR'5_'=Y?7,L&E\F!"SD D<5'#\1)V\%W]PW%W;;<YSWH ]BW C@@_
MC36_U39]#7EWPRU_6?$IDNISB!<C!!ZUZ;.^RVD)["@#D8P?M]^2/^6#55^'
M6?MNJ>F5JY8@R17\[?\ /-A53X=_\?>I_5: .^HHHH **** "BBB@!K_ '#]
M*Q[+/GS_ %K8?[A^E9-A@3S[O7B@"+2A_P 3!^>U;N:PM*Q_:#XZ8K< QF@!
M:*** *&ML5T2\(ZB(XJ#PXH&C6[?Q,@)JQK">9I%TOK&:;HB>7I-NOH@H T*
M*** "C-%(!C- 'CWQZ8#2;4'N#21>#)-7\%Z5?;P?+LEPI^E;'Q=\-W?B"PM
MDM5!*9SFNL\+V,EOX0LK&=0&2V$9_*@#Q/X9VT>IR:TMVPW1< MVKSAGGLO&
M-Y/&"T<4S#(^M>Q)X3U/P]KFIK8(&BN3P<XI+;X7S-HU[<2 ?:Y6+ 8]: /+
M;;Q%(=8O-0!90P&/PHM9=1$<^J2!S$TN0<]<UTW_  J[5(_#^\(OG'=D?C7>
MV_@!Y/AW':LH%SM4GCN* . O+34M0&G2VMJZ@'+,.]0_#JT>]^)36]P?F65L
M@_6O2]+T_5;;3[:%[:,D' YK,\%>#-1T[X@RZK<1JL;2LW'O0![7&@CC5%&
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M91BM>&Q2)%4 <5;Q10 U5VC IU%% ";?FS2T44 %%%% !1110 4444 %%%%
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M.OV^H1,A)$B?>H W">F*6FJ0R@CD4ISCB@ (!&#TK$U305O 3$0C>M;8Z4M
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M2]<K0!W>XXZ=Z=110 4444 %%%% #7^X?I6/9?Z^?OS6P_W#]*Q[+'GSX]:
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M44 %%%% !1110 4444 8L/\ R'[C/MBMJL6)#_;T[^N*VJ "BBB@ HHS1G-
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M5E7'Q.TU)?+123[$_P"%><Z)\.M7ED"W#D#U)KL+7X3M&ZR/<(3^-%D@-/\
MX6%%+_JX7.?8_P"%/_X3*:5E"6TO/^R:T+'P5%:XW%#BNAATJUC0#REX]JEM
M!J9FF:Q)=$!HW'U!K?Y(!J-+6*,Y5 *FI7&%%%%( KEM:_Y#]ICKO%=37+ZR
M?^)_:#'\8H ZBBBB@ HHHH **** "DS\V*6B@ I"<4M(W:@##DE676HH6'<U
MN 8&*YMV/_"3VPQW-=+0 4444 %%%% !1110 A8*,DT%@!DD 5Q?Q \4'PQ8
MQRA68NRC ]S3/%OBEM&\+V^H!6.\ X'TH [8NH&2PQZYI001FO&O$?Q,DT[1
MM.E$3G[6 <CMS7J'AW43JND0WA4KO4<'Z4 :U%%% !1110 4444 9'B69H-#
MFD3[P(_G4NBRA],B;UIFO0^;H\Z>N*C\/-NTQ$[B@#9HI!P,4M !1110 444
M4 %%%% !6-XB)%HG^]6S6+XC_P"/1/\ >H T;#_CQA_W!5FJUA_QXP_[@JS0
M 4444 %%)D[L8IKOL5F/0#- #Z*XJZ\?V$-S) DH9D;:0/6NCT75$U:Q6X3H
MU &E13)9HX$WR,%4=S2QR)*@=#E3T- #J*** "BDR=V,4M !13)I!%"TAZ*"
M37-:)XQL=9NY(()@S(V"* .HHHHH **** "BBD!Y(H 6BBF!B788X% #Z*3/
MS8H!Y(H "<4M5-0NOLEJTN,[1FL[0=:&LP-* 1M)'- &Y12#I0201Q0 M%5Y
M+R%"Z[QO49Q7.6?BU;G5#9A3D-B@#JZ0G!'O1DYZ4#D9- &'JNE275XDR'Y0
M,&H[CPQ;7,Z3RABR^];Q/'3O3AR* *MM8PVT>$7\ZLJJXX%.HH ;PWX4H/./
M2EHH 3/S8I:** "BBB@ HHHH **** "BBCI0 444A.!0 M% Z4PRH'V9Y]*
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MT 5--TJUTNU%I;+B,=C5KRU4A0!@]:49SG'M2DGGCI0 >6A&,=*20*0 1FG
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M$;MU7-(^)\-YJ:VTAQYG*<]17!7VFVZ_#RUN-J^8SOG_ +ZK.U.*.T\5Z$L
M W6T9./K0!]/QL'C5AT8 TZJUNV+:V'K&O\ *K- !110>!0!%<2"*!F/85B^
M'0?,NFQ\K2$U;UZ4IH\K@X-1>&U_XEVX]6.: -FBBB@ HHHH **** "BBB@
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MY4;JV-"^(%MJ.E7<I;$T )(S7BEU9I!XSL8(\!6BYQ6IIJ_9]4\16\?"B-<
M?04 >H6?Q'MKC1Y+S<,)-Y9Y[TS6OB-%8:?9SJ<F<GO7E.DO"G@>X0NHD^W'
M(SS6Q>Q136WA^.0 J7.: .WTSQ_;ZU:W4,[;65&/7MBJ?ASQKI>EZ'-()LR$
MM@9'K7/7-K;VNM7<4  !MF/'XUXU:7%T=3\KYC#YK9].M 'U+H7C*;5+9Y57
M@ D<UFS_ !$:RG6*Y 5F; YI;V]T[P]X!L;J,IN>(;MO7.*\MFU!-<U/3[A%
M(1I#G(Q0!T!^(%])XPFB*?N3&2#N[59T;Q9I,?B"622?$H8'&16?';VP\=/$
MR@#[(3DCZUYCKNZV\8SK$>-_:@#Z+'Q ;[025_<F3:#FG>)?B3;:1<6R(P(E
MQWJC+8V/_" V,P,?G,BD\C.<5Y5K_P"_UC2$EY'FX.: />/"WC2WUV[:U#?O
M-N[&>U=D@PO->$^&\6/Q(CAAX5K<'CZU[NGW%^E "T444 %%%% !1110 444
M4 %%%% !1110 4A&1BEI"<#- #2<844,W8=:5!WJGJ.H6^GP-++(JX]30 S4
M]7MM(LS/=/M7H.:\WF\97T^JM=6L>ZR!^]FF7"7WC#57BB#_ &=3WX!KN=+\
M-6UKHZVCQKN YH GT+Q%::M;@(_[P#YAFM==V\C^'M7F&K^&]1TFY:YL\B/=
MG"FNH\+^)H;R 6T[[)DX._B@#JN$'UIU,+*5!!!!]*4YR* *NH627]G)#(!\
MPP.*\S=;OP;K09P?L<AX:O5U!&<UD>(M'76-->':#(!\M %K3=0BU*RCGA(8
M$<U0U?1_/S-#_K/0"N(\-ZA/X:U:2SOBRQDX4GI7I4-PEU$DT3AE]C0!S&F:
MCB9].U!=K'A<UU5I"MO;K&ARHZ&LK5M&^U2I/" '4Y)K3LD=+95?[PH LT44
M4 0W0!M9 >ZUYC>Z;'#?33HY\XGY1ZUZDX!4ANE8.L:*+Z _9\"3M0!R.G:_
M?Z5.()T_=L<YS78VFIV&MQ/"C#S!][VKFKS3WMIUCFC9B(\9QGFLRVMYK9KJ
M6)MA.,<XH Z.[\/S:>KR6)+[CN:FZ?KT]L?(N5VX]ZJZ'XG^SQM!>;MQ;J1V
MKH);:SU2S+6[1F1O0B@#1L-3M[^,F)\[>#5VN$GTJ^T?3Y&CSEI,_*:MZ9X@
M:TT__2E?</4&@#L*:1N#*>A%4K#4X+R 2"103V)YJ]D$9!XH Y_C2M3&3^[D
MX_&MW./F'0UGZM +BV)49=.15?1+TR(8)3AU]: -GG'3O3AG)S463NV?C4B
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M2S3]F<D4 ='D4M-V#CVIU !1110 4444 %%%% !1110 4444 %%%% !1110
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M:9$/45SWB=6NM7LHD)VJ3NKJK./RK2-?04 3T444 &:3'S9I#MW#)%+D9Q0
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M>+8YXOLU_F&1#@;^]=HCK,JR1ME3T-</XA\&G'VJQ)\T<[0*K^'_ !:;"?\
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MP 21SBM<\#BEHH 3'S9I:** $Q\V:6BB@ HHHH ***3(!Q0 V7_5GVK'L?\
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M-1110 4444 %%%% !1110 44@.12T %%%% !1110 4444 %%%% !1VHI"<4
M07,?G6YCQ]ZN?T-C9ZA-:/QEBPKIB<$>E<_K"BSU&.\ PI 6@#H>HI:BB??
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MM[>23SXV*+N(# FN'OM!?2;)KJYO@BD9Y)KSS3-1N-0\27ULLY>(6S'.>.M
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MIXZ5CZ-JL-Q;HF\%^_-:Y< 9H =112 Y_"@!:*0'(S1N&* %HI,Y.*6@ HI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK-]* -+3]1M]1@66"0.".U6Z\ASJ?A&\9!O2V)X]*[?P]XKM=358O-!E[Y-
M'07%I#=+MF0,/>O/?%OPPMM;+2P^7&?2O2 0>AI: /CWQC\/+_P_(66(O'GJ
M*XM4>+<6.UU[5]R:KHMKJ\/E7,:LON*\>\5?"%)M0#V%H-A/.U: +'PPOI[K
MX7ZHLH8A0P!/TK<^%:_\2:[.>I%:.D>'QX<^'E_:>7L8QEB,8JA\*QG1KH'U
M% '<'!P:% W$D]*0 ;MG?K05_>;10 JY8$=JK7=];:9"\L\H7C@5#JVL6VEV
MC,[J&^M<%+%?^++Y/+#O:@\^E $M]J5WXIU%;>U5Q&#RW:NU\.>%8M*1GFVR
M2-CGTJYH.@6^D1 QQA7(P>*VZ &Y"G'04#&2V:5E##FC:-N* %HHHH ****
M"BBB@ HHHH **** "BBB@ I">U+2$#.: (W&(7YSQ63IXQ+-]:UGQY+X]*Q]
M-.9IQZ&@!FD<:C)G^[6^#G-8.E'.IR'_ &>E;] !1110 4444 %5[N!9X&4C
M/%6*:3@X/2@#@)(9;*_(0%1FNJTS4(KJ((S ,O!SZT:EIPES(H&:YAA/;SL%
M!!!Z4 =T3D\=!2Y _&L*VUO8BK.I3W-;,4\5S"'C8$>M #LD X[TH(V=*5N
M,#- /R]* $WCTIV[D#UI<"D/WNE ";@&VTA8<C%*HY+'O52[U*UM<AI ']*
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M(S\IJ="#FO+M*U:[\+W_ -BO$<PEL!^U>CV>H6U[")+>0.#Z4 %]IUO?)B9
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MZ1A<*.* ,;6=:U%-15;5G\O/.*G_ +)FOY([B526(SS71QZ;"?F=035H1!0
MO0=* *45BD"H44!JO E<9].:=MY/-+@$<T - .0?7K3VSCBFX/'-&#@\]Z
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M]Z?0 @SCGK2+G'-*0<BF<YQGO0 X9R<TO.[VI:0G%  <[AZ4M(0=P-&?FQ0
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MB@ HHHH **** "BBB@ HHHH **** "BD4$9S2T %%%% !1110 4444 %%%%
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M^$FUO_GD?^^:[S[+%Q\HX]J/LD6,;1USTH X+_A)=<!)\H_]\TO_  DNN?\
M/(_]\UWGV:(DC:/?BC[+'G[HZ8Z4 <*GB/67<;HS[?+6A;:]J3/MD3C_ ':Z
M@VL6Y?E''3BD:TAZE1^5 '):II,^KL)3)(I/]UB*U]/T*.*U5)<N0/XCFMN.
M)47&*?P&_"@"JL A@V(H&/059C&$%.!R,TFX8H 4#DGUI:3<.?:E[4 %%%%
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MTN,D&CC[M'"X%  <=Z:W8=J<1FCALB@  YS2TF1G%+0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1THI",C% "T444 1S<PM]*RM-XEFQSS6I
M+A86]Q67IN?-FV^O- $>ED'4'QZ5MY !^M86DKC49#_LUNCG.10 ZBBB@ I
M<YI:* $S\V*6BB@ HHHH ,<TF.<TM% "8S2T44 )@4M%% !1110 4F.<TM%
M!1110 A.!FFE\8]Z?VI.,4 ,9@I48ZTYI$4X9@#[FLW5-9M=+MFDN'52!D9K
MPCQ)\5]3;6B+1LP(V 0.U 'T2"-QI-P\S;[5Q_@_QC!XBLTW2J9<#(%=B, 4
M +GDCTIN^/IN&?K7.>+/%%OX>MP7D578<9KQI/BCKBZNQY^SM)@';VS0!]$!
MP0?:@C< 16;H>I+JVDP7:D$LN3BM$YR#[4 .&,X]*,@''K28W)@]Z:Z9C ':
M@"0D8H!&VHAG;]*>,E@?:@!RD8H)Q05R1[4@.20:  D=/6ER,XIAX8_I7,>)
M_%</AYMLD@5F3<,T =3YB;MNX;O3-)N _.OG>X^*VK_\)"95/^C;NNWC%>W>
M%==77])6[# Y.#B@#<XZ^M'%0RLV1MIP!( /?F@!X&"3VI0<TT@X"U&Y9) %
MZ8H E.,X]:=3"QY]J<.1F@!:*** $/ )HSQFEHH 0<\TA&6SVIU% !28YI:*
M #I28%+10 F!2T44 %%%% !1110 4444 %%%% !1110 4F?FQ2T4 (3@@>M!
M.*:[8Z55O;X6ZJ 1N/:@!U]?16D)9F'TK NY9M1"I &&><XQ2K;3:GJ#&;=Y
M?;TKHX+:.&-551P,9Q0!DV>C!K79=J&/;/-:%GIT%D#Y2!<^U7** &>6OIUI
MVT4M% $4T$<\91QE36<NA6L 9H8PK'OBM:B@#E);:\TRX:Y<EH_0<UI:=K,5
MW+Y9^5L?Q#%:SQK(,.H(]Q6%J.E!)!/ "K#^[0!O9'&.: 0PK)TR^<YCFX(Z
M9K7X(X[T )O&[%.J-!M8BI* "BBB@ HHHH **** "BBB@ HHHH **** $([T
MBX(IU% #,!LC%+Y:^E.HH ;L7TZ4@56[=*?10!%((XT9WP !DDUY;XX^)-K:
M0/I]HQ>X<[0(QG^5=GX\O7T_P??7,9(95X(KPCX7:,_B7Q7)?7@,L<;$C?R,
MYH ET?QGJ6@:G#+J(F\N9N 5-?0FCWD6IZ?'<H.& /(K!U[P'IFMO"7A1?*.
M1M&*Z73K%-.M$MX_NJ * )F*JC,?X1FO$?B#XXEN=0;2]-9VF _@!KV'7KB2
MUT2ZFB'SB,X_*OG?X:74.I?$NZ.IA6VJQ7?ZYH ZKP#XPO+?5;?2]06;S)N!
MN4U[4(T 5@.M83>%M/?58=02%%9"2"HQ5C7]>M]$M!)*X7'K0!KX3G&#ZXI3
M&N,XKQ33/BI=#6KE9W MB_R$@=*[[4_&UK9:7#=B9<2' - '6A5P#BF95E#8
M[UYPOQ( G3S)%$;' /%=XFI1MH[7P(V*F[- %L@'G' I#L)R.:\_N?B99)!.
M$G3S%' XJCX/^)<>I3K:W$J[F; Z4 >H@+P,5YK\5/[36Q3^SQ(3O_@!KTQ&
M#H&'>F2P0S\2Q(_^\,T ?*%UXKUFRECMI7E$AXP<UTWA/4]?77+9[A9S"[@=
M#BJWQ%ABB\>V2I$@4R] .*]\TVRL8-'BF%M"-D8;.P>E &K" \*N1SBG84@<
M=ZXBY^(5A;F:/ST#IG R*J^'/'O]IV=Q/*Z[(E+9^E '?[E)(QT]J7(]/TKS
M=OB7'(V8)$90>>!7:Z#K4&LVBRQ.K$CG% &KA>..M(-N!BN>\4>)X/#]N3+(
MJ.P.S-<5X9^)CW5TMO>NJEFPN0!0!6BUJX_X6NMAO;RRS<=J]>^7@8ZBO#89
M#)\7(GQRS$K],UZCK_BBVT7R8C(HF9@N#0!TFU<4@4$9Q45E+Y]G%-_?4-5B
M@!A4 9Q1QD\4^B@!F 2!CK2JBJN .*=10 F.,4M%% "8YS2T44 %%%% !111
M0 4444 %%%% !1110 4444 %(3@9I:* $!XS0#D9I:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 0'-&>2*6B@!,_-B@G!%+10 4444 %%%%
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M79W&_<Y!!KK<[0,T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "FG.>/2G4TL-I)XQ0!#,_E1%V_&L.T@DU"Z>64$HK8&:
MGN9VO;G[/&<@=:U[: 00A /K0 ^.-8T"J.!3Z** "BBB@ HHHH **** "D(R
M.:6B@#)U&S./-A7YNIQ46D:D97,,K?..QK:8;E(]:YN^M'LKY+I =F<'% '1
M?Q\_A3ZJP7"W,2.A'O5GMUH 6BD7IS2T %%%% !1110 4444 %%%% !1110
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M>RT3R[41B:$J..O6NXTMW;X2W3,3N%JW\J\+U_1-?CM3>W3.8G8$Y/O7N.C
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MW<UKTV-!&@51P*=0 4444 %%%% !1110 4444 %%%% !45Q&LL+*P!R*EHH
MYJRE:RU,V[$[']:Z)5'7/45DZU;*L8N@/F0]:NV%P)K0/G.!0!;'  I::I#@
M,*=0 444=J "BD!R,T YH 6BBB@ HHHH **** "BBB@ HHHH *08-+2 8H I
MZM:I?Z9<6[J&5T(P?I7S;817?@7QO<7489(2I/MUKZ:) ;'KUKG]?\):?K<3
MK/$C,RXZ4 >.:_\ $G4M>L)+:U<Y+ 908/6O5?A]#,?#8^V@NY.?GYJEH/PS
MTG379OLR YR/EKN(+=+6,1( $QCB@#+\0HL6@W,MO$GFJGRX7FO'?#_Q'O\
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M((XI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** (I /):LFP&)9OK6LP!B;%9-C_KIO7/- $>E?\ (2D/^STK=&#G
MCO6'I0/]I2-_LUNMP.* %HHHH **** $)P,T \9I:* $4Y&:6D.1C%+0 444
M4 %%%% !1110 4444 %%%% !1110 4P<-BGT4 4=3TNUU2U:&YB#J1@9KR&Z
M^#<#^)TN(V983SM'2O:R,C%&T<' R.] ',^'_"&GZ"S/! %<CDUTAP!NQR:?
M10!S'B#PC8Z^&DFA!E(X;TKSO0?A%%;Z[-+=,TL6XD*W2O:@,$FC8H.0 ":
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M' 5A:9N6<YS5;5F-U>1VA/!K:MHA#;I&!]T8H D)P0/6EHHH **** "BBB@
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M*%!]*Y#6-+?2Y#?VQ8'/*@\?E6QH^IM?:8LC']X.HH U9Y0%('6JAD. :,$
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M*6BB@ HHHH **** "BBB@ HHHH **** #-%)@$Y]*6@ HHHH **** "BBB@
MS128!.?2EH **** "L3Q,SQ:2S(3NS6RQ[#J:H:Q&);((>I- $'AAVDT*!G^
M\>M;%4M*@^SZ?'&>U7: "BBB@ HHHH ***Q]:\0VVB&,3C.\X'.* -BC/.*Q
M-.\2VNH^?Y?'DC)YK./CK3_M+Q!<L@YPU '69YHKDX_'5A+)M5,D'^]726=T
MMY )5& : +%%%% !1110 5#=)YMK(G]Y<5-10!RV@#[%J,ULW&_I74YQ7,?\
MS:F??%=,0#0 O2BD(R,4M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %(!@4M% !1110 F.0:6BB@
MHHHH ****  G%%(1D<TM !0#FBD P.* %)Q12$9'-&?FQ0 M%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 444@.1F@!:*** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "C/-%)@9S0 N<4@&":",TM !2$<Y]*6D)YQZT
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M.<TM !13<G=CM3J $8X&:,=Z6FY.[':@!U%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4=**122.: %HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** $8X%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6? C69%T^Y@N)68*"_S&IO#A?4?C9?7<<C-"A]>.] 'M]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)[TM(2=P% #6.Z-LBLBQ.)Y\<<U
MK39\IL>E96G &6;=Q@T 1:43_:4@/7;6Z,\YK#TI?^)C)SSBMQ>_- "T444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[2CJ\2A;B 9W8["O.]$\1WNN?#?5=+D8LL(4+S5[7OB9=^(=+_L..$"1A\S
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MRHW#'K7SYX)TG4+/X@6MO*':&)CU% 'T0]DNG_#V6W48"6N*\_\ @M][7O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2! @ '6@!Z @<TZF$D$9Z4^@ HHHH **** "BBB@ HHI"<#- "T444 %%%%
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M-B@G!'O0.GO0.1S0 ,<#-!.!F@9.<T<Y/I0  \9H4Y&:.=V.U!R",4  .<T
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M",D8-!Y'% "T4AY&*!TQ0 '.1B@YQQ0.!@T 8SDT !Z>] Z>]&.2<T8^;.:
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M,T#@<F@!:0].*,8).:,?-G-  .GO0N<<T8Y!S0>>E  ,Y.:.=WM0>1@4=L4
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M-!&2,&@!:*0\CB@\C% "T4@Z8H' P: %HI ,9R:,<DYH 6BDQ\V<T$9(P:
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MVH .I((H[XQQ0<XXH[>] !T(&*#QT% Z>]"YQS0 '@9 H[9QS0,Y.:.=WM0
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M(HYW>U!SD8Z4  YZBCJ2"*#GM0<XXH .^,<4=" !1SCWH&<<T !XZ"@\#(%
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MH&><T'G&#0>1P: #G=[4<[O:CJ,9YHZ#&>:  YXQ0<XXH' Y- XSDT !Z>]
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M@ &<<T#/>CJ00:#ST-  ,Y.>E'.[VH/(P#1VQGF@ .<C'2@Y[4#@8)H''4T
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M  SDYHYW>U!Y& :/;/- !SD8Z4'/:@<#!- ^4<F@ .<<4=O>CH22:,<YSQ0
M#..>M"YQS1U((-!^;H:  9R<T<[O:@\C -';&>: #G(]*#GC%'08S0/EZF@
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M.!\M-R QXHR-P..: %X48HX7)I"0<<=Z4D$'(H , '=1@$[J"1R/:@$<#VH
M.&P:.&&* 0 ,"D! SQWH =P<K1P/EI,@$G%)D;@<<T +PN!1PN32$@X.*4D$
M'(H 7 !+4F 3NH)&"* 1P/:@ P&P:.&&*0$ #CK0"!GCO0 [@Y6C@?+29 ).
M*3(W XYH 7A<"CA<FD)!P<4I((.10 N "6I, G=02,$4 C@>U !@-@T<,,4@
M( ''6@$#/'>@!W!RM''W:3(!)Q1D;LX[4 '"X%'"_B:0D'!Q02".1WH =@ E
MJ,#.ZD)&"* 1T]J # ;!H.&_"D!  XZT9 SQWH =P<K1Q]VDR 2<49&[..U
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M2$C!!'2C(QC':@ X;!HX;\#0",  =:0$#MWH <<-D4<?=]J3(!)Q1D9SCM0
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MP,+2<*,49!(.*0D'''>@!<!<FC !W4A((/'2E)'(]J %P"0U)PV#0", 4 @
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M&P:,@<>U(" !QUH 4X;\*7@Y6FY SQWI<@$G% "\?=I.%P*,C=G':D)!P<4
M+POXFEP 2U-)!'([TI(P10 N!G=28#8- (Z>U(" !QUH 4X;\*7@Y6FY SQW
MI<@$G% "\?=H&%P*3(W9QVHR"0<4 '"_C1P,MZTA((Y'>E)&"".E "X&=U)P
MV#0".GM2\+@4 (<,/I0<-E:.%'UHR 2<4 +Q]V@87 I,C=G':C()!Q0 <+^-
M' RWK2$@CD=Z4D8((Z4 +@9W4G#8-&1T]J 0 !CK0 '##Z4'#96D! '3O2Y
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M*:]I$&Q@X%%% #Q90Y"X.,9I!9Q +P>3S110 &TB )P>#BE^QQ9;@\=***
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-SFM'2D50X%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0Q!WD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I*6BDT 4444P"BBB@ HHHH **** "DI:*0!1113 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0G%
M(&YH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 E+1120!1113 **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHIN[F@!U%(.:6@ HHHH **** "BBB@ HHHH **** "BB@
MT %%-W<TZ@ HHHH **** "BBB@ J*24**61\+61>WFP'FE<N,;EN2\5>]4Y=
M14=ZYR\U;!/S5CS:SC/S5G*1JHW1T]WJN <-7-7NJ.S'#5DW.K;L_-65/JR@
M\FL+W9I&!L27KL>M59;CU-8S:N@[U"^J+)P#57-XHU6N0.]0M>H!C/-4HP\_
M3O4\>A7,[@C.*DOGL,:X=S\II DK],UT-GX6F*C*FMJT\+NI&Y#2<3.56QQ*
M6-R_8T_^R;H]%->GV_AY5 RE:$>AQ#K&*:ILPE5/)XM!N7/*G\JN)X7E<<H?
MRKUB+2(5_@%7$T^ #[@K6-(B54\TTKPOY3@E/TKO=*T];=1QBM1;2)>BBI50
M+T%6H6,G.X!<4M+15V("BBBF 4444 %%%% !1110 4444 %%%% !24QGQ2!\
MF@"6BD'2EH ****+ %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6QCTJ2HXZDI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 138V&N9U<?(W%=0Z;A67>V'G*1BI:*3/,+]-[MQ6:(@AY%>@S>']
MS$[:S;GP_C^&D:QD<>S =JK27BKQ733Z(0#\M94^A-NSM/Y4KFZGH9 O.:>;
MW-7!HCYQM/Y4KZ*R#.TUG(:J(H?;<=Z='=Y8<TD^G,O\)J 0,AZ&LI&ZJ*QO
M07*E*G$ZU@K*4%+]L/K4&ET;C2!^E1D5D"_V]ZE74 >])7N2VC096QD&J,YD
MY&XTO]H#&,U#+<*1G-7%,QE)%[2'D6898]:]-T%RRKDUY?I,JM*.>]>G^'L;
M5YKH@CDJ'3CI2TG:BM;F M%%%, HHHH 1NE0L2:GINT4 ,0<U+2 8I: "BBB
M@ HHHH @D3/-0KD-BKA&:;Y8S0 J?=I2,TO2B@"%EP:>G2G8!HQB@!:BFSCB
MI:0J#0!7A)S5FFA *=0 4444 %%%% !1110 4444 %%%% #6Z5&N<U-28% "
MTAZ4M% $18YJ0=*-HI: "BBB@ HHHH *0KFEHH B/!IZGBEP*,8H 6BBB@ H
MHHH *0C-+10 T+BG=J** (G)IJCFIMHHVB@ '2H92:F) J"1UIH!@&:D4D4Q
M6%3H :+@*3Q439-38I-HH :E24@&*6D 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4TKFG44 0F 'M4$EFK=JNT4FAW,IM)C?
ML*B;0HF["MJBCE0^9F V@1#G JK/HB8^Z*Z@C--,0-2X#4SS^[T$<X6LJ?02
M 2$KT]K2-NHJ-M-A8?=%0Z5RU5L>-7.DRJQPAK,N-/F0?=->V3Z) P^Z/RK(
MN?#\39PGZ5'LS6-4\5GAG7/RFJC/<*?NFO6KOPPISA/TK-D\*9_Y9_I2Y!NH
M>;^=.!R#44EY,!WKOI_"SCHGZ5EW'AB7'"'\J=C/FN9&BW<OG#KUKV'PK,[H
MN:\\TCP[-%-ED/7TKU'P]9F!5R*VB1*1TR]*=2 <4M58R"BBBF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124FP%HHH
MI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!#,<"J+[B:T9%W"JQBQ0! F0:OQ=*@6')JRBX% #J***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2DV M%%%- %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%, I*6BDP$I:2EH0!1110@"BBBF 4444 %%%% !1110 4444@"BBBF 4444
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MBB@ HHHH ****$ 4444@"BBBF 4444 %%%%) %%%%# ****8!1110 4444D
M4444, HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@)2
MT44K %%%%, HHHH ****0!1110 4444P"DI:*3 2EHHH2 ****8!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@%%%% !1110 4444
M %%%% !1124FP%IC-@T[BD*YIH !S2T 8I:FP!24M%.VH!1113 **** "BBB
MDP$)P*8&R:>1FDVX-,!U%%% !28I:* "BBB@ HHI&Z4 +140)S4M !1112 *
M2EHH: ****-0"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4E+12L 4444P$HI:*5@"BBBC4 HHHI@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+1122 **
M**8!1110 4444 %%%% !1110 4AYI:*3 8$P:?113 **** "BBB@ HHHH **
M** "BBBEU ****8"4M%%) %%%%, HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %)2T4K %%%%,!****D I:2EIH
M HHHI@%%%% !1110 4444 %%%% !1124F M%%%.P!1112L 44E+0@"BBBF 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYZ\US:Z4[W(;:>M 'I>EZRUQ$OS=:M7TT@BW9/2LCP[IY&T$5UM_IF;0<=J
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M4=0NA;QDFKI.!6#KI+0$#TH YK5=>!+ -7.O?-.W#&H]1A;S&Z]:CLH,L,T
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M1110 4444 %%%% !1110 4444 %%%% !1110 44F:6@ HHHH **** "BBB@
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MI-V:A\LT\# H D$H!Q3]XJL4.<U(HH >3GI0#CK2?=H^]0 _>*-PJ,C%.44
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MHI,U&Q/:@!Q7- 49H&<4W<=U $M%(.E+0!&\8:H_LPSFK%% #%3 IQ7-+10
MT+BG444 %%%% #2N: N*=10 4A&:6B@!H7!IU%% !3-G-/HH 3;Q2!<4ZB@
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M11S7'>9*+C'-='I[L5&: -(Q"H'CYJV?NU7?K0 Z(8JTO2H8L8J84 +1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT 6:*** "BBB@ HHHH **** "BBB@!#TIF[FI*;MYH <**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "F.FX4^B@#GM2M=V>*YQ]/)N,X[UW<T >JO]GINSB@#/TZT\M0<
M5NQ<*!44< 3@59"X% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR!FG+@4 2+FGT@-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 (149!S4M1L10 JXI]0 \U(K9H ?1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,;-59.M6V-5G&35(
M!J9S5Q>E0QC%39P*& US55SDU._-5FX-"'8L18Q4PJ"'D5.*3 6BBBD(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 ****
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M2CY: *[R;JE@JFYP:LVS4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BF,<4S?0!-2$9J(.:E'2@"%QMYIBMDU)-TJD7*F
M@"Z&Q4H.:J1,6JTO2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%-8X%0/+B@"S4;+4:2$TXOQ3 ;CFI%7%5C)@U+%)NI 6****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C
M"H&.#4DKD56+;C5("R@S3STJ)&XI)I=JYH 5CBH'^8U4:Z)--$YS3L%S6@&%
MJ:JEO)E:M#I4M +1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BDI:0!1113 ***2BX"T444 %%%% !1110 444E)@%+244D
M M%%%, HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2'I2T4 4[B'S%Q6>NFKOSBMLJ#2;!0!F?8%QTJ)K$ \"MG:*38M &,
M;3 Z5 UH2<8K?\M?2D\E?2@#GA9%>U7(("O45J^2OI33$!T% %;! IA7FK9
M J$KEJ %A!S5L=*BC3%34 -*YJ(KS4])@4 "]*#2TQ@: *\H]*2-:D(]:55Y
MH E08%,EZ5(O2D89% &>PYYJ:'VI)HB>E/MXR.M %A:=110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 UL5$PYXJ1P:15]: !5J2
MBB@!CC-59(^:NU&Z9H @B7%65Z4U%Q4E !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% $4N<54.<\U=?I59U]* %C%/8';2PKQ4I Q3
M S6#;JL0=:<Z GBEB0@T6 LCI11VHI %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%(3B@"*4"J^/FXJ67)Z4D:4 2(ORU!<J2M6
MU&!395R*: PC&V[I4D<9SS5UD53S30!GBFP)H%P*MKTJ.$#%2U(!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444AZ4 &1FEJ+!W
M5(.E "T444D 4E+24, I:0&EH0!1113 ***2DV M%%%,!*6DI:D HHHJ@"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BDR*,CUH 6BDR*,B@!:*3(HR* %HI,BC(H C9::!S4W44W;S0 X=*6@=**
M "BBB@ IK'%.IK#- $3'-2)49&*D3I0 ^BBB@!, T  4M% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UCBA3FAAFA5Q0 Z
MBBB@ HHHH 86P:<#FHGZT].E #Z*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 8]0]ZF?I48&33 D2G'I2*,4ZD!$5P<TJD4Y^E1 X-.
MP$]%,4T^D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4QZ?44IP* (BV#4L9!%56;)J:)L4 6:8YP*<#FF2]* *<S9J%&P:6=MIJ.
M+#&F!IP'*U-4, PM34@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ I#2T4F T"G444P"BBB@ HHHH *2EHI,
M HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %1.V*EJ"2@"O-<;1UJO'>[GQFF7JML)%9,!?S: .C\_CK1Y_O5
M)-V.:9(6% &A]H]Z:UR,=:S&F('6H#,V>M &PMUSUJ03YZ&L,2,3Q5^VW8YH
M U$?(YH\SFJVXBF^90!?# TZJD18FK8Z4 %)D4O:H23NH FIC-03\M1,WK0
M$Y-2ITJ$$&IDZ4 /HHHH *C=L&GDXJK,^#0!85LT^J27 '>K"S*: ):*0-FE
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HI-PI: "BBB@ HHIK=* $=J$.:A
M+>M21G- $M%%% !1110 UEJ/.#4IZ5 S#- $X/%+4"M4P;- "T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% #'Z5$"<U(["F+B@"133Z08I:
M(Y#@56#_ #59EZ53)^;BF!;CJ6JT+58!S2 6BBB@ HHHH ***3<,T +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !4,W2IJ@F/% %)R0>*M6XR*KD FK<
M&* )@,5%.<+4U5KHX2@#(O)L9YJ&WN/F'-5=0E.3BH+.;YAFG<#KK5MR59JC
M8.#&*O4@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH 2EHHI( HHHI@%%%% !1110 4444 %%%% !24M%)@%)2T46 ****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1
M,N34M% %2X@WQXQ5"*Q*R9Q6U28'I0!4\CCI44EL2*T<4F!0!@R6;%J;]A8U
MO%!Z4!!Z4 8T5D5/(JXD.*NE!Z4!<4 4G&*C53NJU(F335CYH EB'%3U&BXJ
M2@ /2H#]ZIZC*<T *?NU P+=*L$<5'C% #$C(J=1BD4YI] !1110 QAQ5"XR
M*TJK30;Z ,H[LYS4D4Q#8S5DVW:H_LNTYH NQ/D"K%4H.#BKHZ4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !2'I2T4 1;3FI!TI:* "BBB@ IK]*=2,,T 57&3Q4D(
M(H9<4^.@"2BBB@ HHHH 0]*J.IW5<J,IDT 1+TJ5 : F*DH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "D;I2TA.* (6!I *>3GBG*N* %44ZBB
M@!D@R*ILN#5UNE5W&:8#8AFK2C%10KBIZ0!1110 4444 (>E1[3NJ6B@!!TI
M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH :W2JTE6'.!51VR: $5"QJU$N!
M4,1P:LJ<T .JM=H60XJS367(H Y*^MVR:I0Q,''UKI[VVW#I68+?8W2@#5TT
M$1C-:0JC9C"U>'2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HI,BEH ***3- "T444 %%(2!0"#0!$_6D7K4K+Q4>#NH E'2EI!T
MI: "BBB@!&/%1]34A&:8PQTI@.48IU1IFI*0!1110 4444 -*TUTXJ2FMTH
MA1<-4XZ5 3@U(C9H DHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M:QP*=2&@"+[QJ11BF-[4Y,T /HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "D(S2TC=* (R,4J-FF,>:='0!+1110 A&
M:C9<5+3'Z4 -0U+5?.#4R'- #J*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH CE^[5(YS5]QD5 8^: &PKFK0&*CC7%2T %%%% %>=<B
MLYX_FK6D&:H3+\W% $]JORU:%06P^6K% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4E%%)@%+111L 44E+3 **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *0]*6FO]V@"!Y=AYI%NU)QFJ5Y)@&LR.=A)UH
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M4#G!H EW"E#9JIYE21ODT 6**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "FN<"G5$[9&* (BP)J5*@"_-FIXZ ):*** "F.,T^B@"L?EJ1&&*9*N:
M@\S8<4 7=PIU5XSNYJ<=* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *:6 IU0R XS0 IE%*&#519SNQ4L1H N8I::K9IU !2$TM,<X% #7:J<L
MBAN:66;;5"20NU &Q;L"O%3U2LV^2K@H 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHI %%)2T %%%% !1113 **** "BBB@
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M*:J@4^@ HHHI %%%% !3)/NT^D(R* ,V5-QIT$6PU:>(#FA%% $B=*?2 4M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% #7.!5*5BW%7B,BH6B'6@"M$N
M#FKJ5&B<U,!B@!:*** "BBB@ J-TR*DI&Z4 4Y$Q2PYS4A&33T0"@"4=****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $/2H'XJ<]*A89- $0;)J=*B
M"\U*E $M%%% !1110!&]4I$R<UH%<U T?- $43$'%7%Z5$L0ZU*!@4 +1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4UQE:=3'/RT 9\JX;-.A))Q
M3V7<U2Q1@&@"=5P*=110 5%+]VI:1ES0!E3*350J0U:\L55#$,\T 36F=M7E
MZ5! @"\58H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!*6DHJ0%HHHI] "BBBF 4444 %%%% !1110 4444 %%%% !1112
ML 4444P$I:**2 ****8!1110 4444 %%%% !1110 U_NUC7\YB4G-;$APE<U
MK<N8F H Q+O5B&(#5G-J$LAX-9]PKM*>>]6;. DC- %RWEF:122:['3)SY8!
M-8-I;#CBMNTMV##% &\C96GU#"I"BIJ "BBB@ HHHH **** "BBB@!",T8I:
M* (7%(I.:D85&.M $PZ4M(O2EI( HHHI@%,;-/HH 8N:?1BBA@%%%% !1110
M 4444 ,?I4.[%3L,U5E&* +".#4E58@35E>E "T444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 48S2'@4F_F@!<4M%% !1110 4444 %(>E+10! 5.:<F:DP
M*,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5&V*5FQ4>>: %5
M>:E Q3584^@ HHHH **** "DP*6B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "H7S4U-89% %?C-2)4?EG=4J+B@"6BBB@ HHHH 8X!JC
M*"&XJ\]57'- $UOG;4]10_=J6@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $HI:*5@$HHHI +1115 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+1112 **** "BBB@ HHHH ***0G H C9\&D#Y-5)W.^I86R* +8Z4M(.E+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 44FX9I: "@]**8[@"@"-CS0G6J[2_-4\3 T 6!TH
MH'2B@ HHHH **** "BBB@ ICT^HILXXH @9L&IHGXJH3CK2JYSQ0!H44R,Y6
MGT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !4;G%25$]- 0%CNJS&>*@XS3U- $]%(.
ME+2 **** "BBB@ HHHH ***8YP* %.#0H J#S>:D1\T 2T4F:-PS0 M%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 A.*C+\T.<55:3YJ +JG(IU01MFIQ0 4444
M%%%-=MHH 9)C%49@-W%23S]<&JGFY:@#0MP-M6152W;BK8Z4 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E2 4M)2TT E%+1
M18 HHHI@%%%% !1110 4QAFGTUCB@!%!%/IBMFGT %%%% !1112L 4444P"B
MBF,V* 'T4U3FG4 %%%% !1110 4444 %(>12T4 4Y[97'2LR73P&)VUNN<+F
MLJ]O BF@#-DA"=!5&:X$1Y--N=5 8C-94UR9SP: -VVN]S#!K?M+D%<9KB;6
M4J0*Z&PDR1S0!TRG(I:AA;*"IJ "D89%+10!GW<)93BL@VKJY/-=*RY%5VMP
M>U '/R1O48C8FMJ:VQVIL=GDYQ0!2CM&9<TCVK"MV.$*N,4R2$>E '-O P-7
MK*%C5YK3<>E6+>W\OM0!%Y9 IGE'-766H=WS8H (5(-6NU,1>]24 1N#52;.
M,5>/2J4U- 5(U/F5IQ?=%4$^_6A'TIO4"6BBBI **** "BBB@ HHHH *8X.*
M?0>E &9/]ZI(%-/FBW-FGQ#;0!87I2T@Z4M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>E+10!%
MM.:D'2EHH *K3(35FHW/% &<4.ZK,*FE*Y.:D2@"8=*6CM10 4444 %%%% !
M1110 4Q^E/IK#- %&8<\4D2'-6'CYIT:4 21C"T^D' I: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J-ZDIC"F@*Q4YJ1.*4CFG*M $@Z4M HI %%%% !1110 4444
M %,D&13Z* *1C(-/C4U89<T*N*  #BF;3NJ6B@!!TI:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@"*3I5-HR7JX],'6@!8DP*GI%Z4M !1110 5%,I9>*EHH R)8&
MR:K^60U;4J@U3>,;J )+53MJX.E0VXPM3T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1112 2EHHH0!1113 ****0!1113 ***
M* "D*YI:* &A<4ZBDI7 6BBDH 6BBBF 4444 %-*YIU% " 8I:** "BBB@ H
MHHH **** "C-%1OF@".Y<",\UQNM7A0-@UTMX7\LXKBM621BV10!B"Z:64@^
MM:EK%N%9=M;GS>E=!:H%49H 18MK"M?3SA@*SS&6;BM6QB((XH Z.W'[L5/4
M$&0@J>@ HHHH **** &,@:A4VT^B@ I",TM% #0N*=110!$[5$JC=FI) :A!
M(:@"VO2EIJGBG4 (W2J<O6K$AP*H2O\ -30#T49JW'5*'):M!!Q0] 'T444@
M"BBB@ HHHH **** "BBB@!I7-)M%./2HR3F@"04M-!IU !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4QA3ZB;.: &XYJ15I%Q4@H **** "BBB@ HHHH **** "BBB@
M!C 4S=@TV8MVIB'UH M*<BEIBD8I] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QC3
MZ8PS30#0,U(*BY!J5>E)@+1110 4444 %%%% !1110 4444 %&:*C;- $E%,
M4^M/H **** "BBB@ HHHH **3-+0 4444 %%(#FEH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@")^M"K3RN:CY!H E'2EI
M%Z4M !1110 4444 0RG JJ6R:N2#(JJR\\4 68>E2U%","I: "BBB@ HHHH
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MIW U=W&:C:45 L^1BFN"!FD!,)@#S4R2!^E9;N2:M6S8% %VBD!S2T %%%%
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MG2@">BF*U/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "JTK8-6:@D7)H :AS5@=*@48J<=* %HHHH **** "BBB@ HHHH ****
M $/2JDWWJN5!(F30!#&_.*N+TJLJ &K*]* %HHHH 0U&7.:E-1L!0 QI"!41
M)<U)@'K3U1>U "1KA:BE3J:M 8I&0$4 9FX[L58B.*?) !R*8@(- %M3FG5&
ME24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6.
M*B)S4Q%1,/2J5@!6Q4H-,5:>!BI8"T444 %%%% !1110 4444 %%%% #2,U6
ME&*MU&R TT!65,U,G%(2JT*ZYZT 3CI2TT,,4[-( HHI#TH 1^E5I*=))3$.
MX\T 5GBWU'L*UJ"(4UK<&@#/CSOJXPRE*( #4^P8IV RW0@U8MZG>$4U4V]*
M0%A>E.IJ]*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4QCBGTU@* (2<TY6J*3@\5+$N1S0!*.E+0** "BBB@ IDAP*?2,N: ,RXR]
M5T7!K1EB%5]G- %FW7BK(Z56BR*LCI0 M%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1112 2EHHHL 4444P"BBB@ HHHH **** "
MBBB@ HHHH *2EHI6 ****8!1110 4444 %%%% !1110 4444 %%%%  >E95]
M"SYQ6K360'J* ..GL6+YQ2V\4D35T\ENI[55>U'84 5!<,JXS5:>4N#5U[)J
MC%@Q- ',W%J\DV0.];>G6K*HR*T$TX9Y6KT-L$'2@!UNI %6ATI%4 4Z@ HH
MHH **** "BBB@ HHHH **** &.>*K<EZG<&FJ.: )5'%.I!TI: *MP2%-8DK
M?O\ \:VKG[IK!F!\_/O0!LVOW15\=*SK-_E K17I3: 6BBBD 4444 %%%% !
M1110 4444 %%%(>E !N&:6H@IS4HH *0]*6D/2@""1B*@+MFIY.:C5/FH ?"
M3WJQBF(N*DH ;L%+BEHH *B>I:B>@!@/-3+TJ$=:F7I0 ZBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J%^M357D;!H D7%2"H$!/
M-3"@!:*** "BBB@ HHHH **** "BBB@ I"*6B@"';\U2CI3<C-/% !112'I0
M A8 5"7YI)7Q5;?EL4 3LWI3X2>]1HA-647% #Z*** $(S4;)Z5+36.* &+Q
M4@.:A8TY6H EHI <TM !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% #6IOUIS'%,/--#N2"EIJBG4F(**** "BBB@ HHHH **** "BBB@ J
M-\XJ2D(R* ,V>0K51;DA^35VYB)!-9$JD-3 V(KD,!S5M&S6#;EE;FMBV?(%
M("W37Z4ZD8X% %-U.:(U(-2LX/%.0"FP'KFGT44@$Q2T44 1O2+BEDJ(=: +
M I::G2G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,?
M-/HH K$<\U,G I&7FG*,4 .HHHH **** "BBB@!CC(JJR\U8D.!4.\9H EB7
MBIJ9&>*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4E+128!124M" ****8!1110 4444 %%%% !1110 44446
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MS0!&AR:L+TJH/E-6HSQ3L ^BBBD 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 44447 ****6P!244M&X!1113 **** "BBB@ HHHH **** "BBB@
MHHHI %%%%, HHHH8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !3'7(I]% &7=P;U(Q61]B*OD"NH9 147V=?2@#"6!NXI&MV["MM[<=A2
MK;KCD4 <^UJV.E1BU?/2NF^SKZ4UK9,=* ,!8&'05?MHFQR*O+;+GI4OE =!
M0!292#2JM7#'Q4.SYJ '19S5H=*B1,5-VH AF8!36)+-^_QGO6E=D@&L)B3<
M4 =%;,"@JUVJA9@^6*O#I0 M%%% !1110 4444 %%%% !1110 4U^E.I&Z4
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M1110 4444 1.*9TJ<BHF6@!%;FIATJ%>#4PZ4 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $$]11]:FF4L*CCC(-- 6$Z4ZFJ,4ZD 444
M4 %%%% !1110 4444 %%%% !1110 5&Z\5)1C- %3!SS2,,=*LLHJ,K5(&(C
M8'-12-S0YP>*3:33$"=:M)G%01QD&K0&!2;&+1114@%%%% #'Z5GS#)K0<9J
MK(.: (HAS6@GW:I(O-74&!0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** (ICA:J$Y-6Y1E:J[#F@ 7.>*MQ9QS4<2>M3@8H 6BBB@ HHH
MH *1NE+2-TH S[O.#BL[:V[FMB2//6JCQ#/2@">T7Y:NKTJO;X JP* %HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113
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MZ (%;!Q5I3D56"?-5E!@4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!C]*AJ9^E1JN30 ]*DIJC%.H **** "BBB@ HHHH :RYJG,=IJ
MVQQ528;C0 ^$YJTO2JL(P*M+TH 6BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHI %%%%, HHHI:@)32<TZDV\T#0BBGT44(&PH
MHHIB"BBB@ I*6BDP"BBBF 4444@$I:** "BBBF 4444 %%%% !1110 4444
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M4<C 5"'.ZJMH!=HIB-D4^I **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IKG%.IDAP* (BWK4J55=N>*FA;B@">BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ IC.*1VXJH[$'FF!:#9-2"J,<P-6D<&A@2T4F:6D 4444 %%
M%% !1110 444AZ4 &12U#N^:I U #J*** "BBB@ HHHH ***C:0"@!^:6JXF
M&:E5P: 'T444 %%%% !1110 444UNE ",:%-1[N>:D4@]*=P'T444@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 3%+110 4444 %%%% !1110
M4TKFG4'I0! >#4BL,5#)( :C1SNH NT4U6R*=0 4444 %%%% !1110 44TN!
M49G44 345$LRMTJ7- !1110 4444 %%%-8X% "G!I !5<S#.*EC;- $M%%%
M!1110 4444 %-;I3J1B .: (2WK569_FXJ2=_2J1D^;F@"] <BK:]*IVYR.*
MN+TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH 2EHHI6 **** "BBB@ HI*6F@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M:W2G4C#- &1?PM)TK(:R?=74M%FHC:@GI0!@1V;X[U*;1BM;@MP!TI?('I0!
MS_V1E-7+:$UI-; ]J='!MH 8HVIBJ[@[JO,G%56'S8H =!UI;G[M.B3%+-'N
M% &#.A,G%:=DA"BF/;_-TJ];QX6@"PO2EH%% !1110 4444 %%%% !1110 4
M444 %%%% $4PRM9-S"<FMHC-020[^U &-#;,36M;QE13HX O:K &*  4M%%
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MG&<BM>,8%# DHHHJ0"BBB@ J&4_*:E/2H)* *1!WU;@-0XR:L0KB@"Q1110
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I"<4M,D.!0 C2A:;YZUF7MUY>>:RSJVTX
MS0!T_GBG>:,5SB:EGG-2_P!I9&,T ;HF!IP<&L!;[!ZU<@O-_>@#4W"EP*J+
M+DU85^* ',0!418'I1*V15=6P: +B4^HHFS4M !1110 4444 %%%% !1110
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M:KMO$4[5I"S4=JE2V H BC7Y<TGFD-BK!7:*K,HW4 .>0XJ)22:E5,U((<4
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MTS(-(!8UYJQ429J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "FMTIU(1F@"N>M2)0RTJ"F!)1136
M.!2 =14!DYH\R@ DDQ5-Y"6JV1NJ P_-56T =$Y-7%Z5#%$ *G'%2 4444 ,
M*4FRI** ('.RD27-22+FH@N*8#97.*JC/F9JV5!I%A&<T 2Q'Y:FIBK@4^D
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M8#0G[1FMQFWI5'R\S4 6[+@"M,=*JV\8 %6Z "BBDS0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F:6@ HHHH ****
M"BBB@!C+FF%,"IJAD)Q0!$7YQ4J51=F#5)#*V: -"BF*V:?0 4444 %%%% !
M2$X%+37/RT -W\T;_>J4\Q2HHKG<>30!H,<BJ4KX-65;<*KW*?*30!"MQSUJ
MY!-NK"W/YV,5JVH( - &H.E%,0T^@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HI">*CW'- $M% HH **** "BBB@ HHHH *8]/I",T
M567-/C^6G,N*9S0!8!S2U4,A6A9N: ++-BF?>IN[-.2@!ZC%.HHH **** &,
MN:3RZDI,T -"8I]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0FE
MJK<2E* 'O+@XI,YK,>X.ZIX9BQQ0!=7K4XZ5'&.,U)0 4444 %%%% !1110
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M=U1^0I[4 920$1]*K3+(*W_*'I44]LK+P* .>0ONJ_ &;K4BV1#=*NPP;>U
M$80[:AV?/6GL&*@\GY\T $.ZK8Z4Q5 %/H 0U&<[JEI,"@ '2EHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#THHH B.=U2#I1@4M
M !1110 4444 %%%% !364$4ZB@"LT()I!%BK.!1@4 ,08J2DQ2T %%%% !11
M10 4U^13J* ,J[1L'%4(TD#<5O2QAATJ*.W4'D4 1VP;'-3/'N&*G5 O2EP*
M ,Y;-?,SBKJ0A14FT4M " 8I:** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** (CG-.5:=@4M !1110 4444 %%%% !1110 4444 (1FDV
MTZB@"M*HQ53#!JOLN33?*% $*9JR@Q2*F*DQ0 M%%% !1110 5$<[JEI,"@
M7I2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO)<8.* +6_FGU223)JRC9% $E%%(30 M%1%Z-YH EHIBMFGT %%(>E,WG.*
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M "DI:*3 2EI**$P%HHHI@%%%% "4M%%*P!1113 **** "BBB@ HHHH ****
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M1;1S6^UL#VH6W '2@#+AMR",UIPQ$"GB$ ]*G48%  !@4M%% !1110 4444
M%%%% !1110 4444 %4KY2T9Q5VHY$WC% ')3VCNQZU$FFR[AUKJ?L@STJ1;8
M#M0!D6UDRI@T2635N",#M08P>U ',26;^]0_8W]ZZAK<'M4?V0>E '/QZ=(6
M!YK6MK9HQS5Y$"=JD"Y[4 $:D"I:0"EH **** "BBB@ HHHH **** "BBB@
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MYB^M.S7+PZPCR ;JW;:Y61!S0!;HHZT4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #2
MN32@8I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**2EI7 ****8!1124F M%%%, HHHH **** "BBB@ I***3 6BBBF 4444 %%
M%%) %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI*3 6BBBF 4444 %%%% !24M%)@)
M12T46 ***2@!:**2BX"T444( HHHI@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 (1FHVC![5+10 Q4"T_ HHH 3 II0'M3Z*+ 57M58]*06@QTJW10!2^QC=T
MJ1;8#M5FB@"-8P.U,> -VJ>BE8"L+=0>E3*F!3Z*8!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 )2T44D 4444P"BBB@ HHHH **** "BBB@ HHHI; %%%%, I*6BE8
M!*6BBBP"4M%%'0 HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444TO@T .
MHI <TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+1
M120!1113 **** "DI:*5@"BBBF 4444 %%%% !11128!11247 6BBBBX!111
M3 ****5@"BBBBP!1111< HHHI@%%%% !1124K@+11247 6BBBBX!1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EHN 4PKDT^B@
M! ,"EHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 **** "BB
MB@ HHHH **** "BBB@ HHHH ****5P"BBBF 4444 %%%% !1110 4444 %%%
M% !1110 444E "T444 %%%% !1110 4444 %%%%*X!1113 **2EHN 4444 %
M%%% !1112N 44447 **2EI@%%%)0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%)0 M%%% !13<\THI(5Q:***8PHHHH **** "BBB@
M HHHH ***2DP"EI*6A %%%%, HHHI7 **2EI@%%%% !11247 6BBB@ HHHH
M**2EH **** "BBB@ I*6DI, I:**-@"DHHI +1115 %%%%+J 44447 **2EH
M ****8!1110 4444 %%%% !1110 44E+20!1113 **** "DHI:6X!1113 **
M*2BX"T444K@%%%%, HHHH **** "BBB@ HHHH **2EI7 ****$ 4444P"BBB
M@ HHHH **** "BBDI, I:2EI( I*6BFP"BBBF 4444 %%%% "4M%%2 4444[
M@%%)2T7 2BBEH2 ****8!1110 44E+2 ****8!1110 4444 %%%% !1110 4
M444, HHHH ****0!1110 4444P"BBB@ HHHH ****0!1113 **2EI7 ***2B
MX"T4447 **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 444E(!:**
M*.H!124M !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI
M*6D@"BBDH8!2T44@"BBBJ **** "BBBE< HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 444E)@+124M%P"BBB@ HI*6A %%%%, HHHH *2
MEHH 3%+110 4E+12L 4444P"BBDI +1110 4444P$HHHJ0%HHI*8"T444P"B
MBB@ HHI*6P"T44E%P%HHI* %HHHI@%%%% !1110 4444 %%%% !1110 4444
M %%%%)@)2T44( HHHI@%)12U(!124M- %%%%, HHHH **** "BBB@ HHHI %
M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDI,!:*** "
MBBBF 4444 %)D"EJ-@<T 244U>E.H **** "BBB@ IA;%*QXJ,?,: )%;-.I
MJKBG4 )1FEI,4K"%HHHIH8W=S3A3=O-.% PHHHH$%%%)0 M%%% !1110 444
M4 %(32TF*5P8M%%%, HHHH **** "BBB@ HHHHL 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 )2T44K %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBBP!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$9
MI N*=10 4444 %(3BFO($&36=<ZK%&.HIV TMX]:0R*.]<ZVOPH>6'YU6D\1
MP]F'YU2@3<ZKS5]:3ST]:XUO$T(_C'YU$?$T7]\?G1R,.8[?ST]:7SD]:X;_
M (2:+^^/SIZ>)HN[C\Z' .8[;S5]:7S%KC1XDB)^^/SJS'XAA(^\/SHY+@F=
M3YB^M+O7UKF?[=BZ[A^=*NO0_P!X?G3]F.YTV11FN?7Q#;KU8?G2GQ);?WA^
M=+D8KZ&_D49%82Z_ _1A^=6X=028\&ERC3-*EJ-&R*DJ6AA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36.*=
M2$9H :K9IU)MQ034-V 6BD!I:$QBTF:*C8FFGJ(EHIJ]*=5 %,8XI](5S0 P
M-FGBD"XIU @HHHH&%%%)0 M%%% !1110 444AH 0FA3FC&:7&*0)Z!102,5'
MDYI6 EHI >*6J **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBBD 4444P"BBB@ HHHH **** "BDI:5P"BBBF 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1124,!:**2E<!:***8!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1124F M)2T4 %%)2T( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110@"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBBBX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1112 ****-@"BBBF 4444 %%%% !1110 4444 %%)2TD
MP$I:**+ )2T446 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1112L 44446 ***2@!:***8!11118 HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****+ %%%% !1110 4444 %%%% !
M1110 4444K %%%%%@"BBBF 4444 %%%% !1110 4444K %%%%.P!11118 HH
MHH **** "BBB@ HHHH ****+ %%%%*P!11118 HHHHL 4444[ %%%% !1110
M 4444K %%%%, HHHHL 44446 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "FE>:=10%Q *6BB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBBE8 HHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%%%@"BBBE8 HHHHL 4444[ %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1112L 4444[ %%%% !1110 4444 %%%% !11118
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****+ %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E%%2P%HHHJ@"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ -1,N34A&: *0"*,"G4A.!2 YHV'8=13&D"]36?=WXA7(-%T-1;-!I
MIH\P>M<C=:^5/6JJ>)B7VYI<QI[)G<A@:=6!IVJ?:.]:OGFCF1#@RU1115$!
M1110 4444 %%%% !1110 4444 %%%)2N M%)2T( HHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444M0"BBB@ HHHI
M@%%%% !1110 4444 %%%% !1110 4444@"BBBF 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%%*P!1113 **** "BBB@ H
MHHH ****+ %%%% !11118 HHHHL 4444 %%%%%@"BBB@ HHHHL 44446 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHHL 44446 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHHL 44446 **** "BBB@ HH
MHH **** "DI:*5@$%!YI:*$ P)@YI]%%, HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ IDK;4)IYX%9=[?QQ@J3S2;L-*[,+Q%?-'"V*\TU'5) Q)S7?ZC
M_I8('-<'KFFNA;"USRU.R$3F[KQ ZY7-,L;@Z@^,YS6%JL,B,V*U/!YQ<#S/
M6L_9W-'*QZ!HGA%;@K,17HNFZ&ENBC:.*3PS%$UDI '2NC5 .E;1I(YYU65D
MLT7L*LJ@4=*=16JBEL8.3>XE+244$BT4450!112 YH 6BBB@ HHI,C- "T44
M4 %%%% !1110 4444 %%%-WC.* '4444 %%%% !112 @T +1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME1*N32L!,#D4M(!BEI@%%%% !112'I0 $XH#9J/)8XIZKBGH ZBBBD 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4TJ#3J*&!'Y0J&6T20<BK
M1IO6HDD-29R&K:$DNXA*X'5_#3C<5C/Y5[6\:L.15"YTV.4?<'Y5DX(VC4?4
M^>KC1+B/)V&J=G%=178!4XS7O%WX<213A!^5<[+X0(G+!._I0H=RG4N3^"C)
M@;J[_G%<_P"']*-F>173XJU$R<M1:***U,PI,T-TIB@YYH DHI*6D 4444P"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM,[=!5
MFF[ >M("I"#OR:NCI30@'2G4) %%%%, HHHH **** "BBB@ HHHH ****0!1
M137SVI@.S13$![T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$S2U$0=U2#I0 M)FE[5%@[J ):*.U% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 9HIC@]J
M5<XH =29I:C8'/% $E%(O2EH **** "DR*4U%@[J ):*** "BBB@ HHHH **
M** "BBB@ HHHH **** "DS2-TIJ@@\T 24444 %)D4IJ+!W4 2T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !28I:* $Q12T4K (0*B:!2>E34E)H=QB1!.E2444
M[""BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4UCBG4A&: &JV:?2 8I: "BBB@ HHHH **** "FL<4ZD(S0 U6S3Z0#%+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !11120!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M ****0!1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 8S8IRG(H(S0!B
M@!:*** "BBB@ HHHH **** "BBB@ HHHH **** &%_FQ3ATHVC-+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1124F M%%%, HHHH **** "BBB@ HHHH ***2@!:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BD8X&:S;B_6(D;J -.BLRUOUF; :M$
M-\N: '45!YZ@\FI$D5^AH ?1110 444A.* %HJC<WJ1'!8"F0WHD;@T :-%-
M5@13LT %%&:3.: %HHI,XH 6BDS44LH0=: )J*K1W2'JU$]TD<9;<* +.:*Q
MH]35WP&!K3@DWKF@":BBB@ HHHH **0L!WIC2#UH DHJ-9 >]29H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *2EI*E@%%%+0@"BBBJL 4444 %%%% !1110 4444 %%%% !
M1112L 444E "T444=0"BBBF 44447 **2EI( HHHI@%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%(2!433H#@F@":BHQ,A[TADYX- $M%-5LBG4 %%%% !12,<+FL][Y5DV[
MJ -&BJ\-PLG0U8H **** "BBB@ HJ,DYI^>* %HJ)Y54\FD64,>#0!-29%4K
MR[$ R3BJ<6J*\@&Z@#:HID;;D!I] !1129% "T44F10 M%(6 I-X]: '44F1
M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1M*%
MZTVXE\J,M7,:AK?EM@&@#JE<-TI]96CW7VJ -6K0 445'*VQ<TM0%>0)UH5P
MPR*YG5]7:WINFZX9BHSUH ZNBHX7WQAO6I*8!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$XI
M P-*1D4U5Q0 ^BBB@".8XB8^U>>ZWJ12=E#=Z]!N.86^E>7>(82+EV]Z -?P
MW<23R_>S773W:V\!+'H*X3PE*4E.:U]<OB(V ]* (;KQ"AE95;O5_3-<15^=
MJ\V,C-=L<]ZTHIF5,@F@#TM==@8XR*>=9A ZBO)WUAXI<9-1S^))%'4T >M)
MK4+.%!'-7)IQY.X'M7D>EZS)-<(23UKTNSD-U:J#Z4 <OKNH.MP K'K6CI,[
M>4KL:S_$5ALFW>AK/BU;[/%Y>>E ';R:Q%" ":EAUB)TW9KS:[U0R]ZBCUMX
MEV F@#TR36H>F:A_X2"",X9A7GB:E*[9YK)U/5Y(I0,F@#V2#5XIL8(YI;K4
MHX5R37EVC:XY*Y)J[KNO,D(P>U ';_\ "10#Y=PS5#4-=C$>0U>4C7G:8?,>
MM:GVYKF(#- '<66HM<\JU)JVI-%:,-W.*SO#Z%8>?2J_B'(MWQ0!#HFJ/+<D
M%B>:]%T^<&$$FO(_"P9[HY]:]$2Y-O!^% '1F[0=ZIW&MPVYPQ%<=>>(3$S
M&L&\U:2Z;()H ]+BUV"1L BK#ZI$JYS7DL.J2PN#S6DNMO, "30!VMUKL29.
M:IV_B.*>78&K!:+[1:,^>U8NG(T5^W)ZT >DG457G-/37H,[=PS7!:KK#6PP
M*Q+?6I'N1R>M 'LT6H1R#(-5[C6H;=L,17&66KN(QUZ5CZMJDLDQ S0!Z-!K
M\%P^U2,UK0R!QD5Y%H]U(MP"<UZ7H]P9HAF@#7HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD@"B
MBBF 4444 %%%% !112'F@! P)I2V*:$P<TI7- T+NP,U$9U%17DWD0%L]*YJ
M76,R8![TFPL=<CAQD4I(%8,&IXMB^>E4XO$/F7!CSWH$=4#FEJG9W'G+FK,C
M;5S0D V6=8^M+'*)!D5S^KWYB[U%I^L;L+FCJ!U-%10R;T!]:EI@%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 5[AMJDURNH:N(;C:6KJ+O[AKS;7<_;CS
MWH ZG3]0-RP :M1[D0#YS7): ^R4<U<UV^,?2@#:.M0QGDU-#K4,WW37EMSJ
MTA8KDU-8:K)%D\T >G/K$,9P2*?!JT4S8!%>2W_B&02'DU?\.:U)<704YZT
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M17)H ]"'B.W+[=PK3M+Q+E<J:\2&IRB;=SUKNO#.K,R &@#O:*B@D\R,-4M
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !112'I0!FZS+LLV(]*\PO;B6
M6X(![UZ)K\F+-_I7GULOG71^M '>>%MPLQN]*Z R 5C:,/)LOPJCJFO"R#$]
MJ0'3^:OK0P#K7 0>,4EDQGO75Z=JBW,:G/6BX'.^+82J945@:1.R3HI/>NK\
M58,.<=JX6WFV7R_6C8#UVQ?=;*?:K59.DS[[9![5K=J8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%(3BDWCUH =12;AZTF\>M #J*@:X ;&:D\P;<YH 289B;Z5Y]KMJSS.<5Z!O
M#J1FLF\TS[03QUH Y'0+=HY#Q5_5;5Y$;BMJTTK[*V2*LR6JR<<4 >7?V7-]
MH8[3UJVUN8HCN&.*[[^R%)SM%8NL:40I % 'F<X\R]*KZU<_L:650=AK1MM$
M<ZF"0>M=_9Z,OE+E1TH X+2]&GCN$.PXS7J.EVYCMUR.U)!I:1D':*TT0*N
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M %%%% !1110 4444 %)2T4F 4444P$I:**2 ****8"4445("T444P$I:2BA
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M:O.]0\0EGQO-3Z'J9DO%);O0!Z_ ^Y :9/<B/J:KV$XDA7'I69K4S)$^#VH
MFFUA!P'&:KG56*D@UPD=U-+>LNXXS746=I)+;D^U #I?$31RX+_K4L7B(/\
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M ='12 Y&:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>E><+'*DA&#UKV&^T\3VNW;GBL+_ (1T;L^70!Q MG,6X@T^V>2)N :[E]"
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M@UZ4V@1AAA/TJ<:+&(\;* ,SP]<O&0"#73W8,]DWN*H6VFB%N%Q6U%&#%M-
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M]:,CUK(2]..33&OF!ZT ;61ZU',HDC*YZUBOJ+#H:$U%B.30!,NF 3%S6C%
MB#&!67]O;UJ-M0?L: -O8GH*4*@Z8K ;4I .M1KJCYY- '1E%)S3L+CM61%>
MLR9S4<E\^>#0!MC:.F*7(K!2_D[FG_;V]: -:2-'ZXJ,0*#D8K*?46'0TJ7[
MD=: -L!<8.*-J>@K%>_=1G-0C4G)ZT ;[(A&,"HUA0'H*REU!L=:DCOB>IH
MU@%'I2X7VK"FOW#<&D34)">30!O87VINQ=V:Q_[0;UH^WMZT ;?&*@>%&.>*
MR_M[>M0RZDRCK0!LK$@/:G-$C=A7-QZI*7Y-6?[1D/>@"_>Z?'<0E=HYK(M_
M#RPR%L#K5T:@V.M'V]O6@#2M8%A3%6"JD5C?;V]::]^^.#0!M!5QBJ_V9?,W
M<5F)J#]S2R:@P7.: -L! .U.^6N7_M:3/6K4&HLPY- &]Q2?+64UXP7.:K/J
M#]C0!MM&C=A34A1>PK%747SUISZ@X'6@#:V)GM3MJX[5S_\ :3^M.347)ZT
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MJCDC#C% &'L(Z5%(Q;Y<ULM:@*:RS&!/B@"&*R=Z>=-EW9&:U[9!@5;VCTH
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MM&*0** .;_LR7WIRZ;(.M=%L'I05&.E &$+"3'%5;K39=A/-=.% J"[ \LT
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MSS4U !1110 4444 %03, I%3U5G3.30!7A/[VM%3D5FPC]YBM%!@4 .HHHH
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MH ,55E4[N*M57E;#4 2Q_=I],C.5I] !1110 44F110 M02=:GJ"3K4O8 C
MS4]01GFIZ: ****8!1110 57E&1S5BHY?N4 4T3#?+5R($+S55'VM5N-MPH
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MAJI"I#T 7DZ4ZFITIU !1110 4444 %5Y=N[FIR<51N,LW% %R,C'%/JM#G
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M 4444 %%%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM%%% !1110 4AZ4M(>E %651G-+!P:9(#NI8LYH N44U<XIU !1110 4444
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M HI*6@ HHHH **2EI7 ****8!1124FP%HI*6A %%%%, HHHH **** "BBB@
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M+(%--AG#-BLNZG</3+:=B_!H Z+-&152*4[>:1IB#UH N9%&15'SR:7SSZT
M7<BC(JEYQ%'G''6@":>4*AYK.\Y9&ZU3U2\9(FP:Q]/OG>7#'O0!V=NORU:J
MI8MNB!JW0 4444 %%%% !1110 4444 %%%% !1124F M%%%, HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&<@+4U
M0SXV\T <]?$&4<=ZU[!AY(&*S+M5\T?6M2Q0",4 7QTHH'2B@ HHHH ****
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M6(85:YY]: ,_3],?=FMZ&T9*LV\*H!BK&* (A&<4>74U% $7EU#-;[^E6Z*
M*T<.U<5!<6Y(K0J.3&.: ,/[&2XP*UH8<1 4@5<U93I0!5:(@TJPFK17- &*
M (6B)%(L1 JQ10!4:(YS4;0DU>(S3=@H R'M26J>VM2C9Q5IE&^IU7 H A:(
MGI2^5\M3T4 5/(-'V<U;HH J?9S3Q$0N*L4F10!CW-H22:AAM&+<5M2*&6F0
MQJIXH ;# 53!I5A.:LT4 5GAS3# V*N44 44MF'6D-LV<U?HQ0!EW$!9,"JD
M=J0W-;4B"HUC!- #(8,**D>'-3J,"EH K&+"8K%U&V+ UT+G"UDW+!N#51"U
MS&@TUF0G%4I=//G$5U=H@\H_2LR< 7!I@2Z/:F+K5NYA+29I]@:M2 ;JF3U
MJPQ&KBQ''-)$H!JQ2 J& DTQ[4FKU% %9(,)BHA;-NS5ZB@"IY!Q52YMB4-:
MU0S ;: .?CMF1N:UK>(E*$B5FYJ[&H48% %9H&(J+[(U:-% &=]D:C[(U:-%
M %(6YVXI8H&5LFKE% &'J%L7E&*GMK8A!5R6,,W-21J * (?(.*C-J=U7Z*
M*36Q(I8XS&,5<II7- $ B);-*\614X&*6@#&N;8G-5[2U99<FMB50:BA0;Z
M'B(D<4C6Y(JV!BEH HI;,*0VS;JOT4 4FMB10ML0N*NT4 <WJFGNT3&L>PL&
M$OXUVMR@>,@UEB%(GR* -"QC*1 &K=06Q!2IZ "BBB@ HHHH **** "BBB@
MHHHH ****0!1113 **** "BBB@ HHHH **** "BBB@ HHIC-@T /HI <BEH
M**** "BBB@ HHHH **** "BBB@ JK>9V<5:JM=MA* .=N"PE&3WK:L WE"L6
MX;,H^M;5@_[H"@#0'2EI!TI: "BBB@ HHHH K2JQ/%-B#!N:?)+M.*;$^6H
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M13 B<&F#.:?(^!5:.;+XI,"V@/>G4BG(IU, HHHI %%%%,!CYV\55*OFK;G
MJG)/@T^@%J(';S2M$K#D4R!]RYJ:D!S6K:%'=-G8#^%4M/T$V]R&"8 KL< ]
MJ-H]* &Q+MC I]%% !6/J$;,_%;%9-_-L>@ M$((S6J.E9EK)NQ6F.E "T44
M4 %%%% !1110 E+1120!1113 2EHI*5T M%)2T( HHHI@%%%%+< HHHI@)2T
M446 **** "BBB@ HHIC-@T /HI <BEH **** "BBB@ HHHH **** "BBB@ H
MHHH 9(/D-83Y6ZS[UO2?<-8,C9N2/>@#6MGW 5:JG:K@5<H **** "BBB@ J
MO<YV<58J&?[M %.,MGFK\?W:HC[U7H_NT /HHHH **** "BBB@"LZ,9,U87A
M:A:7#XJ93D4 +1110 4444 %1L#GBI** (&5B*(58'FB638*;!/O.* +-%%%
M !1110 4444 -<9%1!3FIZ@DDVMB@"8=*6FH<KFG4 1S?ZLU@7#$N<&M^?\
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M*K."S4 6$^[3J9&,+3Z (I_]6:P9L>8<UOS_ .K-<_.,R'ZT :>GXV<5).%
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M88]:UM,A?RUH Z%IOEX-1_:#3$B8#FF/&W6@"PD^32O,1TJK&C;L5.8SCF@
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M^:".#7*6OF&7J:W[>-RO- %MI>*B\\TAC:D$9- #A.<T]IOEZU&83BH'1P:
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M HHHH *0]*6CM0!GR[O.JY&ORBH7=!)S4Z,".* 'T444 %%%% !2'I2TAZ4
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M444 %%%% !1110 4444 (RY%5)K4-5RD(S0!G+9 -TJ=K8%,5:VBH;ABJ<4
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M%/HH H2VJL:(K-%;/%33;NU01^9YGM0!="#'2@QC'2G#I2T 1+" <U)@4M%
M"$ TW93Z* *DUL'!JFFG*CYK1ES@XJJC.9,4 688PHQ4FP9H0<4^@!I7-*%P
M*6B@ Q1BBB@!DB@K67<VZYK4DSMXJA,K9YH ?:0@+5W:,56MP0M6ATH 0*!3
ML444 -*YI0H%+10 5C:A:++("?6MFL?4&82<4 6+.W6-1BKXZ5GV<A*@&M =
M* %HHHH **** "BBBD 44E+0@"BBBF 44E+2N 4444P"BBBDP"BBBF 4444K
M@%%)2T( HHHI@%%%%( HHI#UHV 6DH'2BA@+1113 **** "BBB@"K=R^6F:Y
MN\U%%?YB!6YJK;837E'B2YNEN<1$XS0!WMGJ2S2",$5TEO%M4'UKRSPS)<-<
M(9">M>K6YS"OTH EJ*5MHJ6J5^Q6,XH 8]P ",U0>11)NS5*263GFL^=Y^2,
MT =99SA^,U<,@SUKE='>8MSFML^90!HA@>]+D5GH9 >:D!<T 7,BC(J [MM-
M4L#S0!9R*@N-I7K3'+]JH733;>,T 6$VANHJ_&1MZURXDG$@SFMNU+F,$T :
M&:,U#\V*/FH ER*,BH'+ 5%EZ +F136< =:JY>FN)-M $4S#S>M68) <<U@W
M'G^?QFM"U67 S0!L9%&153]Y2?/0!<W#UHW#UJ@YD/2E!DV\T 7MP]:1F&WK
M5!6DSS1*9"IQ0 R:5=Q&:?:L,]:PKG[1YIQFK5AY^?FS0!T0<'O2Y%9R^;NJ
MVI.* )&?!I0XQUJK*Q!J F7M0!I;AZT;AZUF[I:D#2;: +CL,=:JO&KMG-5Y
M3+4*F8MWH V(P%7%.S5>+=LYJ3YJ (KEP$/-8ZNKRD9I=4F=5;!K&TR:22\(
M)[U0T==;+MCJC>L%R:OPJPC_  K*U1)-C$4MP8MC,';K6D' .,UR]@91(>M:
MX,M/H(V$(]:ER*R8#+NYJW^\Q4@6]P]:,BL_,FZGEW7K0!=R*,BJ>YR,BC+T
M 7,BJTY&WK3"7 K/NS-M.,T 6$9=W6M"$C;UKE8S<%^,UN6GF^7\U &EN'K1
MN'K5%S)BH]TM &EN'K1N'K6;F6GH9!UH O[AZT;E]:SV,O6HF>4C H 6[E D
M'-6[9E*#FN>N_.\SO5VQ\_(SG% &[D49%5VW[>*8/,S0!<S29%1#=BHWWYXH
M LY%&1BJG[RGIOQS0!%<$9/-1VQ'F=:J7GF[SC.*;:,_F4 ;P(Q1D54^>DRX
MH N9%&15/+FI/FV4 6-P]:,BL\-)OJ4%S0!)<N!&3FL5[D!^#FK.K-(MHVWK
MBN5L9)WG._/6@#N+)]T0-6ZHZ=_J15Z@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***2DP%HI*6@ HI*6@ HHHI@%%%% !1110
M 4444 %%%% !1110 56NVPE6:K70RE '.W+9E'UK;L'_ '0%9,\8\P?6MBR0
M"(4 7ATHHHH **** "BB@]* *\T@ Q5>*3YZ?<=:AMU/F4 :*G(IU(HP*6@
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M .N* .;UK4/W9%<%?2":7)&>:]"UFP5HB0*Y"73P&Y% "Z,5CD4XKO["X\Q
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M%% !1110 C=*I3$#K5TC(JO-"&H =;D%:GJ*%-JXJ6@ HHHH **** "LF_\
M]8*UJR;_ #YE $MJ!@5H#I6?:]!6@.E "T444 %%%% !1111< HHHH ****
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M-2$\2\]:V <C- "T444 -D^X:PV(^U5N.,H:Q7A_TC=0!IVY) JS56WZ"K5
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M% $$SE:;'<KT)YJ#4+@1(2:Y6XUL1W.,]Z .Y# ]*4\BL#3]928 9K928,*
M$>W4G-5+FU##I6B.105!H Y];(B0<5?DAVP_A5_RU]*ANB%CH X_4K;S)QD=
MZV-,M,0KQ5>X >4<=ZW+%0(0,4 .%N,=*8UHO6KN*,4 4%M^<8J40 "K6T48
MH I-:CKBD2W]15[ HP!0!C7$+"3@4^*$CM5Z3;NY%.1030!$D9(YIQBS5G H
MP* *H@ H\@$U:Q1B@"J801BG+'MZ58P*,"@"E=1YB.*SK6)MYR*V9R!&<U5M
MW0O@"@!/).>E2K !5H 'M2XH K>51Y6:LX%&!0!1>WQT%*MN,=*NX%&!0!G-
M;;N"*S[FS(?Y170[1Z5"^P'D"@#/MK,!02*NK;+BIT"XX%/H K_94J&2S7'
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M,5<H **** "BBB@ HHHH **** "BBB@ I*6BDP"BBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !4%U,(8BV>E3UCZV76S8KZ4 8VH:D)B5+5
MD?8%N9 V:PKJYF6=LD]:W-(NP5 8\T ;^FZ8L1!KHXH@HK+L3NP16PG2@!P&
M!2T44 %07*!DP:GJ"XSMXH P[A DG'K6O9D>4*RKA6,E:-F&""@#0HI!TI:
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M]_6K,=P2.M %V5QBHX&&[K5*XNQL(SS5>TNCOY- &_N%&X>M4/.)&0:!*6.
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M)B.*GJ.;[E '(:EN0\TW3W+.M6-97-4]/;;(HH [&V \L5.>E06Q!B7Z58H
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M:@Y%1RR8-$;Y- %FBBB@ HHHH ***:S8H 9*ORU7CC!;FG7%R$0FJ4%\'?%
M&LBA1Q3JCB?<N:DH **** "BBB@!",U$ZC-2DXJG/<A&Q0!:51BG$9J*&7>N
M:FH 0#%+110 4444 %1NJGK3F;%0NW&: !(QNJ<#%58I@7Q5OM0 A.!6/JC(
M1R:T+V<00ECVKA]5UQ6?:#WH T8(0TX('>NKMQB%1[5RNBS"=%:NLB_U8H <
M5!H(&*6F.<+0!&R#M4B# J%).:L YH 6BBB@ I",TM% " 8I:*0G H 8X7/-
M(JKU%5IY<&B&?) H O44@Z4M !1110 4444 (V".:B5$#9%)+-M&*KQ2Y>@"
M_135.13J "BBB@ HHHH *@FC5NM3,VT9JC<7(% %J) HXJ6JMM+N6K5 !2$9
MI:* $"@4M%% !65?GYZU:Q]1?#T +:_>%:R]*R;0Y(K67I0 M%%% !1110 4
M444@"BBBF 4444 )2T44@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "&H'52:ED.!67=7P@/- %]+= <XJP.!6);Z
MRDCA,UKQR!QF@"2BBB@!K_=-93A?.K5D^X:PGD_TK'O0!JV]6JJVW05:H **
M** "BBB@ ID@R*?44S[%S0!%M -6$^[6>9LM5R)\K0!-1110 4444 %!Z444
M 5)%)DJPBX%5WF"R8J='R* )**** "BBB@ HHHH B:,=:1<=Z)9-HJ%)=YH
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MGUK8LO\ 4C% %P=**** "BBB@ HHHH K2IDYID/WZEEZ5%%]^@"X.E% Z44
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M*B=:Y+5KQ2QPU6=<NGAC8YKA[B_:6;&X]: -JSN)/M0(SC-=OI\[.HS7):1
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M4Y%+4<6=O-24 %%%% !1110 Q^E5R^UJLL,BJ,RMNXH NQG*T^J\.[:,U8H
M**** "BBB@ J*9]JFI>U4[K<5.* (()]TV*T6/R9K%M$=;@D^M;#G]T?I0!S
MNL3Y1EK-T2V$LY/O3M79C(P%2^&T<2Y;UH ZN"'RDQ4U Z44 %-;I3JCFSLX
MH @=L&IXCD53C5BWS5=C  H ?1110 4444 %-8XIU(1F@"M))BF1W.7Q27*-
MGBH88V$F2* -,'(I:1?NTM !1110 4444 12MA35..3]Y5V5<H:HQQMYM &@
MIR*=3$&!3Z "BBB@ HHHH :YP,UFW4W-:,G*UE7,;$\"@"]9G,=6JJ62E8^:
MMT %%%% !1110 5C:BV)*V:R-04%Z $L^2*UUZ5DVG#"M9>E "T444 %%%%
M!1110 4444 %%%% !1112 ****8!24M%*P!1113 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ IKC<N*=10!SFMZ9]HB(KB9=#:.;.#UKU25%8?
M-63=+9QGY\9H RM%MO*"@CI761?<%8-M-#YP"$8K>C(*C% $E5KN+S$Q5FD(
M!H Y>ZTGS&W55-ECY*ZV2)=AK((7[3@^M $>EV9B.:TV@R<U-"B #%3[10!5
M6'M4JQ8%2[0*6@"#R/FS2M#FIJ* (A%@8JG>1[5S6C5:Z7<E &,D.]\^];-O
M'B("J"H0U:D/W* #RZ9Y/S9J>B@!NWC%1,N.*GI"H- $"P\YHD@W"K'2@]*
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MDTD"@/0!>HHHH **** "BBB@""Y&8S6*ZE7K;N/N&LI@"W- &A9?ZH5;JO:
M"/BK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2:>L9 J>B@"L\1-,6)@:N44 4KB,^7Q6+/:LSUT<@R*K&$%J *%K:, .*OB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2BBB@ HHHH **** *\SJ#S38RI/%,N5):FP@@T 7ATI:0=*6@ HHHH ****
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M110!!=9\LUB.#OYK<N/N5DNFYJ -&R_U56ZK6BXCJS0 4444 %%%% !1110
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ME: 9S@WM,":VX(]Z 56-KA\XK1LUP0*0#TL@>HJQ'81KSBIMX7M2/<!5S2;
ME1%7I3\@53BN@QILEV V*0%[(HSBJ/VL*,TY;D2+D4 67=<<TV,IG@UEW-YC
M(S3+6\PW)I] -S(HR*I"Z!&:43YI 7,BC(JB]T$.*>L_&: +E)FJZW(-0M=@
M/B@"\2!4;;&-5Y;@;,U72?<>M &HN,<4M0QO\M*TH% $M)G%0_:!36F!H L9
MHR*KB; IIFQS0!:)IC%3UJ)9A)TJK+/M?&: +RA0>*DR*SDGQWJ839% %O(I
M:I"X^;%2&Y"T 6:3.*B$P*YJ(W()Q0!:X(JG<6\3@[J<;@**J7$_RYS0!3FL
MH5/R@4V)7C88Z4P3[FZU>0J8NE.P%B.[1%&XU,M]">-PKF[\NH)!-9T-S(KC
M+&BP'?*X89%*2!6':ZHJ0C--FUQ%/6D!O9I#@UEV^J+*F:F%X#WIV =/M#<U
M+"J8&*R+R]'F=:LVMSE12L!KT5$DH(J-KD*V* +-%5C<@#-/2<.,T 34F0:A
M,P)Q2;]HH <X3O38RN[BJD\W4U#;W&9,4DP-@&C<*KB8 4UIN],"UFEJDMT!
M3Q=C- %JBJYN0!FG),'&: %F("<UFLRLWRTNJ78B@8U@6.J"24@GO0!UUM]R
MIZK6<@>(&K- !1110 4444 %%%% !1110 4444 %%%%)@%%%%, HHHH ****
M $I:**0!24M%, HHHH **** "BBB@ HHHH **** "BBB@ I#TI:0]* *4\A3
M.*KK=.QYJU+$2:C$'M0!!]I8/BI7FQ'FF/%ANE1SHRQYH S;NZ_>C)[UJV%Q
MNC'-<IJ+-YPP>]:VER,449IH#J0P(IID .,U!'N"\U&X8OD4(!]Y MQ%@UR.
MHZ(N_<%KL&;Y.:B\E90<BF@OH<%*)+9,*#Q5 ZC<JW0UW4^E!W/R\52N-!4C
MY4HN".:A\0SQ_)S6A;:Y+G<<U!<>'I1+D+Q5:\MVL8=S#&*K0&C</B$]"U2#
M6'E7@UY=J.O".X"AN]=5X?OENT09SFFD!NSWTHZ9J..[<G)S6DUAOC!Q42Z8
M^[('%5= C*U74YH[?C->?ZCXAN5N !GK7J&IZ4TMOM"\XKA;WPQ*UP#L[^E.
MX$^G7DUU;J6SS6[86!E;YA4VCZ \4"[D[5T=M9"/&!2=@9%:Z.A49%.N_#T,
MT6.*V(HR$J1%.[YNE3($<2?",*S!MHZ^E=?IEDEK;JH X%67A#'(%+@A<"LP
M)BP XIOF5&B-GFD:-L\4@)?-'<U4N+S8W!HF1PO%9-PLA:@#9AN@PZU964'O
M6#;I*,'FKR[R.#0!I>8OK2[U]:S#Y@XS3U$GK2 T"X]:9YG/6J;"0G@TY5:F
M!;:0 =:HW%T%[T]T?%9-W#,2<9H MVEYOFQFM@,"*Y6RBD$W>NAA#[>: +6X
M49%53N#5(,D4 .+X-/# BH6J-=P- %LL*ADD '6HW+=JKSEMF!0 Y[@ \&K,
M,H*=:P_G#<U=@#D9% &D).:5I,55 ;%(Q('- %GS1ZT>;[U1&XM3W5\<4 6Q
M+[T[S!CK5-5;;3-LF: ))[@*>M-BN]S8S6?=PRLW&:9!'(&&<T ;_F#'!I!*
M/6JD:OCFD=7SQ0!?$B^M+O'K69^\)QFI5#XYH NF0>M-60&J>R3-2!6H FFE
M 0\U0AN,S$9I\Z2%#6;$DB3$F@#HE<$=:=D5GQ,Q YJQD[: )]PH+C%4_GI1
MNS0!8#\U)N%53G'%*A;'- $LL@5<YK,FO.>M6+E7*'%8=Q')NXH V[>Y!'6K
MGF#;UK!M$DVUHHK]Z +RN#33)@U7PU(RMB@"SYN>E/#CN:IQ*PZT.'\SCI0!
M=+ "L'4[WRY0 >]:<Q81<5QVL-)YXY[T =-8W D .:UQTKD]'\SY<FNK3[@H
M =1110 4444 %%%% "4M%% !1110 4444 %%%% !1112 ****8!1110 E+11
M2 ****8!1110 E+112 ****8!1110 4444 %%%% !1110 4444 %13?=J6D(
M!ZT 9DD.]3FN<OK(LYXKL9% !K+D5&DQB@#+T:S,;]*Z#R.,TVT@5>0*O[1B
M@"CY98XIXAP,5:V"EP* ,:^MCY9(%<?J5G+(WW37H[1JPP15673X7_A%,#A]
M/L) !E36G<:>3%TKIH[&).BBG2P)MY%" XN/2\MR*OKI.8\8K>6W3/ JVD*[
M>E5>P'+)H2D]*MQZ#&!G%="(E':G;0*FX&+'I2@XQ5I+!5'2M#:*,47 II:A
M&R*=*N5JU@4A4&G<# G#A\ 58L@Q?D5H/"A;I3HX54Y I-W 5H@1FJDT9QBM
M&FE :$!E11%3TI[6^XYK1\M?2EV"DP,X6V[@T-$8A@5HA0*1HU;J*$!SMQ$Q
MR<4RUA<MR#6^UNIZBEC@C!X%,"G'">E3K!BK>Q1VI<"D!G2V^YJE6#Y<5;V@
MTNT4 43#MZ55:$F3.*V"H--\I?2@#->,E,56"LK# K9:,$=*9Y2 \BD R$'R
M^:<4S4ZJ,<4N!3 J^51Y56L"C H J^54?EDG%7L"DV"@"BRF(<51EWL^<&MQ
MD!ZBH&B3/2@#,A#L<$5>CBXJPD:=A4H4"@"DT&.:01;CS5[:*0*!0!7$>%Q4
M;0[3D5=P*"H-,"B(=PR:IW:,$( K:V@5!/"K+TI <PD;[^E;EI!NCYI8K9 W
M(J_&H4<4VP,V[T]9$Z5E-I0#<"NI*@]:9Y*GM1<#G)+$I#P*P[J"7=T-=^85
M(QBJ<VGQL?NBD!RMJ98X^AJTER^>:W?L""/ 6LNXL&!) I]0*,T@:09-:ECM
M('-<_=P2I+WJ]9SF-0":H#JE"A>#3&A#-FLZ+4%4?,:E&IQYZTK RX8,C%.2
M+;Q4*ZC%CK4T=U')TI .\KO1LW"I!(I%*I!Z4 9ES&1D57@B(DSBM>2,-444
M0#]*5@$6/(YI6BXJT% I=HH S?).>E2);]ZN[%]*7:* *4D/%-0%.*OE0:38
MOI0!B:K 9;9N.U<_IU@5F)([UVERB^6<BLZ)8P_ H OV*;(@*MU%!C;Q4M
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MDI:+@%%%%, HHHH ****0!1113 **** "BBB@ HHHH **2EI %%%%, HHHH
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M@.H.K88"K\%T)$!S7,QVLY&2#5B)ID.WFDP.F5P>]/K-LW<]:T5Z4@%HHHH
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M*6BB@ HHHH **** &L,BH&.TU.QP*KM@GF@"5'R*EJ*-1BI: "BBB@ HHHH
M*@EX%3U4F?G% #(7S)5X=*H0;=_6K_:@ HHHH **** "BBD8X% $<E.3I3 =
MQYJ51B@!:*** "BBB@ HHHH KS*2<TV-L'%+,^*BCY>@"Z.E+2#I2T %%%%
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MS#?5A>E5V"[^M6%^[0 M%%% !1110 4'I10>E $#=:='3&(!I\9!- $M%%%
M!1110 4444 -89J(C!J>H7(S0!*O2EIJ?=IU !1110 4444 %0/UJ>H'(S0
MJ=:FJ&,C-34 %%%% !1110 5!.<J14]0R@;: *L*D-S5Y.E58B":MKC'% "T
M444 %%%% !1110!4F^_5B+[M4[F3#U:@;*"@"6BBB@ HHHH 3 -)L7TIU% %
M"XM5?/%0V]@J29(%6II"IID$Q9\53 L^2FW&T56:S!?.*O45($$46SM4]%%
M!1110!#/]PUCS9W5M38V<UD7 &[B@"]9G]V*NU3LE_=U<H **** "BBB@ HH
MHH **** "BBBD 4E+10P"BBBF 4444 %%%% "4M%%( I*6BA@%%%%, HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *@N 2O%3U7NGV)F@#%N01*,^M:UD
M#Y0K$N)BTH^M;=BV810!<HHHH **** "@]*** *%PKEN*9"K;JMR]*BB^_3N
M!90'%/H'2BDV 44447 ****5P(+K_5&J%ID2&K]R<1&J5H=TAHN!I)TIU(!@
M4M, HHHH **** $;%4IE9F^6K;]*KEL&@"2%6"C-3TR,Y6GT %%%% !1110
M=JIW"$YQ5RH)>AH HVR.)>:U!TJC"V9,5?'2@ HHHH **** "FMTIU-;I0!"
M 2>*F4'%1 X-2J<B@!U%%% !1110 4444 5IE)-,C0AJDF?%01S$OC% %X=*
M6D'2EH **** "BBB@"&0'%0)]^K$C<570X>@"T@.*?3$.13Z "BBB@ HHHH
M8X)7BL^=2#S6D>!5&Z.: )[7[E6*KVOW*L4 %%%% !1110 5C:D"9.*V:QM1
M;$E "V?45KKTK,M%R :TQTH 6BBB@ HHHH **** $I:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ I*6BDP"BBBF 4444 %%%% !1111< HHHH **
M** "BBB@ HHHH **** &R?<-8;QM]IS[UN.<*:R2^;C% %ZVZ"K500K@"IZ
M"BBB@ HHHH *JW@)3BK513_=H RHT8-S6K"/D%4Q]ZKT?W12 ?1113 ****
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MJQ52R_U0JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M  X^?FIH=O:L6YU158BFV^KC-(#HZ*S4U%67-2+?*>],"]153[6OK0;Q0.M
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M %%%% !1110 4444 &*BF^[4M13 E>* ,N5B'_&M"V&8P:@-N6.2*LQ*5&*
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M$XK4JG?0^:F,4 <5)N:3OUK:TR Y4FI1IOS9VUI6UMY8'% %V,844^D'2EH
M**** "L76794.*VJK7-NLPY% 'G4DTGVL=>M=5I<A=5!J&XT<&?<%J_:6C18
MP* ->)0!4E11 @<U+0 4444 %17!Q"WTJ6FR+N0B@#SS5KB07+  ]:@L6D=^
M0:ZJ[TE99"VVEL])2-N5H FTVUR@8UM*-JXJ."(1K@"I: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 3 I<444 %%%% !1110 4444 (1D
M4T)@T^B@ HHHH **** "BBB@ IC(#VI]% #54 4ZBB@ HHHH **** "C%%%
M!1110 4444 %,W\XI]-V#.: %QD4PQC/2I** $"@4TL!2L<"L^ZOHXLY8"@"
M^''K3LBN9.L#S<!N*NPZD'Z-0!LYXI XSBLYK]%C.6JBNK()<%Q0!T'6HWB#
M=JJV]]'*.&!J\I##(H BCA"GI4V*** "BBB@ HHHH *.M%% ";5]*-H]*6B@
M HHHH **** "BBB@!,"C:/2EHH ,8HHHH **** "BBB@ ZTQHP>U/HH :J =
MJ=110 4444 %%%% !1110 8%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4E+12L 444E#8"T4E+1< HHHSBF 44@.:6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ J/RQNSBI** $ Q2T44 %%%% !1110
M48S110 F!2T44 %%%% !1110 4444 )@48%+10 4444 %%%% !1110 4F!2T
M4 %%%% !1110 4A&:6B@"%X%;M2QQ!>U2T4 )@"C(J*>81IDFL>?5T0\.* -
MW(]:6L"'5E=OO5>-ZH3.Z@#0R/6C(KG;K6!&_P!^IK36(Y6 WC- &TR!NHH$
M:CM21R!QD&I* $"@=!2T44 %%%% !1110 4FT'M2T4 -V+Z4N *6B@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"6W20
MY(J>B@" 6R!<8J&2S1NU7:* *4=E&O\ #5@P(5P14M% %![)-V0M6XD"+BI*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHI( HHHI
M@%%%% !1110 4444 %%%% !11120!1113 **** "BBB@ HHHI %%%%, HHHH
M ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** (Y(E<8(J.*V2,\"K%% $$MLCCD57CL(U?.VK]% #%C51@"HGM(V
M.<58HH ABA6/H*FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI=0
M"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 )2T4E+8!:***8!1110 4444 %%%% !111
M1< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI, HHHI@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 44E+2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1124 +1110 4444 %%%% !1110 4444 %%%% !11118 HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "D/2EHH 8'R<4^FA0#3J "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DH
M8X%,5B3S28#Z6FEP.])YB^M-(!]%-WCUI=P]:+ +13=PI0: N+129I: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M444NH!124M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ****5P"BBBF 444E "T444 %%)2T %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1124 +1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%)2TK@%%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*** "BBB@ HHHH **2E
MHN 444E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444@$I:**+ %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%
M- %%%% !1110 4444 %%%% !1110 4444 %%%%%P"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ****6H!1110 4444 %%%%, HI**5P%HHHI@%%%% !1124K@+1
M113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "DI:*5@"BBBF 4444@"BBBF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%)2TD 4444P"BBB@ HHHH ****0!11
M13 **** "BBB@ HHHH **** "BBDI-@+124M"8!1113 **** "BBBEJ 4444
M %%%%, HHHI %%)2T7 ****8!1112 ****8!1110 4444 %%%%( HHI*&P%H
MHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% "4M%%*P!1113 **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *2EHI6 ****+ )2T44P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0R!WD# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%)F@!:*** "BBB@ HHHH *2EHI-7
M2BEHI6 2BFE@*BDN @ZU+*2;)Z0G%9<FJJAQFJTFM*!UJ7)(KV<C;,H6D$P-
M<O-KJ^M1KKRC^*CGT'[)G5FX44PW2CO7*/KHQG=527Q /[U-3!4F=L+E7X%3
M+7%6.N!W^]7465V)@,52E?84HV-"BDS2U5S,****8!1110 4444 %%%% !11
M10 4444F E+24M" ****8!1110 4444 %%%)28"T44E%P%HHHI@%%%% !111
M0 4444 %%%% !1110 44E+2N 4444P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBBA@%%)2TD 4444P"BDHI7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY.::QR:<I% $@Z4M)G IN^@!]%,WTX'- "T44A.* %HIH;-.H **:6Q0&S0
MZBBB@ HII;!I0<T +1110 4444 %%-+T!LT .HI"V* <T +1110 4444 %%%
M% !2$XH)Q43-0!*#FEJ)6Q4@.: %HHHH **** "BBB@ HHHH **** "BD)Q3
M#*!0!)13!(#3@<T +12$XI V: '4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36/
M%.II&:!HRK__ %9KA=7/S,,5Z1-;"12*P;_05D!.*@T4CRV53O/%-5@O45V[
M^&P7/RU2NO#VP<+42C?8TC.QRKW@0=*J2:E@UT$V@L0?E-9,^A.&^X:R<&;J
MJBF-0W\9IWV@]<U*NCR(<[#226,BC[IJ'!W-%4N(EQN/6KT,X YK'=)(S]TT
M+,ZCH:AIW-E-'1K,I%.$BFN;^WLIQ3QJ97O3&FF='@5&\9/0UB)JWJ:L+J8/
M\5*Y#2+;JP[FJTJR 9W&@WBD9S4#W8/&:KF,G%&KHV_S1\QZUZ5HX)5<FO,-
M(G E'/>O3=!EWJM;PE<Y*JL= %XIVVG#I16US"[%HHHJA!1110 4UNE.HH C
M4G-24F*6@ HHHH *0C-+10!"5YIZK3L"EIM@)CBJ\R>E6:0J#2 KPIZU8 Q0
M% I: "HW6I** (D%2TF,4M !1110 5&XJ2DQ0!3;=FIHR:EV"E"@4  Z4M%%
M !2&EHH BY)IX6EP*6@ HHHH **** "BBB@ HHHH **** &E<TH&*6B@ HHH
MH *0]*6B@"%B:;@U/M%&T4 ,0FI.U)BEH A8'=4J]*,"EH :U0,,GFIV('6H
M&<=J )8Q@5)42,,5*#F@!",TFP4ZB@! ,4M%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** "BBB@ HHHH ****3 ****-0"BBBF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4A.*6D(S0!#(<U6((-7/+IC0YI ,
MB!-65Z4Q$VU)3 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ****6H!1110@"BBBF 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+2=J0#,*3TH\M#
MVI=O-.Q0-D?D1G^$4TVL1_@%3T4K"*3V,)_@%5I--A;_ )9C\JU:3;4V+4C)
MCTN-6SL%:$,"QC@8J?%+5I$MC"^*3S*5DS3?+IB):*** "BBB@ HHHH ****
M "BBB@ HHHH *9DYI])B@8"EHHH$%!HHH 9DYIXI,4M V%%%% @HHHH ***2
MDV 4M%%" 2EHHH0!1113 *2EHI %%%%, HHHH ****3 ****8!1112 ****
M$I:**$ 4E+10P"DI:* "BBBF E+112L E+110 4E+10 4444P"BBBD 4444P
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "DI:*3 ****8!1110 E+112 *2EHH ****8!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+12 ****8!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %-8TZDQF@!BDDT^C I: "DI:*5@"BBB@ HHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444E(!:***8!1244K@+112&F N:*8N<T
M^@;04444""BBB@ I*6BE8 HHHI@%%%% "4M%%*P!1113 **** "BBB@ HHHH
M **** "DI:* "BBB@ HHHI6 ****8!1110 4E+10 4444 %%%%*P"4M%%%@"
MBBBBP!1113 **** "BBBE8!*6BB@ HHHI@%%%% !1110 4444 %%%% "$T4$
M4"D(6BBBF,**** "BBB@ HHHH **** "BBB@ HHHH ***0F@!:*0&EI7 ***
M*8!1110 4444 %%)FC-*X"T4447 ****8!1124FP%HI*6F@"BBB@ I*6DS28
M"T4F:6BX!1113 ****3 **** "BBBF 4444 %%%% !1110 44AIN_F@!]%%%
M !1110 4444 %%%% !1110 4444K %%%%, HHHI, I*6BBP!1124-@+1124:
M@+124M&X!112$T; +249I:- "BBDH; 6BDI: $I:**+ %)2T46 2BBEI %%%
M%4 4444 %%%%+< HHHH ****+ %%%%, HHHH *2EHI, HHHI@%%%%*P!1110
M E+110@"BBBF 4444 %%%% !1110 4444 %%%% !1110 E+112L E+110 44
M44; %%%%.X!1110 E+1120!1113 ****5P"BBBF 4444 %%%% !1110 4444
M %%%%*P!24M%# 2EHHIH I*6BBP!1110 4444 %)12U-[@)12T4[ %)2T46
M2EHHH0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "D(I:* $Q2T446 **** "BBB@ HHHH
M****5@"BBBF 4444 )Q2U&V<TY>G- #J*3<*6@ HHHH *0TM)28""G4F*6A(
M HHHI@%%%% !1124F M%%%, HHHH **** "BBB@!#S3=G-/HH *8Q(I](1F@
M!%.:=2 8I: "BBBD 4444P"BBB@ HICYH3- #CTJ/<<U+3=M "YHHICY[5*
MDHIB9I]4 4444 %)2T4F 4444P"DQ2T4 )BEHHI6 ****8!1110 4444 %%%
M% !1110 4444 %)2T4F 4444P"DI:* $I:**2 ****8!1110 4E+12L 4444
MP"BBB@ HHHH **** "BBB@ HHHH **** "BDI:2 ****8!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7:'^(5Y[=>(B3P]-M]<F<\$T >C&Y7^\*A>]1?XA7(C5)3%G)K+N]8F7.":
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M1110 4444 %%%% !1110 4444 %%%% !1110 444F10 M%%% !1110 4444
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MJ,9S4M&*8"#I2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^=<GK&L30QG&:Y ^)YO.(+'K0![';W*3=Q4S.B^E>?:'KQD49:K]]KI1#AJ
M.J:\C#8W"I8[A7[BO)Y?%$GVG;N/6NCT?6FG*_-0!VMQ(JC/%9-QJ:0YY%%Q
M.[19YZ5P?B'4IH"V,T =:WB1%?&X?G5J+75D'WA7B4FN7!N,9/6NFTB_N)0N
M0: /4XK]9>XJ_"R'TKA8[F6*,'FK$.M.IP30!W8V]L4NT'M6%8:CYP'-;43[
MEH 4(/2G8I:* $P/2EQ110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)>><UV3Z-*1T-5QH#F0$KWH P=+T/?(K%?TKT'3-,2&-3BETW35AC&5YK81
MJX H :<*N*SKM^#6C*I(XJA-;,U '*:HLC*VVN(U"WN?,/!Q7JSZ;O'(K/N=
M!5P?DH \L@CE23Y\UTFFR0C'F8K0OO#K)DA:Q9-+N$;Y<T =E:36?&"*U1)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4UNE.HH B7.:EI,4M !1110 4444 %%%% !1112 0F@&@B@"@0M%%%
M,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]!2;N*:7YH =Y:^@HV+Z"F;Z/,H ?Y:^@IIB4CH*3?1OH 00@'I3ME)OHWT
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** $P*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:I@U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 F*6BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I"V*6FL,T 1,V:<K4UEQ2JN: )0<TM(!@4M !1110 4444 %%%% !1
M110 4444 %(3@4M(1D4 0M+SBA6I/)^;-/\ +XH >K9IU,5<4^@ HHHH ***
M* "BBB@ HHHH **** "F/TI],>@" M@U-&V14/E[JGC3:* 'T444 %%%% !1
M110 4444 %%%% !2$X%+36&10!5GDXK+ED^>M*=*SV@R] %BV!.#6H@^6J=M
M'M JZ.!1< )Q49E I)6K-GN2AI :7G"G[^,UA"\/6I5OSTH;L)&P'!I2PK)%
MZ12/?G;1<+E^6Y"=ZK'4T!QFN9U'6&0D9K&.KL7ZFBXDST'^T4QG(I5U%6[B
MN$&K,5ZFI8=3;/4T[B39WJ7(:I@X(KE+346;'-:B7QVTD5<U]XI#(!6.]^14
M7]H,QQ38M3<$P-2 YK#CNSFM*WFW"D-7+1.*@EG""G2286L:^N"H-%QEW[>H
M/6I8[Q6KFH9C+)C-7/,,(ZTP-\7 ]:?YHQ7+2:F4[U5?Q$R\9H Z]KA1WJ)K
MU5[UQS^(&/<TB:JTIZF@#MH[D.,U#+J"HV":QK2\.RH+IV9MW- '0QWZN>M6
MDD#"N.M[IA)C-=#:3[@* +D_(-<_>$K+P>];\IRM8%[_ *V@"5+C$6,U"LQ,
ME/C@+1YIJP8>@#6LWSBM*LRR3&*T^U !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4E+128!24M%%@$I:**$@"BBBF 4444 %%%% !1110 4444
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M7UKDK/5O,Q\WZU<EU'"]: -UKB-?XA40ND+8W5QEYK+*W#?K4-OK1,@RWZT
M>A*X8<&G5SUIK$>T;FJX=8@Q]X?G0!JT5E+K-N.K#\Z=_;5M_>'YT :=%9PU
M>W/\0I_]J0?WA0!>I,UFOJL/]X5&=9@4<L* -;(I<UA'7(-WWQ^=3Q:Q _\
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M\1U#( IJZ@_<U1?.^@"S9L2U:@Z5G6B@&M$=* "BBB@ HHHH **** "BBB@
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MNO,W'B@"^M_D]:NPW.[O7-1E]U:UIOP* -GS/ES6?=7>T'FI6+".L._9\'%
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MV:* .2F\-IG.VGVWAY 0=HKJ&0-0J!: *-MIZPC %7E4**=10 4444 %%%%
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYG-6(FS5/'-6H.E $]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4F:6DQ0(6BBB@84444 %%%% !1110 4444 %%%% $-R<1&L)I=LQK<NO]4:Y
MZ0?OC0!KVDV[%:-8UEP16LIXH ?1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE)@%+24M" ****8
M!1110 4E+10P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *8T@7K222;167=W@ .#0!I"=3WIXE!KFT
MO\'K5^WN?,(YH UP<U%-)M6EC.5JK>DA* $2\4-R:MQS+)TKEVD;?UK7TYR1
MR: -&7&PUDN&\VM*9\*:R9+Q!+B@#2M^U71TK+MKD,:TE;(H =1110 4444
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M!:*** "BBB@ HHHH **** "BBB@ HHHH ***B,H!Q0!+13!)Q2ALT .HHHH
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M !1110 4444 %%%% !3'Z4^D(S0!59<TJ#%2,N*55S0 ]>E.I ,4M !1110
M4444 %%%% !1110 4444 %%%% $3-VI@/-2,M, YH D5LT^FJN*=0 4444 %
M%%% !1110 4444 %%%% !36&:=10! RXH5<U*5S2@8H  ,"EHHH **** "BB
MB@ HHHH **** "BBB@!C+FHV&!4]-9<T 95XA\LFL) ?M'XUU%S'E"*QOLX6
M;- &E8I@"M/M6?:<8K0[4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%)2TK@%%%%, HHHH **** "BBB@ HHHH
M**** "BBB@ HHHI=0"BBBF 4444 %%%% !1110 4444 %%%% !1110 5'+DK
MQ4E(<=Z .:U97VG%<1J)E5CC->D:BBLIKB-65$8Y% &%"9BW>MRQ>4$9JG!-
M"!R!5Z&YCW8&* .ITZ4G%;T9^45S&FR L*Z:)LJ* ):*** "BBB@!,4M%% !
M1110 4444 0RG"FLYI )*T)_N&L.3=YU &O!)FK@Z5FV@/%:(Z4 +1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$
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MHHH **** "BBB@ HHHH **2EI( HHHI@%%%)28"T444P"BBB@ HHHH ****
M"BBB@ HHHH ***2BX"T444 %%%% !1110 4444 %%%% !1110 UVVKFLVZU#
MR@>:TG7<N*Q]2L\H2* ,B[UH'(S7-:A+]IR15VZM&#G@U4,!7M0!B,61\9K2
ML(F=@:'LPSY-:-C&$<"@#H-+@(VUTL*845D:<% 7FMQ?NB@!U%%% !12$@5!
M+.%[T 6**HK= GK5E) W>@"6BD+#UJ,RJ.] $M%1B53W%/R#0!#-]TUF&/,M
M:DO2J!8"3K0!;@3 %6JJPN#5H=* "BBB@ HHHH **** "BBB@ HHHH ****
M"BC-)D4 +1110 4444 %%%% !1110 4444 %%%% !36 (IU% &!J=J&!.*Y.
MYA\N7.*] N80R&N3U&W^<\4$-%.TN]K 9KHK.\X&37,0P8DK8M\*!S3Z#3.B
M$HD6JLJ?-FJT=QMXS5V-A(*#1.P13;3BK6_>*KB 9S0\@B'6A@R;RZE1*J17
M(<]:O1L"*0N@\#%+110(**** "BBB@ HHHH **3(I<T %%%% !1110 4444
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M5G^5^\K4F^Z:S3)B6@"]!& !Q5H=*K0/D"K0Z4 %%%% !1110 4444 %%%%
M!1110 4444 &*C9*DHH 8JXI]%% !1110 4444 %%%% !1110 4444 %%%%
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M(J,)S4M% ""EHHH **** "BBB@ HHHH **** "BBB@ HHHH *,444 &****
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M)FEH **** "@]*3-+0!4G)JB5&^M.91M-939\V@"]!5P=*IV_:KHZ4 %%%%
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MN&&13J0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FMTIU12G
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MI?+7TIPI: &A .U+M%-9L4JG- "&)3U%-%O&#G:*EIK'%  % Z"EQ35;-/H
MB:"-NJBF?8X?[HJQ10! +6(=%%.\A/05+10!"T"8Z52GL$?/RUITF!0!AII2
M!\[:M"P0#[HK2P/2C H R9--1OX:K_V-%OSL%;V!1@>E %&#3X8U^X*N+$JC
M@4^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHICOM% #BV* <U3>XI8Y\
MT 7**:IR*=0 4444 %%%% !1110 4444 %%%% !1110 A.*0-S3&;M3 >: +
M%%,5LT^@ HHHH **** "BBB@ HHHH **** "BBB@ HIC-BE#9H =13-_-.%
M"T444 %%%% !1110 4444 %%%% !136;%0O-@4 )<2 1FL5I@9:L7MSA#6$E
MSON,>] '36; UI5D6)X!K54Y% #J*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "DS2TUJ3 7-%,7-246 2EHHH0!1113 **** "BBB@ HHHH ****
M"BBB@"&X?RXBU<EJ6M-$Q&:ZJ]&8&KSG7H92S;0: 'KK1F?!:K\,2W(R:XNR
MAN//Y!ZUV&GI,%'!H BN+%5?BI;2S&\5;>)R>14UO"0W2@#6L8 H%:Z+@5GV
M@(Q6D.E "T444 0W RE8T\!)/%;Q&14#VZGM0!@" @]*T;6#@9JU]E7/2GK'
MMZ4 2JGRXJI<VV1FKJ]*5E#"@#&BM<MTK1AAV"I1$ :?B@"A=IE37/R0%I^G
M>NIF3*FLQHD\R@!+&UVD&M@)Q56W4#%71TH 0#%+110 4444 %%%% !1110
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M5Q3J** "BBB@ HHHH **** "BBB@ HHHH **** &E<T!<4ZB@!FSFG#BEHH
M**** "BBB@ HHHH **** "BBB@!I7-1/%D5/2'I0!AWT.4-8*P[)R?>NONH@
M4-8+Q 2F@"_IY)P*V5&!638* 16P.E !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% "4M%%) %%%%-@)2T44D@"BBBF
M 4444 %%%% !1110 4F*6BDT @%+113 2EHHI6 ****8!1110 4444 %%%%
M!1110 4444 ,E7<A%85YI@F)RM=!2;0>U '(Q:$JOG96M:Z>J+]VM?8OH*7
M% &1+8Y;@4Z.SQVK5VBD( H K11;35H=*:",T^@ HHHH **** $P*,"EHH *
M*** "BBB@"*4_(:R'8^=6K-]TUD-_KJ -&WZ"KHZ52M^@JZ.E !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (KC_ %9K"E&9
M#6[.,I60Z?O": )[)2#6J.E9]KUK0'2@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6BBE8 HHHI@%%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME7BNBB8%10!+1110!%.VU,UAW=TW(!K9NAF.N>N(R&.: &Q7;[N36W9R%UK
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI*3 *6BBA %%%%,
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M0 4444 (1FF>73\TM $>RG@8I:* "BBB@ HHHH **** "BBB@ HHHH ****
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MV0YQ6LHP*S[-1FM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0#)-9K^)( V"10!6O-.(SM%9AM[F-Q@'%=);:C!=],&KK01,F=HH PK2>1%
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MWT*,$';^E6Y=:MT..*?!K,#D 8H;&:%I81Q*,"KP4 8JO!<K(N11-=+$N2:
M(;V'>O2L233-[<K5V;784."14EMJ4%P>,4 0VNGB,CBMF-=L>!2(4*Y JO<7
MZ0+SB@"GJ\;R1D"N#U#2II'/RGK78S>(+=B5)%,BO;6<]%H"QR=CI$R=5-;$
M=I,HQ@UT\$$+KD**;.\,(Y H"QB6]DS/\PK<MK!54<5G'5K>-^U7[75XICA2
M* *>JVTF"$%<K<:+)/)EE[^E>C8CF&2 :J3^1#R5'%*PF<I8>'UC(;9^E;$M
MDRP845(VLVT3;>*LP:G!<' Q3&<X]A,S'@U/!ITG<&NJ6.%AG:*KSW$-OU I
M- 8K:.)%^9?TK,NO#:')"?I6\^O6R-MXJS!J%O<D 8I@<(^@.A^5/TJS:: S
MGYT_2O0/L\)7=M%59IK>W[ 4 84.@(J_=_2HI]%P#A?TK5?7K9&V\5<M[V"Y
M QCF@:9QCZ1*6QMXI5T%FZK^E=\+>$C.T55N9[>V&2!0#.-_X1P$_<_2K=MH
MQA887]*V!K-KG'%7(+R"7H!3$%G$\: 5IIG%-4ILW 54N-2CMQR10@+4\(D4
MY%<1KVD/*Q*K6X_B: '!(JU;WMO>\X!I"/-DT.X$H^0_E6_9Z*P097]*[86E
MOC=L%5YYX+8= ,4T,Q[?2=O\-6'T[Y>!3O[>ME;'%7K74(;GIBD!RE]I#L3A
M:SETF<2?=->D&&)ER5%4+B6VAZJ* .9@TV3:,K27.D.Z_=_2MK^V+56QQ5VV
MN[>YX % ' 3>'G9ON?I3XO#A R4_2O1WA@ R5%9\]W;0=0*&*QQPT613@+^E
M2?V-)C[OZ5T2ZQ:,^W"UI02V\P& *!G)P:.X/*U?72R%QMKJ/+B49VBJ5Q?P
M0'!Q0!R\^BEV^[^E);^'5,GS)^E=$NJ6SG'%7H)89/N@4 9,6@Q1KPH_*L/6
MM,<9V+7=R.B+DUBWUU!D[@* //#IUV7P%.*NQ:+,R_,I_*NMAN;0L!M6MFVC
MMY$R%% '%Z?HC+("R_I78Z?9B%5XJQ(D,"[MH%9T^O06YQD<4 ;U%8$/B.&4
MX!%:UO=K,N10!9HI!S2T %%%% $5Q_JS6'+_ *PXK<N/]6:Q'XD- %NRSGFM
M4=*S;-@36E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1124K@+1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.Q2T4 %(12T4 ,V#-,D''%34A&: ,YP^:GA4XYJP8U]*4*!3N T1BI.E%%(
MIC(&I]% $8C I2N*?10! <T]*?M%&* &E 33@,"@T"@0C=*CV[CS4U)BG<&-
M5 *5AQ2BE/2D-%*4M421DMR*O$*32A%II@1I"!4P7%+12 *3%+10 F*,4M%
M"4'!I:9@YH&@V#-. Q0*6@1&^:C\O-3XHQ0!&L(!S4@&!2T4 ,;-1^4&ZU-B
MEQ0!&(@*<1@<4ZB@"#)S3UYZT_:*,4 -,8)IP&*6B@ II4&G44 -"@4NVEHH
M **** #M56;)JU2%0: ,2\A8QDXK"2)Q/R.,UV4T:[.161-&F\X'- $^GJ!B
MM<=*RK)2#6J.E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !124M( HHHIH HHHH **** "BBB@ HHHH **** "BB
MB@ HHHI %%%%" ****8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 03\(:QFD_?X]ZV9N5-930_O<T
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M^V?>-*X)G0[U--9 ]80UF)>K#\ZL1ZW!_>'YTTPYB\;-"<X%'V-/2H4U6%^
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M^F@]%JI/I!8'Y:Z; I"HQTIWU X.;19 V0#59]-F7IFN_D@5ATJLU@I_AIZ
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M4 %%%% !1110 4444 %%%% !2$9I:* &A<4%<TZB@! ,4M%% !1110 4444
M%%%% !1110 4444 %%%% #2N32XXI:* &!.:?110 4444 %,D'%/J*4X% %=
MX5;K3HT"=*KN[9XJ:$D]: +:]*=2+TI: "BBB@ HHHH 0C--V4^B@!FRG 8I
M:* "BBB@ HHHH **** "BBB@ HHHH **** "DS0:C.=U $G6H)DXJ<=*9)C%
M &<8@3S5RWC '%5Y>O%6+<\<T 6:*** "BBB@ HHHH **** "BBB@!,4M%%
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MD5+4<AP* *97!YJ:):C9LFI8CB@"PHP*6D!S2T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !28%+10 5#-TJ:H9NE %,MSS4\1]
M*JOUJQ!TH N+TI:1>E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4A -+10 FT4TH#VI]% $!A4GI4,MHK#I5VC% &*^G@_PU7ETX[>
M!70[1Z4A0$=* .*FTV3=P#4:6,\9SS79FW4GI3'M5(^Z* 9S"1S#N:LQO(O4
MFMC[$/2HWL,]JDBS*JWGEC)-))KL4:\D4D^GL5.*Y^_TJ3!P30.YL?\ "2PY
M^\*>/$,1_B%<++8RQL>334653U-# ]%BUR-NXJ]'J"..#7GEMYF1R:WK21@!
MR: .M2X#U+O%84-P5 JR+W(IICN:H8&FDC-99O\ ;33J'/6ANP:FO@&C8M92
M:ESC-2G4 !UI@BXT2'J*;]GC/:J/]H@]ZE2^!/6JL,L&UCQ]VH7LT/:K4<@9
M<YIVX4K@9$VG*>BU6_LL?W:Z E:3"GTHO<#G#I9["FG37'05TVU?04FQ?04[
M@<I)83+TS55[:X4'DUV;PJPZ"JSVBGL*+@><:DUS&K?,:XV]O[M)OOFO7]0T
M03@X%<G>>$#+(<+3Y@.7TK5+AI0"YKT+2+U]J[FK&L?!K12AMM=3:Z(8E ]*
M+B--+]0O)IKZLBCK47]F-BJTVCNWK1H.X]M<C#=13TU^(\9%9$VAR9[U"FB2
MJW>I;!,Z1-9B/<5834HW]*YZ/29..M6!:/".] [FT;R(^E-,T1]*Q&W+SDTW
M[4PXYHT&;9,3=A0HB'85C+=D4IOC2&S9*(1P*@D0=JI)J&!0;[O33!,<T+9I
MHAD[4S^T >*E2^4470WN2+%*!U--,<N[J:E6\5Z>+A<T+<3:&JD@'6HII&C'
M)JX) 169J4H$9JKE7T,^ZU,H?O4EOK'S %JYG5+O:QYJM9W!=Q\W>BX7/3K2
M_#J#FKXOEQ7+Z6"T8YK9^RG;G-2V2R]]N7UI1>J>]9OV<YZT\0$=Z6HC0^W*
M.]+]N7'6J'V0MSFC[*W3-)W$7OMR>M.^VK68;9AWI/*:C4&:PNE-!NEK*&5[
MTA)/>E=C2-/[6M/6[4UCDFE4E:JX6-G[0OK1]H'K65YI/>FF<BD%C2FN%V8K
M+>0;\U%+.=N<U3%QO?%-@;UFX)K3[5C6 ((-; /% F+1110(**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD E%%%(!:***I %
M%%% !1110 4444 %%%% !11128!24M% !1110 4444P"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BF?8N:R+B]8$UKSC*5
MAWD!YP* (AJ+ ]:T[2[,@&:PE@;=R*T[12N,4 ;2MD5#/(56GQ9V5'*FX4 9
MYNV#5=M92XJK);\\"K-K&4% $\Q 4UD-/^^Q5V[=@#6&SGSJ .@MR"!5P=*R
M+)V.*UQTH 6BBB@ HHHH **** "BBB@ HHHH **** &L<5'YE+-G%5<G- %U
M6S3JK1DU87I0 M%%% !1110 4444 %%%% !1110 4444 1LV#3E.:C?K2*30
M!/12#I2T %%%% !44W2I:@N#\M &?+)L-202YJK,22<TZ G(H V(SD4^HH/N
MU+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1E
MCFI*C8"@!V[BJT[\5)DU6NL[: *DDG-7+4Y%99)W<U?M2<4 ::]*6FITIU !
M1110 4444 %%%% !1110 4444 %%1N3FG+G% #J*** "BBB@ HHHH **** "
MBBB@ HHHH ***0]* $S3J@SS4HI"'4TTZDQ38,84##I5::R$@Z5=HI6"QSMU
MHJMGBJ2Z"I/2NM9 U-$0%%@L<Y'HJJ>E7HM*51TK6V"G 46"QG"P&*#8@5I4
MA%%@L9;6 (JG):%6QBN@VU$T"L<T,&87V4KSBF.C>E;YMUQ4;6BGM3&<Q(70
M\ TZ.9QV-;DM@A[5&M@N>E.X%.._D7C!J1K^0+GFKZZ<F.E*;!#VI 9BZC(3
MWJ0:@X]:MMIZ#H*C:R&.E+8G4A_M%J<FI$MUJM-;,#P*KM#(HR!3N#-I;X8Z
MT-?J!]X5SCFX'0&J%S-=C. :5["3.BN-653C<*B&H(W)(KCI9;HGD&F?:+E5
MZ&F.YW*:D@.,BK"ZBIZ,*\Y^VW(;O6A9WD[$9S0V"9Z'!=*_<58WH1U%<C;W
M4H ZU<%\XZFE<+F^51O2D\E/:L,:@V>M2C4/>BX[FRL2]L4R2U#U4M[T'J:N
MBY4]Z87*SZ<&'2JS:0">E:HF0]Z7S4]:!F3_ &0/2D_L<>E:_FIZT[>OK0!C
M'1QCI4+Z9CC%;^Y<4PJI- TSFI--V\XJ'[*WI75- K"H_L:9Z"@1S0C=.QJ1
M0W7!KH#8(>U-^Q(.U"&8GF.!T-9&KSR+$< UV7V!,=*S=1TI)4(Q5Z#1XQK%
MW+O;@U3L-0F61>#UKT#4O#(D8X3]*JVOA4*P.S]*K0.8MZ-J,GEKD&NECU-R
MF.:K6&BB)0-M:O\ 9P5.E+05RD=184Y-2SU-1W5FPS@5G-;S#HII/0:-M=5Q
MQFGC4@>=U<X\5SV4U"1=@_=-%@.K^WJW>GK<(W<5R.;L=C5B&2Z[@T<H61U>
M48=143%=V,UA">Y'8T]99SU!J;#-X(A&<T;4]:R!/,!WICW<H]:1-S:VH.XI
M?)1AU%8'VZ7N:#J4BCK3L,V9H(]IY%9_E(DF0167<:LX4\U1MM4>6?!/>D*Y
MW%@V2!6P.E<_I<FX*:WU/% ,=1110(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *2EHI, HHHI@%%%(3B@!:*8'R:?0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 (PR*K20!NU6J,4 9CV@SP*FA@V]JN;1Z
M48% "*,"D9<BGT4 0B,9YJ0* .*=10!2N8\J:Q&MV,]=#+TJC@>;TH ?:0E0
M*T1TJ&(# J>@ HHHH **** "BBB@ HHHH **** "BBB@!CC(J+RZL48H C1<
M5)110 4444 %%%% !1110 4444 %%%% !1110!$RY-.5:?10 4444 %%%% !
M44HR*EJ.0X% &9/ 2>*?! 1C-6=XS4T>#0 Z,8%/HHH **** "BBB@ HHHH
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MH5Z5D:?(K-Q6P.E V+1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DI:*5@"BBBF 4444 %%%% !1110
M 4E+12: **2EH3 2D/(I:*0#0F#3Z2EIH HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $$E5=HWU:FX6
ML[S3YV* -*.IJ@A.5%3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 444F: %HHHH **** "H9NE34
MR09% %'O4\38J-UP:FA7(H G!R*6D Q2T %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !497FI#41)W4 2#I4%P,BIL\57D)- %%H
M<FKMO%M%5VR#5RWSMYH F'%+110 4444 %%%% !1110 4444 %%%% !1110
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M3&; H <6 I X-4I;H XS42W6#UH U**KQ7 >I=] #Z*0'-+0 44UFVTU90:
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M2,V:SEN<MC-7H_F&:&#0UFQ2*V:F,>:%B I"(Z4<5+LHV4 (K4XMBD"8I2*
M*[R<T++VIDV%[U1:X"MC- &GUYJ&="PJ."?=QFKH0,* ,*:$J:6&,YS6E/"*
MI$A&Q32N!?A?"XJ4M@9JK$PQG-/DF4+R:=K 3>9NIK-BJT=PA/#"K2 /4@,P
M3S0'(XJR(QBF^2,T 1;R*0RYJ<Q TWR!2U!$8E[4[=GFG>0*=Y8 H B\WM2[
M\4R0*G.:JF=<XS0(T%ES44TGRFH(Y1V-60@D%,9D29,E.6$FM![4#FHB E,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M T^B@!BJ!3\444 -90:14Q3Z* "BBB@ HHHH **** "DVCTI:* $VCTI:**
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MT4 -50*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !5.Z4%&JY56Y!*&@#B-7A7<:YT1+YW-=;J=H[,3BN?FLY W H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 44E+0@"BBB@!*6DI:2 ****8!1110 4444 %%%% !1110 4444@"BB
MBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %,=<T^B@#/GM X/%9KZ3EL[:Z*DP/2FV!SO]D#^[4\6FA1]VMO ]*,#T
MHN!SESI._.%K/;0"6SMKL\#TI-@]*0',6NB[&Y6MB&Q50/EK0VCTI<4[@5OL
MR;<;167=:2DK9VUNTF!Z4@.970HPV?+%:-KIL<6/D%:N!Z4N* *S6R8X454E
ML%8_=K4HP* ,F.P"MTJY]E0IC:*LX%+0!E2Z<C_PBJ$NBHQ^X*Z3%)@>E &!
M%HT:CE!5J/3(U/""M7 ]*7% %:*W5.@JSVHHH C9 >U-^SQGJHJ:B@"(0H.B
MU(% I:* $(!J,Q*3TJ6B@!@B4=J#&K#!%/HH SKJPCD'W!5(:1'G[@K>I,"@
M#-AL$3^$5>2%0N,"I<44 59K97'W:P-1T3SLX6NII"H/:@#@E\/%7^[6[8Z6
M(U&5K<,2D]*>J@#I0!0FL5:/&VLJ31@S?=KIJ3 ]* ,"WTD1D?+6G'9QA,%1
M5S ]*6@#(GTU'_@%5/['4-D(*Z+ I,#TH SK2R6+^&KOE+Z5+BB@"+RE]*/)
M3T%2T4 0-;H?X14?V1#U45;HH QY]-1FR%%":>%Z"M? HP* ,\6Q K.U&P,P
M.!70D9J,Q@]J .#?P^[29V]ZZ#3-*$*C*UM"%?2I54#M0 V) BXQ23+N%2TA
M&: .6U73VF)Q69!ISQN.O6NV>$-VJN;(%LXH JV$+*HK4*93%)%%L&*FH K+
M ,\BI#$O85+10 P(,=*8T0/:IJ* *AMESTJ1(%':IZ*=P(C&.PI1$O<5)12
M9Y2^E,DA4CI4U% %9;=>XJ40H.PJ2B@!GEKZ4&-3VI]% $7DKZ4C* I %34U
MES3N!SFH6;RDXS60FD2>=G!KM6A![4T6P!SBBX&9I]DT6,UMJ,"D50!3J0!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444D 4444P"BBB@ HHHH **** "BBB@ I*6BD 4444P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHI*38"T444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI-PI: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****$ 4E+24F M
M%)2T( HHHI@%%%% !1110 4444 %%%%*P!24M)0P"EHHH0!24M%%@"BBBF 4
M444 )1114@+24M%.P!24M%%@"BBBCJ E+110@"BBBFP"BBBD@"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !24M%*P!1113 **** "BBB@
M I*6BEN 4444P"BBBE8 HHHI@%%%% !24M%%@"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****+@%)2T4MP"BBBF 4444
M%%%)2; *6BBA %%%%, HHHH **** "BBBD 4444( I*6BG8 HHHH **** $I
M:**5@"BBBF 4E+12L 4444P$I:**5@$I:**.@!1113 ****74 HHHI@)2T44
MM@"BBBBX!1113 **2EI)@%%%%, HHHH **** "BBB@ HHHI6 ****8!1110
M4444K@%%)FEHZ@%%%%, HHHH **** "DI:*0!1113 **** "BBB@ HHHH **
M** "D/2EHH BVG=4@Z4M% !1110 4444 %%%% !1112 2EHHH0!1113 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI&;%"G-)@
M.HHHI@%%)14W 6BBBJ **** "BBB@ HHHH **** "DI:*5@"BBBF 4444 %%
M%% !1124F 4M)2T( HHHI@%%%% !1110 4444 )12T4K %)2T4 )2T44P"BB
MB@ HHHH *2EHI- )12T46 **2EHN E+24M" ****8!1110 4E%+2 ***2F M
M%%% !1110 4444 %%%% !1110 4444 %)2TE2]P%HHHJ@"BBB@!*6BBDD 44
M44P"BBB@ HHHH **2EH ***2E<!:2EHH: ****8!1110 4444 %%%% !1110
M 4444 %%%)2V 6BBDH 6BBDH8"T444P$HHI:D!*6BBG8 HHHI@%%%% !1110
M 4444 %%%)28"T444P"BDI:0!1113 2EHHI6 ****8!24M%)H HHHI@%%%%
M!1110 4444 %%%% !24M%)@%%%% "4M)12 6DI:*;0"4M%%"0!1113 ****+
M %%%% "4M%%)( HHHI@%%%% !1110 4444 %%%% !1110 4E%%2 M)2TE-@%
M+110D 4444P"BBB@ I*6BE8 HHI* %HHHHN 44E+0 4444; %%%%, HHI*5P
M%HHHI@%%%% !1110 4444 %%(:!0*XM%)2TAA124M !124M" ****8!1110
M4444 %%)2T %%%)2N M%%%, HHHH **** "BBB@ HHHH :RYH5<4ZB@ HI*6
ME<!****0"T4452 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDI-@+
M124M" 2EHHH2 ****8!1110 4444 %%%)28"T444 %%%%, HHHH ****6H!1
M113 ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:**5@"BBBF 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !3)'"J2:<>E9>IW@AMW.>U- 4]3UB.!&^85Q-]XK5'8;_UK
MG_%?B0QR.H>O-Y];DN9R YZUHD2STNZ\3--G8_ZU3&MS_P!\UQ]B\AY9B:TC
M)CO6T8W)OJ;IU>X/1C2?VG<_WC6/'<#H35M) 16BB#9H+JMR#]XU.NLW _C-
M9W!ICG;1*.@.1K?VY..KG\ZL0ZU.6^^?SKEW<YX-2PW&TCFE&!/,=B=8E"9W
M52G\121=7_6LA[K]WUKGM5NF(.#5>S$Y'42^,64_ZS]:(O&;,P'F?K7D]Y>2
MJ_WC3K"::25?F/6I=,5V>Y:=XADG<?/^M=OI-VTNW)KQ_P .1R';DFO4-+?[
M/&I-92@-,[1'^44\-FL+^UU QFI8]54]ZSY&7<V@:6LY;Y2,YIWVY>F:AQ9:
MU+V:,U0:_5>],_M)3W%*Q5C3HJC'>JQJVC;AFD%A]%%% @HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 1ONUSFN(6MI,>E=(>E9VH6WFPL,=J: ^;O&-L_GR'GO7GBNT%
MR2?6O>_%F@-('8)GK7C6L://#,Q$9K>-B=BY8:D" ,U=EU #O7(1>? W*D5,
M;F5NQKH@T2SI!J'.<U/'J^WC=7*":3T-2"1\=ZTT(.N_MS:/O5&^N;^]<H97
M/K49ED'3-%R4]3JFUCWI@UC#=:YD22$=#3#))N[TUH)^1V,>L>8-NZFSMYPZ
M]:Y>*9U.>:UK2X9\ U7,A#9M,\ULXJ]IVE;)%XJU$-V*V+*W+,#BH;079T>@
MVXC"\5V/F8@ ]JYK2X7&WBN@9'\H<5FVAHKR7)4]:6._*\YJ%X7)Z5$\#@<*
M:R;U+L7CKAC&-U0GQ&5/WOUK%N89>?E-9C1SE\;364F:Q.L_X2(R<;JG@U5G
M8<URD%M+G[IKH=,L9&*Y4UFS38[+3,SJ#701+M6L;2X3$@&*VTZ5(KCJ***!
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1112 ****8!11120!1110P"BBBC
M4 HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444F 4444:@%%%% !
M1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:*3 ****8!1
M110 4444 %%%% !24M%)H HHHI@%%%% !1110 5$Q.:EI"!0 B]*=24M), H
MHHI@%%%% !1110 4444 %%%% !12%L4 YH 6BBB@ HHHH **** "BBB@ I#T
MI:* (@3FI!THP*6@ I*6BA@%)2T4@"BBBF 4444 )2T44D 4444P"BBB@ HH
MHH **** "BBB@ I*6BD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "D/2EHH BR<U(.E&!2T %%%% !24M%)@%%%%'4 HHHI@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 E+112 ****8!1110 444
M4 %%%% !1110 4444 %%%% !1110 E+112 ****8!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %-;I3J* (U)S4E)@4M !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 )2T44@"BBBF@"BBB@ HHHH **** "BBB@ I*6BDP"BBBF 4
M444 %%%% !1110 4444 %%%% "4M%%( HHHI@%%%% !1110 4444 %%%% !1
M110 4UC@4ZFL,B@!BMDU+42K@U+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 QES2J,4ZBBX!1110 4444 %%%% !1110 4444 %%%% !1110 4E+118
M HHHH 2EHHI6 **** "BBBF@"BBB@ HHHI, HHHI@%%%% !1110 4444 %%%
M% !1110 4444 %%%%%P"BBB@ HHHH **** "BBB@ HHHH ****5@"BBBF 44
M44 %)2T46 *2EHI- )2T44) %%%%, HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** $I:**2 *2EHI@)2T44D 44446 2BEHHL E+113 *2EHH ***
M* "BBBE8 HI*6G< HHHH **** "BBB@!*6BBD@"BBBF 4444 %%%%( HHHIW
M **** "BBB@ I*6BE8 HHHHL 44446 2EHHHV ****8!1110 4444 %%%% !
M1110 4E+10 4444@"BBBF 4444 )12T5-@$HI:*+ %%%%/4!**6BE8!**6BB
MP"4M%%- %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@!*6DI:E;@%%%%4 4444 %%%% !1110 4444K %%%%.X!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% "&EHHJ>H!1115 %%%% !1110
M 4444 %%%% !11128""EHHH6P!1113 **** "BBB@ I#1128"T444+8 HHHI
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E%%2]P%HHHJ@"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6BBIB 44450!1110 444
M4 %%%% !1110 4444 %%%% !1110 E+114H HHHJ@"BBB@ HHHH 2EHHJ5N
M44450!1110 4E%%2]P"EHHHZ@%%%%4 4444 %%%% !1110 4444 %(:**3V
M!2T44+8 HHHI@%%%% !1110 4444 %%%% !2445+W 6BBBJ **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****3 2EHHH0!1113 **** "
MBBB@ HHHH **** "BBB@!#0***GJ M%%%4 4444 %%%% !1110 4444 )2T4
55* ****H HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **2BE<!:***8!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%,+!>])NP#B0.M-\U/[PK/O]02&,C=^M<U-KRJ2N
MX_G6;JHT5-M7.S\^/.-PIX=2.M>?+KO[Y1O/)]:Z:&\W0J<]13]H#ILW:***
MT,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDHI7 6BBB@ HI
M*6@ HHHI@%%%%( HHHI@%%%% !1110 4444 %%%% !1110 44E+2N 4444P"
MBBB@ HHHH ****+ %%%%) %%%%, HHHH **** "BBB@!K D\&E'2EHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI7 ****8!1110 4444
M %%%% !124M*X!1113 **** "BBDH 6BBB@ HHHH **** "BBB@ HHI*0"T4
M44P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI:5P"B
MBBF 4444 %%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !11
M10 444E*X"T4E+1< HHI*+@+1113 **** "BBB@ HHHH **** "BBB@ HI*6
MD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDI
M,!:***$ 4444P"BBB@ HHHH **** "BBB@ HHHH ***2E<!:***8!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A..M!( K+U34%
MMH&.X5+DD5&+;L6+J_C@!R16'>Z^BJ0K<UR6JZ\\KLJL:R!<2R\EC7+5J';3
MH6W-K4=4DG)PQK%=WY):AI,=35*[NA&A.:Y>=MG7[-)#A<LMW&,]Z]'LLM:1
MG/:O%CJRG4(AG^*O7]-N-UA$<]JWA>QS323.[HHHKO/."BBDI-@+124M- %%
M%% !1110 E+112 ****8!1110 4444 %%%% "4M%%)( HHHI@%)2T4 %%%%*
MP!1113 **** "BBB@ HHHH **** "BBB@!*6BBDD 4444P"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :V<<4*#CFG44K %
M%%%%@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1112L 4444P"BBBBP!1112 ****8!24M)28 :6BBA %%%%, HH
MHI )2T44( HHHI@%%%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1112 ****8!1110 4444 %%%% !1124@%HI*6A %%%%, HHHH ****0"
M44M-.>U #J*2EH ****8!1110 4444 %%%% !1110 4444K %%%%, HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 444E "TE+118 HHHH
M****$ 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%,
MHHHH **** "BBBDP"BBDIH!:*8<YXIXZ4 %%%% !3&SBG$X&:S;W4HX@0&YJ
M).Q45=B:A?+!"?FP:X#6=4>X9HU<FKFNZH7#!6KEO-Y\QC7+.;9W4J20>4=N
M6ZU!).L(P35:^U15!"GFLH23WDFU<G-8/4[=$BY/J2[L;JIS3M<H44DDUJ6W
MA:ZN,,4-=%I?@N0.K/'5PI&%2JD>?V/AZ\EOXWV$C->T:?I-PMC$,=!6AIGA
MR&$@N@R/:ND2-40*!P*ZX4[(\^=1MCZ***V,1.<TM%% !1110 4444 %%%%
M#&SGBGCI110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6J6@ IK, *=4+YW4 2J<BEIJ=*=0 4444 !Z5"S9-2GI42KEJ )1TI:!THH
M**** "BF;OFQ2O\ =H 7(I:KHYWXJ9ONT .HJ)&P<5+0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %(PR,4M% '/:MHB7*LQ6O,]>TGR'8*.]>PZA/Y
M,#'VKRW6]222Z=2.]931T4M=SB3IS&3)%6X-,3@D"M=S&8MP JIYNWD5SRDT
M=T$BU;(ML R\59-](3P36;]IXJQ;.'.2*Q]IJ;1@F:4.H31\Y-;5AX@9!\Q/
M%8A,97M4#KB,LIJXU-29T%8[RW\1K*ZKFNBBNPT8/K7C=G<2?:EY(YKT:UN'
M^S)]*Z(U&<%2G9G54445T'(-89%1#Y6J>F,F: ' Y%+2*,"EH :_W:@63#;<
M59-0%1OZ4 2M]VF(Q!Q4A&5IJICK0 Q^M/08I'(%$9)H <RY-+CBEHH 8$P<
MT^BB@ J-EP<U)2-TYH 13D4ZHAQSVJ0'(H 6BBB@!&^[4$<GS8J<]*A5?FXH
M GHI!TI: "F!LG%$A.*1"* 'XILHRM+NYQ3J *L1P^*LD9%18&_I4U $.,-4
MPZ4F!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC@UUUMIJI J[1P*% ;G<V:***Z#D"BBB@ HHHH **** "BBB@ I"P%+2%0:
M%HHHH 0D"E!S2$ TH&* "BBB@ HHHH **** "BBB@ HI*6D@"BBB@ J"X.4P
M.M3TTH":&!4MU8-S5VFA #3J: **** "BBB@ HHHH **** "BBB@ HI*6D@"
MBBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A8"EI"H- "YHHQ12U
M****8!1110 4$XHH(S0 @(-+2  4M !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%)BEI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HH
MHI %%%%, HHHH *0D"EI" : #.:6DQ2TM0"BBBF 4444 %%%%+4 HHHI@%%%
M% !1110 4444, HHHH0!1110 44E+2 ****8!1112U ****8!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 (6 H!S05!H Q0 M%%% !1110
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M,B@!:*0D"C<* %HHI*5P%I*6B@ HHI*+@+1113 **** "BBB@ HHHH ****
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M, HHHH **** "BBB@ HHHH **** $J"5R*GJK-4H $I/!I^\8QFH%&:""#5
M2>;@X[4AGQP*B89%-6/YN30!-YQ I5F)XICJ ,4U%YI@3F7;TI#)Z&FNO%1*
MN.]# G\W'2CS0.AJ$(:0)@YHL!8,N!FD9^,U'2=: 'B;!IQDR,U%Y6.:=M^7
M-# 43$&G>:".34&SYLTCKGFA@2^=S4JR9Y-4T4GFI<T,"P9*;YN>M1J,CK0%
M]Z 'B09Y-.,RGO4!CW]ZC,9'>@"YY@(ZTW>>AZ574\XJ4$$8HL [>0>>E'G<
MX[4QR"N*8J9&,T@)O/&<9XIXD&.M5&BP<9IR+@XS3L!9$@QC- D&,9J$KS2,
M,=*0$X<#O0' JO1GWH L"0"G>=549-.*X'% #I9"!E::DYH*_+480@YH G,H
MQG/- F&.O-570]:5$/6@"VKYYI6?'-0 X.:<?F&:8$BR;C3C+@56!P:>?F&:
M0#O.SUI#,:A9<FGJH*T .-Q3UN/6JQC^;K3_ "]PH D:XR>M)YQ(J QX/6GC
MI2 F$I/!HW_-BHJ51DTP)?-YQ3Q(%'6J[<&HV;)Q0D!9>?/2FK*>E1(AIY7!
MQ0!(9-O2D:3'(IC+CO0RX% "B7)J57 '6JJK@U(RX'6@!QE(:GK*/7FHBO%-
M\HCF@"=I,<B@/N&3497Y<YIG- $QD"]#S1YA85#Y??-*#@T .,I7K2>=[TCI
MY@S48CP: 'R3E*6.<L:BDCWU)''@4] +/G #DTC2@CDU5<9/6AAD=:0$IN.U
M.67=UJH%).*G1*H"838.*#-SS4+8!QFFD9% $PF&_K4HF&:II'\W6GLN.E)@
M67E&.#4 D.::.N,T[;@XS0 \R8Z4&7'2HV7'>AEP.M(!QD]#2"4BH.4-2=J
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M (IAQQ50]:GN2=O%5=K>M&X%N(#BK%5H6Z"K- !1110 4444 %%%% !1110
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M)2N M%-&<TZF 44E%*X"T444P"BBB@ HHHH @N.E5@">E3W!XXJN"10(LQ
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M #0!@]:85RV>](4YH 5B32)G-2;?W>:CCSNYH )68$"I43Y<FG.H(YJ,L10
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M:5T!(K8%-/--+X/%+R11= ,^[^-&"O-'*FI5(I@,+<=*;@CFGN<=J<C#&2*
M(L'[V*4+DYJ7(W9Q2E<C(H :#@T\X89J.C)7F@!K1Y--\LKS4H?<<XI6.: (
MU>G&3<*/+##-,QN./2@!5;FG>;NXHQ@5']XT 648$8IKG-1*QSBI"<B@ W?+
MBFX-*HS3\[>,4 1X-,9CG%3YW<8IC+@T 1'*C&*=$,]:D'3&*C+8; % $K+C
MI43-@U(&^7FFI'G)HN Z-P#5U3D5GJNUJN1]*+@2T444@"BBBF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %9VL+NLG'M6C5+4_^/)_I4RV*CN>)>(?
MW%R#[U NH?N0OM5CQ81YW%8*ML7.<UQSW/8H;%B27;N)[UES7@!.*FN)BZX
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M4SP:G2,=,5,L8%.VB@!%0#M0R BG44 5C& <8J&52@J]@4UXPPHL!F(>>:L
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MI_"\&@!N1MZ4JL!VI&D4\ 4 C% #BX(J$M@XIU.&W'(YH %(I'2E4@4H;UH
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M#@YK.6#4F;TLP:6YA/<-OP3Q4L(WM[5#+"-YQ5NW0*N*TCET;7-_[4:ZDK(
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MA@TX+SSTIYVD8H 8K9X-+D9QVIAX-)0!)WQVI&8+TIP*[.:C?:>AH ;P:50
M:1 ,]:>0,\4 ./'2DW#M2G@<5!T;B@"9\8R*A9O2GCGK2.@49%  IS4AQBHX
MP">34C*.U !P%R.M,)R:<XPO'6D4@KR>: $#8-/R"O-1J@+9-2-M"\'F@! H
MZ]Z4_=YZU'&3NYJ9MI% %-B<\U-#R/FIP16/-.(11UH %VYYHE5<9J$99JD8
M%P!0 TKE:<L>>M3)%E0#4HB % #$3'':I=@I0,4M " 8I:** "BBB@ HHHH
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M#M6M;'/%$J*BCEJ2;9<135F,$_+44?7%6X(BS\5YM>FCHPT&V2",A:C<5HF
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M@%%%% !1110 4444@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5')TJ2HI.E F4KE2R$ 5S\UM(9NAQ72YR
M<&D:&,\G%2BC,L[=P@R#BGW8*QD5J*$"8XQ69J#;8VQZ5T09$HW/(/&9+WFT
M=ZK^'=(FN& VG!-:NLVCWFL* N037H'AK0TM[=24YQ7>L3RQL>?4P_,S)L_"
MP4*2IKI;/24ACQBMM8548 %*$ KDGB92!8&-[G+:EX?6<\"JMGX86*3)6NTV
M#TI0@]*GZQ(U6$@4+2Q6!!@5>5<4^BL92;W.F%*,=A,4M%%2:!1110 4F*6B
M@!-M,*9J2BG<EQ3(C"#VJ%[-'X(JW134FB72B^AF'2H]V<"KD5NL2X%3T4.3
M8*E!=!HI>HHHS6:N6-*TPQ!CTJ4T"KN0X)C40(.*?112+2ML(::5S3C2T[B:
M3&A0*=112&E80BJ-S9K,.15XTE4FT9U(*6C,5-%C63=BKR6BH, 5=Q0!5.I(
MR6&@46M0PZ5G7FDK(I(%;^*:R@U4*THO0F>$@SQ_Q/IS6ZNVWI7ENH2 LP/7
M-?0'C&Q$EE(P7M7SYK,+17+Y]:^MRG%<R5SAG0Y&8TA.ZC.139'R>:5<XK[&
MDTXW*BACY[U);KE^:C<G/-20-AN:<ZBBBGL;*J!$*B)YYIROF,9JK-+E@H]:
M\VK744V8*C=FU8,97"+S70+ITXCW[3BHO!NC-=7419>#7K\OAN/^S]JJ,XKY
MK&YBD[!+!\QXPC.UZ(2.]>L>%-.Q;QMBL"+P>_\ :N_8<9]*])TFP%I;JF.E
M>)7Q;DC:AA+,T$3:H%/VTX45YM[GJ*"2&%:0+BI:*+A[-&'JRXQ3-*_UE6]4
MC+]!4&G1[')I@DDRS>.V.*K0;@V2*L3."^*S]2OX[*V+Y .*I(KF1JM>Q0QY
M9@,5R?B#QE!91L%D&1[UPGB#QR8VD1).<^M>8ZQX@N+Z1CO)S6T::)<CK]>\
M>2W#LL;9^E<9<:U<3N2Q/-9D>XG>Y.:<V6.%'-:\J,Y-L2YN99> 3FI=+T"[
MU*=?D8@GTK?\.^&9]2F4F,D9]*]O\+>"XK2)6>, ^XK*=AQN<+X8^&^]U:5"
M/K7J-AX,MH$7@<5TUM9QVZX50*LUSN78U1GV^EQ0  *.*O!% P *6EJ;W&&*
M*:"<TZ@ HHHH *0J".E'6FY(.,4 0R6J2#! K(O?#T-RI&.M=!2<"J4F*QY5
MK_@L"-C&I/%>:W^E3:?*VY2!FOIF6%)E((!KA_%?A=+E"T:?D*UA)/1D25CQ
M..Y:,\&K"ZI/$<KFI]8T>2SE.%/6L^('.&%=:@F8N9TNC^+Y[:4;SBO1]'\8
M1W2JI<9->'W"!>5/-6+'4I;%E<,?SHG15@4SZ8MKB.= RG)-+(&!X%>2:!XX
M.]$9_P!:]/TO4%OXE<$'-<DHM&J=RUE@M"KN.34[1=Z8 5/2LC5#2<'FI <C
M/>J\I):I$# 9(H8#G)/6H@V.M/9\TPJ3R12  2:0,<\TJDXYJ-R<T@)]I/2@
M@BG1/\N#0YS2 3S,"FF4L<=J0C(Q3D2F!&X;TXIJ9!QBK#, ,5#NYXH 4DYI
MW:E R>:)%^7B@!!\W2FN2.E,24IFE5F=N!0 QW<=J$R>@JYY.1R*D2W"G-("
MJL9SG%68HO6I@@!IU,!H0 TZBB@ HHHH **** "BBB@ HHHH **** "BBFEL
M4";L*3BH99E122:AN+M(E))Q7,ZMK6%*HU:1A<XJ^+C!:%C5=;$60K5Q][JT
MLKG'2HYII+F0DYQ430XZ5;@>+5QU^I#YCR'FI/LY/.*DCBPW JVP*KP*E4VV
M<%7%W(8(B.@J:1"J]*2.4(U233!TXK>&';.">)N1KTI3&>HZTU'Q0T^VMEAS
MGE6;)>57-5Y9,_6A[C*<5G2W!5MQJO8I(A29;:8(N6-9&H:D%4[3S3+BZ:08
M%4OL;W#<@US58I'91?<SFN9KF3&#5ZTT-[A@S*:U[+1T4AB.:Z2TMUB4<"O-
MK/L>C"21AVOA_;@E:U8=*3@$5JJ58=*1B4YQ7 V[G3[1$ T]$'2H98@!TJWY
MK,.:JW#G'-.,G<F31#Y888(JI<83C%6/M"J,$U2N9E?O7I8=ZG%4(C$'YQ43
MJH&TTOVH*,9JG/<;CP:]FBCD;9'-@-@=*@9]M1R7&#UJG/=<<&O6I4M"XTVQ
MUQ<8X%9\ER<U#+<=:HS7.*]*C2.^E0;+;W)/2H6N=M4?M7I4,DY-=T:1V+#F
ME]I)%"SX.162+K;WIRW'/!HY$BO8V-Q+LGBK5O,2U8<,ISFKL$^ULUFZ5V8S
MHFZEP8^:M1W989K!-SN[U(EYL'6HG05CDG19T,%^R2YJY]L:1@X[5S N=Z9'
M6K]G>;%PYKS*^'003BSMM,U]K90I-2ZAXL;;@-7%O<@G(:F[6N'')KQ*]%)G
M4L6XJQT=KJDM],-W3-=+&$$0.>:YG2+,Q*21S6DLLB-ANE>=5IW9G+&ZFO!>
MO'*!75:?=F4 'TKBH6$A!/:M[3;H(X!-9JFT>GA<7<ZO-+FJD<ZLH.:D$Z>M
M#1ZT:JDB?-+40;=TJ3M4-V-8NXM%1-,J=32I,K\J:CVD2[$E)1FDW"J4D*PM
M!&12>8OK1N!'%.Z"S*[)ALBI$--8G/%.48IE]"4=*6D'2EH("BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *AE^[4U12<BDQ,S?-;S<=JG)XZU#,=I)Q5&6\
M8';0AHU 1MZUFWK%LIZT)<L4IJGS)<'O6B8S*ATD/>K(5SSZ5V5M$(X@ .U1
M6ULBJ#BK@&*F3N3RV84E+14V&(:6BBF 4AI:* $ I:** "BBB@ HHHH ****
M "BBB@ HHHH *3%+10 4444 %%%% !1110 4444 %%%% !1110 4F*6D- &7
MK-L)[)P1VKYR\=6YL[U@!QFOIR9/,B*XKQOXB^&WN \B)D_2O2P-?V<CFJTK
ML\-\P,>33TG.<&K2^'KLW!7RVZ^E:[>$+K[/O\MNGI7UU#-(J-KD*B<]/(.Q
MYK1T.T>_N A4X^E0Q>'[MKL(8VQGTKUGP1X/*S([QXX'45AB<R6]Q2I'/7OA
MLVU@'"'IZ5RVGV,ESJGE.IP&]*^F+[PU%<6/E;1P*XZV\"B+4BX3'/I7C5,S
MYX[CC3LS9\'Z%';VT+A><>E=V$&W;BJ>F68M;9$QT%7^]>+6J.<KLZ(QLB(6
M\8;=M&:EP!TI:*QN6DD%%%% PHHHH IWGTJ.W0 DU;F7/:HD3;DTQ6*$B_OF
M-<KXL20VI"YYKJI90DIS5>\MH[N+D YJTR+7/GZZ\.S7=TQ(?D^E-7P:P/\
MJV_*O>;;PS!Y@<H/RJ__ ,(];[L^6/RK15$@Y6?/3^$'"<1M_P!\U-IW@UGN
M%W1MU]*^@O[ MO\ GFOY4)H5NCAA&./:AU$'*8/A+PU#96ZDH,CU%=JJ*@
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M:KY?+4_C'2F@93^S 18J**/$H%7';C%0QL/- Q0!J0C""I:9&,**?0 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP3O2?:06Z\5JJ;.64+F@95V4Z&X"<GI6:URO:H_M&3P>*KV:)]B;9N!(P*G
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M-&BH/M48X)%2"16&0: 'T57:[C0X)%2)*L@XH DHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&0J*FJM.!B@"O(4Z
MCK6?+?"-]I-7"!ZUEW-HTDV1F@"XDXD7=4\$T>\#/-1P682VR>M51\ER.>]-
M =$&&!2[AFJBRC8.>:7S1U/6D!9+ 4NX"JPDR,FH9+G!Q0!>W"E)Q6;]J(/-
M2FY&WDT 7-PHWBLO[8=^.U3_ &@;<DT 7=XI=PQFLX7.6QFI?M'&* +1D %
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MI5N!T)JG>G>E- 5HS&9235E=N?:J$*_-S5A7&[%# T85^;/:KE4X).E6QTI
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M!3A6)ZD*:B I:**1L%%%% !1110 4=J*0D 4 59LEJEBJ*8@M4L5(":BBBF
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M^T%P.I]*Z*PMA! H':ANX%VBBBD 4444 %%%% !1110 4444 %%%% !1110
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MR6BH_-4]Q3\CU% K"T4F1ZT9'K0(6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBF,P7K28#Z*@:7 S4/VGYNM %V
MBJ?GG.>U+YY)XZ4T!;)Q2 @U 9"5J(2$&@"[14 D)H,A% $]%56F.>*#,<4
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MHH **** "BBB@ HHHH **** "JEQGM5NJLW6@"% 2*&4]!UHR1TI%<YYZTP
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M10 4444 %%%% !1110 4444 %%%% !56=O6K55+A<T 0N3L]JA5235C[R[:
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M4;3Q0V?2AL B;YJO*<K5"-/GS5]/NU/4!U%%%, HHHH **** "BBB@ HHHH
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MCY<4S[-0!4RQ'2H@'W\#BM(087%*L(% %;:Q6JKK(&X%:P0"D\H4 9RAP.E
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MH ;\V>G%2Y.VG?[-1L^#MH :X^3-1H34Q.Y,5&/E.* )ESTIV,<8IJ&G.V*
M$R%/%$GS#BHB3FGJQVTP(A\KC%:$9RHK/^Z_UJ[%2 FHHHI=0"BBBF 4444
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M!;Q'X!YK0M^5R:3 L4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBC- !1110 4444 %%%(6"CF@!:*JRWL4
M7WF%4)==MT/WQ4\R-%2F]D;-%8"^)K0OMWC\ZU+>^BN1E&!IW02I2CNBW12
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M% SWI05 YZU# S1I2]2O-210>2W2M 2\4T@,,GK0 !@1S3.].4#O2H!GF@
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MG04TK2D9'6@! V33MF^FE>*E7E<4 ,V[>**5A@TT@D4 2!LC%!(48J#D<4X
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MM(5P,T )DTP\'-2A,BHF4JV30 \,2*:1ELYI00136!SF@!]."@C-1<L<T_-
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MCF91[UZGX4_U2CVKHIG!C'H=FHP*=35Z4ZNI'B,**** "BBB@ HHHH ****
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M..:I0@[JO+TJ; +1113 **** "BBDI +1113 **** "BBB@ HHHI %%)2T(
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M;DB@!A7YQBKT1&!5(@EABKT8PHH ?1110 4444 %%%% !1110 4444 %%%%
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M? HW'&*-A84 -!R*>K8X[4W&WBF-D'VH G^G2D9L#BFJ^1Q4;ACTH D0D]*
M2*9%E:> 3S0 QLYXIZG I*4#- !N.:%'S9'6I"GRU&"5- #R<<]ZKN[%ZE)R
M::8R1D4 . RG^U4)+HU68N.O6FS#)S0 1DL.>M*RL#DU&A(YJ7?N7'>@! 0>
M#2%2#3 K \T\YXS0 -G'--ISYV\U K_-S0!.<XH.=O-!)*^U)N)&* $I=IQF
MC:<9IW.WVH ;NXQ32K$Y'2G;3C-.7./:@!H4D9HW$#%*S8'%,!S0 X*3TI=A
MI 2.E!E(ZT *$.:MH>,5364L:LQT 34444 %%%% !1110 4444 %%%% !111
M0 4444 8GB.R^UZ>Z8SD5\O^-M&DLM3DDVD#-?7$D8D0J:\Q\<^#UO8I)%CS
MQZ4F:1E8^<K>Z#+L8U<0@<CI4&MZ9)I>H,FT@ U16Z;.WFLV=4:AM"0'ITIV
M[!XZ5GPR\=:M*Q8<5+-5+0L;RW2GJ !59<@T_?G@5#T-%(FW9&!522+9*K+U
MS5@ CD5!</C;CUJXL4EU/<_AG=YAC0GH*]<4Y7-?/_PUOBLZ+FO>K5]\"M[5
MLCSZJU)Z***9B%9.LSB.U<9YQ6G*VU<UQ_B.[*QL,]JB;LCHH4W.1YEXD8S7
M;'WK#CMR7'%=!=IY[LS>M5((AYP&*X*DKGT^'HVB:>C6Y4Y(K=G;$)'M5>RA
M")G%%Q,,XS629MU,&YC9I3GUJU:V9V@D<5=2U$ARPK0CM]J@8JC;GY45$@P,
M8J7R3CI5Y+8GM4PM6 Y%%C*5=&483BD>/$?M6HUN0.G%4;H%5([4K JMSG+M
M]CD=JS9YB1P>*N:@&WD]JQY6.<5:6@I,DC?YZT(R6''2LF/.ZM*%B!5=#G>Y
M:"G:<56())JTAW#BHF4@\4KB9GW"X/%1H3VJU<INZ5712N::%L26+$70^M>Q
M^%\FV3'I7C%JW^E@#UKV;PF?]%3Z5T0/-QCT.N7..:6D'2EKI/&"BBB@ HHH
MH **** "BBB@ JM,WK5FJMPI(H&BNI)>I59M^.U0HK!NG%1RW8BDP::!M6)+
MN/(SBG6O$=0?:A.-H-61^[@S5'/+N<[XED/EL!Z5PD;-]H]LUUNNSF1RE<WY
M#(^<<5WX=H^7S26K+JKE<BGPN5D%) WR8I)$*'<*Z:L(RB?.PJN,CH(7$D8%
M-> 'M698W1!QFM429&:^9QE))L]>E54D5]GEGY:<)#1(3VJ++#H*\2::9TQ;
M2+BN<4_-5T)VYIX)S63A=&L:EF3J>:D/(J%3S4P:L)TF=E*HAI3BHSE14_4T
M,@-<CHLZHR*HF;O4BS9[U%*G-0C<#S3C39E.H7MYIW7K5>-B:ES6CHW)C5)1
M@4!L&H<FE!-92HFD:Y.'YJ0-FJN34BL0*XZE!LZJ6(L6-U.#U7S1N.:Y'AVF
M=<<262](&)J#-2*V!4^PDS15TV2@TXL,5"7J%Y".E-4&BGB4B9G&>*>LHQUK
M/9CVIHE8&J]@R?K)HR;7'-5\!#\M1^:2*<&I>P9,L0B0L=M0CE^:ESFFE0#F
MFL,S-U[DJG XJ53ZU74T[?6L: U7)9.:(B<5&7S4D9XI2H/H;0JW9,*".*5>
M:49SR*5/"RDSJ4RM)$7!R*I-8;VY6MY(]W45*(!Z5[.'RZ30_:V,*+3P>"O%
M0W&FA>0M=*(0.U(\(8=*[O[.:6P*NSE88I$?&.*O^2'3D5>G@"@D"JJ.=V*\
M;%8-IBE5*!MRDF0*L1N5(!JS(!5*56SD5PO#-&/M;%IG&WBE@D8/QTJI&6Z5
M93Y:]#!)PD9SJ7-B%]PJR*R[63FM-3D5]EA)W@3%W0IZ53GSVJY5:X&!Q7<A
MD W 9'6HYF8 'O4R-@5'(=U-@.C)*@]ZN1D[,FJL0Z4M].;:U+^U(#,UG5_L
MBG#@8K/T[Q(LSJK2C)-<OJ=Y+J=^8%R<FK.F^'9X[A&(;K0!W=QJ:1VY?>.E
M5;#6DN'V^8"<U@>(]UII;D$Y"UR/A+4I9=0P['[U 'KUS=B"$LS8XK(L]=2:
M5E\P'!JIXDNMFG$J>=M>>>'KZ>34G4DXW4F!Z=J>L&W3<'Q6+%XLS+M,HI^K
MV,L]AN /2O/(["Z-\1AOO4;@>QZ5JGVMOO9%;8.:Y+PQI\D42L^>E=:!@8H0
M"T444P"BBB@ HHHH **** "FMGM3J* $'3FH9^5XJ8]*JS/@\4 5U+!ZE?E,
M]Z0C*Y'6FKD]:2 6(;NM.E&WI322G(I-Y89-,!$R>M2B($9/6HT)ZFI@_P M
M $$FY>E"LS=:ER'ZTQOEH >HP,FFLV>*0.6ZTN"* (QG=3R<4Y5]::Z9H C!
M);VJ=3V/2H1D'%+D[J !SA_:I$?/%1').*>J$#B@"0G!P.E(<;JB;<&Q3\$B
M@!S*".*A*D'@5(&Q2AL&@!J @<4U\]JF)VCBHZ $QE>: H%+1D4 ($&:=RIH
M7@\4')-  3DYI.AHQBB@!=Q)S2,212D$4W(H CR^:E3]X/GHICMMZ4 ->"/N
M*;' JMD"I!E^M28(% $+YIR9IKDTY": ##$\]*H7]F9U(VY%:H.>#1N4':<4
M <G'I(27[M:MO:[,8%:;1H3D 4W[IZ<4 (C,O':E.<T\$&FDG=0 [M3&//%*
MQ/:E5<4 .7('%+O-"D@<4F"30 X.QI2,CWI@.TTH8@YH 09!J3<=OO4>[G-+
MDELT (<YYI0JD9/6FOGL.::-V.: %.1TH!+]::&XYZTY">IH 4)LI2Q-#-NI
M* %#$=*5B2.:% ZFAG[4 -9>,FHU;G%2M\RU7*G- $@)W>U3H2/I42]*-YSC
M'% $CC)S3<9%-\PCCM3@<K@4 1=&XJPJY3-0X"*334N<_** )<$]*4!A0A-/
M9N.* &/C'%0"1MW%38)J,KM/% $^_P"3WJ%R>U*.E+0 SG;[T]'8+12'..*
M'9).:#DGFD3/<<U)UY/6@!" $YZU$A/4U,1D<U&010!(#NZTTYSS4/F,&J4O
MD<T( ))X--\KOBG4X-NZTP&\[<5"S$&IV;M44G2@ 1V/%/RV<=J9%G..U3-T
MZ4[@)SMH&<4N3MQ2!L#%(!O6HVRO2I1UI608XI 5&D;<,58";U!J-DP>*F5M
MJT -"[3Q5N*JH.6JY&!BD!)1113 **** "BBB@ HHHH **** "BBB@ HHHH
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MQ]*FDO=_?BLZYGW9%(T@FC(O7R3GI65*%/(JSJ#MN/I6=YN!@T&S>A"9624
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MQ;2F_P!VO.[9_P#B;,/]JEZ >G:>JBU3 [5;JIIW_'FGTJW3 **** "BBB@
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M2]1DT ,VGTHP1UJ17S3&8DT )@BF2*<5,!N'--8GI0 @;Y *,<4JKGK3NO%
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MTN(%N=HKY2CD\J=7'K7L'@KQ ZPHF[MZU%[,?LN9'M-[JBPYP:YV_P!9:12
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M--C)(S0 VBGD!NE-Z&@!.]2<,.*:Q'&*<.1Q0!%GYL4\D8IZA<].::Y'0"@
M!!&*"0!BFJ#GBFRY H DW?+3.M+'ADQWH(VT ,9NU"KCK3MN32D8H :S;:>K
M<<TS&:>N.E #<9-2#Y>M&-O6F2$J,T *R]Z83@4]&R.:208&:: A*;^E2QC9
M38_O9[4]V'6D]0$=AUH1LFHMV6]JE4?+D46 5R.U(CY-,Y8U*% &::0#F&Y>
M*J<AJM"=!Q3B8B,\46 KB3 I=Q;I3R8R>,4Y7B]JJS"Y&&[4K D5+NB[8I&9
M3THL*XU<!<=Z@?);%29YQ3_EQTYI/08Z+A<&AY IQ2;ACBF8W'FI 0MS3A(
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M<5BYMGJ4\/&*$"TZBBH-TK!1110,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ II0'J*=10 A'R\51FR#S5\]*J3IGK0!"'
MVC-#/D<TI3Y::< <T[@/A W9Q5Y>E4HL9JZN,<4@%HHHH **** "BBB@ HHH
MI %%%%, HHHH **** "BBB@ HHHH ***2D M5IQBK-138QS3 KJN!DTQV'6I
M^-OM4#X_"@"/KSVH]Q3Q@BFX/0=*8#T;)IQ(S2(G?M2G&>*0"X#=*1R,5(NW
M;Q5=\YXH 3)8\4X "D7%*&!- "T_AEP*, CBEZ#CK0!5(._%3(I/%,;[WO3E
M)% $AP!CO497(J0D%<]Z08Q0!",)UJ195QBFLNZF* #S0!+2^8%7YJ5<8YJG
M>OL4XH &O8]^VK(PRYKG4<O-SZUM6[L%&[I0!.IV-D]*E9PR\57W9;GI4R8Q
M0 @8+R:4,&.>U0LWSX[5*F/PH D"@<]J:V#2,^/I4>XDY'2@ QM;/:GE@XX%
M"D-2L%7I0 (G<4DG)XH1_2G-C'% " X%-=PXP.M,9_2E3':@!\:^E*7!..]
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MKXDL7MY&%<F(N3FNP\4:C'=3ML.17-1!3DMTKTJ:5C!E;RU]*9*%*G%6IVC
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]*J3OCK5H]*J3XQS0
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MY#<PS@%6&3[U,55N]?/>C?$J10JO+S]:[G2_'\4X&^09^M8.)HF>CF$YS3L
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M:EE.U*I?ZSO1S-#-:"=",9JQU%8T*E6&36M$<J*!6L256O(1+"P]JLTA&:I
M<1#H\BZDS[#C-=E:IL@5?2G^6OH*<!@4Y2N*PM%%%2,3%&*6B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4!>>M,#X-*3DT .& ,YICL313P 10! .3S3R<"@ISF@KDT - +'FID3C-"J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#TJI. 15L]*J3C(H
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M,9I HQFFY- #F;--[44Y5R* (1\QYJ9!FHV7FI$&>] #''- X%#J<TA'&,T
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 449I,CUH
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M\BO]E3^[1]E3TJQ11RH7/(@%NH/2I510.!3J*8G)L:5IU%% A*6BB@ HHHH
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M8;GFG>_:E:$YS0L9'7I0!$[ <TSECD5.T)/-"PD<T 1TT@DU8\K<>*5H3G-
M%4KZ4\$@5,8RPXIJPDF@"%@<TNTL.*L- :>(L"@"FP(&*"#MJT\)/2F^0<4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!',NZ)A[5X/\3K G>P'>O>R,C%<5XXT!-0L'VK\V*TINS$]CY;BG,<NSTJ
MYOW"FZ[I$]AJ$GR-@-Z502[8#:4.:]"G42,K,NG.:7S"%Q5)KS QM.:3[9\O
MW36KFF3RLOVYW2@$UTEC:(64X%<3'=.LFX UU>A:H))%0J<TG45C%Q=SU#0E
M\NVP!5RYW;@:- 0/;KQUK=FL%*?=KFG-,UCN<E?7+Q@8JI'?R%P"3713Z46S
ME<U4@T!VF'R]ZY)FZL=%X:9G*DUW47W!6#H>DFUC4L.U= !@5!0M%%%( HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7EO]
MHB*^M6:* /.-;\ PWV]_+!8^U<1<_"\^<=L8_*O?2 1S41MHR<E16D:EB6CP
M+_A5DC?P#\J3_A5;XQL'Y5[]]FC'\(H^SQYZ"M%6#E/ ?^%52[3\@_*KNE_#
M:2UF!*=_2O<?(C]!0+>,'.T4.M<CD.6T?PZUK" PZ5M?V;\N"*U  .E+63FV
M4H(R$TM.=RBG1:6J/G%:F!2U/,4D-1=BX%.HHI#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3<,TFX9Q2#&:=M&<T
M+24M)2 !2XHHI@)2T44@"DHHI:@%+24M" *0D"EI" :8 #FEI ,"EI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2
MT44@"BBBF 4444 )2T44@$S1FC%%*X"T4452 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;N&<4ZF[1G-.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !1113 **** "B
MBB@ HHHH ****-0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBBD 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HI**GJ M%%%4 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 P ;J?30N#FG4 %%%% !1110 4444 %%%% "4M%%*P!1124
M+1113 **** "BBB@ HHHH **** "BBB@ HHHH 2EHHI6 ****8!1110 4444
M %%%% !1110 44E+2N 444E "T444P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 2EHHI( HHHI@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 E+112V ****8!1110 444
M4@"BBBF 444F10 M%%% !1110 4444 %%%% !1110 4444 )12T4K %%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHI %%%%, HHH
MH **** "BBB@ HHHH 2EHHI6 ****& E%&*6A( HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1112L 4444P"BBB@ HHHH **** "BBB@ HHHH **** "D)
MQ2TUES0 ZBD P*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *2EHI6 ****8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %-*Y.:=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1112 ****8!1110 4444 %%%% !1110 4A.*6FLN: %%+2*,"E
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DI:* "BBB@ HHHH ***8\BJ.M)NPTKCB0*3S%]:Q[W5$AR,_K61-KR(A^;]
M:S]HKFBI.QUPE0_Q4[-<+;>(D>=5W=3ZUV$$X>%6SU%4IDN#1;HHHJR HHHH
M **** "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ****+ %%%% !1110 4444 %%%% !1110 4444 %%)2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ IGS;O:GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 )2#.:=12L,****8AGS;O:GT44 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %,E.(F/M3Z9+_JF'M0!Y;XEU62*]*YXW5HZ7JD0LU8D$XK"\:VK
MK.SJIZUS5OJ$T,6TY&!29I%&YXDU".>1EXKS;6XUVDKZUJ:E?223DY.:R[E7
MGCZ$USR>IT).QU7PZN9([B,>]>^:=*9( 3Z5X'X-!MID8C'->QZ9JH$(!(_.
MJC)(SG!LZ:DJE!?I(.6'YU:696Z$5JI)F#BT2444E.XA:***8!43L2<5+4+'
M)Z4 2*.*=2+TI: "DQ2TS=\V* 'T444 %%,9L&G Y% "T4TM@TO:@!:*AR0U
M2@Y% "U$Z=ZEIK, * $3[M/IJL"*=0 4444 (3@5$LN3C%2M]VJZG+=* + I
M:0=*6@ HHHH ***:_2@!U%1(QZ5(3@4 +148DR<5)0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9#[5VPG='GS@DS8HHHK8P"HB_/2I:8R9H <#D4M,5NU/H *86^;&*?3,C=0
MXG S3!)DXIS?=J-,9Z4 .=L4B<TK$4J+B@!0N#0QP*=37Z4 0+)EZL#I595P
M^:LCI0 M0OUJ:H)#@T .1>]2TR,Y6GT (3@4BMFG4@&* !ONU!&XW=*G/2H,
M -0!8'2BD'2EH :S;12*^XTDJEAQ38@1P: )J1AD4F_G%.H C7@XIS?=I,C=
M3^M $"_>J<=*9P&I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%%  3BC.:0C(H P* %HHHH **** "BBB@ HHHH **** "BDI:5P"BBB@
MHHI,<TP%HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBBEJ 4444P"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HI*6D 4444P"BBBD 4444P"BBBDP$I:**8!11
M10 444E(!:*** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444A.!S0 M)4,ES$G5@*8+V _P#+05#8
M[%FEJI]N@_YZ"E^W0?\ /04*0^5EG-+507D.?]8*=]MA_OBJN'*RS15;[;!_
MST%'VV#'^L%+F%9EFBJOVZWQ_K!1]OM\?ZP?G1<+,M455^W6_P#ST%'V^WQ_
MK!3N%F6J*J?VA;_\]%_.E%_;_P#/1?SHN%F6J*JC4+;_ )ZK^=)_:%L?^6H_
M.BX69;HJK]OMO^>J_G1]OM_^>H_.BX6+5%5/[0ML_P"M'YT[[?;8_P!:M%PL
M6:*J?VA;?\]1^=']H6W_ #U7\Z+A9ENBJPO[;_GJM'VZV_YZBBXBS15;[?;?
M\]5_.C[?;?\ /447 LT55.H6W_/4?G2_;[;_ )ZBBX6+-%5OM]M_SU6C[=;?
M\]13N!9HJM]OMO\ GJM+]NM_^>@HN!8HJL;^V'_+4?G0+^V_YZC\Z6@[%FBJ
MWV^V_P">HH^WVW_/5:+B+-%5OM]M_P ]5H-_;?\ /5?SHN!9HJK_ &A;?\]5
M_.D_M&V_YZK^=,=BW153^T+;_GJOYT?VC;?\]5I7069;HJH-0MB?]:/SI_VV
MWQ_K!1?4+%BBJIO[<?\ +0?G0+^W)_U@_.F%F6:6H/M<!'^L%+]JA_OBI$34
M5#]IB_OB@W,7]\4[CL345#]JB_OBC[5%_?% 6)J*B^TQ?WQ2?:8O[XHN@L34
M5#]IB_OBC[5#_?%%Q6)J*@-Y"/XQ3/M]O_ST'YT:#LRU157[?;_\]!^=)_:%
MO_ST'YTFT%F6Z*J?;[?_ )Z#\Z47]N?^6@_.FF%F6J*K_;(/^>@I/MT'_/0?
MG1<+%FBJPO8#_P M!1]M@'6047"S+-%5?M]OG_6"E^W6^?\ 6#\Z+A9EFBJW
MVV#/^L%!O8!_RT%%PLRS153[?;Y_U@IWVZ#/^L%*X699HJL;V#_GH*/ML/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\1+@MCS#^=>=K"QXW59@L&9NM%Q^S/28?'DY _>'\ZM?\)[-MQYA_.N!ALF
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MTO\ X6+./^6A_.@_$6<_\M#^=>;^2SC[U-\ENFZE<2IZGIJ_$6;IYA_.I/\
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M\+BWEID]Z9FT>XH<H#[4M,C_ -6OTI]40%%%% !1110 4444 %%%% !1110
M4444 %%)12N M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M".].X:$H!ZYXIC-AN>E-C<[L$TLJ\YI7#08V#0!3 #GVI]%@"C83S2KUI[,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1110 4444 (V<<4+G'-+10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444AH 6BDHYH%<6B@44#"BD%+0 444@H 6BBB@ HHHH ****
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MT=J %HI,T4!<6BDS10%PHHS13$%+24"@:"BBBD =Z6DHH *.]'>B@ I:2C-
M7%HI,T9H"XM%%% PHHHH ***3- "T4F:6@ HHHH **** "BDI: "DHZT4"N&
M:***8@HS110 9HS110 M)1FBD.X4444 %%%% !VHHS13 444@I:0Q!2T44 %
M)2TE F I:3- H"XM%%)0,.]+2=Z,T"N+129I:!B4M%% !1110 4444 %%%%
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M^E,IZ$T$DW:HV;TI7) XJ-2:0"Y-)D@TX9H9>,B@H>LF.E3 \9[U3!*FI2Y
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M**0PS1113 ,T4=J.U( I:2BF"%I,T9HI!<6DS1FB@ S1UHZTM ;A28HS1F@
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ME(&]J";H<LF!3'I0.:<V *K0"(?+S3RW%0EB#4BFF*XN>,TW/&:DSQ49'>F
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M ?)7ZUX':'_2@?>O?OA<P,*UJ821[3'_ *M?I3J:G^K7Z4ZK, HHHH ****
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MC&!7,M=2OT)J/?,3U- U$ZDW\87&*C>[1UQBN<!F]33P\@&,T!RLUBZ,<8%
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M11WH[T""B@T"F M%%%(84444 )10:*!!1VHHIB"CM129H"XM%%% T%%+2"D
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MF<8I1R,"HG7GBBX[$GF)G&*/,7IBHU7\Z7;S0I#L*SCH!2 #'(IZA3QCFE8
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MV+A\1X_XLY-<A"/F.*ZWQ8<OQ7,0KUQ7!,]O#(?@=J48[4=^*48K*YZ-M!K
M'I3 ,4\D"C (XI7&D,S@T\'/UIPB!%/"*![TFP(B,CWJ(I@\U.V,\=::1GKU
MIH314= 7%$BJ%QWJ8K@\TQES5IF<D4=@SS4F,"I&3GFE &.:T,VD53[U6<#O
M5Z2.JKIQS5(RDBF^*JR8JY( .M573/TJT8R1&<;>>E1D)4CK\M0E3BK,6B-\
M?A46T$Y'2I2N149!'3I00,.-W%3#&VFA5/-.QQB@")MN>*" 1Q4FP4W']VF
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M*<V,96H\@?2@L.@J&6D-,II,YZ4I4=J0**+E-"#&>*E50:41CM3PH'2@&@
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MI;E%QDTU@-M.;@XI",BM$9-%60@=:BW#%2S)D<U (^W:M$8R0WC/M37Q4IC
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MXJ^BJ%XIOE#%/48&*DT2$/7BD=>*D5.:G,2%>#3-"@J\\5HVZ="*C6  YJW
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M_6K1E):'M"?ZM?I3J:G^K7Z4ZK.8**** "BBB@ HHHH **** "BBB@ HHHH
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M-.# ]Z0["T44G>F(!2TE+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M]/\ $=M=J"''YUMQ3I,N5(-48--$M%%% @HHHH **** "BBB@ HHHH ****
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M4<<R2C*D5)00%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKCGO3MQ!I3@"HV)[4;AL/+'MUIP'F+M<5&,[?>EW$#-)HTC(PM=\-6UY"QV
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MA''!IB<&B:BD!S2T$A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_BCPQ)82LP0\&OI-&#+AA7+^*/#Z:A;N50$X]*QG$ZZ534^94D:-\/Q5W<7
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MJCI4G[M5K1E/&,5D^YO$I ;CTJW!'@BDB3GI5Z- *D;1!<DJN!5-%YS6A<@
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M@4U6)-3RC=38TP:!#E) ILB_*<5,?E%1DX!H$S)E)5^E.!^6GW'WN!3%Z4T
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M#H:3 SSUIC\&C0$B0D9J:#'F 54SQSUJS9D&09H Z&V0",YK+O,>=@^M:\1
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M >:U57Y<FN2>YZ%/8A?CI5.8$\FKC]:AE *U#9T+8S),=Z@E7(YJT\?/-12
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M% "54O?]4WTJY5.]_P!2WTJ);%P^(\SUYAYLGUK'M\$=:T/$38FDY[UB6TY
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M&WK3-W:H0_;-(6YZU5B6RTO!ZTYNG6H$;CK3L\8S0%Q"Y4XJ1"3WI@&/>I4
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M5$).*CC7+XJ_;Q_.!2#4W-#@*E37=VK#R<5RVE1;8P*Z.U.U<4BB8J=U3X
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MI5=^>*EE/4#K57YMV*B2&KD@3(Q3@FVA :EV_+S4%$+C*U1(VR5?(SQ569<
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M2#H+;G-R![U[S\+AB)?K7@=MD70^M>]_"X_NE!]:M+4YYH]LC_U:_2G4V/\
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MT]E.W-1*2#[5:9GT+40)/6K]H&6X7GO65&S"3.>*T+:0F9>:F2+@SO\ 3\M
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MD!+<U,%_=XH6(K&2*:!LHZE+A, UR\Y+R'%:NK.^< UD@$U745P"DU($W4T
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M&34KD]*C9,CFM$9M$6<GFG"E*\4S)!Q5$;!N.[GI3@V32'D4]%Q]*E@F3(Y
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MPT"G"G?=IO2BXQK\=*53CFDI"<4PL#DFE7I0.12,V* %9\#B@$XS48&3FI*
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M>O>OAAS$M6C*9[.G^K7Z4ZFI_JU^E.K0Y0HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "8%(8U/44ZB@"(V\1_@%1M8P-UC%
M6:*!W,R;1K:3_EFOY50N/"UK,N/*7\JZ*B@+LXJ3P):N<^6OY5&?A_:?\\U_
M*NYHH"[.*3P':+_RS7\JT[/PO:VQ!\I>/:NBHIW$00VL4(PB 5/112 ****
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M,N.*@<*U*X-/<>L@V\U$&P^:.!UI 1F@G0V].U(VY'S8KL]-\11[0'DKS,Y
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MU&GZS'M 9N:ZX5$<-6@['0MA1QUIJ$'K3(KJ*=>",U)\N>*Z8SN>;.A),5B
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M<'<X"<-:R[3ZU8BE5X_>KFNV;"0D"L6WW))M8UA).YW4JMS012IZU:1L5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "J=Y_JS5RJ=Y_JS6538TI_$<GJ&<\UEG.:U-0[U
MD\YKSZCU/I,-\(IS2].M-S1FL#IL/"TUEIR@T8R>:0KD#+43+5DH<U&RU)I&
M148'\*B8&K;+4++3-XR(-M*H.<T['-&.::+>I8B))X.*TXI2!UK'4E3Q5J.7
M<.#5HY:E.YI^9NZ5#*W'%0>;CO36?(ZU3:,HT[,JS[F. :@(.*L/DFH&!K%Z
MG9 CQDT=#0,YHP<TD:#LY&*4''!INPTA!S0&A)0<FD .*0''!J2;!M]::0<U
M)3>G6EU&F(.*>K8.:C(-(V0*<12BFC:TZX97'-=A8RDH,FO/K.0HXR:ZW3[O
M"C)KLI2L>+C:-]CJ8VSWITBAEK/@N<XYJXLF:[%)-6/"E!Q9B:G9AE8D<5Y[
MX@L=I8@5ZS<0^8IKD-?TS?&Q K.<3MP]:QY&^4D_&D;+<BKNJ6313$]LUGJW
M-8.QZD9*2' 'UIP3=2$[AQ2*3GK0GJ7=(7R\'BITB+4U!NYJ96["ERL6Y"\)
M[4PIQCO5E\FJK*V:0QFTYJ[:M\P&:I9/2G+-L/O30.QVNF3A-HS78:==!H\9
MKRRUORN!GFNDTK5BK!2U7%G/4BFK'<SVT=PAW $FN1UC3'BD+1C%=38WBR(,
MFI+RW2>,\55D]3FBW&5CSV&26-\.2:T4N5( JS>Z9L!(%8;!X).:RE$]6G*Z
M-I">N:M1R8ZUDV]UD &KZ'=WK)LT:31?!R,TI&!FHXP<5(0<4SG>C&8.>:9(
MF14P7-!3BEN-2LR@T7>H73%7W6HS%N&:FQM&H9K+2 '%77CQ49CSTJ;7-U/0
MJ[<T*N.E3^7BFE">E*Q7-<BH''2CI3<YZ4RR1)B#UJRET.E4MO%-8D=*J[(E
M!2-5)E<X-$UE',O09K*21@>M7(;IAP35)F$Z3Z&5JFA@Q%E'-<;>Z;+$QX->
MGF42KM-9M[IJ3*?E&35J1ER/J>8M&R Y'-0\DUV5UH)R>*S7T1UXQ6BD0Z9S
MY7UIK1\5LOHTJ]:B.F2=Q5<QDX&,<K49)K4ETR0<D51EM7CZBIYA.(Q :D)X
MJ,$KUI-_--2)<23<?PIIX.<\4@!)SVH<&J3%9C@23GM2.I/-.AB9N:G^SMFG
M<+&?\P/!J50QYJ[]CSSBAX0J\4T)[&=<YV\&LB1"Q)K8G4L.*HO%@&K1A4>A
MF,^.*B*YZ5--'EN*B*G%6CF>X!2.](2>W6E!)XI^!BJ;'T(!NW<FIQ@+[U ^
M2V%J[9V,L[ 4GL"16"O(^%S5^TTB:60$UO6>BA%!8#-:T216T?(&106D4K.P
MCME!D S1?ZBL,96,XJ'4-1&"%-<W<3O(_)I"'W5X\Q^9LU4#$=*"I[T%2*$*
MXU=V>34O3K0 %'-'3K5 (P/44HW8Y-'3D]*=4L3$ .:4BF\[J=SB@0W!SGM0
M0<4X4&F)$84DYS3B#0>.::<MTI,- .6Z4J1L>AINTBIH<L>*0UOH311'-:EG
M$S.*@MH2["NDL;'.W H+2-;2;? 7CFN@P=F :HV<.Q !5MGXQ298WR\MS4;(
MH;'>G%ST[U&<EL=Z$,9*I*X%0I"=W-6]IQ@T+A3@U2$V.52HQ5>>,LU3L^!3
M58$\TK@0) ,$XJA?.4!!-;) "&N:U:<HQ&:8&/=/EJGTR)GF!/2JF#(]=!I-
MJ1AC2N!O6N(H1]*K7$F6/-6)#LCK-D8EJ0#)6..#4MMN/4\5$J$GFK,:%#GM
M18"X@(%#KD9I(R2,TY@<4R2A." <52P6Y-:,RYJH83GCI0"9"J$MQ6A#%D4R
M*'FK80CI0#(7C]*BF $?O5TID5F:E)Y<9Q1T).<U*4AB :R,LS=:N7LOF,0.
MM4>0: +,1*GKS6M;L"G/6L-'K3MF.V@3+L/-T![UZ]X$&(17C]H"UR/K7L/@
M92L*YJHZG/,]'7[HI:1?NBEK8Y0HHHI@%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %4[S_5FKE4KW_5&LJFQI2^)')ZB!GFLLBK^HN=W-9^<UYU3<^EP_PC,9
MZT@'/-2$8%,ZUSM'4F SFI,TP>E&>>:$#'[C2@YZTVEYQ5$M 14;9J3)Q3"#
MZ5+0T0MFH6)JT5J)EHL:Q:*ISVH/%38(Z"FLM!JI$(S01GI2D8Z48P,TGN5<
M:,B@$YHR<TZE<9)'UI[+42MBI=V15&;O<B;BFY.*>Q-1U++0=1S3>].QGFEQ
MGFI0[@!D<T@6G+FE)Q56%<:#ZT@'-(2<TY2:0P&:82<U+2%<TB0C=@WM4GG,
M'Z\4P+Q2,IQ5*31$X)G1Z5>,,#/%=%#<EL<UP5G=-&X':NCLKT''-==*9X^)
MPW4V[EMR$5P7B"U#2$@5V33AEP*YC6G(8C'6NAVL<]&+B['"W$10\"JCJ?2M
MNX3)X%4)TVCI7.]#U*:NBL@8#B@EQ31*5. *>')[4*02C87DBH9D&,CK5D=*
MBD%-&93W$4W<<YJ23CIUJ DX]Z=B&*Q)IH!Z]Z7=@4WS.:5@2%,C]*LP2,!D
M]:JDY.:>'XI%6+ZW;YZU?@U!P.6K"4D]:FCD/>AL<4;;WK./F-56D#'K5/S2
M1S3/-.:R:-DT7U8H<BM.ROW5@">*Q5E^6F?:F1J20WJ>@6MV6 YJZLA;Z5PE
MIJSK@'I6Q%K!VCFKO8SDD=.II6%95MJ2N!DU>2X5Q@&FFB.5CLG/%(^<<4 @
M'BG]118>Q48M30Q%6&4=JK2J5Z"HL4@+9I"@/2H3O!Z5*NZ@V0QD]!3?*P,X
MJR!GM4@3(I6N'/8RY4;' YIJ*VWD5IM ,TC0C;TI6*C5,QB0*CWD=:N20XY[
MU7>(^E%C5-,B:4@<=:KO*['FIGC/6HMA/44Q2(M[4C9/6IC$>M1/GN*>IF-!
M-,>9DYS3))-O6J4]SD8HL0R\-2D48W4"]E8YS6/YK,:F2<@8-58S=C5$S.>3
M4\2@GGI64MUCJ:4ZD$&,U21#T-]9$C'!%.^V ="*Y275CZU$-3<C@U21&YOZ
MGJ!\LX-<'J5Y(TIP>*U9[F28$#/-9CV,DC?=-6C.1E22,15.5))#P,UT::2>
MX-2KID<7)JD925SETT]G8?*:UK71U!!*5H/Y4'W<5%_:87@8JTS-Q-&".*T0
M$8!JOJ.LE8]L;#-95UJ+R @5D2.Y8DDU1)=N-1EE4Y/-40=QRW6H\G=FFER#
MFD#=B=I2HXJLSLS9J-Y26H5CC.*#-L<X)Y-1_-CWI3(3UH5CG-40V1DOWIR$
M]Z>S;ATIBL<\TR"=<XYI&)IC/Q3 Y)YH*3&-N)IT><\T_BDSS0('+=!TJ/+"
MG[^<=J:S<XIW !EC[4[!!XH1^<5*.>E*Y7*0L&)Z<5:MXO:IK>'>.E7%M2!P
M*06LRL5]*T-.0EQ@5"("6QBM[2;$[@<4MC6)MV$3!!Q6G%P:?;V^R,8%.V8/
M2BY?J$V!'QUK-)._BKDSG&*A5.<T]R630],]Z@O9]J'GFK0PL>:YS5KS:Y -
M(DJ3/NESWIC2E1UJ*(F3YN]-FSNQ0*X M(U7X 5CYJO;QG&<5.\I5*9-R&=O
M6F6ZEGYJ%Y#(U:5C$3C(I ;%@GR<U:<$\=JCMDVKS4_).*>Q:(%4@T_!IY!Z
M8I5SW% Q@'K0<@\4KDTY&&WFEN PEL<TRI'/ITJ/FF(7) XZ4U<DTXG Q2*W
M84B7<F7VI'X7BA:23('%,9B:DS#I7+7K%R173ZDW7%<I<$^::"2!"5/%#C=]
M:=TY%(3CFDQ/4B52&S6K99) -9N[YO>K]JQ!SWH#H;$!V3C%>M>!9281DUXU
M%*?/'KFO7/ +%HE)JHF$]CU%?NBEI$^X/I2UT'(%%%)2V 6BBBF 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 54O/]4:M
M55O!^Y)K*H]"Z?Q(X?5B=_2J<7(YJWJ[?-6?!(6ZUYTVSZ7#_"6<9IA%/!XH
MZFL7N="(^<TG4\T\^E1]30D4A^.*<.E(/2E]J5Q,7V[4$8H'!Q2D\TQ$>#4;
M+5@GM3&%+8:96*D=*:0:G/%-ZT&JD567%,.:LLM0LN*#2,B+&.::"<T]N*;T
M&:S;-$'O4BDU#DYJ5330-#VZ9[U%@GFGDY-!Z55KH2T&YXH&<4F,\TH/%388
M ^M)UZTTG-.'/6F%@QF@9I0<TM2T @SFI ,\5&#S4R$U21,AZI2/'GM4R<T_
M;VQ5.)@YV9G,"AJ:WNV1@ >*?-'DXJL4V'BDGRLII21T5K=E@.:BO[?[0,UE
M6]T4(&:V8)A(G-;JH<-2ERNZ.8NK5HNU8UV".U=S=6PD'2N?U&P" G%/<TIR
ML<H0 U2< <4^XBVOQ4:IBIV828\,0,XIKMD4I/I3&'%7<DJ2$Y-0$G-6I%P,
MU6<?+FG=BL,8G&14))W5+GY,U"6.<U0K6'>81UIZ/49^89I@)!S2L!?5L]:7
M=4$<F>M*STFK#Z$GF$4&6F [A3#R>:5D"F2"X;//2CS]QP:3:"M0-P:?+H:*
M1HQR<"K<5P>F:QDE/2ITF(;':LFAFU'>.C8SQ6I;:L5(!-<SYW%()FW<4A[L
M[Z#40^.:T4F#+P:X&UNW0CFMRVU(C S57&X)G1[B.E'!K/BO@W<5.LX/0T,7
M(R4J,\4N,=*:)!ZT!JD-1]/!(J$M@Y%!E(%4MA.+)L\TC-4._C-!?(S0'*1R
M'G-0LW%3/RN:@(J3:.Q$1D9Q410D]*M[1C-1,0*5QMLA*X'2JLPXZ5:DDJK)
M)NZTV0S,N=Q[5F2+(3R*VV4-4)@W=JM$,S(D8\$5*8".<5H16V6QBM(6*%!F
MJL0SEY$?& *IR1S'C!KL3I\5-.GPCKBGT,VSC1:2MU!JU!8/Z'%=$T$"G;QB
MJ=S<1VYVJ15(GH55LU3K3B8D]*S[O5,9 (K(EU)^1F@RG*QMW%XD8^7%8UYJ
M1/"U0DNV;O561R*M&5R66Y9N]0Y[@U SG-.5L58FQY..>]-;&,U%)(0>*A,C
M&F9M@[X:HFDW=.M))D\TU!CYJ+&;DQ,'.2.:7?Q0[5'U.35&?,..3S2AN.:>
MN"M,9><TQ7N*"32?6E4TUGIHJPO+4XH<<TQ6I_F;N*$(B8GI2'<1TI_4XH!Y
MQ0(14;'2EVG/2I0W&*:"2^,5+9<1BH2U7(8STQ3X(=QZ5IPV>>U*YI8@@4J<
M <5J0IN7&*6.SV\8JW% 0<8H*Y2.*URXP*Z73;8ICBJME:_,.*Z&"$1J.*74
M=K$X&U.!41%3,VT5"[8&135A%25.:9P@S3II=O-9UU=%5SFF)D]W=A(CSS7'
M7\YEF)JY>7K-D9K,VEGS186A=M<^74A0N^2*9#E5Z5;B.>32L3U)(\(M5;EL
MU-*^!FLZ2;<],!T*%GY%=!9)@#(K'M.36W:M18=C47IS4AX&:KJQ84YY,KMH
M*M8>),G%/)XJHK?-4I;(Q1;0+CMVXXII1MWM34^]4_F #%%R2,\<'I3"X' I
MDTG:H5?F@3)W/%-B!I"W:GQG'2@+DZ\5'*V%-.8\<53N)2JFD!DZ@W)Q7,W#
M8D-;-].036%.V6S03L,!.<TU]W:A34F,#- R% 0V3UK1MB>M5.V>]3I)M3-)
MB9.LN+H'WKV/X>2;X5S7B$<A-R#[U[/\."3$M7$PGL>NI]P?2EIJ?<'TIU;G
M(%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGS!FHY#NY%3-#@YI-@QTJDS%KH4BWS4CD&K$D0SD5!L^:KYB+D7>GGYAQ4A
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"DXQ3OK28 '- #:48[T#%)0,0G%-.>].(S3#F@I#" .M1-BIB,U&RTC2+("
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M*9NR>*D.,<4Q,9@"F'KQ4F0::,9XH;%808_&ER*3C/'6D/7CK2$+QGWI,#-
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M&EIV **** "BBBD 4E+24, I:2EH0!1113 **** $I:**2 ****8!24M%)H
MHHHI@%%%% !1110 4444 %)2T4F E+110@"BBBF 4G%+32N3G- #J*** "BB
MB@ HHHH **** "BBBD 444E "T444 %%%%, HHHH **** "BBB@ HHHH **2
MEI %%%% !1113 *2EHI,!*6BBA %)2T4, HHHI@%%%% !1110 4444 %%%%
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M=C4+02_W37K/_"$KNZ?I3_\ A!T(^[^E5[.Q#Q*/'C!*.0#1Y,N-V#FO7O\
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M>V]@V[[I_*MVUL-@'R_I751^'D4_=JT-(5.U+D']8C8YM8C&N *JRJPYP:[
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MBB@ HHHH ****+ %%%%%@"BBDI7 6BBBF 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1124@%HHHI@%%%% !1110 4444 %%%% !1112 ****
M"BBBF 4444 %%%% !1110 4444 %%%% !1110 E+1122 2EHHH0!124M !11
M13 ****5@"BBBBP!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBBD 4444P"BBBE8 HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M112 ****8!24M% #.<TZBEJ4AA1113L(****8!1110 4AI:* $%+112 2EHH
MH ****8!1110 4444 %%%% !1110 4444@"BBBF 4444 %%%% !1110 4444
M %%%%*P!1113 **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH *:P)
MZ4ZB@!!TI:** "BBBD 4444=0"BBBF 4444 %%%%( HHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444D 4444P"BBB@ HHHH **0G% .1
M0 M%)F@'- "T444 %%%% !1110 44F:6BX!1110 4444 %%%% !1110 4444
M %%%% !1110 444P[MU #Z*** "BBB@ HHHH **** "BBB@ I*6BE8 HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4U@>U.HH 1>G-+110
M 4444 %%%% "4M%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 E+2<TM2MP"BBBJ **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2I 6BDI:: **** "
MBBBF 4444 %%%% !1110 4444 %%%% !1244@%HHHH ****8!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44@"BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%%( HHHI@%%%
M% !1112 ****8!1110 4444 %%%% !1110 4444@"BBBF 4444 %%%% !111
M0 4444 %%%% #3G-.HHH **** "BBB@ HHHH ***#0 44"B@ HHHH **** "
MBBB@ HHHH 0C- &*6B@!,4 8I:* "BBBE8 HHHI@%(<]J6B@! *6BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "DI:* $I:** "BBB@ HHHH *2EHHL E+1118 H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHK*U?4A96[-N X]::5P+\EU%']Y@*IOK%LC8,@_.O)M4\;SF[>,-QGUK
M,/B"XF.=Q_.M8TKD.1[8-9M2?]8/SI?[7M\_?'YUX1+XBO8VPI8BK%OXCNV
MW$U3HD\Y[HNI6[#AQ^=/%] >CBO%T\1W"+]X_G5>;QM/ <;_ -:7L1\Y[D+J
M)NC"I%=7Z&O&M(\93W,BC=G)]:]/T>X::%6/<5,J=D-3-C%+0.E%9%A129%+
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% ".<(3[5Y3\0]<>TB90<=J]5D_P!6WTKPGXLN1&<=C5PW$SAEE:ZE\S/6
MMNQ0<!C7':=J8&U#6V=5\M,BNZFC*1V26,+Q9.#52:)(B0HKGH?$Y5=N:&\0
M!SS6O*C%MG0B(-;,<UPNN2O'.5!K:.O8C*#O7.:C*UQ<9QG-4XIH.8ZWP7&\
MI0G)^85[QH[BWMDR>U>,>"5\N%?E[BO26U Q0J!Z5RU(JQ49';I=JW0T]IU"
M]:XBVU@QGYC5A_$" ??_ %KD:.A,Z=+G]YUJ\IW+FN2L-0^T2#!S74P',0J"
MB6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%-= RD>M.HH Y/6O"=OJ".3&"Q]JX:Z^&432'$0_*O9.#3#&I/2KC.PK(\0/
MPN!;_5C\JD7X6K_SR&?I7M7DIGI3O*7TK3VP6/%3\+AMQY8_*I+/X;>1."8Q
MU]*]E*KG&*/)7.<4>U9DZ=V<KI7AE+2)05%;8TU N-HK1)"T!@:S<V-4TBA%
MIR#.5%2I8QJV=M7**@T2L-1 @X%.HHH&%%%% !1110 4444 %%%% !1110 4
M444 %%%)N&<4 +113=PSB@!U%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12$XH!R* %H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***"<4 %%(&!I: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3%
M!I:2D%@%!.**",BE=@-R":?30@%+3NP$*@T!0*=10 44E%%V M%%,&<\TP'T
M444 %%%%( HHHIZ@%%%)2 6BBB@ HHHI@%)M&<TM)2N 4FT9S3J* $I:**$
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MBBB@ HHHH **** "BBB@ HHHH ****3 ****%L 4444P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444P"BBB@ HHHH **** "
MBBBD 4444P"BBDI +1244@%HHHJ@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3-+32O- #J**
M* "BBB@ HHHH **** $(R* ,"EHH **** "BBB@ HHHH **** "DS2TS;\V:
M5@'9HINWYLT^BP!24M%&H!1110 4C+FEHH 0# I:**8!2$9%+10 @&!2T44
M%%%% !1110 T+BG444 (!S2T44 )CFEHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 3%(%P:=10 4444 %)FC%-V?-FEJ ^BBBA %%%
M%, HHHH *2EHI6 ****8!1110 4444 %%%% !1110 4444 %%%%+4 HHHH *
M***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444@&,2#Q2@TN*,4K
M &:6F!><T^F 4444P"DI:*6H!1113 **** "BBB@ HHHH *0C-+10 @&!2T4
M4 %%%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444@"BBB@ HHHI@%%%% "9%+3-OS9I] !1110 4444 %
M%%% !1110 4444 %%%% !1110 4@.:",BD5<4 .HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0T!WP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D(S1FEH **** "D(XI:0T  I:3H*C>54')I-V!*Y(6 ZFF^='_>%8VH:DD:
M$!OUKGVUT(Q!8_G6?M$;J@VKG<><F?O"G[@17!IKX\Y1N/)]:ZF"\#0J<]13
MYT2Z;-2BBBM#(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH0!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2
MTK@%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBBD 4444 %%)2T7 ****8!1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFEJ+/ST 2T444 %%%% !2$XH)P*C'SF@"6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!:*** "BBB@ J/9ELU)10 F!BE Q110 4444 %,*\\4^B@ '2BBB@!KKFA5
M%.HH 3 S2/TIU13-\M ")MSTYJ:JT+<XJS0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M, HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)12N M%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI-PSB@!:**
M* "BBB@ HHHH ***2D M)FEI* %HHHI@%%%%( I"H/:EHHL SRU]!3L"EHHL
M%PHHHI@%%%%( HHHIH HHHH *2EHI %%)2T %%%%, HHHH **** "BBB@ HH
MHH ****0!1244@%HHHIH HHHI@)CFBEHI,!*6BBA %%%)1<!:***8!1110 4
M444 %%%%( HHHI@%%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "4M)2TD 4444 %%%%, HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $I:**5@"BBBF 4444@"BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %-"X.:&=5ZFD656. : 'T44
M4 %%-R,THJ;NX"T4450!1112 ****8!1110 E+1122 ****8!1112 *.E%(1
MD4P#.:6FA<4ZEU **** "BBBF 444E)@+1113 **** "BBB@ HHHH **** "
MBBDI,!:2EHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444@"BBBF 4444@"BBBF 4444 %%%% !
M1110 4444 %%%% !1124@%I*6B@ HHHH **2EHN 4444P"F[><TZB@ I,BEI
MI7)S0 ZBBB@!*6BBD 4444P"BBDI +1113 **** "BBB@ HHHH **** "BBB
M@ HHI* %HI,44K@+1113 **** "BBB@ HHHH **** "BBB@ HHHH *2EHH 2
MEI*6I0!1115 %%%% !1124F M%%%, HHHI %%%%'4 HHHI@%%%% !1110 44
M44 %%%% !1124F M%%%, HHHI %%%%, HHHI %%)2T( HHHI@%%%% !1110
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHI
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M6K%9@%%%%( HHHI@%%%% !1110 4444 )2T44@"BBBF 4444 %%%% !1110
M4444 %%%% !11120!1113 **** "BBB@ HHHH **** "BBB@ HHHH 2EHHI(
M HHHI@%%)2TD 4444P"BBB@ I,<TM%( HHI*& M%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **0]* ,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M44446 **** "BBB@ HHHH ****0!1113 **2EI)@%%%)1<!:***+@%%%%%P"
MBBBF 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444( HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 **** "DI:*5@"BD)Q0
M*$ M%%-P<TP'4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !124M !1112 ****8!1110 4444 %%%% !
M1VHH[4 <)X[!^SM]*X#P=E=9;/K7?^.P?L[?2O/_  A\NL,3ZUJEH![G9<VR
M_2K%5K(YME^E6:R8!1110 4444 %%%% !1110 4444 %%%%) %%%%, HHHH
M**** "BBD[4 +135!!Y-.H **** "BBB@ HHHH **** "BFL"3P:<.E !111
M0 4444 %%%% !1110 4444 )2T44@"BBB@ HII.*4'- "T4E%(!:***=P"DH
MI:6^H!1115,!*6BD-( I:3I2!LG%" =1113 *2D(.*%!QS2 =1113 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHI@!W=: 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, I*6DI +1110
M 4T=:6CCUI:@!&:7H*8,Y]J?5 )2T4S)W>U*P#Z***+ %%%%, HI-P]11GCB
M@ HIHW9I]*P#7R>E"C IU%, HJ"2ZCC.&(I\<JR+E30 ^EINX9Q3J2 ****8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4P [J?10 4444 %%%%( HHHI@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH ****8!1110
M 4444 %%%% !1110 4444 %%%)2 6D)P":6FR?ZMOI30'/ZUKJ:="SLV,5Q)
M^)EN+CR_-[U'X^FD%O*,G&:\P@T"XN(S<JC'OFM$A'T/H7B&+4XU97!S71@Y
M&:^>?!^K7=EK*6KL0H.,&O>[*X$ELKD]JEH$7**S;C6;6W?#R**?;ZM:W/\
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M'[QP/K52+7;.1\"5?SI :I(455DO(XVP6%.>96MVD!XQD5Y)K_BU[753%YH
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M6N_\=G_1VSZ5Y_X/!;6&SZUJEH(]SLO^/9:L56LABV4>U6:R8PHHHH ****
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M\37?AK:!SBGRL93T'Q+)<:T(V;O6EXNU]K5/E;!Q7 6V[2_$>YN,-4WB6_\
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M=G\UE//-+9%'L,'^I7Z5)3(AMC ]*?6(PHHHH ****+@%%%% !1110 4444
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MP@D;<R FIHH$B&$&*=] %CC"(% Z4^D)Q2!LT@'4444 %%%% !1110 4444
M%%%% !1110P$I:*2D M%%%, HHHH **** "BBB@ HHHH X7QVQ-LWTKS[PA\
MVLL.G->A>/!BV/TKSWPASK#8]:U6PCW*Q&+9?I5FJUCD6RY]*LUD]QA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@>(-.^W1
M%?:N8T;PLD%\9-HZUZ(R*_44Q;>-#D"@1AZQHD=]8>25' KD=)\%1VFH-(%
MYKTTJ",&HEBC#\#FG<91_LT-8>0?2O-?$G@T27#,@Q7KV,"H);.&8Y=0:$P/
M(?#?@SRKY7<9YKUG3K);.$*HQQ4L5E#$<HH!JQ0V 5S/B/21?1L"*Z:F/&K_
M 'A2N!P_AKP^+&9F [UW*#:@%,2!$^Z*EI@5[B%;F%D8=17FOBCP2DJLZ 9)
M->H@"HY8$F&'&:+@>):%X'*WH9^0#7K^FV*V=DL8 X&*LQV$$3950*L[1C%
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M_P#"'S:PVWUK1/01[G9_\>ZU8JM8Y%LN?2K-9C"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M);,*=]D*\T (UZR]*1;KN333:$G-)]D:@"1KP@<4U;HGDFFM:L!3?LK;<XH
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M-% %;[**/LHJS10!6^RBFBS .:MT4 5!9C.::;$$U=HH I+9 &E^QC=FKE%
M%9;50>E.-LN<XJ>B@" VRYSBD:V4]JL44 5?LB^E+]D7/2K-% $(MT':D:W4
M]JGHH A$"@=*1K=2.E3T4 5?LB^E/^S+MQBIZ* (5MU Z4/ I4\5-2'I0!F-
M$$DQ5^$?+UJG<#][C-6K=-J=<T 3T444 %%%% #)/NUF2_?.:TY/NUFRKAR:
M38$**0^>U2[ANS3:9M.[/:F!,PSS3#R,9JI=7)B'6JJ7^><T 6)T/>M+2Q^[
MK'>Z$@ZUKZ2=T?% &I1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI50@A^:: X_QT/\ 1#]*\[\&QM_;3<]Z]%\<_P#'J?I7 ^#5QK+'WK5; >S
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %9]Q@R8[UH=JS+@XFH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!&Z53.=_-7&Z55_BYIH#CO')_T4_2N#\&%AK+?6
MN\\<C_1C]*X3P?\ \AAOK6B>@CV5L-:+GTK/D^6KKDBS7Z5F3%MI-3T!,>MW
MM.">*&N0YQGBL.YDE#''2HHKF3IFI91TUFV9QCI6ZGW:Y727=IQGI75I]T4A
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNV\BK#R#O4$DF[K0!8T[=DY%:HZ5FV+;JTATH 6BBB@ HHHH **** "BBB@
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MUCR_-(0*  -EL8HW?-C%"D9QBD8@G H GW97&*S+N/?D8K14@1X/6FE PZ4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2'I2TAZ4 95P<7(K1A.4'%4)U_P!(!J_"04% $M%%% !1110
MR3[M9%QPY(K7D^[6;-M)(H J>:.F.:<#D>]* F[&*FPH7IS0!7^;=BI%;!P:
M?O7IWIF1NH ANL[#5K2!E.:AG(V$&K6E8"&@#3HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JA
M<8#Y-7B<"LRX8F2@"];D&/BI6.!5>U!V58;I0!EW4@W]*B7##BIKI5#9J*,C
MTH <FU.2*@N&#GY:L.01TJI+RW% %ZQ([5I#I6;8D=JTATH 6BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0]*6B@#.G_UE6K?[E0W&/,QBK$"X6@"0]*KRX7K5@]*J3<T 0>8,U*A
MZU  %/-6(QF@"E<_,U7[,$(*HW8V-FKUGDQ@T 6Z*** "BBB@ HHHH ****
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M!?#8H @NQD8K/-OL8%A6I( 2*BN0,"@"_I8 7BM.LK2W'2M6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "D/2EIK'"T 49R/.%6X2-O JE(P,M782-O H EHHHH **** &2?=K)N#
MAJUI/NUDSC<] $8((XZT%L+CO4JHH7WJ*3;^- $8R35A(B1DU''M_&IGN4B3
MGK0!5O/E&.]7-(_U9S6=).LV3GFM/2\>70!IT444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A&16
M7=?+)6H3@5EW/S24 6[1LH*LGI5:U7""K+=* ,J[!,OM2(G>I+DX:HT?/':@
M!7QCBJTF.U/NI5C6L];M6?&: -6RSNXK67I6;8X(R*TATH 6BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *5P0)/>I[<DK4%S@R>]3P A: )3TJG,<-5QNE49%);F@!"O&33D.*
M=V^:FKC)S0!3NVRW/3-:%FP,0 K.N0"WXUHVB8B% %JBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* $;[IJJ/O\ %6FZ56&-W%,:.0\<C_13CTKS_P '$?VRP]Z] \<9-J<>E<#X
M.C_XG+8ZYJUL)GL3G%FN/2J0?FKTBDV:_2J2IS2Z 2<,/>F28$>.]2)M!]Z;
M/MV^]0!6M9 +C'>NB@)*US-KC[9[YKI8/N4 34444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !110>E &?
M>,,<TRTQNIM^-O)I;+GK4VU TQTXK/OFPIK0&,<5GWPR#5 9@<8IZ/S[5%L^
M;VJ9$]* $G;]V<57L_\ 7CZU9G3$9(JO9*3./K0!TR#Y!3J:GW13J "BBB@
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MK]T4M(OW:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** #M6)J&W>?6MINE85__ *TT 6M/8;0*U*RM
M/ P*U.U %6Z90.:S6!9LK5V[7()-4D.U":  R^6,/6=>$,XQ1>7/S#)JJ;@.
MR@F@#H='4A:UZS-*^X*TZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#TI:0]*
M,RYP9@2:NV_W*IW"YF!JY;_<H F/2JDO6K9Z56< ]: (">,5FWMKYJ]*TF3)
MIPC##F@#GH++9)R,5T=DNU!5*X 5L"K]FV4 H MT444 %%%% !1110 4444
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M9[5 &7#_ ,?>[WKJ;%MT=<[##_I&>U='9@".@"U1110 4444 %%%% !1110
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M/DBNAD"M]X5 85#=* +.FJV!6P/NU0M$VBKXZ4 ( =W6G444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M$X%+10!0G<^<*M0ME:K7"?O0>U68<;>* )#TJK(<-5H]*I7 .[B@ ED_='FN
M6U&X)8@>M=!.KLF%K'EL7=B<4 5[&4DBNHL6R *P(;8Q,.*Z.R"B,>M %I@2
M.*%! YI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH 1NE5>C<U:;I5,YW\TT!R'CH?Z*3[5P/@QR=
M98'UKOO'7_'H?I7 >#%(UEC[U:8'LTA(LUQ53<2.:MO_ ,>:U53 ZTN@6(N0
M<D\5$\_.,TR]<A3M-8BS2>?R3BH Z*U^:45O6^ M8&F$%P36^G.,4 3T444
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ME.>E:\GW:QY?]:=W2@!^<BEVG&:B7.?:I=QQB@"&3=^%-5"33I-WX41[OPH
MCN1MC-6-)SMXJK=[B.*O:0I$= &K2'I2T4 ,0$&GTULYXI1TH 6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
M&SCBLJZSO]ZUNU95V"9..M %RS/[H U.^=O%06BD1C/6IWSMXH R[AB&P>M1
MID]:EG7+Y-"X ]Z &/'ZU7<E6&:LLQ-4Y\[AF@#5LVR.:O5F6.<<UI#I0 M%
M%% !13!G=3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^;% #ESCFD<X7-.ILG*&@#,E&^7-7[<$)S6=(Q6<"M*$DIS0!+1110 4444
M,D^[6-/N,AXK9D^[64[9E(Q0!$NX\&I  HI<>U12N0* *EW=%20.E9_VU@WM
M4MSN<D8K-EW*2,4 73>DM@5T>CONBKCX58GI77:*"L.* ->BBB@ HHHH *3(
MI>U0Y(:@":BD!S2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M32>70 UG6->:KB[4$X-4;Z\('%90O<-0!LS2EWX]:UK,YB%<S#=;F%=%8G*
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M TZJ^2*7S2W3M0!/142S B@3 G&* ):*KO/VJ-I6/2@"Y37/RU"A8BI@..:
M*3RMOQS5B($C)J0Q(3G%.  '% !@4M%% !1110 4444 %%%% !67=OB2M,G
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M!+1110 4444 ,D^[6/-S(=O6MB3[M9;J!(30 P(,<T#:&P*1G[#K355MV30
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MJAD()J<LK=*K3@KRM %VS916BK US"WAB;K5I=9C QGF@#?HK#&KJ>]*VM1
M=>: -NDW#.*P3K:-P#S0-80=6YH WZ*PAK2$XS2-K2 =: -ZBN>&N+T)YI_]
MK@)DF@#=) I:YDZ\F<%JE36UQR: .AHK$76XNYI5U=,\F@#9.#28'M6)+K"C
MH:K'6'ZYH Z3 I<#%<R-;(ZFI4UM2>M '0]*"<5BIK"'O44NM*'Z\4 ;X(-!
M.*YX:VF>#Q3FUI2>M &^&!I:PEU=#T-*=90=30!N45A_VNN,YIG]NQDXS0!O
MT5B#5U(SFHGUQ,X!YH Z"BL$:TF.M(VMIC@T ;])N%8 UI2N,\TJZNA.">:
M-*<@O[U8@SMYK-CE\YP:U(QA: ''I5>0#^*K/:JLV=W- #  @R::L@)(-2$J
MRXIBQA22: *5UC=S5ZR^X*S-0;'(IMIJB1_*30!T5%98U6(<D\4\:K"1P: -
M&BL[^U80,DTS^UX2W#4 :E%9CZI'U!I8]4B;O0!I45G2:E&O>A=4A9>#0!HT
MFT5DG5XP2,T]-6B)Y- %]HQV%1M$>HJO_:T&<9I?[4A]: )QD"G&7 QFJO\
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MI\HV\FK>0[<U52V$568TSUH D8#O2$J1C-*X'<TS8OK0 P %L9J[: ;JK&,
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M62R_O36M+]VL>7*RDT@ )\V:-OSYS1O&,TW/\6:=P)]O&:-O%,63O0TG>IN
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M MN >13O)7TJ6B@" 6X!H%N <U/10!7^SC=FE^SC=4]%("+R5IOV<;LU/13
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M;,=:0VF15ZC%%@*"VE*;0,*O8HQ3 I)9CN*<UDIZ"K=% % 6?- L_FJ_BC%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHI( HHHI@%%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (
M<XXI%SWIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 E%+25/4!:***; ****+@%%%
M%, HHHH **** "BBB@ HHI#G%(!:*:N3UIU,!*6BBD 444G>@!:***+ %%%%
M" ****8!24M)4L!:***H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!A+;J=S2TAZT@8M)2T4 ,8G/%.&<<TM%, HHHH *2EI&) XI6 1L
MXXH7..:5<D<TM, HHHI %%%%, HHHH **** "BBB@ HHHI %%%%, HHHI %%
M%% !1113 **** "BBBBX!1110 4444 %%%% !1112 ****8!1110 C9QQ2+G
MO3J*0!244F\4 .HHHH ****8!1110 4444 %%%% !2=J6B@#A/'>?L[?2N \
M'$C66SZUZ#X\_P"/8_2O/?"'.L,#QS6JM81[G9?\>RU8JM8\6RX]*LUDQA11
M10 4444 %%%% !1110 4444 %%%% !1110 AZ4"EHI %%%% !2'I2T4P&*3G
MFGT44 %%%-!.[I0 ZBBB@ HHHH **** "BBB@ HHHH ****0!1113 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "F,6W<4^BD G:FJ3GFAB0>!3ATI@+
M1112Z@%%%%, HHHH 2BEI*D!:***H HHHH ****0!1113 **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBBD 4444P"D/2EHI ,4G/-/HHI@,!.ZGT44
M %%)2TK@%-.<TZDI#%HHH)Q30@HI P/2EI@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4E+12L 4444P"BBB@ HHHH ***
M* "BBB@"A>7RVQP34%IJJ3;LL.*H>((VPS#/ -</!J\EO,ZEL<^M 'I7]J()
M-NX4Z^U)+6#S"P'%<3IMQ+>RAN>#5SQ#+(UB$Y%*X%Z#Q7$]QL+CKZUT<-VD
ML'F CI7BJ021SA\MUKOM)O7^P[<]%H OWOB6.VE92X&#5G3M:%X05.0:\NU5
MIKK57CRV-U=SX6L&B@7.?QI:@=HK;ES3J:B[5Q3JH HI,\TM !1110 4444
M%%%% !1110 444E)L!:***+@%%%% !1113 **** "BBB@ HHHH **3/-,E?9
M&6I 07EXEK&68XQ7.CQ2C7'EAQUK+\5ZJX_=H>OO7/Z5ITTUP)"&Y-+4#TUM
M400!]PZ513Q) \NP.,Y]:QM55[;3\#/W:\XBU"=-2ZG[U,#WE+I3;^9GC%9;
M:[%]H,8<9!K(_M!UT)&SSMKB+2_EFUAAD_>I@>K3ZF([?S,U@OXOB2;87&?K
M5J>V,FC@C.2M>4ZE;S)JA&6ZT >R:=K27A 5@<UM*<BN&\(63"%)&S7<CI0
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ G/->@:%91+:H2@SBN U3]Q?(6'>O0=#NXGM4&X=*!V*OB:%3;, .U>7"T
MO2V/XJ]2\2RKY) [UP2QCS7(YH:$:DEX/[-6(>F*PM,LS'J?G$=31%<LUVT9
M' -:]OA)%;'>CH!W]K@Z:N1_#7G^KPH=6)VCK7H5D=VG*?\ 9K@M6(_M@CWH
M&=OX>118+A<<5LUE:#_QX+]*U:8@HHHH **** "BBB@ HHHH **** "BBB@
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M1[E8C%LOTJS5:Q&+9?I5FLF,**** "BBB@ II/-.I*0"T444P"BBB@ HHHH
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MQOAD@.=M=DOW:I +1113 **** "BBB@ HI**5P%HHHI@%%%% !1110 4444
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M %%%% !1110 4444 %)2T4F 4444 %)2T46 ****8"4M%%( I***3 6BBBJ
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M8('K7H7CW_CV/TKS_P '$?VRWUK5+01[A8C%LOTJS5>S_P"/=:L5DQA1110
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M*6BBE8 HHHI@%%%% !1110 4444 %%%% "4M%%*P!32BDYQ3J*8"8%&*6C-
M"4$ T4M*X!VII -.I*3   !@4M)2TT 4444P$I:**0!1113 **** "BBB@ H
MHHH **** "BBBD 4444P"BBB@ HHHH ****0!1110 4444P$P#1@"EHH *;M
M&>E.I*0!@"@J#UI:*8#0BCH*7&:6B@!GEKG.*?110 A -+110 4444 %%%%
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M )C%%+24@%I"<4M(1FJ !S2T44F 4444P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBBD 4444P"BBB@ HHHH *2EHI6 ****8!1110 4E+128!1110 444
M4P"BBBD 4444P"BBB@ HHHH *2EHI %%%%, HHHH **** "BBB@ HHHH 2EH
MHI) %%%%, HHHH **** "BBB@ HHHH **** "DI:*30"44M%%@"BBBF 4444
M %%%% !1110 4444 %%%% !1110 4444 %)2T4K )2T4E&P"T444P"BBB@ H
MHHH 2EHI*6P"T444P"BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BDI:2 2EHHH0'"^/!BV/TKS[PA_R&&V]<UZ#X\.;9OI
M7 >#=O\ ;+8]:V6PCW"QS]F7/I5CC-06?_'NM6,5DQA1110 4444 %%%% !1
M110 4444@$I:*2D 4M%%-( HHHI@%(:6BE8! <TM(!BEI@%%%% !1110 444
M4 %)2T4@&X!-.HHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1124@%HHHI@%%%% !124M), HHHI@%%%%
M !1112 ****8"4M%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444@"BBBF 4444@"BBBF 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444( HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444P"BBBD 44
M44P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH 2EHHI( HHHI@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 44E+2 ****8!1110 4444 <+X\&+9OI7G?@XD:TV/6O1?'G
M_'L?I7GOA  :PV/6MEJA'N5CS;+]*LU6L?\ CU7Z59K%C"BBB@ HHHH ****
M "BBB@!*6BDI; +1110 4444P"BBDQQ2 7-%(!BEI@%%%% !1110 4444 %%
M%% !1110 4444 (2!2TTKFEQ0 M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2TD 4444P
M"BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *2EHI %%%%, HHHH **** "BBB@ HHHI %%%% !1110 4444P"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHI %%%(:8"T4@&*6@ HHHH X;QY_Q['Z5Y_X/ &L-]:]
M\>?\>Q^E>?>#U_XG#<]ZU6Q+V/<K+_CV7Z58JO9?\>R_2K%9,H**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI:5P"BBBF 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+1122 ****8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 ****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44D 4444P"BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M*0!1113 ***2DP"EHHH0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHI* %HHHH **** "BBB@ HHHH **** "BBB@ I*6BD 4444P"BBB@ H
MHHH **** "D[4M)VI >>_$$GR3]*X;P6G_$W)/K7IOB[3FNX&P,\5Q/AC1)[
M;569@<9K3H(]=LO^/9?I5BH+12L"@U/4,84444 %%%% !11128"4M%% !111
M0 4444P"BBB@ HHHH **** "BBB@ HHHH ***2DP%HHHI@%%%% !1110 44T
M@TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBF'=NH ?1112L 444ULYXHL ZB@=**8!1112 ****8!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %)2T4 %%%% !1110 4444 %%%% !1110 4444 %)2T4@"BBBF 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444K %%%%, HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 **
M** "BBBD 4444P"BBB@ HHHH K75N)A@C-5;;38HI-P0"M.BG<!,!1@4"EHJ
M;:@%%%%, HHHH **** "BBB@ HHHH **** "BBD;..* %HI%SCFEH ****0"
M4M%% !1113 ****5@"BBBBP!1110 4444P"BBBE8 HHHI@%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !136W9XIPZ4 %)2T4
MK %%%%%@"BD;..*;\VVF ^BD7..:6BP!1110 4444 %%%% !1110 4444 %%
M%%( HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2
MT46 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDNI5!;()'>O8M+4"U1LYR*QG&Q:D:-%-4DTZLRPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFL2* '44
M@.12T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%,9B#
M3ATH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7,6%E)%=!R3BNF4_+0 N:*ISW'E'.::E\&0F@"[D4M8KZG^_"U?-U^X+=\4
M63(HZFG YKEKC49#.H /6MZTF+P GTH L/($ZFD656Z&L74[TQ-CI3=+NGF<
MYH UVN0K8-.2X#UA:K<&)N#WJ6RN2T/X4 :AO 'VU8C?>N:P%FWW.WWK=MQB
M,4 2T56EN1&:8+GS%XH LF09Q3LU17._FK#2!$ZT 3<4M4%N26P*2ZOA!MYZ
MT :%%58;KS$S3UN S8% $]%(.12T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,>-64@CK3Z*
M.5U;PI;WX;,8)/M7,O\ #2W)R(ES]*]/S2U2FQ'E?_"LX?\ GDOY4A^&46/]
M6N?I7JM)FJ]K(5D>4?\ "L(N\2Y^E6[3X=QP.#Y8X]J]++ '%+D4>UD)Q1S^
MG: EI&%VCBM+[$@X*U?I"!2YV4HHIBQC(Y44Y+15/2K1.*6IN.PBC:,"EHHI
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** "BBB@ HHHH **** $I:,44D 4444P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI P-+0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 44$XI 0: %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****5@"BBBF 4444 %%%% !1112 ****8!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444K %%%%, HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ****+ %%%% !1110 4444 %%%% !1110 44
M44@"BBBF 4444 %%%% !1110 4444 %%%% !24M%*P!1110 4444P"BBB@ I
M*6BD 4444P"BBB@ HHHI %%%%, HHHH **** "BBB@ II7-.HI6 0<4M%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1
M113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HH
MHH **** "BBB@ HHHH ***2E<!:***8!1110 4444 %%%% !1110 4444 %%
M%%*P!1113 **** "BBB@ HHHH **** "BBB@ HHHH :%Q3J** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** $(R*%7%+10 4444 %%%% !
M1110 4444 %%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M112L 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI6 **
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
21110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0Q!WD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UCBD
M5LTXC-(%Q0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%
M%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8S8-/II7-  IR*
M=2 8I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HI,TUI%'4T /I,BJ[W*KWJA<:BJKPU2Y)&BIMFF\JKWJI->JG\0KG;K
M6""<-6-=:RQS@UFYFT:#ZG2W6N>4>&K.D\1G^]7+2WYDZFJCW'/6L956;1H)
M'33Z^7&-U9<VIECG-9+3KCK4#3KZUA*9NJ1HO>EN]1>?GO6:]PO8U7DO-O>I
MC)@TD;;.-N=U9=[=;01NK.DU-^@-4;FXED7C-=,692L:EGJ!67[W>O2O"][Y
M@7)KR#389WEY4]:]/\,QR1A>#6\3GDT>DPMN6I:IV1)09JY6B.9[A1113$%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%-+<TH.: %HHHH **** "BBB@ HHHH **** $
MI:**2 ****8!1110 4444 %%%% !1110 4E+12 ****8!1110 44W?S3J "B
MBB@ HHHH **** "BBB@ HHHH **** "DI:*0!1113 **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHI6 2EH
MHH ****8!1110 4444 %%%% !1110 4444 %%(3BD#9H =1110 4444 %%%%
M !1110 4444 )2T44@"BBBF 4444 %)2T4@"BBBF E+112 ****8!1110 44
M44 %%%%+J 4444P"BBB@ I*6BD 4444P"BBB@!*6BFL<"D N:6H@V34@HN),
M6BBBF,**** "BBB@ S4;2 4LC87-8]]?"$'FI;L5%7+\EVB=367=ZDHS@USU
M[K8Y :L6XUGK\U9N1O&%CHKG6  ?F_6L6?569OO5SEUJA))W51.K -R:SE(Z
M:<3HYKMF'6LZ6YQU-9<FM(!R:H2ZJLQ^4UE=F]DC8>]4=ZJ2WP/0U0CCDG/!
M/-7K?0+B8@X-#C<;:17^TR,W!J41SS#Y,UO6OA28@94UTNE>&#&P+I2]DV9R
MJI'!Q:5>-U4T2:)>-_"?RKV.+1(0H_=C\JG&C0?\\Q^5.-)IF$JR/$D\/79;
ME#^5:MIX8F;&Y#^5>MKH]N#_ *L?E5N/3H%'W!73"F82JGG>G^&!&02GZ5V6
MEZ6D('RUL+:Q+T45*J*O05JD9RG<1(P@XI]%%,S"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBBBP$97FG@8%+10 4444 %%%% !11118 HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *0TM% $>SFI*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBBP!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11118 HHHH ****
M "BBB@ HHHH ****5@"BBBBP!1113 ****+ %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 (PR*:JX-/HH **** "BBB@ HHHH **** "BB
MB@ HHHHL 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11118 HH
MHH **** "BBB@ HHHI6 ****=@"FL,BG44K 1*F#4M%%%@"BBBF 4444 %12
M2A 3FG.<*:YO6-0>%&Q0-(MWNJ*@(W5SMS=B[8J&KC-7\1S+,R\U3TS7I&GY
M)ZUD[LT@CLFT5I>?6L;4-&:+-=!8ZL&0;CVJAJ^H(0<,*S.A'$7L!CR*PKD,
MI)S6_?W"NQYK(F"OWJ;79M>QA7,S],FHK:<AQDU<O+<!2160V]'X!ZU2B@<S
MTWPU;"YVDUZAI.CIY8.T?E7CWA/47B9!7MN@7@DMU)/:M%!&52<K:&E#8I&/
MN#\JMK&@Z**<)%(ZT!E]:T22.1R;W'!1Z4N!2;QZTNX4:$A@4M)D4M,04444
M %%%% !1110 4444 %,9J&:HB>: 'JV34M1)4M !1110 4A-+3'S0 UFIZ'-
M0]ZE3I0 ^BBB@ HHHH ***;NYH =1110 4F10>E1D'- $M%(.E+0 4444 %%
M%% !1110 4F10>E19.Z@":BD'2EH **** "BBB@ HHHH ***0G% !G%,8^E#
M'/2D4>M #ES3Z3%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !0URFLK\K5U[KN&*R[W31.I&*EHJ+/*[Z,LQXJFL(7J*]#E\-!B3MJG+X:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBBD 4A&:6BF PH#43P U8I,4K%*3
M1GMIR/R0*C;28V["M6BBP<S,;^PXL]!3'T")AT%;E%%@YF<3?^&X^<**YZY\
M,C<2$KU)X5?J*A:PB;J!4.!:J6/))O#K 8"5C7NB2P@D(:]P.EPM_"*H7NA0
M2*?E'Y5FZ1M'$6/!);6=,_*:R;AKF-^%->VWGAF,YPGZ5BW'A$-D^7^E2J>I
MM[=6/,(;FX Y!J62\GV=#7=2>$F7I'^E59?"TG39^E"A8S=:YRFG74YE'!ZU
MZUX/E=E7?7,:=X7=) 2GZ5W>CZ:UL%P,5JC*3.NB.0*DJ"W!"\U8K2Q@PHHH
MIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** (G!Q55LYJ\1D5 8?FS0!$@-64!H5,5)0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 44TMB@'-)L=A:"H/6BEHZ"(C AZBFFTB/
M\(J:BDF,JM8PD?<%5VTV$G[@K3I.*&D"9GIIT*GA!5J.W1>@J4G% .:$K#NQ
M0 *6BBJ)"BBB@ HHHH **** "BBB@ HI*6E< HHHI@%%%% !1110 4444 %%
M%% !124M" **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHI*6P"T444P"BBBE< HHHI@%%%% !1110
M4444 %%%% !1110 44E+0@"BBDI7 6BBBF 44E+2N 44E+1< HI**+@+1113
M **** "BBB@ HHHH **2BE<!:**2BX!2T44) %%)2T7 **2EHN 4444P"BBD
MI7 6BBBF 44E+2N 4444P"BBB@ HHHH **** "BBB@ HHHH ***2E<!:***8
M!1110 4444 %%%% !1110 444E*X"T444P"BDI:5P"BBBF 4444 %%%% !11
M10 44E+2N 44E%%P%HHI*+@+124M%P"BDI:+@%%)2T( HHI*&P%HHHI@%%%%
M*X!124M%P"BDI:+@%%%)1<!:***8!124M*X!1113 **** "BBB@ HHI*5P%H
MI*6BX!1113 ***2E<!:**2BX"T444P"BBB@ HHHH ***2E<!:**2BX"T444P
M"BBB@ HHHH **** "BBB@ HHHH **** "BDI:$ 4444 %%%% !1110 4444
M%%%% !1110 444E)@(1FE I:*+#N%%)36)I"'44Q<T^CJ M-)I3TIG)-,:0=
M:>!B@"EI@V%%%% @HHHH **** "BBB@ HHHI %%%%, HHHH **** "BBB@ H
MHHI %%)0: #-+30*=0A(***2AC%HHHI@%%%%( HHHI@%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124M( H
MHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%+4@%%%%- %
M%%%, HHHH **** "BBB@ HHHH **** "BBBBX!1110 4444 %%%% !1110 4
M444 %%%)2N M%)2T( HHHI@%%%% !124M*X!1113 **** "BBB@ HHHH **2
MEI7 ****8!1110 4444 %%%% !1110 44E%*X"T444 %%%%, HHHH **2BE<
M!:***8"4445("TE%%%P"EI**$ M)110 M%)11< HHHH *6DI:: ****8!124
MM) %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI:2 **
M**8!1124F M%)2T7 ****8!24M%*P!1113 **** "BBBD 4444P"BBB@ HHI
M*3 6BBBF 4444 %)12U(!11130!129HHN M%%%, HHHH **** "BBB@ HHI*
M3 6BBBF 4444@$HQ12T6 3&*6BBA@%)BEHI@%%%% !1110 4444 %%%% !11
M12 ****8!1112 ****8!1110 4444@"BBBF 4444M0"BBBC4 HHHI@%%%% !
M1110 4444@"BBBF 4444 %%%% !1124@%HHHH0!1113 **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I*6BE8!***6@ HHHI@)2T44D 5&^<U)28I@(N:=110 4E+12L E+11
M18 HHHI@%%%% !24M%( I*6BCJ 4444P"BBB@ I*6BDP"DI:*+ %%%%, HHH
MH 2EHHI) %%%%, HHHH **** "BBB@!*6BBA %)2T4F 4E+118 HHHH ****
M8!1110 4444 %%%% "4M%%*P!1113 *2EHI6 *2EHHL 4444P$I:**0!1113
M **** "BBB@ HHHH 2EHHI6 2EHHHL E%+118 I*6BBP"4M%%%@$I:**+ )2
MT44T 4444 %)2T4K %%%%, HHHH **** "BBB@ HHHH 2EHHI6 ****8!24M
M% !1110 4444K %%%%, HHHH **** "DI:*30"4M%%" ****8"44M%38!***
M6BP!24M%.P!11118!*6BBBP"4M%%, HHHH **** "BBB@!**6BE8!*6BBF@"
MDI:*5@"DI:*+ )2T446 ****8!1110@"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI6 ****+ %%%%.P!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44446 **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
MBP!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !112$T +13 <T^BX[!1110
M(**** "BBBE< HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 44E+2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !2$4M% "8I:**3 ****8!2445+8!2TE%"8"T4E+30!11247 6BBBF
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MR+7=GBN2?Q='G_6?K0OBZ,_\M!^=+V(>T.VAT^W3IBK?DQ =17$0>*(R?O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:H@J)QT-C< @Y-:<5M*%ZFNB73P/X:E%D!VH]F'L6<X;>7U-4[BUG/0FNO\
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MHH **** "BBB@!*4444"L%%%% PHHHH **** "BBB@!*6BBE8 HHHI@%%%%
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MHQ3%8,4M%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!&]0%L&IY*JOUH G09YJ8=*@B;BIP: %HHHH
M**** "BBB@ J!Y=IQ4]0O%DYH 59,U+5=1@U..E "T444 %%%% !1110 5%,
M^U":EJM=_P"I- &)=ZMY#'FH;?Q$)'VYK'U99&=@ :S;*&439VGK0!Z%#?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*<BG5%%TJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHI=0"BDI: "BBBF 4444 %%%% !1110 4444 %%%%
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M;50*E(ZJ<;#Z***LV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"-ZA) -/FDVBJN_>: +T9R*?44/W:EH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!&[$5 TI!JRRYJ!H^: ".4DU8'2H$CP:L#I0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(>E
M+10!EWTA -4HIFW5J7<.\54CMP#S0!H6K%DJQ4,"@+4U !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%)2T@"BBBF 4444 %%%% !1110 4444 %%%% "4M%)2L M%%% !1110 444
M4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M :4!ZT@C4=J?10 PH".E59;-'/(J[1B@"@EC&K9VU8.V):FQ4%Q&77B@#(U&
M[7FLV.[CWC-/U2!ESS6*L3&0<]ZI&;>IVUE.C(,5?5@16#IL;!!S6W&IQ29:
M9-1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %)@4M% "8%+110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4F.
M]5FQGBII^E5N] %R'I4M10_=J6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBDI,!:***8!1110 4444 %%%%" ****
M"BBB@ HHHH **** "BBB@ I*6BDP"BBBF 4444@"BBBF 4444( HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IN:=2' H$Q:*C,JKU- G0
M]#0,DHIN]?6D,BCO0 ^H9WVK3Q*I/6FR ,M GL<MK%P>:PH[@^8/K72:O"F#
MTK%B@C\P?6FC&^IT>EN6C%;:=*RM-C41C%:RCB@N+8ZBBBD:!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!7GJ%$R:LR@=ZC7 - $T8P*?34Z
M4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHI %%%%,!*6BBD@"BBBF 4444 %%%% !1110 4444 %%%% !24
MM%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %07,GEQDU/5#4B3;L!0!A7VKK&2-U5K;7%+<M^M8&KQR^8V
M":R[9)M_4T >D1ZHC+]ZF2ZF!_%7,6OFA>2:<XD+=32N*YT4&H;I.M:XN \8
MP:X^T#[QR:Z&V)51FF3/8HZOO(-82%Q(*Z'4I5(K :90]!SG3:9/A ":W(WR
MM<E8S=,5T=M+E12NS6#+]%-7I2FF:W%HI!2T#"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G%+37^[0 GF#.*?5, AZLJ
MV10 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)Q3?,%$G2JH!#4
M7 <TM1(:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ II8"E/2H)": )1(":?52,'=5H=* %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *ET^VJD<_/)J6^/%9J EJ -Z%MRU+5:T!"59H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6BE8 HHHI@%%
M%% !1244K@+1113 **** "BBB@ HHHH **** "BBB@ HHHH ****+ %%%%%@
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **8S$4JG(H =1110
M4444 %5[B'S$(JQ10!S%YHOG$G%4X_#^QL[?TKL2H--\H>E '.II&!TJ*33<
M'I74>6,5$UN&/2D2TSGX+#:^<5J+;_)5P6X%$@V+Q3"2T.?U*WP#6"UINDK=
MU68C-88N#YE)LY>IL6%G@"M^WM]H%96FR$J*W8C\M"-8(E P*#2TF*9L I:*
M*!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %(1D4M% $13FG*N*?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M A&:C\NI:* &*N*?110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%%  :C*9J2B@",)@U)110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% %.[CWBJ*Q[&K3FZ53VY:@"Y;_ ':GJ& 86IJ "BBB@ HHHH ****
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M#-;B=*<3:F/HI*6J-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,T4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!%*V*KXW&K$H!J)0!0!-$,"I*:O2G4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444F 4444:@%)2T46 2BBBI&+1115H04444@"BBBF 4444 %%%% !1110 4
M444 %%%%+J 4444P"D-+10 @I:** "BBB@ HHHH **** "BBB@ JM=X,1!JP
M>E9][)B,T <KJ,";R:ATTQQ2\D=:;J$C%S65YD@;Y30!Z%;7*$#!K1CD##K7
M#Z9<2\;B:Z>TE+ <T :U%,C.13Z "F$T^DQ0" 5#=#,9J>HY1N7% '%:U"V&
M(%<];F5).AZUWM[9>:#Q6:FD#=]V@#+BNIU7O5::>5WYS73KI8 ^[5672_G^
M[28F9UD7+C-=+:YVBJ5O8;#TK6@BV@9I$216NTW#FLMHR'X%;URF1Q5-8 3R
M*GJ86U)+)3M&:U(^E5H(MHJVHQ1$UC<?12"EJT;!1113 **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#TJ-F.:EIK+Q0!%O
M-.5CWI O-.(XXH ?FEJ-,U)0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !4;DBI*0C- #%;BFECFE(.:<J\<T -4G-2TFT4M !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 4KN0H.*IQW#$\U=NEW"J2QX:@#0A<D58'2H+=?EJQ0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%# ****
M "BDI:0!1113 2BEHI6 ****: **** "BBB@ HHHH **** "BBB@ HHHH **
M**74 HHHI@%%%% !1110 4444 %%%% !1110 4444 (W2LJ^4[#6L:K3P>8I
M% '#7D9:0BJ\5M\W(KJ9M)RY.*:FE\]* ,ZTM"<8%;]I"4 S2V]H(NU7D2@!
MZ=*?2 8I: "BBB@ HHHH 8T:GM31"OI4M% #/+7TIC0J>U344 5Q" >E/* #
M@5+36I6):T*DHJ-5R:EFJ-&P:CJ8/<M1C J0"F1G(J05:1M$6BBBF6%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% "8I:** #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "8I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ()ER*K%<&K4K8J #>
M: +$/W:EID8P*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !24M%*P!11118 HHHIW **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHI=0"BBBF 4444 %%%% !1110 4444 %%%% !1110
M 4444 -*@TT1@5)10 W92@8I:* "BBB@ HHHH **** "BBDSB@!:*3-,:95Z
MF@"2D-1?:$/>EW@]*0FR&;BH%ZU/-57G-9O<P>Y?BZ5+BH8>G-3UHC:(4444
MR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BE&:K_=/%33'%
M0I@GF@"S$<BI*8F,4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBDI7 6BBBF 4E%%2 4M)2TT 4444P"BBDI7 6BBB
MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBAZ5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4E+128!1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *CE3>F*DHH PKS11<9XK+/A-2V=M=C10!SMKH0@7&*2XT
MD'G%='3&C#4K <K!IVV;I6]##Y2"IQ;*&S4A48Q183*<AW4Q4YJ:5,5&IP>:
MS>YC?4L11U8 P*CC/%25:-D+124M4AA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$9%+10 P
M)S3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH KSU"BY-69%S48&#0!-&,"GTU.E.H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBDJ0"EI**$P%HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** $I:**5@$--IU-/%#)9%)BJC9W<58F-0+UYK-[F3>I9A^[4XJ&
M,<5,*N)HAU%%%46%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M$;U'WITSA:@64$T 6TZ4ZF1G(I] !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !10:BW'- $M%(.E+0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %>>/=4"PX-37#[:@2;)H NQC I]1Q'(J2@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI:6@!11
M10@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%-G9Q4M-<9% ',
M:L7*FN3D67>< ]:] O+3S%/%9!TC+9VT 9%B)-O-.G\W=6]%INT=*5]-SVI7
M P+97\P5TUCNP,U7ATXJ^<5KPPA%'%2S-C9L[:J%,FK\@XJ#9DU+)8V)2#6A
M']VHXT %2@5:+0ZBBBJ+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F[13J* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** *=UTJDN<\5?N4+565-IYH N6^=M3U%#TJ6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EI %
M%)2T %%%%" ****8!1110 4444 %%%% !1110 4444 %%%% !1112 ****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (5
M!ZBD\M?2G44 -V+Z4;%]*=10 S8OI1TIQIM2R602FH1* :=<'%5T&XU#,KNY
MH1MN%2BH81@5,*N)K$6BBBJ*"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2TE+0@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 (1D54GM0XJY2$9H Y^;25D)XI8-$13TK=V"G!0* ,S^RU Z54FTA6/2
MM^FE : .>BT55?.*UH;,1@5:"#-*>!4B94F08JN(@35J7-5OFW<5%M3'J6XH
MP!5@#%0PYQS4]:(UB@HHHIE!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3-G-/HH 0<4M%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 5+F,,*JK$%-7IAFJVTYH M0C"U-4472I: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI*3 6BBB@ HHHI@%
M%%% !1110 4444 (>:;LYS3Z* "BBBE< HHHI@%%%% !11128!1113 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "D-+36I,3().:8H /-/D.*ASDU!E?4M)BI14,?2I
MJM&D0HHHIE!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#*P'
M6H0ZDTZY!(JL@(- &A'TI]10]*EH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ I,T4F.:5Q,=1110,****8!1110 4444
M%%%% !1110 4444 %%%% !1110 4E+12 ***2F M%%% !1112N 4444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBFMTH 9+($'6JZ
MW0)ZU7OI&"FL<7$F[C- '3K*".M02W2H>M8Z74@3G-95YJ$@?J: .G2^!;&:
MNI*&'6N&MKYVEZFNFLI691FDR67IC5;?@U+.V!5$O\U0V8]34A;(JP.E9]NW
M%7T/%5$UBQU%%%46%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1129% "T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 44UC@5&'YYH FHI P-+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !10>E0L^#0!-
M14*MDU-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% %>>H44$T^Z?:*IK/SUH U(Q@4^H8&W+4U !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444,!*6B
MBDD 4444P"BBDI7 6BBBF 4444 %%%% !1110 4444 %%%% !24M%*P!24M%
M !24M%%@$I:** $I:**$@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4=:** *=W#O7@5G)9'=R*W" >M)L7TH Q9+,A3@5@WUHV
M\\5V[(".E9MQ9!VSB@#E+*T<3C(KKK6(+&*BBL K9Q6A&FT4F3(JW"G%4C&Q
M:M649J * :AK4Q:U$MT(%7DZ5%&HJ<=*:1I%"T4459H%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6Z4Q<YJ
M6DQ0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (W2J[J>U6:3 H @
MA#=ZL4F *6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** $/2JK*VZK=)M% $4:D5-VI,4M !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 9U^K$<5FQQONYK;G (YJNL8)Z4 3V@(3FK-1Q+@5)0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )
M2T44K %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****5P"BBB@
M HI*6@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4F!2T4 )@4C4ZFM0)[%>1L5$#DT^857R0:S:U,.I>CZ5-4$)^
M6I0:M&R8ZBBBF4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %
M>?I4"-@U:D7-0[!F@"Q&<BGTR,8%/H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****2 ***
M*8!1110 4444 %%%% !1110@"BBB@ HHHH **2EI)@%%%)1L M%%%, HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BF,X45
M4EU!(S@F@"[FD-9ZZDC'J*M).''%!+&S57 &:L257*$GBHL9-:EJ+I4XJ&%<
M#FIZI*QI%!1113+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBFEP* '45 ;A0:<LP:@"6BD!S2T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M12$XH 6BHS(!0)030!)12 YI: "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIA<"@!]%1>:*>K9H =1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%,:0"F^:* ):*8) 33Z "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CD8"JS/D\4ZZ)
MJK&<GF@#0B.14M10]*EH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **2EI7 ****8!1110 4444 %%%% !1110 4
M444 %%%% !1110@"BBB@ HHHH 2EHHI( HHHIV **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH IW384UR6HW++*>:ZJ
M\SM-<AJ,3&4\4 %G<,\H&:ZJS4[0:X^RC990<&NMLI"5 -)B:+TAXIJ$42$
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M 7S*89L4_93##F@!!/DU)OJ,08-2>70 UI<4++FAHLT+%B@!WF4>91Y='ET
M'F4>91Y='ET 'F4SSN:?Y=,\GG- #C+Q35FS3C%Q35AP: %:7%*)<BD:+-*(
ML"@!OG<TXRX%-\GG-.,7% #5FS2M-BD6'%#0YH <)<BF^=S3A%@4WR><T .,
MN!2++FE,612+%B@!&FQ3UDS3&B%1;PAZT 66/RU1N)]E3B=&&-PJ.6%)1U%
M%1+DN:OP/Q506JQFK,6T=Z +1;C-1>=\V*DX*U'Y/.: '^91YE'ET>70 >91
MYE'ET>70 ;Z:TN*=Y=-:+-  LN:1IL4JQ8I&AS0 GGT>?1Y%'D4 'GTY9<BF
M^13EBQ0 AFP:=YO%-,.33O*XH :)LFE:7%((<&E:+-  LN12&;FE6+%(8>:
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MEHHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 0C-0294<58J&9U53F@#'N[DIFLE]1??C-2ZI<J&.#64D@DDH V([QL9
MI7U)T')J..W;9G%4K]64<4 7!JKD\&M2SN'D )KD[4G<,UUFFH"@H V(CE:D
MIJ# IU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 -VBD9P@YIQJE?!RAVT 5K_ %%(@<-6,VNKG[]9NKQW1W8S7._9+UWX
MS0!W,>K;^C5(]_\ +G-<W96ERJ?-FKA60#!H TXK]B_6MFUG+XKE[9&+UTFG
MQL ,T :JGBG4@'%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLM+@MWK23YAFL33%8@9K=C&!0 \#%+110 4444 %%%% !1110 4444 %%%%
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M^SMC&H!K048%&!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 1R+N%8]]IYF)XK<I,#TH Y5=$YY6KD6E!1]VM[:
M/2C ]* ,*XTW?'@"J4.CLKYQ758'I1M'I0!1L[;R@,BK]&** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,9HHH C:)#V
MIOD)G[HJ:B@"E<6P8<"LR732QZ5T%)M'I0!SBZ3SRM3MIBF/&VMS:/2C ]*
M.9&D$/G%:ME:F''%:.T>E&!0 M%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1124FP"BBBD M%)11<!:*2EII@%%%%,!F_FG TS9S
M3QTI-@+1110@"BBBF 4444 %%%% !1110 4444 %)12U.X!11156 **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%)28"T444P"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBDI7 6BDI:$ 444E#8!2T44( HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %'6BB@")H$;J*8+:,'(%6** &A0!2-&K=13Z* *YM(R>5%.6W
M1>@J:B@!-H%(4!IU% $1MT;J*C^R1Y^[5FB@")847H*D  I:* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ I**6D 4444P"BBB@ HHHH **** "BBB@
M HHHH **** "DHI:G<!*">*6DI[ ,#9-/%)MIU%@"BBBBX!1113 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ I*6BD 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHI*38"T4F:6F 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%(3B@!:*:&S3J "BBB@ HHHH **** "BBB@ HHI* %HHI*5P%HH
MHI@)12$TM2PN %+24M.X!1113 **** "BBB@ HHHH **2EI7 ***2BX"T444
M7 ****+@%%)2T7 ****+@%%)11<!:***+@%%%%, HI*6E< HHHH8!1110 4E
M+24F 4M)2T( HI*6JN 444E)@%%%+0D 44447 ****8!1110 444E#8"T444
M %%%% !124M*X!124M%P"BBDHN M%%%, HHHH **** "BBB@ HHI*5P%HHHI
M@%%%% !124M*X!1113 ***2E<!:***8!124M*X!1111L 4444P"BBDHN M%%
M%*X!12447 6BBBF 4444 %%%% !1112N 4444P"BBB@ HHI*3 6BBBBX!111
M1< HI*6BX!1110@"BBBF 4444K@%%%%, HI*6E< HHHI@%%%)1<!:***5P"B
MBBF 44E+1< HHI*3 6BBDHN M%%%%P"BDI:$ 4444P"BBDH; 6BBB@ HHHH
M**** "BBB@ HHI* %HHHH ****+@%%%% !1110 4444 %%%% !1112N 4444
MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI=0"BDI:+@%%%%, HH
MHH ***2E<!:***8!1110 4444 %%%% !1112N 4444[@%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI6 ****8!1112
M****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 444F: %HI-U+0 444FX4 +12
M YI: "BBB@ HI,TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY'= FK ES5""WYJZL6* )@<TM(!@5#/+Y:9H D9P*%<&L.74CN(S3H+\YZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME,$4 8-Q<R%R.:=:NQ:M*6P!YQ1!9[3TH GAR5JE>2LA.*UXX<+56YM=^>*
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MP11VIU% ";1BF^4N<XI]% "!0*0H#U%.HH C\E/2G! *=10 W8*0Q*>U/HH
M8(E7H*78*=10 W:*7 I:* &&-3U%-\A/2I:* &"-1T%+L%.HH :$ IV*** &
ME :3RESTI]% "  4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHI- %%
M%% !1113 ****5P"BBD)Q3 6BD!S2T %%%% !1110 4444 )2T4TMBD ZDH#
M9I:&@$Q2TA.*0-FA!8=1113 **** $I:**2 ****8!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EIK-BD HHI V
M:0O@T6 ?12 YI:8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4E!IN_FE8!]%%%, HHHH 2EHHI6 ****8!1
M110 4444 %%%% !1110P"BBBA %%%% !1112L 4444P"BBB@ HHHH **** $
MI:**5@"BBBF 4444 %%%% !1110 4444 %%%% !24M%)@)VI.].HH%8****8
MPHHHH **** "BBB@ HHHH **** "DI:*30"4M%% !11130!1110 4444 %%%
M% !1110 4444 %%%% !132V*4'- "T444 %%%% !1110 4444 %%%% !1110
M 4E+12W ****8!1110 4444 %%%% !1110 4444 %%%% !1110 444TMB@!U
M%(&S2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+12:
M 2C%+118 II&:=13L T#%.HHHL 44446 **** "BBBE8 IC+FGT4P&JN*=11
M0 A&:0+BG44#N%%%%%A!1112L 44446 ****+ %%%%.P!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 44446 *:RYIU% #%7 I"F3
M4E% " 8%+110 44446 ****5@"BBBF 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 (:9LYJ2B@!.U+1118 HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHI6 ****8!1110 4444 %%%% !1110 4444
M%%%%%@&,N:51BG44 %%%% !1110 4444 %%%%%@"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8RYI]% #57%.HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image00014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00014.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ">!+X# 2(  A$! Q$!_\0
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M^IT>P?6ZO<[;_A8+_P#/FOY__7H_X6"__/FOY_\ UZXFBCZG1[!];J]SMO\
MA8+_ //FOY__ %Z/^%@O_P ^:_G_ /7KB:*/J='L'UNKW.V_X6"__/FOY_\
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M_P ^:_G_ /7KB:*/J='L'UNKW/5?#VOMK:3,T0CV$ 8[UN5PO@3_ %4_^_\
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M];J]SMO^%@O_ ,^:_G_]>C_A8+_\^:_G_P#7KB:*/J='L'UNKW.V_P"%@O\
M\^:_G_\ 7H_X6"__ #YK^?\ ]>N)HH^IT>P?6ZO<[;_A8+_\^:_G_P#7H_X6
M"_\ SYK^?_UZXFBCZG1[!];J]SMO^%@O_P ^:_G_ /7H_P"%@O\ \^:_G_\
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M^IT>P?6ZO<[;_A8+_P#/FOY__7H_X6"__/FOY_\ UZXFBCZG1[!];J]SMO\
MA8+_ //FOY__ %Z/^%@O_P ^:_G_ /7KB:*/J='L'UNKW.V_X6"__/FOY_\
MUZ/^%@O_ ,^:_G_]>N)HH^IT>P?6ZO<[;_A8+_\ /FOY_P#UZ/\ A8+_ //F
MOY__ %ZXFBCZG1[!];J]SMO^%@O_ ,^:_G_]>C_A8+_\^:_G_P#7KB:*/J='
ML'UNKW.V_P"%@O\ \^:_G_\ 7H_X6"__ #YK^?\ ]>N)HH^IT>P?6ZO<](T3
MQ:^KZBMJ;=8P023GTKJ:\N\&_P#(>7_<->H#H*\W$TXTZG+$]'#5)3I\TC+\
M2?\ (O7O_7/^M>1UZYXD_P"1>O?^N?\ 6O(Z[,O^&1R8[XD%%%%>@< 4444
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MI9I'DD;[SNQ)/XFF5O%6BD8R=Y-A1115$A1110 4444 %%%% !1110 4444
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MU-)HI(C()5C.1C/!4G@\5G^Z3O;;]"U[5KU_4GTK7L^)AJ=]*D"^65<1HQ#
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MG7'5TOBT7X-D-2:$W&PY,0XZ]_?Z5S5>CA5:DE_6YY^*=ZK84445TG.%%%%
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MQ1[9+B-VE;<3N((Q]/PJHU4VE:W]7(E2:N[[?\!?J9%%%%;&1/9?\?\ ;_\
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M_AS;T_4M._LAM,U.*Y,0F\Y'MRN[.,8.>U77\265Y-?07EM.MC<+&B>2P\Q
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MU'48;O2],MHU</:HRN6 P22#QS6912C1C%W0Y5I25G_7]6"BBBM3(GLO^/\
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MIZ^#_A&7XD_Y%Z]_ZY_UKR.O7/$G_(O7O_7/^M>1UTY?\,CGQWQ(****] X
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH GLO^/\
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MX5W_ ):^@H\M?04?6:O\P?5J78X#_A"T_P">\GZ?X4?\(6G_ #WD_3_"N_\
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M  A:?\]Y/T_PKO\ RU]!1Y:^@H^LU?Y@^K4NQP'_  A:?\]Y/T_PH_X0M/\
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M$+3_ )[R?I_A1_PA:?\ />3]/\*[_P M?04>6OH*/K-7^8/JU+L<!_PA:?\
M/>3]/\*/^$+3_GO)^G^%=_Y:^@H\M?04?6:O\P?5J78X#_A"T_Y[R?I_A1_P
MA:?\]Y/T_P *[_RU]!1Y:^@H^LU?Y@^K4NQP'_"%I_SWD_3_  H_X0M/^>\G
MZ?X5W_EKZ"CRU]!1]9J_S!]6I=CD=%\-C3-06X65FP""#77CH*0(H[4ZL9SE
*-WD:PA&"M$__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image00002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0W!W\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;BYBM8
M_,E8*OJ:FKA_B?>2V?AJ22)B& />@#=_X2K2P<>>/S%'_"5:7_SW'YBOCR3Q
M;J?F-^^;KZTW_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.C_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.C_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.C_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.C_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.C_A+M3_Y[M^= 'V+_ ,)5I?\ SW'YBC_A*M+_ .>X_,5\=?\
M"7:G_P ]V_.G+XMU,L/WYZ^M 'VI:ZA;7:@Q2 YJU7SYX)^((MK=!<S9(ZY-
M>C+\3=,*C]XGYT =[17#1_$K3'D5!(A)..M=A8W:7UJL\9^5J +-%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(M/A\R4B@"W17*1>.M/ENO(#+NSCK72V]RES&'0Y!H FHHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***.U !16-JOB*UTM6,K 8K&LOB!I][=BW1U+$X
MZT =E134<.@8=",TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_&OD.7_6-]37UY\6_P#D5)/QKY#E_P!8WU- #**** "BBB@ HHHH [KX7?\
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MOKKPZ<Z>OTH V:*** "BBB@ HHHH **** "BBL;Q/J1TO19KE3@J* -C<O\
M>'YT;E]1^=?-=S\8+E+B1?,. Q'6HS\8[GG]XW3UH ^BM4U*.PM6E9EX]Z\V
MU3XKPV5P8RX':O+M5^*EQ?VYC9S@CUKSK4M2DO9C(6.2?6@#Z'_X7)#_ ,]!
M^=(_QDA*D"09QZU\U>8_]X_G1YC_ -X_G0!ZIXO\?MJD3K'*1GT-<SX*U"Y?
MQ/;JTK$%^>?>N0R3W-=+X%_Y&>U_WA0!]H:?_P @^#_<'\JLU6T__D'V_P#N
M#^56: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "N ^+7_(JR_P"Z:[^N ^+7
M_(JR_P"Z: /D*7_6M]:93Y?]:WUIE !1110 4444 %%%% !1110 4444 %*I
MQ24XH0,T (QR:2BB@"1,8IK YS2 D5+]X=: (L\8J:WG:"=9%)R*A(P:.O%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\JCIZM@4 >I?"OQ(^FZB!)(<%L<U]/Z;>K?V:SKT-?#^D7IMKV-@?XA7V!X
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MV!*I/UH GHH!!&110 4444 %%%% !1110 4444 %%(S!5RQP*A-Y;CK,GYT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]].T">="00.HKYIN?B=J*7,B!WP#7T1\1/\ D5;C_=-?&U]_Q^3?[] '=_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK[*^(?\ R*MQ_NFOC6^_X_)O]^@"M1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K@/BU_R*LO^Z:[^N ^+7_(JR_[IH ^0I?]:WUIE/E_UK?6F4 %
M%%% !1110 4N"125(I&V@#W[X!]'^IKWVO O@'TD^IKWV@ HHHH **** "BB
MB@""\&;.;_=-?'/Q"M9%\2W+D?*6-?94J[XF7U&*^=OBKX;,'FW.WKWQ0!XC
M@;:B/6G$X)':FT %%%% !3U)"\4RI$.%H 8>II4^^*1OO&GJN"IH ^JO@O\
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M40W<N.,#<:]MAE6:,.ARIKX=T;5YM.O8FC<JH89KZH\ ^+X-6L(;;=F0#UH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(JS_0_RKXYO/^/J7_?- %>BBB@ HHHH **** -?PW_R'K7_ *Z"OM3P]_R
MK7_<%?%7AK_D/6O_ %T%?:OA[_D!6O\ N"@#4KG/&_\ R+%U_NFNCKG/&_\
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MW=,#C"F@#YJ^)VN?VI>LN_.&]:\U/6M36[I[C49][9&XUF $F@!**4C!Q24
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ME7UUI_@S3#80EHER5!Z5:_X0O2O^>*_E0!\=_P#".:C_ ,\6_*C_ (1O4?\
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M#7G*C!Y.:Z'P;_R,UKS_ !"@#[2L93-8PR'JR@U8JGI7_(+MO]P5<H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *X#XM?\BK+_NFN_K@/BU_R*LO^Z: /D*7_6M]:93Y?]:WUIE !111
M0 4444 %%%/ !7)H ]_^ ?1^?6O?:\"^ ?1^>YKWV@ HHHH **** "BBB@ K
MS3XR?\BRW^Z:]+KS3XR?\BRW^Z: /DU_]8WUIM.?_6-]:;0 4444 %%%% !2
MBDI1U% 'L7PN4FXA/O7TO;<6T8_V17SE\*H69XF XR*^CH?]2GTH DKAOB'K
M,=OH=Q 2 2IS7<GI7SM\8==:WU![<,?F.,4 >)Z@P>^F8=V-0(0*)&WR,WJ:
M90 Y\%N*;110 4444 *,]NU=KX$T9[K6+>4*<!@:XH>M?0/P;T-+NT6<C)49
MS0![CI4?E:9 F,805<ID:>7&J>@Q3Z "BBB@ K!\5:5_:NF-%C) /%;U-<91
MA[4 ?%WCG2SIFLO$!CFN3)).37I7QB 7Q/)CU-><JH(H CHI6ZTE #E.&I7.
M:910!-:G%S'_ +PKZT^&.KQR:%#;Y!(4=Z^2(VVLI]Z]D^$_B%GU..UW'@=,
MT ?3 .1FBHX&W0(WJ*DH \_^+?\ R*DGXU\AR_ZQOJ:^O/BW_P BI)^-?(<O
M^L;ZF@!E%%% !1110 4444 =U\+O^1I@^HK[!@_U$?\ NBOC[X7?\C3!]17V
M#!_J(_\ =% $E%%(3@$^E '%_$N95\,3KD9VGO7QY=Y^UR9_O&O=OBOXR:*Y
MFT\,<'/&:\)?$CLQ[F@!B$#K36.33@HIK#!H ;1110 4444 ;/ABT^VZU##Z
MM7UQX(T0:5I\?RXROI7RY\/[=V\46Q"DKN':OLFQ %E" ,?(* +%%%% !2,-
MRD>HI:* /$_BQX?"6,MT$QU.:^;I!B1AZ&OK[XLQE_"LN%).#TKY(FB9)'##
M'S=Z *U%!!%% !1110 444H]?2@#N/A<<>*H#_M"OL&V.;:/_=%?$/A?5#I6
MJ1W .-IS7UGX!\0-KNE"0DG"B@#L**** ..^)/\ R*L_T/\ *OCF\_X^I?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"DIR?>% 'NWPH\,I<"&[*<CFOH2)=D2+Z#%>9?!J%/\ A'5?OBO4* "BBB@
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M)0 4444 %.3[PIM.3[PH ^LO@U_R+0^E>EUYI\&O^1:'TKTN@ HHHH ****
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M,&@#Z"^ ?23I7OM>!? /I)TKWV@ HHHH **** "BBB@ HHHH **** "BBB@
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M#H 9*<1,?:OE7XR-G7SGU-?54PS$WTKY4^,0(\0-GU- 'EYZTE.P<TF#GI0
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MRGQ"_P"15N?]V@#XXN_^/N;_ 'S5-OO59OO^/R;_ 'C_ #JK0 4444 %%%%
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M^(7_ "*MS_NUU=<I\0O^15NO]V@#XTO?^/R;_>/\ZK5;NUS>3?[Q_G54C!H
M2BBB@ HHHH *Z;P+_P C/:_[XKF:Z;P+_P C/:_[XH ^T-/_ .0?;_[@_E5F
MJVG_ /(/M_\ <'\JLT %%%% !1110 5B>+0#X=NL_P!TUMUB>+/^1=NO]TT
M?%NM_P#(7N?]X_SK-K2UO_D+W/\ O'^=9M !1110 4444 %/*X7I3!4F[=Q0
M!'3DZU*+69AD1L1]*/LEQ_SR;\J &.1TJ.K'V.?O&WY4GV2X_P">3?E0!!14
M_P!DN/\ GDWY4?9+C_GDWY4 045/]DN/^>3?E1]DN/\ GDWY4 045/\ 9+C_
M )Y-^5'V2X_YY-^5 $%%3_9+C_GDWY4?9+C_ )Y-^5 $%%3_ &2X_P">3?E1
M]DN/^>3?E0![Y\ ^C\5[Y7@WP&BDC5]ZD?6O>: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N ^+7_(J
MR_[IKOZX#XM?\BK+_NF@#Y"E_P!:WUIE/E_UK?6F4 %%%% !1110 4444 ?0
M7P#Z/^->^UX%\ ^C_C7OM !1110 4444 %8OB+6(-,TZ5GD"M@XYJ[?ZG!I\
M9>9@,>]?._Q5\;M<W9CM),ID@X- '&^.?%DVM7TD3,2JDXKAZDFD,LA=CDFH
MZ #%%.3&>:>PR.* (J7%(>M/CH 92A>*=)UIR8Q0 D2[IU7U;%?1WPK\*I''
M%>[.>.:^>;*(R7D07^]7V!\.+98O#4+8YP* .R' Q2T44 (?NFOE?XU_\A\_
M4U]4'[IKY8^-7_(PGZF@#RG%)4JC"_6HVQGB@!**** "BBB@!0,FO</A=X(M
MM>TPS2J#QU->'CJ*^G_@8V-$(_V: -;_ (5/I_\ =7\J3_A4^G_W5_*O2J*
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M44 %%%% !6)XL_Y%VZ_W36W6)XL_Y%VZ_P!TT ?%NM_\A>Y_WC_.LVM+6_\
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M(OFL+^.=21M.: /NJVF6XMTE4Y##-2UY=\,_&JZS;I!)+]U<<FO4 01D'(H
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MXKU"VVHLK;1T&: /M6">.XCWQME3WJ6O)O _CR%-%07)RV!WKJ/^$_L?3]:
M.QHKCO\ A/['T_6C_A/['T_6@#L::[K&I9C@"N0_X3^Q!Z5DZWX_MFTZ81\-
MMXH [*3Q#I\;%6F4$5BZ_P"+K*WL6,4P)QV-?,6J^,]1?49BDS!=QQS69/XI
MU&X78\I(^M 'KMC\0KFX\4Q6X<E"V*]\M9/-M8W]5%?%7AF_:+Q!#/*>C9YK
MZX\)ZLNH:?&%.<** .CHHHH **** //_ (M_\BI)^-?(<O\ K&^IKZ\^+?\
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M<&ON37(4ETFXW*#\AZU\9>,(FC\0W/RD+O/:@#GZ*** "BC%/*87- #****
M"G*<$8.*;3T&>.U &E;Z[>6J;(Y2%^M2_P#"3:C_ ,]V_.L=Q@T@ZB@#9_X2
M;4?^>[?G1_PDVH_\]V_.LEU %1T ;7_"3:C_ ,]W_.F2>(;^4%6F8@^]9%%
M$YD+.6;DFF@C=FD09%-;AJ +=M*8+A7!Q@U]+?!O4I+RQ(9LX&*^8 _ YYKZ
M,^ Y)LFSZ4 >WT444 %%%% 'G_Q;_P"14D_&OD.7_6-]37UY\6_^14D_&OD.
M7_6-]30 RBBB@ HHHH **** .Z^%W_(TP?45]@P?ZB/_ '17Q]\+O^1I@^HK
M[!@_U$?^Z* )**** "O#_C#X4N-3E>Z0$JO/ KW"L_6;%+_39HF0$LOI0!\+
M74)M[AXCG*G%0UZ)\1/"AT>\EFVX#-GI7GP4$XH 913G&#BFT %%%% !1FBB
M@!\;LC94UI0:]>VZ;8YF4?6LJB@#2GUF[N0?,D)_&L]F+-N)Y--HH **** "
MBBB@!R?>IY(W BHJ* )F(ZUM^'-$EUN\6.($MN'2L!>3@\U[!\%++.M R)QD
M'F@#W3P'I3Z5X?C@D&& KJ:15"J !@4M !1110!QWQ)_Y%6?Z'^5?'-Y_P ?
M4O\ OFOL;XD_\BK/]#_*OCF\_P"/J7_?- %>BBB@ HHIZIGDT ,HI3P:50">
M: -7PU_R'K7_ 'Q7VIX>_P"0%:_[@KXM\.KC7K7'3>*^TO#W_("M?]P4 :E%
M%% !1110 CJ&4@C@U\J_&A%3Q"0!W-?59Z5\L?&F-CXA)P2,T >4A<TG0U+P
MHJ)NM $F05J+O2Y/K24 %%%% #T-*YXJ/)IPY.#0 @/(J1B-E(5 Z"AQ\N:
M(Z*** +-A_Q_0_[XK[/\!?\ (JVO^[7QA8?\?T/^^*^S_ 7_ "*MK_NT =/1
M110 5RGQ"'_%*W/TKJZQ?%-D;_1)H,9W"@#XDO@1>3?[Q_G56NN\:Z"=(OI
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MO-=)X1.)37J9?.TD:TSN12T@Z4M?61U1T!1113 **** "BBB@ HHHH ****
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M!J6ERRQQ@RG/.*^5];TB?2[MTF7;\QQ0!DCK1VI1U%2'&R@"*EQFDJ1,$=J
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M/VLO]M6Q\MN'':@#[-\-$G0+4DY^05K5D^&P5T&U![(*UJ "BBB@#S_XM_\
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MXAS7UY!_J(_]T5X;X0\&RV&MQRF,@*<]*]TC&(U'H* '4444 %%%% !1110
M5ROB7P;;:_*'D45U5% 'SA\2?A\-,M0UK%D]L"O)6\/WZY+0-^5?;6I:3;:I
M'MG0-]:YZ]\":8T#;(AN^E 'QM/;R6[[77!':H:]=\;_  ^NCJC&UC.S/&!7
M*?\ "O=4_P">3?E0!QM%=E_PKS5/^>3?E1_PKS5/^>3?E0!QM%=E_P *\U3_
M )Y-^5+_ ,*]U3_GDWY4 <B%&VI8+&:?_5H6S[5U7_"OM5[QM^5>D>!_ ##9
M]JB_,4 >0V'AN_EO(U,#!2?2O>O#7PRMYK*&62,;L9.17H%MX*TR)48Q#<!Z
M5T5O;QVT2QQC"B@"KI&F1Z79+;Q@ +Z5?HHH **** "BBB@ HHHH Y#XCJ7\
M+3@<\&OCV[M93=2_*?O&OM3Q99-?:)-$HR2*\)/@"=IY"8NISTH \;^QR_W3
M^5'V.7^Z?RKV7_A7TW_//]*/^%?3?\\_TH \:^QR_P!T_E1]CE_NG\J]E_X5
M]-_SS_2C_A7TW_//]* /&OL<O]T_E1]CE_NG\J]E_P"%?3?\\_TH_P"%?3?\
M\_TH \O\.6L@UVUX/WQ7V?X?&-#M1_L"O!].\"SP:G#)Y71@>E?0&F1&'3X8
MSV44 6Z*** "BBB@ HHHH CFB6:%HV'##%>6^)_AO;3-).J LP)X%>K4R2)9
M5VN,B@#XQ\1^%;RVU)XXH6V@]A7,W5G+:-ME3:?>OM>Z\(:;=2F1XER?:O#?
MB1\/YFU/-E%\N>PH \2HKLO^%>:I_P \F_*C_A7FJ?\ /)ORH XVE49;%=C_
M ,*\U3_GDWY4O_"O=4_YY-^5 ')$@"HNIZ5V1^'VJGK$WY&@?#W5,_ZIORH
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M#[%;_P#/):>L,:?=4"I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "J\]C;W)S+$K'W%6** */]D6/_ #[I^5']
MD6/_ #[I^57J* */]D6/_/NGY4?V18_\^Z?E5ZB@"C_9%C_S[I^5']D6/_/N
MGY5>HH H_P!D6/\ S[I^5']D6/\ S[I^57J* ((+."V.8HPOTJ>BB@ HHHH
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M110 4444 %%%% !1110 57FL;:X;,L2L?<58HH H_P!D6/\ S[I^5']D6/\
MS[I^57J* */]D6/_ #[I^5']D6/_ #[I^57J* */]D6/_/NGY4?V18_\\%_*
MKU% %>*RMX2#'$H(]!5BBB@ HHHH **** "BBB@ HHHH *1E#J589!ZBEHH
MIMI=F[9,"Y^E-_LBQ_Y]T_*KU% %'^R+'_GW3\J/[(L?^?=/RJ]10!1_LBQ_
MY]T_*C^R+'_GW3\JO44 4?[(L?\ G@GY5:A@BMTVQ(%'M4E% !1110 4444
M%%%% !1110 4444 %%%% %233;25LO I/TIG]D6/_/NGY5>HH H_V18_\^Z?
ME1_9%C_S[I^57J* */\ 9%C_ ,^Z?E1_9%C_ ,^Z?E5ZB@"C_9%C_P ^Z?E1
M_9%C_P ^Z?E5ZB@"C_9%C_SP7\JM10QPKMC4*/05)10 4444 %%%% !1110
M4444 %1&WB)R4&:EHI.*>X$!M8C_  "@6L0_@%3T5"I0[ 1?9HO[@J15"C &
M*6BK44M@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027820368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Check-Cap Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001610590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">EntityVoluntaryFilers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">5,844,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Check-Cap Building<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">29 Abba Hushi Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">P.O. Box 1271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Isfiya<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">3009000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CHEK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Brightman Almagor Zohar & Co.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Alex Ovadia<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">29 Abba Hushi Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">P.O. Box 1271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Isfiya<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">3009000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">546706451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">Alex.Ovadia@check-cap.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026331312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,090<span></span>
</td>
<td class="nump">$ 26,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term bank deposit</a></td>
<td class="nump">37,609<span></span>
</td>
<td class="nump">25,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">42,630<span></span>
</td>
<td class="nump">52,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">1,060<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">2,811<span></span>
</td>
<td class="nump">2,909<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">45,441<span></span>
</td>
<td class="nump">55,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts payable and accruals</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade</a></td>
<td class="nump">952<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">802<span></span>
</td>
<td class="nump">680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="nump">1,261<span></span>
</td>
<td class="nump">1,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,408<span></span>
</td>
<td class="nump">4,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital, Ordinary shares 48 NIS par value (18,000,000 authorized shares as of December 31, 2022 and 2021; 5,844,463 and 4,840,089 shares issued and outstanding as of December 31, 2022 and 2021, respectively)</a></td>
<td class="nump">83,664<span></span>
</td>
<td class="nump">68,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">84,941<span></span>
</td>
<td class="nump">90,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(127,293)<span></span>
</td>
<td class="num">(108,185)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">41,312<span></span>
</td>
<td class="nump">50,691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 45,441<span></span>
</td>
<td class="nump">$ 55,659<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RoyaltiesProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the liability recorded to pay royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RoyaltiesProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027757744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share, par value</a></td>
<td class="nump">&#8362; 48<span></span>
</td>
<td class="nump">&#8362; 48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">5,844,463<span></span>
</td>
<td class="nump">4,840,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">5,844,463<span></span>
</td>
<td class="nump">4,840,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568025868944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses, net</a></td>
<td class="nump">$ 14,271<span></span>
</td>
<td class="nump">$ 12,349<span></span>
</td>
<td class="nump">$ 10,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">5,763<span></span>
</td>
<td class="nump">4,972<span></span>
</td>
<td class="nump">3,924<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="nump">20,034<span></span>
</td>
<td class="nump">17,321<span></span>
</td>
<td class="nump">13,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Finance income, net</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">19,108<span></span>
</td>
<td class="nump">17,202<span></span>
</td>
<td class="nump">13,846<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="nump">$ 19,108<span></span>
</td>
<td class="nump">$ 17,202<span></span>
</td>
<td class="nump">$ 13,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary share - Basic</a></td>
<td class="nump">$ 3.37<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 9.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary share - Diluted</a></td>
<td class="nump">$ 3.37<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 9.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average number of ordinary shares outstanding - Basic</a></td>
<td class="nump">5,671,786<span></span>
</td>
<td class="nump">4,159,870<span></span>
</td>
<td class="nump">1,537,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding - Diluted</a></td>
<td class="nump">5,671,786<span></span>
</td>
<td class="nump">4,159,870<span></span>
</td>
<td class="nump">1,537,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026020448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Additional paid-in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 5,407<span></span>
</td>
<td class="nump">$ 77,964<span></span>
</td>
<td class="num">$ (77,137)<span></span>
</td>
<td class="nump">$ 6,234<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">433,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodValuePrivatePlacement', window );">Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29</a></td>
<td class="nump">$ 1,894<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares', window );">Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29, shares</a></td>
<td class="nump">136,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing', window );">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361</a></td>
<td class="nump">$ 13,039<span></span>
</td>
<td class="num">(2,900)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing', window );">Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361, shares</a></td>
<td class="nump">958,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction', window );">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920</a></td>
<td class="nump">$ 11,290<span></span>
</td>
<td class="num">(2,578)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction', window );">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920, shares</a></td>
<td class="nump">802,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">RSU vesting</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">RSU vesting, shares</a></td>
<td class="nump">1,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares', window );">Share-based compensation, shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,846)<span></span>
</td>
<td class="num">(13,846)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 31,646<span></span>
</td>
<td class="nump">75,715<span></span>
</td>
<td class="num">(90,983)<span></span>
</td>
<td class="nump">16,378<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="nump">2,331,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of warrants, net of issuance expenses in an amount of $22</a></td>
<td class="nump">$ 18,099<span></span>
</td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants, net of issuance expenses in an amount of $22, shares</a></td>
<td class="nump">1,210,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo', window );">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199</a></td>
<td class="nump">$ 19,011<span></span>
</td>
<td class="nump">12,790<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo', window );">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199, shares</a></td>
<td class="nump">1,296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Option exercise</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercise, shares</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">RSU vesting</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">RSU vesting, shares</a></td>
<td class="nump">1,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares', window );">Share-based compensation, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(17,202)<span></span>
</td>
<td class="num">(17,202)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 68,787<span></span>
</td>
<td class="nump">90,089<span></span>
</td>
<td class="num">(108,185)<span></span>
</td>
<td class="nump">50,691<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="nump">4,840,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo', window );">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199</a></td>
<td class="nump">$ 14,815<span></span>
</td>
<td class="num">(5,965)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 8,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo', window );">Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199, shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercise, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">RSU vesting</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">RSU vesting, shares</a></td>
<td class="nump">4,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares', window );">Share-based compensation, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,108)<span></span>
</td>
<td class="num">(19,108)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 83,664<span></span>
</td>
<td class="nump">$ 84,941<span></span>
</td>
<td class="num">$ (127,293)<span></span>
</td>
<td class="nump">$ 41,312<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="nump">5,844,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares and warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new ordinary shares and warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantIssuedDuringPeriodValueInFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of ordinary shares and warrants issued in financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantIssuedDuringPeriodValueInFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of ordinary shares and warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares and warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of Issuance expenses in an amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodSharesPrivatePlacementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of private placement issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodSharesPrivatePlacementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued upon the exercise of warrants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodValuePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares in private placement, net of issuance expenses in an amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodValuePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026498128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction', window );">Issuance expenses warrant exercise transaction</a></td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="nump">$ 3,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with warrant exercise transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568025920400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (19,108)<span></span>
</td>
<td class="num">$ (17,202)<span></span>
</td>
<td class="num">$ (13,846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">879<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Financial expense (income), net</a></td>
<td class="num">(624)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease (increase) in prepaid and other current assets and non-current assets</a></td>
<td class="nump">273<span></span>
</td>
<td class="num">(549)<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in trade accounts payable, accruals and other current liabilities</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="num">(317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Increase (decrease) in employees and payroll accruals</a></td>
<td class="num">(700)<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRoyaltiesPayable', window );">Decrease in royalties provision</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(18,707)<span></span>
</td>
<td class="num">(16,264)<span></span>
</td>
<td class="num">(13,113)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(486)<span></span>
</td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Investment in short-term bank and other deposits</a></td>
<td class="num">(12,022)<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="num">(10,072)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(12,508)<span></span>
</td>
<td class="num">(16,006)<span></span>
</td>
<td class="num">(10,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Exercise of warrants into ordinary shares, net of issuance expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,219<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceResisteredDirectOffering', window );">Issuance of ordinary shares in the registered direct offerings, net of issuance expenses</a></td>
<td class="nump">8,850<span></span>
</td>
<td class="nump">31,801<span></span>
</td>
<td class="nump">10,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Options exercise</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Issuance of ordinary shares in the private placement, net of issuance expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">8,850<span></span>
</td>
<td class="nump">51,024<span></span>
</td>
<td class="nump">23,582<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(22,365)<span></span>
</td>
<td class="nump">18,754<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the year</a></td>
<td class="nump">26,807<span></span>
</td>
<td class="nump">8,053<span></span>
</td>
<td class="nump">8,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the year</a></td>
<td class="nump">4,442<span></span>
</td>
<td class="nump">26,807<span></span>
</td>
<td class="nump">8,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Purchase of property and equipment</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest received</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReconciliationOfCashToBalanceSheetAbstract', window );"><strong>RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEET</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">4,090<span></span>
</td>
<td class="nump">26,457<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RestrictedCashIncludedCurrentAssets', window );">Restricted cash included current assets</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 4,442<span></span>
</td>
<td class="nump">$ 26,807<span></span>
</td>
<td class="nump">$ 8,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromIssuanceResisteredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceed from Issuance of ordinary shares in the RD Offering, net of issuance expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromIssuanceResisteredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ReconciliationOfCashToBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ReconciliationOfCashToBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RestrictedCashIncludedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of restricted cash included in current assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RestrictedCashIncludedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRoyaltiesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for compensation payments related to the use of copyrights, patents, trade names, licenses, technology. Royalty payments are also paid by the lease holders for oil, gas, and mineral extraction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRoyaltiesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026618544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL INFORMATION</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1&#160; -&#160; GENERAL INFORMATION</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check Cap Ltd. (the &#8220;Company") was incorporated under the laws of the State of Israel. The registered address of its offices is 29 Abba Hushi Avenue, Isfiya 3009000, Israel.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a wholly-owned subsidiary, Check-Cap US, Inc., that was incorporated under the laws of the State of Delaware on May 15, 2015.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening and prevention through the introduction of C-Scan&#174;, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into cancer. The Company&#8217;s disruptive capsule-based screening technology aims to significantly increase screening adherence worldwide and help millions of people to stay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Since its inception, the Company has devoted substantially all of its efforts to research and development, clinical trials, recruiting management and technical staff, acquiring assets and raising capital. The Company is still in its development and clinical stage and has not yet generated revenues. The Company has incurred losses of $19,108 and $17,202 for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the Company's accumulated deficit was approximately $127,293. The extent of the Company's future operating losses and the timing of becoming profitable are uncertain.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has funded its operations to date primarily through equity financings, sale of its ordinary shares and warrants, the exercise of warrants and other financing transactions and through grants from the Israel Innovation Authority of the Ministry of Economy and Industry (the "IIA").</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional funding will be required to complete the Company's research and development and clinical trials, to attain regulatory approvals, to establish manufacturing infrastructure and to begin the commercialization efforts of C-Scan. The Company has not yet commercialized its product. Even if the Company commercializes its product, it may not become profitable in the foreseeable future. The Company&#8217;s ability to achieve profitability depends on a number of factors, including its ability to obtain regulatory approval for its product, successfully complete any post-approval regulatory obligations and successfully commercialize its product alone or in partnership.</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To meet its capital needs, the Company is considering multiple alternatives, including, but not limited to, additional equity financings and other financing transactions. While the Company has been successful in raising funds in the past, there can be no assurance that it will be able to do so in the future on a timely basis on terms acceptable to the Company, or at all. Uncertain market conditions and approval by regulatory bodies and adverse results from clinical trials may (among other reasons) adversely impact the Company's ability to raise capital in the future.</span></span></div>
            <div style="line-height:1.25;margin-left:77pt">&#160;</div>
            <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2023 , the Company announced that following its internal assessment of the clinical data collected to date from its clinical calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study and that therefore, the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 is temporarily postponed. The Company adopted a plan of action that includes (among other things) a cost reduction plan in order to extend its cash runway, which it is in the process of implementing. Based on such plan, the Company believes that current cash on hand will be sufficient to fund its ongoing operations and plans into the fourth quarter of 2024. Management expects that the Company will continue to generate losses from the development, manufacturing and infrastructure costs, clinical development and regulatory activities of C-Scan, which will result in negative cash flow from operating activity. The actual amount of cash that the Company will need to operate is subject to many factors, including, but not limited to, the initiation, timing, progress and results of clinical trials and other product development efforts regulatory path along with cost to commercialize its product.</span></span></div>
            <div style="text-align:justify;margin-left:76pt;line-height:1.25;font-family:Times New Roman, Times, serif">&#160;</div>
            <div/>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As described in Notes 10B(2)(b) and 10B(2)(d), on February 24, 2015, the Company consummated an Initial Public Offering in the United States (U.S.) (the "IPO") concurrently with a private placement.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 11, 2016, the Company consummated a registered direct offering of ordinary shares and pre-funded warrants. See Note 10B(2)(h).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On June 2, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(i).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On November 22, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(j).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 8, 2018, the Company consummated an underwritten public offering of ordinary shares, pre-funded warrants and Series C warrants. See Note 10B(2)(k).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On February 6, 2019, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(l).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In February 2020, the Company consummated a private placement of ordinary shares. See Note 10B(2)(m).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During April and May 2020, the Company consummated three registered direct offerings of ordinary shares and simultaneous private placements of warrants. See Note 10B(2)(n).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 27, 2020, the Company consummated a warrant exercise transaction to purchase ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(o).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During the first quarter of 2021, certain investors exercised their warrants previously issued by the Company</span>. See<span> Note 10B(2)(p).</span></span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 1, 2021, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(q).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 3, 2022, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(r).</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's ordinary shares and Series C Warrants are listed on the NASDAQ Capital Market under the symbols "CHEK" and CHEKZ&#8221; respectively.</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s Series A Warrants, formerly listed on the NASDAQ Capital Market under the symbol &#8220;CHEKW&#8221;, expired on February 24, 2020; and their listing was suspended on February 28, 2020.</span></span></div>
              <div style="line-height:1.25;margin-left:77pt">&#160;</div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated financial statements of the Company as of and for the year ended December 31, 2022 include the financial statements of the Company and its wholly-owned U.S. subsidiary.</span></span></div>
              <div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif">&#160;</div>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 23, 2021, the Company announced that it received a letter from the Staff, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of $1.00 per share. The Company was provided by Nasdaq with a compliance period of 180 calendar days (i.e., until June 21, 2022) to regain compliance pursuant to Nasdaq Listing Rules. On June 22, 2022, the Company received a letter from the Staff notifying it that Nasdaq granted the Company a 180-day extension, or until December 19, 2022, or the Extension Period, to regain compliance with the Minimum Bid Price Requirement. In order to regain compliance, on August 11, 2022, the Company&#8217;s shareholders approved a reverse share split (&#8220;Reverse Share Split&#8221;) of its ordinary shares within a range of 1 for 10 to 1 for 20, the exact ratio to be determined by further action of the Company&#8217;s Board of Directors, to be effective on a date to be determined by the Company&#8217;s Board of Directors and announced by the Company, and to amend the Company&#8217;s Articles of Association accordingly. The Board of Directors subsequently approved a reverse share split of the Company&#8217;s ordinary shares at the ratio of 1-for-20, such that each twenty (20) ordinary shares, par value NIS 2.40 per share, consolidated into one (1) ordinary share, par value NIS 48.00, effective as of November 23, 2022. The first date when the Company&#8217;s ordinary shares began trading on the Nasdaq Capital Market after implementation of the Reverse Share Split was November 25, 2022. Following the implementation of the Reverse Share Split, the Company&#8217;s authorized share capital comprised of 18,000,000 ordinary shares. No fractional ordinary shares were issued as a result of the Reverse Share Split. All fractional ordinary shares were rounded up to the nearest whole ordinary share. In addition, a proportionate adjustment made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase ordinary shares. Furthermore, following completion of the Reverse Share Split, the number of ordinary shares issuable pursuant to the Company&#8217;s 2006 Unit Option Plan and 2015 Equity Incentive Plan and 2015 US Sub-Plan to the 2015 Equity Incentive Plan, as well as the number of shares and exercise prices subject to outstanding options under the plans and the number of shares subject to outstanding restricted stock units (&#8220;RSUs&#8221;) under the plans were appropriately adjusted. The Company subsequently received a letter informing it that, for the 10 consecutive business days from November 25, 2022 to December 8, 2022, the closing bid price of the Company&#8217;s ordinary shares had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7)</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. The Company experienced temporary disruptions to its operations as a result of the COVID-19 pandemic including disruptions to the Company&#8217;s clinical studies For example, during a period of few months during the year ending December 31, 2022, there was a global shortage in iodine due to COVID-19, which is critical patient intake used in the C-Scan procedure. As a result, the Company faced delays in its clinical trials. &#160;The extent to which the COVID-19 pandemic shall impact the Company&#8217;s operations in the future will depend on future developments, which are highly uncertain and cannot be predicted with confidence. In particular, any future spread of COVID-19 globally or the reinstatement of restrictions or other actions that may be required to contain COVID-19 or treat its impact could materially adversely impact the Company&#8217;s operations and workforce, including its research and clinical trials and its ability to continue raise capital, could affect the operations of key governmental agencies, such as the U.S. Food and Drug Administration (&#8220;FDA&#8221;), which may delay the Company&#8217;s development plans, and could result in the inability of the Company&#8217;s suppliers to deliver components or raw materials on a timely basis or at all, each of which in turn could have a material adverse impact on the Company&#8217;s business, financial condition and results of operation.</span></span></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568115551472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></div>
            <div style="line-height:1.25;font-weight:bold">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company`s consolidated financial statements are presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").</span></span></div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates in preparation of financial statements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</span></span></div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's consolidated financial statements include the financial statements of Check-Cap Ltd. and its wholly-owned subsidiary, Check-Cap US, Inc. The Company's consolidated financial statements are presented after elimination of inter-company transactions and balances.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial statements in U.S. dollars</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has not yet generated revenues and the majority of its expenses are in U.S. dollars (dollar or USD) or NIS.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements are presented in dollars, which is the functional currency of the Company. In management's judgment, setting the dollar as the Company's functional currency, is based mainly on the following criteria: the Company's budget and other Company internal reports, including reports to the Company's Board of Directors and investors, are presented in dollars. Management uses these reports in order to make decisions for the Company. All of the Company's equity financings have been in dollars; and it is expected that a significant portion of the Company's future revenues will be in dollars.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances denominated in dollars are presented at their original amounts. Non&#8209;dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents include cash in hand, short&#8211;term deposits in banks and short-term, highly liquid investments with an original maturity of up to three months, with a high level of liquidity that may be easily converted to known amounts of cash, and that are exposed to insignificant risk of change in value.</span></span></div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">E.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposit</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits are deposits with maturities of more than three months but less than one year. The short&#8211;term bank deposits are presented at their cost, including accrued interest, which approximates fair value.</span></span></div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash flow hedges</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264 and $3,466, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company&#8217;s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $56 and an asset, net, of $65, respectively and is included in other current liabilities and other current assets, respectively.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">G.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>

                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div style="margin-left:49pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Length&#160;of&#160;useful&#160;life</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dep</span><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">reciation&#160;</span></span></span><span style="font-size:10pt"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">rate</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10-14</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3-7</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>

              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">H.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's long-lived assets are reviewed for impairment in accordance with ASC 360-10 "Accounting for the Impairment or Disposal of Long-Lived Assets" whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and consist primarily of costs for personnel, subcontractors and consultants (mainly in connection with clinical trials) and materials for research and development and clinical activities. Grants received by the Company from the IIA are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. Such grants are included as a deduction of research and development costs.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>

            <div/>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">J.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent liabilities</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC No. 450, "Contingencies". A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2022, and 2021, the Company is not a party to any ligation that could have a material adverse effect on the Company's business, financial position, results of operations or cash flows.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">K.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes expense for its share-based compensation based on the fair value of the awards granted. The Company&#8217;s share-based compensation plans provide for the award of stock options and restricted stock units. In accordance with ASC 718-10 "Compensation-Stock Compensation", the Company estimates the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the graded-vesting method over the requisite service period for each separately vesting portion of the award. Accounting Standards Update (&#8220;ASU&#8221;) 2016-09, Compensation-Stock Compensation (Topic 718) allows companies to account for forfeitures when they occur.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation cost for awards with performance conditions if and when the company concludes that it is probable that the performance conditions will be achieved. ASC 718&#8217;s use of the term probable is consistent with that term&#8217;s use in ASC 450, Contingencies, which refers to an event that is likely to occur (ASC Master Glossary). The Company reassess at each reporting period the probability of vesting for awards with performance conditions and adjusts compensation cost based on its probability assessment.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the years ended December 31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>

            <div/>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740-10 "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 740, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered 'more-likely-than-not' that the position taken will be sustained by a taxing authority. As of December 31, 2022 and 2021, the Company had no unrecognized income tax positions, and, accordingly, there is no impact on the Company's effective income tax rate associated with these items.</span></span></div>
              </div>

            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">M.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of financial instruments</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures its investments in money market funds (classified as cash equivalents) and its foreign currency net purchased options at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2</span>. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3</span>. Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</span></span></div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>

            <div/>
            <div style="line-height:1.25">&#160;</div>

              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">N.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted Cash</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has granted a pledge in favor of Bank Leumi Le-Israel B.M in the amount of $352 and 350 as of &#160;December 31, 2022 and 2021, respectively to secure certain payment obligations of the Company in connection with hedge transactions. This amount was classified as restricted cash balance.</span></span></span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">O.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for leases in accordance with ASC 842 "Lesses.&#8221; Arrangements that are determined to be leases at inception are recognized as long-term operating lease assets and lease liabilities in the consolidated balance sheet at lease commencement. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As the Company&#8217;s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at the commencement date in determining the present value of future lease payments. Lease terms may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has also elected the practical expedient to include both lease and non-lease components as a single component and account for it as a lease. Additionally, the Company has made a policy election not to capitalize leases with an original term of 12 months or less.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 360-10, management reviews operating lease assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable based on estimated future undiscounted cash flows. If so indicated, an impairment loss would be recognized for the difference between the carrying amount of the asset and its fair value.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">P.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent accounting pronouncements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2021, the FASB issued ASU No. 2021- 10, Government Assistance (Topic 832). This ASU requires business entities to disclose information about government assistance they receive if the transactions were accounted for by analogy to either a grant or a contribution &#160;accounting &#160;model. &#160;The disclosure requirements include the nature of the transaction and the related accounting policy used, the line items on the balance sheets and statements of operations that are affected and the amounts applicable to each financial statement line item and the significant terms and conditions of the transactions. The ASU is effective for annual periods beginning after December 15, 2021. The disclosure requirements can be applied either retrospectively or prospectively to all transactions in the scope of the amendments that are reflected in the financial statements at the date of initial application and new transactions that are entered into after the date of initial application. The Company already adopted ASU No. 2021- 10, in its financial statements.</span></span></div>
              </div>


              <div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;width:29pt">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Q.</span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassification</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders&#8217; deficit, net loss or net cash used in operating activities.</span></span></div>
              </div>

          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568029296912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock', window );">PREPAID EXPENSES AND OTHER CURRENT ASSETS</a></td>
<td class="text">
    <div>
      <div>
        <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 3&#160; -&#160; PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></strong></div>
      </div>
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>

              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">88</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">206</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">260</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">470</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deposits</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">223</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">579</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">839</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure for prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027215088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 4&#160; -&#160; PROPERTY AND EQUIPMENT, NET</span></span></strong></p>
      <div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>

              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">799</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">723</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,915</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,721</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">574</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">540</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,288</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,984</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,537</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,751</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,793</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>

            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation expenses amounted to $346, $205 and $148 for the years ended December 31, 2022, 2021 and 2020, respectively.</span></span></div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027433264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 5&#160; -&#160; LEASES</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 1, 2019, the Company adopted ASU 2016-02, using the modified retrospective approach for all lease arrangements at the beginning period of adoption.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 26, 2021, the Company entered into a new lease agreement, as amended (the &#8220;Amended Lease Agreement&#8221;), according to which, effective as of April 1, 2021, the Company leases a total of approximately 1,550 square meters at its facility located in Isfiya, Israel. The Amended Lease Agreement expires on December 31, 2023, and the Company has an option to extend the lease period for an additional three years. The Company has the right to terminate the Amended Lease Agreement at any time, upon at least 60 days prior written notice. Monthly rental expenses under the lease agreement are $16.1. Prior to entering into the Amended Lease Agreement, the Company leased approximately 900 square meters at the same facility under a lease agreement, originally scheduled to expire on May 31, 2022. According to ASC 842, the Amended Lease Agreement was accounted for as a lease modification and, therefore, the lease liability was remeasured as of the modification date with an adjustment recorded to the underlying right of use asset.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(3)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#8220;Sub-lease Agreement&#8221;), with a Company supplier (the &#8220;Lessor&#8221;) according to which, the Company leases approximately 70 square meters laboratory space for the production of certain components, at the supplier&#8217;s premises in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on January 31, 2025, and the Company has an option to extend the lease period for an additional two years. The Company has the right to terminate the Sub-lease Agreement at any time, upon at least 90 days prior written notice.</span></span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-right:0pt;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended service agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $26.9. Following the effectiveness of the Sub-lease Agreement, the lease is recorded under ASC 842. As the Sub-lease Agreement is part of a service agreement with the supplier, management is required to evaluate the fair market amount attributed to the lease per month and based on its estimations, the amount allocated to the lease is approximately $2.8 and the portion allocated to monthly services is $24.1.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately 140 square meters offices, The lease agreement expires on February 28, 2024, and the Company has an option to extend the lease period for two additional periods of one year each. Total monthly rental expense under the lease agreement is approximately $1.7. The lease agreement is recorded under ASC 842.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(5)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, the Company leases vehicles under various operating lease agreements.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 31, 2022, the Company&#8217;s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $1,060 and $964, respectively.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Supplemental cash flow information related to operating leases was as follows:</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash payments for operating leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          &#160;<div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the Company&#8217;s operating leases had a weighted average remaining lease term of 3.4 years and a weighted average borrowing rate of 4.4%. Upon adoption of ASC 842, discount rates for existing operating leases were established as of January 1, 2019. Future lease payments under operating leases as of December 31, 2022 were as follows:</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">352</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025 and after</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">410</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total future lease payments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,044</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interest</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:4px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease liability balance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">964</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027329648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Employee-related Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_EmployeeRelatedLiabilitiesTextBlock', window );">EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 6&#160; -&#160; EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</span></span></div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  </td>
                </tr>

            </table>

              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits for vacation and recreation pay</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">529</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">573</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability for payroll, bonuses and wages</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">732</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,388</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,261</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,961</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            &#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Post-employment benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Pursuant to Israel's Severance Pay Law, 1963, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. All of the Company's employees elected to be included under Section 14 of the Severance Pay Law, 1963 ("Section 14"). According to Section 14, employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments under the Israeli Severance Pay Law, 1963 in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Paid vacation days</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the Yearly Vacation Law-1951 (the "Vacation Law"), the Company's employees are entitled to a certain number of paid vacation days for each year of employment. In accordance with the Vacation Law and its appendix, and as determined in the agreement between the Company and the employees, the number of vacation days per year to which each employee is entitled is based on the seniority of the employee.</span></span></div>
            <div style="line-height:1.25;margin-left:78pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The employee may use vacation days based on his or her needs and with the Company's consent, and accrue the remainder of unused vacation days, subject to the provision of the Vacation Law. The vacation days utilized first are those credited for the current year and subsequently from any balance transferred from the prior year (on a "LIFO" basis). An employee who ceased working before utilizing the balance of vacation days accrued is entitled to payment for the balance of unutilized vacation days.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Related parties</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For information regarding related parties, see Note 16.</span></span></div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_EmployeeRelatedLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure for employee related liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_EmployeeRelatedLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027275072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 7&#160; -&#160; INCOME TAXES</span></span></div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap Ltd. is taxed according to Israeli tax laws:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate tax rates in Israel</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:77pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Israeli corporate tax rate in years 2020, 2021, 2022 and onwards is 23%.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Law for the Encouragement of Capital Investments, 1959 (the "Investments Law")</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:77pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Under the Investments Law, including Amendment No. 60 to the Investments Law as published in April 2005, by virtue of the "Benefited Enterprise" status, the Company is entitled to various tax benefits as follows:</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reduced tax rates</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has one Benefited Enterprise program under the Investments Law, which entitles it to certain tax benefits with respect to income to be derived from the Company's Benefited Enterprise. During the benefits period, taxable income from its Benefited Enterprise program (once generated) will be tax exempt for a period of ten years commencing with the year the Company will first earn taxable income relating to such enterprise. The Company chose 2010 as the year of election (the "Year of Election"). Due to the location of the Company's offices, the Company believes it is entitled to a 10 year benefit period, subject to a 14 year limitation from the Year of Election, and therefore, the tax benefit period will, in any event, end in 2023.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Conditions for entitlement to the benefits</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">c)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amendment of the Law for the Encouragement of Capital Investments, 1959</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Investments Law was amended as part of the Economic Policy Law for the years 2011-2012, which was passed by the Israeli Knesset on December 29, 2010 (the "Capital Investments Law Amendment").</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Capital Investments Law Amendment set alternative benefit tracks to those in effect prior to such amendment under the provisions of the Investments Law.</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The benefits granted to the Preferred Enterprise will be unlimited in time, unlike the benefits granted to special Benefited Enterprises, which will be limited for a 10 year period. The benefits shall be granted to companies that will qualify under criteria set forth in the Investments Law; for the most part, those criteria are similar to the criteria that were set forth in the Investments Law prior to its amendment.</span></span></div>
            <div style="line-height:1.25;margin-left:107pt">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the transitional provisions of the Investments Law, the Company is entitled to take advantage of the tax benefits available under the Investments Law prior to its amendment until the end of the benefits period, as defined in the Investments Law. The Company was entitled to set the "year of election" no later than tax year 2012, provided that the minimum qualifying investment was made not later than the end of 2010. On each year during the benefits period, the Company will be able to elect that the Investments Amendment applies to the Company, thereby making the tax rates described above available to the Company. An election to have the Capital Investments Amendment apply is irrecoverable. The Company elected not to have the Capital Investments Amendment apply to the Company.</span></span></div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:106pt">&#160;</div>
            <div/>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 22, 2016, the Knesset approved the 2017-2018 State budget, which includes amendment number 73 to the Investments Law. The amendment includes:</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adoption of a new incentive tax regime that applies to high-tech companies that are deemed a &#8220;Preferred Technological Enterprise&#8221; or &#8220;Special Preferred Technological Enterprise,&#8221; based on the provisions and rules adopted by the Organization for Economic Cooperation and Development, creating new reduced corporate tax rate tracks of 7.5% for Preferred Technological Enterprises located in Development Area A and 12% for the rest of the country; and a reduced corporate tax rate of 6% for a &#8220;Special Preferred Technological Enterprise&#8221; regardless of the company&#8217;s geographic location within Israel.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reduction of corporate tax rate for all Preferred Enterprises from 9% to 7.5%.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lowering the threshold for the conditions that were previously set in order to enter the track of a "Special Preferred Enterprise" for very large enterprises entitled to a reduced tax rate of 5% in Development Area A or 8% in the rest of the country.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Updating the definitions of preferred income, Preferred Enterprise, etc.</span></span></div>
              <div style="line-height:1.25;margin-left:107pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with the Israeli Income Tax Ordinance [New Version], 1961, as of December 31, 2022, all of the Company&#8217;s tax assessments through tax year 2017 are considered final.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc.</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc. is taxed according to U.S. tax laws at a rate of 21%.</span></span></div>
              <div style="line-height:1.25;margin-left:49pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Check-Cap US, Inc. operating loss or &#8220;NOL&#8221; carry-forwards was $9 as of December 31, 2022 and $7 as of December 31, 2021.</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred income taxes</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company's history of losses, the Company established a full valuation allowance on its net-operating loss carryforwards.</span></span></div>

                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry-forward tax losses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,232</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,677</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less valuation allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,232</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,677</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

              <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
              <div/>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reconciliation of the theoretical tax expense to actual tax expense</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The main reconciling item between the statutory tax rate of the Company and the effective rate is the provision of full valuation allowance in respect of tax benefits from carry forward tax losses due to the uncertainty of the realization of such tax benefits (see above).</span></span></div>
            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027270256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 8&#160; -&#160; COMMITMENTS AND CONTINGENT LIABILITIES</span></span></div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties provision</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties to an ASIC designer</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has a liability to pay royalties for the development of an ASIC component which is used as an amplifier for the capture of signals at low frequencies from X-ray detectors contained in the capsule. The institution that developed the ASIC is entitled to receive royalties from the Company in the amount of 50 &#8364; cents (53.3 U.S. cents) for every ASIC component that the Company will sell, capped at &#8364;200 (approximately $213). This royalty is considered as a liability.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The royalty liability is calculated based on estimated future sales generated by products which include the ASIC component. As of December 31, 2022, the Company believes that it will be required to pay the above mentioned royalties, and accordingly, recorded, as of December 31, 2022, a provision in a total amount of $94.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reimbursement liability to Predecessor Entity's unit holders</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 31, 2009, the Company entered into an asset transfer agreement with Check Cap LLC (the "Predecessor Entity"), a company with the same shareholders as the Company at the time of transfer. According to the agreement, the Predecessor Entity transferred all of its business operations and substantially all of its assets to the Company, including development and consulting agreements, cash, property and equipment and intangible ownership rights, free of any debt.</span></span></div>
          <div style="line-height:1.25;margin-left:78pt">&#160;</div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a part of the reorganization, the Company committed to reimburse the unit holders of the Predecessor Entity for any tax burdens that may be imposed on them due to the reorganization. The reimbursement liability is calculated assuming deemed royalties are paid to the U.S. unit holders of Check-Cap LLC under Section 367(d) of the Code, and is based in part on the Company&#8217;s forecasted sales with a cap calculated as the fair value of the share as determined at the date of the financial statements. The reimbursement liability is calculated by multiplying the estimated tax rate by the lowest of: (1) expected cash outflows for a period of 15 years ending December 31, 2023, discounted using a discount factor commensurate with the risk of the Company, and (2) value of the shares held by U.S. unit holders of the Predecessor Entity as of December 31, 2022 multiplied by $2.2, the last reported price per share of the Company&#8217;s ordinary shares on the Nasdaq Capital Market on December 31, 2022. Any updates in the contingent liability will be charged to earnings. Since the Company does not expect to be profitable in year 2023, the liability based on the discounted outflows is $0. As a result, as of December 31, 2022 and 2021, the balance of the reimbursement liability totaled $0.</span></span></div>
          <div style="line-height:1.25">&#160;</div>

            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;text-indent:22pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2&#160;0&#160;2&#160;2</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties to an ASIC designer</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>

          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div/>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Commitments</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's research and development efforts are financed, in part, through funding from the IIA and the BIRD Foundation. Since the Company's inception through December 31, 2022, the Company received funding from the IIA and the BIRD Foundation in the total amount of approximately $5,600 and $114, respectively. In year 2021, the Company received grant approval from the IIA to support the funding of the Company&#8217;s transition from research and development to manufacturing. The final grant amounted to $620, of which approximately $349 was received in year 2021, $82 was received in January 2022 and $222 was received in February 2023. The grants received under this plan are not subject to future royalties.</span></span></div>
          <div style="line-height:1.25;margin-left:77pt">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">According to the terms of applicable law as currently in effect regarding the grants received before year 2021, the IIA is entitled to royalties equal to 3-4% (or at an increased rate under certain circumstances) of the revenues from sales of products and services based on technology developed using IIA grants, up to the full principal amount (which may be increased under certain circumstances) of the U.S. Dollar-linked value of the grants, plus interest at the rate of 12-month LIBOR. The obligation to pay these royalties is contingent on actual sales of the applicable products and services and in the absence of such sales, no payment is required. As of December 31, 2022, the Company had not paid any royalties to the IIA and had a contingent liability to the IIA in the amount of approximately $6,199.</span></span></div>
          <div style="line-height:1.25;margin-left:77pt">&#160;</div>
          <div style="text-align:justify;margin-left:78pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On July 13, 2014, the Company entered into a Cooperation and Project Funding Agreement with the BIRD Foundation and Synergy and during 2014-2017, the Company, together with Synergy, had received funding from the BIRD Foundation in the aggregate amount of approximately $127. Based on the aggregate expenses that the Company incurred for such project, it refunded to the BIRD Foundation an amount of approximately $13. The Company will not be receiving additional funding from the BIRD Foundation for the project, which is no longer active. As of December 31, 2022, the Company had not paid any royalties to the BIRD Foundation and had a contingent obligation to the BIRD foundation in the amount of approximately $209.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2)</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rental agreements</span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:78pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 26, 2021, the Company entered into the Amended Lease Agreement according to which, effective as of April 1, 2021, it leases approximately 1,550 square meters at the facility located in Isfiya, Israel. The Amended Lease Agreement expires on December 31, 2023, and the Company has an option to extend the lease period for an additional three years. The Company has the right to terminate the agreement at any time, upon at least 60 days prior written notice.</span></span></div>
                </td>
              </tr>

          </table>
          <div style="text-align:justify;text-indent:18pt;margin-left:72pt;line-height:1.25">&#160;</div>
          <div style="margin:0px 0px 0px 107pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Monthly rental expenses under the Amended Lease Agreement are $14.2. See also Note 5.</span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:78pt">&#160;</td>
                <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#8220;Sub-lease Agreement&#8221;), with a Company supplier (the &#8220;Lessor&#8221;) according to which, the Company leases approximately 70 square meters laboratory space for the production of certain components in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on January 31, 2025, and the Company has an option to extend the lease period for an additional two years. The Company has the right to terminate the agreement at any time, upon at least 90 days prior written notice. The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $26.9.</span></span></div>
                </td>
              </tr>

          </table>
          <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
          <div/>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately 140 square meters offices, The lease agreement expires on February 28, 2024, and the Company has an option to extend the lease period for two additional periods of one year each. Total monthly rental expense under the lease agreement is approximately $1.7. .</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:77pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vehicle lease and maintenance agreements</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="margin:0px 0px 0px 106pt;line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company entered into several 36 months lease and maintenance agreements for vehicles, which are regularly amended as new vehicles are leased. The current monthly lease fees are approximately $13.7. See also Note 5.</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4)</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company issued purchase orders to certain suppliers in order to secure strategic inventory of key components that as of December 31, 2022 have not yet been supplied.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Legal</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of the date of the financial statements, the Company is not a party to any pending litigation.</span></span></div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027306800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">
      <div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 9&#160; -&#160; FAIR VALUE MEASUREMENTS</span></span></div>
        <div>
          <div>
            <div>
              <div style="line-height:1.25">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC No. 820, the Company measures its money market funds and foreign currency derivative contracts at fair value. Money market funds are classified within Level 1. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.</span></span></div>
              <div style="line-height:1.25;margin-left:49pt">&#160;</div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:</span></span></div>
              <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:54pt">&#160;</div>

                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets (liabilities)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53.5</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current assets:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,225</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>

            </div>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027300944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text">
      <div>
        <div>
          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>NOTE 10 - SHAREHOLDERS' EQUITY</span></span></span></span></span></span></span></span></div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span style="font-weight:bold">A</span>.</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Effective November 23, 2022, the Company's Board of Directors effected a Reverse Share Split of 1-for-20 (i.e., 20 ordinary shares were combined into one ordinary share). Share and per share amounts in the financial statements, prior to November 23, 2022, have been adjusted to reflect the Reverse Share Split.&#160;</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>B.</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Ordinary shares</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>1.</span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>The ordinary shares provide their holder with rights to receive dividends in cash and shares, and rights to participate at the time of distributing liquidation dividends. Additionally, the ordinary shareholders have the right to vote at shareholder meetings in a manner that each share provides one voting right to its holder.</span></span></span></span></span></span></p>
                    </td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt">&#160;</td>
                    <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                  </tr>
                  <tr>
                    <td style="width:49pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>2.</span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="font-weight:bold">Changes in ordinary share capital</span></span></span></span></span></span></span></p>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="text-align:justify;margin-left:47.25pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>a)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On May 11, 2010, the Company issued, free of charge, to all of its shareholders (except for certain ordinary shareholders), warrants to purchase an aggregate of 1,609 ordinary shares (hereafter- "Anti-dilution Warrants"). The Anti-dilution Warrants were issued in order to prevent the dilution of the holdings of such Company shareholders due to certain options granted to the then Company's CEO ("CEO options"). The Anti-dilution Warrants were subject to automatic exercise, without consideration (unless the holder thereof objected to such exercise), upon the exercise by the Company's CEO of the CEO Options. The fair value of the Anti-dilution Warrants on the grant date was immaterial. Anti-dilution warrants to purchase 37 and 387 ordinary shares were exercised during the years ended December 31, 2019 and 2018, respectively. The remaining Anti-dilution Warrants to purchase 326 ordinary shares expired on May 11, 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>b)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On February 24, 2015, the Company consummated an IPO in the U.S. of 8,334 units at a public offering price of $1,440 per unit, before underwriting discounts and offering expenses. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $1,800. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $1,656. The Series A Warrants expired on February 24, 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company granted the underwriters a 45-day over-allotment option to purchase up to 1,250 additional units (together with an accompanying 1,875 Long Term Incentive Warrants). The option to purchase additional 417 units was partially exercised on March 6, 2015. The units were separated into one ordinary share and one-half of a Series A Warrant to purchase one ordinary share on March 18, 2015, and the units ceased to exist as of such date. On April 6, 2015, the option to purchase an additional 625 ordinary shares and 313 Series A Warrants was partially exercised. The Company received net proceeds from the IPO and partial exercise of the over-allotment option of approximately $10,800 (net of issuance cost of approximately $2,900, including certain warrants with a value of $196 issued in connection with the IPO).</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>c)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Immediately prior to the consummation of the IPO, certain members of the Company's management exercised options to purchase 1,282 ordinary shares granted to them under the 2006 Unit Option Plan.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                </tr>

            </table>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>d)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On August 20, 2014, the Company entered into a certain credit line agreement, pursuant to which it obtained a credit line in an aggregate principal amount of $12,000 from certain lenders and existing shareholders (the "Lenders"). The credit line amount was deposited in an escrow account at the closing, which was consummated on October 14, 2014. The Company issued to each Lender at closing a warrant (collectively, the "Credit Line Warrants"), to purchase a number of the Company's ordinary shares constituting 2% of its share capital on a fully diluted basis (assuming conversion of all of the Company's convertible securities into ordinary shares at a 1:1 conversion rate) as of the closing for each $1,000 (or portion thereof) extended by such Lender. The Company issued Credit Line Warrants ("CLA Warrants") to purchase in the aggregate 11,078 of its ordinary shares. The CLA Warrants are exercisable for a period of ten years at an exercise price of NIS 48 per share, and may be exercised on a net issuance basis.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Under the terms of the credit line agreement, the Company directed that the entire credit line amount (that was in escrow) be invested in the Private Placement, consummated simultaneously with the consummation of the IPO on February 24, 2015. The Company issued to the Lenders 8,334 units at a price of $1,440 per unit, before issuance cost. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $1,800. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $1,656. The Company received net proceeds from the Private Placement of approximately $10,900 (net of issuance cost of approximately $1,200, including certain warrants with a value of $125 issued in connection with the Private Placement). The Series A Warrants expired on February 24, 2020. As of December 31, 2021, Long Term Incentive Warrants to purchase 18,903 ordinary shares were outstanding. The Long Term Incentive Warrants expired on February 24, 2022.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>e)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>No CLA Warrants were exercised during the years ended December 31, 2022, 2021 and 2020. As of December 31, 2022, CLA Warrants to purchase 370 ordinary shares were outstanding.</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px">

                    <tr>
                      <td style="width:78pt">&#160;</td>
                      <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>f)</span></span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span>On October 14, 2014, the Company issued warrants to purchase an aggregate 924 ordinary shares (the &#8220;Pontifax Warrants&#8221;) to the Pontifax Funds in consideration of their commitment to provide to the Company, for no consideration, certain business development and chairman services. As of December 31, 2021, Pontifax Warrants to purchase 462 ordinary shares, with an exercise price of $1,214.4 per share, were outstanding. These warrants expired on October 14, 2022.</span></span></span></span></span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>g)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Upon the closing of the IPO, the Company issued warrants to purchase 417 ordinary shares at an exercise price of $1,800 to the IPO lead underwriter and warrants to purchase 63 ordinary shares at an exercise price of $1,214.4 to the Company's U.S. legal counsel. These warrants expired on February 24, 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>h)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On August 11, 2016, the Company consummated a registered direct offering of 2,682 ordinary shares at a price of $456 per share and pre-funded warrants to purchase 10,477 ordinary shares at a purchase price of $444 per pre-funded warrant. The pre-funded warrants have an exercise price of $12 per share, subject to certain adjustments and will expire on August 11, 2023, unless otherwise extended in accordance with the terms of the pre-funded warrants. The Company received gross proceeds from the August registered direct offering of approximately $5,900 (including proceeds from the exercise of 2,396 pre-funded warrants at the closing of the offering). On January 23, 2017, the remaining pre-funded warrants to purchase 1,209 ordinary shares were exercised, for additional proceeds of approximately $14.5.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div/>
            <div style="line-height:1.25">
              <div style="line-height:1.25">&#160;</div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>i)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On June 2, 2017, the Company consummated a registered direct offering of 5,623 ordinary shares at a price of $480 per share and a simultaneous private placement of one-year warrants to purchase 5,623 ordinary shares at an exercise price of $510 per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $2,690. On June 2, 2018, all of the warrants issued to investors in this offering expired. As of December 31, 2021, warrants to purchase 282 ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;</span></span><span>These placement agent warrants expired on June 2, 2022.</span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">
              <div style="line-height:1.25">
                <p style="margin:0pt">&#160;</p>
              </div>
            </div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>j)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>On November 22, 2017, the Company consummated a registered direct offering of </span>9,470<span> ordinary shares at a price of $</span>264<span> per share and a simultaneous private placement of five-year warrants to purchase </span>7,103<span> ordinary shares at an exercise price of $</span>300<span> per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $</span>2,500<span>. On April 25, 2018, </span>2,841<span> of these warrants were cashless exercised into </span>679<span> ordinary shares.</span><span style="font-weight:bold"> </span><span> On July 27</span><span>,&#160;</span><span>2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), all of the </span>4,262<span> warrants that were outstanding as of that date&#160;were exercised into ordinary shares. As of December 31, 2021, warrants to purchase </span>474<span> ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;</span></span></span>These placement agent warrants expired on November 22, 2022.</span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>k)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On May 8, 2018, the Company consummated an underwritten public offering (the &#8220;2018 Public Offering&#8221;) of 136,924 units (the &#8220;2018 Units&#8221;), at a public offering price of $110 per unit, and 22,546 pre-funded units (the &#8220;2018 Pre-funded Units&#8221;), at a public offering price of $109.8 per 2018 Pre-funded Unit. Each 2018 Unit consisted of one ordinary share of the Company and one Series C warrant to purchase one ordinary share of the Company. Each 2018 Pre-funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series C Warrant to purchase one ordinary share. The exercise price of each pre-funded warrant included in the 2018 Pre-funded Unit was $0.2 per share. The Series C warrants have an exercise price of $110 per share, are exercisable immediately and will expire five years from the date of issuance.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company granted the underwriters a 30-day over-allotment option to purchase up to an additional 23,921 ordinary shares and/or Series C Warrants to purchase up to an additional 23,921 ordinary shares at the public offering price. The underwriters&#8217; option was exercised in full on May 8, 2018.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>The Company received gross proceeds from the 2018 Public Offering and exercise in full of the over-allotment option of approximately $20,200 (before deducting underwriting discounts and commissions and other offering fees and expenses). During May 2018, the 22,546 pre-funded warrants were exercised in full in consideration of additional gross proceeds of approximately $4,500. As of December 31, 2022, Series C Warrants to purchase 183,390 ordinary shares were outstanding.</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>l)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On February 6, 2019, the Company issued 94,075 units, (the &#8220;2019 Units&#8221;) at a purchase price of $51.6 per unit, and 1,024,876 pre-funded units (the &#8220;2019 Pre-funded Units&#8221;), at a purchase price of $51.4 per 2019 Pre-Funded Unit, in a registered direct offering (the &#8220;2019 Registered Direct Offering&#8221;). Each unit consisted of one ordinary share of the Company and one Series D Warrant to purchase 0.5 ordinary share of the Company. Each 2019 Pre-Funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series D Warrant to purchase 0.5 ordinary share. The exercise price of each pre-funded warrant included in the 2019 Pre-Funded Unit was $0.2 per share. The Series D Warrants have an exercise price of $51.6 per ordinary share and are immediately exercisable and will expire on the fifth anniversary of the original issuance date. The Company also issued placement agent warrants to purchase up to an aggregate of 10,173 ordinary shares, on the same terms as the warrants issued to the investors, except they have an exercise price of $64.5 per share. The Company received gross proceeds from the February 2019 Registered Direct Offering of approximately $7,500 </span></span></span></span><span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial">(including proceeds from the exercise of&#160;</span><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400">51,244&#160;</span><span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial">pre-funded warrants), or approximately $6,500, net of issuance expenses in the amount of</span><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400">&#160;$987.&#160; On July 27</span><sup style="color:#000000;font-family:Times New Roman, Times, serif;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;vertical-align:text-top;line-height:1;font-size:smaller">,&#160;</sup><span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400">2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), warrants to purchase 48,450 ordinary shares were exercised for ordinary shares and warrants. As of December 31, 2022, warrants to purchase 24,210 ordinary shares held by certain investors and warrants to purchase 10,173 ordinary shares held by the placement agent were outstanding.</span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>m)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On December 19, 2019, the Company entered into definitive agreements with certain investors to sell an aggregate of 136,009 ordinary shares at a purchase price of $35 per share in a private placement, resulting in gross proceeds of approximately $4,760. The closing of the transaction occurred in February 2020.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">&#160;</td>
                  <td style="vertical-align:top;text-align:justify;width:auto">&#160;</td>
                </tr>
                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>n)</span></span></span></span></span></span></span></p>
                  </td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>April &#8211; May 2020 registered direct offerings</span></span></span></span></span></span></span></p>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>On April 22, 2020, May 4, 2020 and May 13, 2020, the Company issued 333,334, 375,001 and 250,000 ordinary shares, respectively, in registered direct offerings (the &#8220;April-May 2020 Registered Direct Offering&#8221;) at a purchase price of $12 per share and issued to the investors unregistered warrants to purchase an aggregate of 333,334, 375,001 and 250,000 ordinary shares, respectively, in a private placement. The warrants are immediately exercisable </span></span></span></span></span></span>at an exercise price of $16 per ordinary share, subject to certain adjustments,&#160;<span><span><span><span><span><span>and will expire five and one-half years from the issuance date. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued unregistered placement agent warrants to purchase up to an aggregate of 23,334, 26,250 and 17,500 ordinary shares, respectively, on the same terms as the warrants issued to the investors in the private placement, except they have a term of five years and an exercise price of $15 per share. The Company received gross proceeds from the April-May 2020 Registered Direct Offerings of approximately $11,500, or approximately $10,139, net of issuance expenses in the amount of $1,361.</span></span></span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:106pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On July 27, 2020, as part of the Warrants Exercise Transaction, warrants to purchase an aggregate 750,001 ordinary shares were exercised. During the first quarter of 2021, warrants to purchase 208,334 ordinary shares held by certain investors and warrants to purchase 67,084 ordinary shares held by the placement agent warrants were exercised into ordinary shares (see Note 10B(2)(n)).</span></span></span></span></span></span></span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>o)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On July 23, 2020, the Company entered into a warrant exercise agreement, (the &#8220;Warrants Exercise Transaction&#8221;), with several existing institutional investors who are the holders (the &#8220;Holders&#8221;) of warrants issued in May 2020, April 2020, February 2019 and November 2017 (the &#8220;Old Warrants&#8221;), to purchase ordinary shares, pursuant to which the Holders agreed to exercise in cash their Old Warrants to purchase up to an aggregate of 802,712 ordinary shares having exercise prices ranging from $300.00 to $16 per share issued by the Company, at a reduced exercise price of $12&#160;per share, resulting in gross proceeds to the Company of approximately $9,632 or approximately $8,712, net of issuance expenses in the amount of approximately $920. Closing occurred on July 27, 2020. Under the Warrants Exercise Transaction agreement, the Company also issued to the Holders new unregistered warrants to purchase up to 963,254 ordinary shares, (the &#8220;Private Placement Warrants&#8221;). The Private Placement Warrants are immediately exercisable, expire five and one-half years from issuance date and have an exercise price of $16 per share, subject to certain adjustment. The Private Placement Warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. In addition, the Company issued unregistered placement agent warrants to purchase up to an aggregate of 56,190 ordinary shares on the same terms as the warrants issued to the Holders, except that they have an exercise price of $15 per share. During the first quarter of 2021, an aggregate of 878,628 warrants held by certain investors and 56,190 warrants held by the placement agent, were exercised into ordinary shares. As of December 31, 2022&#160;and 2021, warrants to purchase 84,626 ordinary shares held by certain investors, were outstanding.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div/>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:79pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>p)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>During the first quarter of 2021, as a result of an exercise of warrants by the investors from the Warrants Exercise Transaction and the April-May 2020 Offerings, the Company issued an aggregate of 1,210,235 ordinary shares, at exercise prices ranging from $15-$16 per share, for total gross proceeds of approximately $19,240 to the Company.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>q)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span><span>On June 30, 2021, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of 1,296,297 of the Company's ordinary shares and accompanying short-term warrants to purchase up to an aggregate of 1,296,297 of the Company's ordinary shares in a registered direct offering (the &#8220;June 2021 Registered Direct Offering&#8221;). The June 2021 Registered Direct Offering was consummated on July 2, 2021. The warrants are immediately exercisable at an exercise price of $30 per ordinary share, subject to certain adjustments, and will expire three and one-half years from the issuance date.&#160;The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of 64,815 ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $33.75 per share. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to 5.0% of the number of ordinary shares issued upon the cash exercise of the warrants (up to 64,815 warrants). As of December 31, 2022 and 2021, warrants to purchase 1,296,297 ordinary shares held by certain investors and 64,815 warrants held by the placement agent, were outstanding. The Company received gross proceeds from the June 2021 Registered Direct Offering of approximately $35,000, or approximately $31,801, net of issuance expenses in the amount of $3,199. (See Note 17(2) regarding change of exercise price and term of exercise of date of 926,297 warrants).</span></span></span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:78pt">&#160;</td>
                  <td style="vertical-align:top;width:28pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>r)</span></span></span></span></span></span></span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>On March 1, 2022, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of 1,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to an aggregate of 750,000 of the Company's ordinary shares in a registered direct offering (the &#8220;March 2022 Registered Direct Offering&#8221;). The March 2022 Registered Direct Offering was consummated on March 3, 2022. The warrants are immediately exercisable at an exercise price of $13 per share, subject to certain adjustments,&#160;</span></span></span></span></span></span><span>and will expire five years from the issuance date.&#160;</span><span><span><span><span><span><span>The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of 50,000 ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $12.5 per share and expiration date is March 1, 2027. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to 5.0% of the number of ordinary shares issued upon the cash exercise of the warrants (up to 37,500 warrants). Simultaneously with this offering, the Company has entered into a warrant amendment agreement, or the Warrant Amendment Agreement, with the investors in this March 2022 Registered Direct Offering. Pursuant to the Warrant Amendment Agreement, certain warrants to purchase up to an aggregate of 926,297 ordinary shares of the Company that were issued to the investors in July 2021 were amended to have a reduced exercise price of $13 per share and the term of exercise was extended to January 2, 2025. The Company received gross proceeds from the March 2022 Registered Direct Offering of $10,000, or approximately $8,850, net of issuance expenses in the amount of approximately $1,150.</span></span></span></span></span></span></span></span></div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027230176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">
      <div>
        <div>
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 11 - SHARE-BASED COMPENSATION</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20.25pt">&#160;</td>
                  <td style="width:27pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In connection with the transfer of all of the business operations and substantially all of the assets of Check-Cap LLC to the Company in 2009, the Company assumed the Check-Cap LLC 2006 Unit Option Plan (the "2006 Plan"). According to the 2006 Plan, the Company is authorized to grant options to purchase ordinary shares of the Company to employees, directors and consultants of the Company. The options granted according to the 2006 Plan are generally exercisable for 10 years from the grant date unless otherwise determined by the Company's Board of Directors, vest over a period to be determined by the Company's Board of Directors, and have an exercise price to be determined by the Company's Board of Directors.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 13, 2015, the shareholders approved and adopted the Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 Israeli Plan") and the Check-Cap Ltd. 2015 United States Sub-Plan to Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 U.S. Sub-Plan" and together with the 2015 Israeli Plan, the "2015 Plan"). As of such date, the Company ceased to grant options under the 2006 Plan. All of the remaining shares authorized but unissued under the 2006 Plan were rolled over to the 2015 Plan.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 5, 2020, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 17,500 shares to 77,780 shares.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 5, 2021, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 125,000.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 27, 2022, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 25,000.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022, no shares were available for future awards under the 2015 Plan.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:49pt">&#160;</td>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 4, 2023, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 30,000.</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:20pt">&#160;</td>
                  <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                  <td style="vertical-align:top;text-align:justify;width:auto">
                    <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Details of share-based grants made by the Company</span></span></div>
                  </td>
                </tr>

            </table>
            <div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif">
              <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following tables presents the grant dates, number of underlying shares and related exercise prices of awards granted to employees and non-employees during the years 2022, 2021 and 2020 as well as the estimated fair value of the underlying ordinary shares on the grant date:</span></span>
              <p style="margin:0pt">&#160;</p>
            </div>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">
                <div style="line-height:1.25;font-weight:normal">
                  <div style="line-height:1.25">
                    <div/>
                  </div>
                </div>
              </div>

                <div>
                  <div>
                    <div>
                      <div style="text-indent:49pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options:</span></span></div>
                      <div>
                        <div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="margin-left:49pt">
                            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">
                                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Fair value</span></p>
                                    </div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of options</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">on grant</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$in </span></span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vesting</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">399</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 5, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.44</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 27, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 27, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.47</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,014</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 5, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.73</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">175</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 17, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,036</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 17, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.22</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 10, 2020 (3)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,250</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 10, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.5</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 17, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,274</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 17, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 11, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">903</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 11, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.07</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (5)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,701</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24.6</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.47</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">678</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 13, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">750</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 13, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.92</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 20, 2021 (6)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,250</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 20, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.6</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.15</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 2, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,556</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 2, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.91</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7(</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,334</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.98</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">497</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,167</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.14</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022(9)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,800</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.96</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.98</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,472</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.184</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.02</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,157</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.254</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.27</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,661</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.23</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.91</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,024</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.81</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 29, 2022(11)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,125</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.14</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.64</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                      <div style="margin-left:45pt">&#160;</div>
                    </div>
                  </div>
                  <div style="text-indent:36pt;margin-left:11.25pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>RSUs:</span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of RSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value on</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and PSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (7)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,000</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2031</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.8</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">327</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022 (9)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,200</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2032</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.58</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,850</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2032</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.27</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div/>
                    <div style="line-height:1.25">
                      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                          <tr>
                            <td style="vertical-align:top;width:49pt">&#160;</td>
                            <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span>1.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span>Share based expenses are based on their fair value on grant date. The amount is charged to the statement of operations over the vesting periods.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div>
                    <div>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of three years commencing on the date of grant, such that one third of the options vested on the first anniversary of the date of grant and thereafter, the remaining options vest in quarterly installments.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="text-align:justify;line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 10, 2020, the Company's Board of Directors approved the award of 11,250 options to the Company&#8217;s officers, with an exercise price of $6.4, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of four years commencing on the date of grant, such that 25% of the options vest and become exercisable on the first anniversary of the date of grant and thereafter, vest monthly in equal portions at the end of each month over the subsequent thirty-six (36) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 4, 2021, the Company's Board of Directors approved the award of 36,694 options and 15,000 RSUs, of which, 12,075 options and 5,175 RSUs were issued to certain of the Company&#8217;s officers. The remaining options and RSUs were issued to certain employees.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2021, the Company's Board of Directors approved the award of 1,250 options to the Company&#8217;s VP clinical, with an exercise price of $20.6, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 9, 2021, the Company's shareholders approved the award of 57,500 options to the Company&#8217;s CEO. The options shall vest as follows: (i) two-thirds of the options (38,334 options) shall vest over a period of four years commencing on their date of grant, such that 25% of the options shall vest on the first anniversary of the date of grant and an additional 2.0833% will vest at the end of each month thereafter; and (ii) one third of the options (19,166 options) shall fully vest upon the approval by the FDA of the use of our C-Scan, in humans, subject, in each case, to the CEO&#8217;s continuing service with the Company on each applicable vesting date. The exercise price of the options of $26.8, equal to the average closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders, plus a 50% premium. The compensation expense was based on the fair value on the grant date and was estimated at approximately $749. The fair value amount is charged to the statement of operations over the vesting periods of which $335 and $23 were recorded to general and administrative expenses in the year ended December 31, 2022 and 2021, respectively.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted to service provider. The options vest over a period of twelve (12) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 27, 2022, the Company's Board of Directors approved the award to certain employees of 16,800 options, with an exercise price of $12.96, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date, and 7,200 RSUs.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2022, the Company's Board of Directors approved the award of 8,472 options and 2,850 RSUs to certain executive officers and employees, of which 6,650 options and the 2,850 RSUs were granted to certain officers. The options have an exercise price of $10.184, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 29, 2022, the Company's shareholders approved the award of 29,125 options to members of the Company's Board of Directors. The options shall become fully vested on the first anniversary of the date of grant, subject to each of the Board of Directors continuing service with the Company on the vesting date. The exercise price of the options is $4.14, equal to two times the closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market on the date of the approval of the option grant by the Company&#8217;s shareholders.</span></span></div>
                              <div>&#160;</div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </div>

              <div/>
              <div style="line-height:1.25">
                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;width:29pt"><span><span><span style="font-size:10pt"><span><span><span><span>C.</span></span></span></span></span></span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span><span><span style="font-size:10pt"><span><span><span><span>Options Fair Value</span></span></span></span></span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div>
                <div>
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="line-height:1.25;margin-left:49pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>The parameters which were used in applying the model are as follows:</span></span></span></span></span></span></span></div>

                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected volatility</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>109%-118</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>115%-153</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>95%-98</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Risk-free rate</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>1.7%-3.9</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>0.81%-1.34</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>0.31%-0.83</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Dividend yield</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected term (in years)</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>5.5-6.08</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>5.27-6.41</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:center;width:10%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>5.88 - 6.1</span></span></span></span></span></span></span></td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>Share price</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$2.07 - $9.58</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$0.8 - $2.27</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$0.28 - $1.57</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
                      </div>

                    <div style="line-height:1.25">&#160;</div>
                  </div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>D.</span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Effect of share-based compensation transactions on the Company's statements of operations</span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:49pt">

                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Research and development, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>493</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>329</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>165</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>General and administrative, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>482</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>162</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>243</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Total</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>975</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>491</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>408</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>

              </div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>E.</span></span></span></span></span></span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>A summary of the Company's option activity related to options granted to employees, service providers and directors, and related information under the 2006 Plan and the 2015 Plan is as follows:</span></span></span></span></span></span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2022</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>145,895</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>48.2</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>9.13</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>58,239</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.75</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(12,242</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>59.07</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercised</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>191,892</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>35.35</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.59</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>55,259</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>79.79</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.39</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div/>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2021</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>54,516</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>95.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.74</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>99,935</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>26.0</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(8,206</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>92.9</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">Options exercised</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">(350</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif">)</span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">12.0</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>145,895</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>48.2</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>9.13</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>27,037</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>154.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.03</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2020</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Weighted</span></strong></span></span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>average of</span></span></span></p>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>exercise</span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>price</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(in $)</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>27,456</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>204.8</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.30</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>30,832</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>10.4</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(3,772</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>196.6</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>54,516</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>95.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.74</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>15,486</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>282.8</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.00</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>1.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>The weighted average grant date fair values of options granted during the years ended December 31, 2022, 2021 and 2020 were $4.5, $15.7 and $8.2, respectively.</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>As of December 31, 2022, all the outstanding options in the amount of 191,892, with an average exercise price of $35.35, are out of the money.&#160;</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>

              <div style="line-height:1.25">&#160;</div>
              <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>A summary of the Company&#8217;s RSUs activity is as follows:</span></span></span></span></span></span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <div style="margin-left:78pt">

                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number of RSUs</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at beginning of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>16,628</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>3,637</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>4,985</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Granted</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>10,050</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>15,000</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Vested</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(4,374</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(1,764</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(1,258</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Forfeited</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(2,601</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(245</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(90</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at end of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>19,703</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>16,628</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>3,637</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>

              </div>
              <div style="line-height:1.25">&#160;</div>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt">3.</td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div>The weighted average grant date fair values of RSUs awarded during the years ended December 31, 2022 and 2021 were $9.2 and $21.8, respectively.</div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:49pt">&#160;</td>
                <td style="vertical-align:top;width:29pt">4.</td>
                <td style="vertical-align:top;text-align:justify;width:auto">
                  <div>As of December 31, 2022, 2021 and 2020, there was $1,111, $1,644 and $328 unrecognized compensation cost related to non-vested share-based compensation arrangements (options and RSUs) granted under the 2006 Plan and 2015 Plan. This cost is expected to be recognized over a period of up to 4 years.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div>&#160;</div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027215088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH AND DEVELOPMENT EXPENSES, NET</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <div>
                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 12 - RESEARCH AND DEVELOPMENT EXPENSES, NET</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">

                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;margin-left:20pt">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,257</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,428</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,173</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">493</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">329</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Materials</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,258</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,020</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,792</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subcontractors and consultants</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,375</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">820</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,103</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">289</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">169</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost for registration of patents</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,681</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">861</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">488</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,493</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,780</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less participation of the IIA</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(222</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total research and development expenses, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,271</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,349</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>

                  </div>
                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI https://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027350256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GeneralAndAdministrativeExpensesTextBlock', window );">GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 13 - GENERAL AND ADMINISTRATIVE EXPENSES</span></span></div>
            <div>
              <div>
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">

                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,784</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,042</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,698</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">386</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">243</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional services</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,092</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">710</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">574</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office rent and maintenance</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">246</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">172</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">174</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">116</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,139</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,850</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,210</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total general and administrative expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,763</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,972</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,924</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>

                  </div>
                </div>
              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_GeneralAndAdministrativeExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure for general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_GeneralAndAdministrativeExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027303376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE INCOME (EXPENSES), NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock', window );">FINANCE INCOME (EXPENSES), NET</a></td>
<td class="text">
          <div>
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 14 - FINANCE INCOME (EXPENSES), NET</span></span></div>
            <div>
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Composition:</span></span>
                  <p style="margin:0pt">&#160;</p>
                </div>

                  <div>
                    <div>
                      <div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:90%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on short-term deposits and other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,047</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank fees and interest expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in provision for royalties</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange rate differences</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value of derivatives</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(121</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financing income, net</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">926</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">119</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </div>
                  </div>

              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027297216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">LOSS PER SHARE</a></td>
<td class="text">
          <div>
            <div>
              <div>
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">NOTE 15 - LOSS PER SHARE</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Basic loss per share is computed based on the weighted average number of shares outstanding during each year. Diluted net loss per share is computed based on the weighted average number of shares outstanding during each year, plus the dilutive potential of the ordinary shares considered outstanding during the year, in accordance with ASC 260-10 "Earnings per share".</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">All outstanding options and warrants have been excluded from the calculation of the diluted loss per share for each period presented, since all such securities have an anti-dilutive effect.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The following table sets forth the computation of the Company`s basic and diluted net loss per ordinary share:</span></span></div>
                <div style="line-height:1.25">&#160;</div>

                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,108</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17,202</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,846</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Shares used in computing net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,671,786</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,159,870</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,537,060</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.37</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.14</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9.01</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>

                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;margin-left:49pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Instruments that may potentially dilute the basic loss per share in the future but were not included in the calculation of diluted loss per share, since their effect is anti-dilutive.</span></span></div>

                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(number)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Warrants and share options</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,912,147</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,170,262</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,104,431</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>

              </div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026573808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 16 - RELATED PARTIES</span></span></div>
              <div style="line-height:1.25">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Compensation to the non-executive directors:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25">&#160;</div>

                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fees, including reimbursement of expenses</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">270</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">272</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">251</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:baseline;width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></p>
                            </div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">260</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">327</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              &#160;<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:20pt">&#160;</td>
                    <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                    <td style="vertical-align:top;text-align:justify;width:auto">
                      <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions with related parties:</span></span></div>
                    </td>
                  </tr>

              </table>
              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>

                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees, including share-based compensation and reimbursement of expenses</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:65%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>

                  </table>
                </div>

              <div style="margin-left:48pt"><span style="font-family:Times New Roman, Times, serif;font-size:10pt">&#160;</span></div>
              <div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On April 4, 2016, the Company entered into an employment agreement with Sigalit Kimchy, according to which Ms. Kimchy serves as marcom and user interface lead, in a 50% part-time role (no less than 112 hours per month), for a monthly salary of NIS 10 ($2.84), plus up to 35 monthly overtime hours at a gross monthly rate of NIS 2.5 ($0.7), or an aggregate monthly salary of up to NIS 12.5 ($3.6). Ms. Kimchy is entitled to an education fund, managers' insurance or pension fund and reimbursement of monthly travel expenses. Sigalit Kimchy is the wife of Yoav Kimchy, the Company&#8217;s Chief Technology Officer.</span></span></div>
            </div>
          </div>
          <div>
            <div>
              <div style="text-align:justify;margin-left:45pt;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027325168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">
          <div>
            <div>
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 17 - SUBSEQUENT EVENTS</span></span>
                <p style="margin:0pt">&#160;</p>
              </div>
              <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2023, the Company announced that following its internal assessment of the clinical data collected to date from its calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study. &#160;As a result, the Company has adopted a plan of action that includes conducting additional clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal study protocol that are expected to be part of an IDE supplement submission to the FDA, and which are subject to FDA approval. In addition, the Company plans to continue conducting its calibration studies, albeit at a slower pace, to collect additional clinical data and it is also implementing a cost reduction plan, in order to extend its cash runway. The initiation of the powered portion of the U.S. pivotal study that was expected in mid-2023 is therefore temporarily postponed.</span></span></div>
            </div>
          </div>
        <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568023793408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in preparation of financial statements</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates in preparation of financial statements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">B.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Principles of consolidation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's consolidated financial statements include the financial statements of Check-Cap Ltd. and its wholly-owned subsidiary, Check-Cap US, Inc. The Company's consolidated financial statements are presented after elimination of inter-company transactions and balances.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_FunctionalCurrencyPolicyTextBlock', window );">Financial statements in U.S. dollars</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">C.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial statements in U.S. dollars</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has not yet generated revenues and the majority of its expenses are in U.S. dollars (dollar or USD) or NIS.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The financial statements are presented in dollars, which is the functional currency of the Company. In management's judgment, setting the dollar as the Company's functional currency, is based mainly on the following criteria: the Company's budget and other Company internal reports, including reports to the Company's Board of Directors and investors, are presented in dollars. Management uses these reports in order to make decisions for the Company. All of the Company's equity financings have been in dollars; and it is expected that a significant portion of the Company's future revenues will be in dollars.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Transactions and balances denominated in dollars are presented at their original amounts. Non&#8209;dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">D.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents include cash in hand, short&#8211;term deposits in banks and short-term, highly liquid investments with an original maturity of up to three months, with a high level of liquidity that may be easily converted to known amounts of cash, and that are exposed to insignificant risk of change in value.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term bank deposit</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">E.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposit</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits are deposits with maturities of more than three months but less than one year. The short&#8211;term bank deposits are presented at their cost, including accrued interest, which approximates fair value.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives', window );">Cash flow hedges</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash flow hedges</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
                <div/>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264 and $3,466, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company&#8217;s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $56 and an asset, net, of $65, respectively and is included in other current liabilities and other current assets, respectively.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">G.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:</span></span></div>

                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div style="margin-left:49pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Length&#160;of&#160;useful&#160;life</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dep</span><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">reciation&#160;</span></span></span><span style="font-size:10pt"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">rate</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10-14</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3-7</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>

              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">H.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Impairment of long-lived assets</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company's long-lived assets are reviewed for impairment in accordance with ASC 360-10 "Accounting for the Impairment or Disposal of Long-Lived Assets" whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development costs</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">I.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development costs are expensed as incurred and consist primarily of costs for personnel, subcontractors and consultants (mainly in connection with clinical trials) and materials for research and development and clinical activities. Grants received by the Company from the IIA are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. Such grants are included as a deduction of research and development costs.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingent liabilities</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">J.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Contingent liabilities</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for its contingent liabilities in accordance with ASC No. 450, "Contingencies". A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2022, and 2021, the Company is not a party to any ligation that could have a material adverse effect on the Company's business, financial position, results of operations or cash flows.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">K.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes expense for its share-based compensation based on the fair value of the awards granted. The Company&#8217;s share-based compensation plans provide for the award of stock options and restricted stock units. In accordance with ASC 718-10 "Compensation-Stock Compensation", the Company estimates the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation expenses for the value of its awards granted based on the graded-vesting method over the requisite service period for each separately vesting portion of the award. Accounting Standards Update (&#8220;ASU&#8221;) 2016-09, Compensation-Stock Compensation (Topic 718) allows companies to account for forfeitures when they occur.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes compensation cost for awards with performance conditions if and when the company concludes that it is probable that the performance conditions will be achieved. ASC 718&#8217;s use of the term probable is consistent with that term&#8217;s use in ASC 450, Contingencies, which refers to an event that is likely to occur (ASC Master Glossary). The Company reassess at each reporting period the probability of vesting for awards with performance conditions and adjusts compensation cost based on its probability assessment.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the years ended December 31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.</span></span></div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">L.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Income taxes</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for income taxes in accordance with ASC 740-10 "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 740, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered 'more-likely-than-not' that the position taken will be sustained by a taxing authority. As of December 31, 2022 and 2021, the Company had no unrecognized income tax positions, and, accordingly, there is no impact on the Company's effective income tax rate associated with these items.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">M.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value of financial instruments</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company measures its investments in money market funds (classified as cash equivalents) and its foreign currency net purchased options at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 1. </span>Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 2</span>. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:49pt">&#160;</td>
                      <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#8226;</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Level 3</span>. Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</span></span></div>
                <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt">&#160;</div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">N.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted Cash</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>The Company has granted a pledge in favor of Bank Leumi Le-Israel B.M in the amount of $352 and 350 as of &#160;December 31, 2022 and 2021, respectively to secure certain payment obligations of the Company in connection with hedge transactions. This amount was classified as restricted cash balance.</span></span></span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">O.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for leases in accordance with ASC 842 "Lesses.&#8221; Arrangements that are determined to be leases at inception are recognized as long-term operating lease assets and lease liabilities in the consolidated balance sheet at lease commencement. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As the Company&#8217;s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at the commencement date in determining the present value of future lease payments. Lease terms may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.</span></span></div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company has also elected the practical expedient to include both lease and non-lease components as a single component and account for it as a lease. Additionally, the Company has made a policy election not to capitalize leases with an original term of 12 months or less.</span></span></div>
                <div style="line-height:1.25;margin-left:49pt">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In accordance with ASC 360-10, management reviews operating lease assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable based on estimated future undiscounted cash flows. If so indicated, an impairment loss would be recognized for the difference between the carrying amount of the asset and its fair value.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent accounting pronouncements</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:20pt">&#160;</td>
                      <td style="vertical-align:top;font-weight:bold;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">P.</span></span></td>
                      <td style="vertical-align:top;text-align:justify;width:auto">
                        <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Recent accounting pronouncements</span></span></div>
                      </td>
                    </tr>

                </table>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2021, the FASB issued ASU No. 2021- 10, Government Assistance (Topic 832). This ASU requires business entities to disclose information about government assistance they receive if the transactions were accounted for by analogy to either a grant or a contribution &#160;accounting &#160;model. &#160;The disclosure requirements include the nature of the transaction and the related accounting policy used, the line items on the balance sheets and statements of operations that are affected and the amounts applicable to each financial statement line item and the significant terms and conditions of the transactions. The ASU is effective for annual periods beginning after December 15, 2021. The disclosure requirements can be applied either retrospectively or prospectively to all transactions in the scope of the amendments that are reflected in the financial statements at the date of initial application and new transactions that are entered into after the date of initial application. The Company already adopted ASU No. 2021- 10, in its financial statements.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div>
                  <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                      <tr style="vertical-align:top">
                        <td style="width:20pt">&#160;</td>
                        <td style="vertical-align:top;width:29pt">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Q.</span></span></div>
                        </td>
                        <td style="vertical-align:top;width:auto">
                          <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Reclassification</span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
                <div style="line-height:1.25">&#160;</div>
                <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders&#8217; deficit, net loss or net cash used in operating activities.</span></span></div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_FunctionalCurrencyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for functional currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_FunctionalCurrencyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EEEE<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109999725-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027354976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock', window );">Schedule of Depreciation Inputs</a></td>
<td class="text">
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div>
                      <div style="margin-left:49pt">
                        <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Length&#160;of&#160;useful&#160;life</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom">&#160;</td>
                              <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dep</span><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">reciation&#160;</span></span></span><span style="font-size:10pt"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif">rate</span></span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Years</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom" valign="bottom">
                                <div style="line-height:1.25">&#160;</div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10-14</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7-10</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3-7</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15-33</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>
                            <tr>
                              <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom">
                                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                              </td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom">
                                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">33</span></span></div>
                              </td>
                              <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                            </tr>

                        </table>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the information used to calculate depreciation for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027195136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Government institutions</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">88</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">206</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">260</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">470</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deposits</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other assets</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">223</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">150</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">579</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">839</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027215088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office furniture and equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">799</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">723</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Laboratory equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,915</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,721</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Computers and auxiliary equipment</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">574</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">540</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,288</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,984</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated depreciation</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,537</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,191</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,751</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,793</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026620816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Table)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Operating Leases</a></td>
<td class="text">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ended</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31, 2022</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:88%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash payments for operating leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">389</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfFutureLeasePaymentsTableTextBlock', window );">Schedule of Future Lease Payments</a></td>
<td class="text">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Leases</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">352</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2024</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">282</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2025 and after</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">410</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total future lease payments</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,044</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less imputed interest</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(80</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:88%;padding-bottom:4px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total lease liability balance</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">964</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfFutureLeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Future Lease Payments [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfFutureLeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Supplemental Cash Flow Information Related to Operating Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026573808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Employee-related Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock', window );">Schedule of Employee Benefits and Payroll Accruals</a></td>
<td class="text">
              <div>
                <div style="line-height:1.25">&#160;</div>
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term employee benefits:</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Benefits for vacation and recreation pay</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">529</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">573</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability for payroll, bonuses and wages</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">732</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,388</span></span></div>
                        </td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,261</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,961</span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                </div>
              </div>
            <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for employee related liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027785424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Income Taxes</a></td>
<td class="text">
                <div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Carry-forward tax losses</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,232</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24,677</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less valuation allowance</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,232</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(24,677</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027390256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsTableTextBlock', window );">Schedule of Reimbursement Liability</a></td>
<td class="text">
            <div>
              <div style="margin-left:78pt">
                <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;text-indent:22pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-weight:bold;line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2&#160;0&#160;2&#160;2</span></span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Royalties to an ASIC designer</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
                      </td>
                      <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>
                    <tr>
                      <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
                        <div style="line-height:1.25">&#160;</div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">94</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                      <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">132</span></span></div>
                      </td>
                      <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                    </tr>

                </table>
              </div>
            </div>
          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about obligations resulting from other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027238848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Changes In Fair Value</a></td>
<td class="text">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2022</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current liabilities:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets (liabilities)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(56</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(53.5</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31, 2021</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value measurements using input type</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 1</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Money market funds</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other current assets:</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency derivative instruments</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financial assets</span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,160</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">65</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,225</span></span></div>
                          </td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568029051344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Awards Granted</a></td>
<td class="text">
                <div>
                  <div>
                    <div>
                      <div style="text-indent:49pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options:</span></span></div>
                      <div>
                        <div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="margin-left:49pt">
                            <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">
                                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Fair value</span></p>
                                    </div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of options</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise price</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">on grant</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">date</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$in </span></span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">thousands</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Vesting</span></div>
                                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">399</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 5, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23.44</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 27, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">133</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 27, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.47</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 5, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18,014</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 5, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.73</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">175</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 17, 2020</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,036</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 17, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.22</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 10, 2020 (3)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11,250</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 10, 2030</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.5</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 17, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,274</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 17, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">45.4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">42.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">54</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 11, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">903</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 11, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.07</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">23</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (5)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36,701</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24.6</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.47</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">678</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 13, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">750</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 13, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.92</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 20, 2021 (6)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,250</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">September 20, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20.6</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16.15</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">20</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 2, 2021</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,556</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 2, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22.2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">18.91</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">31</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7(</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">38,334</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.98</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">497</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2021 (7)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">19,167</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 9, 2031</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">26.8</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">13.14</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">252</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022(9)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">16,800</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12.96</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.98</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">134</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,472</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.184</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.02</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">59</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,157</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">May 31, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.254</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.27</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,661</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.23</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.91</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 29, 2022</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,024</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%" valign="bottom">
                                    <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">November 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.81</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.38</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(4</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>
                                <tr>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 29, 2022(11)</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">29,125</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 29, 2032</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.14</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1.64</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">48</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10</span></span></div>
                                  </td>
                                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                  </td>
                                </tr>

                            </table>
                          </div>
                        </div>
                      </div>
                      <div style="margin-left:45pt">&#160;</div>
                    </div>
                  </div>
                  <div style="text-indent:36pt;margin-left:11.25pt;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>RSUs:</span></span></span></span></span></span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">No. of RSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fair value on</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share based</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and PSUs</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expiration date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">grant date</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">expenses&#160;(1)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">terms</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2021 (7)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">15,000</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">August 4, 2031</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21.8</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">327</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2022 (9)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,200</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">January 27, 2032</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.58</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>
                          <tr>
                            <td style="vertical-align:top;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2022 (10)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,850</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">March 21, 2032</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.27</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div style="line-height:1.25">
                    <p style="margin:0pt">&#160;</p>
                    <div/>
                    <div style="line-height:1.25">
                      <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)">

                          <tr>
                            <td style="vertical-align:top;width:49pt">&#160;</td>
                            <td style="vertical-align:top;width:29pt"><span style="font-size:10pt"><span>1.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span>Share based expenses are based on their fair value on grant date. The amount is charged to the statement of operations over the vesting periods.</span></span></div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                  <div>
                    <div>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of three years commencing on the date of grant, such that one third of the options vested on the first anniversary of the date of grant and thereafter, the remaining options vest in quarterly installments.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="text-align:justify;line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 10, 2020, the Company's Board of Directors approved the award of 11,250 options to the Company&#8217;s officers, with an exercise price of $6.4, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of four years commencing on the date of grant, such that 25% of the options vest and become exercisable on the first anniversary of the date of grant and thereafter, vest monthly in equal portions at the end of each month over the subsequent thirty-six (36) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On August 4, 2021, the Company's Board of Directors approved the award of 36,694 options and 15,000 RSUs, of which, 12,075 options and 5,175 RSUs were issued to certain of the Company&#8217;s officers. The remaining options and RSUs were issued to certain employees.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 20, 2021, the Company's Board of Directors approved the award of 1,250 options to the Company&#8217;s VP clinical, with an exercise price of $20.6, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 9, 2021, the Company's shareholders approved the award of 57,500 options to the Company&#8217;s CEO. The options shall vest as follows: (i) two-thirds of the options (38,334 options) shall vest over a period of four years commencing on their date of grant, such that 25% of the options shall vest on the first anniversary of the date of grant and an additional 2.0833% will vest at the end of each month thereafter; and (ii) one third of the options (19,166 options) shall fully vest upon the approval by the FDA of the use of our C-Scan, in humans, subject, in each case, to the CEO&#8217;s continuing service with the Company on each applicable vesting date. The exercise price of the options of $26.8, equal to the average closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders, plus a 50% premium. The compensation expense was based on the fair value on the grant date and was estimated at approximately $749. The fair value amount is charged to the statement of operations over the vesting periods of which $335 and $23 were recorded to general and administrative expenses in the year ended December 31, 2022 and 2021, respectively.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options granted to service provider. The options vest over a period of twelve (12) months.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 27, 2022, the Company's Board of Directors approved the award to certain employees of 16,800 options, with an exercise price of $12.96, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date, and 7,200 RSUs.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On March 21, 2022, the Company's Board of Directors approved the award of 8,472 options and 2,850 RSUs to certain executive officers and employees, of which 6,650 options and the 2,850 RSUs were granted to certain officers. The options have an exercise price of $10.184, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.</span></span></div>
                            </td>
                          </tr>

                      </table>
                      <div style="line-height:1.25">&#160;</div>
                      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                          <tr>
                            <td style="width:49pt">&#160;</td>
                            <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">11.</span></span></td>
                            <td style="vertical-align:top;text-align:justify;width:auto">
                              <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On December 29, 2022, the Company's shareholders approved the award of 29,125 options to members of the Company's Board of Directors. The options shall become fully vested on the first anniversary of the date of grant, subject to each of the Board of Directors continuing service with the Company on the vesting date. The exercise price of the options is $4.14, equal to two times the closing price of the Company&#8217;s ordinary shares on the Nasdaq Capital Market on the date of the approval of the option grant by the Company&#8217;s shareholders.</span></span></div>
                              <div>&#160;</div>
                            </td>
                          </tr>

                      </table>
                    </div>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock', window );">Schedule of Parameters Used in Valuing Fair Value of Options</a></td>
<td class="text">
                      <div>
                        <div style="line-height:1.25">&#160;</div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected volatility</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>109%-118</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>115%-153</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>95%-98</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Risk-free rate</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>1.7%-3.9</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>0.81%-1.34</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>0.31%-0.83</span></span></span></span></span></span></span>%</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Dividend yield</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>0</span></span></span></span></span>%</span></span></td>
                                <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:62%">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>Expected term (in years)</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>5.5-6.08</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:10%">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span>5.27-6.41</span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:center;width:10%"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span>5.88 - 6.1</span></span></span></span></span></span></span></td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>Share price</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$2.07 - $9.58</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$0.8 - $2.27</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">
                                  <div style="line-height:1.25">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  </div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom">
                                  <div style="line-height:1.25;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span><span><span><span><span>$0.28 - $1.57</span></span></span></span></span></span></span></span></span></span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                        <div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</div>
                      </div>
                    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation</a></td>
<td class="text">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>For the year ended December 31,</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Research and development, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>493</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>329</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>165</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>General and administrative, net</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>482</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>162</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>243</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Total</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>975</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>491</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>408</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2022</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>145,895</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>48.2</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>9.13</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>58,239</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.75</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(12,242</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>59.07</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercised</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>191,892</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>35.35</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.59</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>55,259</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>79.79</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.39</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                    <p style="margin:0pt">&#160;</p>
                  </div>
                  <div/>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2021</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average of</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>exercise</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Price</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in $)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>54,516</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>95.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.74</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>99,935</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>26.0</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(8,206</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>92.9</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">Options exercised</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">(350</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif">)</span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif">12.0</span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>145,895</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>48.2</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>9.13</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(255, 255, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom">&#160;</td>
                        </tr>
                        <tr style="background-color:rgb(204, 238, 255)">
                          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>27,037</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>154.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.03</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31, 2020</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Weighted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Aggregate</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Weighted</span></strong></span></span></p>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>average</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>intrinsic</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>average of</span></span></span></p>
                            </div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>remaining</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>value</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>exercise</span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>contractual</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>($in</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>price</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>life</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>thousands)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(in $)</span></span></span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(in years)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
                            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>(2)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at beginning of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>27,456</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>204.8</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.30</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options granted</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>30,832</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>10.4</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options forfeited</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(3,772</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                            <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>196.6</span></span></span></span></span></td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options outstanding at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>54,516</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>95.3</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>8.74</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                          <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;width:52%" valign="bottom">
                            <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Options exercisable at end of year</span></span></span></span></span></span></span></div>
                          </td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>15,486</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>282.8</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>7.00</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                          <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>1.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>The weighted average grant date fair values of options granted during the years ended December 31, 2022, 2021 and 2020 were $4.5, $15.7 and $8.2, respectively.</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                  <div style="line-height:1.25">&#160;</div>
                  <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                      <tr>
                        <td style="width:49pt">&#160;</td>
                        <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2.</span></span></span></span></span></span></span></td>
                        <td style="vertical-align:top;text-align:justify;width:auto">
                          <div><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>As of December 31, 2022, all the outstanding options in the amount of 191,892, with an average exercise price of $35.35, are out of the money.&#160;</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">
                  <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%">

                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Year ended December 31</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 2</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 1</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>2 0 2 0</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Number of RSUs</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at beginning of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>16,628</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>3,637</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>4,985</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Granted</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>10,050</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>15,000</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>-</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Vested</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(4,374</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(1,764</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(1,258</span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:64%" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Forfeited</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(2,601</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(245</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span>(90</span></span></span></span></span></td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                          <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>)</span></span></span></span></span></span></span></div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                          <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><span><span>Unvested at end of year</span></span></span></span></span></span></span></div>
                        </td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>19,703</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>16,628</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                        <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-size:10pt"><span><span><strong>3,637</strong></span></span></span></span></span></td>
                        <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                      </tr>

                  </table>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of parameters used to calculate the fair value of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568033055808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfResearchAndDevelopmentExpensesNet', window );">Schedule of Research and Development Expenses, Net</a></td>
<td class="text">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;margin-left:20pt">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">8,257</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,428</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,173</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">493</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">329</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">165</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Materials</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,258</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,020</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,792</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subcontractors and consultants</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,375</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">820</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,103</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">289</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">169</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">123</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost for registration of patents</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">140</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">153</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">164</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,681</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">861</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">488</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,493</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,780</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Less participation of the IIA</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(222</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(431</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total research and development expenses, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">14,271</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">12,349</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,008</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfResearchAndDevelopmentExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the net expenses associated with research and development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfResearchAndDevelopmentExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026497776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock', window );">Schedule of General and Administrative Expenses</a></td>
<td class="text">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Salaries and related expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,784</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,042</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,698</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation, net</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">386</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">162</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">243</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Professional services</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,092</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">710</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">574</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Office rent and maintenance</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">246</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">172</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">174</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">116</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">36</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">25</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Others</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2,139</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,850</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,210</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total general and administrative expenses</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5,763</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4,972</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3,924</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027469536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE INCOME (EXPENSES), NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Finance Income (Expense), Net</a></td>
<td class="text">
                  <div>
                    <div>
                      <div>
                        <div style="margin-left:49pt">
                          <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:90%">

                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended December 31,</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom" valign="bottom">
                                  <div style="line-height:1.25">&#160;</div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest income on short-term deposits and other</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,047</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">101</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">69</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank fees and interest expenses</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(13</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(12</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in provision for royalties</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">37</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">22</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">28</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exchange rate differences</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(25</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(43</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(6</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value of derivatives</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(121</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">52</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7</span></span></div>
                                </td>
                                <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>
                              <tr>
                                <td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom">
                                  <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total financing income, net</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">926</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">119</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                                <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">86</span></span></div>
                                </td>
                                <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568029360976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Loss Per Share</a></td>
<td class="text">
                  <div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">19,108</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">17,202</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">13,846</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Shares used in computing net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">5,671,786</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4,159,870</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,537,060</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Net loss per ordinary share, basic and diluted</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">3.37</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">4.14</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">9.01</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-Dilutive Securities</a></td>
<td class="text">
                  <div>
                    <div style="line-height:1.25">&#160;</div>
                    <div style="margin-left:49pt">
                      <table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">For the year ended December 31,</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 2</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 1</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2 0 2 0</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25">&#160;</div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                            <td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(number)</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>
                          <tr>
                            <td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Warrants and share options</span></span></div>
                            </td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">2,912,147</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,170,262</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
                              <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">1,104,431</span></span></div>
                            </td>
                            <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                          </tr>

                      </table>
                    </div>
                  </div>
                <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027592624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=chek_NonExecutiveDirectorsCompensationMember', window );">Compensation to the Non-Executive Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text">
                <div>
                  <div style="margin-left:49pt">
                    <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="text-align:center;line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td colspan="2" style="vertical-align:bottom">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;white-space:nowrap">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Fees, including reimbursement of expenses</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">270</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">272</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">251</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:baseline;width:65%">
                            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(10</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">
                              <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">)</span></p>
                            </div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">24</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">76</span></span></div>
                          </td>
                          <td style="vertical-align:baseline;white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>
                        <tr>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">260</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">296</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                            <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">327</span></span></div>
                          </td>
                          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                            <div style="line-height:1.25">&#160;</div>
                          </td>
                        </tr>

                    </table>
                  </div>
                </div>
              <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=chek_GeneralTransactionsMember', window );">Transactions with Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text">
                <div style="margin-left:49pt">
                  <table border="0" cellpadding="0" cellspacing="0" style="width:80%">

                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For the year ended&#160;</span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 2</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 1</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="text-align:center;line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
                          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2 0 2 0</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td colspan="2" style="vertical-align:bottom">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%">
                          <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Consulting fees, including share-based compensation and reimbursement of expenses</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>
                      <tr>
                        <td style="vertical-align:bottom;width:65%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">58</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">61</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                        <td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%">
                          <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">57</span></span></div>
                        </td>
                        <td style="vertical-align:bottom;white-space:nowrap;width:1%">
                          <div style="line-height:1.25">&#160;</div>
                        </td>
                      </tr>

                  </table>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=chek_NonExecutiveDirectorsCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=chek_NonExecutiveDirectorsCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=chek_GeneralTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=chek_GeneralTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026066048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL INFORMATION (Narrative) (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 23, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 23, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,108<span></span>
</td>
<td class="nump">$ 17,202<span></span>
</td>
<td class="nump">$ 13,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse share split ratio</a></td>
<td class="text">1-for-20<span></span>
</td>
<td class="text">1 for 10 to 1 for 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary share, par value | &#8362; / shares</a></td>
<td class="nump">&#8362; 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Authorized share capital | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MinimumBidPriceValuePerShare', window );">Minimum bid price value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MinimumBidPriceValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum bid price value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MinimumBidPriceValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568118380736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 5,264<span></span>
</td>
<td class="nump">$ 3,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_FairValueOfHedgingOption', window );">Fair value of hedging option</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash balance</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_FairValueOfHedgingOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of fair value of hedging option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_FairValueOfHedgingOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568020345184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Length of useful life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Depreciation rate</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Length of useful life</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Depreciation rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Laboratory equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Length of useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Depreciation rate</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Laboratory equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Length of useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Depreciation rate</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and auxiliary equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Length of useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Depreciation rate</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026556576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GovernmentInstitutionalAssetsCurrent', window );">Government institutions</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Deposits</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other assets</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_GovernmentInstitutionalAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current assets related to government institutions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_GovernmentInstitutionalAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027283808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Depreciation expenses</a></td>
<td class="nump">$ 346<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568023802544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 3,288<span></span>
</td>
<td class="nump">$ 2,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">1,915<span></span>
</td>
<td class="nump">1,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and auxiliary equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 574<span></span>
</td>
<td class="nump">$ 540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_TechnologyEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568022499440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 01, 2022 </div>
<div>USD ($) </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Dec. 30, 2021 </div>
<div>USD ($) </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Jan. 26, 2021 </div>
<div>USD ($) </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Jan. 25, 2021 </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,060,000<span></span>
</td>
<td class="nump">$ 1,116,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Isfiya, ISRAEL | Office facilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of lease | m&#178;</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Feb. 28,  2024<span></span>
</td>
<td class="text">Jan. 31,  2025<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">May 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Option to extend the lease period for an additional time</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Amount allocated to lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rental expenses under the lease agreement</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 26,900<span></span>
</td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Monthly services expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027389440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payments for operating leases</a></td>
<td class="nump">$ 389<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568027469888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Schedule of Future Lease Payments) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025 and after</a></td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability balance</a></td>
<td class="nump">$ 964<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568029002192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Employee-related Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Benefits for vacation and recreation pay</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Liability for payroll, bonuses and wages</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee benefits and payroll accruals</a></td>
<td class="nump">$ 1,261<span></span>
</td>
<td class="nump">$ 1,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568021358272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2016</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReductionInIncomeTaxRate', window );">Reduction in income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReductionInIncomeTaxRate', window );">Reduction in income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=chek_DevelopmentAreaAMember', window );">Development Area A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReductionInIncomeTaxRate', window );">Reduction in income tax rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=chek_RestOfCountryMember', window );">Rest of the Country [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReductionInIncomeTaxRate', window );">Reduction in income tax rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Israeli tax rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ReductionInIncomeTaxRate', window );">Reduction in income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">U.S. tax rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=chek_CheckCapUsIncMember', window );">Check-Cap US, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss or NOL carry-forwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ReductionInIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction In Income Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ReductionInIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=chek_DevelopmentAreaAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=chek_DevelopmentAreaAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=chek_RestOfCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=chek_RestOfCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=chek_CheckCapUsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=chek_CheckCapUsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568022394176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Schedule of Deferred Income Taxes) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Carry-forward tax losses</a></td>
<td class="nump">$ 24,232<span></span>
</td>
<td class="nump">$ 24,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(24,232)<span></span>
</td>
<td class="num">(24,677)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568021215760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="5"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 23, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2022 </div>
<div>USD ($) </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2021 </div>
<div>USD ($) </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Jan. 26, 2021 </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Jan. 25, 2021 </div>
<div>m&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>US_cents_Per_unit</div>
</th>
<th class="th">
<div>Jul. 13, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MonthlyVehicleLeaseExpense', window );">Monthly vehicle lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember', window );">Office facilities [Member] | ISRAEL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OperatingLeaseRentExpenseMonthly', window );">Monthly rental property expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of lease | m&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 31,  2025<span></span>
</td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">May 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_LesseeOperatingLeaseAdditionalTerm', window );">Additional lease period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember', window );">ASIC designer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesPayablePerUnitSold', window );">Royalties payable per unit sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">53.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MaximumRoyaltyObligation', window );">Maximum royalties payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember', window );">IIA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GrantedRevenue', window );">Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="nump">620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ContingentLiability', window );">Contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember', window );">IIA [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesPayablePercentageOfProductSales', window );">Royalty repayment, percentage of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember', window );">IIA [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesPayablePercentageOfProductSales', window );">Royalty repayment, percentage of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember', window );">Reimbursement liability to Predecessor Entity's Unit Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_BinationalIndustrialResearchAndDevelopmentFoundationMember', window );">BIRD Foundation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MaximumRoyaltyObligation', window );">Maximum royalties payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GrantedRevenue', window );">Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ContingentLiability', window );">Contingent liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RefundExpenses', window );">Refund expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_ManufacturingProgramMember', window );">Manufacturing Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GrantedRevenue', window );">Funding</a></td>
<td class="nump">$ 222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of contingent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_GrantedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue fron grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_GrantedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_LesseeOperatingLeaseAdditionalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease additional, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_LesseeOperatingLeaseAdditionalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MaximumRoyaltyObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount payable for royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MaximumRoyaltyObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MonthlyVehicleLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly vehicle lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MonthlyVehicleLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_OperatingLeaseRentExpenseMonthly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly rent expense for operating leased assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_OperatingLeaseRentExpenseMonthly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RefundExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Refund expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RefundExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RoyaltiesPayablePerUnitSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable for royalties per unit sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RoyaltiesPayablePerUnitSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RoyaltiesPayablePercentageOfProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties payable as a percentage of product sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RoyaltiesPayablePercentageOfProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RoyaltiesProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the liability recorded to pay royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RoyaltiesProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_BinationalIndustrialResearchAndDevelopmentFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_BinationalIndustrialResearchAndDevelopmentFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_ManufacturingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_ManufacturingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568020295136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember', window );">Royalties to an ASIC designer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember', window );">Reimbursement liability to Predecessor Entity's Unit Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments and Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_RoyaltiesProvision', window );">Royalties provision</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_RoyaltiesProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the liability recorded to pay royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_RoyaltiesProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_DesignerRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_PredecessorUnitHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568021110720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details) - Recurring [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 2,160,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OtherCurrentAssetsFairValueDisclosureAbstract', window );"><strong>Other current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Foreign currency derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract', window );"><strong>Other current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Foreign currency derivative instruments</a></td>
<td class="num">(56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total financial assets (liabilities)</a></td>
<td class="num">(53,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Money market funds</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,160,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract', window );"><strong>Other current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Foreign currency derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total financial assets (liabilities)</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,160,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OtherCurrentAssetsFairValueDisclosureAbstract', window );"><strong>Other current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Foreign currency derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract', window );"><strong>Other current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Foreign currency derivative instruments</a></td>
<td class="num">(56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total financial assets (liabilities)</a></td>
<td class="num">$ (56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_OtherCurrentAssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other current assets:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_OtherCurrentAssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other current liabilities:</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140567928166160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Nov. 23, 2022</div></th>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th">
<div>May 13, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 11, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 04, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 06, 2019 </div>
<div>USD ($) </div>
<div>USD_Per_unit </div>
<div>Unit </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 08, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 02, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 11, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 06, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 06, 2015 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 14, 2014 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 11, 2010 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 01, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 18, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 27, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 23, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 22, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 22, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 23, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 24, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 20, 2014 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 23, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 19, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 25, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 20, 2014 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Aug. 20, 2014 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse share split ratio</a></td>
<td class="text">1-for-20<span></span>
</td>
<td class="text">1 for 10 to 1 for 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,844,463<span></span>
</td>
<td class="nump">4,840,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Issuance of ordinary shares in the Private Placement, net of issuance expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,626<span></span>
</td>
<td class="nump">84,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds warrant from the exercise warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19,219,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Aggregate consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,664,000<span></span>
</td>
<td class="nump">$ 68,787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentMember', window );">Placement agent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentsMember', window );">Placement agent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_CommonStockUnitsIssued', window );">Common stock, Units issued | Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PurchasePricePerUnit', window );">Purchase price per unit | USD_Per_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants', window );">Number of ordinary shares available for purchase through pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares in the IPO, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Value or warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_UnitsPurchased', window );">Number of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfPublicOffering', window );">Proceeds from issuance of public offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Issuance of ordinary shares, gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_FairValueOfWarrantsIssued', window );">Fair value of warrants issued | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares in the IPO, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_UnitsPurchased', window );">Number of units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MinimumBidPriceValuePerShare', window );">Minimum bid price value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">963,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Issuance of ordinary shares in the Private Placement, net of issuance expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfShares', window );">Proceeds from issuance of shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassCMember', window );">Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=chek_PreFundedUnitsMember', window );">Pre funded Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromExerciseOfPrefundedWarrants', window );">Proceeds from exercise of prefunded warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayRegisteredDirectOfferingMember', window );">April-May 2020 Registered Direct Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price range upper limit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ExercisePriceOfWarrants', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantThatWereExercised', window );">Warrant that were exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,361,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants issued to purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayRegisteredDirectOfferingMember', window );">April-May 2020 Registered Direct Offering [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering', window );">Proceeds from issuance of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayRegisteredDirectOfferingMember', window );">April-May 2020 Registered Direct Offering [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Issuance of ordinary shares, gross proceeds | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,139,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayOfferingsMember', window );">April-May 2020 Offerings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,210,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price range upper limit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds warrant from the exercise warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=chek_PreFundedUnitsMember', window );">Pre funded Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants', window );">Number of ordinary shares available for purchase through pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,024,876<span></span>
</td>
<td class="nump">22,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PrefundedWarrantsToPurchasePrice', window );">Pre-funded warrants purchase price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51.4<span></span>
</td>
<td class="nump">$ 109.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_AntiDilutiveWarrantsMember', window );">Anti-Dilutive Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_AntiDilutiveWarrantsMember', window );">Anti-Dilutive Warrants [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Warrants expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_UnderwriterWarrantsMember', window );">Underwriter Warrants [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_LongTermIncentiveWarrantsMember', window );">Long Term Incentive Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_LongTermIncentiveWarrantsMember', window );">Long Term Incentive Warrants [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesAWarrantsMember', window );">Series A Warrants [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised', window );">Partial exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesAWarrantsMember', window );">Series A Warrants [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiry date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 24,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_CreditLineAgreementWarrantsMember', window );">Credit Line Agreement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PercentageOfSharesFullyDiluted', window );">Percentage of shares fully diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_AmountOfPortionOfOrdinarySharesOfSuchLender', window );">Amount of portion of ordinary shares of such lender | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering', window );">Proceeds from issuance of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds warrant from the registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsMember', window );">Pre-funded Warrants [Member] | RD Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PricePerUnit', window );">Price per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants', window );">Proceeds from issuance of shares, prefunded shares and warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1', window );">Issuance of ordinary Shares in RD Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiry date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 11,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PreFundedWarrantsPurchaseSharesIssuable', window );">Shares issuable under pre-funded warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PreFundedWarrantsPurchase', window );">Shares issued under pre-funded warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_LegalWarrantsMember', window );">Legal Warrants [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,214.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_OneYearWarrantsMember', window );">One-year warrants [Member] | RD Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance of shares and Warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsExercisedCashlessBasis', window );">Warrants exercised on a cashless basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1', window );">Issuance of ordinary Shares in RD Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_FiveYearWarrantsMember', window );">Five-year warrants [Member] | RD Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from Issuance of shares and Warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1', window );">Issuance of ordinary Shares in RD Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsMember', window );">Series C Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsOneMember', window );">Pre-funded Warrants one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering', window );">Proceeds from issuance of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesDWarrantsMember', window );">Series D Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants issued to purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantThatWereExercised', window );">Warrant that were exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">878,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Placement agent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | RD Offering [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_IssuanceExpenses', window );">Issuance expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="nump">$ 3,199,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssuedNotExercised', window );">Warrants issued not exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">1,296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | RD Offering [Member] | Maximum [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering', window );">Proceeds from issuance of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | RD Offering [Member] | Minimum [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering', window );">Proceeds from issuance of registered direct offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,850,000<span></span>
</td>
<td class="nump">$ 31,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">802,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,632,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,712,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of Stock Issuance Costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member] | Private Placement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember', window );">Warrants Exercise Transaction [Member] | Private Placement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsToPurchaseOrdinarySharesMember', window );">Series C Warrants to purchase ordinary shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentMember', window );">Placement agent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsOutstandingAmount', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentMember', window );">Placement agent [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsOutstandingAmount', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentMember', window );">Placement agent [Member] | Ordinary Shares [Member] | Warrant Amendment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PontifaxMember', window );">Pontifax Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,214.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentWarrantsMember', window );">Placement agent warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="nump">$ 33.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentWarrantsMember', window );">Placement agent warrants [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssued', window );">Warrants Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,815<span></span>
</td>
<td class="nump">64,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296,297<span></span>
</td>
<td class="nump">1,296,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_WarrantsIssuedNotExercised', window );">Warrants issued not exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">64,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentWarrantsMember', window );">Placement agent warrants [Member] | Ordinary Shares [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
<td class="nump">64,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent', window );">Percentage of ordinary shares issued upon cash exercise of warrants to placement agent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_AmountOfPortionOfOrdinarySharesOfSuchLender">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents amount of portion of ordinary shares of such lender.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_AmountOfPortionOfOrdinarySharesOfSuchLender</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_CommonStockUnitsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents number of units issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_CommonStockUnitsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ExercisePriceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents exercise price of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ExercisePriceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_FairValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents fair value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_FairValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_IssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_IssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MinimumBidPriceValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum bid price value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MinimumBidPriceValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares available for purchase through pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of ordinary shares issued upon cash exercise of warrants to placement agent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PercentageOfSharesFullyDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents percentage of shares fully diluted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PercentageOfSharesFullyDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PreFundedWarrantsPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents pre funded warrants purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PreFundedWarrantsPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PreFundedWarrantsPurchaseSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of share issuable under pre-funded warrants purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PreFundedWarrantsPurchaseSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PrefundedWarrantsToPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PrefundedWarrantsToPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per unit sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromExerciseOfPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents proceeds from exercise of prefunded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromExerciseOfPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents cash inflow from exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromIssuanceOfPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromIssuanceOfPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromIssuanceOfRegistredDirectOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of proceeds from issuance of registered direct offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromIssuanceOfRegistredDirectOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amounts of proceeds from issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of proceeds from the issuance of shares, prefunded shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PurchasePricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents purchase price per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PurchasePricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of ordinary shares and pre-funded warrants in the registered direct offering, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued upon the exercise of warrants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued upon the partial exercise of warrants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_UnitsPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of units purchased, consisting of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share and one and one-half non-transferrable Long Term Incentive Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_UnitsPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_WarrantThatWereExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant that were exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_WarrantThatWereExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_WarrantsExercisedCashlessBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised on a cashless basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_WarrantsExercisedCashlessBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_WarrantsIssuedNotExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents warrants issued not exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_WarrantsIssuedNotExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_WarrantsOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_WarrantsOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_PlacementAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=chek_PreFundedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=chek_PreFundedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayRegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayRegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=chek_AprilMayOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=chek_PreFundedUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=chek_PreFundedUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_AntiDilutiveWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_AntiDilutiveWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=chek_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=chek_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_UnderwriterWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_UnderwriterWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_LongTermIncentiveWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_LongTermIncentiveWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_CreditLineAgreementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_CreditLineAgreementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=chek_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=chek_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_LegalWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_LegalWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_OneYearWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_OneYearWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_FiveYearWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_FiveYearWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_PreFundedWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesDWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesDWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_WarrantsExerciseTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsToPurchaseOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_SeriesCWarrantsToPurchaseOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=chek_WarrantAmendmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=chek_WarrantAmendmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PontifaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_PontifaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=chek_PlacementAgentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140567942182096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="7">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 04, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 09, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 05, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 04, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 10, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 05, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 29, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 21, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 27, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 20, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 09, 2021 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 10.184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,895<span></span>
</td>
<td class="nump">145,895<span></span>
</td>
<td class="nump">54,516<span></span>
</td>
<td class="nump">54,516<span></span>
</td>
<td class="nump">27,456<span></span>
</td>
<td class="nump">191,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=chek_CertainEmployeesMember', window );">Certain Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 4.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=chek_SeniorManagementMember', window );">Senior Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=chek_VpClinicalMember', window );">Vp Clinical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_TwentyTwoJuneMember', window );">June 22 [Member] | Chief Executive Officer [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate11Member', window );">December 9, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 12.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate11Member', window );">December 9, 2021 [Member] | Certain officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate2Member', window );">May 27, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate1Member', window );">March 5, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate3Member', window );">August 5, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne3Member', window );">May 31, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne3Member', window );">May 31, 2022 [Member] | Chief Executive Officer [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1', window );">Additional vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0833%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne4Member', window );">August 29, 2022 [Member] | Chief Executive Officer [Member] | Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 26.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=chek_TwoThousandFifteenPlanMember', window );">2015 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in shares available for additional grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=chek_TwoThousandFifteenPlanMember', window );">2015 Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in shares available for additional grant</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Options exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 15.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in shares available for additional grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options [Member] | Certain officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options [Member] | Certain executive officers and employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options [Member] | December 9, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of options on grant date | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1,644<span></span>
</td>
<td class="nump">$ 1,644<span></span>
</td>
<td class="nump">&#8362; 328<span></span>
</td>
<td class="nump">$ 328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSU's granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Certain Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSU's granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Certain officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSU's granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Certain executive officers and employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSU's granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | December 9, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | December 9, 2021 [Member] | Certain officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of RSU's granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | May 31, 2022 [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | August 29, 2022 [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue', window );">Fair value of options granted | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PremiumPercentageToCalculateExercisePrice', window );">Premium percentage to calculate the exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PremiumPercentageToCalculateExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents premium percentage to calculate the exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PremiumPercentageToCalculateExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=chek_CertainEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=chek_CertainEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=chek_SeniorManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=chek_SeniorManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=chek_VpClinicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=chek_VpClinicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_TwentyTwoJuneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_TwentyTwoJuneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=chek_CertainOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=chek_CertainOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOne3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOne3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOne4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOne4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=chek_TwoThousandFifteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=chek_TwoThousandFifteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140567940826272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 04, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 21, 2022 </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,239<span></span>
</td>
<td class="nump">99,935<span></span>
</td>
<td class="nump">30,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 10.184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate1Member', window );">March 5, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  05,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate2Member', window );">May 27, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 27,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate3Member', window );">August 5, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  05,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate4Member', window );">November 17, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 17,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate5Member', window );">December 10, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 10,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate6Member', window );">March 17, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 17,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate8Member', window );">August 4, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  04,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate8Member', window );">August 4, 2021 [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  04,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate7Member', window );">May 11, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate9Member', window );">September 13, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 13,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate10Member', window );">September 20, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 20,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate11Member', window );">December 9, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  09,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate11Member', window );">December 9, 2021 [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate13Member', window );">December 9, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  09,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne1Member', window );">January 27, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 27,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne1Member', window );">January 27, 2022 [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 27,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne2Member', window );">March 21, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 21,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne2Member', window );">March 21, 2022 [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 21,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOne3Member', window );">May 31, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDate17Member', window );">November 2, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  02,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOneSevenMember', window );">August 29, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 29,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOneEightMember', window );">November 29, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 29,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=chek_GrantDateOneNineMember', window );">December 29, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of award granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 29,  2032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value on grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share based expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate13Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate13Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOne1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOne1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOne2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOne2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOne3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOne3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDate17Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDate17Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOneSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOneSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOneEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOneEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=chek_GrantDateOneNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=chek_GrantDateOneNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568023472208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details) - Options [Member] - &#8362; / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes-Merton option-pricing model assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">109.00%<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">118.00%<span></span>
</td>
<td class="nump">153.00%<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free rate, minimum</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.81%<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate, maximum</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">1.34%<span></span>
</td>
<td class="nump">0.83%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes-Merton option-pricing model assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 3 months 7 days<span></span>
</td>
<td class="text">5 years 10 months 17 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">&#8362; 2.07<span></span>
</td>
<td class="nump">&#8362; 0.8<span></span>
</td>
<td class="nump">&#8362; 0.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Black-Scholes-Merton option-pricing model assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 4 months 28 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">&#8362; 9.58<span></span>
</td>
<td class="nump">&#8362; 2.27<span></span>
</td>
<td class="nump">&#8362; 1.57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026567344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">$ 408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 482<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568026538896">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">145,895<span></span>
</td>
<td class="nump">54,516<span></span>
</td>
<td class="nump">27,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,239<span></span>
</td>
<td class="nump">99,935<span></span>
</td>
<td class="nump">30,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,242)<span></span>
</td>
<td class="num">(8,206)<span></span>
</td>
<td class="num">(3,772)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">191,892<span></span>
</td>
<td class="nump">145,895<span></span>
</td>
<td class="nump">54,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">55,259<span></span>
</td>
<td class="nump">27,037<span></span>
</td>
<td class="nump">15,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average of exercise price</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning of the year | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8362; 48.2<span></span>
</td>
<td class="nump">&#8362; 95.3<span></span>
</td>
<td class="nump">&#8362; 204.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7.75<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">59.07<span></span>
</td>
<td class="nump">92.9<span></span>
</td>
<td class="nump">196.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end of the year | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35.35<span></span>
</td>
<td class="nump">48.2<span></span>
</td>
<td class="nump">95.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end of the year | &#8362; / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8362; 79.79<span></span>
</td>
<td class="nump">&#8362; 154.3<span></span>
</td>
<td class="nump">&#8362; 282.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted average remaining contractual life</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at the beginning of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">9 years 1 month 17 days<span></span>
</td>
<td class="text">8 years 8 months 26 days<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree', window );">Outstanding at the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">8 years 7 months 2 days<span></span>
</td>
<td class="text">9 years 1 month 17 days<span></span>
</td>
<td class="text">8 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7 years 4 months 20 days<span></span>
</td>
<td class="text">7 years 10 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate intrinsic value</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the beginning of the year | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8362; 0<span></span>
</td>
<td class="nump">&#8362; 0<span></span>
</td>
<td class="nump">&#8362; 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding at the end of the year | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at the end of the year | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8362; 0<span></span>
</td>
<td class="nump">&#8362; 0<span></span>
</td>
<td class="nump">&#8362; 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,628<span></span>
</td>
<td class="nump">3,637<span></span>
</td>
<td class="nump">4,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,050<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,374)<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
<td class="num">(1,258)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,601)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,703<span></span>
</td>
<td class="nump">16,628<span></span>
</td>
<td class="nump">3,637<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of December 31, 2022, all the outstanding options in the amount of 191,892 with an average exercise price $35.35 are out of the money.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568032400048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ResearchAndDevelopmentExpensesLineItems', window );"><strong>Research and Development Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Salaries and related expenses</a></td>
<td class="nump">$ 1,784<span></span>
</td>
<td class="nump">$ 2,042<span></span>
</td>
<td class="nump">$ 1,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total research and development expenses, net</a></td>
<td class="nump">14,271<span></span>
</td>
<td class="nump">12,349<span></span>
</td>
<td class="nump">10,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ResearchAndDevelopmentExpensesLineItems', window );"><strong>Research and Development Expenses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Salaries and related expenses</a></td>
<td class="nump">8,257<span></span>
</td>
<td class="nump">7,428<span></span>
</td>
<td class="nump">6,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SuppliesExpense', window );">Materials</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">3,020<span></span>
</td>
<td class="nump">1,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_SubcontractorsAndConsultantFees', window );">Subcontractors and consultants</a></td>
<td class="nump">1,375<span></span>
</td>
<td class="nump">820<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_PaymentsExpensesForPatents', window );">Cost for registration of patents</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Others</a></td>
<td class="nump">1,681<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ResearchAndDevelopmentExpenseGross', window );">Research and development</a></td>
<td class="nump">14,493<span></span>
</td>
<td class="nump">12,780<span></span>
</td>
<td class="nump">10,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GrantedRevenue', window );">Less participation of the IIA</a></td>
<td class="num">(222)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total research and development expenses, net</a></td>
<td class="nump">$ 14,271<span></span>
</td>
<td class="nump">$ 12,349<span></span>
</td>
<td class="nump">$ 10,008<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_GrantedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue fron grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_GrantedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_PaymentsExpensesForPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents amount of payments /expenses for patents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_PaymentsExpensesForPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ResearchAndDevelopmentExpenseGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross recognized cost of research and development during the period, before accounting for costs covered by grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ResearchAndDevelopmentExpenseGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ResearchAndDevelopmentExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expenses [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ResearchAndDevelopmentExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_SubcontractorsAndConsultantFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fees for the services provided by subcontractors and consultants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_SubcontractorsAndConsultantFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesWagesAndOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesWagesAndOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SuppliesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense associated with supplies that were used during the current accounting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SuppliesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568020301424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General and Administrative Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Salaries and related expenses</a></td>
<td class="nump">$ 1,784<span></span>
</td>
<td class="nump">$ 2,042<span></span>
</td>
<td class="nump">$ 1,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense', window );">Share-based compensation, net</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional services</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="nump">574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_OfficeRentAndMaintenance', window );">Office rent and maintenance</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Others</a></td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
<td class="nump">1,210<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total general and administrative expenses</a></td>
<td class="nump">$ 5,763<span></span>
</td>
<td class="nump">$ 4,972<span></span>
</td>
<td class="nump">$ 3,924<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_OfficeRentAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of office rent and maintenance expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_OfficeRentAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, net, allocated to general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesWagesAndOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesWagesAndOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140567942163312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income on short-term deposits and other</a></td>
<td class="nump">$ 1,047<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Bank fees and interest expenses</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_ChangesInLiabilityToPayRoyalties', window );">Changes in provision for royalties</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Exchange rate differences</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Changes in fair value of derivatives</a></td>
<td class="num">(121)<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total financing income, net</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_ChangesInLiabilityToPayRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents value of changes in liability to pay royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_ChangesInLiabilityToPayRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568032285008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Schedule of Loss Per Share) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Basic and diluted net loss per ordinary share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 19,108<span></span>
</td>
<td class="nump">$ 17,202<span></span>
</td>
<td class="nump">$ 13,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing net loss per ordinary share, basic</a></td>
<td class="nump">5,671,786<span></span>
</td>
<td class="nump">4,159,870<span></span>
</td>
<td class="nump">1,537,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing net loss per ordinary share, diluted</a></td>
<td class="nump">5,671,786<span></span>
</td>
<td class="nump">4,159,870<span></span>
</td>
<td class="nump">1,537,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per ordinary share - Basic</a></td>
<td class="nump">$ 3.37<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 9.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per ordinary share - Diluted</a></td>
<td class="nump">$ 3.37<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 9.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568020325840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=chek_WarrantAndShareOptionsMember', window );">Warrant and Share Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive instruments</a></td>
<td class="nump">2,912,147<span></span>
</td>
<td class="nump">1,170,262<span></span>
</td>
<td class="nump">1,104,431<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=chek_WarrantAndShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=chek_WarrantAndShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140568020311424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Transactions with related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="nump">$ 61,000<span></span>
</td>
<td class="nump">$ 57,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=chek_ConsultingFeesMember', window );">Consulting fees, including share-based compensation and reimbursement of expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Transactions with related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
<td class="nump">61,000<span></span>
</td>
<td class="nump">57,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember', window );">Sigalit Kimchy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MonthlyRetainer', window );">Monthly retainer</a></td>
<td class="nump">&#8362; 10,000<span></span>
</td>
<td class="nump">2,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_GrossOvertimeMonthlyRate', window );">Gross Overtime monthly rate</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_chek_MaximumAggregateMonthlySalary', window );">Maximum aggregate monthly salary</a></td>
<td class="nump">&#8362; 12,500<span></span>
</td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_NonExecutiveDirectorsMember', window );">Non-Executive Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Transactions with related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
<td class="nump">296,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_NonExecutiveDirectorsMember', window );">Non-Executive Directors [Member] | Fees and Reimbursement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Transactions with related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="nump">272,000<span></span>
</td>
<td class="nump">251,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_NonExecutiveDirectorsMember', window );">Non-Executive Directors [Member] | Share-Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Transactions with related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,000)<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 76,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_GrossOvertimeMonthlyRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Overtime monthly rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_GrossOvertimeMonthlyRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MaximumAggregateMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate monthly salary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MaximumAggregateMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_chek_MonthlyRetainer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of monthly retainer for services performed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">chek_MonthlyRetainer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>chek_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=chek_ConsultingFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=chek_ConsultingFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_NonExecutiveDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=chek_NonExecutiveDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=chek_FeesAndReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=chek_FeesAndReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=chek_ShareBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=chek_ShareBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>zk2329433_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:chek="http://check-cap.com/20221231"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="chek-20221231.xsd" xlink:type="simple"/>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-26</instant>
        </period>
    </context>
    <context id="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-26</endDate>
        </period>
    </context>
    <context id="C_20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-25</instant>
        </period>
    </context>
    <context id="C_20210101to20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-25</endDate>
        </period>
    </context>
    <context id="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-30</instant>
        </period>
    </context>
    <context id="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">chek:WarrantAndShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200401to20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="C_20210601to20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220302to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20211223_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-23</instant>
        </period>
    </context>
    <context id="C_20221123to20221123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2022-11-23</startDate>
            <endDate>2022-11-23</endDate>
        </period>
    </context>
    <context id="C_20221123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2022-11-23</instant>
        </period>
    </context>
    <context id="C_20220811to20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:DesignerRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:DesignerRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:PredecessorUnitHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:PredecessorUnitHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220131_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20230201to20230223_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:ManufacturingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-07-13</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:BinationalIndustrialResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:FeesAndReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ShareBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:NonExecutiveDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:ConsultingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:NonExecutiveDirectorsCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekGeneralTransactionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">chek:GeneralTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20200801to20200805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-05</endDate>
        </period>
    </context>
    <context id="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-05</endDate>
        </period>
    </context>
    <context id="C_20201201to20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:SeniorManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-10</endDate>
        </period>
    </context>
    <context id="C_20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:SeniorManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-10</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOne3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20191231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_20210901to20210920_srtTitleOfIndividualAxis_chekVpClinicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:VpClinicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-20</endDate>
        </period>
    </context>
    <context id="C_20210920_srtTitleOfIndividualAxis_chekVpClinicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:VpClinicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-20</instant>
        </period>
    </context>
    <context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekTwentyTwoJuneMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:TwentyTwoJuneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="C_20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOne4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-09</endDate>
        </period>
    </context>
    <context id="C_20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220127_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-27</endDate>
        </period>
    </context>
    <context id="C_20230101to20230104_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDateOneNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate8Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-27</endDate>
        </period>
    </context>
    <context id="C_20221201to20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-29</endDate>
        </period>
    </context>
    <context id="C_20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-29</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20200101to20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20210801to20210805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:TwoThousandFifteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-05</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapAwardDateAxis_chekGrantDate11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">chek:GrantDate11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-27</endDate>
        </period>
    </context>
    <context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficersChiefExecutiveOfficerAndBoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficersChiefExecutiveOfficerAndBoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">chek:CertainOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-02</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="C_20220321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TechnologyEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20200101to20201231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">chek:DevelopmentAreaAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-22</endDate>
        </period>
    </context>
    <context id="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">chek:RestOfCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-22</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_deiLegalEntityAxis_chekCheckCapUsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">chek:CheckCapUsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_deiLegalEntityAxis_chekCheckCapUsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">chek:CheckCapUsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20100501to20100511_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-05-01</startDate>
            <endDate>2010-05-11</endDate>
        </period>
    </context>
    <context id="C_20190101to20191231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_20180101to20181231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_20200501to20200511_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:AntiDilutiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-11</endDate>
        </period>
    </context>
    <context id="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-01</startDate>
            <endDate>2015-02-24</endDate>
        </period>
    </context>
    <context id="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-02-24</instant>
        </period>
    </context>
    <context id="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-02-24</instant>
        </period>
    </context>
    <context id="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-02-24</instant>
        </period>
    </context>
    <context id="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-01</startDate>
            <endDate>2015-02-24</endDate>
        </period>
    </context>
    <context id="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-02-24</instant>
        </period>
    </context>
    <context id="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-02-01</startDate>
            <endDate>2015-02-24</endDate>
        </period>
    </context>
    <context id="C_20150301to20150306_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:UnderwriterWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-03-01</startDate>
            <endDate>2015-03-06</endDate>
        </period>
    </context>
    <context id="C_20150401to20150406_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-04-01</startDate>
            <endDate>2015-04-06</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-08-20</instant>
        </period>
    </context>
    <context id="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-08-01</startDate>
            <endDate>2014-08-20</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:UnderwriterWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LegalWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LegalWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2016-08-11</endDate>
        </period>
    </context>
    <context id="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-11</instant>
        </period>
    </context>
    <context id="C_20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-01-23</instant>
        </period>
    </context>
    <context id="C_20170101to20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-01-23</endDate>
        </period>
    </context>
    <context id="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-08</instant>
        </period>
    </context>
    <context id="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-08</instant>
        </period>
    </context>
    <context id="C_20180508_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-08</instant>
        </period>
    </context>
    <context id="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapCommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-08</instant>
        </period>
    </context>
    <context id="C_20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="C_20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-13</instant>
        </period>
    </context>
    <context id="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-13</endDate>
        </period>
    </context>
    <context id="C_20210301to20210318_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-18</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20200723_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-08-01</startDate>
            <endDate>2014-08-20</endDate>
        </period>
    </context>
    <context id="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-08-01</startDate>
            <endDate>2014-08-20</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:LongTermIncentiveWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-02</endDate>
        </period>
    </context>
    <context id="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-02</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2017-11-22</endDate>
        </period>
    </context>
    <context id="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-22</instant>
        </period>
    </context>
    <context id="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:OneYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-25</instant>
        </period>
    </context>
    <context id="C_20200701to20200727_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:FiveYearWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-08</endDate>
        </period>
    </context>
    <context id="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_chekPreFundedUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:PreFundedUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-08</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsToPurchaseOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesCWarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-19</instant>
        </period>
    </context>
    <context id="C_20200701to20200727_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="C_20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20200701to20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-23</endDate>
        </period>
    </context>
    <context id="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-23</endDate>
        </period>
    </context>
    <context id="C_20200701to20200723_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-23</endDate>
        </period>
    </context>
    <context id="C_20200701to20200723_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-23</endDate>
        </period>
    </context>
    <context id="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20150401to20150406_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-04-01</startDate>
            <endDate>2015-04-06</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:AprilMayRegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210601to20210630_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapOtherCommitmentsAxis_chekWarrantAmendmentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">chek:WarrantAmendmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20210601to20210630_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210601to20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20190201to20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_20220202to20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">chek:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="C_20220202to20220301_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20220202to20220301_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-02</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <context id="C_20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-23</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:CreditLineAgreementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20141001to20141014_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-10-14</endDate>
        </period>
    </context>
    <context id="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PontifaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PreFundedWarrantsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="C_20200727_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-27</instant>
        </period>
    </context>
    <context id="C_20221231_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20200727_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:WarrantsExerciseTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-27</instant>
        </period>
    </context>
    <context id="C_20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">chek:RegisteredDirectOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610590</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">chek:PlacementAgentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="Euro">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="NIS">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="NIS_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Percent">
        <measure>pure</measure>
    </unit>
    <unit id="Squaremeters">
        <measure>utr:sqm</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_Per_Euro">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="USD_Per_unit">
        <measure>chek:USD_Per_unit</measure>
    </unit>
    <unit id="US_cents_Per_unit">
        <measure>chek:US_cents_Per_unit</measure>
    </unit>
    <unit id="Unit">
        <measure>chek:Unit</measure>
    </unit>
    <unit id="Usd_per_share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20220101to20221231"
      id="Fdei_EntityCentralIndexKey20220110140253530">0001610590</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20220101to20221231"
      id="Fdei_AmendmentFlag20220110140258433">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20220101to20221231"
      id="Fdei_DocumentFiscalPeriodFocus20220110140316782">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110112754448">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110220558257">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220405010018911">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230304203327546">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230304203402324">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230304203448951">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110112827095">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110112831064">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220111112239172">001-36848</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113004755">Check-Cap Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113025339">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113044188">Check-Cap Building</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113053886">29 Abba Hushi Avenue</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113058527">P.O. Box 1271</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113102150">Isfiya</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113106830">3009000</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113111117">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113523373">Alex Ovadia</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113437511">29 Abba Hushi Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113453015">P.O. Box 1271</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113459773">Isfiya</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113508757">3009000</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113516510">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113605014">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113610333">546706451</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress
      contextRef="C_20220101to20221231_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20220110113627845">Alex.Ovadia@check-cap.com</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113751747">Ordinary Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113759016">CHEK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110113803150">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220110113930779"
      unitRef="shares">5844463</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114044302">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114049951">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114055200">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114059372">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220405010417258">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114407643">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220406182733027">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114457450">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220110114514834">false</dei:EntityShellCompany>
    <dei:AuditorFirmId
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220319133813796">1197</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230304161929360">Brightman Almagor Zohar &amp; Co.</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230304161939673">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_46"
      unitRef="USD">4090000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_410"
      unitRef="USD">26457000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_57"
      unitRef="USD">352000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_511"
      unitRef="USD">350000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ShortTermInvestments
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_67"
      unitRef="USD">37609000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_611"
      unitRef="USD">25104000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_77"
      unitRef="USD">579000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_711"
      unitRef="USD">839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_87"
      unitRef="USD">42630000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_811"
      unitRef="USD">52750000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_117"
      unitRef="USD">1751000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_1111"
      unitRef="USD">1793000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_127"
      unitRef="USD">1060000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_1211"
      unitRef="USD">1116000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_137"
      unitRef="USD">2811000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_1311"
      unitRef="USD">2909000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_147"
      unitRef="USD">45441000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_1411"
      unitRef="USD">55659000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_197"
      unitRef="USD">952000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_1911"
      unitRef="USD">1050000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_207"
      unitRef="USD">802000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2011"
      unitRef="USD">680000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_217"
      unitRef="USD">1261000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2111"
      unitRef="USD">1961000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_227"
      unitRef="USD">337000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2211"
      unitRef="USD">350000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303014440873"
      unitRef="USD">56000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303014449199"
      unitRef="USD">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_237"
      unitRef="USD">3408000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2311"
      unitRef="USD">4041000</us-gaap:LiabilitiesCurrent>
    <chek:RoyaltiesProvision
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_267"
      unitRef="USD">94000</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2611"
      unitRef="USD">132000</chek:RoyaltiesProvision>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_277"
      unitRef="USD">627000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2711"
      unitRef="USD">795000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_287"
      unitRef="USD">721000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_2811"
      unitRef="USD">927000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20211231"
      decimals="0"
      id="Fxbrl_20220110100156262"
      unitRef="NIS_Per_Share">48</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20221231"
      decimals="0"
      id="Fxbrl_20220110100152327"
      unitRef="NIS_Per_Share">48</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220318215058864"
      unitRef="shares">18000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220110100242260"
      unitRef="shares">18000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220110100335726"
      unitRef="shares">5844463</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220204170028268"
      unitRef="shares">5844463</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220110100412456"
      unitRef="shares">4840089</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220204170036612"
      unitRef="shares">4840089</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_337"
      unitRef="USD">83664000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_3311"
      unitRef="USD">68787000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_347"
      unitRef="USD">84941000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_3411"
      unitRef="USD">90089000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_357"
      unitRef="USD">-127293000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_3511"
      unitRef="USD">-108185000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_367"
      unitRef="USD">41312000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_3611"
      unitRef="USD">50691000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110094722862_387"
      unitRef="USD">45441000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110094722862_3811"
      unitRef="USD">55659000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_37"
      unitRef="USD">14271000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_311"
      unitRef="USD">12349000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_315"
      unitRef="USD">10008000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_47"
      unitRef="USD">5763000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_411"
      unitRef="USD">4972000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_415"
      unitRef="USD">3924000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_57"
      unitRef="USD">-20034000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_511"
      unitRef="USD">-17321000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_515"
      unitRef="USD">-13932000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_77"
      unitRef="USD">926000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_711"
      unitRef="USD">119000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_715"
      unitRef="USD">86000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_117"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_1111"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_1115"
      unitRef="USD">-13846000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110100807950_147"
      unitRef="USD">-19108000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110100807950_1411"
      unitRef="USD">-17202000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110100807950_1415"
      unitRef="USD">-13846000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20221103162004278"
      unitRef="Usd_per_share">3.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20220110100807950_167"
      unitRef="Usd_per_share">3.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20230327125341719"
      unitRef="Usd_per_share">4.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220110100807950_1611"
      unitRef="Usd_per_share">4.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20230327125429631"
      unitRef="Usd_per_share">9.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20220110100807950_1615"
      unitRef="Usd_per_share">9.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20230327125604401"
      unitRef="shares">5671786</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220110100807950_187"
      unitRef="shares">5671786</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20230327125547242"
      unitRef="shares">4159870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220110100807950_1811"
      unitRef="shares">4159870</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20230327125532585"
      unitRef="shares">1537060</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20220110100807950_1815"
      unitRef="shares">1537060</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:SharesOutstanding
      contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_223"
      unitRef="shares">433129</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_227"
      unitRef="USD">5407000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2211"
      unitRef="USD">77964000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20191231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2219"
      unitRef="USD">-77137000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20220110102728392_2223"
      unitRef="USD">6234000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_20200101to20201231_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20220110135859552"
      unitRef="USD">29000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <chek:StockIssuedDuringPeriodSharesPrivatePlacementShares
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_263"
      unitRef="shares">136009</chek:StockIssuedDuringPeriodSharesPrivatePlacementShares>
    <chek:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_267"
      unitRef="USD">1894000</chek:StockIssuedDuringPeriodValuePrivatePlacement>
    <chek:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2611"
      unitRef="USD">2837000</chek:StockIssuedDuringPeriodValuePrivatePlacement>
    <chek:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2619"
      unitRef="USD">0</chek:StockIssuedDuringPeriodValuePrivatePlacement>
    <chek:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_2623"
      unitRef="USD">4731000</chek:StockIssuedDuringPeriodValuePrivatePlacement>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_20200401to20200531"
      decimals="-3"
      id="Fxbrl_20220110140010029"
      unitRef="USD">1361000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <chek:StockAndWarrantIssuedDuringPeriodSharesInFinancing
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_293"
      unitRef="shares">958335</chek:StockAndWarrantIssuedDuringPeriodSharesInFinancing>
    <chek:StockAndWarrantIssuedDuringPeriodValueInFinancing
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_297"
      unitRef="USD">13039000</chek:StockAndWarrantIssuedDuringPeriodValueInFinancing>
    <chek:StockAndWarrantIssuedDuringPeriodValueInFinancing
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2911"
      unitRef="USD">-2900000</chek:StockAndWarrantIssuedDuringPeriodValueInFinancing>
    <chek:StockAndWarrantIssuedDuringPeriodValueInFinancing
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_2919"
      unitRef="USD">0</chek:StockAndWarrantIssuedDuringPeriodValueInFinancing>
    <chek:StockAndWarrantIssuedDuringPeriodValueInFinancing
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_2923"
      unitRef="USD">10139000</chek:StockAndWarrantIssuedDuringPeriodValueInFinancing>
    <chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220318175401467"
      unitRef="USD">920000</chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction>
    <chek:StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_323"
      unitRef="shares">802712</chek:StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction>
    <chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_327"
      unitRef="USD">11290000</chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction>
    <chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3211"
      unitRef="USD">-2578000</chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction>
    <chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3219"
      unitRef="USD">0</chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction>
    <chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_3223"
      unitRef="USD">8712000</chek:StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_333"
      unitRef="shares">1258</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_337"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3311"
      unitRef="USD">-16000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3319"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_3323"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_343"
      unitRef="shares">0</chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_347"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3411"
      unitRef="USD">408000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_3423"
      unitRef="USD">408000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_357"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3511"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3519"
      unitRef="USD">-13846000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_3523"
      unitRef="USD">-13846000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220110102728392_363"
      unitRef="shares">2331443</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_367"
      unitRef="USD">31646000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3611"
      unitRef="USD">75715000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220110102728392_3619"
      unitRef="USD">-90983000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110102728392_3623"
      unitRef="USD">16378000</us-gaap:StockholdersEquity>
    <chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220318175413882"
      unitRef="USD">22000</chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220204000202575_xbrl_20220110102728392_293"
      unitRef="shares">1210235</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220204000202575_xbrl_20220110102728392_297"
      unitRef="USD">18099000</chek:StockIssuedDuringPeriodValueWarrantsExercised>
    <chek:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220204000202575_xbrl_20220110102728392_2911"
      unitRef="USD">1120000</chek:StockIssuedDuringPeriodValueWarrantsExercised>
    <chek:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204000202575_xbrl_20220110102728392_2919"
      unitRef="USD">0</chek:StockIssuedDuringPeriodValueWarrantsExercised>
    <chek:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204000202575_xbrl_20220110102728392_2923"
      unitRef="USD">19219000</chek:StockIssuedDuringPeriodValueWarrantsExercised>
    <chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction
      contextRef="C_20210601to20210630"
      decimals="-3"
      id="Fxbrl_20220203235823127"
      unitRef="USD">3199000</chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction>
    <chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220204000224573_xbrl_20220110102728392_323"
      unitRef="shares">1296297</chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220204000224573_xbrl_20220110102728392_327"
      unitRef="USD">19011000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220204000224573_xbrl_20220110102728392_3211"
      unitRef="USD">12790000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204000224573_xbrl_20220110102728392_3219"
      unitRef="USD">0</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204000224573_xbrl_20220110102728392_3223"
      unitRef="USD">31801000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_323"
      unitRef="shares">350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_327"
      unitRef="USD">5000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220204012510481"
      unitRef="USD">-1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_3219"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204001644037_xbrl_20220204000224573_xbrl_20220110102728392_3223"
      unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220204000300886_xbrl_20220110102728392_333"
      unitRef="shares">1764</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220204000300886_xbrl_20220110102728392_337"
      unitRef="USD">26000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220204181420700"
      unitRef="USD">-26000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204000300886_xbrl_20220110102728392_3319"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204000300886_xbrl_20220110102728392_3323"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230324113453670"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="INF"
      id="Fxbrl_20220204000412732_xbrl_20220110102728392_343"
      unitRef="shares">491</chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204000412732_xbrl_20220110102728392_3411"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204000412732_xbrl_20220110102728392_3423"
      unitRef="USD">491000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220318175435891_xbrl_20220110102728392_357"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220318175435891_xbrl_20220110102728392_3511"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220318175435891_xbrl_20220110102728392_3519"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220318175435891_xbrl_20220110102728392_3523"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220204000438363_xbrl_20220110102728392_363"
      unitRef="shares">4840089</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220204000438363_xbrl_20220110102728392_367"
      unitRef="USD">68787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220204000438363_xbrl_20220110102728392_3611"
      unitRef="USD">90089000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220204000438363_xbrl_20220110102728392_3619"
      unitRef="USD">-108185000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220204000438363_xbrl_20220110102728392_3623"
      unitRef="USD">50691000</us-gaap:StockholdersEquity>
    <chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction
      contextRef="C_20220302to20220331"
      decimals="-3"
      id="Fxbrl_20230303025654861"
      unitRef="USD">1150000</chek:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction>
    <chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230326115250330"
      unitRef="shares">1000000</chek:StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230305163210175"
      unitRef="USD">14815000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230303030209057"
      unitRef="USD">-5965000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230303030219827"
      unitRef="USD">0</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303030228341"
      unitRef="USD">8850000</chek:StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230303030241198"
      unitRef="shares">4374</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230303030250501"
      unitRef="USD">62000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230303030301467"
      unitRef="USD">-62000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303030323916"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="INF"
      id="Fxbrl_20230303030334466"
      unitRef="shares">879</chek:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230303030350937"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303030405691"
      unitRef="USD">879000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230303025948552"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303025955824"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20230303025818543"
      unitRef="shares">5844463</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20230303025825034"
      unitRef="USD">83664000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20230303025831895"
      unitRef="USD">84941000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230303025841086"
      unitRef="USD">-127293000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303025853585"
      unitRef="USD">41312000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110113921085"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204002357179"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110113959290"
      unitRef="USD">-13846000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_53"
      unitRef="USD">404000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_57"
      unitRef="USD">205000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_511"
      unitRef="USD">148000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_63"
      unitRef="USD">879000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_67"
      unitRef="USD">491000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_611"
      unitRef="USD">408000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303034308944"
      unitRef="USD">624000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_77"
      unitRef="USD">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_711"
      unitRef="USD">-7000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220204003058063"
      unitRef="USD">-273000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230303034341577"
      unitRef="USD">549000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_911"
      unitRef="USD">-106000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_103"
      unitRef="USD">207000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204003324702"
      unitRef="USD">362000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303033525847"
      unitRef="USD">-317000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303033513587"
      unitRef="USD">-700000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_117"
      unitRef="USD">451000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_1111"
      unitRef="USD">409000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInRoyaltiesPayable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_123"
      unitRef="USD">-38000</us-gaap:IncreaseDecreaseInRoyaltiesPayable>
    <us-gaap:IncreaseDecreaseInRoyaltiesPayable
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_127"
      unitRef="USD">-22000</us-gaap:IncreaseDecreaseInRoyaltiesPayable>
    <us-gaap:IncreaseDecreaseInRoyaltiesPayable
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_1211"
      unitRef="USD">-28000</us-gaap:IncreaseDecreaseInRoyaltiesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_133"
      unitRef="USD">-18707000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_137"
      unitRef="USD">-16264000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_1311"
      unitRef="USD">-13113000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_163"
      unitRef="USD">486000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_167"
      unitRef="USD">1006000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303040610122"
      unitRef="USD">379000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromInvestments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_173"
      unitRef="USD">12022000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204003703620"
      unitRef="USD">15000000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303034540276"
      unitRef="USD">10072000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_183"
      unitRef="USD">-12508000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220204003713499"
      unitRef="USD">-16006000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303034550576"
      unitRef="USD">-10451000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220204011210270"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220318180356453"
      unitRef="USD">19219000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220318180400016"
      unitRef="USD">0</us-gaap:ProceedsFromWarrantExercises>
    <chek:ProceedsFromIssuanceResisteredDirectOffering
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220204011219076"
      unitRef="USD">8850000</chek:ProceedsFromIssuanceResisteredDirectOffering>
    <chek:ProceedsFromIssuanceResisteredDirectOffering
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220318180412989"
      unitRef="USD">31801000</chek:ProceedsFromIssuanceResisteredDirectOffering>
    <chek:ProceedsFromIssuanceResisteredDirectOffering
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220318180415539"
      unitRef="USD">10139000</chek:ProceedsFromIssuanceResisteredDirectOffering>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220204011225719"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220318180429204"
      unitRef="USD">4000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220318180431996"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_213"
      unitRef="USD">0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_217"
      unitRef="USD">0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_2111"
      unitRef="USD">8712000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_223"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_227"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_2211"
      unitRef="USD">4731000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_253"
      unitRef="USD">8850000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_257"
      unitRef="USD">51024000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110112640402_2511"
      unitRef="USD">23582000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303035003661"
      unitRef="USD">-22365000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110112640402_277"
      unitRef="USD">18754000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220204005101962"
      unitRef="USD">18000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110113557934"
      unitRef="USD">26807000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110114107155"
      unitRef="USD">8053000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20191231"
      decimals="-3"
      id="Fxbrl_20220110113614233"
      unitRef="USD">8035000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220110112640402_313"
      unitRef="USD">4442000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110113447569"
      unitRef="USD">26807000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110113504336"
      unitRef="USD">8053000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110113707527_33"
      unitRef="USD">35000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110113707527_37"
      unitRef="USD">161000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110113707527_311"
      unitRef="USD">45000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110113707527_53"
      unitRef="USD">307000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110113707527_57"
      unitRef="USD">1048000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110113707527_511"
      unitRef="USD">151000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110113707527_73"
      unitRef="USD">5000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110113707527_77"
      unitRef="USD">33000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110113707527_711"
      unitRef="USD">5000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303035926934"
      unitRef="USD">548000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230303035935814"
      unitRef="USD">62000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303035952550"
      unitRef="USD">54000</us-gaap:InterestPaidNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220318202840048_xbrl_20220110113707527_33"
      unitRef="USD">4090000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220318202840048_xbrl_20220110113707527_37"
      unitRef="USD">26457000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220318202840048_xbrl_20220110113707527_311"
      unitRef="USD">7703000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <chek:RestrictedCashIncludedCurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220318202844840_xbrl_20220110113707527_33"
      unitRef="USD">352000</chek:RestrictedCashIncludedCurrentAssets>
    <chek:RestrictedCashIncludedCurrentAssets
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220318202844840_xbrl_20220110113707527_37"
      unitRef="USD">350000</chek:RestrictedCashIncludedCurrentAssets>
    <chek:RestrictedCashIncludedCurrentAssets
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220318202844840_xbrl_20220110113707527_311"
      unitRef="USD">350000</chek:RestrictedCashIncludedCurrentAssets>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220318202846878_xbrl_20220110113707527_33"
      unitRef="USD">4442000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220318202846878_xbrl_20220110113707527_37"
      unitRef="USD">26807000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220318202846878_xbrl_20220110113707527_311"
      unitRef="USD">8053000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324124605931">
          &lt;div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 1&#160; -&#160; GENERAL INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Check Cap Ltd. (the &#x201c;Company") was incorporated under the laws of the State of Israel. The registered address of its offices is 29 Abba Hushi Avenue, Isfiya 3009000, Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has a wholly-owned subsidiary, Check-Cap US, Inc., that was incorporated under the laws of the State of Delaware on May 15, 2015.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company is a clinical-stage medical diagnostics company aiming to redefine colorectal cancer (CRC) screening and prevention through the introduction of C-Scan&#xae;, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into cancer. The Company&#x2019;s disruptive capsule-based screening technology aims to significantly increase screening adherence worldwide and help millions of people to stay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Since its inception, the Company has devoted substantially all of its efforts to research and development, clinical trials, recruiting management and technical staff, acquiring assets and raising capital. The Company is still in its development and clinical stage and has not yet generated revenues. The Company has incurred losses of $19,108 and $17,202 for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022, the Company's accumulated deficit was approximately $127,293. The extent of the Company's future operating losses and the timing of becoming profitable are uncertain.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has funded its operations to date primarily through equity financings, sale of its ordinary shares and warrants, the exercise of warrants and other financing transactions and through grants from the Israel Innovation Authority of the Ministry of Economy and Industry (the "IIA").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additional funding will be required to complete the Company's research and development and clinical trials, to attain regulatory approvals, to establish manufacturing infrastructure and to begin the commercialization efforts of C-Scan. The Company has not yet commercialized its product. Even if the Company commercializes its product, it may not become profitable in the foreseeable future. The Company&#x2019;s ability to achieve profitability depends on a number of factors, including its ability to obtain regulatory approval for its product, successfully complete any post-approval regulatory obligations and successfully commercialize its product alone or in partnership.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;To meet its capital needs, the Company is considering multiple alternatives, including, but not limited to, additional equity financings and other financing transactions. While the Company has been successful in raising funds in the past, there can be no assurance that it will be able to do so in the future on a timely basis on terms acceptable to the Company, or at all. Uncertain market conditions and approval by regulatory bodies and adverse results from clinical trials may (among other reasons) adversely impact the Company's ability to raise capital in the future.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 21, 2023 , the Company announced that following its internal assessment of the clinical data collected to date from its clinical calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study and that therefore, the initiation of the second part of the U.S. pivotal study that was expected in mid-2023 is temporarily postponed. The Company adopted a plan of action that includes (among other things) a cost reduction plan in order to extend its cash runway, which it is in the process of implementing. Based on such plan, the Company believes that current cash on hand will be sufficient to fund its ongoing operations and plans into the fourth quarter of 2024. Management expects that the Company will continue to generate losses from the development, manufacturing and infrastructure costs, clinical development and regulatory activities of C-Scan, which will result in negative cash flow from operating activity. The actual amount of cash that the Company will need to operate is subject to many factors, including, but not limited to, the initiation, timing, progress and results of clinical trials and other product development efforts regulatory path along with cost to commercialize its product.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:76pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As described in Notes 10B(2)(b) and 10B(2)(d), on February 24, 2015, the Company consummated an Initial Public Offering in the United States (U.S.) (the "IPO") concurrently with a private placement.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 11, 2016, the Company consummated a registered direct offering of ordinary shares and pre-funded warrants. See Note 10B(2)(h).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On June 2, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(i).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On November 22, 2017, the Company consummated a registered direct offering of ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(j).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 8, 2018, the Company consummated an underwritten public offering of ordinary shares, pre-funded warrants and Series C warrants. See Note 10B(2)(k).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On February 6, 2019, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(l).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In February 2020, the Company consummated a private placement of ordinary shares. See Note 10B(2)(m).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During April and May 2020, the Company consummated three registered direct offerings of ordinary shares and simultaneous private placements of warrants. See Note 10B(2)(n).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 27, 2020, the Company consummated a warrant exercise transaction to purchase ordinary shares and a simultaneous private placement of warrants. See Note 10B(2)(o).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;During the first quarter of 2021, certain investors exercised their warrants previously issued by the Company&lt;/span&gt;. See&lt;span&gt; Note 10B(2)(p).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 1, 2021, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(q).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 3, 2022, the Company consummated a registered direct offering of ordinary shares and warrants. See Note 10B(2)(r).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's ordinary shares and Series C Warrants are listed on the NASDAQ Capital Market under the symbols "CHEK" and CHEKZ&#x201d; respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s Series A Warrants, formerly listed on the NASDAQ Capital Market under the symbol &#x201c;CHEKW&#x201d;, expired on February 24, 2020; and their listing was suspended on February 28, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated financial statements of the Company as of and for the year ended December 31, 2022 include the financial statements of the Company and its wholly-owned U.S. subsidiary.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:77pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/div&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 23, 2021, the Company announced that it received a letter from the Staff, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of $1.00 per share. The Company was provided by Nasdaq with a compliance period of 180 calendar days (i.e., until June 21, 2022) to regain compliance pursuant to Nasdaq Listing Rules. On June 22, 2022, the Company received a letter from the Staff notifying it that Nasdaq granted the Company a 180-day extension, or until December 19, 2022, or the Extension Period, to regain compliance with the Minimum Bid Price Requirement. In order to regain compliance, on August 11, 2022, the Company&#x2019;s shareholders approved a reverse share split (&#x201c;Reverse Share Split&#x201d;) of its ordinary shares within a range of 1 for 10 to 1 for 20, the exact ratio to be determined by further action of the Company&#x2019;s Board of Directors, to be effective on a date to be determined by the Company&#x2019;s Board of Directors and announced by the Company, and to amend the Company&#x2019;s Articles of Association accordingly. The Board of Directors subsequently approved a reverse share split of the Company&#x2019;s ordinary shares at the ratio of 1-for-20, such that each twenty (20) ordinary shares, par value NIS 2.40 per share, consolidated into one (1) ordinary share, par value NIS 48.00, effective as of November 23, 2022. The first date when the Company&#x2019;s ordinary shares began trading on the Nasdaq Capital Market after implementation of the Reverse Share Split was November 25, 2022. Following the implementation of the Reverse Share Split, the Company&#x2019;s authorized share capital comprised of 18,000,000 ordinary shares. No fractional ordinary shares were issued as a result of the Reverse Share Split. All fractional ordinary shares were rounded up to the nearest whole ordinary share. In addition, a proportionate adjustment made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding options and warrants entitling the holders to purchase ordinary shares. Furthermore, following completion of the Reverse Share Split, the number of ordinary shares issuable pursuant to the Company&#x2019;s 2006 Unit Option Plan and 2015 Equity Incentive Plan and 2015 US Sub-Plan to the 2015 Equity Incentive Plan, as well as the number of shares and exercise prices subject to outstanding options under the plans and the number of shares subject to outstanding restricted stock units (&#x201c;RSUs&#x201d;) under the plans were appropriately adjusted. The Company subsequently received a letter informing it that, for the 10 consecutive business days from November 25, 2022 to December 8, 2022, the closing bid price of the Company&#x2019;s ordinary shares had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. The Company experienced temporary disruptions to its operations as a result of the COVID-19 pandemic including disruptions to the Company&#x2019;s clinical studies For example, during a period of few months during the year ending December 31, 2022, there was a global shortage in iodine due to COVID-19, which is critical patient intake used in the C-Scan procedure. As a result, the Company faced delays in its clinical trials. &#160;The extent to which the COVID-19 pandemic shall impact the Company&#x2019;s operations in the future will depend on future developments, which are highly uncertain and cannot be predicted with confidence. In particular, any future spread of COVID-19 globally or the reinstatement of restrictions or other actions that may be required to contain COVID-19 or treat its impact could materially adversely impact the Company&#x2019;s operations and workforce, including its research and clinical trials and its ability to continue raise capital, could affect the operations of key governmental agencies, such as the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;), which may delay the Company&#x2019;s development plans, and could result in the inability of the Company&#x2019;s suppliers to deliver components or raw materials on a timely basis or at all, each of which in turn could have a material adverse impact on the Company&#x2019;s business, financial condition and results of operation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211122094228145"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230303145707513"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122094301552"
      unitRef="USD">-127293000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <chek:MinimumBidPriceValuePerShare
      contextRef="C_20211223_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="2"
      id="Fxbrl_20230304162454834"
      unitRef="Usd_per_share">1</chek:MinimumBidPriceValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_20220811to20220811"
      id="Fxbrl_20230304170954828">1 for 10 to 1 for 20</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_20221123to20221123"
      id="Fxbrl_20230304170702241">1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20221123"
      decimals="2"
      id="Fxbrl_20230304170729148"
      unitRef="NIS_Per_Share">2.4</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20230304170736222"
      unitRef="NIS_Per_Share">48</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230304170806553"
      unitRef="shares">18000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318132820613">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company`s consolidated financial statements are presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of estimates in preparation of financial statements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's consolidated financial statements include the financial statements of Check-Cap Ltd. and its wholly-owned subsidiary, Check-Cap US, Inc. The Company's consolidated financial statements are presented after elimination of inter-company transactions and balances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial statements in U.S. dollars&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has not yet generated revenues and the majority of its expenses are in U.S. dollars (dollar or USD) or NIS.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial statements are presented in dollars, which is the functional currency of the Company. In management's judgment, setting the dollar as the Company's functional currency, is based mainly on the following criteria: the Company's budget and other Company internal reports, including reports to the Company's Board of Directors and investors, are presented in dollars. Management uses these reports in order to make decisions for the Company. All of the Company's equity financings have been in dollars; and it is expected that a significant portion of the Company's future revenues will be in dollars.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions and balances denominated in dollars are presented at their original amounts. Non&#x2011;dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;D.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents include cash in hand, short&#x2013;term deposits in banks and short-term, highly liquid investments with an original maturity of up to three months, with a high level of liquidity that may be easily converted to known amounts of cash, and that are exposed to insignificant risk of change in value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;E.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposits are deposits with maturities of more than three months but less than one year. The short&#x2013;term bank deposits are presented at their cost, including accrued interest, which approximates fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;F.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash flow hedges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264 and $3,466, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company&#x2019;s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $56 and an asset, net, of $65, respectively and is included in other current liabilities and other current assets, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;G.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;div style="margin-left:49pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Length&#160;of&#160;useful&#160;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dep&lt;/span&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;reciation&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10-14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3-7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers and auxiliary equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;H.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's long-lived assets are reviewed for impairment in accordance with ASC 360-10 "Accounting for the Impairment or Disposal of Long-Lived Assets" whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are expensed as incurred and consist primarily of costs for personnel, subcontractors and consultants (mainly in connection with clinical trials) and materials for research and development and clinical activities. Grants received by the Company from the IIA are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. Such grants are included as a deduction of research and development costs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;J.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for its contingent liabilities in accordance with ASC No. 450, "Contingencies". A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2022, and 2021, the Company is not a party to any ligation that could have a material adverse effect on the Company's business, financial position, results of operations or cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;K.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes expense for its share-based compensation based on the fair value of the awards granted. The Company&#x2019;s share-based compensation plans provide for the award of stock options and restricted stock units. In accordance with ASC 718-10 "Compensation-Stock Compensation", the Company estimates the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the graded-vesting method over the requisite service period for each separately vesting portion of the award. Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-09, Compensation-Stock Compensation (Topic 718) allows companies to account for forfeitures when they occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation cost for awards with performance conditions if and when the company concludes that it is probable that the performance conditions will be achieved. ASC 718&#x2019;s use of the term probable is consistent with that term&#x2019;s use in ASC 450, Contingencies, which refers to an event that is likely to occur (ASC Master Glossary). The Company reassess at each reporting period the probability of vesting for awards with performance conditions and adjusts compensation cost based on its probability assessment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the years ended December 31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;L.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income taxes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740-10 "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with ASC 740, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered 'more-likely-than-not' that the position taken will be sustained by a taxing authority. As of December 31, 2022 and 2021, the Company had no unrecognized income tax positions, and, accordingly, there is no impact on the Company's effective income tax rate associated with these items.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;M.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures its investments in money market funds (classified as cash equivalents) and its foreign currency net purchased options at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 1. &lt;/span&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 2&lt;/span&gt;. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 3&lt;/span&gt;. Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;

            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;N.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restricted Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has granted a pledge in favor of Bank Leumi Le-Israel B.M in the amount of $352 and 350 as of &#160;December 31, 2022 and 2021, respectively to secure certain payment obligations of the Company in connection with hedge transactions. This amount was classified as restricted cash balance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;O.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for leases in accordance with ASC 842 "Lesses.&#x201d; Arrangements that are determined to be leases at inception are recognized as long-term operating lease assets and lease liabilities in the consolidated balance sheet at lease commencement. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As the Company&#x2019;s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at the commencement date in determining the present value of future lease payments. Lease terms may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has also elected the practical expedient to include both lease and non-lease components as a single component and account for it as a lease. Additionally, the Company has made a policy election not to capitalize leases with an original term of 12 months or less.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with ASC 360-10, management reviews operating lease assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable based on estimated future undiscounted cash flows. If so indicated, an impairment loss would be recognized for the difference between the carrying amount of the asset and its fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;P.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recent accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2021, the FASB issued ASU No. 2021- 10, Government Assistance (Topic 832). This ASU requires business entities to disclose information about government assistance they receive if the transactions were accounted for by analogy to either a grant or a contribution &#160;accounting &#160;model. &#160;The disclosure requirements include the nature of the transaction and the related accounting policy used, the line items on the balance sheets and statements of operations that are affected and the amounts applicable to each financial statement line item and the significant terms and conditions of the transactions. The ASU is effective for annual periods beginning after December 15, 2021. The disclosure requirements can be applied either retrospectively or prospectively to all transactions in the scope of the amendments that are reflected in the financial statements at the date of initial application and new transactions that are entered into after the date of initial application. The Company already adopted ASU No. 2021- 10, in its financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;


              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:29pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Q.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders&#x2019; deficit, net loss or net cash used in operating activities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125801951">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Use of estimates in preparation of financial statements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The preparation of financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125810887">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Principles of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's consolidated financial statements include the financial statements of Check-Cap Ltd. and its wholly-owned subsidiary, Check-Cap US, Inc. The Company's consolidated financial statements are presented after elimination of inter-company transactions and balances.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:ConsolidationPolicyTextBlock>
    <chek:FunctionalCurrencyPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125825983">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Financial statements in U.S. dollars&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has not yet generated revenues and the majority of its expenses are in U.S. dollars (dollar or USD) or NIS.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The financial statements are presented in dollars, which is the functional currency of the Company. In management's judgment, setting the dollar as the Company's functional currency, is based mainly on the following criteria: the Company's budget and other Company internal reports, including reports to the Company's Board of Directors and investors, are presented in dollars. Management uses these reports in order to make decisions for the Company. All of the Company's equity financings have been in dollars; and it is expected that a significant portion of the Company's future revenues will be in dollars.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions and balances denominated in dollars are presented at their original amounts. Non&#x2011;dollar transactions and balances have been re-measured to dollars in accordance with the provisions of ASC 830-10 "Foreign Currency Translation". All transaction gains and losses from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statement of operations as financial income or expenses, as appropriate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </chek:FunctionalCurrencyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125844556">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;D.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents include cash in hand, short&#x2013;term deposits in banks and short-term, highly liquid investments with an original maturity of up to three months, with a high level of liquidity that may be easily converted to known amounts of cash, and that are exposed to insignificant risk of change in value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125857756">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;E.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposit&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term bank deposits are deposits with maturities of more than three months but less than one year. The short&#x2013;term bank deposits are presented at their cost, including accrued interest, which approximates fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125915126">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;F.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash flow hedges&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a matter of policy, the Company uses derivatives for risk management purposes and does not use derivatives for speculative purposes. From time to time, the Company may enter into foreign currency zero-cost collars or minimal cost collars contracts to hedge foreign currency cash flow transactions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div/&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2022 and 2021, the Company had outstanding foreign exchange collars in the notional amount of approximately $5,264 and $3,466, respectively. These options were set for a period of up to eight months as of December 31, 2022. The Company measured the fair value of the options in accordance with provisions of ASC No. 820 (classified as level 2 of the fair value hierarchy). The fair value of the Company&#x2019;s outstanding collars on December 31, 2022 and 2021 amounted to a liability, net of $56 and an asset, net, of $65, respectively and is included in other current liabilities and other current assets, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303142439415"
      unitRef="USD">5264000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303142448068"
      unitRef="USD">3466000</us-gaap:DerivativeAssetNotionalAmount>
    <chek:FairValueOfHedgingOption
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303142457720"
      unitRef="USD">56000</chek:FairValueOfHedgingOption>
    <chek:FairValueOfHedgingOption
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303142508937"
      unitRef="USD">65000</chek:FairValueOfHedgingOption>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125934006">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;G.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;div style="margin-left:49pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Length&#160;of&#160;useful&#160;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dep&lt;/span&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;reciation&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10-14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3-7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers and auxiliary equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            </us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324223227787">
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div&gt;
                      &lt;div style="margin-left:49pt"&gt;
                        &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Length&#160;of&#160;useful&#160;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;text-align:center" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dep&lt;/span&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;reciation&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10-14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7-10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3-7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15-33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;
                            &lt;tr&gt;
                              &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:66%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers and auxiliary equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:14%" valign="bottom"&gt;
                                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;/td&gt;
                              &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;/tr&gt;

                        &lt;/table&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      id="Fxbrl_20211122102619344">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      id="Fxbrl_20211122102653603">P14Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="2"
      id="Fxbrl_20211122102715061"
      unitRef="Percent">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="2"
      id="Fxbrl_20211122102732737"
      unitRef="Percent">0.10</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      id="Fxbrl_20211122102833075">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      id="Fxbrl_20211122102839885">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      decimals="2"
      id="Fxbrl_20211122102845493"
      unitRef="Percent">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      decimals="2"
      id="Fxbrl_20211122102850414"
      unitRef="Percent">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      id="Fxbrl_20211122102933869">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="2"
      id="Fxbrl_20211122102939725"
      unitRef="Percent">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125949406">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;H.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's long-lived assets are reviewed for impairment in accordance with ASC 360-10 "Accounting for the Impairment or Disposal of Long-Lived Assets" whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. Recoverability of assets (or asset group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years ended December 31, 2022, 2021 and 2020, no impairment losses were recorded.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130002877">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;I.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Research and development costs are expensed as incurred and consist primarily of costs for personnel, subcontractors and consultants (mainly in connection with clinical trials) and materials for research and development and clinical activities. Grants received by the Company from the IIA are recognized at the time the Company is entitled to such grants, on the basis of the costs incurred and applied as a deduction from research and development expenses. Such grants are included as a deduction of research and development costs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130020717">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;J.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Contingent liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for its contingent liabilities in accordance with ASC No. 450, "Contingencies". A provision is recorded when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;With respect to legal matters, provisions are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other information and events pertaining to a particular matter. As of December 31, 2022, and 2021, the Company is not a party to any ligation that could have a material adverse effect on the Company's business, financial position, results of operations or cash flows.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130045079">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;K.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes expense for its share-based compensation based on the fair value of the awards granted. The Company&#x2019;s share-based compensation plans provide for the award of stock options and restricted stock units. In accordance with ASC 718-10 "Compensation-Stock Compensation", the Company estimates the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the Company's consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation expenses for the value of its awards granted based on the graded-vesting method over the requisite service period for each separately vesting portion of the award. Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-09, Compensation-Stock Compensation (Topic 718) allows companies to account for forfeitures when they occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes compensation cost for awards with performance conditions if and when the company concludes that it is probable that the performance conditions will be achieved. ASC 718&#x2019;s use of the term probable is consistent with that term&#x2019;s use in ASC 450, Contingencies, which refers to an event that is likely to occur (ASC Master Glossary). The Company reassess at each reporting period the probability of vesting for awards with performance conditions and adjusts compensation cost based on its probability assessment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company selected the Black-Scholes-Merton option-pricing model as the most appropriate fair value method for its share-based awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying ordinary shares, expected share price volatility and the expected option term. In the years ended December 31, 2022, 2021 and 2020, expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with Staff Accounting Bulletin No. 110, as adequate historical experience is not available to provide a reasonable estimate.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130059523">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;L.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Income taxes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for income taxes in accordance with ASC 740-10 "Accounting for Income Taxes." This Statement requires the use of the liability method of accounting for income taxes, whereby deferred tax assets and liability account balances are determined based on the differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with ASC 740, the Company reflects in the financial statements the benefit of positions taken in a previously filed tax return or expected to be taken in a future tax return only when it is considered 'more-likely-than-not' that the position taken will be sustained by a taxing authority. As of December 31, 2022 and 2021, the Company had no unrecognized income tax positions, and, accordingly, there is no impact on the Company's effective income tax rate associated with these items.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130115207">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;M.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company measures its investments in money market funds (classified as cash equivalents) and its foreign currency net purchased options at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 1. &lt;/span&gt;Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 2&lt;/span&gt;. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&#x2022;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Level 3&lt;/span&gt;. Unobservable inputs for which there is little or no market data requiring the Company to develop its own assumptions.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130138280">
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;N.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Restricted Cash&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;The Company has granted a pledge in favor of Bank Leumi Le-Israel B.M in the amount of $352 and 350 as of &#160;December 31, 2022 and 2021, respectively to secure certain payment obligations of the Company in connection with hedge transactions. This amount was classified as restricted cash balance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220204103001310"
      unitRef="USD">352000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230327201802154"
      unitRef="USD">350000</us-gaap:RestrictedCashCurrent>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130152596">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;O.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company accounts for leases in accordance with ASC 842 "Lesses.&#x201d; Arrangements that are determined to be leases at inception are recognized as long-term operating lease assets and lease liabilities in the consolidated balance sheet at lease commencement. Operating lease liabilities are recognized based on the present value of the future lease payments over the lease term at commencement date. As the Company&#x2019;s leases do not provide an implicit rate, the Company applies its incremental borrowing rate based on the economic environment at the commencement date in determining the present value of future lease payments. Lease terms may include options to extend the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases or payments are recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has also elected the practical expedient to include both lease and non-lease components as a single component and account for it as a lease. Additionally, the Company has made a policy election not to capitalize leases with an original term of 12 months or less.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with ASC 360-10, management reviews operating lease assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable based on estimated future undiscounted cash flows. If so indicated, an impairment loss would be recognized for the difference between the carrying amount of the asset and its fair value.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130207004">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;P.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Recent accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2021, the FASB issued ASU No. 2021- 10, Government Assistance (Topic 832). This ASU requires business entities to disclose information about government assistance they receive if the transactions were accounted for by analogy to either a grant or a contribution &#160;accounting &#160;model. &#160;The disclosure requirements include the nature of the transaction and the related accounting policy used, the line items on the balance sheets and statements of operations that are affected and the amounts applicable to each financial statement line item and the significant terms and conditions of the transactions. The ASU is effective for annual periods beginning after December 15, 2021. The disclosure requirements can be applied either retrospectively or prospectively to all transactions in the scope of the amendments that are reflected in the financial statements at the date of initial application and new transactions that are entered into after the date of initial application. The Company already adopted ASU No. 2021- 10, in its financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324130219815">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:29pt"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Q.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:top;width:auto"&gt;
                          &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reclassification&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, shareholders&#x2019; deficit, net loss or net cash used in operating activities.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318134426817">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 3&#160; -&#160; PREPAID EXPENSES AND OTHER CURRENT ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-weight:bold;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;206&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deposits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324113850184">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Government institutions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;206&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;470&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deposits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;223&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;839&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <chek:GovernmentInstitutionalAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122111256860_33"
      unitRef="USD">88000</chek:GovernmentInstitutionalAssetsCurrent>
    <chek:GovernmentInstitutionalAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122111256860_37"
      unitRef="USD">206000</chek:GovernmentInstitutionalAssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122111256860_43"
      unitRef="USD">260000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122111256860_47"
      unitRef="USD">470000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122111256860_53"
      unitRef="USD">8000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122111256860_57"
      unitRef="USD">13000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122111256860_63"
      unitRef="USD">223000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122111256860_67"
      unitRef="USD">150000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122111256860_73"
      unitRef="USD">579000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122111256860_77"
      unitRef="USD">839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230303041948260">
    &lt;div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 4&#160; -&#160; PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-weight:bold;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;799&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;723&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,915&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers and auxiliary equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;

            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation expenses amounted to $346, $205 and $148 for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324114327481">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office furniture and equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;799&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;723&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Laboratory equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,915&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,721&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Computers and auxiliary equipment&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;540&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,288&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,984&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,191&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,751&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,793&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042931920"
      unitRef="USD">799000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042940323"
      unitRef="USD">723000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042916493"
      unitRef="USD">1915000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapTechnologyEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042951755"
      unitRef="USD">1721000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042911561"
      unitRef="USD">574000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapComputerEquipmentMember"
      decimals="-3"
      id="Fxbrl_20230303042956743"
      unitRef="USD">540000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303042612131"
      unitRef="USD">3288000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303042620142"
      unitRef="USD">2984000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303042429767"
      unitRef="USD">1537000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303042437863"
      unitRef="USD">1191000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230303042324075"
      unitRef="USD">1751000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230303042347481"
      unitRef="USD">1793000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303042112113"
      unitRef="USD">346000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20230303042120726"
      unitRef="USD">205000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20230303042136779"
      unitRef="USD">148000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318135101502">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 5&#160; -&#160; LEASES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 1, 2019, the Company adopted ASU 2016-02, using the modified retrospective approach for all lease arrangements at the beginning period of adoption.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 26, 2021, the Company entered into a new lease agreement, as amended (the &#x201c;Amended Lease Agreement&#x201d;), according to which, effective as of April 1, 2021, the Company leases a total of approximately 1,550 square meters at its facility located in Isfiya, Israel. The Amended Lease Agreement expires on December 31, 2023, and the Company has an option to extend the lease period for an additional three years. The Company has the right to terminate the Amended Lease Agreement at any time, upon at least 60 days prior written notice. Monthly rental expenses under the lease agreement are $16.1. Prior to entering into the Amended Lease Agreement, the Company leased approximately 900 square meters at the same facility under a lease agreement, originally scheduled to expire on May 31, 2022. According to ASC 842, the Amended Lease Agreement was accounted for as a lease modification and, therefore, the lease liability was remeasured as of the modification date with an adjustment recorded to the underlying right of use asset.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(3)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#x201c;Sub-lease Agreement&#x201d;), with a Company supplier (the &#x201c;Lessor&#x201d;) according to which, the Company leases approximately 70 square meters laboratory space for the production of certain components, at the supplier&#x2019;s premises in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on January 31, 2025, and the Company has an option to extend the lease period for an additional two years. The Company has the right to terminate the Sub-lease Agreement at any time, upon at least 90 days prior written notice.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-right:0pt;margin-left:78pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended service agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $26.9. Following the effectiveness of the Sub-lease Agreement, the lease is recorded under ASC 842. As the Sub-lease Agreement is part of a service agreement with the supplier, management is required to evaluate the fair market amount attributed to the lease per month and based on its estimations, the amount allocated to the lease is approximately $2.8 and the portion allocated to monthly services is $24.1.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately 140 square meters offices, The lease agreement expires on February 28, 2024, and the Company has an option to extend the lease period for two additional periods of one year each. Total monthly rental expense under the lease agreement is approximately $1.7. The lease agreement is recorded under ASC 842.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, the Company leases vehicles under various operating lease agreements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 31, 2022, the Company&#x2019;s operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $1,060 and $964, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;margin-left:78pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Supplemental cash flow information related to operating leases was as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:88%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash payments for operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &#160;&lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the Company&#x2019;s operating leases had a weighted average remaining lease term of 3.4 years and a weighted average borrowing rate of 4.4%. Upon adoption of ASC 842, discount rates for existing operating leases were established as of January 1, 2019. Future lease payments under operating leases as of December 31, 2022 were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025 and after&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total future lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,044&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less imputed interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease liability balance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;964&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230304132358476"
      unitRef="Squaremeters">1550</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304132411140">2023-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304132425123">P3Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230304132433773"
      unitRef="USD">16100</us-gaap:LeaseAndRentalExpense>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230304132441183"
      unitRef="Squaremeters">900</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20210101to20210125_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304132449132">2022-05-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230304155709886"
      unitRef="Squaremeters">70</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304155916068">2025-01-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304155752972">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230304155722508"
      unitRef="USD">26900</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseCost
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230304160448438"
      unitRef="USD">2800</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230304160233683"
      unitRef="USD">24100</us-gaap:OperatingLeaseExpense>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230304160535364"
      unitRef="Squaremeters">140</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304160621890">2024-02-28</us-gaap:LeaseExpirationDate1>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230304160548676">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230304160601125"
      unitRef="USD">1700</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230304160826542"
      unitRef="USD">1060000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230304160834192"
      unitRef="USD">964000</us-gaap:OperatingLeaseLiability>
    <chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318135110150">
            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:88%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash payments for operating leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;389&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20211122114553545"
      unitRef="USD">389000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="C_20221231" id="Fxbrl_20230304140659061">P3Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="C_20221231"
      decimals="3"
      id="Fxbrl_20230304140718589"
      unitRef="Percent">0.044</us-gaap:DebtWeightedAverageInterestRate>
    <chek:ScheduleOfFutureLeasePaymentsTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318135119231">
            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Operating&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Leases&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;352&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;282&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2025 and after&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;410&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total future lease payments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,044&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less imputed interest&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:88%;padding-bottom:4px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total lease liability balance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;964&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </chek:ScheduleOfFutureLeasePaymentsTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_33"
      unitRef="USD">352000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_43"
      unitRef="USD">282000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_53"
      unitRef="USD">410000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_63"
      unitRef="USD">1044000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_73"
      unitRef="USD">80000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122114633102_83"
      unitRef="USD">964000</us-gaap:OperatingLeaseLiability>
    <chek:EmployeeRelatedLiabilitiesTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318135318310">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 6&#160; -&#160; EMPLOYEE BENEFITS AND PAYROLL ACCRUALS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;

              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits for vacation and recreation pay&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability for payroll, bonuses and wages&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;732&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,388&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,261&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,961&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Post-employment benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Pursuant to Israel's Severance Pay Law, 1963, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. All of the Company's employees elected to be included under Section 14 of the Severance Pay Law, 1963 ("Section 14"). According to Section 14, employees are entitled only to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments in accordance with Section 14 release the Company from any future severance payments under the Israeli Severance Pay Law, 1963 in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Paid vacation days&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with the Yearly Vacation Law-1951 (the "Vacation Law"), the Company's employees are entitled to a certain number of paid vacation days for each year of employment. In accordance with the Vacation Law and its appendix, and as determined in the agreement between the Company and the employees, the number of vacation days per year to which each employee is entitled is based on the seniority of the employee.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:78pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The employee may use vacation days based on his or her needs and with the Company's consent, and accrue the remainder of unused vacation days, subject to the provision of the Vacation Law. The vacation days utilized first are those credited for the current year and subsequently from any balance transferred from the prior year (on a "LIFO" basis). An employee who ceased working before utilizing the balance of vacation days accrued is entitled to payment for the balance of unutilized vacation days.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Related parties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For information regarding related parties, see Note 16.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </chek:EmployeeRelatedLiabilitiesTextBlock>
    <chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324115006385">
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Short-term employee benefits:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Benefits for vacation and recreation pay&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Liability for payroll, bonuses and wages&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;732&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,388&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,261&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,961&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            </chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122115411339_33"
      unitRef="USD">529000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122115411339_37"
      unitRef="USD">573000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122115411339_43"
      unitRef="USD">732000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122115411339_47"
      unitRef="USD">1388000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122115411339_53"
      unitRef="USD">1261000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122115411339_57"
      unitRef="USD">1961000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318140733171">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 7&#160; -&#160; INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Check-Cap Ltd. is taxed according to Israeli tax laws:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate tax rates in Israel&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:77pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Israeli corporate tax rate in years 2020, 2021, 2022 and onwards is 23%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Law for the Encouragement of Capital Investments, 1959 (the "Investments Law")&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;margin-left:77pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Under the Investments Law, including Amendment No. 60 to the Investments Law as published in April 2005, by virtue of the "Benefited Enterprise" status, the Company is entitled to various tax benefits as follows:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:77pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reduced tax rates&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has one Benefited Enterprise program under the Investments Law, which entitles it to certain tax benefits with respect to income to be derived from the Company's Benefited Enterprise. During the benefits period, taxable income from its Benefited Enterprise program (once generated) will be tax exempt for a period of ten years commencing with the year the Company will first earn taxable income relating to such enterprise. The Company chose 2010 as the year of election (the "Year of Election"). Due to the location of the Company's offices, the Company believes it is entitled to a 10 year benefit period, subject to a 14 year limitation from the Year of Election, and therefore, the tax benefit period will, in any event, end in 2023.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:77pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Conditions for entitlement to the benefits&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:77pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Amendment of the Law for the Encouragement of Capital Investments, 1959&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Investments Law was amended as part of the Economic Policy Law for the years 2011-2012, which was passed by the Israeli Knesset on December 29, 2010 (the "Capital Investments Law Amendment").&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Capital Investments Law Amendment set alternative benefit tracks to those in effect prior to such amendment under the provisions of the Investments Law.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The benefits granted to the Preferred Enterprise will be unlimited in time, unlike the benefits granted to special Benefited Enterprises, which will be limited for a 10 year period. The benefits shall be granted to companies that will qualify under criteria set forth in the Investments Law; for the most part, those criteria are similar to the criteria that were set forth in the Investments Law prior to its amendment.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the transitional provisions of the Investments Law, the Company is entitled to take advantage of the tax benefits available under the Investments Law prior to its amendment until the end of the benefits period, as defined in the Investments Law. The Company was entitled to set the "year of election" no later than tax year 2012, provided that the minimum qualifying investment was made not later than the end of 2010. On each year during the benefits period, the Company will be able to elect that the Investments Amendment applies to the Company, thereby making the tax rates described above available to the Company. An election to have the Capital Investments Amendment apply is irrecoverable. The Company elected not to have the Capital Investments Amendment apply to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:106pt"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 22, 2016, the Knesset approved the 2017-2018 State budget, which includes amendment number 73 to the Investments Law. The amendment includes:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Adoption of a new incentive tax regime that applies to high-tech companies that are deemed a &#x201c;Preferred Technological Enterprise&#x201d; or &#x201c;Special Preferred Technological Enterprise,&#x201d; based on the provisions and rules adopted by the Organization for Economic Cooperation and Development, creating new reduced corporate tax rate tracks of 7.5% for Preferred Technological Enterprises located in Development Area A and 12% for the rest of the country; and a reduced corporate tax rate of 6% for a &#x201c;Special Preferred Technological Enterprise&#x201d; regardless of the company&#x2019;s geographic location within Israel.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reduction of corporate tax rate for all Preferred Enterprises from 9% to 7.5%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Lowering the threshold for the conditions that were previously set in order to enter the track of a "Special Preferred Enterprise" for very large enterprises entitled to a reduced tax rate of 5% in Development Area A or 8% in the rest of the country.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Updating the definitions of preferred income, Preferred Enterprise, etc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:107pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:107pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with the Israeli Income Tax Ordinance [New Version], 1961, as of December 31, 2022, all of the Company&#x2019;s tax assessments through tax year 2017 are considered final.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Check-Cap US, Inc.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Check-Cap US, Inc. is taxed according to U.S. tax laws at a rate of 21%.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Check-Cap US, Inc. operating loss or &#x201c;NOL&#x201d; carry-forwards was $9 as of December 31, 2022 and $7 as of December 31, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Deferred income taxes&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized. Based on the Company's history of losses, the Company established a full valuation allowance on its net-operating loss carryforwards.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carry-forward tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

              &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;D.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reconciliation of the theoretical tax expense to actual tax expense&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The main reconciling item between the statutory tax rate of the Company and the effective rate is the provision of full valuation allowance in respect of tax benefits from carry forward tax losses due to the uncertainty of the realization of such tax benefits (see above).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20200101to20201231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"
      decimals="2"
      id="Fxbrl_20211122122241320"
      unitRef="Percent">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20210101to20211231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"
      decimals="2"
      id="Fxbrl_20211122122240606"
      unitRef="Percent">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"
      decimals="2"
      id="Fxbrl_20211122122236098"
      unitRef="Percent">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember"
      decimals="3"
      id="Fxbrl_20211122122652529"
      unitRef="Percent">0.075</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember"
      decimals="2"
      id="Fxbrl_20211122122812392"
      unitRef="Percent">0.12</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <chek:ReductionInIncomeTaxRate
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapDomesticCountryMember"
      decimals="2"
      id="Fxbrl_20230328162152638"
      unitRef="Percent">0.06</chek:ReductionInIncomeTaxRate>
    <chek:ReductionInIncomeTaxRate
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember"
      decimals="2"
      id="Fxbrl_20220318140037075"
      unitRef="Percent">0.09</chek:ReductionInIncomeTaxRate>
    <chek:ReductionInIncomeTaxRate
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember"
      decimals="3"
      id="Fxbrl_20211122122857615"
      unitRef="Percent">0.075</chek:ReductionInIncomeTaxRate>
    <chek:ReductionInIncomeTaxRate
      contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekDevelopmentAreaAMember"
      decimals="2"
      id="Fxbrl_20211122123027464"
      unitRef="Percent">0.05</chek:ReductionInIncomeTaxRate>
    <chek:ReductionInIncomeTaxRate
      contextRef="C_20161201to20161222_usgaapIncomeTaxAuthorityAxis_chekRestOfCountryMember"
      decimals="2"
      id="Fxbrl_20211122123042461"
      unitRef="Percent">0.08</chek:ReductionInIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_20220101to20221231_usgaapIncomeTaxAuthorityAxis_usgaapForeignCountryMember"
      decimals="2"
      id="Fxbrl_20220204121746373"
      unitRef="Percent">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20221231_deiLegalEntityAxis_chekCheckCapUsIncMember"
      decimals="-3"
      id="Fxbrl_20220318140650322"
      unitRef="USD">9000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_20211231_deiLegalEntityAxis_chekCheckCapUsIncMember"
      decimals="-3"
      id="Fxbrl_20230324120001584"
      unitRef="USD">7000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324120023591">
                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Carry-forward tax losses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less valuation allowance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(24,677&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122123118515"
      unitRef="USD">24232000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122123131030"
      unitRef="USD">24677000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122123222958_xbrl_20211122123118515"
      unitRef="USD">24232000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122123222958_xbrl_20211122123131030"
      unitRef="USD">24677000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122123314296"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122123319762"
      unitRef="USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318142620632">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 8&#160; -&#160; COMMITMENTS AND CONTINGENT LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties provision&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties to an ASIC designer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has a liability to pay royalties for the development of an ASIC component which is used as an amplifier for the capture of signals at low frequencies from X-ray detectors contained in the capsule. The institution that developed the ASIC is entitled to receive royalties from the Company in the amount of 50 &#x20ac; cents (53.3 U.S. cents) for every ASIC component that the Company will sell, capped at &#x20ac;200 (approximately $213). This royalty is considered as a liability.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;margin-left:78pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The royalty liability is calculated based on estimated future sales generated by products which include the ASIC component. As of December 31, 2022, the Company believes that it will be required to pay the above mentioned royalties, and accordingly, recorded, as of December 31, 2022, a provision in a total amount of $94.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Reimbursement liability to Predecessor Entity's unit holders&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 31, 2009, the Company entered into an asset transfer agreement with Check Cap LLC (the "Predecessor Entity"), a company with the same shareholders as the Company at the time of transfer. According to the agreement, the Predecessor Entity transferred all of its business operations and substantially all of its assets to the Company, including development and consulting agreements, cash, property and equipment and intangible ownership rights, free of any debt.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;margin-left:78pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As a part of the reorganization, the Company committed to reimburse the unit holders of the Predecessor Entity for any tax burdens that may be imposed on them due to the reorganization. The reimbursement liability is calculated assuming deemed royalties are paid to the U.S. unit holders of Check-Cap LLC under Section 367(d) of the Code, and is based in part on the Company&#x2019;s forecasted sales with a cap calculated as the fair value of the share as determined at the date of the financial statements. The reimbursement liability is calculated by multiplying the estimated tax rate by the lowest of: (1) expected cash outflows for a period of 15 years ending December 31, 2023, discounted using a discount factor commensurate with the risk of the Company, and (2) value of the shares held by U.S. unit holders of the Predecessor Entity as of December 31, 2022 multiplied by $2.2, the last reported price per share of the Company&#x2019;s ordinary shares on the Nasdaq Capital Market on December 31, 2022. Any updates in the contingent liability will be charged to earnings. Since the Company does not expect to be profitable in year 2023, the liability based on the discounted outflows is $0. As a result, as of December 31, 2022 and 2021, the balance of the reimbursement liability totaled $0.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;text-indent:22pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&#160;0&#160;2&#160;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties to an ASIC designer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;

          &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
          &lt;div/&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Commitments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:78pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's research and development efforts are financed, in part, through funding from the IIA and the BIRD Foundation. Since the Company's inception through December 31, 2022, the Company received funding from the IIA and the BIRD Foundation in the total amount of approximately $5,600 and $114, respectively. In year 2021, the Company received grant approval from the IIA to support the funding of the Company&#x2019;s transition from research and development to manufacturing. The final grant amounted to $620, of which approximately $349 was received in year 2021, $82 was received in January 2022 and $222 was received in February 2023. The grants received under this plan are not subject to future royalties.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:78pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;According to the terms of applicable law as currently in effect regarding the grants received before year 2021, the IIA is entitled to royalties equal to 3-4% (or at an increased rate under certain circumstances) of the revenues from sales of products and services based on technology developed using IIA grants, up to the full principal amount (which may be increased under certain circumstances) of the U.S. Dollar-linked value of the grants, plus interest at the rate of 12-month LIBOR. The obligation to pay these royalties is contingent on actual sales of the applicable products and services and in the absence of such sales, no payment is required. As of December 31, 2022, the Company had not paid any royalties to the IIA and had a contingent liability to the IIA in the amount of approximately $6,199.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;margin-left:77pt"&gt;&#160;&lt;/div&gt;
          &lt;div style="text-align:justify;margin-left:78pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On July 13, 2014, the Company entered into a Cooperation and Project Funding Agreement with the BIRD Foundation and Synergy and during 2014-2017, the Company, together with Synergy, had received funding from the BIRD Foundation in the aggregate amount of approximately $127. Based on the aggregate expenses that the Company incurred for such project, it refunded to the BIRD Foundation an amount of approximately $13. The Company will not be receiving additional funding from the BIRD Foundation for the project, which is no longer active. As of December 31, 2022, the Company had not paid any royalties to the BIRD Foundation and had a contingent obligation to the BIRD foundation in the amount of approximately $209.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Rental agreements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 26, 2021, the Company entered into the Amended Lease Agreement according to which, effective as of April 1, 2021, it leases approximately 1,550 square meters at the facility located in Isfiya, Israel. The Amended Lease Agreement expires on December 31, 2023, and the Company has an option to extend the lease period for an additional three years. The Company has the right to terminate the agreement at any time, upon at least 60 days prior written notice.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="text-align:justify;text-indent:18pt;margin-left:72pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin:0px 0px 0px 107pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Monthly rental expenses under the Amended Lease Agreement are $14.2. See also Note 5.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 30, 2021, the Company entered into a Sub-lease Agreement (the &#x201c;Sub-lease Agreement&#x201d;), with a Company supplier (the &#x201c;Lessor&#x201d;) according to which, the Company leases approximately 70 square meters laboratory space for the production of certain components in Petach Tikva, Israel. The Sub-lease Agreement entered into effect on September 21, 2022, after receipt of certain permits including a business license from Petach Tikva municipality. The Sub-lease Agreement expires on January 31, 2025, and the Company has an option to extend the lease period for an additional two years. The Company has the right to terminate the agreement at any time, upon at least 90 days prior written notice. The Lessor has the right to terminate the Sub-lease Agreement, upon at least 12 months prior written notice. The Sub Lease Agreement is part of an amended agreement with the supplier for certain additional services. Total monthly rental expenses under the Sub-lease Agreement and the payment for other services is $26.9.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/p&gt;
          &lt;div/&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 1, 2022, the Company entered into a lease agreement of certain offices in Petach Tikva Israel, according to which, the Company leases approximately 140 square meters offices, The lease agreement expires on February 28, 2024, and the Company has an option to extend the lease period for two additional periods of one year each. Total monthly rental expense under the lease agreement is approximately $1.7. .&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:77pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vehicle lease and maintenance agreements&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="margin:0px 0px 0px 106pt;line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company entered into several 36 months lease and maintenance agreements for vehicles, which are regularly amended as new vehicles are leased. The current monthly lease fees are approximately $13.7. See also Note 5.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company issued purchase orders to certain suppliers in order to secure strategic inventory of key components that as of December 31, 2022 have not yet been supplied.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Legal&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of the date of the financial statements, the Company is not a party to any pending litigation.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <chek:RoyaltiesPayablePerUnitSold
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="0"
      id="Fxbrl_20230303125601175"
      unitRef="USD_Per_Euro">50</chek:RoyaltiesPayablePerUnitSold>
    <chek:RoyaltiesPayablePerUnitSold
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="1"
      id="Fxbrl_20230324231014545"
      unitRef="US_cents_Per_unit">53.3</chek:RoyaltiesPayablePerUnitSold>
    <chek:MaximumRoyaltyObligation
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="-3"
      id="Fxbrl_20230303125625894"
      unitRef="Euro">200000</chek:MaximumRoyaltyObligation>
    <chek:MaximumRoyaltyObligation
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="-3"
      id="Fxbrl_20230303125635366"
      unitRef="USD">213000</chek:MaximumRoyaltyObligation>
    <chek:RoyaltiesProvision
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="-3"
      id="Fxbrl_20230303125702678"
      unitRef="USD">94000</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20211231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember"
      decimals="-3"
      id="Fxbrl_20230304213706931"
      unitRef="USD">0</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekPredecessorUnitHoldersMember"
      decimals="-3"
      id="Fxbrl_20230303130051073"
      unitRef="USD">0</chek:RoyaltiesProvision>
    <us-gaap:OtherCommitmentsTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318142631222">
            &lt;div&gt;
              &lt;div style="margin-left:78pt"&gt;
                &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;text-indent:22pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:#000000 solid 2px;vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-weight:bold;line-height:1.25;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&#160;0&#160;2&#160;2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:76%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Royalties to an ASIC designer&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr&gt;
                      &lt;td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                        &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;132&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          </us-gaap:OtherCommitmentsTableTextBlock>
    <chek:RoyaltiesProvision
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="-3"
      id="Fxbrl_20211122192727517_33"
      unitRef="USD">94000</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20211231_usgaapOtherCommitmentsAxis_chekDesignerRoyaltiesMember"
      decimals="-3"
      id="Fxbrl_20211122192727517_37"
      unitRef="USD">132000</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20211122192727517_53"
      unitRef="USD">94000</chek:RoyaltiesProvision>
    <chek:RoyaltiesProvision
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20211122192727517_57"
      unitRef="USD">132000</chek:RoyaltiesProvision>
    <chek:GrantedRevenue
      contextRef="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"
      decimals="-3"
      id="Fxbrl_20230303130424349"
      unitRef="USD">5600000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20220101to20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"
      decimals="-3"
      id="Fxbrl_20230303130437477"
      unitRef="USD">114000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"
      decimals="-3"
      id="Fxbrl_20230303131255141"
      unitRef="USD">620000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20210101to20211231_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"
      decimals="-3"
      id="Fxbrl_20230303130457366"
      unitRef="USD">349000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20220101to20220131_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"
      decimals="-3"
      id="Fxbrl_20230303130523298"
      unitRef="USD">82000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20230201to20230223_usgaapOtherCommitmentsAxis_chekManufacturingProgramMember"
      decimals="-3"
      id="Fxbrl_20230303131341021"
      unitRef="USD">222000</chek:GrantedRevenue>
    <chek:RoyaltiesPayablePercentageOfProductSales
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"
      decimals="2"
      id="Fxbrl_20230303131451718"
      unitRef="Percent">0.03</chek:RoyaltiesPayablePercentageOfProductSales>
    <chek:RoyaltiesPayablePercentageOfProductSales
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"
      decimals="2"
      id="Fxbrl_20230303131502151"
      unitRef="Percent">0.04</chek:RoyaltiesPayablePercentageOfProductSales>
    <chek:ContingentLiability
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekIsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember"
      decimals="-3"
      id="Fxbrl_20230303131519358"
      unitRef="USD">6199000</chek:ContingentLiability>
    <chek:MaximumRoyaltyObligation
      contextRef="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"
      decimals="-3"
      id="Fxbrl_20230303131658340"
      unitRef="USD">127000</chek:MaximumRoyaltyObligation>
    <chek:RefundExpenses
      contextRef="C_20140713_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"
      decimals="-3"
      id="Fxbrl_20230303131712431"
      unitRef="USD">13000</chek:RefundExpenses>
    <chek:ContingentLiability
      contextRef="C_20221231_usgaapOtherCommitmentsAxis_chekBinationalIndustrialResearchAndDevelopmentFoundationMember"
      decimals="-3"
      id="Fxbrl_20230303131736830"
      unitRef="USD">209000</chek:ContingentLiability>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230303132047038"
      unitRef="Squaremeters">1550</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230303132119508">2023-12-31</us-gaap:LeaseExpirationDate1>
    <chek:LesseeOperatingLeaseAdditionalTerm
      contextRef="C_20210101to20210126_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230305013713959">P3Y</chek:LesseeOperatingLeaseAdditionalTerm>
    <chek:OperatingLeaseRentExpenseMonthly
      contextRef="C_20220101to20221231_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20220204020137808"
      unitRef="USD">14200</chek:OperatingLeaseRentExpenseMonthly>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230303133133621"
      unitRef="Squaremeters">70</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230303133155444">2025-01-31</us-gaap:LeaseExpirationDate1>
    <chek:LesseeOperatingLeaseAdditionalTerm
      contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230303133212039">P2Y</chek:LesseeOperatingLeaseAdditionalTerm>
    <chek:OperatingLeaseRentExpenseMonthly
      contextRef="C_20211201to20211230_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230303133234812"
      unitRef="USD">26900</chek:OperatingLeaseRentExpenseMonthly>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="0"
      id="Fxbrl_20230304195943361"
      unitRef="Squaremeters">140</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230303135553595">2024-02-28</us-gaap:LeaseExpirationDate1>
    <chek:LesseeOperatingLeaseAdditionalTerm
      contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      id="Fxbrl_20230303135605430">P1Y</chek:LesseeOperatingLeaseAdditionalTerm>
    <chek:OperatingLeaseRentExpenseMonthly
      contextRef="C_20220202to20220301_srtStatementGeographicalAxis_countryIL_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapLeaseholdsAndLeaseholdImprovementsMember"
      decimals="-2"
      id="Fxbrl_20230303135615013"
      unitRef="USD">1700</chek:OperatingLeaseRentExpenseMonthly>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember"
      id="Fxbrl_20230303140128537">P36M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <chek:MonthlyVehicleLeaseExpense
      contextRef="C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember"
      decimals="-2"
      id="Fxbrl_20230303140147513"
      unitRef="USD">13700</chek:MonthlyVehicleLeaseExpense>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318143124445">
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 9&#160; -&#160; FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In accordance with ASC No. 820, the Company measures its money market funds and foreign currency derivative contracts at fair value. Money market funds are classified within Level 1. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;margin-left:49pt"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;margin-left:54pt"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements using input type&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency derivative instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financial assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements using input type&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency derivative instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financial assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324124144953">
                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" rowspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements using input type&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current liabilities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency derivative instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financial assets (liabilities)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(56&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(53.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value measurements using input type&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Money market funds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other current assets:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Foreign currency derivative instruments&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financial assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,160&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,225&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-2"
      id="Fxbrl_20211124093302962"
      unitRef="USD">2500</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-2"
      id="Fxbrl_20211124093320293"
      unitRef="USD">2500</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20230303044122846"
      unitRef="USD">0</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20230304191528089"
      unitRef="USD">56000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093337142"
      unitRef="USD">56000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-2"
      id="Fxbrl_20211124093423085"
      unitRef="USD">2500</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_20221231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20230304191856646"
      unitRef="USD">-56000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-2"
      id="Fxbrl_20211124093458697"
      unitRef="USD">-53500</us-gaap:FairValueNetAssetLiability>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516658_xbrl_20211124093302962"
      unitRef="USD">2160000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue
      contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516658_xbrl_20211124093320293"
      unitRef="USD">2160000</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516665_xbrl_20211124093405438"
      unitRef="USD">65000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516665_xbrl_20211124093337142"
      unitRef="USD">65000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel1Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516671_xbrl_20211124093423085"
      unitRef="USD">2160000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20211231_usgaapFairValueByFairValueHierarchyLevelAxis_usgaapFairValueInputsLevel2Member_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516671_xbrl_20211124093444574"
      unitRef="USD">65000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_20211231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fxbrl_20211124093516671_xbrl_20211124093458697"
      unitRef="USD">2225000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318150316478">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;NOTE 10 - SHAREHOLDERS' EQUITY&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;A&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Effective November 23, 2022, the Company's Board of Directors effected a Reverse Share Split of 1-for-20 (i.e., 20 ordinary shares were combined into one ordinary share). Share and per share amounts in the financial statements, prior to November 23, 2022, have been adjusted to reflect the Reverse Share Split.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The ordinary shares provide their holder with rights to receive dividends in cash and shares, and rights to participate at the time of distributing liquidation dividends. Additionally, the ordinary shareholders have the right to vote at shareholder meetings in a manner that each share provides one voting right to its holder.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;&#160;&lt;/td&gt;
                  &lt;/tr&gt;
                  &lt;tr&gt;
                    &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;Changes in ordinary share capital&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:47.25pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;a)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On May 11, 2010, the Company issued, free of charge, to all of its shareholders (except for certain ordinary shareholders), warrants to purchase an aggregate of 1,609 ordinary shares (hereafter- "Anti-dilution Warrants"). The Anti-dilution Warrants were issued in order to prevent the dilution of the holdings of such Company shareholders due to certain options granted to the then Company's CEO ("CEO options"). The Anti-dilution Warrants were subject to automatic exercise, without consideration (unless the holder thereof objected to such exercise), upon the exercise by the Company's CEO of the CEO Options. The fair value of the Anti-dilution Warrants on the grant date was immaterial. Anti-dilution warrants to purchase 37 and 387 ordinary shares were exercised during the years ended December 31, 2019 and 2018, respectively. The remaining Anti-dilution Warrants to purchase 326 ordinary shares expired on May 11, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;b)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On February 24, 2015, the Company consummated an IPO in the U.S. of 8,334 units at a public offering price of $1,440 per unit, before underwriting discounts and offering expenses. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $1,800. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $1,656. The Series A Warrants expired on February 24, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company granted the underwriters a 45-day over-allotment option to purchase up to 1,250 additional units (together with an accompanying 1,875 Long Term Incentive Warrants). The option to purchase additional 417 units was partially exercised on March 6, 2015. The units were separated into one ordinary share and one-half of a Series A Warrant to purchase one ordinary share on March 18, 2015, and the units ceased to exist as of such date. On April 6, 2015, the option to purchase an additional 625 ordinary shares and 313 Series A Warrants was partially exercised. The Company received net proceeds from the IPO and partial exercise of the over-allotment option of approximately $10,800 (net of issuance cost of approximately $2,900, including certain warrants with a value of $196 issued in connection with the IPO).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;c)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Immediately prior to the consummation of the IPO, certain members of the Company's management exercised options to purchase 1,282 ordinary shares granted to them under the 2006 Unit Option Plan.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;d)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On August 20, 2014, the Company entered into a certain credit line agreement, pursuant to which it obtained a credit line in an aggregate principal amount of $12,000 from certain lenders and existing shareholders (the "Lenders"). The credit line amount was deposited in an escrow account at the closing, which was consummated on October 14, 2014. The Company issued to each Lender at closing a warrant (collectively, the "Credit Line Warrants"), to purchase a number of the Company's ordinary shares constituting 2% of its share capital on a fully diluted basis (assuming conversion of all of the Company's convertible securities into ordinary shares at a 1:1 conversion rate) as of the closing for each $1,000 (or portion thereof) extended by such Lender. The Company issued Credit Line Warrants ("CLA Warrants") to purchase in the aggregate 11,078 of its ordinary shares. The CLA Warrants are exercisable for a period of ten years at an exercise price of NIS 48 per share, and may be exercised on a net issuance basis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Under the terms of the credit line agreement, the Company directed that the entire credit line amount (that was in escrow) be invested in the Private Placement, consummated simultaneously with the consummation of the IPO on February 24, 2015. The Company issued to the Lenders 8,334 units at a price of $1,440 per unit, before issuance cost. Each unit consisted of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share. Each unit was issued with one and one-half non-transferrable Long Term Incentive Warrants. Each whole Series A Warrant entitled the holder to purchase one ordinary share at an exercise price of $1,800. Upon vesting, each Long Term Incentive Warrant entitles the holder to purchase one ordinary share at an exercise price of $1,656. The Company received net proceeds from the Private Placement of approximately $10,900 (net of issuance cost of approximately $1,200, including certain warrants with a value of $125 issued in connection with the Private Placement). The Series A Warrants expired on February 24, 2020. As of December 31, 2021, Long Term Incentive Warrants to purchase 18,903 ordinary shares were outstanding. The Long Term Incentive Warrants expired on February 24, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;e)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;No CLA Warrants were exercised during the years ended December 31, 2022, 2021 and 2020. As of December 31, 2022, CLA Warrants to purchase 370 ordinary shares were outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);border:0px"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;f)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On October 14, 2014, the Company issued warrants to purchase an aggregate 924 ordinary shares (the &#x201c;Pontifax Warrants&#x201d;) to the Pontifax Funds in consideration of their commitment to provide to the Company, for no consideration, certain business development and chairman services. As of December 31, 2021, Pontifax Warrants to purchase 462 ordinary shares, with an exercise price of $1,214.4 per share, were outstanding. These warrants expired on October 14, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;g)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Upon the closing of the IPO, the Company issued warrants to purchase 417 ordinary shares at an exercise price of $1,800 to the IPO lead underwriter and warrants to purchase 63 ordinary shares at an exercise price of $1,214.4 to the Company's U.S. legal counsel. These warrants expired on February 24, 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;h)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On August 11, 2016, the Company consummated a registered direct offering of 2,682 ordinary shares at a price of $456 per share and pre-funded warrants to purchase 10,477 ordinary shares at a purchase price of $444 per pre-funded warrant. The pre-funded warrants have an exercise price of $12 per share, subject to certain adjustments and will expire on August 11, 2023, unless otherwise extended in accordance with the terms of the pre-funded warrants. The Company received gross proceeds from the August registered direct offering of approximately $5,900 (including proceeds from the exercise of 2,396 pre-funded warrants at the closing of the offering). On January 23, 2017, the remaining pre-funded warrants to purchase 1,209 ordinary shares were exercised, for additional proceeds of approximately $14.5.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;i)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On June 2, 2017, the Company consummated a registered direct offering of 5,623 ordinary shares at a price of $480 per share and a simultaneous private placement of one-year warrants to purchase 5,623 ordinary shares at an exercise price of $510 per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $2,690. On June 2, 2018, all of the warrants issued to investors in this offering expired. As of December 31, 2021, warrants to purchase 282 ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;These placement agent warrants expired on June 2, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
            &lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;j)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On November 22, 2017, the Company consummated a registered direct offering of &lt;/span&gt;9,470&lt;span&gt; ordinary shares at a price of $&lt;/span&gt;264&lt;span&gt; per share and a simultaneous private placement of five-year warrants to purchase &lt;/span&gt;7,103&lt;span&gt; ordinary shares at an exercise price of $&lt;/span&gt;300&lt;span&gt; per share immediately exercisable. The Company received gross proceeds from this registered direct offering of approximately $&lt;/span&gt;2,500&lt;span&gt;. On April 25, 2018, &lt;/span&gt;2,841&lt;span&gt; of these warrants were cashless exercised into &lt;/span&gt;679&lt;span&gt; ordinary shares.&lt;/span&gt;&lt;span style="font-weight:bold"&gt; &lt;/span&gt;&lt;span&gt; On July 27&lt;/span&gt;&lt;span&gt;,&#160;&lt;/span&gt;&lt;span&gt;2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), all of the &lt;/span&gt;4,262&lt;span&gt; warrants that were outstanding as of that date&#160;were exercised into ordinary shares. As of December 31, 2021, warrants to purchase &lt;/span&gt;474&lt;span&gt; ordinary shares issued to the placement agent in connection with the offering were outstanding.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;These placement agent warrants expired on November 22, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;k)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On May 8, 2018, the Company consummated an underwritten public offering (the &#x201c;2018 Public Offering&#x201d;) of 136,924 units (the &#x201c;2018 Units&#x201d;), at a public offering price of $110 per unit, and 22,546 pre-funded units (the &#x201c;2018 Pre-funded Units&#x201d;), at a public offering price of $109.8 per 2018 Pre-funded Unit. Each 2018 Unit consisted of one ordinary share of the Company and one Series C warrant to purchase one ordinary share of the Company. Each 2018 Pre-funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series C Warrant to purchase one ordinary share. The exercise price of each pre-funded warrant included in the 2018 Pre-funded Unit was $0.2 per share. The Series C warrants have an exercise price of $110 per share, are exercisable immediately and will expire five years from the date of issuance.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company granted the underwriters a 30-day over-allotment option to purchase up to an additional 23,921 ordinary shares and/or Series C Warrants to purchase up to an additional 23,921 ordinary shares at the public offering price. The underwriters&#x2019; option was exercised in full on May 8, 2018.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The Company received gross proceeds from the 2018 Public Offering and exercise in full of the over-allotment option of approximately $20,200 (before deducting underwriting discounts and commissions and other offering fees and expenses). During May 2018, the 22,546 pre-funded warrants were exercised in full in consideration of additional gross proceeds of approximately $4,500. As of December 31, 2022, Series C Warrants to purchase 183,390 ordinary shares were outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;l)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On February 6, 2019, the Company issued 94,075 units, (the &#x201c;2019 Units&#x201d;) at a purchase price of $51.6 per unit, and 1,024,876 pre-funded units (the &#x201c;2019 Pre-funded Units&#x201d;), at a purchase price of $51.4 per 2019 Pre-Funded Unit, in a registered direct offering (the &#x201c;2019 Registered Direct Offering&#x201d;). Each unit consisted of one ordinary share of the Company and one Series D Warrant to purchase 0.5 ordinary share of the Company. Each 2019 Pre-Funded Unit consisted of one pre-funded warrant to purchase one ordinary share and one Series D Warrant to purchase 0.5 ordinary share. The exercise price of each pre-funded warrant included in the 2019 Pre-Funded Unit was $0.2 per share. The Series D Warrants have an exercise price of $51.6 per ordinary share and are immediately exercisable and will expire on the fifth anniversary of the original issuance date. The Company also issued placement agent warrants to purchase up to an aggregate of 10,173 ordinary shares, on the same terms as the warrants issued to the investors, except they have an exercise price of $64.5 per share. The Company received gross proceeds from the February 2019 Registered Direct Offering of approximately $7,500 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial"&gt;(including proceeds from the exercise of&#160;&lt;/span&gt;&lt;span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;51,244&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman, Times, serif;font-size:13.3333px;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial"&gt;pre-funded warrants), or approximately $6,500, net of issuance expenses in the amount of&lt;/span&gt;&lt;span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;&#160;$987.&#160; On July 27&lt;/span&gt;&lt;sup style="color:#000000;font-family:Times New Roman, Times, serif;font-style:normal;font-variant-ligatures:normal;font-weight:400;text-align:justify;white-space:normal;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;vertical-align:text-top;line-height:1;font-size:smaller"&gt;,&#160;&lt;/sup&gt;&lt;span style="text-align:justify;color:rgb(0, 0, 0);font-style:normal;font-weight:400"&gt;2020, as part of the Warrants Exercise Transaction (see Note 10B(2)(n)), warrants to purchase 48,450 ordinary shares were exercised for ordinary shares and warrants. As of December 31, 2022, warrants to purchase 24,210 ordinary shares held by certain investors and warrants to purchase 10,173 ordinary shares held by the placement agent were outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;m)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On December 19, 2019, the Company entered into definitive agreements with certain investors to sell an aggregate of 136,009 ordinary shares at a purchase price of $35 per share in a private placement, resulting in gross proceeds of approximately $4,760. The closing of the transaction occurred in February 2020.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;n)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;April &#x2013; May 2020 registered direct offerings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On April 22, 2020, May 4, 2020 and May 13, 2020, the Company issued 333,334, 375,001 and 250,000 ordinary shares, respectively, in registered direct offerings (the &#x201c;April-May 2020 Registered Direct Offering&#x201d;) at a purchase price of $12 per share and issued to the investors unregistered warrants to purchase an aggregate of 333,334, 375,001 and 250,000 ordinary shares, respectively, in a private placement. The warrants are immediately exercisable &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;at an exercise price of $16 per ordinary share, subject to certain adjustments,&#160;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;and will expire five and one-half years from the issuance date. The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued unregistered placement agent warrants to purchase up to an aggregate of 23,334, 26,250 and 17,500 ordinary shares, respectively, on the same terms as the warrants issued to the investors in the private placement, except they have a term of five years and an exercise price of $15 per share. The Company received gross proceeds from the April-May 2020 Registered Direct Offerings of approximately $11,500, or approximately $10,139, net of issuance expenses in the amount of $1,361.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:106pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On July 27, 2020, as part of the Warrants Exercise Transaction, warrants to purchase an aggregate 750,001 ordinary shares were exercised. During the first quarter of 2021, warrants to purchase 208,334 ordinary shares held by certain investors and warrants to purchase 67,084 ordinary shares held by the placement agent warrants were exercised into ordinary shares (see Note 10B(2)(n)).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;o)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On July 23, 2020, the Company entered into a warrant exercise agreement, (the &#x201c;Warrants Exercise Transaction&#x201d;), with several existing institutional investors who are the holders (the &#x201c;Holders&#x201d;) of warrants issued in May 2020, April 2020, February 2019 and November 2017 (the &#x201c;Old Warrants&#x201d;), to purchase ordinary shares, pursuant to which the Holders agreed to exercise in cash their Old Warrants to purchase up to an aggregate of 802,712 ordinary shares having exercise prices ranging from $300.00 to $16 per share issued by the Company, at a reduced exercise price of $12&#160;per share, resulting in gross proceeds to the Company of approximately $9,632 or approximately $8,712, net of issuance expenses in the amount of approximately $920. Closing occurred on July 27, 2020. Under the Warrants Exercise Transaction agreement, the Company also issued to the Holders new unregistered warrants to purchase up to 963,254 ordinary shares, (the &#x201c;Private Placement Warrants&#x201d;). The Private Placement Warrants are immediately exercisable, expire five and one-half years from issuance date and have an exercise price of $16 per share, subject to certain adjustment. The Private Placement Warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. In addition, the Company issued unregistered placement agent warrants to purchase up to an aggregate of 56,190 ordinary shares on the same terms as the warrants issued to the Holders, except that they have an exercise price of $15 per share. During the first quarter of 2021, an aggregate of 878,628 warrants held by certain investors and 56,190 warrants held by the placement agent, were exercised into ordinary shares. As of December 31, 2022&#160;and 2021, warrants to purchase 84,626 ordinary shares held by certain investors, were outstanding.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div/&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:79pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;p)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;During the first quarter of 2021, as a result of an exercise of warrants by the investors from the Warrants Exercise Transaction and the April-May 2020 Offerings, the Company issued an aggregate of 1,210,235 ordinary shares, at exercise prices ranging from $15-$16 per share, for total gross proceeds of approximately $19,240 to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;q)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On June 30, 2021, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of 1,296,297 of the Company's ordinary shares and accompanying short-term warrants to purchase up to an aggregate of 1,296,297 of the Company's ordinary shares in a registered direct offering (the &#x201c;June 2021 Registered Direct Offering&#x201d;). The June 2021 Registered Direct Offering was consummated on July 2, 2021. The warrants are immediately exercisable at an exercise price of $30 per ordinary share, subject to certain adjustments, and will expire three and one-half years from the issuance date.&#160;The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of 64,815 ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $33.75 per share. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to 5.0% of the number of ordinary shares issued upon the cash exercise of the warrants (up to 64,815 warrants). As of December 31, 2022 and 2021, warrants to purchase 1,296,297 ordinary shares held by certain investors and 64,815 warrants held by the placement agent, were outstanding. The Company received gross proceeds from the June 2021 Registered Direct Offering of approximately $35,000, or approximately $31,801, net of issuance expenses in the amount of $3,199. (See Note 17(2) regarding change of exercise price and term of exercise of date of 926,297 warrants).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:78pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:28pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;r)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;On March 1, 2022, the Company entered into a definitive agreement with several institutional and accredited investors for the purchase and sale of 1,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to an aggregate of 750,000 of the Company's ordinary shares in a registered direct offering (the &#x201c;March 2022 Registered Direct Offering&#x201d;). The March 2022 Registered Direct Offering was consummated on March 3, 2022. The warrants are immediately exercisable at an exercise price of $13 per share, subject to certain adjustments,&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;and will expire five years from the issuance date.&#160;&lt;/span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The warrants may be exercised on a cashless basis if at the time of exercise thereof, there is no effective registration statement registering the ordinary shares underlying the warrants. The terms of the warrants did not include features that would preclude equity classification. The Company also issued registered placement agent warrants to purchase up to an aggregate of 50,000 ordinary shares, substantially on the same terms as the warrants issued to the investors in the private placement, except they have an exercise price of $12.5 per share and expiration date is March 1, 2027. Upon any exercise of the warrants for cash, the Company agreed to pay the placement agent warrants to purchase up to 5.0% of the number of ordinary shares issued upon the cash exercise of the warrants (up to 37,500 warrants). Simultaneously with this offering, the Company has entered into a warrant amendment agreement, or the Warrant Amendment Agreement, with the investors in this March 2022 Registered Direct Offering. Pursuant to the Warrant Amendment Agreement, certain warrants to purchase up to an aggregate of 926,297 ordinary shares of the Company that were issued to the investors in July 2021 were amended to have a reduced exercise price of $13 per share and the term of exercise was extended to January 2, 2025. The Company received gross proceeds from the March 2022 Registered Direct Offering of $10,000, or approximately $8,850, net of issuance expenses in the amount of approximately $1,150.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_20221123to20221123"
      id="Fxbrl_20230304164957895">1-for-20</us-gaap:StockholdersEquityReverseStockSplit>
    <chek:WarrantsIssued
      contextRef="C_20100501to20100511_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124094323826"
      unitRef="shares">1609</chek:WarrantsIssued>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20190101to20191231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124094416032"
      unitRef="shares">37</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20180101to20181231_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124094508471"
      unitRef="shares">387</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_20200501to20200511_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekAntiDilutiveWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124094532066"
      unitRef="shares">326</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124094641298"
      unitRef="shares">8334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="0"
      id="Fxbrl_20211124094804955"
      unitRef="Usd_per_share">1440</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20211124095429429"
      unitRef="Usd_per_share">1800</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember"
      decimals="0"
      id="Fxbrl_20211124095138755"
      unitRef="Usd_per_share">1656</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      id="Fxbrl_20211124095535508">2020-02-24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <chek:UnitsPurchased
      contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"
      decimals="INF"
      id="Fxbrl_20211124095650607"
      unitRef="shares">1250</chek:UnitsPurchased>
    <chek:WarrantsIssued
      contextRef="C_20150201to20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"
      decimals="INF"
      id="Fxbrl_20211124095812364"
      unitRef="shares">1875</chek:WarrantsIssued>
    <chek:WarrantsIssued
      contextRef="C_20150301to20150306_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124101201799"
      unitRef="shares">417</chek:WarrantsIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20150401to20150406_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"
      decimals="INF"
      id="Fxbrl_20220204193323740"
      unitRef="shares">625</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <chek:StockIssuedDuringPeriodSharesWarrantsPartiallyExercised
      contextRef="C_20150401to20150406_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapOverAllotmentOptionMember"
      decimals="INF"
      id="Fxbrl_20211124101333474"
      unitRef="shares">313</chek:StockIssuedDuringPeriodSharesWarrantsPartiallyExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="-3"
      id="Fxbrl_20211124101510980"
      unitRef="USD">10800000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="-3"
      id="Fxbrl_20211124101654428"
      unitRef="USD">2900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <chek:FairValueOfWarrantsIssued
      contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="-3"
      id="Fxbrl_20211124101745433"
      unitRef="USD">196000</chek:FairValueOfWarrantsIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124101834470"
      unitRef="shares">1282</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="-3"
      id="Fxbrl_20211124102153309"
      unitRef="USD">12000000</us-gaap:DebtInstrumentFaceAmount>
    <chek:PercentageOfSharesFullyDiluted
      contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="2"
      id="Fxbrl_20211124103616710"
      unitRef="Percent">0.02</chek:PercentageOfSharesFullyDiluted>
    <chek:AmountOfPortionOfOrdinarySharesOfSuchLender
      contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="-3"
      id="Fxbrl_20211124103659011"
      unitRef="USD">1000000</chek:AmountOfPortionOfOrdinarySharesOfSuchLender>
    <chek:WarrantsIssued
      contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124102444128"
      unitRef="shares">11078</chek:WarrantsIssued>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20140801to20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      id="Fxbrl_20220110192914574">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20140820_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="0"
      id="Fxbrl_20220319002514196"
      unitRef="NIS_Per_Share">48</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_20150201to20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20220204024348217"
      unitRef="shares">8334</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="C_20150224_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="0"
      id="Fxbrl_20220318145627566"
      unitRef="Usd_per_share">1440</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20211124105747562"
      unitRef="Usd_per_share">1800</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20150224_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember"
      decimals="0"
      id="Fxbrl_20220204024414745"
      unitRef="Usd_per_share">1656</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20220204024422784"
      unitRef="USD">10900000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20220204024430984"
      unitRef="USD">1200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_20140801to20140820_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="-3"
      id="Fxbrl_20220204024440096"
      unitRef="USD">125000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekLongTermIncentiveWarrantsMember"
      decimals="INF"
      id="Fxbrl_20220204024448385"
      unitRef="shares">18903</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekCreditLineAgreementWarrantsMember"
      decimals="INF"
      id="Fxbrl_20230324202950754"
      unitRef="shares">370</us-gaap:ClassOfWarrantOrRightOutstanding>
    <chek:WarrantsIssued
      contextRef="C_20141001to20141014_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"
      decimals="INF"
      id="Fxbrl_20230324232851708"
      unitRef="shares">924</chek:WarrantsIssued>
    <chek:WarrantsIssued
      contextRef="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"
      decimals="INF"
      id="Fxbrl_20230324233006688"
      unitRef="shares">462</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPontifaxMember"
      decimals="1"
      id="Fxbrl_20230324233147669"
      unitRef="Usd_per_share">1214.4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssued
      contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekUnderwriterWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124105644803"
      unitRef="shares">417</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesAWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20220318145759564"
      unitRef="Usd_per_share">1800</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssued
      contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124110133547"
      unitRef="shares">63</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekLegalWarrantsMember_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="1"
      id="Fxbrl_20211124110246407"
      unitRef="Usd_per_share">1214.4</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124110341728"
      unitRef="shares">2682</chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1>
    <us-gaap:SharePrice
      contextRef="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124110618048"
      unitRef="Usd_per_share">456</us-gaap:SharePrice>
    <chek:PreFundedWarrantsPurchaseSharesIssuable
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124110919512"
      unitRef="shares">10477</chek:PreFundedWarrantsPurchaseSharesIssuable>
    <chek:PricePerUnit
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124111056314"
      unitRef="Usd_per_share">444</chek:PricePerUnit>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124111140944"
      unitRef="Usd_per_share">12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      id="Fxbrl_20211124111308614">2023-08-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <chek:ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20211124111222278"
      unitRef="USD">5900000</chek:ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants>
    <chek:PreFundedWarrantsPurchase
      contextRef="C_20160801to20160811_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124111248575"
      unitRef="shares">2396</chek:PreFundedWarrantsPurchase>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"
      decimals="INF"
      id="Fxbrl_20211124111349653"
      unitRef="shares">1209</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="C_20170101to20170123_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"
      decimals="-2"
      id="Fxbrl_20211124111433554"
      unitRef="USD">14500</us-gaap:ProceedsFromIssuanceOfWarrants>
    <chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1
      contextRef="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204025055336"
      unitRef="shares">5623</chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1>
    <us-gaap:SharePrice
      contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20220204025106575"
      unitRef="Usd_per_share">480</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220319004246376"
      unitRef="shares">5623</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20220204025117630"
      unitRef="Usd_per_share">510</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_20170601to20170602_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20220204025124736"
      unitRef="USD">2690000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <chek:WarrantsOutstandingAmount
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20220204025134703"
      unitRef="shares">282</chek:WarrantsOutstandingAmount>
    <chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1
      contextRef="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204025449015"
      unitRef="shares">9470</chek:StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1>
    <us-gaap:SharePrice
      contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20220204025500424"
      unitRef="Usd_per_share">264</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220319004210858"
      unitRef="shares">7103</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20220319004353025"
      unitRef="Usd_per_share">300</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_20171101to20171122_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20220204025517711"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <chek:WarrantsExercisedCashlessBasis
      contextRef="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204025529639"
      unitRef="shares">2841</chek:WarrantsExercisedCashlessBasis>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20180425_usgaapClassOfWarrantOrRightAxis_chekOneYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204025537363"
      unitRef="shares">679</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20200701to20200727_usgaapClassOfWarrantOrRightAxis_chekFiveYearWarrantsMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204025616278"
      unitRef="shares">4262</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:WarrantsOutstandingAmount
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"
      decimals="INF"
      id="Fxbrl_20220204025623599"
      unitRef="shares">474</chek:WarrantsOutstandingAmount>
    <chek:UnitsPurchased
      contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124114029535"
      unitRef="shares">136924</chek:UnitsPurchased>
    <us-gaap:SharePrice
      contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="0"
      id="Fxbrl_20211124114154689"
      unitRef="Usd_per_share">110</us-gaap:SharePrice>
    <chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants
      contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="INF"
      id="Fxbrl_20211124114235593"
      unitRef="shares">22546</chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants>
    <chek:PrefundedWarrantsToPurchasePrice
      contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="1"
      id="Fxbrl_20211124114522142"
      unitRef="Usd_per_share">109.8</chek:PrefundedWarrantsToPurchasePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20180508_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="1"
      id="Fxbrl_20211124114604887"
      unitRef="Usd_per_share">0.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20180508_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsMember"
      decimals="0"
      id="Fxbrl_20211124114631756"
      unitRef="Usd_per_share">110</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124114737970"
      unitRef="shares">23921</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapCommonClassCMember"
      decimals="INF"
      id="Fxbrl_20211124114824795"
      unitRef="shares">23921</us-gaap:CommonStockSharesIssued>
    <chek:ProceedsFromIssuanceOfPublicOffering
      contextRef="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="-3"
      id="Fxbrl_20220204030024134"
      unitRef="USD">20200000</chek:ProceedsFromIssuanceOfPublicOffering>
    <chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants
      contextRef="C_20180508_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20220204030031742"
      unitRef="shares">22546</chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants>
    <chek:ProceedsFromExerciseOfPrefundedWarrants
      contextRef="C_20180501to20180508_usgaapSubsidiarySaleOfStockAxis_chekPreFundedUnitsMember"
      decimals="-3"
      id="Fxbrl_20220204030041295"
      unitRef="USD">4500000</chek:ProceedsFromExerciseOfPrefundedWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekSeriesCWarrantsToPurchaseOrdinarySharesMember"
      decimals="INF"
      id="Fxbrl_20220204030048453"
      unitRef="shares">183390</us-gaap:ClassOfWarrantOrRightOutstanding>
    <chek:CommonStockUnitsIssued
      contextRef="C_20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="INF"
      id="Fxbrl_20211124115346120"
      unitRef="Unit">94075</chek:CommonStockUnitsIssued>
    <chek:PurchasePricePerUnit
      contextRef="C_20190201to20190206_usgaapSubsidiarySaleOfStockAxis_usgaapIPOMember"
      decimals="1"
      id="Fxbrl_20220321200754325"
      unitRef="USD_Per_unit">51.6</chek:PurchasePricePerUnit>
    <chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants
      contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="INF"
      id="Fxbrl_20211124115419176"
      unitRef="shares">1024876</chek:NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants>
    <chek:PrefundedWarrantsToPurchasePrice
      contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="1"
      id="Fxbrl_20211124115624763"
      unitRef="Usd_per_share">51.4</chek:PrefundedWarrantsToPurchasePrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember"
      decimals="INF"
      id="Fxbrl_20220318145520350"
      unitRef="shares">0.5</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember"
      decimals="INF"
      id="Fxbrl_20230325013509983"
      unitRef="shares">0.5</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20190206_usgaapAwardTypeAxis_chekPreFundedUnitsMember"
      decimals="1"
      id="Fxbrl_20211124115959557"
      unitRef="Usd_per_share">0.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekSeriesDWarrantsMember"
      decimals="1"
      id="Fxbrl_20220111022603144"
      unitRef="Usd_per_share">51.6</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssued
      contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"
      decimals="INF"
      id="Fxbrl_20211124120101870"
      unitRef="shares">10173</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20190206_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"
      decimals="1"
      id="Fxbrl_20211124120230764"
      unitRef="Usd_per_share">64.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20211124120405294"
      unitRef="USD">7500000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"
      decimals="INF"
      id="Fxbrl_20230324234508720"
      unitRef="shares">51244</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsOneMember"
      decimals="-3"
      id="Fxbrl_20230324234518122"
      unitRef="USD">6500000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20190201to20190206_usgaapClassOfWarrantOrRightAxis_chekPreFundedWarrantsMember"
      decimals="-3"
      id="Fxbrl_20230324234526379"
      unitRef="USD">987000</us-gaap:PaymentsOfStockIssuanceCosts>
    <chek:WarrantThatWereExercised
      contextRef="C_20200727_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember"
      decimals="INF"
      id="Fxbrl_20230324234556493"
      unitRef="shares">48450</chek:WarrantThatWereExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember"
      decimals="INF"
      id="Fxbrl_20230324234609207"
      unitRef="shares">24210</us-gaap:ClassOfWarrantOrRightOutstanding>
    <chek:WarrantsIssued
      contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember"
      decimals="INF"
      id="Fxbrl_20230325005545784"
      unitRef="shares">10173</chek:WarrantsIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20220204030818101"
      unitRef="shares">136009</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20220204030825749"
      unitRef="Usd_per_share">35</us-gaap:SharesIssuedPricePerShare>
    <chek:ProceedsFromIssuanceOfShares
      contextRef="C_20191219_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="-3"
      id="Fxbrl_20220204030832565"
      unitRef="USD">4760000</chek:ProceedsFromIssuanceOfShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124121633331"
      unitRef="shares">333334</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124121704182"
      unitRef="shares">375001</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124121729365"
      unitRef="shares">250000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124121813472"
      unitRef="Usd_per_share">12</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124121813015"
      unitRef="Usd_per_share">12</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124121748933"
      unitRef="Usd_per_share">12</us-gaap:SharesIssuedPricePerShare>
    <chek:WarrantsIssued
      contextRef="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122016310"
      unitRef="shares">333334</chek:WarrantsIssued>
    <chek:WarrantsIssued
      contextRef="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122110422"
      unitRef="shares">375001</chek:WarrantsIssued>
    <chek:WarrantsIssued
      contextRef="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122227687"
      unitRef="shares">250000</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200727_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="0"
      id="Fxbrl_20230325000105180"
      unitRef="Usd_per_share">16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122338170"
      unitRef="shares">23334</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122358593"
      unitRef="shares">26250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="C_20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20211124122415696"
      unitRef="shares">17500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20200501to20200513_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      id="Fxbrl_20211124122513983">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20200501to20200504_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      id="Fxbrl_20211124122513720">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_20200401to20200422_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      id="Fxbrl_20220110171535516">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <chek:ExercisePriceOfWarrants
      contextRef="C_20210301to20210318_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20211124122805852"
      unitRef="Usd_per_share">15</chek:ExercisePriceOfWarrants>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20211124122911740"
      unitRef="USD">11500000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20211124123003429"
      unitRef="USD">10139000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20220101to20221231_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20211124123036734"
      unitRef="USD">1361000</us-gaap:PaymentsOfStockIssuanceCosts>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20200701to20200727_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204031334117"
      unitRef="shares">750001</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:WarrantThatWereExercised
      contextRef="C_20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204031345805"
      unitRef="shares">208334</chek:WarrantThatWereExercised>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20210101to20210331_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember"
      decimals="INF"
      id="Fxbrl_20220204031358005"
      unitRef="shares">67084</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="INF"
      id="Fxbrl_20220204031543892"
      unitRef="shares">802712</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="2"
      id="Fxbrl_20220318145932131"
      unitRef="Usd_per_share">300</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20220318145940852"
      unitRef="Usd_per_share">16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20230305032326163"
      unitRef="Usd_per_share">12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:ProceedsFromExerciseOfWarrants
      contextRef="C_20200701to20200723_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="-3"
      id="Fxbrl_20220204031613492"
      unitRef="USD">9632000</chek:ProceedsFromExerciseOfWarrants>
    <chek:ProceedsFromExerciseOfWarrants
      contextRef="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="-3"
      id="Fxbrl_20220204031626235"
      unitRef="USD">8712000</chek:ProceedsFromExerciseOfWarrants>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_20200701to20200723_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember"
      decimals="-3"
      id="Fxbrl_20220204031635811"
      unitRef="USD">920000</us-gaap:PaymentsOfStockIssuanceCosts>
    <chek:WarrantsIssued
      contextRef="C_20200701to20200723_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="INF"
      id="Fxbrl_20220204031650283"
      unitRef="shares">963254</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200723_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"
      decimals="0"
      id="Fxbrl_20211124135317049"
      unitRef="Usd_per_share">16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssued
      contextRef="C_20200701to20200723_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentsMember"
      decimals="INF"
      id="Fxbrl_20220204031714579"
      unitRef="shares">56190</chek:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20200723_usgaapClassOfWarrantOrRightAxis_chekWarrantsExerciseTransactionMember_usgaapSubsidiarySaleOfStockAxis_usgaapPrivatePlacementMember"
      decimals="0"
      id="Fxbrl_20220204031721899"
      unitRef="Usd_per_share">15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20220204031814388"
      unitRef="shares">878628</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20210101to20210331_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekPlacementAgentMember"
      decimals="INF"
      id="Fxbrl_20220204031746214"
      unitRef="shares">56190</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20230305031312094"
      unitRef="shares">84626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20220204031754796"
      unitRef="shares">84626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <chek:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"
      decimals="INF"
      id="Fxbrl_20211124135204986"
      unitRef="shares">1210235</chek:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"
      decimals="0"
      id="Fxbrl_20211124135258333"
      unitRef="Usd_per_share">15</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20220318150021220"
      unitRef="Usd_per_share">16</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20210101to20210331_usgaapSubsidiarySaleOfStockAxis_chekAprilMayOfferingsMember"
      decimals="-3"
      id="Fxbrl_20211124135340669"
      unitRef="USD">19240000</us-gaap:ProceedsFromWarrantExercises>
    <chek:WarrantsIssued
      contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204035038567"
      unitRef="shares">1296297</chek:WarrantsIssued>
    <chek:WarrantsIssuedNotExercised
      contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20220204035137374"
      unitRef="shares">1296297</chek:WarrantsIssuedNotExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20230325001816522"
      unitRef="Usd_per_share">30</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssuedNotExercised
      contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20220204035407847"
      unitRef="shares">64815</chek:WarrantsIssuedNotExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210630_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember"
      decimals="2"
      id="Fxbrl_20220204035503645"
      unitRef="Usd_per_share">33.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent
      contextRef="C_20210601to20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="3"
      id="Fxbrl_20220319012440955"
      unitRef="Percent">0.05</chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20220319012541037"
      unitRef="shares">64815</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20230305032837835"
      unitRef="shares">1296297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20220319012108113"
      unitRef="shares">1296297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <chek:WarrantsIssued
      contextRef="C_20210101to20211231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20230305032852538"
      unitRef="shares">64815</chek:WarrantsIssued>
    <chek:WarrantsIssued
      contextRef="C_20220101to20221231_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20220319011829600"
      unitRef="shares">64815</chek:WarrantsIssued>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20210601to20210630_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20220318150552113"
      unitRef="USD">35000000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20210601to20210630_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20220318151127189"
      unitRef="USD">31801000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <chek:IssuanceExpenses
      contextRef="C_20210601to20210630_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20220318150637536"
      unitRef="USD">3199000</chek:IssuanceExpenses>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20210630_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentMember_usgaapOtherCommitmentsAxis_chekWarrantAmendmentAgreementMember"
      decimals="INF"
      id="Fxbrl_20220318150759991"
      unitRef="shares">926297</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <chek:WarrantsIssued
      contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20230304183011229"
      unitRef="shares">1000000</chek:WarrantsIssued>
    <chek:WarrantsIssuedNotExercised
      contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="INF"
      id="Fxbrl_20230304183031955"
      unitRef="shares">750000</chek:WarrantsIssuedNotExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="0"
      id="Fxbrl_20230304183054018"
      unitRef="Usd_per_share">13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:WarrantsIssuedNotExercised
      contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20230304183129070"
      unitRef="shares">50000</chek:WarrantsIssuedNotExercised>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember"
      decimals="1"
      id="Fxbrl_20230304183147156"
      unitRef="Usd_per_share">12.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent
      contextRef="C_20220202to20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="3"
      id="Fxbrl_20230304183202872"
      unitRef="Percent">0.05</chek:PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_20220301_usgaapAwardTypeAxis_chekOrdinarySharesMember_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20230304183218647"
      unitRef="shares">37500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="INF"
      id="Fxbrl_20230304183235983"
      unitRef="shares">926297</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20220301_usgaapClassOfWarrantOrRightAxis_chekPlacementAgentWarrantsMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember"
      decimals="0"
      id="Fxbrl_20230325013051672"
      unitRef="Usd_per_share">13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20220202to20220301_srtRangeAxis_srtMaximumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20230304183340856"
      unitRef="USD">10000000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <chek:ProceedsFromIssuanceOfRegistredDirectOffering
      contextRef="C_20220202to20220301_srtRangeAxis_srtMinimumMember_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20230304183403195"
      unitRef="USD">8850000</chek:ProceedsFromIssuanceOfRegistredDirectOffering>
    <chek:IssuanceExpenses
      contextRef="C_20220202to20220301_usgaapClassOfWarrantOrRightAxis_usgaapWarrantMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapInvestorMember_usgaapSubsidiarySaleOfStockAxis_chekRegisteredDirectOfferingMember"
      decimals="-3"
      id="Fxbrl_20230304183429250"
      unitRef="USD">1150000</chek:IssuanceExpenses>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_20220101to20221231"
      id="F20230326072614723_213">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 11 - SHARE-BASED COMPENSATION&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20.25pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:normal"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;General&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In connection with the transfer of all of the business operations and substantially all of the assets of Check-Cap LLC to the Company in 2009, the Company assumed the Check-Cap LLC 2006 Unit Option Plan (the "2006 Plan"). According to the 2006 Plan, the Company is authorized to grant options to purchase ordinary shares of the Company to employees, directors and consultants of the Company. The options granted according to the 2006 Plan are generally exercisable for 10 years from the grant date unless otherwise determined by the Company's Board of Directors, vest over a period to be determined by the Company's Board of Directors, and have an exercise price to be determined by the Company's Board of Directors.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 13, 2015, the shareholders approved and adopted the Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 Israeli Plan") and the Check-Cap Ltd. 2015 United States Sub-Plan to Check-Cap Ltd. 2015 Equity Incentive Plan (the "2015 U.S. Sub-Plan" and together with the 2015 Israeli Plan, the "2015 Plan"). As of such date, the Company ceased to grant options under the 2006 Plan. All of the remaining shares authorized but unissued under the 2006 Plan were rolled over to the 2015 Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 5, 2020, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 17,500 shares to 77,780 shares.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 5, 2021, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 125,000.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 27, 2022, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 25,000.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of December 31, 2022, no shares were available for future awards under the 2015 Plan.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 4, 2023, the Company's Board of Directors resolved to increase the number of ordinary shares of the Company reserved for issuance under the 2015 Plan by an additional 30,000.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                    &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Details of share-based grants made by the Company&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following tables presents the grant dates, number of underlying shares and related exercise prices of awards granted to employees and non-employees during the years 2022, 2021 and 2020 as well as the estimated fair value of the underlying ordinary shares on the grant date:&lt;/span&gt;&lt;/span&gt;
              &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;
                &lt;div style="line-height:1.25;font-weight:normal"&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;div/&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;

                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="text-indent:49pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="margin-left:49pt"&gt;
                            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;
                                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Fair value&lt;/span&gt;&lt;/p&gt;
                                    &lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;expenses&#160;(1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expiration date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;on grant&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$in &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Vesting&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;terms&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 5, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 27, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 27, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,014&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 5, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;175&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 17, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 17, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 10, 2020 (3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 10, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 17, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 17, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 11, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 11, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2021 (5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 13, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;750&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 13, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 20, 2021 (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 20, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 2, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 2, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2021 (7(&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;497&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2021 (7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2022(9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2022 (10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,472&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 29, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,661&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 29, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 29, 2022(11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;

                            &lt;/table&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                      &lt;div style="margin-left:45pt"&gt;&#160;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="text-indent:36pt;margin-left:11.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;RSUs:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value on&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vesting&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;and PSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expiration date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;expenses&#160;(1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;terms&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2021 (7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:26%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2022 (9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2022 (10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Share based expenses are based on their fair value on grant date. The amount is charged to the statement of operations over the vesting periods.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of three years commencing on the date of grant, such that one third of the options vested on the first anniversary of the date of grant and thereafter, the remaining options vest in quarterly installments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 10, 2020, the Company's Board of Directors approved the award of 11,250 options to the Company&#x2019;s officers, with an exercise price of $6.4, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of four years commencing on the date of grant, such that 25% of the options vest and become exercisable on the first anniversary of the date of grant and thereafter, vest monthly in equal portions at the end of each month over the subsequent thirty-six (36) months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 4, 2021, the Company's Board of Directors approved the award of 36,694 options and 15,000 RSUs, of which, 12,075 options and 5,175 RSUs were issued to certain of the Company&#x2019;s officers. The remaining options and RSUs were issued to certain employees.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 20, 2021, the Company's Board of Directors approved the award of 1,250 options to the Company&#x2019;s VP clinical, with an exercise price of $20.6, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 9, 2021, the Company's shareholders approved the award of 57,500 options to the Company&#x2019;s CEO. The options shall vest as follows: (i) two-thirds of the options (38,334 options) shall vest over a period of four years commencing on their date of grant, such that 25% of the options shall vest on the first anniversary of the date of grant and an additional 2.0833% will vest at the end of each month thereafter; and (ii) one third of the options (19,166 options) shall fully vest upon the approval by the FDA of the use of our C-Scan, in humans, subject, in each case, to the CEO&#x2019;s continuing service with the Company on each applicable vesting date. The exercise price of the options of $26.8, equal to the average closing price of the Company&#x2019;s ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders, plus a 50% premium. The compensation expense was based on the fair value on the grant date and was estimated at approximately $749. The fair value amount is charged to the statement of operations over the vesting periods of which $335 and $23 were recorded to general and administrative expenses in the year ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted to service provider. The options vest over a period of twelve (12) months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 27, 2022, the Company's Board of Directors approved the award to certain employees of 16,800 options, with an exercise price of $12.96, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date, and 7,200 RSUs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 21, 2022, the Company's Board of Directors approved the award of 8,472 options and 2,850 RSUs to certain executive officers and employees, of which 6,650 options and the 2,850 RSUs were granted to certain officers. The options have an exercise price of $10.184, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 29, 2022, the Company's shareholders approved the award of 29,125 options to members of the Company's Board of Directors. The options shall become fully vested on the first anniversary of the date of grant, subject to each of the Board of Directors continuing service with the Company on the vesting date. The exercise price of the options is $4.14, equal to two times the closing price of the Company&#x2019;s ordinary shares on the Nasdaq Capital Market on the date of the approval of the option grant by the Company&#x2019;s shareholders.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;

              &lt;div/&gt;
              &lt;div style="line-height:1.25"&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;C.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                        &lt;div style="font-weight:bold"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="line-height:1.25;margin-left:49pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The parameters which were used in applying the model are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="margin-left:49pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;109%-118&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;115%-153&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;95%-98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk-free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.7%-3.9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.81%-1.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.31%-0.83&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:62%"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected term (in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.5-6.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.27-6.41&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:10%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.88 - 6.1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$2.07 - $9.58&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.8 - $2.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.28 - $1.57&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;D.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Effect of share-based compensation transactions on the Company's statements of operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:49pt"&gt;

                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Research and development, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;General and administrative, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;482&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;491&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;408&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;E.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A summary of the Company's option activity related to options granted to employees, service providers and directors, and related information under the 2006 Plan and the 2015 Plan is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;145,895&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;48.2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;9.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;58,239&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.75&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(12,242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;59.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;191,892&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;35.35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;55,259&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;79.79&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                  &lt;/div&gt;
                  &lt;div/&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;54,516&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;99,935&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;26.0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,206&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;92.9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(350&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.0&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;145,895&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;48.2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;9.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;27,037&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;154.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;
                              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;27,456&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;204.8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;30,832&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10.4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;196.6&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;54,516&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,486&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;282.8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                          &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The weighted average grant date fair values of options granted during the years ended December 31, 2022, 2021 and 2020 were $4.5, $15.7 and $8.2, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                          &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2022, all the outstanding options in the amount of 191,892, with an average exercise price of $35.35, are out of the money.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:78pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A summary of the Company&#x2019;s RSUs activity is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:78pt"&gt;

                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number of RSUs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;16,628&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;3,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;4,985&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10,050&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(4,374&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(1,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(1,258&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,601&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(90&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;19,703&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;16,628&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;3,637&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;

              &lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;3.&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;The weighted average grant date fair values of RSUs awarded during the years ended December 31, 2022 and 2021 were $9.2 and $21.8, respectively.&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;width:29pt"&gt;4.&lt;/td&gt;
                &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                  &lt;div&gt;As of December 31, 2022, 2021 and 2020, there was $1,111, $1,644 and $328 unrecognized compensation cost related to non-vested share-based compensation arrangements (options and RSUs) granted under the 2006 Plan and 2015 Plan. This cost is expected to be recognized over a period of up to 4 years.&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div&gt;
        &lt;div&gt;&#160;&lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614678_185">10 years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_20200801to20200805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"
      decimals="INF"
      id="F20230326072614504_0"
      unitRef="shares">17500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_20200801to20200805_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="F20230326072614506_1"
      unitRef="shares">77780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_20210801to20210805_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"
      decimals="INF"
      id="F20230326072614771_245"
      unitRef="shares">125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_20220101to20220127_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"
      decimals="INF"
      id="F20230326072614726_215"
      unitRef="shares">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_20230101to20230104_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember"
      decimals="INF"
      id="F20230326072614727_216"
      unitRef="shares">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="C_20220101to20221231"
      id="F20230326072614716_209">
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="text-indent:49pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="margin-left:49pt"&gt;
                            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;
                                      &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Fair value&lt;/span&gt;&lt;/p&gt;
                                    &lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;expenses&#160;(1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expiration date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exercise price&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;on grant&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="border-bottom:2px solid rgb(0, 0, 0);vertical-align:bottom" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$in &lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;thousands&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;Vesting&lt;/span&gt;&lt;/div&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;terms&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;399&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 5, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23.44&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 27, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 27, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 5, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18,014&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 5, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;175&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 17, 2020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,036&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 17, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 10, 2020 (3)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 10, 2030&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 17, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,274&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 17, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;45.4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;42.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 11, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;903&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 11, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.07&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2021 (5)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36,701&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 13, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;750&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 13, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 20, 2021 (6)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,250&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;September 20, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16.15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 2, 2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,556&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 2, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22.2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;18.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2021 (7(&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;38,334&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;497&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2021 (7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;19,167&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:bottom;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 9, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;26.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;13.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;252&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2022(9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;16,800&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.98&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;134&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2022 (10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,472&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.184&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;59&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;May 31, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 29, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,661&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.91&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 29, 2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,024&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;November 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.38&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;
                                &lt;tr&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 29, 2022(11)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;29,125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td style="vertical-align:top;width:20%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 29, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1.64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;48&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                  &lt;/td&gt;
                                &lt;/tr&gt;

                            &lt;/table&gt;
                          &lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                      &lt;div style="margin-left:45pt"&gt;&#160;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="text-indent:36pt;margin-left:11.25pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;RSUs:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;No. of RSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fair value on&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share based&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Vesting&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;and PSUs&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expiration date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;grant date&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;expenses&#160;(1)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;terms&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2021 (7)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;August 4, 2031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21.8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:26%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2022 (9)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,200&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;January 27, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2022 (10)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:bottom;width:26%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;March 21, 2032&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                    &lt;div/&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;color:rgb(0, 0, 0)"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:top;width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;Share based expenses are based on their fair value on grant date. The amount is charged to the statement of operations over the vesting periods.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of three years commencing on the date of grant, such that one third of the options vested on the first anniversary of the date of grant and thereafter, the remaining options vest in quarterly installments.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 10, 2020, the Company's Board of Directors approved the award of 11,250 options to the Company&#x2019;s officers, with an exercise price of $6.4, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of four years commencing on the date of grant, such that 25% of the options vest and become exercisable on the first anniversary of the date of grant and thereafter, vest monthly in equal portions at the end of each month over the subsequent thirty-six (36) months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On August 4, 2021, the Company's Board of Directors approved the award of 36,694 options and 15,000 RSUs, of which, 12,075 options and 5,175 RSUs were issued to certain of the Company&#x2019;s officers. The remaining options and RSUs were issued to certain employees.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On September 20, 2021, the Company's Board of Directors approved the award of 1,250 options to the Company&#x2019;s VP clinical, with an exercise price of $20.6, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 9, 2021, the Company's shareholders approved the award of 57,500 options to the Company&#x2019;s CEO. The options shall vest as follows: (i) two-thirds of the options (38,334 options) shall vest over a period of four years commencing on their date of grant, such that 25% of the options shall vest on the first anniversary of the date of grant and an additional 2.0833% will vest at the end of each month thereafter; and (ii) one third of the options (19,166 options) shall fully vest upon the approval by the FDA of the use of our C-Scan, in humans, subject, in each case, to the CEO&#x2019;s continuing service with the Company on each applicable vesting date. The exercise price of the options of $26.8, equal to the average closing price of the Company&#x2019;s ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders, plus a 50% premium. The compensation expense was based on the fair value on the grant date and was estimated at approximately $749. The fair value amount is charged to the statement of operations over the vesting periods of which $335 and $23 were recorded to general and administrative expenses in the year ended December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options granted to service provider. The options vest over a period of twelve (12) months.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On January 27, 2022, the Company's Board of Directors approved the award to certain employees of 16,800 options, with an exercise price of $12.96, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date, and 7,200 RSUs.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 21, 2022, the Company's Board of Directors approved the award of 8,472 options and 2,850 RSUs to certain executive officers and employees, of which 6,650 options and the 2,850 RSUs were granted to certain officers. The options have an exercise price of $10.184, equal to the higher of the share price at the grant date on Nasdaq and the average closing price of our ordinary shares on Nasdaq during the 30 trading days prior to the grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                      &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                      &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                          &lt;tr&gt;
                            &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                            &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;11.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                            &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                              &lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On December 29, 2022, the Company's shareholders approved the award of 29,125 options to members of the Company's Board of Directors. The options shall become fully vested on the first anniversary of the date of grant, subject to each of the Board of Directors continuing service with the Company on the vesting date. The exercise price of the options is $4.14, equal to two times the closing price of the Company&#x2019;s ordinary shares on the Nasdaq Capital Market on the date of the approval of the option grant by the Company&#x2019;s shareholders.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                              &lt;div&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member"
      decimals="INF"
      id="F20230326072614522_9"
      unitRef="shares">399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member"
      id="F20230326072614523_10">2030-03-05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate1Member"
      decimals="1"
      id="F20230326072614525_11"
      unitRef="NIS_Per_Share">36.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member"
      decimals="2"
      id="F20230326072614527_12"
      unitRef="NIS_Per_Share">23.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member"
      decimals="-3"
      id="F20230326072614531_13"
      unitRef="USD">9000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member"
      decimals="INF"
      id="Fxbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">133</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member"
      id="F20230326072614535_18">2030-05-27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate2Member"
      decimals="1"
      id="Fxbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">11.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member"
      decimals="2"
      id="Fxbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">8.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate2Member"
      decimals="-3"
      id="Fxbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">1000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member"
      decimals="INF"
      id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">18014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member"
      id="F20230326072614537_23">2030-08-05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate3Member"
      decimals="0"
      id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member"
      decimals="2"
      id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">9.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate3Member"
      decimals="-3"
      id="Fxbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">175000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member"
      decimals="INF"
      id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member"
      id="F20230326072614539_28">2030-11-17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate4Member"
      decimals="1"
      id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">6.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member"
      decimals="2"
      id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">4.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate4Member"
      decimals="-3"
      id="Fxbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">4000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member"
      decimals="INF"
      id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">11250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member"
      id="F20230326072614542_33">2030-12-10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate5Member"
      decimals="1"
      id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">6.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member"
      decimals="1"
      id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">5.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate5Member"
      decimals="-3"
      id="Fxbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">62000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member"
      decimals="INF"
      id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1274</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member"
      id="F20230326072614544_38">2031-03-17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate6Member"
      decimals="1"
      id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">45.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member"
      decimals="1"
      id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">42.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate6Member"
      decimals="-3"
      id="Fxbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">54000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member"
      decimals="INF"
      id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member"
      id="F20230326072614547_43">2031-05-11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate7Member"
      decimals="1"
      id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">11.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member"
      decimals="2"
      id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">26.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate7Member"
      decimals="-3"
      id="Fxbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">23000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member"
      decimals="INF"
      id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">36701</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member"
      id="F20230326072614550_48">2031-08-04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate8Member"
      decimals="1"
      id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">24.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member"
      decimals="2"
      id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">18.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member"
      decimals="-3"
      id="Fxbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">678000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member"
      decimals="INF"
      id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member"
      id="F20230326072614552_53">2031-09-13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate9Member"
      decimals="0"
      id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member"
      decimals="2"
      id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">16.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate9Member"
      decimals="-3"
      id="Fxbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">13000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member"
      decimals="INF"
      id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member"
      id="F20230326072614554_58">2031-09-20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate10Member"
      decimals="1"
      id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">20.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member"
      decimals="2"
      id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">16.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate10Member"
      decimals="-3"
      id="Fxbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">20000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member"
      decimals="INF"
      id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1556</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member"
      id="F20230326072614773_246">2031-11-02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate17Member"
      decimals="1"
      id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">22.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member"
      decimals="2"
      id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">18.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate17Member"
      decimals="-3"
      id="Fxbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">31000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member"
      decimals="INF"
      id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">38334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member"
      id="F20230326072614789_258">2031-12-09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate11Member"
      decimals="1"
      id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">26.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member"
      decimals="2"
      id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">12.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate11Member"
      decimals="-3"
      id="Fxbrl_20230324195957964_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">497000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member"
      decimals="INF"
      id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">19167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member"
      id="F20230326072614775_247">2031-12-09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDate13Member"
      decimals="1"
      id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">26.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member"
      decimals="2"
      id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">13.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate13Member"
      decimals="-3"
      id="Fxbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">252000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"
      decimals="INF"
      id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">16800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"
      id="F20230326072614777_248">2032-01-27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"
      decimals="2"
      id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">12.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"
      decimals="2"
      id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">7.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member"
      decimals="-3"
      id="Fxbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">134000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"
      decimals="INF"
      id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">8472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"
      id="F20230326072614778_249">2032-03-21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"
      decimals="3"
      id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">10.184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"
      decimals="2"
      id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">7.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member"
      decimals="-3"
      id="Fxbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">59000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"
      decimals="INF"
      id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1157</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"
      id="F20230326072614780_250">2032-05-31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"
      decimals="3"
      id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">7.254</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"
      decimals="2"
      id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">6.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne3Member"
      decimals="-3"
      id="Fxbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">7000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"
      decimals="INF"
      id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614522_9"
      unitRef="shares">1661</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"
      id="F20230326072614781_251">2032-08-29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"
      decimals="2"
      id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614525_11"
      unitRef="NIS_Per_Share">8.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"
      decimals="2"
      id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614527_12"
      unitRef="NIS_Per_Share">6.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneSevenMember"
      decimals="-3"
      id="Fxbrl_20211202123343203_xbrl_20211202123258754_xbrl_20211202123157704_xbrl_20211202122929093_xbrl_20211202122630364_xbrl_20211202122322017_xbrl_20211202121214349_xbrl_20211202121136517_xbrl_20211202121057404_xbrl_20211202121004786_xbrl_20211202120857683_xbrl_20211202120725888_xbrl_20211202120648348_xbrl_20211202120559968_xbrl_20211202120426049_xbrl_20211202112838263_20230326072614531_13"
      unitRef="USD">11000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"
      decimals="INF"
      id="F20230326072614730_217"
      unitRef="shares">1024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"
      id="F20230326072614783_252">2032-11-29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"
      decimals="2"
      id="F20230326072614733_219"
      unitRef="NIS_Per_Share">4.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"
      decimals="2"
      id="F20230326072614736_221"
      unitRef="NIS_Per_Share">2.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneEightMember"
      decimals="-3"
      id="F20230326072614739_223"
      unitRef="USD">2000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"
      decimals="INF"
      id="F20230326072614731_218"
      unitRef="shares">29125</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"
      id="F20230326072614784_253">2032-12-29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"
      decimals="2"
      id="F20230326072614734_220"
      unitRef="NIS_Per_Share">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"
      decimals="2"
      id="F20230326072614737_222"
      unitRef="NIS_Per_Share">1.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOneNineMember"
      decimals="-3"
      id="F20230326072614741_224"
      unitRef="USD">48000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614742_225"
      unitRef="shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614744_226">2031-08-04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="1"
      id="F20230326072614745_227"
      unitRef="NIS_Per_Share">21.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate8Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614747_228"
      unitRef="USD">327000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614559_83"
      unitRef="shares">7200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614559_84">2032-01-27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="F20230326072614561_85"
      unitRef="NIS_Per_Share">9.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne1Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614563_86"
      unitRef="USD">69000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614565_87"
      unitRef="shares">2850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614567_88">2032-03-21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="F20230326072614568_89"
      unitRef="NIS_Per_Share">8.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="C_20220101to20221231_usgaapAwardDateAxis_chekGrantDateOne2Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614569_90"
      unitRef="USD">24000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20201201to20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember"
      decimals="INF"
      id="F20230326072614508_2"
      unitRef="shares">11250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20201210_srtTitleOfIndividualAxis_chekSeniorManagementMember"
      decimals="1"
      id="F20230326072614509_3"
      unitRef="NIS_Per_Share">6.4</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614686_190">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_20190101to20191231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="F20230326072614687_191"
      unitRef="Percent">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="F20230326072614679_186"
      unitRef="shares">36694</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210801to20210804_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614681_187"
      unitRef="shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member"
      decimals="INF"
      id="F20230326072614682_188"
      unitRef="shares">12075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20210801to20210804_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardDateAxis_chekGrantDate11Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614685_189"
      unitRef="shares">5175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210901to20210920_srtTitleOfIndividualAxis_chekVpClinicalMember"
      decimals="INF"
      id="F20230326072614689_192"
      unitRef="shares">1250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20210920_srtTitleOfIndividualAxis_chekVpClinicalMember"
      decimals="1"
      id="F20230326072614690_193"
      unitRef="NIS_Per_Share">20.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekTwentyTwoJuneMember_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="INF"
      id="F20230326072614692_194"
      unitRef="shares">57500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="INF"
      id="F20230326072614710_205"
      unitRef="shares">38334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614694_195">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="F20230326072614696_196"
      unitRef="Percent">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <chek:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne3Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="6"
      id="F20230326072614698_197"
      unitRef="Percent">0.020833</chek:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="INF"
      id="F20230326072614712_206"
      unitRef="shares">19166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapVestingAxis_usgaapShareBasedCompensationAwardTrancheOneMember"
      decimals="1"
      id="F20230326072614699_198"
      unitRef="NIS_Per_Share">26.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <chek:PremiumPercentageToCalculateExercisePrice
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="2"
      id="F20230326072614713_207"
      unitRef="Percent">0.50</chek:PremiumPercentageToCalculateExercisePrice>
    <chek:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue
      contextRef="C_20211201to20211209_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardDateAxis_chekGrantDateOne4Member_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614700_199"
      unitRef="USD">749000</chek:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="F20230326072614789_259"
      unitRef="USD">335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="F20230326072614702_200"
      unitRef="USD">23000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember"
      decimals="INF"
      id="F20230326072614791_260"
      unitRef="shares">16800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember"
      decimals="2"
      id="F20230326072614749_230"
      unitRef="NIS_Per_Share">12.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614752_231"
      unitRef="shares">7200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="Fxbrl_20230328162410605"
      unitRef="shares">8472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficersChiefExecutiveOfficerAndBoardMembersMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230328162420796"
      unitRef="shares">2850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="INF"
      id="Fxbrl_20230328162431460"
      unitRef="shares">6650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20220302to20220321_srtTitleOfIndividualAxis_chekCertainOfficerMember_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fxbrl_20230328162441044"
      unitRef="shares">2850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20220321"
      decimals="3"
      id="Fxbrl_20230328162447947"
      unitRef="NIS_Per_Share">10.184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20221201to20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember"
      decimals="INF"
      id="F20230326072614756_234"
      unitRef="shares">29125</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221229_srtTitleOfIndividualAxis_srtBoardOfDirectorsChairmanMember"
      decimals="2"
      id="F20230326072614758_235"
      unitRef="NIS_Per_Share">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <chek:ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock
      contextRef="C_20220101to20221231"
      id="F20230326072614724_214">
                      &lt;div&gt;
                        &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;div style="margin-left:49pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;109%-118&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;115%-153&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;95%-98&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Risk-free rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.7%-3.9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.81%-1.34&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0.31%-0.83&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:center;width:10%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:62%"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Expected term (in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.5-6.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:10%"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.27-6.41&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:center;width:10%"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;5.88 - 6.1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:62%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Share price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$2.07 - $9.58&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.8 - $2.27&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);width:10%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;$0.28 - $1.57&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                        &lt;div style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/div&gt;
                      &lt;/div&gt;
                    </chek:ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614571_91"
      unitRef="Percent">1.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614577_94"
      unitRef="Percent">1.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614572_92"
      unitRef="Percent">1.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614578_95"
      unitRef="Percent">1.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614574_93"
      unitRef="Percent">0.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614579_96"
      unitRef="Percent">0.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="3"
      id="F20230326072614581_97"
      unitRef="Percent">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="3"
      id="F20230326072614582_98"
      unitRef="Percent">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="F20230326072614584_99"
      unitRef="Percent">0.0081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="F20230326072614585_100"
      unitRef="Percent">0.0134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="F20230326072614588_101"
      unitRef="Percent">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="4"
      id="F20230326072614590_102"
      unitRef="Percent">0.0083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614591_103"
      unitRef="Percent">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614592_104"
      unitRef="Percent">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614594_105"
      unitRef="Percent">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614595_106">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20220101to20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614597_107">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20210101to20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614703_201">P5Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20210101to20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614705_202">P6Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20200101to20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614768_243">P5Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_20200101to20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      id="F20230326072614769_244">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharePrice
      contextRef="C_20221231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614600_108"
      unitRef="NIS_Per_Share">2.07</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20221231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614601_109"
      unitRef="NIS_Per_Share">9.58</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20211231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="1"
      id="F20230326072614603_110"
      unitRef="NIS_Per_Share">0.8</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20211231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614714_208"
      unitRef="NIS_Per_Share">2.27</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20201231_srtRangeAxis_srtMinimumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614604_111"
      unitRef="NIS_Per_Share">0.28</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20201231_srtRangeAxis_srtMaximumMember_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="2"
      id="F20230326072614605_112"
      unitRef="NIS_Per_Share">1.57</us-gaap:SharePrice>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_20220101to20221231"
      id="F20230326072614719_210">
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Research and development, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;493&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;General and administrative, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;482&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;975&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;491&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;408&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                </us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="F20230326072614607_113"
      unitRef="USD">493000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="F20230326072614608_114"
      unitRef="USD">329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="F20230326072614611_115"
      unitRef="USD">165000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="F20230326072614612_116"
      unitRef="USD">482000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="F20230326072614614_117"
      unitRef="USD">162000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapGeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="F20230326072614615_118"
      unitRef="USD">243000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="F20230326072614616_119"
      unitRef="USD">975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="F20230326072614618_120"
      unitRef="USD">491000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="F20230326072614619_121"
      unitRef="USD">408000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_20220101to20221231"
      id="F20230326072614720_211">
                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;145,895&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;48.2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;9.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;58,239&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.75&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(12,242&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;59.07&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercised&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;191,892&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;35.35&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.59&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;55,259&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;79.79&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.39&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                  &lt;/div&gt;
                  &lt;div/&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;54,516&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;99,935&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;26.0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(8,206&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;92.9&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(350&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12.0&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;145,895&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;48.2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;9.13&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(255, 255, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
                          &lt;td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;27,037&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;154.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.03&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31, 2020&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Aggregate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong&gt;&lt;span&gt;Weighted&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;average&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;intrinsic&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;
                              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;average of&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;remaining&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;value&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;exercise&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;contractual&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;($in&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;price&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;thousands)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in $)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(in years)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-align:center"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;(2)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;27,456&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;204.8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.30&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;30,832&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10.4&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(3,772&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;196.6&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options outstanding at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;54,516&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;95.3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;8.74&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;width:52%" valign="bottom"&gt;
                            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Options exercisable at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,486&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;282.8&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                          &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;The weighted average grant date fair values of options granted during the years ended December 31, 2022, 2021 and 2020 were $4.5, $15.7 and $8.2, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                      &lt;tr&gt;
                        &lt;td style="width:49pt"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:29pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                          &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;As of December 31, 2022, all the outstanding options in the amount of 191,892, with an average exercise price of $35.35, are out of the money.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20211231"
      decimals="INF"
      id="F20230326072614622_122"
      unitRef="shares">145895</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20211231"
      decimals="1"
      id="F20230326072614623_123"
      unitRef="NIS_Per_Share">48.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20220101to20221231"
      id="F20230326072614625_124">P9Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20221231"
      decimals="-3"
      id="F20230326072614626_125"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="F20230326072614627_126"
      unitRef="shares">58239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="2"
      id="F20230326072614629_127"
      unitRef="NIS_Per_Share">7.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="F20230326072614630_128"
      unitRef="shares">12242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="2"
      id="F20230326072614633_129"
      unitRef="NIS_Per_Share">59.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="F20230326072614707_203"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20220101to20221231"
      decimals="0"
      id="F20230326072614709_204"
      unitRef="NIS_Per_Share">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20221231"
      decimals="INF"
      id="F20230326072614634_130"
      unitRef="shares">191892</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20221231"
      decimals="2"
      id="F20230326072614636_131"
      unitRef="NIS_Per_Share">35.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree
      contextRef="C_20220101to20221231"
      id="F20230326072614637_132">P8Y7M2D</chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_20221231"
      decimals="-3"
      id="F20230326072614638_133"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20221231"
      decimals="INF"
      id="F20230326072614640_134"
      unitRef="shares">55259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20221231"
      decimals="2"
      id="F20230326072614641_135"
      unitRef="NIS_Per_Share">79.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20220101to20221231"
      id="F20230326072614644_136">P7Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_20221231"
      decimals="-3"
      id="F20230326072614645_137"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20201231"
      decimals="INF"
      id="Fxbrl_20220110143351049_20230326072614622_122"
      unitRef="shares">54516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20220110143351049_20230326072614623_123"
      unitRef="NIS_Per_Share">95.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220110143351049_20230326072614625_124">P8Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110143351049_20230326072614626_125"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20220110143351080_20230326072614627_126"
      unitRef="shares">99935</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="1"
      id="Fxbrl_20220110143351080_20230326072614629_127"
      unitRef="NIS_Per_Share">26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20220110143351102_20230326072614630_128"
      unitRef="shares">8206</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="1"
      id="Fxbrl_20220110143351102_20230326072614633_129"
      unitRef="NIS_Per_Share">92.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20211231"
      decimals="INF"
      id="Fxbrl_20230304182917882_xbrl_20220110143351102_20230326072614630_128"
      unitRef="shares">350</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_20210101to20211231"
      decimals="1"
      id="Fxbrl_20230304182917882_xbrl_20220110143351102_20230326072614633_129"
      unitRef="NIS_Per_Share">12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220110143351121_20230326072614634_130"
      unitRef="shares">145895</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20211231"
      decimals="1"
      id="Fxbrl_20220110143351121_20230326072614636_131"
      unitRef="NIS_Per_Share">48.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220110143351121_20230326072614637_132">P9Y1M17D</chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110143351121_20230326072614638_133"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220110143351150_20230326072614640_134"
      unitRef="shares">27037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20211231"
      decimals="1"
      id="Fxbrl_20220110143351150_20230326072614641_135"
      unitRef="NIS_Per_Share">154.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20210101to20211231"
      id="Fxbrl_20220110143351150_20230326072614644_136">P7Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220110143351150_20230326072614645_137"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20191231"
      decimals="INF"
      id="Fxbrl_20220110143354706_20230326072614622_122"
      unitRef="shares">27456</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20191231"
      decimals="1"
      id="Fxbrl_20220110143354706_20230326072614623_123"
      unitRef="NIS_Per_Share">204.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_20200101to20201231"
      id="Fxbrl_20220110143354706_20230326072614625_124">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110143354706_20230326072614626_125"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20200101to20201231"
      decimals="INF"
      id="Fxbrl_20220110143354723_20230326072614627_126"
      unitRef="shares">30832</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_20200101to20201231"
      decimals="1"
      id="Fxbrl_20220110143354723_20230326072614629_127"
      unitRef="NIS_Per_Share">10.4</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_20200101to20201231"
      decimals="INF"
      id="Fxbrl_20220110143354731_20230326072614630_128"
      unitRef="shares">3772</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_20200101to20201231"
      decimals="1"
      id="Fxbrl_20220110143354731_20230326072614633_129"
      unitRef="NIS_Per_Share">196.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20201231"
      decimals="INF"
      id="Fxbrl_20220110143354740_20230326072614634_130"
      unitRef="shares">54516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20220110143354740_20230326072614636_131"
      unitRef="NIS_Per_Share">95.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree
      contextRef="C_20200101to20201231"
      id="Fxbrl_20220110143354740_20230326072614637_132">P8Y8M26D</chek:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110143354740_20230326072614638_133"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_20201231"
      decimals="INF"
      id="Fxbrl_20220110143354757_20230326072614640_134"
      unitRef="shares">15486</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_20201231"
      decimals="1"
      id="Fxbrl_20220110143354757_20230326072614641_135"
      unitRef="NIS_Per_Share">282.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_20200101to20201231"
      id="Fxbrl_20220110143354757_20230326072614644_136">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220110143354757_20230326072614645_137"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="1"
      id="F20230326072614761_238"
      unitRef="NIS_Per_Share">4.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="1"
      id="F20230326072614761_239"
      unitRef="NIS_Per_Share">15.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember"
      decimals="1"
      id="F20230326072614764_240"
      unitRef="NIS_Per_Share">8.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"
      decimals="INF"
      id="F20230326072614765_241"
      unitRef="shares">191892</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="C_20221231_usgaapAwardTypeAxis_chekTwoThousandFifteenPlanMember"
      decimals="2"
      id="F20230326072614766_242"
      unitRef="NIS_Per_Share">35.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      id="F20230326072614722_212">
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Year ended December 31&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Number of RSUs&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested at beginning of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;16,628&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;3,637&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;4,985&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Granted&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;10,050&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Vested&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(4,374&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(1,764&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(1,258&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Forfeited&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(2,601&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(245&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;(90&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                          &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Unvested at end of year&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;19,703&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;16,628&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;3,637&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614655_170"
      unitRef="shares">16628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614656_171"
      unitRef="shares">3637</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20191231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614657_172"
      unitRef="shares">4985</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614658_173"
      unitRef="shares">10050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614660_174"
      unitRef="shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614662_175"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614664_176"
      unitRef="shares">4374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614665_177"
      unitRef="shares">1764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614667_178"
      unitRef="shares">1258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614668_179"
      unitRef="shares">2601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_20210101to20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614669_180"
      unitRef="shares">245</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614671_181"
      unitRef="shares">90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614674_182"
      unitRef="shares">19703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614675_183"
      unitRef="shares">16628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="INF"
      id="F20230326072614676_184"
      unitRef="shares">3637</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20220101to20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="1"
      id="F20230326072614511_4"
      unitRef="NIS_Per_Share">9.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_20200101to20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="1"
      id="F20230326072614513_5"
      unitRef="NIS_Per_Share">21.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_20221231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614517_6"
      unitRef="USD">1111000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_20211231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614519_7"
      unitRef="USD">1644000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_20201231_usgaapAwardTypeAxis_usgaapRestrictedStockUnitsRSUMember"
      decimals="-3"
      id="F20230326072614520_8"
      unitRef="USD">328000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318170316474">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 12 - RESEARCH AND DEVELOPMENT EXPENSES, NET&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-weight:bold;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;

                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;margin-left:20pt"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;493&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subcontractors and consultants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;820&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;289&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;169&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost for registration of patents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Others&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;861&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,493&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less participation of the IIA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(222&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total research and development expenses, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <chek:ScheduleOfResearchAndDevelopmentExpensesNet
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324125052875">
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;margin-left:20pt"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;8,257&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;493&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Materials&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,258&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,020&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,792&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Subcontractors and consultants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,375&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;820&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,103&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;289&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;169&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;123&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Cost for registration of patents&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;140&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;153&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;164&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Others&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;861&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;488&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,493&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,780&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Less participation of the IIA&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(222&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total research and development expenses, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;14,271&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;12,349&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,008&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    </chek:ScheduleOfResearchAndDevelopmentExpensesNet>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110121226219"
      unitRef="USD">8257000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_37"
      unitRef="USD">7428000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_311"
      unitRef="USD">6173000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_43"
      unitRef="USD">493000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_47"
      unitRef="USD">329000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_411"
      unitRef="USD">165000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SuppliesExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_53"
      unitRef="USD">2258000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_57"
      unitRef="USD">3020000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_511"
      unitRef="USD">1792000</us-gaap:SuppliesExpense>
    <chek:SubcontractorsAndConsultantFees
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_63"
      unitRef="USD">1375000</chek:SubcontractorsAndConsultantFees>
    <chek:SubcontractorsAndConsultantFees
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_67"
      unitRef="USD">820000</chek:SubcontractorsAndConsultantFees>
    <chek:SubcontractorsAndConsultantFees
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_611"
      unitRef="USD">1103000</chek:SubcontractorsAndConsultantFees>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_73"
      unitRef="USD">289000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_77"
      unitRef="USD">169000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_711"
      unitRef="USD">123000</us-gaap:DepreciationNonproduction>
    <chek:PaymentsExpensesForPatents
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_83"
      unitRef="USD">140000</chek:PaymentsExpensesForPatents>
    <chek:PaymentsExpensesForPatents
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_87"
      unitRef="USD">153000</chek:PaymentsExpensesForPatents>
    <chek:PaymentsExpensesForPatents
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_811"
      unitRef="USD">164000</chek:PaymentsExpensesForPatents>
    <us-gaap:OtherExpenses
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_93"
      unitRef="USD">1681000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_97"
      unitRef="USD">861000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_911"
      unitRef="USD">488000</us-gaap:OtherExpenses>
    <chek:ResearchAndDevelopmentExpenseGross
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20230324125535959"
      unitRef="USD">14493000</chek:ResearchAndDevelopmentExpenseGross>
    <chek:ResearchAndDevelopmentExpenseGross
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_107"
      unitRef="USD">12780000</chek:ResearchAndDevelopmentExpenseGross>
    <chek:ResearchAndDevelopmentExpenseGross
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_1011"
      unitRef="USD">10008000</chek:ResearchAndDevelopmentExpenseGross>
    <chek:GrantedRevenue
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220204020317683"
      unitRef="USD">222000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20230303045057570"
      unitRef="USD">431000</chek:GrantedRevenue>
    <chek:GrantedRevenue
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_1111"
      unitRef="USD">0</chek:GrantedRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_123"
      unitRef="USD">14271000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20211231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_127"
      unitRef="USD">12349000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20200101to20201231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fxbrl_20220110120609957_1211"
      unitRef="USD">10008000</us-gaap:ResearchAndDevelopmentExpense>
    <chek:GeneralAndAdministrativeExpensesTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318170550975">
          &lt;div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 13 - GENERAL AND ADMINISTRATIVE EXPENSES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-weight:bold;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="margin-left:49pt"&gt;

                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,042&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,092&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;710&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office rent and maintenance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;172&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Others&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,972&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,924&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </chek:GeneralAndAdministrativeExpensesTextBlock>
    <chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324124200824">
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Salaries and related expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,042&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,698&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;386&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;162&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;243&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Professional services&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,092&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;710&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;574&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Office rent and maintenance&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;246&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;172&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Depreciation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;116&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Others&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2,139&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,850&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,210&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;5,763&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;4,972&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;3,924&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    </chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_33"
      unitRef="USD">1784000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_37"
      unitRef="USD">2042000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_311"
      unitRef="USD">1698000</us-gaap:SalariesWagesAndOfficersCompensation>
    <chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_43"
      unitRef="USD">386000</chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense>
    <chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_47"
      unitRef="USD">162000</chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense>
    <chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_411"
      unitRef="USD">243000</chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_53"
      unitRef="USD">1092000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_57"
      unitRef="USD">710000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_511"
      unitRef="USD">574000</us-gaap:ProfessionalFees>
    <chek:OfficeRentAndMaintenance
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_63"
      unitRef="USD">246000</chek:OfficeRentAndMaintenance>
    <chek:OfficeRentAndMaintenance
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_67"
      unitRef="USD">172000</chek:OfficeRentAndMaintenance>
    <chek:OfficeRentAndMaintenance
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_611"
      unitRef="USD">174000</chek:OfficeRentAndMaintenance>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_73"
      unitRef="USD">116000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_77"
      unitRef="USD">36000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_711"
      unitRef="USD">25000</us-gaap:DepreciationNonproduction>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_83"
      unitRef="USD">2139000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_87"
      unitRef="USD">1850000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_811"
      unitRef="USD">1210000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121809950_93"
      unitRef="USD">5763000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121809950_97"
      unitRef="USD">4972000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121809950_911"
      unitRef="USD">3924000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318170710488">
          &lt;div&gt;
            &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 14 - FINANCE INCOME (EXPENSES), NET&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Composition:&lt;/span&gt;&lt;/span&gt;
                  &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                &lt;/div&gt;

                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="margin-left:49pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:90%"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income on short-term deposits and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,047&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank fees and interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in provision for royalties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange rate differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value of derivatives&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(121&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financing income, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;926&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324115006791">
                  &lt;div&gt;
                    &lt;div&gt;
                      &lt;div&gt;
                        &lt;div style="margin-left:49pt"&gt;
                          &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:'Times New Roman',Times,serif;font-size:10pt;text-align:left;width:90%"&gt;

                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Interest income on short-term deposits and other&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,047&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;101&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;69&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Bank fees and interest expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in provision for royalties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;28&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Exchange rate differences&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(25&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value of derivatives&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(121&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;52&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="vertical-align:bottom;width:64%;padding-bottom:4px" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total financing income, net&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;926&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;86&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121730045_33"
      unitRef="USD">1047000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_37"
      unitRef="USD">101000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_311"
      unitRef="USD">69000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121730045_43"
      unitRef="USD">12000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_47"
      unitRef="USD">13000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_411"
      unitRef="USD">12000</us-gaap:InterestExpense>
    <chek:ChangesInLiabilityToPayRoyalties
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121730045_53"
      unitRef="USD">37000</chek:ChangesInLiabilityToPayRoyalties>
    <chek:ChangesInLiabilityToPayRoyalties
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_57"
      unitRef="USD">22000</chek:ChangesInLiabilityToPayRoyalties>
    <chek:ChangesInLiabilityToPayRoyalties
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_511"
      unitRef="USD">28000</chek:ChangesInLiabilityToPayRoyalties>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121730045_63"
      unitRef="USD">-25000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_67"
      unitRef="USD">-43000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_611"
      unitRef="USD">-6000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230303045658403"
      unitRef="USD">-121000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_77"
      unitRef="USD">52000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_711"
      unitRef="USD">7000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121730045_83"
      unitRef="USD">926000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121730045_87"
      unitRef="USD">119000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121730045_811"
      unitRef="USD">86000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318170846973">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;NOTE 15 - LOSS PER SHARE&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Basic loss per share is computed based on the weighted average number of shares outstanding during each year. Diluted net loss per share is computed based on the weighted average number of shares outstanding during each year, plus the dilutive potential of the ordinary shares considered outstanding during the year, in accordance with ASC 260-10 "Earnings per share".&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;All outstanding options and warrants have been excluded from the calculation of the diluted loss per share for each period presented, since all such securities have an anti-dilutive effect.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;The following table sets forth the computation of the Company`s basic and diluted net loss per ordinary share:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,108&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Shares used in computing net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,671,786&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,159,870&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,537,060&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9.01&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

                &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Instruments that may potentially dilute the basic loss per share in the future but were not included in the calculation of diluted loss per share, since their effect is anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Warrants and share options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,912,147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,170,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,104,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;

              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318170853896">
                  &lt;div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net loss&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;19,108&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;17,202&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;13,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Shares used in computing net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;5,671,786&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4,159,870&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,537,060&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Net loss per ordinary share, basic and diluted&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;3.37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;4.14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;9.01&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110121317968_33"
      unitRef="USD">-19108000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110121317968_37"
      unitRef="USD">-17202000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110121317968_311"
      unitRef="USD">-13846000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20221103164109496"
      unitRef="shares">5671786</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20221231"
      decimals="0"
      id="Fxbrl_20220110121317968_43"
      unitRef="shares">5671786</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20230327130014330"
      unitRef="shares">4159870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20211231"
      decimals="0"
      id="Fxbrl_20220110121317968_47"
      unitRef="shares">4159870</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20230327130044155"
      unitRef="shares">1537060</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20200101to20201231"
      decimals="0"
      id="Fxbrl_20220110121317968_411"
      unitRef="shares">1537060</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20221103163923054"
      unitRef="Usd_per_share">3.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20220110121317968_53"
      unitRef="Usd_per_share">3.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20230327130101595"
      unitRef="Usd_per_share">4.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20211231"
      decimals="2"
      id="Fxbrl_20220110121317968_57"
      unitRef="Usd_per_share">4.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20230327130116883"
      unitRef="Usd_per_share">9.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20200101to20201231"
      decimals="2"
      id="Fxbrl_20220110121317968_511"
      unitRef="Usd_per_share">9.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230324120311516">
                  &lt;div&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                    &lt;div style="margin-left:49pt"&gt;
                      &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;For the year ended December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="10" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;(number)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;
                          &lt;tr&gt;
                            &lt;td style="vertical-align:bottom;background-color:#CCEEFF;width:64%;padding-bottom:2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;Warrants and share options&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;2,912,147&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,170,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom"&gt;&#160;&lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom"&gt;
                              &lt;div style="line-height:1.25"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;1,104,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                            &lt;/td&gt;
                            &lt;td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                          &lt;/tr&gt;

                      &lt;/table&gt;
                    &lt;/div&gt;
                  &lt;/div&gt;
                </us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"
      decimals="INF"
      id="Fxbrl_20230304173554680"
      unitRef="shares">2912147</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20210101to20211231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"
      decimals="INF"
      id="Fxbrl_20220110121447078_37"
      unitRef="shares">1170262</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20200101to20201231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember"
      decimals="INF"
      id="Fxbrl_20220110121447078_311"
      unitRef="shares">1104431</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318172242420">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 16 - RELATED PARTIES&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;A.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Compensation to the non-executive directors:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fees, including reimbursement of expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;251&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:baseline;width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/p&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              &#160;&lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:29pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;B.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify;width:auto"&gt;
                      &lt;div style="font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Transactions with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;

                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consulting fees, including share-based compensation and reimbursement of expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:65%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;

              &lt;div style="margin-left:48pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;font-size:10pt"&gt;&#160;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:49pt;line-height:1.25;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On April 4, 2016, the Company entered into an employment agreement with Sigalit Kimchy, according to which Ms. Kimchy serves as marcom and user interface lead, in a 50% part-time role (no less than 112 hours per month), for a monthly salary of NIS 10 ($2.84), plus up to 35 monthly overtime hours at a gross monthly rate of NIS 2.5 ($0.7), or an aggregate monthly salary of up to NIS 12.5 ($3.6). Ms. Kimchy is entitled to an education fund, managers' insurance or pension fund and reimbursement of monthly travel expenses. Sigalit Kimchy is the wife of Yoav Kimchy, the Company&#x2019;s Chief Technology Officer.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;margin-left:45pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember"
      id="Fxbrl_20220318172300169">
                &lt;div&gt;
                  &lt;div style="margin-left:49pt"&gt;
                    &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                            &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td colspan="2" style="vertical-align:bottom"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Fees, including reimbursement of expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;270&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;272&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;251&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:baseline;width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Share-based compensation&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;
                              &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;)&lt;/span&gt;&lt;/p&gt;
                            &lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:baseline;white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;260&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;296&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                            &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;327&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_33"
      unitRef="USD">270000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_37"
      unitRef="USD">272000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekFeesAndReimbursementMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_311"
      unitRef="USD">251000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_43"
      unitRef="USD">-10000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_47"
      unitRef="USD">24000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekShareBasedCompensationMember_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_411"
      unitRef="USD">76000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_53"
      unitRef="USD">260000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_57"
      unitRef="USD">296000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_chekNonExecutiveDirectorsMember"
      decimals="-3"
      id="Fxbrl_20220110113112075_511"
      unitRef="USD">327000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekGeneralTransactionsMember"
      id="Fxbrl_20230324123455756">
                &lt;div style="margin-left:49pt"&gt;
                  &lt;table border="0" cellpadding="0" cellspacing="0" style="width:80%"&gt;

                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For the year ended&#160;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December 31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="text-align:center;line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)"&gt;
                          &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2 0 2 0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td colspan="2" style="vertical-align:bottom"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:65%"&gt;
                          &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Consulting fees, including share-based compensation and reimbursement of expenses&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;
                      &lt;tr&gt;
                        &lt;td style="vertical-align:bottom;width:65%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:8%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:9%"&gt;
                          &lt;div style="text-align:right;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                        &lt;/td&gt;
                        &lt;td style="vertical-align:bottom;white-space:nowrap;width:1%"&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                        &lt;/td&gt;
                      &lt;/tr&gt;

                  &lt;/table&gt;
                &lt;/div&gt;
              </us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"
      decimals="-3"
      id="Fxbrl_20220110113620668_33"
      unitRef="USD">58000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"
      decimals="-3"
      id="Fxbrl_20220110113620668_37"
      unitRef="USD">61000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20200101to20201231_usgaapRelatedPartyTransactionAxis_chekConsultingFeesMember"
      decimals="-3"
      id="Fxbrl_20220110113620668_311"
      unitRef="USD">57000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220110113620668_43"
      unitRef="USD">58000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="Fxbrl_20220110113620668_47"
      unitRef="USD">61000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_20200101to20201231"
      decimals="-3"
      id="Fxbrl_20220110113620668_411"
      unitRef="USD">57000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <chek:MonthlyRetainer
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-3"
      id="Fxbrl_20220110114924624"
      unitRef="NIS">10000</chek:MonthlyRetainer>
    <chek:MonthlyRetainer
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-1"
      id="Fxbrl_20220110114910685"
      unitRef="USD">2840</chek:MonthlyRetainer>
    <chek:GrossOvertimeMonthlyRate
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-2"
      id="Fxbrl_20230304175229439"
      unitRef="NIS">2500</chek:GrossOvertimeMonthlyRate>
    <chek:GrossOvertimeMonthlyRate
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-2"
      id="Fxbrl_20220110114933927"
      unitRef="USD">700</chek:GrossOvertimeMonthlyRate>
    <chek:MaximumAggregateMonthlySalary
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-2"
      id="Fxbrl_20220110114940757"
      unitRef="NIS">12500</chek:MaximumAggregateMonthlySalary>
    <chek:MaximumAggregateMonthlySalary
      contextRef="C_20220101to20221231_usgaapRelatedPartyTransactionsByRelatedPartyAxis_usgaapImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"
      decimals="-2"
      id="Fxbrl_20220110114945527"
      unitRef="USD">3600</chek:MaximumAggregateMonthlySalary>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_20220101to20221231"
      id="Fxbrl_20220318172458396">
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 17 - SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;
                &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
              &lt;/div&gt;
              &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:49pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On March 21, 2023, the Company announced that following its internal assessment of the clinical data collected to date from its calibration studies, it has determined that the current efficacy results do not meet its goal in order to proceed to the powered portion of the U.S. pivotal study. &#160;As a result, the Company has adopted a plan of action that includes conducting additional clinical data analysis and approaching the FDA to make amendments to the U.S. pivotal study protocol that are expected to be part of an IDE supplement submission to the FDA, and which are subject to FDA approval. In addition, the Company plans to continue conducting its calibration studies, albeit at a slower pace, to collect additional clinical data and it is also implementing a cost reduction plan, in order to extend its cash runway. The initiation of the powered portion of the U.S. pivotal study that was expected in mid-2023 is therefore temporarily postponed.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        </us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F20230326072614626_125"
          xlink:label="F20230326072614626_125"
          xlink:type="locator"/>
        <link:footnote id="FN20230326072614795_263" xlink:label="FN20230326072614795_263" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of December 31, 2022, all the outstanding options in the amount of 191,892 with an average exercise price $35.35 are out of the money. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20230326072614626_125"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20230326072614638_133"
          xlink:label="F20230326072614638_133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20230326072614638_133"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F20230326072614645_137"
          xlink:label="F20230326072614645_137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F20230326072614645_137"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143351049_20230326072614626_125"
          xlink:label="Fxbrl_20220110143351049_20230326072614626_125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143351049_20230326072614626_125"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143351121_20230326072614638_133"
          xlink:label="Fxbrl_20220110143351121_20230326072614638_133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143351121_20230326072614638_133"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143351150_20230326072614645_137"
          xlink:label="Fxbrl_20220110143351150_20230326072614645_137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143351150_20230326072614645_137"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143354706_20230326072614626_125"
          xlink:label="Fxbrl_20220110143354706_20230326072614626_125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143354706_20230326072614626_125"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143354740_20230326072614638_133"
          xlink:label="Fxbrl_20220110143354740_20230326072614638_133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143354740_20230326072614638_133"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220110143354757_20230326072614645_137"
          xlink:label="Fxbrl_20220110143354757_20230326072614645_137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220110143354757_20230326072614645_137"
          xlink:to="FN20230326072614795_263"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>94
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MZ!05&U".XXQJU(FT82UMV"OM+\JH('FIC"P@(61Z=^C<68LSZ:I(AT>^#,/
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M46;K^D<\G[.RS)+Z[8J2!<TK _;],LO*YXOJ=T&[7YI-_P-02P,$%     @
M_8-_5CE4*?T] P  H0P  !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6RM
M5VUOVC 0_BM65FVKM#4O0+9V@$1)&$QM881NFJ9]<,,!41.;V0;:?S_;"2F4
M-&VU?"'VY9[GSL_9SM'<4';+%P "W24QX2UC(<3RS#1YN( $\Q.Z!"+?S"A+
ML)!3-C?YD@&>:E 2FXYEN6:"(V*TF]HV8NTF78DX(C!BB*^2!+/[<XCIIF78
MQM8PCN8+H0QFN[G$<PA 7"]'3,[,G&4:)4!X1 EB,&L9'?NLYRI_[? C@@W?
M&2.UDAM*;]5D,&T9EDH(8@B%8L#RL88NQ+$BDFG\S3B-/*0"[HZW[#V]=KF6
M&\RA2^.?T50L6L9G TUAAE>Q&---'[+U-!1?2&.N?]$F\[4,%*ZXH$D&EADD
M$4F?^"[380<@>8H!3@9P'@/J3P!J&:#VT@CU#%!_#'"? #0R0..E*;D90!?3
M3,722GM8X':3T0UBRENRJ8$NET9+@2.B-E8@F'P;29QH=X=7P?!BX'4FOH>"
MB7Q<^E>3  U[J-OO7'WU S2X0D&_,_;[PPO/'P?OD/_]>C#YA=Z/, ,B%B"B
M$,?'Z".Z#CST_N@8':&(H,F"KC@F4]XTA4Q4A3/#+*GS-"GGB:1L=$DE,4<^
MF<*T .^5XYWG\/XS\<L(3*EP+K.SE?G<*66\Q.P$U>P/R+$<IR"A;CG\VXI(
MN*7A=I$>ST6_WP:WBM0H1WL0YKD7!>^]'&Z52%G+=VQ-\]6?X!MPOL(D! 1W
M\G;E4+B_2BG497W&ESB$EB%O8PYL#4;[[1O;M;X4U:9*,B\E<S69NO77;;OF
M2EG7NP6I,F*O(K*]8M7S8M5?5RRTP8QA(J0!6!AQ0$)..=;?F:)*U@_ULAO6
MOE[=0Z>:?7JZ[^259OI*4?W#B.I<[\;K';J<.@^)[\G9R.5LE,HY8M$:"T"C
M6"8J/^\"_;Z$Y ;8GR+I2KE>>PBJ)/.J)/.K).M51+9773>OKOO_-ULIQ6N+
M6B695R697R59SST\K*>/#J*YTT(EP.:ZV>4HI"LBTF]3;LW[Z8YN(Q_9S^VS
MKEU@]V7_G;;+#_1I\RY[@WE$.(IA)D-9)Y_D'F1I0YQ.!%WJ!NZ&"MD.ZN%"
M_H< IASD^QFE8CM1 ?)_)>U_4$L#!!0    ( /V#?U:Q4KACC @  )<H   8
M    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULK5I=<^(X%OTK*G9J:KHJ-)9D
M@Y-)4D5CLDU5FF0#W?VL8!&T;2Q&,OG87[^233"69$.Z_)+8YNA:Y^K>JR-9
MER]<_)(K2C/PNDY2>=599=GFHM>3BQ5=$_F9;VBJ?EERL2:9NA5//;D1E,1Y
MHW720Y[7[ZT)2SO7E_FS>W%]R;=9PE)Z+X#<KM=$O'VA"7^YZL#.^X,']K3*
M](/>]>6&/-$9S;YO[H6ZZ^VMQ&Q-4\EX"@1=7G6&\"+"H6Z0(WXP^B(/KH&F
M\LCY+WTSB:\ZGNX13>@BTR:(^O=,1S1)M"75CW]V1CO[=^J&A]?OUF]R\HK,
M(Y%TQ).?+,Y65YVP V*Z)-LD>^ O7^F.4*#M+7@B\[_@98?U.F"QE1E?[QJK
M'JQ96OPGKSM''#2 _9H&:-< F0W\F@9XUP"?VL#?-?!SSQ14<C]$)"/7EX*_
M *'1RIJ^R)V9MU;T6:K'?98)]2M3[;+KT=UT=G<[B8;S<01F<_7OVW@ZGX&[
M&S :SKZ"F]N[GS/0!=]G$?CKCT_@#\!2,%_QK21I+"][F>J#MM1;[-[WI7@?
MJGD?1. ;3[.5!.,TIG'50$]U?L\ O3/X@AHM1G3Q&6!X!I"'D*-#H].;0T?S
MZ/3F7@,;O!\/G-O#=>-1.OWFX>X;N+L?/PSGD^F_P7 TG_R8S"?CF<OKA57?
M;547CPNY(0MZU5'505+Q3#O7?_X+]KV_71YKTUC4DK&*-_V]-_TFZ]=353@3
M+IUQ6K3LYRUU=7R^[L)SZ(67O>=#7[A@ S7855CD@N'0[^]AE?X'^_X'C=$P
MC/^K2H JLYE41?:?+1,T!AE7UPN>+EA"0;ICJ)_JZP61*["5"J;R5,T.@F0L
M?2K**\L8E1<N7P1M1D^;QJ*6C%6\W]][O]\8/1%51A>,%!-4&@.RYB)C_\L?
MN-Q8F L.@L#W?".>; SR B.8; ST0W<D#?9<!HU<9BLB:%?/D#%8\+62#;*6
MQL!Z?3@X-VC8&/\<&C0<&*^&1KBG$3;2N&$I48%/$D!?-0<*_F*IXD,_G>GP
M=[$)K5YT^\@<%1OD&61LQ,!-Y7Q/Y;RYTJ](^D2ESE,B)549KD,L8>21)7FF
M I;1M3M?S]O,US:-12T9JW@4>J68\8YD[$*)WUU4Y%>?M'_5NS:$Q;F#>;:B
M0BDK(515/?1\RM-N];%3W7AV_@ZP$4T.4#?PC12*'"CHU4P8\$#/P4873-)W
M%\3TP 69(#%5T\"";_5DLB%OY#&A9_J)V))$.GQS$(I.3T!')1N8GK!!N&_.
MG0Y0%\.:](*H] 3Z'4_0]2;A;Y06E)4C!$^2O1^<3)'=OX'GF51ME!^8)=$%
M\LYKF)::$3:*J#+L%3W!WTB2EX^-X,],UM3XG<6JSTWMXP(A:_1<H)HR#TOA
M!H\KMZ-:QDG,M[L#PX$=F2Y<'_5]DYX+AR'$-0Q+:0>;M9VI]"?3'^/9"4H?
MMBK66K46M66MZM)2K\%FP7:_%8N5S@.^U-&O(B9[R[-<2^>-EM%.A]IRJ^N'
M?3->'"CH>7TS7!PP/*C+\%*]P6;Y-DF?:;$0T+D@5TJ'=C,JUN"1I+\.:G=,
M-URRFJG+UF-=6"R:JTQ=N, S"U[DQ'G> -60+34>;!9Y5NZSG/T)N>_0>A %
MUIK.B>L[!M.%\PZK>I5A*?W@$>UGY/[-9#J<CD[(_5:%7ZO6HK:L53>!2NF'
MFJ7?^)6*!2MR_X4(0;3,8:E:%G,1JU6#>%-IH]9 ,E\H:!23<JL6$_1]*>$,
M*62+-'/B=T#@.8*FW&NT5"5=BCUT1.R]4U!T#)JYZ%M1(.@3DZI4J$R*F5K.
M:NI+*E0R?=03MDH+P\!RAD/PP= S=9 #!CV(:^HD*C4?:M9\=QN]J)6*2!$-
M3B*V!K-8.&2:R:#)2K7WI8Y#S3JN:3AUC3^(ZWQL?Q;W8!_[<W4K2;ZC_L'!
MM46<Y9.CD,@!"0>P9CY I19$S5KPA"C?"/9,,O4_415&3Y,?I&^+/(O^44CD
M@/@#7#-9H%(HHD;55$Z'N:"/52(_OH%EL1%R=$K<V3Z6M38J@)ZY2Q(Y8 @'
M8=T E[H-->LVS9"Y5VN:^%E!7XNX9Y+DFZ$Z&]3P9X(M,KVCI7YWLG>H,81P
M/S#Y.W;<PD%@\7?!:LB7T@XU2[O1R0P!R?)@?U0E/4WUV*OXU@_>*!%.^K9"
M0_W06@HY8*$78).\"X6#&OJEV$/-8N_C]*E6NT>(V\+-]WU3Z#I0#O=$#EC%
M/57BI09$S1IPMMULDKQ6D41-S7*1<+D5>9'+MZ(TXV6BK+*T^+Q;LY)'K6K"
M5JU%;5FK?DHK-2%NUH2_MQ[$ME##9L%P8&#?%#D.D%^3+[B4?+A9\MWF1?)P
MFY@()G4Q6 J^!OPQ(RRO#4)_\>[R95>MHAHV-+%#L%D5P@%2ZZ#0Y.M U:V5
M<"GI,/K=/#DY1W"C:OSPY]$VK45M6:NZ]^![<[/F'.7*0N^.*P^"C+RZ=02V
MI9V5$S8$FY-(HYDJ@U(>XB/R,-7+&YGIKZ*4/9N'"G;]M[598 ;PR &R-JN=
MAFHHE!(/-^\%/HQ'=VK]?SL9SB=WT_?#%V?%$8SQ?[Y/?@QO\V,9PVD$'L:S
M^<-DI ]LY+_/[\#\ZQA43G)\&=X.IZ,QF'T=C^=.?[2ZB]BJM:@M:]7!*-4H
M;E:C>4;H6<(4)4X_NK[YGIOZVH%"?3\PE88#-AAX-4H#EPH3-RO,!T-'*:F=
M;/4ZXOCG+FR+/AR8.LH),A='1T!5:J5ZQ,WJ<<[UK.!>))R=NDK8O>/P\(9#
M+3I0+K7H@#G48N_@Q-::BJ?\Y)L$^=>YXNC3_NG^=-TP/U-F//\"+Z+BC%QI
MICBR]XT(M4R0(*%+9=+[/%"N%\4IN.(FXYO\7-@CSS*^SB]7E,14:(#Z?<EY
M]GZC7[ _BWC]?U!+ P04    " #]@W]64MXC@&<2  "2,@  &    'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;,U;6W/;.)9^]Z] ::9FK"I9EF0[E^XD58J=
M3'NW<]FX,]G:K7V 2$A$FR(8@+2B^?7SG7- BI1E)[O5N[4/B242.#@XE^]<
M +W8.'\;,F,J]6V=%^'E(*NJ\J?3TY!D9JW#V)6FP)NE\VM=X:M?G8;2&YWR
MI'5^.IM,GIRNM2T&KU[PLX_^U0M75[DMS$>O0KU>:[]];7*W>3F8#IH'G^PJ
MJ^C!Z:L7I5Z9&U-]+C]Z?#MMJ:1V;8I@7:&\6;X<S*<_O3ZG\3S@[]9L0N>S
MHITLG+NE+]?IR\&$&#*Y22JBH/'GSER:/"="8.-KI#EHEZ2)W<\-];>\=^QE
MH8.Y=/D7FU;9R\&S@4K-4M=Y]<EM?C%Q/Q=$+W%YX/_5)HZ=#%12A\JMXV1P
ML+:%_-7?HAQ^9,(L3I@QW[(0<WFE*_WJA7<;Y6DTJ-$'WBK/!G.V(*7<5!YO
M+>95K_[VYOV;3_-?U?7[MQ\^O9O_=OWA_8O3"H3I]6D2B;P6(K,'B$QGZITK
MJBRH-T5JTCZ!4W#4LC5KV'H]>Y3BE4G&ZFPZ4K/);/8(O;-VFV=,[^P!>A_\
M2A?V'YHL8:0N71%<;E,MAE&DZJ,WP125/'!+]=86NDBLSM4-'AI88174?\X7
MH?*PH_\Z)")AX/PP ^1;/X52)^;EH*2U_)T9O/K+GZ9/)C\_LKWS=GOGCU'_
M42T^3N3]A]_>J*DZ40>H'<W'1W\SA?$Z/SJ>#H\N,Y/<JDM=JE^K=*R.J\RH
MO_SIV6PV^?G2K4M=; =#M=%!V2)QOG0>0DQ5#>OPBL;F>A-(SO29)4Q?KH/7
M)A^KW_#0FY4-E?&8I=,4$N/AMJ(_2YL84 YJ]ES-%PNM?JE#9M7\SA2U&8',
MTFZU.IM,GD\FDU%#]NAX-CPBTI%!E8$]K3:9R_/MB=L46"K4BV!3"W2"D= 6
M3VB+GV] I$C&(["KJ__VMJX,'FN/SX5ZI[=J>D%F/;T 1V=]CBPQE$ O-M'Y
M2:B BFIM4OJFP-6J<*&R25!)'*\M$&&E*@=Q 8F@3[S*G0?B848""P9?QY>?
M+H<J)-Z8@D:3N<,$(2PV]BKSKEYES+(M*N_2.FF\X/+D!D1@I4_/?Q[QB*7U
MH6(2KLBWJH3#@,[)TN-/2@^\*;5G-\)#8SKK5@8SP6IJ*O"G2I=ORZ 6!H'%
M$.TM8&VKX%]%H%A#S+BX!S&)*"4RL^G3GP,D$GQ=$JAC6!GJW)P0/J>]-9.L
M@$16+*M RP>[*BPL2!<5^(4>$<I"ET^=9C [+$OQ)$\!QX8WG)F\! +G.?;&
M2BZ-*W/#-"MPGAF=5]FV%6@C8[ '#>P6&$>QJCK BNEOCDV?(#JJU(&3?S_Q
MH!9W-*(!D(19B:F5+E@2+NB,H&O25\[<0>?.I\1_V,)OUI@8U ;!COZ6WI70
M4 6[5L$M*[9&\+UBCX:5PENN(/ZRL5U;X(4B0P3!^(PLJVB9AZD6T+$M[G2@
M+0H/7VL+5\6;KB$HAR3 I!%[=8Z=LFY ,]H/*X9V8^' ],)ZE6H+_4"4%9GU
MQE89D251>-8Z 7<0QD14Q!)M%'N&H+IFO=* ;4=3X3X%/(-!7"VVJM!5#4A3
M:U?9W%9;N.3Y\.C&DO8):^A#*7Q7>\B1FCM71<BH8$R(%> 7_S4X998P8]D:
M ;[V2<92PD2D0B6%E%'K[& )!,*(].AKJ!@"6NL" $#C>![;,H_%>LLE))F0
MN-ED0S!5$!UH&^@1A&(! CW/(0E! F#1%LQBAQ6>W'(CT,-6KTF=E=HB/VS,
MA33-6!OZY#,!QMH3:N<ND'U#&'^>/A]-)\^8W)^G3T<(Z0JB88EN(1>(BK(&
MX&1BU@O871/W>08^3$DLH32<P.7;L9H'P=6]\3TE_17R2))Z7>?,,<%C8@6\
M=0D[^6:1TH$:6)J!I^=GLA?SK2)I1)O?T5K6L!1 >$D2( ''_;%F,+(2*,:\
M!3R1/V.1)72P@&F2O]6$9!72Y/M"6]8L (YNL@!!#&$E.2=<%_DR>4-CU.1G
MU19@S$E*L8+=!)V;-D(2$+"O9]I''N'R0-8JB(S,-^,3&WA&\T90'6_]CK#
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M;[A0 _85IIX)@8F'0B+U#+2&MA'94IBZ=<X15Y[N.;HA@'(6<*=8Q8,3U9H
M9I4>GU$P99I*6HJ@W 8FV:/@Q@:/VCI)WA#KD4Z$!WI",/[U<XXC?I)VX'64
M6D&T[+P/CEV,6,H?+0/@<&-KI(.3+-=.)F(0R :@&FB!7P  &P,0*&'&M"+A
M.U- _61\,1@/V)U728%3-5'"?3D=<;0CT^E!>B]''<DE*8MBW&4X.,B?5JT&
M= !,015MM6FI8,(GAW)+J?W$'QM"'+!YNUKGBULVF\3]HV!O*>^0*G,J,9]<
MVW@2NAO5Y_?&//6JL"-J(_HM/)7DRQ (:3-0S&U)#1G:8\<3E::4*F KW284
MTG^P@WE?C"#O0X0DY&%1CQ1.*"$H*PD@:X4#-YQ[;M@5]^AOD,.B7+Y0!QBT
M":'C^XX,@L^-:EL6A9*PW%;P45BK32W3R1]=!+%7-B\/JT;QI3;<:5"@9W6?
M*%(#J;0,LPO 281QF+%8 N4Z)Y;M-P57^4J.C5^^IA82F2336'\G')'U5_G]
M_H!<NN#:0S1P(57B0F"C\(F(JWJ$\1664EZ%+%S;PX*8P)'Q1)4>'LZ6M*T
M/=130HW+5D9G>[ZQK,QE(@M.Q7;$P1WSU1M'U2+3_R_Q;?4/T%Z7QT<H[_(H
MY9'=4'$_8/;0%.:U+,QKSQN#FB<<(B' C<\O 50Q#0T=$&NQK6^?=C%Z3.N2
M: %;B1*N?MO,_I+8.T&MLECP1_],QC016*.?/#^)+P:7 _9>*YP]ZK&FV>%]
M/58<UHG@KDRDW1%8<*PB8-"R?=;)-G9_![(^!ON<KQMA(_XLI:EVA7NNRCK?
M*RX-UIKO.+3QC/@=B79&+DNW8]BFP /$'K*EW\=0%]2?PCHB):3%AEAK5:J>
M2O8TR4,F.XD'LUTBM D[25NXSNU^3B;8DJ/3B2?X3]R  !I..4+NA]M[BW#T
M:A6T[[-=17;=<]Y?\O1X<DC4E9F^[Y5#=UJ\]%XL39AH9SZNR?](3$1%K08*
M7WSE8A_P),4$@C[>4$<&I:>)'0]>#CJC?+X/HM/I6?1AU^F="-\+@*^:YK[G
MB*1$) @)=8C\'-@#27Q^.N'NUTFSZ3W10I.$]=#OCS(2#IPN==5\26E,S2BY
MSE_4SU5!GP5JV==MP\@/$$[&_1$&5Q(^N;Q IE$#U4%)81=;4&?[4)")A%L<
MFL!$*-1PFQ(N-E3=+D^L^ $.IP7/7_95]#MR'?GS=E2#$M6@1+>DON)#V^EU
M=!*=SR[W]K/23PEALS:UHYA'3.!+0XQ3[3VIM'Z4#"])/\D%S?UZD<S 9(FL
M%J$A]_@#FPVCFR.)(DM%M8<ME? LBGK^L4Q;M!/F4;;U-S TFM[C^UK0M IZ
MV%4$&20SYX-)V-M]WCH$#P" R&0P^<> ??-;:G6 ]:?#>@S? R>@+QZD]4X^
M32MXC=@7H4N[:6;I@[,Z]JW28=2N":'.;.B=)TIY-X+!6+N(/M>24;@AB>C0
M2*4QC>GG)(IG_L<TH$-37C09CZ+ +JLNGR)TP602T;!"%5"&$RW1MW71Z6P4
MG572AV>*)5<\3P2LHWE8UYW*L'6UE0FS]A=XEGFPPRU7\[:Y(YR'J['=\G#!
MB+T&!RXJV15$1X.7TUX8J.H'IPM_409N<#KS/S>H5F%H ;ZOM';U QEH;DYO
M_@M02P,$%     @ _8-_5G(CL;5L!0  I0P  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&ULI5=M;]LV$/ZN7W'0L"T!'+_(29JDB0$[==$ :6(D;8=B
MV =:.MM<)5(EJ;C>K]\=*<MV6QL#]D46R;N'S[WJ?+W4YHM=(#KX5N3*WL0+
MY\JK3L>F"RR$;>L2%9W,M"F$HZ69=VQI4&1>J<@[2;=[WBF$5/'@VN]-S.!:
M5RZ7"B<&;%44PJQ&F.OE3=R+UQM/<KYPO-$97)=BCL_H/I830ZM.@Y+) I65
M6H'!V4T\[%V-3EG>"WR2N+1;[\"63+7^PHN[[";N,B',,76,(.CG!6\QSQF(
M:'RM,>/F2E;<?E^CO_6VDRU38?%6YW_(S"UNXHL8,IR)*G=/>OD.:WO.&"_5
MN?5/6 ;9TVX,:66=+FIE8E!(%7[%M]H/6PH7^Q226B'QO,-%GN4;X<3@VN@E
M&)8F-'[QIGIM(B<5!^79&3J5I.<&X_>3^\?/XS&,Q@_CMW<?GF'X\ 8FP\]/
MC_?W,+R]??HXO'^^[CBZBS4Z:8T["KC)'MQ> N^U<@L+8Y5AM@O0(9(-TV3-
M=)0<1'R#:1OZO18DW20Y@-=O+.][O/X^RXLRURO$$X.Y<)C!O113F4LGT<*?
MPZEUAE+FKY^9'H!/?P[,971E2Y'B34QU8M&\8#SX[9?>>??U =JG#>W30^C_
M(V"'<1\>/XSA'$[@OUT0#=O1K2Y*;257UU5$X<%BBH9#%"70A022^K<7/2^T
M<2<.30%8NQVFJ' FG;V*1O4;4(^!%Y&*4*\JHZI/J=/X92E6T5ER&9V]ZD?K
M2*V\!IT8G><MF&I560H>:RZIH]CH53^)>JW^Q04]D_,>/2_I.6I'$VW=2:!"
M'<8U9&!2&5L)VG$:[JP1F/]NX1E?T B5(DS$"N[%L@6]R_-^JY:0C5%TMT$@
M0.ERRBC"L(TJT03\6HF<M[5"*+@^"-V*G-JA-P5%NH 5"@-Z!AMZ+: S 24Y
MD5WA%FA0S]HPS',6I#5P+(1:$=R&BV]]@<840:HTKZ@4H:*"-&13:(N]TS7$
M'BOA*-[(QL=T:YIJDTDU9^#-46N?%[3*5RSJ[:77#'W6V!8(1U89*CZF<-'N
M]W^MN4C32 ?OM*CG96Q#?:I$@=0IW8*V;!58I]X%5+UM-H#]9EE!>+I>PBML
M&4Z5C]31MQT(,Z,+\"^5J\B,G0 &T.! 5EK'?Y_K)'^X;$DW!L,T7=9XZ74(
M),4=6[!N0L):="&%\ZU^Q Y5VH%O*(H%@ROHBY3[>_T7@$JR?;#6HJ/><301
M,MN46296%NY^=!.#?Z9,I!!\6LN282>]R[,>'/%IO+T?'[?VYN'W-2$@1>-H
M8 !5^99!OBE_)'6@(-K[&&]3\D[DFA8EC3"9_-;R.\)2!K)[J $V;A1S@UAW
M K=$5#LYP6J\;DP*MF[8[Q(O:=-S)EN7"TD6>#.::$B[<0>]\U#!5>(Q*;I2
M&VYM=56NM=KP86M%Y; ":G;?W=Q +0B7W$?Y!0HQJWOBVDN;(*5:6=]@O&?2
MU%2A&@SR0)<%ZRINJ]]%IT5CW/1O3FPRDC5*HU^D']5JXMNA".1WN5:.DOL?
MPIU)8YU/DE @U/(SR2G."<!(:64,A\;[E(G2U99:*>WE6P6[+@7Z;BL[0]+)
MPF&@1VX-"$?\<8'X_N[M8\P>DY:;FMKX=KG0E*'>E3Q2<J>;^C*M.?O6MU5[
M/R1 <&2V$VAR4]U &KNV],G%:W?L0+6CH^0X>JJ;0RF,[P8TCU+BAHD\#,=S
M$3JRV96D*)$]#YHZ;.^\_;/IH[,U.A9HYGY YKRHE M39+/;S.##,'INQ,,
M_UZ8.75CR'%&JMWVJ[,83!B*P\+IT@^B4^UHK/6O"_H?@88%Z'RFB6B]X N:
M?R:#?P%02P,$%     @ _8-_5J16H,G9"0  %QH  !D   !X;"]W;W)K<VAE
M971S+W-H965T,30N>&ULG5EK;]LX%OWN7T%X)K,-X,BV\FJ;!^ \!EMLVQ1-
M.KN+P7R@)=KBAA(U)&4W^^OW7%*295=),(O!-+9T>>_A?9Q[29^OM7FTF1".
M?<]582^&F7/E^_'8)IG(N8UT*0J\66B3<X>O9CFVI1$\]8MR-8XGDY-QSF4Q
MO#SWS[Z8RW-=.24+\<4P6^4Y-T]70NGUQ7 Z;!Y\E<O,T8/QY7G)E^)>N&_E
M%X-OXU9+*G-16*D+9L3B8CB;OK\Z(GDO\)L4:]OYS&@G<ZT?Z<N']&(X(4!"
MB<21!HX_*W$ME")%@/%GK7/8FJ2%W<^-]E_]WK&7.;?B6JM_RM1E%\.W0Y:*
M!:^4^ZK7?Q?U?HY)7Z*5]?^R=9 ]/!RRI+).Y_5B(,AE$?[R[[4?.@O>3IY9
M$-<+8H\[&/(H;[CCE^=&KYDA:6BC#WZK?C7 R8*"<N\,WDJL<Y<?/E_??;IE
M#[-_W=Z?CQTTTO-Q4J^^"JOC9U9/8_9)%RZS[+9(1;JM8 PH+9ZXP7,5OZCQ
M1B01.YR.6#R)XQ?T';;[._3Z#I_;7Y'H7+ '_IW=2)LH;2LCV.^SN74&&?%'
MWYZ#QJ-^C50E[VW)$W$Q1!E8859B>/G+3].3R=D+>(]:O$<O:7\U'B^O_GSW
M<,M.V0'KJAG,HL%#)MBUSDM>/+'K3"2/!]>\9!]=&C%IF>/?18H"2;1)9;%D
M3K,/UG"A)+UBBJ_M^\$T&EQK4VK#G?"/Z8-ELJAE&=EHEB4_2)+@D^#&4F0G
M/KYUE!DO4J:+-3>I)33QX5XTB /FCWS-P#S,X?,M0ED9, 4XP3&]8-B"=%RQ
M#\5*6$=/[8A-WQV_8V](?MAY3HJ&^^P;LC0HVWDW KQ$57[W,SQ-O8W/.F(G
M$W)'SQ+&+2NKN9(HOI1V-RN-5-C1Y'C$YD]L)8VK!.'T8*Y$(1;20?2V<,)
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M;DC@F!J$=LT7,M#^%G3Y/U!+ P04    " #]@W]65WI*A8(,  #8(@  &0
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M"IS(IXW0&'+RC!XNYCJ>"^U$Y50B2"R2/RV,GFKHK,7$LB@INA!!UDB#=:4
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M2ZMJRZ1;LR5@$QC@[*R-0"!KO]*!.0ZU6?XPSTUH-C,F$5#(TP#-I'+(7X>
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MJ\?L6C2U@X8N=]L"KGF\J_=LQ6#;O*UH.]V$FI&3'&R>TPA'U_IM<J "2%@
MF)NZ7M]"\JSV6942Q/&@'Y\V(+G-&6O^"FT6I-^CR_=NCE87B%,L]>Q6E&W]
M!>&'E=?W5')U]X7:3<'WQ->V#3-OIKF+:>YNMQJXRI>:)T*Z'/^YZ;+(_U_)
M<O9BLI VCZ)O*=OBGDU5PTBD_A]BNY5!S+.\HS8^W.]QV?/9*9^W#4T2D =K
M +3<6'=E4,7#6_I-*M@6]#JN===&RG)N-YJNCX;]Z*2/TC)B7KCA<6MK)=S@
M!*]L=;86DO/IU M?3Z.01;W_+;V'X\W\#FIZ'(Y-<UJ 7\UAK_A<XS^(>,)X
M*U;^#==%T(<?G!0._7+L6J';-%UO'GUOV$??UN^,^YU?%=QEFCTPD?Z9#UOY
MXF75$ZQEWUKD'/V7"7:,3FJ,?U,6'?K)*W9U1T5Q0.=88=ZAV_<:ZNBSU*)9
MS*M8?.*3)HRCC4^\ZJD*2Y^WAZ=;*MC^^*#3/IYVKJ)KO0K0)7'T+QS+[5D-
MR#K=&)+\FB\F5,S_L"II_)KI&"\Q?'*]0"P?U;)=$K@KWG4--I=/?FY?*NI=
M5:,QZ7<N^YUK=-@FM)O?<UV\G@W:W_7Y?QTL_578$JCSG3!H/S26_6W_I#YJ
M?=L@Q7#!WZF@>1%-IO_B0?.T^=K&N?^VPFJY_\X'J&&F,X++%%L'_=/CKJ?8
M^D.9%_S=A4E>EGG*?\Z5A+-I =Y/<P0P?" %S9=9WO\74$L#!!0    ( /V#
M?U9Q$YW(]P,  *H)   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;+U6
M36_;.!"]ZU<,U*)H -<?<IQF4]N DSAH@"8-\K6'Q1YH:6P3H4B%I.)D?_W.
M4(KBP(G17GJ11&KF\;V9X9##E;%W;HGHX3%7VHWBI??%0:?CTB7FPK5-@9K^
MS(W-A:>A771<85%DP2E7G:3;W>OD0NIX/ QS%W8\-*574N.%!5?FN;!/AZC,
M:A3WXN>)2[E8>I[HC(>%6. 5^IOBPM*HTZ!D,D?MI-%@<3Z*)[V#PUVV#P:W
M$E=N[1M8R<R8.QZ<9J.XRX108>H90=#K 8]0*08B&O<U9MPLR8[KW\_H)T$[
M:9D)AT=&_2TSOQS%^S%D.!>E\I=F]1UK/0/&2XURX0FKRK:_&T-:.F_RVID8
MY%)7;_%8QV'-8;_[CD-2.R2!=[508'DLO!@/K5F!96M"XX\@-7@3.:DY*5?>
MTE])?GY\,CF]A-O)CYLIG$TG5S>7T[/I^?75L.,)G$TZ:0UT6 $E[P#U$C@S
MVB\=3'6&V6N #K%JJ"7/U Z3K8C'F+:AWVM!TDV2+7C]1FH_X/7?DRJDA5NA
M2H1CZ5)E7&G1P3^3F?.6JN/?MT17D+MO0_*..7"%2'$4TY9P:!\P'G_ZT-OK
M?MM">+<AO+L-_7=RLQ7H;9KG/Z^G\!=\@7>6B4YYSZ3&9D*G2&7IES"Y.H)S
MTX;]I-L"OT0X,GDA]!/D**IH2N\@-QII2M@[:BKS4F<.A,Z .@CM$4U5;2WJ
M](DVCY4/@G<EI%0ZG .R)!=.U ,GJLTUM8%ER5X)Y^1<8A:(20T_\ $5]-IP
MO91$P\$,4U$Z9)KT)'/TE6] SJ!T4B_@OC2>!O4"A94IB3 6A/)H=46.9]G6
MF=+R;Q:3FPR5@])+)?_CGS6"F7%XQ4PA2%V4U##AY-=T;U&5$/T0;J8N0C>K
MP(,7-Z4,:*[64HL(+#=(9=0DP,S!R5PJ80F'BK^D+LM,KU\R^NG#?M+[^LW!
M7&K*OQ3J.81UJK/7F>+U!75I%LGA(%+2M0 ?4U5F/$&E9#GL4E-@T7F2GA>4
M7%JXQ6$@<R9/U%CHW"@Z+MC//Q6<D?DZ4P['AB$I0W<04=? ?(:VZ1S1R0O)
MFGL%4A5 "&18):I+J'XGT;7Q0D5'PBU#,%/^P/N2<J<8X"#:+,[H8Y2T!_7S
M)Q&T==H]*"EF5"Q>,LMM-;$F-/I"4)\'>]%.\PZD-K/R>0U^IV'QXMJG\<Y&
M<'I_/#@MZHW-^W6 *B6_'IN/T=Z@>KP=D[7E@F'22I(!O-67.VOG9XYV$6X)
MCJJRU+XZ2IO9YB(RJ<[?%_/J%G,F[()(@L(YN7;;7P<QV.IF4 V\*<)I/#.>
MSO;PN:3+%%HVH/]S0YNX'O "S?5L_#]02P,$%     @ _8-_5GDQP7+C$P
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MG8B;%2W6WEF?.=9Z]LV-;;'KSEYUAC--([E#56++C)(<NU9CKILQJL6X^^#
M48YKS&ZU N[!Y3H/G1Y6[CJN=>HG9@M4T^ ]H,4B84$$0"-):F*HO' :*M=.
M6AI<2H]A>"W1&5DJNNJ)'M+JV8F(Y;C8(=J9^T#*TEG.3FI!Z3PX[,W<L>T7
M%Z^T7\;<\7Q#O_]9T -YI?B13/6I^HG1:_'+FLUP\?NDL-$-8 N6\#5,=0%U
MGXG?KJO?E-F>?F?S/BO+;$<OMSP 7XX#X/MU!F!*OL$%U ^OOOHG4$L#!!0
M   ( /V#?U:<K"WO9@\  #LR   9    >&PO=V]R:W-H965T<R]S:&5E=#$X
M+GAM;-4;:7/;N/4[?P7&Z[32# 7S/K))9AS;V4UGU_'$278ZG7Z@14AB0Y$*
M#\OJK^][#R!%4D=L=]O9_9"(!(&'=U^ 7ZWSXFNY$*)B#\LT*U^?+*IJ]?+L
MK)PNQ#(J>;X2&7R9Y<4RJN"UF)^5JT)$,2U:IF>687AGRRC)3MZ\HK&;XLVK
MO*[2)!,W!2OKY3(J-F]%FJ]?GY@GS<#'9+ZH<.#LS:M5-!>WHOJ\NBG@[:R%
M$B=+D95)GK%"S%Z?G)LOWSHXGR9\2<2Z[#PSI.0NS[_BR_OX]8F!"(E43"N$
M$,'/O;@0:8J  (UO"N9)NR4N[#XWT-\1[4#+752*BSS]+8FKQ>N3X(3%8A;5
M:?4Q7_\L%#TNPIOF:4G_L[6<Z]@G;%J75;Y4BP&#99+)W^A!\:&S(# .++#4
M HOPEAL1EI=1%;UY5>1K5N!L@(8/1"JM!N22#(5R6Q7P-8%UU9O;G\\_7DW>
MGM]>7;*+#[_>7%W?GG]Z_^'ZU5D%T''.V51!>BLA60<@F1;[-<^J1<FNLEC$
M?0!G@%:+F]7@]M8Z"O%23#FS39U9AF4=@6>WM-H$SSY$ZR(JQ 1E&+.;: .J
M5;'SHHBRN:#G?YS?E54!>O+/?=1+V,Y^V&@[+\M5-!6O3\ X2E'<BY,W?_G!
M](P?CV#NM)@[QZ _24K'(5U_^'3%3)--V"&8VCG7?A*9**)4,[GV/F/3/,N4
M$:V3:L&JA6# IZR<B8+E,Q:E*?[@\%U=PH9ER<!K%!$N*5F4Q6#SP-HHJQ*8
MN^DNB,I25"6^72S$].OD(EJQ7WZY8%5.GR_RY2K*-BS)0 F,4.\-PMIZ";*D
ML=YJ=$GL<Y94[,.*\+Y)HXR-<.()?</WDS%GY]-I7L1)-F\V;+_VMTJ C+I:
MY$7R;]PP9W.@OP(J)8DPL*J+Z0)4BQ$\\&^L1'4K&T(;2#!5+%=IOA&BU%F<
M%,#9O)!< D:7X$T \G 99Y_@I=F.-@<\HH/8,]B:S:44@>'B0133I(SN4L'
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M#'2C$*!X>F 8@T^VI;! IO@2&=-VNDIEJ5 #AF^,M4!W?*OW18(PN!DX!,/
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MH+(*=+^3TIP$Z^#\]9K]#5!+ P04    " #]@W]6*81N+OP"  !<!@  &0
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MCSOR\3GTO\W96="7*2_N'E(((W@+?^"37:MZITSINNV24<^ +1!^HM" K@R
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MK*K]&[M1EEYLWRWI%PFUVT#K6T6WUPW< ?U/U_)?4$L#!!0    ( /V#?U8
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MC0!_<_#8G?JLN0;4M?P^VS9M6IBG_2W,8(4\FL\.MB<\0>*_R):UJ(BK$(2
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M    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;'U47V^;,!!_YU.<F#1M4E7
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M4$6#B>![$"9;HYE)8[6IUN)R9BXE5D+OYKI.!<M5M SO%A!]7T8/<11#^+"
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MFX8#/GI#.;FDNB(W6#;D3OCRL^_X 3@U4! CR9<&%"Z*-?$F]SD[>/=^9S^
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MY6C>CT+K@GIHF+4!IDT \DJ /H&%DG9GX%;FF/]/$#JUG61RD#PE9QGGF%W
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MRQ2_*E!6 <_74IH7P3JH/[_H#U!+ P04    " #]@W]6I/)Z:U@,   &*
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M/V*5_NI,-YIRKK[TNBV;IIRIQZE,L?NA 7@_*<NF;= $W:=_9_\&4$L#!!0
M   ( /V#?U9)\3VC.P,  * &   9    >&PO=V]R:W-H965T<R]S:&5E=#,U
M+GAM;'U5;6^;,!#^[E]A,6GJ)%; D(1V2:2T86JEM8M*]R)-^^# ): !9K;3
M=/]^9T-9)J7YD/CM[GF>\_F.Z5[(7ZH T/2YKAHU<PJMVTO/4UD!-5?GHH4&
M3S9"UESC4FX]U4K@N76J*X_Y_MBK>=DX\ZG=6\GY5.QT53:PDE3MZIK+/U=0
MB?W,"9R7C8=R6VBSX<VG+=]""OI+NY*X\@:4O*RA4:5HJ(3-S%D$EU>1L;<&
M7TO8JX,Y-9&LA?AE%K?YS/&-(*@@TP:!X_ $UU!5!@AE_.XQG8'2.![.7] _
MVM@QEC57<"VJ;V6NBYD3.S2'#=]5^D'L;Z"/9V3P,E$I^T_WG>T(&;.=TJ+N
MG7%=ETTW\N?^'@X<8O\5!]8[,*N[([(JEUSS^52*/97&&M',Q(9JO5%<V9BD
MI%KB:8E^>OZ0I,GBX?J&+NZ7=)E\33Y]7MTE]X\T^;Y*[M,D=>E]\DC/'OFZ
M O5NZFDD-:Y>UA-<=03L%8* T3O1Z$+1I,DA_Q_ 0[6#9/8B^8J=1%Q"=D[#
MP*7,9^P$7CA<06CQPM>N !1PF164-SE=PA,^U!:?G:8_%FNE);Z;G\?"[D"C
MXZ"FEBY5RS.8.5@L"N03./.W;X*Q_^&$Y&B0')U"GZ=8F_FN BHV]%7YR3-6
MK@*%&01]+(*3',<CP$J@N@#Z!RDIF(0B90;U&J1)"6'4IXRR?@SZT2<IK[@L
M05F1$BJNT1-Z@21VV6A")F[$8C)V@TE(TH)+>&_*+:>9J(T=-U5,HHN0A.R"
M!.,1N4,46?)*$88 ,0E=G_DD<"<7C*2[=8;/SF1/R(X6UPIKE3=:H5$X&9'8
MF@=^2): ,69EQ\%B@X\_%I)KH33%WH>BMZ5Y#;:7X+6W2&Z1(L08A>@0D<]X
M-=* C^. Q.. 1'&,!JX1'3!W$J.I[_I^3#Z!4@@A=9F5[8!I;O;V=D'.&&/D
M'3F+P@"']^11:%Y1>9CH_"#1,"2Z 6WXV"0P?&%TT?/18V_..^@:-<BM[8T*
MKVG7Z*Z!#+M#^UUT7>>?>=>[[[C<EHVB%6S0U3^?C!PJNW[8+;1H;0]:"XT=
MS4X+_(2 - 9XOA%"ORP,P?!1FO\%4$L#!!0    ( /V#?U9Y(V@V]@(  #8&
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;(55;8_3, S^WE]A%0F!
M-*YMVKT=VZ0=&W 2=TRWXT5"?,A:=ZUHDY%D[/CW.&FO#&DWOC2Q8S]^[,3N
MY"#5#UT@&GBH*Z&G?F',[C((=%I@S?6%W*&@DURJFAL2U3;0.X4\<TYU%; P
M' 0U+X4_FSC=2LTF<F^J4N!*@=[7-5>_K["2AZD?^8^*NW);&*L(9I,=W^(:
MS:?=2I$4="A96:/0I12@,)_Z\^CR*K'VSN!SB0=]M >;R4;*'U:XSJ9^: EA
MA:FQ")R67_@&J\H"$8V?+:;?A;2.Q_M']+<N=\IEPS6^D=67,C/%U!_YD&'.
M]Y6YDX?WV.;3MWBIK+3[PJ&Q3<@XW6LCZ]:9&-2E:%;^T-;AR&$4/N' 6@?F
M>#>!',L%-WPV4?( REH3FMVX5)TWD2N%O92U471:DI^9O5O>+N_F'V!^NX#Y
MXN;Z]GI]?S>_O_Z\A.77U?)VO5S#BWN^J5"_G 2&(EJ_(&W1KQIT]@1ZQ.!&
M"E-H6(H,LW\! J+:\66/?*_86<0%IA<01SU@(6-G\.(N_]CAQ4_ECP(5KX"+
M#.89%;C41G'[4F#Y0"]?(WR;;ZPN-=]/%:"!3T[#VY:ZU#N>XM2GGM&H?J$_
M>_XL&H2OSY!/.O+).?39FEHTVU<(,H?_)Z)/T3\;X#1]Z@8P!<)OY K0WBO0
MK6"]065OQF,0 @/6KE&[AMZ:5UR5J!U%A14WY(DM-R_J#4>)QWIAPF@_&(^\
M=<$5OK(MET$J:VO';2?W0*#QXM' BP84)8F]E9(Y:CLGJ "699DZQ'#,O&$4
M>OUAXGW,<])27&$< 3NP# HN4B0,PAI27+);(&6:EBZ2%T4#+QYXK.]]I(R5
M)GY1/";D43^D+R/L>VDHZ/:H^OS?ZG<9]GO#0>PEO3%%BGMCEL"I)Q <]7*-
M:NLFEJ8"[(5IVKK3=D-QWLR"O^;-1+WA:EL*#17FY!I>#/L^J&9*-8*1.S<9
M-M+0G'';@@8[*FM Y[F4YE&P ;I?Q>P/4$L#!!0    ( /V#?U;@G3Q_^@(
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M)Z@[Q[+F'!24#,3:E$V)VQ2Y*FM+/5M7YF%9D/Z9EV7]B8EU@N)-886N[DV
M-UJ4I;(<*+XQY6G)%18[TXWQZP*$-L#U%>=J/] ;U-\K@[]02P,$%     @
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M$NP2'C=0]U\9DV\7<8#\2'C\'U!+ P04    " #]@W]6MQL=,Y8"  !D!@
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M^P2PK\9Y0F@?S0 S?Z^)T)V1P'"K5<[Y!VTBFIG6;!0OZ[&PX4H/F7J9Z<\
M"E.@KV\Y5P\;,VFZ#TOX%U!+ P04    " #]@W]6^7R5YY(#   K$   &0
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M!YZR/E^U0ZN)9&G>4<R85/U)/ERH%A*X#E#W0\;D\T0W*653ZO\#4$L#!!0
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M-,6I )DG"1&[2V1\VW<\9W\PHZNU,@=NV,O("N>H'K*IT)Y;L<0TP512GH+
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M0YW&#3/Z%Z"R";2^DM(\![;=='^7^ ]02P,$%     @ _8-_5C#SZ88;#0
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M1Y5T.=?#) H3H-]/.5?;C9E7\O'4^P=02P,$%     @ _8-_5FU+]5T9!
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MY9J6:UFN;;F.Y5++=2W7LUQFN;[E!I8;6FYDN;'E)I:;6BX">[@'!"X"@9M
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M6ZYAN:;E6I9K6ZYCN=1R7<OU+)=9KF^Y@>6&EAM9;FRYB>6FEHO 'NX!@8M
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M<@/+#2TWLMS8<A/+32T7@3W< P(7@<!-(' 5B/^OM[MK3MO>MP#\53S] &G
M>:GW[.G,;PH( 9( \2)TYS9NFCG9=L=V]M[]]L=.2B++/F#HT],K$I,'>I&L
M->*/%NX"@<M X#80K@ZTBFZW470/V3<[Z"CN;OGPSFO7S"C7M]S <HGEAI9+
M+3>RW-AR$\MEELLM5UAN:KF9Y>:6*[?<@R6XMYVGCN+2%UY:;F6YM>4JRVTL
M5ULN]H7]$746+YY9#X=\X)0/'/.!<SYPT(=+^E:=;2R>G>U>//LK1W%WTX?W
M63MY1KF^Y0:62RPWM%QJN9'EQI:;6"ZS7&ZYPG)3R\TL-]]RS0+:>?.P>Y;V
M-1>66UIN9;FUY2K+;2Q76R[V!?T1518/F5D/YWO@@ ^<\($C/G#&APOY5I5M
M#)G=/=YY9?;\CW]=W!?7KZ<0TIN;3^>7=[7VIZN;7==E=[J']UC)]2S7M]S
M<HGEAI9++3>RW-AR$\MEELLM5UAN:KF9Y>:6*[?<@ULDW%^5?7Q95K[NTG(K
MRZTM5UEN8[G:<K$OZ8_HLM3#$1\XXP.'?."4#QSS@7,^7-"WNFQCJ^QL]U;9
ML[]5-KW^\._SVXN3Z<>[MW-??_=\O\QNF5&N9[F^Y0:62RPWM%QJN9'EQI:;
M6"ZS7&ZYPG)3R\TL-[=<:;F%Y9:66UEN;;G*<AO+U9:+?77AB$*,%\^LAYM
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M+#>T7&JYD>7&EIM8+K-<;KG"<E/+S2PWMUQIN87EEI9;66YMN<IR&\O5EHO
M'NX!@8M X"80N H$[@*!RT#@-A"N#K2*[K=!M?O'NR[V_GF-]^3JT^W-[?GE
MNP^7[Y\NN'1(S7(]R_4M-[!<8KFAY5++C2PWMMS$<IGE<LL5EIM:;F:YN>5*
MRRTLM[3<RG)KRU66VUBNWG(/;M+QP^GIV<N'!UIB7[ ?45WM1!KV<,8'#OG
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MN;GE2LLM++>TW,IR:\M5EMM8KK9<["L#AY\DL!XN H&;0. J$+@+!"X#@=M
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MS2U76FYAN:7E5I9;6ZZRW,9RM>5B7^8?T6JIAZ,[<'8'#N_ Z1TXO@/G=[@
M_])JO[_Y[>+BMG=^>_[C/_]U<?W^XJ>+CQ]O3GZY^G1Y>_\BC=\]N;[X]>X=
M=/X1W>^^?_3[1><?5>>)WZ_OGM][Z@<QO/M)^ODGWW][Y1__^?M=R<W.K]]_
MN+PY^7CQZ]V[>/GB[>OO3JX_O/_MZR]NKWZ_2[#O3GZ^NKV]^M?GA[]=G+^[
MN+Y_PMW/?[VZNMW^XOX%_G-U_3^?_T]__%]02P,$%     @ _8-_5B$M_>KV
M(P  U_8" !D   !X;"]W;W)K<VAE971S+W-H965T-38N>&ULQ=U;<]M&@H;A
MOX+RIF:3JHQ$@.>,XRK':)S/C60OIO:"D2")%8G4D)03;\V/7U"B!#9$M0CG
MS<@7"2T33Y.BW9_0S8]X__MR]=OZJJHVQA\WUXOUC^^N-IO;'TY/UV=7U<UL
M?;*\K1;UGUPL5S>S3?W;U>7I^G95S<[O#[JY/K5ZO='IS6R^>/?A_?W7LM6'
M]\N[S?5\464K8WUW<S-;??FINE[^_N,[\]WC%XKYY=5F^X73#^]O9Y>5K#8_
MWV:K^G>G3\KY_*9:K.?+A;&J+GY\]]'\H32M_O:(^[O\,J]^7^_=-K;/Y=?E
M\K?M;_SS']_UM@^INJ[.-EMC5O_O<_6INK[>4O4#^==.??<TZ/; _=N/NG/_
M[.MG\^ML77U:7O_/_'QS]>.[R3OCO+J8W5UOBN7O7K5[1L.M=[:\7M__U_A]
M=]_>.^/L;KU9WNP.KA_!S7SQ\/_9'[OOQ-X!EOG" =;N *M]P/2% _J[ _K'
MCC#8'3 X]H#A[H!AZX"^]<(!H]T!HV-'&.\.&!\[PF1WP.38 Z:[ Z;''F#V
M'E^YWM&'/+W8SU[MX4N'/+[<YM&OM_GX@IOM5WSPXE_"QY?<?/::OSC*XXMN
MME_UET=Y?-G-9Z_[BZ,\OO!F^Y5_\:^*^?C2F^W7_N51'E]\L_WJO_BZ6(^O
MOG7_ZI\^_(._GRWLV6;VX?UJ^;NQVMZ_]K8W[J><^^/K26*^V$Z/<K.J_W1>
M'[?Y(+V/A?C[3Q^EL(U/:9R)1'XL_30QODUFJ]5L.W5]9WQK5YO9_'K]G?&-
M,5\8Y=7R;CU;G*_?GV[JA["%3L]VPWD/PUDO#&<:\7*QN5H;8G%>G1\X/GKE
M>$L#G-;/_>D;8#U^ WZRM&(P6YP8O<'WAM6S^L;Z:K:J#CVO3WK%KLYJ97JO
MF,;/TC:^_>:[ES5;KWV\NZRUX4Y[41''*(/7%.>(9V;V[I6>\;?_FO1'UC^,
MTYWW,NL>_Q1[+RO>$0_.>OBV6QT>G*]GX]FJ9LW.;'#$7S5KW)D-]:RL;FNV
MMWN=CV>C([ZW_9>^"0>\N(OWZC^1Y'BM^0=W_)-/OX9_4<N.UWI?\6#SK^%?
MU(JC-7/ZLB+15[OL,KWJ_RXJ*=!_BL'^_0#]E_X-;:&_;W_,/C<^+6_JDX_U
M[/ZG]X]U""XNJ_J$8&/\^L78OU\V^W+_Y8^_SU;GQC^CFC3\376S_M\#3_"G
MA_$'A\??G@3]L+Z=G54_OJO/<M;5ZG/U[L/?_LL<]?YQ*(Q(S"8Q06(.B;DD
MYI&83V(!B84D%I%83&()B:4DEI%83F(%B4D2*R%,R9'!4XX,=/H'MTZ+39T-
MYW>K^>+2V%Q5QFVUFB\/G>K\I*6Z1@*)V20F2,PA,9?$/!+S22P@L9#$(A*+
M'[#A/;9=%?[\83BQ^M/WIY_WYWIRR/3YD-/IM#]4A\S((?/G0_9[D[ZE#EF0
M0TH2*R%,F9V'3[/S4#L[BS^JU=E\7<_)J_E99?S[F+/:G[1DUUF:Q&P2$R3F
MD)A+8AZ)^0^8N?^/T>R=F).!^J\Q( <-22PBL9C$$A)+22PCL9S$"A*3)%9"
MF#+KCYYF_9%VUE?6<ZH_MK>W<_\WAR9[K=1ULB<QF\0$B3DDYI*81V(^B04D
M%I)81&+Q S;:__EXW/KI."$'3)\/.)B:K1_'R0'S P/V)JT?QLD!)8F5$*9,
MR^.G:7FLG9;3V^V$O#:6=YOU9K8XGR\N#\W(6J3KC$QB-HD)$G-(S"4QC\1\
M$@M(+"2QB,1B$DO&S]8BS,%P,FW-\.EQ=\N>WVTX&)HC]5[Y4?<JGM_+&@^&
MK7O) P]L:DZFK<64$OJ>*;/DY&F6G.@7E*M%M9I=&_4$:7P\OYDOYNO-P]MR
M#+'[4?:?<77S:[4ZN.NHQ;O.GB1FDY@@,8?$7!+S2,PGL8#$0A*+2"PFL83$
M4A++2"PGL8+$)(F5$*:$Q/0I)*9O_.Z5*9DC)&:3F" QA\1<$O-(S">Q@,1"
M$HM(+":QA,12$LM(+">Q@L0DB940IN2(V7L*DFU[!%HKUU-=0P'5;%03J.:@
MFHMJ'JKYJ!:@6HAJ$:K%.TU959ZT5B42=,CTP)#FJ#5DA@Z9'QC2&O1;"SGH
MD!+52DI3Y^J]YI:IGZNKU68V7QCBYO9Z^:6JUMJ5(#W6>;8F-1O5!*HYJ.:B
MFH=J/JH%J!:B6H1J,:HEJ):B6H9J.:H5J"91K:0T-2BL)BBL-UX>VCT *EQ(
MS48U@6H.JKFHYJ&:CVH!JH6H%J%:C&H)JJ6HEJ%:CFH%JDE4*RE-#9>F.&MJ
M^U3=&D]ZJW-.H#585!.HYJ":BVH>JOFH%NPTY1T>HTFOIRXRA.B@$:K%J):@
M6HIJ&:KEJ%:@FD2UDM+4 &@:K]L/:=($P%>5JO1FYR @-1O5!*HYJ.:BFH=J
M/JH%.\U4UK>MD^FHG03DJ!&JQ:B6H%J*:AFJY:A6H)I$M9+2U"1HVK6FOE[[
MTW*[5K2\,.SYJCK;+%>O[$B@S5I4LU%-H)J#:BZJ>:CFHUJ :B&J1:@6HUJ"
M:BFJ9:B6HUJ!:A+52DI3DZ)IY)JCM]Z10)N\J&:CFD U!]5<5/-0S4>U -5"
M5(M0+4:U!-525,M0+4>U M4DJI64IH9+TRLV]<7B;CL2:+\8U6Q4$ZCFH)J+
M:IYYH/TY-:U6W]1'!PU0+42U"-5B5$M0+46U#-5R5"M03:):26EJ #25:5/?
MF?ZZ'0FT*HUJ-JH)5'-0S44U;Z<IJ_Z#$W/0#@*T"HUJ(:I%J!:C6H)J*:IE
MJ):C6H%J$M5*2E.#H*E%F]JVW =9+>;+E1'/%K/=FI)V/P(M.:.:C6H"U1Q4
M<U'-0S4?U0)4"U$M0K48U1)42U$M0[4<U0I4DZA64IIZ";"F]FSUWG@_PD++
MTJAFHYI -0?57%3S4,U'M0#50E2+4"U&M0354E3+4"U'M0+5)*J5E*:&2]/3
MMO0][4[[$7JK<TZ@-6U4$ZCF[#3EG?ZF-6R]T]]%!_50S4>U -5"5(M0+4:U
M!-525,M0+4>U M4DJI64I@: U02 MH+W=?L1>K-S$*"5:E03J.;LM.E>$(Q.
M!NT80)O2J.:C6H!J(:I%J!:C6H)J*:IEJ):C6H%J$M5*2E-CH&E*6_JF]"^W
MQJ?Z:_.SV;5V'T+/=)[YT9(TJ@E4<U#-134/U7Q4"U M1+4(U6)42U M1;4,
MU7)4*U!-HEI):6I$-%WJ^N8;[T,,T' A-1O5!*HYJ.:BFH=J/JH%J!:B6H1J
M,:HEJ):B6H9J.:H5J"91K:0T-5R:>K:EKV=WVX= R]FH9J.:0#4'U5Q4\U#-
M1[4 U<*=INP&/=L,BM Q8U1+4"U%M0S5<E0K4$VB6DEIZOS?E*XM_760OVX;
M NU1HYJ-:@+5'%1S4<U#-1_5 E0+=]K^9I#5.QFU<P#M1Z-:@FHIJF6HEJ-:
M@6H2U4I*4W.@Z4=;^GYT<+>H#,MZVH.HD^#3U;RZ,.J .+N[O[1H>G%11\1J
M_RYE??9P5I\RI O]%4?U@W<.#+10C6H"U1Q4<U'-0S4?U0)4"U$M0K48U1)4
M2U$M0[4<U0I4DZA64IH:+$WOVIJ\]>X%6M)&-1O5!*HYJ.:BFH=J/JH%J!:B
M6H1J,:HEJ):B6H9J.:H5J"91K:0T-5R:+K>E[W)WV[U J]P[;7\U>3@>MJ\B
M8*.#"E1S4,U%-0_5?%0+4"U$M0C58E1+4"U%M0S5<E0K4$VB6DEI2@#TFXYV
M7W]I:KLZNU]U,J;?&U;/,K6K4'JK:P"@FHUJ M4<5'-1S4,U']4"5 M1+4*U
M&-425$M1+4.U'-4*5).H5E*:FA--W;IOOO$J5!_M:*.:C6H"U1Q4<U'-0S4?
MU0)4"U$M0K48U1)42U$M0[4<U0I4DZA64IH:+E83+OHJ=Z=5*+W5.2?0"C>J
M"51S4,U%-0_5?%0+4"U$M0C5XIVVOR+;G_3[K9I_@@Z:HEJ&:CFJ%:@F4:VD
M-#4 FA)W7U_B=F;SE?%Y=GU7;2]TM[S=GEFLC?KLXG*;#,;Y;'/L.VOU W5.
M![3FC6H"U1Q4<U'-0S4?U0)4"U$MVFG/+L\Z42?T&!TU0;44U3)4RU&M0#6)
M:B6EJ?'0%+CKF[IX^*J.A=[LG 2D9J.:0#4'U5Q4\U#-1[4 U4)4BW:::>TE
M@34Z>18$Y* )JJ6HEJ%:CFH%JDE4*RE-#8*F;-W7EZU?W*W>MBVJU68V7]0G
M$/<M"_U5LO7C= X'M(B-:@+5'%1S4<U#-1_5 E0+42U"M1C5$E1+42U#M1S5
M"E23J%92FIHA36&[_]97R>ZC[6Y4LU%-H)J#:BZJ>:CFHUJ :B&J1:@6HUJ"
M:BFJ9:B6HUJ!:A+52DI3PZ5I@??!JV3KK<XY@9:Z44WTGU\[VK1ZX]:UHQUT
M4!?5/%3S42U M1#5(E2+42U!M135,E3+4:U -8EJ):6I ="TM?OZJV3'LR^&
M-;Y?G>KI5Z#0TC6JV:@F4,U!-1?5/%3S42U M1#5(E2+42U!M135,E3+4:U
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MR^7F\3?; 7Y?KGZ[?SH?_A]02P,$%     @ _8-_5H_=P(6$%@  <EP! !D
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M\%L#FLL&-*:ME5'102B[;6TQR$+!@195*$VC-$/1_"18\YG+;C"FK951T4E
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MHOF!L )V_.+Y4YD0??Q1Z=JS=YNN-AL*72VZ.1JE&8KF1\-ZUK$\?MK?U<J
MZ&1L&SH==CY_B195*$VC-$/1_.-O!>A8%J QC:V,BDY"OK6Q3<.E<M&J"J5I
ME&8HFA\%ZS['/78PHK&54=%10"5H2_/NUG8N%E#/B=(,1?-C8#WG6/:<3P^
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M 5<"N+]B3.XGZH#J 3CZ U!+ P04    " #]@W]6BMSLR"\'  #!(P  &0
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M2?",)$* /Y_',=O]$!T4;^V,_@-02P,$%     @ _8-_5IXJ/:*^!   _1,
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MI@#R>4:I>-FH%[03>/034$L#!!0    ( /V#?U9W?*>WB0,  -D*   9
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MM&\F_?/K-T);>PX3^T>H[71QP<J'40^.TMPYI+J#D@]WR8O1IXI)XTXQ6&"
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M8=J&1L\0Q0Q1C$:9/-/BB\4Q8P+U,<\T"#S/][$5G4Z-"J;8NOD^_)C9,&V
MP.) I*>M-9YMO$(.UP&6TT,5@LT4KT1LIOA:@\>\;H ( G.VL3B P+* U0[$
M-\>!FC)C/ ^RBFG#=C#N"0+, [5HKE'?1U;'AZ\Y/]@N\;P@,'O 9U;@>9@'
M=B/NP12 !LSC><5[<.]]Y&S?4T[]SZC)7U!+ P04    " #]@W]6EXJ[',
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M]=4M:K5_D^:;L&+M3__EBVFU*].[8Y[/U+Z@<,MT>_HX]?1A[?5_4$L#!!0
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M;_EL_"/:X@502P$"% ,4    " #]@W]6!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /V#?U:2PMS_
M[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /V#?U:97)PC$ 8  )PG   3              "  <L!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ _8-_5HTUTD'+!@  9B
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M965T-2YX;6Q02P$"% ,4    " #]@W]6.50I_3T#  "A#   &
M    @(%9)   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @
M_8-_5K%2N&.,"   ER@  !@              ("!S"<  'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+ 0(4 Q0    ( /V#?U92WB. 9Q(  )(R   8
M          " @8XP  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M    " #]@W]6R0C3@Q@5  "V.P  &               @($K0P  >&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ _8-_5@6-@:.0 @  J@4
M !D              ("!>5@  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q0
M2P$"% ,4    " #]@W]6H-MYU/ "  !&!@  &0              @(% 6P
M>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( /V#?U9H_&.?
ML@<  $45   9              " @6=>  !X;"]W;W)K<VAE971S+W-H965T
M,3(N>&UL4$L! A0#%     @ _8-_5G(CL;5L!0  I0P  !D
M ("!4&8  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " #]
M@W]6I%:@R=D)   7&@  &0              @('S:P  >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( /V#?U97>DJ%@@P  -@B   9
M          " @0-V  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#
M%     @ _8-_5G$3G<CW P  J@D  !D              ("!O((  'AL+W=O
M<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #]@W]6>3'!<N,3  "$
M50  &0              @('JA@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM
M;%!+ 0(4 Q0    ( /V#?U:<K"WO9@\  #LR   9              " @02;
M  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ _8-_5O1%
MC$@^ P  R08  !D              ("!H:H  'AL+W=O<FMS:&5E=',O<VAE
M970Q.2YX;6Q02P$"% ,4    " #]@W]6*81N+OP"  !<!@  &0
M    @($6K@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (
M /V#?U;%QEI1]P(  %$&   9              " @4FQ  !X;"]W;W)K<VAE
M971S+W-H965T,C$N>&UL4$L! A0#%     @ _8-_5LM.1'\"!   @ D  !D
M             ("!=[0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"
M% ,4    " #]@W]6 ']OP?\#  "A"   &0              @(&PN   >&PO
M=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( /V#?U95[K&)PP,
M & (   9              " @>:\  !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&UL4$L! A0#%     @ _8-_5C(L^V(C%@  .D0  !D              ("!
MX,   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #]@W]6
M2WO:!YD"  !U!0  &0              @($ZUP  >&PO=V]R:W-H965T<R]S
M:&5E=#(V+GAM;%!+ 0(4 Q0    ( /V#?U9S+4/\E (  '\%   9
M      " @0K:  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%
M  @ _8-_5@(N/!.W @  Q04  !D              ("!U=P  'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #]@W]6]S^?(+T"  !8!@
M&0              @('#WP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+
M 0(4 Q0    ( /V#?U8U0/'>J0(  )<%   9              " @;?B  !X
M;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ _8-_5C1Y).!H
M @  +P4  !D              ("!E^4  'AL+W=O<FMS:&5E=',O<VAE970S
M,2YX;6Q02P$"% ,4    " #]@W]6+(<W0G8"   R!0  &0
M@($VZ   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( /V#
M?U:;7!O&^P(   @'   9              " @>/J  !X;"]W;W)K<VAE971S
M+W-H965T,S,N>&UL4$L! A0#%     @ _8-_5J3R>FM8#   !B@  !D
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M=#,X+GAM;%!+ 0(4 Q0    ( /V#?U;+?C=X^0(  +L(   9
M  " @9P' 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @
M_8-_5J$9F_BE!   'AX  !D              ("!S H! 'AL+W=O<FMS:&5E
M=',O<VAE970T,"YX;6Q02P$"% ,4    " #]@W]6MQL=,Y8"  !D!@  &0
M            @(&H#P$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4
M Q0    ( /V#?U;Y?)7GD@,  "L0   9              " @742 0!X;"]W
M;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ _8-_5K8J;WW8 @
MV0<  !D              ("!/A8! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6Q02P$"% ,4    " #]@W]6E:,YXY,"  "B!@  &0              @(%-
M&0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( /V#?U;2
M^2VH;0,  * .   9              " @1<< 0!X;"]W;W)K<VAE971S+W-H
M965T-#4N>&UL4$L! A0#%     @ _8-_5D5IM!Y !0  <B   !D
M     ("!NQ\! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /V#?U98O;(\@0(  &D&   9              "
M@;\R 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ _8-_
M5C#SZ88;#0  B\,  !D              ("!=S4! 'AL+W=O<FMS:&5E=',O
M<VAE970U,BYX;6Q02P$"% ,4    " #]@W]6>DD@#OT"  "J"@  &0
M        @(')0@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0
M   ( /V#?U9M2_5=&00  /T6   9              " @?U% 0!X;"]W;W)K
M<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ _8-_5K'M0?;/:P  $-<)
M !D              ("!34H! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q0
M2P$"% ,4    " #]@W]6(2W]ZO8C  #7]@( &0              @(%3M@$
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( /V#?U:/W<"%
MA!8  ')< 0 9              " @8#: 0!X;"]W;W)K<VAE971S+W-H965T
M-3<N>&UL4$L! A0#%     @ _8-_5N6GJ7Y6!   1A,  !D
M ("!._$! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " #]
M@W]64TX#67 #   ,#@  &0              @('(]0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( /V#?U:*W.S(+P<  ,$C   9
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M970V-"YX;6Q02P$"% ,4    " #]@W]6440Y%LL"   H"   &0
M    @(&^$ ( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    (
M /V#?U:ND+-U# 4  /D@   9              " @< 3 @!X;"]W;W)K<VAE
M971S+W-H965T-C8N>&UL4$L! A0#%     @ _8-_5H6M,H>? P  F1H   T
M             ( ! QD" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #]@W]6
MEXJ[',     3 @  "P              @ '-' ( 7W)E;',O+G)E;'-02P$"
M% ,4    " #]@W]6NI%_RDP%  #<*P  #P              @ &V'0( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ _8-_5A[?F5X< @  /2<  !H
M         ( !+R," 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ _8-_5J5_#G'N 0  D"8  !,              ( !@R4" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     $H 2@ ]%   HB<"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>323</ContextCount>
  <ElementCount>327</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-dei</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/check-cbs</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-csoo</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-equity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-equityp</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-csocf</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - GENERAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-info</Role>
      <ShortName>GENERAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sigp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-peaoca</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-ppe</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-ebapa</Role>
      <ShortName>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0014 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-itax</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-cacl</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0016 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-fvm</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0017 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sed</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0018 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sbp</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0019 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-raden</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0020 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-gaae</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0021 - Disclosure - FINANCE INCOME (EXPENSES), NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-fien</Role>
      <ShortName>FINANCE INCOME (EXPENSES), NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0022 - Disclosure - LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-eps</Role>
      <ShortName>LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0023 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-relp</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0024 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sigpp</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sigpt</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sigp</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0027 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-peaocat</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-peaoca</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0028 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-ppet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-ppe</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0029 - Disclosure - LEASES (Table)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LeasesTable</Role>
      <ShortName>LEASES (Table)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/Leases</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0030 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-ebapat</Role>
      <ShortName>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-ebapa</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0031 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-itaxt</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-itax</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0032 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-caclt</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-cacl</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0033 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-fvm</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0034 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sbpt</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbp</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0035 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-radent</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-raden</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0036 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-gaaet</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-gaae</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0037 - Disclosure - FINANCE INCOME (EXPENSES), NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-fient</Role>
      <ShortName>FINANCE INCOME (EXPENSES), NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-fien</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0038 - Disclosure - LOSS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-epst</Role>
      <ShortName>LOSS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-eps</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0039 - Disclosure - RELATED PARTIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-relpt</Role>
      <ShortName>RELATED PARTIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-relp</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0040 - Disclosure - GENERAL INFORMATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-infod</Role>
      <ShortName>GENERAL INFORMATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-info</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sigpt</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sosapd</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sigpt</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-peaocad</Role>
      <ShortName>PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-peaocat</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-ppet</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-pped</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-ppet</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0046 - Disclosure - LEASES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LeasesDetails</Role>
      <ShortName>LEASES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/LeasesTable</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0047 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails</Role>
      <ShortName>LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/LeasesTable</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0048 - Disclosure - LEASES (Schedule of Future Lease Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails</Role>
      <ShortName>LEASES (Schedule of Future Lease Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/LeasesTable</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0049 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-ebapad</Role>
      <ShortName>EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-ebapat</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0050 - Disclosure - INCOME TAXES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-itaxt</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0051 - Disclosure - INCOME TAXES (Schedule of Deferred Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-itaxd</Role>
      <ShortName>INCOME TAXES (Schedule of Deferred Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-itaxt</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0052 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-caclt</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0053 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-caclt</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0054 - Disclosure - FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0055 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sed</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0056 - Disclosure - SHARE-BASED COMPENSATION (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/Share-basedCompensationAwardsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbpt</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0057 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbpt</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0058 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbpt</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0059 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-sbpced</Role>
      <ShortName>SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbpt</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0060 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/Share-basedCompensationOptionActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-sbpt</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0061 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-radend</Role>
      <ShortName>RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-radent</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0062 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-gaaed</Role>
      <ShortName>GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-gaaet</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0063 - Disclosure - FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/chek-fiend</Role>
      <ShortName>FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-fient</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0064 - Disclosure - LOSS PER SHARE (Schedule of Loss Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails</Role>
      <ShortName>LOSS PER SHARE (Schedule of Loss Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-epst</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0065 - Disclosure - LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails</Role>
      <ShortName>LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-epst</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="zk2329433.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0066 - Disclosure - RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails</Role>
      <ShortName>RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://check-cap.com/role/chek-relpt</ParentRole>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" original="zk2329433.htm">zk2329433.htm</File>
    <File>chek-20221231.xsd</File>
    <File>chek-20221231_cal.xml</File>
    <File>chek-20221231_def.xml</File>
    <File>chek-20221231_lab.xml</File>
    <File>chek-20221231_pre.xml</File>
    <File>exhibit_1-1.htm</File>
    <File>exhibit_12-1.htm</File>
    <File>exhibit_12-2.htm</File>
    <File>exhibit_13-1.htm</File>
    <File>exhibit_15-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image00014.jpg</File>
    <File>image1.jpg</File>
    <File>image10.jpg</File>
    <File>image11.jpg</File>
    <File>image12.jpg</File>
    <File>image13.jpg</File>
    <File>image3.jpg</File>
    <File>image4.jpg</File>
    <File>image5.jpg</File>
    <File>image6.jpg</File>
    <File>image7.jpg</File>
    <File>image8.jpg</File>
    <File>image9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="801">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>99
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2329433.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 801,
    "http://xbrl.sec.gov/dei/2022": 45
   },
   "contextCount": 323,
   "dts": {
    "calculationLink": {
     "local": [
      "chek-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "chek-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2329433.htm"
     ]
    },
    "labelLink": {
     "local": [
      "chek-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "chek-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "chek-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 633,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 80,
   "keyStandard": 247,
   "memberCustom": 66,
   "memberStandard": 32,
   "nsprefix": "chek",
   "nsuri": "http://check-cap.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://check-cap.com/role/chek-dei",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0010 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://check-cap.com/role/chek-peaoca",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0011 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://check-cap.com/role/chek-ppe",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0012 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://check-cap.com/role/Leases",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:EmployeeRelatedLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0013 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://check-cap.com/role/chek-ebapa",
     "shortName": "EMPLOYEE BENEFITS AND PAYROLL ACCRUALS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:EmployeeRelatedLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0014 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://check-cap.com/role/chek-itax",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0015 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://check-cap.com/role/chek-cacl",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0016 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://check-cap.com/role/chek-fvm",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0017 - Disclosure - SHAREHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://check-cap.com/role/chek-sed",
     "shortName": "SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0018 - Disclosure - SHARE-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://check-cap.com/role/chek-sbp",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0019 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://check-cap.com/role/chek-raden",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://check-cap.com/role/check-cbs",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:GeneralAndAdministrativeExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0020 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://check-cap.com/role/chek-gaae",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:GeneralAndAdministrativeExpensesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0021 - Disclosure - FINANCE INCOME (EXPENSES), NET",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://check-cap.com/role/chek-fien",
     "shortName": "FINANCE INCOME (EXPENSES), NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0022 - Disclosure - LOSS PER SHARE",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://check-cap.com/role/chek-eps",
     "shortName": "LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0023 - Disclosure - RELATED PARTIES",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://check-cap.com/role/chek-relp",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0024 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://check-cap.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://check-cap.com/role/chek-sigpp",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://check-cap.com/role/chek-sigpt",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0027 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://check-cap.com/role/chek-peaocat",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0028 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://check-cap.com/role/chek-ppet",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0029 - Disclosure - LEASES (Table)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://check-cap.com/role/LeasesTable",
     "shortName": "LEASES (Table)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "NIS_Per_Share",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "chek:EmployeeRelatedLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0030 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://check-cap.com/role/chek-ebapat",
     "shortName": "EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "chek:EmployeeRelatedLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0031 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://check-cap.com/role/chek-itaxt",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0032 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://check-cap.com/role/chek-caclt",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCommitmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0033 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://check-cap.com/role/FairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0034 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://check-cap.com/role/chek-sbpt",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfResearchAndDevelopmentExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0035 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://check-cap.com/role/chek-radent",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfResearchAndDevelopmentExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "chek:GeneralAndAdministrativeExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0036 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://check-cap.com/role/chek-gaaet",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "chek:GeneralAndAdministrativeExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0037 - Disclosure - FINANCE INCOME (EXPENSES), NET (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://check-cap.com/role/chek-fient",
     "shortName": "FINANCE INCOME (EXPENSES), NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0038 - Disclosure - LOSS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://check-cap.com/role/chek-epst",
     "shortName": "LOSS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0039 - Disclosure - RELATED PARTIES (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://check-cap.com/role/chek-relpt",
     "shortName": "RELATED PARTIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapRelatedPartyTransactionAxis_chekNonExecutiveDirectorsCompensationMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://check-cap.com/role/chek-csoo",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0040 - Disclosure - GENERAL INFORMATION (Narrative) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://check-cap.com/role/chek-infod",
     "shortName": "GENERAL INFORMATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221123",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "NIS_Per_Share",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "us-gaap:DerivativesMethodsOfAccountingHedgingDerivatives",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://check-cap.com/role/chek-sosapd",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "chek:ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_srtRangeAxis_srtMinimumMember_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapOfficeEquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "chek:GovernmentInstitutionalAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0043 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://check-cap.com/role/chek-peaocad",
     "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid Expenses and Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "chek:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "chek:GovernmentInstitutionalAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0044 - Disclosure - PROPERTY AND EQUIPMENT, NET (Narrative) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0045 - Disclosure - PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://check-cap.com/role/chek-pped",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Schedule of Property and Equipment, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0046 - Disclosure - LEASES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://check-cap.com/role/LeasesDetails",
     "shortName": "LEASES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0047 - Disclosure - LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails",
     "shortName": "LEASES (Schedule of Supplemental Cash Flow Information Related to Operating Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfFutureLeasePaymentsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0048 - Disclosure - LEASES (Schedule of Future Lease Payments) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
     "shortName": "LEASES (Schedule of Future Lease Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfFutureLeasePaymentsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "chek:EmployeeRelatedLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedVacationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0049 - Disclosure - EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://check-cap.com/role/chek-ebapad",
     "shortName": "EMPLOYEE BENEFITS AND PAYROLL ACCRUALS (Schedule of Employee Benefits and Payroll Accruals) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "chek:EmployeeRelatedLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedVacationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://check-cap.com/role/chek-equity",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20191231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_srtRangeAxis_srtMinimumMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "chek:ReductionInIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0050 - Disclosure - INCOME TAXES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_srtRangeAxis_srtMinimumMember",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "chek:ReductionInIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percent",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0051 - Disclosure - INCOME TAXES (Schedule of Deferred Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://check-cap.com/role/chek-itaxd",
     "shortName": "INCOME TAXES (Schedule of Deferred Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "chek:RoyaltiesProvision",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0052 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapPropertyPlantAndEquipmentByTypeAxis_usgaapVehiclesMember",
      "decimals": "-2",
      "lang": null,
      "name": "chek:MonthlyVehicleLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "chek:RoyaltiesProvision",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0053 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Reimbursement Liability) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember",
      "decimals": "-2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0054 - Disclosure - FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Schedule of Market observable data of similar instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231_usgaapFairValueByMeasurementFrequencyAxis_usgaapFairValueMeasurementsRecurringMember",
      "decimals": "-2",
      "first": true,
      "lang": null,
      "name": "us-gaap:MoneyMarketFundsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221123to20221123",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0055 - Disclosure - SHAREHOLDERS' EQUITY (Narrative) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
     "shortName": "SHAREHOLDERS' EQUITY (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ClassOfWarrantOrRightOutstanding",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0056 - Disclosure - SHARE-BASED COMPENSATION (Narrative) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
     "shortName": "SHARE-BASED COMPENSATION (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20220127_srtTitleOfIndividualAxis_chekCertainEmployeesMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0057 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
     "shortName": "SHARE-BASED COMPENSATION (Schedule of Awards Granted) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapAwardDateAxis_chekGrantDate1Member",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0058 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION (Schedule of Parameters Used in Valuing Fair Value of Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "chek:ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapAwardTypeAxis_usgaapEmployeeStockOptionMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Percent",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0059 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://check-cap.com/role/chek-sbpced",
     "shortName": "SHARE-BASED COMPENSATION (Schedule of Share-Based Compensation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20200401to20200531",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://check-cap.com/role/chek-equityp",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20200401to20200531",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0060 - Disclosure - SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION (Schedule of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "chek:GeneralAndAdministrativeExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalariesWagesAndOfficersCompensation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0061 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://check-cap.com/role/chek-radend",
     "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET (Schedule of Research and Development Expenses, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "chek:ScheduleOfResearchAndDevelopmentExpensesNet",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapIncomeStatementLocationAxis_usgaapResearchAndDevelopmentExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:SalariesWagesAndOfficersCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "chek:GeneralAndAdministrativeExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SalariesWagesAndOfficersCompensation",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0062 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://check-cap.com/role/chek-gaaed",
     "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Schedule of General and Administrative Expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "chek:ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "chek:GeneralAndAdministrativeExpensesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "chek:ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0063 - Disclosure - FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://check-cap.com/role/chek-fiend",
     "shortName": "FINANCE INCOME (EXPENSES), NET (Schedule of Finance Income (Expense), Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:OtherNonoperatingIncomeAndExpenseTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0064 - Disclosure - LOSS PER SHARE (Schedule of Loss Per Share) (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails",
     "shortName": "LOSS PER SHARE (Schedule of Loss Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0065 - Disclosure - LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails",
     "shortName": "LOSS PER SHARE (Schedule of Anti-Dilutive Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231_usgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_chekWarrantAndShareOptionsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0066 - Disclosure - RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
     "shortName": "RELATED PARTIES (Schedule of Transactions with Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://check-cap.com/role/chek-csocf",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0008 - Disclosure - GENERAL INFORMATION",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://check-cap.com/role/chek-info",
     "shortName": "GENERAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://check-cap.com/role/chek-sigp",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2329433.htm",
      "contextRef": "C_20220101to20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 100,
   "tag": {
    "chek_AccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Policies [Line Items]",
        "label": "Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "AccountingPoliciesLineItems",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_AccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Policies [Table]",
        "label": "Accounting Policies [Table]"
       }
      }
     },
     "localname": "AccountingPoliciesTable",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.",
        "label": "Share-based compensation, shares"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionShares",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with warrant exercise transaction.",
        "label": "Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Warrant Exercise Transaction",
        "terseLabel": "Issuance expenses warrant exercise transaction"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsWarrantExerciseTransaction",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_AmountOfPortionOfOrdinarySharesOfSuchLender": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents amount of portion of ordinary shares of such lender.",
        "label": "Amount Of Portion Of Ordinary Shares Of Such Lender",
        "verboseLabel": "Amount of portion of ordinary shares of such lender"
       }
      }
     },
     "localname": "AmountOfPortionOfOrdinarySharesOfSuchLender",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_AntiDilutiveWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti-dilutive Warrants [Member]",
        "label": "Anti-Dilutive Warrants [Member]"
       }
      }
     },
     "localname": "AntiDilutiveWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_AprilMayOfferingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April-May 2020 Offerings [Member]",
        "label": "April-May 2020 Offerings [Member]"
       }
      }
     },
     "localname": "AprilMayOfferingsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_AprilMayRegisteredDirectOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April-May 2020 Registered Direct Offering [Member]",
        "label": "April-May 2020 Registered Direct Offering [Member]"
       }
      }
     },
     "localname": "AprilMayRegisteredDirectOfferingMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_AsicComponentDesignerRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about ASIC component designer royalties.",
        "label": "Asic Component Designer Royalties [Member]",
        "terseLabel": "ASIC component designer royalties [Member]"
       }
      }
     },
     "localname": "AsicComponentDesignerRoyaltiesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_BinationalIndustrialResearchAndDevelopmentFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israel-United States Binational Industrial Research and Development Foundation [Member]",
        "label": "BIRD Foundation [Member]"
       }
      }
     },
     "localname": "BinationalIndustrialResearchAndDevelopmentFoundationMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_CertainEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Employees [Member]",
        "label": "Certain Employees [Member]",
        "verboseLabel": "Certain Employees [Member]"
       }
      }
     },
     "localname": "CertainEmployeesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_CertainOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Officers [Member]",
        "label": "Certain Officers [Member]",
        "terseLabel": "Certain officers [Member]"
       }
      }
     },
     "localname": "CertainOfficerMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_CertainOfficersChiefExecutiveOfficerAndBoardMembersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Officers, CEO, and Board Members [Member]",
        "label": "Certain Officers, CEO, and Board Members [Member]",
        "terseLabel": "Certain executive officers and employees [Member]"
       }
      }
     },
     "localname": "CertainOfficersChiefExecutiveOfficerAndBoardMembersMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ChangesInLiabilityToPayRoyalties": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 20.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents value of changes in liability to pay royalties.",
        "label": "Changes In Liability To Pay Royalties",
        "verboseLabel": "Changes in provision for royalties"
       }
      }
     },
     "localname": "ChangesInLiabilityToPayRoyalties",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_CheckCapUsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Check-Cap US, Inc.",
        "label": "Check Cap Us Inc [Member]",
        "terseLabel": "Check-Cap US, Inc. [Member]"
       }
      }
     },
     "localname": "CheckCapUsIncMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ChiefExecutiveOfficerAndBoardMembersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CEO and Board Members [Member]",
        "label": "CEO and Board Members [Member]",
        "verboseLabel": "CEO and Board [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerAndBoardMembersMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ClassOfWarrantOrRightExpiration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights expired during the period.",
        "label": "Expiration of warrants",
        "verboseLabel": "Expiration period of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpiration",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_ClinicalTrialsAndRegulationExpense": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 10.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical trials and regulation.",
        "label": "Clinical trials and regulation"
       }
      }
     },
     "localname": "ClinicalTrialsAndRegulationExpense",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies [Line Items]",
        "label": "Commitments and Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments and Contingencies [Table]",
        "label": "Commitments and Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_CommonStockUnitsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents number of units issued.",
        "label": "Common Stock Units Issued",
        "verboseLabel": "Common stock, Units issued"
       }
      }
     },
     "localname": "CommonStockUnitsIssued",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "chek_CompensationExpenseEstimationForGrantDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation expense estimation for grant date.",
        "label": "Compensation expense estimation for the grant date"
       }
      }
     },
     "localname": "CompensationExpenseEstimationForGrantDate",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ConsultingFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting fees, including share based compensation and reimbursement of expenses",
        "label": "Consulting fees, including share-based compensation and reimbursement of expenses [Member]"
       }
      }
     },
     "localname": "ConsultingFeesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ContingentLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of contingent liability.",
        "label": "Contingent Liability",
        "verboseLabel": "Contingent liability"
       }
      }
     },
     "localname": "ContingentLiability",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_CreditLineAgreementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CLA Warrants [Member]",
        "label": "Credit Line Agreement Warrants [Member]"
       }
      }
     },
     "localname": "CreditLineAgreementWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_DerivativeChangeInFairValueOfOptionOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of option outstanding.",
        "label": "Change in fair value of option outstanding"
       }
      }
     },
     "localname": "DerivativeChangeInFairValueOfOptionOutstanding",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_DesignerRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties to an ASIC designer [Member]",
        "label": "ASIC designer [Member]",
        "verboseLabel": "Royalties to an ASIC designer [Member]"
       }
      }
     },
     "localname": "DesignerRoyaltiesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_DevelopmentAreaAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Area A [Member]",
        "label": "Development Area A [Member]",
        "verboseLabel": "Development Area A [Member]"
       }
      }
     },
     "localname": "DevelopmentAreaAMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_EmployeeRelatedLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for employee related liabilities.",
        "label": "EMPLOYEE BENEFITS AND PAYROLL ACCRUALS"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-ebapa"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ExercisePriceOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents exercise price of warrants.",
        "label": "Exercise Price Of Warrants",
        "verboseLabel": "Exercise price of warrants"
       }
      }
     },
     "localname": "ExercisePriceOfWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "chek_FairValueOfHedgingOption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of fair value of hedging option.",
        "label": "Fair value of hedging option"
       }
      }
     },
     "localname": "FairValueOfHedgingOption",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_FairValueOfWarrantsIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents fair value of warrants issued.",
        "label": "Fair Value Of Warrants Issued",
        "verboseLabel": "Fair value of warrants issued"
       }
      }
     },
     "localname": "FairValueOfWarrantsIssued",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_FeesAndReimbursementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees, including reimbursement of expenses [Member]",
        "label": "Fees and Reimbursement [Member]"
       }
      }
     },
     "localname": "FeesAndReimbursementMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_FiveYearWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five-year warrants [Member]",
        "label": "Five-year warrants [Member]"
       }
      }
     },
     "localname": "FiveYearWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ForeignIncomeTaxRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Highest income tax rate applicable to foreign jurisdiction.",
        "label": "Foreign maximum tax rate"
       }
      }
     },
     "localname": "ForeignIncomeTaxRateMaximum",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_FunctionalCurrencyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for functional currency.",
        "label": "Functional Currency [Policy Text Block]",
        "verboseLabel": "Financial statements in U.S. dollars"
       }
      }
     },
     "localname": "FunctionalCurrencyPolicyTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_FutureFederalIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax rate to be applied in the next taxable year and thereafter.",
        "label": "Tax rate in 2018 and thereafter"
       }
      }
     },
     "localname": "FutureFederalIncomeTaxRate",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_FutureFederalIncomeTaxRateNextYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax rate to be applied in the next taxable year",
        "label": "Tax rate in 2017"
       }
      }
     },
     "localname": "FutureFederalIncomeTaxRateNextYear",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_GeneralAndAdministrativeExpensesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for general and administrative expenses.",
        "label": "General and Administrative Expenses [Text Block]",
        "verboseLabel": "GENERAL AND ADMINISTRATIVE EXPENSES"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpensesTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-gaae"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_GeneralTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General Transactions [Member]",
        "label": "Transactions with Related Parties [Member]"
       }
      }
     },
     "localname": "GeneralTransactionsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GovernmentInstitutionalAssetsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-peaocad": {
       "order": 0.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current assets related to government institutions.",
        "label": "Government institutions"
       }
      }
     },
     "localname": "GovernmentInstitutionalAssetsCurrent",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-peaocad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_GrantDate10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 10 [Member]",
        "label": "May 06, 2019 [Member]",
        "terseLabel": "September 20, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate10Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate11Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 11 [Member]",
        "label": "November 04, 2019 [Member]",
        "terseLabel": "December 9, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate11Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate13Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 13 [Member]",
        "label": "December 12, 2019 [Member]",
        "terseLabel": "December 9, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate13Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate17Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 17 [Member]",
        "label": "August 05, 2019 [Member]",
        "terseLabel": "November 2, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate17Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 1 [Member]",
        "label": "February 27, 2017 [Member]",
        "terseLabel": "March 5, 2020 [Member]"
       }
      }
     },
     "localname": "GrantDate1Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 2 [Member]",
        "label": "May 09, 2017 [Member]",
        "terseLabel": "May 27, 2020 [Member]"
       }
      }
     },
     "localname": "GrantDate2Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 3 [Member]",
        "label": "June 22, 2017 [Member]",
        "terseLabel": "August 5, 2020 [Member]"
       }
      }
     },
     "localname": "GrantDate3Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 4 [Member]",
        "label": "August 03, 2017 [Member]",
        "terseLabel": "November 17, 2020 [Member]"
       }
      }
     },
     "localname": "GrantDate4Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 5 [Member]",
        "label": "November 02, 2017 [Member]",
        "terseLabel": "December 10, 2020 [Member]"
       }
      }
     },
     "localname": "GrantDate5Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 6 [Member]",
        "label": "February 13, 2018 [Member]",
        "terseLabel": "March 17, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate6Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 7 [Member]",
        "label": "July 30, 2018 [Member]",
        "terseLabel": "May 11, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate7Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate8Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 8 [Member]",
        "label": "September 20, 2018 [Member]",
        "terseLabel": "August 4, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate8Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDate9Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 9 [Member]",
        "label": "November 01, 2018 [Member]",
        "terseLabel": "September 13, 2021 [Member]"
       }
      }
     },
     "localname": "GrantDate9Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOne1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 1 [Member]",
        "label": "March 5, 2020 [Member]",
        "terseLabel": "January 27, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOne1Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOne2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 12 [Member]",
        "label": "May 27, 2020 [Member]",
        "terseLabel": "March 21, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOne2Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOne3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 13 [Member]",
        "label": "August 5, 2020 [Member]",
        "terseLabel": "May 31, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOne3Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOne4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date 14 [Member]",
        "label": "November 17, 2020 [Member]",
        "terseLabel": "August 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOne4Member",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOneEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date One eight [Member].",
        "label": "Grant Date One Eight [Member]",
        "verboseLabel": "November 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOneEightMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOneFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date One five [Member]",
        "label": "Grant Date One Five [Member]",
        "terseLabel": "November 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOneFiveMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOneNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date One Nine [Member]",
        "label": "Grant Date One Nine [Member]",
        "verboseLabel": "December 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOneNineMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOneSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date One seven [Member]",
        "label": "Grant Date One Seven [Member]",
        "verboseLabel": "August 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOneSevenMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantDateOneSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Date One six [Member]",
        "label": "Grant Date One Six [Member]",
        "verboseLabel": "November 29, 2022 [Member]"
       }
      }
     },
     "localname": "GrantDateOneSixMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_GrantedRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 10.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue fron grant.",
        "label": "Granted Revenue",
        "negatedLabel": "Less participation of the IIA",
        "verboseLabel": "Funding"
       }
      }
     },
     "localname": "GrantedRevenue",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_GrossOvertimeMonthlyRate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Overtime monthly rate.",
        "label": "Gross Overtime monthly rate"
       }
      }
     },
     "localname": "GrossOvertimeMonthlyRate",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Israel Innovation Authority of the Ministry of Economy and Industry.",
        "label": "Israel Innovation Authority Ministry Of Economy And Industry [Member]",
        "terseLabel": "IIA [Member]"
       }
      }
     },
     "localname": "IsraelInnovationAuthorityMinistryOfEconomyAndIndustryMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_IssuanceExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of issuance expenses.",
        "label": "Issuance Expenses",
        "verboseLabel": "Issuance expenses"
       }
      }
     },
     "localname": "IssuanceExpenses",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_KeyManInsurancePolicy": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of key man insurance policy held.",
        "label": "Key man insurance policy"
       }
      }
     },
     "localname": "KeyManInsurancePolicy",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_LegalWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Warrants [Member]",
        "label": "Legal Warrants [Member]"
       }
      }
     },
     "localname": "LegalWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_LesseeOperatingLeaseAdditionalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease additional, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Additional Term",
        "verboseLabel": "Additional lease period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAdditionalTerm",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "chek_LongTermIncentiveWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Incentive Warrants [Member]",
        "label": "Long Term Incentive Warrants [Member]"
       }
      }
     },
     "localname": "LongTermIncentiveWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ManufacturingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Program [Member]",
        "label": "Manufacturing Program [Member]"
       }
      }
     },
     "localname": "ManufacturingProgramMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_March2022RegisteredDirectOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2022 Registered Direct Offering [Member]",
        "label": "March 2022 Registered Direct Offering [Member]"
       }
      }
     },
     "localname": "March2022RegisteredDirectOfferingMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_MaximumAggregateMonthlySalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum aggregate monthly salary.",
        "label": "Maximum aggregate monthly salary"
       }
      }
     },
     "localname": "MaximumAggregateMonthlySalary",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_MaximumRoyaltyObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount payable for royalties.",
        "label": "Maximum Royalty Obligation",
        "verboseLabel": "Maximum royalties payable"
       }
      }
     },
     "localname": "MaximumRoyaltyObligation",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_MinimumBidPriceValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum bid price value.",
        "label": "Minimum bid price value"
       }
      }
     },
     "localname": "MinimumBidPriceValuePerShare",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "perShareItemType"
    },
    "chek_MonthlyRetainer": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of monthly retainer for services performed.",
        "label": "Monthly retainer"
       }
      }
     },
     "localname": "MonthlyRetainer",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_MonthlySalary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Salary.",
        "label": "Monthly Salary"
       }
      }
     },
     "localname": "MonthlySalary",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_MonthlyVehicleLeaseExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly vehicle lease expense.",
        "label": "Monthly Vehicle Lease Expense",
        "verboseLabel": "Monthly vehicle lease expense"
       }
      }
     },
     "localname": "MonthlyVehicleLeaseExpense",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_NetProceedsFromIssuanceOfSharesAndWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Net Proceeds From Issuance Of Shares And Warrants",
        "terseLabel": "Net proceeds of shares and warrant from registered direct offering",
        "verboseLabel": "Net proceeds warrant from the registered direct offering"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfSharesAndWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_NonExecutiveDirectorsCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Executive Directors Compensation [Member]",
        "label": "Compensation to the Non-Executive Directors [Member]"
       }
      }
     },
     "localname": "NonExecutiveDirectorsCompensationMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_NonExecutiveDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-executive Directors [Member]",
        "label": "Non-Executive Directors [Member]"
       }
      }
     },
     "localname": "NonExecutiveDirectorsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares available for purchase through pre-funded warrants.",
        "label": "Number of ordinary shares available for purchase through pre-funded warrants"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesAvailableForPurchaseFromPrefundedWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares available for purchase through pre-funded warrants.",
        "label": "Pontifax Funds [Member]",
        "verboseLabel": "Number of ordinary shares available for purchase through pre-funded warrants"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesAvailableFromPurchaseFromPrefundedWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_OfficeOfTheChiefScientistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office of the Chief Scientist of Israel's Ministry of Industry, Trade and Labor [Member]",
        "label": "OCS [Member]"
       }
      }
     },
     "localname": "OfficeOfTheChiefScientistMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_OfficeRentAndMaintenance": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 30.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of office rent and maintenance expense.",
        "label": "Office Rent And Maintenance",
        "totalLabel": "Operating Leases, Rent Expense, Total",
        "verboseLabel": "Office rent and maintenance"
       }
      }
     },
     "localname": "OfficeRentAndMaintenance",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_OneYearWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One-year warrants [Member]",
        "label": "One-year warrants [Member]"
       }
      }
     },
     "localname": "OneYearWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_OperatingLeaseRentExpenseMonthly": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly rent expense for operating leased assets.",
        "label": "Operating Lease Rent Expense Monthly",
        "verboseLabel": "Monthly rental property expenses"
       }
      }
     },
     "localname": "OperatingLeaseRentExpenseMonthly",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_OrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary shares [Member]",
        "label": "Ordinary Shares [Member]",
        "verboseLabel": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_OtherCurrentAssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other current assets:",
        "label": "Other current assets:"
       }
      }
     },
     "localname": "OtherCurrentAssetsFairValueDisclosureAbstract",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_OtherCurrentLiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other current liabilities:",
        "label": "Other current liabilities:"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_PaymentsExpensesForPatents": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 20.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of payments /expenses for patents.",
        "label": "Payments /Expenses For Patents",
        "totalLabel": "Amortization of Intangible Assets, Total",
        "verboseLabel": "Cost for registration of patents"
       }
      }
     },
     "localname": "PaymentsExpensesForPatents",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of ordinary shares issued upon cash exercise of warrants to placement agent.",
        "label": "Percentage Of Ordinary Shares Issued Upon Cash Exercise Of Warrants To Placement Agent",
        "verboseLabel": "Percentage of ordinary shares issued upon cash exercise of warrants to placement agent"
       }
      }
     },
     "localname": "PercentageOfOrdinarySharesIssuedUponCashExerciseOfWarrantsToPlacementAgent",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_PercentageOfSharesFullyDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents percentage of shares fully diluted.",
        "label": "Percentage Of Shares Fully Diluted",
        "verboseLabel": "Percentage of shares fully diluted"
       }
      }
     },
     "localname": "PercentageOfSharesFullyDiluted",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_PlacementAgentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Placement agent [Member]",
        "label": "Placement agent [Member]",
        "verboseLabel": "Placement Agent [Member]"
       }
      }
     },
     "localname": "PlacementAgentMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PlacementAgentWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the placement agent warrants.",
        "label": "Placement Agent Warrants [Member]",
        "terseLabel": "Placement agent warrants [Member]"
       }
      }
     },
     "localname": "PlacementAgentWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PlacementAgentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Placement agent [Member]",
        "label": "PlacementAgentsMember",
        "verboseLabel": "Placement agent [Member]"
       }
      }
     },
     "localname": "PlacementAgentsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PontifaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pontifax Warrants [Member]"
       }
      }
     },
     "localname": "PontifaxMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PreFundedUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre funded Units [Member]",
        "label": "Pre funded Units [Member]"
       }
      }
     },
     "localname": "PreFundedUnitsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre Funded Warrants [Member]",
        "label": "Pre-funded Warrants [Member]"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PreFundedWarrantsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded Warrants one [Member]",
        "label": "Pre-funded Warrants one [Member]"
       }
      }
     },
     "localname": "PreFundedWarrantsOneMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PreFundedWarrantsPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents pre funded warrants purchase.",
        "label": "Pre Funded Warrants Purchase",
        "verboseLabel": "Shares issued under pre-funded warrants purchase"
       }
      }
     },
     "localname": "PreFundedWarrantsPurchase",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_PreFundedWarrantsPurchaseSharesIssuable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of share issuable under pre-funded warrants purchase.",
        "label": "Pre Funded Warrants Purchase Shares Issuable",
        "verboseLabel": "Shares issuable under pre-funded warrants purchase"
       }
      }
     },
     "localname": "PreFundedWarrantsPurchaseSharesIssuable",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_PredecessorUnitHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Predecessor Entity's Unit Holders [Member[",
        "label": "Reimbursement liability to Predecessor Entity's Unit Holders [Member]",
        "verboseLabel": "Reimbursement liability to Predecessor Entity's unit holders [Member]"
       }
      }
     },
     "localname": "PredecessorUnitHoldersMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_PrefundedWarrantsToPurchasePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants purchase price.",
        "label": "Pre-funded warrants purchase price"
       }
      }
     },
     "localname": "PrefundedWarrantsToPurchasePrice",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "perShareItemType"
    },
    "chek_PremiumPercentageToCalculateExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents premium percentage to calculate the exercise price.",
        "label": "Premium Percentage To Calculate Exercise Price",
        "verboseLabel": "Premium percentage to calculate the exercise price"
       }
      }
     },
     "localname": "PremiumPercentageToCalculateExercisePrice",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_PrepaidExpensesAndOtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Text Block]",
        "verboseLabel": "PREPAID EXPENSES AND OTHER CURRENT ASSETS"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-peaoca"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_PricePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per unit sold.",
        "label": "Price per unit"
       }
      }
     },
     "localname": "PricePerUnit",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "chek_ProceedsFromExerciseOfPrefundedWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents proceeds from exercise of prefunded warrants.",
        "label": "Proceeds From Exercise Of Prefunded Warrants",
        "verboseLabel": "Proceeds from exercise of prefunded warrants"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfPrefundedWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents cash inflow from exercise of warrants.",
        "label": "Proceeds From Exercise Of Warrants",
        "verboseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceOfPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock.",
        "label": "Proceeds From Issuance Of Public Offering",
        "verboseLabel": "Proceeds from issuance of public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPublicOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceOfRegistredDirectOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of proceeds from issuance of registered direct offering.",
        "label": "Proceeds From Issuance Of Registred Direct Offering",
        "terseLabel": "Proceeds from issuance of registred direct offering",
        "verboseLabel": "Proceeds from issuance of registered direct offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRegistredDirectOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceOfShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amounts of proceeds from issuance of shares.",
        "label": "Proceeds From Issuance Of Shares",
        "verboseLabel": "Proceeds from issuance of shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfShares",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount of proceeds from the issuance of shares, prefunded shares and warrants.",
        "label": "Proceeds From Issuance Of Shares, Prefunded Shares And Warrants",
        "verboseLabel": "Proceeds from issuance of shares, prefunded shares and warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesPrefundedSharesAndWarrants",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceResisteredDirectOffering": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceed from Issuance of ordinary shares in the RD Offering, net of issuance expenses",
        "label": "Issuance of ordinary shares in the registered direct offerings, net of issuance expenses"
       }
      }
     },
     "localname": "ProceedsFromIssuanceResisteredDirectOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ProceedsFromIssuanceResisteredDirectOfferingTwo": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceed from Issuance of ordinary shares in the RD Offering, net of issuance expenses.",
        "label": "Proceeds From Issuance Resistered Direct Offering Two",
        "terseLabel": "Issuance of ordinary shares in the registered direct offerings, net of issuance expenses"
       }
      }
     },
     "localname": "ProceedsFromIssuanceResisteredDirectOfferingTwo",
     "nsuri": "http://check-cap.com/20221231",
     "xbrltype": "monetaryItemType"
    },
    "chek_PurchasePricePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents purchase price per unit.",
        "label": "Purchase Price Per Unit",
        "verboseLabel": "Purchase price per unit"
       }
      }
     },
     "localname": "PurchasePricePerUnit",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "chek_ReconciliationOfCashToBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation Of Cash To Balance Sheet [Abstract]",
        "terseLabel": "RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH TO THE CONSOLIDATED BALANCE SHEET"
       }
      }
     },
     "localname": "ReconciliationOfCashToBalanceSheetAbstract",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_ReductionInIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction In Income Tax Rate",
        "label": "Reduction in income tax rate",
        "verboseLabel": "Reduction in income tax rate"
       }
      }
     },
     "localname": "ReductionInIncomeTaxRate",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_RefundExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refund expenses",
        "label": "Refund Expenses",
        "verboseLabel": "Refund expenses"
       }
      }
     },
     "localname": "RefundExpenses",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_RegisteredDirectOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered Direct Offering [Member]",
        "label": "RD Offering [Member]"
       }
      }
     },
     "localname": "RegisteredDirectOfferingMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ResearchAndDevelopmentExpenseGross": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 0.0,
       "parentTag": "us-gaap_ResearchAndDevelopmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross recognized cost of research and development during the period, before accounting for costs covered by grants.",
        "label": "Research and Development Expense, Gross",
        "totalLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseGross",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ResearchAndDevelopmentExpensesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expenses [Line Items]",
        "label": "Research and Development Expenses [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensesLineItems",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_ResearchAndDevelopmentExpensesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expenses [Table]",
        "label": "Research and Development Expenses [Table]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensesTable",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_RestOfCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of the Country [Member]",
        "label": "Rest Of Country [Member]",
        "verboseLabel": "Rest of the Country [Member]"
       }
      }
     },
     "localname": "RestOfCountryMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_RestrictedCashIncludedCurrentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of restricted cash included in current assets",
        "label": "Restricted Cash Included Current Assets",
        "terseLabel": "Restricted cash included current assets"
       }
      }
     },
     "localname": "RestrictedCashIncludedCurrentAssets",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_RevenueFromCashCommission": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash commission.",
        "label": "Cash commission"
       }
      }
     },
     "localname": "RevenueFromCashCommission",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_RoyaltiesPayablePerUnitSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable for royalties per unit sold.",
        "label": "Royalties Payable Per Unit Sold",
        "verboseLabel": "Royalties payable per unit sold"
       }
      }
     },
     "localname": "RoyaltiesPayablePerUnitSold",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "chek_RoyaltiesPayablePercentageOfProductSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties payable as a percentage of product sales.",
        "label": "Royalties Payable Percentage Of Product Sales",
        "verboseLabel": "Royalty repayment, percentage of products sold"
       }
      }
     },
     "localname": "RoyaltiesPayablePercentageOfProductSales",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_RoyaltiesProvision": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the liability recorded to pay royalties.",
        "label": "Royalties provision",
        "verboseLabel": "Royalties provision"
       }
      }
     },
     "localname": "RoyaltiesProvision",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for employee related liabilities.",
        "label": "Schedule of Employee Benefits and Payroll Accruals"
       }
      }
     },
     "localname": "ScheduleOfEmployeeRelatedLiabilitiesTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-ebapat"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfFutureLeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Future Lease Payments [Table Text Block]",
        "label": "Schedule of Future Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureLeasePaymentsTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/LeasesTable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for general and administrative expenses.",
        "label": "Schedule of General and Administrative Expenses"
       }
      }
     },
     "localname": "ScheduleOfGeneralAndAdministrativeExpesesTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-gaaet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of parameters used to calculate the fair value of options.",
        "label": "Schedule of Parameters Used in Valuing Fair Value of Options"
       }
      }
     },
     "localname": "ScheduleOfParametersUsedInValuingFairValueOfOptionsTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prepaid expenses and other current assets.",
        "label": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-peaocat"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the information used to calculate depreciation for property, plant and equipment.",
        "label": "Schedule of Depreciation Inputs"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentDepreciationInformationTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-sigpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfResearchAndDevelopmentExpensesNet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the net expenses associated with research and development.",
        "label": "Schedule of Research and Development Expenses, Net"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentExpensesNet",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Supplemental Cash Flow Information Related to Operating Leases [Table Text Block]",
        "label": "Schedule of Supplemental Cash Flow Information Related to Operating Leases"
       }
      }
     },
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/LeasesTable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "chek_SeniorManagementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Management [Member]",
        "label": "Senior Management [Member]"
       }
      }
     },
     "localname": "SeniorManagementMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Warrants [Member]",
        "label": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_SeriesCWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Warrants [Member]",
        "label": "Series C Warrants [Member]"
       }
      }
     },
     "localname": "SeriesCWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_SeriesCWarrantsToPurchaseOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Warrants to purchase ordinary shares [Member]",
        "label": "Series C Warrants to purchase ordinary shares [Member]"
       }
      }
     },
     "localname": "SeriesCWarrantsToPurchaseOrdinarySharesMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_SeriesDWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D Warrants [Member]",
        "label": "Series D Warrants [Member]"
       }
      }
     },
     "localname": "SeriesDWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options granted.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Granted In Period, Fair Value",
        "verboseLabel": "Fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodFairValue",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Intrinsic Value [Abstract]",
        "label": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "chek_ShareBasedCompensationAwardTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fourth portion of share-based compensation award differentiated by a particular vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Compensation Award, Tranche Four [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheFourMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 10.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation, net, allocated to general and administrative expense.",
        "label": "Share-based compensation, net",
        "terseLabel": "Compensation expense recorded to general and administrative expenses"
       }
      }
     },
     "localname": "ShareBasedCompensationExpenseIncomeAllocatedToGeneralAndAdministrativeExpense",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ShareBasedCompensationInome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Noncash Income, Total.",
        "label": "Share based compensation income"
       }
      }
     },
     "localname": "ShareBasedCompensationInome",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ShareBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation [Member]",
        "label": "Share-Based Compensation [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ShareCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued and total premiums for shares issued presented as the amount of share capital.",
        "label": "Share Capital",
        "periodEndLabel": "Subtotal"
       }
      }
     },
     "localname": "ShareCapital",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_ShareCapitalLessIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of share capital raised, less the associated issuance costs.",
        "label": "Share Capital Less Issuance Costs",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "ShareCapitalLessIssuanceCosts",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional percentage of vesting of award under share-based payment arrangement.",
        "label": "Additional vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Outstanding at the end of the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermThree",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "chek_ShortTermInvestmentInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate applied to short-term investment.",
        "label": "Short-term bank deposit, interest rate"
       }
      }
     },
     "localname": "ShortTermInvestmentInterestRate",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "percentItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodSharesInFinancing": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares and warrants issued during the period.",
        "label": "Stock And Warrant Issued During Period, Shares, In Financing",
        "verboseLabel": "Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361, shares"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodSharesInFinancing",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares registered direct offering, net of issuance expenses, shares",
        "label": "Stock And Warrant Issued During Period, Shares, In Registered Direct Offering",
        "verboseLabel": "Issuance of ordinary shares and warrants, in the 2019 registered direct offering, net of issuance expenses in an amount of $987"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new ordinary shares and warrants issued during the period.",
        "label": "Stock And Warrant Issued During Period, Shares, In Registered Direct Offering Two",
        "terseLabel": "Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199, shares"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodSharesInRegisteredDirectOfferingTwo",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodValueInFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of ordinary shares and warrants issued in financing.",
        "label": "Stock And Warrant Issued During Period, Value, In Financing",
        "verboseLabel": "Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodValueInFinancing",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares and warrants, net of issuance expenses in an amount.",
        "label": "Stock And Warrant Issued During Period, Value, In Registered Direct Offering",
        "terseLabel": "Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199",
        "verboseLabel": "Issuance of ordinary shares and warrants, in the 2019 registered direct offering, net of issuance expenses in an amount of $987"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of ordinary shares and warrants issued.",
        "label": "Stock And Warrant Issued During Period, Value, In Registered Direct Offering Two",
        "terseLabel": "Issuance of ordinary shares and warrants in the June 2021 Registered Direct Offering, net of issuance expenses in an amount of $3,199",
        "verboseLabel": "Issuance of ordinary shares and warrants in the April - May 2020 Financings, net of issuance expenses in an amount of $1,361"
       }
      }
     },
     "localname": "StockAndWarrantIssuedDuringPeriodValueInRegisteredDirectOfferingTwo",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares and warrants issued.",
        "label": "Stock And Warrants Issued During Period, Shares, In Warrant Exercise Transaction",
        "verboseLabel": "Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920, shares"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodSharesInWarrantExerciseTransaction",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of Issuance expenses in an amount.",
        "label": "Stock And Warrants Issued During Period, Value, In Warrant Exercise Transaction",
        "verboseLabel": "Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses in an amount of $920"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValueInWarrantExerciseTransaction",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period as part of a private placement.",
        "label": "Issuance of ordinary shares in the Private Placement, shares",
        "verboseLabel": "Issuance of ordinary shares in the Private Placement, net of issuance expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssuesPrivatePlacement",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares and pre-funded warrants in the registered direct offering, Shares",
        "label": "Issuance of ordinary Shares in RD Offering, shares",
        "verboseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssuesRegisteredDirectOffering1",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodSharesPrivatePlacementShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of private placement issued during the period.",
        "label": "Stock Issued During Period, Shares, Private Placement Shares",
        "verboseLabel": "Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPrivatePlacementShares",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodSharesWarrantsCashExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued upon the cash exercise of warrants during the period.",
        "label": "Stock Issued During Period Shares Warrants Cash Exercised",
        "verboseLabel": "Number of warrants exercised in cash"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsCashExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued upon the exercise of warrants during the period.",
        "label": "Exercise of warrants into ordinary shares, shares",
        "positiveLabel": "Exercise of warrants, net of issuance expenses in an amount of $22, shares",
        "terseLabel": "Number of warrants exercised",
        "verboseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodSharesWarrantsPartiallyExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued upon the partial exercise of warrants during the period.",
        "label": "Partial exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsPartiallyExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period as part of a private placement.",
        "label": "Issuance of ordinary shares in the Private Placement, net of issuance expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesInitialPrivatePlacement",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares and pre-funded warrants in the registered direct offering",
        "label": "Issuance of ordinary shares and pre-funded warrants in August 2016 registered direct offering, net of issuance expenses",
        "verboseLabel": "Issuance of ordinary Shares in RD Offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesRegisteredDirectOffering",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockIssuedDuringPeriodValuePrivatePlacement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of ordinary shares in private placement, net of issuance expenses in an amount.",
        "label": "Stock Issued During Period, Value, Private Placement",
        "verboseLabel": "Issuance of ordinary shares in private placement, net of issuance expenses in an amount of approximately $29"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValuePrivatePlacement",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of warrants.",
        "label": "Exercise of warrants into ordinary shares",
        "verboseLabel": "Exercise of warrants, net of issuance expenses in an amount of $22"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_SubcontractorsAndConsultantFees": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 30.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fees for the services provided by subcontractors and consultants during the period.",
        "label": "Subcontractors and consultants"
       }
      }
     },
     "localname": "SubcontractorsAndConsultantFees",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_SubleaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the sub-lease agreement.",
        "label": "Sub-lease Agreement [Member]"
       }
      }
     },
     "localname": "SubleaseAgreementMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_ThreeAugustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August 3 [Member]",
        "label": "August 3 [Member]"
       }
      }
     },
     "localname": "ThreeAugustMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_TwelveDecemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 12 [Member]",
        "label": "December 12 [Member]"
       }
      }
     },
     "localname": "TwelveDecemberMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_TwentyTwoJuneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 22 [Member]",
        "label": "June 22 [Member]"
       }
      }
     },
     "localname": "TwentyTwoJuneMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_TwoThousandFifteenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Plan [Member]",
        "label": "2015 Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandFifteenPlanMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_UnderwriterWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriter Warrants [Member]",
        "label": "Underwriter Warrants [Member]"
       }
      }
     },
     "localname": "UnderwriterWarrantsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_UnitsPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units purchased, consisting of one ordinary share and one-half of a Series A Warrant to purchase one ordinary share and one and one-half non-transferrable Long Term Incentive Warrants.",
        "label": "Number of units"
       }
      }
     },
     "localname": "UnitsPurchased",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_ValueOfCertainWarrantsAssociatedWithIssuanceExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of certain warrants associated with issuance expenses.",
        "label": "Value of certain warrants associated with issuance expenses"
       }
      }
     },
     "localname": "ValueOfCertainWarrantsAssociatedWithIssuanceExpenses",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_VpClinicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents company\u2019s VP clinical.",
        "label": "Vp Clinical [Member]",
        "terseLabel": "Vp Clinical [Member]"
       }
      }
     },
     "localname": "VpClinicalMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_WarrantAmendmentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Amendment Agreement [Member].",
        "label": "Warrant Amendment Agreement [Member]",
        "verboseLabel": "Warrant Amendment Agreement [Member]"
       }
      }
     },
     "localname": "WarrantAmendmentAgreementMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_WarrantAndShareOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant and Share Options [Member]",
        "label": "Warrant and Share Options [Member]"
       }
      }
     },
     "localname": "WarrantAndShareOptionsMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_WarrantLiabilityReclassificationToEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of warrant liability to equity.",
        "label": "Warrant Liability Reclassification to Equity",
        "verboseLabel": "Reclassification of liability warrants to equity warrants"
       }
      }
     },
     "localname": "WarrantLiabilityReclassificationToEquity",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_WarrantThatWereExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant that were exercised.",
        "label": "Warrant that were exercised"
       }
      }
     },
     "localname": "WarrantThatWereExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_WarrantsCashlessExercise": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cashless exercise of warrants into ordinary shares.",
        "label": "Cashless exercise of warrants to purchase ordinary shares into ordinary shares"
       }
      }
     },
     "localname": "WarrantsCashlessExercise",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_WarrantsExerciseTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Exercise Transaction [Member]",
        "label": "Warrants Exercise Transaction [Member]"
       }
      }
     },
     "localname": "WarrantsExerciseTransactionMember",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "chek_WarrantsExercisedCashlessBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants exercised on a cashless basis.",
        "label": "Warrants exercised on a cashless basis"
       }
      }
     },
     "localname": "WarrantsExercisedCashlessBasis",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_WarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants issued.",
        "label": "Warrants Issued",
        "verboseLabel": "Warrants issued"
       }
      }
     },
     "localname": "WarrantsIssued",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_WarrantsIssuedNotExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents warrants issued not exercised.",
        "label": "Warrants Issued Not Exercised",
        "verboseLabel": "Warrants issued not exercised"
       }
      }
     },
     "localname": "WarrantsIssuedNotExercised",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_WarrantsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of warrants outstanding.",
        "label": "Warrants Outstanding"
       }
      }
     },
     "localname": "WarrantsOutstanding",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "chek_WarrantsOutstandingAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsOutstandingAmount",
        "verboseLabel": "Warrants outstanding"
       }
      }
     },
     "localname": "WarrantsOutstandingAmount",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "chek_WarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policy for the accounting practices applied to the classification of warrant instruments.",
        "label": "Warrants to purchase preferred shares"
       }
      }
     },
     "localname": "WarrantsPolicyTextBlock",
     "nsuri": "http://check-cap.com/20221231",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Isfiya, ISRAEL"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_ILS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILS [Member]"
       }
      }
     },
     "localname": "ILS",
     "nsuri": "http://xbrl.sec.gov/currency/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "EntityVoluntaryFilers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://check-cap.com/role/chek-dei"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r281",
      "r401",
      "r422",
      "r443",
      "r444",
      "r454",
      "r459",
      "r466",
      "r505",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "verboseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r281",
      "r401",
      "r422",
      "r443",
      "r444",
      "r454",
      "r459",
      "r466",
      "r505",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "verboseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r273",
      "r281",
      "r311",
      "r312",
      "r313",
      "r400",
      "r401",
      "r422",
      "r443",
      "r444",
      "r454",
      "r459",
      "r466",
      "r501",
      "r505",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r273",
      "r281",
      "r311",
      "r312",
      "r313",
      "r400",
      "r401",
      "r422",
      "r443",
      "r444",
      "r454",
      "r459",
      "r466",
      "r501",
      "r505",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r229",
      "r230",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r455",
      "r465",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r229",
      "r230",
      "r428",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r455",
      "r465",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r498",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accruals"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r14",
      "r448"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-ebapad": {
       "order": 10.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Liability for payroll, bonuses and wages"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-ebapad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r14",
      "r78"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-ebapad": {
       "order": 0.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Benefits for vacation and recreation pay"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-ebapad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r57",
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r18",
      "r19",
      "r102",
      "r387",
      "r423",
      "r424",
      "r484",
      "r485",
      "r486",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental information for Cash Flow:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r8",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r492",
      "r493",
      "r494",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional paid-in capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Capital investment"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r93",
      "r94",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r67",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Issuance expenses"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments required to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 50.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Compensation expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/chek-radend",
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "verboseLabel": "Share based expenses"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Anti-dilutive instruments"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "verboseLabel": "Area of lease"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r117",
      "r128",
      "r153",
      "r180",
      "r223",
      "r225",
      "r227",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r346",
      "r348",
      "r362",
      "r464",
      "r503",
      "r504",
      "r548"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r148",
      "r159",
      "r180",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r346",
      "r348",
      "r362",
      "r464",
      "r503",
      "r504",
      "r548"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total financial assets",
        "totalLabel": "Total financial assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r180",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r346",
      "r348",
      "r362",
      "r503",
      "r504",
      "r548"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-sbpt",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "auth_ref": [
      "r41",
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in lease obligation from new lease.",
        "label": "Recognition of operating leases and operating lease liabilities from adoption of ASU 2016-02"
       }
      }
     },
     "localname": "CapitalLeaseObligationsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r38",
      "r150",
      "r446"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r39",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r32",
      "r38",
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the year",
        "terseLabel": "Total cash, cash equivalents, and restricted cash",
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r32",
      "r109"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r180",
      "r199",
      "r200",
      "r203",
      "r205",
      "r212",
      "r213",
      "r231",
      "r243",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r255",
      "r256",
      "r259",
      "r263",
      "r270",
      "r362",
      "r445",
      "r477",
      "r490",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "verboseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Exercise price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Warrants issued to purchase ordinary shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of shares called by warrants",
        "verboseLabel": "Number of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrant outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r61",
      "r237",
      "r238",
      "r429",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENT LIABILITIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-cacl"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Series C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r492",
      "r493",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Ordinary shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary share, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Authorized share capital",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Ordinary shares, shares issued",
        "verboseLabel": "Shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Ordinary shares, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Aggregate consideration",
        "verboseLabel": "Share capital, Ordinary shares 48 NIS par value (18,000,000 authorized shares as of December 31, 2022 and 2021; 5,844,463 and 4,840,089 shares issued and outstanding as of December 31, 2022 and 2021, respectively)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r20",
      "r162",
      "r164",
      "r170",
      "r415",
      "r419"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "negatedTotalLabel": "Comprehensive loss",
        "terseLabel": "Comprehensive loss",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer and auxiliary equipment [Member]",
        "terseLabel": "Computers and auxiliary equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r126",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of credit risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r101",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation",
        "verboseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "verboseLabel": "Conversion of preferred shares into ordinary shares"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r487",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "verboseLabel": "Depreciation expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r110",
      "r112",
      "r252",
      "r375",
      "r452",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "verboseLabel": "Issuance expenses"
       }
      }
     },
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Weighted average borrowing rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-itaxd": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r100",
      "r535"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-itaxd": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Carry-forward tax losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-itaxd": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-peaocad": {
       "order": 20.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Deposits"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-peaocad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r36",
      "r221"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation expenses"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationNonproduction": {
     "auth_ref": [
      "r36",
      "r55"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 40.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-radend": {
       "order": 70.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.",
        "label": "Depreciation, Nonproduction",
        "verboseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationNonproduction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed",
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.",
        "label": "Cash flow hedges"
       }
      }
     },
     "localname": "DerivativesMethodsOfAccountingHedgingDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r285",
      "r316",
      "r317",
      "r319",
      "r324",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r80",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Summary of Awards Granted",
        "terseLabel": "Schedule of Awards Granted"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Israeli tax rate [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r171",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r196",
      "r199",
      "r203",
      "r204",
      "r205",
      "r209",
      "r353",
      "r354",
      "r416",
      "r420",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Loss per share:",
        "terseLabel": "Net loss per ordinary share - basic and diluted",
        "verboseLabel": "Net loss per ordinary share - Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails",
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r171",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r199",
      "r203",
      "r204",
      "r205",
      "r209",
      "r353",
      "r354",
      "r416",
      "r420",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Net loss per ordinary share - Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails",
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted net loss per ordinary share:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-eps"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r181",
      "r328",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "verboseLabel": "Income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-ebapad": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employees and payroll accruals",
        "totalLabel": "Employee benefits and payroll accruals"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-ebapad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities [Abstract]"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Period for recognizing compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r67",
      "r146",
      "r166",
      "r167",
      "r168",
      "r183",
      "r184",
      "r185",
      "r187",
      "r193",
      "r195",
      "r211",
      "r232",
      "r272",
      "r320",
      "r321",
      "r322",
      "r336",
      "r337",
      "r352",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r387",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r36",
      "r63"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 40.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Revaluation of fair value of warrants to purchase preferred share"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r355",
      "r356",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Summary of Fair Value Assumptions"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r253",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r356",
      "r397",
      "r398",
      "r399",
      "r452",
      "r453",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "verboseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r358",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "verboseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fvm"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r253",
      "r274",
      "r279",
      "r356",
      "r397",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r253",
      "r274",
      "r279",
      "r356",
      "r398",
      "r452",
      "r453",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r107",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Changes in Fair Value",
        "verboseLabel": "Schedule of Changes In Fair Value"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r253",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r397",
      "r398",
      "r399",
      "r452",
      "r453",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r359",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "terseLabel": "Total financial assets (liabilities)"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r41",
      "r42",
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Purchase of property and equipment"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "verboseLabel": "U.S. tax rate [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 30.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Exchange rate differences"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://check-cap.com/role/chek-gaaed": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses",
        "totalLabel": "Total general and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo",
      "http://check-cap.com/role/chek-gaaed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Abstract]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember": {
     "auth_ref": [
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Family member whom a principal owner or a member of management might control or influence, or by whom they might be controlled or influenced, because of the family relationship.",
        "label": "Sigalit Kimchy [Member]"
       }
      }
     },
     "localname": "ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r54",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of Long-Lived Assets",
        "verboseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r21",
      "r115",
      "r121",
      "r134",
      "r223",
      "r224",
      "r226",
      "r228",
      "r417",
      "r451"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 20.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "negatedTotalLabel": "Loss before income tax",
        "totalLabel": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/chek-radend",
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/chek-radend",
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "verboseLabel": "INCOME TAXES [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r181",
      "r329",
      "r330",
      "r334",
      "r338",
      "r341",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-itax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r182",
      "r194",
      "r195",
      "r222",
      "r327",
      "r339",
      "r342",
      "r421"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 30.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r325",
      "r326",
      "r330",
      "r331",
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r33",
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 50.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (decrease) in trade accounts payable, accruals and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 60.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (decrease) in employees and payroll accruals",
        "verboseLabel": "Increase (decrease) in employees and payroll accruals"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities items:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 40.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Decrease (increase) in prepaid and other current assets and non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInRoyaltiesPayable": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 70.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligations due for compensation payments related to the use of copyrights, patents, trade names, licenses, technology. Royalty payments are also paid by the lease holders for oil, gas, and mineral extraction.",
        "label": "Increase (decrease) in royalties provision",
        "verboseLabel": "Decrease in royalties provision"
       }
      }
     },
     "localname": "IncreaseDecreaseInRoyaltiesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r111",
      "r124",
      "r169",
      "r220",
      "r374"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 10.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Bank fees and interest expenses"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r174",
      "r176",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Cash paid for interest",
        "verboseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r27",
      "r219"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Interest income on short-term deposits and other"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r544",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 50.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses",
        "terseLabel": "Issuance of ordinary shares in the registered direct offerings, net of issuance expenses",
        "verboseLabel": "Issuance of ordinary shares and warrants in the Warrant Exercise Transaction, net of issuance expenses"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Rental expenses under the lease agreement"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r384",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Amount allocated to lease"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "verboseLabel": "Lease expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement.",
        "label": "Leaseholds and Leasehold Improvements [Member]",
        "terseLabel": "Office facilities [Member]"
       }
      }
     },
     "localname": "LeaseholdsAndLeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails": {
       "order": 20.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025 and after"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Option to extend the lease period for an additional time",
        "verboseLabel": "Additional Lease expiration date"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "verboseLabel": "Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r118",
      "r131",
      "r464",
      "r491",
      "r499",
      "r540"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r149",
      "r180",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r347",
      "r348",
      "r349",
      "r362",
      "r464",
      "r503",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r180",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r347",
      "r348",
      "r349",
      "r362",
      "r503",
      "r548",
      "r549"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "verboseLabel": "Short-term bank deposit"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 20.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 10.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r32",
      "r34",
      "r37"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r22",
      "r37",
      "r122",
      "r133",
      "r147",
      "r161",
      "r163",
      "r168",
      "r180",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r201",
      "r223",
      "r224",
      "r226",
      "r228",
      "r231",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r354",
      "r362",
      "r451",
      "r503"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-csoo": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "negatedLabel": "Net loss",
        "negatedTotalLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails",
      "http://check-cap.com/role/chek-csocf",
      "http://check-cap.com/role/chek-csoo",
      "http://check-cap.com/role/chek-equity",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r196",
      "r197",
      "r202",
      "r205",
      "r223",
      "r224",
      "r226",
      "r228",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net loss attributable to ordinary shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash flow information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 10.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-fiend": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Finance income, net",
        "negatedLabel": "Finance income, net",
        "terseLabel": "Finance income, net",
        "totalLabel": "Total financing income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo",
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office furniture and equipment [Member]"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r223",
      "r224",
      "r226",
      "r228",
      "r451"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedTotalLabel": "Operating loss",
        "terseLabel": "Operating loss",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Monthly services expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Lease liabilities",
        "totalLabel": "Total lease liability balance"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails",
      "http://check-cap.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 40.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r378",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Cash payments for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating leases",
        "verboseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails",
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r383",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r142",
      "r143",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Schedule of Operating Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-caclt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss or NOL carry-forwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails",
      "http://check-cap.com/role/chek-itaxd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "GENERAL INFORMATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-info"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r158",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-peaocad": {
       "order": 30.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-peaocad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other assets.",
        "label": "Foreign currency derivative instruments"
       }
      }
     },
     "localname": "OtherAssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESDetails",
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about obligations resulting from other commitments.",
        "label": "Schedule of Reimbursement Liability"
       }
      }
     },
     "localname": "OtherCommitmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-caclt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Change in fair values of cash flow hedge",
        "negatedLabel": "Change in fair value of cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 50.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Others"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r26",
      "r135"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 60.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Other Expenses",
        "terseLabel": "Others",
        "totalLabel": "Other Expenses, Total"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 30.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of other liabilities.",
        "label": "Other Liabilities, Fair Value Disclosure",
        "negatedLabel": "Foreign currency derivative instruments"
       }
      }
     },
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsScheduleOfMarketObservableDataOfSimilarInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Financial expenses, net",
        "negatedTerseLabel": "Financial expense (income), net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeAndExpenseTextBlock": {
     "auth_ref": [
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the components of non-operating income or non-operating expense, including, but not limited to, amounts earned from dividends, interest on securities, gain (loss) on securities sold, equity earnings of unconsolidated affiliates, gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "FINANCE INCOME (EXPENSES), NET"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeAndExpenseTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fien"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.",
        "label": "Payments for (Proceeds from) Investments",
        "negatedLabel": "Proceeds from (Investment in) short-term bank and other deposits",
        "negatedTerseLabel": "Investment in short-term bank and other deposits"
       }
      }
     },
     "localname": "PaymentsForProceedsFromInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "verboseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustments": {
     "auth_ref": [
      "r47",
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.",
        "label": "Preferred shares dividend"
       }
      }
     },
     "localname": "PreferredStockDividendsAndOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 20.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-peaocad": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-peaocad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r157",
      "r233",
      "r234",
      "r447"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-peaocad": {
       "order": 10.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-peaocad"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Issuance of ordinary shares in the 2018 Public Offering",
        "verboseLabel": "Issuance of ordinary shares, gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 40.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Issuance of ordinary shares in the private placement, net of issuance expenses",
        "verboseLabel": "Issuance of ordinary shares in the Private Placement, net of issuance expenses"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Gross proceeds warrant from the registered direct offering",
        "verboseLabel": "Proceeds warrant from the registered direct offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "positiveLabel": "Proceeds from Issuance of shares and Warrants",
        "terseLabel": "Gross proceeds warrant from the registered direct offering",
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total",
        "verboseLabel": "Proceeds warrant from the registered direct offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r91"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Options exercise"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r488"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds warrant from the exercise warrants",
        "positiveTerseLabel": "Exercise of warrants into ordinary shares, net of issuance expenses",
        "terseLabel": "Proceeds warrant from the exercise pre-funded warrants",
        "verboseLabel": "Exercise of warrants into ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r136",
      "r137"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 20.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional services"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "verboseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails",
      "http://check-cap.com/role/chek-pped",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r60",
      "r431",
      "r432",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-ppe"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Disposals amount"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisposals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r56",
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r58",
      "r132",
      "r418",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r58",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.",
        "label": "Depreciation rate"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-ppet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/LeasesDetails",
      "http://check-cap.com/role/chek-pped",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Length of useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r280",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r114",
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Transactions with related parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r141",
      "r390",
      "r391",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r280",
      "r390",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r388",
      "r389",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-relp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r95",
      "r138",
      "r556"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csoo": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://check-cap.com/role/chek-radend": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development expenses, net",
        "totalLabel": "Total research and development expenses, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo",
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and development, net [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-radend",
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "verboseLabel": "RESEARCH AND DEVELOPMENT EXPENSES, NET"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-raden"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r38",
      "r44",
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r479",
      "r489"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 30.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "positiveTerseLabel": "Restricted cash",
        "terseLabel": "Restricted cash balance",
        "verboseLabel": "Restricted cash included current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails",
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r74",
      "r130",
      "r426",
      "r427",
      "r464"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 20.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r146",
      "r183",
      "r184",
      "r185",
      "r187",
      "r193",
      "r195",
      "r232",
      "r320",
      "r321",
      "r322",
      "r336",
      "r337",
      "r352",
      "r423",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r382",
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Assets acquired under operating leases",
        "verboseLabel": "Lease liabilities arising from obtaining right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalariesWagesAndOfficersCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://check-cap.com/role/chek-gaaed": {
       "order": 0.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      },
      "http://check-cap.com/role/chek-radend": {
       "order": 0.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salaries and related expenses"
       }
      }
     },
     "localname": "SalariesWagesAndOfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-gaaed",
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfAnti-dilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Anti-Dilutive Securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-epst"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-itaxt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-epst"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r89",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpced"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule of Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Finance Income (Expense), Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fient"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/RelatedPartiesTransactionsWithRelatedPartiesDetails",
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-relpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r44",
      "r116",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r282",
      "r284",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r82",
      "r84",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Fair Value Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r154",
      "r155",
      "r156",
      "r212",
      "r255",
      "r256",
      "r257",
      "r259",
      "r263",
      "r268",
      "r270",
      "r454",
      "r477",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [
      "r480",
      "r481",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D preferred stock.",
        "label": "Series D Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-csocf": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting terms",
        "verboseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited",
        "verboseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted",
        "verboseLabel": "Number of RSU's granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Fair value of warrants on grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of year",
        "periodStartLabel": "Unvested at beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested",
        "verboseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.",
        "label": "Expiry date",
        "verboseLabel": "Expiration date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black-Scholes-Merton option-pricing model assumptions:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price of award granted",
        "verboseLabel": "Exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Warrants granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Increase in shares available for additional grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Increase in shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable at the end of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable at the end of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Warrants expired",
        "verboseLabel": "Options expiring during period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "positiveLabel": "Granted during the period",
        "terseLabel": "Granted",
        "verboseLabel": "Number of award granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Fair value of options on grant date",
        "verboseLabel": "Fair value on grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Outstanding at the beginning of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Options outstanding",
        "periodEndLabel": "Outstanding at the end of the year",
        "periodStartLabel": "Outstanding at the beginning of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end of the year",
        "periodStartLabel": "Outstanding at the beginning of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average of exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r306"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Outstanding at the end of the year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award",
        "terseLabel": "Options exercisable period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/Share-basedCompensationDetailsOfShare-basedGrantsDetails",
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-sbpt",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Tranche One [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Compensation Award, Tranche Three [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Compensation Award, Tranche Two [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r289",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Exercise price range upper limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Exercise price range lower limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationScheduleOfParametersUsedInValuingFairValueOfOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "negatedLabel": "Exercisable at the end of the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Exercisable at the end of the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Outstanding at the beginning of the year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Purchase price",
        "verboseLabel": "Price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r119",
      "r120",
      "r127",
      "r482"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term bank deposit"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r45",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r180",
      "r199",
      "r200",
      "r203",
      "r205",
      "r212",
      "r213",
      "r231",
      "r243",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r255",
      "r256",
      "r259",
      "r263",
      "r270",
      "r362",
      "r445",
      "r477",
      "r490",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r17",
      "r67",
      "r146",
      "r166",
      "r167",
      "r168",
      "r183",
      "r184",
      "r185",
      "r187",
      "r193",
      "r195",
      "r211",
      "r232",
      "r272",
      "r320",
      "r321",
      "r322",
      "r336",
      "r337",
      "r352",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r387",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/chek-equity",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-infod",
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r183",
      "r184",
      "r185",
      "r211",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/chek-equity",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-infod",
      "http://check-cap.com/role/chek-sbpt"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of preferred stock and warrants for common stock issued.",
        "label": "Value or warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r16",
      "r67",
      "r68",
      "r74",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Conversion of preferred shares into ordinary shares, shares",
        "verboseLabel": "Conversion of shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r67",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of ordinary shares in the 2018 public offering, net of issuance expenses in the amount of $2,413, shares",
        "terseLabel": "Issuance of ordinary shares",
        "verboseLabel": "Issuance of ordinary shares in the IPO, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r67",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "RSU vesting, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r7",
      "r67",
      "r74",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Option exercise, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationOptionActivityDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r17",
      "r67",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Conversion of preferred shares into ordinary shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r6",
      "r7",
      "r67",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "RSU vesting"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r67",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Option exercise"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r53",
      "r464",
      "r491",
      "r499",
      "r540"
     ],
     "calculation": {
      "http://check-cap.com/role/check-cbs": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs",
      "http://check-cap.com/role/chek-equity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/check-cbs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r179",
      "r256",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r272",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sed"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r67",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Amount raised, gross"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Reverse share split ratio"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r373",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "verboseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r373",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r373",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails",
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails",
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r394",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-equityp",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csocf"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SuppliesExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-radend": {
       "order": 40.0,
       "parentTag": "chek_ResearchAndDevelopmentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense associated with supplies that were used during the current accounting period.",
        "label": "Materials"
       }
      }
     },
     "localname": "SuppliesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-radend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals.",
        "label": "Laboratory equipment [Member]"
       }
      }
     },
     "localname": "TechnologyEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-pped",
      "http://check-cap.com/role/chek-sosapd"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) related to derivatives designated as cash flow hedging instruments, recorded in results of operations to the extent that the cash flow hedge is determined to be ineffective.",
        "label": "Unrealized Gain (Loss) on Cash Flow Hedging Instruments",
        "negatedLabel": "Loss incurred"
       }
      }
     },
     "localname": "UnrealizedGainLossOnCashFlowHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://check-cap.com/role/chek-fiend": {
       "order": 50.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Changes in fair value of derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-fiend"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r214",
      "r215",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates in Preparation of Financial Statements",
        "terseLabel": "Use of estimates in preparation of financial statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-sigpp"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/COMMITMENTSANDCONTINGENTLIABILITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/Share-basedCompensationAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails",
      "http://check-cap.com/role/chek-infod"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants value"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/ShareholdersEquityOrdinarySharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r198",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in computing net loss per ordinary share, diluted",
        "verboseLabel": "Weighted average number of ordinary shares outstanding - Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails",
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r46",
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted average number of ordinary shares outstanding - basic and diluted",
        "terseLabel": "Shares used in computing net loss per ordinary share, basic and diluted",
        "verboseLabel": "Weighted average number of ordinary shares outstanding - Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/chek-csoo"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r196",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "verboseLabel": "Shares used in computing net loss per ordinary share, basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://check-cap.com/role/LossPerShareScheduleOfLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "https://asc.fasb.org/subtopic&trid=2197926",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123389372&loc=d3e36991-112694",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EEEE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109999725-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r467": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r468": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r469": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r471": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r472": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r473": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r474": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r475": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r476": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>100
<FILENAME>0001178913-23-001275-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-001275-xbrl.zip
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M7<C3V^OKSN0WWI:G@\\W@_Z@V[F9!9UN=W1[,QO<? [&K.EW![VV@5=EOX:
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MCZS]-4.:L>$(/KN@BE+_0M)Z;CEI)/2B?3'$,#)UQA4?[D;S<8K%NON\&L+
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MLL76'EK D;:!"23:0,8&B9BS_<7D,'M(#Q2%R'D,TI"GT)HYC#99QA7!$*U
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MUD]#\F)]Z],98:RMP,__#U!+ P04    " #]@W]6B!OSAE\,  !VIP  %0
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M(;V(L[>88CLKZD7<O8T4:NRN)P^4V@.O-]0[Q=P?NF+4(>3W'_\/4$L#!!0
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M\8YZD##[.$<F[HZ<77=@&R'U,7RZ3]QDQ[XYR%V<HV,#Y/X1!3MTZ,+]I1\
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M3L?G*B(+"HQ']GRU+B=0*R9A(KC:P0P%L..Q CL(ARCPG(P5SV$\10'H=*R
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ME58^]K<0^G3T$;^:4*F=<UY1Z/8<7[H^3(F\!FZ\@YF8G4JAL5E'<DD(NCT
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MV739M"4<@G\!5W"S$QO+YJ:F$'*)-JDX)>36TGE>F!OJ3&9#G1U2HN8\;JU
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MK?-)3=#;S0Y?R8M5T]\^>W;] $>_7\)H4TR?_AN-U8AXH]'<=USGDVD-A7*
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M5OP1X;I[@9_L[]"A=XUVU&:W,1?(R2!BDOQU7RS@;T:$[%-MN_A[Y\=_74(
MYB$ZE=%],L#J99 @^PY]!+PUNW(9),@^LK>+M\66/,>U3Y&0<J?IE8'HW+(Y
M ]1PLR5J">229"'"]6JX<<]:)I5->J"&?T+/+3)=6<V[W[9D24M0PVHNFZ1@
MH&>1IJF<PLLXTSPK,YYCLWBF?'$?1%+[O'[Q8=]"QC"I<0W]5'$,%PR_PV12
M=G#C[]*9+[J30UUL!RW,D)2+G4RB&FT,D95);&RRZFVDDX88^("'Z]RH,4_
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M1%8F7+/)JK>1=IH;^(##W,L7JQ7PL+!?[C^L?]T!+PH]/\A>R,^22X!T$S?
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MF Q<6EQG"74B<I-8I&B)>B(B%#L&M40KG.WVM_=XCD<TS-__/U!+ P04
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M?OBG@-0"^FA.0&GD_3Y.DHSY^+\8O)Y'29K\ZL:Q&Z:7SRSV>,*F\$/B>MC
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M-"?O: P[&1P:VUZ+.GYF_@)BC3SX:,+35!X T1AX0D T5K[602E]]3))8P6
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M/ ( L27L#H#8$NH&AU5L2'1[\7  1-<3CP! ; EUP\(J*B2Z?'@$ &)+V!T
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M:@.R*1Z>:KF;=T230(O& PR.%HUO&1PM&@^%R1O<T*MN@31CW2T' (@\TN$
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M#J,XJ;_TU@)*KSK I?$;QN#2^!II?P= K&#1>!MR6#3^YB9Z% T>OA&GWP*
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M ]<33TN/%HI'M.AZ -)$L<"K(DV41>"5D2:*96J0<BA761!L+GB0*7:TU+4
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M#WA->(-JY[&.0/&-&\L#7A.>0$1%D_DX]/DC]S,E5FE9P&G"-[SH&[,RW+%
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M.J-5U)K]:#S_K S-Z4$<3BL.UN(AM0,5'O-K&#TD+'Y$+RG [VY?=%)#PNY
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M=-V@>FM#9W.8I'T4C/'HY1C@'3T@<5<@+N/))&MIDC6FH2\*(V3CT<L61?5
M[U::>O E%9&*\2@%$>$9&IYJ#\R&*@C?>&RRCT7]8HZL.,(V'F/LX:AE7^J
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M$[/V<]--=9" :0]>[@]=1?%M''F,^>*M9;U7GMLK(R73OMX )=,^WP ETY%
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M,:A1&TF9CQ(4L%K?-=6HC:3,1PTYK/I0#GW,+)"E++Z/YNF3&W=,I7=PFR@
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M.C]KNM;"0*9@-0:YX/LF0J%G^:6,MJ!LJTP[RL>J9@:G8P4OJ77#FG@"HSS
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M5*$:$R^-$/;[$R'LCT/"_5Y3I=\/0:7?*U2Z4HZ3TX&I]/M7JM(?%*J!CD5
M/ODT),@_*"#GKQ.=#@_T1P7H8I'\_?!0?](T'/V"UC0<GQ2&HQ#QNQ\&9C8^
M*<Q&Y;]/AV<V?M0[1B.D_<.0@&LJ]!#T67D"HSP=\\F T>BBT I]SL\MB!%X
MVN^DJIM.J**ZFDZ<#D G3A4Z(::!)MQU!W4X5:I#J;Z#T@;-6'D(H;(J4C87
M"'50!U607'CHX9D'581<4X@/ U"(#QH1D(DHLX-*?- )@$Z&9R94DY":5O0;
M^^AIQ0\*K=BN$0W,5/R@T(OM*L"[P>F%:IY7TXM^EX?T].*C3H!YDMN+?@_$
M=]"+CZT!9F$LAC1=TIQ&#V$6K9I$B[?$W[\;ED*H9M 88IZ<#$X=5)/GFCKT
M*V(]=?A1H0[[VSC#T8D?V^/,#X/3BL]Z6M'OVI6>5GS6BBA.AJ44GQ5*L57E
MW-\-2C$FX6M:MJJAE:]2F%H$ZJ :-<PR[?BK&]86VT[[70CJK!N:RU<G0UB_
MJL%M6L(RLB3433?4JUBHSZ<G0]2,U[3M6X.K6+T8GMU0+6FA.K\?I&9HKFF=
M#&%1JP97&6\8623JIARJQ:U"HT\_&] /;4&+:_)ZNH'WRD7Q86EVG8'T/.(N
M [;#H)=SE5HGE!L8J+>%3:A.YP^ EV;U-6B.A\4'H?HUW!IZ<]4W[FZ&I@;>
MOLIHB_R&*_-9[(D<2P]+U6OX-52F=_Q=#4T-OG*5?5A*<\\>6:BO-:+XL-2F
MSD!#;Y+>&715G#J!5Q/:W//G#EK#GP>F,Q5Z'8WI&7UG?:G OQ;G-'V*_IO%
MJOQ$-9%C4B(L/2"-V<7?HC*(_^]U_+V$P?H$F'^'!B:37QPM_N;,XRC,7].@
MA?LYAQNRA4CVV:HN6[0R,5^S)''6>$/-X^OJ]4^\8ST>C^SH]Q:P]+9C7L0I
MRE@U'UND[R5(\9T!FTG0?XJC))D F92OV)<H3)?!IC$[@BCLE*6=55Y<W%6W
M<)FO";G<4#0BMR9Z&#L*TPQ_M>="MM!DPNP;FI[T=FYPAO[(\\2C$<P?AX\L
M22/E2^ [M9T17OVNZCM5 _WZ$O47T*8G_4+=Z-FRC_HD949^EZ3(2+ ER8V0
MU-34'(I&BKFRZ(!2^HV3V&7!. RCQSRY>Y8NHYBGFR]Y#H+-9'[I16&TVL '
M'(=^AK]34)PN>>*L\EA9/ &2B,02>3?.MA^GZJB,-<H.\>>B2_'5RTXM#-(C
M9",=M@HA5.PG6_:C&GO+ZWC'B$(ZN ?A8XJ,K66*#?V$VKS,]6HO*\H+\'*-
M*W!>]OBXG98KV$<K58I]J5K3C.(PQ16?M^9C+L]=#.$&&=ZGP//1=VP!@Y*!
ML[S@,?/2R7S.\!5Z%0UQ%0//5F\K.WEMIZP^#()Y$MH6)@,X&H4X[OFS6GD0
MZP!NX2,.\-RQZG4-@;7?4QA:6/^3;;ZX(42'68S&(D]A*+^R7-GKW]G&6;DA
M9G?):Y4))Y<LL)!W7TY!9L#_LP&X9>E?\SG;PH_9BF<KA>J4+ *H5J>25[0D
M?@4'U9>0<[ _+*[9P@TTYB"BW !>CI3AE2].&L.K*><D86RR9IB>+5Q<,S=A
M(Q]FI6*>.F6Q//4S_@$M42"J_SEQHK(%^!4TX;A5&YB'W_GS;?A;^"6\F(8_
MPW_N_^SD3VB]R9^>>G97ZX"]@5(GO_WPY>3]Q9^=>!NGPC^C&&?)<]<3YB\*
M\PR9;_*C#&)Y+'E39 ?E,<8XCN]N+$2Q&M)L6K%FP+^JZ(B:;YQM70<KVPIW
M-6A)]R2WZ'.E@ 9X9.]ADNLH7"#8,5BZ$),1ZM@7J"-D[U2UAF!M6IA(E<P6
M$ZUO QXLP_&=861^&T>+V%6YX)WB3E'>WO=0H)>?N3:-7O,;Q-X2=X,/F' 5
M9[)Q*]G2C*OE ^E1:[X^89.:_M?3F>(75S8',,$O'F 8+1:QV/HM]L7NW<"-
MY7.@HH;CEE6JS;%$5#+O\M4<Y/JDYF#[<^0/&&\F#P%?N(TO\U4L\EGIVMV(
MS.48S\7E"\C6OL9+"JH/491VML5M!5J-\.57'7+XE;C+CV!1@;36&,45X4&8
MGPV>Q]3#V^\=4#V\/,0/?L9]\?2G>"?PEL7W2S>6GX H*C@/W"\> !6/!5H8
MEBKDTJ$I1VY/],6)#2P77+$&<9?G-$0I9\YL2'H?J%2Z+X#:%VSJPE!LR-58
M+7Q6)V&*XL+=)"Q^! U)<'J)RPHVGA[=IZ&6>E[(MLQ5858!]=Y64-4>1.T@
MM"W*7]B2>P$3"R/%GJ!2KH]Y^6)9I-@?M"9F&7J5S(OR^2)5N1=K+61JYB -
MFE1?P)H:W;#T-HX\QOSD*HY6Y<[Q9"X\9#(*?=UGUCTW63H\G ?1$Q[778FS
M*-7^/IA0+UJ!%762-/)^?X/K_3!_Q?EL\8LT!H%D\:;\6?RG>*"Z6&.-\ DF
M!R62B*=4_\AX:L%&=)"9] XK2YVROH,-U)[OG3MY&^+(2I_/O;>?5.G 4GK0
M'UBN2Y;PL9*<%W[&XGW-7$OB[<*&GR]L1,7"AJUQW8&X[*3R#O$=JC@@S-+5
M,P%X,TSY6J)(#6Y_%G(3A9?/S,MP 3E?!(OBY#Q:H045%144H.[;JK)3U7;J
MU>TM$NHRDYF3'09I)+2LB>TP/V'+9V.&B73_4LJ$!8/]$OE%K ./.6WO<0W]
MJ---AOU/YI/8YR%$[(45?W1Y@$M65U%\"_TN(1A#:W\+84D6^DP=]N1MBAWA
MHM7*OY7MB@GBNF@9!F4<98LE1CUO\_:K5Z8MQ"]'2D2JYX02&:RJH#3^J2O=
M1")3EEN8"O&Y^^S@K2[[URN.YBB-?[^E 9%+Y(XE:<R]E/GW.#?[!7YD?L.T
ML"Q93..RD*?.HZA@3X=5+&1J>G?_-2E 6_\"I:Y-HS-67)?\NA:Q2.SQA&T+
MM$W3PTHO2^TJ7@5>%'=!,VC6846[]7+V/IP^>85K@KEU=>AD&CEGS"EOOV);
M3ME8O9QM@Z3/6VV!NGYI:]I>/*MV!:VW[HV53[#UG+:L"^[I$YYN8EJPAY#'
M'()TC@L;TR4[7W(VO_<X$E#>"LCKE'?-1#6GJH>_SF\X_3G9N8=6WF1Z@\_1
M^DPL \$0 /]G;2;71EYF2B;G]T/Y:KC/-@K]+RZ'L1SB I7:\HO/M;UX%>6?
M,7^)%C[&:MN.O5V!1F;2;Y$SP-)BM;16OI<%TRAU Z75;D0O,\Y[!VZ3-SF1
M8@,!A@EV9\O_-#*1K7=.FC7)\A")<:WV<K4.H@UCJE6FLKC0HZJ"Q5OM"OS-
M0Z$1OUTUDK*0#HF2!6H1,\)"3YE"]AMS=:ZE0\FW>#U@&W#9\VY2T%+E,0I:
M3^([Y_W1#A5VL=A#;3T#4[HP,</>NR#B%R^O6QC5;;2DGV?74>RX":>H:&V
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M7@,/8BW3TR-86_SD,0=_> '8DG&(WDZAR45AQ\?2N#0KO., U';+00.]*#<
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M 8-;->\M1/M>ZP-@]=4GX!EDF4^=ZE5$W4EB73Y=S)@?C^'Z$JL6OGK0D,=
MX !R3]%[%0/E'(MAT.[9E1ADO522'L>G2_4G[Q]7;.%#W78)_#C%0*PV0Y6D
MNEZ4>YM0L(<1S6[RR^88EE@XX]ZWI'!@NWM'4ES1Y7XKN<)M#IXN'9'UVH^X
M7"Q?15D@EDH%1S+NE+8 ])XJCM5P$%N&#@-N)8LH$4ODZ*@3@S%?7;_PNK3
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M7'+=!/Q*DO<9N[H]/*X2&)NJMI7WC N>1/+ZV4[FX^-<.CX@=ICNJ@"-=9K
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MFVSOWIY_]#;%0QP%@DKH6MXO2IA<\D05/U/5-VLN7TU/@N3_?7?VX?S],2W
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M^>?L>WXA./X2.-%89$ KA#8[""L:LPQHA=!V!V%%HYD!K=#9L!A!8HS!NEQ
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MK$:1G(K6#9!IR1XAXO9M&S@!'2(!@6T#9+-%5T"Y+_X!2:F(T3MD@Z7\2,2
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MUREO50<\%]V+AX^O*XGK?2Y\Z@5+V"+*JV(X^]74/N*IJ5_H"R[T$5R&G6Y
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M2G8RW@KCFS^Q^)%]29-\):86/$GVP6V>@+XU_6"(2@YL\P3LX4_F\_F*,S$
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M$X!0A]_'2JBA6R9DR59W/'V,0A9>;+]F+)PDUU'B)P&<0D(5-?4&XQ.>L'=
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M2N0(:Z%!-Z5QE#6'T+?O.?MW"[MUN\;.&"%8B!5R^0[K/E5'.@F)P-82/D+
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M _9AH4_3CD.],\PCW+R@1_,'.L.8R PDF/,ZU5Y4<8HD3D^GNHOM8>5"V*V
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MS:.!B*(ZZA.N2E$U/W>5]ZG[4UR591P9';9$/5HJU%U.]R>=G<N=]6 .Q3Q
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M,,A"4U)+9Z:LLR1<ZAS]O1ZNP7-4\Z&CUS;&5MS4,9S=PT7P8 >XR%CV,SL
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M$@GS9O(FXSZ32LS)(")NEL9BXN3XO!L@U:(LO )N$*F$M4 /;N/M)40J 71
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M.NFH U93SC*J;JQB9$W@5M6,LR#+N*5K?F?/ M'16WM%6G\6V([6FBO02[1
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M-"N%?!J-D9MKE$-\>@U@1<L8Q#38@ +WN9T*B>MV3P-,K[C][<#YNYT3-G-
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M<5"*P;APAW)(P!YX$K"4PW$]#-70W& 'D#@TE>&X)H5J:.ZA)W%BRM&XE,,
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MNJ(V!<;$4((4"K2+1RPR11BEO]0TDQYMY81J(>>!5$6N!$_R=8J)U:;%.,B
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MS\FS0G"*>NGPV#X\+AYN'I?_F-U?W_S/C_G#]YO[Y?W-\A['/20JPQ!>VH<
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M :C#M03!%F?$>#P?!7^R=:&[M /.;\(U+&WW)L027Z[#,-"@3;$N!E$9T)&
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M.8G2-.,E*XM$$)%10I+3]IYL;_+UMK=C>1K9:&+;)6U;0!Z@&6=BA&I_,QU
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MW19SN!K3BKEJ=3K!X'+&-([5%S?F0I/5'LJS],.E$U6-[@"!=1C$2^]UK:'
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M<(Y>PDI69*)(0A(1GD@K+ G2DB7RIX@%]&B0-L=4M:1"Q;CA=\4+_1ML7WV
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M.6P4EQ47WH^?>+F#_K#>+^KKY_/I#\6>4KJ!:T>-0IC1[^ K*= _[0#N#.A
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ME =CVUHF"DN(2ZC3VRV]:.GV$OP.Y5])8VO6$#,@UD18\(L,@F&A[?&(6=B
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M&_TUUV&F@<.%.;Q2"ST\E.2MVCG3[2V$'%_\Y6J79^^[O?=9^."H<',2/F\
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M!$TXB8N,DN@D9 [.FWJO**2_A2P9DMA&FBP(CP5?ZEM)DUDJ876W/$'LE_R
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ME[72[#>7O4^')FX96S<*I8PC(78P>@0VF(/;DX-Y>L(Y/#[.(3CA'!ZE9NJ
MC+VWMK&)BGC<E=%02A9<MUH7M()2L) COM;^S(1+>GC)CG^RF/'1#>1-)P!T
M8-RP^"P!-&H:\'Y7O!CR/6?T7 775TLA[GUQ!HS]P@0YMWYKH],R"^%XY52^
MU_,.0_*7L10=.<?2VS01YI$3!HIBWNIVX)56:V,6:V5[)#LS 'G9E#NU*##N
M6\:\W;70 6$YOSMQA\$'AAIG6VHZ9I0J!O@?-0XC,DE7)J\Y4GPJQ*=C^8L[
M1U-*#3G1RVIC6O7:BF8,ZS"]E28#'J\"KIR\;TVKULT'C_DD1NZB_,)#2:V_
M#<4G\P5+XB(O14+*/"]RZH=^Y!>4$I*71T/Q>43E)A\F(:H])]+)6MM3MMLR
MJK>^E"\F1^=B/K78F<5*4-X("*D5NPY0$9WJ9CN/[\_#.$/ !>)OF+P84BWS
MJ(Q)K]^2B-6)Y^-J8)MG4< 8]RG/!4D9ST,:YP5-@C0(?!$4IZ-X< UL7X_<
M#9-V/#-'Q8*R8@!E:=I2O>^EOVN=X3%0JQKW)H(00O70.^HV%W0K_>F%$XFJ
M?88:&]_NMD&M7*37K3"J.^O)5@MP+'/C<>;+V"M.;'V*XK$8JZE):.*!TM";
MKX:U_"90'\?N<[%!**#&8)*CDD-,1#'QP[B,(T*B(LK]* JC("-!Q/TP/_55
MFN*>TP/%/?]LT7?32M%7WB^&CU[:"O\!DD5=_(2+QAZ"["=!P1/&1![[)"9A
M5C":,9&*E/" )_&Q[/ CPDA_<+.>'?JZ+M#H K;P@#9=2/:YO0G19:N1]6I>
MY;?@R+KT0FAZHK_^4I^9;A2;,/_LK_:&L2)8RDY !PS&U.(/2S$_!VJ$*.9^
MQ/,\*+)2GF!2E"$G>5$$?A[D9<!/Q_8@?55:EI IZ2$RZ&B=NXZL.:G3K)8*
MK=4O'$9N?9=.YU2F7)$K!Z-;U=@&&7'[>^C]+4&=!;F-2VT=,!IES=9BXNDT
MXO-X9_#;'#?!6<D2$6<\)7$8Y2+A0>DG818F-!='8P<>D3_Z<S,!0R) =;4,
M-%V9DG)$HYO64GOP[04?57MWG'\T 5C8/-24BMOS96!J*J]HS]02H'DX4)T]
M4>;LS<K=%5)]YY2O<TSFFTXA5J",CBXF8;50L74"6I@@?\E0RZ!/>=7S#=2?
M._!1]X[/0-WR/)4KFQ5A&N8D\=,BCY@@*14^#WR>G=3MO<X_^\K-=*;E'[B[
M49?-LR\0Q-D #0.]HM4:=X9 "L^K2KZHXF:,]L7TUPZ", -4>X!]NX=89UJ&
MHTSO$QR>&\2SDL'QT.5478B@GJF8ED\B\P7.2"%N%T;L EIIK: /-9<G7DJ!
M)Z#4GQF$(#Q!"+X%A.#1.&3?C6WL)T@I6S"694F0IG%:D##C-$U27@0DYK%?
M'A%)WZ.%2+,##9'^?[NFW6V.CP2"9K&@629*DI&2YD7"TZBD/,N3L(C][%CV
MYQ$%.*7K9C/KUN4RQ31[2 64L]+O)P#3+0W!</H7[O2%.A8WM24,W_L"R]AR
M ?J,&VJ9(K[JC#.*S).JCD??6[N'RFS42_ ,W*NL8 7)A2^B7"J.(*,L"^59
ME0Y6&A6^.#5+/+QHYMM9ET+#_^?&[E4DPCE6JU';TI%O<J9BDA#$H+MUKXHT
M1NQ\'1Y:P5N=Z9!7F QU0#QUT,]7]G0MM3I0H1]D::"ZQEB%@2AR4O0<6GNL
MUW(D9V-$8<O7_$JJ4HT1-_@&#5*7<X=A:6I556UUT7(LG+#<-/VUO-'-BS%X
M(8QG)#6FNF'DY$%!/Y2P>9?R[$$\2]T BC'F)7EW$H2@8)O=Z=Q$AX&-HJ_Z
M'2)2M;1<2)T"[Y]:0\MCRS>V)!5 %5"?L_BRIXC)"3F N<P6EH\R0Y],*\MG
M(!J9GP8YX3P0841R3FD4<QIS$?/4%S0_M5<[O,CS6V%H6+ ZCLK_2KM@*#93
M;-$6>VM*YXP-8$^<SNW:R'4/UH*I#P*9('8MIC]UH->]B36;!J-$<^$@TK&9
MRP6L7($.8PS+D=2IA.C6-><?5X8R *^8TET; #9*%?BZRX0_OAB),6HFE[=W
M6EHO!JI7&N[UH'NCR+RD%10<[8%5JK69+\# 3*O[ &FAQFF[KE1-C-,TP-9Z
MNY),'D5H^(-H>,!+G4->_&Y;=C!9!]L1JJ/YMA^^K,>$-5>JZR]T]+5=ML>W
M'.TGR#14%U5-X1N*7UU*[@7P%Z[I@A6K*2',7>R=KZD%M;$YW?@8R)]$BXE\
M5=RV+/U=3;Z<LW$4\5B)V*9Z6BT*+&BZ@SRJ,@5O>Y6@:A^A*\@4] !->\P<
M2;L&:C]OM6D 9P\@X8Y6[/RNZ>T=QC-0>WE1Y"SS2Y&1G(@\R[E@042*B!9E
M3(Y'[3U:5"D_T*B2*XQ/K.R?45GV84&S+8",E=  R5(QU(CN=U1'G%E 8^1I
M.)2*TI#1ZLE(_)%Z'=LGQN89=].IZAT46@_M=%!EB^J3%LJN^':P)?+6N_JZ
M6J\-^*7LW;FL'%*:H0P-%?:>F;OW/],E4>,O8RKC7-J P_S-JNITVS*CWTK_
MX:]2-=:(ZK9_&!@#=2)=2_EQ/\715*3/V$!*W5G[4?*^!J]J>K6^;^>&EN")
M2&S$[UA)N).KLX;IFUN=+>HGTX:IO&R@ FU?P\I/-_8^$[M$>8EF((IV1?56
MA G:EV?Q2NBTR[ORM5@9  ;>4#]31_KN:A)0*V(%8/KJ[6V4/XSW&>:/;7T[
M8-9!W@FHS>QZ7:, 1J*VQ.5WF@NJ+"7+,F^-_8%Q%I]AIV5'.>WXB,0)&)<0
MTUZ0 M$K0/L&-?C(O;KN%GH/F]RN?$E?I6S[(=DB*LI,D- G049HDF1!RJ1C
M&\1Q["=E=C1 JL?2ZY'_9?7Z+?EHU.'[TYFHW5^SQK)P_>I"E_K]* ?X9]RV
M4-/4!(G_RGO,_XQ^.:JD5DHCJ(U+:$%+$L=EEO$PXL)G29SG)#HEM0XOJ?6C
M\N?O@O9H)-XH9&X!.<OT,"8&3GS%<+="1DX+S#7MQUR_U D/*6!2M0#;1V)O
MAP#9X6"GT,5ZNX:DUC]50^>E$+8;O=U#.;F']E-J7'TGI=5K3*6![:/I\^ *
M5G408F\55*GH($Z/TL<J7PN.G W-VB3V20M4XO]P%]M8J9HJQ9FSM<,F"S^C
M$[(4[J:;#YK 4RR:V0B6LKD;HO[#<K>CP).F'G(*.-0F4_'$Z9>OF]V:.;$C
M%;9?" DVSD5R$YI>ZYH';+I-(39RVX2P'U0WS;/*&^FJQX&Q837?H)BB^9*;
M;F'_?]XNQ.2N"2J:W7/7)CPN?_CS05?/ <,7G3!\!^:EL# ,XBP.$N9G1&1Y
M5F8L#8*89[R,19B<S*N#PR/\B*$MPTX#)8ZZ11TJWKV%'(R76&^OU L0P ,/
M/$4N.]!G]\DG0=C);6N(\"3'#MC?KGKT]#'^ '+K$T2"SD>A#MSHG/A .;*
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M<F9826YP\;OQZ@^XN5OXC/Y3%0M@E.,:S@[_! '+;GTSE.'LW[)RNN940S6
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M&@F>_!S=BEE_B Q<.QA?O>L.+;K?\&-Z*?-3($73@F3J%^[>IMZ"&(7A_PE
M^HBD'&#\$R"@87L_M#IA0MZDR:>]5T7&_R^3) \!<7A4O2K>[*V,9+@V'UHJ
M"YIT?%$+9(R."XI.+T%'%[QO6SB>C[+=S,21Q[*(53RR*]]+ 8.HBD>"1E%2
M2J+BM!)I$;$BS9*$1Z4XFP+&&?7309)D<3<O$P]DVN '@X:USA]Q5M[8Q4.S
M-I9#/Z.=9\_IJ.&TV=+:0Z@!.KX+-_,Q9=?Y)AQE ,8-U#M>[[&NXG!9DQ3;
ML2.8B-ZNUN=AQ_G.S)4BS-CSCX9T<,94F-JFNRN((G]2/\ W _3I9+T_^%[
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M8).CC0K.:D-DX)BUX:FK RZ=:*=O+1S"(@;G)WX*A4;XH2<L9[AZV^+Q6![
MB6XIS!S7($5="\3S>"=E@/'ZO  +\*Q7%]C'R\,^X@OL8_*O$,+QVJ'!]S6^
M^N+4IKP5CPF1JB)1P4C,%255DN<)4W&9Q"PAET!@$@@D)QH(?"_U@VI])2)X
MW]YM_?5TP"CCLHW 6VT+/9SVG1P5\A"D^6"+2\(^!W":V'#;[P%>&HH%'/'!
M)K@P%UN'D%C0 IAF<::<TD'5!KVT__BH\C,KD#UMU-JX=)^[!A@11-0^N!;@
MZ(([7SHRSMUR6X85'7=$1P'ZZZ!9T0685P@)#LV;A 3/(0;G61$5I.!IH4@<
M":JR*$JJE&=I1-/\ MV;&LY7%EC_W8;STQ:'9'ZF#_CP];[Y.WUX,Q/Z=7JN
M>4I%DK!"E/K=Y8RJ0J21RO(\+JKJH@A[@MVJ+W4V)CJ:TTE&2T8)F+5F9YH+
MP(Q\H/S68%8,N,(V):R64.L'"_0& C*JJ=.Y:2GR1<YKB/M6*@E,YS50TB%-
M.WS=C!&VT+085@0=,W<D0QME_C05C/.>96W&V9QGW=-ZXNY"):3-IC$D5W3;
M+/F9*\NEJ1=&^PW^&+@TTP[9KEJW;+V.@&@K)O-+-X-QUS,'AD=N&ZP=( NV
M[638*X0BKQ7B\<X=GP$V0X+BKI&SF?K:5MH!3+@;[[4^^QSW6W!>ED6>5TK"
M"'9%546IC*.TC(N47SCS3J\;\O=;N4.^\, @>1,46IW.E>0@/,3-4'==+R>[
M0C06X(S37J$<F?V 50C3.\-,4:&=Z/?8P?5_XGI3UV@>.O.Q^8:V8V/N"(X&
MPF#60-_!'"W8I8Y18KP_\=O&,,VAQ9W_DITEM\9MR6B *8.0);B@\#+<K\=F
MP\S\ZFA;V^$[NNF'T5][NS!<;^:7[Z: X?/.,KJU7NFUK7322?6C HZ*NKL^
MKXG@/">%CNZCF!() SI53 4GO,QXS!CA9X/K>;$H_U3%-IW YON(Y;]"Y>.G
M(<!R-7S:MH. (N)Q;RCPA8>1UKL8>V!%4B59RE3%2A)1PLJ"2DEE+B,F9'$I
M<DYW\:G*T/UL_8]V;;]"3B$OU<T7JFZ&U3TZVN&H.X# 1*QTXG!#LY,/'2A@
MWFG+ $\D$-4:;K+>4E+'>*J! ]]@$.4BD=X0EB.-S%(]4^\F/ZY@Z7HPPC&#
M$C CUMY!7+>SHP&/?\:/L>F_ZSC%U<AM5KNV\KH8C%&(UI9JJW>TWJ#%48AJ
M\ZFHT7XS4VNC5%C_;EOWV\[H]@!CCB4R@V"6VB9H$'L=OV ?]+IC.F:7M2T2
MVPM!85@XE*@!7\GZ(>VU3-#S]!>T6)M^(Z9\-7;1YMP@S52KT6&9D=<-@ES#
M5!9@5OU7AP!V[>Z!:IJ#GT7!F0XGB33-FO4"P^<T?A'=*V5D<(.[@$_=<M^#
M%KRY^X.8,'YA="-,W@]K,J$S) -KAP*E$&PC/M'1[/@GX>@1'"//</VP5)N=
MF(I%O\,\1@19CI!,7W$__9=^&1K^>?H>VLP_$)\>GC+GB->ZV3RL@Q+&VEV)
M?<7A?JV'/:@M.-QJ$#"N-SA-9O*:YRTS$/08(7;-8[*%"KO4VBIJN3S"/"'.
MY?X0\%Q-'PQ> 6!+.S42]ZO;(3RQ&QBFA49O0M=OWT6,(EC.(E:FC.N<(R-5
M%251QE21)G%*:"PO,<HD1CE5NNT?M_L-XBY]+_;GYEZ^:[W<KQ"J_)=C&S/B
M>7 ;;VI4!T%C8)3S7-5HL+Z6]=+59[/,-&GOCY/ A0X[K*G[0Q2VHOLH$[4.
M=*">8^K2 -7M-P=GL+'MVP+\%RLR-W  QZX6VD5J=$V!;[H#S27M_M&$4PAR
MK/&& ]/6B+58)+ZMYIBP)#2SMGIM)%*YB\;<F(D/^$*'K;T;I]VML\\!>="6
M"M\:&)EGS\_*:%?[T,FL";0F8')B&-]4+>4>A8S@:/-)U$BGVC*V!XK%>(^3
M-G^W0QGZ LT-E%@90TP1KDK NSCJ="@CTPKW3%J^5SC('::R;L@!+G:,76OA
MPX.[6\]]<CN[I>!Z6GU^*>WM,-,V\*O.AYYV5F@49)E7P(9/R"<PB6"H>[OD
M=G@CW#?GK^(WJ[_CE.MX,L1$0!Q=T<8('D-$%D;J@0K8P%Z(V'-SHTUX@4$K
M=F5^E<8-)U5\;$3Z\1F88?+C89 %122E?3!N+F44M?W>^_CU H /AC%,+AC#
M/Q !QB*G(HFYD@41I*@44:+,I<J5B)/H;,0@7RP"/%7VR>^EZ*V7PRCC@L5[
M^6H5W&%S=T=8 %>$LB4J"&0,3_LL<@G:8\.-QLJ1*;7XP@^DGKUI0^)!P=OL
M_(%UR@HBD1-5[#'Y+J39W5AT?MR;<XGVK.ST+7QI1N1KKQ"Q\_@ERSX"'OE>
M1UE=(^<$[*>9]6KC%B=2\3)G,4DJRK(B3ADM"R5SE:FS02*]F,T[50*\7V0@
MU7X.!N\Y+W%!HTRJBI9I0J)2O\4JR?)">W"215+DY_(2GQ&<[A'?TDI,09_D
M5I L'E*IP\.0?.-?Q@;>.14TT% 3".W\+>J=;G1J-Z2ID+(M0%&&:OS.M#V
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M*[_"D'4[A1LQ!W>NQ94<YT.F(,$2/\^0O>KXWZ@1I!%R,E^DU##?X:J!"^7
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M"#(+@A5ZQ"*=YCR;^VKW^ZBC,H6L8)$!7F"STLILPCX8S8618@+L^LOOL53
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M4N.(72828G:U]!B_>WK[_>4YN/8':BC#EC0N+J[JWZ].X:H&^P6)1[BWY[U
M%BEN[7GCPY?KJVL,!%=:T]W(FDCW3;VFS>,N66[=HZQ?LMRZ@?FW7++<6+G:
MV^IY\71V3'=?W4-UB?</4$L#!!0    ( /V#?U:E"]QRW@0  /05   0
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M6]QYV%KO:-F8!RP!E8+)$*Z9CIG$TK^8Y#B%X\38F580M&"[K.*R%BEAF^T
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M0N:LGM9I7>4SZJ?_6@3$R<G)P\US_-"AXZ<E1"1._Y^-V0'P<0#Z(',(2!(
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M8>?FX>?GIV(2D1#F%>?DX^?]PP0)$Q,3&PN;Y-DS$EX:<AK>_\<-T0; PP!
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M1$%V,-D9@")X8NZM/G*HX"<'<)P=A;5&Q61Z51SSEG+=JE[VL["?&O/-6D;
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M81XHTF;U1SU.N8*,XTX'\>HE,W0'YWF!K\9Q%)\VZ(8[I99J?!CS_9YU5>V
MO,U03FGTR33-^LZ>D-"0&+JWT1;L)N8DN4W//%^0H:EI>>;Z C TZOT93.14
MI=6#13)O!(ECZ+]U\%1TW[B&+*VN&== IPY?*JSAK\LUDJ'$_+I IKP OIZF
MC=[3O',?M0]QHHVV#PH&H42G]RR27Y:(0L Z846S+>5L"^>8 MIQEZM3[EA
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MB0TYPQ<$L+Y-X! ]U[\44TM22%\N&IDVUH6*# 1$AO5,KIP9\'BYK-HR=AU
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M^"V2BX*-5,;FKB%4L>(B!$#S("XBAR/PQ^V/J]='AD72@#I#<LO*HQU=?@0
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MX@XX+2*!<S>\<G3VCDQ7>NAT&[<Q-]-3=-JU_8/Y_8G*"2_/KC5_#2XJNPK
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ML@.4S2NT8[]7B&NL#2[QMPBO^Z"KSYCKZKUZ4V4?&[[:U6?",?KQJX,+QI9
MUX ?>T.22:2_5?Q0&Q6G:VI_M?4)Z#Q#)QS6OV0K-P,E*:>A.L*WG<QF 2HW
M?I+X141'O/]_M??=45%N2[X@*H@DE9RCY"PY(T&RY Q*QJ;)+4E$49",@("
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M61(37DE! B69]R/KCR(I%V2J%3U>,IB6W^K\3 Q"L\S-V8^6%1^S;U4)#3\
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MHD30<R*&+ZB>C-XA.6 5WN;(B66DYGFR&T%019OM4%T/Z<N1F+".SU8_T"3
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M*F2J37OBS*1_U&7;.0L>W?@"A CABR\AU@WV$^]7-$S.&\LQJ#Z!,I"O*<M
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M,>/U*0A5K>KGHI9E!'3W', ;BQ6DI82KXU'S6N]=V23TG=BUM@BE(VC6T'5
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MGU6P*>Q6*%4B%R*OT;*]\;SFQ&@J)-D=V ?F3=0/R7NA2@9,R;]I7@%(OIR
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M+O7#V9J10L->YF\E@1G6K]"_?<Z"WI*H;S*KW4.=G,E,]:UA6/O:"%N[II<
MK2A,:+XB^I<02_VWR4]G?%>^8\MPAT-142&ZFB';Z,/=&M.I.]LL6)P%)Z?
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MI%=1C& BM+M"]M24DNNLF+L4+'/&#H+PTV4Q0+6[XH[N3@]4-2RJI'<-#>[
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MO0..1< L?1UE;$;++!#V/C64'[H,*[7D+7?S9&Y 1$%&T1^P+,)M6H-B8^X
M:S19_E6:(I?6!OC'M"(Z"L+EEYTF.G> AY;+M=O7VS7-XQ36#W.B*/J<.\'D
ME0WWL*$VJ,^5(:V5TT>X8^CSS+3G-XT9E*G9],#IMC'K^)6>PDII#\0(H867
ML5*T-HQ6:'P'5T"#BG[[["A2[YNOIWUFTQ.3=IXL+2G(:^\'HEX"$#_V.\<]
M18,E_=*#<TZKO""LZ,E&7IK=5XKVJT!_-U718>4JOB*C)S_V3>+RG2OVO'WT
MJSS.3H#RN^\2:"L,<K0O^DMC=*NJT49",-O?W^G<S\JT?ULI:KIDSS?WG8C\
M:@ (5$ZD*O:0]&IDPK95.=J=Q]TLA1];-E9)/XFH#&=H@<_%;#$LDPML7>K=
M#JJX>IPVTAK5PU1LOXMJ&!\$,3_#1_F(D>Y^&$3C-'W#-PLWB45X&G[W;DV
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M[5]_+^;+Z6FQU,<N;S&NRWQ]JX Y\_33=3H*+!W_"N<JG\[#U=&P.3I4E2
MF'(643*M+H8S*C ST>CTW>>K'T--_U,L /KM7]R+^\8;MZ9>?Z&+L,?W& 5_
MKQI]7;<>43%,(Z0>NZVZ^Z&(Z^:8:/Q-HA@Y.6HP^/9WV[L+B]R=;G0QQ3'J
MHR$>?M6GVR<1-SF-VPF.3">?_Z=)GNX362LO>4PX90I8E'-W7U5"&P#1Q1KF
M<I+\@3GZNAL70=^Z"9#FI+_/4QF>UP,,^\A)Z83C<('HB$X !=@YG!Q5Y+$1
M$9-P,883P.H4XBF/7]':"?U6>.&Q!II\B8BK50' #TZCY\2.@.+/>\%E']1
M='*=M0L)W'<(::SX5;VM$M*H!GWSDHGI2TCI?@I;0?L.Z2^^C'V,BHHCF.1%
M/DP9;=GHAGQJRZZ8:-!# PD+L'!6_)O#3->E-/R/V+6/B!ZX#WI:USO6?M\V
M'TXANXCM>F]'-5!VK(L;>-#9&<%*D]5_?$I=9<S8@O'1%YA;Z%2&F'[Z!>L7
M5=EKGYL<U,<L*X-/=%7O@5+@9&0?GST30V.9:?9(6[/_L*?3E71U<PN!I)<^
MNZ\,=37(_M5LTT7;B^]4O12&/3_,GN,&&T0TBU\[A4O81G+)GFW)YW1DI]21
M;<D2\NZJ2MC&Z=I,'>;%\$P5FS[#V.KF!%FF9D@J:DUF*3[ QX?U#IZ4 -52
MB+)VQQ*T$*:)<?#U:Q/(J[$<NJ/QCY/%.$.V$S2A>?"-:\.>VROQQSX-7A:/
M&F;L1\5TX)T'._SE 54YSY'*Z%<'"U_&KJ5=FP/G4*XVYZ"2BB7!N7+<?&@*
M6Q&N.U(%SWB.I?KZN3)RR;"/%@#.M@D(SZU9!9M69Y589M#!=TX<SYQ<IE/,
M7Z+6JZHK5]7[J]7AV";NE''+$.T[P.O#O+6\O =T<2.GY'S^HRDY&H)X(5O$
M6.*(/S=!NOQ,<:./#V]+WVY ;1V\@P='4P(U<2N(FU]Q78P+O6.58A"GF^)=
MR7Z]<_!Q;-_P].8$XO_1/BE<<-AE@-_]UZ2?F"_HK2_"*ZD=RYD4.12UCLLJ
MLO#2@,8MQ=]:O&R?<RQO,.D)W129I_VAS->O/]:ZF^GT!3,ML0YV<IC&;=L:
M]+Z J:O<H0LB-R ;N3'HX$%/')PRD0X 6+-']CMXE@?LZB?%^KTSAT+QJ1IU
MA>K*A^WPB/O58N)L&5IY7KS[_:SAK9VBCRK1&IV/\IN4J,54S(K<@8SG9%/0
M4*$"J!*=7= /?/08@IU)D'"#GJM&H@>$<#+!L)<B:)\ OM VT))N+ Q//]>;
M^0[J]JF?[;P,-WB8V6BYRMRF"K435B^N=ZZ.3UY7_"A*?#%I^'F?M;M7D;HR
MW$0R>AI$S\-O@DR?Y-T1[RLO?% &:T(1B>-/EE^+IMRROY:?GQ#J/ADBFPA3
MC?HNEFL_R:%^ROZ)5ZYVXE?<AV')\4V<7T7N[$PSVVHD3\<GL[&1?",*%*S_
MS7 $Y3M 8L]J:Y!+R-A)%>G%^]RO=%?'L@P*Y?$E =OFC1RA7M#?IWG!-1K>
M+WZ5\%(R@;<$R;8M(Y8^'J\ O*Y!59)O4WP8P=V6[Y8,PRZ4#7QZ9C%R>C_]
M_F;= M/" DXPDCU_DB1L3O@%YCN$1S?.AVYF.Y3#S>]<X?S(D.:A.5'0"DLB
M@<VV() 8[J'GVXM-N=C*#BW)SWU@&I&26V$38J-MWF]S+[3\= ,P<B^G1D;#
MREPA1JB=KH!50[FIH/M5<3:J;I@.TBIL;_*:JU<S;=BY4N= <K+=^\O2'0#R
M!:CR<#@*>'("5!KZ\?X,GE&;KBY(IP]VX9/P+3-]=P=0P&(IF>LPD=Y&F)^3
M/^&J?A4:G)R+X!8GVV X3<,/8&,Z!R*HQ.<A\!$ZX>)]&A]G@L%P'WV:=>-W
MKG0&-AXL_; LAK3"5Z2F?M28=<*IK./%9_7<FMS)Z#;YE%$$\]<:_F5]TUDK
M%0H@)9Q66Z=1JEY6%&P:L[ZG*9JB_?9I"L,XFNNG)R["IVA,^J%B]Z!9_TQ'
MNI21TJ?Y0$BY74S@]7;:E\5S6@4_RO2]#X*M#A9<9<+#E9>6L86+SH(B5EZC
MC=FJ6J)6A@4-0DU*]5(G)3H6=C?+5_8MLZGC6N#LQHS$!N=JNM=5G@>!'.K4
M]&5=3\,N,KOR#G-XYH-9\$;UQNB,4BR<0X@PZ!^1ZYCWE@3/5%4SDE=BT'N#
M3;?V"A[/E<'BIOA79'M74KL8,L 5OE=O8EP4J-<(]CLDA3>.P>_U:'9NES/I
M79);DY(FIA;#>G,MGT]1^S368[Q44UB@,PYDZZNHR0C347NP77[ICN/$-!^J
M-YOYVHU]/B'M1QYDY%>J1D9E2]\3+)$+DQ>!+#6[A6%L/ R1==86(Y%:Y)>Z
M4E?CR;8)&Q<!GWTL-/-.N\V9O*(,/!A)=E&B^3;DT5%#<!9-3>?H,?)4GA >
MS>_U*>WES8.!Z\WB)2KTX_H*SQ$3HJ=E(]-"7UQM@!F_-,@/JS=Y\NH;G.SP
M<V0_ZR@8.K'0"UL[\ZP3Q;2"E<=Y6>,/R'^YH!ZDW'RIW[ P?&]U1"T='3A=
M4A0(="BM?KK;\M6'316# ^F9P_M^ #IQF-4')G(Q3_^:HX"F7J]M,6\O?W:Y
MUH!>Y^GOXE'(_O@TL&"ASN,29^N2WH9QH%Y)]?O(?#98$WU]?"]M#\).D@SO
MW\7"+W]M[,/H*P",CLCB!9B^1]-^'2].4GC!1-V?A[M_:T V)%;"6J'VQ;5;
MOPE.10,6B*O^OA[.FTY]S44IZVA1F<N%8E&(0@&4I9T<_]-;?LF_@GN=".GO
M5>'95KT47F$<7 VQ.C\FXL1"'P7W?-^7XT#1Z<FOOF[,JW9Z0E]"/3I-G*8I
M#+TB6XYBW.D67V\+&XL(*&"-F_J12YA4F=/V<26" ?8_O7L<"TE?2JR*L4&5
M]Z!P'RY\;!T9V"U ?%8RSWG6Z^Q"%$#/B:%)_$L#T7>R*[>15P0 (YA$&AFR
M2^L RXFC:5XHT=0D'$<<UM)A!=K(8M1L=G,50H%Y7IR:'+ <69BB2B8%MXXO
MX$"*:^8NDH?CGQ9E[7T^IXE[?&2LQS3!6T1-Q!W>I,5HZGC^R0&J2&M,D[1*
M35Z)Z:F_7M!#Y/A,,0!!/(RW)8O9WX]>5>YOV$/QT]: "JT5!<3)\:&:\Y ?
M@6!3VBPOM8[XWKQM^6G'GD/%DB;-I"/*3AOHX4=DE<S-HN(=P'B&8N;BZ@ZP
M.\9;Z);&@=.R:EA_BZX_]HK,YGXF%/;8&3;;-5!Q+%#9N:P4$_PFQ%*A/\F6
ME ?E^YXVD<P9]NA-;Q)^5:'O0Y(BQX/9Z)X?#R0Q2HS)C8## ;DZQKLM"'?3
M>G<SQTL(AF70RL,4T3QR7UR<4A9U7TF+5I7*YHY9S_CKR3T?\[RXUB/N2B7(
M"8H;@SZ2OH'9*2)_<3PZ1DCBI##^G,BQ%P5WQ$EH&4L FZK;YHP7%+,B!!])
M821VY#3,='/H)',)[RKC? $0!(*;48\BN? ?" 3DX?1\ARY)V06PC[,J@#F!
MBP.&>-2)6+CPH\RM^/5B9K"?%LZG#Z0YQ4)S)C+$.MU:!S6]Z-:@(5NL]DJ/
M[M<5M H$=P#J;LBWS@J>/V!YPO[(59%\=K^@3K'!.01^?8@0"Z4AMGX6SXUS
MEY#2((9Q*',*Y<6^&9KJS^G01:2L(E>>P&J_+\7<EM5#"HJ>]F,U*JP*_Z^L
M;I_C]##=I8-&ZQ% K]R>#R"ILSS9AF$N<Y\(==QU#H:34REWEG!K.G[YR1@,
M092(72.6>$'HI6PO9@0N[7?IK>'!AUC7;#[:"V0M>#TN8+-QF[I1MJ>]&?6)
M%0Z\L3X)AVU-'L6W@Q%MEA= 6/&+9[R1]99K$](RU'SN=BVYH$5/#6'C"=+)
M606;6(\F;@)%#R@PNLGCR]Q7BYA%GNH+EV7^FAZ^8O7Z4HK."TFYA@GD25,&
MONSE>EODUP1)6KL$(%9"ZD1/MQ_1Y6:9<@(Q!Y)'=%1 N!DI'MT#J-!E?O2J
M;K79KU@EOF7T23\CG]<B;/BF@;I;<-I+NZPI(WN>*/NW(>O@+&2<:4?2ZSDV
M5[  N62@J_!8*^@'QK?1FM/,TYAY-] K93R_"@VKZ,@<%YC3[1SST\16%>"8
MA<HQ8>*&>B0=N(_S"V$"8,AH$LDK4L!#"&U^5>3@XH9&^AI.#E)A>;"4.'ZR
M0WP&#\D@8U>#C$<[(^8=CBM',K0/0!2]%RO:9W-*);=^A$06 )I0_$UDQ#+H
MZT7RJQPLFDWCQ"^PN&#DX";NX"2'%6@^L.2Y0Y,9.-.Y =2MA<_@B%-[ I)"
M 56V1ZM>A(T",$LC14KRH;!__,'S=\C'+<OJ[H8,<C?V+VJ:W*Z4VX_*>V'<
M@",W'T9[-B,:O/X-A-\MD\>))0Y/(M:OJQ\B*JX^WKFF)UJ8U??F'PR\4"6)
MO'0O8 NC@"A%TH<MLVF"8R(SMNIC;7<N5^!3E+L>@SY0"\V%-5P''V.W8G,!
M)E!>9%$Q=PRFZ%.7M@OW/U&0E0:]HH%WL=A9Z\W?8M_:9/^(\U)HSXGGORJZ
M,AHFJ;P#,/SNN@,$W@&R0QC_OHB&N,J\3D0&$R[_O)R0FU42Y;+,9&M+/+=*
MR.;);0O?)PKAJ6M!L@C=ORL4-C]GP\G==E\J1%56V*SS?>+5Y/Z58S@+ZE:S
MI39SHFB]^?AP[^$4'"XM@M7 H;I_]GE#:>I9N74=QISX>I6"1Z.^7N%;1(_H
M(7PL6N"SO\$??1_];HKK.MNCOC6_ST,QHK,J[17?J@5N#M2C#)Z^J?5L[&98
MX"MBF.GK<PD6]# -DGOK4P__@7^\RY-E,,,BYS% E-I:(\$U4=U/,4W+2I%+
MT"B4Y5>QW1#^S'_,M]D.9CO?ZCRF)S')*L^C$AW=[BV.!H[-J3+XXF2XN= T
M8L@6!_(3MD>> -%F"^+;D\V2X-JNKS#!D_7&"LVED%JKU2VS1_XH)[Q>YXY6
MC:E/U>9DP7T]CWS,!_UYRGJ;)UNWV_>;5;00 =)3-*E*]!I!Q9'#OKZKR,"/
M)3.,:I'36YOYT&5IUO4;%Y=@W::-ZEN_1L]EDG?ES9LO<BG=8R2BKK=+QT]:
M9+N()I#< \\.:VF">Y_R[$=JNCS<F9M(;/4=-:DQ \WE\ B-R"C-MVYO>C:\
MF=R(2XD2DNG3:>\UA?\62+*%CB<S-VHN<DO+X<Z$[D*<:R1*IWXI/DFUY$^N
MJ\CWJ%G: /)]A,H1MKKH,-%CC@_4")6^S/A8\WP@_-CDF-F=R*4Z?8CJN!;Y
M:EZ6\KGH^.<1^\<E>X;5>C0KY:+C]MZXF)6FLGBX'JJE@5E]HJMQ!L?=.[X=
MR+CF]V]@'^R%];:&?KKKS9;VDAQ_2#BM=Z!YGWKII:E;0V_:1/DI(W0Z[QPX
M[RB'^Q'W/*#RZ?+1'JP:NGDM#='\Q$URM'IEE&'IE!.</9-1FLAM@G]::=,E
MAJE0HZOUD^IZNW+RPY *%=%IITOX?NTJUA#C<(/S3'=.)>9UWY6\$H:KR,]S
M\>NR_,K7RN!-"<?>@S#5S;)^V(DCYW_A'\9I9/8QGT1Z #MY/H&94;Y5YQ"_
MST==#0:L^UZRCQWG;GL>;@ +U!,$R8/T/;DZ$?^.LOAW"LXXI KK=BHGOG)"
MA3B\9 ]67.UIZ@U;#/7%V%"B=@\:K13S48&ETQ_+KB:<8$QNQ9[K1/VL"'EX
M,'@K]_YJ:KC)AI%+VF7S6XS2[5,F&R0 POL/WY'_VPD/HC/,*<U5-@:WDLP*
M&AD&$V@*YSJ+WW "-J:0'#*M):M32*R?HQ_?L)*'PQ0=7;UD.^&<!0@!0MT<
MS4?L3L3J4%D^H3?VF;1X!4^G =).6@L+YN"X:Y6SAX'W<'=ZQTD "$RD-#5U
MCQ/GW7&);SDL>,/.<>7M HU;=*[-,/D8&>)BC>Y<T97J"-F*L-SH?EVOA32I
MOAB7[S*:E&=&;UN KUG.=-AWCG]"(ZY!'N*T38S. "VBBYE%;?;@$)7*H\&N
M ^7OU#C$FBZ#5=="O/B.^+BSI3R+IICX[M*;#0R71)\\O'&FS&^<OQ/X]'4'
M6"2^9Z]-(6;UFH)OUZ%IGPWDV!Q!CI6)GT\O?VGEFE_-F<BTJS+5HF*7:_@S
MF:]"-W@$?XW)M(.*,$"^KZL=8_.W$I?^?1%O4)N#W  _/M4MX;7V29X/=\1*
M%E/<U\F8/F&#;D@I^+O/[>3]2J2JL+\#*-:;^* A_0>W.7[[I#C4=J0^R@Y%
MUZ('X_XTNO,2P;TY:9O?$SGK\U9*IV<0\7&>1 "ZB;<]R[T+..&<"_/EHKJ2
M60R0J:Q%M74UMO#SRLR>)W/D<M0]D)5&-HN1B/D)9MHVAFHQ7=Q>YWVW*=?G
M8#EC2XJZ(S<YU@I?)NY&T#[4FBH/ER6M?Q%W5?&'"JBHGC=7%;OWJPI5(=MZ
M A&7?\(-"N-5X6'47 6N^*UO;$(8MUX<H1Y5%BSN>!$>ZAXB,98$6'",P^FG
M?Z!,E?/LVQ_V5/]Z-NN6LVDRNH3>*F#]RC9:8G^GN0:C,D@WS;5N]_LJ-$87
M)$<'OP.\+_@J:V+C!;]B'P77F+03YX>[],E0;*G)- +_5,J!L*%G*N.4NI)Z
MSU]Q8O%?CGF;<1P7<QEJ%!ZKX&$*7QGDNS/[.Z+K3=>04_-KH7Y3R:74P![G
MIT^;W -PX-CRQ?%C>2? ^>>B'?D-*''.9G5?E+_M@WC/(&W,)<J^PG:I/R-4
MN%EGB.4P&MDWO8SQ](K2FZM3K4S4[A)Z5 7GCEWZ#@_=1U^+5/1/2XYE4$P-
ME+KB??*+62A.#<>5FLJX2-%V4](CZ?*AW/.R>!V'?%$].CM#2VB$A=/PB$%,
M4"3Y:$@(O\35L=%7=[B/,+Q5PXM47NSMZ?0HDPFK^))]U46NX=&*Z.?>($]0
M9>^R0RRV87R0=X;]&BFW*Z[-LALIK["F5BJ^X-9BO:TF%@,2WT[E.QVOFB0.
MEE,%*1DYG^+>*N)%W.LDB#]B\8DCFH(U>MJT<O*)3J&->"&@F/6;*AD1/L>V
M&BR+(75/5 #36'!+#9G1\^A9=(!V:%U*'U.BES2N2#CT]M>K>G<E31YH4[,8
MF0!Z<+;B]VQBE@D6W8T+%;\>2H#-$:JH&DK16+"%8B)<31D#$B7:G$5B1_V2
M=BDS<_P4Y[:2@O'JG=6?!@0IZ34-MFW<K2^JV7S]C9"^Q2Y\^=K\9^O<OL6\
MND#O#Z.< ,2YLT)0B@Z3(!)?*EZ*\<PEYP>&F-[@''QZRI@/VBL58=)&A[7#
MU]M0^C;1^*"E2$/<9['^%54CRON6*(GV><:FCX6(\1\C2^YI5D4H9\D_LB[]
M&U<E*6S[++96_]OI!&IF.LLC9IZB%1 -\JM4MB6SD&D*\_4,31LLI4MVY$S_
MR;Z% >ZV3%PJU*GZ=%8E5M\[JT<O?"\C<<V?$TLZ8DWPV=D%<ZU\,K+;F$R[
M=0#M..$0*2%9J)D>\HFM^KOD'7@93+#)W<RNP]14IO(JOCV(NJGGEXH6J:24
MIM0Z=3NIPCN89CSX<IKU+UP55-?2]5/U(/<1)_BQ7U;N2MC&BVP8A0V*K+RM
MWH1U(.%TZ+?@<B1\^Z?5P'JCFRVQ.$5EG"A++VJ54[)6 C@'VS:TQC"(*.JE
MFA4>GTC]VG_-,V:<,J"_9CV(YY*#"_G:;D/0=LKVHUR([K0$[UA9)G610UZK
M[*M;.=2- M?<T)LEAK75#%GO;E);!ZUZQJ:5XX(+%4F@SB\S31'GF9_8SGQY
MXG=E\/85D3X)&H(,H5(>I_'LL9@>FZ[SFIJ,MF8[W34H3\O7Q87,3>3+:#-Y
MNCP5RO,ZK7KYR,)X6%4Y9U%H-.K2H AF,@'FCL&Q%)YJ9>GJ60*=EA_ZI8#L
M*-?<AZ!?OZQ6.7<W\I[%?TMSF^] >6"LU^[GX7/GW&Q'J&\A5.8W^,\?;GIM
M6VXL&?'G,Y]5/9Z8T%WG0.M93AU<Q_Q(/>\%]KY-0R/:>_KI_<AUS!WR QY6
M[K__\.),[WJ[J?5R=]J(% "FW!>\&;O>KFMF,"?U66QT5AU>!Y8NF'?ES-U@
MFD-HUMV6GUIH5?B;R8W9<I3B-/YQ<6M/_&,P$]LUP\# \KZ1P%BD!!=A.%X.
M-=NE&.W%,_Z 6>I\8/TSE&<L@5\_<#BS<6A&#AD31+!0$ZY\^H'FNC#AM!71
M^?:<X13AZM"D[_C5-'GH[<66L1$D0-B!8FJ'G2&;A\\QM3^2)]IF^.TRK?"N
M[X[2: V27BJ#"L/BC< K"4.+$_D@+XMQP2VHL1%9 DT0VWOX:,R<[3;<Q.+%
M9^E#0]5?XU7%%#-2IHZ_LLS\GPS\T1@HV9AL>L2C\AC-EGUH/.M*R)^:=;K2
MS M26Y!("#?Z8$926O%,TH&CM(@Y->C87.NM'HDIXY6C\.54WK;H'^R&/9=W
MAR^8>7?0?VPN)XFJA*35@3*&08NIRG5C6G_H;@U&SBH=U'MG[M$4&.';B?"1
M1CM+WN,$Y5?_P<6J#/%24P!P2(;\IL0NY;B Z)]B)V"%2QXX8BI/UV!"QK:>
M  C_"]WL/4Q2P+TED[;:*&PQFO0[<NC2R:5QP;J%^\@R^"1^K \>2[29UW?M
M$B:&A'J#\H@2-5+6WC,@3V([F313B^>@EV7J/2Q74Z-W ,)O:X\;3_*(Y?\I
M.N?_<L(H%R^"&K+1N'NIXSK,(;'_^!?^^18OQG;KVR59Y2P/FTW\^'I;K>^W
M(P8G&DFN+8"0.MM2EMZT5L*J -!#].0N^W:5,V15I.!1VKD[9]UIX:[:.!S0
MEA=-TIDV*0D\@\%;4DI>ZZ*>O0CS0[<3>-I2>-:Q89V%P PWQ4K,@UVP.K0?
M,Q6GLHF;K@0!U[I%/J>J]5M/^XY5;4W, GO/];WXL7:BJ0);<M"/[Q *C].H
MO[S" [31ES9T8Y')2JW*B)3PP%UE(N<_G1C9V3R40?@[%^K7R$T&]^4Z Z=G
MV!NX=&.RGI.SB-WR\'2W_*8*<*_W[(O/E^+["77U.8QZU+,/K-"?JA<C(+XK
MF5@O=2^*)G<(JJA/*A6U*.A=C(]M&9G7[,L6 _R*YLLE@@Q=MG1-'@A&M6]
MDX#7*B5O7?T5O5$_C,(./G3&/TKZ]M&':5[84@U3I=3%TVR(:%%B:E2&6M!D
M2]!L3Z=:EFX,RU]=@+5-O$@2CY?J9.6MK0I5LA)%1I4EGAL4:UP[? 7X#M7]
MA^P8X 1WE?'KHUH%FBHM"#.:;@4+%HN@6J[62XB^#@AZV#;0/V!3WZ-*V]=Z
M9L,B_$-O(5()MAB.E:95P;)4P;X><,39/K</M7W[9F]-AY6^(TWENH114EN[
MH6\#JOG3U(1X4,/ U2HG]8H4%+ V$?2NNZ(,M,I2G").)2TQ!5K95;#Z>A1%
M"-O6%O$Z=^4'^J=<^$R--H:1SV=0S565  QW- TYPBR1*-5BW<-G@L5@,?%2
MSM.PV";KK5OZ!.N&UW13)ED)01,NM"^KG6#R/QW+2!^E+YU_9EDU\;>">KE5
MG_0X%?CT8(!-??/J9$/]GK,VB-=RS#:\J]UHE$;Y7;V)YCW;J ?V]/V:J=U&
MB0@K/0\?]+E?S:>4,>*]QOTK@SJWZNR;<'%#@_2HIKO!5;A( 0=_)RS2KE&,
MKH, 1'R;8=]ZFA%(A"22R-%*R;VKK_L# OCK,?53]W 'D6NZKV.3C1Y4OWMZ
MNI[''W^CPJF%&8(>N?\ZC7<:\SJ::!H#TA:.N=Z^7#:-U3 B& 4O>FP8TYR.
M+9A7Y&<E3S/IXU4L+PAYD%V\D8(&?[EQ^;GK1J;Z)6%60)R^+.. .)9,XXM9
MK+D@]9;%ZZLSA]M=T^?69'_*=P=I]%>>":PGXSSKRIG74_;A JW4*>-^WC/L
MN]*5G<NU(?!7%OG(_3H!J64->2\HL('%-!I'=;SX(2,%5*+V^ )-P>F:#$0/
M=19O&\,7$=4$G,/<-S?G,\OB4F>5SW]O53YU#TWMT>]4X<@P<JV(BX]O7"^;
M8XOYI5>]9>&?640NQZ$J:XJ\A](?G)?&[RV#GQ7*-:(2A^INW3V<&&I4JVA3
MW'TB+WEOK^W1[.PW!"$ 7QMG,>HJX4/L3Z<W!9.MS-DP-J9#Z%%S_?'IS4VH
M<X^\X+6&Z +OZJ9*@<+[P9$"F?RR@)%(#3J;,@Q32FX]I??2X0@2^OJH?FJ
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MVG(O;+7.6!)U9!DB_H>/(L#2%$8CA!VEX#ZG1? 0@# <EWPH>T&\V/XC!J@
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M@LXOI9ONZ](3/8P<_;#YEP.)W. ]_E^:. DG@)_LX,OU;VD,ZF''J##N$'(
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MFL=[WM,EZ4L$ZU<GL]+RH@&%$/M=D07!7\,$<5#TA5MA6VNY3 &WG7"2AFU
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MNFAX(^'&@SY[+\.MGE< 7=F;*S+ -H &H0*P9A_[S#AR43']T<OX5EL@J3Z
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MRV82$"3JV_<J;[.CQN'6, YK13-T7U!YFU?5@\*,:AKW^2\[UG,4=8'-. N
MLIBW2[ETT"NVG?-1:'N=?G0GY2T:W0E[*V+_GLGL,^ $8K8T8R43\"#<S<A5
M%7U:)>$C^WS<S/+F-UT&0.S7)UV1'4R$R@1/Y%WE3(,8)@J3)O5;UZ< 6I?Q
M$+O*[K4&[BUQ W!USSSOZY9"%D+"I;/E\(M5397" MCX2[A\/;.R4$MJ'$%Q
MVR11'V_<G08=D)WZK]YX0N',LOHPE.!U9]VI%?- JV;JT/T7EWU7KM#2=BCY
MVG_EPK9!_ZFX8*"@H&GW5=<]OT9O;:KH,]A#1F0B!6 SA6T5[D\^2%,@&2X!
MH3C>3:&MU1 @OB$#%.%1@S5TYH][!HFRB'3@4Q-39A>8PE]<!.,[$S![-R,4
MO3\T"#AT.WYOJ6<\GW3/5!1^(I,F8:17#LGZ&?>[H,E9\AV\D%TKZ.6$Q.QJ
MI/F;9L5NSR J/!JR/8:IK];BY2%(8@U%D-0%&9D8 <'UD28@9H5H)C5B-7DB
MAQIG)6:*<5K9/C']K CHA.4S0*=BLY1/'6BMDHLDYR(9OI.=?US*[IZXD("_
MR\5UE_N*?WA,4#<@;>NWC8GMA &1\..CJ6@-!AHW"F&\#-CM![6ZF[)' 6=]
M],W!A(W$C3]_$!<0CEFW$<5V0-=O8M7:%2'BH^3+-RW[=N;P,/W->. 7F^"J
MI.;O/?0Q@^4)U^1[2[;28<7Q2]W2$XR/.WA=#9#/4N>NJW5LU3^JOI[RP#RM
M3+_W@E-/D83!V6IZ_YU8DO^/2F1))VN[W0W_6#;(;U#G'O=LF'OY6C).XI<5
MXI@R^1J5-D<@NF830D5)."!M7<95O7"3?%_ZT<B"WKZ%ASN_+^41XB(9>^.P
M(OQKN1O@DO+M.4QGYT-R4,CBN5-$XKJJ(<4>MJ=6K?L-]\=-!T;6BAKV$2NB
M9M<;9M*JD="G")+O?Y4]AO^CP#&TI:!T?JN!JL_EF'>1OY\4.*=3V8N45XS3
M1 QI2NH=78IOQUWN0P6<8..)FZ7)&G#A7C*1J&TJ]7$&R4/#:E/HB_87P?.(
M5)(FYV%F;_6S9U/Z%]DU* T^)N.H"[*C$K);]F R 5[V4.Q'3RIZR;G)@LD8
M ;V]J&+X/"<PQ]_5?+);GCR6>'Z4XL0C2+M/-_\'MG(-W_(;&]TO)&WF!9E"
MN@DD!TZ*Y-=^I1&C#\-?J)1F</@DT:.PJ$\EA(^-C<<T*'R*+CS>P>=7]!!!
M(_C;<Y%RZ &(8BC'88%(TJ?,^^ ]>,)/__"\*0QB+4O5 &L ?2*G557!Q9AW
MX3D"H-,VBM"=H(APTLF@"YH-. ^:PG(^V:4IX-=4W]@[+<^/_*"X\R@2@HM'
MH%*.H3(4Y%OQ3K(-V6"T<8D$':VL7!TJ^X?,N6.6NV?\5 1<(G&L&JY/5-BE
M#<$2<R4 :P1&.AQ+ ],]0;^[2DR;V0H_@((":0L[YD9DI1#@XXZ"9OY_BLS_
M!^_N"37I*&/TJ-W$CO\!X TU$*V>_P=#!I[EC:9P2O@>BD_J6X_N^$% &>@Y
MBL'NPZ%V:C0<T&Z7W#RX7\!YZ!%+?P9(EEG=[%%HE-F'1<]ZUM>%41#=I"@J
MV5$B":_^+8V%;5JI#5>O8>A$(Q;NF#'L!$)E0M=$&HG8D?G&T;I^_6;/R,VW
MM(.>DTBS"=ABU[NOD_-QJ%ANAL=[)ID7MANYJ$+3L*^I,"$@H8LM3BXJB\ 8
M>"7@J0C3Y7 5*RMY=19$E9KTP^U066[;!H5]NZ'KY@PANM&#B(M3"'WTH9DU
M9=A%3. =:C!0A%TY#1]?E#FPRF2*C8@D.;=#'$/PDY2VUF+M5OLVYKC^ $2\
M+XK[8 ?WIVI,"<'S@<Q+8C*JB;8K@B>JO5IDG7: /!ITU?VTV=:7A[2R#ES"
M[_JW<'6\O_L1\C^-!Y!E__4'@)\0RJ$2X%'[$H_R=KX(/Q#,3ME0 G]$OR^K
M&P#FU]R&DY&MWLRFIR<MCC^__U2<RQ3(EP6BT?ZJR!I7/][\(<)E@D>P4K5M
M[W&ZZ1KK7->GZ>-MQ)>IVAQ;'J6U"E=SC7A(PZ>*Z#SOEQ^#'TW6@HGEQE9'
M!Q5+8YDO6%+E<_I?F]F0L0#%*<F&L;PD[%^S>E@T 8[6 R+EK"HF]93+Z>4A
ME)0T0=J8'6G\\@#!)$=Q)LQ:87EL)B$ 7?NPJBAAP#@[J]CEOLH'2J:?2)P-
M=I8,X)P7Z% EH8[HFUQ(=9/_/H20=X(_;\:&MB.LJ=1JZZP$!I:\0.+0?68/
MT!5#]='X'ZDDO"8#E%K9D U(G4G,U07TEI%D7@\"0 "?J[*"8)]#34"6&<*(
M48M6 R @X#VR)4QMS2+P!X K=+WRS!'L(F/0QO<U4-5S*()?6,72J.MLW@LX
M*&HXGY2."BT48_3;;+V31/WR!&\O#DDNY(0HSI7\=B(IN-F8P7S;D[WBK*N^
M.NX:0 <,W:)V_+QM&R[1[THM(]CC,MU#_/V)A4OJVNMOA-YPI'1::Z);S?,X
M0CB;7H2F&"K[C,R/9B:""ES0-7]!_/:M]Y'92?RE9>,^5_QU\A=SC+!M?BFC
MW)OW-^;KH7ETET^P;!7WL>R5*'0%-+R67CZJOYDW9!YS7MEJ=@F '[DUV="%
MN6=^^/FN_\AULD*]ZZ/X\S1Y,)3<5-*QUL 3Z5L9_],I4OU]6MAW9,+I4I.R
MO/1O$M4@0GXM?0:'\[+/ >/:_%_I+,'[N7=-S GAJEYWT]OSH7(:63%[K4(Q
MWA(U:W;KFNQ<4T*'@T8.Y]OBE[4:(@PS['??,4LC,7K%ALE)K%^L@%0S<TDB
M-3#9PJ%8 (\O)&H47VC[(^6B&@J<TL23)E3PAG <V;;O+,-W-AGOE,A')1^Q
M28W92.W6'#YSJU@3%5^<3]^4S$Q6'OK629Z7_UF1&Y5ZROKVF]A*Q9;P"<(M
M(\@N39XJXA\>V$)E+KK+8;T"E_G\/C%0I!YY1?:\E4';MKZ-V+X2Q]<?3HIJ
M#LVND-65BR.MY()0)TI-O!\!I=JR=)]0[L]%6,>&.!RGR+F4A*;/I4/9+2"I
M_!/\4(%4-=TN8[=L'V8CMC1WPC')4R-?M6@83V\P.F!7(?EG*<'T=.W=5ZB<
M8+0Y!XNM+D@55;J4[99]L0I5Z=LXA<2JXKKC:$A2+ ]*4DIVLU/DW0?IP!+\
M^C!KI3Q[FK!HG62Q8!",U+S-(AFF/5JG'WY);!XY9&'Z3YCWV/C$'WR5+#N>
M(M1H-E*AU%K<^S-MA53.DHNFG# =UB+EG1]XP>VH5W,_0UV(++H6H:N:Q@4%
MS5.#<4*;VQO(S78U-7'A=5)%O>QK_>)D@YO@TOLW<L]>\/T0-%[ZL7QL%P\^
M[/D@6_;]$RN#JP7G>#.+B0<J,XA@GH'G.]]Q1V+$A%B]@DWS<XJ+.M9/L&=?
M?B]XWG 0(:L:GW_ 9.L]TJ(_S)@3[WVL6W][*=W,^^K=]_\N$SP\1$>,Z.36
MJ+D@]B_,* +T_$46M<J[V_?.5=N8@Z9S0SPJQQH&CR>%" >R]D1U;MWK57Z:
MT"]7R'RM%VG^ T@NG;RNG@EY]@? N$W_8]H3+&=A/\X"NBQ75GP(IM'U!3O.
MY1[P?TA2\ A@<]!+(>1K?L.X2M\FW+E1TJJ=#E9&.A3I:'!A6N?_'5$_ Q0S
M&F(<^I_# X@7IQ 0Z$YA8(Z2-4V%60LJVP*O;J<POQ<G3'O^WP9E!O[+S==Q
M)-%ZLRK B@;B)D9-!9:5!.L:6[X21Y059[%#*]D? !OA/ M$TBE 6)Z"F&2<
M3ON>0Y4=]VUZ>9!&=%ME!1)7Q#L!IFD\+%[IA-<[#C"R93Q/N"H/##U=0Q'B
M#8JH9/&G.0*QK*)3=;*#;V?1WRA%\5/-1%4!KVU^=?B6DMC](A>YW$L=%.-C
MQ8A@,.YQ5X)ZL^#V_O-BC((8/;^4>XEY!!LPXENC_ AQI+ZPN>%CJM$Z=UQ\
M\$'2VWKH3:S@BTZ,9VL1HB974\Q8]D7)+^)L9BK-S>/,ZE^A(X1%=4&3SD5T
M)=1*D\ZO+W-]Q$;N#FIP&CTE9J5VJO@M![WXRB\KHX WTZ^RI-8< Z-^.F/P
MX8"=FW:Z=D!%8LBL1'*W7BK:*SCRG22S'2O*ZS89'B,Z1+M*C8EPHNC(DK1+
ML6'MYCDM:.X?W:3,!\IYJ_IVCN>^#[B=]WI2)=A.P.YMX<\;O]/Z:E?TO"Y9
M'CV$HOL9K-^&X'@CVZ5+R5&=1NBT\21B%]GTA?H7X+H^[>&YPP-IOL.C/!5+
M[56+&B,=Q> 4SEW+N&B/1&%_4&P0OM3B:6?2):D(Y+)20,4U:,Y.4Q!":OP'
M,+P=XK!;7_= $3[RD=XC(TSX[$52V->G,MV6YB$"DW=,TW\ '?P0VJ/_<E4;
MNI>'934V3! *0I[N="21QGH$C7<M'"$M:.S;\K4L<K89!0+J[ \>#A29CU&>
MDAIJ SW^7Z@O+X1?^P?#!(Y6%J5\CPQ\4O?:UKH6U%Y$47B1YNEXBO,V3$RV
M"8;Y?D"9->=&_'"!4A,3V_I574-AOT?:3U2WE%Z5K@_#Z$2]H5Q\_O@;/IWE
MS>VXH2X?6STD5OB/V>2I1;_0.0YM[Z*^=DCQH? !52_>T_.RD@OP8"M>\S,<
M")I\..1_>6,/,& >\6IL4"9#VRVCJ^)16<MC"<<4A\9&T*FD?>O'!8%ER*'\
MB<A2 EAAK:Q012G!O7/7.W;"PCW2"4Z)B;TCF HC6,*@(MJ^K2U9;-4D**DB
MI5U[O=9[UOF(_ N;ZP8ZY'S4:S!64P8ZFY&;GUE[H,G?66N<$KE^:-:"."XU
M4J+DX0NL2)FE46:(<@8O![#D, GTK&@/%PW:>0VU"F*XE#8-?UV@RQQ/?4=Q
M$%"7-AGOB^5#%E$ 9RO]GV8S8#LE3XXK0I[G\X2LS'J%<DQE\PBB\U-GTH^O
M2EY,;7@CU%,%&X<DJ,9/L6^ABWR/SZGFXB)J/S8'[L'KK]>:@GMD57=*\MJ]
MP_T(-?V--%R>R#[QDW0!J42,^G9Z?";T-CUKV>>?PH<P#\,&GU3%S?%:-"5^
M :HM7B.!@?&[94-57GA%IE(D<$+9$5HV8)]^(TYFU(^R^O ]E1$LDCQMC*()
MK2!<"N:")I+D;+\BS=,1)%#K2]MU*5BK/.B1U=&@>.PSL4/(8[L]<&4G;*$5
M:NB1#1OD).TL)P-$1)6FRVV]VDTO A"R*\DGP2 X7H*_9DTK+LO9/YVQV9PG
ML0%Q)RV:T%@$\."_/9P-?]EL^R)Q" $>'NBW$4!C_[]:Q/F.@P?98E\*<; /
M$CM1+60/Y8W(O:_7-;86![;?HG=105DM7$#JQIGW=_RN=NU9![Z_ JTT (Z'
M_J.H %L6OT::>Y>]<;_#H^NDL8&(4)<I:9: Z$"11A$^6*2%%1SZ7(M;&5!_
MK,N_LC#]$4=HIWF&2K?$VV>S)WCVE4OU2(G!BI< Y_="G+5$#C2N:4($;C7F
M#+E6]M@]^ZO1E%M\QPZ55]3B7!RF7B(DR8AL.'3GT]+^V*^^>J9V&^^*G#--
MJLYP2F<*6<+@+?(!)BP3-8+',=':O;N^R8(Z:*;WZIE<G*L78&E)[B?S3 #B
MK@VCU "<D8,'!I<WZE6BEJI7E^:-OZQL'#<K&=,$L76?IC,QK>52LF H[^:5
ML++"FQB_TE:)&(R8S39&SR!Z8R<]=M3EHZH2VV\->3Z(+(Y9H5N\_/WJ/ S3
M0[9MX,1,$D++(P=!1@JEIMC4R=^,1;YFF;>=F+MEF#+U46Q&Q1,\\Z2\U:/>
MH;@L\K),A0?7;>"2/1EJ75F21!/!??4;FIX>K'0LR$%6L .3$_<"[^3)5 7@
M.,ZV0PG+GN1K1E+"L%O4EG/075#0$_T&BJNZ$H,,Z.*(RM S8?EO0_"EGK:%
M]RP&A/*&*@F7]8_V4[_?OM3A)?C,:3[KO"<4"ZZGNM+355XN70*15T$&AH^'
M*U$;,+743MI*ZA.?,H4W-#1ZF@(*@$)5ZR<FL6P-&#_#FG.JS>+T_H)B@Y^-
M6=*9GYW/?Z6_+HO566_[X(!XI]4B:!8KC.4(M=.6N*PKUVHRSM1<#YG"B8NW
M92N916CDOY'7%;RDRUB=BTP$T=#=._4ZU#)2@MEE^_J0..GOE@NZG51C:,.:
M.L/CNQ5W<N&VECI;+GEZ@K]/OTO,SO.Q&8RYW1^O7>2H//(7D,<4%S/SME )
M]/3EUC6<@#C_D+*LRC7GW]+[W3^TM'GA2Y(5*!./F#!]"I=F[C'E!B-78V'P
M]1M+I/V7(]WZ"4TOA<"UIME#.K:D&083@R&8I5R MY8YKQJ<@4^5D/TE)>BM
M+8E)"S6--_P\RM^];T+#CXXK[Y>"J%>P$7TYHV]_Z(_Y8G?_GF<?7C9B^4JA
MO^E\=)(RT"!D(D>D\0^KMFUQMYT:8HA10T!%E39,$]K.?(+GA$JJ*0Z3FAP6
M?7-3Q7!.@7_+9^_QK^#*)ZEV3\YG4<%Z_Q#*/KM)'LX#W#EB[B6^Q/3Z+$E5
MV>!W,E/G[-*R'W?L7"G#MAF9W*+-4W+!Q3E]1P6Z8^8_OQ/>XPL?'K,\,2H)
MX%<+R.(*]PF7X*Y@FK.G; ?X5.R:20LNE74\ETP>0IQ0BZ@<08>X/NFJO@P8
M"$&L_W08K_R[5ZQI1#%:0ZCX*WO ["K&\Y(E'VT)O!77=S2+/U"2RN%-.!KW
MBE]4.B+]B7U0Q7 L,AUE8R#DD0*#.%D3D#)YCYFN*9YX0@N:!0>H K8+H5!V
MX[_?]T\48A\'72*$$,0$AUH'Z7T'5-AIO1/?+:O8$4N8RG[\5MILM]0!'P(^
M:%TBM]'6%*^P:Z-WA! U$SSR8IQ00I<J+'V$UN]ELJ0?1= IX"H4PV09#"R;
M<*R"M1> A1B16:^YA:F]9N  J$M"K00<\-8:X'MH<.S6RHMU6=UD(P14?&3=
MN%70;"_FAS2;:QLD QKW>O<)"R@^HYG]_G<&7$1F!#7_-1.$'D,2> M-62V&
M5@.P*!?6WC52#P+()R7OPA-2\[P$^=_ZKD/R4?PJD33)$\]^5BV(F"X$'AHQ
M+R%ANJK^BF2$35,Y*4+?MK^I_,52(A$G603KM3XZ=<\*L%5VL2FJ'F5W^+U[
MT4@PL-D\08@Q=9[@.BQ6:DABXT^)Y&$$Y#GDS1E1A]ST'7"\.A=WGS?T6_4J
M:4,&1[Y?E:3)XZN#_@'TN<$J*/M<'<"'C2NR..4F/7(:DN]I2,4[/0AJ'#$)
M,]W=GO(3#EJ4T'+J<I8&C@7NUEI1A8Q-?JVFH;V.>CVJ-_D1.CLE9#^SP^\-
M/R#;ON?DU9Y[]2'E*0-_"6)K1Z$2A_F1ELWKWHMRR!<8OBI(!Y'[:)*< ,TB
M=1M8<"PJOMEC?_,F>HO66NI^83#4%G (_R6Y^>0/8-"CUJ8K ^Z02U@C:1_%
MEWVWWQ]U_ZM(A2T *5^CZ&%-?V2T8$GP8$DT1'2MZ+*=+Y7<,CBL6%_[0$7@
MR%[0JPT*_*\2$IG=4M./S'C:A5I%"4K$OG.VMN^R6#KO+HUK#.W2GJM$1KL5
M/S.?8&>=*@$_NZBKQ\WCE=>1>+PJ,8/C=76KTYI"3EXGBC5HFB9,#TUD7%DL
MBDM^_ %>@&;Q])YI=JMY]GG;2T$]R^DIY$39@=77YOWAN,[40_.LX\R'_E@P
M!^=O6_UK8<6A[Z;F' Z5@T(&$X5B4HBBJK5'DHKIX"J7-[TC8!?0P(\9)ZW6
M.O%:ZV:!7'&7<!*UP J!ZI#V+02JWDP]COEQ;YD3PO]KC6V[1_<<VGD]W$G5
MBE7JW)S_[=C7KS?>QO;3)FI>H* !I;3@A>P"8/E^0Q/#IVXB:-;+IX,9"4^K
M8.S*'X(KN[+DB)U#I>W?:,'R;&$F+7Z)DHVNIT9I(KP[^HN=V0+]G"L?SD<W
M6RY^@VQ!S<Z/V442DKH#JAM?IBK WS +P9]>V8O@-*7>-3P6Q1>[VZ\1@)FH
MK#2]23/;.ZM8?,AXW9(7YDM-VBJ<__GE3W:G^4[[#L=8)O*)_0,+V4+H/MDK
M"-+Z?Q$,!(2:G6PBQM5$UW>SE6C0<>K>]!F8Z.R=$@#<\F<E&1,/$8I%);W6
M/%<2LK'14,\[7R[JKD_3&'3095XSA&EZLA/D;;86;=^Z@.,@KJ-K\@'ULN7J
M;9N7(H>#KHKX5K.*D&Q&W"WWRW*D3"+#LU=V-.?J#$5#07\ $H%;TE&(S]2[
M+!&D3G\ TDT?18B$D$D%<W#9422VPA[E9G0>3)%/Y;*4F5CV" *2.E<9V?#?
MU_SF%>KT%Y)=(P%1FN$<80'#*$5" 2VH3N]*\!2&V[#F*MN*UI:FF"M<'4,9
MB87)Q-2JZHP#3 JZ0$V*23G4$@W!;J8PI/>&V,PBP,':FD9,IZ4CS*00HE$>
M0J=6[%Q\(F>BM=%#%?J)O:4(NF/#>:.VLNI ;:&8\Y8<)KP72Y(&&M -67M]
M^NPI$#B0:Z$5I:BZVWK"\TQEB@\7JTY#OLB$:[KIC#!H@>GT$?2W0""P08+0
M$7-"^'!X[K),?&3<\&R,>&0BD):]D=U?,$DS'"IP?3T-+?<"#@J!7OW<4CL_
M>9@5N&L_EC2J,!MNV>+_ R#20ME]ATHX2:A+*E)&'*VU#(1W/J%KFJ)]]D88
M8YLY<81VW'<+5VI3$5#/VYRSV:6H"V%M]EVJJVM9HP[T#[GIW<U.8AJXC>A
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MG0PB\4M7W6:L[0/@9_&_S2KQZ.'0#+G83>>L+%(@,U3XMSSC_]1#& QC.OL
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MI76">K </2UF; "(LK8B-T1UK;AZTCF-C5R@2'G>J%G/FMS4.W7?PF4SFR8
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M[>'OYO<-J2O?1C[#S\;]]D^*O/;V6%^7+E)X-B&:9\T$2:-OC61M4$.+&7\
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M,F(.C$@>SNN%#^PA3 [#FAFIZO ]$@6NT@WKKLV'O2-1C_0AEY:%$T-:,9;
M5^.!=_&O'294A$.QC&>M19\5@2"!]4I-K6=N4\%&[-^H^<Z$:MH'_7)CQPCG
MS-+XKZ\>A$['>7#\@4L(HF8!5_XAY=NYO,#]<28?"MK]];.?>?KO4_]!LW;_
M/33[P&SUJZ?YZ/$_1D^'3:4Q^UXD48$P8VXQJ%:?B3/RQJ!;_0\ ]0045&:\
MA1(1D5AXD-:36:O7_"EF>73A^@> '5A*?WI*.1SF,MU%MKB@1[^*"B8G]YZG
M70B)*8@M449L"B@ZBTY<4QRXV"CI,[/?.55F3^#O0MYNV12J&_X!1(VX&?2!
MGU8=J#[=B>(EEXG&#'=32XULFDGG8*<=7,NEG2M6E-HB-_[.]T3K&W0@$IT
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M*2T],K4:K DRI;#;@01RQ[P:"=R85<&%K)9!TK"&UZA IXL?" /"2G8ZU +
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MC$WVKP2@#$^OIQ(G<QP_8:6M)?1W;U%8]#[Z:,,Y\!3/8$R#WD5_7=^:Y4O
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M@LGM-YN)B_1_^;+*Y#.!=Q/N5V5P]%*.(_Q9[5\MN9*K*N&2^0^JLGN/Y @
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M=H"I!0^T3C13)+BE^1F:@]"MS@S:\G[ZN2E>BL[E4P<O.W4/R5"F-4+N!W^
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M7KDJMV>9*#'$""=[^M4G#@XYU=T0\=IMTW?(02$48DZM>"CQHNN>\N@64ZI
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M<]3)YKS'DE+2%.%[ME([0S]]V7U.JNE[W>!R"<4&L/J&N:YHK"0W\(8Y(;>
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M>W?>1(39_;E('J.?*S$Z?E<A,Y6J2S%0N?3MGWC9^N9_&H#_*39.3-:G--#
MTD9Y0F:/T&Z:=O[C;,C('02SF/H;8KU+,Y;6L?PQS)S3\T[![^&G=:;F,YI#
M]O5)1G,)L N3QQ$EC8R__:R5?32#2?J@#<F3Z8WL/W$I!\R9R9&T JW(5#S$
ME8-17J!;(P+>L$08F\J19H5P:%@"\K;)T.+O *P$Y&VQ: @-S\TI4715&/>
M'GFE;K$_L>\X[&SZ\N;2Q=:&"M'=L3M6MC0R=[2 AJG;*6X='9]=_+0RD->"
MI.AG7TX##ORZ-.1O1G\/(+@8#BZ>N3C*1W;>90MUA]HD#1.2R%GG:PT_JV+H
MR,90J]=OOAXVBS?7SX1W-GI-GM.3O*>;%F1:R=?Q ^[R].PKVT@[7!JV-"0C
M3.EE[.>E8>WO6F&VP[^WZG/LG?X"NRM5Z<QWC)\)I_D[]D4KM?VR:0MY(P#/
M^;:'<' [4MO;1YW^J4-LO0.?#]1C@ AUM\P&K#E+1UJ.1Q;5!JP9WS92"#B)
MS;)JQ?A3[U_&CI(S"; UIV?QF+JF%LJ:R'E)@C>U3:0N*^)-9^W%V\$<W^81
M 648K$SFK<O6YZ:D+B:0 @^>Z7'[7?Y@>"ZO=K8&.H_&"BY=FD^YW57DOWT+
M5U?[8-^QY?$32Y6 X:JXD&^P;CWHVH?>PN*YO NB#ZVHMJOGJTRA)-WX.%/_
M6W71?=(3I2CX*4.+II#"J#9YZ>_:9@P0VIOL064/4ZR\5&_/=OY+<)*93UY?
MN:=;@9M$R%Q^>_;G:LW(/?62$;&+SWFR0QQO:56LAG"O>KY^HV80_>!MUKJ/
MNKA;BTL7_ZLA%8-E$06>E;8K[0D&FYT]S8\P'+!*AE<3$RWE^T9]<$57U6OT
M!YZR!9LQ3]O8!BA58M<,@X2E5QSY+Y&\2\H"K#U$EP/?C)^9[2AY5,3TS:;5
M@WPZM\M?QXV'W"U>W_0Q!J1\SJLWKM9X$X["N(PEFK2B-J9PEBE)E&@NG[^
MSM 5@8BW1E7SQ+] !4;IGB7H9C16^GS&'E%GM;A'66.6^5@&\&/+U0@H[O1.
M$:-D\Z8FOE$GF4]?&4:)P2.=P<.97R %T6.$>'_#^\,%VPL.,^&O45(J!0>'
M&9IZ%HQ'==LN2=BT@+;!!?8!<30T=@;0_@%R,=YR]<V3N!?IHW3'C+#8NCY9
MT9[GN<-7?A+E["=<W["\&E9"I3P9?X)<0FDGRG3W0$IHQ=_Y!!C\IAIS!+HL
MR:P?Q(YWVD6;7OB(I6OE@RFH<XHOYK$Y<%=1&%!T\(B$\QM+OMPQSPU4S(JH
MKUA$7^]JV.5A\W'[#G;,6$;+XT_\F)=T-N/E]U?.Z_\,K$O(]?6[S;[BS::$
M<[57>WY9O'7XXJL1*2*FGVG56J_ XQ$9U15:F7-TM[2NLM0P^*%=/'+D(^F1
MX\V6TVW,O!TJ,]$+BDI&(R=F_+TG9;*+7QJJ->/0&F*AA_Y@@;W6\,AUY-4O
M3N,($QO.*GDP!KTW<#Z-U8#WAQ1]"^7<A6:.&EKW6%1Z9)\_M.@&G_>HX7(M
MH.8![X%$.59'4FG%J:H:_C*=)8'=4B O&$8+E=11T17YH^+QAWY%*7$'DW^+
MY_\+TS]KV22LB?5$_H]M)0MTM<JYW@W8JT0-5B>K&$R6LY^](8XKR]+?;\T@
MW!J%C)[*B86X,*72U:6<:B;H"B]/Q;'.^[)24 HP=D0/,E@BCK$S/06LO'KV
ME\WULR MM"^(FWV?FZ@^E_/T JA<! 3MT@3S%2YKJY=4L75K!.,!1)<,C>AR
M=$BA*Q"(RM'E-<TR1091+?#7_58& PGSD(1RR:^W1?S&<%?)(*(QZ^GY7&G;
M>2CD6\VRY"8Q.C>U/]HOV4RJ6R?' \ ^03$7 4!WA 9EQD4\@ #"8&,()Y!=
M+.X#/IG9*R>XZ&PA5F]L3:Q<-'P0]*B_09:" UN-Y?&?;DGX"]B)\+9NK5BS
MNRB[ '.YJ+6E1'8&'XAM7G"]C?Z'AM/2"ZZT(GJ40J(T;('?GT8 ]O%RC+:)
ML!* %\PM@W,?SFW<@#GY +H$=?:$_*4,+W?U$KN0W_WT #-YUOC:4RV$"7]:
M7T0($763"PW0QY?"UBS4E]$W&-C5C)W-0PI!J'5-6@'HB<: O[F'.&:Y5?X\
M9&N:H"7'N5U4HME(]-'^"_##0! _ UY>P@]H(5]?!!Q5P\[!>$6=P/>>^^F%
M[EE#7WE&Z;Y0[A@MM\R/O/,)!*D.$9<8H]Z%8^66W2Y5X.,54.L57G+MA4\$
M/OJG:!!V*A7BEV ,YG;];5/U 40KB.ZI!:M3#=3W\4F(\;'$0VL:9/=DLJ0Y
M9I-^6T.":(47FEFM&D!),+H>3T4U=JM>[ACECSVJTGC,?!6!P84I$Y&W>#63
MW4?+DC<4'QEP-KK'D<<B4YUJ32>A->4YE?87$+Y6JAH\1!)/\5<82U$V,-#C
MMDW_CQ[1^-\S5<DMBI8H\ZJ3'5O-'@J: 6XU@@XJUK=M8ARKY683-6SO=OA+
MXZ$'WG?!/':O93+)*I1$#*=@*68/_[9C+I,W]]:)9D.G8.H\Q,MUYX-DDE[$
MCPH[ D]]NI5&:/ADW-GAW)O26I !P[.JAK\I=*H;?'U2<8SHW,'=&>\>X^#T
MLIU@;7CR9PWB%Y_0N49>T4/](@XD_T^51M7O]16R>9MC!_7^2M@<3SV& "4
M7<RI7N1:"F@,L&TTB^P1WPK!29KI<Q(3)9+EXMXM:Y)_@7+C2&J1'"#9*IO8
MHS IST>],?6JT/FJ#ZWAE/'(9;/OW$ CB6&#5QGGRNH+@'J0&>;S\;<DQ'WU
MCR"!%5$.WV(.,#$EI,<EW8:$"4YV=14A4D%=3IB7&#G;O*'V(!$R%'?'?/T<
MO=D$<L3]$I?">^?:E&+J%]'C-8TPV[&> O[-K*K#RP\E+UR,U%ZQJW@=I/<R
M5KOL>899KNIG>BBMY'Y3[M>C R+)17KV_L6 X$O-+\8& ?97DO@*Z^F/#;[E
M><93U6W8F87<-MK0=5)9;/+W6@&WA2S$]NU<VMK;91D#'5HG[]G=<FYLL+$5
MU\VW[]<,1':IOP?$PSE3_>&E1S$Q)&N]JZ(V*V;"+0PQ'40?)Y?A@I[1UZ,K
ME/@7Z4^3PGL1_?9F=3Z[PST3V#>>]:\[/\CN9Q/LWJ7"?U_LHN7)5O5*5/J5
M" 5O7;?SRKDQVGW M5=Q3IGT#JR%[A_R:9M\,W$'VBN)[NL[Q%R9+'%!QBS>
MMW(<=@R/%6]8]E#)1/M<<8FFTYI'[\JN751N9^[HDE_5EC%:_"GW*D@"K>*2
MTV+;U(9SSPX7PZ]-5:VZ*LA4+V=1:64SE.K/B![N;H37E>0%S7OH1GA I1!+
M2:5R5-VDTL?")V&L^0@7B>PASDICH,W?:+GV0N]&+T^&=_B4>Q^'4@JM;&OR
MNG*#%>Q,R50;[17TTYI1S4N.J30)IM4LP!R!VRM*R(9J2Q_<&0^SX06FI?!,
MR>;R2#_CK]]7C/'LAVA,U66,)4/<#C9"FM<;PG]CI:<<VG0,Z:<7_0N<M2G2
M:[ D[A1*IO'.#+P$$L$G]G"Y+DS2/;Y=AC(0?M6/A74=5O(4+@>BJ3A&Z*@^
M3D1,H33C->^B;W8O0X:[6JC0B?+WE1<?J_:O,0QW$5^XOHT'G8GP %$PXGT"
MZCQG%RN"UCLJHLRWKGU%/]0M#Y#_POB1:4:>N@+CXS_ZNOV&*[>V'[[50_!8
M<A-1</:B[V-J:_6*%4@[I;?%Z<CO'/_6G 6R Q.ZOL7FX$5ZF.3Z>7W!X<JB
M<KW"ZYWF<A/9OX#'9.M'''IL,S)O;^W.K<%4&RI,B#BC?3%@39,D6]M;01C_
M]<YJ_+7>8WZ963^2SAV\"S?0._%N7HO?*UE8Y)A'%$4D,J%*G<Y(T?UH%/F-
M]?0N;'JF;2:*:IRK@"<>U'LE)<$$?1(X,]P*=U4*K#J>J*<9$(S^?P!RN,U?
MX()82J[74/:_$#GNU^!+H1;+IU_?[!'$&!!=7,4/)Y!H?1^_ [M\IBD-2H4!
M7[[AAGEO:4.,$*T ;<XY:\[;)8NQZ0'ZN;%_/!B0-O6L'M=Y(5CX!YVV05>D
M51)U+#H!A*UQP=D@DDRR'D!"YK*0#U)Q%#\CC#]6XUO,BG'#,MH)LSQ6:/8B
M1)U\EX(+=0(9?Q_'!:Z8F1^LP*(YU$F:E7Q%29_F5\RMNBV<:>Q!++PDD,@N
MD5Z!/&_20[ $5H93<S5VB[:P4KS=AM1AE,OSB6X_?5TR <RG6PYL(G[U&[H4
MD[00W?!RK+E.S>(*R9!C?" K]+"!!/%>RL[U.T; UM799VPZR'Q40R9&* !>
M,7R H1&??=XM[)C$V6;V&#_@<JB#_VR7+YJ'H!,#R <D^O.0>>V?L,:BZ&AK
MC L1">L&(CSUP-%95@GFM*WH7&F4]S[>S\ Y=9..[TB:7>^ [)S:RD1'->)E
M_6B])OC<.?4WREM,9[#9))AJ,<$RXPNGXP6"\<'\2!=M74>K$;X3ZU(7G>!I
M"L"Z1,[S;>AS0BCTZD @$>>.3?THBKGBZ/^;XD<U]H5RHSAM2/(<)P$QQ!UM
M/@3CW2<!]Y'?*#A?!%J._7'XM^ERB NW'W4L+OZ"QCZA8[=0?<U L+BA:V,8
M>T!2:Q7\"[ "?N^UX9IGLRSI"K4] &O#E;$L_S#*6[ZYC 1*-',/J)QEQ5@^
M2L:@\YMO5<LY<JT$E"1A0/0T/4ZM,&$/)O$=O,U2Y# @&/P%+AL0D0S/<0<Y
MGDM8SK%W=AQ:'3)+R=/4VU$:Z1Y8+%JJT/(_'4S_[R53*/49-S;UIQ0]KBIG
M@D-&TBH7+%K#W-MUXQZ#30,?F6-^ %VF4L*0*'O_-4A]PTHKE)<\#^.UOH5S
MYS&W51 "4YI8+$_#2N,])&S(HBA%U$%PI"UIO _L^?9R&0==EVAQPF*/9"L_
M2P'(.<WZ=&ZK3.S3Z(=!5L.OYH45W&\X*YG,SEAK01?V"WM -CZC;',%#._<
M*82,)[[PM_=B]__(F,EEG@GA?OFIAR J_R"4:M[C"Z^&W*!V4$UP')H4CJ=N
M"8_Z7WYGBG+4=Y/D7;LJOBD]<0\Y_#+#F\$91W&]%V-\DRO!^$X^:NGES=S(
M:%ZR)"5CL9N9FU+(#C*8XB4;?WK=F#5TNH8+JL7^1R9M. 52:@Y>=-B#+!5N
M?^*5G'J;:HX.>2E9TN7D42U.2+716HF[,(U>Q<CT,.7G&:$?KI'D;-I49H:)
MLIPO"+<B'_B"M4:LBGYN.1=;ZOLY'1/PC\CIVBN771H')KA[B6_[\\VMM.EZ
M#33?&@CZ.977U6-"2;V[Y2MWS*=^RI=^4'F=M#C8V?S#B>NMP(NYE["L0.[7
MINSNH@6OGC4I-_:!N1LK[J\*VXA9Z@^JV%6#U,5$WT6*_P294,YT<8S(QM(W
M<7)^R+EFIG^WB0ZJLJ"C.YSML,76390I1 ]?Z@Z8N/494WUJTF@I)^%=>I"@
MGL9I_FNO#MO+[1OS2!? 6G,E\4K%OZ**_@*>7M&O_/-;98=;0N'U>EANJU1(
M]$U=-IJ"MT^]J4)2UGK@;;'2JSI1SZ(TXE+WM/),/O;+"^HYQX4;;P>(V-NE
MKYA=\[  5&6)-PN2)[OUUVK$5!HV6+PLSR?Y^"6&DH*"<X7JA[WCOXKP@"@M
ME08U"E]\$9^T[-=SYF0G=16:J^*TI3$IUIL;26DGB&B^VV?F)9?5XZOR,RNH
MTJ74\<EX,!J]<[5^T*J!FVYQ#]E90W"LR4^<.%O]YF?DV7,5&\*>G7:--0]@
MRG2%[P=GL B+R9YV8R+C=MT-XBGL;BB/LVXKC%TS6\# F/499)?$F*ZTW\1J
M671/0'T)Q7^5(2PK:"-[G,#Y3,!C?&,,)?R$:4;#AF=T6V$J,1GL/#@CC\@=
M!#+']"V4-WT1IF#$&0^7\1T\TX&SUZD9UX#2=X[G4EWP5(?Z9V#='/T?7T/4
M28#M*\++M/M4FP]S+\NMO&_UNHRK/%!/8I8+B[1[_@?W./"Q A($$ZJ<^?*+
M_]/3ISXB25G;42^=+VKDYE_$>.<\%_2*W+?Q9NJ1"<(]:"D]M@DL-0KH28>2
M@.L"6AYB/>)SK3&S>[&75V]45_ U0AQ>A429>]O<BC>03<KZ+6E1C?UB^E)?
MJ0X%>0-C9=1?S%P6U+!%W8L(&[!2.P?%@T0JM0V,+?UJ<E.?NG!OM%Q=@YUU
M50#UVQ_'<"Q-@)$?;KX7B1E!KP28N'!#=_&GDCK^JX=<!/[!5(>X2&^3'Z&5
M=O\Z6#DE(?L'?[!;]/3KO5'SDXCT"H+RC"X#A$[T!OG )Y)U6P;_M%+'Z;>R
M%,:5G5PB4]D'/J/\LE0Q\\H=<.@22A$^KN^7%=31<%#BQ/07X&%PP\%V3RSZ
MZQEE5\18+E1XN5P9JY"[*P>8NF4]<(U2(R+O5I;SCD]#"6Q8VOJ%&;]D*1%(
MF"7SS%GS,6TX@$O!^(UAN'JY9]2[D12.VWSXJV-HFR>_F+!%3YZ6@,UU66%,
M"A8=U*Q[2@Q"NJRA"ZZLINQ).)LZ[*LN!07@0.\$.]+ ^7P$X"QF+O.-I%67
M3#)_*AW.#6<#YBOF7?RC:1T=DV*"8H0(23/[;J!#P,!<)K :9EO<_-R1"8H@
M<[?\#LHW(&'F"D>WY[5_T 'B'#)ZSO*:UI?<3VR3?TP*29X'/J_M8==I,V<9
MUB\"4EXDC"EA!NKB&YA09QG8YS&62GF=2?ZW&08SA5JI[%=QAS;/)Z$;9H)(
MRJY8%N!DJ:\Q8"A"S^%G;G=)*3<50!@J8;)\G;"M4O>4,/WT-H-!NO'*=)AE
M@G1'GR.*/A3*3:C6J<$I+E,P3]J-@6N^4(*U4HQ1#U*]2)/50AF-1*OOXN^5
M0*FP)YBD0>O@/H^^4()_HFM"-U9/(I0D4(W0ZW".F<K0<H$,(%*RE*900HH:
M%"Z2%'3#]#+9\9[ZO' \A+%H73"*E8Z7Z,MQ-?\=U2@/J;1A"!)A#R[DZS%V
MHC?*]\,L)8GZJ^?KW^3\C.OP[@LMZD9<I!=,R,Z=E!E.20K2_HE9>Y<S]/B&
M]TX)R>2RH JWU=6K_^%[B?^?66EXP#HT\B6N&&LK&(\X"O"53M(O9A%+&:Y(
M/*6_^40=_U#@A:B,+_3-@&<GS%"=Y-5B+OX7<$L; 7E8K<$@PB]7[;WUY3NK
M$R_7CG>")[L"A61>OFY$+V#T-;*6-\K%#2/'"BXT\3,/UG0PJ^5&>$H!4CW#
M^-KFG0=<GSX(/:F\=%^L<W?-^J4_/,T&J-/<)2ZSZCI:7"J;%S9.1&667C9*
M>@N L!:.UQ1(6GLTHKSZ'KY\GQ?XX^'=< 3'UVO9/$D.?3U+ZH<#'&!'Y*:>
MH>V]!_D,L8\&ZR12+JJS1M:>F1$NUXKM7O]>=&%>Q8-W[K,ZODU/OLQG*>^/
M]"B+K *K>Q[RKA((-!S[ #R<> 5!O?6)8?P'1^F7'?8AN/)W]T54F?OZ &^:
ML[:L*K;IYG-N?XT*E.ET(Z]C_JF6/<X.]8H?/7EMTBG4;U_X+A@(AA2_TRQQ
MB'/$C:^TV7IR(&RF5Q2^G'XFD(*ED:Y?=WM1)Z\QHN;E@E@^(.- )/ZLKFN/
MKU>U#<U36B0F9D?-0ES]7];RN4>:G$5OM#@$7ZH3,GB$< Y[^VT+ZV7X+N6\
M2895Z37C#6RKC)FPN5I3H0=WXFU*UNC#<6S8R,/-0U.O<CW7T41.+?OB';Y5
MC<OHFS^2] M.H0=>4C2#K*%^Z+@_3L8YJ*6LV?JC21GOXO71Y2G1?IU/(2/,
MS]G]U=],*FZ)N[ET@" C1,^]U[^_I4I=Q@147AH,:*05YQ@G&BT5LZSN"3Q7
MH$FB6R_7J/'%9X#+$?S:*WIAA_-/P5DKXN-0HP(M+JP42%%=8D!20C1H=ZX^
M8(.[)=P(%[!AR0B*!6)6[-RKSZBM]RRNP 0)M8O8 KXIAXMA6<1@_.VOSS\#
M"T%=_JP9JI4?Y'M:'U&;CM)_W3(/799 *:IPLGQ-/F^G>T5;T]YT*@)/E]:J
MX5 Z[IG>E+RF&?';3MOB@Y]SR7:_L"DKL!.2([%8.M97&E1)N#FHI1;H+GN?
M0U>H]F63AYO4_!(32B5-;2&+15"[%!<<,HN5&?1YR.<49DF7]D>Z(V;[T/K1
M3]T7"#/&U&V-+"!R47\A*#\H'4J=2K;K4SU6$8@=WP["LQ!LNQ5&RD6@][$Q
MY0:G@Z_FM5J1=4?[L31@G+H=="6R-NK:<\;,A'+7V_HC&5QK)\'\^E! A';.
M9F$YX/L7.!W($W3;53M"]F40Q]LBQ9YRN&>&_O$!P261I<N>LOJP95 T_KRZ
M)T#;>*X!H .;DB*=$%W(@()+P.'KM[0P<%7_K  LW/X;PSA8*!7HEJW.;+#T
M8 VO&HRYX&N@70RHNS0+:@R^B*E5X.35_FW[MN@<ZO+W;G&<G-*=VM?,,Y9@
MSZ6 .'M%)JNLG_WW@3T\^+_\P1C%0H><7^_,92\D2A^5??-2LQ\8WJ-OOJIK
MS$ 6>;:W("^R1]S\>BI (^.Y1/SV63X:3W+ ..HP*&#%>.XMQVR7[&G&6QIW
M.E%=9B#3!I]K.#>4K#2X_,J7WW;Y1>:Z3W?_P*='$7^!H)QNVWF^0@Z6,A=3
M7"[WUA%5MWH9K&FFP%.ME!6D/XVL4F[&1CK>76W\"S1%P.D<Q'S@X]&.M7_2
M5'6H9$?? 8F>R:+,59L#/W,&X2^TLN>FV7QL9L=?\RK&@L_J6<60"48-=I6K
MU+<Y-7FC RZ:(41?F74^G4$(7?-.V=W1=QQ!NU23/]EJ^Y&ISQZ\;MKM,DDK
M:7_G?GT_9,WZE(Y//GPB2);)B=]Z!5VE?-#TK&#UK+NF1\/-L@9WB0S?C5]#
M245?0\<I":O4!+W7LP^J1#!YW:F0OX!CC3*U6\<Y312>(A3T1ZI!W ZFN5O2
M=G>K#&2>%O4\RZ+*K/G93/\Y$?$'A3=L^F3NW[_RL+>8,.FC.,_][/Z4>>B)
M9Q3'9[5AE_Y'=4%(ZOC;]7YLFB-=\)=EY8U+*;FCI5^*B_H,J>9FU[1;J@H9
M.]IRVG,DH.2H%;M8PGFS#Y54@_'Y/G\I+L1Z L(:X'8_6BK._K[-RQ\U/B<2
M/M'/2&F)63%YE[<S7/P7@-\03C\9 ^*YH_6YQ/-U?KFT6$4]F^/!N" U=JL_
M)4*&DZ8>36=Y]_"5D*!2%YN$1MZ"0W.M76ZZ$'9VR_8KQH5CJ?=VA6C3:[Q_
M@=9AE'*F]R.TS]=$S[R]U)L?U)3+2J\5I'/?9'N@@[(V$2; FG!:R9WI@M>@
MA=^?GIU*/$,OS\@+1-N;E6$@?H:77;7UZ"]X-[>G27X9(QQJY::RA=)1A^-2
M]8.6HV'C55M=)GMP$ 2M0Y9C'C>>^<;D,%#+QWLDTS-ZEY(XUC;0XYFH%UXQ
MW9EDO"=8&EB7*&D./S=L"JET5&'C>GS77#I82O>985WR/7KIR$^28CR&S'%
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MXVS>9<1$@>F[4.%ZQS%)-6A_B,VF0?>K7!@?V;]7JN!_-O"_+A'1=+)<9J_
M4K[-\)"Y<><^;ED0HE'T>(A16\SI6/PKEB-@)N[E:%,U2&8-;G^UD)/R"X,"
MI+[-J<_J.+;'L"!&7K6OS\/U"(B57@&<-DR5^9E:)1&N.9].48:KE3PYF]I
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M")F+2Q]"B)5BY:O$#UZ<'TE$<.,#?)9\CBN_\PDYD+G)"=G1<.6+R4$-P'M
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M>&#6IJO'FQ"RQ<#+S?"OL<(C2A0I6;KM$0P0/%S%ZJE )3ZEV8+RG1\80A3
M_3WJA6P5&5L,:W>:!)XGLYM++2A&#V\_6XEMVR+8@QO,&:=KWEMMX&4,*8_C
M(J7#C6#]FT@BX?UE)\>1] )?V'X*)5?;'/$Z_'>9S]"<F1A.,NQ0_5))\%;5
M6:AS'"_U.Q"G1FL\//WPKF&$^Q.7T2I"8FQI6VZ=YW=$&.]M%3S'%%_$[Q+B
MY#&&J>NNU'QI'3FHCA6[7L?*%7^Y]L>W1G'=R'<S((M'&F$S%1+'(_F&?<<G
M!1A[.F6D/QSZGFYA @*W\'\ZDK+IX_PK/.65?=:32)Y5,-L7O*NI>6VN-WO'
M)^B[6GY>AO&HN[QM%FPRTX9"N?:I:[4$2$SN2*S"8?L0@=1D'EMHT]C[0M4X
MTZ,RU"B"*15MTANYZAH9?97V=?:*5];\YA,:.-Q:P^91K,XV#P34R"A_=K)V
M#(X@)'I.VR<>G*C([RREF+6$[YK;V,3RA0@)N/81M5^G#@F5+*<6U%0YIYX/
M$2H^KXQY=<7/74D4>-.;R:L&SZ+^6H,^A0V(K[9G%&".]O. T-&.J3NI#\R7
MF2![80=-!C:^NG2DK:4_[/P_ $RF9MRI?.%W8;'5!2J]NA4TEEJK\;]F^ BG
MJL"\WS\#$>LU_I3YWS@_\K5M=YDF/T[YEHD(6'H?Q[W>4<GI7AT=/=+,R!2]
M:?GUE8?YN*(#<"6 1O/^T\[X?S6^C]G=9U\^+-V]3X]W:!$@T%BK@<&CM^#8
MAM#"?VA"Y] *.7(M-</*9![B,'7!L>A(-0J]UCXH$C$<VQF]:2$^'9,(&TPC
M+V2C<HW44<8)/D%9>@QFH[E>_IR%O?.F?BVG!YK^?2*</8%T/?N\+R>L>+%^
M7/'PBZ/:1[5MRV-L?*.118KU=0J.;Z?D4]?JSM TVOX?@<]Z<0V^2@:5+Y'G
M\X;/NJGC\:6"T$L1TO.TC:J%4ZW-/?U6>S4-%A8(LCLKX_WNVA:[]]VNYMS6
M/A:^#VRS[>;%'89,KA=*/.-<EC<0!M6R"MT[4V7>P"F4;E7@5V;EL4X9CO\
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MO9P^C-Q'EB&H8<6QIPW\RR2Q^TMOC'=-A[EE<??0FR8[-T6.>*U4-COI@C]
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MMW<T4% X C$\PO@+-1/L3R.Z624W6$JNT.#D$])Z4A'&ILYB#N&S:S);4$*
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M7$P(!;'); ;]CI2ZGWNL85T6Z'P)4(G\/6(.RK'._FOJ#[_2^%L7CY)3GNY
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M6<O(PSQ/%?+7'\BFTY""_\K5.+)(C+/')JPYQ8UK(J;XU)#!][E="K?.3BF
MXL,'FN-)PS\$I!S@.64BS6;:_&7)W+ ^R/27 #G+ O).E8G/80F&7-T)])J,
M)M 4[YT1L>$_(X?*0@+VQ:X+XDFI(YFH^F5EJR-L+9+?S!2PS EZ/W((Q$U
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M]KT3$!<7%R\/KS ?G[#:$;$C:O_U\:T3$.!DA7/$L( D +  B$4 ].T1<!@
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MTTQEMMJG\F&+:H- 5>2^_60E<6%( S"U8E^)):1\=K3\6 ;&R:TS X"#R+O
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M_NN/ 2KHRM9N%6--9&:D((L<E)?@@F1IK2$%SQVH)0J?0^SUYI<W'"@!31'
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M97D?+@I(3@ZU*(M$E:AN191DJX2:@0PYB,EQ9I5M!62_IUVEEY 73FF7S<,
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MJ'5K42S#A"C.#5;29CVQB]?['I]2OZIJ*>(=I"TRN(56&:!&%ZB=$>39S95
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MG7+8Q_':#3A()#@P20WC;R-_K#44R7VK,=?& 25/ &Z?!.=TP9=/6]Q@XP\
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M5#FK9.L-KEBL-/L0$CMS6L0F^$3N=SKK.>S-:&%9H$ISE^,5M,V^F"UU>*G
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M>U NHUFU;.[4"(K.B!,^]D$V0.O<F"92'N#6&[LODR4TL6O'#X1'%>YB:F/
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M&?I6QR];+A%:@[-6UPNP.!$O:W^=PH2:YIU7>=[VZ7 ^Q$#GN7$%Y"E;UU\
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M^@2&72:!Q5M8KJISP'_U[>:":[9+2Z L)]*^9%C:+CI2XA.J)"Z$T5IITV,
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MM$U]7JD28.Y\\_.,RS4Y%FY>5Z%(G5<C3_".-_S(1G6X+Z4?2BP<G,S+N8.
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M>%^?-3E*DYXHREQ HR^X!?DTJ (&$!+.*IDPE9QT^T9#(L(O 3P-E<][B/P
MIO/24<A]VNR+]EV-S2E6QJWN>QEC8 J.)<5),ANI( !>(1-A2B5EA^,0B37A
MQYY64;5[.T?QQ%Y&S;[ZD<7C*9MAXGVZKPKZV6ADQ'?EQ'AH<:I4$-+CW=?D
M/_4\A HD0#$Q50\XTHY2[SD@RM\950'W^1,%?"YQEE%_,+2T2_9KW@*P,&M>
M'U$VI6@N=:]PIPE5GC8X!%W3( #$K^O+%91D6;=7-M%<ORT<=35 <?JH+6(V
M$$Q4<>T9W%5E\H['7"EH+@S=/"L7^9-2B+]YVHPM+Q4N%LK(,*]YP5$DH8G)
M(.JK429?E'MLH%6UN4EQ0NBD7.$R]0@D@"$]#.BC<EG?*JW#.5-!D-J<PC2D
M/'0;>_^.,=BPQEB44FK1&!R@MYZ*N:UV,]R"TI#'PGCO"YC=2MFYG)G ?X65
M1CIQ'"BML)X'_D";[BFT7M@ZE0'L<1(Z+?>.-C9K/M+PF(KO$7B$K@,/S])-
M;Q$?F'1:S%SZ)W7O?V6J?Z]D8/QTMZUVFF<H'J2_.;LZZ)LE]S.H:H1U'EO/
M*JE;5<N_4@F58=-(C[",UF:44A!$XYYY#A1!ZSAZAH#S]^7?4:;SCCT=$P26
MWL7/VMW]3'#M D3.-#R >,"W8?[<F;#[DMEJI)H89G[V_]2*2E>98,"IL=*U
M07C*#>?,!Z)/NRSOL \IN]VG0L-W'EJ]4KP;7C!E0!E AV7V&S46)T4:K$5+
M>+LX+E>/'#97O^2TVY0?+W\\D6>UE6+'=."Z-&I>-2)-@$/?HEG"9SEKR@!K
M1A$0K\J&F%+GROQMHY.O!6)E>Q,*@U7,_6'CT%TSA.X")$DK5WDF^F0:YX(;
M&@<%K)C;"7>&082#DA;E'J)(OU)7U*!$NV%C:;L6UC9!Y+&_?X='KLW]SRZ+
M7%O=QJ\,EQC*KQU*=U0H.2O87D@$TXY6S?I#</L+FS][\44-[#U0-_A<CJ_7
M$V&;#%PD,5*\_?-[#B/FR36C6YM1_<SN#OI.3E:%3'5!4K]H FL8W0OM6\TW
M6;/M^;(4C9I79RE$,D-FS$<O!K<M)!@3LF4. ]4C.S;->'MT0Z2QD\M).2Z6
MMWU5A3#K;8BU4Q4>E8CDMZ\;0TYKSKK$0M#1AP[)2_YZ/)<A4>M=%].ZIS=,
M)W3@BD&8$! &Y_.S[!U(7%2$LA$E272#?:@R7LGLW=.AQ$&;^&)2!#W,'$[]
M]O-@_O2<1D+1;2 963Y\Q"!JF@ODJ!6>Z?>]P,?>4!M7];"CS,#U$MH,#.NI
M:&H@=X?+1S0-XQ+;SE\+7 =S8@DKUH/ .=23]; *7$]"Q%RU <OX75C^R U]
M5 $>^$I+3*134AZ[MYAL]'CZO9S[CGWAOHGHMM$0;_C,W7!-&5WLU$=:7^:0
M]TR3S[/FW6U"R4V5>7DSC^\8(2O<;YU75\Y#+)T(87?X$'G'J5TS->O5AH]1
ML+T@=6'OQO3^[)7EBJ=9;M[SBY6@.A_O5'Z5W0*\$<MW:4/7*QP3OJ!R+\\Y
M0Q M_&MV^LK@%9%AKS<3D?*I8IW)3W:'<)9G56N?;@3Q4EC-&Z"XMG'[5LM^
M)17)-U%.#!F@ ;#]5_#4)U6P9TG1\G\4YRR8D-U&@+M_@B8,?C![[9,R*7#%
MZ,:J:=1$P;Z9O#+)^U6=B/[CS*E:.\C-VFFTBZ9967I>/=35SLGUK-H,<*T2
MDCQ?QI1(IT'4_PL@#V(9ESHA&,30J$@(T"/[VH4;#O!IU[FKC0_N9-'5.I\;
MIBT6[^HR&SPQ'-6!=C,^2G!O5^(&._>KU99\?)Q)460EXINS;_KBO7/!_0R4
MA>U=&5%J///2#_-C$UYPK/P[C&E4&Y#)_F<G/-?FLC%XE:]9MF&#QY3:K0=S
MM5&^@J[)Q.P3\@D@(*,#)[#JCA7\N02;_=$<]=_B6R\Y&K \;7OW8T<[:OF'
MZ%?BU^@4.@6,'MRW<QII\[=/&D?:^9O.CB/"3UO/-:F.,V""K7!N$>AS+!^!
MB;MAZC)0ET66H/]&PNVW&/E3BZ6QD:O#W6F\;>.6XN]JMO+92,-S3IAW[/W)
M4;=(]'@<(Y^QENUXMI08KP8BR(7]0;IJ-0'FE<W#D#!LQ+^=H2='_.3:?(TH
M%FAFA$VPKL):GV_[OB#7:I];P>D9O+38_<9J*[X6UV53@VO=CW?T] 259]VR
MRB(SK&*J[$EI1H+TL/8"IMQ&N W]5K=#D)5],IZEGQ=;,YI7U\#C5*>RT[OD
M%#$=XNK1K?I9C<A+W_YH3$*44WF]6MOX +&.ILTAEIT!V\818<[A$X%(!D.G
MN\TT0J?K&0K*1\9_5GO&GO=YZ&,6A""]HY8M<P&S$B?P0$.WJFG\.F.>M5K9
MMZE=D\6K0J(U-0 %$#7)&3984:99\GJ_@.-;5-.>CK_CZPJO*RM%8JMS@U]?
ML7W09<B(=FA]T16ADE>%^BCY!'&1#)]N/^U1X 3B":$1_5<>]'66<=X]FWOO
MSS/,P#,K$EA@ZHE&BE:H_L_'TYP@FV"5$(K[LN A'EA$DN8-@FWFP4O/&L9J
M.)\Z #+!13I_\PCDWEBSZAE%A NR^AOM 3:GA ,M9%8M5 <0H*BL< M[EAE:
M_J"*DX+,!Z9 N073GJ"J1;\-H%BKO2G5N=-46(ZR6?-W"W4I[_6747OG$%\@
M&;5?]=R;Q=,VZN<4&T%74,C]U3 DJE;V'*N5<UZ9DPPNT'-! QA=R?EDBSY.
MX$>Q5":/P:J9D\%J2IX)?G*4.+M3*+#"?0#JJD:$+![(%]%960E2FXT=(O*=
M!D"W,X[7H\#2?WZRO&_],^45<+S)E,:P@5>,__HS*N34E8?^^O71JJ"6!EOL
M+K\OC1<U9<8PD"*ON&=;U7I<?_(X3A3% *@ )6P;BO8<6?<R3=:[1\F.:J(V
MT-3>M/Y$3V_.4B<BP,S290AX"&[*@Q%C%2J=3&FHKH[K6["%PWJC\J;K12E+
M^G4W+2)CEA$'-!Q "BV?=DPDN@EI"ZC>_&&>H% -,:7F>^!M8:@\BQ:E?'G#
M8JI$* ,%N[ 6A]$M>%* I,!E>=-=2_XZM@"SJ9R^6(+RW07CBAP6=7]CP2F4
M-W#B P0 YI\NI#;55JCP0%-+1$(=+-(L7\6B6SF')Q^F_#/_,K/93+_G7]+C
M, H$.^RK2T *AEK/^1/STF2\R!_ 0<L4:W(.(2Z1TPH%4AGVC*2O103JEZ41
M)4-.#"]UB5E5&?CDI5DK]Y[.>A=X4DD*0DPFUIOWZ^CEP\,2'8S,T@4JD8 %
MF[0.KE0>$O5CIJ18VPE[<=&A(D:(A09E:.6_SW.@-N]K!#-1U%HX?ME\3$<P
M]=AVB)-.E7J'1=5X*")T+W8?3'E,2][5E!>NM@.E^:UZ@/96;GQ9WZ'3Y9E[
MC?C-EVNTM%,V]X1AB(>UW /3^RWFG>4U_<V<+'GHDL-!;H 4(2 \/T.=,!#^
MG4F8O]R8<#-23LLA?C7VT";ASTT\\RP"NM\?.2E0!DM&#F^ZLI$Z& T*L@;L
M&IB8']T?F8:^=[RCC#T=*Y8<$UON?)T"?<GF^PZGI"<G)5_'WDUS:UP,ZW_G
MUO[@)NRSA^<8LU5CIQ4'%/+"?[!.K);Y[@NEJLD V,G<XW(=YO?J'P0I<YDG
MJ. 5#E+\5\UXN#05][)M;+4'MZT$G(9B355AI;NPBC:IAAII#L\R+VW<A]W*
MX^- @JM1N$U+K%'73%>/*4,EG'M$?G #>O(!*R;2&O>ZVH-1?T,0N=+:>K5.
M'SE\E<>):T+U,FC#^*5'-5>+AIJS-#* $$\N5W(!.=3*^(F6Q\\@<_(9[6:O
M(4N5RPK$-*9QL-<QUOCXWKL#&0^ 4 -RP26<]0\GM:D2K]$"FO#3^HZ],+S7
M,KO;#5HMB_1S>$\EI*S6WZ:)DCLX B+5L.>GB,M&?\KS-]ULBIR];RQ(+LHU
M-W-$B4KV9*05G="]L,7<NA@ O98K?H/-+4:1.S%F.IJ>2]VWIN]9P'Y.L002
MS;TFS;AQ_1U/\I,VU%YM=KJO3O-Y(TO.*3/V*;85W7YPLUMI!Q)-N'R59V]F
M,H2^H4*NU1V@+<I#X%T8!I;7U6B'YH[GPY3Y[36=2GIX, QF+.M8OO;H<JZK
ME?]"%^+,.X+#&SI?6N*I1^TYVK7>$60:"S!-N.H'[K'.!2OPS2I&(GLGM4"T
M[_[NCR#N8:SB!-6Q&-B=KLLJN+_X4\LE*%TGO&W %F"7;]^GBZW&0/:C/#NF
M;6$?QZ&.)&)Q1C< 3KB:Z3K[_+D(1PDM0]?,Q?7P* YM)7,^&I;Y3<NG#P]$
M*7KRS&M-;(&;%B\N00"?3!6G9-WSSPFRQ46TJ(*2E";!7VOFFU+CY=IN0P0
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M<LAL3_33$D_83(S5*>SMO$W[K<*./NMF(.H<.J8C=NHVAE!*T/]]+(N"]>M
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MH_LR,<K6U3^UOIST3AEP1>(W6=D8LYXJU)6]LS+7W<#0WB/2JX^?!*]7Z^[
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M,%,'%3(-NS753-UEH<LD$SX!X+A*E.U64#W4C_)  P #MEYZ%G+21&LG62)
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M%)Q$=[_ SXVAC*_(N49QI^4(ZS2GTI?W;\DA1IM[YAE*H!"9]:V0A '0X\A
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M/N/XT+,1G*F $]MR]HF*(_\Z()@G'I6%D^)HS>(0J-SV(F#'&F+QK!<64=8
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MO# ;[.".QV<)[;8QC6'QKC/,)$&:GYJ2J(V=A\%0Z[!C(?NKV0)L=B,K+MS
MV+=U_2-Q.-,DF IMSGTP$&CX0#+JS] OV@DD\AST44YEQ 3YC!\E;.HJ/^"X
MYSC1R&HW:'XJXZIRQC72X*,@A;WGZE,9S@$98Y2;T4KS_3VCH3+FSR'B]C?+
M-0.N&X^6E-9'#CBAGC@YDNH>$%B)_.9P]P721T:]D0^R(^KP67ELX@VWY;H'
MG([RQ7M^)AN9;A8]'YP2'<.-1E:;%T?E4UM@8:I&<1ONT^_%=?V=%<P&8'[D
MO5*3U:5FCZ,/'])!5[ VKMX"L%1T8/:D='/",LUMOMC0Q^;I0#W.YM&Y8N3
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MSQ^D]DOUGLQ[WTL"=G#XMHH A9VD[OBA3#<28NF7[C9@ 6W)V7A)X]&'WR4
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M=['?JYGJ)]!)2ECUE5&+9Q^<ZW0FF$&,M64A5S(0;+57:8B\\?@RD&B4\W9
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M#<V=K31SN^Q@92+33-N/'QF&@I [N8&U$3R<27:"3UJQ$C+IF3Y'<ERMLOJ
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M=3M;/B46V]">Z<>S<':(KK&G>NB<.*UU'I&5C(SP8.%;-XFTF+7Q<:2U,/^
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MVC_2"6U-['FR@D' W:VZB*2[*-#N<RU'_&:HY04VSO4GG*T X[^53ON[[X;
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MU<G@2R HR*(XBDM5S3:@2XJ 18"BH"AN8?F3JB0H/] OH&ZC3K%4F$FK/QO
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M 8_W*/EE?T 9!E^S^0V81!C 1L9&(L-.D!6UJ4#1.]CY%V<8!K_'S)?*F!#
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MB#LO/>0(#)#QQ6F>9>7J4(?"C1-]&!-8BFAE@:36B,GK$_9\0#7%Z9)K..
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M03U[]_[C&+NKR(]'L$7W-JZ=^^+=<?E\FZ6@<8T)([8X9'Q'?H>-6\K\^0C
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M@%E4^UAW40/>(:_FIISRB-AL?"JM':;[^=-#:RJS>9ND \57U\/9(W*@$AU
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M;D= !2:O'5R%&7^--7,!E:%M;O".X(0?6[)-CN (T<85?Z=+=.L'K GX:*:
M- P/\6#_/>_)<C0(8)I&.SY V8)&-[-8U3<:*XGNP*>V%!UC)EDKKHNG&YA%
M% :&Q;UX$ VBGC_?>^BJNC>%RO"@V2'WTXB>9Q@+3!C\Z@0F&@,FY!I-D9?6
MW3[6L3A*VLWE>UTO[^AS.U+NHABQ^HY3@RF!9*:XJ1&_W1VTS%EM<-'WA;Z?
M-\YMM.B/[A!62U KBLIPWB'XAY7('_/T"S@(@OS)+EMKKB]VSI(I=KXRF*Z
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M2:FJLAI7!CTJ;4SM$U5V?]IAF&6^/C-H+EA:,A542"0@.T1G5%A]ZLP4A6T
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M.2W<V@D^G<66\4:2!"XS[Y&O)6?8LFBR>%47O$FYCF+;Z6E&D?#$]T43;72
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M>+'T5 XH35#AJQ4?3!^I9AS=*5G(A0F(5&7ZKW;PC.= I<QV4AW2Z!.-+PA
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M4C;CS<[:H$F^>D$==3*K685LM&O*C8^!G#>H-'(SI.Z4>%K8I ="IJV2N.:
M@/,WM[<;>H?CG?4U*$(;]G:%@?'U@$FPCPSJ"YDG[3Z\X,. ,<*HJ+(2@YM>
M\P5<4&&?K_>8A*-7.#[.'2O_*D&C543R/-4G-!W6?6A?HZ+32G.E0[>!+(<3
M,JH#W\1;(<_B82\D>*1TC13U 7!G&+UZW3/?520*D>:W9[VV9I<=+(1J$!_=
M<DP>SJ&HO?Q27L!F_EQT+N,R'\6-\W FQR<6%>JMOE1Y6R2/=31O2,ZT.LZ>
MJUP4[>#VW%<M@C\0[4#+[SBDWI#JI\:E9._.UI@D.ZN8&^PS>C%B % ,3F1X
MLM/-_#"<YZU\Y(%XFXT1-KS!;/UN\%WE.[;#?VC")_=+AXJ]'3<_:L8N3CP9
M\@S)=FS/V(@YV<O7&>8G5ZEDDIGNV@">F^LZ,A_6Y#?*?3Y#)]/V_4.C<O-&
M= ,M;U361.NNB<2@1<74S9OUYQ[K-VB]$)%1_9R-UM,<.+R$;D)+A(PLEMP,
MR+EE:N"U\"3/>MCJZC7D+<=%J5[Y8Y&[^SE=*).P5U[8N0<68?.W;[L=R3&K
MS-88#JNW3Y:>RB0VO^D0 ;@;SLF+&"-LW[N]_R([)/$-<R*%5=@5ON"(R_;%
M08=].+3\?QA=2H/(M GF:HPYECSM"^_=.C3[ OY](--.__7/3;544/GAG641
MLY_[CAP";E[YOP(* MQ.^(C+TS]\REK%UC.7HB?"-.XO%+X!EU5_6NC,[R@0
M\JE4,M?<*6N]-,\^\-,WS/GG6[)QO']8M/SW1=GLG@BJG&MS[9<'OYR,JG55
MNK6#?\%[2T'=L+-GKKN6;&A[F\ 7#L!WTJE3>Q6'E)<CYT(6NE\+#D,U(%&7
M2V(D\S,O28 %;!#!T=*H-I7'!/KW\M?<,_<N[;K?W8^1=')+QG[+,CI,^1(F
MVX.[&[#8J[$I\]'3=D)/<]I*""SS-*U\VD$^!+IVQY7L+= ZX8-==076K\=B
M)Y_.>[:AV]<A0Y5OAI(UB5OS9FTL5>\WCQLDG Y[0U-ITW;=V.LVBRR$T?<U
MJ51AQ4&UK@,KLB''=\K//:8V=L3.M=U;.F7\KWVUBH^)Q4,=YBL=:KMV$T&G
M-\I,JTD7.)X^*S&_MB[Q*6OB:63;X=;/.Y.[KIBO&VZ^,3_??4GZ7JPSW[A^
MH63_VSRRSI!#^=JN^Y5KF=YR);O']7O: 5KM1F439:T" ZUW:;KQTK]=K^W"
M*'&"_]!<_+F_NZ3MJQOF]CNB,6BSZQ*_UW"?R"Q4!%"Z)66T"NO@<#TRU15%
MLU&_+Q :LS:R$]SN1;CMV'!(QEH!1F]\'5K65Q'_'5'#]"Q$YL<&R4Q%S=AT
MN;+%F'SNMY*- ([AUZ'UNS)?\5\ AVN>R,'S./.:BLH-A-]=GH1DB[_L]_\4
MX/_P'QI(R-\ __1_:$S@$U53G?$F.=&X.RUN+^0?!]0>&HSNN;7*'7.CUHAQ
M7QW"S="GU0=4.54KX8"BEAEN?G6";NZ:?QH9))E"8?#V+.L,HD!R>O@(8:GH
M9%0V.[#G:: G 38D0UL.ZR/%(HR5'!!*:*69*E(6764P&T,SH?V$>+-G#F\/
M#:\(]A+GEM*T5Z#=P?4W@B\\E?,KLD (TMBS38(.5G>J,'6&_(*?D99OYH+'
M8%^'$%:!WD,?-T&3?:,$KQP3.\O4-H%HO%'GL1&].:/RU/<P):HRWMU/9/N!
M5BJ;N@*;$J->%!_1IYDYI( G/XPSE+D/M'5H$43I!Q1KBD9UW_B80 ]S^QQ=
MJVG_1^.0^6WX*-X_BE_@F39GR ,B+/ATC3VG*GU9XVG&4=E.@-4EW,*#$1J'
MJP>U75>]#NVZ#ZU]=@E ;6@GZG%&+^KQ LTNZ#&JQZ-W7HHAZF(0>LV1\65>
M 7CIIB@G-VJ[D2<&/\O)>NL-F47BF,FTUD[H_$Q;L"P:[_H@$D6.X?UH=2L]
M"FG9]4@.>]=RNSEAO]D*&=OB"YYUQP$;C*"Y/9RN5:7&#/@"T!3M/LR4ENJX
MBD0[/MS)GK# +)=!I&)J59K>.&]49RB9=DKAME+Z>1XY7KU!,\O8\'A"%'/2
M$&>64;KF'=70S.WI!< 5M7IJBB-1^5!]RE6E0QP,+^39'+B? E+!81QPV?"3
ML?;:D5Z8)4D.4!@+XUF;JZ'#.&'[6%V]\W?EJ:Y78>5$NT@DE'<3Q/-PJ_"4
M8G*6:J71I0-,?71N*>,I#-L(E,:6PAY0[1_;O,YQA?!90RR*\^U%(\AZ%_PY
M2&_$(M0G"5[++Q8+7B9$@#_ITGVNO=)M.9J\2 @WE&8T6WH7+[>^5"_.UE*&
MN.D<LGY"@)A*+*M7,S%@WRAI?V_I8;9:G342R1/%;[0J!CKL9)^60X-'*;13
MEL<H923*[1BEDHRB)_8!8V?YMC9PSV3*506LV1B["%X30&8A6Z5^F#<_"']0
M7HJS%7L660KD.[1+':@)2)3C I9[8:&#_%7C7_ @J2.@F:0/]H8TZ.?/5K:E
ME!PLYM9V=9FKO_9.'5*M2YD+[LX?&D.DCR^JA@"O4:]CVE013S4__W1J1_^(
MH6]J++L6A'UY.LM $[!_TWP^N/XU H?Z=C:LR>WZ6J76"[N3&QPU4_32.*Q\
M/B&*58 44FIP  O>!4Q*QEY\W'1=26W35>VR3B>@5'.GH2IFM+UFO!IY)IF.
MVD3=#E9R:A1; ?+5*G2"/MP6ZP059R*@UR1X'H3"4]*8^BD7!GVJ? ?V#$?S
M\2YM=T)?*NU#ID8FR0;P)5*U-DS E8<3<<6EZXK8A!;T^C,=B[LOA+7LIE*1
MT/B9'.OS-%00SM)__"O E-J\;3Q^1@Q#VG!0Q/:Q'LEOLH]'"6?56O89ETZ^
MZ47+38&JNE<^-ZHVYW!?6^B[9!RXPD$0JWS:T"6T<+,]RG&B5HT]KX!#>L]R
M6L#.[ $^ _UXH[9W:8/0%M]'WS7M\KG<H=T-505_1=>J=@>AK\S$+XAP_HXZ
M,*($L_?)J<'<AJ++\S-Y#],+Y^_VU,Z?<7.B4+JY#_T:OF4E6CE*SAUES"W-
M,B6R0_6K1YX!*9;W[.QR$ORXE>]<N450OYQ?ACCKY*'L6='X8I4H8NKX:XG8
MJ(M#ZJ#!49)*J9]$GV[Y2-"1PO!"WZ?U$,6&NP$#8GI["3\6^WXJ[ #J-';B
MH/\*,2B^_-<NJIT(_?>9VU=HY.U[];I#"*ZU'6EG)GMV\G_Y6T"#,>OD<.Q0
MNCX?)5QS>?MMYFD*SQ\JIU'Z&W!QC#WV?&)Y_YZKJ?I M6;R<E.4CGH1Q-3-
MDV1VB>IZK/!FOD1C@/@^A*_.+8&MU[YY.&>F^+)4XXM"(=3CO&S*HS&>#[YM
M5N@Y5'$,17Q6S/GKGMDV#1+5@D8:T)6D8^Q-CL-K8MQV 7?$!T9)JNA='NZP
MCGS5$^*X;R3\RQM_2Y<=[&5EX(,OU:9=.PT\P_"LL56D:10$DJ5#<KWZI<Y3
M.[(&P #K8G>2*3Q>QMZ>A/>T+*?2H,_[3;@63?(RR:)K'LM!PY10X[D9\Y4F
M(!3YI+: \Z/0^:?&_M=OI"HY!(A#E:Z;\%&,1PR&Y&+(^NYY)=K.@9XE'S+N
MEHQO)'?6YK@R96MFYN'?Z0\!Z_B'E PQ["AOU;/'RW=GX&=?J&.LP> ;(P-;
M#@^#A@EJRG>3)/Q].G^\P,WE?X%<CM1<2+&E72;CU0]LMY'.4#%377=&\V;.
M9;+X@;"L514_Q6CN%:P94GE:#1)MI&L >9<"KTN&^2O"AVZ]^@51-\J<+Y_V
MQ=E[>[7133WP?+U<,+)+<'U$WV;3*H*PO(J2>JM#&J,9%B?G"S\0]7A-8H,
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MA*LLY7ZRU[5/B'F)8.4F'=*3]($1BO [9@DZ5*H_#=N$DB''6SJ@"M6*912
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M-Q%P/GXF$F@: 2Q$5^9[VC6(!.3#.RV<5Y$[]S]4WCSMSR)(MVNK]@U! CB
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MRN=&/ZB\ZTVD1.-@^T]&&N]::CFHCVN[ILCJ3*4\(#\::4!UU=S+?[I-W3[
M.5G/4Y])'=:R0E=T#O#94P;(MM+:5=T%JL*ZR(A(1./Y +S/2QP:)/Y:%)S9
MM^LXW)O<("T0Q2I[U'*;F>\?9L'CD%$GA2KCUJ6;;N*)?BIY2P*'YTIZ9=R.
MJ@>QF8\J0=9#VG]O?5O&&;*[A%MB4/(E*1:I;Q"C67@N1XN@L^I?9BO)1=H(
M+ L3VH^DP:#&9?!XIE1H]!%-)4"NG^%S/L*D*CD@/=/K6Z.L]^.(V$YSS2!?
M-0OX8,X?2_4%<%/KS'8QYRC];-<G55N^[EWK'HGX%HC0<G$.J=7K]LL**Y%\
M]7E\.!]>M:9\H5%^9[E1,Q@2V46=XG\%5!5)T5GH8B@,,2!G QN SQS#T,H>
M];K$#L]LY_J<QNJ!))3'@^Q2N(_!+&C90NK T\#,6R9N5F/Y9 X/]7YWVIBB
MQ0^&MB767])C\L];][H<HC7:2&_*YSX_H? FE*&+<VG FXGCQK Q0SL'A Q_
M>+@]2J%77X).T+G4X<B(G+LSEL3J>A;>GLR(1)OM.#+"[</)?+/Y43G@9VI'
MK&:Q3CY6;8PAO^^7J%?>^4EA6"(52N,124;ZF0;R* ;8,&O [OAV<*KC"5:#
M5B7-DE.7;,TCUBB;4S3K$!@\Y@BJO?VNP2_W.(8T?^"T-\C3F#K]&KOQXE/I
M7N(+]+?L<_\8)HUC][+/&'=NY:*/%GD])]@(AQM5<$7%5X)Q63^=2F^_JWGP
M+'^9\3Z%0JY2'IO3L'N@9.MH[($XT4^&#840?Y&K:*G6L43]S#HE;?5^AA(<
M8Z6DF)(V&%N=A:@2L%#ZP$KF819-;M>%L$LR2V@@-.9'0U+WXG?'R@4$^, >
MK&%=K3*H9>W"7@A=SNEQ8(]WZGC;411!9^?#X;E%'/C9<-,9G(@H^F7=Y>)T
M!;[H>OF57NTL1 .4[O3NHKN8*R,V8V#D[!=NUE&+G=_[X-6JF94KI^L_GFK^
MLA]$L-NNC3606BRL.IJ94Y3CGNN.=[TSJ55U-&VR;S+;'@;['(=DIJL]_J@A
MWA18J 0A4:5G.5D404>W'+MX/H%V<7$HP^#O$,V58I6!/AMZ+ZP >P-N_I-;
M2$=,T6XS^=T+9'.D!'3KO;.Z3]^4>AL!Z#18P>L\"&8U8#6E2[D(%YY)_?YB
MM[Z%$' 1*0\;(,#3&TX? :"D03@(Z3LQ)+)CK[SF +*W\R\5B"$_M)L^DDX]
MIP-&FL+!NK.7\"]NGAL[(3N],+$$1LY&8U^-T,/FD.X^[$_UG=IQUK7>]9'V
M20"*6U_]T%&-?.%YV66*)X!;L<UD3D4!,::K_=H"R?&&@>GK\7\<TL\(FN?C
M%;O<8(:R7Y18O;Y6>N"9TY![<5;:(&!,,274VM(%2O&T0E=IK]#.MP943%P%
M::Y.YRLQX">U&-;5H6*UR]C5?QS\EBDC,C)MLW_<FMY+:DY(% !_&*H8!>]
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M-9&KVK,;ZZL)*VLGA#-^O-WEK=VD2RMLOG<&XQ:VLMYDHTU/%*]_"@4\YZ(
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MR)IVA2FK^/T>OKQD8RN@"@I2S.D!OZLBG$\*76]E]I<^%,^W+"?A#3$$VI0
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M"!- 4V]?.KK0W'AUTM9)I=0&<5F*!*KT>$I$V/3<K8N+L'7['#$&\-BJ1G5
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MKBM+QSYH.P07TOG<1\W;:5.T)@#-;JID27-O+WP(B/^7R7[T'8;V^'[J:2J
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M=%3JCGON_)%9Y9W+SY>#-(4V&HS+]\WD;KUCT*_T@,(""G_Y:=__JI_Y[V9
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M(1NF!,R>*K@V3]HX)8K@S7GN;^5E.)F']'-\'3[N^)P7QH%^C:E"VI-%QO4
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MYL'PYWW7CLCP+\PBPD%=MY9N)\]398;>\='MGKR[<D:-NIY?V9K"53(#1T*
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M&5T?+ @_727]DX7FS/"FO#.T&C/<%:F-DK+QU 6T:WI"F,@]/$!DWS[OM<;
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M_"Q6[9<MK,$7GI,>K@L%33&!S? 5YJ*"50JWQ_/HM>=CC*AY\L[&642;IOC
M2+GK4,#2S4:PDF?7E@]_A:!*( &CEJ7SAJ=[$.AKR[-,<#^ERE<'(#?.WXZH
MLO48>.[Q53Q2G8^T5"+BWQ#/^\A95"HK5'#+W:]3"/SU==\[C7D!!)8T$/$L
MF<LLW&C7/JF[TOA0Z7ZO#KA#PC2GW:+\T3+F*SJWI_9>4*1*^"I5L$6+KI)$
MX."./W$LGRY+#+3>XB FR 3X.=<<16JY!L#W_$S>@P\S);WP6F79&>B;&X=U
M40MNF R???/),Q)7?TQK>M5?+E+1765=N%R8%M1S8V'ZC48AS09B\_BSIN/
M7$B^G86!0Q+O&&+L22E&9KK+-5NS=$IE;>V3@W;@E4O=0P*DRI8C1/1"U%]3
M=F3G2W/WA5;>)P3W=KX=,&6PXUZ8WZ3+O[X?^@<Q%T3 6F^6[N#^.7@3^:]?
M+>-K_UG6KD3PD@T@Z3\=*)3G?UHC34)@$=B3Q_[[P5IT7OM+-J?^U12%FK#_
MI[W'448UZ=PO!W\GN$3X_W/WJ%^--/[G/O_?OO]S&^E_E%T!@4+-_UO]/8WJ
MO/\V+D6IF.JN#N'9!H%P"D*6-EK*VK@D%)<W^9+]?_78!R[Z^KW&W0G!B$\1
M_V<CC=.*Z=\\/C^FLT[R]5X-2R;./*@1IHG&M[O53;S%JQC=ASP6(FC.386/
MS,V:E6X/X*I=\>UG>$?Q!>([:$V-#QB*6DS0>-]7)J]4PTMT))$#;WK2CE<W
M@=]=*B3.Y".^3WZL*^>N*ZTZ:@S8F @O< /YX-HZ)[#.9CA'4/<A@[#PZ^Y.
M<$7>5,!,<G[J!G6$6G(><L=W@NG]0MY'>PGLS8? 1%?>8+MA4XN;@1LE$Z1S
MWL'H-P-XN'>(=%T/3]>NJX7U+5%H- RQ\4+9#/PL&<,*=KC>V/)0_A#Q!:9V
MJ%S$#RXDU1BQU(7LL"S5GE4E2A98LB5?X7D@VLJ_Z54RTC5<*"UG:,02<V,Z
M%6H-9X[&-^HZ-'=S5 D&6<(I'"-J^BOGA,D4IBFUQL H*IX1Q!$X>EAWHVMM
M_+22\(ZCF+$SVRDAVUR=8EZF\F,Q5/<V:/O81=_J5S"27B70,V\FZX5@;<G=
M2(V6ZM+BMRUD@H,@3=-^Q=LUBB2JJ;M?VJIF5#]!P)Z0:=FHT=%81L-+]<J2
MN37B?&Y!F>Z]NC$Y^DYH@Y?-1Z94[5BAEV3$9YB%%DM,;T=XTQL;6U?C%#0\
M<\<EPN8O<$*IP2\'0>T39YO-7*B<LBE*G%8V&(C@;85O'^=<C YY"@F^4,H"
M#D6!3_*A?8@<C[C54:*#FNY2=B1RXDC2"<C&<Q3,:JE&K#*02F_G'Q^4W4>(
M>Q MHG]['.KFN-'PHD-1$:_TIF?J_GK^UX8C 8=U_F<L"33<XV!RC6QP=LNJ
M=!5[H9@]9!K#$&C7"1>07BG'ZBX5I4:GZR5U<VSZ&7HUHMT,>8^S"4D]Q[ G
M3-%W\E>E :DU?QV>/JLGCM&2EF,*UP78]^B.3ZM>V[!,,D'#!Q'.$SEI],53
MQI/K8OXZO>]X@LM]3&2<\D0V:I_UR/2%*+,,OTU^KB!RM -V:+@TLB_?)WJX
MD,_P(Q8($TE$O)>6M]C(>Y@_O%'X_K"V)#\7*ZT2R ^1^A-_/?LTLRXI=VI<
M2^@-;V6]J6M>1B*W2<-)+0OHWY5UC6UD*P ,51+31R@[? X-M18^:89[R_,K
M0G#EDUZYXSP(2/<K<Z,Z2R:[GYHS! :?$>DZJ,0!E%+*8QJS(@:!M9!EW60W
MB7'P2C%#LR1-JVW]#B7)>*;5,\W4]8W9^7-&] EX8QWN3I[YCH]9,4U)(=_]
M'&0MVX)])31/3%101NV.J[6CJ.4$/XR_5KS9>.+.Y;0"X6J5.V+(B[Z["*Y=
MSN,IM;C9BBE=;_L2V][XIDM;K33\^OI4G/IU7Y]%YA#G%' 6E;I&LM^D5CXH
M/0N].KS_NU+;^X/E.14T_*43*KOWGNE,>4P\L)&_I'=[]G6^ .2;^4C'P\T-
MX,UJ.$6+#;]L-%6LX/_@,.+R^7/UA&_3*I=:Q!B_R0MI"FT$JWF*): O^ZF\
MN+L\_</K>AFPVGKIF:?7>KJLNXL?CW<( ]/6:NV"M82O.@17I$:/2#Q46I9)
M>>6$9:F\W/W:52M*7Y;1EI$<LHJNK3]"SU',:=O,O!DJ7*TV+P#$'#8F F+K
M%T^*M?&GAE@/8D<?!]F8SJ1\"[@(]<=+# Z)V@R/OR(^B81M](AJG^0QVSDU
M ]';A$YYL*6<B8XKY\_YDH0J5TVGDFM<=SCH NO]"X<JSWY%G'P*^YB%G],F
M/?GETS%@)ZRV8L&QH+5IIW.1C4%68FUKF0;KN1"A=R2C 5C]ABO'TT0@ 9<:
M9!;ZH#O#]XXD!V=["LJQ?5#-2W$,S@T6=O'M=OO\%I&'))[F1@9L86<_VQ48
MNEDW_)I09B+=.DB8LM$7YCQ =):4"/!X( I1<R$G1_$>W@_Y(^JELK?,)XNT
MGIVE7LK;9V_=:8<NL,V6]_\BCX.C\A6&D>Q,G4(;2@8;\U]LX$&AN,Y](-S_
M  ")8A)(X5]%PE2U -3_!2#_HDYAFXOE?S"(< FI22D?YZO_7R."7SW:F_\G
MD-#_.>#_8 7%>?]9&\/A2$$QR>$?BIW\9TR=__\*92@4;^C_E/_ S[QR?@_;
M/(6VVU#$EFI65[\?TYL=21D(XS^O(Y_6>Q8U;KW1.OO<PN16T;!QK)FQ*]=H
MY>P#R&+NN[ V>7F^=L@?B?,M7^P"":&K?82YR0ZC3?Y'QSY^E&NX\IY' ,&P
M3QG $Y+I<MD(EGI5<^M?XA/E*[GO?\W2Z.:+S3;E"T%C+*SY8 OK8#P)QG:$
M))U 7'Z5GI4Y%A](7BFT]J+XG/[B&,\^_\7I!NJ+PX5.R0H=F2NMQ;L^)[G[
M\X6XN=U+<[?9+S8OC-H%P)6"C11FD7^62T77_A:\STVU9I SD]?RYZE^6O,]
MDK4_G"&OOM2\UC7U=@P;A@V(GB\D^BAR]P= =8A!J9K7)W8R-F4D:472=_:V
M?"Y^N2+%-ORAGE/X9_ZE,Y)WJ9(/DC1/A=+=WX6-7WR8*.YR,7WZ;YZTNRT!
M<7/ED&#XF#3K3 AEJ>?\'W:6M")3[''':01%MUA+_W08H;\.:)+@;@FIJ&&<
M_^)H@OX2?DI;_0Q1,HK@6:"\6=7\Q>=,++[IQ@7!+=2[LJ9P1]'56UW0<W[3
M^BD^51^7S9XB+-X^2;A56*3P_;VCC17M&CYT^OORK)NIJ0"^*%I\%O#GO3P:
M5/:9,JUR_&UZ@(_'A*TQVLOJ]U&-+Y:_7BY]-%'FFMM!<^,/X?G<]Q?Q9GDW
MH]0-3VV8B5[.45IL##8[(<# YB(&\;>&G*0E[QETRX&;\@P(*3Z$R4$'3 0C
M;=?NX;%L.P6_X&]P*-8K6(!'9C<G3Y=;$NV<Z/+>[G"N7+'SYEQ_K:EV357S
M_@]!)WSF 4\<6W[HBD_FYOTS%+),:N5U,]$$Z8_C8PC;CR_S_Y_VKCT<RK2-
MSR"'2MIM%&*(96?&(7)JBF:D"3-.,^.TDZ2T#JD4Y7.*J42-<PU:.3,FE,,V
M2N=$6%$,262C3$R+=9BLY/ ]@S9*M?M]>UW[7=^U?]S7S'MZGOOPW+]Y?O?[
MO/-&!M,#E_M5IQYXU7%(][L700/B 02_+<# I@&_?@P^N.;N6)>5MI_LLK!\
M,Z'4L)NV-Q1NI3%P4Q!19^ +PS-KGC<:,#)C?767&*W]S2+@X?@:U>M,KM44
M)%1.].UMAOVE8HFO8^":>#2DH>M^5 NZT D<^DH[.9@>U8'C3:"NBH[5&)S(
M2MQ_8 _F4G7Y-S*OIR"CV*;(%SP&7,#\T 326^RQ293NC90#'FEN<6$'/%N>
MW<$'\M5;_+J*:UN]=K_?C<M#,9V8>!TC[64VCTMNE_."RX>RIR G E+3&/:(
M%)>*5NG;U_;(J^SR)[^Q+]4O;S(,YUA@EM4#&\;/%VL4/X<[EH]:""!C!M)J
M;I;<DE5:=GPH>T>X6:,7U^J,T88JFK^VVVHKCH6FN:6FYU-,IR,S?3QWYN,\
M1\(]9MG*8>&>$)1_V/YS5ARG)U.0Q5S](\_8B9.2-6[],36)B)NYG7U"Y9E7
M.!9#KE7M7C4WZX/0EB=,.!8A83V8T& ;[R6MJ3**Y]XRA]*--7M#4"._CMJ+
MWBX?(R=V7I/HG$ .B928G'RS0J+3JR9&Q<O8J1-TT2GBQ4[:M#H=?6<\MR6X
M:1!SJ2ZR#Q-O8*3_&U"B99.<PJ0\FQZTP;S;BTMV'F&>.I+DV"TRE*.S0C E
MYV;YI&2KVWKY^#6CAT(G&MZ0#KJ,,$^*JKQMLS# Z3V[!E0H&^ 88O!\*YE<
M$\0C<H7X#68*<XAY8=T)_MOUKH3<+35W$QS*20LW%6F7CY?-'#D_J+2T\)&%
M]OT?0D(G;?NR.FNN#$S2;P]<K!^90'#D2TPB<$*U( 2VA9=J1-HQ\8%J(<MB
M?2=05J/V/4_W 2O#+YM$,%BA0\RAW.:&MBCF4*$+1H(LA\%O&9#IK\3@'3/Z
M8K[9;MCBXC&>5R&SK;\2Z%%HTG&(R/_C6*U1#5U#$0Z!7GA!J68GN^T B!CE
M@ >#KPO7Y>[!PM4F'++$DLQHNG?$+U\9#.X]*=4:@HHFJ/3 )FU[IB #T6L9
MFJ/^/E$L;WJQ&#S0R[GM%G<\W[>YW%E^+7>[33 <A_&]*+Z&7*)A-+%+#UUR
MLK)4(*_F KJLX [76 ZUJL%(#L%1:LN*7+>^=\^W<6]=KS77>U?18B:_Z@\@
M5I>W)9O_:';=X)'9-_3D82=JD(94M^1JORTK'_*R8IW:X6[>K@K),AE=9JK>
MX@'71W6MUD\@<SLJVD&>O!%L2X:GY%RNC<?$>[4^V2?=-F:_72+\ZS61MO$-
M,!\:6NQPM-5]U ;;;5'=);X_NF=<MUG;.5#.6+PT^''ML#CE.SN].[IWVW4K
MV+'&+KK]CV]]M4IA<,P./2"0"!*4=#*%7'.1]>8;0=2S^$,!^R(4I$&69%%&
MX;K6>M&&^;@@!5JIP$5%95NX=V<C557CE?^5/LCSFW@K,>$@6X\@V 6 %0)Y
M,3JG<@R6[^&)(7>6%0QAA/.277CY17X6*ZYP\>4CX<OS%0LT/197!\K\FE:.
M6J9E 4#@>Q.I"411()FJA<G(^Y< 3E;0B1ZDLZK$6/^$9"*3H@9O&MKX@[)C
MATQWP=)?M3H>7ZKKN%#\)@1/#=I$:KL\27=P:H#O9!JI&*$\,X_NQG7(]*</
M*%9%8_#U.X11!2&,C2(;##K':]V2\NPV/RDKM P1+MS!):X]5K9W"H)??C.C
M>YL\ !VEU=WK=;E]'7=$IB"4#*"6Y@K@<^]7\/KAGDY?Z;+LTV@!GBZ7Z&=H
M7_+U*'H'.*A\_NI#Y/>Q5XSM^AH&JW5[3,H\ =+@4\5WX-&X!_XO\J^XV/3;
MV3I!"\F;Q,E3D%?GNP=(UUSD&1LED@<)9U_&11OE_;(/^<)C//])VQU$^VV\
MM]^B#2X\AG.W ;%/F<N:M'4B>)B  >S4-0FU/"L?OR48GB$GPL'Z/!W(#T1;
MU+^QVH$?V1%>Q,*G'V^^R"RO,/-A!=L^Z@F -%(AMLJY9]S,L[0*V<GYET](
M62/JOJ/*4(P)YD9@[J(Y?]Z"A,S>9),"$Q(SR"?NN'U(IJFS+-O#48"&IZQX
M-Z>BSOYA9<X<QO[[9&NZ+(!$,+(.O"L6S$R!SCY/RC-*%VF8R^6S&1GO5.%W
M#0&3*.MW#!\"H[/BU804X)EG&V+PIR,/XLO-0[=FE0A(\G*Q3&(-S7NWHN1#
MO)"2KKJZ;.;+W<&4,9(_@4LBXLMJJ\<9O*S[\'AEV'>+6AZJ6;O Z6,4].;>
MB/LP?V,V(S,-X;-NK1J1(X%/H*&-?X@#UYDDH"@(SC)7'(=F4 SFBC7'P6YC
M=HQ:@ V+6"-;&U&S T^4XN4BLNB.M3%@0\B%G3W=$$:-!!,L(9C19$UJJROV
M!!(Y:QD$,P(=_8,\_19]6B4R:(!_C0&#EXOT& K75AIZS(Y!'D'A 1AJ*PXE
MSFQ0T/MGSK-2LV$UP[Q/M)0OU_$'F&/$3HBV 8?NP^EA"C@"3C:CMCH42WK#
M;]L$<?7L0_4C2(,,L&%%UZ@>+P;&9)68X32LK_/[H6^Y11]#MFA4^GNFTJ^+
M,#;0U%:Y^!8R5MO+(=W3-2I[^?T%D'L8SM>E.;E])D#I,8K'HB?R";?HMRAC
MY)[,,E_M^^ D=: BWFY),=C)MW$3+7N5BT%)%9XO1V"]8(/O]1W@^['>_?=X
MZ97,$GY?TN#<M:"M5T '_9EVD#Q2T?9(H%OBKC'R>="^":<@@ C$ADXJ<G2]
MQ\O:-=.O_JX7#)5[/&:#Y=U28"2B!>B&*.K741RS_NH(LHGH7-J>Q3[#/YE1
M XR*P6LBF^@.&BJ+I&"OD X:^NZ\;/XE>+55*]QY.;V2RL"IU;1=R<O)Q03+
MLH.IE&X&G&\B$]A>Y!IU7&<,7%6Y5SK+F=F ._9";VE#T8S]SNGI.J#G[9%:
M,7@O^JUX=>652XH%H/6DYS2*D+[[0_QBP=84W,9%E4+$UD1W'H.1O?$4*X"T
M=P?^,*Q7-0HH >-_=1#V-PT)Y7MO0T+HQLBA.WV6=ZI -@&CRY+TE@)#-QOY
MKB%R+5H,D3RB\_75H(T^.& M.QUW1@80BT"8<C86Z]'T8O 4I(/]ZN(CB%9#
M9)-UO:,'-I D!)_VCOZN,=()P1)UF"@_E=;HL*BD>@4  U(+/2< AKKI3"HK
M"9C $ H^V#FE.&L!4@/NFX5IT(P4@>3&@90]'7^'\H?>S[P $YH5A?EXL<!+
MG0DXV&DHTCTS%(I35H?,8E4\'S#4/J?CAQ!H]ZGBXL>%1CK+6A!=MX%&H8>!
M[C:*_HY-80DTB!'A8RB<*Z1/]7/A VV1"^(Q\H(8US*3NOP0XSTXRV$1[YVG
M\ ??B/T!W&=_"Q., U%6<1?1@;#FQH#DFA#Q!;]H]K=C)1;R;S9C)A)??L:_
M603  @3'K5.?/\[^J#ESQH-9G3K^*?!^WA="OY#@8U>"WS3WV5+Q)^Y?*L.H
ME"^,RB^(Z9P:^*=NDG[T^_FI]%A0"7'^ /W0.G$(S'J!E89*.E :!0'5PDHQ
MIJV:#5FX8:Y[NI! PI]VXO^N@/'(KPC-VQ$! 4B*HRXP\?D_E!]+CIA^M^W2
M?L$8BH?CDJ'M./F?G5'G?EE9W;).XL&-<S:#-U[VO1"O/.*I.7KLN4M*U?!%
M%WP7&MZB>XX4TBSQ(/&MTS-,4/#ASJ]':2-Z=Q,4+VP;C>ZC/K4@9UJA^R-R
MMQ5U5G5;K:J'1ZO>:ZSXE^AMO\G#3EZKK:"54Y#FQ&)Y=/_F5RH]=[/M[7L\
M*UDQTE8^BE%/?GI=:-70+^-N&W.0C/(U)NMI$;!<W&X'HED<X:]]:>T_\K>(
M:+>H58F_587AP3[%[T7D\A_MGH+8/<,/I$5H;'&3BW+47['^^_@"QK!V\^5>
MZP-2C^68>YSW&6]SLQUJ5+R>FX64.^UP=W!WQR.S3--3BU53PRLX]OO=O9:+
M&#3?.'_O\B%%A>9:'T>-JZI5:&M/]U]:(M-_=7R9I>KHZ"9=1Z:YHZ.OE!V\
MP1#[Z<V)P,KHYS\_61=H'^FG'%1JS^E796^SUMJ<'F"O;IHO*2UW;7O^(9V1
ME,VO"Q3;'+32SCX*'Q2 _@:889=[CSF7W?U;RIZAE/M)71=T)5BFFC[;S46T
M%A\[Y?ZW9_4_\M^*YT3EF'WDN'6CQ;WKL:JM$OB70<2, J;KJ_P'J([>BH=Q
M4$_/NZEAK*@'K]LH/R,&6"/V[")CZL_Q]_<G?-M*O(WJ9^HVA45!),P;3ZY_
M^RAM)/&!GC['4M]RJYY></REN#-1=:*R8:V6GJ[-#=_O3.*X)-CLC==M\) Y
MN@Y%1X]9O[S@W'B5FRI3XK!34+*A74/2<U5Y+47RC<5AB;V[C>[Y6.*V=NN>
MKQYDWG=P?>6E&51UT;?18ZNM0L$>FM^^),>^7QUCR#DJA:%Q*?%)-X6U0@6*
M#JFK412[[(VM]_S=?TGQC_P%\AA;8W(1S)"[7A>*M;T2[:I<(K^GL^"6]!:V
M[!8,:L127+,RFY<?V:NJ5"%QMV/;A,-X'FZ4<GNXVHWK]*@K)X!\@\&[:%CD
M,$@>*-U7E8!!G7[8>25NO8K68_9->EZW5-9/CMVP0+O=W/;D@OA..NN4$7&;
MBP6VM%5U2RQ+6/B2CXL-&X%C*CRPL<EUD;GL^Z@&)?YU41/V^%'+3)KPIU4W
M*W6#05A$BZ?:-,CA__JW)/0YU1L!_=\$W&,'@8)'CS+^]B>'_BH1NB><<#K6
M89'0<YIH-<-7T%N,V;@92K#L%4*)0[%,?CSH1%^!!IRFFT$CE/>>D*2F@[B;
M+LJ<7;!#VB==IZZL.OT)1C#@QAGSN.?F@UAT>F2]\*<">SIVR0PS1LXK"ZZ1
M3E^ZF(*DTEET5BS_3BN$3F+/UA&.'EW/R%X,K8.HSUMOA!17 /0.4;H$IZPN
M.DV]S @XU;G*8)5A+#[Q0E%G=^A^DHG/BAU44. @P10FF$1QUC_P .FA%_DR
MX0S4/3LS@LJ:\8GF[ZN0^%KRVT)*Z+"L!195X9'N#.=W%&ZI>@MQ>-]OC%;M
MI,,0Q6Y9=L/TU>K8V9[>\[\5-(22#H1ZG& *@;$^JE%L?; ^V_%%TN&%548B
M/9 ;J2P2J9Y?+UDU38G^)),U_0QK?4>1U><7B'*T \C<C*T^V,4;2 V_8P/V
M1&8LJ7ZV*(W'JL/HP)JM8#CP6Z?/DNSLC%D_\F^_\S7./$V#3!]"(KZ%@8!.
MZP)0AKC59P[RD$! ((CL.O7I"@;U@_KU_ 5A[P<(5)BZ\MW2M'?Z9RO2*%C8
M0C7P_T1FZN;SJN0?KFO[U@A8JO!9(,GFQW;EG3^AU4(6O[-QVO73J9/^E]CX
M1\2<W8@?QB[[@*%#1:OY6;T <Z]3U_:J2[*#/LD\=^5EW:8(?HUR:_ITJ".O
M@C&\G']9#M1T*P[D&-7Y_2C#070TD$V A8CHL(A8L6@/]S^FX0K8T0,>33/C
MV2Q)R^+)L&M"^B;:'/!"SLW>!81@_:7BY;N$$M92&,2+:R#NJ4)<$\ZN2F[D
M3C_^Q._@_$=QBXUD-V!%A1>I?[Z>^)\(]2.H^?,RKV(K%D<P;QMV3?L\I"@
M_*?A'*T76G?SC_R?R=23?P-02P,$%     @ _8-_5IQX:."JK0  _P(!  L
M  !I;6%G93$R+FIP9^R\!5Q4V_8X?H9N1 :D0U 8$)%N&(/NAB%$Z2$$:1 <
M0%"';AQJB*%#&B1$D7;H#@.4E!($%)7_H-YX]]U[WWOW?N/W_WR^HPO.['/.
MWGOUVFNOS='DT2O@A)J2JA(  H$ *]P_X&@&N R0$!$1$Q&2$!,3DY*2D%&
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M/!>&A(8B@?AO2G;-F<EW!><6]$U>Z0!8I,Y-/M&WQ3! 29+.V'W'PVBUFF<
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MJ=@KQ]>FPUQ\5SY[P#+!X^=%OUR\EH1$N&/UH(&T[0C'L<L:S>IIO%,FM,C
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M&:YF[A=1YXEY7E=0GHF-ZF;$J_LP)VLQE;H]7:=W)O*:$L04/Y)&L6U>U *
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M<";0Z<HNS8;W[>V-VNL_J;3=A;]=(/8GD-<&KADGV$43.L=UD,=*97M$.SJ
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M]:OY%'%<K0E^\$\<RG08.":W/0J&HQ;V.[4CC\=!B?Q"?WLD#("0=&-65%$
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MX-Q%$V5T^.6'+!2HQ5UF:^&[(?AV+Q]Q!^\S6^(F)\F*=B<D2WP3?H[0+]M
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M'NKZL;</HJQS@TUQWEO UKK?>;Z,X/Q%!/#[]%L6D!?>NM4CP(/Q#8\;Y+,
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M-$)IH.6.#:C<"9T8V#AX=9*$W/1NU,HQ<S:%58;%(#,+@C$K_?\2$H6ZBC3
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M:F:7B_P/\>KJA.-I#1P3L,38\.)W2NK2_+;LAX+44D%6*P>E BQ<Z#;;S(B
MR9,%&T ( /^+9F8V0RBL\OGQ:R1I+U,S&&VX9N^-SDF&/I97_R$,E2VJB3!=
M(!U&'+ ]04B%7.>GW+\0[#A BL@A,M:5'.JE" Z+KGB:U]R6: +[KPN]%)%V
MZ&VP)TQ#3)M.'#N@()R;/(L/)C$-]XB@M_^O89^5?QXLY6_T1QN L.)5D.U
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M\O!\W&SF1I.D#A,X_=(YQLE>BW)S[5D/:):D)X3@\3=/J(VG%^H@08_-Z_$
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M7LIV?'EX*Q82:AG'+A F7TX54Z$?V=T:8@VL PG^1E\U'0>>/ELK@"OM0NU
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M&T_0<5]PP4K*L8,.G0/5)X6)N@&X#B3HMO?B"<KKF#3)T@-# 9?2"FZ20%0
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M:K*HNRP9@UE59XUHT\0Q&#$GJ/W8F'F^=7);XT<7X!LDRBZ9%O?S):R1QD
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M3U" AED^?+G%+R,-SR^@!([:3X9PTIB9\2.'RU<*\.:^/B_M>"O K"8K.VQ
M7C@:OSAL4=XWQ=8.G^*'1NMC3Z>T2>-[]W@>/W,V8$EHS9.M%9K5QU)\I%:(
M4.5[P+RMM2Q0+QLQ7H1<D,E[>&EG'V-)!/SV9.AIK)[?GC+S3=.$IFZ9>P')
M"3JH7] R?6Y\@F#,\HH>M&0D'.^[7*V&?7B2R_]M$;N016)Z00 T<C@+]@YP
MK):UB)@_I3[%-[CB#['8ME'0G'+8><_": .B-U/TKU R*8-$:ORLO4;B>[UM
MT-6IARJF00:SCWU'/$XHL[/:#Y0>5\R]=<7*A[UGX9:C <CB!&^74-$.+SW0
M\$S5@2GL;#..G^.EZR(.91ERI]A,/2^IHCI, :D#P3*MVFB^[2V?3.V#;^6^
MI&A8&B-Q?4"!FN]WUDCDX/9 %(/(FN;NTMN8_)4H4YR*@<8+:-18;;N8B7!@
MCZUL'$5../H2K[+:Z88!J<$V1=N(-5F).U4?0V\X$U6K+^T.[-/WY^@?='O,
MF\+)=702=WGO96S56>[T6IN)>N=!_Z-G'Q .9]Y^&KVU@ TTHYR\,)>,2,KK
M/TG7[B4&=*[]G0$^= RDJ?=/V"Y8-E]^FA*P-KS-K;VK;K5)1+GX9A:\]+[.
M-8LP*[FN_%X<]X7#K\V(K6&?3!WI^7X2B5ZE^ LKJ*T"C2C4%C&*/#=O!0\9
M%X@4BCX_KR&LX OCOQ\FS($N7#D*M5$2]"F2N%;A#S=17LME6S1V_J;+??O;
M$'SK@M# X.)-^+V;?E5]D@SSDS4B4*NK)83).3>B0/EF>^(ZH81G<<>>Z4U
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MF2U3$W_D0?(''F 0M<1?4F8)^88NEU++\FN.F&S_AGS0[]B&?F.9\JU"\ET
M@9#&?ZQ EI:)IWQS>1$J]:^ <'L7['YIB&:H;1EQDXU2[DI%B(TF01KUQ"L1
MA$H^PICWWW@0$. [HC0&PNV0@&YU;=YP;@N&2,]H?N/]MV6>OP"YE,3?"?U[
M%28@G,:<W;Y_4 S;$.GW! %]HL[ \PLB?S\I*G\P_QLZ &,.L$'P-]10D#L'
M4[ES81"+3980H#MK_GG,9N9W  H<!MF0&P@%0N%XO^E %L>O^O\10!$_%@QS
M"[[I&@,+'-X/O07\61%^41 $@31$?S1B2XBZ!>.)#<-"L-\S(PS4FN.;129"
M-2'JHBR:&(1*:2+<*_^[\O]17K^L8?Y4Y:,RQZ3]QH' ?V/QV^48Q)5^3Y.8
MP& !I!+)M 5FD^T AHC-< QA6S"HA,8D4N#POE^JAM)O/%5A*> [QI&/8TC;
M[A:4(7UM%BM+*YL?L5LSI<NT%CL>B#JPAA4^L(%(-9%A1(3OSSL3<BEP)'.^
MF;@,C7^D'@I";M2/I'_B!\3\S79&>,@*LX*H 7+A_0=O;0=28)["& 2483?]
MD$0HDT($2&6$@Z%J6.9\&#-8MK7CA:HP?0#T!_>B_9-B,GQ$SH\"_5$0ZL8,
M1!O%VAW,*K(H"PBE0F"Q@@ '?BEZZC>?22BO^*55[@<0E/)S@+>.(8Z7 :DZ
M7B80H"/?!CL(J&H0TVVO?AMENQ)KOR7#HS&8UOZ]H?S:4;A\9Q6!UW]'US?>
MEOQ88O[7 10!<F''8S8294]F(=I81'(&O%T)E)B*#?^AV,Z8#\H/)4'/'R>5
M*=T,W$]&Q1A$@_'EI^K@AH@M?Z>YC!:ES/JV)=,F?ZHQ_DISF!3\,,KY?(P3
M$TWJQC",KK][7<041EXBXPG^!UW9H("',9LN&S/,+*!K__C"0.V[9L3H4.ZY
M8:<,O#^NKS6_PL-4(V.F9F[PS\#C,,(4UX;^[&4V_QG9KXR)H;B@C4?(7W#R
M2SG^W2AA@^ -H;S\%R?%?Z$,_6M(_8^_I/S/@KPV@&+/TKTO-:/MYU  ] ?Q
MX>_CQ?^+Y?\O@CB14"#7524\W]!.PXA)Y.9E89_ONG7$R9OF';^2>--F4K7E
MZJ&6;H?8_FMD#3 ;FY5KRHDR$NF"G>EDXLZ5BNC48D<],/L]!.'8'LLV''*<
M70)1R7'+4Z_:\[F=/!*/=>$%A(M7#4S4>.<X^- 5[-,P'&'^OOD-970%92*9
M>^? D;:*/O<K$*VH\D<@OG#@Q!3V*&LJRW9@>Q9X+T.(#KYV(/8GV A6!*C$
MLY*SF[$ @GANX3CP^.73N[ JF\[#;"9!-Y ]*JQ0$$NW.@#H8"N'$+4S0XIT
M(8EIMV SO)Q6$+"[!'R$T:>H&;Z5-5$6 IGA&[S>9BR(QVL1<=;\ "M+[.E7
M0-ZSBQA!!. :Q/@"[V=^W1Y\XG9\Z3*MSP]FO 7FF#Z6L4(*J>OKN]4 46A$
M>B=A 0A5MN.XJ2QW=37,"XSJE4-5[RKB6K72!L5#,"E*SE(.A5.)HIB4BDWT
M+'<0CH=(O(L;;.MDD)%5#[RC F39+B*6*W%8PXYMEO@0Y^#[ @)PP5?'D>/0
MD (PP JBA!*_C0&$BW"-;=6.*T5NRNF'I9@0EL\@61&JBAILVFUAA-7RXSM@
M,)ZDRNADX*TX$<&2EG:+6GZ /@94\\2.=3K]=M6#D"K](25:3H26L<33I/*:
MV9W))=0P"VX<CPHQ;9Y2K8(&G,=8I_D6'&5-W(8ON,QF<ER%9<4^$N-]'X#C
MT;)R0"S9O45UG<CL&VC>JE+U%8 ZC#A,(6LHXTNW\J)./#46'A0(M5FF%P1M
MU<4AB\/**]1.[@:-XO;WV^S@D,N2 ,0![\@!>PU#,0 L!GD<1?N7VQI<R H"
M4&+X_1^6=D:P:.4)I.3:%?RX]N>Z<_QAVO0O@,+RB@$,>P'#C<N?WHBW?EBV
MOI]C^(=5PC4Z<7SI4&^I \,\5?.V+8G>'DFQ_C/R(EV/WR=$*Q]#M *>/QTB
MF+](/^:RP#?RH>KF)T5EHX@Z-Z32CF!(XE F?,=%M/)5O1ZTQ<I RD!9K/T@
M4!-/&4LRH3.F)Q!H%%/36YDOK7II#13ZSD:N01^=#EIP]FS>$3-D$98LB^X_
MV5F'WI&DZ-2>HHA]9'M53;1G=XTNF2"K0CB(U_(B/7(/M'<B2#G93%HJ9%U\
M&&<%D]/@;-E+MAGJ>N1?TS)H/:I;$YLIN%7Y16GV_8?(\#,3[]+#QCQ:&J+!
M63>D5!]'4.3Z,;M,K2GIKB<L2).E,CMMQB.=1-9*GLFQN=P\DF73-ZAM9=HW
MM23<-5GY97!97^(Y9=U<MQ-\D[](10K>HG1WZX@T:E@"E[%[=,Y1H7$O.K^,
M+7H'0%M@#/CJA%,UR(:V?DRHNFFR=N?;#M.P@X*(FY6CELT^$H&G,]Y*.T"Y
MP,%@0.N"0$=_KH":U<M3&&<AU*I=F5[-@SJA'9[+L$/&;1;BM?YVC2$"+)6!
M[*BNJ78G([!MX-3IW-5: 2N0:R]GW=S:;GDI";?2D"M]3^D'DLEN&<\>!DRW
M3.SK/R?.>57-+0[G,'*BXM2Q]MW^V6*5-5&(\IA3I#*8:^$[+-&>7IKI!O &
M%R:P!1E($/.[TY[TUP_L&7?F*A[86:]%KQ<7"TZVR&Z,'6AVG[N <)#"GCPF
MC']7DQ30HR_QL/5*<#';?L^,U"_"A)X]CJ>76#MUP;=307MF.*D!@5)9W-KN
MD>;. I73>Q!8&ZL'[M-5KG-W <'P21?I7,.[S]/&;VX^-T[6D16N#KY:'^[&
M)7@+S%]2\N(>9^J6A^'WG"8+.4DWB"8+!R2"-05 Y^?\!K "WF9W[!]/DKMC
M7[N.Q9?8K9"Y&AZI''EH''ZH4KSB1JW.*G%FT$*\W=OC0/])#:2 MR4U[MYK
MQW&USW=#W4T?=DXLV%I?];J=[A(JDQ*X<[5[ZY9 4X>PT4UFJNWW@_:C2I?%
MST]DS6#1$SF3N'QA'_ V'4))GL[VS8<\\EX[G%X^-N_O:Z/6+:U:AEQW*P<?
M;TV-</X \*USGU<0:_(EFE1^.#&%ITWY)M;NA?GNS=WYZ6#5W2"B_)*&=_I0
MSV,7R^O%$D=++LH?:2OWY8KSJTJI#T541^GXMES<W9]MW%:;%'@S_.!#[F/@
M8-8<[)VB=FB-V7R.2Z/76<#PELBC2LMMY<T>,_['IL(3ILBZX<$J"QZQ1U%*
MYIQ7_;E=/#T'O,VMUL@+=(91Y(IW(YJH]WFMBO@7!HHXO2RK/_B1%:(*O9]0
MG6AA=/<G$C.5EW,B38TSQHR 99&DFTU.)FVU I-C-D\\ARW]*J^H;), BW0?
M7I0JH53:W8MQT>Z^4[XO<!=RS@*LMN^JPCRZZ=.VU)NO':T6]5IN@=/7N)8;
MDO>+]-2M1UDT<Q9^KJ;,@"_YE6L"LM#K<\K'H-Z09O"AB?G0*CZ&JDDG95+Y
M T+-<"45F,-!\532L>!F9Z-C/),<0>.FIX%4Z0?'@NN=XCIPG-'56DI.#:\\
MMPT^VMD9="R5+=DU/E0\- >1<&1'2[O3NM*H/JS>O<4/)#9-[B5Q;\UQQ)U%
M5GT\?4V_!*01U!Y[25CUYF2U3HF<LYQOB]H#KF5]&6K0[>ZAI#;\1XZ>B56[
M^J!N'YLI,)\9ZOSMCF&IE=J0J:Z'9Y,AM]_ILTP1,JL=;)\!)]Y5YV-OFY;P
M'^T^JMK5-S@MX#V@?MTN9[,6G3)N]UCTB7_/2K7>'I+<<' @VAH@9-FIA[D0
M65DL42= \#; 4B,]C><<!@_N&LM;E5[//TA-*J;Q3QE72E:U=F#O"W(V5 Y>
M2C#=GU\:6IYZUR03<5.T?MMK]_3RY/P._F-NJ)<X*<=0?BT8U2"2>,%N0FX:
M%ZL0:Z](59.;.M5VI:SIZL.P!Q<MC%N4BHYQRM=,.+'V9ZD.-.>\<KJV!#>S
MF(#4I= /3]7N<KB2I7?+$!VGT+.?TP07>)&"G7^I#"[\"N#9G=+XJBH4891K
MQN_9FGL)V<,ONEVK/^RSC[NG;U-9SG'.9AO.B;QA!G>\3SD4:E-F"9SY2:=_
M"LH*R\N/\X*TK'Z1[6E!M@+P.=J46M8MQMKAA%+N<$;&U?%7JY_?,I7\'U(3
M0V-&^IS%6"2!KWZL+_ZNR/>]%.L/@;"#0QUV+1>GS:)WT63AX!8E_6%P<$S;
MQP%^D\9GVBS]K;<%5MJO6;\=ZK:,>M_CO^^9 _(K ).X]Q*U_?-3BZ"I>Y,B
M,WZ'CWQ*(.\S1$TT'Z,G[GW1XA3$[^K$[JSL'=%CHG25N^(#)Y)UT**:1DM
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MB)"45RFF+7*EJG'L;JC0<CRU6IKF%HKMFC5O/+ TMY0T5K3S OO%8+LN$EZ
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MDNK[H="]9MJ+4F0X/S7>U21%GQI+&BM1-R^WW5$(%=;KH%R8S-]KJ35YU32
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MK[(_TJME0N63H=P\)K;@JJ2GV4?C4^(JK>RY@PT8ESACBPAN?4;V4GTP9Z\
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M>2ZC("+_A<FH_WK?="KOA06!AK-?:%M6!G9KMD05EIXM.*8M#6."J82RJ_\
MG_G?BO0JOPSRLEPCNA@QK^."4_)<55@0H:_/V3<P2Y/;V%C0N(8H-.ZI2: J
MIVC/7O*;2<+QZ;H!?P;Q3@_2\F%T"2T>U,.?>M-D*;[KON=Q*.AV]U-S2 -<
M!Y$0P0T+:XA#:H&:KN3N2&?MM%B8?"!7NDD!J8:+PWGK9AP.7^M(HSEQ+7-%
M:+P7VZ+L%ENY '5YC]<[I1"[!,H.?E9VC/\-F+;%K%F)>#=W2A0?:X=5(_W0
M/$OA!0!&MBZWS9%E/,=U9N8#+";CH&![ROMOO#73U487Z&=BUF-O;,?[%.CO
M"7'10 J]&2K_ZK1!OI_*!4=J[%JNO68_\3 .+84^] ^0-?Y-6%QK]2!3[U">
M-!8#N#LDC_"EQ#-S$[#LT():"2U3R=[__)&17UFT2*3B8)B0D?I]'+MQ)1O?
M'K2>LQ)YYP- 3MFEAU*B-8H^P][8!7U3I+7#ONP-,^O;#4_!.X*N&/(<5(*+
M"0JMO@T!D=V>39I!%KY'ER*%>^1I5G4%>'L+IZV.!@&TQ5F:.*>S2<B0A5(A
MOM>BH#@GXI?6QO]V8,G:UQ$@;6@,:PY,9 :N61LZA.IC'#U,NJ,U;M#GE\:)
M1UGQQ: _$?60F)I*@>+^8HK"83(SG#AWY:"@6V1N$VU@P&U/!KBS5NAUVRU'
M[G:EY=J9'-!)GQ7W><;[#<)WHG-&E>!;,7?(KF"AKJVWI-HVOZCCN1YVT)S@
M!M2+HA6=RO7U T<+#NF2)V.H,7X8._7C1ZV19U5Z\QZC(+80@K8D@ZIY[$M+
MIW\[@EH<_EP+\-ZP KN,5ZXOL!4N3MT1]/FI$_<=V['C<PVN24Q-$(2W"GBH
MJO@?B]*?'Z'^HV8L)9+'?'VW-1,-&/B\PY5&P=NQ8/W5+"5X0SK^QO8EM(.V
MH%P/1><PA>,6NA>JSRH$2<'RO&6EUA0>+4+SR8/ZQ9?K7X9E"='.FP?:Q\8+
MZMF Q^$7[170#9J$V7@-96?6V@[+;^\XBO_-(LA?7SN=!T!/"S$2P\UN%.S,
MTXAL%CYBQ"KZ[F52)].@Y3$;<.>I%6CMEPOT8Z]HZF<FBMT-MY)?1+YVT,EG
MHS"C^[0[_MK^W6=PV0<,\RVU[.3/\A5#WR\M+OS;(/5$F+%QJ,@6]0RG)?$*
MM93.%W87O?J(\^LO QRN+]#<!17?8%6?35.GU:ZVI?6Y1/7><$: [' 9APR1
M=](/]WR]S?%A;ZE&^3*_DS58X2*=YWJT%57AC\,7^;JR'&M"+[!45YDMY]1B
MPEQ\J7&T ;:_"5&VF-%@[N24X%X5Q2COWG:![5FMD%I^RS\<_4;O$NO[B'>A
MA+49U)N5![\)<% [Q%X<HL[?@8[_]^;C'XJ$#'%"7"49\)QL&T%N"9V[$1VB
M=;Y;D^;A]:90Y@<M8X1Z'CBHMU*'',DFKYE] ((@G"HQ]:# XA-;1X##23,V
M0O-@>/0$7>P3 <;,9K$9BOO\2)F#VYUM1BVHU=:61/"9=!LWL?[4!8NAX^S>
M QE0<>#6^YM88V<;SJ%MK97#+!!=,E);RGF,VAE[RQ)"$-6SW2NUS-<FP:?P
M2#22[-&Q,WV/E'3[]?P@6)V4EX33FB>*[6\82 %7.VWV5^H!_P;8=_%,J( 9
M5WON;4#LTNK%"THAR$AO&ILS1-$V7U.!1,O8SB;@ALD4:.24WTHZHA$YSY\@
MWDWY@7]9L^DOL@)9V&'(]O8''$A48'W;@&%>:!+6-\K.AIKLM'8\OZ"%:<Y_
M(O9+6U#^90!)%(D0#AHG.53/HQ918E#RB\=S9R\',WG0M*&4:]=QTXE:/N:,
M_9554&"*]IJI9&G;]_G$D5-I"VPOFZ=$KND5BNSX:E@67A02HO&"KZ4;-_&U
M=+NPO,A.8T_KI1F=SD-G5;_.H1B'78*4TFH28Y4"8L]?VGTJOYC6Y.(KQ[SA
M.WS<Y6$,_O8]J8V7>=BN$XYXZ<9",,O_?J54U$(I'/*8$AKJ+#TW9=7FY-S#
M:_XTD/$02Y4LHA 9#@;/Z<SM#)13YILL #!H<W:2X]SWFH@1*!9C,OR6FE,^
MUDE!+I>%OHL5[IE=#+G$+TL@)OZ!JT)=&UHD.$<%3(<(I$[7-3SXZ?C/WR*<
MS_!R]TB^Z7/9Y:;40^U15>:DR[12UFXO5W. >#TDZ(]Q=S^GQ*>DAVQ7*J<"
M@ZO8B@ZZ6L451U;Y,*AU6OY29^5W0$_K:O; N?BUI>2.9#^Z."@OP%&Z8DFO
MJ%2$L1,N+_^Z+4D>S2</9]I<UF5!4#+W-IE@_W/)][\;QUL+:[(Z_)*$**H'
M#2)+;2CP.:K,4W$'!4WW"WHU6E"++9E.O?ES.R0^!;F[(]="W$H;OJ]F5]<M
MIQ67'HC$SGM+.3A4U!ZB [&94YM3-D?0?PZFF.)U=,'I<^"S2>U'I E2\'GA
MD<:T=K'GKB=+<>"D36G.^Q("]"O6C&PYP<)@S;\F),MS M-&_B_*.W\2D(AW
M3J+WD&0TSZ+$C[+*<A=\O+$!8O)G+02)'Y.%57^Z@"]8"VH$)P?^IPC?WR-'
M[Y 4WM-LN:$&16<HH3-RQ/IZ7J&-80AW7FFY<[ P^5J*Q]F5U&-RR'RR3HIA
MGK>')#F2642"\FE)]^KLE4E6'5T$AU4X))Q1+DP7(S)%$)PY;@QJAG0((UL7
MA$I>BEJ"LY8DS757\!844G3:0LPM]*,HS7GIUS*%TH<$^2F\$I;.71T7'?#2
M+#?9!'W&0!649F01P>;+3^+G:"7\C/PK/]6Q%3 \@9DPUVNVQ GOU8?>5<_K
M*6N**"X86X?9)1]G[[L>"_(/O@.3*R[@.30'G"@[GHH-#F"7):0 K3[$6K5^
MVD&<&A">DPU_:8?7SO=2ADM4L3P6=R9P:7O@"\:&;^J0LM ;?+BZE)LQMBL:
M<]+*2%?7BWLI^PK;KJ^1"$NK *FO/FV]G/5ZF(Q0]N7_>"I[KEFH>T+WA,X)
M'8JLWY5<,5UXCB(M^(001>96]JWLF]DWZ>!/?Q"6J\Z-N.B7/C!&VY/"!1"8
MI$UCFLNENX.A()WG5+9>GR,-==&/?C+E, %@K<@-R1_-*,V;9/D]<WETR#&#
M"G!RA4Y%Z>UZU[I=>1RD&AFQWHE<H::(!:]OVH:A[C]E3PQ%22X9<-SW@G1U
ME?C.)!Y@>#,:XU;NL':[HPO_LF];AG"#+8/-H"'<ISX((:J8;J$6:)KT*BRX
MLGE[';_7UT^B)):&;AJ#'U FO?<$IB<" @-TO1SG];1*/8$6+C2BB\@%:U[H
M<1J5O8X$;\RM!5P"8BY((>QM>&KG/9X@"@^^1,DLKLJ5YKK86$:V=TG 0/N:
MO-.A/R372Q)!\R:0&N_BS&+P$6% YRGHJNJS#-Y\:1CHP<R4 \H_?]"[/71F
ML&U]%G^DNJ^FQA:"V1Q,!!$\\$=WP>57M1XI@8$N[4$\UH$8W'B">"P#!3K2
M$6Q]N+0BMGF(HJC>F#/1TW9P,_3ARHQF<%P5])@.R=X->HS_./E QT[[-GDU
MW$[1R&9(JJDVKNJ,K\-*2]D>32-O&RL<2FK)0'7A-Z926$*17Q&7LX<^'UW%
M0S_9=R_?4 LWL7Z(HO+[B;U$:^W/'&PCK&H&RH9.YG UN53+PP@@*THY2AFM
MC :4HXQ\^5V"#AZ# K&!\GO2N8CZ)(?7573AHV4D_J!$@TE3]P[@Y:I9FTNM
MO8<HRBL:LV\Q%_?A)\* B&3^3QA_WNZLH^U-6G9Z8&S3XCXLZ-+Q24?;_M/5
M5HZHQ4V;"'EM*8:%0:^R#,0/7E'(8E#DI.[P"(MO5#EOK' V:LPO*_V6/C^L
M89_C$E3OL$H22B3S-KS?07.MI /93 7*?T9#.O0#H)/6/- ,3O6@>HX?DX;O
MJP$L3T&/Z?-[U[K*D"ZRDW[#ZI39"2K@G\DSO943L9Z_3/S1I_'?D8FP>DD,
M8&C70&($A3@L#L$L&J,!CCJ0^3K$M=NQI3X4I2&L@-"8:P>PX(T]K9PJ*)_2
MIF<L\Q*CZWR&B!Q=K)QK$(7R QXCOFGZB@H<&!APPA9CW,)=7IIKYH:@EC:L
M@;]9E"+R2GRKD>E%F)"MIBER_T6X\Y67J(6?K>JQ&$D"L?J8(-KL,ZR/<+B^
M('\4@;_QV60(,L.J&K%FY?Z8M^3ZI?+<-N?;(83OF)HPL*0VTL4A)>R:JH/F
MMZEZSB_:G_=3_#;T#MN/N3UV]/I.^'1^X8$ I?D[Y?+4R;M3#?Q0N@%;]%)X
MH?)^S[7#2O872ED3^9I!SIK9"*JB/#,-IQ 73;E,9P<B6/G%0$Z ^AN9AW'M
M-:RF6$-D<J+8"OJ"(R\5Y%A1-LV[R(:C]_U"G,YU)(>@9(0+!KX)P-]^- #0
M!D9M>O0\_6@4.O_B>!=F#KTN=U9\#;R;:AD<0PLI<+W2I,0!$3X ..OH>A>]
M@,(SE]UJ+NZQVJWG\;)KM>=W/&#/VI'[[Y#6W_(I,M2C-X75E,NC5;F@UA#!
M#EIO5W>>W^&_FCHX>O+879O<ACJ)9N&"+'@[)61V\K?4DUT% >GMX4L7K[]K
MM8N9':5UI),]M.H>#W"5'SM:6M59FU.V58[\B-:]?UUMP+UZW<=&=,GS&*OX
M"GFR=I57Y_H#'HY]*];P@/#SIR!W:2V.)S>GRFEJ^9E>^'QRG(&0D21D5\T0
M\^VU463;G<R<JMZO-:+:07'[T/HO-G<\P^QV];Y13+:#VV> .SE%12S9OF81
M=^4\KB[&D*Q^@L E#L2;D$HN2-,ERUK[*B-;-Z7YE2*X/L(!N]=&HQ:"9W,2
M=H$6C;T.ZDBMQ#JD)S2+K-L3^;1'_IQDKMJ^)63N8-+%PT(%.6=4@Y)!S-5I
MYPAL$^;P@T/1S?NNEI]+B0]!+>85VYZC8.876ULYNN$)C;S6:-\U<E?H"^[O
MV&(59%,<VS#0*(*\=M]RY$W',/"*!CPDA*L._QE%__=*M.#-MA9*3*7*@ZKX
MDHB95TX)SY@*D"4<G\XA"B<[Q4 \D0K4U[;=JJXKRF:83/9?D !W'R\<MJW;
M[N8FF[S=I4Q"6T>$I3U["R$K?*FA82''AV(TOU?#;7,66<%3>F/RD@6[?:%O
MZ<OBVT'FZU"J\ZEW+K9)U$+"9*$[E)-!C=>SC<^'N+^5;N SO1\*ART!.F36
M-IY#%N%\Q4TXO)=J:_*TX)OAD'-.4N54>W'@MKZHS"$I!T^#D#Z7M_ U&V!@
MX8<8V,2R\\N.J"HZW;?Z502$M0,$T)8Z$Q*Y[ Z2%G[ELD(>F,$HUT8N-'Q3
MF&B_R!\!VB"5I,-<]"9'HZ#H7B]* >&L?@$22MO5$_,@DU*)WE@6\X IL3 2
MI?V;512M7U;V<M6\ZHD %[ZB;K3\[/MOUY%[(JVQ)H2GYT_8ZI^P!9X\M&L<
M=OX E+E_C2K.)H[S?^D2WZ_;)D\),+.$R$)GK0B %(]5N6QXF^6WDMK#K!NG
M2SJ'.400JJ63H5'=#[HWP/A?26@=-]BW5RC?(KOL4HBGBPA+P8H%X,K/OZ8T
M%H[[S/)L9@.105E.3'B;,R%VID:3#!-*X99XUQ7="&N]S@J#IO-;#CW&'&MJ
M'\V!GU (".6/$-Q*,3K)7#3!)7<1TD*XQ%'E9*_9&%+4-002/'^RDW'!TGQM
MGR10 >O\WI/JVO1#-RD)&-VGW/_JT(IU_*NE7.8>K?(/0UZ.H06^35W. J6X
MNSQL^()4D_KS.^'QD7=)^?<XQ7N++NR06?I"ZV$K935)\CN\&=NNN@N?4U:Z
MN3W$9G^0;88X\#A<VWQC:%SG/N.,(3-*@-^87<2*[VM'N*FQNO-7#Z/$2%'K
M\AJ1C$H\Z %'M35[HR(.F0".=NC#R<? !SKRD NN;>\,YS$IWVC*/LK<'$P"
M=5JL"7_F&$.KYXRAY'@!W,QL! CY5VV+7Q1XO,!8_IGA W#X5$[M@P(+A+X@
MM^;'*?+?!B7^Z[Z,N+B&ZG4^3C':!487/@3@$>1>M D5*-ZQ?&4*=+ 2_92_
M#X#THZVQ\N%0T.)*RQ%-TS*K,Q=<B'315.B6 TQ G/#EWYR_&DR&(/CH#\@C
MD4K(K+,5ZT]-S*I;HX]9C]^1.W6N_!@%-X<,8_^/OQ<"#_POE(#/.=EGBZ%P
M\'ZI__Z7_O\D\$L%AZK.ECM\;',7)+)(G/:!B:'5$!6K= !\*[[M(Z% M@17
M 2GH"(02@8."T<?G(RW!T^^]#5I&<!)(9YJ@9FR3TU%KZMKJ&C,A1HFI!7U\
MM5V0C%U;3" $_=*IGZS_L^AD8V?[8^M,1M_O>=443_K19#YU\93+E\GBRU&"
M!M6UM03_"YRA[^E.%PNR9/SBOFD4_^(=F$H/-!4&A1:D+6/T_2*:%S\S)=/3
M(&A"?6K(,W_9V/%O820F":;S&(6#0\L ,TQSJ@,*'\D7DDB1GA[0U'-^JQ-H
M?<YFZHGZL9LSNLY/,_ K17^J[PZ_?<KT$^!%>G;\"5SK"GWW!V&D_.%)S&-0
M">E ,KX%0^<_C#8S9W#@E_T4Y,=)$.A\@G/]6*&I=<;C6[%U<")CZOMO?YP6
MW,_5?_C"K"I_M=M0ZGP5!L+D*>6OQ1PA$&P)UM[\E5PGF%Q!M)"M[/SI A_\
M^9XZF:C.5Z,%?"=-X%A+F";V9(Y /(D5PMG96/^TU,DX.X'YNP D*)=6 H%R
MDJ>(',5_:+. 6*;7F#]&#:%?)K6P$:SCQY5(6P(<(1B=ZLQ,V,I"M-6U5X"F
MSM].\T_,],#Y;27SO^8(""J'WRWTSQ-R\%=O"P#[(VL^_Q[4;^(:^/,)Y5#@
MNG"RO@BB>0D.LR5YQ$O-D*[8YB&_2!Z(^OUF\%/ZZ[.49$YR!4SP(GUZC+^,
MSIGR>_,Y1_;/JZ;QR&P81PE%+6E!_<'-YB22*!V0)Z#@I,^BZ'\*7&9>\D\F
M _A_.+H=B*.Q3,XJ1F% N]ZB%0YY7;H\SS]5)=/\@7KE!L6OPVU7C"EI/+)\
MY'%G<D5G?>&)V[1]N$#3N*_#)F3O&Q^_FA1<O/F[XKO?/Q[+74T=75<U^71@
M^YB2"2G4X^&DNO[A[!.WLRZMK#!M,#4VVEP=?WA9'+7N W"0VO,!6#0YO/^1
M6N7[;R:'=Z7<VCE$O:JL5JERS=1XX1'VY8N"ZT.7AR*JB]!W1^]G+[S-MLBW
M6FT.=SMJW<+(=@-+4/<B-A<>XV^+_Z#C>!I$$)'9*["[X8.@  </ILT$B#-Y
M<S_C\K\:<;N+2>3:MM%#)RH0PGZY!>R+&%[$"W8_O;AN@RFWN]#\Q(& AG,5
ME;17IT*>/2.L.$I^$AK:OS(MLTSE=J$.VV!R''FKR^#T 0)G,^2E>\.*D<"H
M2WN&U9C?8^I#AN0;W4LR_(JL]NIE=%(SKW7MK;BM5WO9F/A5]N0..Z7NJ@:T
MW9-E<0,N68WI<4L]SKG)Y\0//39]MO")LV_-5L+!+91[//$CE?J=;[TN[VO?
M-5)V3=>C Q0F[H],CPJIMA8^56J^VF,OZ_$'(/7P6$%V@Z2[LO?DLQ/M;J]#
M:'>B/0>5(MMKK%TW[,3<96:>>H+L?5IY0LVC]!S\FXYR/57D,V/G,R>#SKDU
MB4+CF\1"Y ?>%N*:Y*L/M9?H/V%MDLZMK-T&D\[*M:O)I%WQQ"J_T1PY]L,(
MKZ$A/UTA?WZTFS_.PS^XX#4YYOL.B((/BM0W5,H^MZ^^D_,X:1EE)2-!L;7Y
M2\98@)7>4O.U^QP[3^=M&LP?JIY8/;^2 #S-KE[H<O*[XMW=?0.AA):;WU]L
MAIQ>*:ZYL$(HLL,H9\5)W/5$(A@7!.2WHNJ1":/G#]5V-1#!;JSYV-IF*8O1
M=7<(^ M/A0;VH&@EZCSL@8>TFE(?BH8(@D/Q<M*[.9A#%+(,AKD*EPRVQ_?K
M.1R8?,(&@EJ<SY[9^\QNQ14K I >;EPN_XWPLTW4L9 &$D?XD&6K5P<IZ#PU
M6WV8MPY4QJ:%^YI%VG")V0>J-9ABL+QN9Z41TPU11"&NE'RCZ#,+:^ 9:@G.
M2?VBV /&"6Q/" UH9Q1H-Z"7>VZK!3P8Y9=Z]#ISXI_LCP0JT:Z).QCY-_9S
MWM 7V&J9:/7^,-)M4T-19U!)AG01)S^4I&;1M^[K.J1K)VJ:A>\902M.0QYM
MHU:U>8>BEK8X7>K4Z\RJE'N)DLYG%5SH\0YUPKQ:304Z%]#"\;$[.KQ9P"ZB
MD'D[V"UIRZ%]?D7UP4J1S9 :S>4:$*LGS1 :*=!)>8^42P"#\QSR$N$OI6HD
M=62UY+OFV,?!C#H/1N$-_9;.LS);QBFU:&>W,;P<RF.(HL'(5RB2=Z[F\4=2
M&#$9GA-5.-1 %!J$MN^H1XQ\:6;^6="L[1[JO93B<QK6*P<%/;ZDR_%?$K)%
M)?\^0B;PWLNMV+V';<8>[=/![+US9-]: ]J VF0AD6/7_*@H7#JNC]9FG/.H
MLSR(\]6QW:9PJ<T6AB,+PN!:2_.+=Y;?)F7CU6HZUS&[GI+2-<:11=MM6A9L
MIC>2@SN[JK0]7C.OYR$>2]1&LYV:CX\5#$2-1%<LO\#V>9ZQ&_$FWO$NTI9H
MWXMQ+HUKOQD^] 9Y<''=L,N.BW4]S0-'J_/>'C4@!!)V%<6 :TVT!R1<,C,O
M7)"@\FZL59(YS+X*-3RW,1Y_WFNA[>.P "N%O<5-AK+WHZD-@;OU)A\/R9<K
MTN,Q:/4,2A(UFI$<)ER6I*WVK<'0JK[.P)J!(WLUF%F=_B(Q;J'#Y:G?YY1%
MTI:U?D?%AR2Y,#J8R?&8;==9]NXO:-UMXZ?W2+#]MUF&O5O!UM#SM+>@UK>N
MHBW2U6(<7P-?NV2U0"?X8AL*)I1KG!#7+*R<7YU\U[#I48W\J Z[/CXE\X<,
MYCA=XMF*;7'4;O2UL(3N>4\UVZR.?$>7Z'("8^(H)/]XS'7JN<&;6<D@/_,%
MKFN7-D+'J>:6:.*5G2D#6&'KGER66[R'<_6HI:$4[94UNXZ^("#"[*5KM'#)
MCLFZ $)/J6(S)';822?>B7HITMD][?5A*"AFE585S8>22TTE^O8$:R(K3ZVG
M M42@U;0&R^VDI[A+8+N#3B="SC92EFS9<A"PXBMH.&W'/$!*%DPP=U242$:
MB0O6>!US#HEW]^TEZ# E-;,+I7.#1=G).N1UA4GB(2Y.^CW.Z_+DVE]92ZS+
M]''V,<KK[QC<=IM,XG3ZF6IO1%QWO-HLS#I/?P[9\E7L6K_RT55=(2<)A3N3
MK_ [%Q*JMLLHEW!!F@T/!#V!FOESQNEBCVX06!%::H;LO8^N=KBG>T[T4]9P
MZU-?$G8[W+(D@WSV/4AA!P0NDH2!VL!EY1IQ2>YQ%"H+H?@-3.B@D00D\/ZY
M1DVFR^03J;.RW55TD8Z 6$W#0J3B$5FL\*K1))X3(%-8F:#OT.*\1,P@C+Y@
M_EX*T-K;B#/,=<^FZ.$]ZFMAX#-?Y2YXP%DUY ]&RI6JUSC?#]@1PP+L+0>'
MZ-\;O^!Y$E^I2-D%9OE7 (1#0-$/+H./1':0-C(ER>PWYS*,L2*K[I9=S'SF
MU_"H*6Z(\?[6Q/6;A-1.[Z4LP+9518<>[U&)]&88<AUI,EMK8& S_<K(P-21
M>B2AW>8!.[,=M-%]H6ZQZ"2GD;7Y]O-VEHT'5GA?FWR\P;PW^3IG@Z[FK\+'
M#J/D [[=I2FVTIN+$5KK0-KR<$.>4-'V"\Y/&?W9!X146%ON1W,!7\_&;>N=
MK9]L4V5K'9G_MB" ?-4A&<0.[#)S(5?4I!#*C+\8TYTMYBUU9U+-Y(KWXYJ]
M,S>]X(:-'S(;@>=Z(R*4S_6=U1\]^3[EULUOW@=F6.[7_'9LGG_!B2;:#N\/
M0%; A'-H"7'BT23(='+,- 7] 1!__]ATY,[@5HN*N!4?@,*M3>EO1?<_29LL
MW$3$%.V;7 \*^0"LOS.X21G("(][[_SRV391TY'K@PX!L$V3Y5N;3I"Y3?LF
M'P 9XW'OG1Y^A](1F2PW38D2/H\],>%W.46M]+#IR-W7.85K!DWVF0#5[Q]-
MYLO4G5+]H7["M?FRSV$5_C_S/@#EC^Z\JYC,_][/+OI1ZGOQ*L<FE:;*P'WJ
MFB>335,B+]];]KYOLF#SZ+:M?2HI=OGT=LEUFYKC-'4KJB7/4$!2Y8.PIXQD
MV'A^N.PNV=?#33>_)5>^Q:Y\<1?-B<251FE&='GD;O@A\7(O<X>\KLE@V%=6
M D^ECD]1*.YIH\H+%]:ES"7;!J6R*Z)@P[:/91,885(:<+TIF\47/78V3U4>
M<VS8@4%1*,&/RK($#A.GMSG:-4]8FQDIE#CSF(KU,"@'6Q>@NHS^5?B& AZT
M+B>U3SG%5V;'.BH!@(O'=*92@2-UARM4_#?9\C]Z';4B2P3$)[^#":G _%G6
MB\3#H<!!, [AE96"A )<E(BM!/DKQZ=TT4MW5%@KN[+'\_/HHM=$C<5W7^%W
M0W:;8W>T?'S[.QAH#5P<S/]F^6O7#?!'*'[7Q$DH4CL6O!OD,,//MVUDMSM]
M;<Z7B-' VFVX[N0\Q A,R!0>!;\"W3U5'M G?5 GE!H%!:)13-A"W%1SCJT9
M4YWJ/9!P+;?"1-!E5SKKGN"(]&ZJAS@!!HI%;D ;-$X/Y[B5F5V)8QY=^*!0
M)G^^A).%DYH\QG-;4*+ GTEV_O=BJHJ2NK;,CP:]GZRCL4F($7NL*AW?@H)H
MP(ET;WL_KDE",1$$'<JT%H9C &CRZ:'4%&Z53RH5'C?#YF>5*?"O06+J= !U
MIR'3A6<8URS#5Z!Q:-4E@L(WVE"<TY0I$M]B8^<E+3A'::YG+RR\HCVYE_-1
MP7319\V:)2\&[V@[1($804=FBM%9"\SI'RM5+G"?_+>R%OVW(#!P@G[V$ F.
M),#%N&NDJ:C07P<'B=FA$>?AP(@MV"\UEF*/;UU*176=A1S^T=;WQQG3_PBQ
MJ30>%05C).B3YO>U>*G,.M+O9^NU6<[+H11*U(P?82I)#_"1D'O!$AV<N0M?
M\EL7R"=OFP*>3V"4S/QU;7ET%X&-].I'/:>I5(R@  ]JRC[\26L01IN*#?WT
MF2\;.[1VW7^>4GXK0#@TNOPO#.;Z$>K:4!H(QM6&;A:B69+:'4L6@*$C,$8=
M=#I7X-0VLEDH[28M"EI'+A;4+A6U) GU9Z+!5?P!;C:;F5ZT@# $:<D=2V;Q
M>#0%7E3-W\ EG.N8\"0\OVUAR/3YU2EO0,JLJ$TM)W"(R: LK=#^G-SH_SW\
M8:^E07'5+!PU_'>DLGE6''UJ/8 .#\>\?\ &\__XQ\/T0]?_ %!+ P04
M" #]@W]6J*AV)ML7 0 86@$ "@   &EM86=E,RYJ<&?LO D\E.O[/_[,# 99
MPBC+D"UF2%E&C*VA,XS=C*(F.L*)H60,B5(CK9-$)$V#B1E+1:I16L](MLHV
M1 E9RH1H04G;_WE4YWO.9_N?S_+]?5_?U^OKO*[3X_$\]WU?RWW=[^N^KOOY
M^NCK +#0W<7-!8#!8$ P^!_P]0FP&I"6DD)*24HCD4@9&6E9.92\W((%<NK*
M*HHH+8TEVEH::+2.P7(C';UE^F@TQAJ[S,P<A\,M,<([V%C8+[?$64"-P&1D
M9.06R*G)RZM9Z*)U+?[IGZ]"0$E:P@J9C(#I 7 E&$()]O4NL 0 8)*P^1_@
M^P\,CI"0E$)*R\@N !^H6@C 80@$7 (A*2DA ?XU&?P[(*$DJ:QK[B2E0MZ$
MU*.C+%(RSTCK.U^L4:6TOS:P#(G=*R.[:+&:NL920R,,UAAGM=+:!F^[^B>B
MBRO)S=UOS5K_@'7KJ:%AOVP.CZ!%,N+BMR?L2$Q*W;?_P,%#AUG'L[)/Y)S,
M/<4N+.+QBTM*R\Y>NBRHNG*U^MKU.[5WZ^H;&IONB3HZ'W9U/WK<,S@T_.SY
MB/C%Z-B;MU/3,^_>SWZ8@_B" 0C8CY^_R9<2R!=<0@(A@83X@L$3H >4)"1U
MS:64G<C(3705/8L4:91SYIF+-3+ZEI37JB&Q[;*+#'"#2]] K,US]N<8V_LO
M<?8;8__%5P\@AX"!RD,H :N ]W.6Q)^<6G>Q@!P6(=:2")BB\EX8P4\(J5AK
M1AHE>M@&)XQ']?5.%R5X*^* ,:R,D(M.:X.WDQ1VDE,XT 6@A?5Q!S \I#Y.
M )")J.^D:S-!6$!$^<+F"?S-@R")XDR^XW/A+"R ** "5$QQ9@'?A#F&Q2 0
MK.5@4SO MMMC%K&B)V]J8_I:W0&HZSC<M:'<!40=/"J<$\)<Q,) #4@WZRQB
MT?PXZ8*Q8!39K1\:,*9PP!25+9@$>ZPW>(VI5BS,50"$N)>B:NAM=7XQC&BX
M>TO(7GH/V(JGW$@.4Q:+;U87HRK KKTE3<UDL=*-Q;&*MP WHG4"(M5E\F8<
M%TDF*2;!6B,!*E9&K,;GQ\AB"G,E4620F7T#F],?<R4+,]#IV8(*L%<_H)#E
M^6R:#W+@V4X$1V1)DL$%(LE>3<U8FPGHQK6&2#.9UJ3EB%(>TJ&,QIP7%<E;
MT9T6FL^1!9)1=WR<O+7P8*,L##!/&1RY-D44(* @\CN_B]?K24[3)VPG^**/
M39WAI*TOHK1X4JS&ZV5PT!20Z]/Y=!85%*<;<3$L@E=XA"GPV_UBP%?*,;0K
M5Z$P5VHX:Y8R@6_\% 'KI(1S**)J212%#(X9E!_*+R%^F*]C9/^^&/&B^%G6
MA#<H;!<;+8QZ PX<PT)%*DRL]GUT60@\EYD$6L!O*I_G!>E.!3"%+- @'&R*
M#%;8@P]XD;.J15DIW\T!R0>5\8-#]_EQFC %%)544<X12"#"^;<+600412F3
M, 3I2A3*:8_1 I4XX>$]@**HI'>&R8(**8EFC))6<EB@W$0^3JZ]&R4!6Y83
MAP%9FE\"0"<H%&94PIE.4&>*H(D61P\S:;$$<3ED<[!F5*!DX?&<O&_]%:]T
M$Z(3S@1<^X2!35.TI6C<L&<BV+2?X^@[?K^E)Y),/HG_DEWV5)\-]I;;; J@
MR,0_DM]ZX5CD^>[7=_%T,I9_S=WT96"Q@%64@WA3D31>M^CUWL4&7?)/#VT<
MUU4_$*D5ME7._M03+6?)D 7'6K)_%KH^79*7F)D_OGLD8ZJ#'78R05;!P/%3
MY\Y0UP/A)7MH&[X"NW;'[:$]V;-K=_RSB<3M"KMJ)YI_ZDX(5AFQ%CN?-SJP
MW6&OYJR1C:OZW$/VVPMR3[W?5R<8B+MNN5OF=H]N<$G BQ7\'7.]-2N2RZ;K
M)?)/A$G%)G4<\Q;T[_A ZSQ@5((KL1DG@E,A6%QNBA)(NV,*F2K(?%K,CI&<
M#+$^*QA9@D05\4$%>M4TC60KN^KEY,K7"$>RI_G0@^DT!<(J*]L,T#4P,IO5
M;,;=L;1 B9I6*CC)X<%3S6KV# \B8 TVN)-,]!)ZIV:Y&LSP[6<*<V524YJ7
M*]JW.XT2A9[:^!** D?4!@?M@(E11V0146 K32-IVGC^M_%$%#+!&<B4M0-%
M;JB(;D]MQ0G(,2I(AXB:!K S8,(M-5T@\*M>X :U4)C#U(#-\$$%*^S4 %];
M*.Y**:!2G3CY&*"F<20-K4VCT;@*G4QT+"VB&.:%=Y!?CBD+AO2)2&DJ0N);
M4:'Z;"I7S<)5OC\[O[8<(QQUD6*0)%[@<0(E(H#$H]L8Z?(H"LR,T96%U*)U
M^D("!/GW "<??J8(%$S$&0!(;"KBB.TI[9X2+4GDV7:FK2S63!,<:#4>?/"O
M32E8C!]B>3,Z6 N1Y!H^*$6@P<G#4P*4AQO(;Y'-,TH; E1,:H8B;LQEM ,'
MY#4TNRB68[3>$ $C_+B+ A(GF!\2*+<2LJ?4PIC=D1N]\?PQS"2  G)M[$53
M^0*!+R*&WI6-@*[FG;0;-)1]VO4Y+,#=EB*B1 "4>6, %M*[LC@SG[#>A %?
M!QHSUP;LP0<WAH%5VZ#;6\ KS] J ,$W5% $NZV62<ULQC:]H(.J0U09@D,9
MPS)%H(*;&G"W(@H'C&QL<,'/&$X#,5C76XMA9H_ QI(ZRO!](E"_"+:?:*_/
M)@]/J2G(BNQ%0ZR >3[0\7P>_B6F>D%+4IMENA><M1P&2B(7M"H/HC!:T5XT
M\ PT,#/0-#(DC?#V;8Q'9()T4CK='=;45*0.KCTR+4EOW%+3-N?-2\BK!IE3
M(@KM KLT8IOM&,F;M\T(T"3RW(A"[^0(R'*QP#RG2:)V@DQJ PZT8EM6,&AS
MHEBG6K\RH,Y,9?;Z.SZDE$]!JS3B=520VQEU$N@T#2H&9ID/*RI),I,T!9:"
MW=69@K:($_@1=-30;*]K6]CQAMX^*$"4NJHE8T;X:<S=$R9B+LH(4_"F17 E
M:OHX;YR:7H"74@-3S8:M>\H=6<&6X;\ZE,HZ#72\X$%J.UD%ZJ47K4"+B4WD
M\[C03).&C$Y'(9EV,^5^0@F9F<2*@&Z;Q8!S:B5=6 S+9%LX1)!37I$6<_)I
MP)A7;=<!&_6S=W.VG9PZPYR8N(%ZO>^8>VQI@UX!07YM@U&Y+0O+_-UZ'FS+
M!JA1MA?Z;<X_Z8OL?Y#QTL+DQ,.;&R^\K5M_K]#E8I'A=L;8HC;=\!,N)@6W
MW^Q2,E?*>#1M=2<P<G% V-YFP</XB[N>YW+>5R2&*.1N2M\[56]M8:ZD;&+H
MM7EN\':XC<-92SDZDZ1>&G9B\9F&6['>1>'QRVQ)5YHSK[5X!5C;V-/7'JU9
MM8)ZS B_J2Y\>QRF+B+P8UQZS,\VGR-V%C>8K@EZ'7MN+3^WLL>VXT9E 3;Q
MPM[WK3-G.\8BD?VJ.7=-/K5^!;K.?SQ2'<K(8E>7J3?7-X0/;GAE24%LQU^(
MN+I%>! _=#OQ=?*8UWGCAO&NV_NJ_-Y%?-Q5>'VT]^TYP>/-N8JMW:]+.G_:
M:O4H]EAT$9OJU*@^[D$"UY=1#[<ZG47'YQ?%O/[.L64PMTP.F6@&)ZCC<IM:
M:/1Q"%=E"Y@87A&XE)/G[?2;&W.GNL^O=8:,-E&["%R'6B O-;57'J,C1I'K
MOADT2I -^/YXXS?"?8=6* &0#3D-0?:/&]F P!?C8%,H1 E2^W/8$)" S2^H
MY/EQ^%7+O'<U3&-PWGC4%%4!ZA)D5Q1E'FT4SZ UXM%)/]KQA4>C;AR@NTBJ
MH814=PSO^VUR\"*6.P9&^]UHY)AX?O-25""PD @$9['-06=E($<1T?M!C.69
M"HH'4%>O0]'9U&5P7P4B6L,&M0Y<>UD@!(3>YW'G?Y%N0N*4,M/:B8N!QA8[
MD2BA:!S$3 0&<8D[ 7F&)P'@^45P)J(9 E^F2U& "@LSUTZ8EP[9)>);&]!:
MCC5C<, Y"Q3IVQ2F6WHB=$#?,2#J@$1P&O E:45PCWV#*%@:-@)$&61/" <P
M5:#GQB'LD T!K:60J"C5DD!P_#<\,D_FKDD8+K"7-))%$[.IV%X@!H/0>@%B
MK((&T#@H9'<(@OK^P%Y%N$D [*\UR7:&)]YNYPM/95,]*6WP, 0+A!]T$! M
MA: =&;H $<6W"VC9^M89U9DP3D3[ ;V6+!EXFJS+*,<7X8:WP;T<9'2=OE'6
M0 WUJ%^,CN=*N9EMRT8G=5ZL!Y!6<F:INKOKRSN WR DRR6XR(@/F+I,&<ME
MU87W1[Z^(ZU@N2Z!RLO:JW10#$W>Z1?7-!.2!+YIB&9&=[X!MAH[W'6)?]+@
MPW'.YTC.:4V#S&/EC'OG7B3XW>$1=R8NG;[Q'IWP[NS]B/0/IID]IW'M#1RS
M\V4SAFZ.+G/=]L6/'VM@-:82Z6C$6O%-+//FF_5^D?M/FJ9U;>G)\'7;TW7I
M\N8<EK7$A"6:(\O:Q/2>/-'B4VZQ_-&UT%'RDZ] 5*0R#!V]AA-7HK;R0<E:
M?7<O;]R6Z%==)S_^(CL@U^UUYI-#_L3:BM!-F5E!^TMJCSJ:3U7L+KRNNJB]
MP=[=\ZW+PX+9T&7RQ'>/^=%Z^G,!5UT'3+'K"I8EFP<,OLXY(;/D13LGB<4_
MN-D'M6.-K53)V25]^K)=EV8WE?::62HCD]YC</?MMLWXZGV67"]]KIU0/DS4
MQX8L3WQU8+=6 Z_%</N'@Y'32X/.HK:CQDS62J0GNE46VX:SDU5_RBQM;8OC
M.7BOT@#7T#1EJ57&/L_[0>"B>?66WLPPWY$%> 9G>2I.Q5F!>C^=]+'#F3/U
M!+KM;&'NM;G'##OMB_";["@M9*H]!L,?N@U*X M7<*&9"U2\"YE*L8DX)3:X
MN& C"D\PL>#_A4M1 G*P"HK23F2ZS_^.BW>@39.#E3-O3]BREL$5LM-BL)WD
M8+6B:^/>_,(C,.U^FGM^YQRF4NY)':8%! ?@BR"T.@)TV7RBI>*_Q)NBUDG4
M0:TJLZB82NFD$1!-@;^ $0XY6$,*2_<@+H)AH!>RF<\RO<%_<YN:<<H^58ZL
M90C-5_2N#'32$*\P5SK);_%T&88?O#"-Y1F2![YD[J7/3D:MDY(<OF6'#LD!
M'R<(^6#(2 [6KU<+?UTB GF@;61X0-W*/^D429: -T+A^"5'U0=@705$,_7*
MN9EQEXYN40$1<"ERK"[*ZXTOPW"EK)U(OOF,&>A2$B^^ZDY75X.P(BJ%[@V*
M*1K?; KR))6?_=!F3OO$4O#RJC<-]0X'RD >J;?7.\86E+=0UP9<H_U@Y6DL
MQW=$6Q80&@_$<]-6X$O M5\0S\.^'8;PSJ'3B8:9EV]\6)/MBW"F-XU[7"T!
MUV&8MHR!0O:-#1>2DE$P)8ED;, K1A>OD*F<L5R!UDFIE"'M0(V!O2$X;2XT
M4!DJZ) ,.=EX<"3[:_CZ1I (E-,@%7J20;3X7:G*&?-/3(AQ''%/P;S\C$+>
M^( "?]@4R%XY!8D^NPL]?Z?-#/.D"1Q?I5)9@RC[> /B34F[I]36;??YFHH7
M-@KF,+ SWK$[*9F0[1SM3A?T[U%X" Y[L?T7P1DW]4]GW3%P'1F#W7$3)14T
MT *WOTD3@?V"I@=+86U2#SU6#S*S4$Z.LG6\E1J/ H0E]J*)89 EV$&'LEJ^
M*>H\8OO4]R&);'@M"EC( K.6K)QG%M4Q;V_R"/A)B"\-RWXH9#@"4V_9,>Y-
M3H%>NJ/PDI40">G= 8-@@6Q+Z.NQ86/SAGRZY0O4G$8#"N/@0X5$,I"5->NW
MZ@2(]M1\-I%*M*LAS6=V=N ;KD:"T^X(YRM@NP,$G>NDAE'5D*6*+#W2S2&[
M-=\OY)'3H5:$F^02/Y5QE>D?.@6^$JXZP[>T;@R!5K,P'-VF0 1EH_(56+1*
MH]2GF:EH=<;KT;46#)"V"2CY'4A718UIZ_&&K20_?]I.7AQKHWIG7-OL=.@A
M X3H0*YH\=U%QQM,;/&.N5;WKY3$G2(<_>!??.Q<ZYX=93$?'QZSZBM07'<?
MH"M/ZI<S6DZ';S$NS7>*+PW"+'=JWM07]9Z>6E.7Y'I(<&BK&XSPL_O02-65
MS VQ:5V.S9?+0BCXT*'UZH=B:KMR^_7WXW6/!ET7Z>2X/.+*/CA-. 9BZ O!
MUBST];+.TV'V 3_S=L#' P[_\K3F_06[MWS1\P?AR*JD@RGV=(OLJ]O5D%*'
MVB^;Y>M6G>FD_;Q YU 9YYE"5<_H[<65'<+':@9)K,Z+U1^]+GED),@]9+](
M4ZJSO12JC$O;M$:1"\[/H+2]+$PQ[+==GN_D%;Z@4^2A0VQ)/+LS;:*6,4Y8
M]*DMB?(A_R&:',SP"P[' 1V&4B2<_D$M<V\=;8$D ER=4'X_3[*!0[WRLV5K
MK\H]5%URT\A>7!YT9+(-\>)W"S"&U]B"C?C=XO8;P8TX*[1>L)P_$]?DIF#O
MA[+S^PXWCF'@\WCA#^07=*4B MB\P'.JVV#MRNHI UWJ>:)"3,-;KDS[>[D!
MEO.L@SSHE+UZAZ5R_KJ?_Z-_GQ#I;_;%YKI1Z*RW\OZT3?&R;C,7N%9>-C\_
MN:22QIK28M18'FUA9MC2U^2V'QF\P4L/RWPB$9"TBYKS[I.Y4'7D*_#H:LZI
MC[5:%SWT[^GI]IQI0F6MF#U6%_(JP<BJ\<G/]J)\;Q'M_9MSVCZ.)PJ4<P\_
MZNW:U:1AO*67ID=J\3&\K#UF$$TMBC*Y7RD[^>GLSCT+@GH9AH.S\;PQ7B#-
M<H'?=9;?OD!VU^O=>72KL4OPFS.?HBA+I"1B6C>\6[GG<:2$/K*CB]_EDE_S
M:&9"85%5Q]!Z])*<JM2R29/&DW>OGS5L:TX1EBVNHYZ=,76N.+S#3;NJ6GNZ
MZKGYCJX/TD\+RFE/9J<5EC:(UTX4AB_#9;Z("]#=.GS$VF8[^06CZZKIS(T-
M^^4NK1"O.6NX>=1-(VZ-4M]/G]76U*2,BLKM,CJ<VXFHNS_\D.^ON\X@KB8M
M*QI0\;JF%IH_$_EH18XY0>7'MAPTK>*MOHQRY5X.17.2_/>YFJQ_ ,MF1CDO
MF8D#AC-B\>]*G^7Y#LR4G>7WAFI>;@;6'7U?L;-C[.A-#A Y _JYCD0/3E@'
M+_E(9E<IWN*J7_HT;.G-5L?A] /E%2^?=9@.*Y4@RKU(TL\,DK$4XF[8R&&8
M21V9$I(E\9XKKX%%/6=X99](R_24..Z;^E1T1N$M6L&X<-4I1QDKWB'5'5RD
M0G:7W(;4.G#&07MW1!3LU [D*6'KJA.!55^!@ Y5]Q<IUAMG=LNIU6AG ^*L
M7_Q-]1VE(K(8;JG^9 !XSY7TG/AP'0)-LE@9(*Q#HM&'"AQG$<"PC""YYN;I
M^T&WJZ(OQ\.NU2OB@'&<7Y,3N^WL(GW]U( 7OYED\6W24![HMKJ8ZMHS!M;Z
M77L?*-IOSANIH+-=:M-!X'YN.V[N;&A(KXI?O32:#20[,72) T,E9P->;F?:
MMDED-+98T%Y6)*FL+9=YDBJZ("*8Y<AX*0^G4KJ2[TN$IJZ&SU5N\EA;_G/L
M0W;P7VWW_!_].>HFQNLR=3K.:IZRKU8_&*FF7]!==#%]T3V,S?C&K;LR[KW4
M)W?S(V9+UN7V"1)UDORMCO,*+/'-#*^\:>RY2+\OC;1C#RQ?^1&Y!KNNLSJW
MKVN]]] _JEYK]GQ02V,'@953#4,N*??Y?.[)_8;I\TW;4*]]'M!4WN\]<^F:
MLI7+^8,'J"[7G!-DA3>.MH4I&]OMS*GO"F4W7UZ3*3(=4SAKO&,R9#?+1 -M
M^S9RVOBLC=7B7S2D^M5=^Y:XITR7<N)4-9HNY]7G1[\YQC[I<)BV,$_B8N]!
MM<_8>LWQGV>\']*L%IK)C%.L1$I@Q%7D>Y+H%KC7P77MOO#EKEW%/HLC_1O$
M<H3WI?Q;:C#"V5A<+-8T2*FT)7&PY4GM[>4Y7X*.N\YF!5W/NZ=8>@'[^N+1
MZ,]3&\MDI);63 3%G&@7^Q\T,2ADF?C-^]Z5KR\ID^;67(F-!C2.3\(LAF^M
MK?)3TKU<PY6WQ;(&IDO:H'P-ZJFY&Q?9 7D/?;0I\,L-I97FS1&U7RZPS[P]
MU8HLCW!]CX'-4%_9V=+](Q>DOLUT2Z%V2UX<I:JZ/-&L/M>I8_S4<ID!Z]SF
M]:<SC#^]^9"9N?[-ER&_FCHSW(=&M:%L<94K^NPP"XR[JRSO(W,04$C$# XI
MY'!"9WVH[*)3"49:$7#>AEU/LV5OV_I'%I@VU0C' T0$8>@MP'$^"X3ARNT\
M\!4@Z4P;"@8:<H#S3[B.;0NVVX<(3 \V%5"!N%3.0'+$E*OWM"?_H"KYYRU"
M:W>@30M3?$Y*72J/()?IL4+5X^6E5XU&R M5$62"DMZEY;:=124X$"20;WM.
M!9S%#B_GQ'-EKQA=D8K\O%E8OF!S!:\FW2P"/K]Q@;UQ@.[-E=C<8[G^<I/!
ML?WE,BZAJ]Q;4SIG&D>8IK5*CZQWQQOVY6''G )96XY6>0$_1:MNT!K[96NM
MWN6U'N[K4EF_*KH3/-9<.!TAD6X\0;G5H$5C;C S$56DGW!Y=,%)=($"\E2[
M-U8R(O_$J9B$&PAVL$?8 V%PC/'GM55!+..'__-S\G\KI9W)WFLA#R+]IO&-
M*@<^]!"]??BQ;W>XC,&WZ[Z[L*98[<1!O3,UECO\Z?:QXMHY5MB^$(<HC;%[
M[W36%N*U=EQ(7-FNM+?H[=GC+ZYD)3];<F+SJ.:R#8[)=-P6Z_I86WK UHH^
MUV;M5;+OUM_4+?%,]+[]<-VLOL^2.&WC(+TO@E//&>X&W@'3YY\O&!E&J(YU
M]TL?;CMTH]L\>2"J5$T0V&7!HZ'=PVTOG65:-KM?)?J?IO-^WA#](&RXYW+/
M^I!M_2["8Y'-HLWMYT\E7D"'I]..).9\N+A>]+/X;(;CB76]!_9D3ZVW]7R1
MEF4K>2.H[W)_L35W@![8T*.UH7S=^J=:25W1\A8?<AJ<Q.>.G2R7\^X-#NOZ
M:?&6@YR=?D_("D\BAV,-IFV_ K+F4?V$"P&'OHSNI&^T&WC<^N2U-/Y"R,'/
ME,\F5_)>[I@]VA11R'J)=X:F8VY[:AO#IY!I\L&S1)_OCM@ZW@PNZ9LH/@[8
MO6AT9^=\.*GV"]V#"/@O:GC0E^F/VHH2G$(!5>B+'PZY)NTF+F<05+DI0V/$
M]=#FW#'E7Z/!<%0RGGGF@S<R*5>J 0H^P6CX.R:'6^_?<!57=SCS0$>=#Q'0
M*N/')HYZ?]N/-/&(&ED9&9%1.%0 1FH274,_?=@1F<\"]DI3]9N&2GX?3X 4
M6J_)=[EHD2\-M6,6W>)@*[H^J3T-!KBG[;:_\GD!-HAH/'N<&OT\1I[:R.=*
M#[O\5(,[8/%T!Q@](NPKD?>PI9KQ(%^J+I^O7#"LL-NG;G5R3X*2':GUUF*X
MA]>36.GQ+D%BPZWP=38F3)OI<F,W9O.%WC=.AV5:;/U>%,/! ,CT+V*H_Z-_
MG4AK?=8B7_.+^,#:DSY73K^Z6^+X\$3"H(/ML^.; C^;[&:=1-VC1$Q-K![L
M5*ZO5_7UHK_?H[ B-#/-HR'RO88S<O>,PG&KHXGZ8I,"F<@N449(Z+1JP<J"
ML@U7- R'>VZ?R.F147S ?"CS:55)KS(5UOR+L6'[W=LE+=P@C%W1IMDUWMV:
ME_2W/AIGS<E_TN0W=2GY+D'0#O*<BQY=_!RU^MXNB6ZO<X,/+[[:^'&A(R6\
M0C*$UH^ZV%$\%9*&G"D?,#/?<&>1ZS+Q@[IB\<CXK%^9F27ULMFXJZ. 3))B
M"M_28NA=.2S $SU3) ]MSL6H( U&V)8%MWR*$&]+8KXG;4\W.=XI("@]$P-?
M<&<4&77+GY[6RY9+*$9L7[(QPMAU=8H/CX<@X%O&Z*,NYJ+3K?;D&"U.C)>1
MY_&(:0/*S!@V4$*,1[*\GR;E]>0Z37_"5"N('2+$"#8@Y!<.&$(9MS?-J(/X
M4>\!-?NI^2P941CM_?26^S4CPY,1#>[48-VF%Q$U8C;5G0 ES52WS)20B<((
M_U9J(#J>7\1ICY%#S_!JA"-Y;@0IUPONSHPT#=EG(R<CIKE286+@*S!3]@@_
M3AC;P8=RP W454<N1&YDS.?:EL-24YK5\./?DG_?DL"4:ID65USPP)03.#[7
MRN%RTJ\)%1%<.7(,0E34U$K-F*JS5M.'YPFEAFQG2A2R*>TQ^CD.8\E1RJ^\
MM\?4VK2Z]P8S,KWKDUB$S8^=VQ2\(LH:BR)>8B-@BN3FY>#XS/,[1:EX+C+^
ME1-2*Z+P"),Q3H)!.6>866SB?**W<,#(?LJ#$ZS2C HYPE1 &J8I,_(Q];2=
M?M7R( -F#%!OR^'! PP74'R@N,QVC&2\M<$)XD:)0LLG]FT6X!L)8,/!DRT[
MN.(T#<Q\QA.T:$1,XD@:>H8OD05Z'ZF!X7*(=Z()E(GU:#3(JD/YPF-)-7S[
MU_*H4-3D? 9Z2SP?:DE<;KI4UPA4[F+0+,#^Y@<P-2\[XF*8&;WKI/8TF20!
M:B%-.[&$X@<#GP&O^* ,K3G'V%""G-X",H86ET.IW!^I]F$VE!VUGW*%TOJ+
M8?@:L&',#6 ^0<WYULF;9M N/(AV3 9+RM4/#$09'#%K=>. J#TM#E4!RW\\
M<KJQH=F[(<D\'QPH9ZH9882&A.()=AG#Z&))T7HE:D/+?XQTQTAZ;"*_*+V:
M*R'69_LJ,EPPA0,2H &!SYA^*UM0LP$;^&:.H$U +\4D\B>(IH!.(YH]+WP@
M&N2AVGYJOJI@F&V6" YU/K^<=;7_E3>OQP';*UG32O5$*T#*!(V\/;4!XAG!
MH;M&@I90;3/N^DWRJ08*-"^U.M0D8('$Y4*,@MJ ,N^VT!",OE^Y#Q@J)'UO
M0^5;?AF4#6#9VPZ- .\ X@]RZ??<LBFDN#=0TKN-D9\M"$1P9KAQXQYN!"1^
M'!0S^$)PQ 01)4WUAJZ!U'1YK;((KH1Z@R&DK_D:C AU]28^CPM/R>QLGQ\/
M./X4L&&063$[4!M?R$J 9%*$U&=3,=4RJ>F"X&=3\]*-P1?E@])5ARSXAW7^
MEX/Y/D^AH7O'PHILA(9IY+1WWP64V6S+6@ZEI#,0O1VE/ "<$I[H_/D\]G<)
M$ZRC]B0=+?\\%H^:1,3T"ZIMYA6MZ.X)574<88+B<Z(DL:GR=LS>A>;L!$=!
M"(M@Y"C8%S;#%9?K2$QYGD,$*PCV*=O@;EBFL>AJ&Z5H+Q:K(>;:5#]6V3'V
M;,\.2W<QWJ*[6.=MYUQD!7[<NW@?JG5XJ,#3X, 9)H^Y6R#8/L+R_RW8Y^D[
MO! [=J+?U2T"&FM0<!MU?F&NM!THB>^IMZ)Q$" J98*@!E$%D FM2:ME,> +
MOCJ%+&J$Q M,47Z$&/?2[..=- :H'RD0_<R)VJOW%>F,Y&1,#Y<O@M*7;9@O
M<7+O"X6FO]MYE/'XOB>3'<*B$I;.WZ6TP4@DM??@"&185'<JX#Z?\/WM'2)4
MPW($2O#JR&+XQ4QWSZ./7GD7YC&C%DHNX##<+=-!/#4_:G>?&RVTSFPSN1$6
MOFB4!$_/)L]P)1H,1M)YH+@)THEJS2N\H>2RG() 0&F#D\&A?^N$41"I0 =E
M4<CR.:U56KE E-**8V3E9Z/?I&>_A(>A4UQ<Z&R_CG0!1URU" 8"/O\_;.=Q
M.62WJ>"X0J$Z?\P"([:?!EU72!XTIHQOE3KMW_+=\TMS)H?LFD0-1I'=6M6X
MDKRB*JU2L!$L*!538.GO1 7C+G2!*G*@)'0,-H('BE](Q?"@%/2:-(R^/O@(
MDTQ$.(PRR:[X=X5' +)3BPTW'-U1N0!*4,NZ*WIC(RIEB*9+#<%7M#D4H(B/
M\E,#A2^-*4QK^QU<@#+?JSET3TG>J*L]Y7-$96U_5BD?[$^P3N(=5Y:*J?RQ
MQPU7!O@\_GS<"3\.%<E\4Q4)_NWO8*^8HEN %$MA)Z4]6)GUK7_4.HG"G.-'
M( 8A"6.9V101Y8?L*B5UU=6:3>?-#I2)4S,@,905,^KAX0SCA<7S1YV:)38S
M54IYPT:@_%D$:8>+A :%;$$VF2X)%5%2VHD4H'@@NMDVEY$O,$-[F[M&.G5D
M>9 D6A2P$4-I'T7 *R> %>WFV/FK^Z;@UD@" 9[GA*Q":-;[4&V&RR7=\)_*
M8G9\IAVBV7_T2WDF&T@98BIGJ1E &3&S#,*XM[[>2=3!$A1P"@$_7:](C0E,
MILEF?<8RB] :%$NO1WMDS1Z-NPMM,S*P\,RGK)7:MSZV!R^. <>C4K!)Q'%J
MU<)4RB:B_&)ZIZ;Y8I20ZLE@>ZZT!>%"!(S4K"[6SI8#5Q*"^<5,0K %[>YF
MMDK^'EE@H^7UK!UU6(I/E6'M; ?L28H-MQ(E*1PZ73GSJC]#H1G5=_ 3IG8A
M4DQD)J,>F"$+^,LU<<)X0WRSH:96(I\+I+5W^@KSL]MXR1A8[&)X=H:D-:UE
MCZUL5NMS@L)XLQJOIA'R;.<195@SAIM@IA4'O!1UR!ZGQ?0R9KB(;1N31"DI
M+$]K^\^8FN&"<C,4@'GEU</@3+FOR;^%72=9R%3 \_E0AG2SR.=M2? 2-](:
M#F*V_4"])6$!48=B&\?KZ6,T+X)UAF3)L\T>H4&AJ*MQ@^EN!\1L F^)V!G6
M*6@NP;?B^&YS?L C\S31,Q@[6C/:TJ5VUA?^2JTH1MRS/S VJ?VJ:=:L+ZRF
MY@R]!1/LHU5:"V,!\3H W4O6J2@J'AJWW,A>RR[VFBR/^<Y=42FDQB7[=2B*
M4_Q@+98YV&$!7VU+>[!4/:;7DN6Y$O/X@R\BI9&;@0%2FB7@B5R$3IHH;"5Q
MN076O%X2P-2;$P _YXP(:/P MG[,-Q8K^VQ*=!(%]%MK"T!LZN3KA0+:"*U4
M"VN$QU5.P9V]U\"I:2VW^62,$4JI =(3."GZ(.94#;X"QLL0U<4YZ/;*N<\1
MC_;<.0(,IE&BU?CD%-+]?%<J8"W77AV*.XU_Q]?)3/$$*O&H?IMQGR<I*:1S
MZ;=H )/I5A+C0N-[,SY03A@=:SD"G+[VCM]KZ58IVB\<8LH/H[:A3BMNG)80
M]QP!E!44<0/"D<SL_&QN"!->JT.)*<)MK0W;C1, .]L4H!6IQ8WJ50V'BKT0
M72<1K&A(>Z %P@=36.;@-)2LOP+P>BV]==C1+<FEL(1TAQ>]>%X/[=$P:YFY
MM8+#J)N0*T?9ZA!1N2!MRNT.*U##12(=4RF]+HYKMJ!.4]ZX N] .V2Y?R0;
MS7()%$GJ? 5L@< #0SD9%^A=:>@V>'N=-:2U+0YVE$J%PBSYM,U,7I@B*)4P
MN"02V)R!1:[*LP-%;8$-4..6&?6 8A<P@RGM+EQ=FQ%FK"54H'=*C!+D<A'[
MB](%*8E-?'VCGJ,NB$P/DM.$BSQ\T6F66;]@3,I0*D)?+PW]$?3SX1Q?T!46
MWI%UOH8#9Y\U^C-4]\L@ A(#E+#->5XF6:WNH!["46$J+&F;H>SEDH"A\U &
M$R8N-X'3X%"! H!! .TI+-FLADBS1_41L B>K*MW]FF?P"EH!M[AL<WNP@K*
M 3O<YM.5<].C+K4?9KB2_>8>[ A/-)MRS7ZZ&)YY/2<C-1UK]IB'*+MQP*=*
M+1H_)YHW$" &S^7(>FJOH@;ZPL$Q>*/(5Y'IV6<2F\8)"SR\:IJFB^13H+E$
MD7LF:H.YI3,\2."*!6 :\!#V6PZZD@AHNP#6;&J( 5IQI^NQG<TE%Y* [1$2
M2E[&;F*^IN)P/W,Q.*6.UK*"JM50*71PDN]OFBD"\CKWNWW)EM3I@-T-9WE;
MA^9GG]Y0D5C2AMB>1AE L*F;*-Z,::ZDOA'N)F4A:7R&]RAY=_9Y@-2"D8"Y
MU+K4=M]:!-LQ[L&F479G;[4!/>%R&F0FSL.C'JQE"">$ TW8X<X1O^77;LY=
MX))89ZC9=?+)+0 (IFQ])FHG 7*REB :\)7"%.Z#MQ-5":@'NQI8R>;>&RX,
MNC%ON&IW@B$? @&:(#;"GB5EM#O["&>ZSI:)@5W[< PU*,I0/(TO\7/^KXKT
M_Z/_560HQ>C_AB-X((:P?\_=Q(+Q&FZ9SA<+MNW-Y:9VO"GI<+'.]S);E*&2
M56>J5@:SB+4!8QI# DIG$0NK^,!6!$X,62J_$FS0$_Y]5_P?D[,E5)7W5^6$
M?T%8\Y;Y.OK_:3'M&P@3M<&579W D.5/,/>7A+6P_%%E^"=I-=C1?^';##E*
MV]_88]H7EO[-[6#^FP@K#:Y'(.SGM%-@+A@]J.YA%=4"F/,UI]$./2[I<):-
M/.Z]TZ_LR/OTI Y8 UZM<&\,$94KN82*J2?J*# F(+S:3L+2RK]CR[^S#7X0
MKS;ZMRK0_[N)$@RZU[_)N7<"")]__R3PVXF2OT<\'6W!CZ-'.O.'9PC Z.\.
M'_VSVX>6Z2!8^.=M[6_:G^74CS-+/^C[R2,S&'2(!#H0]4\8YV^S\\<Q+)!G
MB@9UM1LSU68D)S.)[D&2Y/%YQ4(LOH;?@ O5.Z[6^6[4AR<1CJHB.7DMV5EN
MRW;\,/R&*VE3N!<V3C2$N;66FZKQI#%%6B_0(C4!A?)0]\^[DM^XE)9@_%[>
MI^PN_IU99TG4!?[BR!#1FBY.SP;&L$B]/^&7("+$^J $_Y)NX8P;/;^5]&0P
M7?]P8NU/$FD'2@&JH_Z?]HS_).GR>;A\H9X85=)&3J.$(G%,,S#:X8MQ"D34
MHP6D1#29C11EW/5%HL; *(W*TRE&3*$+[A1X;KS=":@<QY=0M+DP;Y[0LXV$
M,&0Y9752"%K>-()PG(B2 _$E>R%T= MRMU1/N;_4\'^8G&S4(>O_U_,#,(FI
MO^7T_);&9N9HG5.;/?YXN7U),+X.V'H<2:6FN1]88E9P4OU\V2YBE%;#B9N;
MF5:O/9)@WJ6;3K<<#MMXH!B< G=NOS'E<^I7TC.[SKD./4F0..Y0BBCF]9JL
M\GDX\:IA\I$*50W:\3"0I7K* M*-=8@4@I$19'\D1OI\05LZ[2>R95:;KT1V
M&FFB+L1U2#I??%_.=FH#Z<Y/<K8:($Y&D86\!GPS8/0FGH_49SG?PQM0TK;7
M >C,4=<^-<.<#":-*? +<)"WS9 T=*%[N#50 1B2O\(]>L8OC:7XP 8')+]<
M2.L\TL&6&08G*%:*#OF@?>&WP+6FU7SUUE8]CK2^7D9A5O[T9/:_I2-*\&0+
MY$2SEJQD_/^M+]K99(*TE!0VXE]PA/]P)?=P<V/"TJ=]L1$P:8,9[I0'*;DT
MV-!AU!4E*T63HV*QM#.2YKO?S$R7=#CAWQ4#]$QW;TE=(QL4(S^) @.=0[9
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M-':H7"C=%HJ 5T[:VRUMMSO]O-4YJKBFA5%G:I>2LFDPRL1%&1?<:-<U #>
MN:+FL,"I81MN+/8_%:G^O:DYC)[FG^^+3#1]:1#Q1)X%"+ISVF,Z, VWS"+]
MFT5K5QW=T<FNFFDI;7>+(;12)^.2#>[+XJ\WG:W4.MFC]Z2Z&GYH9'^Z4HUA
M]07E6RUY4;G\ELB2 _$FIRHR[CUK#W98*$;[2DFNN=:YJ>K@3K,66W_K3TO;
MDHONF324FYC94HWY5XJV,=1^H;=&_M)?LBU*?7L&W5VXL?!:]<WU<AV'3MAR
M-N>5S6:LWX!+L61M1YQ!H*I&<O8H/7A_0&6Q>CTCZ'E%&:HKRBZ#RUHF_)48
M$CB;(U)WUC_H^#!)WEMFD_+B!?F=ZU-BF$GM3(4HC8]W_;N8&:M#"B^_\<KK
MLJAQFR#)SQE?_IEP,?%T?4_#M3=K>19;Y&1*@FWEIM(H:)WS"[:AGG@.NB&J
MMGPNQF]:EFY+#M:.#M%:)YNYSJRQ8OG0I%-2P!Y@NH+=,XF[')#9X"U8MV Z
MP"YAZ-R.I6_;D%:[&P+21RV>FBY">+/NW>XNW]+P5*)C2[S@EGZDJ%)#"#H7
MZ+LE?Z$0SG;HH)(VJ<Y4U\;A^U$8'DYP( M :&%I@$XLPP.$D.9U1ANQ?31Y
M.8G1.G@.TV%4SKR%1L,WFUI5[CWU*7F51K+E[-P7E)F6JQ/)6WHD)T/*<B]1
M(HS2$? K_FRP*0 39>G;-)N2)$V7FO[1E_YO(%Y37QKE=R@[+)):*?A ;XY2
M26$/SG3<?GGT\U? .$*AR/-7:WJTGB!JB=/!K=PM774Z?['- D";H(92?Q7#
M^((!0LI_[7$L1+_C_S?N!OX],C&ZJZ8151#9=5;CUKF@Q_8>G:R%VIBN<OHY
MZY,-5B^25I[>@S8?6GWU5]7&I[-1:R]UVC^ZNK4U>J:#1LTYAS+1O-.@E7C.
M<X'V\M6JQP]KVOM+';.XDQ^)OO2NO,_]WOMU7N</HM@K#J2M.+Q#O20&?W1U
MT+7J&TH+8[PM Z2.+GV@1YJZH=H6I:UV%)DG*[7IB>JI7TP_GZ_1T%MTI%<N
M;9P::@[[=/$IZDFR2_)&NL0#5_ON8B(JX)UCX"'$B=% _Y)!S>KEU"C/8YZ4
M:LT>U_T30VNS*T-=#PL>!?CLR4J+/V]J[!7=,TKQ_8AZ:QF4]V!K*6U"<X5!
M'#_&OH0D>KF[WR/4[GK MHJ?MD[[7FE8<+F*\6IPY_C.=SE6=@S.7(#;TKSF
M+HY.L-.3-+]J=,#!98:=5HN4\38.)C_?[;:DR>JE93ZQJAI\I>A3TG_YHHT5
M?VB)8D49(E3R3=WB2:31X U8N>YBY7!]/@C8YF@*!@=\[IRYVCX3I$?1"Q\6
ME1.+(\$%;L[E,W<JBX Z<#7FW492BWG:W-J@5>ZV^U\_-?(+.M^O2MHB[;E(
M7U38;F^WS-HQU%Q8.! Z]D7;=HO',DJL5&3KP2HLS\5-1D?V17RY\<Z[C_9E
M2)FL\&P+9UH'BJK5J/L[CG09TYN=5MZ(>7,DED3M.UG;X1:W+DU<Y9,P"+-*
M#]WB=LQ]N82&0HKD6YGG,0\2*]*]%AH8.#\AH0,4H\++:7[9DO<0XT'^>2N+
M]":S$L3N W1V\>$R?N=Q+WVURZ,;-FIWQSUQSID,:![E/.S;^BHZ),(9K3W3
M2KN-K#[^(9K7*,8)9S!A;GH*!W4Z3VR\]_1EUWUM1HJ_,>'OFB6.HJ$&X%':
M$6@6E:"CIE:8<SQ#$A!7H5)_Q0%0#"Z%I7%E@]5P<R&?)Y/:A E:+WCZACD9
ML!876\I"NK#$+T%VBP20ZEUT 4>!]M@CX-_J*\ X^G_!KAM%&4G]JZU/;&3
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M<?W@A%\-%+IC+O7BK7W#IS>%F5A 6L?'_*; WPXH3_-MUUP3;%VX2G)R)&6
MB6"ID[#38D4[1UBII[X9/]7J45&X_7*645II\[1,N<2 C#EOYW*HN I5HX]-
M[);>4'YN$P)5^5URYFY&:#;=;:5<YV,IL78*[9FCS!M^#>Z"(_=AB3N6(J(<
MJM]<KV5IV'C_?,)DHW>*BH'9 <_]3_(3]@);KWC3R]L362T?]#[>0?PHY60Z
M,=2-XOL L>61 -5(._=X]HOHW>ZV-,ZPX8F3/"@B_B=!%4PGXXMMTE(M__JN
M?"4PAY)_%?KX5!>DG/ @*LY+IT3::4&\RY73#>KXU_CSWTK,Q@[B^5^)]F+&
M=/^U^=;P=_--6&$#2N:8Y?E825#U!E0R&TE!1E>-7D]!34'AAM $+_U1Y=?>
MRQ^)7D)%WYY/T6W&$4N"1*\;Y)8<=(*/*+%3F/$6F?]EMO9_>7?!-/XWQ1%%
M+-._X$W0ACV[9/+@>FD&_R-(Q+A"G[94]6&*TCX3*C7S[Y8G<O+_':#Q-]_9
M?PI0'"B[#VH\J/;6,5,T\+ 87IW+T^>_8RI=MSL&N,W]*E4B+TGU T?\[_R8
M] T"*9%\!("C_.,^_A-_EC[0]51?9J_[/6C+U(3AU_XM&@@O\=.R^>FA"M-*
M0HNW+QS]NCQ<Y) >UTO]"Y9Q*%O234VT'B(N1A[/V&R#U4<JKZQ;\^/5[:/&
MC%YK8='>6U!JW8*IWBZM>@=@B^)]@\/BN[,WN"[%5-_AR)^6^N=.?5VD:&05
M@RCQ-_L/*O,G<*S)<Z[U#BBM)< 0(QF&TQ&<8L1]X?@HBM6;M()A5,8M%_A$
M%%ZD0'*YXO!&>"T1QMK\,:>@[&103>4]_J+7Y?1F7[X?3^/H&X?/<V+&R'.9
M:A>%<\F47KUWKK\'\%Z.?7"J^SA'2WPA7[0+I2PO0KMA@OPG)ND[^RE%+@E+
MYEDWRNSIN<H,-C)6TZ YTQW+0/S!'S"X MV_+V'M? 68[H7P_A9:M$XDL5?'
MJ!@@BI35(%OVOSBG*">"!J<*11&<=;7/I[G&/]06C0UW>_6L?_)B&JIS5GYG
M$\K#@_0^+JHL.B!LF>0:Z*H2R1T@E%T*0$RB$8!3H_?:C@194@ 4 ;*LQCQ]
M1,_W0CN)5+)+2"!B)6/>F8=)QCBFH[:8?N9"KCKD0=S.IDO0_&-2![-_7H>I
MX.LXM2I6=3ERLO8!O7*'HS]J%[M!DB7W%?'>I56J6N6"0('-=A5:)K&^QG6+
M!)>\21;2*HLI17]+)<JGW(JZ*[M%!31/4<T#$3B"+K 12L:K"7KPU$V#-F9\
MX$]$1T2(%V)S1G[NB?J2C ;]\&#7@"L9B/0UVZF&\&'>@P^C8@]2)I%?_37]
M#W*9 _O>##"Q-IOX2-[N?H-I2V?C?P(>G:.3AJD"9"Y]1@(2GG@FJ&TKCW/Z
MZN!S9]J65*';HRT,1&EL$6#O?%=)'%Q?(D^:DH?.@>XG>%1;9;1&(/*)PUX6
M0/N&!,8B/G,P?#2FI7#N 81,1$N&V6-C0( 0PS='TM[]<W]#JUU@(JF8[=C)
MU(K29T?UJ2_R3#^L0%D2LQZ=SS,3%3(:GN'D09X#DLSA.CAWBNE4&X(4SMDP
M_4V[/!%'2:D/D-!^NQQ#-.C_.12L?\OK6K^T9$&/Q&\Z$D6N[.6N7D+XYF[5
M6^PZR=]!2(*V)C*$E;I% 0SA X\L#]Y"OO\<K<U(*E4=Z1C"4"[6JL#]F"SA
MOGD_V3.D#(@DAO!)]1*,F X2L.Y6YI9:.4N$VXT<W]%0G9O=TD>8Z= !!DAD
MI>XA%[,^V=SJZE'6.Q"70;D'W]P#$29@8I=:'!UU&SZN\+P1?UL]5)5BU,Z<
M<[=T\LN=QU(VI2[10>\/2SN_2.X;( C8\L$K@,4WI_N?"BV3EYF;K>8K>@==
MYL1P@S'M-$MEU&-1@2V5TI.?Q*GF;WWUM;K3]=P(6;; \5FU,ANC:\+1@"E,
M?/D;&=(=#W!813U_NXBOGVD.$EW*8;;'%D[7@6(.<]J\_4H">.P%MLT=11AT
ML.Z!5 :-(G9(GP687E>L-/99O;$!OKB;^OQLK#)ZBIRWQI%_96MRIGBZT XP
MOEVO20'R;!W)D ZJCH!"M#0J0E;UJL,D3G7O<LY(X?UM)'L+H3SL%+XT^0/0
M6]M,1UE%93<-Z'"00F(A6:EA$BA\6-?6\.R:"Y(B5,'4+8[$W$"Z"8LRLGSR
M9W#O#;V_@58DY>R'W)];%*6-OKG.=BL)_@P8!>B"1/N:>KG&# H$3.RCJ .=
MJ^MGSPN8TJJ<-EV4>SP?:^E;SU;$8E]4SIG"H'5/.)3\NK6>.!>>^.=_N:$>
M5[@5XWB3?E=$HVXA[_<?G+/;A,7U;924O5#BL0;ZI#SQZH89L"$X(*J 7:_:
M$)'/&8N13(J19JTFC?2--=,1"""(\1J#EU&OJ</7LLBGZ5CS,FL\J+6DB2ZK
M\R6(5""%Y&7>EA*5)3H8+Q/2#'W+QMZQ$Q7.+8N6Y>0D=" ?D05_C)?R, X+
MS,B,YI&/=;YAG<RTN!S_F(4S'ZLJY:56?4!W(Z%2X*'7@,-@_: : ?-",[GH
MF+:J3#OIQAQ^%_%E)JP8'3*WWD+0&K4*\-CCY0&;##9RE9'^D)5S$_A!0_Y=
M>@:Y'S] K)PS]3:TW;+%I?N28R.55X.7W:0EI5_30Z GB&MNF8..F)>/]9&[
M6^&]?7 XJN5W_#LNBL*S7C=J!O3X168CX#"76^ECTGF)E@R D*AI2JUVOO',
MU 8BK<^]]IGYQ!9HR/TA\;[787&\VQ6 &:(!Q(F6,H@ULQ5IN?@A;#DSS8[F
M'ZZY9X'\94R&C 57%QYJD[E,-4,"DX R*Q.%(O\,%CDJQL!']8XH#P=,TS1"
M.EN>5MM <&:5[Y*,K>8N^!VG/F]U;*BFS8YN*#""C[>@=W <":_!7F83D^JZ
ME >+)G)=[SEW"UU_F4I<. (+]1EM]<?NXD%(PP/ V]")Z,Y,9S-> (A3]+\$
M":I>,R% -/(_)FEE9X0XRO(RX42K0ZR8@"2CH2#1ZB3 L+:'$[1+D"[$C#>[
M@/ACFQ\!*X>2.S8#*'<K22$4T(>%1 %X!]%-=8#6W')*S#5QI/PGUA4FYE]R
M_0OU)9G4$7?$129J:D8ND3C98H9.VZ@\@BC1U%'V-:L0J67\S9;W-S8+3,&;
M1<+YGT9S<@>]TC_()?@&Z!*/:S1H6FUO(6KAQMR%(IQ6K+Q _N5U-5M^N'W6
M/2@NZ,#]?J_L!DLXC@YP\(]E@UQ2925CY$9,]8\.QTMKD6>3[N5"\U> B2P*
MAM@Z">X"\M\1DYEFY3\MDGDD\Q^8DZG0$3%#1O8G4!4/?Z)'C] $3M9D&4?A
M,5W2**=DZN_.W':]G)\WC-X9[4H9QDQ!_'>@%.71F$IG0Y [TX!@MDB&Y '6
ML:378F_'$#G[N!P7 U-4X;%V,35+F))81J=,@5?H/W\21KHV%1M0NF<<UD_D
M,RT7\]^::N\BJ;7OR667.3/6N.L422@3&YUG-PWP7J]P77X\1XNSY#>-=A5O
M?TQV7JS9+EQ'AG4ZPKP$K&!,'6M9A5%D]OYLZ3QQ#1T@^MR7/&B]-8>8 ],[
M(DB@#%#[;B<0^^*WZC*:DSU8BLPA$ T<'EFC@0_SJFTCG$)0)L1QD7!F [>;
MX0ME):Y(&,JC3M:1Q.NXG;>=K.K+6@?GECF\B+:=HXH#)+$<7W0GQ&NH1JS'
MPY.FQ?*WPM-1,:.8[\F.CB-,HXIDY&+*AAVR+OJV8HK6NLOQ:O04MOMJY3;@
ML=R=RVPTM)T]5EW1[LV;KP"G/@"C9.'8RXIN7H%!$]8#\O R1M$.-IGQ4F5_
MUK&>_>;?O$S.(XKQ'5CM#PM9E;'QHV*Y>]'I!<0M!50/)4N+.L05:6J\)F@O
MSQ";'-+WSGF!0+/ :9"L7PEI8 G\;**[BOLD$M1B1U1M>[RA%NGD+A3#7[V;
M+&EQMEQ:3N1)?ESTY=EY.VA>;HR+6-EV$3PV@+F_2-3UC/,5MTI[^WJ#ED9W
MQ<;OGR:KQKL*FS["?I8#=QX4F6]8'$=6-[GXF7_3P5<Q+.MO=P@^:\R,OGNB
M3L#Z=-P>5-&/MZFW YR-.TZK$S*=4[8COJYK(EF3VAM6/$K?0J/WX?AM3N)4
M$MI]"M]M+)(@!E7I.<2<;Q RR[!/6H4-B6G>C'Q'CU;UKCJT@&%#^"BA^FYV
M5A$E]<Z;:&1&=3]])U I1)/2D]K)J*IC0\%3133G'1CQ0-BH<FI'M>_6ZF\^
MS_JCW-[>55WB,!KY=$HRZ3-=(GXA%;HT23<E 4 F'R-A(?JSRN_/RN2=E/@8
MD40<W(J':4>M2RU$V5-D)G[,)DQ8Z:V0U>ERD@UDH]W*0]FQYY!-_0$#2^C.
MM@( ?C9:-1F_H^J/XYR) KB^"';6294@0#9U_MPZSHO?=_#(%?R'DP<A)/*=
MSC-\!ZBL_2L' V0HFVP!D=C\QL1*R" <>X.;>8G$,P(+.ZA%3O3E7OO0N4OB
M7I@!F& #W M2Z+&W,/2^%DE,.A]@CCI? A/+Q!&7?@4PB^/5ZQ*F9.<;DAN;
M8$=>>F/*YZZG9O$CNH]]_8_EDWTM:036>7E:8(/?PF2E)I\NJ;C7\():;$P,
MI3,RL1&7?1*7VW[O2ABN97Y8YC2A=MFSUA;6;&Z8(/QF%NU3)E6D2,^P2F*?
MR;P?CHH1[PNCH9>8ZV1'K(FDA-OJT]!]$0D=T#9<D:ONNF^.<OR(,GLC4.V#
MM0)HORLTM4,<8)V2(NN['--&[O##XKM,HM42(9MS#8?TE/);#7G/HS^)4>1(
M8@%9R$L?Y>_9IZ<3"&#=B:[P1]9,=?N.GL/"N=MM@ZCB6"Q $6 ,1'E_@L6C
M$IUV\*DOP7O06\I/ZD1_9V4<7*3)P+1G@ED/B !,/-A'-W%B<M\O:]B?SL7"
M 27?0N"+A_E%A4P= ZJ<'3WYCQ-QS@#;AS=7P(;'-QIE$+:P1<)A<1'P'R6
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M]0UZP)YLZ\^[>LK9QF(HV@PTWO\9#FQHW%C"X$"QZ64&H-1_A6&I+*@C;31
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MYQ7I8(H# ??W(KPG<9G.]6W47-UOJC1FJ7%I)P5DJGEIPS1-?TPPO;L+3Z\
M#P9$+NES6X;W%JX;D)EW8V![S381*RE\+-<ZOL&VB[6[7#J%ZUT!*/ 6%Z.X
M+97:FZQNW+&9J9D$[?V5GKXKP&'Q\.02^JQW!G9>2%C*;?%EE3<+FB>-?2+"
M\[P9KI\6=\!X7*9ZW44G/DO#T> E<RVTOP-=@/==F:W!6+;7* =4VJ#D89FJ
M/)4#\*V\F>,?UR=:[S+K%&P&FW]TK/IL;VBL?Y85DD^'\Y^+?$0GB?&<"SAY
MD'V1QSQR"\-].AD!(G7MHB ">)I.2?EZ+=%SL40VCY'MN!,=B=O=$IRB3(EL
MGBWW@IB^(;=%KP!_C"N#O8>WV-=DAH;TVMFB)=0SY[L%1H8ZG\$N2_;5@YCZ
M0?.B+94W66'KROX<<3WH1:O)G. OU>A@(GE\XB5]R5Q"7NRKL!E6'P*?Q 7O
MODEI,/.!^W6K!S-!U>^7<C%^BK(%1SV?6'U:I"Z3UM(\7C,?*.SB7Y[S;*F<
M"SS[< 4P=CSJ\959.O)P^J<G9\LR)9,2@^/7HMGM5EZ\1SC(F<VJ6,/D//0'
MB8WX>9JN-%C03C2.[C9:]OA=.*]G[FZ:.XE4Q\ G#(IA4U.H:1\J7G;)^S#+
M@"(_TM5DS P4?%"FF:B3J55W,[%]PXC+Z9>U+6D58JG@EU$L8W.-.+7UP8IH
M[:;'#;8(QS^)V@WO3J;#:5&#=>ZI)(L39"+_5-Z6R+M%(\MO0E(@D4<WUXPV
MXA2-#A1^30]Q\77<I]$>C\JUB8 $N@39<5#7V/=\J==":,M3O)O6:%4]=_[9
M%Y#!SVMSKXZFKY#Y0,S51H98 JND#<!= 2R+IU4^=G"7AD)IDYEP)W3X$&_P
M%4 J^=UHO ++>PQ ^4X%G2L$]L?PLZ=(AHJSTR ,2CD]*/P'G\RXH9/+"<0"
M1(#GQQB![<F#?%(NAW,$G,8 2G^4J6[$M,(6K?TM0R1V PK-N3[-\28RB%Z&
MKT%+J.!FDY@]_K&"=3 %@."C>M3 Y2.6&D+47OK>Y*VG%[Y<G%4;?IE$E''6
M_)/H6@7%LOC!8;T7SH)9<EY#^\4IBZF,\A?.@+&:D+=,Q9^$Q)?3B"$AA-UB
M +%P$XK$Z'?KF\L:GN1M@_CP"SYH.W@?VM=J*<&)HLAX&WQ8-/C]D^A\\^I1
M%L7",X/TM@NX!WA7GDT]/:X.[JBI"Q3?0SJ(?D&O'!;?HQ9!.1E,A+"3TW %
MT2$;)&X:G-C%$)T[+<OF)ZHJO>#-WA40,$!^'&*[@/\0/V :.BR20K)_U3FA
M>POS5-D/_-X=$OZ9Z:AX\E8"_'HJ;K)5@1U\ #WD L/VB6%!.TLF2A6S\2<&
MS%.'@[SL'SA(O/,_MEK0%PLI*JSG.VIX\#([2/IB!T>>FX3:VS4!SQ'=3>%N
M.\'XTC\O,P06&610%!4'D/ /)5"<<^>X]_W&;T*$B1H9&;4*?6T_[,V";RI=
M=YF^S/QQXRU];("8;1VUCM)FY_8K[G5;U\[?,E.>4Z/N/L@?ID$W/W^U9PF)
M!SO\+O5=>.*U?^\*P'PJ8+P;V+(S4..U4*_E\$4CW\W.4CY9XU[.8-!@42<0
M=&)4'5)Y4*QCO2W/1%R**>;P.AECK'WYC8@\8-2[76GJ!#:D/I% DX0T%#>>
M=0N5:W'*3I35Z&2#^5TR_YBB3)PHEY%HX[@0^)Q$+Q/DXSA-"YP%LU9C#"E#
M,W6<71SRRS;T^4G;Y]'C=%^-.QCIZ?KGR0N_A,Q6=0ED!6.(^6:MU(X#)C7L
MS^)HW&H&>EH-//P.L<\?>WHT9%$EXN--V,QT/?^K.8#_E7*6@D]J%0AEI/L;
MBPZ@0]X ,YO1J .<#S80!M?_OLYM!W'&*PG>9Z=0VND29#]1Z,TC7G00K>Z2
M=-_0R0OA"T_\6\R*# C6MY+>S8Z+HQ)DI]05F=,'NX'Q851_@]OUK?[6O?K_
M3HXG(A8GU_U316&B8?[&V+R0WB#<1*4D9$);9*8AFD(L9N]C/5!V0!]8S^8=
MR.<4]L^,'&QT(K5?9Z>,H \LR#OY<'%X_F,A<^'%8 A$Z<GU2/,+\G;7V7E$
M@%)G?VH);I:7>I)_G+J?!=+36FA;8$M_>'BY>_Z#R#'W7[]84L\Z][-(LQ,]
M_W6AVXL=FL&0NPBM;Q=+)R,-@2H$Z$TE[K7#OR>.!7D#JO7=7NC]^P$Z]X\_
M)<%P$T$OUHW?<MO>C8EAN6Z,IQ,W2UD*SC>R. WYZPMSM ,W]![+[9YO_A/+
MM.JP94C*<G23B<N8N;)J%?MJDT*U6X5@6B2T"E,EY0(FF]$?>V_ITQ/YXT3C
MNT70L8,AS+WQVD]CLC&T9+_DI70>.!2<_R@',+%-Y+V_<%Y\G5<4\S7(1ZRR
M$ T(&+TCK24F/EMXK?2T&96$W-TZ*!8#Q%DC]92 MV*=-0T*LK3 DY$QXDB#
M:OG&9NO</4KGOMP,9RU::*0-OFC]3>,G+B.-J& Q]=-1-_>5VE?"Q.GTJP:E
M1CB"(MU/VZ&LW-Q?,A.R.^\J^E _/X!:#!NU-B*XL8R'$F?2STK<5/I]PY\/
MO+WT:4R<:/BP8A?\::+.^_W%(+^M*ZBP6(G.D(54;+]Z.5T)X-6(>)+6<\Y?
MPIO_!V8.?\M>JD-XMOLEUVLBA+\Q?G:W:'"['O;7_T>-X[RHNCR/5#I4$%,W
MPRD!1GP;MQ(6%QZM\3'S5B\/DQ6@^5KPN?(&6!^8J-0_&]FEV<G#X@1@"=RT
M@\(3H?1I.KK-^JY#?XR^/Z"M:U'BXA!2E5<'P5PYJ<\")C:GZ*.\*/I'L/UU
M]V+@^\_1M1U9%""%+B(O= Q'[&@LP9A9Z!O:$$L]38[A"^T":-@WF3,6F^C_
MO%;\1XC/OX[6D+_IN31[ !+T_"<QL?8CB-YCZO;T.MJ;\/([Z@'I[=P8$+ -
MPY.BQG2].+8<@: JHH'1]:NCMVHM]6M?T.>ZN=X*X[ 8)W+.:1-C,9,@\-#M
M6*G./%<<+NM'4&G6U<J&34H>J;&MKP88=*'3/V &I2',WTT):,K1Z/D8?TX$
M(:B#C\"SG_\PC9/R)/IDQ*-B.+#VZU[\@/2V<6!DJ5WU"?WEF:X@]U!??S#S
M0P'(DYF?^TCDR%&QO/.Z%OKB-=M@;,70Q<K)*!!S]CQ>HF<YW-^6S%, =<:5
M)B^<+_@I>2V6CF@DZAN'!(XNT[7BD'[P J'=/W>0>T89GHY;2 _#J3YZ$#*H
M0M?F5CL[9B)VQ"??&OC.4;PJ8C-82I,:^7V658%N*=#1KV? B\]=,N=GU:+/
MUD14Z"C+[ L]M:.M%^[P]8'T3O J/HIORBHQDZ#4OB$W[W2Q=-V!VEP?L,F#
M"0;);O/O*,_IN3+?+!5-=T'H(A+/<J;KSTD_$)BR&$8D>M,\+,B9S-M!OQ8,
MU@]VG%EYS2@V=)&@Z:DMZT15$EJ1B#"!Q(2?:8^Q"G=).(NC$Y1=TL\$@&-G
MNJZY.(,!@8JI']V?'0-"M:2B/_;TE/J9]706@FJ(NY7=\F+L[TH!B\R 8]9Q
MFRGI9#=*'OT\MKQQX?3M9>AQ-/B+_>113=ZOL6 7LU4@HOLNIZP33EO?J_Y,
MKY_3UCFE=4KTO5'UT"OJFJ0'4,:A"=2,WPK)OO:BRQ7 :<8!",8'.T\3:FS2
MY3EW:&/A[E.R/^JY7*\ SN8V8+V+8F?)%?J8!]12E]40F8/L%=5I9FPA1(4N
M<^:H);+D):9!DF0T5=U#3=:1[+J]5V9ADJP'*T7F-DBO9VS3FBH3B6="!)9/
M=.3/S7X+A$;H.DO?O"]<_0FD;CM!)N<O45S;;UW[ZJ#+@5VF#E=WZZNM'N-\
M1LUZ2D3&:@HC:_*/5BD_RV7%A9J.V2(FZH5D,D]!VC!I!$*OWD-(/OF9$8FK
M&#BJZORP2-G)8FS$P.41^-1$1XJFR@%2G#&2<[%<ZU>:;4OV?;=(N8  T5Z)
MSW3VUO.46)G(M>U$$^@%&TB_+!?>=9HN96#<QI>^_7*P=3KFH2Q1W*H"6!U^
M7!Y;JO+7A)<G!#.NM<5'>GIX0>F^.I2?.S]E@$@>%%N:LCV"4SY=".'SM_#>
M48A%6Y<]> H>%L059E'PY\)BVK"2-KWM$/Y9A?#8WWS+W]FB ?J_I?:NEQ+,
M;W\F^M<]I_@3-C/B[H!_%"]F1BKJYM)%U+B ;I*G$ZUISC*-@#6?*->F+11M
M3/"@2]T>?>LXNP/6TWHVL3>+PE+_UZIQ1)) DT1!ZU#](F&F!GM/D_1@"WHW
M._H9%,AZ< 6HVO: ]AX4E\^4#COWU"J*# #L_$VO=7#T/4FNF)9BG9\=3083
M4ZY9E)GLBY3Z)SP9_X.S]XZ'Z_O:AH?1:R0D.D%TB=Z9$;WW-M%)&)W1$RU"
MD@F#J-$3!H-1$J.%(,(@&9U$C1@EHT;OO/*]V^]YG^=]/_?]_+'_.;N<M?8Y
M9Z^UU]GKND1<UV.25W0/P)*D@(<4\J>MH[3MC3+O?<" F,C?-V,2YY=C)%4'
M9@)T)K[<8VIJ>-68-X))44D"P-9NX0X#-LQ?^<Q^@/QT41N4D?O1,Q,3*$2!
MU6</9B(]?RE^_O.BS:_;I[EY$*,/<RL5O0:EV%6JO,X6:_)*]F(IY%9.Q.:\
MA01T]>Q:0 X9C%--L^=G3X$H7W"?WIX2B.K.%S5X3@&^"^7'941*\F,W>X-B
M'JT\^6D]?NW$VB*HR)V7*P/B(V0FL3-DA,UWG&P\C#[9ETM VWB*9&P=6ZNA
M;((7*G^G'%OCX_*&S-S1'G7K[QTDNJ'[5>?<RSBO^RA&;LV_><XF1';M+T47
MFTB$_:,AJT*O-5[3B)/%*,<'43X9S2@IU'AC)'N&6<65=AB%P(L?([67ZDQ-
MAM/?A?-->0DJ./94J#LMS'.TQX>&YCRR6=*IJ"5P]TO229F]>%GV:]K=XKYF
M4-:UM.$(\_I*I@2FWA4.$8.>,HQ'4NK3X>MJW:"OG_\T@_HQ214W\LPBTV$G
MYH+8G5P%+&?ZEMAV?JM5XZ0U3YY/"ARPXFO>H+(ZD.V/Y]U&!5,'F^85HM7+
M:@;(PAF)AO[FKI>6S9;]]RGJG-S_Z\?57RSMOE4A:.4H6K&$^#7<<U]Y"(A2
M1&B2[,)OL>\:D +^-C8@3LN?K=,W9)[S(#*&*!3!A;78EW,'E,P_Q!F2 "*&
MGBDF#O]EK'N:F?-O2(9_6?#20++_@5#W5%+PG\/21519$QLP:BV)IR*OF_^,
MKYO=BC\]^1Z@ U;15(K%8LM6YTS8>E3KM]9QYO*[Y"OV(<._!3OVWLT'WBOS
M+*+/>PS3\0[6-'+<KVX'#IEB(DEO 9-E<XJF0B,52DXY2RWR9R*]ZGZTSW)E
ML-TZ+=YY-Q]02FN^F;"<E]F2,M^X9A_UY>+W6?D_#6X!4[U\#+7G5M9TV2%%
M?0(U>FL']PZUE[3^-D$183?&QG+,.<OU\KX[+I7]Q_5R8*K;6"]^&WD)>)D3
MZ87>&;VZ2_%7X\WD_AB%>T=OW#\)WD/M8U76_M;$_5-#?U7#?9+*H9H>BS'8
M_8D._@2)#H@6=A0#-8&$0X'IUF//3?=*^_C+ZN<#[/TR"V>X,FXG21R2+VEV
M[.82@@T*(>\^>-*H^GNUCO$^(PZA[W^_36\?MU/FKWWWT1CC"EF)[CYP4&;T
M7@J>3%4U_4_F?)X 0;-C8>O.&&4?%V1PUX^H1V'#'KW3C;CV.,!6_GGHM[_S
MXB2#^V%?55I\PT&PEWRJQ?;ZS/S&"D&GKI.[PX[NS(1<N?'6:TXB@$7"X\^S
M=%[O$%-\\E,@82L$F3SUB4G,RMEI'E$<!*)OQU;5CK;WLHGIA326==TJ: U%
M^BL]X.B9I+QR^VB;B.\ 1TK_$QZ!S*J.(I5(QM7XA=A[5PYA%5-J[C(;W>S/
MB#&*_FW^?-&#I5\",IVR92CHZPSA;K4]F76:"CP-$5-6<)&M?<)U[I4A\V8Z
M<JE?/QEPC[EUKUWP?#06U67&EU>MW:.;_-'WB1L&F7=R,O4WV7PX [UOWEG9
MD/EYCKMMM9OQE5[GU?W%W\$%B=$+FP:6@BZNG5B,8XN9ZT%%+;O<DR&2>]1D
MW,$5@UP&.:-O*)<KE/4+8#F $0QSO#;&)2Q>S<D8Z?N 1H,<X[I6P?8="0B\
M@&QNP-\ L(!'.:G)4BB4!C<G93= 2T&^6]O_.5,XC]J@0KD $4*BH^CA3WHM
MJR<'_"U]'Y:V[3X]N_\-7%V56"H(I$TY/AZ4X1428%XHV$ZN#T5]"7?R(*K]
M$H:#9%[[&J=+%=>MSX=B/OYHSI#%1\O2"Y0FX1/B*6Z;0+MXWYA[>S&-$4KQ
M(!Y^F9U2]'B4-N]9$).#6,B8G #!*OH7;UWGH*<WE?D#799Y=O,GDZJ;P\=6
M7^0ROU?NX'/8C,&!M$;SKE&["MU*09^>-FCF,.0E#HF:O^6%1]#T\#L1=9/I
MZER$H0OK:LJ7<X+V:%,\:EFB6Z=[:+58372Z?<1>)ZPJ($]IPF=3<W(INOE-
M C5YE<MB1/PG>?UU2DZI@A?R8[Z0=A &(\C.MH^LL =/PI5',S_+L!<8BDNT
M1Q !6;8,S.45> D/VIU??4?*VVIO7"UQ@WD/Y!<*3R>X79F:O/'8KW#:1 VB
M0C2WQ-![1$: VI1D.U+?_Z#!]:ZFR<7<>]=&9: !-8T=)Z#,^0B_9GD):!!5
MFWFP7W(Q5WMQ>&42=9P'R#'B'R\!H7OEB&87ZZVH^N</:@'7HR%DQKN7@"#8
MAJD>HBO68G%;YD7DNRK(ZL$A?3PO?S9#=BF'($/_U[0'PUTWBGC9AWQN**!J
M[3IW2EFD$Q00\M5QZW47%NV/DCE0-J$*6W==(BS>W@%!IDZ%@_%PU?ZXT1Q1
MD>R'=PBZ2U_ALW\O2E-K]- )O>B4P$TCY=6EZ)2"T3\_\$MT"T_W?,IF)'J^
M9(PEZ)FYE*E4AO8E%^0-.24B9DPZ.G269_4/PAU+O4+7MR/@-YEC>WDR8C[+
M?HCM1!7KR@*\'/M?,?>6*IL*BC5%!=&4,SRE_8GD=:.)L]P,SGU@-7F;,/(!
MN<U4["947,1:$$4GM5^:^YD-R(0S1-]^<EMU;&S">9#O=!=LLV:K.I1WD8YM
MF*;V64/LW\PH[_*'%RML/*!GK1?;*S+X\Y.=VRJ%8:Y)A%WZ!Q-!536>Y/W3
M\!JENI=6=L1>L@]Y#5U6E!];6 O%)@]45X49C$,CAMX(#@]?.ZZTM]N^X9<V
MRH3['4/)6) Q\4VM 3]2-2(@(WA^(%_6>6L+-O5&D S?9M=HPNZ.EO;P@O2$
M\=<_<RLG;)A,:=$X%>17+,00L8]S<^^$#ZYH9^*PG.-N@MSF#31N4=(Q%;PB
M4R4["$6J;$'7+:,IB8( ,-.3N%&,3IU;",[@1EYHV8M/GH":Q?D51(39L79!
MP;[/6Y+'B/H"&_EW'5;7"A0?FS\CB;#,2%Z6/DATA8N2N59F=G"L(8?14G2&
M;ME9[!'?M4L8EEQB%-JO3ZW3A54SU@PZ)"T@::FM"^3/"8R ;09O5\[]B/X;
MR]'"L;S'UBQH-DNJF2&R$HDG[VJT'\Z]\<Y-9QU-%&)>82327V]B;'?'.0K%
M&>[$ ." TMIK$L:G"H1DM(.%F0+[:*;,_!#I;:+Y%/FR8Y+$>9>:<(^PE8+Z
M>.(A4M"'/#PP)S1=-JBRDEDY<?1B(!%V9D'TVF=GLE+B,]5>)<C=(;^B'UPA
M9:"ILR['.8F:PQYJT+@W>(8]QZ4.C6>>ELF(TMTS>2\B8(R6G!HZ?M6!?GS4
M]4U8D)?J>)V6@G9-FAH L#34FUPB01O3COA0FV=I.?1D(SRI#72?@A0_BKW<
M:<*VV7D]E%P,OG)_&5S>EJIUK5IEDW-;1>6Z& X)DSMX%8T7D]0RJ>NSW8U5
M$5;C0,*]&\"1PN.:?LEW=/907AH>_QEQT6)A1KZ+D:P.N@1(O =T2W)(B\:D
M2$%P<",ILT.>S^_B34@5X<*O_B,J(^CI%,XA(F<\L+V/-M3WFVRNVI"1$%#Y
M#0R.,!OY[^>UOTM)_"]>BG^C,S8; :;JWP>4J([5/T\%DRN;1)838G4BS)A7
M!3D$*ZZ9$_$M%QJPUW6<>1 9P;I9]J0YB^'BPF"%HG^X3,UH#O_2O E!2<7^
M Y162#+4]=]#5_]2!)3:4![_+1PB38#+JHJ1MBHF>>"B-<+JXEW[;>\HIL$4
M_46:QT,D18L!$QFAI,LYK9S6,CRO9YB*J*Q+GJV*T%P"JOK.1-Y^?$&R!#L7
M87^7J6Q"XEGQ)5HX.MW"S>P9,$5(/85.2QL)4+"I=-K#ZCD+A) S(FT'?DT\
M50# KUU__VE(GPKC!'I"%U'@62GQFYS)SQA;T'XONC]&2=_U-./$8IRI78).
M^+]FNBRZ4 3^$'Y6M%S:RO:N1RA3%Z-H0MK_3UH9F#W/Q(C,B\ML+.3)R[Z]
M(EI'!3D?&DJ4"+6A+=)9!!CW(,;)Z;]@DOO(K(IL>BXZ+)\31J5Q^75@FBC&
MPXHB/^4+IC"\^VSY_:2?(3&BW)^);$YZ^_&?%"=Z"18R@F-?=%D.BNA<!!,"
M1F+97Q5F!R,SX-\ S)7WQ3O<3$AT/EJ+JI4O@2U2X9F:O&5ZFD3I9_4T40B]
MF2B9"40&#FI*I!HPUV(Z$LO$ GK\D:= C2_"S%7R?$XX,HY# MQYB_@])EG.
ME:D/C_&*'.XH"=+F$B^B%VYK:,UQ"?DD9< :25"+^<&T"IH\F+P$6 E%=7NW
M=RB4!7#:27^=N/B#,C=H-G(,J-$[9:K['0>G*_1!F#P>DHJ%>YUJ?-,YL_RQ
M[_-P-#[@R.JBN-P&&K=L*<^)>:'L4T8^Q>LX\(I"=;(J<@.=C.2:4NQTW0$M
MF4=_]G&1%VPZ&2E+\E8,]P2QBG;$G>I;,[-Q[91%>W@>+SGN5/)V'W#<KU'=
MVSK2]XYN:GT\NN1DX75NY[3AUY_MM_\T K1D;?S*.^#P5F&$\9'^NAQ]:K2B
M@HU=N8R8JW+E>8#Q:52U]FQT?U7T9WLG\AG'@3@\-0!6%Q$QNN0<2/)I7/O/
MI\@ O4-(%RP!.Q*'UU>[!(@^7S&\!#Q;^!'TPG5-FQ=P"]++3K8R5="8TR/[
MZ\->>3("O1U+<79BX8?_04[,4%@#40#79RD.A,\>FV$&WM-O1UEJA.V CA=5
MFPDZRB'MN_T(+6GU:+]*AQKA2T"&6S*=9Q4L >>7S,&O\"(2^O-/P1=%#9"B
M K/=9U7.<=GYYP?EUEVLU4:AUAK*D9S18\D#J6<1V<<N7/GLB3?$<[L42\FH
M'V4H2Z!20GT/T0^W3Q*6N2:0JJ#[\L_WBS->=*9]SD%L=,ANCJN4)E5,-=QO
M$'%Z G[!Z3S8 ,5BAU)3 5Q)-YWK^*P5O^@!:+$89?LUS199U0SMBQMC8A?%
M^Z@TK&DU?5IA3Z$(\>^6"6-FORC!4Z.Z/.=F0K>9'U</V[GVFHYR-(LWLW:C
M=&!M\Y/9U=_BZEP.PB",UYTFVF-+XR,CTP_9[1#H]NKM2X#IR7!_Q]"MG$\S
M/G[]:1L0K''N&OR=<C0#:!4$<3PR?G<)*(R>0%A)_FF>H']TABI=L>TD#UVR
M)$]^-W@2>SSTY/'-Z+&H^L"ZF_$]==BYLPIUU=JNH[J?\"+E<"Y0TSDT^I=J
M\D585)O@DI,=%!,H3WMLP1GRGIZH;J_\$O!+]17OM:AZ>LXOVB>QA78C2TX&
MH ;VL^YVX; XR^A6+&>&7=B!\BY9-*OQD?&-OR+955'XMH(>A^BF\1U4!!RI
MKH,4#M!!VS/:?)TG>V4U"![0#G:_.#7^V_ O_8P5+DB"(Z6]'^GCB1_;]7S1
M%5SYTF'+Q/XN[(^OM*Y[YS%J&]M>M&9/4CUGJ[D&[Z_;9K?^0@*6VGJ@<2_K
M(T<%,Z<<_J.M;<DCCK4![[$[V&\=K/O1G(Z:+V]PY^P$$U5+(:1,OI5XO:'8
M2ITJRD",>&J:6+B6[9:D:@F;4HP/$T&M/K*,^I1N_JC6UIANTP)1K6WVR<IC
M/8=9B]]D:CY(1&!\:3[04 UD\?AJ1XPV#BSQY$@K*IF>UDHJ6B*/C3R1*%(R
M4GL[U]1+P/?2&.L.%HZ3D0UO8%. :19Y8O0^*M ?P!$- 43Y2TVWW352A#LS
MVT75C\PXT:D($@]QW?68"32\G]Q#JQ1]Y5A*7K]5,X((7[3@-^ DY4XK*'3T
M=!7U59$4LGR)ER';\KMH4WF R!L"]L@%AJ,W9!*^42WG-^1=9%26&H%!1O4Q
MZ 6H;GQM>(UJG]1^==>71L=F9_@O*^]O'D![76#Y,D8L()Z_SF03F'@)T)O
M1#&:D&MZ2!:MP(>M3#Y=8-*\CTSK+6N4$DU(WY\YL5H&TBUH6M$5N>X7Z93
M.O:*J!./V6*9RW@S.\C7+ [/BLPSP66QHU?72^W$.=/="XPAY>YVR5EK6VJ%
M>4-D3_4;DL7=%<Z$7QO^Q-"*W\.N@&_%H52B65/=@(GG(O(&Q;%&MM]E>*07
M^'3[4$O^+W3EJ[(WVR/DBTW:IBGQ\+ND#YK5LI]T4'D:M+VH8JO<&*&+,.?]
MQ-O^"\Q!7XAI4K8@!)GG3\H,B)T&"VPC#<&'9^5W/J#@OS_Z?T;7EWWM=,8%
M!GC**P=8&:$Z_IYK,/-.E='UU^FM6F.1"&J'5%8X/IDLEW[U5FSUZ>,1<+(^
MQF=B-;(BXND0_8=2<L^">FFU_^1K-R)EBU'Q3#I?Z&+!\L?*.?O>_>+.4L[3
M3O-CUFY\&9T%DL-;.H_7"3*]FNENB*#Q:8;NIR$=CW\7G02C%;@\TR#H)/.A
M2'YMM+E77,,[.3'$8W/!X;\L"A,?2+OJ!M6,=J=9N@'\*&Z)=?+MBA,H8&-C
M*G,^O!BI[TYA740K'K8XBLI5."C[[T%TZ\"F,N& OU"  PK(_\#8T=>!BC/
MYO)U%(.*=L&T?0*(IX4Z9(*$/"J ^IA903ZT=27'1'%;QR4N!^*Q9E1Q@\JI
MPS7NR)P IP!-I!%-_@6!?EZ^G)FR3]#_"R^MFIY G)EB-B[V[!_GS8!C$B?&
M;[3N"O_?R,?^O\H-7GED"5;AWTE44E*$H!)@(GD6Z39-#H\K]Z5N60H'>UVI
M=;2V8>_6)5$@U0V3$^Y=9)C+[TB"C>6D<SD(I=1.[M)!M\\VU@6;:)I?].;)
M70(<:A>_^(83[$F^A<203]15F\,*),ZA1+9\ \:>*>F\'$(,82*)C\<^.:HA
M/(B>/5..LAB@#O0$/V_JW4<]0<?="=\K(JM(:HWB*6F4;[*3BQYX$3U;215K
M)_OS @,(;G ZIM+=&*FR5%%Y!98:9;?L_T^_!^Y/%>BI9#6@%6&Q262>DW"-
MFIW&)4;45//1:L3SR2*GN'L_3(@]K3^9K9OW57VDOO4QKW<]9 4M95C?TM(D
MB7O]?*+%XZU..JF="3&6]4NLA1-5Y/_KN>K&D/]%W";JK<CJ8$:$50:;_7D8
MC03 =M0^V8TB>+?,KX5RK>A8"RC!-L"]_<\=A#[*O@6A(1W3B2[9_?Y@1@!.
M\KX =\&5_0PJWOPN12P-BTN$'4^<F:,<VB&  "X062F'L."/FPI<>IFQI+?_
MLGP&E;8D, \([;G$<%O^" >=1UC[!Q;ME_5]WBO'<Q=HXPT>W7W[:VQ,73HY
MV=M:^8E J;HL7T:T\&:-'=9C70GHP+30SO#SP:H![Z!#AG^R>*X*R9&?[FRL
M,*>*4%D7Q.QLSC/*<G%MP5[/0':9Z=X97T2FN'Z ?4I7P\M %?U3>GV3 .'3
M[9'BB_Z12\#*^PM[KV^@7[?'J/9]/>]MX-3+9*(Z[+ 5M%)ZL$:<8W]!D+U$
MP&GW665_UH-V*PZ87O"&QN*F9[1U$XRS^#RI-'KP(;9:Z.>/E@?!5S+NU%5[
MJM!Y7,R-13Y@O*C^O(*2344&[5KOE+!:98Q^<^QOK?7*>0GJ+M2+/I@]VB]>
M77^"+4\2T3.]J(L6-EY/$JC>.ZO\>@EHV*?9S3.9VM^>?Y0UWO6&LT0ZB9O^
M4V$&4'>$\A( :<\(=UD+/>_KIJUV7 %*1]HC?N_[K>=SE>449LB=WM*Y!!2@
M"I'AQ@<3Q0CT?O&IG^E X%BD_7-)%?>K6MYS3_=11OZD$J%EB[/*OO9&F;O=
MG^JW-F:UFWT5A_<?W77]GI#ZMO828//FQ").9V@H</O"$E\X'8%0HYD9"D;K
MQ&5Z%E:J_OKVF/S Z)F1.O;8/"'U':><]EYWV.\)S#589O%IJ)EOXD^(:L7I
M<XEUQTE%_JB=* M=I$=QL<"2@\IY,PK8)2-W^MA4Q195);5)6_!^RA?.MO5V
M$"-U>D]K(+1L::2U^-3W$O I^G-LE2?+ZH^*DX],@Q!#)5V!+8&EB3)[$4U0
M>-I.#??%U!B9/R0.O6K_!J6LQ#'HRFKU# 0']2>OMY'0MW,M.<B<-Z+<MV3N
M'2PC?X9$"D=5_96H<!)"%[47G2$XLB=U%G"EG.-T"T(1 [0?2[[_\Y?V>&'
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M'R<%V5K&>#9:-N6KID_SOA;JO;!C=[_:+W>W^ROP9RIMJA[B;1("K=$JCZ9
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M%@W7_F:G"Y6Q8?GSM2/^+XE+<K[$+\0P)5A,<.R!ZYP4T-T#"A6-UWS[."3
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M<G^'G6Z_WTMN[O%Z[$O?'T5TR5;;UQ7KK;8R53/T=3#A*[ONKHC6G)Z1*N3
M:0QX7P9]I_?5B^0E [J:C91I]7H?D@C+@,KM 8FI9LR;/%^7  -).0'^&+FE
M";W%.$M'LXR>^8@)HX4.,S\L<+O,67)O*A'I3R\#,QQ_$:PM\_(P>0?U[+$U
M7%1W1DT\0Y("Y95=U^9Q:UFFO"7/%T"KF?"F3-/TUM=1Y2&_=,YV/2LZEWTF
M#4>!P^8RMB\<AC=O*=Y]E":COX$Z7U4+:\,I4>>U:[KG+IJ_#BMAA7.6Y5BQ
MOBG6=)<YN0D,9?)4>A;02=!\_LW8M+<D,3;-F(0A1UL>HLD\6F>MP"A:-F0:
M6/R-;W_#8@I,3O8T%9J=*4\PN ON6!Q7DS62PBGW%K=)[#%^,E8SGNT!LP=7
M>!\K<"7)#8*R]#0RORX>5$Y(Q72&!E=I^F\D%D2,O;J7QI,R2TNLN#V260DQ
M7/Y2$F&9 Q"B_/L:<T.Q>LE1^-B)JG"OO(5<GG>\-[KUU=D*#SZUCEY8&ZA2
M5-^SFG"8>T0Q@\@;]P@^3>-BP4[$^RM.YU__O-&HK&-<+4SZ9R ;'4L<95E8
MNOI^1M:Q1H^0MIS( -G5I2Q6#GML!.1R-^[/O010+.=?N0LW=M# IL9=)+;Y
M +EQ9X9FZTA;^N?Q?&&&3*M,:=U@2F&&QWSJ7")GWO#@W?E'A32$IDN 26&&
M\)&7H>.Q4V$&U&E_0ZLK;W0ERU\P"6A,SD-RAKH$_ AAC_HE?U#Y7!Z/Y!:%
MP>UVB',]6L)[=VXD>UH.!YT%^'$M6<%O(.K?BNOV'187V'=4!;T"M&]O<2WI
M25<"M+B-^ZO.MVH\#6@.BW/ ZN=9#Z]$Y3V[LO;>@<8I>:>6\8.^]>+'@27+
M"/>9*^,V>5/^'[$$1[P_%-X&";\)G5]! T/)$(](R'7K!$#NR3O%ISQ8\D/*
M00R$&[\VD:U.5QC/_DU4[3S-M7"?\M@LVLT&?WX_RM*5G 7)%EO\YI"X\4#S
MQ24@*^BLG-7R)=?JC9U*1X=TR:5:P>7(#O15M\%-WI6I%,)-/M=>XWYT+8"H
M $J<&&C,X7%5CSI/?OC/Y)9%N_U84;T:UVDQ>4E+M6E+6VKSIDAUAFOR/S=]
M:..+G<2?5?3VGWMTK*5I2\?$0&5Y+^SQ_Z@:?OX9MF$E6]B3?EL:IB-J==%7
MAS^DQ&*X)F_:7?Q2.*A44I@OC @ 7)-23T]AO 2\KPJEGQ%8TCZP?/&/O)K@
M%6F?08C=NJ;C>B[G)XWH#*Y)V7_$+5,@X.2!HVWLZR$BEP"W'[L7B+Q3TRNE
M+@&JA&/+MCQ_Z#.N[>+\6.M35JS"J6*4Q0?1FQ*/Y#,"?@O/LW2;CH/&\O:Z
MV7&Q.$](5:BOZQ2]:[=5_-O84#ZOEHJ9(EO;YVAU]C?X/-,0TC<8!3YO)Z(-
MD_K7-S()!A* 4/-/]L4%0N*<BF1E.O/86!/IRD2Z6:BKSX]SH2*%#3TR=]>&
MRJF:S AKS6 JO1)6G)<I%Z]"!5')2GEE2+\.FS8G1A]G(O[88MBN_'<XLH@-
M+MFN=U]+6R9;AH1*?.S=OF(FBN6='1 NEP<[LO*;OM:@'T30^UZ'WS(AW9ED
MX1"T[L5&#'CM679X)GKJM?T&/I!7';LE'*8\X3&6@6V[-XWO@1F*RSBG?'2Q
M\U$1IFZ398GEMN1JK/8O6S.V-[G="=(+97@CANQ.SQU[TE;IJ#-Q*([PE5@S
M5=DS=P.I?X<C0P_">HX&<0@)W5A,^5P73XIM.(>4G?TJ@RRX/VWB?<V6;W%*
M8:ZOYW)A- GA=.*XC?8F,&K8I*--RLB?UQD+&;BEU^Z?9UGN.YP\X '4F@Y7
MJI6=* G<[G:[L_C OXQ@Q=MBZ= .(8.&YR;(X^1"Z"1PK@WE+^^9YV2=&HDU
MSVK&#.VJ*9L_>^XWBG:C50,&HT#UUX"#C#&CURL#Z?FSPH&<^5[<CMP<5SL9
MMB4.>HYRH'6 "HC*^1%3UGE1$:?'Q?@K9H'E#<T>CX_7A1E:/VGKO?,]W$UK
M2-Y@3-PO"V#MM^$,L-SDL?WN6;LR5^<;C"2)=[6]!$Q]\+L#,^/9WWRA*VJ\
M9M/(:I>*(&>"G1JY<\D&:$_K^W^.M67>(GDAD3@Z#XC\A?-HA:\PGPM+L8?W
M#B[I?:ZCZD/$F(02O59 ?:$@V]S#]9.Q(6^RJEL>IF!FPAQTN T'&,77[$2S
M*&IV+@'"6:?V"R:HCW]*G[M^7]X.QE3,MVR/-/NX8Z&2DEI=.;^039D!39D*
M:R:,>)B["JI6^LX8WZ<0W['4;[R^316FG^0[@00S?-YNCB%1>=9ZWG*)W-$K
M!9:J1Y(,&(O"SV6C>_;W=Y:T,Z=U5] Z;(J:7^WF[FJ!E;]7$SY+CZ;$2,"7
ME4&_)/Q86U_%V4<\6'^AH;IA!B3S>G9+&W&1WF=D=TU!1<2#$""U*;VUWML&
MC8T)6X0_/RR9%PMR-U0?$"*4];25:Y3 A*"B T3D.=/O1VYRLV!5,TIK>?:
M.RA 1[=L/VLJ#PU :,]4A_AO[+_^?QSO^%]B'U2"C*Q@+CUZ#D$@D-',B3CS
M=>)0C ).3(XW6+&<.+LH;L.X--%7V8S(HT0@M5N,FTHU_?DHHP]S-T!,0'7,
M9T4ZF\0$&"_&C2QM^)?D6&7\_YXL\G];F!A3BA%/D27<G/5$R<'%E!\:/BR.
M<'X+?T/ !:UW,M;]%LD9WX\/V7%9W),F&O1LJ:HJO<,Y;JXSNO@:QM=&N65_
M,_?M*Y1R7]J2\NX#<ZA_-]T/U\Z#(IK'^4D N#(9<1VN/O6U,4\#FWZ^32U9
MCO.3J&TZ:&R*@R9S1\DNQZ *J2>;1X\NI,K9;$8,</]]?JOK7$H3$&,K^^(6
MM[DFO!:?#!'MB'6G'N7<V\+ IDKM)21V8:8R,;.)[*;EV5L808?Z812CK^ %
MKOA4BC=>NEKD!H=;"JW<J6WV)4#QU:GHYG+^>18"4-%4)31NJ],MXOF>,YU6
MU)VLBC\SK@FG]"H]/EB(: 55%@UM01M)[^WAA$9O*,.M;PE9>-[%[0:7L?5T
MR#R4_F$1V#IF?=,5Q(WT-WD(O;<XVZU_LY&/F7&L;G".26CD%^\R^W#@L7[*
M41:[S-57^0RNTKI?I3WJ0D)*KH("?3!%4,B_6^+5BX1RI9"Z?ZU "QPX36G1
M8RRS#!WUU)N%5[?WRI(,N/1P%P/V/7EB3-9I8+N6J7>;"^\B+8DV$/NYDEHE
MR0/E!F].FXMH43*]0_B=BI4'QFV#9+5S8C/BTI&%19T$,.)0:SOH+HE8YWYU
M"W73YC7) LP"U'<HOY<9EO-[KX;!&&!SR"D('/.H-KK'>+OG;'QLFYV%1:&(
M]J3K.X:IL<&-=I<S;]176=VO?OW*05W"Z,X=]P3"=&B^7P+T\YH%6)9+0QGX
M.Q/',D^>M'\NL4P8^1JY;5[>)YU[M('=DIAH:=I?,Z6XDQ"P9@>#LK  QM0-
M4O*;?=HA]7MCVB[!1]3NO(R["VSVS;WXN:;]43Z[Q+S(B%$N_1 '.=<U=>![
M8P:(^*K4?O'%=1$_TV[_*Q?#[!YWXXJ1O:1A\PH( MAH_\73L,^(7V"S^Q,-
M68C^P#>X[;JF(TT@4I@=K8;.T$T^4?.,?A&P]9=$YNGH:5=!WG=:SHS;%P>J
M]>^A1FV49P2BF;OM7@/+[(]'Z*]!&L @M'_[Y.OMP^9#%%V6H!UMETIX$=W8
MT=,Q3HJSWU>#)(QR:$5ANN]F;G7=P+8IG=[I&,0=CP+K_ZE2@=*_\ DX3(C"
M?.&0O>\/*[0;;7^?AY!S7P-SU&Z3-DC:1 6]6J!VZ?#ER@_@U<\.53T;/L^X
M>PE(3ST:(O=]HN;3E-0UG0/ZQ=UP\>=L[54DOZ7]I,#W'.\(N\1P@=TB=Z]+
M "5IX^'S%>TS/MFV4/J!I@](W;Q%_)K^^>LO^*L6VA[*:IY:0)J_61K<&/9-
MYI/O-\Y?=P921P453K[&<\FM@#G*MVD;PIV/1RX!G]6@@[B_+;*X!;8>P[0/
MW)Z?SIV- AO^T28Y=Q_)R8U1Z#SW>G[Q-:VP;0.G#/7[@#K[/437UZKIV6:H
M,2> <9#"!8(FJ[[NNA6BQ:&V\Y510=E[BOB%,(H!*#G<";M;K7\JFM;A-U#0
M8BW?>?8;6/F7SV=Z(NOB>JZ+5$%&W]>WAW;)/=DY:H,*9[\9OD=_MO33/KLC
M>PJS*QI^3^\XD+P.^\A^$50/K/C;<:I V=0GL6 ?F\0.3)1SA,"@2L;JQ\-%
M'.YG=ZPZ:PU%PDJGRY59%]OKLMCC!MON'>AQ=Y*<+A?$!+]<R'6)^"/,AHM@
M*;ZM4^UURB$_16?<1HUD(J^6&I7V( FU=LY_L5^>Z4V3^*C^AEYR)159)MSH
M%AQL*D?:M&&X&\9R)?JDAP)6>C*H,[G% ZBRQ/8<:<S>07,1_#!HZ0>1.=8Q
MPG_4&MIQ8D)JUHEX;,ZNS;-!L.[)4W1%[(V6WMUJ@?T8;6(Q@[[%T@@3O6N(
MN@1P0:8N!KU7R#DS!"8ICJ/A*<P_?[BSS$GME[!*"3(')*.]V+3Y]LN0N;4K
M\EM@9KPVWPX>T3H6""67IU-I1G]P@CT3V"W-5_DP$+:V!?Z6'?3P]];)^-[0
M+Y&OB>>>V!]<RL$;:G4I.[!D]&TFQ$NR37;7-;6A=[_YN/)M'Y /\IW#],]S
M8&,K:X9$ED$ZUA<0^H'\\Y= M^.X7=1 @:["X IX5 IAS+D/UI!^07S^:P.G
M>?[*=W$S2A439B/.?3U@OU0V#]<KL%O24?Y$ZB%LYR,5]M,?"]EO$$I)E:0@
M8V<Y W&4"\;GHR,H28D("YDLD4S/3J2:;1BNJAYB2J?O0=N'0>^YWI9W'H2L
M; 9%:NM'#G_PX=R+F5%E1TCM]-+C3<^?<D]3(U365+M,4W^((F,/95H.KN&8
M@Q1<O^?<:.J/4V](>XW?+1](\D609X,4WXL^5(]K*;$7E?+UQJ^![=!WD[P9
M.<XBH65Z#=-=R0/5^F4WG:C/VB%P0[[4G>O1K("J%LV/[.%Q',VHGE?D9WM<
M^5:9GW7Z>M:3(] O![1Q6",HQ4?^5-^\-^2-,G;0D(_OW9A/QAV%'_4J71F4
MIUY*R;]F"^V&E'+%?![5;=!)[5=-KF\,A#1A)]X[3.S>T3K1?$H@HULEF;SW
MX^TNG4U4,,\#M1^)EM$?] M;QJDALS?O ,V NM[OTI:845JO2Q(9NMVGW[QS
M8F%MN/W_L/?><4TO6?_X)P0((DT-2%-0%!**@M10@UZZM*" H0B"D-"D-Q6#
MH&BD5PDM J$'1>F(THM*"U401$"*5!50P?+[!._NL[O/W=W[W-VG_%ZO[Q\G
MQO#YS)PY<^;,^\R<F9-AHRL<=IK%*'5O9 5[?LM(F_B6<*S/Y\MF7^^>N?P-
MQQ?OYM##+;1I%U=G7G#[=);OQXG[I_)$]J C$5?4X!$)Z\6[WE0G5BY9F#*G
ML7KK*%%<_9P\T.WZ%M",F.;>20:\<029/3*2==Z^'(9"<8M;MC\]^)0BC;KW
M!O=JQD&M:"/F.DT/I2'E-Z3L^,N5>5UJH-1API4P.*3;ZO,QFCS336-:E;MO
ML=59B(@M^#0<( #2S,C?<T+UGQ(=?OP%I-'%@5 IELTW.W:WGA9OERA$KQNQ
MT'H<,)$I'LK2!;KQ^'O2><@C&U^1ZZV-'K!I--1K(LG[,DU1C"%)6[T<>'=Z
MF];O'Z//NUL+[EL(P,NO)Q>Z@8#,[ _%F?P6Y4U.?C2BGTFVRY'T.D6/M"BU
MLAB^_LP^<F9]BG!T6-Y"^X.=6[Q7ZZD<W/?+Y9\$YX82#&BC*YJJDQ^[#?UD
M#O\2RF7'"IS1BF(H:#B '#!%[R*X\$DY)!04$J 4*<!)CU+\GE2RI0![-EAI
MI(+IA2EO.1(<Y,\MB4$CA\\2\*S(=\A7'#I+G\25,S6P)X]NY_HLVMA716Y@
M[1\2?@ P.6L.8]_B1GBQU^%AHRU?2?55>:%-PZ>?7-Q@TI_<9^.(UT;/68B1
MYC7*I#H[SZ?5Y!_@'XETSX,I5;%]?TV+?05'P=2?;-".17DP*] .\(P)'D-
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M<T?>MP+&)2Y%.<]N/VPGWLN;=UIH^<B1CY*KM8U1_?!E6'BC1WXP6Q+'K0W
M@1%[+O+9>9A^"+./P;]A1>>NRB/2WXL5BIT3-*7OB^7RK1K\9NXA%K MQ['*
M?;^=F&@GQZ$8W-$97@V_\+MP'5>L,JWOMP$49!?@8Z #<II#@9LP0./B="8Z
MF),C31B]M>./M?-UE+"?:C;MH$HJ[?5O*(T1G"7:>9I,G%_8YQ8K<WIKV")_
MD<M6^ZD"[V:QV4M-3^GWA9]:?4C)H9ZEMBUQ2^S"RK&H;KQN1ZO79D#MS?3M
MX[+E ?)]YUPJ/[DV1XVW C9GQU[+O8/ */^U?!#_*MUE3@:[P$0V&K>S-TD_
M(;2@1X!F)F*.ZV/14G+1C_L+D83,=%H,52PDL?PF_<+AWNMWGU[.+-_"=:^,
MD!DU+F<UI0N(P2-0R_H(0"P6D1WK7"_,$UU.#US.)KK:[>2G$@UJE?KC7&*<
M9^FOASLETV&NBJ2^)<E'VC3!>H):HC#-9IW0"LB:#XY:**P%Y,^/"FOOWQMO
MF?[1%*]L\.('@$NKZ?)C">5"S", Z^//F.FX]N_ITK^%Z,FR?JHKBS;^#W@B
M7)%_E2KLWT%GGCX@;D$%(B\39XZM%ZZG!HSQ2*S:]* V"]X248-Q X+;)C U
MBNLVL57I4-VP;KPDD4]7>%BE8![B@)>JCO4M*59S^MYT2=3Q65AG*Q @E_JE
M[%PEMJM^:/ 55,@,BP[K0-%O>_8<_]T7&/UQ0M9I(P?^PM8%8^CQA+;I9H7,
MZ-D$,?4!X!TB]QZA_'6MK(&N[$12P]F>8*P^%L=P5]IR*LL0RDZXQFK''AG-
MC@#X3S#!"4CU3Z8&VE<7 %,2DO/  I"]<TD  :S*#FZJ%Y8^]]<7!+#UZ0('
M?MV'_SV4HY27TGPAD: %2(E(:QU)AQA*BIPN6[!>H5+];A[4FR8"(=02)O4S
M8I*!4V2:;S+IO+I7XQPI0J__X.QY!3MMCJ#2,K@.KVD#?(3U5AGY+"]#HN F
MY6=Z5YBI+C,ST[\PKOXU$M7V^O?,5_^ER,T,V3,KOO/'M/79VT=+$T*[X) V
MV\_>E_%1+>P?HCW9]>RG9"X)5]4<D5YQ+141#INHV?X![!ZS>>$D* ^XGU*U
MD+FI#9-7\Y)2F[@CVAB?755>[Z'2"NDP;S^%%H!C&'@=!6F]$"WA(PFM4N#8
M0:,6_F:$1^X2%,30[[5(_77# ^-# K6>O)[WIAX'&<#8?>R"4@"IG6?[8CWQ
M _])<N&3)AQ:?]-KF'VA]#GRP$[ Q]>1UK_$+;IX/+LHP*$EVD?:GV_=7PAD
M,/]DQ82S7ICM8R0(-T"%11)9U#3XKTJGRTO#-P2=DA-6[<(,, V(ANP$D2$"
M3]J -W(@(JZ1S$1?>2"-,/QFZ*PHQ](_R!+\M\3[O#MX&_.(T;JL(5?R\,D7
M@:4.%H/C^1_NK<B@.8<J] Y$U3]X92QH5AYUI/K<L?VSBUW';N15JBY\OW#5
M-1L0ANC @2.NO$T$9(LS]7]6C7Z3]$+3:7\?9_P^PMBM=./^89B/9CP*_AMY
M%B%\B[HZO(+@S $L@,PP[AL]I73X%YAZQ?-W6*F6O:GNFI-SQ,5;/5=,T"+,
M!*7GABXKG=>M[T&?&/IN!B?N=V&5[BR0ESHH,? EQ+S495K_,8TS0_!&HC^9
M8Y;X=OW^GB_QMYQMGFS0<@L/KYAWD&&]S,H8$#;MA6$!K&MM=K(# 8G^\HAT
MKWAE6X1)2>D>T%FQK Z-2(>>-MZ#7Z79$S]DR;P=XCOFA A=,W1[E\)_A8=@
M]6K%4TV\!KU>?9RZXO565T#^PN/[C0_/&P=]+R-Z3-5UZ9A?59:^4O_*]!ES
M*W>;YG0@=K$SSC_!BC_Z 7,ZS8I]YOY;@Z30BAJ?2*+2HJWX%=?"YI*[I]W.
M9&%7;U;Y?(M^Q/O *\$X*73(,9@V''T\V@]:],5@C["@WZ)M$N5=YL7K79X*
M7@GZ#6Y]UA,Y4\]5[,P5.;XG:;>WQ3Y7Z+S9N B^^M+TG)GKIHQ5ZB_D2:>:
MP?<;Y2DA^@C5-?RYT)?/Q9MNW%T3YSU^+RO<;5@EB+K[UJWM>S<,LN4TJ_B"
M3>V4+P1VS(;2RBY]U<$[Q_(*^I7@'U_:J__T^/-%+<(RHL3 >.^(,>SN189'
MQ[^ZNK)-G+%T($G";+3L%K#-KS/WQ6#'#R!_VHCPN%X0N_QG?<B%,OR=X7;*
M0$N4@9,"9U6A_8SY6AA-)J(9DHGBL4S:7\:7,6>,H\870H47#$X#7*@%H]P&
MY.-IBC)1%TI"=,$!5JRF@>&_MKR85U>$/!)*Q*#YQ+@[W]4V=WH.O<_\/$40
M*G;=*\M+GDF(%C>4T#TQ=:X1-4<*2<T1022?3A@FS9LR($R4X,!A21=N-&!6
MR-(%VE','M)_,S+([>GZH^ CM[WKOYN['?IY@;0:'>(Y"_9?O"UZLI0<MFB<
M34#56Z#-SY]XY6Z_8/G@O(OY7O<DHT&U;Q)/%L_./KIY\5"LSS*:KS:DCKV/
MU8B_,M#>\MJ(C([WD9.:F]1RFUO[:00X&]M9=FO%D8P(>RPWTV!U]:U[:GBR
MJOLA@WK[9*>1W1NEUW\ S5M7%,9H[BTQ6-K %0ZGV.?0I L^0VGXR<7$\Z]/
M6_K/%M_E<#4>>*V=)8,4%M*?W]?B6MAF?N9\B_FWJIM2YGL?'C,N%8_J"4_R
MMI_*4KCG<&>(JNDE"3#WN,R7RZ>64Q_.O)_(-X8]E[B8]18V5&O%?E#%U4O
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MZ-/V&GI8H>8QT>C9\S'8A)G*W= S'73VK@[SFT52EN'[BZTM#:J,T'X2L+S
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MGR-:A%YZ SIOS.6$N*+.HL=B@OVAY%RAP(_:6M #VB"BPCB:QBW2E24\=(@
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M 60F2B[8]8()K5*'&*/+R?2$X7K@:( =3HXG'@/0<G1#[<D?LC:5H1>6/IN
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M.7!GNK5#Y>.BSH/8P5^"N?D.5LS%7T'?4;+H7*=&[6LY7J#75,9]+,$J)N.
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M-*V4G#9L+"TE K-25XZ_?790^TA,\,"3)#?)<YY&,)?^@F/4Y%F>J A3],&
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M+WN.]\@![O<^W]?[\OT\#ZQS]^E$K>[3UQ(=Z=]]S/G=6P)?ZD>)#:QSNXA
MW &Z(C.+SG0JZK:]LR__WBL:\[I+]\9E1W;75/XV;\FE+0B=N/#6)P];#_6U
MM"T6M\^D-I0?*W^4I3:H$8??9C]Y>$5.WN+^7__QT?O.W%O+;Q%U6XNQN8AM
M&Y[MSWOM5SU[=VQ>]1Y%T_WQ&I^7ZY@BO[.R)D*7]?.O7EO?-=,B\^[:L'GD
MO)='^>Z'C+SIR)OQ\]V?RRY^GO'GG<ZMG:K5:Z(3\E2O'WA:]O:.-S[-?.GR
MK=.2V=ZUYTT@CW/')Y;\,$.R_5M6RO\O;!NJ<=GJ;'41Z1!KJK9[IY9N(?B$
MA4U-[CR5S1U4;E0?J)_)_<:"VF][[=VD$Y=2;E#;,]"/;_OF9@:F85MR%6..
M4!5X)!T;W%@0DSN$)A4O10N=RP_(2[IFGWTD6YM%E/M.G:[<.+LI_PGW]J+V
MXG%_V6-W!OZ!JBH8;QF[7BWS"^4O'69.B6^Z*O',>BDR5C!GK#53IWR^ONMS
MZPZK%R6KQ#TW//B[Q:.[&5? 3@,NR3;%B"I.26SB+WZEO#F9Q;A?AAT,B+R\
MB$'L9)\G.E>-%#W1B*HFSW2+A-4_@]0%[-7&(30BTYP_B=GT<TA,@>SL9\DA
M#J JOWJ?69FT&+.)^A8D&LM\3>WT[FK*$W64JY+>&5@VH:K)YF(A$1E(2>2R
M3KC/Y!FSDHU+@R-'5"?[CS&JOLX7-;AH#!NBFA+Y8A4C!E5<_D2C_*Y&,]'(
MN2]%94#$AVA[]@U,-,Q9SH3 (3(V6D$ZH61'IV..JKGL)G?BU<>^4]R4.&5)
MKJ\J8$S&_6(TIX:$2RW6ZMB+GBQ^#!<[3#MCK4YXZ'B$V\<A?#/D>FLC9_NX
MGMAALVTAS3$]T:FLA_C\J (,C, SO9S[M74942?@.H[M5SC1S_/5K6HEFK,_
M ?Q)Z&B. IB)+2_I;(ZRGT_"<];6U7:7HD1=>P;A98X[9;LQH3Z-CI#9O6=O
MST*BR>%BN9:L7(EM(=EG71'3)Z\%S_32G;#GWN9Q/(K!YX75"0=;W,S+ES!5
M[#[&%B+0+O%J];X0$32V-U\4[$Z"W6[@)5SA"8%.QCW0)3N;N Y)U=RU9/K
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M?ERU?E#H7N4/%Y1X$T)16KM4BG U^]_W+?^__<<VXM_O_ -02P,$%     @
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M>N=^ '[ 0$(*6X\23+_)E*!*C3#WG+">'\ZTAAVJ^<91-W42B/NQ._W F'8
MG@@];;_D,7KM4A$]1%> F(V<ZW-\IM,D4@*4'G)0%_S!?'/^)Q*NRSQK\JS:
M\%*S99*GM_4YCJ>;%N-(SGB+E<OQX'E#6+#6X'8+63++&1L5K)*.0_2<&2\S
MPCH;497$6XLE'1^S?&HH:5SMC7>XFS%5(G-[8LN.@IEB-16Z(G!GS2+)"H6;
M]X\U+\XKE]=LJ"JBNX-HOQN%(QM]@WKJ"HT#@7C,*R?^17E^WNL",!D##U#U
MO'^?UYC(G?!6:$3Z0'5@F(/IH$1GY>&9;+P=4;5 RN*B+WFLUP))"E([HIFU
MM3E=W86EYZCBZ[!"M$L)4(3,G&0*NG7_.:*_@3[&UQ3;)9C33SR52<G%3.)R
MJCN33'#2<W@SE.R!D#6E^"IB!C#*&B]WU5BL8[@:2-B3'>%Z>9YJ^-!:;> S
MMN!AZ[DYK*_W6<*MH6R+FM&ICS[(./=LO0ZC:AW!/BL]&D5=H=K.7ZG9]WM+
M.._.P"%?[0<8>"H[NO-OH__O-W%>.VEK-,N,NQD+KU')_> )B]@:71F/$&R7
M?&EZEK%,U'M)P^I/9DU?O?5\F62?!#VAGE+[1;<'V4>99CA$TQ"+DW-]H1=F
MI^MAH!I* %?+%6YEA%PWN?1&#[;3-?A.*CZ&-<+-8</JH\QD0^9#H?[AW#&B
MIL[U]$:K<&$8N\R&AC#6.!Z<KZ7H6[RVXQ<WCM+-&R7!T=DO. 82Y&Z<8J)3
MEX5K$@ W<N;<PI&S2+%B&-!%]_CH;\D.XE>*-@.OZ-TB7.0P[21J@.1D$(3&
M*]6A!N.!*@X%*]932N:7(\I2_&/-),8IM;0'F 8>T$9"=L>8<\DB@I=%D!,7
M&!CRI8E@]QN%_%E,=_WK:%\Z$ =ZT531N*=0)=!U.3IQ%6GF> >)6N3P!_X0
M,3)BKVQR.$@M!:CNKV\PDK/,ID"2K#_%RYZ$>N@F=M4[>Z21LN%-Q[!L:I(:
M:%YE(J\ QNV(+_3HP$)4)+BVQ1'S2S)N .4U1;LB-9OR#J>BG*S5K  ^/3V8
M0VWWIH>?2<)[9%%L9^IBG3G^IUY['&CUK*&,A%N%@#N8P=P#G4*C!RUC,V;R
M//-'=_VWT]Q2;=&'K(MS*/>]@=.'!\T] UIW)_OU8T_M6%W7PV27_^OGV;^[
MH#KP6H"E875+,4W?.8JK3> 9^^PM&B)YC']MIFXE718(3=1G()Z?;%%2@5U/
MJOT,/_H,;+5^ZB+;$.MF$\$RA]J"("+RFR"]Q!<C0=B9-S\@[38I?;"%B U>
M3[7Q#.BZGRY$0<T"IMMX]ISPODZSG0<(:RD.R<TW;'J0CUFV85D>.W+LQ$AA
MV;$CL/M%C4&P.B^\#*YOP]AJ1UT/ 0M<.1*\J('"^:I0W^U@>2W )P)7Z^$A
MUYB;Q%-,=/9"F=J08$"AC+/4B)LI'@1AR<X\\^)5 ")*-$%[-C39+4']#:\+
MI+(#E"V8!;0QMY'<50SJLR.VD3U/ZXB-=1J17O;^'GCZ!&["C[@^B3[+]I\I
MZAC(':#-[_)5$IN<;OAG)9C;T/NE*7YLM [O*=[>RYX(Q1%=+M>$=8#>V^[&
M2)H$X<9C8GTA<:;ZBD0IG<X3WCG*M9-7MMCK\A0Q[P]0?8=U?B/)JK@3I:1L
M0]"17(1W6"$I:XAMZ#">R&A=H4PO:9K.\3AO4K^=$9E"LA0;>;A+[T67\FR_
MU-\S%V^(]>PMH!X?BHJ\[(P9!21'.062/*_,X<-+@295;VL[) D*;T*.*6)C
M= 27[+U+MX7,$33>Z_69I9%>NP@0X=P[V$94?S^V:$?$"6;4#8FBU_GNX(N7
M$QV"0]XX8V +_^K9^.\J"X<35-?7Q/6RA%\%XR="Z/'?.,K3AS.S/F1_:Z),
MSO91+YR<>H?T^1F^[+WE[K>62_+BMP)DY$OTLK\C)Z/EBJ^4M86H+9[^\/DR
MK2E?%XL["\**;RWXIM[W]#86P[PP(*6[V5(+A<\'U+&N-X>N81,\V?M-T^S*
M?MR4M;>-7WXH<O( ;<P!'/ Q*P B\C@Z*F\#8Z<QW2&ZS-H6XN[B6_B&MUS3
M-*,-&C1KMJ<.IJ"'XW%'3*C&Y+"A*E"ND69Q5=E[.QYM!.D)%#8]<M@,JA&^
M0.2J O/%>XM@00AJU@QXE*=:0H0#9=QH%FXU!-B,HS?IBFSLO"8E<#\PH"Q1
MC#RN1'),Q]\/CF42BU\Q ]79!W3J2S5M%J**50XSHB@D+?COUWPW8OKMW"+"
M]* &X3C3\!0W0"\H3:>]]!] &4>";JDDV6&^BGL/1S&>8)1D86OG1U)*(>AF
MI@@>K:/G#I264BRIZ93W7+(YW9%-Q#O$946>>C]TJ[I A;Z/IGK^*3WWHU>*
M=Q@@BK(/6.-SM306F5 !#/_*?8I7D6=IO/2[53^ OT/'^)"VL.W'P3!7J5GZ
M;WM'M.S\O)N1>E&95/\QL<L5[>WS&1)M-CV UGW!3+%O2Q7YPR"FFNFN;S;E
M)U<YCQEN!-9Y!S"VRN([@3;:VD%Y\_;=)O5'9@%X0,#%X!T;6OWF@Q_]^,Y1
M/[[;"?NSZHG.K(071J%O;T]Q5(,I*G^'DU6M0E:&:.=!,8QT"QR.;KKY.T.K
MYUDFK&].9;_#U?$YP_D=SR&PNI7HN>G!OB^7O][.+'S[DJA5NYB1>1:JJF K
MSYU/2+!(J,$T?8H,=@9>*V?""L]E)MT+W:E/7]2B(6H?E0,S+<>P5LE!J)C#
M-[A%ZIT)YN/)D1(%$P-9LY9%B([07<ZR?-\H$'E[X4+$,%RDQ L_-N%3*(-E
M,0,V6B/?-K0BM5L-\=O(H\7W6K?X!I3% .\17[A/<?/>7@L*]Y:I_2*3 JI
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MZ#(U* FIK>7(:_6A+M48S3I \MJ/6?''EQ)/#]"9T.4Q6+%ZH?JBV/Q]2N
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MBB$2))WIZX7OV,WJH_^'P8#PRYGG>P-72:F(H\)T<^*H46:!S]V0ST00[:!
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MUI:^2)YMC?\+1ELW14,V;ZO:OJ";9J#1^51_4J-3=5_Y,E'_F:!\.0A"L);
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MMV_R]L0&(BI)'4ZY&(U^2]N:,I[/W3L^LE4C>WH#J=7WIUG;M]T;VV^TK']
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M@*V;*Y09W6'6-LG:[9(9VAV%H=R7Z.Z@0W@CK-248ZSGV-8PNLZOR"8D5&<
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M8E,5YH$8,*VW2Q8\*1G8ZQW]Q05Z?+'L%@BRKX$?++%**E6H42NX$L&./V<
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M377^.T'":% NP0#$5&DMYI<WQ^V.J98-A#-*B7QJC&F0EE\_J3R$)NS6GY1
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M8.LA\F6+T#OY5+$.)J<U4$OD8E]E% ]>2I4F]1U$\3^LQC\*!LB4.1)O!5%
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M_BNA_^[/C4_O%BFK7R^ Q#EZCG6P$RMP6A@5JOF'\>XE!E\IS@B]W %VIYY
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MFC&7[^2XFW*15Z'-(D23 74E;V U9O[3 + U<KDBD*%86Y((:+$#?(F&;L>
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MGJZY3OYH833&W6\P^(4=&,O5VT9@!SI>%3JDHAPP!MF^OKY=]*% 9<5GKL]
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MO/5T?WZZR*(_XW[FAR_2XA>O>APA[4Y_>PZE@,J5I1X[M5V5]D6DLUV]S>S
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M10IT>K!T_?QS8U>=."ZPI^L4QN)>*!A-1=JN10X3I&5N=8MR.687XKRSV.H
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MY$Z57[+E-PKG'- 6&9JD=X*KK@(7<&LH7#R\<80\Z?P6CK=IKDA,*L%N92#
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M4LV!R3P<?I/#_0V48^I\!"9KWE%<&C!/.\G.)<FJ#C@))@WCT>#D3%P]Q/2
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MAGEBX!0<<,#SA&Q8B>Y;.W!%L 4?.)]L?+M( %=5-X.(\TQ]P L8RZ2IXNO
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MZU;<=>,I!M9H#%_R.TW>]Z'M7\OWC\^7=BMY8?.IZ\ZZZ5S [#M]#>>2WM=
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MO[^_M3K5!O'#N;E'&E^D#D2=)(C&PM6.[K<O"%&+1:E40PB,IL3EIV;>IN2
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MB6K]HQ&GR[N']8(KX,KQ53CJW.H&K"V5^>WGNO!S%@:/^J29/S=H_V)\UMC
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M7<W&Q*MK9B*%%U!PFQE:(?A.8SW;M>/&XA#5?[]CEK%]RN/F(<]JVM88+.]
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M&]849K#*-?@YO0U8QBS3ZR!1:7ZU11=.US;G_V30^CH]+9=\]P3.PBX3NY0
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M>=8<D3M!W4]1!#F)Q=D>_0C_;#I&PA+/A>J:3)TVI@P#IIC;5@G/OB/VU3I
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M\F-$2AN)&2'=-4,$RH)U(&%X#RJ78VU- +M*#^N+6U%-71Z>[_#=2@);K^=
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MV)3H!+;ME7/*XRX'WJ-EJ/&TGXIUA:A0-TF@36"IPW=98=_\0Q>.T'K5X7N
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MBI2]'#\%U((M*%HBI>(6##6?\QQHN(AV\&'32$FVN3.W,-17'"T&/O*3MS=
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MX_%&=07X6PW+4*UX:D1(&YD^X]+ %>TE$5^,#IMZ&#<<H:(.\$^'$4HKD#X
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MLX'G+M74A4P!5?A>4XH0XV0^35%S>P07[]7FK]Q>:C))KMGCO85:$JPGAF^
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M #T=#].P^%1"X552ED:/P%]<6Q+I#'\03M@F0C-U?BG:(_T&O\MMAW$#Q.Y
M,3N4KL@O.:;BVU]!H48 Z:GXRS1<7Q7UF"Q4YF-#[5*&?.;/A%3&2;]?*M=E
MXOU>^/52P^6#]6&O!Y!]8#&@R[8VH*@8!_IQDMD0F2B>BD(!3E=#NUZ+C62$
M8:_P*F_X%]5Q"HZZ'KNK-[X3,CM/7RK/,(RLBQ Y@FZ8Q5GG>JBNM!M"H=@!
MJDR9=95W3Q6WT;RH9)89S-RL\!8N?#IC/FT9I>XHSF>,CH7K'/["E<4/SN?E
M+]Y)X&DF;_*!L[Q4Q?!#&CM)J4/^)&XV:A]& 2M6%Q?&Q"_5/Z+LQ[=HWEY8
M]0_>+2"Z@67V++FF@0[X38$QS?M/?%?Z8T=<[6:M@@?J"S++U]<09_20<X#F
MG'6M%^]95Z,GV1AWVP,'"LR%B%1\F\<@]07%UN7-3ZI75V0F\OP!>\;?C7RW
M+2R]? E\$%FRHO<AX G?+6Q"]W)Z\*XWH>-@'B.@%*O3)/X^WOQ(NNG%<A)Q
M9/%HL,CO,LI%:^)[/-GV6/G49!,7JHG &=7:^ 1R4=8NQ-$)UF+@;]XM\I >
M#\0C%0=5:E9NR0X(]",GWE#2^)!]#I(QC<":*)140D;&NW(9R@$$@DLW+_L9
M+WQT7&>^_OW7AOBO-W!1]+$6]5M<DJ#P%KLB!XI%/'>5&9,]X>Z%_",1MI4=
MV61[PA(2>(>5Z>#TIOTX1-RE*:7/]S#H@.PVXUR0WR'9$HZ7$+QIN(]U]\C%
MD'<PGLB$B3N4F=[+\_(C^WDAI^;+[W:Q((R*VM?;\N984I%U[,&Z*6E2I0?$
M2<I<^(\/K%!%7*><$AANRI;"^V,B;R(-O<'Z<)A(7/NLV-79:!4;E\RF 70]
ML"9R.P7V%E:R3\Y(F__^*J;B$=RJ71!N4<)E$MXG!"X8\Z@^R18E^BM-?<F-
M-DRBET-#++WI121W!/ZQ!.="3 BK-0;J;2:^IDXX>"GD98Y\=6[ZFGF8^9[*
MZ(5->\8-$\ST@NB]5!8?@?7<-7.>T^H:>23VPBM/E:BP*]W&50_&9KZ8D1?N
M8*OG[Q2,KM>?L^^+GWCOGWW2X,#$W?4C7U]:>H9J6H=,I*^L)-JZ:'-/^+TF
M?"=\E*JDD/_U8Z=?_W[ROP!02P,$%     @ _8-_5O@0&&$P/0$ K9H!  H
M  !I;6%G938N:G!G[+P'6%3)MC:\FR8H$D1R!D$!$9&<!!J1+#EG!"0U03*"
M0","TB1! 44$E)PEYYQS;B1+SCDI\6]@YMP99^;>.=_SSYEYON^V+A_L8N^J
M6N%=[ZJJO4^_G'X%KDJ+2XD#(! (,$#^ 4Y' %'@$CHZ!CK:)0P,C,N7+V%B
M$6!C7;F"17H-'Y> DHR:BI*,@H*&_@X#S?7;=!04C#Q,M^^R<7)R4C/P"?*R
MW[O#P<E^=A/0Y<N7L:Y@D6!CD[#34M"R_]N?TVH [Q(J%X8'&'0=0,$#@?%
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M.VRF]+:L]$;P^9W5ZVNUFB:8=;TP 7YF?-D![S(QYF=?]S/C:GQ%XM#^C<F
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M]";_;_?OOUA 'S(>TA6,C'4R#3^DDHV:>=:4:;(\#M4?OFZ<M2'K@ DH  T
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M #Q1N[U7R=2K)_9=-C=;L"1Q,S@U1?M() ^OO79T?E$O_.DD,W/3<_G2;H#
M:U%QB0H[M_^%#<]!_<*7.=@]M\DI:0_&<1WV:Y2XPD&:WS:Q<BV&^1[0HPPL
MN[)Z6W)"IYTOH8OK)H0JN7C7.@E=#R,J4WR;5P0'-CS)Q\?US \>.+&%TA,M
MR3#.PYLK2_K7[U%>'Y->>2(DJO_ _ 2SS_(*F*P5\ZN-SE3:^#/!WG5Z2UC*
M1"T& 6CVA-A-XXB@A24ML1:[>3X+&MB]QL7Z3=Z@_PXX7Y&MA@Y^0#9?3>:
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M-ZLWYPX1,Z48O0[&JZE"4==NE)@W,"HFD>8.5BW 5#B3UY2!TYLV1UJ>1@%
M9^1K;F A /P$4W&>)H()\$(AESAB:U]_^-Y%L&(+-U>"S,$HAJ8)WMZ;3Z3M
MA"0CV\\)LLYF$?:4RENG3JCUDBAA1C"_5X/!-P]SUCMKQN&2S($F,'[I/X&E
M9!<+PFU"S[[_O(TA2HR_'8,,,4UJ:]L1PC(-+0UJ:WOD#W][R7,NIDN(1BBQ
M8K^]%L&@PH+*?AS6!TP#A*>IT7:RUB )A3I[QK!'8=V)9LE<J0IMM>VH DIH
M&&XBR^^O-:)06!,8FQ*\@-5Q-C[YF+""!ABY^-K22YDES[]"!+_'@P^(8E&H
M8=E6QF=G))RLT?66)@*,*/]5XO]?+%@L=BC6M+'"M_"T$%L9>VTT"Q:5F=3O
M#$[B;%7S+SM_><JR_SH3@,*XIV!WV1ZJ-8JLRF/0<0+YOQ<@H]-\BW))PG0V
MF8#R (-D!KV38'%:)54@N?(3X=E$D>QF2KI\O8Q11$RDS9XV@=]A/LCISZQW
M&?G<S,GX7AP=HC5DK0)OR"$I*:9>50 [Y)T"^!C314@:+<AZ(AR]WV#]]^]N
M_B3H)IDF] &=8L=3O<AD";5+3J,@ZWF,E4"U^\+9W+E8S_#53!0PJC?3F]HA
M.N>OJBFTN*R,A18'4$DF)K'QHIFWVIV=!WME6O&O1<5+N/2*L>\)L&;FHCH:
MQ8!K3$Q-6JV(M9,NBQS:[Z-3!50B%&(CG[.<H19:+QG6LCE!;O<+V2"=TW/6
MNSF*]>^)K7D);_S]$/H?$.X'UVB5>+FZM$IR$28!).KWU"4TM&;+&M76:".T
M@*'#>@/'Y$ '0GG9$AYNB_EU'&QMQ=%=3F"),:$3!ZGTA'GG @P^ J2#2]H'
MG_V?D@E).MY'')OW RIV>&0".5\Q;7EM+%H066\?T 9$6&,#)EK,2ZZI[_)R
M< D'0%Z:PV*O"KP9UGFX$O\4TEU0'V-[6V%$H?9:-(+K54-'4Q(2E_4\\ZF%
MPLLT7#5/ 3G''<+_9J?V/RT* RS8#25#^W[259*VP6;@V%Y6JFN(P7N$"[(V
MM*A&*8+,#*J?[U1:"KL-!_$H/WQY0T!3G"\.VQ+O%9/*53.2V;R:Q'MP0(LI
M'09T@&>77*, 1X*S8H:)G0FWHQN91:LZX[\:QQ"X]KU]62= P?)HB;^4_ZU5
MYYZ@+02GGU6VOLT&M+B?-O?.$-&J>;*95BH>4WUY]K"IP&KG;P?4_YC$Q]!R
MBI%_3$5BN(;^(?MRJ_UAT:+6QRUG)C3W--\<DT$\=/GR G7Y_@>W"GNC>7?C
ML&OMT+'OL-LO*J:T^F*,QU 8G>G]'8&Q B#8P<)A[;:?;*R TB,5*A,%,*';
MF6, ^TG$EP)7GJ !W!)X3$]) +X,>FSW='_BMR))^OJ"AV^O=R5!U25SN OK
MG%D@9+>X4\ %?Y"!?W_W3R/,F@$C)S.)5PE*UD5M7DQ7$H=N+GHLV&6IMOK(
MW/18L GYP]^.*/\2*G$DD\(W&_'6&4]-:*.H="]BB0[59>':+ J- FIR!_:\
ML)MOU64QFUQYFX6_;WH]1<]L4X=9BN2ZJ$9H4\I"CG0?Y30?N80%L/S&?H5)
M"F,[RU1ZD^;MW2CNASNCES)MT[2-UG'U\D'/)G.9I"@%T[P&K 89GAPM9J9K
M8T4'Q^2#G(LH2U64=>O,O>B,;I:LBM8_UN,L"@J6YT4=<%M@W;4GK]L"!7^"
M<7()JF91C(Q@[1D][.44I9@S#Y:BO+7W+IZE_-:V/=MA8T&M5R\,32' Z_^%
MK>]?R@N4NU"P<N\7N3O7EP34121;*9^X*J"+OT^C]VYY[4>AEJHXR.6=:FYU
MY?C3H'=_/Y'6=,8G\G":@RD8OP)HQIVQ&A7S.?G;A)!;2WR[Z4"ZW27>G3CP
M"VJMAUCXRW(T>!T\=&M3,#S7F;YB2S)K5?L2V)'%Y6S:(N5(?6LS%,-E$A.&
M64HHALK @^3FHA:6FK3(J(S]06P;BPP,)=L&W=Y\PP19X=MF*%9T,FP>>_+E
M4#,L+$P ,'#Z@SWYWV-+UBK'S$1-)T+6&(>J^1,.",'8HV>CKG,PTL13H&D[
MYMOBV8FE^4.1[47M?]BV+0)96B=)79-,X)^+%0.,=1=Z1A\\,*#E$GO&=3UV
MM[94BQ$<+41N)['N1^!=)]]H0@E-^ 1CM]S16!U[5VTCW2/YZ@ZA+;)"NQ0/
M)LC_!V3)OT$NM9(8!")T]P(C)9A\A I2[(<C8+QE;="1RR]LF?EWF]/WB@:Y
M"T=F_7VA\<9J,RDWT\9%\;7N1F)6]H,ZY:<)8.&/^2A3]\:9B16)'QC6%2@)
MD?LI5ICB.(&"PPV;'G@_K# ;\U?N@P-YCD^=.:]K3'E(2&="D\:6A#D3FE:@
MJ;Z7!@ %S/Y)55=D_104_)XRPX6&:#>]&KC+9/9O9;>?-[D9J'8_3SC,71R6
M]GS8#>:L^G9B>Z21V5K;ZW?TD+KOGU*O_J_\OM@/=]0/.K,-:5/@[P>96_!\
M&KKO%6E=F[ZXE[']/I)$: =DU]BN-9(66Q42%5^9AX^RO-\D7:4X#0US)0,Z
M>]>=R[2EZK(S+1#8.[A0UR+;0.\:E(*,-;6YJ]7;HPIH<,;._T/'VNFPY!F[
MV OF.#9#$;P=4L2["D?6DK=QBP1<X:-_/\'[G^4>)L"8@"S'_V% _A\0Y1ON
MH1$[R;UWL>Z:@<->JSS753A.+'RQJ&4^)<LFWL,@GRAC&R_&''F)W:)DXTB#
M5P1"YJ2^J?^@ZXHQ&/[\%% OZ!OF+'%//%!S]GW5<*-=-[R+,')*4G;P9<8C
MP<N<H *>EYPM\6SO^$,L.GIW7YST0\WD9HQJ,M$VCK055D@I+>K);BO(SWT"
MQE+ JAAMN\G*"H0Z9([_%I^D<^^#-^:= B'O0W2VM5GV98V0E5Y3^_0X,E>_
M/HX[<CH[L8G$O>^G0$4P])]Q:/._)($!?!-&%,^>%LU6DT86G$X9!U"_13S(
M6R(NRFFQHC(8:>ER!48J!JPRJMDET2T^#])$W*X_?"^()F8?=R<1\_N:8ME7
MI2$7BRL\H[E$TQ1PP'DO(VZ^U5(IR D5H\,JP17A]R7^"W%O[EHY%UI/RZN0
MN+@K>U$?*GJMI4"[Z>:WI/:UN7RCJ/?<TS/SB UY.Y0+2RKZVKAZK:2!I86,
M50$5W^\>:C.(H/_9%$H<:#HQSW.L"[X\*M<067H:A_T)LF1>:>'IFG/'.ON&
M0-S#;(LT:D4]+>%D3E"?C>+XJV;O='6.^:60:K_@HRBE@[CO"0& 6S?&0TIY
M49EBUT'LE&^^<XUT+]IPH@<$< G'QP*?ZG,_X8O#?;"-CPA:<AO$OW&2H6XG
M&EO?][$2 6JK":GOQH 6DT'9-U\'0[TK-EEV7[6)=2$RS(=7.S^24Q97[ZY#
M*).C8L<3MXD1)<4Q)ZJM2;;KBAG#J4[HU @8?PB;N]E92S:'RO2^KN#"-M=#
MT*Q#'$YDN[[6O8;=+%./Y*ZUTL,H?0Z5%B%U?5=@\5G#;CRR<:Z\0SEDS&$_
MOGW@+D9X+XQ?G\W=5>EIZO&D#N)8/G;,<3^.4F$'COR>2[B<"7E1EDYA:O#U
M8_-QDU38O:R8'5#?TX!EJ3F:I8$.F_[OQX/Z]I*]%NX/]3,!AW$+3Q?%N9L<
MI24.[K+^QX/+<E%S>XR-,]/+$$J(@;A( CO-$K2+]9ZZFPU_?>B,*494/I>L
MG$O=;5V)3,"9"GFUDI\2._:36"ABZY+W+A>'A6MB08FI7W(%X#3BEWESMY-#
MSS*&H_10J79S6FBW1\S9G?UI:)*=H!DX^4Y\:AQ_C&])YD$>%HGKSDS?@X-/
MA1/,NW$XL:X'O?-S#?92-Y/(WQ9WW1MX_\%,!.B:6&,$.\&3'[E&.BU]W9+@
M^@=%F^B^+ L2*G;B<#Q%D&"QG'<RE*95([P1;C[JS&53]_W0?<ZSTB(II^SD
M6J9 \#P!")$]1I ?L"_&\F]7N,AN--6D2I^>%*1-.,SWYEFB,\1VQS"B9+W!
MW?,^9G;ZO)-W$KV\\ \Y0'XA<=%84<!]""D#RN==67FFV;H(RZ^KJ;O:FQ18
MH5M-24Q10K&Y'+<GV.QCW!30M 7O:(=KFI!B)$%=+Q%=>LY8G4IX/Q#D]8L=
M2C&N<ONL(>+KB9]@?",5W#*RVY"[<1MH6KD#*JO!\N%5PU,%0Z)8>*$:495O
MC9EOZ]_!M0!&4.\V\Q$41":.8<>:AGZ>3G)#P&<H%,!_>")M@=TLA55'PI09
M/Y I#JM":2<_%94^;-1627/Q\DFN(UJ01((6T<VG?%W7"Q=  ==HJBD4C)3X
M" X2/9]%]'RER%F%H WT$[V4HEO44"?NG=#-P&.&N4W#/;\D]R<K#:EV/LUZ
MSJP1?\6''-9H!L81QHU\0UK]>#^3UP'*:YM+(XS9_0E&2]0#"OKD;?W"(34E
M#E/97"TO).:N)V;[>Q$F&N[J6_/1ZB)B@-W&A*#/?.3UPM&OT;;:W3HB0J2:
M=NX+I;G!4S=UX]C6=8XB7B]:DER;E'.)PXDWV$'^34,XI]I?BYY\.:,:9\<(
MXL:51OYU) #&O'N#O'L_B $\!CN)PV@LO_XFJ5A,IQ #$2.I&/8$S6!)O>/>
M^ .@$%<1@EL^8!BDQ?O=<T],\:2SO)]&D^#5Y059W;Y\(XJ39PD4V_!1514=
MQNHX+&U9%$+2#R"+/AE&A4<JF#EB@-B,Q*)L6"\3,93Q>C*R5&38.'[_O.W:
M^HJMILTCY^3&WIEPO>I!=5D'==T,=FS@T1<H$_LG_G#>I3K"_'3RHSJ,1<W!
M8:4VTJW/22E#^BWFPJ]Y:25(.4'=*U3A6E9"EU5FT64U)30)V"F\N_M2P&\C
MF/)'7JE0LPJF?WIN''57U8MW4<H6I8,4U1Y>G_-F>"GH2I$>&N# J00*[/T/
M/? EPC5;45*?BR:T2]IOU>X6!IF0!HK$3$X!"QI+JO!;%G@4CW,@Q&9I?HH%
M:L-]C%R&?$JJHT&OW+I_UW>9<,<X\X/VY7MA?,>H(85CIT"E1<1GW*,;6IZ"
M'3H;I\"1QSCN@1GR.^&IM+[O:V;@+/U2)G/B-;C6O_U8-Q+V3#0+1_R;*LQC
MPM\;(6DZ#[46D)[HM;=/EX2$HOSS[9^=!NO_D";_A*AP"63?O OW,%+W!XRC
MU6B4GZ92+>4#R\QT'-]SLR0L$:TIJIC\F(3W&16[E7X[;$F(@<BZC!A@?S"6
M-T*RMEJ#ADNO%AS^=*],H7XF&%O['9%&NR4[V>>/V$E+ KAX5?+2P()9PCGT
M_'X!H"97P+L5,4H=)=[(K%7"XBI.19,K$DU*!..'\AZE2_:15*<N))6][,[A
M18'1E)7*N&B^G29\_0AW9(U,4US%H8.E[KAT45%<^1ZBH*+8]VX:&P3_.JI"
MG$/RCZFCQ5!3'8H%=R< =>G6#[O7MI'0<G0R6PQ/WKF.E7Q/.8M6<^I6'5<
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MF+# PZ=S'&4$?T0R /\X!)Z752YX7]:!:\YUW,OQDW11E"&[SV&#A,67C:(
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M&Y\8^YB$BHS:(\K=ZERM&L93L5X&JI+@-[B#"3MCTV5,K>X@PDF?(&L;UX+
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MUGM;RP^R)V5#B'56 &OU^IE#^:"_%LG;7&@/MVE'\.Y>,>XV_Q#BH-BB\Z;
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MF-V]G/G];+!D%\EWDT;V[@>M*@A8;H[E3[MH.:._CIE?]<8N$UF\!)2KVGO
MQ9PG%6W9EBO%81OB5Q_A[PTEC*$ZET!8R(G%_R$@](?##;7PAB;6\;T;ZEG>
M,K,ZRS(+IWN+)Y,=_K5'>^DDUATFG;Q8MYW:4$^FCKZJJ=]);%["2UI/&N,T
MRP91J9H1:K[_=+L,!;CQSY6Q70*ZQR=#D<*M'!OW$12!GKUIQ"M6T7N_Y//O
M$4M.+/"_H0?:!XD/,K'"E4;WLRJV5GMH3UVZ%3Q*Q]O(CRE!NM,P;1P3!GR^
MC]<)I@E0SY+[]_Z;MW%A/SG(90RV^:O<2CM*&R,*HDTGR;B"(#'!37CU_!CX
MJXTKD)FA)+;)2AM87=0ZN-BO8_E(F1^^5I#=_<')K<KGF;0"8!"N]\K$TT[R
MW/Y,J(UU0\\4G9FN:7Q/6++@$L O0/CYYI:\P T\9@V6$BY/7HS@0LJ?.F^R
M'2JEV:N 3TO$\.M+X<":]7NVB$_DS_1MAAY'T3'Y\E2OF?8<O-S(\$<4!9\0
M5#NDF[J0\G5W#N9O< $7@U6# QW1O W%=DG7#+^SN[Y=2_K\)%<.F\:X<>\
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MH^'NH.CR\-KE;^9EW6,-OOU7"_M;F"MZEN@\5G9J,5B$[]\;\U=)@CI8LHF
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M_58H7M+@C8_3=[^M&_?9LEZGZSLY*/KHDB]7M#&UCK\.88J\)7X3-BPF!L]
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M9-8TN!(H\W=TARV56K/L,:D.=.3( YJ1-L3TAJ[-\&OQ=Z0P=VL5!G7 0>-
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MF4$?'[#,8>K(TK^4X.RA8GTM" 5,.F._X7)#+<.H<$V]R^OS.[D5C(F4 ,Y
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M!3OUX!']V447;ZO>9J7=DK[5DK(;8P_J29&(I88AGKN!J*@E*=^:!>I8^6\
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M',[5L\(!@><:2&GOO\Y3'A+0 : MFL71V^=@,H2K#*, ;@]EQ-G3X5M2_$0
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MZ>:'!6C'[T%'=95RC#JMWX[(;$BO('F?_O/-W)55IVU]XB(<&_),T@& O:%
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M$G\'=9]M:WDV?/HH.*<;6.V#$&%&=2(%(AT4=K1K??.(6P[;4-HB*[)E4'D
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M5U;@:DTLRRO_<;S@OWH8:5O^57V_IHYKC\3$^08YJ/-#"6WP=2U+Q7/EQ6R
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M[DVDKK]_?2'2R88-%O0X-1AY@A)+@H'B^9.@##BWODO(=E$M-SYNU7YO.A;
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M< <XZC?G6-HU[2W"^IGA&BMA\.K\.B-&8K2B;3^MQ=:$:M>]+6BP_D)O^1>
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M[/AL14*9/5]OL^>3LB=>ERD7]RQ-:Y$O&6Z>OMFO>FU!@WFTTN;#4W$9BLQ
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M_&G@PU8/]60BE'2ZT^L9W5Y?!KC#=@%Z&'<X% W7AWB@M!>X5_K:,* 9IP4
MC=&,XG5U-8OR ?K43%QA[]>7RAK_Y4KXC+A'C]\6T9].)4-H&</M:161[E5P
MSONA&#9E..5.SBL(>+(FFUQ,+B>GX8FI;$E/$$ZUHZ?D1B"D(0^C'=@!:#>0
M0/TB0V_KH32 : V@/O?H-"7M'H@6<&F5.DZE1< 3+-/$Q/9Z,B@>$$]#C"'5
M)D:**A9C\"-J/IG?M;>]FEE%A2H]U<=C*\/@MP5Z+70F[\DY#:R.="I[(;/4
M!1B]5T&18>I@WB#[ 2%AJT<"<$"CJPEP'>L'U?<$5A(OK?O64 D"GL#6$/!1
MUZ 2FG6SC$8'&$>\2>,\X'$5)*F;A5'Y[Z]F#56[=N?CU$<W$*E2X^2-7FY*
M/H8<5I"<;!S##,;A,\)>X=BJ(^]^ZQ(J[ZH>*4B@/ERNK?J>N?\SN7!L[R>/
MQV6Q/1N[F3Y/3_GBSH-B;4&-6^J T%K-;KA0U1*4$=HTB]0LI-JJ0LIL(J07
M&-)<'KKBN%]#O2DF=^6JAL)(U]3XG0[2,I[T#@-=L=&Z9UU2;PTVQI'/*VTH
MI?EM.UQG33+3,%8I)ZDRQ>1?<M/VXV%F>"X8=OO_<1B_YL$LJ^D! <D&LQ6>
MME3;9^$9%QBLF1U"Z]+*W+V7Q>098D>%<OSVDMSM+R5MWTO:KI*%UB55N>J'
MN9Q]A7'Q:]$T\@J#]/YV>^LTT;57$!PK'3\F95:#[.D)V,"/X7]R0S.%HIGR
MB/=7<Z2R%49I6:_8.JU/=&UO 7(E[ 5*+R9&^XT@LG5:$,R6:ZL**OO"%%_-
M@U#:1\8#3MX2U/9] G_E<.[VDA%]F[A1R6CM#*]HR>-'%<T$7TG;2_+:MDP.
MWU&:UW9U#(JF+&1V;W"A3N\-R3Q<B"!RW9Q629O45]*V9;QP#*1!]E3"C]+R
M7\ IRN9]"Q?K9UK36 CT6F?=C90(N.9*_&=%B.5IZV+[;#(1U'6#F<YS?DQ?
MXUK?LS<GW?=?+K;."O]^2<0V:8N$[.%?G#!COV!1S?2ENCE%\DOI;,_U^V9>
M6IUH;/UX^73-!;TU>8K&M:&<3_5-^(C?I62__?!L_.J[&1S8]T>,FR4N0C-M
M56%1->>_]\@:/IEB$?7DN\\^_''.1PEK'1<,"2VNB,,;]F_T*%ID=FGVA]%4
MUH?+I\3]H)0-I7RKFUA1A*:N=RKB7DMGQ/IEV[C]%F;VZ"(O]G"#SE.<_SZN
M0"F1(3[SDT@HDI+1=I;;\=  Z(#*H=85$38S.T)*RR)LYK0)*6:=QL'##0=M
M,TU)E";P/[MV@&-7J)O9#N4XZYKZHE#W_D*<?AK%@@.5N\*:S<&56P&?V@,/
M[C NV@,/J)2L'2]=DTC64%W0G"E3#^R]''0-)B=,AE]3AX-%X (>][Y;2D2<
MYWQ[\WZ]16NK$2IW$6W/:Y-R"8-S9[A89X64//\/C<.O52EM"2J+"P?*HJBX
MAWD ]DKJ6M;[%FBFC;N8^DM>6T!"JN-LQ*+OUS!B-/3JH#(; PE\[Z!N<+'-
M#!!Y2TBRK$M9.TKQ<ZGP<X*NN)6S'/=G;;?/;_V\ 4G](OGAZ?RYLUUL/(14
M[$-5'CB49#5=2)F5$@'LLT?]N>](N:34E>E\ 4/'K9Y)GB&DDL&R%/R>C9]#
M]9\91X6**"$M]LU!&?AY1G/:0DHK\P $!]+VZ\FX(JT1@T]/\M=,1L2'64!"
MR@'@.Y(=;O@:M Q <- Z34B""@/?_;>_3$BU3T1\# (+  'D0$\F/L1D2Q@U
M*;95 ?&-T@L.@*"RWF!IDBN-L1FX!R!W3$X#B=E;+"R#!4UZ=<],\C0 "K?U
ME\U<DJSF 7@RR^-\%B8\>8=C\&)59J T%W3CEQ,D0!ZPEK7Y 64*!71JU&B;
M& @OM-:DA)>MJ -O=>]3"R#.UH30*5.SMK]<Z'JMTT"J:-&OE'([!C:%N=WF
M(8!R0FJ4-A24BM#&^ W =Q;PW@4B!6&<O'A')0C+^&" "@+-8((,@&;8>-HB
MK!G1D[#'MBS/^6@F$:O8OKD?$AD&2:)D0^)!,XS $<3:W$2A8(=%.\I _?<6
MS+3."G0#);3--'E<6IKKY)V :8F 9::A-[+;DB0(Z.GF!@Y'V'A.5D+NL+\B
MR =_S=Y@%"6_I*'9VD--2Z[]9L"E.6Z;B47TN'66D.J8K"&,\OF)2 127A*E
MI4QYE/O.68!-S0./3*A,G2',/"*V:MWJOY4YK+D]4K#,O?/\=-._]9;#WVUP
MM7PU$'SWU]2!I9$!<POC1IJ77VG]74)JH<C$X3IYH,?EI@.X$T433TVK2>(*
M.N H!V>4++4L0"K##QKN8?OV()]8,U5):Y@'\;AOM-Z^G!T@@_/1;_A(AJA.
MSF&"FOGX* KK.*DA,]U#I29.Z?#',K7$+/L1GT'3&3QJ)*C'(]U+W6%JG&&K
M 8%ZN2X=3G4B.!Z03SHQXJE,W$](J[^GM!M46KBV2KEL_(QO \D0STB&O2#1
MR^H7HLZX=*HO-GKTG(:+'@26LP<)=_M';;XL)GI@0UKD9=.NN5/!&SV0()8Z
M4]A]0F]Z32IB!S%S?W0OIQXOAA,OB<Y$$4<.Z/7KN])RY$*J2!?>S._2)!%/
M)4?DS'U<QSGA(M,;5)'7/DMB)+\#'Y91C]!,]5AC 3NKM)QAY$ 1YMYGX=W8
MFQ3YK?M&I5.'W8'S^ ;GL>+/8]/Q ]&]-T%D2@OJ+[CU5DW&N;9)$_\H>-,B
M)%+4$";/3*=M@N1FS,=QPNX*=F/(RP[I!PU$60:$I-:X,=[QK#=])5)E%8.F
MP+DUXB\O@LW @%#WY@+7&GZN;I/!8GGS_$NJFRNS;O^V9$:AL<?(C+.H.Z3J
M_1@VW/^(W)-Q:5O'0(QRVHZNZ;N>OF/;M[C;6MNYIOO(@LN2+L?+OZ[._^'R
MC@=NE1*S&P\/,A[$/AD^3LM&A=MT'8RX>(9GLFZ#WKRE?NK6>[KZ@ 5;YC!.
MB$7",707=82.E!6^\&\WU#52BY6)7O=^L9+,<><+]%:SUX9G;B^^]'!&V=B7
MO&J7D*D=_1[LZYH=6<%G4V8MY#\_XKA]W8W+R$S)FM3ME_T':N\-JN450]Y=
M,KAS9XKPGA%./@:4:F^V]W,Y;$TE;TKFUAF.&QWR)B4M;RMW *!90W37V)9,
MG#VO38:+%3RB8N>A @(!D?8-]N7DK@?<T5Z7I:!RZ@$")HSDIWKR43+#P6L,
M=9%B$FP#R"65&)BPB^;AM--R^?K/6^:/'K=(5(%YQ-,;<&1IU]P;1NLY,:H;
M;ER@E/VH2?U?1R8)&/+,7E$M4V_.ZAP;HM/%IL/Q#C?F>H3E5/4*["V4FP")
M2/<F3J"CL#/I+]X*^!4,!UV8 N,K+9W.+,'-Z'B<(=88+WRFWDAT-<@GP %L
M]7(3T=3#;R9Q 0KJ3&TVK % ?J!C&E@C 1M[3"(PZG!76F4GT9=)+4=D76<X
M=I@FPW1"]J40]J :IPF0C:AI)1 L%P_-ZA5207N$0.'19A!B=4_5Y*G#Y 2%
M40W-O?R=#C0F' N!%M').-@PT _\Z@V3U2K"8^ 3 ND!$F/IP;'J6+'I_C<0
M(_<X/FTA!ZJ91L77FTYPB'U.(P'Z8QD05(+#.=]@H\!(!Z!LR@U^GL\*4DBS
MR>9-0S@H#N@':)6>C)$!6!KMN"%Y0SC(W!0^T?JD/:M@[%0CUTVXHR,D/5=
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MC0L"I?\7A__LQI)&.[BQ^5AKB,+4)N)E .=H'\#, 1N%)(6#)B)B!:^FYNS
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MS@I WB><[9*X. 14XH)[C$A#+4)*B@4"?L^D3E]H#NP\ $ 46I<\3^!'C5F
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M$92-G:>JPIY,KIGJY4!S/9U@MV8%5FZ?9?X9%_@W$M[,@M9.13JX J"R'!B
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M*65I:663Q>J+37[X\WL'("<N;"RV50BD!8#E0$)RH-\O (L  "0">O\!/GY
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MIUT)T\AY*(>K*,1*!,@,LINIK8X!FP:5+-$KR9I,ZD: C)@KH6Q+)6T$VI8
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M MGIC/T!!9G*!%14F.7'-_/!+& @2.S'8CF8#A@)Q"SZ&'GX4,#E(LQD,"N
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M=JP/A?H<9# /:77]!&XQ0D.$I57H?\.BD_KS; X';#2Q<[3#"Z(HM!M)\.9
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M]FB _'C&=5?%^YM/P"\O3&7FBUZ_B+Y)C"T*F&480.J!W1MIHR#5HD>%#@R
M?@1.B<$^E]" 3&4E*CIV;'Z&XDUF$<RC0WV2;1C+7,8=AUVG#!U=M>!EHXWO
MD(/+FU>JY\>1(\+BYT<\I=VSBF"'",:;('W&HW1RK3P5#/-C&),@\=82AR-R
MWBY#O-8Y>! E'>'KJ2QG'FD(*^[HXK9(W4A@R;YR!+9 N8CC3TH>(Y6-V0!E
M;8Q":X3R+EC0SF5_&MV4&GD0Y3>(0Q':N1OJ4-G/-HLA?)D5M#A.Z!"URN&'
M$LG!_B><HW(S8!61W^'S?-; =PR0_!7#PQA@Q8VSIUT%P5MVE]Q3ZM6"J$^Y
M>D5$M\R0?PS7OE&K='U35 >17W,W&:T[3#WA0 Z4#(IJ5A\OXZ#XJ5--92 !
MRULIPZ%9NHQ3)YISTV>E*<Q'PPZY(GF5:QH$"X]+E3LF6Y(GRE\DP%VC&QRB
MDWQ2A,.O5YX.6Y("*34VZL0K8"+J6"5+>#LRY_J4G/]&7!+UBE2LPP'(1H^+
M"PP+HH0ST=TE:V;JI7N%=//7\\K+D$EJ#2]YO6^N<7=OH AZ%H(VTT@,7EV'
MD9*T'\XR"UC)/)J#J$VH*3K L95Y^"7\-9IX=&4PQ1#9SN>\ZQM+@LG.UGZ,
M #<-C*<#:;J_4LKHR0T88QHU7)D!%,PP,GI2O-0:-],MP;MUW(4N;N?+DGM1
ME!G;C['E"5[6452O"W0;;$;G,T23RXF]\=;/.2S"Q_P764]X#B(:84P%,)&T
MY:*\I2H>8WM;(+(O8%MH86E'N7<3$W"0Y0ZD8IZ5Y[?K:Q-J!HB$Q%8Y#]U!
MU_-3$<VFW":)?N#T@!B":V?K P4&CMTVT81:<4@P7S=8NT)>SKA>NCS$]Y24
ME1>MP^?7TTH3F ##0!AJ<H/G>DHBUAQ;AK!AYAU:GCTJDI#.JU4-!?P?,$YJ
M1 E=)L6);W]"F4JN(8*TTTNU+:IFCN&1W2>,#CC1"GZS$=%-*I9E'"G#EJVF
M(^I^A#O\<8=(3[%4CC'TLJO*9WV!4L'/B:&?E+6U_2'<F_'^5LK@C^DAA:K4
M77VNIT.A4:)M:TRG(N!^4+K-DY!Z3(CAZDSMDVOM3KNM4M!OE=_!_2V03R88
M:WQ#0XZT9#58P?&L--#B-EY'3_J=NS27SPQZ%@I%K6:6EF%W!#Y 66K".L:_
MBP6] Q@U^H@FV 75R-M6GK>_CH-\0_GFIBO #G@>^$[B4()(>F]KC-(I47]W
M]FQ>U7BW>%<<T)WDXZ]$_4)-N[K *O"RF^R+I/;UV";0+=Y];,";*70[?Z<
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MO(SL9L9*)"1 5R19:$#5B R%-MO"#\=EU2+OL12X H</C,%J]K->K$>KS(+
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M0I&B- 7$0E/$\H)GM[//WN?L<_[_OGO?NW]P\&'66G..,>;H8\[U?>+["^"
MH:Z!+@ "@0!GR@_P_3EP&J"GI:6CI:&GHZ-C8*!G9(:P,#,Q,7.S'V*#\/,<
M$>#GX>,3%)4])B@L+<+')ZXB(2TGKZ2D=.28FJ:J@H:LHI+"_B @!@8&9B9F
M+A86+@4A/B&%?_OSO0,X2$^M0!<)!@D#5 =!X(.@[X^!(P  H@']^  _?4!4
M8&H:6CIZ!D8FR@T-!P J$!A,10VFH:&FIER-HEP'J _2L O):],>,G.A$PZ
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MJ')\Q5'S>NPUYT-<7RJ0VG<MRZW?^V1UT%IBWLFA<G-*;OF][$(YVSBX%9=
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MD65B&QYG+*9$6@=RRS08U:K2HD\03"V]PD^#IUIZOQ@HSI;[OL!Z5(3L-'/
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MCJK1GY1, R20.-I&^?^'M?<.:RKKVH=/ @D=$1.DJA0AA"(E04#!(-);("1
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MWX <L8I:0B;_UXSM?PF<_;/1VQ6(%?1V4R+0T^YGK[.[[RNVH337N8 1>CL
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MO#(M33\H]!;YRM/./,]*R=QY%.BJH#?Z4YZ5I1)V8P)@T.F*X.&-@[&:W5R
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M=K.&@U"@?#WHFX(DM0V[D5%5@T4PD,W3CW"/@])#W,@ 3P_(6!Q""/Q@\NI
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M:G12'Y=_'Z,I6YOO3[0"#Q6(YU%VZ*1Q<!W/] T)/'+AAN>BK=C7E]/MZFS
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MQ.\;]/#:\EA$#?6Q[@X57K3AH"63+[WYJ0!NTS%C_K<J+>-C_R%F67X_);$
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M)8]X<>Q,WJTO!S&K[L+8(H?>=)4SL'SEEQMWO0VU\ QE"$MDRA:<+U;,\0I
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MWK=6N1EUO6\ZA&8_$KD>JJIX5W#*ME"\X!@L.+LABS^P8I&>;6_@A*]G=,W
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M>PP5\Q>V(E9.5G/,;%:R@4!"!&RTL$\K(613A'1?L>\>(G "[F)&30+=P)+
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M#X4W?\.AO42#1^7VPM>Z\HWY9\D202@,YV!KH6*(9V@GYIWB0H)W'K\U@;B
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M__ 8<N5_(0]K38LGZS$-B(S(4>YYIDXF_W.!D)A6J3(:;T&^X;-_H4BN&:H
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M%+VBO1D8_U!'@_*U-/?EONQPZL)U!<[3IIAXI[I>B3Z6DN\ [O+'22S:H8S
MZ=NY&IKF*8!;]$.X(K>+P;4;$$Y3/<F!0^ML\Z="<Q6$HU<=6GIO."AN=P,1
M(6>D7SZ5<5:\@ J/NG-]5N)\:TW^2'QJTM!A395LX'/S;=^ZMG6VJ;7SQYH2
M!"NEUB%M:Q4%HZ+I[V=[7^S+MB6$!GZ("C^N\65;Z$;Y35/:K;>[+< -[0BF
MKD)$>RGMC!,.3*Q;OV%#!!8.A=K$:_LF#7UQEJP4-0W#4B^O^K%M'-JSN'#.
M!<VX?O:=A9A0; CQ#*$@BSVY.SQ$A>-]9%O$ZN8SCSBH]FOPHYKA^RV,Q,'+
MZ_LH;%."&QU.'(J($JN'&&_P(",A@MLT*<3J<W.]B8@=4;ABU6XL_3J[W78)
M26/C8N1ZG=7UM?Q+,]!9BX_%U]0NT:@^WV!A 4XY^(@18L;G9HI)V(TONG7D
M=6Z/SUNZ&XX)"[Z"R#//BO7MA=H6K//K]?>=M4GD")LU&9JID;M_='^3)_RP
MMFR7L[GY@Z>X\),.^)%=S@]LL>DW)&+C^ ?  U%#[E_7,=N4F/G[A/&6<D\V
MAV^AM#'?R[9')Y%"8]$D^:'LX2Z'CT7/SK.4'MD_-/$T+&=X8</IQ+O@G"K0
M<HVH&&]D&K4XE.EBF6S;YOBVFSFM>ORI/+OS.6:\-MKQJ0$= -H']5\WWP\Z
MQ&_H.7[_6^B@#W;#+)Z(UP;:2:%0K,E3BP]1+J:E2JTGZ *_CQ(_CG2CX;7E
M#W%G"D5A;:R%!=]U:SKDV"$[RE\=KT]".3XG<8231W>5^UJ./.PTZ[97'?"/
M^2K[[+[%V<[N*TA!55&$],>7J$<Q+ZQ;E][5KY'/9073&K1Y7A@)&-''9&%*
M([X20/2U!+$N.YC&R#/ 6GP-+E26D#A+/%@>:$:\H@;KV<8:'#)_V+COPVMP
M\8:-ML_YH6]OR]6K^R*TK=.=/%CF29S/R]V<RG4T;JY6K+6N;X]DO/Q(]#B5
M&HNY^;26_96<-W@T*>3DARA-NMB=@MUF!%B%,FA9Q(^[Z!V6I<WQ?HP2=[S]
M;;_3N= 9<3,NT]H1J>#'<-#KUKE+]V7V/D!]V^]P?5A2T4OJWMK6C70U*;QF
MS5#")?[BUN*"K]-.;@J/#FLE8^Q]N[J4AD#+81]DQ1=.EWQIV2IG>V+GFC]/
MW4L+:\L> @W=;]>Y;L$WK_,FOJ=.]A%W:F^O'<_'/.1+V=P>O+;+B6OY;.P=
M\?=E>_S.ZZ_E*@NFG>)._!(">H$8<OL897/N8]MZ?,_]^5=/,5FK;G8+SO63
M'7#0,K=3_G=@#\5'O#;BW;C(Q>,Q%>6/C@]UD8*1(MI0"-<#Y;]P</\)N@7Y
M.^X3!= S4<Q=IC^V\/ZO4\E+@X=\T"#B<GT@4M3MSJ*_PINTNM9^";M=5MH7
M9,?>A,QE[$N[IW_Y]CT,7FMMH'F11<^BHZCK.W!6<-.R'\U5;^K/[[76QY+5
MDI>KO#^<>AV^V*\/*G\H+RSKY>]DJJT8FX=7VYWIB]>D':<-\'9'7&A-*5?#
M=F0^F1N/(G$R^7OU/B/6BU!?J'6'W7T-BJ ZQQL<_<* UZ*M#6RE/W#O\ HJ
MFN\^!R%J^3TZ;6WZ\AHXAP>O]0#^W#WP,;516Q0-&O.MK'W[HE7 ^/DUPV/'
M_2"@A4&["=2^9T2J<'I@K<1(@5F!;+D*X5GFDVTM>2!PP"RD\[2I^\3C4-D/
M=XZ9<>U;&[HYW=\H*0WN60FAY,(5F1LH]NJ)S,J.#AHRXE\?6^\UL_S&C11F
M+N'H&:357=!O7C,* BT[38:2Y9Y$E75HP<N"[^&UTGJ/-["K(0:>+XXPZ1\M
MG]G'49KX[F(JF2_N^I$I$M>17..@^U2OCL*&]W<LTHVL]X45FY"B=<+P6F.:
ML*?YP(B!VZG#1VD-MIL UR3E_2=#O0_>X/A'5?7>C9OEF(T3#1-G$2OO%ML[
M8O/NS?<E]DY 0//6UF=VQ\Q7HZC]\3$C[@T 1[/5QZJH79>K0/-*MH[*9TJH
MFS=&OS2-T.>'F]3*"E3#Q_!1DS2X>ZY_?E^HJ</=BKK8$;$1TB5/_4MXC (Q
M\AX$S>2OH YE]HW0:9"1/LE:UV)+8K.I>&/AH%]9=,VMY<P[J6D[FX@SQ @T
M2Y9"BE8/7_6!P3G;.N8&]_ZWV^-8DZ+BFT+>X%X%N7GM6,GR;)C6%<>N!O3!
MM<';@]!+T7CU2%^YP#W*#N75IX(>5Q"WH@<?8U1HIB\N2QZ<)7&Q);5N]D3,
M5)6M!(R(^ Y=FH8Z/G_78GOS"6YGU%>J:QK:U*G\51US!\1&_(@\)9\O5\EO
M/CU12F^[P'R4+RRWLSA6:5IB2G K[%Y,6VP>W:E[2'U9@8":6HHFH:]]]UH/
M!H1/C=PIS.;?=]HZ]!LAV8M5&MS\K24L74]@V3$N*7T_1'C$\L5>YN,KU-V.
MK*CX-+SZS49UR9OST(00_;#I2\:;]?"$9[%5[56I%IU]+(Q$N9O<S<2%4%.E
M%3XV3MFQ:&)FX%WK"[2K25ZS$-"T]9CCFS$-T>H79R^9U2,;(\OO[>,0?Y8K
M=]&JUI\L@3P)D#@]E\9.2;_2EKWY:+!<],WM9:<GDI?OO?+W,,J3-6MT648*
MYT3E=0G8I8S<'AV[GN<$>Q\6^(1?".4P;0 !91:W=EUEV]#9LZC<>\!%<.L6
M<'$X^TBV<%$J!#1S^JQG6!WC[2^4AGXX\U68^U?9\GC#&\Z:3#@#?T$I!@+0
MG&XF+@8)*],<];A.'^*VR82U]>VB7951)*[##]->*XZ9HKG.=@^-D$RG9Q;6
M!EW?OJ!U& .S\K<;796)E?+93PX)E+_0YK8R>&;-:^2T) WNRM6O2WC'-6<6
MKYMQ:=<7RI"-2<PEH.@[X&GP]3%2U!O>F"(,1IMYG(O;6G)^GO@=.&T9M&A^
M]_-EO-:%E;4KYY]3'RA-7HYM;I2-9;)]>SG_IJ[T62S08Q_D-F6UFZH]*BI[
M[^;QL3KQK#$7G2=(4:M+A9WU38A,:&S/>LP(Y86WZ]$/N*HC^ZRTR$"PAG_!
MC&+6,"73-U?N%6)T?-'XRAHAQQ0AH%B%9DE\,>:8%#',OU*^^_SS.S9U?<,W
MMIFL1$49WZ: GH[;.JQL!Z.?>9QY]" BM(90G $SDKH>57D7S9*-]0ENY&BB
M7?T$R7'>W3O0V'A!DOOA%*7[I("#/P0T^^IX76PKJ/S.L9KLL 5$W[." RJZ
M;(T^KA6@=WU,F8>/(04K3:W&8$/_D5IN2I6Y<9,DI,K<9<]F<6LPII_@(K;X
MW[SFDP&)8B%K$ !O\T7]QSO+;4)5;F15 -,^;H.(O50<+K:!%!)*'K+D,;ZN
M:2/_M>[I% (52%&/C?,&DRX8P_W<+>^^S,]RMTG!B>XG:F8Q1 P_4'V*48ZI
M(''9\I2(H/3DNWR'"'.W:?>NR-M^NG-=1&@.!VPR-L1LBN=*-A>$S]S_;$J;
M2Q>0JAU;,ZCMU99FF&RMJN!-DDE<Y_%ZP_:J>GGQMO4!1,>3LIYW4PM4X)Q'
M85DR9]Z="]6*682-"X*?/&-$<9/S5+@B/2@=>U;:FOM41Z,<D1+6.KT]DOSB
M8X[+; #\V:$]IA+9IL Y*^I81QS*6X$FPG1:D/.V7&,P<97J+G>_C^D>A#,5
M,S]WTF'6,ET)<ITXO?75<=IZ'J_Z$HN2"-B7O;NLM>T-V_JS[P!O9Y(*_U;)
M9N^>;F7V9*1H/\<GHPGKJP%ERD[GR$L\1G'5PT=#FN6(P$3G)X)IQY+LK8<T
MK2@=%5G(QX)3;;>0HI=5<C(*))&K#M]NE16LSS[82RQL.CT$JAK,^P#I#[JZ
M!7TRN;Q2\&486O[0;ILN+'BB_0,=V56' L&FINW2,)HEUR.DB-262,O!C(=Y
M];M"5_8]0%]JUNM]2>(<IX>=^IOT'G2NKW\)W?=%XII.!%YSHJBXR,.7<,5Y
M<ICB.FC!P[V!9IY&GT-#.(?:YZS-NTV0NR(-=3^0W2+M:M,O8GB)0*ULZY5J
MSXDE([YP:/>2X,;^ Z'!9R(F[O%>]@;7:KR+;A*O\D=PJZC?4:DB^F2X"R[#
M*\7 8GTL7D+,#H,WS"U/9OHY#,OK61GN^3*#5ZDM*B9WYAI/%:QK4-RZ*.]S
M]L>9?[M[,01$F]8NWM:F9&ETAD5$;C7IQ.$URHJ*"S3-R($+3X%]CRR>W)'=
M1V?6!K!4/GY=@] I2*PZ%EU^SI+F?GR*""R+/X@M:$5YR\*$N9W,F1^)Y98L
M.SJE4[2FW/M8K"0(I2=0KI.X14C&A$P.^9*,_GCPP/T%&YJ"]>S6,E*4S%Q^
M;X\JVQ A4%IX)&XQ8J+0BMTT@C.Q>)M0CP,6A>:@^C-?3[)(8"8=2]NR)RF1
M(UO78D=A<-"0ZG5+D]K37Y9/]%KPOB*NCV[!YNI%(D:"I[<]7!LC25Q(B]1N
M%I$EZ8YWUP9N$UWQ?4Q)O&,9;P3C\NH_=YOG]2)Z7YQ-3#\0"H0IORRXT&)^
MP<=R"_KXT751F]97NB^>'3Q.3\-%JP3PW7[V#KO<)HD;C7HP%T/$X+B#D<BC
MBRF@!_+-8CTH"W\CT [(#Y;Y\NH)M/HF'#F8V2-60>>L[510\AFHLL8A<OC[
M:W<$(!ZE7]\WF',*XC4*[\>HJ+*E:49=G+F?XPPQ>I_=&(]]O7G!ITAV \WB
M&RA>W M-#BPI4)\U#]2LLEL@G[ZX?Z@07Z.,%/$]FPA=K[L8BI,/=:<GFC>,
MRAV$8MRWRC,-']6E*!PE<5D0OGJLR7R1NS909[OF03@<3MFS?**(L8\E3.5]
MBT+?.6MH=/X"J-O_V.<T/$1LL\@UC0 <YS)V^"_8XO338H%GVA]?F?I_1#*.
M20<0+<M!'=$M9U1W/5!TJ*&X&!Z$@-KMM:*V*3UE_?O()B(WN)JH:GXF4HI(
MT? 2.\WC)V0>%"BU2$9(? *E+/A;GN*H]2!Q!JX5'&M"H+J2:Q'#CZ(]=9I]
M^CZZH@[(>#/$Q?N-IQ/6_%<>5\^&E49<C#EY0-91[C#3S0!I<*^60>$5H4 '
MQX<9C-^!,P_.<=XI"E]/8 I:)MTS//%B$UCE><RH%3?,7.WQN69,ECRX(L#+
M7Z)052F32 #6=T^J>-6KL5!]?#3DQELMOUF]SGT;"U:92:5ZY1GP'3$&>OI"
M:-<54&%[#*I]TMY3^/FAOOPDMMJ72QSA\03NY\[^$;%='J_$Z^5M#'QJSU>!
MIL^DO=NFUHE6E^0;1&.7MO:Q*RLV"U*]2,_ [%>0(OK1O+CYA@?Y*]^!0^2@
M3XXQUVVH87Q]^R3 2.&#-\YOQ=9XWI_QO=F2\BYBI'99T):H_&Z$-W@Z:>UT
M]FNPYM&A %V\47GJFJBADAD"^^1)+]\1"_O^U[USKYCQ:N?>J(8O6XGYI'X>
M\0\D*7O-E;H==3_5B!38%:H15YA8OL:EZQL.WWOQIL6A:Q.A6&#NV80.54]\
MDC.\?$8$6$BE<)$NYP;AM5[N=?]0PJ.9LUV^=5X+]#GUX'O@VQP0>/@"V3:T
M_-J)'+2^$=5Y13@$>QZKJ?^\!<"-.E2 I6HP2)3K^+A2(%:1V:D*Y+^M1UC8
MLIV5'BV/5(=R=.V6<'?%:Z5;&NG5!-LE0+D^=V[*6QQ36MOOF_C@[9>EI\5P
M$+E0N[@UT-$TBS;*+W[_T_B)^AL-Q$7XLDF<DBD0DIX.\N_0<SIW![=WWV&,
M;Z,O3/0E"Z+GY6L>8[-.;W#GJ4-WP%F\M#N+Q-@IL,2(E<Y5Q_$UP0K_Z8.H
MS]%X95Z+7*\NTV-C6>0&&K4G4@YW%I$0\IPQXS&)=>YA1GP*T?[<,^J39*S*
M)\V'2AR^]F?#;[#X T:%SP(E'.:S+P7T<DL$._+E%H2;3U&- LE\&#J4<6D#
M\H]?/0B+8/2*&>R)/C,K[^=#]$7JHP"34+]X@?95AR.59/T>0^RFR?5=%H3Y
M-ZN[%?GI":&]!?M+Z?)DX[JSZ]UVWUI]]NW';0H*WVQGQ@N<.3^GIDU)>QA;
M+KF0->+^"5X0@G#PYG1GO!,!/![8U'XG"_TJVQ?2K;@_]@0L9!)Q,L8CG'H5
M2<%+@XK8ZLJ6:Z=H,:6&,\6F?MU(X<+B>THU8S.(W>=R#[\-="K[%+#>7O8Y
MF\EA7Q)>ZQ[KG-&1\R-&A1VL;;<(?0_?+DL98EN23>KTMX.1(JD%M/,NA&$>
M9/]TH .43!ZXVX&@^= L4AB3D0)C<[FW=N^1[3FTXF%D6ZSM.U8TV)6P*E[_
M^1&' ']V"JCY]8 )ZW:ES:%RB5 Q7D>6+P>4]D\;%GP'K@99+Q7BM3X^T9R8
M!=,:G3F.RK0W1K8X7VE>D>@P?KT"CQ?C2H> ;L_)(H^D/OV8U.)0"WW- *Z%
MWBQ9-#UREL0E[*_\%7[^P7)?B(B2(EL23.A)EP)H_$6#B8CZ[>N!2.@;__PX
M3A;<[!UWV,%GRXXY9"'^N[*I.8]GDV\O(P7'&,L[Z\L'1C29@C6@-\5C",MB
MIA0D#^?/BYO_>4(T6!236-/52WP4_V:CHB&C%-Y;'"^]I\H<I1CU!WH'%><X
MYN5,RAY9I --3K[](-58DG_98;LN]" 5?9_FQ*0UD]H:5VA2;38#95AB<Q:*
M"G<J>24@GH!O+<%^[!@[F0[':8I."M^^ADU&+(S9W+AZ6T\[M"8BQ4)ZNX75
M&BYJ6I@36V<IF;C-#EM"+B([O L#()F+$]82>7F'3G"T,.Q#V2CM&2V2NT4.
M'"423N*BR&*#W)Z$2/?VHO 4D+Q Z8!956CI=\!W@<K*(2B3Y,"#:SI?[EW'
MTV]U?K 1>O!6"V"*TK]CV(ODZ4=KU6$C#TI6(/<6%]>N&\T'(GG-K8X7(<22
M"0"1</."_KM$))]WM\7&6W5X;W4P#7^HWXKG_(>2X0TDC[EYY4SF/)IQ&+,V
M>KRNQ>1A["8HJ0'-HD8)M&-<M?[0_Q#/%*7[BB&Y_?C7_IU6X(V,SAK!>>>;
MURW]3T"">!S>HJ[X?"=[%AH\J1<*=5Q->0\1>.L3'QRW"=(R9URU\'<V+DA'
M?BBA.<15@12>;D(:;0;R7M+OS23(5!H;&%NE$X!< L'6JNVH^791J-:S%L \
MW=3@&_>VE75_2@[DHE79O=G!#WW,YP5/QU=[M_&;$W2W]A&#D5Q$;K%6F=Q1
M7IT0JWY)H=<,]^SRO@.L%!.>J%8F_8&9C(##&GV,L0RBS:1SB%/3D,O+.=4:
MID3 3Z4TMUE&C\%KC>"X>8K$(F>LR1;6L@G)K"M,G\>+S-TAY;M^8O/\I-4)
M7$I[>)GHBM%@,Z5?R+@''V%1@SF5?P$PS(<LN03 &K=)3&=3KXE9[=K<3/Z(
M<C[35*SU">CT%SGCY?VE=+6:\%2#+;$\\(1]#)UU%_W&0$(LM8\^Q,(;]W#H
M31#7Z*MOK[^4S(P=/D+_\?GU2R1$H6HNA;O*6O-LB("J_U?9HI?Z2\"3*RA;
MNL&PSN+#T<<=E@RYH>#-X($2*7;':%BH#FRG /T,"VI0:91(J?8./_<NRVJ<
MV_,FRVIU2\CD"A(Z76&I1;A?01)ALO;%LV!QDW0,*/ /]J'%S8ZB"YZ_L6#A
M)[$ +,;8ZX_@.1Z J5&D^0Z/)E41&']GNDY23I%8R_TQ5JW]=J?R*?L:9+TN
M"+T&"\"CK%F\J;[G0F,5(_5,NM4]9O#[[D9@MGU>PQYZ(,C@!X"L[K6/*-65
MQ:_]QS\CMTAF.9L@M1LL;PEH@J:EKW0;]LPM)(\+!D(7;WP7>4.:0:I&]_F8
MC)FT7Q-4()-XZ=:[/B;UE?L]PQ:?)0)ZQH;L@GRP#FC&L+0\:*O,'#)IUB(F
M"\TX9&6NV"-C^H7^FZ7F:R674-*NXE(=G^UUXMU*F(@W T[FT.$(.HXE\VZ_
M--Y'!-(()T\S*7=]H%]67+MQ8D(1R46?E-T';]&GS7'K;ATX8&Z4J#^]C-R-
M.BK1=*8XJI.>USKDW3:Z<J9$CQW-T&^4B.Y0& -R".5)"P]TZ')"Z3W,NO-C
M+FVT2 =(@S8M4=L%='9P,H>WBV=3KK0 MGDEF3%L?F>.Y@J0=@]96$5"EO[(
M4KO<[Y;7?][D=//')@!CK/0_OR5AOT"QU-7#%(@;')3RWF6!,'M>STM!R'6$
MM (U7FI5C^R<C\Q?Z'8^WN"S:]172O[(.W7ENR,/)L]&".PZXNC5,5UW3E]'
M!C7Q;CR\?#7E-.K48L[^''%PQ;[8D#,7^3N_E'RRD2]YK;J'!\V-%*G)G4&=
M#[A$:]#TQ\+VO@EV$D]R&*OM>NI:4[6*0X4RO>:[=H?:%Q!=L!$IXAM?,7RE
M56F"5J6:N=XMI1SJ[C1?P*EIK9IU3C!B<E6+N*<,=V_6W5+G,(+'64H=_AVH
M:5G5GTU6>$5+*?2Y$2H44O*DI)"]7 ]L.%YA_;8PW07.H.3Q E<STAT ESEG
MZ3IY 6;+ACYPAE+*J8@I,]:T>$^08[(^L7E="''*NV!4YJJU_Q.R-".AH@JS
M"@$=+SD(*91C)U3?W?G+"E3@\IQBCQ)" =:L@89@3^HJ)),)L'$)-"PUPU97
MF5>Q 1UUG%Q0^P5JB3C'&.FS6J\Q0.;[,OSQ@VM.@O2J!2,#7M:H(4/5L]P?
MX@<!L;) _'>V+S,!5J>]T8'685=,JM!,ND*A:E=JROP@C2C $OV\)"S+LI%)
M@0FP=!F:4*1D,@DQ 5[&92Q0?<P4;4.?==%*JH:%1&*_ZJ,:2!RL?6%#3!)"
M:Q!J*DK?DUCQ:H5U""^&6'JV(I-,B\9P04]Y0S+IXQ\-))[DL DCF%[&P_Q/
M8HK5*$),"OU(*+^*3YBP9]G*SP\GN]!'Q>9(OWU%\H2OTJLNKC;CR3%%M!%#
M+0YHCU%'!!T>5AK'3\H,M))"2&RY"$/2<.SE=&\2:WC!&.Y"7@P;<,6G>%0%
M]X))ZC$2VJ16.%UK]2 OV87$ML()VR,\3,U+]H: ]HJ97['PA[B@&=EW08T]
M3@Y4JQ!B9UBJ =?LS5D>SRK!"2^RB3 ;BS%01AC'67)87P;IT[O+$OXQ<-3.
MP%G]!M^&#7W>80)BZ(:TAIYQR:<_98D35N<_O*-::88]17\6]_!NBC_E,VK_
M40+P..'9PY13U#.U%F,9::^T" "%^=N6E[SU,3HZ:NCC9Z0>9IZT?K\CJOUC
M@?J#%E/FD3N"6@KCE&E]O*,Q%$=#:F2+W2@LC "4[DGLUOW\)! KA(*W%E4#
MF.WW0SP"LC;/G(W==.E_GZQ/U_(LO'91G7JHLF356 Q,(K'Y/D)(3Q)JQ)V-
MPUI(;.T<G!QV8])C' !F['D^!Z'QKOE=-)-\F;1,:_G*#FP,F:$J@S5%/QY7
ML&>MI";+<GP'($?C9,I6F@)M'*Q@DTAQO-+\K=22BLF.1@%RXIE'D->K1MK2
M#"N\?,LV5J4%?"O57L]P80Q8:S$V3U:HD&<"1[@@,>;I8 4Q<0];$8F-"Y(9
MYV.<=+;(;R85[Z.%S@XG[>^6/40^+"''!.]H024;P&WE8&'=*#DZ%%7Y6XZM
M\^J"->ROE9J%2JW)&I_#1+"5R=EK$30BY<O6D-T^LC5CU%,XFVK'Y^]FTM$"
M\X+1F-:BW54;>M(!*8=E*(<1_O:SQ5]*PYX0D*#Z(N4("Q7!B)(W2(9'5$.A
M 8IQD99EQ95:(A L>/6!>DJR>8,P&GQ_+(%CIEAS16LX,_PQ!,31[E($S18N
MEZ(N6CEI//-6Z<A",T>51>&[G5;M: ]0WG$I_^Z*;<:_O(29,$#'+MD#3+;8
MV-NU:+UPO*3LR=-J0P7O4OWE#R@OG*#QB2)66=V)TS+SS#)8D5Z%X?MRMDD4
MAXD&B;3>+%'9\8/5=BS&+0_[:*B#_MI@O6YJT5G.75HV1]V*%\#P](9]:;-1
M94]XQT5!!2H]G;N>1';;?E9/3O!-K!K*-NSQ#1NQGF+O$TKOXGS0K3L]4D\Q
MGY#+IYK,R?8EK)D3YO*UB'7$0LTA92P;'NN9J+&&*RQ6I)%-T;PQ-"'=9P/Y
MVWT+S#<CAR5' [8TU'!S!^Z';E%VERH-U*V.+MZ#^3)HHVLC:D7>GQMFD45(
ME^JN!GZ(,DR7?OE4&GH3;J%7\AJE"6?]FQUFAW\YX_%[E,RP4ZYBP_Y]V3(V
MD?\')_L_=L&0#*GZPZO@C$HU3!X]NQ$^G?6E"H>'0.S6VP@R1(PSI=V&4,,"
M 2*1JR:1Z.[]1^W>O4PE<8CGPVE(E%NV>:6IOQ6>Q!$5SYQ;<]?&QA7GO*K?
M%D&U%7(!9&">E@+=+@Z^\H*\Q-E0Y[U&W"Z[R"[:W*?Z<P-06&M.C1&"WBO8
M^6]%U%"B&4$BUUMB^-U=KXMNW=(G9#FU[3(LBRQ<8':1I0>V2QWSH9%?R\<K
MC,<J09BFR=&J<)-%VT!<66N52X."M(N#F,RPD0*#8/9$2IE]!VNWV*$+93H,
M!7;(\@C-RU0;OME$I%"QGN5]U_KT82POP6=$2,0;G']>_K A5\3<W(BSB"F2
M.+ZVY VN!! <[V)H3IGG!PM-34*#.@OQ!_<"#V4NW$ZKOU-SF%@C5]Z5P8SG
M61K-2772>AIHSZ-@75D8<XJT6[$CI5"-.9._>3!C"@U>'6&^8R44UD'Y=R\F
M24KMG&S]IS=3PAI;5*S'JG/E:8,T//Q^RQ:9433UYONNG.J(%U/<':3=55'X
M9:,Z;B+Y3&!%1!]3WU*$8."B;=B'5Y>DJO.RW84% 4+0:5_E7)7J^?&[-,V[
MO&CFU$=';0R,;_N+J5&>D %Y1,KA%@T"T%,_.'!TX.X;.,KO2S6-F^BF2QU"
MLV0[+,IS:UJ70)-X^T8*NMV$KK0$$^-2.V2J;01N^E_L;.*U1SO-&2!Z33WD
MS 8*+H==_](:&ZDI<BC'*2=)>LE71FCH).U&.==;8EI4<#CCH2%"YDI"W2MH
MI^33Z8\'H53?B":.UG1I%<=,,_-.0B'-0%L6=6A&+$"\T&[J8D9>TZT$>;MS
MF(>;3DS^D;R<,NKRJ6T,R;#.!?G@"_#P94L;["W[)-^\AX.J)<TCB&"R<=EI
M#B$&SV_9E*JZB>'^\>YYA6 ':.S]_KO+CF%977L"BDY7W(7Y$,X6>69$Y1&D
M]_Q905+3].C\7]J-<HT,"$"J]_0L)83\SCGE/Y]71G/^]='_OZ)\>&;QW[F"
MW@.(B+U!S$H!?N^50 >2R5X='Y:^7&.HG M\B%?0^X!K$B]I$1LGW+U%8K#]
MP-;>4*,^9?T2YW:,2L.KOZQ('DMXSCO6<*BRB+S/R\S8/[)G-P^7\2VY=^K0
MQO<AF_D=YDCAZM5(&22T;8FXN]UVY8Z-KWM WNT+*GN7\FY>7S<\KWHP]P,7
M=AF>S9TW_FXD!'[N='"5Y:(;3PC4H<GM\<FH1>/W7@.UQV0TT2X68W$GLQ9&
M3T1@,L7/V>C-RA]Z/CA CNRAWK)HHIJH&8(1YU86%T_8-F^2F%.V?17>CZ:J
M02L)L:^LA0? *7'#M>]DC\I?=$HM]D\095+?#Z[>"^T)FV]*'B@6VCL98^/M
MW[<%>>*UCPQ6JP^9'V\>E-^DR7>.^+Y7Z\4%/==_P 2@!^6UR&!HT#ET.ZZS
ME9>L%D, %DSCWT18IU+OQD.#.QSF<R!L@%L"7Z4"_YN9<H?DL6(!B$XWDN]
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M6H3$7PSK/UU_T3XA>ZEBJ$_8LS[;P-9=PK,BKKSE$U%!HO?HM_[C7N*IH="
MF;JC%$6G0O(U"[\M^)K$\Q?D=ER&FGB]B2DJ4YB6YRQ2E6B#^$#0$X/&?9BU
M=!YC;X.,5JLR-@WAY^^^:E2GRH;7LNG9R/,2+MLULX4DG?05_#15#'?P>%E;
MK(VS?0.E$*/=Y#*Z'3;8#U /J[8T;15MYT.?&96DO+%R?GK\OB=>XWV=^8L\
MWV&GK3:=Z_P?X#=*JXI*2)QCF@FO$.P-E_-=B*U5]S5E=A=Y^D_TL>B)?*I?
MMDY"-M<MGROD<4/TC9G5L0'U.F(C.F>-GSU^8_\NB^KB]!V@DG9A7G&[(=BZ
MCJ=\G)(7]:$PB^(192_5J#)=]XZ[5GW^]VZ>_'&6A?Z-[\>1OW^NM$-##RU)
M@PB1/IMT$[5?@)R'%W]WC:QM 5F29MB5 $7$K7_[5..A RNCM=TZOENEG5GF
M[:+E%.4*>>?<VE^$OLSWKEC-5=OT0G$)@Z8W,FRPV'LYLID/!]G=$ZI?IK"K
MEU:.MHF_@]7SNG5]>+9[$U%R\N)1 <2=$N_ER^:7C!<D[^7PJ3'?O&EQIZ8^
MSO+QR6Y4N$OR_@/$N:FZNAO1P837\@BXXFK8?"PP'RJOG2=G::UD"L>$(%XK
M2^S=/3I?<2>DO5X&!M=,D;LS.R5,^UJL#!B6&<JK')YIH"IQWPVT<*G[F)HO
M(C.K>E"-(C5Y_F&J45^^9VJ95;=MP:0%S;'J/NUR-;I?\G>7!0::S.^[P0$R
M'LJ=#?H\;/QI6SQFPZ&L8>W@@3/+2)'FKJ('.EW.V-FRK5/*^U27;22'3C_P
M!H>6'W">@>YIT!V==/"8O]<YH;J,'E\^UJ[TD@I$\-2=?%QDH^U39E 5@*L+
MO:[XX=H"4K#*&K.L\HK"U9/]M=K_Z_1V'W,V- MQ+OB+;N[7$I8/48!30;?G
M0PK7ARC]T Q(4#,><0\6;&O@<.7,RWW99GP5X._ GB^OP5C"'>A$4 A"99T
M8)#%8S.(I>82IY<%BC6F@1'QU^_7V[)\]0;W,0T=^SIMQG/[M6^7V#K,ZS,=
MO:?L?",KZA]A@94/8!/;OJ6*PY^'W7%WN68@H-N&MIS5!I^MN=ZPE812CK&P
M2X/UC8;-L.>#*)S5[;UE'"\CJ%A<9V :B9.BGE<Y->3J\7E8_7X,^SQ>KM\R
MKHCUVW[TD0I Y^S%$%!1HHF=+$6W[0U;K<A*@!H<%$# U06D_+GTZ>,P$$G
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MA;-8+?7(FD.8*"5\-0HNS(' &"W_0_)1W5OCLR*0 UQK ^>%$I',<0* K^W
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M7,'0Y*K6C*Y^7!G=8XC%!UAO>]Z<^.K0=N6!.T0Z/5[SP>6,Q<\=4V?]I+:
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MCU'A0 J#I93VU'V237" A<S9Q1#6P8-#2P4^BR)=I<4C<[>LX#2H^::NZ8L
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M<AA+: ZYJN2EUFVNL>"A;M,9L0TJ9VU2N-V)6\V)VJ;9M,@O#Y:#K8P @<0
MLFQ72QY]>9*G8ZWS$E1LI'V9FWGWV]Q ?Q&D(DM=F:JIR'@.3BPG[C40MI*E
M>3Q4&4>\MY$>DAJ^3>+CMAR=/Z^;1U]J4GFH <_9*A>ZS)>DT#^Y[+=%K[,
MPD4GR4]-Q2&+GS-+9*8U.2L=FT:$0J4_T,)?M0\]6:@;Y% JP*+,%%F)6ZZ:
M'D,)G]'V-Z\5UEV,<H6T$A\P%RQ?75]U7-_YS)(PY>ED[K!*[^:1X5G3;9K'
MFP<"?4K^!7B=0WRNIN-0YN"53^@<KAQN7--[L(R3]J>/.4_%#3(5S4!<P*3T
MA$++RA=D^D"[ 6X<)BEY%MA%"V?VTK"W/R!$%S(=&]8-6XH/O-QS'S%P=^.N
M<W*[D9]!MNG[ST@.T<K^1\SG/MIR/U-G,W/5C5+F2]$TAH(_&AP\&80!/!H\
M-.\K*#=>,O$LS8]^O>2CI4J7="@MDQLH<<H'E#>^[MRKW7?^V<+K K<2:N3:
M8G(]-!J:U[AQ,>#I%%QDDNU=+BG-=;OEU>NG[RMRCS[T/9NDB_Z,8;OA#P@F
M;J_NFF#!]<-XC>V3F0[:ZN?8A'HNIHO^JKU;5K .K^._Y[U)6+<!;D3CZ<!3
MG:T*O;W<\C4\AQ KU ,G M=(?*==FLX8M\/:!JX<RCG/?/%#H?8-J%VKCM8O
MNIYV3RH5L6M=/W0'FHJ[5Y_3PK'LA#XB9NYQ&!H.517S+VY[2?\D0@&Z^9:V
M0RT>>;76O3-V3IA'Z^<))!GW#Z&$]9\?NYO>I3ON+]8B\&'9N<Y-)&EB7I'R
MUF>E-P')05R9I#QL3G/)N2<3?N>40JN#W4:!%?7MN/#Y%]7@C@<CB_LRMAX<
MBNOJQP5]5:Y72BZ\@^VMK<-Q+">@O]UKLH'WR<L$!(D-7,V305QU&5Y6GYK&
M,\<>0UP[R\>G4S+U,5P\DP=>\D1[>F%+XY9F-*:IKB&B0"(OH]%[-KL0@%>^
MT"K $]'!ACT?VUC6G1:-8Y$,L,OF[6.T[D5NW'UBW>M4V-;C'-[#'E^K<IY
M,Z-5;W^KXKO@ -M]O8\T&VD3QAIM0!(SM+CAN*GTBM<Q&7?V0.&BP27?<;'3
M_59VPY-+]YQ!A*):)?76P8"O75D*]8? L+I+E/01$6=I46K'/2?;4Z=L<6R3
MVG?XI_36.W%7[UAF]WYUQ4W)C\@TK29A[W^525;M9S- 2:X'1@JE'&RSPI'?
M%L4>\!QW\,[O"&@ V-U=6GI)*EJ7&U ;I2U<$TQS'%P-CE=MV*ZTOK=1;E5"
M:+_=;B:^1X@,UC(>[RGM%1MKW)1VO-GG6&*L61BS[#@9C0 B>4$-V'O0 Z_S
M!U[9;?5YF1T\LKFZZJ12;*;Q21D78C'44LQC=+AQ"0/ION6@4!<P46&2-];O
M>T %OUB?0-%U3X$GB3LVIGAI[Z>B1P+F?=NZ:4TO#9,6+391DQ\]%"<TV104
M7(<E"32L/QH5%[3LX.^7"0"LF9WWV8]2'$WKA>5:G<C&6YJ0L7L,'LP37Y^]
MJ)"UNX&J.?(@GA6_EE]575/L(AQS.</6]59A0@IQLK:*GP2>6E,-R&*U=1"8
M__#A[5E]HNM1F[0!I-FJ*_7QM90I/=^J""-9]ZE(U.GJ0K)+9E2P#T/^K-S+
M81K&<1=8Q3K$O>8QH:A"MB?,O%LV)#IRI+;W$S=S>!FK#^(#S:"6]1O$XVTQ
M14(:&C>B-Q)&B2TQ_O%2&>$#5OR*(F4!KXT>.5L"S@M12KM2Z_=3?2(NV(6?
MZ88-SWP\KC.12U?(G;6KDXZRRQ;/M+VE\F[-$?.Z0M9/T-6@-3O6@&[U!>$<
M(TT ;'[I73Z=VVB LSTQZIG2:48K/LMAHIYJ9T_9N^NQ7[#0+>.D6SJ'WRT[
M33YZ7?[(P?!L29PMQ.T=PFDT(:R,.\_^7&G7?ED%>JW>8S6>-.>W'XVD7*>P
M"R6QPQ/S7!ZP ^N<-S<J#((_)6MR4K?J!0XJ9RRFUL/GPXIXWJ[V(:QK\ZPQ
M4X-GB\ZG[XED3.?Q)2[T3XY4;31AJMP5T2!CT:YK>[&OZ+V=R F%IB%/%H^[
M8;P2UGFZ@[(]M&TE(X9:Y+@UR4U/=YXX=(5#+C4 BF%(23)U@BZ2_:Z%9=,W
M*'$\0!3D3EP5FE &VAW2"&OBD(FB2%F&75%LD,BC,WR$:>W'%"H'7GR<M%BC
MNAY]V!T !)%9-%K>UK5]<=@[)VD47<4Z'LBXVO/4$9.$KP=LPJ5.?:,H9HD:
MX*H& V:016EHX?:@&F__@.7/+!A@U#"1M0\PC_&>;*CD7]DM5L=)6YMED:3W
MK>C*/)L78-R(6KB+3:TM26,TG^29:>1.Q=ION)QY5]?$J_Z0@DO@XA?;[+&L
M/C+6C:NO*&\3="V?8BI6SY,^YB$Y2;4NNQ6SD.D63,58M='QLK=>;FQQP\7O
MZ234V6KCL^-+EF1AS%+%B0L.2M29NQ1^RW!+3Q&/FK.A; W'=Y$N2*'"G"R[
M=QY[8^%EM4L:^N@L]\W^9W5U6VM _Z"HX2AA^>SLF\,-N>&;@TR# 8X[5@.)
M*EV"!EM+^H">S(Z2OW@Q._M2_K.:\GEBI?#50>MF_] Z,9DIQ382IW>#DM0E
MRK5QNI89'V>E46:7[EQCKO7#&X&?.@!!Z,C:Q,.BL!F?<5YI%^) W09!-G;*
M%9:46=?#'"=@:0^*YXL#&V7%*B'0,M*HCW1+<_SH^=G0!KDYO+:>*\KX%O.%
M[P^=->\D,2*9BRE9DC[HZ'O\F3$;0*SB&F8^TB$;EY4*K>-<=6L.\=I_PY=V
M&KE1X+*'N=?OUAV!B5X<8\VCK]S;F]P;4/09;5 9_3+QJK^$@\TISP.#BI**
M(+-(U#!?^H[1:_RF5@Q@]BM@C/CP]AMBS;EP.P''Q:7:=&#-:0;],:)C)#L5
MZOEO,A85D7>B<47DXO^^^,X_(MJ\7;N,/*8GYW.XGI]*08H<TV<Z,/<>/5W&
MA(<OP.=J+_??RU ^09G$BPARVJW+RJ$SE1)%9/ Z[^O\GT$1G3*%Q#IIEZTR
M>Y8MTJ[]<6IB;7E3'UJA1<F)Q7?G)SU)NUZ_>,@'/<,/M/<?M=^AO3#L4P$#
M^JYJ?&;>/ALI:%V %P-SB>\4@$\,L5+D/:CDPZ(JTJ>=P*<TBF3S?F9A-WV>
M<L$("">QR["5[:2&1C2O6@6DCW%H /(!)< =;N7?.9*!5FM,AT.@W_=%D'F4
M.9R30 ETE%)^ID$*J 4B-$,8)78#F'3C0KH>"UYV C 7TX]U0;DC64:X6'RW
MD"S **2+DBRAVM)=;Y!=;DA5GT#WY0<1\^PQCEG#^ /*4=9%;LSAM46 K)@/
M<7"'&I\_8?00?]D2:9>0@.UO#S*U Z02V3FY9&&S<SY>B5<%G"V@?^HZ[,ZY
M$N.5"*J:4D4C.%Z;]R1BDM.(YF:N%Q/REKA=]IH!#X9J^DMI+F7HIN'RSK':
M4OAX0XFA;XN!?7Z2$!.C(C'G?2]L66^%<P_S>P[W7KQV::5$I8*0XW7W(-JG
MNQMV;M#;B*>JZ[*'\E;0\8<)#EQ9J;)AU&9>T\W,(H+%$N;!?DDV^]LF\=>/
MV;9'DB/'8II,YDJ-69OD3A<0"C73[20IKDD"94<&Q,.+GYKD3$]-=SY7)M)2
M766#>2-/-(4>/+)4T;V5W:V'OL;35G,OPW3:$LMK"WIC)[AL=62I?'?Q]-69
MQ F%4 $LP40%+8A*N-/JDD)OM,8$' 1O:VCH3:\SW@KOC4!II4FO0 E)<Z$K
MEF[7;:%CI0NL?M,3)M+:D)M'HE.UH ZS#!F;=RE6ER*'(E.,KH=(? R B>XZ
MJAQ?6WQSG>I??-_G58##.TI\F+_B@,3@]2?!QC-S1PA81\R"HZ?8*F.&,Q)H
M^OGBI<R,Z$7+BGYP *4[4KBL=.'NJ0]&-IG]%S>):.[;9A=+6BT.%J[CB(XE
M"6\M=>:SJC7PRU^7;D:"C"U#@@:D)8AY>G7H^9%JO5R9E"2EL0R^@NQVF/O)
M_#=F(*.[I&'P7+XP]L)HM+L/KS%D,:>QC)WW()LJ9Y19E*%MH"_$X]@.]"9U
M']*7)8HY5;B.JS,GA;I[G]Y.5253H]]F?S>'A-WH-2^\>LX1;(3=2V+5Z9,(
M),FV@5> D$8&HP#%:NPE0W"!N#8R=(<8#MAGH/3%2(3$GLXZ@F\C#2KR)PX7
M3C6\LT5YY+8GVK%D7 <7I&\5::#2Z2=24J<)+<?3$ *^Q:R^NR"'75!#IM]+
M.K%X)*"&X)S'VLG%[HM1I EU*Q"8"\-J_*GT:\OHQT(P4.P!L,^4G8WYA)U]
M)@OLJ[8>66"@2!Q7D(C$3J%:M1!KM\B1]P15.*]JM&_;3O5T)?*Q$ALX+Q?;
MP<G?.<[7[+VZ*78QQT@\YEV.G5903IF@H[()XV<T<#4I3H+&M_LY-(!'\D@>
M3$78<Q?%B_U/<)YFYM_!K/B?Y,AWX.K_%>4BJ^!&;#71^OG+F3JO!<LS&D=;
M^P GZY:4EY;MJ!]9:'SI/^1(_+=D?-FJ=%X;#$1[M9?Y]QLYI"W"-(XJDKA#
M4:"4'Q$P_4-*'5XT8<#4E:#P0^1]B9>4MI!LYZ71DE#E+Y;O@&W4R5B4*KPB
M2'WIM3CY@"ZN1'\<N22Q5:+2($L&#%WC/I'=)W<N9B_5WZR$0U(YG6BETP$X
M8F#!5!!C[$'$G@OJ>['XPD/:&H..RW/->_CHA\^<1<QG?IK37J09EM53-=0+
MWPZ^!W?6)_P*V%6N^6%V,\V!<4;V#1?<-K/#61O#W"FMGU';5BX0PM%)[CJW
M0CT>1CG5++TU2>L[)P)A'>1D5[4T1^HSWHMZ<*2Y9))+^T "#>-5SWPHA_7#
M:"=1&ZA^LRDTN=0U[Q1'W!GS))?Q4\41*=F*![!:&[L$O<_X8CX:=C_NM:Q:
MU%71<V/E(4[>=#21Q!&O&Q].2O]@<IT$TU5="N,NE94:.^.F)<D6='SEA,'*
MH\B')1*CM1PVL*8N;9;R7P'>[X;OLK<\;#U9R]"?*<YX'!Q2LA<1:ZF#IZQ>
M+-J&G#F3.%Z:3QI])?;TI<%R<^X%XI)<U-Z&\E?6Z$(2S9/ZU*JXPJ3T9:NU
M0CJOPR4]G^7CAHW^,"0'YE88_ )#=DHM+S8;DKZE<;AZU#!4[@T:!'(IF*F5
MHGL8.#4S-9+D02,5CXZR 'UB2Q;"9 :\QZ6 Y'QM_>&[DOC"HX\461!*]SSR
MYK+^&5G%'R1Y:Z<&QN0YNQU6S/\&/[T3OFMZE%*]C]H=BZI>2!#6 'KUU6#"
M;GEEPXK_D^)"WP4U^M^LS/\CIJ;@I"DCFX9F^S=PX7J""Z'+?&$ T\QSSQL!
MJ#=+L>P7HO1J(P#T!N0NV*WW;=;LU':%3?B>+O;)_BO;&9=MWS)P7?I/D&P-
MRB^6[=8F).Q_Q,[U'3#4'",> ]#]"3_:CMR.^0-#0S>[T9'"<P"F-6,AI>SH
MD(35O 5<+"88!:0#%47^[I1ST7[FE<PO#Y@U)_X$>EG\!C#(4H^@*FU3Q&.5
MR0_QBBSL?F+U <$Z%<\/>U4Z:YJ @2$2MDX@VRRR"@!]P3Y@#&/.]A@QS#24
M6'0^U7:L$HK>^^6RA7D=QFK2#2?Q.@J^!4N\6FL?N"Z,(]^KYHTA+L$NJ( 4
MIU;4]K82AV*_&%AZF7NN7+:QJ0C.+UCT6T;-FJ[:<MI]H(5YATGZSGWQGM&@
M<>;R;6LPX-O78-E9E-W]%2;4]F^SGT8L=&YT]G'VL^T];8V(@3F>Q#^H4!G6
M,C1Z3'KH=2^#E8@YBE3>2!=+YO<1.RP_-#)HSUF;K,/2-(P?$6,-*,!K7Q^Y
M?32<TBW!^!40*K;>E^--/W8P5W!WDY*CSZSE=H]4+/D&NI%#8OQ84)%"!*9\
MTEA7!7/&)4D2C=)1J%VC'_CVTNE025<NFX-/B6&G[Y(9@SKO__5X^@!PY4&C
M?.JLB:U]<5.C[>@PZ*[,LX$9\)TS,4T>#0W;.AF-IS'O(^M46^]C7(VQ+KXK
MD5P#J=W)&U S&"Y8YY35ETN4O(+L]=-JB*O28K0/60+O8<,<=<E!A,H@;_"-
MMU%PV?1F!LU#PNNV;^6TZJ=XJGBKQ+W+F*(FO?Q97[54-&PMS%<B(<TY\\/M
M=,]QV-E3RN^IBNZW3"+1W')GY=L,5JQU+N%$..$E!Y)TATZ]O<UBOUW8)[KJ
MQ.ZU37:ZS;C!G3[!MSLR?-8)%^A01L:-@:@L"QKFJ*M.IY''1H<3C8]B@(_&
M"FK&43=&;>_7>FR#!3VV(99ANZ;R(8<;T$L^ C!P^__3WG= -;4M#2>A*5)$
M ])%::$*DM#1@((0")!  @10BD(*H'3!!B*6"(AT0PLE]"!(KX)*4^DA*B J
M* (**H)>Q?(GW.LM7O7=>]_[_^_[UWIK,6N1DYRS]^S9,V=F]A09Z$$PX+V2
M#B_NZQJ%5J^Y@.U4U1UDJZ&!'S!?=#1 #>P-_?Y;U"YCC^/"9T SC'[HH1E)
MP(DG#<]A/7"2! \J.[_I%K;^WTQ%_S8@_G6&_E<@TZ"[R^7)LPI%RJRW"\VS
MWWMZ8P? O4O6;XZ4,[S_G1DQ83;-2 4]-.8&!OJ.O0TK<^ZQ-N>NO7\BE-S5
M6">7"!>K[&Y_SYR/6A!.Y<\)G77&UGZRI?*,[UC/Y*SR\*MI"LC>4AYP0.&H
M+7=-TLI9X?(6%9%K&]; JJ^&?%NJYWD54F)36P!FO>QR/2J-L>EXD*F/?<1T
M+J87P<WUW0"[]5=Q 2VP]P.;8@8X&?;$\<G\+P5;K!^1R?5A)75"?F!@K&&9
M<Y2#JI<,'X5NR"F=[#&T <_A)'&HD.&O/E+\J]4)O#!$]>JP_JC<I(X'ME>A
M5>P1]<680/@&#@K.N(WV[>0((^6JI\&XHGM:\&&9"7_[!<=(A]L8]+0JF6/7
M-KD:HE,M#RR[BD!?A^FF2D#M']L5%VDH,7XM%*7$&S7*TBLC']J-EO;@USS$
MO$=@A6/V5/HLE8T]4P)E>#7>YA@M[?>3DX+@LW?=?I&"/_<NUOO8E0,'FTFM
M5P<Y[[TC<9\07/\@)"?A=M,QS)2>*@GWX 998QU&#RK2J4&L&)#4V66^H6%D
MC/1,08^>[FOA(D Z6S>\5[JSAJHFHC]L19QYGI>DVVO.'WAH3IY;>8XH][;$
M04W+)0,-XO>2>/ZVV*.Q/SPGE:PT;_%$D:;IQ1E,>[V'KD*>DJ\SVQR$4:Q
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M]>.T$%/ZF)9='TSR-]ZX[^@@>J#!;B+-;R%R"J;-$!I+%/JTQ6IQTJ@C /7
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MB7,R(0/<WQ;+=M@F//=*,:C,J@86FII*1IXFL#N7V7O!(4Y ZEI(P<%";S(
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M=S*>?C#1&$85T,?LK(A9HJYY[O13+[$\A*']DE-*F<D%L$O2+(F+*]Q:0^9
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MZ7:;2N9'*X,MW_24S6S;=YBU0K<WJ/"F6.PF4:[7-!R$2!-K:<75+(MG]-.
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M7XA7>A;UR%$W$"\-^+DN@C]AZ 4S6OD1R2R)-B/@6 R[5_3Q[GL'M5PG0X,
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M?46WHD:CQ"O:6=HNA_[<-3V><6%S@M#3!=Z)?-;P=WV$=I["/(XVF0+1.L!
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MAJ ;M$,K[=&II#V+(\;]LR ([ZEFP&&:W(413.6K%WAQ$CU>#$[@'>'P\3
M4]]-\;N-I_P+9OW6C-DY\?39"YCP#<EE\YA_Q6/.(N<.UO*8WW,_I")GIV$:
MN'3MQL-I\4F_-315Q[Q-1=-7%J0#YB1IY 6WEQ$6XQMN/%JF3VH-:*A5N%N!
MM^A&@X;UHV%!WD#=+%^;-S2:2_TTEUIQ%TM71?/A4^:0;[C+VM!@49W8.=%
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MS:+S<,5N'L*;NS"-6>">>H.$\P#CWC8##J792  \-9_U*#/=15J&P4VM5\&
M^.YD./+#1\ZI)N#%:',DQQ@$U-=3Y_/F(&"8N7UCZ!@'?N,E6/[Q+'"]>\]-
MF9^?5/' "Z-<,ZLW!#"XNW(NZB"I<C9K 8 Q?PHMW60LO_%=0_;UQ-Z/T6_%
ML?=5//R*8W*+ _H1<3VLCA5?77^K-S6?X>-/SNGMJ715OJH&"F_13=4 8!T
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MUH5PBVN ;:G(MC=;D6T7HL'V)D/!\F&1D3L<^>$CYRM38[&I?!U@L>EJ;#G
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M\#VGX>X.C.R8.WS8AXE:^AZ@RS3%JC\QD9,T"M5,M.5,9'?G5_%8_:!G=?>
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M^#/UR,'7I^KL&P=6'LJ!=AWZ')Z,L12@3-QS^!9XR-[X,M*?NSN"] 0;5.
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M-DODG87UE+H=Z5SX0^0YB4\; ]@>[&S:>J@XD=\DV=T9LB0AQ?"&'C6=NH0
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MB,H9Y0-)"!XR "#WPQ;=R-4%V?H<G5ET0NER!YXJH@;NT3$E"[^'JF<!=0I
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MP>+ +_&=2M3 MF4B'61:'HG0Q28+)GI"O\Z.#,G(P#G0AJ?:_SXC$P',*PJ
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MSEGLLK\TV6I#$^U3ZR7DVKK3<;I=W6Q;KNWTV[V^;1JVTS%:O-_1^TUR:CU
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MDCD.:.,HU_"5VGG9A=?R;QA#=H_LY?<SK1IR9@SLJ!)KJAP\+@Z&OJLMB-&
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M2?X/,8D09X&J;0"9"0!"0Z@7A)K'.4E.5!8J8Z,":>@.[/I;K=D2281TK=%
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MJA=>H_Z=:OD]<[*5SU?K9;Z>IY/).)MFZT66Y<5Z/BZFT[/,/;W,=>;V..-
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MLTF9+\;C57$>[7UZV0M!")?T&.,722^<6/5!#"D%9%1S#&*$T \;!9%,0(U
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M(#M@VHR++U&YI5MHD6BQ&X)0_)R,KNL[BZTZ'G8#394=W=>'V%;)]""ZI*I
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M+O\14-CK#^\A\R+;2'49$&\<T/0_]T_(:\RH\N\5^BHJ'7_P0#B7Q&+A[NY
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MRRC#7_$@Z!R\.%@]BJT06PW&K7/G4@!8@FF=#7H3@::I V!C2 OU+4/,<A<
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MYNCOI.3>*YQ2, 0NB@7UB$EAXQ3@!DA_H4T0*=OKQAD4=*MA_]%G>R8J\#E
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MAT0=@*TA44?2ZV>D>;W=H6D/$47.X-+[B7$_QDV()S1SR*T0]!Z]L3 _!AS
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MO_O1\?Y1@CFT"9?TF-O%7A89-1G_#[0U71VG"5;@[*J;-I"<X<P.)XB<"XX
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M)=[O]7MBG%L-R*/WD?-^>8'>.\$UPD:X XU))/'ODI"ZYN2) >16J.S4@Y&
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M>T10EG&LZP3QM*1LLLIF)E\MG<<V3E?EPJ1V-G%1R'ANYS-CSB0N3R]E5&.
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MCWMZQ>FAT#XI)^?D&\E2BWB#>YW+WD55'3D8MM5P N3KY!A;FGN5*&\_)TD
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ML$@_ETM!' .]YK$J2;]5LL  0Z!/9_ U",%'#Z<NKW/DH#=+OH*9THT.QM=
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M-) 9;;@#BTAQQCTL!=K -+,-B*Z:]6.$' Z&30RP*2;;)C,\E];BW*<*;=^
MY]-;B^.^9'@8(_.1MC+1;S&#;NJH*_FTY4&3L DHEM,02 >3"*2'>.S:&,+4
M2V2H2PD?LP>L^;KYK^*[_\!V&4 YZ$I>*JZTZ#@V"6M),.@T)SQIZ" LJ<1
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M'U^.KXOC\1?9^^RR%Q1EK_C.XS8=Q$9P  M49\S8C1R1-4=O#[9_N$K;3R:
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M2S 6L16VFA $I((ZL8 6WZXWX?HE1+VTI 7/EJMZU7?SX-6TXBB8V8%L(;-
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M:F8T)O3]G.'Q/D/EB5$Y=RU\9Y+<+V_RV<8 \+BQ%5TXOH[N[KV7FB##^DF
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MVY->=]SNCF>MT21K]8?3=C9KC9\%]\L+KBA,9NL&P=V285H::]]*RVN^GIY
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MI/%A;Z,1C'2.B&\$8HZA*H*R2@QFI<Z9*(5@[$TX[RGTC[\3J'6HI1P"&W<
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M53:E]>(L,K"&:^=R8T?3M4?J2! $ZW+C*_W^W&^*J,C@,&6LK4[H_U1;&2"
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M^%#G>'6X($^P[7Z'"6K1^^4WF;SXZ<RK8-\7L,/!SIG$=A.D%@JZX+FV*?/
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M;4.1_!$[<!43QR,),(D9V<T<GV0Z9+<6UII& Q4J'BUX<"8P>KPP)\+L[Z*
ML->2"\^E%NHW#5?5O'W8I@5*Q(VV@DN"7 :BL3*CK7=5*#.O\34L9SG-T80U
MO_<I?,EU,(P&H"$)<_:O 23NBGO*Q&V=$?Z[CMQ.ZB=N1S.V#P_B(=O>%W>:
M8[M>%0$MH%G%$-<HP>9;KTUJ1-=Q+/.!JS8#*.4$-V&E=BJ9+VNN=,:ADO0
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M\7[X \(GM"W)IE3B6.+IRS5-VVE20W1:V+/\3=(T9'P&WWOE$<=#\,8.36M
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M0C'O)+QM(#:B?(]\2FA[.S(,CBKA%:23%)#"W0#N/@(0"E28# 7]0O[Q2)K
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M!##)+1GMB\5/^%G6P-S'#>@$>KJ[L3NFBZU%\'POF[V7!-.J339JWY#:@NQ
M!H(\.Z\_^23:LR;0"D=5M2X## ]J<47E)-Z].SWI=9.K\U?G[\X3ZFM/B.9$
M0L+O(^B4MU*M[\[PI12EO4LS[N#L:+2X\;!!>-@[>#=N+'_A5*F/9*)W#!;\
M"Z+R<@9K\A.221(4^F&OE85O9.;^;;0SS3>._!O?R-K\RFMX^!Q%[\&Z7Y)W
M00=,^25,68B:P/; \$JG;3*QJ)S?=%=6'_7<AHM ZFA,#ZT:. 2^0>FL<&N<
MGKAQ/;Y2O^=,DLM5L<9"XMCH&"/*D#B/*9!37CA><3'R8ZR(NT.(B?938%#/
MJ*UGR5U:%@$CC K."-E1#1 I^I52?2@(W=Y^$0BY"C,GNN0=ZIR 6&JL-'N3
MB I) #I5!XXG20O#,5:W2*X,\Z3[KI8Z==H#8 7Y':4%W&8P,#\C-(2NW7Q]
M+;1O81VAU2SS!/#)!?J8:6K=8>6">KVR\!VALF730VIXA8@O$/,T=I[PQ>B,
MOGKG1GC>[W8'SV;/??<!.Z\,(_PINYV!B@]G[QD"#$-&<RT/KPK%;?_55TR[
M@?M<DV"PD+*V;?KZJ(,)Q=K5OED!"SA WG9EW3LK03%S5BJ/B"I,D%UWV^8O
M#3]L@<2249I=E)VC0BRLM_-RZ(;$$QA3O&/YY]IH-<+083+K==N$6)OIPN?@
M'FF55[]CGCJ'N4H:SPG, +$9+8:>,U+6X&DIHR9FC^R@*8_<3\M 4RKO1.TT
MMA-AM%VD^\CGXC(_CLMX7HW(*8-]Y(L<[^$BL4R"AL>#*RUP38-]\G ,BB?9
M+L.),ED55A<+FH*>18 4W*-JG_0-(\+8.=!CZA40TV8-&>!@%Z,%%^LC8AR*
MCY"YHN !==<S@0!0#A6:2 E'MNY<2)#,EV32"$)62Y&X!7:;1G3F^RZ7WI1!
M?"Q^QI$;S9@2\476@H;XO\\J)S+FTA)WF0Z&^-OF<E/=]Q5C3O]"_$#@I]#;
M7'$?3+JT=%R,%J5(5*UH%4=\'!6;N'HO13H*Z^G,MF4F/F++@5/ (VDCHUL\
M"B=;DP4EV]%-6'-A 9/6VL!D8D&XHID?]9(+RT1D5R10$L"-2;5UA1 ;G&(,
MX@,T;?Y;QQ3ZV4Z3J*J+(LT>![CVF2CWS4,;6*@<(.J!V-/BC$FS+T]3Z@\[
MP<CBA&G])U]<(0!L0M'R>6,E'_Z>P9IC^1C<N)( >+FC_JN.CU/\-:54,4T&
MU7'./97XQ]--9LD<W+"=<^MF1<I6*'!HHW)WS&H*A%8,_NG9I<3+U+/B;VL.
M?I@CT&E:X2'"*E4.ALS.%*@O3*62@IR<GKRD(I;&D!G.2OPT&K^MM3)X1QP%
MDJ'6>7)T4F(F^WI;H ]*Q6.(:;F[0SL\WKO#^<^\6J8$&@'CX;9<NH\QVXLN
MYU%TEF155!7LEC(@:S<FR7=/7F]$;1XNS0L+W'K@AS7@W7RMB]J=ZN5%BVD7
MS+I6C;'YA91\&J6DEFH2NF-[]1(I[9)LX#VBY;+Y'3&!T%[;4=C*H&/<#$*(
M,5,C3&D5[%#KYK(YVVX=-S2$8.3!"I&HZ1;$DL'V.J-LP37@[ 7W,>J,;KDT
M/+,Q4QK+=K\1A#?F9U%^(8YI,- .%X8PX4>YA"S2T&:F8K?.EXLS Z0KEG64
MYL%)BJJ XR^DIR<28OFYW#*FQ0^ELW9#6(8RRYYOC&'*=ML*+ASW[,H)0H0[
MPCPW*Q%>*C']]A&!Y\\3FY+*W#DO.S0VAHEY-XE0K.D-AAO9ZY6H"L+&4 VF
MI76RVEX H";D:9++=7/QDFC1T%"PSD6@]B9'TCP811U XCT?%;?S1KO'5H@7
M>I-XRJW$- ] _+9&6VO3;GW]_I>D-Y@,1W\&+;D;7;RD-3/9>\?MM6TY.#WY
MQ?0<8 KO#1BKR< 9C-;@0-5:-JC$B-Q"Y<4FM!S7M2!>10J+E^SJ)<%807DT
MYKHB6RF<;^UI.X#F+:H8[*]#6>JY]/E;H!U=$B[I8]@LWQPB(N-.=@#1$H1J
MWV+\9!VT7P)GZ+23>(9S-LX$5D 7NK%+ 6W4W866%K77,:#]7BC?O'BG(D7%
MK>O\+N1$W8V %WCUKS&KE[\:K&D:WL6?+H8C4%]J;%CO.4VXQ-G7AMO1>BXI
M0;4LJ'5R6RS#/'@:X\>N/#J6VY<9X4*+2DT8 XB,=8OD'"?J+]]<OO/<IT!T
M(+C60@*L8@)<2[$IG\]FGJ((^3C:5J5;YJQX;,H[?5 X*UV+CJ).=7VL1]3&
M67Z?.Q-)2'9%)#T"<LQY3S-Y\-[S@,\MT:68,OQ$^QI/8;E690^PU >** L_
M!A>>GM8L^((>4=16\,AB$\D;L.@-'UWT[N6"WZ3KMOQEV /96JT4J(4EA9-C
M_F)Y>Y.ZRWKNK O(P>5BD195316=<'[?7O[$VKV1J,!7+W^*? NMH?>NI4BA
M,-F8D3J%UA!G3W_UAHNL]Z%ZL>,&,P-*HIO>;\[Z0K<#%>+_^--O1#ZAK['W
M.[@ 4]0P1?G8)5G5$ENB" _9$VL\2=[,@?)?2,;N<6=_[Z9^8[GZ1&%V[]^L
M,/OQE8H_1UEL#<?W$]W]R_WAB3Y$0'V]%AR#0V"!-FA742C^;*JUE[SQ7[NT
MN/NG)S\*50]I@LL?.V'X!)5-![KE9MWLMMN6T7(*B0>(5..Y9-#%L#E0JHG1
MJ>0?4)M3%A)1@<)Q +?3E&A6/"2_*C$Y&(76W3<?CN[Z1?H>AVDWS;-\/,K'
M_>$P'<W&V:Q_,<\G>=Z?9^/9M[['K]OWV/*ZG\OSI =9:MRJ*IAP@WK?)^^9
M+&?)>0PBEJ<#W9#:9U?"4/NZD[S^^_.OTBGVV5(YF(S[DW0RNQAUY\-)-IHL
M)NDPO9ADBZX3UXOA-ZE\$E+9?XA47CU %B,Q?'3I2[NC0;;(!K.LEPW[69XN
MQA?I<#2Y&.?=?IHOODG?DY"^P4.D3POFCHG>%Y.\/RA\=-1F^XN"IG0T,(E2
M!X!;SZ2IP*+PSSV-6$L^ASQT3ID!,5A]LKM\2;EU)\\W;L68 DYP[3A:3_;@
M+<&,K(HU/;7,C#DC "WN#>6NIDN)1D".EP91*=U$GWS._,@+=TR8B['!?L%9
M6.)V1M_2G=8&/WH=_W$?/028N=]8HI*F"X%K64.H5-LFTM9J78WW2-B#W&'>
MKV=*70?8JJA;^CF"-]8MMZ6W$AJ1WCB;@PEU *8Z4$/4AV7/=1YFT=(=8KLA
M#_)?"">'D1 88\1VA]R-4YFQ<Q^5>""=<&L@@309@% ^?E2N34;,I( K-\/@
M+3ZDK\4M<E3D7>".\"4Q[S5Z)&'3P.3V\E<)?C=37,B\LU-PGKQ*B^6.2]F/
M;TEBEP%20L]56"*='H#DA;600AOM4B8\%]6JR37AN>$K2O?N<BD!E0]JI]MC
M-WW)*?B;$YZL7#WAW#T=',(^#P63\="39[_^[3DQ'DJHRYWA;5E^%"Y/R@%I
M+L"'\$7^!5F^?]'(LG(Q(C>BRB//DTND\0X>A?'\C>0VU?INI ,I^P=ITN2C
MY+:MZ^Y&^JS!4$8X1B'-^RL]^D-%J!2^4H[)HMV?"'YJGJ?2U,GI(,_[H*?J
M;^?DT=_E('R4L=X@8FM2(>YAT;F_)K6 \6H39WS[,-SC.DN7E"%T3S3U!U'E
MIKS0EM_(TPM?RKK<^S)V-XTP%%9PE#WFBG:ZG")>)X0UZ:X%=W@ =@C)$R#3
MR!C0<T,U"L(7E;7 6M!G,N+&O,X3*T[^M;>YKHZ_Z/W+#T(8'ER-T,73:GX3
MM<MHV5U<:.1VZQ72@-N[\@SH)<285:)N@RM&C@F@+6D!LDDA=1V'#:TH'4[<
M.].X98B3'!(&:LV-R ?=Z_0&H8;LS5;3)%<OST*!$[H^*/>$G.<Z8U0R)S!N
MW(-.6ZNP3<[4@I@F[XLW^L< ]/%6K2;3,'.)TF]W)= >_G6WU-5R;XWJKPPJ
M-4D724G<0VKDC:H6N<3.,J(S:[.WW$IM5L)=$<Z@ETP?EXN*QF::ET*SLT\$
MO/GQW67$>(JH&%Z9Z:O^0K1YR0]5P<<4+VZ^+@X\"I7O;EL74H_NY@WQOT.+
MND[*UX>WO8E3I_FV,1&IG*".2*IVP:/?F5CA6W2>,\4WDW:R@@;\67Z3+A<0
MA[2B1,7.9!22;5I_-&BS5E*^:FF<)=K\\MR:#[K-J3[/<OFUM6T]]G7^>?UR
M;:BK=/()ID.H;Y0NT//B'&BG@'0)VA-([2&K9Y/OIX'OI<!['@I!(+UP[,#8
M4H;B"M!@0ENCG"]T8<P)3R)JN3F$X-+"3S-W#WR\<UJS^&?<'/#86=.C6^K)
M3*7GXGI'UO66-$)=P/.9,;X%FGF,0Q#(?U]<&M_$N"TH6 $\Q-7;#_2/'Z_>
M7KT'UC%K+/7*M/2&'QXPI!N R+KIIIU90AA9OG &G^ZAQQ*P6!Z6\I+,'FUQ
M.,9[^0":4TK?,],I_#.F.I4>SW2K;*<\N8?1G3ZZE!P5DF5)EBD54-,N5\FS
MJW=7SY-")E=2UPMP6%"@351+\CDU-.J<*O&(/DPPV:0#53Z6N66]:2<G]]T\
M@=RYE.]3 GR;C/J=T:BKC\@DE4[V@GJWM%%L' $VL-Z%@I((6:Q1([\I-YY_
M\I)D^A\%-5,XJ1J>]\BRFXL@K'(N>;DKZ2<U-$1PM&."8Y;1(CHAJ:EBGV_=
MT"?EC,YEL<C)O>_HA8\JCK'$[JC^),G2;2H=>E2-LI7^<\R%ZMHPV,S93H/Q
MJ-,;C)P2S$MWD-RS@=)S9%#M;<2^$1#M/UIT_#I0I018I6<_O_[Q>?C,%3_6
M?_3TY-G/5Z^?FQ%JSU\5^B!(*26]4:_3[79AW#%K!6J]EE(Q^^EA2_<HU %5
M)1&7[C8<:%C)XS%'UHC6^6 I:L864J1?>&BRJ5)0*$N:$M7)V(=6+X82KL-:
M<'WNI1,KPM'3!2%>G'R[#\I,%R14C84FA,-MX@5IG35]G<0?@1'WN:TNY^#3
MRTD]>/1\L;Z=: WHO+G_3Q4HOEC/"7=H3HVS]+JL*C?2BLP'LO<=%YG0$JA<
MPL&NBIJ]<GT K^'>>=K7=!RRW7)+K5>XL=U.$=F@E%$7V5EO.NW685Q]K33%
MP>B  5Z@GC,JU'<J'!Z8&U;_.S1=\5;IVQ!/='H#S=[V ^YW;L;CH1!**VI$
MBKZJ;:ZAM.:&^ XPK <*CS [ #S'&@+1,^FEI]Z\#'B)K+^./!W/\B<XGL.(
MR_G#[-UTB'$'TU_P<G4GLHT7?R#N0EO]!-: +*TJA1UUN>!3H,<AX"XE-^Z+
MU$P:UOH\^4&U'VD[H79Z__+ENZ1W 2$X\\HO63AKA)UN!I>F*.W.W?EDB6#C
MJ-1M/#KO?<<'TGV2 *O;5""!9!.8,S]XEA.@$@(/'!:%&W1Z0CL.Y&MZ"=I!
MZ)U\\+E?FF%UO<Y@>^;@?9UDX*[>[Y@E,.@7EGRF0JX9\IR&/8KG2 T>,DD2
M*WR\^"?1_[1-:]H]GW[WZ%;&45OTE[^_?N'..<X2KGBJ271N/H.Y<K-,5M2"
M1,YI I[;!L%:6(!"Q&RCZ\Y8(4Y$=SJU+ELLQT[+,OD/*F4:Z[;^Y#OXR%3.
MQTX()2<3<J:S@GA>F>C#UW>O,[YL]$];)#Q9+FAC"?+;NQE^YAOWO7Q5S,^3
M%VH.N&WC*%)'DSV^.-WI[K*>EYLBUR(_V#YD,6MO1GU3HK333X:^Z4[!Q7<=
M2&[N;ES(=7C:OOU+P^'YF%;@8OI=1QTY+I2W7_5K=GHRAB*=]+Y3;$>W$A4P
M <OVMPT'W]'W23*XO))<$"UB73FW84D;\=K9YQ_33N)6CS90ET[N7G7,JIR<
M">[2@YA0ZR(<,WX<(^!SEJ)A+_4NQIWIL ^%V>GVAIW>>$@IN%9=X:7%"=RD
M,QABB7K]SF1Z^!V]7/TI%^-VW.-;=CKH]N1+I)SV9SCV+2_UW_?LM.Z^YZM,
M[%YA#%6L0HY"HIL17-FG)]&1J+49&7Z8B& GV6WH=[0K!,WLCCJB0')-,ZX>
MQ]K=$>5G.1WWV)5\GU-(^IY,#4P:QD5P,5FY*WZA;0>-U@U0;7)G$[=7L;Y-
MA=2>M#:;[OR96.8[AIXCY<PR3O1-Z=L&!)2 F]#='TIAC(-%&A V*?ZNS ?N
MB*2,-_;8NW!?0HC"*V><W7%+M184 A^O?,;&K[O7U&'7=)[_"*$QN95][J$8
MDX_YG@ :MDP=';+\C1A2WNBM84N,U+D&2WWL@7,7Y"105(2=6NJ3U-=8S//S
MX$9"9&K#.]SN.#<E2$BEW"4'X-((4)WIX>;,[2)QM57NM%^ Z*23R?E+IY-1
MK(V E6  _9,OL/>YM*7W)N/>L_KYL_[S9^\X'87?;#;/]3IJX^QL-(7"0'=*
MDO!*AKWNN3-A$I^IBI<C9>%N.SEIS;$;SQ$F@_0C>M9[_NS%<\WL*8 4[9A4
M!=!C$'X)RR> AU'.BW1;VTIK"J$ ^&K-;^^81GOQ_>:<Z^=R;ENWW8CM"D2]
M@/#44J_=4;2T]W0[ K DRYGSA%O!G,M040L]4[PS^R3?4PJ I)^(B74\U-2S
M?$6H(>1F94[C/W_TYJZCZ)_VK'+7FD9*#Q4#//3[+#2RC12\!5!XP 6XU!\3
MT+]7)3/CXLE\%E2Y*D,9Q1W<\Z",##MG4$E6'2FO&BMO_LQSQL$U\EV6;)%?
M?0[8UGW:N(EJ=VR%^1D/_Z^GS8.%9:EEN5->L'"<34#,N)7RS2%*?J#&RPUW
MS$1WW=4'^?=UE6YN]DX'?KAZWI%+4E '.:$J<!A$'(3O.I?'W6G[CKK+!%(H
MD"1D\YXEKW[YX4/RI^35ZP^=Y-4R_P<LE/?%]:HL,GW]+S*F*SNF'YPZW:V2
MEVMGP(C"(,;7,W<XKW.B\J3]>_'SI8_I>'7&Y2^G)^T*&JJY,-3S;=J9[QTO
M*XMVKY##+:KGS+2-8_/AJA-@D_RR=00@VWD$Q'Y;;FID'Q'@#WE[G0UU!NA<
M1&*-M_38EL0]N:A^MSL5 *DV)A)+%G%ZXC'>GUV]>?\\='TZAP/Y=0K!NU.]
MSG8KD&/[PBQQQ/-;"5I1&,%Y5YF[%P3GFDAJJ+^P_=J+A?_T!-+?LM#DW1=4
MJ$D>276]\P8*:R(9);W=AX0#[8T?'<8;1 O7AWNA,"&3 &B*HUBBGD.)P'">
MZ_06[H /OJ5>8,Q#3=MVQ>%AO"'E#%(-#C;2ACA#%H5[4VZY=1HE+N):-G2Q
M,RR")D=_OK^N _[ S%D:5!M!L/Z'/?64]ULL8O8S$^G$;A*>.CW2_54'0%N)
MN*$A/7&CB6"!)1WP\A\$G$M/+.8:S]PR7QHSN[E7-;6>$'BOO'T!9XNS""(K
M'FMJK76DN7G1Z8E_/'D,A7"=)R..3(S'WYTGKQA_#,M!FV)7G$P.*G-8Y@QG
MKD4$=H$Z1,V#^,NZM$5Q1 F_4,L\)[H=WX/;-GTT.NK-3!-!.8!;5F;WVZ\V
MVW)%UA?H7!752L T*G]-7[F;NY([.7/GK'QT;73<KY%J-,\ 3I'!2,.#NG .
M5$3WDG*5"G"'_$NV![$)TBO/_"F/XCS/1?\ D ;P^X?@7551?V1\5M**MW(=
M-VX7'0X'&021\-9^ /2_6P9(M'_ZXMV?_<_QV?]MFS_[WYH_O[:O8O/&'IZ!
M ?^>73E_ERB3G85'M\32XP-?D1OSLFD87XF-]E)M--*1[R,%81*0G"/TR#?^
M2]]S*F?8=3O3&YX-^[WG@@/#M:"G)U[A'S'0&Z:!M]>;)J3'%42]=X& WT'<
M)GY$,*_/3T^N6J,\YNT42'?W_TYP9WSE+(9-Z2M*@7.NPUDE 5G)AOK=HF7$
MU4$J3"HKR-U*.,RT%KZQTY.[M Z&7/NZ'"Z &U0<LD!RFO&'8*5QF1(MC;DH
MI>K#VDB2I)64 VV1KRMXJI+_X:#VJC75?'HRRZ^INL(9TVP8BMU+#,%SI6UL
M75H$N$F:^QV.O#"7KEM!JB?R)41(H["56RC/%!=:*S(E!;L+MG Z9,_:\)X?
MAM2E96&$[0.3IS,A!!N9OK.[40SD?-U9/2<3\H!4P1GDH!YTQ^"]GQJU(\6C
M\V/QJ6-GE:8*5*N0P^S_A8@_5@3O;T)S$$QS5*8RZ':3%44VZ Q(ZKBU8@ N
MOW5:$! SZ)\,;F3J$1ZR<F0,:OS- ,-_<ME((&JI];FJRIM U9D5-;D,]@/V
MA=O="E6"<^=SIW/]M(%7,Q\F%B-GEK)'_>CG\&CAE3KKIH["&>8MY8_<(A2*
MEWSM8TO$^^CNL8]TM*@D4H=4L4 8FAP-LF<443LJ^4.EW[1'V:V_M!./"',*
M&*:=;MPQR].S_/SZO',XS.<==5)P\30PM#E S;PW<#I).\W351Z4?:/\OO]4
MW8G7Z^15/JLP5,KLL5<6P(828,F!VI/QM^5\:LV5/\H:919(-/(67VZ*:W(X
MBKDDI=;D!%;1\7>?(95YQ8M-Y9)2A,F9FMFR++,S]D]F18E:<HJ01L']]JC6
M>?++K23 EQ1?T#(85$UTVI\LD7L&O%Y1>T?&9;A"6^<M'IN"<T*X\3AP6RGW
MV!LGJRVR3+@Y[4-XIO3$P,[%KY1H-N;8X>\_YX(G-G!2((2\^/FRD[S[^9+K
ME-V8&:EVXU9W[;%K,^F\\(H.+T$]"C43RB!_,$.4D+@?:>TO#LI?:=!/TKYN
MP]TV*88T&23):K?59AU"D-POO5]/?Y9<"K&FN7^*PWIDDZ2@UAIU6BL3+TX"
MK/=9+H".-.522,"D5S<4>JL.)Y=65H[AM4DP 7UO?J-)UH:G2]$'(2 $<F>E
M-0+<HI(FRQ(RBPZ_+6$HA_>OR/HGI::UI-O]1@(5;EP%XR+*E.EDV.40@,UJ
ME^MSO4_N!+KE'=(%UR*640]8>,D*Q(JTP<B"7M/BNI&X%4&A6LGUM_1WA,8:
M4V>5KP"588@2"XC&J)D7K35"2[,,&R7/Q=:,1G@)]R8(Q,?/*1YP4Y7.#]5"
MF(#-[&D*9=>=_?2+T3U;C"C635I770L/H3T9]^2-H*!F>S]0GX(JJKEB!:_>
MOWS[89H\(]BW8CU]SN7F")6ZQ3Q;$&LD)0B*NN0UY:YNI]96Z3GN2K9'6'%!
MUK6<B 1W6=R47).1_^.FF#'S5CJC$AE W(:S*'X+<9,ZM<',4:9=@8>)L;GA
M//J5]HG>D0UI_=BO^OGJ1>WCCL 5G>_@T-JT)W;,:1/<?*A7TER*BBA74=<Y
M>N=N"^G.5FV'](NZLW$Q!FNU^*JD4V!>#R^QJ&VK(]M+?'EZG7DG2M"./(3P
MD3^$%O+!@A!HKT,>2;I,B(^M9H@"XP8M<]/>8-^#$[5&4:!/"W\P9'!QU-8G
M#%AJ=\(B@>A&H=!3_FAR]25EO<Q,T#]?H=07BN[&J0P0S=.,N?31C$]6&='=
M\/9Z=WT=^.N]C>M?C)*M+3S&'8J'D? #0/ZKUQ\$T.[3%[N474@K"[VGSL6L
M0*%8'K29[_P1'41!: FVQD8X3X6BX3(7>C<KT?I0M_.BW&/>H-K13?,3:4%W
M^ZL@J]*B[Y-_9\[&34KFM3L>Q'N%XF(NLJ#6WW! .O9T"(E@B3\""!<\!H03
M[N2&L 47*!UOEG!0QSPVQ8V6TK"G)W22@0**P!21'L!.LY/GK_*%@7;7)=-K
M@'%>2;&T@(]61>V >#W;4[ D:3N"/B_$)[U')<AFMTT,*<2:+]44>0LI!/97
M^R<>K,L"487LK(, D>'3>A2BI".-ZSZAH0(H$>!#F0^VRV/?"?<A=J[5R^GQ
M';#;9+A-0P.).":$16I5=)^JCCHH#=(UZQA7C^0C4]1U+=[@F"$7X7I?<.IQ
M!>Y9:V@E3I@[=0SU;)7O)XT-0&IP6\) :L2/2W#RK'A.YV:M-YZ:TU>J%PG\
MLY*>_-<<<H1[3Y5:SZY^>GWY7%NY >JO'^ZX)^NC$?27O@UN;&-NQGU-PV!_
MVGU:/XYNR87T>RF0GX4L<<M2 8;^S]#T:O@5]9_1>3/JGDU&///O!5=?\H I
M<?,]6Y<M"<)8EZL2"/4/C$YO_9L$G#LM3*>;M%B+@PDU2\GI3M!WU[N48D9<
MDU+.YY05YP_S]E7RIV*UVJW+^0U5R$KURG.=C[O%Q8=F=V4!E%F"#.#@Z,&E
MM"X-Z7I1H_N=_"#."&Z)4693+O>;NJ5.G:WN]6*9KE;<-\]!,.,Z^BH1&T1S
MQ\C$Q7;+.<P7Q/^H=M1MCAO5(ET1*X09T\'[L5%M(\5W8<0T_TB!TP[#F-/M
ML@7%NG/:_1\/W_+\/I>S<<1@C["QW2*K?T9@67K[4PN:J7[@VD0LVR_?\$;9
M<AR\=8MQ&E_ $I^QLVB,'?X8)=>HT"S<*M=T+/7*(5N'P(90A#_\[N#*.?KA
M*?H4Q B]UTPR%C*;>N[/Y?4:):2*FI\\8]0(-B=L(3\N+?*1BQ5!+)'YX]35
MB@;A;4/PE-2FK1%.@>'2"@5.4'H\#-HZ961Y]-OL:/L*V3VE#MW?X<&VUJO>
MJ84REV*9F_(N?#28^.T"?UA"&[J,I>?=6Z#WVT>Y-T", ?LLV)7W"BNY[^M0
M?\OC]TD,FM+:IL*"S:96L;%Q6Y0J,Q$_3UH6B0>5M(Z*6H3=;>2L50.K$,G[
MDFK[5"U!?['O(&T68E]_:#6I%=/'1!^<>%T,O^>7^[&B,OL^PY /@&7N0T%J
M5=!P="<(S@-U4\CIVIH2]H)@?38,C-T6902 JH)9[G=?"YP>/\UQ'W;[#OE
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M$G?Q!'USBX_:A8_6@*'@8)<['!-5RDC@E5L))E]+WD"4&H_EC^#+/(7BG'5
M#2I8T?M?*3"\'*OPYJELT/N6(*O5Y&YJ9$4;DM-5@:3U-<AN'/F4'J>$NZIX
M9H=BE' 0.#[<%WW7=YRA,W0]?S9U_6#8'T\&@3?0K[*V&*7-[FXS_EN:^/XR
M_EN2>&R2."&%:Z^(HF@N?:<7EM5_<:2X40+2UGK\9(R<9ZWU.--Q(,LM'MM\
MK3;9_3XKFYCV</S<S-UF=K5$_Y1$/S8=>](2?4OTWQ/13^RVIJE>P7LDU:W&
M$]T6,C6_+&7:EC&U]+(]O0P:)%Y;>FD^O5BCYA34/';1VS,[4#Z(<&3K+'FB
MR>V57FR;]K U!EM*WG]*'IA]N]]2<DO)>T_)!^-1<R !'GQUA_K2]LJ=<7,V
MW\'_'K:.C>8;'N9@/&P,<[6F:O,I9M(@K:*EE^;3RW#84/GR\EP;;[0V*:UW
MH]6D-[T;D^:XI5N+L%&3VRLZMD8M';=T_ +HN$&Z]/>2A7&29%S#FF(+NU6J
MVK=A7\1XU<+*-M^DL)SFL$UK@NX!O0S;[)V67G8(.%A-HI<F11*>T[OQ:;O:
M^V>,.[2Z=I-U;7,T>0%0KRTE?_>4/!FU=-S2\0N@X];[<:/WHS44FFXH6([9
M5H:T)+,3R=CF>-(<N=>2S!Z0C#ENE$/B"7(H*@ ^GM/U\#[(L@T</D/"\!V$
M2;H(TODU_?+IY.P9'1#WV+@FMP%X1E7Y$9L%/!^([X'=&"BZAR'>A]^BNV =
MM;S<\O+3\[(S: J&8,O++2^WO'P/0K7[^]'JIWGNLLH& (]C#7Q-5NY\2QCM
MYD@<YSE:?>W4!:3M[W$G]\ NWDI[O >JPJZ4VO)-RS>/RC>V.7#VX%YN^:;E
MFT;QC3G=!R]3-:$6%=6:%E %C7$PJM$7C<V^)#N/<?"_A\:7@/8H"J/ OT=/
ME(UO/TA/JO+054]5KNS69E:_!G&0@L*->O:QOXABD;5_&1AO%>XU#B(;674[
MG]:I<:Z]YA9?DQKZW5M9#?->-Z:A-[):)<5'NQUXMK]3&RMSHX]57_\:-[*:
M_BB[=I7;^]2ON]M1"X_JFE;AQQRM?5(^+BPJ##+L-H6]C(+T,O+RQE&J'52Y
M_5+^OM:'"9LZY?"7&RV1HILGPCV8Y#+SEU6;K"S!&EC95<R/TH 0*O[G_TYL
M:_PS?20)0YB^^JW;F4?N+)I'JVOX0K9.L1.Y6=D^"Z8UJ&QSE-T$S*YF)_:Z
MN@V7.B#9A^MNG9+*S"XDZ^LOG]]]=L^#US#E;\?P#R5AO3F0(\G*"V4%@WG]
M$_4T4K](>8D__E [^L<U$G-A^,T&!)+K*]_]H2 ,9$>".$D7[ERT*1 2@G_[
MX1=G) 3 %@M7HR_AEZ,9_G3DAC"GGPQW?N5>9RBO+U+YE+ASQ?5!<E(*3;QR
MZ8?"]LF+IM^'JT:>$7E,O%*KITT/BOC3#R"PY4J>IO=5WQNZ]CB8>-[$<0:6
M.QTYWF08#%UO[ ^G5MO[JFUJ4\W(;>^KEB;:WE<M2;2]K[[K"ZOM??7"R;(9
M%8!M[ZO'FMP=_)LOK1K%,L>3YH"PMW55+=$_"=QYW]D_;-V6Z%NBOP^>]#Y"
M_-\AUW'?\*3;]EC[6J$TF(P:PU!M15OSZ<5J$*!_2R_-IQ?;;HYE]L(QI#]7
MA?E;WTJS:A\:H49;9G_:'#'>VHZ-FMQ>4?+8:@X@0TO'C9K<7M'Q8/("Y#'-
M>7^\%I\HD]!(L?(+PU*8Y[<*8DP@;!T7S3<LG-9QT=++#CKON#D2MJ67YM/+
MN/5;M+VO6N6X"<JQ937GJF^-O$9-;J_H>-"2<4O&^T_&#<) ;9ZKHB;+]U'\
M%X5JRAN*99N#9+-K3OR3HV+M&][5HR!9F=9@#S SGJ&^HJ7L_:9LRYP,^RUE
MMY3]XBA;;P^]9W3]A*J8\[Q8Y(P^N%<*VPX[UFC J.?#!=U76*GGV[&A.1X-
MFB_-'H<U6G9NV?EEL;-C3L=- 1!IV;EEYY:=[[5CXVE3H%\>B3&*]D@-?.0M
M.&Z/B-9X*^CBIV6 YD1\;KQ/LDI\Q40],8<GMH12=+,RDJ+=S^$1BU"*A-Y7
M>MH:Y^A[W<Z=T!3+W^^-R]B*XQ][151%FG9&H'W9>KZ2O9]>6;UI/AD=HG [
M;/CM]@R'H*]I*)"[ SYN\ZD-),O;]K8&GO !Z;0I[/ NHHQ.XS2&_0G,;H>@
M_76F,) G0O%8Q(]M?\@5C#&U1V:_W[\57M2RIOC<W:!%2]^<],<X%I._1V!,
MA+A9LS0=1;3;D="6)?#2J4/KP'_'S%A@C948Q$@0%31)5T?P\P+X9)EDT2H#
M[O'PTO/O1+3=SNV;4(GK:8T'-$\=TS-TH]2X=.=K6@K<P]$E,=9V<^QV'IJS
MGA'?]U86^0@[.M?N"KXE8O'KG=G FO:L[:!VZ7:PRU"[W<YN6+N:3+\;^NJM
MCU?"3?T;)_FV>I+&B;;D&Q[L/PU8Z,2UAA,K](+ 'SACVYDY@1LX[G@66.',
MMENPT*?%7ALU%'KM-JCO2J#T(HQOK?-<3',W1+=JSFF(&=*"#6X]A9UA+[<-
MN]U ]?=#OK7V@[K:@]YG\98K *TPVQ\:;V_ON^*QFD;PAQ> *KF$>YR:2QB^
MNW);F-:?C/'HX5V[7QK>[O %I'K?(=[PTK+"2ZW6GC\FT/!87DOU+X+J^V:_
MOW^0E$]WF^VPE[\V-S&NK9N^8[K'<S-$6VG??(H9F-/O""3PX37\2J/K4R'&
MWRKW;1WG-E1CC<W!\_L\6R6^F9/;>^J&FV;0'-UDKY7U=YM)):URWGA5R[*:
MXZ%I5?/FTTM3FP/LKUZ>YUJU&OGC.QXW4]^*I_&J$/AZ@?[)VS8 %'Z[;]]A
M%YJI&;4\U/+0T_/0P)R4^MCO,P\5K8O]JW\IA+O?Y.'N;N=M,=Y=J '8+DB^
M5:J^<16DP4:"LYV7OYC=SJW5,EIMS38?[6^F0VL?Q.H8>]!S2M4Q6/E26_#"
MZU55*+-@=14$,2\0'\6/4M:WJB,P1!G!071X2[&"I4TMBKN=#+O#7E?UAC4)
ME1O>*17QP/CPA!MG/(1Q$;C(96L!Y8WB-(B]:TPTX5J(%$8UPOG:6ZT):-2$
M:>(\<3)V=2D0SC:-W+E& O#.K8OK]ZR1MCI.<*EHCF;23 ^BRYL'['9@1$<?
M,"'<KRT*E6#,^1I364#F1#%*"_7'4IG45H5/5#I330@F44)E<49?.VN]0"-;
MSSS@WM3U5DG*?8'AO_%\W7C%_TUO._GKYRG\">LW@N@R\+N=,$T6Q!BGI\<F
MBDF<_8*( *>C"CV(=N!?X/")G?"U6Y>+<[QO/<<.J?GV9#3P)O8@=$/7":W
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M>38'\R;&%'=IIZ%2.,<T$J0SV&_XYNJ:+X0L"+Z1>@8/Z%\2>5WH)DAB*NI
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M@?2C:L$W%6V[K6-UH5-UMT.MJG60>C(7>V<]8QE=)D@EV6KM7YNW=K-N&H&
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MCU__=:A$-4DW)V>.;B=_4?"(>&B DU-+=NXV*]$N=WY]1+U8/[O9-WB@P*O
M!:8QH]('!+90K'H6+%<*QG."D_F(]:;\@V5176))Q"-#W3"9$W>Q"KZ5MN?D
M^,/7P[*PZ':J%ZL)6HF!G6)ELM:Y  3FVWD*<OXML6 21QYPEP]4G2K)=/#U
M^.PMG,S[+Q\/-TAI%IP#A2-H#(I:K$TB>2CDMJ@I<%DTOU_/DNPB6OUI_-W-
MHB E#$>J2*(ZFBMCZ:8D-=^FP. &25KCWS# ^28%2T'B>G!4C/AXG#*X8%[Y
MP8GP;[TD!C/<TYIL_Q9'U">-2]C_ZD:A*S.P&08QPL%/4%NEJI;/ZQGPIAP9
MEW/ 3Q\VKC;T+B('$\VZ'<XTNTW<;"9("6[%1_!?N+8$ST%P8W\JKO(JQ8Y
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M,,S]XK96MLWZI%"["\[\7*TEKV^1-J5/RBQ82%*SQ&^A^QGCDJ!2A0D8-/J
M18=3[GE7X84-_Y"9AR1*\34Q,;BYSZ,Y/JIS=YZ+00Y9P877-4G'<"QXPUUX
M\VL_X-RQW-/#=U[D^Z"U@O6G!ZJ O<&RQ=H,ZG#S)EK.$TQ:5!_,)U>;[AS@
M-J5^=@$4A+*M=LCW[I54-U8HX2[<146R6MW+Q/V?TR1DYQCZCB4_L.F,8^ G
ML&%6,H>9O$]BGW0_N:E11168*PH(SN>N"%7\3MH]SZ;XL!2E19%(DM6+7DBX
M[TV*>E81QN6NFD3-C5_6%L@Y4ZD%=#N%THWA-KI(K;_+T-Q=& ,1B\MU<W&_
M"T%6E48.__5NGF08[%9%6*8N+KG2HYR)II3X$Y VOFOFBC1]#;/E2MWK9'VJ
M/M$\336C#MDXR3A9'0'S'8'^'\*>TISI*@2Z!B7$^%MP%647QE^3;(D';,)8
M<S]TTYG@$C(%UFDF,P#.5LE5P"U0==8D.U'<)C+?<2IRE66\4\RR&.@L9<"K
M['62&^BI!@OHFEH,N\8EG (F$&+J#TI Y<G.#1FE5\P3C[I8L L.6;W@@ZO;
M-YS6!YFCH@?^N"=XBG$!WB?TLY'? NS<\T#7#T,,:6J7WE4"/Q^AV2]MC@#]
M'Z=D,X\*>R/M:;C177+ G)[\ABG< 2?7TPV48<.L>: <!?B(6K\P\U1"'QP1
M[@*=%U=:LO&. 5U<-O"/5J@D[-V;?*&R3F(DL_4=<>"Z#C?*,UTK#YXZB$4@
MD=]^$B( ;X6B**6>)#FA4] P!6D?\':X7"2HUHMO:;LBHJ]5)(*EL-\B<L/$
M@K!#T!M$\VW8$#U+,DOFU'+N!*[JRTB09*]B5;4R@3R;^MLJ)DVJ(97LLI8K
M<THEWY1H0V[?RCC]?'*$72PDTZ+.<R(DB:S<@F<^',H(-:Y1.B5SQY*!Z7-+
MV$)LV(1JB"I6DP$D<>C=S@&FN![AE&#,S:BC?%[JK?BXA8\/#F7\D;\M'U2<
M=8#KQ2>MPWP#1L5"@,+Z*=Q6^/AIO(2EX7\@91B_XJ)PX1?:[O!*J]WQIL82
M%ZZO>%#KTJ</)>F(S!$0ZPN\"8G"<H\=7T+B)=%@2OG,*ND+CBM?OR62BNO8
M1U]^MW,B&V'3\J7*(XO0=4V=KAXO29>BDT'-PHO3Q:Z7J9KGAF#2>:';H<IF
M["J*OF/IQLV;K7##T9\X</,FHD:N<!87*/'FZT4<&<?XA&F<)6MT!\;&Z1P4
MG 34,NVNR2^F#X+;?^:*S,*(8!85AOPTQ^-7KTHCW 1M#A33^!Q;I^8?^9G=
M46__C96C!=?E[U%,<>+?4:I__6"<8)8LCH@O_,PFW]=DB67PIYS@OJ(>2O0\
MDF >@,7ZY0^)C^OD'^D$/[CG[I\PMX*4R8M(CO4DB9.+8(&N*]:-7T?LX3PX
M62] T5W[P:$H%I54W^T4='O,NH 1"V; ;ON49V^\Z8EO;75TE"])9W=C@\8'
M47(;7'^B$/) Q J(O(<,0+,'& <MCE8,O55<]]V.%OO$I]]F7L*B57Q'%!G+
MTE7=;Y\5W/TBH(G:$<A[#A4"P2W QD6#% 6M'@YS/5"T,DUW0<.5E9?C+'(U
M5 #RI^?E-.^CLFH9BM@%%U@)G0Y+56)1$_[/?QG_9)6RH%YZK.*)* ,)PMDZ
MFONBSQ6O)1/E5AA8R ,5<OHXU>+F>\F1E*\4GUS.M?B&%JX!$4 AJ*]Y.1U?
M()_A9OT7LKCP<M/ 5? &6OTQ17!$);8RSG\'VQ29N(K'BX;[YR".L^OY)=;O
M?-=L2OB%W0X#&-Z//[7,A4U+M2I1I,(6IG2(+5SB0[-NT!TS1JJ&4%:TGIRQ
M848CI?*VY:L\XUK]W= )?HT0.UIF U"V8Q$'@33FH2$#?FH3I'V2KZO?5T^I
M_+?^T'R8N9(+X.\)O%.&-:BJZ.62=5'76W0<]ZLGM.-,/IZ>O"UFB16J8MD]
MK!M1IW&&W,#3HVP&T<[59"B*4-=1\^F;QL7-*<Q@6$E)=,M)RW1_Z<.F;)E4
MS5FZ3(+XG/RR4<&K+-T4&Q4E*E-X(4I85+9KOLN8 @@CR@G R-9T,BP%-4^$
M_HSI"9B, 8:DR!Y2?_C*':^IZ3O3&6Z8_J6"I\8523N4.:+A$1T4<L[=6*Q$
MKS8^43?(>_?J$/]Z1C&#SQ)!Z(/KSI-5S:>-XI=A3^[U:="$YWA!:;%VC0<T
MCU:%1$$/%UG\IMYW-*5.HO),JSU@V4V+*_D4JJWSSU@%_Y&R78E12TY)XB.<
M7XY:4YQ7R5.AO)KE]6DN(LU_M^WDNYWJV7],9A+4AFR +W\MY7^>!//Y&:79
M'\N4;RD*/B:HY_R3BCW98%2+Q\PTOA_>?3(.""@%FQ,?TFX<IZO"1PHI]U52
MJWS<7S5">L?NLM3X#875._A8FF"O^.10F\P&=X#"?!<:_:OK@[GF7N0N#CTY
MK.:ZRP\_V"!$K LN'[Q^<OCN"IMLRY:A2;SAPBV1P%)MIJY@W"(A,-"TY1Y4
ME+=QAL0M"<;Y\O10(+X%EZAZ NUN+YFE;EZ?52;OJE%0<?;6@@5-BM6 &FM\
M^H^)SLMT"5;VJGRE@DG@NR*2:QSP/0&;]L']!O;"1;0X.CYW*5^S\-:A:;P]
M.44T!+ X%F(@[M1N?(H#Z3AY_<\OI8OSJPLS=EG?6L>BWD3^#6VD>01[+AU0
M,'[J^L9'3D0#,;_5/A^\ 8/\XV%Y[^HP)+2FTQ7(0S"%HQ+@PS.I\2^_AMIN
M:Z@?!^GT.*5, (;^ Y4+M$02<V]E?IAN9/ULO.-4T2_!G./H%]&R<6"HO\,U
MDE)H#MVS+N9VKQ)1>"I_)_B&),1?K[N=RX1Y'/F>=\)=)"CKP1#+P)X/4$
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M%[G\BX!*PSE[+HFULD=[*AFT[(?A\[P,J/I%9K]15BO]3BC=-]6V421G(X6
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MF'K?#C?8=\5M FMM0GZ<QZ+(0/<:W\)KP'MH5G"014R,PV9FU"95N$>LV^^
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M,7C+9/%W>@^^'/?1KU2]G/M073=^>OU:%%%5[E*'5*';>&V,E+=F6#&^M3/
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MK/:$%?7PU.\TX( 39T(":/<XGYSS_6NOKDS+K,@+762JWW4X4.@*'&3W 6W
M-"2Z-:6ZP6O!A<AH82(\GBU)8#7F]=S_:-I.5?-\^_P"KT7<%/@Q'*A?N'$
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MV*'GH5>ZTDX%D%;NJ3YRA_"3<T9ZN$:7 G4V&"+XMKOA;H1_I# ^;1.@T)%
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M\3199!7P_WU9O>]YE#U!?$?2AAQB<(-3+_]_]MZTJ8UL2Q?^K@C]A[PGJFY
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MOKI/9GXO"J)VIQGT7_'1+R_V$3/ :!&C4'.^_6PJ+>UB[C!'?;>X:1;=/M!
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MD,@YF2B1BPJ(U>;/T!.89'V.-=7X)U_WFM14$Z@!G-((]6!$SD.0GE)YM%D
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MMP'G4P<9!1)(?*A08TY(*5\\&GP;7G71;9P1-FG_+KM'+9+)9TAED"%W[J^
MVUTMS'6$2=43[W<_12@I,+30[T[E=\>></%;5YN_TU<MMU/G=I2^3VZ7T)@
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M;W5>:XPD8(=T0:QPN.@ YSO^[G&;R=_4I!)$ZDU)+=I=SLLC2"@F#2O)A)=
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MT7\RPXOXA*LT_H3L<@"+3O4 .::MD7O.G!A0KUPAR -P+!PH#,BR(1@@P$H
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MN=\EWS8%+5$*'V!@00^%)[>O4_0&QC8]5K'I)6WG1[!?1K&BRIIA"KIC*(H
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M[T[P*]*?"9+.SJ_S3][BY<3QZ11KER;%*"/!%)+$M>0I*O1,[X0+.(!P .$
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M_:BZ9@QPOUB@@?/,L/:+!1J.FF<.VJYO046X>$6![4:5]M]A$$!O'@+7F_O
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ME#W _6*!!LXSP]HO%F@X:I[AL8!V8@&N9P<(A@B\QRH@_>L#27(B(8)1%"A
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MJXL'& 1(8M!]WZ(KII;G!S2$Z]A+90$^,<,7]> ?$S_PV$+WR%.&#QE+/#?
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M'#T(\51P[@;4L;Q12:]-)54_!=JW\NJ^0N7U8*&<1*\,?UEP#@\R-J;)GMQ
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M)RIWQPDMA=W'G^]1M+HE8J3 (GKR9I\AXR1+#(K&B\[0V,\%7QYD/,N\H(T
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M+,J*BL70#?HIDB>FNN6=K$(9J3U5RRF4CXS0O2S0]Y]9,'--_VX:Y[_^E9E
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M,+8"FVMSTO6/])B6[!8]T6&U(LN#EBFUG/IB80L(0QW>PPSY,H@VM"7O*/O
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M]"@"?+AAAT1GNC+!V"N0(2@W ^UQ9>JY\]3<E#FLNF$M=-1\*R:XB4?>ZXU
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M:Z]%_ET5.HG:B2?1.O8,!CS.H6AN->TMT(#31'00EL$26]<GH."UA8K1)$O
MD8M\JZR?5.13K2G+U;JJVFNW^YUAKZ24<864VVE%8R'?9[=MT]*)LHI(CIE=
M3'<G5A-95A6Y.J"Z]S*Q792\K(E^'*=8+//4_N'*Q>I9,):LT=XDL+7OS=U-
M3&OEB47#8@=AL0-69-:3Q32EK6C*1M!FI\)=#8'5A\#4UTA@^Q3?90A.NQ/B
MA]G^AYGK!1<$Y,.$M:],F,.F5K >826WW#LCBGTE FW*_95W^27R;E,TL*.(
MWV9']KXC^Y17W$4=]#=*\#W"*?\'(7L(>.I)-WC7$(PU>\SP&/]SH2^/)YI>
ME*1=XV?M)"6\IGDAO:ZJ=CJC@CKLL6%X(3/_)BCMBG=NVFM:2$][&>#D?LCY
M2&JEX:83YJ;!UMRD[HZ;!IU7S$W'<&%B6V'/0:I]E%A$:;1H/X"=X+FVW5(F
MKD/ K&A'/.N/FX%<[8E"#E@*O#,[=Y]=$78UR8.@:]=<,N?A&81D?M!MW;.8
M?P@[9]!Y&0K#MGQ7-W#M%5-M1$0C(HXE(LJ,M_4B8G?&F]KJ#(>-D)#OL?_H
MSPM+I.IW[+CK@J4#ERP=T/'<?0E0S25<'O6D/)_I$/:0VM+Z:AU]U7T5!>UR
M1@TSOW%FSIDKVS#S+BV7T5MCYA4&2DDV:V&=7W&E7UG]7V&[H":SNUZ9W1_>
M4F;WO>L'%SQ7 A&#HFR)HV5Y;UL?<9"F6]U]T=Q]Z/FA#NL?N,J-[^G,_K.O
M/#!LL>083+G7E\JM_MQ2U%&_TQ)76%&.BZ]@T1)LGQ78S,0Q_.C6!=S*_@AU
M&S]V':;,$7D91O?1,^:19:8;,^HBA:V*8F)H*?"=KBQ<CQ1:,&,><Z>7RMBV
M\<)$[RT8+IX+LYD1\&E,L,F788<F_,G[(STPKAW5KARBY"V5\[/XVK-W\%3#
M "L!.RO!P/%7K;)5<!U[B9?2^U)',2IAP&9D ;R5[(8UO.QT?A%SL;SH:KXZ
M+66NF[)1&7R+.EMYMH(9?.2'?-8&+0$HZDM%PF[A#3I-EZZ@&Q(O[C'1<"S1
M:6WJN7.%?N%0<:D-3#:8PIOD_I<M'3S>8_X"GLA?S(6'1:OTGF\D[#MKX51T
MZA;F^RS@)PIV;'K0@F)7M@4,AVE]INS9)F ]%'_&6)"3ETW9TZM5CE=O23FN
M2B<\.07YJCF)*^:3XJ1S-5=A_(I9Z5ZWS#@#SM27I\= ![$P]];6]29ODJ B
M1TAD,'=DC@L:$1?JJ*<JY_CM6?+SLW>M4ILO:W_J(%B\0 =KP0FII@KLD$6.
M!%89GY=*R8R34R*#!?,K]<6".:;UL\6QT?VH?VQLLNB/'F/"QPF>&7-2]A?>
MAG]'K\3?-9Y]>N((%4!SAG=]GEGP!O0:D9:P_'@YX/<)F'MHD=*88$E9KH=9
M'<("EG>]T(XJH*-72\W?$LL&-CIU*LYL4;3F,]@ H#,P>A6',5/DS4ARBJG9
M<!V?O!XB(3H^I"MXGV"3DT&(J3<9,H8W#R?_1&L;J 'O6'CND^6+7K19FKU4
M</+IN88!6-S_@G&GEN<'Q$W<:C<\9EIH=R.GX$@&CP9RXL.)PJ-]\._@,SOA
M14C[/ #WP)\RN,?D7_+I ?WQ$<XQ'5DYN[WY='>&*V;YZ&DY\=H^SUQ@95K*
M9]?[@>[7A'P',6?RQQ(.08Y3^$*:*8Z 91)>3?1>B?MAB>5RI(9JW(R,!GS-
MQI'VEHPC$?0'IO#0[3YERZCNBN,3-J9W^&$("A://>H\JN2E-P%GQ90O;L 4
MM;]6].2@8%; ]Q6 ]L6X/BNW0(R001KZ-15%B+""&H"]MP6P-VH ]AJ O09@
M;[.5:@#V&H"]2&EN#:K7;0\Z'76@9I,Z;AS#G;-O^L^/EF_8KA]ZNT"9*@#4
M2]LB1R_#)X2]009A[^;+U=WG:^7;^'^NU^'H-;AZY:8[G_3K/6!Z4[AZW^(
MU"D[?2>8<'$U8\:/BRM]H=P&YB5&IP+])S-%Q%ED&<AS=OA*L?7G*A BC1Q2
M7D<$2GU+<NC*]18N9<0@J>,O9,MQ^C]ER;2K<-1@C^<84LH8N4W /< PO:^
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M^B1"5X/^+[MES7T$\)(!?GX^17&'XPIC$8;]);_"6&JMM;LM1>L,X4>O]^Y
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MI:)WOWDZ5FY]A05TPL(6H>FBE76GC#>^IS/[QG'<)][2+P3[UK."Y6?+L?S
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MVD$:5;NK$-S@XPC:C @31#I929^$6SE.([H5!5'PMH>EP[Q'#E1FDH%(C[Z
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MNOLBL'$$D&0*#*9@)O%[+<S^DT$'/QVW)6P(D(F49+CDO::7"MA0%.NUK4
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MP-[NL3=R;DN:(*<"EZUB+X E@&7AU@WEHA^1"\%OSYJJHSZ+>>D9$6'L^_M
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MM(Z;P;$^@X9R/\C26W$;:X>3V9:6M?*X)]=Y)0R /3ZD ,2_SL$D"4)?=*4
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MI$@>Q/\S/TN1-6IH(>E1R4C"/:22IL\N/DZAW)G(NJ(IY92-,6U[/05:HC7
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M26YFM:XDLJ#(JIYJ]ISK*6NZ4VWT!LF*+_MC&K%7J]33(_FN&,FH8*CL)X>
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MLC^7EXTX*Y67ELA)(Y]J-@]$4B1<MI(*2+6K/U1Q=$81S-[5M()<P\+#A9S
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M0_N3K&,)-:;E:@M%?B/JQ<F*,X65NS+*N("$HT7"B83\:@%E4<A/GHNCR<H
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MQ_QWA\+,> 5F>'XOR$*I8DRFCU0SY/9*S^M9D^CHJEF&10$3I/X(.C1,R_T
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M'8)#50_V4D["3 4<,_O<;X^*,99J_IO>G8+#D-JZM[Y[]FS179#?'*XI8$X
M'2<$A0/A'NS@2'=P:E+@7^3NUHIYQ <R&S.973P_N]8S,K-/A\Y C6"4MT (
M CJ!$ 0RZYW,3/3<YO,)B4"@L@&HS-[L7'OCV<O3H3-0M1CE+5"U )VH,I!S
MGDX'GH#0!B TUWHU[8V]>08Z SKKD,[0\^U/2*4'58M1O@)5"Y I^=/Z8;E+
MVSLA< (R&X#,<&H>3BC?=U#D"90&E';X>?87>W,Z) ::%J-L!9H6 %/R)YDR
M?#K(!#0V (VM[2<@,2"Q+DEL]^+L/7.S\MZ?#J%UK&5!=4R;+ A%&[=[7*?!
M/'N>0($1D&J1M6YON+^P+TF 5(%4,:GB8<TC4'Q.@%R+[MM-<YN*BTAUL>F0
MB>@LD]GE(U4Y'F.NCRF&'(+=Q,GR6=-#3>!@2[I]UR9.08M31:PX^Z_(Y.F=
M7H/>%)RSWWD[9!\CNN#,'?=H/=L;G&&$&Y9@\<$\4?<P-"AS1?V.#6IK&6,<
M'"2*"T$44UU8J+U7+ES7W#R31M._OAT^\L5\PR]=?#?=54#]=P?B]XU06O?"
MHVYE'KZ@%V]3=G/[J:C#O*S,=*.+OJ5MD^9@BA>P\4FPL838.#77LT4V#JO>
M+OR4[.L@78@$LTHP]^W-_>*+Y2[([:*FA'R<VX7"X3'S+L9) *,#H[/%Z#E-
MTU1107R>FNE)N.JQF,\?*_/YUS Q_O*0N/5@N:]BF2YK,78^]ZSEA]7>Q9KO
MNU^,N2 =M\8$3@9.GAHGYXML%;%R:F1GBR+[)JSM_">N.J Q;-U^P4_V#VMU
M_G\MUWGWR_E)R>2NW2-3\X($G59'X^SH%^ '\CZ/ 1PU!(ZIT9A-P?$W3(W>
MS099(K:S^LUU/*_2<)4Z+@I%GXE2%Y/)ZRH50VLU4[S;*%D,CR%(C:,L9#&O
M$H]5=!MDLUX)!X)8P(G:O),)1\"'[-RM A]V:KC!V<+9#FY+G$RH%:'^DV6/
MR<P S\Y8/3MG950KB4>J56KT;U/KY9-/YGMD@EQL5M<_MK9+KA I6YW;,H(X
M$^7)!&%&A77L)T$!MHT=VTI!&PXTIP;9=@YM+-F1BC'GM:F (,2O1H8$@VP/
MD!*0$G.D!+&X:F9RV.)I/&;RB;NQ6%'Z-%Y#2E4ZNQ"/8KSQO+VUNMJ[]N;9
M5]6(9N7%YS2&VEKK!NI@>0@#6Y_#U'$#5S+&E09B('HN8), 7LBM@]A>_'08
M?/Q,P2P+CB.^P_1NP]F.P_:H9_BV6EG*2@FEM5E!\>2$5I0)"O66R(I>IDKR
M0I#X(4HJ6XGQ&<),-WH-\C4GV,&%-CM<Q=Z*)LOG*N)S@9V:RPY"79(REUC*
MF00H&/>*1@P%>569DH:0(&JBL'RQ_AR@)//AQ;5*^6,RRS+UN6+T6)8)O#[I
M%8V8U_/%OHZ8O?56"_^T/,SB)/G%6J)?'QS\4@P&HJGH$ZSK9 D*1AI6AI@0
M."W'O-MPMG"V<+;CVVTXVW%H&Z<<2 HRW\S'M06!I.FM:*J6ILPC2[-Z@D^Y
M_![,#)T&DA1E)BHL-;X A]*X5S19-A<0F[?>""S&YL/'D31CK@$4C)7QV%O1
MB*$@+XXDX\P1>M>K!J&D;"3("B4)C<)(VER",-)(&8N]%8V8U?.EOH)XG=Y^
MJQU>3X:)J"P-<:*N/#?TU]%7\,ED?.MOV_ Q7TWWV=Y\('05KF5+_5:V.P+[
M9@@A6C^6Z_TJ\Z:Y0:6LQXM_:[E&J(^/XN6CO^[SG;/%:P__]'?5?YK<<5_)
MMV,7$])7$^3MCS@VK*VG$I<O9. FR)"\PH$ ^1F'_WWO>\3(VXCR$#>M$SXR
MF>>S@2;X3/QK\0N]^^43=\[168W^L]K5):F&HRSF+_.)\<6-:H?]^5<^X_+H
M)&-$%' SS__T,:!%/$\I*#'V)V516EL%;\2(1J90X(^/6Z3VG#^ZEOGGN?F$
MB.*#N?YNOGGON+^&2XT63"%$*E5_3%+2QSS:X7SBX>+4PQ)!EO#B7O[]^O)_
MN<N++]SGAZM*%)#)F66 8X0[=7OW<'W//=QQEW>W]W>?;ZXN'JZON$\WMQ>W
MES<7G[G[!_3"[]>W#_>CW\:VMRYHMO7'_'[.K9SUVG0]SMYPT=#I&8?$FK7=
M<<0SR:&7N*WE!G^MS)U9T"\IQNG^SVTU;B^S,?F2.UOBYYQ1>6S)($=.$)"@
MN/_[Q=?K\U\O[A$Y7M[]_N7Z]O[BX>;NECO#AN#\L'=92\^+@E0,"E7;FZ(]
MS=&'_AK3A?+5IB-2P*K%!]G M\^X*='J.%^H$<_8TEJO@Z& T=]8Y0S_3G!+
M*+M*$M:QN#E2@@+YJ?,_9>]MA_%&&&'>XK#=H4:S3F]*+%]PXY.?:OQOI'_C
MP+BUXJZLI87C@IPD()N9%P7F@^1=4G#'"1H30,<)0>% N <[.-(=G)H4".-#
MS",^D-F8R2PJ93D=.@,U@E'> B$(Z 1"$,BL=S(S_1P<H#*@L@ZIS ZS0$Z'
MSD#58I2W0-4"=*+*0,YY.AUX D(;@-#<,-,9Z SHK$,Z^X9S;4^'QD#58I2O
M0-4"9$K^#*>_G XX 9D-0&;+0R494!I06H>4=O87>W,Z) ::%J-L!9H6 %/R
M)^FK<#K(!#0V (VM[2<@,2"Q+DDLJK4:P>CYD6A94!W3)@M"T8;?OXUY]CR!
M B,@U2)KW=YP?V%?D@"I JEB4L6=K$:@^)P N1;=MS*Y]M*DJD,FHK-,P!,_
M'S'%S^G*\1AS?2S5(Z=K=A,GRV=-#S6!@RWI]L4F3KBF,OW5FIE#@S4G9V>H
M[:/U;&]P8A)T))_0BB;3M/#'H[L.NG\*O"!+DB+PLK$XZF4HB@M!%(>8>,NW
MT:A<GBF"RE ;P[1H88>RV>,U]E9T:MPO(>YO?2!>_3FXQYA0HG^Y4  1AC*7
M "!&RH[LK6C$ )%H7UX2'Q2$#_0Q)KT.R!4I6"%$7<V%PN&XFLQ.5W- @'&O
M:,0(4$M%4!$$M#[B) 8!A3-QA:GU.N\5 9HZC12%W+X7IU'R7M-P&CTCEAA%
M1XI\H"TXF@&@?X 5587^@B6R!?TZGX)^#4$_?:9- ^C_#3.$=[-!=IWMK'YS
M'<\KH]TU\A,9QLR0E#&* . [)E=T:DA@("2@3[S)0P*O$A14]!5E(T0+7B-1
MG?, %R-E3O96U#)<]#P?F\%%PHJ UOJVA"%]HIDEC 3NDV5/P!8&-^A(W:!G
M955@@1>/56")1RJPWK8Q_,GGB3VR:"\VJ^L?6]LE5XB4XLY-8WTF\E/,H!@5
M1+*?1LD> +&WHC%"8A-$Q,DC1N^(R)*;P!#GQ@2Q\S38E;T5M0P@;)AN<+),
MK@AH+6N))Q,PW](5A J32NM,K2VCQ(0N@[#SW<%ED#V1-3B[2?OVV%M1R][&
MT5)LOFL!J<V\+.BB(6BZ+BX:>1QVSO+/&\_;6ZNKO6MOGGVMF"BQ'GDS8)Y0
M,>[>A2 I.;&R01BV+;]R/5IXWZV6SPSOL[<B0*/ "= ^&-4S]HLR $*08M*Z
M%\2\)(!1 ]MIP %[*X+@[%1/EKT5 :UE+1$2 =AHUY/16,':K*"EPH16-.FX
MF"BD5&5Y(4C\$"T5VC#F!5F9Z<8H<^6!V9A<T:FQOXK87V"GIT('AK&LST4
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M$T#;C-)V[Y+7#;.*3D?R IT-0&??< ++Z= 8:'>,\A5H=Z-#II84JW#&Q[2
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MR14B':Q[RV>F:;T:/ETZC4:%@.PG:0'BC1WQF@ >#GD;O0,>4T:GH<XA)P8
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M%!Q@;:\'6J% B4B4>7^#.%-Y853.X1$AU3@4:4 H%A#*6 AZC[GV91"*#1^
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MO,6L<&?&G$T6SKE-+@2B8X_H4J,S@>B Z+HFNM0TS*D170_ZQF24BY[XJR\
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MQ>I$@Y1AC>A8LRJ!!,]PB',;B7#*7F:9F#!!. J5:)5HHUG6&X[9?K^MA[X
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M%?,5]-0[%4?L/V&L.3$*$.B]T;#9DY-B-AZ6?"+Y1&@^8:Q&,8HE:+U)P^F
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MP\1EH%_AVJ;GGCDN[XFH8 B#B\0^X"WTF+=E!R\)LDI!3Y8@(VL N$&?,-9
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M'OR;]//163S#/RM_;;U'_P]02P$"% ,4    " #]@W]6%\'#0? =   E<P$
M$0              @ $     8VAE:RTR,#(R,3(S,2YX<V102P$"% ,4
M" #]@W]6B!OSAE\,  !VIP  %0              @ $?'@  8VAE:RTR,#(R
M,3(S,5]C86PN>&UL4$L! A0#%     @ _8-_5E 7Q-%J0@  #W4$ !4
M         ( !L2H  &-H96LM,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    (
M /V#?U98T'7A[^X  )VK#  5              "  4YM  !C:&5K+3(P,C(Q
M,C,Q7VQA8BYX;6Q02P$"% ,4    " #]@W]6 ,B@B^Q=  !A2 8 %0
M        @ %P7 $ 8VAE:RTR,#(R,3(S,5]P<F4N>&UL4$L! A0#%     @
M_8-_5C_3AN1.E@  :V\$  \              ( !C[H! &5X:&EB:71?,2TQ
M+FAT;5!+ 0(4 Q0    ( /V#?U;/*@;@ZP<  *\J   0              "
M 0I1 @!E>&AI8FET7S$R+3$N:'1M4$L! A0#%     @ _8-_5N&<+]\M"
MS2L  !               ( !(UD" &5X:&EB:71?,3(M,BYH=&U02P$"% ,4
M    " #]@W]6I0O<<MX$  #T%0  $               @ %^80( 97AH:6)I
M=%\Q,RTQ+FAT;5!+ 0(4 Q0    ( /V#?U;_X5)ADP,  "4*   0
M      "  8IF @!E>&AI8FET7S$U+3$N:'1M4$L! A0#%     @ _8-_5N1!
MS/4Z$P  +A0   H              ( !2VH" &EM86=E,"YJ<&=02P$"% ,4
M    " #]@W]6/\9<\(!A  !4>0  #@              @ &M?0( :6UA9V4P
M,# Q-"YJ<&=02P$"% ,4    " #]@W]62,Q0'UVL 0 5[ $ "@
M    @ %9WP( :6UA9V4Q+FIP9U!+ 0(4 Q0    ( /V#?U91O*;X&W4! )BF
M 0 +              "  =Z+! !I;6%G93$P+FIP9U!+ 0(4 Q0    ( /V#
M?U8I&>\R9U8! %B- 0 +              "  2(!!@!I;6%G93$Q+FIP9U!+
M 0(4 Q0    ( /V#?U:<>&C@JJT  /\" 0 +              "  ;)7!P!I
M;6%G93$R+FIP9U!+ 0(4 Q0    ( /V#?U:G[%&'/&D  -/)   +
M      "  84%" !I;6%G93$S+FIP9U!+ 0(4 Q0    ( /V#?U:HJ'8FVQ<!
M !A: 0 *              "  >IN" !I;6%G93,N:G!G4$L! A0#%     @
M_8-_5F%J["RBVP  +AL!  H              ( ![88) &EM86=E-"YJ<&=0
M2P$"% ,4    " #]@W]6SU(41_X? 0 T3 $ "@              @ &W8@H
M:6UA9V4U+FIP9U!+ 0(4 Q0    ( /V#?U;X$!AA,#T! *V: 0 *
M      "  =V""P!I;6%G938N:G!G4$L! A0#%     @ _8-_5J&4U 55;P
MM\D   H              ( !-< , &EM86=E-RYJ<&=02P$"% ,4    " #]
M@W]6=QU#;2++  !&%@$ "@              @ &R+PT :6UA9V4X+FIP9U!+
M 0(4 Q0    ( /V#?U8L*Y0H$KP  /D+ 0 *              "  ?SZ#0!I
M;6%G93DN:G!G4$L! A0#%     @ _8-_5E$ 7<T$_P0 ?S4O  T
M     ( !-K<. 'IK,C,R.30S,RYH=&U02P4&     !D &0#3!0  9;83

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
